Citrus Sinensis ID: 007248

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-
Protein Sequence
MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSSSESSSTHSSDAHSRSRELTQK
Secondary Structure (PSIPRED)
cccccccccccccEEEEEccccccccEEEEEEccccccHHHHHHHHHHHHHHHHcccccccEEEEEccEEEEEccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccEEcccccccccccccEEEEEEEcccccHHHHHHHHHHHHHHHHHHcccccccEEEccccEEEEccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHccccccccccccccccccEEccccccEEEEEEccccccHHHHHHHHHHHHHHcccccccccEEccccccccEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccccccccccccccEEEEccccccHHHHcccccccccccccccEEEEEEEccccccccccccccHHHHHHHHcccccccccccccccccccHHHHHHHHHHcEEcccccccccccHHHHHHHHccccccccccccccEEccccccccccccccccccEEEEEEEEEEEcccccccccEEEccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccEEcccccccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHcccccEEEEEEccEEEEEccccHHcccccccccEEEcccccccccHHHHHHHHHHHHHHHHHHHHccccHHHEcccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHcHHHcccccccEEEEccEEEEEEEEcccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEcHHHHHHHHHcccHHccccccccccEEccEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHEEEcccccEEEEEEEcccccccEEEEcHHHcccccHHHHHHHHHHHHHHHHHHHcccHccEEcccccHHHEEEcccccEEEccccccEEccHHHcEccccccccHHHccHHHHHHcEEcHHHHHHHHHHHHHHHHEcccccccccccccHHHHHHHHHHccccEEEEcHcccccccHHHHHHHHHHHHHHccccHcccccHHHHEEEEccccEEccccccccEEEccccccccccccccccccccccccccccccccccccEEEcccccccccccccc
Coil and Loop (DISEMBL)
MEILSQLITANTHFAtfnlnktpyvpiyALAQCHLDLSHTDCLLCFAasrtklprclpslsatiffdgcflryDIYSFyqesvspslddvkcsaenatvenenendavDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWEslgrdgcrECLDKAGmrvrrscrmrkegrgfnagcylrystdkffnhddetgddrgssRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKAtnyfnpskklgqggagsvymgslpngtTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLgcsiegpesllvyeyvpnrsldqfifdknktkLLNWNKRFNIILGTAEGLaylhggsetriIHRDiktsnilldkdftpkiadfglarcfaadrthVSTAVAgtlgymapeylvrgqltekadvysFGILIIEIVCgrrsnafsqdsaspLQRVWTLYRsnklveavdpnlkddfpaeQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNkvceiptpsqppflnssvmepgnssrscsanSFISNVAKRIEVSysssesssthssdahsrsreltqk
Flexible Loop (DISEMBL)
MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENAtvenenendavDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKagmrvrrscrmrkegrgfnagcyLRYSTDKFFNHDDetgddrgssRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSnafsqdsasplqrVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYsssesssthssdahsrsreltqk
Low Complexity Region (SEG)
MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSaenatvenenendavdGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVsysssesssthssdahsrsRELTQK
Disordered region (IsUnstruct)
***LSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESV***********************AVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNH***********RLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQ**ASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEI***************************************************************
Disordered Region (DISOPRED)
*EI****ITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKF*******************IAIVLSTTAFLMLSLFAAYAAY***********************CLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPF*******************************************************
Disordered Region (DISEMBL)
MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSSV**********SANSFISNVAKRIE**************************
Disordered Region (DISPRO)
*****QLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDD********SRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSK****************KSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSS***************************************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSSSESSSTHSSDAHSRSRELTQK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	611	2.2.26 [Sep-21-2011]
Q9FNE1	651	Cysteine-rich receptor-li	yes	no	0.890	0.835	0.599	0.0
Q9CAL2	646	Cysteine-rich receptor-li	no	no	0.903	0.854	0.523	1e-165
Q9LMB9	615	Cysteine-rich receptor-li	no	no	0.844	0.839	0.5	1e-152
Q9CAL3	649	Cysteine-rich receptor-li	no	no	0.882	0.830	0.459	1e-136
Q9M0G5	625	Putative cysteine-rich re	no	no	0.864	0.844	0.386	1e-106
O65476	662	Putative cysteine-rich re	no	no	0.756	0.697	0.369	4e-90
Q9M0X5	675	Cysteine-rich receptor-li	no	no	0.906	0.820	0.336	2e-89
Q8S9L6	679	Cysteine-rich receptor-li	no	no	0.883	0.795	0.340	5e-89
Q9SYS3	654	Cysteine-rich receptor-li	no	no	0.888	0.830	0.364	5e-88
O65468	676	Cysteine-rich receptor-li	no	no	0.906	0.819	0.345	1e-87

>sp|Q9FNE1|CRK42_ARATH Cysteine-rich receptor-like protein kinase 42 OS=Arabidopsis thaliana GN=CRK42 PE=2 SV=1

 Score =  676 bits (1743), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/567 (59%), Positives = 412/567 (72%), Gaps = 23/567 (4%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           M  LS  +T    FAT +LN T    IYAL QCH DLS +DC LC+A +RT++PRCLPS 
Sbjct: 61  MHSLSLKLTTR-RFATESLNST--TSIYALIQCHDDLSPSDCQLCYAIARTRIPRCLPSS 117

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           SA IF DGCFLRY+ Y FY ESVS + D   CS       N+   D   GF  S      
Sbjct: 118 SARIFLDGCFLRYETYEFYDESVSDASDSFSCS-------NDTVLDPRFGFQVS-----E 165

Query: 121 NVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGF 180
             +R+AV KGG FG     GV+ALAQCWESLG++ CR CL+KA   V+R C  R+EGR  
Sbjct: 166 TAARVAVRKGG-FGVAGENGVHALAQCWESLGKEDCRVCLEKAVKEVKR-CVSRREGRAM 223

Query: 181 NAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKM 240
           N GCYLRYS  KF+N D         ++ GV++AIVL+T+AF+ML L A Y    ++SK 
Sbjct: 224 NTGCYLRYSDHKFYNGDGHHKFHVLFNK-GVIVAIVLTTSAFVMLILLATYVIMTKVSKT 282

Query: 241 KEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAV 300
           K+++ NLGL +     S   FKYETLEKAT+YF+  K LGQGG G+V++G LPNG  VAV
Sbjct: 283 KQEKRNLGLVSRKFNNSKTKFKYETLEKATDYFSHKKMLGQGGNGTVFLGILPNGKNVAV 342

Query: 301 KRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD 360
           KRL+FNTR WV+EFFNEVNLIS I+HKNLVKLLGCSIEGPESLLVYEYVPN+SLDQF+FD
Sbjct: 343 KRLVFNTRDWVEEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNKSLDQFLFD 402

Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           ++++K+LNW++R NIILGTAEGLAYLHGGS  RIIHRDIKTSN+LLD    PKIADFGLA
Sbjct: 403 ESQSKVLNWSQRLNIILGTAEGLAYLHGGSPVRIIHRDIKTSNVLLDDQLNPKIADFGLA 462

Query: 421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDS 480
           RCF  D+TH+ST +AGTLGYMAPEY+VRGQLTEKADVYSFG+L++EI CG R NAF  ++
Sbjct: 463 RCFGLDKTHLSTGIAGTLGYMAPEYVVRGQLTEKADVYSFGVLVLEIACGTRINAFVPET 522

Query: 481 ASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQ-----VCNVLQIGLLCTQAAAALRPSMA 535
              LQRVW LY  N+LVEA+DP LKD+F   Q      C VL++GLLCTQA+ +LRPSM 
Sbjct: 523 GHLLQRVWNLYTLNRLVEALDPCLKDEFLQVQGSEAEACKVLRVGLLCTQASPSLRPSME 582

Query: 536 QAIMLLTNKVCEIPTPSQPPFLNSSVM 562
           + I +LT +   IP+P+ PPFL  S +
Sbjct: 583 EVIRMLTERDYPIPSPTSPPFLRVSSL 609

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1

 Score =  580 bits (1496), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 300/573 (52%), Positives = 388/573 (67%), Gaps = 21/573 (3%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           M+ +S L+ A  +     +N T  + +YA  +C  DL   DC LCFA  + K+PRCLP  
Sbjct: 52  MDAVSPLVEAKGYGQV--VNGTGNLTVYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQ 109

Query: 61  SAT----IFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVG 116
             T    +F DGC++RYD Y+FY E++S   D   C+ +  T  N         F ++  
Sbjct: 110 KGTRGGQVFSDGCYIRYDDYNFYNETLSLQ-DRTVCAPKEITGVNRTV------FRDNAA 162

Query: 117 YAVGNVSRIAVEKGG---GFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRM 173
             V N+S  AV  GG   GF     + V+ LAQCWE+L R GC ECL KA +R+  SC +
Sbjct: 163 ELVKNMSVEAVRNGGFYAGFVDRHNVTVHGLAQCWETLNRSGCVECLSKASVRIG-SCLV 221

Query: 174 RKEGRGFNAGCYLRYSTDKFFNHDDETGDDR--GSSRLGVMIAIVLSTTAFLMLSLFAAY 231
            +EGR  +AGCY+R+ST KF+N+   +  D   G + LGV++A+  S  AF++L   A +
Sbjct: 222 NEEGRVLSAGCYMRFSTQKFYNNSGNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGF 281

Query: 232 AAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGS 291
               R +K + ++  LG       KS L F YE LE+AT+YF+   KLGQGG+GSVY G 
Sbjct: 282 LLKKRHAKKQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGV 341

Query: 292 LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
           L NG TVAVKRL FNT+QWVD FFNEVNLIS ++HKNLVKLLGCSI GPESLLVYEY+ N
Sbjct: 342 LTNGKTVAVKRLFFNTKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIAN 401

Query: 352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT 411
           +SL  ++F +   + LNW KRF IILGTAEG+AYLH  S  RIIHRDIK SNILL+ DFT
Sbjct: 402 QSLHDYLFVRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFT 461

Query: 412 PKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           P+IADFGLAR F  D+TH+STA+AGTLGYMAPEY+VRG+LTEKADVYSFG+L+IE++ G+
Sbjct: 462 PRIADFGLARLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGK 521

Query: 472 RSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALR 531
           R+NAF QD+ S LQ VW+LYR++ + EAVDP L D+F   +   +LQIGLLC QAA   R
Sbjct: 522 RNNAFVQDAGSILQSVWSLYRTSNVEEAVDPILGDNFNKIEASRLLQIGLLCVQAAFDQR 581

Query: 532 PSMAQAIMLLTNKVCEIPTPSQPPFLN-SSVME 563
           P+M+  + ++   + EI TP+QPPFLN  SV+E
Sbjct: 582 PAMSVVVKMMKGSL-EIHTPTQPPFLNPGSVVE 613

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMB9|CRK1_ARATH Cysteine-rich receptor-like protein kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=2 SV=2

 Score =  538 bits (1386), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 282/564 (50%), Positives = 361/564 (64%), Gaps = 48/564 (8%)

Query: 26  PIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSP 85
           PIY   QC  DLS +DC  CF  SR +L R        I  D CFLR+D   F +E V P
Sbjct: 79  PIYVFLQCREDLSVSDCRHCFNESRLELERKCSGSGGRIHSDRCFLRFDDRDFSEEFVDP 138

Query: 86  SLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGA---VKVMGVY 142
           + D   C         E        F   +  A+ NV+  AV K GGFGA   +K   VY
Sbjct: 139 TFDKANC---------EETGTGFGEFWRFLDEALVNVTLKAV-KNGGFGAASVIKTEAVY 188

Query: 143 ALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETG- 201
           ALAQCW++L  + CRECL  A   +R +C    E R F  GCYL+YST KFF+   E   
Sbjct: 189 ALAQCWQTLDENTCRECLVNARSSLR-ACDGH-EARAFFTGCYLKYSTHKFFDDAAEHKP 246

Query: 202 ----------------DDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRN 245
                            DR  +RL +  AI LS     +L+   A+ +Y R+S+ ++   
Sbjct: 247 DADQRNFIRSSFFPHLSDRDVTRLAIA-AISLS-----ILTSLGAFISYRRVSRKRK--- 297

Query: 246 NLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIF 305
                  +   SC++FKYE LEKAT  F+ S KLGQGGAGSVY G LP+G  VAVK+L F
Sbjct: 298 -------AQVPSCVNFKYEMLEKATESFHDSMKLGQGGAGSVYKGILPDGRIVAVKKLFF 350

Query: 306 NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTK 365
           NTR+W D+FFNEVNLIS ++HKNLV+LLGCSIEGP+SLLVYEYV NRSLDQ +F KN   
Sbjct: 351 NTREWADQFFNEVNLISGVQHKNLVRLLGCSIEGPKSLLVYEYVHNRSLDQILFMKNTVH 410

Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
           +L+W +RFNII+G +EGL YLH GSE +IIHRDIKTSNILLD++ +PKIADFGL R    
Sbjct: 411 ILSWKQRFNIIIGISEGLEYLHRGSEVKIIHRDIKTSNILLDRNLSPKIADFGLIRSMGT 470

Query: 426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ 485
           D+T  +T +AGTLGY+APEYL++GQLTEKADVY+FG+LIIEIV G+++NAF+Q ++S L 
Sbjct: 471 DKTQTNTGIAGTLGYLAPEYLIKGQLTEKADVYAFGVLIIEIVTGKKNNAFTQGTSSVLY 530

Query: 486 RVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV 545
            VW  +++N L  ++DP LK  F  E+   VLQIGLLC Q++  LRPSM++ + +L NK 
Sbjct: 531 SVWEHFKANTLDRSIDPRLKGSFVEEEALKVLQIGLLCVQSSVELRPSMSEIVFMLQNKD 590

Query: 546 CEIPTPSQPPFLNSSVMEPGNSSR 569
            +   P QPPFL++SV+ P   +R
Sbjct: 591 SKFEYPKQPPFLSASVLMPDEETR 614

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL3|CRK2_ARATH Cysteine-rich receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=2 SV=1

 Score =  484 bits (1246), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 256/557 (45%), Positives = 345/557 (61%), Gaps = 18/557 (3%)

Query: 28  YALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSL 87
           Y LAQC+ DL   DC+LC+A +RT LP+C P     IF DGCF+R + YSFY E   P  
Sbjct: 84  YGLAQCYGDLPLNDCVLCYAEARTMLPQCYPQNGGRIFLDGCFMRAENYSFYNEYKGPE- 142

Query: 88  DDVKCSAENATVENENENDAV-DGFVESVGYA--VGNVSRIAVEKGGGFGAVKVMGVYAL 144
           D + C   N T +N+   DAV  G   +V  A   G  +R + + G      +    + L
Sbjct: 143 DSIVCG--NTTRKNKTFGDAVRQGLRNAVTEASGTGGYARASAKAG----ESESESAFVL 196

Query: 145 AQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETGDDR 204
           A CW +L  D C++CL+ A   V + C    EGR  + GC+LRYS   F N     G  R
Sbjct: 197 ANCWRTLSPDSCKQCLENASASVVKGCLPWSEGRALHTGCFLRYSDQDFLNKIPRNGRSR 256

Query: 205 GSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYE 264
           GS  + V+  +       + +++         + + +    ++   A ++K S L+FKY 
Sbjct: 257 GSVVVIVVSVLSSVVVFMIGVAVSVYICKRRTIKRKRRGSKDVEKMAKTLKDSSLNFKYS 316

Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI 324
           TLEKAT  F+ + KLGQGG G+VY G LP+G  +AVKRL FN R    +F+NEVN+IS++
Sbjct: 317 TLEKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLFFNNRHRATDFYNEVNMISTV 376

Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           EHKNLV+LLGCS  GPESLLVYEY+ N+SLD+FIFD N+ K L+W +R+ II+GTAEGL 
Sbjct: 377 EHKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRGKTLDWQRRYTIIVGTAEGLV 436

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH  S  +IIHRDIK SNILLD     KIADFGLAR F  D++H+STA+AGTLGYMAPE
Sbjct: 437 YLHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQDDKSHISTAIAGTLGYMAPE 496

Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGRRS--NAFSQDSASPLQRVWTLYRSNKLVEAVDP 502
           YL  GQLTE  DVYSFG+L++EIV G+++  +  S  S S +   W  ++S +L +  DP
Sbjct: 497 YLAHGQLTEMVDVYSFGVLVLEIVTGKQNTKSKMSDYSDSLITEAWKHFQSGELEKIYDP 556

Query: 503 NL--KDDFPA----EQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPF 556
           NL  K  + +    +++  V+QIGLLCTQ   +LRP M++ + +L NK   +P PS PPF
Sbjct: 557 NLDWKSQYDSHIIKKEIARVVQIGLLCTQEIPSLRPPMSKLLHMLKNKEEVLPLPSNPPF 616

Query: 557 LNSSVMEPGNSSRSCSA 573
           ++  VME  + S   SA
Sbjct: 617 MDERVMELRDGSDGDSA 633

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M0G5|CRK43_ARATH Putative cysteine-rich receptor-like protein kinase 43 OS=Arabidopsis thaliana GN=CRK43 PE=3 SV=1

 Score =  384 bits (987), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 217/562 (38%), Positives = 318/562 (56%), Gaps = 34/562 (6%)

Query: 23  PYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQES 82
           P   +Y L+QC  DLS  +C LC++ +   L +C P+       DGCF+R D YSFYQE 
Sbjct: 75  PPERMYVLSQCVSDLSSDECSLCWSRATDLLSQCFPATGGWFHLDGCFVRADNYSFYQEP 134

Query: 83  VSPSLDDVKCSAENATVENEN-ENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGV 141
           VS     +  S +  + E +    +     VE+  Y+ G     +V K G    ++ + V
Sbjct: 135 VSHQDTKICASDKEKSAEFKGLVKEVTKSIVEAAPYSRG----FSVAKMG----IRDLTV 186

Query: 142 YALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETG 201
           Y L  CW +L  + C+ CL    + V  SC   KEG   NAGCYLRYS   F+N      
Sbjct: 187 YGLGVCWRTLNDELCKLCLADGALSVT-SCLPSKEGFALNAGCYLRYSNYTFYNERGLLA 245

Query: 202 DDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDR----------NNLGLYA 251
                  L  +  I +     +    +     Y R S  K+ +           +L +  
Sbjct: 246 MSFTKENLTYIFVISMVGVLAIAAGFWCGKCFYMRTSPKKKIKGTKTKKFHLFGHLRIEK 305

Query: 252 TS----MKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT 307
            S     +   +SF+Y TL+KATN FN S KLG GG G V+ G+L +G  +A+KRL  + 
Sbjct: 306 ESESICTESHLMSFEYSTLKKATNNFNESCKLGVGGYGEVFKGTLSDGREIAIKRLHVSG 365

Query: 308 RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLL 367
           ++  DE  NE+++IS  +HKNLV+LLGC      S +VYE++ N SLD  +F+  K K L
Sbjct: 366 KKPRDEIHNEIDVISRCQHKNLVRLLGCCFTNMNSFIVYEFLANTSLDHILFNPEKKKEL 425

Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           +W KR  IILGTAEGL YLH     +IIHRDIK SNILLD  + PKI+DFGLA+ +    
Sbjct: 426 DWKKRRTIILGTAEGLEYLH--ETCKIIHRDIKASNILLDLKYKPKISDFGLAKFYPEGG 483

Query: 428 THV------STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA 481
             +       +++AGTLGYMAPEY+ +G+L+ K D YSFG+L++EI  G R+N F  D++
Sbjct: 484 KDIPASSLSPSSIAGTLGYMAPEYISKGRLSNKIDAYSFGVLVLEITSGFRNNKFRSDNS 543

Query: 482 --SPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM 539
             + + +VW  + SNK+ E +D ++ +D   +++  V+QIGLLCTQ +  LRP+M++ I 
Sbjct: 544 LETLVTQVWKCFASNKMEEMIDKDMGEDTDKQEMKRVMQIGLLCTQESPQLRPTMSKVIQ 603

Query: 540 LLTNKVCEIPTPSQPPFLNSSV 561
           ++++    +PTP++PPFL+ S+
Sbjct: 604 MVSSTDIVLPTPTKPPFLHDSM 625

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65476|CRK16_ARATH Putative cysteine-rich receptor-like protein kinase 16 OS=Arabidopsis thaliana GN=CRK16 PE=3 SV=2

 Score =  332 bits (852), Expect = 4e-90,   Method: Compositional matrix adjust.
 Identities = 184/498 (36%), Positives = 265/498 (53%), Gaps = 36/498 (7%)

Query: 130 GGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYS 189
           G G G + +  VYA   C + +    C  CL       + SC  +  G  F+  CY+R+ 
Sbjct: 181 GAGTGKIGIQTVYAFVLCSKDISPWNCSRCLRGNVDNYKLSCSGKPRGHSFSPSCYMRWD 240

Query: 190 TDKFFNHDD---------------ETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAY 234
             +F+   +               E  DD G      ++ I ++   F+ + L   YA  
Sbjct: 241 LYQFYGFIEYRASPTLPREKGRISELSDDGGKISTRNILGITVALAFFITVLLVLGYA-- 298

Query: 235 ARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN 294
             LS+ ++                L F ++ +E ATN F  S KLG GG G V+ G+ PN
Sbjct: 299 --LSRRRKAYQEFATENDITTSGSLQFDFKAIEAATNNFQKSNKLGHGGFGEVFKGTFPN 356

Query: 295 GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL 354
           GT VAVKRL   + Q  +EF NEV L++ ++H+NLV+LLG S+EG E +LVYEY+PN+SL
Sbjct: 357 GTEVAVKRLSKISGQGEEEFKNEVLLVAKLQHRNLVRLLGFSVEGEEKILVYEYMPNKSL 416

Query: 355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI 414
           D F+FD  +   L+W  R+NII G   G+ YLH  S   IIHRD+K  NILLD D  PKI
Sbjct: 417 DYFLFDHRRRGQLDWRTRYNIIRGVTRGILYLHQDSRLTIIHRDLKAGNILLDVDMNPKI 476

Query: 415 ADFGLARCFAADRTHVSTA-VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRS 473
           ADFG+AR F  D+T  +T  V GT GYM PEY+  GQ + K+DVYSFG+LI+EI+ G++S
Sbjct: 477 ADFGVARNFRVDQTEATTGRVVGTFGYMPPEYVANGQFSMKSDVYSFGVLILEIIVGKKS 536

Query: 474 NAFSQDSASP---LQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAAL 530
           ++F +   S    +  VW L+ +   +E VDP + + +  ++V   + I LLC Q   A 
Sbjct: 537 SSFHEIDGSVGNLVTYVWRLWNNESFLELVDPAMGESYDKDEVIRCIHISLLCVQENPAD 596

Query: 531 RPSMAQAIMLLTNKVCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSS 590
           RP+M+    +LTN    +P P  P F+     EP             + +A+R+E   S+
Sbjct: 597 RPTMSTVFQMLTNTFLTLPVPQLPGFVFRVRSEP-------------NPLAERLEPGPST 643

Query: 591 SESSSTHSSDAHSRSREL 608
           + S +    DA   S +L
Sbjct: 644 TMSFACSIDDASITSVDL 661

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  330 bits (845), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 201/597 (33%), Positives = 306/597 (51%), Gaps = 43/597 (7%)

Query: 27  IYALAQCHLDLSHTDCLLC--FAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFY-QESV 83
           +Y +  C  D+S   C  C  FAA+ T L RC     A I++D C +RY   S   Q  +
Sbjct: 82  VYGVFLCRGDVSAEICRDCVAFAANET-LQRCPREKVAVIWYDECMVRYSNQSIVGQMRI 140

Query: 84  SPSLDDVKCSAENATVENENE--NDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGV 141
            P    V  + +    EN+    N+++   +  V       SR    +   F   +   +
Sbjct: 141 RPG---VFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKFATEKANFTVFQT--I 195

Query: 142 YALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHD---- 197
           Y+L QC   L    C  CL +    + R C     GR     C  RY    F+N      
Sbjct: 196 YSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIAAA 255

Query: 198 ------------------DETGDDRGSSRLGVMIAIVLSTTAFLM--LSLFAAYAAYARL 237
                              E G  +  + +   IA+ +S    L+  +    A     +L
Sbjct: 256 PMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNNKL 315

Query: 238 SKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTT 297
           S   ED +  G+ +T      L F++  +E ATN F+ S KLG GG G VY G L  G T
Sbjct: 316 SAETEDLDEDGITSTET----LQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGET 371

Query: 298 VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
           VA+KRL   + Q  +EF NEV++++ ++H+NL KLLG  ++G E +LVYE+VPN+SLD F
Sbjct: 372 VAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYF 431

Query: 358 IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF 417
           +FD  K ++L+W +R+ II G A G+ YLH  S   IIHRD+K SNILLD D  PKI+DF
Sbjct: 432 LFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDF 491

Query: 418 GLARCFAADRTHVSTA-VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAF 476
           G+AR F  D+T  +T  + GT GYM+PEY + G+ + K+DVYSFG+L++E++ G+++++F
Sbjct: 492 GMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSF 551

Query: 477 SQDS--ASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSM 534
            ++      +  VW L+  N  +E VD  ++ +F   +V   + I LLC Q  ++ RPSM
Sbjct: 552 YEEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSM 611

Query: 535 AQAIMLLTNKVCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSSS 591
              ++++ +    +P P +  FL  + M+     RS  + S  S  +K + +S   S
Sbjct: 612 DDILVMMNSFTVTLPIPKRSGFLLRT-MKDSRDPRSGGSASDHSATSKSLPLSVDDS 667

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1

 Score =  329 bits (843), Expect = 5e-89,   Method: Compositional matrix adjust.
 Identities = 204/599 (34%), Positives = 306/599 (51%), Gaps = 59/599 (9%)

Query: 28  YALAQCHLDLSHTDCLLCF-AASRTKLPRCLPSLSATIFFDGCFLRYDIYSFY-QESVSP 85
           YA+  C  ++   DC+ C   A+R    +C  +  A +++  C  RY   + Y ++  +P
Sbjct: 83  YAIGLCRREVKRDDCVSCIQTAARNLTKQCPLTKQAVVWYTHCMFRYSNRTIYGRKETNP 142

Query: 86  SLDDVKCSAENATVENENENDAVDGFVESV-GYAVGNVSRIAVEKGGGFGAVKVMGVYAL 144
           +      + E  +   ++      G ++ + G A          +G G  +      Y  
Sbjct: 143 T--KAFIAGEEISANRDDFERLQRGLLDRLKGIAAAGGPNRKYAQGNGSASAGYRRFYGT 200

Query: 145 AQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHD------- 197
            QC   L    C +CL      +   C      R F+  C  R+ T +F+  D       
Sbjct: 201 VQCTPDLSEQDCNDCLVFGFENIPSCCDAEIGLRWFSPSCNFRFETWRFYEFDADLEPDP 260

Query: 198 ---------------DETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKE 242
                          + TG  +G S+  V+IAIV+     L+++L A          +K 
Sbjct: 261 PAIQPADSPQSAARTERTGKGKGGSK--VIIAIVI---PILLVALLAICLCLV----LKW 311

Query: 243 DRNNLGLYATSMKKSCLS---------------FKYETLEKATNYFNPSKKLGQGGAGSV 287
            +N  G     + KS LS                 +ETL+ AT+ F+   +LG+GG GSV
Sbjct: 312 RKNKSGYKNKVLGKSPLSGSIAEDEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSV 371

Query: 288 YMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE 347
           Y G  P G  +AVKRL  N+ Q  +EF NE+ L++ ++H+NLV+L+G  I+G E LLVYE
Sbjct: 372 YKGVFPQGQEIAVKRLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYE 431

Query: 348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD 407
           ++ N SLDQFIFD  K +LL+W  R+ +I G A GL YLH  S  RIIHRD+K SNILLD
Sbjct: 432 FIKNASLDQFIFDTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLD 491

Query: 408 KDFTPKIADFGLARCFAADRT---HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILI 464
           ++  PKIADFGLA+ F + +T     ++ +AGT GYMAPEY + GQ + K DV+SFG+L+
Sbjct: 492 QEMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLV 551

Query: 465 IEIVCGRRSNAFS----QDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIG 520
           IEI+ G+R+N       +D+   L  VW  +R + ++  +DP+L       ++   + IG
Sbjct: 552 IEIITGKRNNNGGSNGDEDAEDLLSWVWRSWREDTILSVIDPSLTAG-SRNEILRCIHIG 610

Query: 521 LLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISN 579
           LLC Q +AA RP+MA   ++L +    +PTP +P F+  SV+ P N S S       SN
Sbjct: 611 LLCVQESAATRPTMATVSLMLNSYSFTLPTPLRPAFVLESVVIPSNVSSSTEGLQMSSN 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SYS3|CRK40_ARATH Cysteine-rich receptor-like protein kinase 40 OS=Arabidopsis thaliana GN=CRK40 PE=2 SV=1

 Score =  325 bits (834), Expect = 5e-88,   Method: Compositional matrix adjust.
 Identities = 214/587 (36%), Positives = 299/587 (50%), Gaps = 44/587 (7%)

Query: 4   LSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAA-SRTKLPRCLPSLSA 62
           L+  +  N  F   +L + P   +YAL  C        C  C  + ++  L  C     +
Sbjct: 53  LADKVIINDGFYNASLGQDPD-KVYALVSCARGYDQDACYNCVQSLTQNTLTDCRSRRDS 111

Query: 63  TIFFDG----CFLRYDIYSFY------QESVSPSLDDVKCSAENATVENENENDAVDGFV 112
            I+       C +R    S +         V PS D ++ S++N T+  +   + V+  +
Sbjct: 112 FIWGGNDDVTCLVRSSNQSTFGSVQLKPPVVWPSPDTIE-SSKNITLFKQQWEEMVNRTL 170

Query: 113 ESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCR 172
           E+   A G+ S +   K    G  +   VY L QC   L    C++CL    M  R+   
Sbjct: 171 EAATKAEGS-SVLKYYKAEKAGFTEFPDVYMLMQCTPDLSSRDCKQCLGDCVMYFRKDYM 229

Query: 173 MRKEGRGFNAGCYLRYSTDKFFN---------------HDDE-----TGDDRGSSRLGVM 212
            RK G      CY R+    F N               H  E     T     S   G +
Sbjct: 230 GRKGGMASLPSCYFRWDLYSFHNAFDNVTRVPAPPPRPHAQEKESCITVKKGKSIGYGGI 289

Query: 213 IAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLG--LYATSMKKSCLSFKYETLEKAT 270
           IAIV+  T   +L        YAR  K+    NN+G   Y+ S  +  L F    +  AT
Sbjct: 290 IAIVVVFTFINLLVFIGFIKVYARRGKL----NNVGSAEYSDSDGQFMLRFDLGMIVMAT 345

Query: 271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           + F+    LGQGG G+VY G+ PNG  VAVKRL   + Q   EF NEV+L++ ++HKNLV
Sbjct: 346 DDFSSENTLGQGGFGTVYKGTFPNGQEVAVKRLTKGSGQGDMEFKNEVSLLTRLQHKNLV 405

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           KLLG   EG E +LVYE+VPN SLD FIFD++K  LL W  RF II G A GL YLH  S
Sbjct: 406 KLLGFCNEGDEEILVYEFVPNSSLDHFIFDEDKRSLLTWEVRFRIIEGIARGLLYLHEDS 465

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA-VAGTLGYMAPEYLVRG 449
           + +IIHRD+K SNILLD +  PK+ADFG AR F +D T   T  +AGT GYMAPEYL  G
Sbjct: 466 QLKIIHRDLKASNILLDAEMNPKVADFGTARLFDSDETRAETKRIAGTRGYMAPEYLNHG 525

Query: 450 QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP 509
           Q++ K+DVYSFG++++E++ G R+N+F  +  +     W  +   K    +DP L ++ P
Sbjct: 526 QISAKSDVYSFGVMLLEMISGERNNSFEGEGLAAF--AWKRWVEGKPEIIIDPFLIEN-P 582

Query: 510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPF 556
             ++  ++QIGLLC Q  +  RP+M+  I+ L ++   IP P  P F
Sbjct: 583 RNEIIKLIQIGLLCVQENSTKRPTMSSVIIWLGSETIIIPLPKAPAF 629

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2

 Score =  324 bits (831), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 206/597 (34%), Positives = 304/597 (50%), Gaps = 43/597 (7%)

Query: 11  NTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTK-LPRCLPSLSATIFFDGC 69
           +T F      +TP   +  L  C  DLS   C  C A S  + L RC     A  +++ C
Sbjct: 75  STGFQNIRAGQTPDR-VTGLFLCRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYEEC 133

Query: 70  FLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEK 129
            LRY   +F           ++     ++++N+      D F++ V   +   +  A   
Sbjct: 134 ILRYSHKNFLSTVTYEGELIMRNPNNISSIQNQR-----DQFIDLVQSNMNQAANEAANS 188

Query: 130 GGGFGAVK-----VMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGC 184
              F  +K     +  +Y L QC   L R  C  CL  +  R+    R+    R F   C
Sbjct: 189 SRKFSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSINRMMPLFRI--GARQFWPSC 246

Query: 185 YLRYSTDKFFNH--------------------DDETGDDRGSSRLGVMIAIVLSTTAFLM 224
             RY    F+N                             G+S + V+  +VL+   F+ 
Sbjct: 247 NSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPGKSGNSTVLVVAIVVLAVLLFIA 306

Query: 225 LSLFAAYAAYARLSKMKEDRNNLGLYATSMKKS-CLSFKYETLEKATNYFNPSKKLGQGG 283
           L     Y   A+ +K   D  +       M  +  L   Y T++ ATN F  S K+G+GG
Sbjct: 307 L---VGYCFLAQRTKKTFDTASASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGG 363

Query: 284 AGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL 343
            G VY G+  NG  VAVKRL  N+RQ   EF  EV +++ ++H+NLV+LLG S++G E +
Sbjct: 364 FGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERI 423

Query: 344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSN 403
           LVYEY+PN+SLD  +FD  K   L+W +R+NII G A G+ YLH  S   IIHRD+K SN
Sbjct: 424 LVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASN 483

Query: 404 ILLDKDFTPKIADFGLARCFAADRTHVSTA-VAGTLGYMAPEYLVRGQLTEKADVYSFGI 462
           ILLD D  PKIADFG+AR F  D+T  +T+ + GT GYMAPEY + GQ + K+DVYSFG+
Sbjct: 484 ILLDADINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGV 543

Query: 463 LIIEIVCGRRSNAFSQDSASP--LQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIG 520
           L++EI+ GR++++F +   +   L   W L+ +   ++ VDP + ++    +V   + IG
Sbjct: 544 LVLEIISGRKNSSFDESDGAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIG 603

Query: 521 LLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFL--NSSVMEPGNSSRSCSANS 575
           LLC Q   A RP+++   M+LT+    +P P QP F   +S V +P +S +S +  S
Sbjct: 604 LLCVQEDPAKRPTISTVFMMLTSNTVTLPVPRQPGFFIQSSPVKDPTDSDQSTTTKS 660

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	611
255567375	605	kinase, putative [Ricinus communis] gi|2	0.986	0.996	0.677	0.0
225452394	659	PREDICTED: cysteine-rich receptor-like p	0.985	0.913	0.654	0.0
356573847	673	PREDICTED: cysteine-rich receptor-like p	0.978	0.888	0.635	0.0
224060104	605	predicted protein [Populus trichocarpa]	0.970	0.980	0.639	0.0
147765625	653	hypothetical protein VITISV_038880 [Viti	0.909	0.851	0.666	0.0
449446869	601	PREDICTED: cysteine-rich receptor-like p	0.975	0.991	0.581	0.0
225456979	611	PREDICTED: cysteine-rich receptor-like p	0.942	0.942	0.571	0.0
297733755	696	unnamed protein product [Vitis vinifera]	0.942	0.827	0.571	0.0
356513949	598	PREDICTED: cysteine-rich receptor-like p	0.968	0.989	0.574	0.0
356573321	666	PREDICTED: cysteine-rich receptor-like p	0.972	0.891	0.587	0.0

>gi|255567375|ref|XP_002524667.1| kinase, putative [Ricinus communis] gi|223536028|gb|EEF37686.1| kinase, putative [Ricinus communis]

 Score =  807 bits (2084), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 414/611 (67%), Positives = 495/611 (81%), Gaps = 8/611 (1%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           ME LSQLIT N+HFAT++LN +  +P+Y LAQCH DLS TDCLLC+A SRTK+PRCLPS+
Sbjct: 1   METLSQLIT-NSHFATYHLNSS--LPMYVLAQCHQDLSQTDCLLCYAVSRTKIPRCLPSV 57

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           SA IF DGCFLRYD Y+F++ESVS S D+VKCS EN +  N  END +  FV+SV +A+G
Sbjct: 58  SARIFLDGCFLRYDNYNFFEESVSVSFDEVKCSQENVSGSN-GENDKLR-FVKSVEHAIG 115

Query: 121 NVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGF 180
           NVS  AVE GG FG V + GVYALAQCWES+G+DGCRECL KAG  V+  C  +KEGRG 
Sbjct: 116 NVSSKAVENGG-FGVVGIEGVYALAQCWESVGKDGCRECLRKAGKEVK-GCGAKKEGRGL 173

Query: 181 NAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKM 240
           NAGCYLRYST++F+N   E       S LGV IA+VL+  A LMLS+FA YA Y R  K 
Sbjct: 174 NAGCYLRYSTERFYNVGGELEAGHTISGLGVAIAVVLAAAAVLMLSIFAVYAVYVRRMKN 233

Query: 241 KEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAV 300
           K +R NL   + +  K+ L+FKYETLEKAT+YFN S+K+GQGGAGSVY G+LPNG TVAV
Sbjct: 234 KAERINLEKISINFSKTSLNFKYETLEKATDYFNASRKIGQGGAGSVYAGTLPNGETVAV 293

Query: 301 KRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD 360
           KRL FNTRQWVDEFFNEVNLIS I+HKNLVKLLGCSIEGPESLLVYEYVPN+SLDQFIF 
Sbjct: 294 KRLTFNTRQWVDEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNKSLDQFIFG 353

Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           K+K   LNW +RF+II+GTAEGLAYLHGGS+ RIIHRDIK+SN+LLD+DFTPKIADFGL 
Sbjct: 354 KDKPTTLNWKQRFDIIVGTAEGLAYLHGGSQERIIHRDIKSSNVLLDEDFTPKIADFGLV 413

Query: 421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDS 480
           RCF AD++H+ST +AGT+GYMAPEYL+RGQLTEKADVYSFG+L++EIV G+R NAF++DS
Sbjct: 414 RCFGADKSHLSTGIAGTMGYMAPEYLIRGQLTEKADVYSFGVLVLEIVMGKRCNAFTEDS 473

Query: 481 ASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML 540
            S LQ VW LYR N+LVEA DP+L+DDF AE+V  VLQ GLLCTQA+ ALRPSMA+ +++
Sbjct: 474 KSLLQTVWQLYRLNRLVEAADPSLRDDFSAEEVSRVLQTGLLCTQASVALRPSMAEVVVM 533

Query: 541 LTNKVCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEV-SYSSSESSSTHSS 599
           LTN   EIP PSQPPF+N++ +EP +S RS S +SF+SN A+++E  SY+S+ESSS  SS
Sbjct: 534 LTNSGGEIPLPSQPPFMNATSLEPESSRRSYSTSSFVSNAARKLEAYSYTSTESSSMQSS 593

Query: 600 DAHSRSRELTQ 610
           D  SRS E  Q
Sbjct: 594 DRASRSEESKQ 604

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452394|ref|XP_002273718.1| PREDICTED: cysteine-rich receptor-like protein kinase 42 [Vitis vinifera]

 Score =  772 bits (1994), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 401/613 (65%), Positives = 482/613 (78%), Gaps = 11/613 (1%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           ME LSQL+T N   + F +N TP  P+Y LAQCH DLSH DCLLC+AA RTKLPRCLP+ 
Sbjct: 55  MEFLSQLVTLNLWGSHF-VNSTP--PMYGLAQCHQDLSHLDCLLCYAAGRTKLPRCLPAT 111

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           SA I+ DGCFLRYD YSF+ ESV P  D V CS+ +  + ++    A   FV++V   + 
Sbjct: 112 SARIYLDGCFLRYDNYSFFSESVDPDHDTVNCSSGSGAIVDQV---AKLEFVKNVHRVIN 168

Query: 121 NVSRIAVEKGG-GFGAVK--VMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEG 177
           NV+  AV  GG G   V+   +GVYALA+CW+++   GCR CL KA   VR  C   KEG
Sbjct: 169 NVTATAVANGGYGVAVVEGGAVGVYALAECWKTVNSSGCRACLQKASNEVR-GCLPGKEG 227

Query: 178 RGFNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARL 237
           RG NAGCYLRYST+KF+++  E+    GSSR G+ IAIVL+  A +++SLFAAYA YA L
Sbjct: 228 RGLNAGCYLRYSTEKFYDNGGESEGGSGSSRTGLTIAIVLAAAALILVSLFAAYAGYASL 287

Query: 238 SKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTT 297
           SK+KE+R NLG  A+ + KS L+FKYETLE+AT YFNPS+KLGQGGAGSVYMG+LPNG  
Sbjct: 288 SKIKEERKNLGKVASIINKSSLNFKYETLERATEYFNPSRKLGQGGAGSVYMGTLPNGEI 347

Query: 298 VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
           VAVKRLIFNTRQWVDEFFNEVNLIS I+HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF
Sbjct: 348 VAVKRLIFNTRQWVDEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 407

Query: 358 IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF 417
           +FDKNK + LNW +RF+II+GTAEGLAYLHGG + RIIHRDIK SNILLD++ TPKIADF
Sbjct: 408 MFDKNKIQTLNWEQRFDIIVGTAEGLAYLHGGLQMRIIHRDIKGSNILLDENLTPKIADF 467

Query: 418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFS 477
           GLARC  AD+TH+ST +AGTLGYMAPEYLVRGQLTEKADVYSFG+L++EIVCGR+++ F+
Sbjct: 468 GLARCLGADKTHLSTGIAGTLGYMAPEYLVRGQLTEKADVYSFGVLVLEIVCGRKNSVFT 527

Query: 478 QDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQA 537
           QDS S LQRVW LY+SNKLVEA+D  LKDDFP ++  +VL+IGLLCTQA+ ALRPSM + 
Sbjct: 528 QDSGSLLQRVWKLYKSNKLVEAIDDCLKDDFPEKEASDVLRIGLLCTQASVALRPSMTEV 587

Query: 538 IMLLTNKVCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSSSESSSTH 597
           + +LT+K  EIP P+QPPFLN+ V+E    SRS SAN+ +SN+A +IEVS   +ESSS H
Sbjct: 588 VWMLTHKDWEIPPPNQPPFLNAHVLESA-ISRSNSANTSMSNMATKIEVSGPFTESSSMH 646

Query: 598 SSDAHSRSRELTQ 610
           SS  H   ++L Q
Sbjct: 647 SSMDHQEEQKLMQ 659

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356573847|ref|XP_003555067.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Glycine max]

 Score =  772 bits (1994), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 388/611 (63%), Positives = 469/611 (76%), Gaps = 13/611 (2%)

Query: 1   MEILSQLITAN---THFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCL 57
           ME LSQL+T+N   TH    + + +  +PIY  AQC  DLSHTDCLLC+AASRT+LPRCL
Sbjct: 67  MESLSQLVTSNNWGTHSVKISGSGSS-IPIYGFAQCFRDLSHTDCLLCYAASRTRLPRCL 125

Query: 58  PSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGY 117
           PS+SA I+ DGCFLRYD YSFY E   PS D V C+   A  E E          E VG 
Sbjct: 126 PSVSARIYLDGCFLRYDNYSFYSEGTDPSRDAVNCTGVAAGDEAERVE-----LQERVGR 180

Query: 118 AVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEG 177
            V NV  IA   G GFG  +V GVYALAQCW +LG  GCRECL KAG  V+  C  +KEG
Sbjct: 181 VVDNVVNIAERDGNGFGVGEVEGVYALAQCWNTLGSGGCRECLRKAGREVK-GCLPKKEG 239

Query: 178 RGFNAGCYLRYSTDKFFNHDDETGDDRGS-SRLGVMIAIVLSTTAFLMLSLFAAYAAYAR 236
           R  NAGCYLRYST KF+N D + G   G   R GV++A VL+  A +ML+L A+YAA+ +
Sbjct: 240 RALNAGCYLRYSTQKFYNEDGDAGGGNGFLRRRGVIVAEVLAAAAVIMLALSASYAAFTK 299

Query: 237 LSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGT 296
            SK+K++ NNLG  ++S+ KS L++KYETLEKAT+YFN S+K+GQGGAGSV+ G LPNG 
Sbjct: 300 FSKIKKENNNLGQISSSISKSSLNYKYETLEKATDYFNSSRKVGQGGAGSVFKGILPNGK 359

Query: 297 TVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQ 356
            VAVKRLIFN RQWVDEFFNEVNLIS IEHKNLVKLLGCSIEGPESLLVYEY+P +SLDQ
Sbjct: 360 VVAVKRLIFNNRQWVDEFFNEVNLISGIEHKNLVKLLGCSIEGPESLLVYEYLPKKSLDQ 419

Query: 357 FIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD 416
           FIF+KN+T++LNW +RFNIILGTAEGLAYLH G++ RIIHRDIK+SN+LLD++ TPKIAD
Sbjct: 420 FIFEKNRTQILNWKQRFNIILGTAEGLAYLHEGTKIRIIHRDIKSSNVLLDENLTPKIAD 479

Query: 417 FGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAF 476
           FGLARCF  D++H+ST +AGTLGYMAPEYL+RGQLT+KADVYS+G+L++EIV GRR+N F
Sbjct: 480 FGLARCFGGDKSHLSTGIAGTLGYMAPEYLIRGQLTDKADVYSYGVLVLEIVSGRRNNVF 539

Query: 477 SQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
            +DS S LQ  W LYRSN L EAVDP+L DDFP  +   VLQIGLLCTQA+A+LRPSM+Q
Sbjct: 540 REDSGSLLQTAWKLYRSNTLTEAVDPSLGDDFPPSEASRVLQIGLLCTQASASLRPSMSQ 599

Query: 537 AIMLLTNKVCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSSSESSST 596
            + +L+N   ++PTP+QPPFLN+ +++  +S +S S NSFISN  K+I VSYS SESS  
Sbjct: 600 VVYMLSNTNLDVPTPNQPPFLNTGMLDSDSSIKSYSTNSFISNALKKIGVSYSYSESS-- 657

Query: 597 HSSDAHSRSRE 607
            +SD  SRS E
Sbjct: 658 RNSDGPSRSEE 668

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224060104|ref|XP_002300041.1| predicted protein [Populus trichocarpa] gi|222847299|gb|EEE84846.1| predicted protein [Populus trichocarpa]

 Score =  771 bits (1991), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 394/616 (63%), Positives = 478/616 (77%), Gaps = 23/616 (3%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           M  LSQL++  +HFAT NLN +  +  YALAQCH DLS TDCLLC+AASRTKLP CLPSL
Sbjct: 1   MGTLSQLLST-SHFATNNLNHSSTLTFYALAQCHQDLSQTDCLLCYAASRTKLPLCLPSL 59

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           S  I+ DGCFLRYD YSFYQESVS S D  KC   N  ++ ++++  +D F   VGYAVG
Sbjct: 60  SGRIYLDGCFLRYDNYSFYQESVSSSFDTFKCG--NEYLDVDDDDKHLD-FPTRVGYAVG 116

Query: 121 NVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGF 180
           NV+  AVE GG F  V V G+YALAQCW+S+GR+GCR CL+ AG +  R C  +KEGRG 
Sbjct: 117 NVTIQAVENGG-FAVVNVDGIYALAQCWDSVGREGCRGCLEMAG-KAARGCVPKKEGRGM 174

Query: 181 NAGCYLRYSTDKFFNHDDETGDDRGS---------SRLGVMIAIVLSTTAFLMLSLFAAY 231
           NAGCYLRYSTDKF+N+    GD+R +         + + ++  +VL+T A LMLS+FAAY
Sbjct: 175 NAGCYLRYSTDKFYNNGG--GDERNARGNFLHQYFATVSLLCFVVLATAACLMLSIFAAY 232

Query: 232 AAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGS 291
           A+Y RL K K  R N      S+K S L+FKYE LEKAT++F+PS+KLGQGGAGSV++G+
Sbjct: 233 ASYVRLLKAK--RGNY----CSLKISNLNFKYEILEKATDFFSPSRKLGQGGAGSVFIGT 286

Query: 292 LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
           LPNG TVAVKRLIFNTRQWVDEFFNEVNLIS I+HKNLVKLLGCSIEGPESLLVYEYV N
Sbjct: 287 LPNGETVAVKRLIFNTRQWVDEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVRN 346

Query: 352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT 411
           +SLDQF+FDK K++ LNW +RF IILGTAEGLAYLHGGS+ RIIHRDIK+SN+LLD +  
Sbjct: 347 KSLDQFLFDKTKSRTLNWKQRFEIILGTAEGLAYLHGGSQVRIIHRDIKSSNVLLDDNLN 406

Query: 412 PKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           PKIADFGL RCF AD++H+ST +AGT+GYMAPEYL+RGQLT+KADVYSFG+L++EI+ G+
Sbjct: 407 PKIADFGLVRCFGADKSHLSTGIAGTIGYMAPEYLIRGQLTDKADVYSFGVLVLEILGGK 466

Query: 472 RSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALR 531
           R NAF ++S S LQ VW LYRSN+LV+AVDP L+D+FP  +   VLQIGLLCTQA+AALR
Sbjct: 467 RCNAFVENSGSLLQTVWRLYRSNRLVDAVDPCLRDEFPTREASCVLQIGLLCTQASAALR 526

Query: 532 PSMAQAIMLLTNKVCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSSS 591
           PSMAQ +  LTN  CEIP P+QPP++N+S++E  NS  S S NS +SN    +E S +S 
Sbjct: 527 PSMAQVVHFLTNNDCEIPPPNQPPYMNTSLLETENSRWSYSINSLVSNGPTEVEASSTSM 586

Query: 592 ESSSTHSSDAHSRSRE 607
           ESSS  SS+   RS E
Sbjct: 587 ESSSILSSNGQIRSEE 602

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147765625|emb|CAN69244.1| hypothetical protein VITISV_038880 [Vitis vinifera]

 Score =  752 bits (1942), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/566 (66%), Positives = 452/566 (79%), Gaps = 10/566 (1%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           ME LSQL+T N   + F +N TP  P+Y LAQCH DLSH DCLLC+AA RTKLPRCLP+ 
Sbjct: 1   MEFLSQLVTLNLWGSHF-VNSTP--PMYGLAQCHQDLSHLDCLLCYAAGRTKLPRCLPAT 57

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           SA I+ DGCFLRYD YSF+ ESV P  D V CS+ +  + ++    A   FV++V   + 
Sbjct: 58  SARIYLDGCFLRYDNYSFFSESVDPDHDTVNCSSGSGAIVDQV---AKLEFVKNVHRVIN 114

Query: 121 NVSRIAVEKGG-GFGAVK--VMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEG 177
           NV+  AV  GG G   V+   +GVYALA+CW+++   GCR CL KA   VR  C   KEG
Sbjct: 115 NVTATAVANGGYGVAVVEGGAVGVYALAECWKTVNSSGCRACLQKASNEVR-GCLPGKEG 173

Query: 178 RGFNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARL 237
           RG NAGCYLRYST+KF+++  E+    GSSR G+ IAIVL+  A +++SLFAAYA YA L
Sbjct: 174 RGLNAGCYLRYSTEKFYDNGGESEGGSGSSRTGLTIAIVLAAAALILVSLFAAYAGYASL 233

Query: 238 SKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTT 297
           SK+KE+R NLG  A+ + KS L+FKYETLE+AT YFNPS+KLGQGGAGSVYMG+LPNG  
Sbjct: 234 SKIKEERKNLGKVASIINKSSLNFKYETLERATEYFNPSRKLGQGGAGSVYMGTLPNGEI 293

Query: 298 VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
           VAVKRLIFNTRQWVDEFFNEVNLIS I+HKNLVKLLGCSIEGPESLLVYEYVPNRSJDQF
Sbjct: 294 VAVKRLIFNTRQWVDEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNRSJDQF 353

Query: 358 IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF 417
           +FDKNK + LNW +RF+II+GTAEGLAYLHGG + RIIHRDIK SNILLD++ TPKIADF
Sbjct: 354 MFDKNKIQTLNWEQRFDIIVGTAEGLAYLHGGLQMRIIHRDIKGSNILLDENLTPKIADF 413

Query: 418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFS 477
           GLARC  AD+TH+ST +AGTLGYMAPEYLVRGQLTEKADVYSFG+L++EIVCGR+++ F+
Sbjct: 414 GLARCLGADKTHLSTGIAGTLGYMAPEYLVRGQLTEKADVYSFGVLVLEIVCGRKNSVFT 473

Query: 478 QDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQA 537
           QDS S LQRVW LY+SNKLVEA+D  LKDDFP ++  +VL+IGLLCTQA+ ALRPSM + 
Sbjct: 474 QDSGSLLQRVWKLYKSNKLVEAIDDCLKDDFPEKEASDVLRIGLLCTQASVALRPSMTEV 533

Query: 538 IMLLTNKVCEIPTPSQPPFLNSSVME 563
           + +LT+K  EIP P+QPPFLN+ V+E
Sbjct: 534 VWMLTHKDWEIPPPNQPPFLNAHVLE 559

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449446869|ref|XP_004141193.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Cucumis sativus] gi|449515394|ref|XP_004164734.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Cucumis sativus]

 Score =  697 bits (1798), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 355/611 (58%), Positives = 449/611 (73%), Gaps = 15/611 (2%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           ME +S+L+T  + + T  +N TP  P++AL+QC  DLSHTDCLLC+AASRT LPRCLP++
Sbjct: 1   MEAISELLTTRS-WTTHFVNSTP--PMFALSQCFNDLSHTDCLLCYAASRTSLPRCLPAI 57

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           SA IF DGCFLRYD YSFY+ES     D V C++E   ++          F E+V   V 
Sbjct: 58  SARIFLDGCFLRYDNYSFYKESTDSVRDSVNCTSELGEIDQSERLV----FGENVRVVVE 113

Query: 121 NVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGF 180
            V+  A+EKGG FG  +V G++ LAQCW S+  +GCR CL+KA  R   SC   KEGR  
Sbjct: 114 TVTTKAMEKGG-FGMGEVSGMFGLAQCWGSVEPEGCRACLEKA-KRSIGSCLPSKEGRAM 171

Query: 181 NAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKM 240
           NAGCYLRYST KF+N  DE  D  G S    ++ I L++ A L++   A +A Y R+SK 
Sbjct: 172 NAGCYLRYSTVKFYNDKDEDRDHDGFSGRRAVVTIALASAASLIIFFSAVFACYTRISKF 231

Query: 241 KEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAV 300
           K+++    L   S+K S L+FKYETLEKATNYFN S K+GQGGAGSVY G+LPNG  VAV
Sbjct: 232 KKEKKRQSLIPVSLKDSDLNFKYETLEKATNYFNLSNKIGQGGAGSVYKGTLPNGQIVAV 291

Query: 301 KRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD 360
           KRL+F+TRQWVDEFFNEVNLI  I+HKNLV LLGCSIEGPESLLVYE+V N SLD FIFD
Sbjct: 292 KRLVFHTRQWVDEFFNEVNLIRGIQHKNLVALLGCSIEGPESLLVYEFVSNGSLDHFIFD 351

Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           KNK ++L+W +RFNII+GTAEGLA+LH G + RIIHRDIK+SN+LLD++F PKIADFGLA
Sbjct: 352 KNKAQILSWKQRFNIIVGTAEGLAHLHEGCKIRIIHRDIKSSNVLLDENFNPKIADFGLA 411

Query: 421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDS 480
           R F AD++H+ST +AGTLGYMAPEYLVRGQLTEKADVYSFG+LI+EIVCGRR+++F+++S
Sbjct: 412 RHFGADQSHLSTGIAGTLGYMAPEYLVRGQLTEKADVYSFGVLILEIVCGRRNSSFTENS 471

Query: 481 ASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML 540
              LQ VW LY++ +L EA+D +L  D+PA++  ++LQIGLLCTQA A+LRPSMA  + L
Sbjct: 472 TPLLQTVWDLYKTERLTEAIDTSLNKDYPAKEAMDILQIGLLCTQALASLRPSMATIVKL 531

Query: 541 LTNKV-CEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSSSESSSTHSS 599
           LT+ V  ++  P QPPFLN      G S RSC  +S +S+   ++EVS S + + S  SS
Sbjct: 532 LTSDVERKVGIPEQPPFLNPC----GTSKRSCRISSLVSHAVSKLEVS-SCTSTDSGFSS 586

Query: 600 DAHSRSRELTQ 610
           +  SRS +  +
Sbjct: 587 NLPSRSGDFAE 597

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456979|ref|XP_002278823.1| PREDICTED: cysteine-rich receptor-like protein kinase 1-like [Vitis vinifera]

 Score =  687 bits (1773), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/595 (57%), Positives = 434/595 (72%), Gaps = 19/595 (3%)

Query: 18  NLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYS 77
           N+ K+P   I+ L+QC+ DLS  DCL CFA SRTKLPRCLP+++A I+ DGCFLRYD YS
Sbjct: 17  NITKSPV--IFGLSQCYSDLSKDDCLSCFAESRTKLPRCLPAIAARIYLDGCFLRYDNYS 74

Query: 78  FYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVK 137
           F+ ES+ P+ D V+CS  +  ++   +N     F + V   + NV++ AV+K G F    
Sbjct: 75  FFNESIDPNHDMVRCSEPSGVLK---DNYTRSEFSKKVDEVINNVTKTAVQKQG-FAVAG 130

Query: 138 VMG----VYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKF 193
           + G     YALAQCW+++ + GCR+CL  A   VRR C    EGR  NAGCYLRYST+KF
Sbjct: 131 MKGGAVVAYALAQCWKTVDQKGCRDCLVNAESAVRR-CLPGSEGRALNAGCYLRYSTEKF 189

Query: 194 FNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNN-LGLYAT 252
           +N        +G S  G++IA +LS  A  +L+   A+  Y  LSK K + NN L    T
Sbjct: 190 YNDGTAKKSGKGLSDTGMIIAFILSVLAVCLLAFLGAFVGYILLSKRKRNNNNALARIPT 249

Query: 253 SMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD 312
            + +S L+FKYETLE+ATN+F+ S+KLGQGGAGSV+ G+LP+G TVAVKRL FNTRQWVD
Sbjct: 250 CINRSDLNFKYETLERATNFFDSSRKLGQGGAGSVFKGTLPDGRTVAVKRLFFNTRQWVD 309

Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKR 372
           EFFNEVNLIS I+HKNLV LLGCSIEGPESLLVYEYVPN+S+DQ +F KN T  L+W +R
Sbjct: 310 EFFNEVNLISRIQHKNLVGLLGCSIEGPESLLVYEYVPNKSVDQILFGKNPTSCLSWQQR 369

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
           F II+GTAEGLAYLHGGSE +IIHRDIK SNILLD++  PKIADFGLARC A D++HVST
Sbjct: 370 FEIIVGTAEGLAYLHGGSEVKIIHRDIKGSNILLDENLNPKIADFGLARCVAPDKSHVST 429

Query: 433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR 492
            +AGTLGYMAPEYLVRGQL+EKADVY++G+LI+EIVCGR++  F Q S S LQ VW  Y+
Sbjct: 430 GIAGTLGYMAPEYLVRGQLSEKADVYAYGVLILEIVCGRKNCIFVQGSDSVLQTVWKHYK 489

Query: 493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPS 552
           SN +V +VDP+LK DFP  +  NV+QIGLLCTQA+ ALRPSM+Q + +LT++   IP P 
Sbjct: 490 SNSVVRSVDPSLKGDFPLNEARNVVQIGLLCTQASFALRPSMSQVVQMLTDQNSVIPEPM 549

Query: 553 QPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSSSESSSTHSSDAHSRSRE 607
           QPPFLN+SV++P NS +    NS   N+       ++++E  STHSS++ + + +
Sbjct: 550 QPPFLNASVLDPSNSLK----NSITRNLTPSF---HTATEPPSTHSSNSSAMASQ 597

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297733755|emb|CBI15002.3| unnamed protein product [Vitis vinifera]

 Score =  687 bits (1773), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/595 (57%), Positives = 434/595 (72%), Gaps = 19/595 (3%)

Query: 18  NLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYS 77
           N+ K+P   I+ L+QC+ DLS  DCL CFA SRTKLPRCLP+++A I+ DGCFLRYD YS
Sbjct: 54  NITKSPV--IFGLSQCYSDLSKDDCLSCFAESRTKLPRCLPAIAARIYLDGCFLRYDNYS 111

Query: 78  FYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVK 137
           F+ ES+ P+ D V+CS  +  ++   +N     F + V   + NV++ AV+K G F    
Sbjct: 112 FFNESIDPNHDMVRCSEPSGVLK---DNYTRSEFSKKVDEVINNVTKTAVQKQG-FAVAG 167

Query: 138 VMG----VYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKF 193
           + G     YALAQCW+++ + GCR+CL  A   VRR C    EGR  NAGCYLRYST+KF
Sbjct: 168 MKGGAVVAYALAQCWKTVDQKGCRDCLVNAESAVRR-CLPGSEGRALNAGCYLRYSTEKF 226

Query: 194 FNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNN-LGLYAT 252
           +N        +G S  G++IA +LS  A  +L+   A+  Y  LSK K + NN L    T
Sbjct: 227 YNDGTAKKSGKGLSDTGMIIAFILSVLAVCLLAFLGAFVGYILLSKRKRNNNNALARIPT 286

Query: 253 SMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD 312
            + +S L+FKYETLE+ATN+F+ S+KLGQGGAGSV+ G+LP+G TVAVKRL FNTRQWVD
Sbjct: 287 CINRSDLNFKYETLERATNFFDSSRKLGQGGAGSVFKGTLPDGRTVAVKRLFFNTRQWVD 346

Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKR 372
           EFFNEVNLIS I+HKNLV LLGCSIEGPESLLVYEYVPN+S+DQ +F KN T  L+W +R
Sbjct: 347 EFFNEVNLISRIQHKNLVGLLGCSIEGPESLLVYEYVPNKSVDQILFGKNPTSCLSWQQR 406

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
           F II+GTAEGLAYLHGGSE +IIHRDIK SNILLD++  PKIADFGLARC A D++HVST
Sbjct: 407 FEIIVGTAEGLAYLHGGSEVKIIHRDIKGSNILLDENLNPKIADFGLARCVAPDKSHVST 466

Query: 433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR 492
            +AGTLGYMAPEYLVRGQL+EKADVY++G+LI+EIVCGR++  F Q S S LQ VW  Y+
Sbjct: 467 GIAGTLGYMAPEYLVRGQLSEKADVYAYGVLILEIVCGRKNCIFVQGSDSVLQTVWKHYK 526

Query: 493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPS 552
           SN +V +VDP+LK DFP  +  NV+QIGLLCTQA+ ALRPSM+Q + +LT++   IP P 
Sbjct: 527 SNSVVRSVDPSLKGDFPLNEARNVVQIGLLCTQASFALRPSMSQVVQMLTDQNSVIPEPM 586

Query: 553 QPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSSSESSSTHSSDAHSRSRE 607
           QPPFLN+SV++P NS +    NS   N+       ++++E  STHSS++ + + +
Sbjct: 587 QPPFLNASVLDPSNSLK----NSITRNLTPSF---HTATEPPSTHSSNSSAMASQ 634

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356513949|ref|XP_003525670.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Glycine max]

 Score =  686 bits (1769), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/608 (57%), Positives = 436/608 (71%), Gaps = 16/608 (2%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           ME L +++T   ++ T +   +   PIY LAQC  DLS  DCL CFA+SRTKLPRCLPS+
Sbjct: 1   MEKLQEVVTKQ-NWGTHSEGMSSTTPIYGLAQCFQDLSSIDCLQCFASSRTKLPRCLPSV 59

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           SA I+ DGCFLRYD YSFY E   P  D V C+++   V  + E      F ESV   V 
Sbjct: 60  SARIYLDGCFLRYDNYSFYTEDTDPLRDTVNCTSQYGAVVGDGEKLV---FAESVAKVVE 116

Query: 121 NVSRIAVEKGGGFGAV-KVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRG 179
           +V R+AV +G G  AV +  GVYALAQCW+++G  GC +CL KA   V+  C  ++EGR 
Sbjct: 117 SVVRVAVNEGRGIFAVGEGGGVYALAQCWKTVGVKGCSDCLRKAENEVK-GCLPKREGRA 175

Query: 180 FNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSK 239
            N GCYLRYST KF+N   E G        G ++A      A ++L+L A+Y A+ +   
Sbjct: 176 LNTGCYLRYSTVKFYNQGGEDGQGDAIVAAGSVLA-----AAVVVLTLAASYVAFTK--- 227

Query: 240 MKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVA 299
            K  +NN      S+K S L++KYETLEKAT+YF+ S+K+GQGGAGSVY G+LPNG  VA
Sbjct: 228 -KRKKNNFIEAPPSLKNSSLNYKYETLEKATDYFSSSRKIGQGGAGSVYKGTLPNGNDVA 286

Query: 300 VKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIF 359
           VKRL+FN RQWVD+FFNEVNLIS ++HKNLVKLLGCSIEGPESL+VYEY+PN+SLDQFIF
Sbjct: 287 VKRLVFNNRQWVDDFFNEVNLISGMQHKNLVKLLGCSIEGPESLIVYEYLPNKSLDQFIF 346

Query: 360 DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL 419
           +K+ T++L W +RF IILGTAEGLAYLHGGSE RIIHRDIK+SN+LLD++  PKIADFGL
Sbjct: 347 EKDITRILKWKQRFEIILGTAEGLAYLHGGSEIRIIHRDIKSSNVLLDENLNPKIADFGL 406

Query: 420 ARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQD 479
           ARCF  D+TH+ST +AGTLGYMAPEYL++GQLT+KADVYSFG+L++EI  GR++N F +D
Sbjct: 407 ARCFGTDKTHLSTGIAGTLGYMAPEYLIQGQLTDKADVYSFGVLVLEIASGRKNNVFRED 466

Query: 480 SASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM 539
           S S LQ VW LY+SN+L EAVDP L +DFPA +   V QIGLLCTQA+A+LRPSM Q + 
Sbjct: 467 SGSLLQTVWKLYQSNRLGEAVDPGLGEDFPAREASRVFQIGLLCTQASASLRPSMTQVVS 526

Query: 540 LLTNKVCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSSSESSSTHSS 599
           +L+N   + P P QPPFLNS +++   S    S  S  SN  K+  VSYS SE SST S 
Sbjct: 527 ILSNSNLDAPIPKQPPFLNSRLLDQA-SPLGFSIGSSSSNTFKKTGVSYSPSEFSSTCSL 585

Query: 600 DAHSRSRE 607
              +R+ E
Sbjct: 586 IGPTRNEE 593

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356573321|ref|XP_003554810.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Glycine max]

 Score =  681 bits (1757), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 360/613 (58%), Positives = 445/613 (72%), Gaps = 19/613 (3%)

Query: 1   MEILSQLITA-NTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPS 59
           ME L +L+T  N    +  ++ T   PIY LAQC  DLS  DCL CFAASRTKLPRCLPS
Sbjct: 62  MEKLLELVTKQNWGTHSEGMSSTTTTPIYGLAQCFQDLSSIDCLQCFAASRTKLPRCLPS 121

Query: 60  LSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAV 119
           +SA I+ DGCFLRYD YSFY E+  P  D V C++E  +   E E      F ESVG  V
Sbjct: 122 VSARIYLDGCFLRYDNYSFYTENYDPLRDTVNCTSEYGS---EGERLV---FAESVGKVV 175

Query: 120 GNVSRIAVE--KGGGFGAV-KVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKE 176
            +V R+AV   +G GF AV +  GVYALAQCW+++G  GC +CL KA   V+  C  ++E
Sbjct: 176 ESVVRVAVNNNEGRGFFAVGEGGGVYALAQCWKTVGVKGCSDCLRKAENEVK-GCLPKRE 234

Query: 177 GRGFNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAI--VLSTTAFLMLSLFAAYAAY 234
           GR  N GCYLRYST KF+N   + G    SSR  V+IA   VL+  A ++L+L  +Y A+
Sbjct: 235 GRALNTGCYLRYSTVKFYNQGGQDGQGDDSSRKRVIIAAGSVLAA-AVVVLTLAVSYVAF 293

Query: 235 ARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN 294
            +    K  +NN      S+K S L++KYETLEKAT+YF+ S+K+GQGG+GSVY G+LPN
Sbjct: 294 TK----KRRKNNFIEVPPSLKNSSLNYKYETLEKATDYFSSSRKIGQGGSGSVYKGTLPN 349

Query: 295 GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL 354
           G  VAVKRL+FN RQWVD+FFNEVNLIS ++HKNLVKLLGCSIEGPESL+VYEY+PN+SL
Sbjct: 350 GNDVAVKRLVFNNRQWVDDFFNEVNLISGMQHKNLVKLLGCSIEGPESLIVYEYLPNKSL 409

Query: 355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI 414
           DQFIF+K+ T++L W +RF IILGTAEGLAYLHGGSE RIIHRDIK+SN+LLD++ +PKI
Sbjct: 410 DQFIFEKDITRILKWKQRFEIILGTAEGLAYLHGGSEIRIIHRDIKSSNVLLDENLSPKI 469

Query: 415 ADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSN 474
           ADFGLARCF  D+TH+ST +AGTLGYMAPEYL++GQLT+KADVYSFG+L++EI  GR++N
Sbjct: 470 ADFGLARCFGTDKTHLSTGIAGTLGYMAPEYLIQGQLTDKADVYSFGVLVLEIASGRKNN 529

Query: 475 AFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSM 534
            F +DS S LQ VW LY+SN+L EAVDP L +DFPA +   V QIGLLCTQA+A+LRP M
Sbjct: 530 VFREDSGSLLQTVWKLYQSNRLGEAVDPGLGEDFPAREASRVFQIGLLCTQASASLRPFM 589

Query: 535 AQAIMLLTNKVCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSSSESS 594
            Q   +L+N   ++P P QPPFLNS  ++   S    S +S  SN  K+I VSYS SE S
Sbjct: 590 VQVASMLSNSNLDVPIPKQPPFLNSRFLDQ-TSPLGFSIDSSSSNTFKKIGVSYSPSEFS 648

Query: 595 STHSSDAHSRSRE 607
           ST S    SRS E
Sbjct: 649 STCSLIRPSRSEE 661

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	611
TAIR|locus:2026785	646	CRK3 "cysteine-rich RLK (RECEP	0.903	0.854	0.521	1.6e-148
TAIR|locus:2026821	649	CRK2 "cysteine-rich RLK (RECEP	0.880	0.828	0.462	7.8e-126
TAIR|locus:2139845	625	AT4G28670 [Arabidopsis thalian	0.852	0.833	0.393	8.4e-97
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.630	0.570	0.392	1.5e-85
TAIR|locus:2141201	679	CRK29 "cysteine-rich RLK (RECE	0.620	0.558	0.420	4e-85
TAIR|locus:2121606	673	CRK13 "cysteine-rich RLK (RECE	0.602	0.546	0.408	2.5e-83
TAIR|locus:2123126	666	CRK31 "cysteine-rich RLK (RECE	0.689	0.632	0.404	3.1e-83
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.716	0.679	0.392	3.6e-82
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.623	0.563	0.411	5.8e-82
TAIR|locus:2125766	654	CRK40 "cysteine-rich RLK (RECE	0.554	0.518	0.461	9.4e-82

TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1450 (515.5 bits), Expect = 1.6e-148, P = 1.6e-148
 Identities = 299/573 (52%), Positives = 386/573 (67%)

Query:     1 MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
             M+ +S L+ A  +     +N T  + +YA  +C  DL   DC LCFA  + K+PRCLP  
Sbjct:    52 MDAVSPLVEAKGYGQV--VNGTGNLTVYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQ 109

Query:    61 SAT----IFFDGCFLRYDIYSFYQESVSPSLDDVKCSXXXXXXXXXXXXXXXXGFVESVG 116
               T    +F DGC++RYD Y+FY E++S   D   C+                 F ++  
Sbjct:   110 KGTRGGQVFSDGCYIRYDDYNFYNETLSLQ-DRTVCAPKEITGVNRTV------FRDNAA 162

Query:   117 YAVGNVSRIAVEKGG---GFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRM 173
               V N+S  AV  GG   GF     + V+ LAQCWE+L R GC ECL KA +R+  SC +
Sbjct:   163 ELVKNMSVEAVRNGGFYAGFVDRHNVTVHGLAQCWETLNRSGCVECLSKASVRIG-SCLV 221

Query:   174 RKEGRGFNAGCYLRYSTDKFFNHD-DETGDDRGS-SRLGVMIAIVLSTTAFLMLSLFAAY 231
              +EGR  +AGCY+R+ST KF+N+  + T D  G  + LGV++A+  S  AF++L   A +
Sbjct:   222 NEEGRVLSAGCYMRFSTQKFYNNSGNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGF 281

Query:   232 AAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGS 291
                 R +K + ++  LG       KS L F YE LE+AT+YF+   KLGQGG+GSVY G 
Sbjct:   282 LLKKRHAKKQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGV 341

Query:   292 LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
             L NG TVAVKRL FNT+QWVD FFNEVNLIS ++HKNLVKLLGCSI GPESLLVYEY+ N
Sbjct:   342 LTNGKTVAVKRLFFNTKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIAN 401

Query:   352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT 411
             +SL  ++F +   + LNW KRF IILGTAEG+AYLH  S  RIIHRDIK SNILL+ DFT
Sbjct:   402 QSLHDYLFVRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFT 461

Query:   412 PKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
             P+IADFGLAR F  D+TH+STA+AGTLGYMAPEY+VRG+LTEKADVYSFG+L+IE++ G+
Sbjct:   462 PRIADFGLARLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGK 521

Query:   472 RSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALR 531
             R+NAF QD+ S LQ VW+LYR++ + EAVDP L D+F   +   +LQIGLLC QAA   R
Sbjct:   522 RNNAFVQDAGSILQSVWSLYRTSNVEEAVDPILGDNFNKIEASRLLQIGLLCVQAAFDQR 581

Query:   532 PSMAQAIMLLTNKVCEIPTPSQPPFLN-SSVME 563
             P+M+  + ++   + EI TP+QPPFLN  SV+E
Sbjct:   582 PAMSVVVKMMKGSL-EIHTPTQPPFLNPGSVVE 613

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2026821 CRK2 "cysteine-rich RLK (RECEPTOR-like protein kinase) 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1236 (440.2 bits), Expect = 7.8e-126, P = 7.8e-126
 Identities = 258/558 (46%), Positives = 342/558 (61%)

Query:    28 YALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSL 87
             Y LAQC+ DL   DC+LC+A +RT LP+C P     IF DGCF+R + YSFY E   P  
Sbjct:    84 YGLAQCYGDLPLNDCVLCYAEARTMLPQCYPQNGGRIFLDGCFMRAENYSFYNEYKGPE- 142

Query:    88 DDVKCSXXXXXXXXXXXXXXXXGFVESVGYA--VGNVSRIAVEKGGGFGAVKVMGVYALA 145
             D + C                 G   +V  A   G  +R + + G      +    + LA
Sbjct:   143 DSIVCGNTTRKNKTFGDAVRQ-GLRNAVTEASGTGGYARASAKAGES----ESESAFVLA 197

Query:   146 QCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETGDDRG 205
              CW +L  D C++CL+ A   V + C    EGR  + GC+LRYS   F N     G  RG
Sbjct:   198 NCWRTLSPDSCKQCLENASASVVKGCLPWSEGRALHTGCFLRYSDQDFLNKIPRNGRSRG 257

Query:   206 SSRLGVMIAIVLSTTAFLMLSL-FAAYAAYARLSKMKE-DRNNLGLYATSMKKSCLSFKY 263
             S  + V++  VLS+    M+ +  + Y    R  K K     ++   A ++K S L+FKY
Sbjct:   258 S--VVVIVVSVLSSVVVFMIGVAVSVYICKRRTIKRKRRGSKDVEKMAKTLKDSSLNFKY 315

Query:   264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISS 323
              TLEKAT  F+ + KLGQGG G+VY G LP+G  +AVKRL FN R    +F+NEVN+IS+
Sbjct:   316 STLEKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLFFNNRHRATDFYNEVNMIST 375

Query:   324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
             +EHKNLV+LLGCS  GPESLLVYEY+ N+SLD+FIFD N+ K L+W +R+ II+GTAEGL
Sbjct:   376 VEHKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRGKTLDWQRRYTIIVGTAEGL 435

Query:   384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
              YLH  S  +IIHRDIK SNILLD     KIADFGLAR F  D++H+STA+AGTLGYMAP
Sbjct:   436 VYLHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQDDKSHISTAIAGTLGYMAP 495

Query:   444 EYLVRGQLTEKADVYSFGILIIEIVCGRRS--NAFSQDSASPLQRVWTLYRSNKLVEAVD 501
             EYL  GQLTE  DVYSFG+L++EIV G+++  +  S  S S +   W  ++S +L +  D
Sbjct:   496 EYLAHGQLTEMVDVYSFGVLVLEIVTGKQNTKSKMSDYSDSLITEAWKHFQSGELEKIYD 555

Query:   502 PNL--KDDFPA----EQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPP 555
             PNL  K  + +    +++  V+QIGLLCTQ   +LRP M++ + +L NK   +P PS PP
Sbjct:   556 PNLDWKSQYDSHIIKKEIARVVQIGLLCTQEIPSLRPPMSKLLHMLKNKEEVLPLPSNPP 615

Query:   556 FLNSSVMEPGNSSRSCSA 573
             F++  VME  + S   SA
Sbjct:   616 FMDERVMELRDGSDGDSA 633

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010193 "response to ozone" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006457 "protein folding" evidence=RCA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0009408 "response to heat" evidence=RCA

GO:0009644 "response to high light intensity" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

GO:0042542 "response to hydrogen peroxide" evidence=RCA

TAIR|locus:2139845 AT4G28670 [Arabidopsis thaliana (taxid:3702)]

 Score = 962 (343.7 bits), Expect = 8.4e-97, P = 8.4e-97
 Identities = 221/561 (39%), Positives = 318/561 (56%)

Query:    27 IYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPS 86
             +Y L+QC  DLS  +C LC++ +   L +C P+       DGCF+R D YSFYQE VS  
Sbjct:    79 MYVLSQCVSDLSSDECSLCWSRATDLLSQCFPATGGWFHLDGCFVRADNYSFYQEPVSHQ 138

Query:    87 LDDVK-CSXXXXXXXXXXXXXX--XXGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYA 143
               D K C+                    VE+  Y+ G     +V K G    ++ + VY 
Sbjct:   139 --DTKICASDKEKSAEFKGLVKEVTKSIVEAAPYSRG----FSVAKMG----IRDLTVYG 188

Query:   144 LAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETGDD 203
             L  CW +L  + C+ CL    + V  SC   KEG   NAGCYLRYS   F+N        
Sbjct:   189 LGVCWRTLNDELCKLCLADGALSVT-SCLPSKEGFALNAGCYLRYSNYTFYNERGLLAMS 247

Query:   204 RGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRN------NLGLYATSMKKS 257
                  L  +  I +     +    +     Y R S  K+ +       +L  +    K+S
Sbjct:   248 FTKENLTYIFVISMVGVLAIAAGFWCGKCFYMRTSPKKKIKGTKTKKFHLFGHLRIEKES 307

Query:   258 ---C-----LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ 309
                C     +SF+Y TL+KATN FN S KLG GG G V+ G+L +G  +A+KRL  + ++
Sbjct:   308 ESICTESHLMSFEYSTLKKATNNFNESCKLGVGGYGEVFKGTLSDGREIAIKRLHVSGKK 367

Query:   310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
               DE  NE+++IS  +HKNLV+LLGC      S +VYE++ N SLD  +F+  K K L+W
Sbjct:   368 PRDEIHNEIDVISRCQHKNLVRLLGCCFTNMNSFIVYEFLANTSLDHILFNPEKKKELDW 427

Query:   370 NKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
              KR  IILGTAEGL YLH   ET +IIHRDIK SNILLD  + PKI+DFGLA+ +     
Sbjct:   428 KKRRTIILGTAEGLEYLH---ETCKIIHRDIKASNILLDLKYKPKISDFGLAKFYPEGGK 484

Query:   429 HVS------TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA- 481
              +       +++AGTLGYMAPEY+ +G+L+ K D YSFG+L++EI  G R+N F  D++ 
Sbjct:   485 DIPASSLSPSSIAGTLGYMAPEYISKGRLSNKIDAYSFGVLVLEITSGFRNNKFRSDNSL 544

Query:   482 -SPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML 540
              + + +VW  + SNK+ E +D ++ +D   +++  V+QIGLLCTQ +  LRP+M++ I +
Sbjct:   545 ETLVTQVWKCFASNKMEEMIDKDMGEDTDKQEMKRVMQIGLLCTQESPQLRPTMSKVIQM 604

Query:   541 LTNKVCEIPTPSQPPFLNSSV 561
             +++    +PTP++PPFL+ S+
Sbjct:   605 VSSTDIVLPTPTKPPFLHDSM 625

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 741 (265.9 bits), Expect = 1.5e-85, Sum P(2) = 1.5e-85
 Identities = 155/395 (39%), Positives = 236/395 (59%)

Query:   195 NHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSL--FAAYAAYARLSKMKEDRNNLGLYAT 252
             N   E G  +  + +   IA+ +S    L+ ++    A     +LS   ED +  G+ +T
Sbjct:   271 NIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNNKLSAETEDLDEDGITST 330

Query:   253 SMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD 312
                   L F++  +E ATN F+ S KLG GG G VY G L  G TVA+KRL   + Q  +
Sbjct:   331 ET----LQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAE 386

Query:   313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKR 372
             EF NEV++++ ++H+NL KLLG  ++G E +LVYE+VPN+SLD F+FD  K ++L+W +R
Sbjct:   387 EFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRR 446

Query:   373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
             + II G A G+ YLH  S   IIHRD+K SNILLD D  PKI+DFG+AR F  D+T  +T
Sbjct:   447 YKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANT 506

Query:   433 A-VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAF-SQDSASPLQR-VWT 489
               + GT GYM+PEY + G+ + K+DVYSFG+L++E++ G+++++F  +D    L   VW 
Sbjct:   507 KRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTYVWK 566

Query:   490 LYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIP 549
             L+  N  +E VD  ++ +F   +V   + I LLC Q  ++ RPSM   ++++ +    +P
Sbjct:   567 LWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMNSFTVTLP 626

Query:   550 TPSQPPFLNSSVMEPGNSSRSCSANSFISNVAKRI 584
              P +  FL  + M+     RS  + S  S  +K +
Sbjct:   627 IPKRSGFLLRT-MKDSRDPRSGGSASDHSATSKSL 660

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 745 (267.3 bits), Expect = 4.0e-85, Sum P(2) = 4.0e-85
 Identities = 167/397 (42%), Positives = 236/397 (59%)

Query:   198 DETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATS---- 253
             + TG  +G S+  V+IAIV+      +L++        R +K       LG    S    
Sbjct:   276 ERTGKGKGGSK--VIIAIVIPILLVALLAICLCLVLKWRKNKSGYKNKVLGKSPLSGSIA 333

Query:   254 ----MKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ 309
                      L   +ETL+ AT+ F+   +LG+GG GSVY G  P G  +AVKRL  N+ Q
Sbjct:   334 EDEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQ 393

Query:   310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
               +EF NE+ L++ ++H+NLV+L+G  I+G E LLVYE++ N SLDQFIFD  K +LL+W
Sbjct:   394 GDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDW 453

Query:   370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT- 428
               R+ +I G A GL YLH  S  RIIHRD+K SNILLD++  PKIADFGLA+ F + +T 
Sbjct:   454 VVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTM 513

Query:   429 -HVSTA-VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFS----QDSAS 482
              H  T+ +AGT GYMAPEY + GQ + K DV+SFG+L+IEI+ G+R+N       +D+  
Sbjct:   514 THRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAED 573

Query:   483 PLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT 542
              L  VW  +R + ++  +DP+L       ++   + IGLLC Q +AA RP+MA   ++L 
Sbjct:   574 LLSWVWRSWREDTILSVIDPSLTAG-SRNEILRCIHIGLLCVQESAATRPTMATVSLMLN 632

Query:   543 NKVCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISN 579
             +    +PTP +P F+  SV+ P N S S       SN
Sbjct:   633 SYSFTLPTPLRPAFVLESVVIPSNVSSSTEGLQMSSN 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2121606 CRK13 "cysteine-rich RLK (RECEPTOR-like protein kinase) 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 744 (267.0 bits), Expect = 2.5e-83, Sum P(3) = 2.5e-83
 Identities = 156/382 (40%), Positives = 232/382 (60%)

Query:   195 NHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSK--MKEDRNNLGLYAT 252
             N D +  +  G   +  ++AIV+     L++        +AR  K   + + N  G+  T
Sbjct:   284 NRDKKRDNSSGKISMKTILAIVVVGIVILIIISGILARRFARKEKPYQEVELNQTGI--T 341

Query:   253 SMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD 312
             S++   L +K++T+E ATN F  S++LG GG+G V+ G LP+G  +AVKRL   T Q   
Sbjct:   342 SVRS--LQYKFKTIETATNNF--SERLGHGGSGHVFKGRLPDGKEIAVKRLSEKTEQSKK 397

Query:   313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKR 372
             EF NEV L++ ++H+NLV+LLG S++G E ++VYEY+PNRSLD  +FD  K   L+W KR
Sbjct:   398 EFKNEVVLVAKLQHRNLVRLLGFSVKGEEKIIVYEYLPNRSLDYILFDPTKQGELDWKKR 457

Query:   373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
             + II GTA G+ YLH  S+  IIHRD+K  NILLD    PK+ADFG AR F  D++   T
Sbjct:   458 YKIIGGTARGILYLHQDSQPTIIHRDLKAGNILLDAHMNPKVADFGTARIFGMDQSVAIT 517

Query:   433 A-VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
             A  AGT GYMAPEY+  G+ + K+DVYS+G+L++EI+CG+R+ +FS    + +  VW L+
Sbjct:   518 ANAAGTPGYMAPEYMELGEFSMKSDVYSYGVLVLEIICGKRNTSFSSPVQNFVTYVWRLW 577

Query:   492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTP 551
             +S   +  VD  + +++ +E+V   + I LLC Q     RP  +  + +LT+    +P P
Sbjct:   578 KSGTPLNLVDATIAENYKSEEVIRCIHIALLCVQEEPTDRPDFSIIMSMLTSNSLILPVP 637

Query:   552 SQPP-FL----NSSVMEPGNSS 568
               PP F+    N S   P + +
Sbjct:   638 KPPPSFIPGRPNQSTTRPSSQN 659

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=IEP;RCA

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)]

 Score = 801 (287.0 bits), Expect = 3.1e-83, Sum P(2) = 3.1e-83
 Identities = 181/447 (40%), Positives = 250/447 (55%)

Query:   141 VYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFN-HDDE 199
             +YAL QC   +  + C  CL K     +  C     G      CY R+   K++    DE
Sbjct:   193 IYALMQCIPGISSEDCETCLGKCVDDYQSCCNGFIGGVVNKPVCYFRWDGYKYYGAFGDE 252

Query:   200 TGD--------------DRGSSRL--GVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKED 243
                              D    ++  GV++AIV+S   F++L +      + R    K  
Sbjct:   253 APSQPPTPLPLPPPPPRDPDGKKISTGVIVAIVVSAVIFVVL-VALGLVIWKRRQSYKTL 311

Query:   244 RNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRL 303
             + +     TS +   L F + T+E AT+ F+ + KLGQGG G VY G LPN T +AVKRL
Sbjct:   312 KYHTDDDMTSPQS--LQFDFTTIEVATDNFSRNNKLGQGGFGEVYKGMLPNETEIAVKRL 369

Query:   304 IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK 363
               N+ Q   EF NEV +++ ++HKNLV+LLG  IE  E +LVYE+V N+SLD F+FD   
Sbjct:   370 SSNSGQGTQEFKNEVVIVAKLQHKNLVRLLGFCIERDEQILVYEFVSNKSLDYFLFDPKM 429

Query:   364 TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
                L+W +R+NII G   GL YLH  S   IIHRDIK SNILLD D  PKIADFG+AR F
Sbjct:   430 KSQLDWKRRYNIIGGVTRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNF 489

Query:   424 AADRTHVSTA-VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQ--DS 480
               D+T   T  V GT GYM PEY+  GQ + K+DVYSFG+LI+EIVCG+++++F Q  DS
Sbjct:   490 RVDQTEDQTGRVVGTFGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKKNSSFFQMDDS 549

Query:   481 ASPL-QRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM 539
                L   VW L+ ++  ++ +DP +K+ +  ++V   + IG+LC Q   A RP M+    
Sbjct:   550 GGNLVTHVWRLWNNDSPLDLIDPAIKESYDNDEVIRCIHIGILCVQETPADRPEMSTIFQ 609

Query:   540 LLTNKVCEIPTPSQPPFL--NSSVMEP 564
             +LTN    +P P  P F   N   ++P
Sbjct:   610 MLTNSSITLPVPRPPGFFFRNRPNLDP 636

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 769 (275.8 bits), Expect = 3.6e-82, Sum P(2) = 3.6e-82
 Identities = 181/461 (39%), Positives = 256/461 (55%)

Query:   141 VYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDE- 199
             +Y + +C   L    C +CL K G  + +    +  GR     C  RY    F+N  +  
Sbjct:   190 LYGMVRCTPDLREQDCLDCL-KIG--INQVTYDKIGGRILLPSCASRYDNYAFYNESNVG 246

Query:   200 TGDD------RGSSRLGVMIAIVLSTTA-FLML-SLFAAYAAYARLSKMKEDRNNLGLYA 251
             T  D      +G +   ++IA+V+  T  FL+L ++F+  A   R    KE     G   
Sbjct:   247 TPQDSSPRPGKGGNSSVIIIAVVVPITVLFLLLVAVFSVRAKNKRTLNEKEPVAEDGNDI 306

Query:   252 TSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV 311
             T+     L F ++ +E ATN F P  KLGQGG G VY G+L +G  VAVKRL   + Q  
Sbjct:   307 TTA--GSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGE 364

Query:   312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
              EF NEV +++ ++H+NLVKLLG  +EG E +LVYE+VPN+SLD F+FD      L+W +
Sbjct:   365 KEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTR 424

Query:   372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
             R+ II G A G+ YLH  S   IIHRD+K  NILLD D  PKIADFG+AR F  D+T   
Sbjct:   425 RYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAM 484

Query:   432 TA-VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQ--DSASPLQR-V 487
             T  V GT GYM+PEY + GQ + K+DVYSFG+L++EI+ G ++++  Q  +S   L    
Sbjct:   485 TRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYT 544

Query:   488 WTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCE 547
             W L+ +    E VDP+  D++   ++   + I LLC Q  A  RP+M+  + +LT  +  
Sbjct:   545 WRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTTSLIA 604

Query:   548 IPTPSQPPFLNSSVME---PG-NSSRSCSAN-SFISNVAKR 583
             +  P  P F   S  E   P  +SS  CS + + I+ V  R
Sbjct:   605 LAEPRPPGFFFRSKQEQAGPSIDSSTHCSVDEASITRVTPR 645

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 727 (261.0 bits), Expect = 5.8e-82, Sum P(2) = 5.8e-82
 Identities = 165/401 (41%), Positives = 235/401 (58%)

Query:   199 ETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKS- 257
             E G  R SS   V+I +V+   A L+L + A ++  A+ ++   +R  L   +  +  + 
Sbjct:   280 ERGKGRNSS---VIIVVVVPIIALLLLFV-AFFSLRAKKTRTNYEREPLTEESDDITTAG 335

Query:   258 CLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNE 317
              L F ++ +E ATN F  + KLGQGG G VY G  P+G  VAVKRL   + Q   EF NE
Sbjct:   336 SLQFDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANE 395

Query:   318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             V +++ ++H+NLV+LLG  +E  E +LVYE+VPN+SLD FIFD     LL+W +R+ II 
Sbjct:   396 VIVVAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIG 455

Query:   378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA-VAG 436
             G A G+ YLH  S   IIHRD+K  NILL  D   KIADFG+AR F  D+T  +T  + G
Sbjct:   456 GIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVG 515

Query:   437 TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRR-SNAFSQDSASPLQRV---WTLYR 492
             T GYM+PEY + GQ + K+DVYSFG+L++EI+ G++ SN +  D  S    V   W L+ 
Sbjct:   516 TYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMDGTSAGNLVTYTWRLWS 575

Query:   493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPS 552
             +   +E VDP+ +D++   +V   + I LLC Q  A  RP+M+  + +LT     +  P 
Sbjct:   576 NGSPLELVDPSFRDNYRINEVSRCIHIALLCVQEEAEDRPTMSAIVQMLTTSSIALAVPQ 635

Query:   553 QPPFL-NSSVMEP-G-------NSSRSCSAN-SFISNVAKR 583
             +P F   SS  E  G       N+S  CS + + I+NV  R
Sbjct:   636 RPGFFFRSSKHEQVGLVDRLSINTSALCSVDDASITNVTPR 676

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

TAIR|locus:2125766 CRK40 "cysteine-rich RLK (RECEPTOR-like protein kinase) 40" [Arabidopsis thaliana (taxid:3702)]

 Score = 746 (267.7 bits), Expect = 9.4e-82, Sum P(2) = 9.4e-82
 Identities = 162/351 (46%), Positives = 220/351 (62%)

Query:   210 GVMIAIVLSTTAFLMLSLFAAYA-AYARLSKMKEDRNNLGL--YATSMKKSCLSFKYETL 266
             G +IAIV+  T F+ L +F  +   YAR  K+    NN+G   Y+ S  +  L F    +
Sbjct:   287 GGIIAIVVVFT-FINLLVFIGFIKVYARRGKL----NNVGSAEYSDSDGQFMLRFDLGMI 341

Query:   267 EKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH 326
               AT+ F+    LGQGG G+VY G+ PNG  VAVKRL   + Q   EF NEV+L++ ++H
Sbjct:   342 VMATDDFSSENTLGQGGFGTVYKGTFPNGQEVAVKRLTKGSGQGDMEFKNEVSLLTRLQH 401

Query:   327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
             KNLVKLLG   EG E +LVYE+VPN SLD FIFD++K  LL W  RF II G A GL YL
Sbjct:   402 KNLVKLLGFCNEGDEEILVYEFVPNSSLDHFIFDEDKRSLLTWEVRFRIIEGIARGLLYL 461

Query:   387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA-VAGTLGYMAPEY 445
             H  S+ +IIHRD+K SNILLD +  PK+ADFG AR F +D T   T  +AGT GYMAPEY
Sbjct:   462 HEDSQLKIIHRDLKASNILLDAEMNPKVADFGTARLFDSDETRAETKRIAGTRGYMAPEY 521

Query:   446 LVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK 505
             L  GQ++ K+DVYSFG++++E++ G R+N+F  +  +     W  +   K    +DP L 
Sbjct:   522 LNHGQISAKSDVYSFGVMLLEMISGERNNSFEGEGLAAF--AWKRWVEGKPEIIIDPFLI 579

Query:   506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPF 556
             ++ P  ++  ++QIGLLC Q  +  RP+M+  I+ L ++   IP P  P F
Sbjct:   580 EN-PRNEIIKLIQIGLLCVQENSTKRPTMSSVIIWLGSETIIIPLPKAPAF 629

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FNE1	CRK42_ARATH	2, ., 7, ., 1, 1, ., -	0.5996	0.8903	0.8356	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00020696001 SubName- Full=Chromosome chr14 scaffold_21, whole genome shotgun sequence; (659 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	611
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-52
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-46
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-46
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-46
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-46
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-40
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-36
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-34
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-32
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-32
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-31
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-30
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-30
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-28
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-26
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-26
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-26
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-25
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-25
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-25
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-25
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-24
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-24
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-24
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-24
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-23
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-22
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-22
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-22
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-22
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-21
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-21
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-20
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-20
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-20
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-20
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-20
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-20
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-20
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-20
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-19
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-18
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-15
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-15
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-15
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-14
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-14
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-14
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-13
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-12
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-11
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	5e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-11
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	7e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	8e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (450), Expect = 9e-52
 Identities = 70/193 (36%), Positives = 106/193 (54%), Gaps = 10/193 (5%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCS 336
           LG+GG G+VY+      G  VA+K +        ++E   E+ ++  + H N+VKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     LV EY    SL   + +      L+ ++   I+L   EGL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 397 RDIKTSNILLDKD-FTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL-VRGQLTEK 454
           RD+K  NILLD D    K+ADFGL++   +D++ + T V GT  YMAPE L  +G  +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEK 174

Query: 455 ADVYSFGILIIEI 467
           +D++S G+++ E+
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  171 bits (435), Expect = 4e-49
 Identities = 69/199 (34%), Positives = 102/199 (51%), Gaps = 11/199 (5%)

Query: 277 KKLGQGGAGSVYMGSLPN-GTTVAVKRL-IFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +KLG G  G+VY       G  VAVK L   + +   D+    E+ ++  + H N+V+L+
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
               +     LV EY     L  ++        L+ ++   I L    GL YLH      
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLH---SNG 118

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL-T 452
           IIHRD+K  NILLD++   KIADFGLA+      + ++T V GT  YMAPE L+ G    
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177

Query: 453 EKADVYSFGILIIEIVCGR 471
            K DV+S G+++ E++ G+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  164 bits (417), Expect = 1e-46
 Identities = 65/198 (32%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +KLG+G  G VY+      G  VA+K +     ++  +    E+ ++  ++H N+V+L  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 335 CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
              E  + L LV EY     L   +  K + +L     RF  +      L YLH      
Sbjct: 65  -VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLH---SKG 117

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
           I+HRD+K  NILLD+D   K+ADFGLAR    D     T   GT  YMAPE L+     +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFVGTPEYMAPEVLLGKGYGK 175

Query: 454 KADVYSFGILIIEIVCGR 471
             D++S G+++ E++ G+
Sbjct: 176 AVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  163 bits (416), Expect = 2e-46
 Identities = 68/208 (32%), Positives = 98/208 (47%), Gaps = 23/208 (11%)

Query: 277 KKLGQGGAGSVYMGSL----PNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           KKLG+G  G VY G L       T VAVK L    + +   +F  E  ++  + H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFI------FDKNKTKLLNWNKRFNIILGTAEGLAY 385
           LLG   E     LV EY+    L  ++      F   +   L+     +  +  A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG-----Y 440
           L      + +HRD+   N L+ +D   KI+DFGL+R    D          T G     +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR----DVYDDDYYRKKTGGKLPIRW 173

Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIV 468
           MAPE L  G  T K+DV+SFG+L+ EI 
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIF 201

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  163 bits (416), Expect = 3e-46
 Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 20/205 (9%)

Query: 277 KKLGQGGAGSVYMGSL-----PNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           KKLG+G  G VY G+L        T VAVK L    + +  +EF  E +++  + H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +LLG   +G    +V EY+P   L  F+  +   + L       + L  A+G+ YL    
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE--- 119

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY-----MAPEY 445
               +HRD+   N L+ ++   KI+DFGL+R    D            G      MAPE 
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSR----DIYEDDYYRKRGGGKLPIKWMAPES 175

Query: 446 LVRGQLTEKADVYSFGILIIEIVCG 470
           L  G+ T K+DV+SFG+L+ EI   
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  163 bits (414), Expect = 4e-46
 Identities = 67/198 (33%), Positives = 100/198 (50%), Gaps = 11/198 (5%)

Query: 276 SKKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
            KKLG+G  G VY G L          VAVK L  + + Q ++EF  E  ++  ++H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLLG   E     +V EY+    L  ++  +     L+ +   +  L  A G+ YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
                IHRD+   N L+ ++   KI+DFGL+R    D  +        + +MAPE L  G
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178

Query: 450 QLTEKADVYSFGILIIEI 467
           + T K+DV+SFG+L+ EI
Sbjct: 179 KFTSKSDVWSFGVLLWEI 196

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  162 bits (413), Expect = 6e-46
 Identities = 71/197 (36%), Positives = 105/197 (53%), Gaps = 10/197 (5%)

Query: 277 KKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLV 330
           KKLG+G  G VY G+L          VAVK L  +   Q ++EF  E  ++  ++H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           KLLG   E    ++V EY+P   L  ++  KN+ K L+ +   +  L  A G+ YL    
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
               IHRD+   N L+ ++   KI+DFGL+R    D  +        + +MAPE L  G+
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 451 LTEKADVYSFGILIIEI 467
            T K+DV+SFG+L+ EI
Sbjct: 181 FTSKSDVWSFGVLLWEI 197

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  153 bits (388), Expect = 2e-42
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 30/211 (14%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIF--NTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           + LG+G  GSVY+      G  +AVK +    ++ + ++    E+ ++SS++H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 334 GCSI-EGPESLLVY-EYVPNRSLDQFIFDKNKTKLLNWNKRFNI---------ILGTAEG 382
           G    E   +L ++ EYV   SL   +  K          +            IL   EG
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL--KK-------FGKLPEPVIRKYTRQIL---EG 113

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA-VAGTLGYM 441
           LAYLH      I+HRDIK +NIL+D D   K+ADFG A+      T   T  V GT  +M
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRR 472
           APE +   +    AD++S G  +IE+  G+ 
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  148 bits (375), Expect = 1e-40
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)

Query: 272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
            F   +K+G+GG G VY       G  VA+K +   +++  ++  NE+ ++   +H N+V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLA 384
           K  G  ++  E  +V E+    SL           L + N+         +     +GL 
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDL--------LKSTNQTLTESQIAYVCKELLKGLE 112

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      IIHRDIK +NILL  D   K+ DFGL+   +  +   +    GT  +MAPE
Sbjct: 113 YLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPE 167

Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGR 471
            +       KAD++S GI  IE+  G+
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  135 bits (341), Expect = 7e-36
 Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 10/197 (5%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLG 334
            +G+G  G VY G +L  G  VA+K++       + +     E++L+ +++H N+VK +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                    ++ EY  N SL Q I    K      +     +    +GLAYLH   E  +
Sbjct: 67  SIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLH---EQGV 120

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK 454
           IHRDIK +NIL  KD   K+ADFG+A            +V GT  +MAPE +     +  
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGTPYWMAPEVIEMSGASTA 179

Query: 455 ADVYSFGILIIEIVCGR 471
           +D++S G  +IE++ G 
Sbjct: 180 SDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  133 bits (335), Expect = 4e-34
 Identities = 81/352 (23%), Positives = 130/352 (36%), Gaps = 20/352 (5%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSI-EHKN 328
           +   +KLG+G  G VY+    +   VA+K L   + +  + V+ F  E+ +++S+    N
Sbjct: 2   YRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           +VKL     +     LV EYV   SL+  +    +   L+ ++   I+      L YLH 
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH- 118

Query: 389 GSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCFAADRTHVS-----TAVAGTLGYMA 442
                IIHRDIK  NILLD+D    K+ DFGLA+      +  S     +   GT GYMA
Sbjct: 119 --SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 443 PEYL---VRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           PE L        +  +D++S GI + E++ G     F  +  S                +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP--FEGEKNSSATSQTLKIILELPTPS 234

Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNS 559
           +   L    P         +           R S +  +        ++        L  
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKP 294

Query: 560 SVMEPGNSSRSCSANSFISNVAKRIEVSYSSSESSSTHSSDAHSRSRELTQK 611
               P   S   S  + IS++              S  S +        +  
Sbjct: 295 DDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPH 346

Length = 384

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  126 bits (318), Expect = 2e-32
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
              +   +K+G+G +G VY       G  VA+K++    +Q  +   NE+ ++   +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRL-RKQNKELIINEILIMKDCKHPN 76

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWN-KRFN------IILGTAE 381
           +V      + G E  +V EY+   SL         T ++  N  R N      +     +
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSL---------TDIITQNFVRMNEPQIAYVCREVLQ 127

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL YLH      +IHRDIK+ NILL KD + K+ADFG A     +++  ++ V GT  +M
Sbjct: 128 GLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWM 183

Query: 442 APEYLVRGQL-TEKADVYSFGILIIEIVCG 470
           APE +++ +    K D++S GI+ IE+  G
Sbjct: 184 APE-VIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  124 bits (313), Expect = 6e-32
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 26/216 (12%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           K++G+G  G VY+     +G    +K +  +  + +  ++  NEV ++  + H N++K  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKT-------KLLNWNKRF-NIILGTAEGLAY 385
               E  +  +V EY     L Q I  + K        ++L+W   F  + L     L Y
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FVQLCLA----LKY 118

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEY 445
           LH     +I+HRDIK  NI L  +   K+ DFG+++  ++      T V GT  Y++PE 
Sbjct: 119 LH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE- 173

Query: 446 LVRGQ-LTEKADVYSFGILIIEIVCGRRSNAFSQDS 480
           L + +    K+D++S G ++ E+   +    F  ++
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKH--PFEGEN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  120 bits (304), Expect = 9e-31
 Identities = 75/201 (37%), Positives = 96/201 (47%), Gaps = 11/201 (5%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGC 335
            +G G    VY    LPN   VA+KR+     Q  VDE   EV  +S   H N+VK    
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  LV  Y+   SL   +        L+      ++    +GL YLH       I
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQI 124

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA--ADRTH-VSTAVAGTLGYMAPEYL--VRGQ 450
           HRDIK  NILL +D + KIADFG++   A   DRT  V     GT  +MAPE +  V G 
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG- 183

Query: 451 LTEKADVYSFGILIIEIVCGR 471
              KAD++SFGI  IE+  G 
Sbjct: 184 YDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  119 bits (300), Expect = 2e-30
 Identities = 69/192 (35%), Positives = 99/192 (51%), Gaps = 6/192 (3%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KKLG G  G V+MG     T VA+K L   +    + F  E NL+  ++H  LV+L    
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+      KL   NK  ++    AEG+A++        IH
Sbjct: 71  TQEP-IYIITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIE---RKNYIH 125

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+ +    KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185

Query: 457 VYSFGILIIEIV 468
           V+SFGIL+ EIV
Sbjct: 186 VWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  118 bits (297), Expect = 6e-30
 Identities = 85/275 (30%), Positives = 132/275 (48%), Gaps = 48/275 (17%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIF-----NTRQWVDEFFNEVNLISSIEHKNLVKL 332
           LG G  GSVY G +L +G   AVK +         ++ V +   E+ L+S ++H N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 333 LGCSIEGPESLLVY-EYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAE---G 382
           LG   E  ++L ++ E VP  SL          KLL   K++       I L T +   G
Sbjct: 68  LGTEREE-DNLYIFLELVPGGSL---------AKLL---KKYGSFPEPVIRLYTRQILLG 114

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           L YLH       +HRDIK +NIL+D +   K+ADFG+A+         S    G+  +MA
Sbjct: 115 LEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMA 169

Query: 443 PEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD 501
           PE + + G     AD++S G  ++E+  G+    +SQ     +  V+ + RS +L     
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGK--PPWSQ--LEGVAAVFKIGRSKEL----- 220

Query: 502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
           P + D    E    +L+    C Q   +LRP+ A+
Sbjct: 221 PPIPDHLSDEAKDFILK----CLQRDPSLRPTAAE 251

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  117 bits (294), Expect = 2e-29
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 25/211 (11%)

Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
             K+G G  G VY   +L  G  +AVK  R+  N  + + E  +E+ ++  ++H NLVK 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQF-----IFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
            G  +   +  +  EY    +L++      I D++  +       + + L   EGLAYLH
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR------VYTLQL--LEGLAYLH 116

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG---YMAPE 444
                 I+HRDIK +NI LD +   K+ DFG A     + T +   V    G   YMAPE
Sbjct: 117 ---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173

Query: 445 YLVRGQLTEK---ADVYSFGILIIEIVCGRR 472
            +  G+       AD++S G +++E+  G+R
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 1e-28
 Identities = 75/196 (38%), Positives = 100/196 (51%), Gaps = 13/196 (6%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           +KLG G  G V+MG+    T VAVK L   T    + F  E  ++  + H  LV+L   C
Sbjct: 12  RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           S E P   +V EY+   SL  F+      KL    +  ++    AEG+AYL        I
Sbjct: 71  SEEEP-IYIVTEYMSKGSLLDFLKSGEGKKL-RLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT---LGYMAPEYLVRGQLT 452
           HRD+   NIL+ ++   KIADFGLAR    D     TA  G    + + APE    G+ T
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAANYGRFT 182

Query: 453 EKADVYSFGILIIEIV 468
            K+DV+SFGIL+ EIV
Sbjct: 183 IKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  113 bits (284), Expect = 4e-28
 Identities = 64/195 (32%), Positives = 96/195 (49%), Gaps = 9/195 (4%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KLG+G  GSVY       G  VA+K  +    + + E   E++++   +   +VK  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +  +  +V EY    S+   +   NKT  L   +   I+  T +GL YLH     + IH
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLH---SNKKIH 122

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RDIK  NILL+++   K+ADFG++     D       V GT  +MAPE +       KAD
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSG-QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKAD 181

Query: 457 VYSFGILIIEIVCGR 471
           ++S GI  IE+  G+
Sbjct: 182 IWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  112 bits (280), Expect = 1e-27
 Identities = 79/222 (35%), Positives = 111/222 (50%), Gaps = 14/222 (6%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KKLG G  G V+MG   N T VAVK L   T   V  F  E NL+ +++H  LV+L    
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+   SL  F+      K+L   K  +     AEG+AY+        IH
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIH 126

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +N+L+ +    KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186

Query: 457 VYSFGILIIEIVC-GR-----RSNAFSQDSASPLQRVWTLYR 492
           V+SFGIL+ EIV  G+      SN+   D  S LQR + + R
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQRGYRMPR 225

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  110 bits (278), Expect = 4e-27
 Identities = 73/281 (25%), Positives = 127/281 (45%), Gaps = 22/281 (7%)

Query: 276 SKKLGQGGAGSVYMGSLPN-----GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNL 329
            K+LG+G  G V +          G  VAVK L  +   Q   +F  E+ ++ +++H+N+
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 330 VKLLGCSIE--GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           VK  G   +  G    L+ EY+P+ SL  ++  +++ ++    +         +G+ YL 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINL-KRLLLFSSQICKGMDYLG 126

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YMAPEY 445
                R IHRD+   NIL++ +   KI+DFGLA+    D+ +      G     + APE 
Sbjct: 127 ---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183

Query: 446 LVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSA---SPLQRVWTLYRSNKLVEAVD 501
           L   + +  +DV+SFG+ + E+   G  S +   +        Q    + R   L+E + 
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR---LLELLK 240

Query: 502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT 542
              +   P      V  +  LC +A    RPS A  I+++ 
Sbjct: 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 1e-26
 Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 27/205 (13%)

Query: 279 LGQGGAGSVYMGSLPN-GTTVAV----KRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+G  G V +    + G   A+    K+ I   ++ V+    E N++S I H  +VKL 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE-VEHTLTERNILSRINHPFIVKLH 59

Query: 334 GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN---IILGTAE---GLAYL 386
             + +  E L LV EY P   L            L+   RF+        AE    L YL
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGELF---------SHLSKEGRFSEERARFYAAEIVLALEYL 109

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL 446
           H      II+RD+K  NILLD D   K+ DFGLA+  +++ +  +T   GT  Y+APE L
Sbjct: 110 H---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVL 165

Query: 447 VRGQLTEKADVYSFGILIIEIVCGR 471
           +     +  D +S G+L+ E++ G+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 2e-26
 Identities = 72/206 (34%), Positives = 107/206 (51%), Gaps = 25/206 (12%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN-----EVNLISSIEHKNLV 330
           +KLG+G  G VY       G  VA+K++  +     +E        E++L+  ++H N+V
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---EEGIPSTALREISLLKELKHPNIV 61

Query: 331 KLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNI-ILGTAEGLAYLH 387
           KLL   I     L LV+EY  +  L +++ DK    L  N  K     +L    GLAY H
Sbjct: 62  KLL-DVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIKSIMYQLL---RGLAYCH 115

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYL 446
                RI+HRD+K  NIL+++D   K+ADFGLAR F    RT+    V  TL Y APE L
Sbjct: 116 ---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEIL 170

Query: 447 VRGQL-TEKADVYSFGILIIEIVCGR 471
           +  +  +   D++S G +  E++ G+
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  108 bits (271), Expect = 3e-26
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 24/205 (11%)

Query: 277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIF----NTRQWVDEFFNEVNLISSIEHKNLVK 331
           K LGQG +G VY     P G   A+K++        R+ +     E+  + S E   +VK
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCESPYVVK 63

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA-----EGLAYL 386
             G   +  E  +V EY+   SL   +      K+    +    +L        +GL YL
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEP---VLAYIARQILKGLDYL 115

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL 446
           H  ++  IIHRDIK SN+L++     KIADFG+++         +T V GT+ YM+PE +
Sbjct: 116 H--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERI 172

Query: 447 VRGQLTEKADVYSFGILIIEIVCGR 471
                +  AD++S G+ ++E   G+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 4e-26
 Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 35/271 (12%)

Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE 338
           +G+G  G V +G    G  VAVK L  +       F  E ++++++ H NLV+LLG  ++
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
           G    +V EY+   SL  ++  + +  ++   ++    L   EG+ YL    E   +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127

Query: 399 IKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL--GYMAPEYLVRGQLTEKAD 456
           +   N+L+ +D   K++DFGLA+   A +   S    G L   + APE L   + + K+D
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK--EASQGQDS----GKLPVKWTAPEALREKKFSTKSD 181

Query: 457 VYSFGILIIEIVCGRRSNAFSQDSAS----PLQRVWTLYRSNKLVEAVDPNLKDDFPAEQ 512
           V+SFGIL+ EI        +S         PL+ V         V  V+   + + P   
Sbjct: 182 VWSFGILLWEI--------YSFGRVPYPRIPLKDV---------VPHVEKGYRMEAPEGC 224

Query: 513 VCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
              V ++   C +   A RP+  Q    L  
Sbjct: 225 PPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 4e-26
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 29/206 (14%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTT----VAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G  +P G      VA+K L   T  +   E  +E  +++S++H ++V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTK-----LLNWNKRFNIILGTAEGLAY 385
           +LLG  +   +  L+ + +P   L  ++ + +K       LLNW  +       A+G++Y
Sbjct: 73  RLLGICL-SSQVQLITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQI------AKGMSY 124

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTP---KIADFGLARCFAADRTHVSTAVAGT-LGYM 441
           L    E R++HRD+   N+L+    TP   KI DFGLA+    D            + +M
Sbjct: 125 L---EEKRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 442 APEYLVRGQLTEKADVYSFGILIIEI 467
           A E ++    T K+DV+S+G+ + E+
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  106 bits (267), Expect = 7e-26
 Identities = 68/214 (31%), Positives = 111/214 (51%), Gaps = 33/214 (15%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNT---------RQWVDEFFNEVNLISSIEHKN 328
           +G G  GSVY+G +  +G  +AVK++   +         R  +D    E+ L+  ++H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIILGTAEG 382
           +V+ LG S++     +  EYVP  S+           LLN    F      N +    +G
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQILKG 118

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST-----AVAGT 437
           L YLH      IIHRDIK +NIL+D     KI+DFG+++   A+     T     ++ G+
Sbjct: 119 LNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           + +MAPE + +   T KAD++S G L++E++ G+
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 1e-25
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 40/215 (18%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEF----FNEVNLISSIEHKNLVK 331
            ++G+G  G VY   +   G  VA+K++     +  + F      E+ L+  + H N+V+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62

Query: 332 LLG--CSIEGPESLLVYEYVPN--RSLDQFIFDKNKTKLLNWNKRFNI---------ILG 378
           L     S       +V+EY+ +    L           L +   +F           +L 
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLTGL-----------LDSPEVKFTESQIKCYMKQLL- 110

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
             EGL YLH      I+HRDIK SNIL++ D   K+ADFGLAR +    +   T    TL
Sbjct: 111 --EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITL 165

Query: 439 GYMAPEYLVRG--QLTEKADVYSFGILIIEIVCGR 471
            Y  PE L+ G  +   + D++S G ++ E+  G+
Sbjct: 166 WYRPPELLL-GATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  106 bits (265), Expect = 2e-25
 Identities = 71/214 (33%), Positives = 114/214 (53%), Gaps = 26/214 (12%)

Query: 276 SKKLGQGGAGSVYMGSL--PNG----TTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKN 328
            ++LG+G  G VY G L  PN     T+VA+K L  N    V  EF  E  L+S ++H N
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN 69

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIF-------------DKNKTKLLNWNKRFN 374
           +V LLG C+ E P  +L +EY+ +  L +F+              D+     L+ +   +
Sbjct: 70  IVCLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTA 433
           I +  A G+ YL   S    +HRD+   N L+ +  T KI+DFGL+R  ++AD   V + 
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
               + +M PE ++ G+ T ++D++SFG+++ EI
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  105 bits (264), Expect = 3e-25
 Identities = 75/283 (26%), Positives = 130/283 (45%), Gaps = 37/283 (13%)

Query: 278 KLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQ-WV-DEFFNEVNLISSIEHKNLVKLLG 334
           ++G+G  G V+       G TVA+K++     +  + ++   E+  + + +H  +VKLL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
               G   +LV EY+P   L + + D+ +       K +  +L   +G+AY+H      I
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHA---NGI 120

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ-LTE 453
           +HRD+K +N+L+  D   KIADFGLAR F+ +   + +    T  Y APE L   +    
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180

Query: 454 KADVYSFGILIIEIVCGRRSNAFSQDS------------ASPLQRVWTLYRS----NKLV 497
             D+++ G +  E++ G  S  F  ++             +P +  W    S    NK+ 
Sbjct: 181 GVDLWAVGCIFAELLNG--SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238

Query: 498 --EAVDPNLKDDFPAEQVC--NVLQIGLLCTQ-----AAAALR 531
             E+    L++ FP       ++L+  L+        AA ALR
Sbjct: 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  105 bits (264), Expect = 4e-25
 Identities = 83/274 (30%), Positives = 126/274 (45%), Gaps = 33/274 (12%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIEHK 327
           F   +++G G  G+VY    +     VA+K++ ++ +Q    W D    EV  +  + H 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQQLRHP 75

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           N ++  GC +    + LV EY    + D  I + +K K L   +   I  G  +GLAYLH
Sbjct: 76  NTIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHK-KPLQEVEIAAICHGALQGLAYLH 132

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV 447
             S  RI HRDIK  NILL +  T K+ADFG A   +   + V     GT  +MAPE ++
Sbjct: 133 --SHERI-HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVIL 184

Query: 448 ---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL 504
               GQ   K DV+S GI  IE+   R+   F+ ++ S L  +          +   P L
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALYHI---------AQNDSPTL 234

Query: 505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
             +  ++   N +     C Q     RPS  + +
Sbjct: 235 SSNDWSDYFRNFVD---SCLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  104 bits (261), Expect = 4e-25
 Identities = 70/223 (31%), Positives = 107/223 (47%), Gaps = 25/223 (11%)

Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNE 317
           L ++YE  E           LG+G  G VY    L     +A+K +     ++V     E
Sbjct: 1   LEYEYEYDEN-----GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEE 55

Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDK------NKTKLLNWNK 371
           + L S ++H+N+V+ LG   E     +  E VP  SL   +  K      N+  ++ + K
Sbjct: 56  IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK 115

Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAADRTHV 430
           +   IL   EGL YLH   + +I+HRDIK  N+L++      KI+DFG ++  A      
Sbjct: 116 Q---IL---EGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166

Query: 431 STAVAGTLGYMAPEYLVRGQ--LTEKADVYSFGILIIEIVCGR 471
            T   GTL YMAPE + +G       AD++S G  I+E+  G+
Sbjct: 167 ET-FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 4e-25
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 11/199 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN--EVNLISSIEHKNLVKLL 333
            K+G+G  G VY       G  VA+K++               E+ L+  + H N++KLL
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
                  +  LV+E++ +  L + I  K++ + L  +   + +    +GLA+ H      
Sbjct: 65  DVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR-GQLT 452
           I+HRD+K  N+L++ +   K+ADFGLAR F +     +  V  T  Y APE L+     +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYS 177

Query: 453 EKADVYSFGILIIEIVCGR 471
              D++S G +  E++  R
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 5e-25
 Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 7/217 (3%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           +KLG G  G V+ G   N T VAVK L   T     +F  E  ++  + H  L++L   C
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           ++E P   +V E +   SL +++      + L   +  ++    A G+AYL        I
Sbjct: 71  TLEEP-IYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYI 125

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HRD+   N+L+ ++   K+ADFGLAR    D           + + APE  +  + + K+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 456 DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR 492
           DV+SFGIL+ EIV   R       +A  LQ+V   YR
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR 222

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 1e-24
 Identities = 71/270 (26%), Positives = 120/270 (44%), Gaps = 33/270 (12%)

Query: 277 KKLGQGGAGSVYMG--SLPNGT--TVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVK 331
           K+LG G  GSV  G   + +G    VAVK L          EF  E ++++ ++H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT---KLLNWNKRFNIILGTAEGLAYLHG 388
           L+G   +G   +LV E  P   L +++  + +     L             A G+AYL  
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE- 112

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYL 446
                 +HRD+   N+LL      KI+DFG++R   A   +     AG   L + APE +
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170

Query: 447 VRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD 506
             G+ + K+DV+S+G+ + E        AFS   A P   +    +  +++  ++   + 
Sbjct: 171 NYGKFSSKSDVWSYGVTLWE--------AFSY-GAKPYGEM----KGAEVIAMLESGERL 217

Query: 507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
             P E    +  I L C +     RP+ ++
Sbjct: 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSE 247

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  102 bits (257), Expect = 1e-24
 Identities = 64/196 (32%), Positives = 96/196 (48%), Gaps = 5/196 (2%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           F   +KLG G  G V+ G   N   VA+K L  +      +F  EV  +  + HK+L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
                 G    ++ E +   SL  F+    + ++L      ++    AEG+AYL    E 
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLE---EQ 123

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
             IHRD+   NIL+ +D   K+ADFGLAR    D  ++S+       + APE    G  +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKED-VYLSSDKKIPYKWTAPEAASHGTFS 182

Query: 453 EKADVYSFGILIIEIV 468
            K+DV+SFGIL+ E+ 
Sbjct: 183 TKSDVWSFGILLYEMF 198

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  103 bits (259), Expect = 1e-24
 Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 44/230 (19%)

Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE------ 325
           F   K +G+G   +V +          A+K  I + RQ + E   +V  +  IE      
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIK--ILDKRQLIKE--KKVKYVK-IEKEVLTR 57

Query: 326 ---HKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
              H  ++KL   + +  E+L  V EY PN  L Q+I    K   L+             
Sbjct: 58  LNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILL 113

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF------------------ 423
            L YLH      IIHRD+K  NILLDKD   KI DFG A+                    
Sbjct: 114 ALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 424 --AADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
               +R   ++ V GT  Y++PE L      + +D+++ G +I +++ G+
Sbjct: 171 QIEKNRRRFASFV-GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  102 bits (256), Expect = 2e-24
 Identities = 64/194 (32%), Positives = 100/194 (51%), Gaps = 12/194 (6%)

Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KLG G  G VY G       TVAVK L  +T + V+EF  E  ++  I+H NLV+LLG  
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
              P   ++ E++   +L  ++ + N+   +N      +    +  + YL   +    IH
Sbjct: 72  TREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FIH 127

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT---LGYMAPEYLVRGQLTE 453
           RD+   N L+ ++   K+ADFGL+R    D     TA AG    + + APE L   + + 
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 454 KADVYSFGILIIEI 467
           K+DV++FG+L+ EI
Sbjct: 185 KSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)

Query: 279 LGQGGAGSVYMGSLPNG------TTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVK 331
           LG+G  G V++G   +         VAVK L         + F  E  L+++ +H+N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF-----------IFDKNKTKLLNWNKRFNIILGTA 380
             G   EG   ++V+EY+ +  L++F               +    L  ++   I +  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLG 439
            G+ YL   +    +HRD+ T N L+  D   KI DFG++R  +  D   V       + 
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEI 467
           +M PE ++  + T ++DV+SFG+++ EI
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  102 bits (254), Expect = 3e-24
 Identities = 66/194 (34%), Positives = 101/194 (52%), Gaps = 10/194 (5%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KKLG G  G V+M +    T VAVK +   +   V+ F  E N++ +++H  LVKL    
Sbjct: 12  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 70

Query: 337 IEGPESLLVYEYVPNRSLDQFIF--DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            + P   ++ E++   SL  F+   + +K  L    K  +     AEG+A++    +   
Sbjct: 71  TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPL---PKLIDFSAQIAEGMAFIE---QRNY 123

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK 454
           IHRD++ +NIL+      KIADFGLAR    +           + + APE +  G  T K
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183

Query: 455 ADVYSFGILIIEIV 468
           +DV+SFGIL++EIV
Sbjct: 184 SDVWSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  101 bits (253), Expect = 4e-24
 Identities = 72/216 (33%), Positives = 106/216 (49%), Gaps = 6/216 (2%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KKLG G  G V+MG+    T VAVK L   T    + F  E  ++  + H  LV+L    
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            E P   +V EY+   SL  F+ D  + + L      ++    A G+AY+        IH
Sbjct: 71  SEEP-IYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++++NIL+      KIADFGLAR    +           + + APE  + G+ T K+D
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR 492
           V+SFGIL+ E+V   R      ++   L++V   YR
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 221

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  101 bits (253), Expect = 7e-24
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 38/217 (17%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNT----------RQWVDEFFNEVNLISSIEHK 327
           +G+G  G VY+  ++  G  +AVK++              +  V    +E+  +  ++H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 328 NLVKLLGCSIEGPESLLVY-EYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
           N+V+ LG      E L ++ EYVP  S+   +     F++   +               E
Sbjct: 69  NIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLE 119

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR----CFAADRTHVSTAVAGT 437
           GLAYLH      I+HRD+K  N+L+D D   KI+DFG+++     +  D+     ++ G+
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---MSMQGS 173

Query: 438 LGYMAPE--YLVRGQLTEKADVYSFGILIIEIVCGRR 472
           + +MAPE  +      + K D++S G +++E+  GRR
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 99.1 bits (247), Expect = 3e-23
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 26/206 (12%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLV 330
           K LGQG  G VY+   +  G  +AVK++ F+     T++ V+    E+ L+ +++H+ +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 331 KLLGCSIEGPESLLVY-EYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAEGLA 384
           +  GC +   E+L ++ EY+P  S+   +       +  T+     K    IL   EG+ 
Sbjct: 68  QYYGC-LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-----KYTRQIL---EGVE 118

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMA 442
           YLH      I+HRDIK +NIL D     K+ DFG ++      +  +   +V GT  +M+
Sbjct: 119 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175

Query: 443 PEYLVRGQLTEKADVYSFGILIIEIV 468
           PE +       KADV+S G  ++E++
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEML 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 98.2 bits (244), Expect = 7e-23
 Identities = 66/195 (33%), Positives = 98/195 (50%), Gaps = 6/195 (3%)

Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H  LV L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V E++   SL  F+  +   K L   +  ++    A+G+AY+        IHR
Sbjct: 72  EEP-IYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D++ +NIL+  +   KIADFGLAR    +           + + APE  + G+ T K+DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 458 YSFGILIIEIVCGRR 472
           +SFGIL+ E+V   R
Sbjct: 187 WSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 98.3 bits (245), Expect = 8e-23
 Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 30/273 (10%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL-IFN-----TRQWVDEFFNEVNLIS 322
              F   KK+G+G    VY    L +G  VA+K++ IF       RQ   +   E++L+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57

Query: 323 SIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFNIILGTA 380
            ++H N++K L   IE  E  +V E      L + I  F K K +L+     +   +   
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTIWKYFVQLC 116

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY 440
             L ++H     RI+HRDIK +N+ +      K+ D GL R F++  T   + V GT  Y
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172

Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           M+PE +       K+D++S G L+ E+   +  + F  D  +       LY   K +E  
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMN-------LYSLCKKIEKC 223

Query: 501 D-PNLKDDFPAEQVCNVLQIGLLCTQAAAALRP 532
           D P L  D  +E++ +++     C       RP
Sbjct: 224 DYPPLPADHYSEELRDLVSR---CINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 97.8 bits (244), Expect = 9e-23
 Identities = 62/203 (30%), Positives = 90/203 (44%), Gaps = 22/203 (10%)

Query: 277 KKLGQGGAGSVYMG--SLPNGTT--VAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           KKLG G  G V  G  S   G    VAVK L        +D+F  E  ++ S++H+NL++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK-----TKLLNWNKRFNIILGTAEGLAYL 386
           L G  +  P  ++V E  P  SL   +          + L ++       +  A G+ YL
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYA------VQIANGMRYL 113

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL--GYMAPE 444
                 R IHRD+   NILL  D   KI DFGL R    +  H        +   + APE
Sbjct: 114 E---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170

Query: 445 YLVRGQLTEKADVYSFGILIIEI 467
            L     +  +DV+ FG+ + E+
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 97.7 bits (243), Expect = 1e-22
 Identities = 73/284 (25%), Positives = 135/284 (47%), Gaps = 29/284 (10%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNL 320
           E   ++    K +G G  G V+ G L         VA+K L   +  +Q  D F +E ++
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASI 59

Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           +    H N+++L G   +   ++++ EY+ N +LD+++ D +     +  +   ++ G A
Sbjct: 60  MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIA 117

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG- 439
            G+ YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +  
Sbjct: 118 AGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174

Query: 440 -YMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLV 497
            + APE +   + T  +DV+SFGI++ E++  G R               W +  +++++
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP-------------YWDM-SNHEVM 220

Query: 498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           +A++   +   P +    V Q+ L C Q   A RP     + LL
Sbjct: 221 KAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 97.4 bits (242), Expect = 1e-22
 Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 6/195 (3%)

Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 72  EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 458 YSFGILIIEIVCGRR 472
           +SFGIL+ E+    R
Sbjct: 187 WSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 96.8 bits (242), Expect = 3e-22
 Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 23/205 (11%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN--EVNLISSI-EHKNLVKL 332
           K+LG G  GSVY+  +   G  VA+K++      W +E  N  EV  +  + EH N+VKL
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKL 63

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
                E  E   V+EY+   +L Q + D+   K  + +   +II    +GLA++H   + 
Sbjct: 64  KEVFRENDELYFVFEYM-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIH---KH 118

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS-----TAVAGTLGYMAPEYLV 447
              HRD+K  N+L+      KIADFGLAR        +      T    T  Y APE L+
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYRAPEILL 171

Query: 448 RGQLTEKA-DVYSFGILIIEIVCGR 471
           R        D+++ G ++ E+   R
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 48/231 (20%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEF----FNEVNLISSIEHK 327
           +    KLG+G  G VY    +  G  VA+K+++ +  +  D F      E+ ++  ++H 
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHP 67

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIF-------DKNKTKLLNWNKRFN------ 374
           N+V L+          +  E        +          D + + LL  N          
Sbjct: 68  NVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQI 117

Query: 375 --IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF--------- 423
              +L   EG+ YLH   E  I+HRDIK +NIL+D     KIADFGLAR +         
Sbjct: 118 KCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174

Query: 424 -AADRTHVSTAVAGTLGYMAPEYLVRG--QLTEKADVYSFGILIIEIVCGR 471
                T   T +  T  Y  PE L+ G  + T   D++  G +  E+   R
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPE-LLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 77/271 (28%), Positives = 126/271 (46%), Gaps = 38/271 (14%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKR----LIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           +K+G+G  G VY G L   T VAVK     L  + ++   +F  E  ++   +H N+VKL
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR---KFLQEAEILKQYDHPNIVKL 57

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           +G  ++     +V E VP  SL  F+  + K   L   K   + L  A G+ YL    E+
Sbjct: 58  IGVCVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYL----ES 111

Query: 393 R-IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT----LGYMAPEYLV 447
           +  IHRD+   N L+ ++   KI+DFG++R    +   + T   G     + + APE L 
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALN 168

Query: 448 RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD 507
            G+ T ++DV+S+GIL+ E      +      +    +R+ + YR               
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR--------------- 213

Query: 508 FPAEQVC--NVLQIGLLCTQAAAALRPSMAQ 536
            PA Q+C   + ++ L C       RPS ++
Sbjct: 214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSE 244

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 96.8 bits (242), Expect = 3e-22
 Identities = 73/215 (33%), Positives = 100/215 (46%), Gaps = 40/215 (18%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +     +G   A+K L    I   +Q V+   NE  ++ SI H 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHP 61

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN----------II 376
            LV L G S +   +L LV EYVP   L    F       L  + RF           ++
Sbjct: 62  FLVNLYG-SFQDDSNLYLVMEYVPGGEL----FS-----HLRKSGRFPEPVARFYAAQVV 111

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           L     L YLH      I++RD+K  N+LLD D   KI DFG A+     RT+    + G
Sbjct: 112 LA----LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRTY---TLCG 160

Query: 437 TLGYMAPEYLVRGQLTEKA-DVYSFGILIIEIVCG 470
           T  Y+APE ++  +   KA D ++ GILI E++ G
Sbjct: 161 TPEYLAPE-IILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 95.9 bits (239), Expect = 4e-22
 Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 23/203 (11%)

Query: 277 KKLGQGGAGSVYMGSL--PNGT--TVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           K +G G  G V  G L  P      VA+K L    + +Q +D F  E +++   +H N++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNII 68

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +L G   +    +++ EY+ N SLD+F+  +         +   ++ G A G+ YL   S
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---S 123

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG------YMAPE 444
           E   +HRD+   NIL++ +   K++DFGL+R     R   S A   T G      + APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSR-----RLEDSEATYTTKGGKIPIRWTAPE 178

Query: 445 YLVRGQLTEKADVYSFGILIIEI 467
            +   + T  +DV+SFGI++ E+
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEV 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 71/242 (29%), Positives = 107/242 (44%), Gaps = 30/242 (12%)

Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIF--NTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +LG+G  GSV    L N   +   + I          +   E+ +  S +   +VK  G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 336 SIEGPESLL--VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE----GLAYLHGG 389
            ++   S +    EY    SLD  I+ K K +     ++  ++   AE    GL+YLH  
Sbjct: 68  FLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEK--VLGKIAESVLKGLSYLH-- 122

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFG----LARCFAADRTHVSTAVAGTLGYMAPEY 445
              +IIHRDIK SNILL +    K+ DFG    L    A   T       GT  YMAPE 
Sbjct: 123 -SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-------GTSFYMAPER 174

Query: 446 LVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK 505
           +     +  +DV+S G+ ++E+   R    F  +   PL  +  L   + +V   +P LK
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFP--FPPEGEPPLGPIELL---SYIVNMPNPELK 229

Query: 506 DD 507
           D+
Sbjct: 230 DE 231

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 95.7 bits (238), Expect = 5e-22
 Identities = 71/208 (34%), Positives = 102/208 (49%), Gaps = 21/208 (10%)

Query: 279 LGQGGAGSVYMGS----LPNGT---TVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLV 330
           LG G  G VY G+    L  G+    VAVK L    T Q   EF  E +L+S+  H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTK----LLNWNKRFNIILGTAEGLAYL 386
           KLLG  +      ++ E +    L  ++ D    +    LL   +  +I L  A+G  YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 387 HGGSETRIIHRDIKTSNILL-----DKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
               +   IHRD+   N L+     D D   KI DFGLAR  + +D           + +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIV 468
           MAPE L+ G+ T ++DV+SFG+L+ EI+
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 96.0 bits (239), Expect = 5e-22
 Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 22/202 (10%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIEH---KNLVKLL 333
           +G+G  G+VY G  +P G  VA+K +  +T    V +   EV L+S +      N+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFI----FDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           G  ++GP   ++ EY    S+   +      +    +        II      L Y+H  
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV--------IIREVLVALKYIH-- 118

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
            +  +IHRDIK +NIL+      K+ DFG+A     + +  ST V GT  +MAPE +  G
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEG 176

Query: 450 QLTE-KADVYSFGILIIEIVCG 470
           +  + KAD++S GI I E+  G
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 95.4 bits (237), Expect = 1e-21
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 9/195 (4%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA+K++    +   +   NE+ ++   +H N+V  L  
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVI 137

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HRDIK+ NILL  D + K+ DFG       +++  ST V GT  +MAPE + R     K 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 456 DVYSFGILIIEIVCG 470
           D++S GI+ IE+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 65/234 (27%), Positives = 100/234 (42%), Gaps = 34/234 (14%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFN--TRQWVDEFFNEV 318
            YE LE           +G+G  G+V  +    +G  +  K + +   T +   +  +EV
Sbjct: 1   DYEVLET----------IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV 50

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVY---EYVPNRSLDQFIFDKNKTKLLNWNKRF-- 373
           N++  ++H N+V+     I    +  +Y   EY     L Q I  +   K     K    
Sbjct: 51  NILRELKHPNIVRYYD-RIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKE---RKYIEE 104

Query: 374 ----NIILGTAEGLAYLHGGS--ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
                I+      L   H  S     ++HRD+K +NI LD +   K+ DFGLA+    D 
Sbjct: 105 EFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS 164

Query: 428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRS--NAFSQD 479
           +   T V GT  YM+PE L      EK+D++S G LI E+ C       A +Q 
Sbjct: 165 SFAKTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL-CALSPPFTARNQL 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 14/195 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV---DEFFNEVNLISSIEHKNLVKLL 333
           K+LG G  G V++G       VA+K +    R+     D+F  E  ++  + H NLV+L 
Sbjct: 10  KELGSGQFGVVHLGKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQLY 65

Query: 334 G-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           G C+ + P   +V EY+ N  L  ++  + +   L      ++     E + YL      
Sbjct: 66  GVCTKQRP-IFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLE---SN 119

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
             IHRD+   N L+ +D   K++DFGLAR    D+   S      + +  PE     + +
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 453 EKADVYSFGILIIEI 467
            K+DV+SFG+L+ E+
Sbjct: 180 SKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 59/262 (22%), Positives = 121/262 (46%), Gaps = 22/262 (8%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           K+G+G  G V+      +    A+K++  +   R+  +E  +E  +++ ++   +++   
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             ++  +  +V EY  N  L + +    + + L  ++ +   +    GLA+LH     +I
Sbjct: 67  SFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKI 122

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK 454
           +HRDIK+ N+ LD     KI D G+A+  + +    +T V GT  Y++PE        EK
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKPYNEK 181

Query: 455 ADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVC 514
           +DV++ G+++ E   G+  + F  ++   L          K++  V P +   + ++Q+ 
Sbjct: 182 SDVWALGVVLYECCTGK--HPFDANNQGALIL--------KIIRGVFPPVSQMY-SQQLA 230

Query: 515 NVLQIGLLCTQAAAALRPSMAQ 536
            ++     C       RP   Q
Sbjct: 231 QLID---QCLTKDYRQRPDTFQ 249

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 13/205 (6%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
               N+     K+G+G  G V + +    G  VAVK++    +Q  +  FNEV ++   +
Sbjct: 19  SYLDNF----VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ 74

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           H N+V++    + G E  +V E++   +L   +        +N  +   + L   + L++
Sbjct: 75  HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLAVLKALSF 130

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEY 445
           LH      +IHRDIK+ +ILL  D   K++DFG     + +     + V GT  +MAPE 
Sbjct: 131 LHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEV 186

Query: 446 LVRGQLTEKADVYSFGILIIEIVCG 470
           + R     + D++S GI++IE+V G
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.1 bits (231), Expect = 3e-21
 Identities = 51/192 (26%), Positives = 94/192 (48%), Gaps = 6/192 (3%)

Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            +++G G  G V++G       VA+K  I       ++F  E  ++  + H  LV+L G 
Sbjct: 9   VQEIGSGQFGLVWLGYWLEKRKVAIKT-IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             E     LV+E++ +  L  ++  + +    +      + L   EG+AYL     + +I
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVI 122

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HRD+   N L+ ++   K++DFG+ R    D+   ST     + + +PE     + + K+
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182

Query: 456 DVYSFGILIIEI 467
           DV+SFG+L+ E+
Sbjct: 183 DVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.4 bits (232), Expect = 3e-21
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 19/205 (9%)

Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNT-------RQWVDEFFNEVNLISSIEHKNLVK 331
           LG+G  G+VY G    G  +AVK++  +T       +++ ++   EV+L+ S++H N+V+
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEY-EKLQEEVDLLKSLKHVNIVQ 66

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
            LG  ++     +  E+VP  S+   +          + K    IL   +G+AYLH    
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL---DGVAYLH---N 120

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS-----TAVAGTLGYMAPEYL 446
             ++HRDIK +N++L  +   K+ DFG AR  A    H +      ++ GT  +MAPE +
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 447 VRGQLTEKADVYSFGILIIEIVCGR 471
                  K+D++S G  + E+  G+
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 93.8 bits (234), Expect = 4e-21
 Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 16/198 (8%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN-----EVNLISSIEHKNLV 330
           KKLG+G    VY       G  VA+K++    R+   +  N     E+ L+  ++H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            LL          LV+E++    L++ I DK+   L   + + + +L T  GL YLH   
Sbjct: 66  GLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIV-LTPADIK-SYMLMTLRGLEYLH--- 119

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG- 449
              I+HRD+K +N+L+  D   K+ADFGLAR F +    ++  V  T  Y APE L  G 
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLF-GA 177

Query: 450 -QLTEKADVYSFGILIIE 466
                  D++S G +  E
Sbjct: 178 RHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 93.4 bits (232), Expect = 5e-21
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 30/216 (13%)

Query: 279 LGQGGAGSVY----MGSLPNG--TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVK 331
           +GQG  G V+     G LP    T VAVK L    +     +F  E  L++  +H N+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-------------------LNWNKR 372
           LLG    G    L++EY+    L++F+  ++                       L+  ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVS 431
             I    A G+AYL   SE + +HRD+ T N L+ ++   KIADFGL+R  ++AD    S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
              A  + +M PE +   + T ++DV+++G+++ EI
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 80/283 (28%), Positives = 132/283 (46%), Gaps = 46/283 (16%)

Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV +          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNK-----TKLLNWNKRFNIILGTAEGLA 384
             G C   G  +L LV EY+P  SL  ++  K++      KLL +  +        +G+ 
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQI------CKGME 122

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMA 442
           YL      R +HRD+ T NIL++ +   KI DFGL +    D+ +      G   + + A
Sbjct: 123 YL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK------- 495
           PE L   + +  +DV+SFG+++ E+        +S  S SP      +  ++K       
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELF------TYSDKSCSPPAEFMRMMGNDKQGQMIVY 233

Query: 496 -LVEAVDPNLK----DDFPAEQVCNVLQIGLLCTQAAAALRPS 533
            L+E +  N +       PAE    +  I   C     + RPS
Sbjct: 234 HLIELLKNNGRLPAPPGCPAE----IYAIMKECWNNDPSQRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 93.6 bits (232), Expect = 6e-21
 Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 25/220 (11%)

Query: 278 KLGQGGAGSVYMGSLPNGTT---VAVKRLIFNTRQ----WVDEFFNEVNLISSIEHKNLV 330
           ++G G  G+VY  +  N  T   VAVK++ ++ +Q    W D    EV  +  ++H N +
Sbjct: 28  EIGHGSFGAVYFAT--NSHTNEVVAVKKMSYSGKQTNEKWQD-IIKEVKFLQQLKHPNTI 84

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +  GC ++   + LV EY    + D     K   K L   +   I  G  +GLAYLH  +
Sbjct: 85  EYKGCYLKEHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN 141

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV--- 447
              +IHRDIK  NILL +    K+ADFG     +A ++  + +  GT  +MAPE ++   
Sbjct: 142 ---MIHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFVGTPYWMAPEVILAMD 193

Query: 448 RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
            GQ   K DV+S GI  IE+   R+   F+ ++ S L  +
Sbjct: 194 EGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALYHI 232

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.9 bits (228), Expect = 8e-21
 Identities = 73/261 (27%), Positives = 126/261 (48%), Gaps = 33/261 (12%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           + +G+G  G+V  G    G  VAVK +  + T Q    F  E  +++ + HKNLV+LLG 
Sbjct: 12  EIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQ---AFLEETAVMTKLHHKNLVRLLGV 67

Query: 336 SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            +     L +V E +   +L  F+  + +  L++  +     L  AEG+ YL      ++
Sbjct: 68  ILH--NGLYIVMELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLE---SKKL 121

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARC--FAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
           +HRD+   NIL+ +D   K++DFGLAR      D + +       + + APE L   + +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP------VKWTAPEALKHKKFS 175

Query: 453 EKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQ 512
            K+DV+S+G+L+ E+        FS   A P  ++ +L    ++ E V+   + + P   
Sbjct: 176 SKSDVWSYGVLLWEV--------FSYGRA-PYPKM-SL---KEVKECVEKGYRMEPPEGC 222

Query: 513 VCNVLQIGLLCTQAAAALRPS 533
             +V  +   C +     RPS
Sbjct: 223 PADVYVLMTSCWETEPKKRPS 243

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 92.2 bits (229), Expect = 9e-21
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 21/208 (10%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIF------NTRQWVDEFFNEVNLISSIEHKNL 329
           ++LG G   S Y    +  GT +AVK++ +         + V+    E+ L++ + H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           +++LG + E     L  E++   S+   +  +   K  ++      N       GL+YLH
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLH 120

Query: 388 GGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCFAADRT---HVSTAVAGTLGYMAP 443
              E +IIHRD+K +N+L+D      +IADFG A   AA  T        + GT+ +MAP
Sbjct: 121 ---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177

Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGR 471
           E L   Q     DV+S G +IIE+   +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 92.5 bits (230), Expect = 1e-20
 Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 37/220 (16%)

Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V              +TVAVK L  + T + + +  +E+ ++  I +HKN
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG--------- 378
           ++ LLG C+ EGP  ++V EY  + +L  F+    +      +                 
Sbjct: 78  IINLLGVCTQEGPLYVVV-EYAAHGNLRDFLRA-RRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 379 -----TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
                 A G+ +L   +  + IHRD+   N+L+ +D   KIADFGLAR    D  H+   
Sbjct: 136 SFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYY 188

Query: 434 VAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
              T G     +MAPE L     T ++DV+SFG+L+ EI 
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 18/201 (8%)

Query: 279 LGQGGAGSVYMGSL----PNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           +G+G  G VY G+L          AVK L  I +  + V++F  E  ++    H N++ L
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-VEQFLKEGIIMKDFSHPNVLSL 61

Query: 333 LGCSI--EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           LG  +  EG   L+V  Y+ +  L  FI  +++T            L  A+G+ YL   +
Sbjct: 62  LGICLPSEG-SPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGFGLQVAKGMEYL---A 115

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAGTLGYMAPEYLV 447
             + +HRD+   N +LD+ FT K+ADFGLAR          H  T     + +MA E L 
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175

Query: 448 RGQLTEKADVYSFGILIIEIV 468
             + T K+DV+SFG+L+ E++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 14/198 (7%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---EVNLISSIEHKNLVKL 332
           + +G+G  G VY          VA+K  + +  +  DE  +   E+  +S      + K 
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIK--VIDLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
            G  ++G +  ++ EY    S      D  K   L+      I+     GL YLH     
Sbjct: 65  YGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE--- 117

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
             IHRDIK +NILL ++   K+ADFG++    +  +  +T V GT  +MAPE + +    
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYD 176

Query: 453 EKADVYSFGILIIEIVCG 470
           EKAD++S GI  IE+  G
Sbjct: 177 EKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 81/284 (28%), Positives = 127/284 (44%), Gaps = 24/284 (8%)

Query: 272 YFNPSKKLGQGGAGSVYMGSL-PN----GTTVAVKRLIF-NTRQWVDEFFNEVNLISSIE 325
           Y    + LG+G  G V +    P     G  VAVK L     +Q    +  E+N++ ++ 
Sbjct: 5   YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64

Query: 326 HKNLVKLLGCSIEGPES--LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           H+N+VK  GC  E       L+ EYVP  SL  ++  K+K   LN  +         EG+
Sbjct: 65  HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHK---LNLAQLLLFAQQICEGM 120

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLGYM 441
           AYLH       IHRD+   N+LLD D   KI DFGLA+       +  V       + + 
Sbjct: 121 AYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV--CGRRSNAFSQ--DSASPLQRVWTLYRSNKLV 497
           A E L   + +  +DV+SFG+ + E++  C  + +   +  +   P Q   T+ R   L+
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR---LI 234

Query: 498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           E ++  ++   P      V  +   C +  A  RP+    I +L
Sbjct: 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 91.7 bits (227), Expect = 2e-20
 Identities = 69/284 (24%), Positives = 133/284 (46%), Gaps = 33/284 (11%)

Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           ++LG+G  G V++    N         VAVK L   +     +F  E  L+++++H+++V
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFI----------FDKNKTKLLNWNKRFNIILGTA 380
           K  G  +EG   ++V+EY+ +  L++F+           + N+   L  ++  +I    A
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLG 439
            G+ YL   +    +HRD+ T N L+ ++   KI DFG++R  ++ D   V       + 
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           +M PE ++  + T ++DV+S G+++ EI        F+       ++ W    +N+++E 
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEI--------FTYG-----KQPWYQLSNNEVIEC 234

Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           +        P      V  + L C Q    +R ++ +   LL N
Sbjct: 235 ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 31/208 (14%)

Query: 277 KKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFN-----EVNLISSIEHKNLV 330
            +LG G +G V  +   P G  +AVK +    R  ++E        E++++       +V
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTI----RLEINEAIQKQILRELDILHKCNSPYIV 62

Query: 331 KLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGL 383
              G     G  S+ + EY+   SLD+         L     R        I +   +GL
Sbjct: 63  GFYGAFYNNGDISICM-EYMDGGSLDKI--------LKEVQGRIPERILGKIAVAVLKGL 113

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
            YLH   + +IIHRD+K SNIL++     K+ DFG++         ++    GT  YMAP
Sbjct: 114 TYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMAP 168

Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGR 471
           E +     + K+D++S G+ +IE+  GR
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 91.7 bits (227), Expect = 3e-20
 Identities = 71/223 (31%), Positives = 108/223 (48%), Gaps = 21/223 (9%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIEHK 327
           F   +++G G  G+VY    +     VA+K++ ++ +Q    W D    EV  +  I+H 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVKFLQRIKHP 85

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           N ++  GC +    + LV EY    + D     K   K L   +   I  G  +GLAYLH
Sbjct: 86  NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH 142

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV 447
             +   +IHRDIK  NILL +    K+ADFG     +A     + +  GT  +MAPE ++
Sbjct: 143 SHN---MIHRDIKAGNILLTEPGQVKLADFG-----SASIASPANSFVGTPYWMAPEVIL 194

Query: 448 ---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
               GQ   K DV+S GI  IE+   R+   F+ ++ S L  +
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALYHI 236

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 74/272 (27%), Positives = 120/272 (44%), Gaps = 31/272 (11%)

Query: 279 LGQGGAGSVYMGSLPNG--TTVAVKRLIFNTRQW----------VDEFFNEVNLI-SSIE 325
           LG G  G VY     N     +A+K +  +   +          + +  +EV +I   + 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSL-DQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N+V+     +E     +V + +    L + F   K K +     + +NI +     L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH   E RI+HRD+  +NI+L +D    I DFGLA+          T+V GT+ Y  PE
Sbjct: 128 YLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSCPE 183

Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL 504
            +      EKADV++FG ++ ++ C  +   +S +          L  + K+VEAV   L
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQM-CTLQPPFYSTN---------MLSLATKIVEAVYEPL 233

Query: 505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
            +   +E V +V+     C    A  RP + Q
Sbjct: 234 PEGMYSEDVTDVIT---SCLTPDAEARPDIIQ 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 91.3 bits (226), Expect = 4e-20
 Identities = 70/223 (31%), Positives = 107/223 (47%), Gaps = 21/223 (9%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIEHK 327
           F+  +++G G  G+VY    + N   VA+K++ ++ +Q    W D    EV  +  + H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 75

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           N ++  GC +    + LV EY    + D     K   K L   +   +  G  +GLAYLH
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH 132

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV 447
             +   +IHRD+K  NILL +    K+ DFG A   A     V     GT  +MAPE ++
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184

Query: 448 ---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
               GQ   K DV+S GI  IE+   R+   F+ ++ S L  +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL-AERKPPLFNMNAMSALYHI 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 69/222 (31%), Positives = 101/222 (45%), Gaps = 42/222 (18%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEHKNLVK 331
           K+G+G  G VY       G  VA+K++   T    DE        E++L+  + H N+V+
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPNIVR 62

Query: 332 LLGCSIEGPESLLVYEY-----------VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           LL       +  LV+E+            P   LD  +      +LL             
Sbjct: 63  LLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ------------ 110

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLG 439
            G+AY H     R++HRD+K  N+L+D++   K+ADFGLAR F    RT+    V  TL 
Sbjct: 111 -GIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLW 164

Query: 440 YMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDS 480
           Y APE L+   Q +   D++S G +  E+V   R   F  DS
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMV--NRRPLFPGDS 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 90.9 bits (225), Expect = 4e-20
 Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 9/201 (4%)

Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
            Y +   K+G+G  G V + ++  +G  VAVK++    +Q  +  FNEV ++   +H+N+
Sbjct: 20  TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V++    + G E  +V E++   +L   +     T++ N  +   + L   + L+ LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRM-NEEQIAAVCLAVLKALSVLHAQ 135

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
               +IHRDIK+ +ILL  D   K++DFG     + +     + V GT  +MAPE + R 
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRL 191

Query: 450 QLTEKADVYSFGILIIEIVCG 470
               + D++S GI++IE+V G
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 90.2 bits (224), Expect = 4e-20
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 20/207 (9%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           LG G  G VY       G   A K +   + + +++F  E++++S  +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
              +  ++ E+    +LD  I  + +  L     R+ +     E L +LH     ++IHR
Sbjct: 73  YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH---SHKVIHR 127

Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE---- 453
           D+K  NILL  D   K+ADFG++    +      T + GT  +MAPE +      E    
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVA----CETFKD 182

Query: 454 -----KADVYSFGILIIEIVCGRRSNA 475
                KAD++S GI +IE+      + 
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPHH 209

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 90.6 bits (224), Expect = 5e-20
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 9/195 (4%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA+K++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLH---SNQVI 137

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HRDIK+ NILL  D + K+ DFG       +++  ST V GT  +MAPE + R     K 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 456 DVYSFGILIIEIVCG 470
           D++S GI+ IE+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 89.7 bits (222), Expect = 5e-20
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 16/192 (8%)

Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +G+G  G V +G    G  VAVK  I N  T Q    F  E ++++ + H NLV+LLG  
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVK-CIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVI 68

Query: 337 IEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           +E    L +V EY+   SL  ++  + ++ +L  +      L   E + YL   +    +
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FV 124

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HRD+   N+L+ +D   K++DFGL +  ++ +      V  T    APE L   + + K+
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKS 180

Query: 456 DVYSFGILIIEI 467
           DV+SFGIL+ EI
Sbjct: 181 DVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 91.5 bits (227), Expect = 6e-20
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 8/152 (5%)

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E  L+ ++ H +++++    + G  + +V   +P+ S D + +   +++ L  ++   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
               EGL YLH     RIIHRD+KT NI ++      I D G A+        +   +AG
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL--GLAG 218

Query: 437 TLGYMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           T+   APE L R +   KAD++S GI++ E++
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 90.5 bits (224), Expect = 6e-20
 Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 10/211 (4%)

Query: 278 KLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+G+G  G V +     +G  VAVK +    +Q  +  FNEV ++   +H+N+V++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           + G E  ++ E++   +L   +   ++T+L N  +   +     + L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV---SQTRL-NEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RDIK+ +ILL  D   K++DFG     + D     + V GT  +MAPE + R     + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVD 199

Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
           ++S GI++IE+V G     FS      ++R+
Sbjct: 200 IWSLGIMVIEMVDG-EPPYFSDSPVQAMKRL 229

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 89.6 bits (223), Expect = 8e-20
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 32/207 (15%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL-IFNTRQWVDEF-FNEVNL---ISSIEHKNLVKL 332
           +G+G  G+VY    L  G  VA+K++ +  + + +      E+ L   + S EH N+V+L
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 333 L----GCSIEGPESL-LVYEYVPNRSLDQFI-------FDKNKTKLLNWNKRFNIILGTA 380
           L    G   +    L LV+E+V ++ L  ++             K L        +L   
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ-----LLR-- 118

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY 440
            G+ +LH     RI+HRD+K  NIL+  D   KIADFGLAR +        T+V  TL Y
Sbjct: 119 -GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWY 172

Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEI 467
            APE L++       D++S G +  E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 89.4 bits (222), Expect = 9e-20
 Identities = 80/275 (29%), Positives = 111/275 (40%), Gaps = 33/275 (12%)

Query: 277 KKLGQGGAGSVYMG---SLPNGTT---VAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G             VAVK L  + + Q   +F  E  ++S   H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+L+G S E     ++ E +    L  F+ +      +   L            A+G  Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGYM 441
           L    E   IHRDI   N LL         KIADFG+AR  + A            + +M
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV-EAV 500
            PE  + G  T K DV+SFG+L+ EI        FS      L  +    R+N+ V E V
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEI--------FS------LGYMPYPGRTNQEVMEFV 234

Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMA 535
               + D P      V +I   C Q     RP+ A
Sbjct: 235 TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFA 269

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 89.0 bits (221), Expect = 9e-20
 Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 30/273 (10%)

Query: 273 FNPSKKLGQGGAGSVYM------GSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH 326
           + P + LG+G  G   +       SL     V + RL    R    +  NE+ ++S ++H
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER---RDALNEIVILSLLQH 58

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
            N++      ++    L+  EY    +L   I  + K +L         +      ++Y+
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYI 117

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL 446
           H   +  I+HRDIKT NI L K    K+ DFG+++   ++ +   T V GT  YM+PE L
Sbjct: 118 H---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPE-L 172

Query: 447 VRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK 505
            +G +   K+D+++ G ++ E++  +R   F  D+ +PL  V  + + N           
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKR--TF--DATNPLNLVVKIVQGNYTPV------V 222

Query: 506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
             + +E +  V        Q     RP+  + +
Sbjct: 223 SVYSSELISLVHS----LLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 89.5 bits (222), Expect = 9e-20
 Identities = 72/215 (33%), Positives = 109/215 (50%), Gaps = 18/215 (8%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 330 VKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILGTAEGLAYLH 387
           VKLL   I     L LV+E++ ++ L +F+     + + L   K +   L   +GLA+ H
Sbjct: 62  VKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCH 117

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYL 446
                R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L
Sbjct: 118 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 172

Query: 447 VRGQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDS 480
           +  +    A D++S G +  E+V   R   F  DS
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDS 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 89.8 bits (222), Expect = 1e-19
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 13/205 (6%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
           +K T Y    +K+GQG +G+V+    +  G  VA+K++    +   +   NE+ ++  ++
Sbjct: 19  KKYTRY----EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK 74

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           + N+V  L   + G E  +V EY+   SL   + +      ++  +   +     + L +
Sbjct: 75  NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEF 130

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEY 445
           LH     ++IHRDIK+ N+LL  D + K+ DFG       +++  ST V GT  +MAPE 
Sbjct: 131 LHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEV 186

Query: 446 LVRGQLTEKADVYSFGILIIEIVCG 470
           + R     K D++S GI+ IE+V G
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)

Query: 278 KLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           +LG+G  G V++    N         VAVK L   +     +F  E  L++ ++H+++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF---------IFDKNKTKL---LNWNKRFNIILGT 379
             G   EG   L+V+EY+ +  L++F         I    +      L   +   I    
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTL 438
           A G+ YL        +HRD+ T N L+ +    KI DFG++R  ++ D   V       +
Sbjct: 132 ASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEI 467
            +M PE ++  + T ++D++SFG+++ EI
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 74/226 (32%), Positives = 118/226 (52%), Gaps = 13/226 (5%)

Query: 269 ATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEH 326
           AT+Y N  +KLG+G   +VY G S  NG  VA+K +   T + V      E +L+  ++H
Sbjct: 4   ATSYLN-LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 327 KNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
            N+V LL   I   E+L  V+EY+ +  L Q++  ++   L  +N R   +     GLAY
Sbjct: 63  ANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYMI-QHPGGLHPYNVRL-FMFQLLRGLAY 118

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEY 445
           +HG     I+HRD+K  N+L+      K+ADFGLAR  +      S+ V  TL Y  P+ 
Sbjct: 119 IHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDV 174

Query: 446 LVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL 490
           L+     +   D++  G + IE++ G+ +     D    L+++WT+
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 18/207 (8%)

Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           ++LGQG  G VY G           T VA+K +  N + +   EF NE +++      ++
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI-------FDKNKTKLLNWNKRFNIILGTAEG 382
           V+LLG    G  +L+V E +    L  ++        +          K   +    A+G
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGYM 441
           +AYL      + +HRD+   N ++ +D T KI DFG+ R  +  D           + +M
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           APE L  G  T K+DV+SFG+++ E+ 
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 29/209 (13%)

Query: 279 LGQGGAGSVYMGSLPN-GTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           + +G  G V++    + G   A+K   +     +  VD+   E +++S  +   +VKL  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 335 CSIEGPESL-LVYEYVPN----RSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
            S +G ++L LV EY+P       L+     D++  +          I      L YLH 
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR--------IYIAEIVLALEYLH- 110

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-------CFAADRTHVSTAVAGTLGYM 441
                IIHRD+K  NIL+D +   K+ DFGL++           D       + GT  Y+
Sbjct: 111 --SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCG 470
           APE ++    ++  D +S G ++ E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 88.0 bits (218), Expect = 2e-19
 Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 8/192 (4%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           K+LG G  G V  G       VA+K +I       DEF  E  ++  + H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           + + P   +V EY+ N  L  ++  +   K    ++   +     EG+AYL      + I
Sbjct: 69  TKQRP-IYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFI 122

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HRD+   N L+D     K++DFGL+R    D    S      + +  PE L+  + + K+
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182

Query: 456 DVYSFGILIIEI 467
           DV++FG+L+ E+
Sbjct: 183 DVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 69/242 (28%), Positives = 123/242 (50%), Gaps = 22/242 (9%)

Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+G+G  G V + +  + G  VAVK++    +Q  +  FNEV ++    H+N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           + G E  +V E++   +L   +     T+ +N  +   + L     L+YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALTDIV---THTR-MNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RDIK+ +ILL  D   K++DFG     + +     + V GT  +MAPE + R     + D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVD 200

Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNV 516
           ++S GI++IE++ G     F++    PLQ +       ++ + + P +KD   + +V +V
Sbjct: 201 IWSLGIMVIEMIDG-EPPYFNE---PPLQAM------RRIRDNLPPRVKD---SHKVSSV 247

Query: 517 LQ 518
           L+
Sbjct: 248 LR 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 75/264 (28%), Positives = 115/264 (43%), Gaps = 16/264 (6%)

Query: 277 KKLGQGGAGSV-YMGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLVKLLG 334
             LG G  GSV  +  +P GT +A K +    +  V  +   E+ ++       +V   G
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             +      +  E++   SLD+      K   +       I +   EGL YL+  +  RI
Sbjct: 71  AFLNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLY--NVHRI 125

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK 454
           +HRDIK SNIL++     K+ DFG++         ++    GT  YM+PE +  G+ T K
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELI---NSIADTFVGTSTYMSPERIQGGKYTVK 182

Query: 455 ADVYSFGILIIEIVCGRRSNAFS-QDSASPLQRVWTLYRSNKLVEAVDPNL-KDDFPAEQ 512
           +DV+S GI IIE+  G+   AFS  D       +  L    ++V+   P L   DFP + 
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDL 242

Query: 513 VCNVLQIGLLCTQAAAALRPSMAQ 536
              V      C       RP+  Q
Sbjct: 243 RDFV----DACLLKDPTERPTPQQ 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 88.6 bits (219), Expect = 3e-19
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 23/204 (11%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTV----AVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G  +P G TV    A+K L   T    + EF +E  +++S++H +LV
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEGLAYL 386
           +LLG  +  P   LV + +P+  L  ++ +         LLNW       +  A+G+ YL
Sbjct: 73  RLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL--GYMAPE 444
               E R++HRD+   N+L+      KI DFGLAR    D    + A  G +   +MA E
Sbjct: 126 E---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN-ADGGKMPIKWMALE 181

Query: 445 YLVRGQLTEKADVYSFGILIIEIV 468
            +   + T ++DV+S+G+ I E++
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 88.1 bits (218), Expect = 3e-19
 Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 34/222 (15%)

Query: 277 KKLGQGGAGSVYMGS------LPNGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIEHKNL 329
           K LG+G  G V   +          TTVAVK L  N     + +  +E NL+  + H ++
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 330 VKLLG-CSIEGPESLLVYEYVPNRSLDQFI---------------------FDKNKTKLL 367
           +KL G CS +GP  LL+ EY    SL  F+                      D    + L
Sbjct: 66  IKLYGACSQDGP-LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
                 +     + G+ YL   +E +++HRD+   N+L+ +    KI+DFGL+R    + 
Sbjct: 125 TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 428 THVSTAVAGT-LGYMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           ++V  +     + +MA E L     T ++DV+SFG+L+ EIV
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 24/201 (11%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +++G G  G VY    +  G  VA+K +        +    E++++    H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLAYLHGGSET 392
            +   +  +V EY    SL Q I+   +  L        I     E   GLAYLH   ET
Sbjct: 69  YLRRDKLWIVMEYCGGGSL-QDIYQVTRGPL----SELQIAYVCRETLKGLAYLH---ET 120

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLA----RCFAADRTHVSTAVAGTLGYMAPEYL-- 446
             IHRDIK +NILL +D   K+ADFG++       A  ++ +     GT  +MAPE    
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEVAAV 175

Query: 447 -VRGQLTEKADVYSFGILIIE 466
             +G    K D+++ GI  IE
Sbjct: 176 ERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 10/203 (4%)

Query: 273 FNPSKKLGQGGAGSVY-MGSLPNGTTVAVKR--LIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   KKLG+G  GSVY +  L +    A+K   L   +++  ++  NE+ +++S+ H N+
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHG 388
           +      ++G +  +V EY P   L + I  + K  KL+   + + I +    GL  LH 
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH- 120

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
             E +I+HRD+K++NILL  +   KI D G+++     +    T + GT  YMAPE    
Sbjct: 121 --EQKILHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQI-GTPHYMAPEVWKG 175

Query: 449 GQLTEKADVYSFGILIIEIVCGR 471
              + K+D++S G L+ E+    
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 87.1 bits (215), Expect = 9e-19
 Identities = 58/195 (29%), Positives = 101/195 (51%), Gaps = 9/195 (4%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVI 138

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HRDIK+ NILL  D + K+ DFG       +++  ST V GT  +MAPE + R     K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197

Query: 456 DVYSFGILIIEIVCG 470
           D++S GI+ IE++ G
Sbjct: 198 DIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 86.4 bits (214), Expect = 9e-19
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 19/207 (9%)

Query: 277 KKLGQGGAGSVYMGSL--PNGTT--VAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           K LG+G  GSV  G L   +G+   VAVK  +L  +T   ++EF +E   +   +H N++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 331 KLLGCSIEG------PESLLVYEYVPNRSLDQFIFD---KNKTKLLNWNKRFNIILGTAE 381
           KL+G   E       P+ +++  ++ +  L  F+         + L        ++  A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           G+ YL   S    IHRD+   N +L +D T  +ADFGL++  ++ D           + +
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181

Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEI 467
           +A E L     T K+DV++FG+ + EI
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEI 208

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 85.8 bits (212), Expect = 9e-19
 Identities = 61/190 (32%), Positives = 98/190 (51%), Gaps = 8/190 (4%)

Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLGCSI 337
           LG+G  G V+ G+L + T VAVK    +  Q +  +F +E  ++   +H N+VKL+G   
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           +     +V E VP    D   F + K   L   +     L  A G+AYL        IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117

Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT-LGYMAPEYLVRGQLTEKAD 456
           D+   N L+ ++   KI+DFG++R    D  + S+ +    + + APE L  G+ + ++D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 457 VYSFGILIIE 466
           V+S+GIL+ E
Sbjct: 177 VWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 23/211 (10%)

Query: 277 KKLGQGGAGSVYMGSLPNGTT------VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           ++LG+G  G V++    N +       VAVK L   T     +F  E  L+++++H+++V
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-------------LNWNKRFNIIL 377
           K  G   +G   ++V+EY+ +  L++F+       +             L  ++  +I  
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAG 436
             A G+ YL   +    +HRD+ T N L+  +   KI DFG++R  ++ D   V      
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 437 TLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
            + +M PE ++  + T ++DV+SFG+++ EI
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 38/91 (41%), Positives = 49/91 (53%), Gaps = 5/91 (5%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L YLH      IIHRDIK  NILLD+     I DF +A     D   ++T+ +GT GYM
Sbjct: 112 ALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYM 166

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRR 472
           APE L R   +   D +S G+   E + G+R
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 36/231 (15%)

Query: 267 EKATNYFNPSKKLGQGGAGSVY------------MGSLPNG-----TTVAVKRL----IF 305
           E      N  +KLG+G  G V+                 N        VAVK L      
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 306 NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI------- 358
           N R+   +F  EV ++S +   N+ +LLG     P   ++ EY+ N  L+QF+       
Sbjct: 61  NARE---DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET 117

Query: 359 -FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF 417
                 +K L+++    +    A G+ YL        +HRD+ T N L+ K++T KIADF
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADF 174

Query: 418 GLAR-CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
           G++R  +++D   V       + +MA E ++ G+ T K+DV++FG+ + EI
Sbjct: 175 GMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 78/283 (27%), Positives = 128/283 (45%), Gaps = 47/283 (16%)

Query: 277 KKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLV 330
           K +G G  G V  G L         VA+K L   +  +Q  D F +E +++   +H N++
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNII 68

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL------GTAEGLA 384
            L G   +    ++V EY+ N SLD F        L   + +F +I       G A G+ 
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAF--------LRKHDGQFTVIQLVGMLRGIASGMK 120

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YMA 442
           YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +   + A
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177

Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNK-LVEAV 500
           PE +   + T  +DV+S+GI++ E++  G R               W +  SN+ +++A+
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWEM--SNQDVIKAI 222

Query: 501 DPNLKDDFPAEQVCNVL--QIGLLCTQAAAALRPSMAQAIMLL 541
           +   +   PA   C     Q+ L C Q     RP   Q + +L
Sbjct: 223 EEGYR--LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 23/204 (11%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLI-----FNTRQWVDEFFNEVNLISSIEHKNLV 330
           K LG G  G+V+ G  +P G ++ +   I      + RQ   E  + +  + S++H  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 331 KLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK----NKTKLLNWNKRFNIILGTAEGLAY 385
           +LLG C   G    LV +  P  SL   +       +  +LLNW       +  A+G+ Y
Sbjct: 73  RLLGICP--GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYY 124

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGYMAPE 444
           L    E R++HR++   NILL  D   +IADFG+A   +  D+ +  +     + +MA E
Sbjct: 125 LE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 445 YLVRGQLTEKADVYSFGILIIEIV 468
            ++ G+ T ++DV+S+G+ + E++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 56/217 (25%), Positives = 106/217 (48%), Gaps = 29/217 (13%)

Query: 277 KKLGQGGAGSV----------YMGSLPNGTT-----VAVKRLIFN-TRQWVDEFFNEVNL 320
           +KLG+G  G V          ++G            VAVK L  + T+   ++F  E+ +
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDK---------NKTKLLNWNK 371
           +S +++ N+++LLG  +      ++ EY+ N  L+QF+  +         N    ++   
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHV 430
              + +  A G+ YL   +    +HRD+ T N L+   +T KIADFG++R  ++ D   +
Sbjct: 131 LLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
                  + +MA E ++ G+ T  +DV++FG+ + E+
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 85.5 bits (212), Expect = 4e-18
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 21/217 (9%)

Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDE---FFNEVNLISSIEHKNLVKLL 333
           ++GQGG G V++    + G  VA+KR+  +    ++E      E +++++ + + LVKLL
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 334 GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
             + +  E L L  EYVP       +   N   L   + RF +    AE    +    E 
Sbjct: 68  -YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYM----AEMFEAVDALHEL 120

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
             IHRD+K  N L+D     K+ DFGL++         + +V G+  YMAPE L      
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYD 176

Query: 453 EKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWT 489
              D +S G ++ E +CG     F   S S     W 
Sbjct: 177 FTVDYWSLGCMLYEFLCG-----FPPFSGSTPNETWE 208

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 26/213 (12%)

Query: 277 KKLGQGGAGSVYMGSL-----PNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNL 329
           ++LG+   G +Y G L      +   VA+K L  I N +QW + F  E +L++ + H N+
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-FQQEASLMAELHHPNI 69

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIF--------------DKNKTKLLNWNKRFNI 375
           V LLG   +     +++EY+    L +F+               D      L+     +I
Sbjct: 70  VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAV 434
            +  A G+ YL   S    +H+D+   NIL+ +    KI+D GL+R  ++AD   V    
Sbjct: 130 AIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186

Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
              + +M PE ++ G+ +  +D++SFG+++ EI
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 20/213 (9%)

Query: 279 LGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG GG G V +        T A+K +    I  T Q  +  F+E  ++    H  +VKL 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59

Query: 334 GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
             + +  + + ++ EY     L   + D+       +  RF  I        YLH     
Sbjct: 60  -RTFKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARF-YIACVVLAFEYLH---NR 112

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
            II+RD+K  N+LLD +   K+ DFG A+   +  +T   T   GT  Y+APE ++    
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGY 169

Query: 452 TEKADVYSFGILIIEIVCGRRSNAFSQDSASPL 484
               D +S GIL+ E++ GR    F +D   P+
Sbjct: 170 DFSVDYWSLGILLYELLTGRP--PFGEDDEDPM 200

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 70/220 (31%), Positives = 109/220 (49%), Gaps = 37/220 (16%)

Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIF-------------DKNKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++               +   + L++   
Sbjct: 84  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR    D  H+  
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 195

Query: 433 AVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEI 467
               T G     +MAPE L     T ++DV+SFG+L+ EI
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 9e-18
 Identities = 60/221 (27%), Positives = 88/221 (39%), Gaps = 34/221 (15%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           KYE L            +G+G  G V    +   G  VA+K+  F   +  ++       
Sbjct: 2   KYEVLGV----------VGEGAYGVVLKCRNKATGEIVAIKK--FKESEDDEDVKKTALR 49

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNK 371
           EV ++  + H+N+V L           LV+EYV    L+           +  +   W  
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ- 108

Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
                    + +AY H      IIHRDIK  NIL+ +    K+ DFG AR   A      
Sbjct: 109 -------LLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158

Query: 432 TAVAGTLGYMAPEYLVRGQLTEKA-DVYSFGILIIEIVCGR 471
           T    T  Y APE LV      K  DV++ G ++ E++ G 
Sbjct: 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 72/281 (25%), Positives = 130/281 (46%), Gaps = 45/281 (16%)

Query: 279 LGQGGAGSVYMGSLP----NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           +G G  G V  G L         VA+K L    T +   +F +E +++   +H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL------GTAEGLAYLH 387
           G   +    +++ E++ N +LD F+   +         +F +I       G A G+ YL 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYL- 122

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAGTLG--YMA 442
             SE   +HRD+   NIL++ +   K++DFGL+R      +D T+ S ++ G +   + A
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS-SLGGKIPIRWTA 179

Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNK-LVEAV 500
           PE +   + T  +DV+S+GI++ E++  G R               W +  SN+ ++ A+
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWDM--SNQDVINAI 224

Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           + + +   P +    + Q+ L C Q     RP   Q +  L
Sbjct: 225 EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 15/201 (7%)

Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
           K LG G  G V       +        VAVK L         E   +E+ ++S +  H+N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           +V LLG C+I GP  L++ EY     L  F+  + +   L      +     A+G+A+L 
Sbjct: 101 IVNLLGACTIGGP-ILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFL- 157

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-TLGYMAPEYL 446
             +    IHRD+   N+LL      KI DFGLAR    D  +V    A   + +MAPE +
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215

Query: 447 VRGQLTEKADVYSFGILIIEI 467
                T ++DV+S+GIL+ EI
Sbjct: 216 FNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 78/217 (35%), Positives = 110/217 (50%), Gaps = 31/217 (14%)

Query: 277 KKLGQGGAGSVYMG-------SLPNGT-TVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V          S P+ T TVAVK L  N T + + +  +E+ L+  I +H
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ EGP  ++V EY    +L +F+           FD  K   + L++   
Sbjct: 78  KNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A G+ YL      R IHRD+   N+L+ +D   KIADFGLAR    D  +   
Sbjct: 137 VSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARG-VHDIDYYKK 192

Query: 433 AVAGTL--GYMAPEYLVRGQLTEKADVYSFGILIIEI 467
              G L   +MAPE L     T ++DV+SFGIL+ EI
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 83.1 bits (205), Expect = 3e-17
 Identities = 84/287 (29%), Positives = 132/287 (45%), Gaps = 42/287 (14%)

Query: 277 KKLGQGGAGSVYMGSL-------PN-GTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M          PN   TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNK--TKLLNWNKR 372
           KN++ LLG C+ +GP  +LV EY    +L +++           FD  K   + L +   
Sbjct: 78  KNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVS 431
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR     D    +
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193

Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
           T     + +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ ++ L 
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF----TLGGSPYPGIPVEELFKLL 249

Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +            + D PA     +  I   C  A  + RP+  Q +
Sbjct: 250 KEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLV 287

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 32/209 (15%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLVKLLG 334
            ++G G  G+VY     P G   A+K +  N    V  +   E+ ++  + H N+VK   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 335 CSIEGPESLLVYEYVPNRSLD-------QFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
                 E  ++ E++   SL+       QF+ D  + ++L+             G+AYLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-QILS-------------GIAYLH 185

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEY-- 445
                 I+HRDIK SN+L++     KIADFG++R  A      +++V GT+ YM+PE   
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERIN 241

Query: 446 --LVRGQLTEKA-DVYSFGILIIEIVCGR 471
             L  G     A D++S G+ I+E   GR
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 85.3 bits (211), Expect = 4e-17
 Identities = 81/333 (24%), Positives = 145/333 (43%), Gaps = 40/333 (12%)

Query: 215 IVLSTTAFLMLSLFAAYAAYAR---LSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATN 271
           I  +  AFL+L+L A    + R     ++K   N  G +      S +S K  T+    +
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVS-KSITINDILS 690

Query: 272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISS------- 323
                  + +G  G+ Y G S+ NG    VK +            N+VN I S       
Sbjct: 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEI------------NDVNSIPSSEIADMG 738

Query: 324 -IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
            ++H N+VKL+G       + L++EY+  ++L + + +      L+W +R  I +G A+ 
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKA 792

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           L +LH      ++  ++    I++D    P +    L      D     ++      Y+A
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVA 846

Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCGRR-SNAFSQDSASPLQRVWTLYRSNKLVEAVD 501
           PE      +TEK+D+Y FG+++IE++ G+  ++A      S ++     Y    L   +D
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID 906

Query: 502 PNLKDDFPAEQ--VCNVLQIGLLCTQAAAALRP 532
           P+++ D    Q  +  V+ + L CT      RP
Sbjct: 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939

Length = 968

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 275 PSKKLGQGGAGSVYMG--SLPNG--TTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNL 329
             + +G+G  G VY G    P      VAVK     T   V E F  E  ++   +H ++
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILGTAEGLAYLHG 388
           VKL+G   E P   +V E  P   L  ++   NK  L L     ++  L TA  LAYL  
Sbjct: 70  VKLIGVITENP-VWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTA--LAYLES 125

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               R +HRDI   N+L+      K+ DFGL+R    +  + ++     + +MAPE +  
Sbjct: 126 ---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182

Query: 449 GQLTEKADVYSFGILIIEI 467
            + T  +DV+ FG+ + EI
Sbjct: 183 RRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 71/271 (26%), Positives = 122/271 (45%), Gaps = 30/271 (11%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEF--------FNEVNLISSIEHKN 328
           ++LG+G  G+VY+  + +   VA +RL       V E           E  L+S ++H  
Sbjct: 6   QRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD-KNKTKLLNWNKRFNIILGTAEGLAYLH 387
           +VK     +E     ++ EY   R LD  + + K+  K L+ N+     +    G+ Y+H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV 447
              + RI+HRD+K  NI L  +   KI DFG++         ++T   GT  YM+PE L 
Sbjct: 124 ---QRRILHRDLKAKNIFLKNNLL-KIGDFGVS-RLLMGSCDLATTFTGTPYYMSPEALK 178

Query: 448 RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD 507
                 K+D++S G ++ E+ C   +       +  L          ++VE   P+L + 
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL----------RIVEGPTPSLPET 228

Query: 508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +  +   N +   +L      +LRPS A+ +
Sbjct: 229 YSRQ--LNSIMQSML--NKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 80.8 bits (199), Expect = 7e-17
 Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 21/219 (9%)

Query: 273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL-IF-----NTRQWVDEFFNEVNLISSIE 325
           F   KK+G+G    VY  + L +   VA+K++ IF       RQ   +   E++L+  + 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQLN 60

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++K L   IE  E  +V E      L Q I + K + +L+     +   +     + 
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           ++H     R++HRDIK +N+ +      K+ D GL R F++ +T  + ++ GT  YM+PE
Sbjct: 121 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPE 176

Query: 445 YLVRGQLTEKADVYSFGILIIEIVC------GRRSNAFS 477
            +       K+D++S G L+ E+        G + N FS
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 80.6 bits (199), Expect = 7e-17
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 16/206 (7%)

Query: 275 PSKKLGQGGAGSVYMGSLPNG------TTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHK 327
               LG+G  G V++            T V VK L     + +  EF  E+++   + HK
Sbjct: 9   EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFI------FDKNKTKLLNWNKRFNIILGTAE 381
           N+V+LLG   E     ++ EY     L QF+       +K K   L+  ++  +    A 
Sbjct: 69  NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           G+ +L   S  R +HRD+   N L+      K++   L++       +        L ++
Sbjct: 129 GMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWL 185

Query: 442 APEYLVRGQLTEKADVYSFGILIIEI 467
           APE +     + K+DV+SFG+L+ E+
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.5 bits (198), Expect = 8e-17
 Identities = 73/272 (26%), Positives = 125/272 (45%), Gaps = 30/272 (11%)

Query: 273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL-IFN-----TRQWVDEFFNEVNLISSIE 325
           F   KK+G+G    VY  + L +G  VA+K++ IF+      R    +   E++L+  + 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQLN 60

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFNIILGTAEGL 383
           H N++K     IE  E  +V E      L + I  F K K +L+     +   +     L
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPEKTVWKYFVQLCSAL 119

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
            ++H     R++HRDIK +N+ +      K+ D GL R F++ +T  + ++ GT  YM+P
Sbjct: 120 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSP 175

Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD-P 502
           E +       K+D++S G L+ E+      + F  D  +       LY   K +E  D P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDKMN-------LYSLCKKIEQCDYP 226

Query: 503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSM 534
            L  D  +E++  ++    +C       RP +
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 80.5 bits (199), Expect = 9e-17
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 23/206 (11%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE------FFNEVNLISSIEHKNL 329
           +K+G+G  G VY G +   G  VA+K++    R   +E         E++L+  ++H N+
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 330 VKLLGCSIEGPESLLVYEYVP---NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
           V L    ++     L++E++     + LD     +     L  +  + I+    +G+ + 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFC 117

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL 446
           H     R++HRD+K  N+L+D     K+ADFGLAR F      V T    TL Y APE L
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-VRVYTHEVVTLWYRAPEVL 173

Query: 447 VRGQL-TEKADVYSFGILIIEIVCGR 471
           +     +   D++S G +  E+   +
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 62/258 (24%), Positives = 118/258 (45%), Gaps = 52/258 (20%)

Query: 256 KSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQW----- 310
           +  L FK              +KLG+G  G V++  + N   +   +  FN R+      
Sbjct: 4   RGHLLFK--------------EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLV 49

Query: 311 -------------VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
                         ++F  EV ++S ++  N+++LLG  ++     ++ EY+ N  L+QF
Sbjct: 50  AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF 109

Query: 358 I-----FDKNKTK-----------LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKT 401
           +      DK +              ++++   ++ L  A G+ YL   S    +HRD+ T
Sbjct: 110 LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLAT 166

Query: 402 SNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSF 460
            N L+ ++ T KIADFG++R  +A D   +       + +MA E ++ G+ T  +DV++F
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAF 226

Query: 461 GILIIEIVCGRRSNAFSQ 478
           G+ + EI+   +   + +
Sbjct: 227 GVTLWEILMLCKEQPYGE 244

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 68/215 (31%), Positives = 104/215 (48%), Gaps = 37/215 (17%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEF---------FNEVNLISSI-E 325
           +KLG+G  G V+          VA+K+ IF      D F         F E+  +  + +
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKK-IF------DAFRNATDAQRTFREIMFLQELGD 65

Query: 326 HKNLVKLLGC--SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLL-NWNKRFNIILGTAEG 382
           H N+VKLL    +    +  LV+EY+    L   I    +  +L + +KR+ I+    + 
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-IMYQLLKA 119

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA-----VAGT 437
           L Y+H G    +IHRD+K SNILL+ D   K+ADFGLAR  +    +         VA T
Sbjct: 120 LKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA-T 175

Query: 438 LGYMAPEYLVRGQLTEKA-DVYSFGILIIEIVCGR 471
             Y APE L+      K  D++S G ++ E++ G+
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 22/209 (10%)

Query: 276 SKKLGQGGAGSVYMGSLPNG-------TTVAVKRL--IFNTRQWVDEFFNEVNLISSIEH 326
           S++LGQG  G VY G +  G       T VA+K +    + R+ + EF NE +++     
Sbjct: 11  SRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKEFNC 68

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNKRFNIILGT 379
            ++V+LLG   +G  +L++ E +         RSL   + +       +  K   +    
Sbjct: 69  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTL 438
           A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R  +  D           +
Sbjct: 129 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEI 467
            +M+PE L  G  T  +DV+SFG+++ EI
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 33/222 (14%)

Query: 266 LEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLI--- 321
           L   T  F   + +G+G  G VY       G  VA+K ++       +E   E N++   
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKY 59

Query: 322 SSIEHKNLVKLLGC------SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN- 374
           S+  H N+    G            +  LV E     S+   +       L    KR   
Sbjct: 60  SN--HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKE 112

Query: 375 -----IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
                I+  T  GLAYLH   E ++IHRDIK  NILL K+   K+ DFG++    +    
Sbjct: 113 EWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169

Query: 430 VSTAVAGTLGYMAPEYLVRGQLTE-----KADVYSFGILIIE 466
            +T + GT  +MAPE +   +  +     ++DV+S GI  IE
Sbjct: 170 RNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 13/200 (6%)

Query: 274 NPS-----KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
           NPS     K+LG G  G V++G       VA+K  I       ++F  E  ++  + H  
Sbjct: 2   NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKA-INEGAMSEEDFIEEAKVMMKLSHPK 60

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           LV+L G   +     +V E++ N  L  ++  + +   L+ +   ++     EG+ YL  
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLER 118

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-TLGYMAPEYLV 447
            S    IHRD+   N L+      K++DFG+ R +  D  + S++ A   + +  PE   
Sbjct: 119 NS---FIHRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFN 174

Query: 448 RGQLTEKADVYSFGILIIEI 467
             + + K+DV+SFG+L+ E+
Sbjct: 175 FSKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 59/198 (29%), Positives = 104/198 (52%), Gaps = 8/198 (4%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLVKLLG 334
           +KLG+G   +VY G +   G  VA+K +  +  +        E++L+  ++H+N+V+L  
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                 + +LV+EY+    L +++        L+ N   +      +G+A+ H   E R+
Sbjct: 66  VIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRV 121

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           +HRD+K  N+L++K    K+ADFGLAR F       S  V  TL Y AP+ L+  +  + 
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYST 180

Query: 454 KADVYSFGILIIEIVCGR 471
             D++S G ++ E++ GR
Sbjct: 181 SIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 78.8 bits (194), Expect = 3e-16
 Identities = 56/202 (27%), Positives = 108/202 (53%), Gaps = 15/202 (7%)

Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLV 330
           + LG+G  G V +          G  VAVK L   +    + +   E+ ++ ++ H+N+V
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 331 KLLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           K  G C+ +G   + L+ E++P+ SL +++  +NK K+ N  ++    +   +G+ YL  
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKI-NLKQQLKYAVQICKGMDYL-- 125

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLGYMAPEYL 446
           GS  + +HRD+   N+L++ +   KI DFGL +    D+ +  V   +   + + APE L
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 447 VRGQLTEKADVYSFGILIIEIV 468
           ++ +    +DV+SFG+ + E++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 24/206 (11%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLV 330
           K LGQG  G VY+   +  G  +A K++ F+     T + V     E+ L+ +++H+ +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 331 KLLGCSIE-GPESLLVY-EYVPNRSL-DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           +  GC  +   ++L ++ EY+P  S+ DQ       T+ +       I+    EG++YLH
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLH 123

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-----CFAADRTHVSTAVAGTLGYMA 442
                 I+HRDIK +NIL D     K+ DFG ++     C +        +V GT  +M+
Sbjct: 124 S---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR---SVTGTPYWMS 177

Query: 443 PEYLVRGQLTEKADVYSFGILIIEIV 468
           PE +       KADV+S G  ++E++
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 29/216 (13%)

Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D  +   + + +   
Sbjct: 81  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVS 431
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR     D    +
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196

Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
           T     + +MAPE L     T ++DV+SFG+L+ EI
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 78.4 bits (193), Expect = 6e-16
 Identities = 54/194 (27%), Positives = 100/194 (51%), Gaps = 19/194 (9%)

Query: 298 VAVKRLIF----NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRS 353
           VAVK L      N R   ++F  E+ ++S ++  N+++LL   I      ++ EY+ N  
Sbjct: 49  VAVKMLREDANKNAR---NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105

Query: 354 LDQFI--------FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL 405
           L+QF+         +K     ++++    +    A G+ YL   S    +HRD+ T N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCL 162

Query: 406 LDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILI 464
           + K++T KIADFG++R  ++ D   +       + +M+ E ++ G+ T  +DV++FG+ +
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222

Query: 465 IEIVCGRRSNAFSQ 478
            EI+   +   +SQ
Sbjct: 223 WEILTLCKEQPYSQ 236

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 77.8 bits (191), Expect = 6e-16
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 24/209 (11%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLV 330
           K LGQG  G VY+      G  +AVK++ F+     T + V+    E+ L+ ++ H+ +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 331 KLLGCSIEGPESLL--VYEYVPNRSL-DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           +  GC  +  E  L    E++P  S+ DQ       T+  N  +++   +   EG++YLH
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE--NVTRKYTRQI--LEGVSYLH 123

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-----CFAADRTHVSTAVAGTLGYMA 442
                 I+HRDIK +NIL D     K+ DFG ++     C +        +V GT  +M+
Sbjct: 124 ---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM---KSVTGTPYWMS 177

Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           PE +       KAD++S G  ++E++  +
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 12/206 (5%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN---EVNLISSIEHKNL 329
           F   +++G+G  G VY G + N T   V   I +  +  DE  +   E+ ++S  +   +
Sbjct: 6   FTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            +  G  ++G +  ++ EY+   S      D  K   L       I+    +GL YLH  
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLH-- 118

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
           SE R IHRDIK +N+LL +    K+ADFG+A      +   +T V GT  +MAPE + + 
Sbjct: 119 SE-RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176

Query: 450 QLTEKADVYSFGILIIEIVCGRRSNA 475
               KAD++S GI  IE+  G   N+
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 68/233 (29%), Positives = 110/233 (47%), Gaps = 21/233 (9%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL-IFNTRQWVDEF-FNEV 318
           KYE LEK          +G+G  G+V+   +      VA+KR+ + +  + V      E+
Sbjct: 1   KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 50

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            L+  ++HKN+V+L        +  LV+EY  ++ L ++    N        K F   L 
Sbjct: 51  CLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQL- 108

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
             +GLA+ H      ++HRD+K  N+L++K+   K+ADFGLAR F       S  V  TL
Sbjct: 109 -LKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TL 163

Query: 439 GYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL 490
            Y  P+ L   +L +   D++S G +  E+    R      D    L+R++ L
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 78.1 bits (192), Expect = 2e-15
 Identities = 72/227 (31%), Positives = 101/227 (44%), Gaps = 25/227 (11%)

Query: 255 KKSCLSFKYETLEKATNY--FNPSKKLGQGGAGSVYMGSLPNGT--TVAVKRL----IFN 306
           KK   S K    +    Y  FN  + LG G  G V + +  N     VA+KR     I  
Sbjct: 12  KKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK 71

Query: 307 TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL 366
            +Q VD  F+E  +++ I H   V L G   +     LV E+V       F         
Sbjct: 72  QKQ-VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTF--------- 121

Query: 367 LNWNKRFNIILG---TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
           L  NKRF   +G    A+ +          I++RD+K  N+LLDKD   K+ DFG A+  
Sbjct: 122 LRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK-V 180

Query: 424 AADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              RT+    + GT  Y+APE L+     + AD ++ GI I EI+ G
Sbjct: 181 VDTRTY---TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 45/217 (20%)

Query: 279 LGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           LG+G  G V  M  +P GT +AVKR+                 ++S E K L+  L  S+
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRAT--------------VNSQEQKRLLMDLDISM 54

Query: 338 EGPESLLVYEY---------------VPNRSLDQF---IFDKNKTKLLNWNKRFNIILGT 379
              +      +               V + SLD+F   ++DK  T   +   +  I +  
Sbjct: 55  RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK--IAVSI 112

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
            + L YLH  S+  +IHRD+K SN+L++++   K+ DFG++           T  AG   
Sbjct: 113 VKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDAGCKP 168

Query: 440 YMAPEYLVRGQLTE-----KADVYSFGILIIEIVCGR 471
           YMAPE  +  +L +     K+DV+S GI +IE+  GR
Sbjct: 169 YMAPER-INPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 20/207 (9%)

Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 70

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI------FDKNKTKLL-NWNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +  L  ++       + N  +      +   +    A+
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           G+AYL+     + +HRD+   N ++  DFT KI DFG+ R  +  D           + +
Sbjct: 131 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEI 467
           MAPE L  G  T  +D++SFG+++ EI
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 78/297 (26%), Positives = 126/297 (42%), Gaps = 41/297 (13%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQ-WVDEF-FNEV 318
           KYE L            +G+G  G V        G  VA+K+ + +     V +    E+
Sbjct: 2   KYENLGL----------VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREI 51

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  + H+NLV L+          LV+E+V +  LD     +     L+ ++    +  
Sbjct: 52  RMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQ 108

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
              G+ + H  +   IIHRDIK  NIL+ +    K+ DFG AR  AA     +  VA T 
Sbjct: 109 ILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TR 164

Query: 439 GYMAPEYLVRGQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDS------------ASPLQ 485
            Y APE LV      +A D+++ G L+ E++ G     F  DS             + + 
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG--EPLFPGDSDIDQLYHIIKCLGNLIP 222

Query: 486 RVWTLYRSNKLVEAVD-PNLKDDFPAEQV---CNVLQIGLL--CTQAAAALRPSMAQ 536
           R   +++ N L   +  P +K+  P E+     + L + L   C +     RPS +Q
Sbjct: 223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 16/158 (10%)

Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           NE  ++  + H  +++L     +     ++ EYVP   L  F + +N  +  N    F  
Sbjct: 50  NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFY- 106

Query: 376 ILGTAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
               +E    L YLH      I++RD+K  NILLDK+   K+ DFG A+    DRT    
Sbjct: 107 ---ASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW--- 156

Query: 433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            + GT  Y+APE +      +  D ++ GILI E++ G
Sbjct: 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 26/203 (12%)

Query: 277 KKLGQGGAGSVYMG---SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVK 331
            +LG G  G+V  G      +  TVAVK L    N     DE   E N++  +++  +V+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF------IFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           ++G   E    +LV E      L++F      + +KN T+L++           + G+ Y
Sbjct: 61  MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVH---------QVSMGMKY 110

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAP 443
           L    ET  +HRD+   N+LL      KI+DFGL++   AD  +      G   + + AP
Sbjct: 111 LE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167

Query: 444 EYLVRGQLTEKADVYSFGILIIE 466
           E +   + + K+DV+SFG+L+ E
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 71/252 (28%), Positives = 111/252 (44%), Gaps = 48/252 (19%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE------F 314
            YE LEK          +G+G  G VY       G  VA+K+    TR  +DE       
Sbjct: 2   AYEKLEK----------IGEGTYGKVYKARDKNTGKLVALKK----TRLEMDEEGIPPTA 47

Query: 315 FNEVNLISSIEHKN-LVKLLGCSIEGPES-------LLVYEYVPNRSLDQFI---FDKNK 363
             E++L+  +     +V+LL   +E  E         LV+EY+ +  L +F+        
Sbjct: 48  LREISLLQMLSESIYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPG 104

Query: 364 TKL-LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLAR 421
             L     K F   L   +G+A+ H      ++HRD+K  N+L+DK     KIAD GL R
Sbjct: 105 RPLPAKTIKSFMYQL--LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Query: 422 CFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDS 480
            F+      +  +  TL Y APE L+     +   D++S G +  E+   R+   F  DS
Sbjct: 160 AFSIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS--RKQPLFPGDS 216

Query: 481 ASPLQRVWTLYR 492
              LQ++  +++
Sbjct: 217 E--LQQLLHIFK 226

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 22/201 (10%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +LG G  G VY   +   G   A K +   + + ++++  E+ ++++  H  +VKLLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
               +  ++ E+ P  ++D  + + ++   L   +   I     E L YLH     +IIH
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLH---SMKIIH 133

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST-----AVAGTLGYMAPEYLVRGQL 451
           RD+K  N+LL  D   K+ADFG++        +V T     +  GT  +MAPE ++   +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS------AKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187

Query: 452 TE-----KADVYSFGILIIEI 467
            +     KAD++S GI +IE+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 75.9 bits (186), Expect = 4e-15
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 20/210 (9%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN---EVNLISSIEHKNL 329
           F   +++G+G  G V+ G + N T   V   I +  +  DE  +   E+ ++S  +   +
Sbjct: 6   FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI----FDKNKTKLLNWNKRFNIILGTAEGLAY 385
            K  G  ++G +  ++ EY+   S    +    FD+ +   +        IL   +GL Y
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM-----LKEIL---KGLDY 116

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEY 445
           LH  SE +I HRDIK +N+LL +    K+ADFG+A      +   +T V GT  +MAPE 
Sbjct: 117 LH--SEKKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV 172

Query: 446 LVRGQLTEKADVYSFGILIIEIVCGRRSNA 475
           + +     KAD++S GI  IE+  G   N+
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 76.3 bits (188), Expect = 5e-15
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           K +G G  G V        G  VA+K+L   F         + E+ L+  + HKN++ LL
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81

Query: 334 GCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTAE- 381
                         + P +SL++F        + D N  +++     ++R + +L     
Sbjct: 82  NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC 129

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           G+ +LH      IIHRD+K SNI++  D T KI DFGLAR  A     ++  V  T  Y 
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV-TRYYR 184

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE ++     E  D++S G ++ E++ G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.0 bits (188), Expect = 5e-15
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 36/215 (16%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEF-----FNEVNLISSIEHKNLV 330
           K +G G  G V        G  VA+K+ I N     D         E+ L+  + H+N++
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKK-ISNVFD--DLIDAKRILREIKLLRHLRHENII 62

Query: 331 KLLGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTA 380
            LL   I  P S        +V E +    L + I  K+   L + + ++    I+    
Sbjct: 63  GLL--DILRPPSPEDFNDVYIVTELMET-DLHKVI--KSPQPLTDDHIQYFLYQILR--- 114

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR---CFAADRTHVSTAVAGT 437
            GL YLH  +   +IHRD+K SNIL++ +   KI DFGLAR       ++  ++  V  T
Sbjct: 115 -GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-T 169

Query: 438 LGYMAPE-YLVRGQLTEKADVYSFGILIIEIVCGR 471
             Y APE  L   + T+  D++S G +  E++  +
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 75.8 bits (186), Expect = 7e-15
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 25/209 (11%)

Query: 273 FNPSKKLGQGGAGSVYMGS-LPNGTT----VAVKRLIFNTRQWVD-EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G      VA+K L   T    + E  +E  +++S+++
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTK-----LLNWNKRFNIILGTAE 381
            ++ +LLG  +     L + + +P   L  ++  ++K       LLNW       +  A+
Sbjct: 69  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAK 120

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LG 439
           G+ YL    E R++HRD+   N+L+      KI DFGLA+   AD      A  G   + 
Sbjct: 121 GMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH-AEGGKVPIK 176

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           +MA E ++    T ++DV+S+G+ + E++
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 9/195 (4%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE---FFNEVNLISSIEHKNLVKLL 333
           KK+G+G  G +Y+    + +   V + I  T+  V E      EV L++ ++H N+V   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
               E     +V EY     L + I ++ +  L + ++  +  +  + GL ++H   + +
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIH---DRK 121

Query: 394 IIHRDIKTSNILLDKD-FTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
           I+HRDIK+ NI L K+    K+ DFG+AR    D   ++    GT  Y++PE        
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPEICQNRPYN 180

Query: 453 EKADVYSFGILIIEI 467
            K D++S G ++ E+
Sbjct: 181 NKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 80/285 (28%), Positives = 124/285 (43%), Gaps = 54/285 (18%)

Query: 278 KLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEF-FNEVNLISSIEHK----NLVK 331
           +LG+G  GSVY +   P G T+A+K +    R  +DE  FN++ +   I HK     +V 
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEI----RLELDESKFNQIIMELDILHKAVSPYIVD 63

Query: 332 LLGC-SIEGPESLLVY---EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
             G   IEG     VY   EY+   SLD+       T+ +  +    I     +GL +L 
Sbjct: 64  FYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL- 446
              E  IIHRD+K +N+L++ +   K+ DFG++    A    ++    G   YMAPE + 
Sbjct: 120 --EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPERIK 174

Query: 447 -----VRGQLTEKADVYSFGILIIEIVCGR-------RSNAFSQDSASPLQRVWTLYRSN 494
                     T ++DV+S G+ I+E+  GR        +N F+Q SA             
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA------------- 221

Query: 495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM 539
            +V+   P L   +  +    V      C       RP+ AQ + 
Sbjct: 222 -IVDGDPPTLPSGYSDDAQDFV----AKCLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 25/205 (12%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTT----VAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G  +P+G      VA+K L  NT    + E  +E  +++ +    + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTK-----LLNWNKRFNIILGTAEGLAY 385
           +LLG  +     L V + +P   L  ++  +NK +     LLNW       +  A+G++Y
Sbjct: 73  RLLGICLTSTVQL-VTQLMPYGCLLDYV-RENKDRIGSQDLLNW------CVQIAKGMSY 124

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAP 443
           L    E R++HRD+   N+L+      KI DFGLAR    D T    A  G   + +MA 
Sbjct: 125 LE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH-ADGGKVPIKWMAL 180

Query: 444 EYLVRGQLTEKADVYSFGILIIEIV 468
           E ++  + T ++DV+S+G+ + E++
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 58/190 (30%), Positives = 91/190 (47%), Gaps = 31/190 (16%)

Query: 295 GTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR 352
           G  VAVK+L   F  +      + E+ L+  + HKN++ LL              + P +
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQK 93

Query: 353 SLDQF--------IFDKNKTKLLNWN---KRFNIIL-GTAEGLAYLHGGSETRIIHRDIK 400
           SL++F        + D N  ++++     +R + +L     G+ +LH      IIHRD+K
Sbjct: 94  SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150

Query: 401 TSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSF 460
            SNI++  D T KI DFGLAR   A    + T    T  Y APE ++     E  D++S 
Sbjct: 151 PSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 208

Query: 461 GILIIEIVCG 470
           G ++ E+V G
Sbjct: 209 GCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 37/212 (17%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIF-NTRQWVD-EFFNEVNLISSIEHKNLVKLLG 334
           ++G+G  G VY      +G  VA+K++   N R  +      E+ L+ ++ H N+V+L  
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK- 72

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIF------DKNKTKLLNWNKR-FN------IILGTAE 381
                       E V  + LD  IF      +++   LL+     F+      ++L    
Sbjct: 73  ------------EVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLR 119

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL YLH   E  IIHRD+K SN+LL      KIADFGLAR +      ++  V  TL Y 
Sbjct: 120 GLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYR 175

Query: 442 APEYLVRGQL--TEKADVYSFGILIIEIVCGR 471
           APE L+ G    T   D+++ G ++ E++  +
Sbjct: 176 APE-LLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 32/212 (15%)

Query: 279 LGQGGAGSVYMGSL-PNGTTVAVKRLIF--NTRQWVD-------EFFNEVNLISSIEHKN 328
           LGQG   ++Y G L        V          + +         FF   +L+S + HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILGTAEGLAYLH 387
           LVKL G  +   E+++V EYV    LD F+  + K  + L+W  + ++    A  L YL 
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFL-HREKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 388 GGSETRIIHRDIKTSNILLDKD-----FTP--KIADFGLARCFAADRTHVSTAVAGTLGY 440
              + +++H ++   NIL+ +      + P  K++D G+     +    V         +
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-----PW 170

Query: 441 MAPEYLVRGQ--LTEKADVYSFGILIIEIVCG 470
           +APE +  GQ  LT  AD +SFG  ++EI   
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 18/199 (9%)

Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +LG G  G VY         +A  ++I   + + ++++  E+++++S +H N+VKLL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
                  ++ E+    ++D  + +  +   L   +   +   T E L YLH   E +IIH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLH---ENKIIH 126

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHV---STAVAGTLGYMAPEYLVRGQLTE 453
           RD+K  NIL   D   K+ADFG+    +A  T       +  GT  +MAPE ++     +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 454 -----KADVYSFGILIIEI 467
                KADV+S GI +IE+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 22/200 (11%)

Query: 277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEHKNLV 330
           +++G+G  G V+ G L  + T VAVK    + R+ +      +F  E  ++    H N+V
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIV 56

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +L+G   +     +V E V       F+  + +   L   +   ++   A G+ YL    
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLE--- 111

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT----LGYMAPEYL 446
               IHRD+   N L+ +    KI+DFG++R    +   V  +  G     + + APE L
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEAL 168

Query: 447 VRGQLTEKADVYSFGILIIE 466
             G+ + ++DV+SFGIL+ E
Sbjct: 169 NYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 73.6 bits (180), Expect = 2e-14
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 12/201 (5%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN---EVNLISSIEHKNL 329
           F   +K+G+G  G V+ G + N T   V   I +  +  DE  +   E+ ++S  +   +
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            K  G  ++  +  ++ EY+   S      D  +   L+  +   I+    +GL YLH  
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLH-- 118

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
           SE +I HRDIK +N+LL +    K+ADFG+A     D         GT  +MAPE + + 
Sbjct: 119 SEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 450 QLTEKADVYSFGILIIEIVCG 470
               KAD++S GI  IE+  G
Sbjct: 177 AYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 28/187 (14%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFF-----NEVNLISSIEHKNLVK 331
           K+GQG  G V+          VA+K+++    +   E F      E+ ++  ++H+N+V 
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 75

Query: 332 LLG-CSIEG-------PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           L+  C  +            LV+E+     L   + +KN    L+  K+  ++     GL
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFC-EHDLAGLLSNKNVKFTLSEIKK--VMKMLLNGL 132

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF----AADRTHVSTAVAGTLG 439
            Y+H     +I+HRD+K +NIL+ KD   K+ADFGLAR F     +     +  V  TL 
Sbjct: 133 YYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLW 188

Query: 440 YMAPEYL 446
           Y  PE L
Sbjct: 189 YRPPELL 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 22/220 (10%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPN-GTTVAVK--RLIFNTRQWVDEFFNEVNLISSIE---H 326
           + P  ++G G  G+VY    P+ G  VA+K  R+  N          EV L+  +E   H
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 327 KNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
            N+V+L+  C+    +      LV+E+V ++ L  ++ DK     L      +++     
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLR 119

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS-TAVAGTLGY 440
           GL +LH      I+HRD+K  NIL+      K+ADFGLAR ++     ++ T V  TL Y
Sbjct: 120 GLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWY 173

Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDS 480
            APE L++       D++S G +  E+   RR   F  +S
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNS 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 24/212 (11%)

Query: 277 KKLGQGGAGSVYMGSLPNGT------TVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNL 329
           ++LG+   G VY G L           VA+K L       + +EF +E  + S ++H N+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIF-------------DKNKTKLLNWNKRFNII 376
           V LLG   +     +++ Y  +  L +F+              DK     L      +I+
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVA 435
              A G+ +L   S   ++H+D+ T N+L+      KI+D GL R  +AAD   +     
Sbjct: 131 TQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187

Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
             + +M+PE ++ G+ +  +D++S+G+++ E+
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 26/209 (12%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE----FFNEVNLISSIEHKNLVKL 332
           + +G+G  G V++        + + + I    Q   +      NE  ++  + H N+++ 
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY------- 385
               +E    ++V EY P  +L ++I            KR N +L     L +       
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYI-----------QKRCNSLLDEDTILHFFVQILLA 113

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           LH      I+HRD+KT NILLDK     KI DFG+++  ++ ++   T V GT  Y++PE
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYT-VVGTPCYISPE 171

Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGRRS 473
                   +K+D+++ G ++ E+   +R+
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 5/90 (5%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL +LH   + RI++RD+K  N+LLD     +I+D GLA      +       AGT GYM
Sbjct: 107 GLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYM 161

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L         D ++ G  + E++ GR
Sbjct: 162 APEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 40/227 (17%)

Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLI--FNTRQWVDEFFNEVNL 320
           +T+ +  + +     +G G  G V        G  VA+K+L   F +       + E+ L
Sbjct: 8   KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRL 67

Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI----------FDKN---KTKLL 367
           +  ++H+N++ LL              + P  SL+ F            D N   K + L
Sbjct: 68  LKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKL 115

Query: 368 NWNK-RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           + +  +F ++     GL Y+H      IIHRD+K SNI +++D   KI DFGLAR    +
Sbjct: 116 SDDHIQF-LVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171

Query: 427 RT-HVSTAVAGTLGYMAPE-YLVRGQLTEKADVYSFGILIIEIVCGR 471
            T +V      T  Y APE  L      +  D++S G ++ E++ G+
Sbjct: 172 MTGYV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 71/226 (31%), Positives = 110/226 (48%), Gaps = 30/226 (13%)

Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFN-EVNLI 321
           E+L   T+ +   + +G+G  G VY + +  +G+  AVK  I +    VDE    E N++
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK--ILDPISDVDEEIEAEYNIL 72

Query: 322 SSI-EHKNLVKLLGC-----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN- 374
            S+  H N+VK  G       + G +  LV E     S+ + +       LL   +R + 
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127

Query: 375 -----IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
                I+ G   GL +LH     RIIHRD+K +NILL  +   K+ DFG++    + R  
Sbjct: 128 AMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184

Query: 430 VSTAVAGTLGYMAPEYLVRGQLTE-----KADVYSFGILIIEIVCG 470
            +T+V GT  +MAPE +   Q  +     + DV+S GI  IE+  G
Sbjct: 185 RNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWVDE--FFNEV 318
           KYE L K          +G+G  G V+   +   G  VA+K+ + +    V +     E+
Sbjct: 2   KYEKLSK----------IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREI 51

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  ++H NLV L+       +  LV+EY  +  L++   +KN  + +  +    II  
Sbjct: 52  RMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNEL--EKN-PRGVPEHLIKKIIWQ 108

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           T + + + H   +   IHRD+K  NIL+ K    K+ DFG AR         +  VA T 
Sbjct: 109 TLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TR 164

Query: 439 GYMAPEYLV-RGQLTEKADVYSFGILIIEIVCG 470
            Y APE LV   Q     DV++ G +  E++ G
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 21/220 (9%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTT-VAVKRLIFNTRQ--WVDEFFNEVNLI---SSIE 325
           +    ++G+G  G V+    L NG   VA+KR+   T +         EV ++    + E
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62

Query: 326 HKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           H N+V+L   C++   +      LV+E+V ++ L  ++ DK     +      +++    
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLL 120

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY 440
            GL +LH     R++HRD+K  NIL+      K+ADFGLAR ++       T+V  TL Y
Sbjct: 121 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWY 175

Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDS 480
            APE L++       D++S G +  E+   RR   F   S
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSS 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 72.8 bits (179), Expect = 4e-14
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 16/201 (7%)

Query: 281 QGGAGSVYMGSLPNGTT-----VAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLG 334
           +G  G ++ G L +        V VK +  +  +  V     E  L+  + H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 335 CSIEGPESLLV-YEYVPNRSLDQF-----IFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
             IE  E   V Y Y+   +L  F     + + N  + L+  +  ++ +  A G++YLH 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGYMAPEYLV 447
             +  +IH+DI   N ++D++   KI D  L+R  F  D   +       + +MA E LV
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192

Query: 448 RGQLTEKADVYSFGILIIEIV 468
             + +  +DV+SFG+L+ E++
Sbjct: 193 NKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 73.2 bits (179), Expect = 4e-14
 Identities = 66/216 (30%), Positives = 111/216 (51%), Gaps = 12/216 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLG 334
           +KLG+G   +VY G S  NG  VA+K +     +        E +L+  ++H N+V LL 
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV-LLH 69

Query: 335 CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I   E+L LV+EYV +  L Q++ DK+   L   N +   +     GL+Y+H   +  
Sbjct: 70  DIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKL-FLFQLLRGLSYIH---QRY 123

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV-RGQLT 452
           I+HRD+K  N+L+      K+ADFGLAR  +   +H  +    TL Y  P+ L+   + +
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 453 EKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVW 488
              D++  G + +E++ G  +    +D    L+R++
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF 218

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 73.9 bits (181), Expect = 4e-14
 Identities = 55/188 (29%), Positives = 91/188 (48%), Gaps = 31/188 (16%)

Query: 298 VAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLD 355
           VA+K+L   F  +      + E+ L+  + HKN++ LL              + P +SL+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 99

Query: 356 QF--------IFDKNKTKLLNW---NKRFNIILGTAE-GLAYLHGGSETRIIHRDIKTSN 403
           +F        + D N  +++     ++R + +L     G+ +LH      IIHRD+K SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156

Query: 404 ILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGIL 463
           I++  D T KI DFGLAR   A  + + T    T  Y APE ++     E  D++S G +
Sbjct: 157 IVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 214

Query: 464 IIEIVCGR 471
           + E++ G 
Sbjct: 215 MGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 17/205 (8%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVA---VKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
            ++G G  G V +G    G + A   VK L    T      F  EV     + H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG--TAEGLAYLHGGS 390
           LG  IE    LLV E+ P   L  ++            K     +    A GL +LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARC-FAADRTHVSTAVAGTLGYMAPEYL-VR 448
           +   IH D+   N  L  D + KI D+GLA   +  D        A  L ++APE + +R
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 449 GQ------LTEKADVYSFGILIIEI 467
           GQ       T+K++++S G+ + E+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 18/206 (8%)

Query: 277 KKLGQGGAGSVYMGSLPNGTT---VAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K LG+G  GSV  G L    +   VAVK  ++   TR  +++F +E   +   +H N+++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 332 LLGCSIEG------PESLLVYEYVPNRSLDQFIFDK---NKTKLLNWNKRFNIILGTAEG 382
           L+G  ++       P  +++  ++ +  L  F+      +  + L        +   A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA-RCFAADRTHVSTAVAGTLGYM 441
           + YL   S    IHRD+   N +L+++    +ADFGL+ + +  D           + ++
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 442 APEYLVRGQLTEKADVYSFGILIIEI 467
           A E L     T K+DV+SFG+ + EI
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 28/208 (13%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLV 330
           K LG+G  G VY+      G  +AVK++ F+     T + V+    E+ L+ ++ H  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 331 KLLGCSIEGPE----SLLVYEYVPNRSL-DQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           +  GC +  PE    S+ V EY+P  S+ DQ       T+  N  +R+   +   +G++Y
Sbjct: 68  QYYGC-LRDPEEKKLSIFV-EYMPGGSIKDQLKAYGALTE--NVTRRYTRQI--LQGVSY 121

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-----CFAADRTHVSTAVAGTLGY 440
           LH      I+HRDIK +NIL D     K+ DFG ++     C +   T + + V GT  +
Sbjct: 122 LHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG--TGIKS-VTGTPYW 175

Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIV 468
           M+PE +       KADV+S    ++E++
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 48/230 (20%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL--------IFNTRQWVDE------FFNEVNLI 321
             LG+G  G V        G  VA+K++        +   RQ V           E+ ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------I 375
           + I+H+N++ L+   +EG    LV + +            +  K+++   R        I
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTESQVKCI 124

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD--------- 426
           +L    GL  LH       +HRD+  +NI ++     KIADFGLAR +            
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 427 ----RTHVSTAVAGTLGYMAPEYLVRGQLTEKA-DVYSFGILIIEIVCGR 471
               R    T+   TL Y APE L+  +    A D++S G +  E++ G+
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 37/220 (16%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FF 315
           +YE +EK           G+G  G VY         T+A+K++        DE       
Sbjct: 3   QYEKVEKI----------GEGTYGVVYKARDRVTNETIALKKIRLEQE---DEGVPSTAI 49

Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
            E++L+  ++H N+V+L           LV+EY+    LD     K+     ++ K   +
Sbjct: 50  REISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL---DLD---LKKHMDSSPDFAKNPRL 103

Query: 376 I----LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAAD-RTH 429
           I         G+AY H     R++HRD+K  N+L+D+     K+ADFGLAR F    RT 
Sbjct: 104 IKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160

Query: 430 VSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIV 468
               V  TL Y APE L+     +   D++S G +  E+V
Sbjct: 161 THEVV--TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198

Length = 294

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 30/220 (13%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFF-----NEVNL 320
           ++  + F+   ++G+G  G VY       G  VA+K++  +  +   E F      E+ +
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKI 59

Query: 321 ISSIEHKNLVKLLGCSIEGPESL----------LVYEYVPNRSLDQFIFDKNKTKLLNWN 370
           +  + H+N+V L     +  ++L          LV+EY+     D  +    ++ L++++
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFS 114

Query: 371 KRFN--IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
           +      +    EGL Y H   +   +HRDIK SNILL+     K+ADFGLAR + ++ +
Sbjct: 115 EDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171

Query: 429 HVSTAVAGTLGYMAPEYLV-RGQLTEKADVYSFGILIIEI 467
              T    TL Y  PE L+   +     DV+S G ++ E+
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 14/196 (7%)

Query: 278 KLGQGGAGSVYMGSL---PNGTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLVKLL 333
           +LG G  G V  G          VA+K L     + V DE   E  ++  +++  +V+++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 334 G-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           G C  E    +LV E      L++F+  K     +  +    ++   + G+ YL G +  
Sbjct: 62  GVCEAEA--LMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEGKN-- 115

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLVRGQ 450
             +HRD+   N+LL      KI+DFGL++   AD ++     AG   L + APE +   +
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 451 LTEKADVYSFGILIIE 466
            + ++DV+S+GI + E
Sbjct: 175 FSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 38/185 (20%)

Query: 295 GTTVAVKRLIFNTRQWVDEFF-----NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
           G  VA+K+L         E F      E+N++  ++H N+V              V E V
Sbjct: 30  GEIVALKKLKMEK---EKEGFPITSLREINILLKLQHPNIVT-------------VKEVV 73

Query: 350 PNRSLDQ------FIFDKNKTKLLNWNKRF------NIILGTAEGLAYLHGGSETRIIHR 397
              +LD+      ++    K+ +    + F       ++L    G+A+LH   +  I+HR
Sbjct: 74  VGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHR 130

Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV-RGQLTEKAD 456
           D+KTSN+LL+     KI DFGLAR + +     +  V  TL Y APE L+   + +   D
Sbjct: 131 DLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLGAKEYSTAID 189

Query: 457 VYSFG 461
           ++S G
Sbjct: 190 MWSVG 194

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 30/209 (14%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTV-AVKRL---IFNTRQWVDEFFNEVNLIS-SIEHKNLVK 331
           K LG+G  G V +  L     + AVK L   +      V+    E  +++ + +H  L +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRF---NIILGTAEG 382
           L  C  +  + L  V EYV    L   I     FD+ +        RF    I+LG    
Sbjct: 61  LHSC-FQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA-------RFYAAEIVLG---- 108

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           L +LH   E  II+RD+K  N+LLD +   KIADFG+ +         ST   GT  Y+A
Sbjct: 109 LQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCGTPDYIA 164

Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           PE L         D ++ G+L+ E++ G+
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 25/216 (11%)

Query: 272 YFNPSKKLGQGGAGSV----YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSI- 324
            +   K+LGQG  G V       +     TVA+K++  +F+ +        E+ L+    
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSE-EETVAIKKITNVFSKKILAKRALRELKLLRHFR 59

Query: 325 EHKNLVKLLGCSIEGPES---LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILGT 379
            HKN+  L    I  P +   L +YE +    L Q I  ++   L + + +  I  IL  
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTDAHFQSFIYQILC- 116

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS---TAVAG 436
             GL Y+H  +   ++HRD+K  N+L++ D   KI DFGLAR F+ +    +   T    
Sbjct: 117 --GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171

Query: 437 TLGYMAPEYLVRGQLTEKA-DVYSFGILIIEIVCGR 471
           T  Y APE ++  Q   KA DV+S G ++ E++  +
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 28/209 (13%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            +G+G  G V      P G  VA+K++  F  + +      E+ ++   +H+N++ +L  
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGIL-- 69

Query: 336 SIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
            I  P S        +V E +    L + I    KT+ L+ +     +     GL Y+H 
Sbjct: 70  DIIRPPSFESFNDVYIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHS 124

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA-----VAGTLGYMAP 443
            +   ++HRD+K SN+LL+ +   KI DFGLAR   AD  H  T      VA T  Y AP
Sbjct: 125 AN---VLHRDLKPSNLLLNTNCDLKICDFGLAR--IADPEHDHTGFLTEYVA-TRWYRAP 178

Query: 444 EYLVRGQLTEKA-DVYSFGILIIEIVCGR 471
           E ++  +   KA D++S G ++ E++  R
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 8/95 (8%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA---ADRTHVSTAVAGTL 438
           GL Y+H  +   +IHRD+K SN+L+++D   +I DFG+AR  +    +  +  T    T 
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 439 GYMAPE-YLVRGQLTEKADVYSFGILIIEIVCGRR 472
            Y APE  L   + T   D++S G +  E++ GRR
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 37/213 (17%)

Query: 279 LGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLI-SSIEHKNLVK 331
           +G+G  G+V  M   P+GT +AVKR+    R  VDE        +++++  S +   +VK
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI----RSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLAY 385
             G      +  +  E + + SLD+F     K                 I + T + L Y
Sbjct: 68  FYGALFREGDCWICMELM-DISLDKFY----KYVYEVLKSVIPEEILGKIAVATVKALNY 122

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFG----LARCFAADRTHVSTAVAGTLGYM 441
           L    E +IIHRD+K SNILLD++   K+ DFG    L    A  R       AG   YM
Sbjct: 123 LK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD------AGCRPYM 174

Query: 442 APEYL---VRGQLTEKADVYSFGILIIEIVCGR 471
           APE +    R     ++DV+S GI + E+  G+
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 52/195 (26%), Positives = 89/195 (45%), Gaps = 15/195 (7%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           LG G  G+VY    L     +AVK +  + T +   +  +E+ ++   +   ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
                  +  E++   SLD  ++ K    +L       I +   +GL YL      +I+H
Sbjct: 69  FVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKILH 118

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD+K SN+L++     K+ DFG++         ++    GT  YMAPE +   Q    +D
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQYGIHSD 175

Query: 457 VYSFGILIIEIVCGR 471
           V+S GI  +E+  GR
Sbjct: 176 VWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 25/215 (11%)

Query: 273 FNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIE 325
           F   + LG+G  GSV    L     +   VAVK L   IF++   ++EF  E   +   +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFD 59

Query: 326 HKNLVKLLGCSIEG------PESLLVYEYVPNRSLDQFIF-----DKNKTKLLNWNKRFN 374
           H N++KL+G S+        P  +++  ++ +  L  F+      ++  T  L    RF 
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF- 118

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTA 433
            ++  A G+ YL   S    IHRD+   N +L+++ T  +ADFGL++  ++ D      A
Sbjct: 119 -MIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174

Query: 434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIV 468
               + ++A E L     T  +DV++FG+ + EI+
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 65/218 (29%), Positives = 90/218 (41%), Gaps = 50/218 (22%)

Query: 279 LGQGGAGSVY-MGSLPNGTTVAVKRLIF------NTRQWVDEFFNEVNLISSIEHKNLVK 331
           +G G  G VY M     G  +AVK++        N R  +D    +V L S  +   +VK
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL---DVVLKSH-DCPYIVK 78

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG-----TAEGLAYL 386
             G  I   +  +  E      L     DK   ++         ILG       + L YL
Sbjct: 79  CYGYFITDSDVFICME------LMSTCLDKLLKRIQGPIPED--ILGKMTVAIVKALHYL 130

Query: 387 ---HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
              HG     +IHRD+K SNILLD     K+ DFG++      +    T  AG   YMAP
Sbjct: 131 KEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAP 183

Query: 444 E----------YLVRGQLTEKADVYSFGILIIEIVCGR 471
           E          Y +R      ADV+S GI ++E+  G+
Sbjct: 184 ERIDPPDPNPKYDIR------ADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 35/221 (15%)

Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLI 321
           T+ + TN +   + +G G  G V        G  VA+K+++  F+T       + E+ L+
Sbjct: 4   TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLL 63

Query: 322 SSIEHKNLVKLLGCSIEGPESL-LVYEYVP---NRSL------DQFIFDKNKTKLLNWNK 371
             + H+N++ L    I   E +  V E +    +R L       QFI            +
Sbjct: 64  KHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFI------------Q 111

Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
            F  +     GL Y+H      ++HRD+K SNIL++++   KI DFGLAR     +    
Sbjct: 112 YF--LYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQM 162

Query: 432 TAVAGTLGYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGR 471
           T    T  Y APE ++  Q    + D++S G +  E++ G+
Sbjct: 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 70.9 bits (173), Expect = 4e-13
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)

Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 81  LLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 128

Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 183

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 69.6 bits (170), Expect = 6e-13
 Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 10/198 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLG 334
           +KLG+G   +V+ G S      VA+K +     +        EV+L+  ++H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                    LV+EY+ ++ L Q++ D      ++  K F  +     GLAY H     ++
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRKV 125

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV-RGQLTE 453
           +HRD+K  N+L+++    K+ADFGLAR  +      S  V  TL Y  P+ L+   + + 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184

Query: 454 KADVYSFGILIIEIVCGR 471
           + D++  G +  E+  GR
Sbjct: 185 QIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 39/216 (18%)

Query: 279 LGQGGAGSVYMGSLPNG---TTVAVKRLI-FNTRQWVDEFFNEVNLISSI-EHKNLVKLL 333
           +G+G  G V    +         A+KR+  + ++    +F  E+ ++  +  H N++ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA------------- 380
           G         L  EY P+ +L  F+    K+++L  +  F I   TA             
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 381 ---EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
               G+ YL   S+ + IHRD+   NIL+ +++  KIADFGL+R            V  T
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 181

Query: 438 LG-----YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           +G     +MA E L     T  +DV+S+G+L+ EIV
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLGC 335
           KLG+G   +VY G S      VA+K +     +        EV+L+  ++H N+V L   
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 336 SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I   +SL LV+EY+ ++ L Q++ D   +  ++  K F  +     GL Y H     ++
Sbjct: 73  -IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRKV 125

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV-RGQLTE 453
           +HRD+K  N+L+++    K+ADFGLAR  +      S  V  TL Y  P+ L+     + 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184

Query: 454 KADVYSFGILIIEIVCGR 471
           + D++  G +  E+  GR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 56/157 (35%), Positives = 78/157 (49%), Gaps = 17/157 (10%)

Query: 320 LISSIEHKNLVKLLGCSIEGPESLL-VYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NI 375
           L  + EH  L  L  C+ +  E L  V EY+    L   I    +        RF    I
Sbjct: 49  LALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE--ARARFYAAEI 105

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           I G    L +LH   +  II+RD+K  N+LLDKD   KIADFG+ +         ST   
Sbjct: 106 ICG----LQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FC 157

Query: 436 GTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           GT  Y+APE +++GQ   E  D +SFG+L+ E++ G+
Sbjct: 158 GTPDYIAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 39/91 (42%), Positives = 52/91 (57%), Gaps = 8/91 (8%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR--CFAADRTHVSTAVAGTLG 439
           GL YLH   E +I++RD+K  N+LLD +   KIADFGL +      DRT  ST   GT  
Sbjct: 113 GLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGTPE 166

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           ++APE L     T   D +  G+LI E++ G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 22/222 (9%)

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLL--VYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
           E  L+S ++H N+V     S EG + LL  V  +     L   +  + K KLL  N+   
Sbjct: 49  EAQLLSQLKHPNIVAYRE-SWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVE 106

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
             +  A  L YLH   E  I+HRD+KT N+ L +    K+ D G+AR         ST +
Sbjct: 107 WFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163

Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN 494
            GT  YM+PE         K+DV++ G  + E+   +  +AF+    + L     +YR  
Sbjct: 164 -GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK--HAFNAKDMNSL-----VYR-- 213

Query: 495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
            ++E   P +  D+ + ++  ++   +L  +     RPS+  
Sbjct: 214 -IIEGKLPPMPKDY-SPELGELIA-TMLSKRPEK--RPSVKS 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 37/91 (40%), Positives = 56/91 (61%), Gaps = 4/91 (4%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           A  L +LH      II+RD+K  NILLD++   K+ DFGL++  + D    + +  GT+ 
Sbjct: 108 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVE 163

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           YMAPE + R   T+ AD +SFG+L+ E++ G
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 10/201 (4%)

Query: 273 FNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLV 330
           F    +LG G  G V  +   P+G  +A K +    +  + ++   E+ ++       +V
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
              G      E  +  E++   SLDQ + +  +       K   + +    GLAYL    
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VSIAVLRGLAYLR--E 121

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
           + +I+HRD+K SNIL++     K+ DFG++         ++ +  GT  YM+PE L    
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTH 178

Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + ++D++S G+ ++E+  GR
Sbjct: 179 YSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 29/211 (13%)

Query: 277 KKLGQGGAGSVYMGSLPNG---TTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKL 332
           K++G G  G V +G + +G     V VK L  +   Q   +F  E     S++H NL++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF--NIILGTAEGLAYLHGGS 390
           LG   E    LLV E+ P   L  ++    K +L+  +      +    A GL +LH   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARC-------FAADRTHVSTAVAGTLGYMAP 443
           +   IH D+   N LL  D T KI D+GL+            D+  V       L ++AP
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP------LRWIAP 171

Query: 444 EYL--VRGQL-----TEKADVYSFGILIIEI 467
           E +  V G L     T++++V+S G+ I E+
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 5/90 (5%)

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           L +LH   +  II+RDIK  NILLD +    + DFGL++ F A+    + +  GT+ YMA
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 443 PEYLVRGQL--TEKADVYSFGILIIEIVCG 470
           PE +  G     +  D +S G+L  E++ G
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 14/216 (6%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLGC 335
           KLG+G   +VY G S   G  VA+K +     +        E +L+  ++H N+V  L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70

Query: 336 SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I   ++L LV+EY+ +  L Q++ D      ++  + F   L    GLAY H     R+
Sbjct: 71  IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQL--LRGLAYCHQ---RRV 124

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLV-RGQLT 452
           +HRD+K  N+L+ +    K+ADFGLAR  +   +T+ +  V  TL Y  P+ L+   + +
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGSTEYS 182

Query: 453 EKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVW 488
              D++  G +  E+  GR     S D    L +++
Sbjct: 183 TSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIF 218

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.9 bits (171), Expect = 2e-12
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 18/170 (10%)

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLL-VYEYVPNRSLDQFIFDKNKTKLLNWNKR 372
           F  E  L + + H N+V LL      P  L  V+EYVP R+L + +        L   + 
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADG---ALPAGET 81

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTP--KIADFGLARCF----AA 425
             ++L   + LA  H      I+HRD+K  NI++      P  K+ DFG+         A
Sbjct: 82  GRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138

Query: 426 DRTHVS--TAVAGTLGYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGRR 472
           D   ++  T V GT  Y APE L RG+ +T  +D+Y++G++ +E + G+R
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 42/215 (19%)

Query: 277 KKLGQGGAGSV-YMGSLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           K++G G  G+V        G  VA+K+L   F +  +    + E+ L+  ++H+N++ LL
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80

Query: 334 GCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNWNK----RFN-IILGTA 380
                         + P+ SLD+F            +  KL+   K    R   ++    
Sbjct: 81  DV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML 128

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG---T 437
           +GL Y+H      IIHRD+K  N+ +++D   KI DFGLAR          + + G   T
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVT 178

Query: 438 LGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
             Y APE ++     T+  D++S G ++ E++ G+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 41/231 (17%)

Query: 279 LGQGGAGSVYMG--------SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           LGQG    ++ G           + T V +K L  + R + + FF   +++S + HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILGTAEGLAY-LHG 388
              G  + G ES++V EYV   SLD ++  KNK  + ++W       L  A+ LA+ LH 
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISWK------LEVAKQLAWALHF 115

Query: 389 GSETRIIHRDIKTSNILL-----DKDFTP---KIADFG-----LARCFAADRTHVSTAVA 435
             +  + H ++   N+LL      K   P   K++D G     L +    +R        
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER-------- 167

Query: 436 GTLGYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ 485
             + ++ PE +   Q L+  AD +SFG  + EI  G      + DS   LQ
Sbjct: 168 --IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ 216

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 25/209 (11%)

Query: 279 LGQGGAGSVYMGSLP---NGTTVAVKRLI-FNTRQWVDEFFNEVNLISSI-EHKNLVKLL 333
           +G+G  G V    +         A+K L  F +     +F  E+ ++  +  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY-------- 385
           G         +  EY P  +L  F+    K+++L  +  F    GTA  L          
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 386 -----LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-TLG 439
                +   SE + IHRD+   N+L+ ++   KIADFGL+R    +  +V   +    + 
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLPVR 183

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           +MA E L     T K+DV+SFG+L+ EIV
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 27/174 (15%)

Query: 313 EFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           +F  E+ ++  +  H N++ LLG         L  EY P+ +L  F+    K+++L  + 
Sbjct: 41  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDP 97

Query: 372 RFNIILGTAE----------------GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA 415
            F I   TA                 G+ YL   S+ + IHRD+   NIL+ +++  KIA
Sbjct: 98  AFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIA 154

Query: 416 DFGLARCFAADRTHVSTAVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           DFGL+R       +V   +    + +MA E L     T  +DV+S+G+L+ EIV
Sbjct: 155 DFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 66.6 bits (162), Expect = 6e-12
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLGC 335
           KLG+G   +V+ G S      VA+K +     +        EV+L+ +++H N+V L   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 336 SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I     L LV+EY+ +  L Q++   N   L++ +     +     GL+Y H   + +I
Sbjct: 72  -IHTERCLTLVFEYLDS-DLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKI 124

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV-RGQLTE 453
           +HRD+K  N+L+++    K+ADFGLAR  +      S  V  TL Y  P+ L+   + + 
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183

Query: 454 KADVYSFGILIIEIVCGR 471
             D++  G ++ E+  GR
Sbjct: 184 PIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.1 bits (161), Expect = 7e-12
 Identities = 45/144 (31%), Positives = 71/144 (49%), Gaps = 21/144 (14%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL ++H      +++RD+K +NILLD+    +I+D GLA  F+  + H S    GT GYM
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162

Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL--YRSNKLVE 498
           APE L +G      AD +S G ++ +++ G           SP ++  T   +  +++  
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH----------SPFRQHKTKDKHEIDRMTL 212

Query: 499 AVDPNLKDDFPAEQVCNVLQIGLL 522
            +   L D F  E     L  GLL
Sbjct: 213 TMAVELPDSFSPE--LRSLLEGLL 234

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 66.5 bits (162), Expect = 7e-12
 Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 28/208 (13%)

Query: 277 KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEF---FNEVNLISSIEHKNLVKL 332
           K LG+G  G V +  L   G   AVK L  +     D+      E  +++       +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 333 LGCSIEGPESLL-VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT---AE---GLAY 385
           L C+ +  E L  V E++    L   I DK          RF++   T   AE   GL +
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQF 111

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR--CFAADRTHVSTAVAGTLGYMAP 443
           LH      II+RD+K  N++LD+D   KIADFG+ +   F  +R   ++   GT  Y+AP
Sbjct: 112 LHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPDYIAP 165

Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGR 471
           E L   + T   D +SFG+L+ E++ G+
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 66.4 bits (162), Expect = 9e-12
 Identities = 68/228 (29%), Positives = 103/228 (45%), Gaps = 39/228 (17%)

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVP--------NRSLDQFIFDKNKT 364
           FF E   I SI +   +  L  + +  ++L LV EY P        NR  DQF  D++  
Sbjct: 47  FFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF--DEDMA 104

Query: 365 KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
                  +F +    AE +  +H   +   +HRDIK  N+L+D+    K+ADFG A    
Sbjct: 105 -------QFYL----AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153

Query: 425 ADRTHVSTAVAGTLGYMAPEYLV------RGQLTEKADVYSFGILIIEIVCGRRSNAFSQ 478
           A++   S    GT  Y+APE L       +G    + D +S G++  E++ GR  + F +
Sbjct: 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR--SPFHE 211

Query: 479 D-SASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQ 525
             SA     +    R  K  E  DP +  DF      +++Q  LLC Q
Sbjct: 212 GTSAKTYNNIMNFQRFLKFPE--DPKVSSDF-----LDLIQ-SLLCGQ 251

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 85  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 131

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 132 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYR 184

Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 40/220 (18%)

Query: 273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNL 329
             P + +G G  G V+  + P +G  VA+K++  +F         F E+ ++   +H N+
Sbjct: 2   VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61

Query: 330 VKLLGCSIEGPESLLVYE--YVPNRSLDQFIFDKNKTKLLNWNKRFNIILG----TAE-- 381
           +  L   I  P  +  +E  YV        + +  ++ L        II+     +++  
Sbjct: 62  LSAL--DILQPPHIDPFEEIYV--------VTELMQSDL------HKIIVSPQPLSSDHV 105

Query: 382 ---------GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
                    GL YLH      I+HRDIK  N+L++ +   KI DFGLAR    D +   T
Sbjct: 106 KVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162

Query: 433 AVAGTLGYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGR 471
               T  Y APE L+  +  T   D++S G +  E++  R
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 36/232 (15%)

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
           F  E   +   +H N+V+L G    G   ++V EY+ N +LD F+  +     L   +  
Sbjct: 53  FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLM 110

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
            ++ G A G+ YL   SE   +H+ +    +L++ D   KI+ F   R    D+   S A
Sbjct: 111 GMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDK---SEA 161

Query: 434 VAGTLG------YMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQR 486
           +  T+       + APE +     +  +DV+SFGI++ E++  G R              
Sbjct: 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP------------- 208

Query: 487 VWTLYRSNKLVEAVDPNLKDDFPAEQVCNVL--QIGLLCTQAAAALRPSMAQ 536
            W +   + +++AV+   +   PA + C  L  Q+ L C Q     RP  +Q
Sbjct: 209 YWDMSGQD-VIKAVEDGFR--LPAPRNCPNLLHQLMLDCWQKERGERPRFSQ 257

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 9/92 (9%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA--VAGTLG 439
           GL YL    + +I+HRD+K SNIL++     K+ DFG+     + +   S A    GT  
Sbjct: 111 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRS 163

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           YM+PE L     T ++D++S G+ ++E+  GR
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 11/199 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           K++G G  GSV        G  VA+K+L   F +  +    + E+ L+  ++H+N++ LL
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
                        ++       Q    K     L+ +K   ++     GL Y+H      
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG--- 137

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLT 452
           IIHRD+K  N+ +++D   KI DFGLAR   A+     T    T  Y APE ++      
Sbjct: 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILNWMHYN 193

Query: 453 EKADVYSFGILIIEIVCGR 471
           +  D++S G ++ E++ G+
Sbjct: 194 QTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 7/92 (7%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L +LH   +  II+RDIK  NILLD +    + DFGL++ F  D    + +  GT+ YM
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 442 APEYLVRGQLT--EKA-DVYSFGILIIEIVCG 470
           AP+ +VRG     +KA D +S G+L+ E++ G
Sbjct: 174 APD-IVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 50/203 (24%), Positives = 96/203 (47%), Gaps = 14/203 (6%)

Query: 273 FNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLV 330
           F    +LG G  G V+ +   P+G  +A K +    +  + ++   E+ ++       +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT--KLLNWNKRFNIILGTAEGLAYLHG 388
              G      E  +  E++   SLDQ +    +   ++L       + +   +GL YL  
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLR- 120

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
             + +I+HRD+K SNIL++     K+ DFG++         ++ +  GT  YM+PE L  
Sbjct: 121 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG 176

Query: 449 GQLTEKADVYSFGILIIEIVCGR 471
              + ++D++S G+ ++E+  GR
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 23/205 (11%)

Query: 277 KKLGQGGAGSVYM-GSLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           K LG+G  G V +     +G   A+K L   +   +  V     E  ++ +  H  L  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 333 LGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
              S +  + L  V EYV    L      + +F +++T+                 L YL
Sbjct: 61  -KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE--------IVSALDYL 111

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL 446
           H G   +I++RD+K  N++LDKD   KI DFGL +    D   + T   GT  Y+APE L
Sbjct: 112 HSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVL 167

Query: 447 VRGQLTEKADVYSFGILIIEIVCGR 471
                    D +  G+++ E++CGR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 33/89 (37%), Positives = 49/89 (55%), Gaps = 4/89 (4%)

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           L YLH      +++RD+K  N++LDKD   KI DFGL +   +D   + T   GT  Y+A
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLA 163

Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           PE L         D +  G+++ E++CGR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 30/208 (14%)

Query: 279 LGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSI-EHKNLVKLLGC 335
           +G+G  G V+ + +  NG+  AVK  I +    +DE    E N++ ++ +H N+VK  G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVK--ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 336 -----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLA 384
                   G +  LV E     S+   +        L   +R        I+     GL 
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           +LH     + IHRD+K +NILL  +   K+ DFG++    + R   +T+V GT  +MAPE
Sbjct: 139 HLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPE 194

Query: 445 YLVRGQ-----LTEKADVYSFGILIIEI 467
            +   Q        + DV+S GI  IE+
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 35/218 (16%)

Query: 277 KKLGQGGAGSVYMGSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL-- 332
           + LG G  G V+  ++ +     VAVK+++    Q V     E+ +I  ++H N+VK+  
Sbjct: 11  RPLGCGSNGLVF-SAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69

Query: 333 --------LGCSIEGPESL----LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIIL 377
                   L   +     L    +V EY+       L+Q    +   +L  +        
Sbjct: 70  VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ------- 122

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTHVSTAVAG 436
               GL Y+H  +   ++HRD+K +N+ ++ +D   KI DFGLAR      +H      G
Sbjct: 123 -LLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178

Query: 437 TLG--YMAPEYLVR-GQLTEKADVYSFGILIIEIVCGR 471
            +   Y +P  L+     T+  D+++ G +  E++ G+
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 59.8 bits (145), Expect = 5e-11
 Identities = 25/53 (47%), Positives = 33/53 (62%), Gaps = 1/53 (1%)

Query: 27  IYALAQCHLDLSHTDCLLCFAASRTKLPRCLP-SLSATIFFDGCFLRYDIYSF 78
           +Y LAQC  DLS +DC  C A + ++L RC P      I++D CFLRY+ Y F
Sbjct: 54  VYGLAQCRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L YLH  SE  +++RD+K  N++LDKD   KI DFGL +    D   + T   GT  Y+
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 163

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L         D +  G+++ E++CGR
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.8 bits (155), Expect = 6e-11
 Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 24/206 (11%)

Query: 277 KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEF---FNEVNLIS-SIEHKNLVK 331
           K LG+G  G V++  L       A+K L  +     D+      E  ++S + EH  L  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 332 LLGCSIEGPESLL-VYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAEGLAY 385
           L  C+ +  E+L  V EY+    L   I     FD  +           II G    L +
Sbjct: 61  LY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY----AAEIICG----LQF 111

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEY 445
           LH      I++RD+K  NILLD D   KIADFG+ +          T   GT  Y+APE 
Sbjct: 112 LHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEI 167

Query: 446 LVRGQLTEKADVYSFGILIIEIVCGR 471
           L+  +     D +SFG+L+ E++ G+
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 59.0 bits (143), Expect = 7e-11
 Identities = 29/76 (38%), Positives = 34/76 (44%), Gaps = 4/76 (5%)

Query: 122 VSRIAVEKGGGFGAVKVMG----VYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEG 177
            S  A   G GF A         VY LAQC   L    CR CL  A   +RR C  +K G
Sbjct: 31  SSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRSCLATAVSELRRCCPNKKGG 90

Query: 178 RGFNAGCYLRYSTDKF 193
           R +   C+LRY +  F
Sbjct: 91  RIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.5 bits (157), Expect = 7e-11
 Identities = 34/91 (37%), Positives = 54/91 (59%), Gaps = 1/91 (1%)

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT-HVSTAVAGTLGYM 441
           L  +H      +IHRDIK++NILL  +   K+ DFG ++ +AA  +  V     GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRR 472
           APE   R   ++KAD++S G+L+ E++  +R
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 62.5 bits (152), Expect = 9e-11
 Identities = 51/194 (26%), Positives = 98/194 (50%), Gaps = 8/194 (4%)

Query: 277 KKLGQGGAG-SVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           KK+G+G  G ++ + S  +G    +K +  +  + +  +E   EV ++S+++H N+V+  
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
               E     +V +Y     L + I +  +  L   ++  +  +     L ++H   + +
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVH---DRK 121

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
           I+HRDIK+ NI L KD T K+ DFG+AR   +      T + GT  Y++PE         
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNN 180

Query: 454 KADVYSFGILIIEI 467
           K+D+++ G ++ E+
Sbjct: 181 KSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 7/152 (4%)

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           E  L++ ++H N+V     S E    L +V EY     L Q I  + + KL   +     
Sbjct: 48  EAVLLAKMKHPNIVAFKE-SFEADGHLYIVMEYCDGGDLMQKIKLQ-RGKLFPEDTILQW 105

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            +    G+ ++H   E R++HRDIK+ NI L ++   K+ DFG AR   +   +  T V 
Sbjct: 106 FVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV- 161

Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
           GT  Y+ PE         K+D++S G ++ E+
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 11/199 (5%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           F   +++G G  G VY   ++  G   A+K +     +       E+ ++   +H N+V 
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
             G  +   +  +  E+    SL Q I+  + T  L+ ++   +   T +GL YLH   +
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSL-QDIY--HVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV---R 448
              +HRDIK +NILL  +   K+ADFG++    A      + + GT  +MAPE      +
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERK 183

Query: 449 GQLTEKADVYSFGILIIEI 467
           G   +  D+++ GI  IE+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 8/158 (5%)

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E++++ +I H+ ++ L+          +V   +P    D F +      L    +   I 
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSGPL-PLEQAITIQ 191

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA-RCFAADRTHVSTAVA 435
               E LAYLHG     IIHRD+KT NI LD+     + DFG A +  A   T      +
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRS 473
           GTL   +PE L       K D++S G+++ E+     +
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 72/258 (27%), Positives = 110/258 (42%), Gaps = 29/258 (11%)

Query: 234 YARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLP 293
           +  L K K   N L  Y   ++K         L+     ++  K +G+G  G V +    
Sbjct: 12  FPALRKNKNIDNFLNRYEKIVRK------IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHK 65

Query: 294 NGTTVAVKRLI--FNTRQWVDE-FFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYV 349
           +   V   +L+  F   +  D  FF E   I +  +   V  L C+ +  + L +V EY+
Sbjct: 66  SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 125

Query: 350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD 409
           P   L   + + +  +   W K +     TAE +  L       +IHRD+K  N+LLDK 
Sbjct: 126 PGGDLVNLMSNYDVPE--KWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKH 178

Query: 410 FTPKIADFGLARCFAADRT---HVSTAVAGTLGYMAPEYLVR----GQLTEKADVYSFGI 462
              K+ADFG   C   D T      TAV GT  Y++PE L      G    + D +S G+
Sbjct: 179 GHLKLADFG--TCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235

Query: 463 LIIEIVCGRRSNAFSQDS 480
            + E++ G     F  DS
Sbjct: 236 FLFEMLVG--DTPFYADS 251

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 36/89 (40%), Positives = 51/89 (57%), Gaps = 4/89 (4%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-TL 438
           A G+ +L   +  + IHRD+   NILL ++   KI DFGLAR    D  +V    A   L
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEI 467
            +MAPE +     T ++DV+SFG+L+ EI
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 54/169 (31%), Positives = 78/169 (46%), Gaps = 24/169 (14%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-TL 438
           A G+ +L   +  + IHRD+   NILL ++   KI DFGLAR    D  +V    A   L
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE 498
            +MAPE +     T ++DV+SFG+L+ EI        FS   ASP       Y   ++ E
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEI--------FSL-GASP-------YPGVQINE 284

Query: 499 AVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
                LKD      P      + +I L C Q     RP+ +  + +L +
Sbjct: 285 EFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGD 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL +LH   + RII+RD+K  N+LLD D   +I+D GLA      ++  +   AGT G+M
Sbjct: 109 GLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFM 164

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L   +     D ++ G+ + E++  R
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 42/127 (33%), Positives = 68/127 (53%), Gaps = 11/127 (8%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL ++H      +++RD+K +NILLD+    +I+D GLA  F+  + H S    GT GYM
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162

Query: 442 APEYLVRGQLTE-KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV--WTLYRSNKLVE 498
           APE L +G   +  AD +S G ++ +++  R  + F Q        +   TL  + +L +
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLL--RGHSPFRQHKTKDKHEIDRMTLTVNVELPD 220

Query: 499 AVDPNLK 505
           +  P LK
Sbjct: 221 SFSPELK 227

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 55/202 (27%), Positives = 83/202 (41%), Gaps = 18/202 (8%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K + +G  GSVY+      G   A+K L    +    Q  +       ++   E   + K
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILGTAEGLAYLHGGS 390
           L           LV EY+        I  K    L  +W K++  I     G+  LH   
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG 117

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
              IIHRDIK  N+L+D+    K+ DFGL+R         +    GT  Y+APE ++   
Sbjct: 118 ---IIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVG 169

Query: 451 LTEKADVYSFGILIIEIVCGRR 472
             + +D +S G +I E + G  
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 61/237 (25%), Positives = 94/237 (39%), Gaps = 52/237 (21%)

Query: 273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K +G+G  G V++      G   A+K L    +    Q +     E ++++  +  
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSP 61

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIILGTAE 381
            +VKL   S +  E L LV EY+P   L      + +F +          RF I    AE
Sbjct: 62  WIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-------RFYI----AE 109

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD--------------- 426
            +  L    +   IHRDIK  NIL+D D   K+ADFGL +                    
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 427 -------------RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
                        R   + +  GT  Y+APE L       + D +S G+++ E++ G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 35/90 (38%), Positives = 55/90 (61%), Gaps = 6/90 (6%)

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           L +LH   +  I++RDIK  NILLD +    + DFGL++ F ++    + +  GT+ YMA
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174

Query: 443 PEYLVRGQL--TEKADVYSFGILIIEIVCG 470
           PE ++RG+    +  D +S GILI E++ G
Sbjct: 175 PE-IIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 11/195 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +++G G  G VY   +L  G   AVK +             E+ ++   +H N+V   G 
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            +   +  +  EY    SL Q I+  + T  L+  +   +   T +GLAYLH   +   +
Sbjct: 75  YLSREKLWICMEYCGGGSL-QDIY--HVTGPLSELQIAYVCRETLQGLAYLHSKGK---M 128

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV---RGQLT 452
           HRDIK +NILL  +   K+ADFG+A    A      + + GT  +MAPE       G   
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187

Query: 453 EKADVYSFGILIIEI 467
           +  D+++ GI  IE+
Sbjct: 188 QLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 21/200 (10%)

Query: 278 KLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEF--FNEVNLISSIE-HKNLVKLL 333
           K+G+G    V    S   G   A+K +     + +++     E+  +  +  H N+++L+
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 334 GCSIEGPE-SL-LVYEYVPNRSLDQFIFD--KNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
               +     L LV+E      +D  +++  K + + L   +  + +    + L ++H  
Sbjct: 65  EVLFDRKTGRLALVFEL-----MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE-YLVR 448
               I HRDIK  NIL+  D   K+ADFG  R          T    T  Y APE  L  
Sbjct: 120 G---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTD 173

Query: 449 GQLTEKADVYSFGILIIEIV 468
           G    K D+++ G +  EI+
Sbjct: 174 GYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)

Query: 279 LGQGGAGSVYMGSLP-NGTTVAVKRL---IFNTRQWVDEFFNEVNLIS-SIEHKNLVKLL 333
           LG+G  G V +  L  +G   AVK L   +      V+    E  ++S +  H  L +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 334 GCSIEGPESLL-VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
            C  + P+ L  V E+V    L   +F   K++  +  +           L +LH   + 
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLH---DK 115

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV-AGTLGYMAPEYLVRGQL 451
            II+RD+K  N+LLD +   K+ADFG+  C        +T+   GT  Y+APE L     
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGM--CKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173

Query: 452 TEKADVYSFGILIIEIVCG 470
               D ++ G+L+ E++CG
Sbjct: 174 GPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 46/141 (32%), Positives = 68/141 (48%), Gaps = 20/141 (14%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL  LH   + RI++RD+K  NILLD     +I+D GLA      +T       GT+GYM
Sbjct: 114 GLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYM 168

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPL-QRVWTLYRS--NKLVE 498
           APE +   + T   D ++ G L+ E++ G+          SP  QR   + R    +LV+
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQ----------SPFQQRKKKIKREEVERLVK 218

Query: 499 AVDPNLKDDFP--AEQVCNVL 517
            V     + F   A  +C +L
Sbjct: 219 EVQEEYSEKFSPDARSLCKML 239

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 4/89 (4%)

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           L YLH      +++RDIK  N++LDKD   KI DFGL +   +D   + T   GT  Y+A
Sbjct: 108 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLA 163

Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           PE L         D +  G+++ E++CGR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 41/195 (21%), Positives = 89/195 (45%), Gaps = 19/195 (9%)

Query: 286 SVYMGSLPNGTTVAVKRLI---FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES 342
           S+Y G   N   V ++         +  +D   NE+  +  I+  N++K+ G  I+  + 
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 343 L----LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
           L    L+ EY     L + +   +K K L++  + ++ +   +GL  L+    T   +++
Sbjct: 94  LPRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKN 148

Query: 399 IKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL--VRGQLTEKAD 456
           + + + L+ +++  KI   GL +  ++        +     Y + + L  +  + T K D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDD 204

Query: 457 VYSFGILIIEIVCGR 471
           +YS G+++ EI  G+
Sbjct: 205 IYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 36/89 (40%), Positives = 52/89 (58%), Gaps = 4/89 (4%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-TL 438
           A+G+ +L   +  + IHRD+   NILL ++   KI DFGLAR    D  +V    A   L
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEI 467
            +MAPE +     T ++DV+SFG+L+ EI
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 10/92 (10%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT-- 437
           A+G+ +L   +    IHRD+   N+LL      KI DFGLAR    D  +V   V G   
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNAR 275

Query: 438 --LGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
             + +MAPE +     T ++DV+S+GIL+ EI
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 41/146 (28%), Positives = 67/146 (45%), Gaps = 26/146 (17%)

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESL--LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF- 373
           E+ L+  ++H+N+V L+   +E  +    L+++Y     L Q I    + K ++      
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYA-EHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 374 -NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP----KIADFGLARCFAA--- 425
            +++     G+ YLH      ++HRD+K +NIL+  +       KI D GLAR F A   
Sbjct: 111 KSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167

Query: 426 -----DRTHVSTAVAGTLGYMAPEYL 446
                D   V      T+ Y APE L
Sbjct: 168 PLADLDPVVV------TIWYRAPELL 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 36/100 (36%), Positives = 53/100 (53%), Gaps = 8/100 (8%)

Query: 375 IILGTAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
           +I  +A+   G+ +LH      I++RD+K  N+LLD     +++D GLA      +T   
Sbjct: 97  VIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--I 151

Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           T  AGT GYMAPE L     +   D ++ G  I E+V GR
Sbjct: 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 31/210 (14%)

Query: 277 KKLGQGGAGSVYM-----GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           K LG+GG G V+      G+   G   A+K L    I   ++       E N++ +++H 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGA-DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIILGTAEG 382
            +V L+     G +  L+ EY+    L      + IF ++            I L     
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY----LSEISLA---- 112

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR--CFAADRTHVSTAVAGTLGY 440
           L +LH   +  II+RD+K  NILLD     K+ DFGL +        TH      GT+ Y
Sbjct: 113 LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH---TFCGTIEY 166

Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           MAPE L+R    +  D +S G L+ +++ G
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 8/94 (8%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR--CFAADRTHVSTAVAGT 437
           A GL +LH      II+RD+K  N++LD +   KIADFG+ +   F    T       GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR---TFCGT 164

Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
             Y+APE +      +  D ++FG+L+ E++ G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 24/201 (11%)

Query: 279 LGQGGAGSVYMGSLP-NGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG G  G V +      G   A+K L    I   +Q V     E +++  + H  +V ++
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSHPFIVNMM 84

Query: 334 GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLAYLHGG 389
            CS +    +  + E+V    L  F   +   +  N   +F    ++L       YLH  
Sbjct: 85  -CSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELVLA----FEYLH-- 135

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
               II+RD+K  N+LLD     K+ DFG A+    DRT     + GT  Y+APE +   
Sbjct: 136 -SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTF---TLCGTPEYLAPEVIQSK 190

Query: 450 QLTEKADVYSFGILIIEIVCG 470
              +  D ++ G+L+ E + G
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.1 bits (145), Expect = 2e-09
 Identities = 43/179 (24%), Positives = 82/179 (45%), Gaps = 22/179 (12%)

Query: 300 VKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE---YVPNRSLD- 355
           + + +    +   +  NE+  +  + H+N++K+        E +L  E   Y+  +  D 
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDF 247

Query: 356 ---QFIFDKN---KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD 409
               F++D+    K + L    R  I+      + Y+H   + ++IHRDIK  NI L+ D
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCD 303

Query: 410 FTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIV 468
               + DFG A  F  +R        GT+   +PE L      E  D++S G+++++++
Sbjct: 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 58.6 bits (141), Expect = 2e-09
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 21/219 (9%)

Query: 266 LEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI- 324
           L      F   + +G G  G VY G       +A  +++  T    +E   E+N++    
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60

Query: 325 EHKNLVKLLGCSIE-GPESL-----LVYEYVPNRSLDQFIFD-KNKTKLLNWNKRFNIIL 377
            H+N+    G  I+  P  +     LV E+    S+   I + K  T    W     I  
Sbjct: 61  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICR 118

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT-HVSTAVAG 436
               GL++LH   + ++IHRDIK  N+LL ++   K+ DFG++     DRT        G
Sbjct: 119 EILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIG 173

Query: 437 TLGYMAPEYLVRGQLTE-----KADVYSFGILIIEIVCG 470
           T  +MAPE +   +  +     K+D++S GI  IE+  G
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 5/89 (5%)

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           L +LH   +  I++RD+K  NILLD      + DFGL++    D    +T   GT  Y+A
Sbjct: 109 LEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLA 164

Query: 443 PEYLVRGQ-LTEKADVYSFGILIIEIVCG 470
           PE L+  +  T+  D +S G+L+ E+ CG
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 10/164 (6%)

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E +++ +I H ++++L G       + L+   +P    D + +   K  +   +    I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI-LAIE 188

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT-HVSTAVA 435
                 + YLH   E RIIHRDIK  NI ++      + DFG A CF  D   +     A
Sbjct: 189 RSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244

Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQD 479
           GT+   APE L R       D++S GI++ E+     S  F +D
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS-LFEKD 287

Length = 391

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.9 bits (143), Expect = 3e-09
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 28/212 (13%)

Query: 275 PSKKLGQGGAGSVYMGSLPNGTT---VAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNL 329
           P K +G+G  G V   S  N  T   VA+K++   F+ R        E+ L+  ++H+N+
Sbjct: 9   PIKPIGRGAYGIVC--SAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 330 VKLLGCSIEGPES------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILGTAE 381
           + +    +  P         +VYE + +  L Q I  ++   L + + ++ +  +L    
Sbjct: 67  IAIKDI-MPPPHREAFNDVYIVYELM-DTDLHQII--RSSQTLSDDHCQYFLYQLL---R 119

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H  +   ++HRD+K SN+LL+ +   KI DFGLAR  +     ++  V  T  Y 
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYR 175

Query: 442 APEYLVR-GQLTEKADVYSFGILIIEIVCGRR 472
           APE L+   + T   DV+S G +  E++ GR+
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 35/89 (39%), Positives = 50/89 (56%), Gaps = 4/89 (4%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-TL 438
           A+G+++L   +    IHRD+   NILL      KI DFGLAR    D  +V    A   +
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEI 467
            +MAPE +     T ++DV+S+GIL+ EI
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 36/123 (29%), Positives = 59/123 (47%), Gaps = 5/123 (4%)

Query: 346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL 405
           Y+   +  +   + D + ++ L      +     A G+ +L   +    +HRD+   N+L
Sbjct: 214 YKGSNDSEVKNLLSD-DGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVL 269

Query: 406 LDKDFTPKIADFGLARCFAADRTHVSTAVAG-TLGYMAPEYLVRGQLTEKADVYSFGILI 464
           L +    KI DFGLAR    D  +VS       + +MAPE +     T  +DV+S+GIL+
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329

Query: 465 IEI 467
            EI
Sbjct: 330 WEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 56.8 bits (138), Expect = 6e-09
 Identities = 41/150 (27%), Positives = 65/150 (43%), Gaps = 18/150 (12%)

Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD--KNKTKLLNWNKRFNIILGTAEG 382
           ++ N +KL          +L+ +Y+ +  L    FD  K + KL +  +   II    E 
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKL-SEAEVKKIIRQLVEA 121

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKI--ADFGLARCFAADRTHVSTAVAGTLGY 440
           L  LH      IIH DIK  N+L D+    +I   D+GL +       +      GTL Y
Sbjct: 122 LNDLHK---HNIIHNDIKLENVLYDR-AKDRIYLCDYGLCKIIGTPSCY-----DGTLDY 172

Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            +PE +         D ++ G+L  E++ G
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.5 bits (139), Expect = 7e-09
 Identities = 32/83 (38%), Positives = 43/83 (51%), Gaps = 10/83 (12%)

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRT---HVSTAVAGTLGYMAPEYL----V 447
           IHRD+K  N+LLDK    K+ADFG   C   D        TAV GT  Y++PE L     
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFG--TCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGG 220

Query: 448 RGQLTEKADVYSFGILIIEIVCG 470
            G    + D +S G+ + E++ G
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 57.0 bits (137), Expect = 9e-09
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 20/202 (9%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLL-- 333
           +G G  GSV           VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 334 ---GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                SIE    + +   +    L+  +      KL + + +F +I     GL Y+H   
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIV---KCQKLSDEHVQF-LIYQLLRGLKYIHSAG 138

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG- 449
              IIHRD+K SN+ +++D   +I DFGLAR   AD     T    T  Y APE ++   
Sbjct: 139 ---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADDE--MTGYVATRWYRAPEIMLNWM 191

Query: 450 QLTEKADVYSFGILIIEIVCGR 471
              +  D++S G ++ E++ G+
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 19/228 (8%)

Query: 256 KSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFF 315
           +S        L      F   + +G G  G VY G       +A  +++  T    +E  
Sbjct: 1   RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIK 60

Query: 316 NEVNLISSI-EHKNLVKLLGCSIEGP------ESLLVYEYVPNRSLDQFIFDKNKTKLLN 368
            E+N++     H+N+    G  I+        +  LV E+    S+   +    K   L 
Sbjct: 61  LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALK 119

Query: 369 WNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
            +    I      GLA+LH     ++IHRDIK  N+LL ++   K+ DFG++     DRT
Sbjct: 120 EDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRT 174

Query: 429 -HVSTAVAGTLGYMAPEYLVRGQLTE-----KADVYSFGILIIEIVCG 470
                   GT  +MAPE +   +  +     ++D++S GI  IE+  G
Sbjct: 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 4/107 (3%)

Query: 362 NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           N++  L++          A G+ +L   +    +HRD+   N+L+ +    KI DFGLAR
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287

Query: 422 CFAADRTHVSTAVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
               D  ++S       L +MAPE +     T  +DV+SFGIL+ EI
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 22/200 (11%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           F   + L  G  G V+  S P+    V VK        W     +E  L+  + H  ++ 
Sbjct: 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKA------GWYASSVHEARLLRRLSHPAVLA 224

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           LL   + G  + LV   +P    D + +   + + L   +   +       + Y+HG   
Sbjct: 225 LLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG- 280

Query: 392 TRIIHRDIKTSNILLDKDFTPK---IADFGLARCFA--ADRTHVSTAVAGTLGYMAPEYL 446
             IIHRDIKT N+L++    P+   + DFG A CFA  +  T     +AGT+   APE L
Sbjct: 281 --IIHRDIKTENVLVN---GPEDICLGDFG-AACFARGSWSTPFHYGIAGTVDTNAPEVL 334

Query: 447 VRGQLTEKADVYSFGILIIE 466
                T   D++S G++I E
Sbjct: 335 AGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL  LH     RI++RD+K  NILLD     +I+D GLA       T +   V GT+GYM
Sbjct: 114 GLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYM 168

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE +   + T   D +  G LI E++ G+
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 24/206 (11%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTV-AVKRL---IFNTRQWVDEFFNEVNLIS-SIEHKNLVK 331
           K LG+G  G V +  L     V A+K L   +      VD    E  +++ + +H  L  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 332 LLGCSIEGPESLL-VYEYVPNRSLDQFIFDKNKTKLLNWNK-RFNIILGTAE---GLAYL 386
           L  C  +  + L  V EYV    L   +F   +++  +  + RF      AE    L +L
Sbjct: 61  LH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFY----AAEVTLALMFL 112

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGYMAPEY 445
           H      +I+RD+K  NILLD +   K+ADFG+ +       T  +T   GT  Y+APE 
Sbjct: 113 H---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEI 167

Query: 446 LVRGQLTEKADVYSFGILIIEIVCGR 471
           L   +     D ++ G+L+ E++ G+
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 20/216 (9%)

Query: 279 LGQGGAGSVYMGSLPNGTTV----AVKRLIFNTRQWVDEFFNEVNLI-SSIEHKNLVKLL 333
           +G+G    V +  L     +     VK+ + N  + +D    E ++   +  H  LV L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLAYLHGGS 390
            C         V EYV     D     + + KL   + RF     +AE    L YLH   
Sbjct: 63  SCFQTESRLFFVIEYV--NGGDLMFHMQRQRKLPEEHARFY----SAEISLALNYLH--- 113

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV-AGTLGYMAPEYLVRG 449
           E  II+RD+K  N+LLD +   K+ D+G+  C    R   +T+   GT  Y+APE L   
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKLTDYGM--CKEGLRPGDTTSTFCGTPNYIAPEILRGE 171

Query: 450 QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ 485
                 D ++ G+L+ E++ GR        S +P Q
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           A GL +LH      II+RD+K  N++LD +   KIADFG+ +    D     T   GT  
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTPD 166

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           Y+APE +      +  D ++FG+L+ E++ G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 49/193 (25%), Positives = 95/193 (49%), Gaps = 22/193 (11%)

Query: 290 GSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY- 348
           GS P    VA K ++ N  +      +E++ +++ +H  +VK         + LL+ EY 
Sbjct: 89  GSDPKEKVVA-KFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147

Query: 349 --------VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK 400
                   +  R  +   F + +  LL     + I+L   E    +H     +++HRD+K
Sbjct: 148 SGGDLNKQIKQRLKEHLPFQEYEVGLL----FYQIVLALDE----VH---SRKMMHRDLK 196

Query: 401 TSNILLDKDFTPKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYS 459
           ++NI L      K+ DFG ++ ++   +  V+++  GT  Y+APE   R + ++KAD++S
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWS 256

Query: 460 FGILIIEIVCGRR 472
            G+++ E++   R
Sbjct: 257 LGVILYELLTLHR 269

Length = 478

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 47/149 (31%), Positives = 67/149 (44%), Gaps = 13/149 (8%)

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEG 382
           H  LV L  C         V E+V    L  F   + + KL   + RF    I L     
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDL-MFHMQRQR-KLPEEHARFYSAEISLA---- 108

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           L +LH   E  II+RD+K  N+LLD +   K+ D+G+ +         ST   GT  Y+A
Sbjct: 109 LNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIA 164

Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           PE L         D ++ G+L+ E++ GR
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 4/92 (4%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           + GL +LH      II+RD+K  N++LD +   KIADFG+ +    D     T   GT  
Sbjct: 111 SVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCGTPD 166

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           Y+APE +      +  D +++G+L+ E++ G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 33/90 (36%), Positives = 44/90 (48%), Gaps = 5/90 (5%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL  LH       ++RD+K  NILLD     +I+D GLA               GT+GYM
Sbjct: 114 GLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYM 168

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L   + T   D +  G LI E++ G+
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 48/147 (32%), Positives = 68/147 (46%), Gaps = 15/147 (10%)

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLAY 385
           LV L  C        LV EYV     D     + + KL   + RF      AE    L +
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYV--NGGDLMFHMQRQRKLPEEHARFY----AAEICIALNF 111

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV-AGTLGYMAPE 444
           LH   E  II+RD+K  N+LLD D   K+ D+G+  C        +T+   GT  Y+APE
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDADGHIKLTDYGM--CKEGLGPGDTTSTFCGTPNYIAPE 166

Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGR 471
            L   +     D ++ G+L+ E++ GR
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 41/126 (32%), Positives = 58/126 (46%), Gaps = 19/126 (15%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL  L      RI++RD+K  NILLD     +I+D GLA       T       GT+GYM
Sbjct: 114 GLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYM 168

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD 501
           APE +   + T   D +  G LI E++ G+          SP ++     +     E VD
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQ----------SPFRK----RKERVKREEVD 214

Query: 502 PNLKDD 507
             +K+D
Sbjct: 215 RRVKED 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 28/167 (16%)

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
           FF   +++  + HK++V L G  +   E+++V E+V    LD F+    K+ +L    +F
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM--HRKSDVLTTPWKF 108

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILL-----DKDFTP--KIADFG-----LAR 421
            +    A  L+YL    +  ++H ++ T NILL     D +  P  K++D G     L+R
Sbjct: 109 KVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165

Query: 422 CFAADRTHVSTAVAGTLGYMAPEYLVRGQ-LTEKADVYSFGILIIEI 467
               +R          + ++APE +   + L+  AD +SFG  + EI
Sbjct: 166 QECVER----------IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 54/232 (23%)

Query: 277 KKLGQGGAGSVYMGSLPN-GTTVAVKR----LIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + +G+GG G VY+   P     VA+K+    L  N       F  E  + + + H  +V 
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPL-LKKRFLREAKIAADLIHPGIVP 66

Query: 332 LLGCSIEGPESLLVY---EYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNI 375
           +   SI   +   VY    Y+   +L   +  K+             KT +  +   F+ 
Sbjct: 67  VY--SICS-DGDPVYYTMPYIEGYTLKSLL--KSVWQKESLSKELAEKTSVGAFLSIFHK 121

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-------------- 421
           I  T E   Y+H      ++HRD+K  NILL       I D+G A               
Sbjct: 122 ICATIE---YVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 422 -----CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIV 468
                C++     +   + GT  YMAPE L+    +E  D+Y+ G+++ +++
Sbjct: 176 DERNICYS--SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 1/92 (1%)

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           TAE L  L    +  +I+RD+K  NILLD      + DFGL +    D    +T   GT 
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTP 157

Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            Y+APE L+    T+  D ++ G+L+ E++ G
Sbjct: 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 38/155 (24%), Positives = 74/155 (47%), Gaps = 6/155 (3%)

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E+ ++ +++ +N+V+L        +  LV+EYV    L+  + ++    +    K  + I
Sbjct: 50  ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPP-EKVRSYI 106

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
               + + + H   +  I+HRDIK  N+L+  +   K+ DFG AR  +       T    
Sbjct: 107 YQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA 163

Query: 437 TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           T  Y +PE L+     +  D++S G ++ E+  G+
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 49/210 (23%), Positives = 95/210 (45%), Gaps = 28/210 (13%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVA---VKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKL 332
           +++G G  G V +  +   T VA   VK L  N + +  +EF  + +    ++H N+++ 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL-------GTAEGLAY 385
           LG  +E    LLV+EY     L  ++  +       W++R + +L         A G+ +
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTH 114

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC-FAADRTHVSTAVAGTLGYMAPE 444
           +H   +   +H D+   N  L  D T K+ D+G+    +  D           L ++APE
Sbjct: 115 MH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171

Query: 445 Y-------LVRGQLTEKADVYSFGILIIEI 467
                   L+  + T+ ++V++ G+ + E+
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 5/96 (5%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           AE +  +H   +   +HRDIK  N+LLD +   ++ADFG       D T  S+   GT  
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD 168

Query: 440 YMAPEYLV-----RGQLTEKADVYSFGILIIEIVCG 470
           Y++PE L       G+   + D +S G+ + E++ G
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 46/194 (23%), Positives = 74/194 (38%), Gaps = 26/194 (13%)

Query: 293 PNGTTVAVKRLIFNTRQWVDE----FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY 348
           P  T VAVK+   N      E       E+     ++H N++  +   I   E  +V   
Sbjct: 23  PTNTLVAVKK--INLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80

Query: 349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK 408
           +   S +  +   +  + L       I+      L Y+H       IHR +K S+ILL  
Sbjct: 81  MAYGSCEDLL-KTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSG 136

Query: 409 DFTPKIADF---------GLARCFAADRTHVSTAVAGTLGYMAPEYL---VRGQLTEKAD 456
           D    ++           G  +    D    S      L +++PE L   ++G   EK+D
Sbjct: 137 DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN---LPWLSPEVLQQNLQG-YNEKSD 192

Query: 457 VYSFGILIIEIVCG 470
           +YS GI   E+  G
Sbjct: 193 IYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.7 bits (124), Expect = 5e-07
 Identities = 30/83 (36%), Positives = 45/83 (54%), Gaps = 5/83 (6%)

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV----- 447
             +HRDIK  N+LLDK+   ++ADFG      AD T  S    GT  Y++PE L      
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181

Query: 448 RGQLTEKADVYSFGILIIEIVCG 470
           +G+   + D +S G+ + E++ G
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 32/94 (34%), Positives = 44/94 (46%), Gaps = 7/94 (7%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR--THVSTAVAGTLG 439
            L Y+H  +   + HRD+K  NIL + D   KI DFGLAR    D       T    T  
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 440 YMAPEYL--VRGQLTEKADVYSFGILIIEIVCGR 471
           Y APE       + T   D++S G +  E++ G+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 51.1 bits (122), Expect = 7e-07
 Identities = 60/200 (30%), Positives = 88/200 (44%), Gaps = 14/200 (7%)

Query: 277 KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVN-LISSIEHKNLVK 331
           K +G+G  G V +     +G+  AVK L   T   ++  +    E N L+ +++H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L   S +  E L  V +YV    L  F   + +   L    RF      A  + YLH   
Sbjct: 61  L-HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARF-YAAEVASAIGYLH--- 113

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
              II+RD+K  NILLD      + DFGL +         ST   GT  Y+APE L +  
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEP 172

Query: 451 LTEKADVYSFGILIIEIVCG 470
                D +  G ++ E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 14/200 (7%)

Query: 277 KKLGQGGAGSVYMGSLP-NGTTVAVKRL---IFNTRQWVDEFFNEVN-LISSIEHKNLVK 331
           K +G+G  G V +     +G   AVK L       ++       E N L+ +++H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L   S +  + L  V +YV    L  F   + +        RF      A  L YLH   
Sbjct: 61  L-HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARF-YAAEIASALGYLH--- 113

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
              II+RD+K  NILLD      + DFGL +    + +  ++   GT  Y+APE L +  
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQP 172

Query: 451 LTEKADVYSFGILIIEIVCG 470
                D +  G ++ E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.0 bits (122), Expect = 9e-07
 Identities = 34/121 (28%), Positives = 49/121 (40%), Gaps = 46/121 (38%)

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST---------------------- 432
           IHRDIK  NIL+D+D   K+ DFGL  C     TH S                       
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL--CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 433 ----------------------AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
                                 ++ GT  Y+APE L+R   T+  D +S G+++ E++ G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240

Query: 471 R 471
           +
Sbjct: 241 Q 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 64/256 (25%), Positives = 103/256 (40%), Gaps = 25/256 (9%)

Query: 234 YARLSKMKEDRNNLGLYATSMKK-SCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL 292
           +  L K K   N L  Y  ++ K   L  K E  E         K +G+G  G V +   
Sbjct: 12  FPALRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVV-------KVIGRGAFGEVQLVRH 64

Query: 293 PNGTTVAVKRLI--FNTRQWVDE--FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY 348
            +   V   +L+  F   +  D   F+ E ++++      +V+L     +     +V EY
Sbjct: 65  KSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 124

Query: 349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK 408
           +P   L   + + +  +   W + +     TAE +  L        IHRD+K  N+LLDK
Sbjct: 125 MPGGDLVNLMSNYDVPE--KWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDK 177

Query: 409 DFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR----GQLTEKADVYSFGILI 464
               K+ADFG       +         GT  Y++PE L      G    + D +S G+ +
Sbjct: 178 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237

Query: 465 IEIVCGRRSNAFSQDS 480
            E++ G     F  DS
Sbjct: 238 YEMLVG--DTPFYADS 251

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 14/200 (7%)

Query: 277 KKLGQGGAGSVYMGSLP-NGTTVAVK----RLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G+G  G V +     +G   AVK    +++ N ++          L+ +++H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L   S +  E L  V ++V    L  F   + +        RF      A  L YLH   
Sbjct: 61  L-HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARF-YAAEIASALGYLH--- 113

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
              I++RD+K  NILLD      + DFGL +   A ++  +T   GT  Y+APE + +  
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFCGTPEYLAPEVIRKQP 172

Query: 451 LTEKADVYSFGILIIEIVCG 470
                D +  G ++ E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 50.1 bits (119), Expect = 1e-06
 Identities = 28/81 (34%), Positives = 44/81 (54%), Gaps = 5/81 (6%)

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV-----RG 449
           +HRDIK  NIL+D +   ++ADFG       D T  S+   GT  Y++PE L      +G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183

Query: 450 QLTEKADVYSFGILIIEIVCG 470
           +   + D +S G+ + E++ G
Sbjct: 184 KYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 33/147 (22%), Positives = 54/147 (36%), Gaps = 15/147 (10%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV--KLLG 334
           K L  G    VY+  L       V ++  +  +  D    EV ++  +  K L   K+L 
Sbjct: 4   KLLKGGLTNRVYL--LGTKDEDYVLKINPSREKGAD-REREVAILQLLARKGLPVPKVLA 60

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                  S L+ E++   +LD+   ++ +             L     LA LH      +
Sbjct: 61  SGESDGWSYLLMEWIEGETLDEVSEEEKEDIA--------EQLAEL--LAKLHQLPLLVL 110

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLAR 421
            H D+   NIL+D      I D+  A 
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAG 137

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 34/123 (27%), Positives = 51/123 (41%), Gaps = 46/123 (37%)

Query: 395 IHRDIKTSNILLDKDFTPKIADFGL---------------------------------AR 421
           IHRDIK  NIL+D+D   K+ DFGL                                 A 
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 422 CFAADRTH-------------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           C   DR               ++ ++ GT  Y+APE L+R   T+  D +S G+++ E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 469 CGR 471
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 57/248 (22%), Positives = 97/248 (39%), Gaps = 65/248 (26%)

Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K +G+G  G V +      G   A+K+L    +    Q V     E ++++  ++ 
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNP 61

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQF-----IFDKNKTKLLNWNKRFNIILGTAE 381
            +VKL   S +    L L+ EY+P   +         F + +T       RF I    AE
Sbjct: 62  WVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET-------RFYI----AE 109

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST--------- 432
            +  +    +   IHRDIK  N+LLD     K++DFGL  C    ++H +          
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL--CTGLKKSHRTEFYRILSHAL 167

Query: 433 ------------------------------AVAGTLGYMAPEYLVRGQLTEKADVYSFGI 462
                                         +  GT  Y+APE  ++    ++ D +S G+
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227

Query: 463 LIIEIVCG 470
           ++ E++ G
Sbjct: 228 IMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.4 bits (117), Expect = 5e-06
 Identities = 60/254 (23%), Positives = 102/254 (40%), Gaps = 43/254 (16%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLI----FNTRQWVDEFFNE 317
           KY+  E   N +   KK+G G  G V++            + I       R+   +   E
Sbjct: 4   KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE-KSQLVIE 62

Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---- 373
           VN++  ++HKN+V+ +   +      L   Y+     D     +N  K      +     
Sbjct: 63  VNVMRELKHKNIVRYIDRFLNKANQKL---YILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119

Query: 374 --NIILGTAEGLAYLH----GGSETRIIHRDIKTSNILLDKDF----------------- 410
             +I       LAY H    G +  R++HRD+K  NI L                     
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179

Query: 411 TPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR--GQLTEKADVYSFGILIIEIV 468
             KI DFGL++    +   ++ +  GT  Y +PE L+       +K+D+++ G +I E+ 
Sbjct: 180 IAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237

Query: 469 CGR----RSNAFSQ 478
            G+    ++N FSQ
Sbjct: 238 SGKTPFHKANNFSQ 251

Length = 1021

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.9 bits (114), Expect = 6e-06
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 22/178 (12%)

Query: 308 RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKL 366
           R  + + F E ++++  E+  +V +  CS E    L +V EYV        +  KN   L
Sbjct: 42  RNQIQQVFVERDILTFAENPFVVSMF-CSFETKRHLCMVMEYVEGGDCATLL--KNIGAL 98

Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
                R      T   L YLH      I+HRD+K  N+L+      K+ DFGL++     
Sbjct: 99  PVDMARM-YFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154

Query: 427 RT--------------HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            T               +   V GT  Y+APE ++R    +  D ++ GI++ E + G
Sbjct: 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 48.0 bits (115), Expect = 8e-06
 Identities = 62/240 (25%), Positives = 94/240 (39%), Gaps = 54/240 (22%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTV--AVKRLIFN---TRQWVDEFFNEVNLISSIEHK 327
           F   K LG+G  G V++  L  GT    A+K L       R  V     E  ++++++H 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRL-KGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GL 383
            L  L   S +    L LV +Y P   L + +  +    L     RF      AE    L
Sbjct: 62  FLPTLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYA----AEVLLAL 116

Query: 384 AYLH--GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV----------- 430
            YLH  G     I++RD+K  NILL +     ++DF L+   +                 
Sbjct: 117 EYLHLLG-----IVYRDLKPENILLHESGHIMLSDFDLS-KQSDVEPPPVSKALRKGSRR 170

Query: 431 ------------------STAVAGTLGYMAPEYLVRGQLTEKA-DVYSFGILIIEIVCGR 471
                             S +  GT  Y+APE ++ G     A D ++ GIL+ E++ G 
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 43/167 (25%), Positives = 79/167 (47%), Gaps = 28/167 (16%)

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
           FF   +L+S + H +L  + G  + G E+++V E+V +  LD  +  +     + W  + 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-----DFTP--KIADFG-----LAR 421
            +    A  L+YL    +  ++H ++   NILL +       +P  K++D G     L+R
Sbjct: 121 TVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177

Query: 422 CFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEI 467
               +R          + ++APE +  G  L+  AD +SFG  ++EI
Sbjct: 178 EERVER----------IPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 31/91 (34%), Positives = 43/91 (47%), Gaps = 4/91 (4%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           A  L YLH      I++RD+K  NILLD      + DFGL +         ST   GT  
Sbjct: 106 ASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPE 161

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y+APE L +       D +  G ++ E++ G
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 33/123 (26%), Positives = 50/123 (40%), Gaps = 46/123 (37%)

Query: 395 IHRDIKTSNILLDKDFTPKIADFGL---------------------------------AR 421
           IHRDIK  NIL+D D   K+ DFGL                                 + 
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 422 CFAADRTH-------------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           C   DR               ++ ++ GT  Y+APE L+R   T+  D +S G+++ E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 469 CGR 471
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 34/211 (16%)

Query: 277 KKLGQGGAGSVYMGSLP----------------NGTTVAVKRLIFNTRQWVDEFFNEVNL 320
           K +G GG G VY                        T+ ++ L++N    +D+     N 
Sbjct: 18  KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN- 76

Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK--TKLLNWNKRF--NII 376
           I +I+H  + K  GC        + Y ++    L++ + +  +   ++   NK+   NI+
Sbjct: 77  IHNIDHLGIPKYYGCG-SFKRCRMYYRFI---LLEKLVENTKEIFKRIKCKNKKLIKNIM 132

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA- 435
                 L Y+H   E  I H DIK  NI++D +    I D+G+A  F     H+  +   
Sbjct: 133 KDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189

Query: 436 -----GTLGYMAPEYLVRGQLTEKADVYSFG 461
                GTL Y   +      +T + D+ S G
Sbjct: 190 KDLHRGTLYYAGLDAHNGACVTRRGDLESLG 220

Length = 294

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 48/191 (25%), Positives = 64/191 (33%), Gaps = 64/191 (33%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPN-----GTTVAVKR--------LIFNTR----------Q 309
           F   KKLG+G  G VY  SL N          +K+        +  N R           
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193

Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN-----KT 364
           +V  F   V+                S +  E  LV+ Y    +L   +  K      + 
Sbjct: 194 FVYGFLEPVS----------------SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEP 237

Query: 365 KLL-------NWNKRFNIILGTA-----EGLAYLHGGSETRIIHRDIKTSNILLD---KD 409
            LL          +R N I+ T        L  LH    T I+HRD+K  NI+       
Sbjct: 238 YLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSEGSGS 294

Query: 410 FTPKIADFGLA 420
           F  KI D G A
Sbjct: 295 F--KIIDLGAA 303

Length = 566

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 31/153 (20%)

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTP----KIADFGLARCFAADRTHVS--TAV 434
           +G+ YLH      ++HRD+K +NIL+  +       KIAD G AR F +    ++    V
Sbjct: 119 DGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175

Query: 435 AGTLGYMAPEYLVRGQLTEKA-DVYSFGILIIEIVCG-----------RRSNAFSQDSAS 482
             T  Y APE L+  +   KA D+++ G +  E++             + SN F  D   
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ-- 233

Query: 483 PLQRVWTL--YRSNKLVEAVD-----PNLKDDF 508
            L R++++  + ++K  E +      P L+ DF
Sbjct: 234 -LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDF 265

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 19/110 (17%)

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---------A 424
           NI+ G   GL YLH   +   IHR+IK S+IL+  D    ++                  
Sbjct: 105 NILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161

Query: 425 ADRTHVSTAVAGTLGYMAPEYLVRGQL---TEKADVYSFGILIIEIVCGR 471
            D    ST+V   L +++PE L+R  L     K+D+YS GI   E+  GR
Sbjct: 162 YDFPQFSTSV---LPWLSPE-LLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 37/161 (22%), Positives = 65/161 (40%), Gaps = 40/161 (24%)

Query: 344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSN 403
           L+ E++P   +   +  K+   L     +F I    AE +  +    +   IHRDIK  N
Sbjct: 78  LIMEFLPGGDMMTLLMKKDT--LTEEETQFYI----AETVLAIDSIHQLGFIHRDIKPDN 131

Query: 404 ILLDKDFTPKIADFGL----------------------------------ARCFAADRTH 429
           +LLD     K++DFGL                                  A  +  +R  
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191

Query: 430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           ++ +  GT  Y+APE  ++    +  D +S G+++ E++ G
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 7/90 (7%)

Query: 383 LAYLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           LAY+H      I HRD+K  N+L+D    T K+ DFG A+   A +  VS   +    Y 
Sbjct: 183 LAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF--YR 237

Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCG 470
           APE ++     T   D++S G +I E++ G
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 10/95 (10%)

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTP----KIADFGLARCFAADRTHVS--TAV 434
           +G+ YLH      ++HRD+K +NIL+  +       KIAD G AR F +    ++    V
Sbjct: 119 DGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175

Query: 435 AGTLGYMAPEYLVRGQLTEKA-DVYSFGILIIEIV 468
             T  Y APE L+  +   KA D+++ G +  E++
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 28/110 (25%), Positives = 46/110 (41%), Gaps = 34/110 (30%)

Query: 395 IHRDIKTSNILLDKDFTPKIADFGL----------------------------------A 420
           IHRDIK  N+LLD     K++DFGL                                  A
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             +  +R  ++ +  GT  Y+APE  ++    +  D +S G+++ E++ G
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 36/131 (27%), Positives = 54/131 (41%), Gaps = 31/131 (23%)

Query: 366 LLNW-------NKRF--NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP---- 412
           LL+W       + R    II  T   L Y H  +E  ++H D+K  NIL++   T     
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPV 275

Query: 413 ------------KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSF 460
                       +I D G   C   D  H  TA+  T  Y +PE ++        D++S 
Sbjct: 276 TNRALPPDPCRVRICDLG--GC--CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSM 331

Query: 461 GILIIEIVCGR 471
           G +I E+  G+
Sbjct: 332 GCIIYELYTGK 342

Length = 467

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 16/29 (55%), Positives = 21/29 (72%)

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCF 423
           IHRDIK  NIL+D+    K++DFGL+  F
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 40.7 bits (96), Expect = 8e-04
 Identities = 22/81 (27%), Positives = 36/81 (44%), Gaps = 11/81 (13%)

Query: 341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK 400
             ++V EY+    L   + + N  + L  ++    ++G       LH      IIH D+ 
Sbjct: 73  NFIIVMEYIEGEPLKD-LINSNGMEELELSREIGRLVGK------LH---SAGIIHGDLT 122

Query: 401 TSNILLDKDFTPKIADFGLAR 421
           TSN++L       + DFGLA 
Sbjct: 123 TSNMILSGG-KIYLIDFGLAE 142

Length = 211

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 39.2 bits (92), Expect = 0.003
 Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 14/86 (16%)

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            ++    L+V EY+    L   + ++ +  LL   +    ++G       LH   +  I+
Sbjct: 68  DVDPDNGLIVMEYIEGELLKDAL-EEARPDLL---REVGRLVGK------LH---KAGIV 114

Query: 396 HRDIKTSNILLDKDFTPKIADFGLAR 421
           H D+ TSNI+L         DFGL  
Sbjct: 115 HGDLTTSNIILSGG-RIYFIDFGLGE 139

Length = 204

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	611
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
PRK10345	210	hypothetical protein; Provisional	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
smart00090	237	RIO RIO-like kinase.	99.75
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.71
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.64
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.57
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.51
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.35
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.33
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.31
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.21
KOG1243	690	consensus Protein kinase [General function predict	99.21
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.17
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.17
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.15
KOG3087	229	consensus Serine/threonine protein kinase [General	99.12
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.08
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.94
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.82
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.65
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.61
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.6
PRK09902	216	hypothetical protein; Provisional	98.58
COG4248	637	Uncharacterized protein with protein kinase and he	98.55
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.41
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.35
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.34
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.29
PF01636	239	APH: Phosphotransferase enzyme family This family	98.27
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.23
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.21
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.19
PLN02876	822	acyl-CoA dehydrogenase	98.01
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.96
PRK10593	297	hypothetical protein; Provisional	97.87
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.8
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.78
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.75
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.71
PRK05231	319	homoserine kinase; Provisional	97.69
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.65
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.6
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.6
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.53
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.34
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.33
PLN02236	344	choline kinase	97.05
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.05
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.02
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.01
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.93
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.54
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.43
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.22
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.17
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.8
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.78
PRK11768	325	serine/threonine protein kinase; Provisional	95.77
PLN02756	418	S-methyl-5-thioribose kinase	95.76
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.68
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.67
KOG2270	520	consensus Serine/threonine protein kinase involved	95.6
PRK06148	1013	hypothetical protein; Provisional	95.6
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.34
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.24
COG2334	331	Putative homoserine kinase type II (protein kinase	94.97
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.66

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-58  Score=476.97  Aligned_cols=286  Identities=48%  Similarity=0.791  Sum_probs=253.9

Q ss_pred             cccccChHHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeee
Q 007248          257 SCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS  336 (611)
Q Consensus       257 ~~~~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  336 (611)
                      ....|++++|.+||++|...++||+|+||.||+|.+++|+.||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45679999999999999999999999999999999999999999988765432145699999999999999999999999


Q ss_pred             eeCCc-ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEe
Q 007248          337 IEGPE-SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA  415 (611)
Q Consensus       337 ~~~~~-~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  415 (611)
                      .+.+. .+||||||++|+|.++|+..... .++|..|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99994 99999999999999999876544 89999999999999999999999888899999999999999999999999


Q ss_pred             eeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCC--CCCChhHHHHHhhcc
Q 007248          416 DFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQ--DSASPLQRVWTLYRS  493 (611)
Q Consensus       416 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~--~~~~~~~~~~~~~~~  493 (611)
                      |||+++..........+...||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...  ....+++|++..+..
T Consensus       220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            999996554312222211189999999999999999999999999999999999999887654  334488999999999


Q ss_pred             CccccccCCCCC-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          494 NKLVEAVDPNLK-DDFPA-EQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       494 ~~~~~~id~~l~-~~~~~-~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      +.+.+++|+.+. ..++. +++.++..++.+|++.+|++||+|.||+++|..
T Consensus       300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence            999999999997 66665 789999999999999999999999999999954

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3e-48  Score=397.78  Aligned_cols=256  Identities=34%  Similarity=0.490  Sum_probs=211.6

Q ss_pred             CCCccccCCceeEEEEEcCCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC-cceEEEeecCC
Q 007248          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-ESLLVYEYVPN  351 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~~~~  351 (611)
                      ..+.||+|+||+||+|.+.....||||++....  ....++|.+|+.+|.+++|||||+++|++.+.. .+.+||||+++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            345699999999999999554449999987543  222679999999999999999999999999988 79999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCc-eecCCCCcccEEECCCC-CeEEeeeccceeccCCCcc
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR-IIHRDIKTSNILLDKDF-TPKIADFGLARCFAADRTH  429 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~  429 (611)
                      |+|.++++.. ....+++..+++|+.+||+||.|||   ..+ ||||||||.||||+.++ ++||+|||+++...... .
T Consensus       125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~  199 (362)
T KOG0192|consen  125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T  199 (362)
T ss_pred             CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence            9999999764 4567999999999999999999999   566 99999999999999997 99999999998765432 2


Q ss_pred             eeecccCCccccChhhhh--cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLV--RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~--~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                      ..+...||+.|||||++.  ...++.|+||||||++||||+||+.||.....    .+.+...         +....+..
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~~~~v---------~~~~~Rp~  266 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQVASAV---------VVGGLRPP  266 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHH---------HhcCCCCC
Confidence            233478999999999999  56899999999999999999999999875443    2222221         12223344


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCC
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEI  548 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~~~  548 (611)
                      .+......+..++.+||+.+|+.||++.+++..|+......
T Consensus       267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            45556677889999999999999999999999997654433

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-49  Score=400.04  Aligned_cols=251  Identities=30%  Similarity=0.472  Sum_probs=217.3

Q ss_pred             CCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCCh
Q 007248          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      ..+.||+|.||+||.|.+.....||+|.++... ...+.|.+|+++|++|+|+|||+++|+|..++.++||||||+.|+|
T Consensus       210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL  288 (468)
T KOG0197|consen  210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL  288 (468)
T ss_pred             HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence            357899999999999999877899999987653 3347899999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecc
Q 007248          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV  434 (611)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  434 (611)
                      .+||.. .....+...+.+.++.|||+||+||+   .+++|||||.++||||+++..+||+|||||+...++........
T Consensus       289 l~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~  364 (468)
T KOG0197|consen  289 LDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG  364 (468)
T ss_pred             HHHhhh-cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence            999965 34556899999999999999999999   89999999999999999999999999999996655554444455


Q ss_pred             cCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHH
Q 007248          435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQV  513 (611)
Q Consensus       435 ~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~  513 (611)
                      .-+..|+|||.+..+.++.|||||||||+||||+| |+.|+..              +....+.+.++...+-+.|..++
T Consensus       365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~--------------msn~ev~~~le~GyRlp~P~~CP  430 (468)
T KOG0197|consen  365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG--------------MSNEEVLELLERGYRLPRPEGCP  430 (468)
T ss_pred             CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC--------------CCHHHHHHHHhccCcCCCCCCCC
Confidence            56789999999999999999999999999999998 5555321              12234455666777777788899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          514 CNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       514 ~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ..+.+|+..||+.+|++|||++.+...|...
T Consensus       431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  431 DEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             HHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            9999999999999999999999998888643

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=406.28  Aligned_cols=272  Identities=27%  Similarity=0.475  Sum_probs=232.7

Q ss_pred             ccccccccChHHHHHHhcCC---------CCCCccccCCceeEEEEEcCC----CCEEEEEEeeccc-hhhHHHHHHHHH
Q 007248          254 MKKSCLSFKYETLEKATNYF---------NPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFNT-RQWVDEFFNEVN  319 (611)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~f---------~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~  319 (611)
                      .+.....++||+-.+|-..|         .+.++||.|.||+||+|+++-    ...||||.++... .+...+|+.|+.
T Consensus       603 ~k~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAs  682 (996)
T KOG0196|consen  603 TKTYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEAS  682 (996)
T ss_pred             ceeecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhh
Confidence            34445667787766665555         445899999999999997742    4679999998764 455678999999


Q ss_pred             HHhcCCCCceeeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 007248          320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDI  399 (611)
Q Consensus       320 ~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  399 (611)
                      ||.+++||||++|.|+.......++|+|||+||+|+.||+...  +.+++.++..++.+||.||.||-   ++++|||||
T Consensus       683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDL  757 (996)
T KOG0196|consen  683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDL  757 (996)
T ss_pred             hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHh---hcCchhhhh
Confidence            9999999999999999999999999999999999999996543  56999999999999999999999   899999999


Q ss_pred             CcccEEECCCCCeEEeeeccceeccCCCcceeecc--cCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCC
Q 007248          400 KTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV--AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAF  476 (611)
Q Consensus       400 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~  476 (611)
                      .++|||++.+..+|++||||++.+.++.....+..  .-+.+|.|||.+...+++.+|||||||++|||.++ |.+|+  
T Consensus       758 AARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY--  835 (996)
T KOG0196|consen  758 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY--  835 (996)
T ss_pred             hhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc--
Confidence            99999999999999999999998876664333332  23679999999999999999999999999999875 77773  


Q ss_pred             CCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          477 SQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                                 |+ +.+..+.+.|+...+-+.|++++..|.+|++.|||+|..+||++.||+..|.+.
T Consensus       836 -----------Wd-mSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  836 -----------WD-MSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             -----------cc-cchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence                       33 334556777888888889999999999999999999999999999999988653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-46  Score=364.81  Aligned_cols=247  Identities=26%  Similarity=0.416  Sum_probs=205.8

Q ss_pred             CCCccccCCceeEEEEEc-CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc-ceEEEeecCC
Q 007248          275 PSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE-SLLVYEYVPN  351 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~E~~~~  351 (611)
                      ..+.||+|..|+|||+.+ ++++.+|+|++..+ +....+++.+|++++++.+||+||.+||.|..+.. ..++||||.+
T Consensus        83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg  162 (364)
T KOG0581|consen   83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG  162 (364)
T ss_pred             hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence            367899999999999966 46899999999554 45667889999999999999999999999999984 9999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      |||++++...   +.+++..+-+|+.+|++||.|||+  +++||||||||+|||++..|++||+|||.++.+.+.   ..
T Consensus       163 GSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a  234 (364)
T KOG0581|consen  163 GSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA  234 (364)
T ss_pred             CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence            9999999433   558999999999999999999995  499999999999999999999999999999876544   44


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCC-CCChhHHHHHhhccCccccccCCCCCCCCCH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQD-SASPLQRVWTLYRSNKLVEAVDPNLKDDFPA  510 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~  510 (611)
                      ....||..|||||.+.+..|+.++||||||+.++|+.+|+.|+..... ....++...... .+.     -|.+    |.
T Consensus       235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~p-----pP~l----P~  304 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEP-----PPRL----PE  304 (364)
T ss_pred             ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCC-----CCCC----Cc
Confidence            577899999999999999999999999999999999999999876522 122222211111 111     1222    33


Q ss_pred             -HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          511 -EQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       511 -~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       ....++..++..|++.||.+||+.+|+++
T Consensus       305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             25566889999999999999999999885

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8e-45  Score=374.25  Aligned_cols=247  Identities=25%  Similarity=0.404  Sum_probs=211.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ..|...+.||+|||..||.++. ..|+.||+|++...   .....+...+||++.++|+|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999965 88999999998753   2344677889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      |+|++++|..++.   +.+.+++.++..++.||+.||.|||   +.+|+|||||..|+||+++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999983   5678999999999999999999999   899999999999999999999999999999988755


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      ... ..+.+||+.|.|||++.....+..+||||+||+||-||.|++||+...     ++..+..++....          
T Consensus       172 ~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vkety~~Ik~~~Y----------  235 (592)
T KOG0575|consen  172 GER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKETYNKIKLNEY----------  235 (592)
T ss_pred             ccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHHHHHHHHhcCc----------
Confidence            433 346899999999999999999999999999999999999999987432     2222222222211          


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+|........+|+..+|+.+|.+|||+++|+.
T Consensus       236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            123344455778999999999999999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-45  Score=357.57  Aligned_cols=199  Identities=31%  Similarity=0.530  Sum_probs=179.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ..+|...+.||+|.||+||+|++ +++..||||.+...  ..+.++....|+++|++++|||||.+++++..++..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            35677888899999999999966 45899999999766  5677788999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC------CCeEEeeeccc
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD------FTPKIADFGLA  420 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DfGla  420 (611)
                      |||.+|+|.+||+.++   .+++.....++.|||.||++||   +++||||||||.||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            9999999999996543   5999999999999999999999   8999999999999999875      45899999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCC
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAF  476 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~  476 (611)
                      +.+...  ....+.+|++-|||||+++.++|+.|.|+||+|+||||+++|+.||+.
T Consensus       163 R~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  163 RFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            987643  234568899999999999999999999999999999999999999863

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.2e-46  Score=397.21  Aligned_cols=258  Identities=27%  Similarity=0.431  Sum_probs=213.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccchh-hHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (611)
                      ..+....+.||+|+||+||+|...      +.+.||||.++..... ..++|.+|+++|..|+|||||+|+|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            344456788999999999999653      3568999999876544 788999999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCC-----------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC
Q 007248          343 LLVYEYVPNRSLDQFIFDKNK-----------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT  411 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  411 (611)
                      ++|+|||..|+|.+||.....           ..+|+..+.+.||.|||.||.||-   .+.+|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceE
Confidence            999999999999999964211           234899999999999999999999   899999999999999999999


Q ss_pred             eEEeeeccceeccCCCcce-eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHH
Q 007248          412 PKIADFGLARCFAADRTHV-STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWT  489 (611)
Q Consensus       412 ~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~  489 (611)
                      +||+||||++.....+... .....-+.+|||||.|..++||.+||||||||+|||+++ |+.|++...+     +.+..
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-----~EVIe  716 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-----QEVIE  716 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-----HHHHH
Confidence            9999999998765433322 224445789999999999999999999999999999997 7777542221     12223


Q ss_pred             hhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          490 LYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       490 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      .++.+++         -+.|..++.+++.|+..||+.+|++||+++||-..|..-
T Consensus       717 ~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  717 CIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             HHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence            3333332         345778888999999999999999999999999998643

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-46  Score=347.18  Aligned_cols=256  Identities=24%  Similarity=0.385  Sum_probs=208.4

Q ss_pred             CCCCCCccccCCceeEEEE-EcCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEee-eeeeCCc-ceEEE
Q 007248          272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLG-CSIEGPE-SLLVY  346 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~  346 (611)
                      +|.+.++||+|.||+|||+ .+.+|..+|.|.+...  +.+..+....|+.+|++|+|||||++++ -+.++.+ ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            3556789999999999999 6779999999998755  3455678899999999999999999999 4445444 89999


Q ss_pred             eecCCCChhhhhhc-cCCCccCChhHHHHHHHHHHHHHHHHhcCCCCc--eecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          347 EYVPNRSLDQFIFD-KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       347 E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      |||..|+|..+|.. ++..+.+++..+|+++.|++.||.++|+.. ++  |+||||||.||+|+.+|.+||+||||++.+
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999954 345667999999999999999999999522 44  999999999999999999999999999988


Q ss_pred             cCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      .... ......+||+.||+||.+....++.||||||+||++|||+.-+.||...    .+++. ...+..+..       
T Consensus       179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L-~~KI~qgd~-------  245 (375)
T KOG0591|consen  179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSL-CKKIEQGDY-------  245 (375)
T ss_pred             cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHH-HHHHHcCCC-------
Confidence            6543 3345678999999999999999999999999999999999999998643    22222 222222221       


Q ss_pred             CCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          504 LKDDFP-AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       504 l~~~~~-~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                        .+.| .-....+..|+..|+..||+.||+...++..+..
T Consensus       246 --~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  246 --PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             --CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence              1223 3456678899999999999999997666655543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-44  Score=353.89  Aligned_cols=253  Identities=26%  Similarity=0.321  Sum_probs=203.1

Q ss_pred             HhcCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccch-----hh--HHHHHHHHHHHhcCCCCceeeEeeeeeeCC
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTR-----QW--VDEFFNEVNLISSIEHKNLVKLLGCSIEGP  340 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-----~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  340 (611)
                      ..+.|.+.+.||+|+||.|-+| ..++|+.||||++.....     +.  .....+|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            3456778899999999999999 556799999999864321     11  122469999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC---CCeEEeee
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD---FTPKIADF  417 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Df  417 (611)
                      ..|+||||++||.|.+++..   .+.+.+..-..++.|++.|+.|||   ++||+||||||+|||+..+   -.+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999999954   345777777889999999999999   8999999999999999876   67999999


Q ss_pred             ccceeccCCCcceeecccCCccccChhhhhcCcc--c-cccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC
Q 007248          418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL--T-EKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN  494 (611)
Q Consensus       418 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~-~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  494 (611)
                      |||+...  ....+.+.+||+.|.|||++.+...  + .+.|+||+||+||-+++|.+||...-....+.+.    +..+
T Consensus       324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ----I~~G  397 (475)
T KOG0615|consen  324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ----ILKG  397 (475)
T ss_pred             chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH----HhcC
Confidence            9999765  3456678999999999999987543  3 3789999999999999999998754443333222    2222


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       495 ~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ++..      ......+..++.++++.+++..||+.||+++|+++
T Consensus       398 ~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  398 RYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            2210      11122345667889999999999999999999873

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=362.69  Aligned_cols=267  Identities=25%  Similarity=0.391  Sum_probs=214.1

Q ss_pred             ChHHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC
Q 007248          262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG  339 (611)
Q Consensus       262 ~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  339 (611)
                      ..+++++..+.+...+.||+|.||+||+|.|..  .||||++...  ..+..+.|++|+.++++-+|.||+-+.|||...
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            345666666777788999999999999999953  7999999765  356788999999999999999999999999988


Q ss_pred             CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecc
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  419 (611)
                      +. .+|+.+|+|.+|..+||...  ..++..+.+.|+.||++||.|||   .++|||||||..||||.+++.+||+||||
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             ce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccc
Confidence            77 99999999999999998654  45899999999999999999999   89999999999999999999999999999


Q ss_pred             ceeccCC-CcceeecccCCccccChhhhhcC---ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc
Q 007248          420 ARCFAAD-RTHVSTAVAGTLGYMAPEYLVRG---QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK  495 (611)
Q Consensus       420 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  495 (611)
                      +.....- .........|...|||||+++.+   +|++++||||||+++|||+||..|+.....++-    +|.   .++
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI----ifm---VGr  607 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI----IFM---VGR  607 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe----EEE---ecc
Confidence            9643221 11222345678899999999764   789999999999999999999999873222211    111   111


Q ss_pred             cccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       496 ~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                      =.-..|..   .......++|.+|+..||..++++||.+.+|+.+|+....
T Consensus       608 G~l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  608 GYLMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cccCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            11111111   1234556778899999999999999999999998876543

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=382.43  Aligned_cols=257  Identities=29%  Similarity=0.440  Sum_probs=208.7

Q ss_pred             CCCCCCccccCCceeEEEEEcCC--C----CEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPN--G----TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      +....+.||+|+||.||.|...+  |    ..||||.+... +.+...+|++|..+|++++|||||+++|++.+....++
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            34456789999999999996533  3    34999998765 46677899999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccC----CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          345 VYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      ++|||++|+|..||++..    ....|+...++.++.+||+|+.||+   ++++|||||..+|+||++...+||+|||||
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence            999999999999997541    1456899999999999999999999   899999999999999999999999999999


Q ss_pred             eeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCcccc
Q 007248          421 RCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVE  498 (611)
Q Consensus       421 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (611)
                      +.+...... ......-...|||||.+..+.++.|+|||||||+||||+| |..|+.. ....   +........+    
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~-~~n~---~v~~~~~~gg----  921 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS-RSNF---EVLLDVLEGG----  921 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC-cchH---HHHHHHHhCC----
Confidence            954433322 2222344679999999999999999999999999999999 4445432 2111   1111111122    


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          499 AVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       499 ~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                            +-+.|..++..+.+|+.+||+.+|++||++..+++.+..+.
T Consensus       922 ------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  922 ------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             ------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence                  33557778888999999999999999999999999876544

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=344.67  Aligned_cols=254  Identities=28%  Similarity=0.413  Sum_probs=202.8

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC--cceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP--ESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~E  347 (611)
                      .+|...+.||+|.||.||++... +|...|||.+........+.+.+|+.+|++++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            34667789999999999999664 49999999987664333677899999999999999999999854444  6899999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-CCCeEEeeeccceeccC-
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAA-  425 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~-  425 (611)
                      |+++|+|.+++.....  .+++..+.+++.||++||.|||   .++||||||||+|||++. ++.+||+|||+++.... 
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999965433  6999999999999999999999   899999999999999999 79999999999987663 


Q ss_pred             -CCcceeecccCCccccChhhhhcCc-cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          426 -DRTHVSTAVAGTLGYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       426 -~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                       ..........||+.|||||++..+. ...++|||||||+++||+||++||...   .....+........         
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~~---------  239 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGRED---------  239 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhccC---------
Confidence             2222234578999999999998643 345999999999999999999997643   11111111111111         


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      ....+|........+++..|++.+|++|||++++++..
T Consensus       240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            11133444556678999999999999999999998653

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-43  Score=362.91  Aligned_cols=257  Identities=29%  Similarity=0.406  Sum_probs=205.8

Q ss_pred             CCCCccccCCceeEEEEEcCC--C---CEEEEEEeec---cchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          274 NPSKKLGQGGAGSVYMGSLPN--G---TTVAVKRLIF---NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       274 ~~~~~iG~G~~g~Vy~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ...++||+|+||.||+|.+..  +   ..||||..+.   ...+...+|++|+++|++++|||||++||++..+..+++|
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv  239 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV  239 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence            345899999999999996643  2   2389999875   3467788999999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      ||+|.||+|.++|.....  .++..++++++.++|.||+|||   +.++|||||.++|+|+..++.+||+||||++.-..
T Consensus       240 mEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~  314 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ  314 (474)
T ss_pred             EEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence            999999999999954432  6999999999999999999999   89999999999999999999999999999875431


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      .... .....-+..|+|||.+..+.++.++|||||||++||+++ |..|+.....    .+ +...+        +-...
T Consensus       315 ~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----~~-v~~kI--------~~~~~  380 (474)
T KOG0194|consen  315 YVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN----YE-VKAKI--------VKNGY  380 (474)
T ss_pred             eeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH----HH-HHHHH--------HhcCc
Confidence            1111 112235789999999999999999999999999999998 6766532211    11 11111        12223


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCC
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIP  549 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~~~~  549 (611)
                      +...+...+..+..++.+||..+|++||+|.++.+.|........
T Consensus       381 r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  381 RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            333444566678888889999999999999999999976554433

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.3e-42  Score=343.51  Aligned_cols=260  Identities=26%  Similarity=0.401  Sum_probs=203.8

Q ss_pred             CCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--CcceEEE
Q 007248          272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLLVY  346 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  346 (611)
                      .|+..++||+|.||.||+| ...+|..||+|++..+.  .+......+||.||++|+||||++|.+...+.  ..+|||+
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF  197 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF  197 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence            3555678999999999999 56789999999998764  45566778999999999999999999987766  6899999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      |||++ +|.-++..  ..-.+++.++..++.|++.||+|+|   ..+|+|||||.+|||||++|.+||+|||||+++...
T Consensus       198 eYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  198 EYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             ecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            99977 77777743  2335899999999999999999999   899999999999999999999999999999998877


Q ss_pred             CcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC--------cc-
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN--------KL-  496 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~--------~~-  496 (611)
                      .....+..+-|.+|.|||.+.+. .|+...|+||.||||.||++|++.+....+. +.+..+..+....        ++ 
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHHHHHhCCCChhccccccCC
Confidence            76667777889999999999875 7999999999999999999999775433221 2222222221111        11 


Q ss_pred             -ccccCCCCCCCCCH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          497 -VEAVDPNLKDDFPA-------EQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       497 -~~~id~~l~~~~~~-------~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                       .....+.  ..+..       ......++|+..+|..||.+|.|+.++++.
T Consensus       351 ~~~~~kp~--~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  351 HATIFKPQ--QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cccccCCC--CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence             0111110  01110       112346788889999999999999998853

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.5e-42  Score=325.30  Aligned_cols=261  Identities=24%  Similarity=0.336  Sum_probs=202.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      +.|+...++|+|+||.|||.+.+ .|+.||||++....  +...+-.++|+++|++|+|+|+|.|+.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45777889999999999999765 59999999986543  3334556899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      ||+..-|+++-+.   ...++.+.+.+++.|+++|+.|+|   ++++|||||||+||||..++.+||+|||+|+.+.. .
T Consensus        82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p  154 (396)
T KOG0593|consen   82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-P  154 (396)
T ss_pred             ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence            9988666655422   234888999999999999999999   89999999999999999999999999999998764 3


Q ss_pred             cceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCC----------hhHHHHHhhccCcc
Q 007248          428 THVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS----------PLQRVWTLYRSNKL  496 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~----------~~~~~~~~~~~~~~  496 (611)
                      ....+..+.|.+|.|||.+.+ .+|....|||++||++.||++|.+-|....+...          +......++..+..
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            334556778999999999988 6899999999999999999999976643332211          11112223333332


Q ss_pred             cccc-CCCCC------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          497 VEAV-DPNLK------DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       497 ~~~i-d~~l~------~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..-+ -|...      ..+| ....-+++++..|++.||.+|++-+|++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1111 11111      1111 22335789999999999999999999874

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-42  Score=349.33  Aligned_cols=249  Identities=28%  Similarity=0.462  Sum_probs=214.1

Q ss_pred             cCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      ..|..-.+||+|+-|.||.+ ...+++.||||++........+-+++|+.+|+..+|+|||.+++.+..++++++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            45666788999999999999 56678999999998776666778899999999999999999999999899999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++|+|.+.+.    ...+++.++..|+.++++||+|||   ..+|+|||||..|||++.+|.+||+|||++..+..... 
T Consensus       353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            9999999983    344999999999999999999999   89999999999999999999999999999988765544 


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      .....+||+.|||||++....|.+|.||||||++++||+-|.+|+..    +.+++-.|.....+.      +.+  ..+
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~ng~------P~l--k~~  492 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATNGT------PKL--KNP  492 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhcCC------CCc--CCc
Confidence            34567899999999999999999999999999999999999999754    445555454444433      222  234


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ......+.++..+||+.|+++||++.|+|+
T Consensus       493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  493 EKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            455666889999999999999999999984

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-42  Score=340.30  Aligned_cols=260  Identities=28%  Similarity=0.425  Sum_probs=197.5

Q ss_pred             CCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhc--CCCCceeeEeeeeeeCC----cceEEEe
Q 007248          274 NPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISS--IEHKNLVKLLGCSIEGP----ESLLVYE  347 (611)
Q Consensus       274 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~E  347 (611)
                      ...++||+|+||.||||.+ +++.||||++...   ..+.|.+|-+|.+.  ++|+||++++++...+.    +++||+|
T Consensus       213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~  288 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE  288 (534)
T ss_pred             hhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence            4467899999999999999 4599999998643   45678888888775  58999999999877665    8899999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhc------CCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG------GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      |.+.|+|.+||    ....++|....+|+..+++||+|||+      +.+++|+|||||++||||.+|+++.|+|||||.
T Consensus       289 fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  289 FHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             eccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            99999999999    44579999999999999999999995      457899999999999999999999999999998


Q ss_pred             eccCCCcc-eeecccCCccccChhhhhcC-ccc-----cccceehhHHHHHHHHhCCCCCCC--CCCCCChh--------
Q 007248          422 CFAADRTH-VSTAVAGTLGYMAPEYLVRG-QLT-----EKADVYSFGILIIEIVCGRRSNAF--SQDSASPL--------  484 (611)
Q Consensus       422 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~-----~ksDV~S~Gvll~elltG~~p~~~--~~~~~~~~--------  484 (611)
                      .+...... .....+||.+|||||++.+. .+.     .+.||||+|++||||++.......  .++-+.++        
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            87644332 22357899999999999764 222     378999999999999986544321  11111122        


Q ss_pred             --HHHHHhhccCccccccCCCCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          485 --QRVWTLYRSNKLVEAVDPNLKDDFP-AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       485 --~~~~~~~~~~~~~~~id~~l~~~~~-~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                        +..+.....++    ..|.+.+..- ...+.-+.+.+..||+.||+.|-|..=|-+.+.+..
T Consensus       445 t~e~mq~~VV~kK----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  445 TLEEMQELVVRKK----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             CHHHHHHHHHhhc----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence              22222222211    1122211110 133555778889999999999999988888776543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=349.05  Aligned_cols=249  Identities=27%  Similarity=0.449  Sum_probs=207.8

Q ss_pred             ccccChHHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeee
Q 007248          258 CLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI  337 (611)
Q Consensus       258 ~~~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  337 (611)
                      .+.+.|++|.+       .+-||.|+.|.||+|++ .++.||||+++.-.       ..+|+-|++|+||||+.+.|+|.
T Consensus       118 ~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt  182 (904)
T KOG4721|consen  118 LWEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT  182 (904)
T ss_pred             hccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec
Confidence            45677777765       56799999999999999 56899999875221       25789999999999999999999


Q ss_pred             eCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeee
Q 007248          338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (611)
Q Consensus       338 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  417 (611)
                      ....++||||||+.|-|...|.   ....+.......|..+||.||.|||   .+.|||||||+-||||..+..+||+||
T Consensus       183 qsPcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDF  256 (904)
T KOG4721|consen  183 QSPCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDF  256 (904)
T ss_pred             CCceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccc
Confidence            9999999999999999999994   3456888889999999999999999   899999999999999999999999999


Q ss_pred             ccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccc
Q 007248          418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV  497 (611)
Q Consensus       418 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (611)
                      |.++......  ..-.++||..|||||++.+.+.+.|.|||||||+|||||||..|+.......-    +|   .     
T Consensus       257 GTS~e~~~~S--TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----Iw---G-----  322 (904)
T KOG4721|consen  257 GTSKELSDKS--TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IW---G-----  322 (904)
T ss_pred             cchHhhhhhh--hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EE---e-----
Confidence            9998765432  22357899999999999999999999999999999999999999653322111    11   1     


Q ss_pred             cccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       498 ~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                       .-...|.-..|..++.-+.-|+++||+..|..||++.+++..|.
T Consensus       323 -VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  323 -VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             -ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence             11122334456777788888999999999999999999998774

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-41  Score=354.09  Aligned_cols=260  Identities=27%  Similarity=0.383  Sum_probs=203.3

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeC-
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG-  339 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  339 (611)
                      ..++|++.++||+|+||.||+|..      ..+..||||++.... ....+.+.+|++++.++ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            346788899999999999999953      235689999986543 33456799999999999 899999999988764 


Q ss_pred             CcceEEEeecCCCChhhhhhccCC--------------------------------------------------------
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNK--------------------------------------------------------  363 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------  363 (611)
                      ...++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            457899999999999999864211                                                        


Q ss_pred             ---CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc-eeecccCCcc
Q 007248          364 ---TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH-VSTAVAGTLG  439 (611)
Q Consensus       364 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~  439 (611)
                         ...+++..++.++.||++||+|||   +.+|+||||||+|||+++++.+||+|||+++........ ......++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               134888899999999999999999   789999999999999999999999999999865432221 1223445678


Q ss_pred             ccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHH
Q 007248          440 YMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQ  518 (611)
Q Consensus       440 y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~  518 (611)
                      |+|||++.+..++.++||||||+++|||++ |..||........    .......+..         ...+......+.+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~----~~~~~~~~~~---------~~~~~~~~~~l~~  308 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE----FCQRLKDGTR---------MRAPENATPEIYR  308 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH----HHHHHhcCCC---------CCCCCCCCHHHHH
Confidence            999999998899999999999999999997 9988764332211    1111111111         1112233456889


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          519 IGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       519 l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ++.+||+.+|++||++.||++.|+..
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-42  Score=335.56  Aligned_cols=242  Identities=26%  Similarity=0.298  Sum_probs=199.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .+.|+..+.||+|+||+||.++. +.++.+|+|+++...   ....+..++|..+|.+++||.||+++-.|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            45788999999999999999955 458999999987542   34567788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      +||+.||.|..+|.   +...+++..+.-++.+|+.||.|||   +.+||||||||+|||||++|.++|+||||++..-.
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999994   3445888888889999999999999   89999999999999999999999999999985433


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .. ......+||+.|||||++....++..+|.||+|+++|||++|.+||.....    ..+ .+.+..+++         
T Consensus       178 ~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~----~~~-~~~I~~~k~---------  242 (357)
T KOG0598|consen  178 DG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV----KKM-YDKILKGKL---------  242 (357)
T ss_pred             CC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH----HHH-HHHHhcCcC---------
Confidence            32 233458999999999999999999999999999999999999999864321    111 121222220         


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCC
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRP  532 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RP  532 (611)
                      ..++.-......+++...++.+|++|-
T Consensus       243 ~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            111222344567888899999999995

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=343.44  Aligned_cols=251  Identities=25%  Similarity=0.323  Sum_probs=206.4

Q ss_pred             hcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (611)
                      .++|...+.||+|.|++|++|+ ...++.||||++....   ....+-...|-++|.+| .||.|++|+-.|.++..+|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            4678889999999999999994 4578999999885431   22334566788899999 89999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      |+||+++|+|.++|.+.   +.+++....-++.+|+.||+|||   ..|||||||||+|||||.|+++||.|||.|+.+.
T Consensus       152 vLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            99999999999999543   56999999999999999999999   8999999999999999999999999999999876


Q ss_pred             CCCcc----------ee--ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc
Q 007248          425 ADRTH----------VS--TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR  492 (611)
Q Consensus       425 ~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~  492 (611)
                      .....          ..  ...+||..|.+||++..+..+..+|+|+||||||+|+.|++||....+-- .++.+.    
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-iFqkI~----  300 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-IFQKIQ----  300 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH-HHHHHH----
Confidence            43222          11  34789999999999999999999999999999999999999986433211 111111    


Q ss_pred             cCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       493 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                            .++-    +++..-...+.+|+...+..||.+|+|.++|-+..
T Consensus       301 ------~l~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  301 ------ALDY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ------Hhcc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                  1122    33444445678888999999999999999987653

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-41  Score=332.12  Aligned_cols=261  Identities=25%  Similarity=0.356  Sum_probs=208.7

Q ss_pred             hcCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .+.|+..+.||.|.-++||+| ..+.+..||||++.... ....+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            456888899999999999999 55778999999997653 3346889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      ||.+||+.+.+...-.. .+++..+..|+.++++||.|||   ++|.||||||+.||||+.+|.+||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999999654333 3899999999999999999999   8999999999999999999999999999988765433


Q ss_pred             cce--e-ecccCCccccChhhhhcC--ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          428 THV--S-TAVAGTLGYMAPEYLVRG--QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       428 ~~~--~-~~~~gt~~y~aPE~~~~~--~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ...  . ....||+.|||||+++..  -|+.|+||||||+...||.+|..||...+.-..++..    +.... ....-.
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t----Lqn~p-p~~~t~  255 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT----LQNDP-PTLLTS  255 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH----hcCCC-CCcccc
Confidence            221  1 456899999999997653  5899999999999999999999998765543333221    11111 100011


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+..+-.......+.+++..|++.||++|||++++++
T Consensus       256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            1111111222335788899999999999999999985

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=339.27  Aligned_cols=261  Identities=27%  Similarity=0.394  Sum_probs=203.6

Q ss_pred             hcCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccchhhHHH-HHHHHHHHhcCC-CCceeeEeeeeeeCC-cceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIE-HKNLVKLLGCSIEGP-ESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv  345 (611)
                      .++|...++||.|.||.||+| ....|..||||+++..-..+.+- =++|++.|++|+ |||||+|.+++.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            456777889999999999999 45678999999987654444332 258999999998 999999999998888 99999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      ||||+. +|.+++.++  ...+++..+..|+.||++||+|+|   ++|+.|||+||+|||+..+..+||+|||||+....
T Consensus        89 fE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             HHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc
Confidence            999954 999999654  678999999999999999999999   99999999999999999888999999999997654


Q ss_pred             CCcceeecccCCccccChhhhh-cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc---------
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLV-RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK---------  495 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------  495 (611)
                      ..  ..+..+.|.+|.|||++. .+.|+.+.|||++|||++||.+-++-|....+ .+.+..+...+....         
T Consensus       163 kp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  163 KP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             CC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHHHHHHHhCCCccccchhHHH
Confidence            33  345677899999999865 57899999999999999999998866533222 111111111221111         


Q ss_pred             cccccCCC--------CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          496 LVEAVDPN--------LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       496 ~~~~id~~--------l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      +...++-.        +..-.+ ....+.++++..|+..||.+|||+.|.++.
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11111111        111112 256678899999999999999999999875

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=350.80  Aligned_cols=260  Identities=27%  Similarity=0.407  Sum_probs=218.2

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEcCC-CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc
Q 007248          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       264 ~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (611)
                      ++++.-..+....++||-|.||.||.|.|+. .-.||||.++.+..+ +++|+.|..+|+.++|||+|+|+|+|..+...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4444444455667899999999999998865 568999999866544 68999999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      |||+|||.+|+|.+||++-. ...++-..++.++.||+.||+||.   ++++|||||.++|+|+.++..+||+||||+++
T Consensus       339 YIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            99999999999999997643 345777888999999999999999   89999999999999999999999999999999


Q ss_pred             ccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      +..+.........-...|.|||.+....++.|+|||+|||+||||.| |..|+.     +..+..         +.+++.
T Consensus       415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP-----GidlSq---------VY~LLE  480 (1157)
T KOG4278|consen  415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP-----GIDLSQ---------VYGLLE  480 (1157)
T ss_pred             hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC-----CccHHH---------HHHHHh
Confidence            88765443333344678999999999999999999999999999988 444421     112222         234445


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      ...+.+.|..++..+++|+++||+.+|.+||++.|+-+.++
T Consensus       481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            55666778888999999999999999999999999987764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-40  Score=310.37  Aligned_cols=261  Identities=26%  Similarity=0.395  Sum_probs=204.5

Q ss_pred             cCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccchh--hHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .+|...++||+|.||.||+| ..+.|+.||||+++.....  ......+|++.|++++|+||+.++++|...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            35677889999999999999 5678999999999765322  23467899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      ||+. +|+..|.+  +...++..++..++.++++||+|||   .+.|+||||||.|+|++.+|.+||+|||+++.+....
T Consensus        82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9965 99999854  4567999999999999999999999   8999999999999999999999999999999887544


Q ss_pred             cceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc------ccccc
Q 007248          428 THVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK------LVEAV  500 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~i  500 (611)
                      ... +..+-|.+|.|||.+.+ ..|....||||.|||+.||+-|.+ +.....+-+.+..+........      +.++.
T Consensus       156 ~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P-~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP-FFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             ccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC-CCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            332 23367999999999887 478999999999999999998864 4333333333333332222111      11111


Q ss_pred             C---------CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          501 D---------PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       501 d---------~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      |         +.+.. .-.......++++..++..||.+|.+++|++++
T Consensus       234 dY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1         11111 112344556899999999999999999999866

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-40  Score=337.05  Aligned_cols=257  Identities=19%  Similarity=0.302  Sum_probs=202.6

Q ss_pred             cccChHHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccch---hhHHHHHHHHHHHhcCCCCceeeEeee
Q 007248          259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR---QWVDEFFNEVNLISSIEHKNLVKLLGC  335 (611)
Q Consensus       259 ~~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~  335 (611)
                      ..++.++|+     ......||+|++|.||+|.+ +|+.||||++.....   ...+.|.+|+.+|++++||||++++|+
T Consensus        13 ~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~   86 (283)
T PHA02988         13 KCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF   86 (283)
T ss_pred             eecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence            344555552     22346799999999999988 789999999875432   335778899999999999999999999


Q ss_pred             eee----CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC
Q 007248          336 SIE----GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT  411 (611)
Q Consensus       336 ~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  411 (611)
                      +.+    ....++||||+++|+|.+++..   ...++|...++++.+++.||.|||.  ..+++||||||+|||+++++.
T Consensus        87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~  161 (283)
T PHA02988         87 IIDIVDDLPRLSLILEYCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYK  161 (283)
T ss_pred             EEecccCCCceEEEEEeCCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCc
Confidence            876    3467899999999999999954   3468999999999999999999993  247889999999999999999


Q ss_pred             eEEeeeccceeccCCCcceeecccCCccccChhhhhc--CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHH
Q 007248          412 PKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR--GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWT  489 (611)
Q Consensus       412 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~  489 (611)
                      +||+|||+++......    ....++..|+|||++.+  ..++.++|||||||++|||++|+.||.....    .+. ..
T Consensus       162 ~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----~~~-~~  232 (283)
T PHA02988        162 LKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----KEI-YD  232 (283)
T ss_pred             EEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----HHH-HH
Confidence            9999999997654322    23457889999999976  6889999999999999999999999863321    111 11


Q ss_pred             hhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          490 LYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       490 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .....        ......+......+.+++.+||+.+|++|||++||++.|+.
T Consensus       233 ~i~~~--------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        233 LIINK--------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             HHHhc--------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            11111        01111232345568899999999999999999999999864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.7e-40  Score=388.95  Aligned_cols=260  Identities=23%  Similarity=0.433  Sum_probs=213.3

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ....|...+.||+|+||.||+|.. .++..||||++.....    ....|++.+++++|||||+++|++.+++..++|||
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            345677889999999999999975 5789999998864332    12356889999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++|+|.++++      .++|..+.+++.||++||+|||..+.++|+||||||+||+++.++.+++. ||........ 
T Consensus       764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            999999999994      28999999999999999999997767899999999999999999888876 6665433211 


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCC-CCChhHHHHHhhccCccccccCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQD-SASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                          ....++..|+|||++.+..++.++|||||||++|||+||+.|++.... .....+|....+........+|+.+..
T Consensus       836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence                223578999999999999999999999999999999999999854332 334555555444455555666776643


Q ss_pred             --CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          507 --DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       507 --~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                        ..+.+++.++.+++.+||+.+|++||+|+||++.|+..
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence              33556777889999999999999999999999999754

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.9e-40  Score=338.58  Aligned_cols=262  Identities=25%  Similarity=0.406  Sum_probs=201.6

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC-----------------CCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN-----------------GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKL  332 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  332 (611)
                      ++|...++||+|+||.||++.+.+                 +..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467788999999999999996532                 3479999887543 3445679999999999999999999


Q ss_pred             eeeeeeCCcceEEEeecCCCChhhhhhccC----------------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceec
Q 007248          333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKN----------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH  396 (611)
Q Consensus       333 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  396 (611)
                      ++++.+.+..++||||+++++|.+++....                ....++|..+++++.||+.||.|||   ..+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999985421                1135788999999999999999999   789999


Q ss_pred             CCCCcccEEECCCCCeEEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCC--CC
Q 007248          397 RDIKTSNILLDKDFTPKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR--RS  473 (611)
Q Consensus       397 ~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~--~p  473 (611)
                      |||||+|||+++++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||+++.  .|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999976543322 1222344578899999998889999999999999999999754  44


Q ss_pred             CCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          474 NAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       474 ~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      +.... ...........+....      .......+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus       242 ~~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELT-DEQVIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCC-HHHHHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            43221 1112221111111110      00011112234456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.5e-40  Score=333.93  Aligned_cols=254  Identities=23%  Similarity=0.357  Sum_probs=202.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcC----CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ++|++.++||+|+||.||+|.+.    .+..||+|.+.... ....+.|.+|+.++++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46788899999999999999653    35789999987543 34456799999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++|+|.+++...  ...+++..++.++.||+.||+|||   +.+++||||||+|||++.++.+|++|||.+.....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            9999999999999543  246899999999999999999999   88999999999999999999999999998765322


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ..........++..|+|||.+.+..++.++||||||+++||+++ |+.|+...... ....    ....+         .
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-~~~~----~~~~~---------~  225 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-DVIK----AVEDG---------F  225 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHH----HHHCC---------C
Confidence            22111122345678999999999999999999999999999775 99887532211 1111    11111         1


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ....+...+..+.+++..||+.+|++||++++|++.|..
T Consensus       226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            112233345568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.2e-40  Score=349.02  Aligned_cols=258  Identities=28%  Similarity=0.387  Sum_probs=203.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  341 (611)
                      .++|+..+.||+|+||.||++..      ..+..||||+++... ....+.+.+|+.+|..+ +||||+++++++..+..
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            44678889999999999999853      345689999986442 33456789999999999 89999999999999999


Q ss_pred             ceEEEeecCCCChhhhhhccCC----------------------------------------------------------
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNK----------------------------------------------------------  363 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------------------  363 (611)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999864221                                                          


Q ss_pred             --------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          364 --------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       364 --------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                                    ...++|..+++++.||++||+|||   ..+|+||||||+|||+++++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          125789999999999999999999   789999999999999999999999999999866433221


Q ss_pred             -eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          430 -VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       430 -~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                       ......++..|+|||++.+..++.++||||||+++|||++ |..|+.........    +.....+         ....
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~----~~~~~~~---------~~~~  337 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF----YKMIKEG---------YRML  337 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH----HHHHHhC---------ccCC
Confidence             1122345678999999999999999999999999999998 77776533222111    1111111         1111


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .+......+.+|+.+||+.+|++||++.||+++|++
T Consensus       338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            112223468899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.9e-41  Score=335.50  Aligned_cols=248  Identities=33%  Similarity=0.514  Sum_probs=193.0

Q ss_pred             CCccccCCceeEEEEEcC-----CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          276 SKKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      .+.||.|.||.||+|.+.     .+..|+||.+... ..+..+.|.+|++.+++++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            468999999999999775     3578999999654 3345789999999999999999999999999888899999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc-
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT-  428 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-  428 (611)
                      ++|+|.++|... ....+++..+++|+.||++||.|||   +.+++|+||+++|||+++++.+||+|||++........ 
T Consensus        84 ~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   84 PGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            999999999654 2346899999999999999999999   78899999999999999999999999999987633222 


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                      ...........|+|||.+....++.++||||||+++|||++ |+.|+...    ...+.... ...+..         ..
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~----~~~~~~~~-~~~~~~---------~~  225 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY----DNEEIIEK-LKQGQR---------LP  225 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS----CHHHHHHH-HHTTEE---------TT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc----cccccccc-cccccc---------ce
Confidence            22234456789999999999999999999999999999999 66775322    11111111 122211         11


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      .+......+.+++..||+.+|++||++.++++.|
T Consensus       226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            2333455688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.5e-40  Score=328.66  Aligned_cols=254  Identities=30%  Similarity=0.434  Sum_probs=205.3

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      ++|+..++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++..+...+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            4678889999999999999988888899999876543 335789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +++|.+++... ....+++..++.++.|++.||+|||   ..+++||||||+||++++++.+||+|||++..........
T Consensus        85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            99999999643 2345889999999999999999999   7899999999999999999999999999998765433222


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      .....++..|+|||++....++.++||||||+++|||+| |+.|+...... .....    ....         ...+..
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~----~~~~---------~~~~~~  226 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-DVMSA----LQRG---------YRMPRM  226 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-HHHHH----HHcC---------CCCCCC
Confidence            223345678999999988899999999999999999998 88887432111 11111    1111         001111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ......+.+++.+|++.+|++||+++++++.|++
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            2233457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.1e-40  Score=346.70  Aligned_cols=258  Identities=27%  Similarity=0.398  Sum_probs=202.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  341 (611)
                      .++|+..+.||+|+||.||++..      .++..||||++.... ....+.+.+|+++++.+ +|+||+++++++...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            34678899999999999999853      234589999987542 33456789999999999 89999999999999999


Q ss_pred             ceEEEeecCCCChhhhhhccC-----------------------------------------------------------
Q 007248          342 SLLVYEYVPNRSLDQFIFDKN-----------------------------------------------------------  362 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~-----------------------------------------------------------  362 (611)
                      .++||||+++|+|.++++...                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999985321                                                           


Q ss_pred             --------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc-eeec
Q 007248          363 --------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH-VSTA  433 (611)
Q Consensus       363 --------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~  433 (611)
                              ....+++..+++++.||+.||.|||   ..+|+||||||+|||+++++.+||+|||+++........ ....
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    1124788999999999999999999   789999999999999999999999999999765433221 1122


Q ss_pred             ccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHH
Q 007248          434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQ  512 (611)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~  512 (611)
                      ..++..|+|||++....++.++||||||+++|||++ |+.||.........    +......         .....+...
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~----~~~~~~~---------~~~~~~~~~  340 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF----YKMVKRG---------YQMSRPDFA  340 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH----HHHHHcc---------cCccCCCCC
Confidence            345678999999988899999999999999999997 99987543222111    1111111         111111222


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          513 VCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       513 ~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ...+.+++.+||+.+|++||++.+|+++|++
T Consensus       341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            3568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.6e-40  Score=328.28  Aligned_cols=251  Identities=23%  Similarity=0.357  Sum_probs=201.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      ++|+..+.||+|+||.||++.++++..+|+|.+.... ...+.|.+|++++++++||||+++++++..+...++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            3577788999999999999998888899999876432 234678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +|+|.++++...  ..+++..++.++.|++.||.|||   +.+|+|+||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            999999986432  35899999999999999999999   8999999999999999999999999999997654322222


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....    ..+..... ..+..  .       ..+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~----~~~~~~~i-~~~~~--~-------~~~  223 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS----NYEVVEMI-SRGFR--L-------YRP  223 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHH-HCCCC--C-------CCC
Confidence            223345668999999988889999999999999999999 888864322    11111111 11110  0       011


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      ......+.+++.+||+.+|++||++.++++.|
T Consensus       224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            12234678999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=337.34  Aligned_cols=262  Identities=26%  Similarity=0.425  Sum_probs=211.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchh-hHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      ....+.++||+|.||.|.......+..||||+++..... ..++|.+|+++|.+++|||||+|+|+|..++.+++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            445677999999999999999988899999999876544 3589999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC-c
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR-T  428 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~-~  428 (611)
                      ++|+|.+|+...... .+.-...++|+.||+.||+||.   ..++|||||.++|+|+|.++++||+|||+++-+.... .
T Consensus       618 EnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             hcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            999999999654322 2566777889999999999999   8999999999999999999999999999998654333 3


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh--CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC--GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      +.....+-+.+|||||.+..++++.++|||+||+.+||+++  ...|++...+. ..++..-.....+.      .....
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-~vven~~~~~~~~~------~~~~l  766 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-QVVENAGEFFRDQG------RQVVL  766 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-HHHHhhhhhcCCCC------cceec
Confidence            34445566889999999999999999999999999999865  44565432221 11111111121111      11112


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ..|.-++..++++++.||..+-++||++++|...|.+
T Consensus       767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            3355677789999999999999999999999988864

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-40  Score=328.26  Aligned_cols=255  Identities=27%  Similarity=0.376  Sum_probs=205.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      .++|+..+.||+|++|.||+|...+++.||||.+.... ...++|.+|+.++++++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688889999999999999988778899999986543 23567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999995433 345899999999999999999999   889999999999999999999999999999876533222


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      .......+..|+|||++.+..++.++||||||+++|||+| |+.|+....    . ..........         .....
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~-~~~~~~~~~~---------~~~~~  225 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT----N-AEVLQQVDQG---------YRMPC  225 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC----H-HHHHHHHHcC---------CCCCC
Confidence            1122223468999999988899999999999999999999 888864221    1 1111111111         11112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      +......+.+++.+|++.+|++||+++++++.|++
T Consensus       226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            23344668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.6e-39  Score=328.33  Aligned_cols=250  Identities=23%  Similarity=0.294  Sum_probs=200.0

Q ss_pred             CCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      |+..+.||+|+||.||++.. .+|+.||||.+....   ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66778999999999999965 578999999886442   22334678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++|+|.+++.... ...+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||++....... 
T Consensus        82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999998885432 335899999999999999999999   8999999999999999999999999999998654322 


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...........          ...+
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~----------~~~~  224 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRRVKED----------QEEY  224 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHHHhhcc----------cccC
Confidence             12345689999999999999999999999999999999999999865432211 11111111110          0112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPS-----MAQAIM  539 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt-----~~evl~  539 (611)
                      +......+.+|+..||+.+|++||+     ++++++
T Consensus       225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            2233456788999999999999997     788774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-41  Score=331.58  Aligned_cols=248  Identities=23%  Similarity=0.374  Sum_probs=206.3

Q ss_pred             cCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ..|...+.||+|.||.||+| ....++.||+|++.... ....+++.+|+.+|.+++++||.++||.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            35666789999999999999 45568999999997654 44567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      |.+|++.+.|.   ....+++..+.-++.++..||.|||   ..+.+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus        93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999993   3344588888889999999999999   89999999999999999999999999999988766554


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      .. ...+||+.|||||++....|+.|+||||||++.+||.+|.+|+.....              .++.-+|-..-....
T Consensus       167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--------------mrvlflIpk~~PP~L  231 (467)
T KOG0201|consen  167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--------------MRVLFLIPKSAPPRL  231 (467)
T ss_pred             cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--------------ceEEEeccCCCCCcc
Confidence            43 678899999999999988999999999999999999999999653322              122222221111111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .......+.+++..|++.+|+.||++.++++
T Consensus       232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            2233445889999999999999999999985

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=336.08  Aligned_cols=249  Identities=22%  Similarity=0.344  Sum_probs=203.8

Q ss_pred             HHhcCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeecc----ch-hhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCC
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN----TR-QWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGP  340 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  340 (611)
                      ...+.|...+.||+|.||+|+.| ...++..||||.+...    .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34568889999999999999999 4457899999976543    11 23456668999999998 999999999999999


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC-CCeEEeeecc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGL  419 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl  419 (611)
                      ..++||||+.+|+|.+++.+   ...+.+....+++.|++.|++|+|   ..+|+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999965   345888999999999999999999   8999999999999999999 9999999999


Q ss_pred             ceeccCCCcceeecccCCccccChhhhhcCc-cc-cccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccc
Q 007248          420 ARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ-LT-EKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV  497 (611)
Q Consensus       420 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (611)
                      +.... .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+....    ...... +..+.+ 
T Consensus       168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~----~~l~~k-i~~~~~-  240 (370)
T KOG0583|consen  168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV----PNLYRK-IRKGEF-  240 (370)
T ss_pred             ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH----HHHHHH-HhcCCc-
Confidence            98764 2233455788999999999998866 75 789999999999999999999876221    111111 111111 


Q ss_pred             cccCCCCCCCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHH
Q 007248          498 EAVDPNLKDDFPAEQ-VCNVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       498 ~~id~~l~~~~~~~~-~~~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                               .+|... ...+..++.+|+..+|..|+++.+|+
T Consensus       241 ---------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  241 ---------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             ---------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                     112222 55678999999999999999999998

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1e-39  Score=325.97  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=201.4

Q ss_pred             CCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +|...+.||+|+||.||+|...++..+|||.+.... ...+.|.+|+.++++++||||+++++++.+....++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            466778999999999999988777789999886433 2346799999999999999999999999999899999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      ++|.+++....  ..+++..++.++.||+.||.|||   +.+++|+||||+||++++++.+||+|||+++..........
T Consensus        84 ~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          84 GCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            99999985432  25899999999999999999999   88999999999999999999999999999986544332222


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPA  510 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~  510 (611)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......     ........+.         ....+.
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~~~---------~~~~~~  224 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVEKVSQGL---------RLYRPH  224 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHHhcCC---------CCCCCC
Confidence            22345678999999988889999999999999999999 88886532211     1111111111         111122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          511 EQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       511 ~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      .....+.+++.+||+.+|++||++.+|++.|
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence            2345688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-39  Score=329.48  Aligned_cols=256  Identities=28%  Similarity=0.471  Sum_probs=204.7

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC------CCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcce
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (611)
                      ++|+..+.||+|+||.||+|....      ...||+|.+.... ....+.|.+|++++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            357778999999999999996533      2579999886443 344567999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhhccCC-------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC
Q 007248          344 LVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF  410 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  410 (611)
                      ++|||+++++|.+++.....             ...+++..++.++.||+.||.|||   ..+++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            99999999999999964321             145889999999999999999999   78999999999999999999


Q ss_pred             CeEEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHH
Q 007248          411 TPKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVW  488 (611)
Q Consensus       411 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~  488 (611)
                      .+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....     ....
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-----~~~~  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-----QEVI  236 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH
Confidence            999999999976533221 12233456788999999988899999999999999999998 9888653211     1111


Q ss_pred             HhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          489 TLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       489 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ..+....         ....+...+..+.+|+.+||+.+|.+||++.||++.|.+
T Consensus       237 ~~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 EMIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1111111         112234455678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.6e-40  Score=334.21  Aligned_cols=246  Identities=28%  Similarity=0.368  Sum_probs=207.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ++|...+.||+|.||.||||+. .+.+.||+|.+.+..  .+..+.+.+|++++++++|||||.++++|+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4677788999999999999955 457899999886543  3456778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+.+ +|..+|..   ...+++..+..|+.++..||.|||   +.+|+|||+||.|||++.++.+|++|||+|+.+.. .
T Consensus        82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N  153 (808)
T ss_pred             hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence            9977 99999943   445999999999999999999999   89999999999999999999999999999998765 3


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                      +...+.+.||+-|||||+..++.|+..+|.||+|||+||+++|++||...    ...+.+..+..        |+.   .
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~----si~~Lv~~I~~--------d~v---~  218 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR----SITQLVKSILK--------DPV---K  218 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH----HHHHHHHHHhc--------CCC---C
Confidence            45566789999999999999999999999999999999999999997521    11121111111        111   2


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +|......+..++...++.||..|-+..+++.
T Consensus       219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            34456667888999999999999999999875

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.6e-40  Score=327.54  Aligned_cols=256  Identities=30%  Similarity=0.419  Sum_probs=210.3

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ...+|...++||+|+||.||+|...++..+++|.+........+.+.+|+.+++.++||||+++++++......++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            45568888999999999999998888999999998876665667899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++.... ...+++..++.++.||+.||.|||   +.+++|+||+|+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999996543 346899999999999999999999   78999999999999999999999999999976543221


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                       ......++..|+|||.+....++.++||||||+++|+|++ |+.|+..... ...+..    ..         ......
T Consensus       160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-~~~~~~----~~---------~~~~~~  224 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-HEVYDQ----IT---------AGYRMP  224 (261)
T ss_pred             -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHH----HH---------hCCcCC
Confidence             1223345678999999988899999999999999999998 7888753321 111111    11         111112


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .+......+.+++.+|++.+|++|||+.++++.|+.
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            233445568899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-39  Score=325.09  Aligned_cols=254  Identities=26%  Similarity=0.451  Sum_probs=204.3

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC----CCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ++|+..+.||+|+||.||+|.+..    ...||||.+... .......|.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568889999999999999997642    458999988654 334456799999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++++|.+++....  ..+++..+++++.|++.||+|||   +.+|+|+||||+|||+++++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            99999999999995432  36899999999999999999999   89999999999999999999999999999987652


Q ss_pred             CCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          426 DRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       426 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....     ..........         
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~~~---------  224 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----QDVIKAVEDG---------  224 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHcC---------
Confidence            2221 1222345678999999998899999999999999999998 8888643211     1111111111         


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ...+.+......+.+++.+|++.+|++||++.+|++.|..
T Consensus       225 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            1111223345568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-39  Score=325.51  Aligned_cols=254  Identities=28%  Similarity=0.422  Sum_probs=204.2

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      ..|...++||+|+||.||+|... .++.+|+|++.... ...+++.+|++++++++||||+++++++..+...++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            34677889999999999999654 58899999886443 34567999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++.... ...+++..++.++.|+++||+|||   ..+++||||||+|||+++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999985432 345899999999999999999999   789999999999999999999999999999766443222


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..|+...    . .+..+.....         ......
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~----~-~~~~~~~~~~---------~~~~~~  226 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----D-LSQVYELLEK---------GYRMER  226 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----C-HHHHHHHHHC---------CCCCCC
Confidence            2222334668999999988999999999999999999998 88886422    1 1112222111         111122


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      +...+..+.+++.+||+.+|++||++.+++++|++
T Consensus       227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            33344568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=335.15  Aligned_cols=253  Identities=25%  Similarity=0.305  Sum_probs=201.8

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|++.+.||+|+||.||+|... +++.||||++....   ....+.+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888899999999999999764 58999999987542   234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999953   345889999999999999999999   89999999999999999999999999999975533 


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                         ......|++.|+|||++.+..++.++|||||||++|||++|+.||.....    .+.........   ..+......
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~---~~~~~~~~~  223 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP----NETWENLKYWK---ETLQRPVYD  223 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH----HHHHHHHHhcc---ccccCCCCC
Confidence               22345689999999999988999999999999999999999999753221    11111111101   111111111


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      .........+.+++..|++.+|++||++.++++.
T Consensus       224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0011234557889999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=323.45  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=200.7

Q ss_pred             CCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +|++.+.||+|+||.||++..+++..+|+|.+.... .....|.+|++++++++||||+++++++......++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            467788999999999999988777889999876432 2345788999999999999999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      ++|.+++....  ..+++..++.++.||+.||+|||   +.+++||||||+||++++++.+||+|||+++..........
T Consensus        84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            99999996432  36899999999999999999999   88999999999999999999999999999976543222211


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPA  510 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~  510 (611)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......    +.... ....         .....+.
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~-~~~~---------~~~~~~~  224 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EVVES-VSAG---------YRLYRPK  224 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----HHHHH-HHcC---------CcCCCCC
Confidence            22234567999999998899999999999999999999 78887532211    11111 1111         1111122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          511 EQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       511 ~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      ..+..+.+++.+||+.+|++||++.+|++.|
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            3455688999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.3e-39  Score=326.25  Aligned_cols=263  Identities=20%  Similarity=0.253  Sum_probs=201.1

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ++|+..+.||+|+||.||++... +++.+|||++....  ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999764 57899999987542  3345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |++++++..+..   ....+++..+..++.||+.||.|||   ..+|+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987765542   2345899999999999999999999   8899999999999999999999999999998764433


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHH----------HHhh-ccCcc
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV----------WTLY-RSNKL  496 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~----------~~~~-~~~~~  496 (611)
                      ........|+..|+|||++.+..++.++|||||||++|||++|+.||.............          +..+ .....
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            323334568999999999988889999999999999999999999986432211111000          0000 00000


Q ss_pred             ccccCCCCCC------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          497 VEAVDPNLKD------DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       497 ~~~id~~l~~------~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .....+....      .........+.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000011100      001112345889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.2e-39  Score=341.55  Aligned_cols=259  Identities=24%  Similarity=0.342  Sum_probs=204.3

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCC
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGP  340 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  340 (611)
                      ..++|.+.++||+|+||.||+|...      .+..||||++.... ....+.|.+|+++|+++. ||||+++++++.+..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3567888899999999999999642      23479999986543 334567999999999996 999999999999999


Q ss_pred             cceEEEeecCCCChhhhhhccCC---------------------------------------------------------
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNK---------------------------------------------------------  363 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------  363 (611)
                      ..++||||+++|+|.++|+....                                                         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999999864210                                                         


Q ss_pred             ------------------------------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC
Q 007248          364 ------------------------------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD  407 (611)
Q Consensus       364 ------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  407 (611)
                                                          ...+++..++.++.||++||.|||   ..+|+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence                                                124788899999999999999999   78999999999999999


Q ss_pred             CCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhH
Q 007248          408 KDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQ  485 (611)
Q Consensus       408 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~  485 (611)
                      +++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.........  
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--  349 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--  349 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--
Confidence            9999999999999865433221 1223446788999999988899999999999999999997 88887543221111  


Q ss_pred             HHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          486 RVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       486 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                        +.....+         .....+......+.+++.+||+.+|++||++.+|+++|..
T Consensus       350 --~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         350 --YNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             --HHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence              1111111         1111223344568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.7e-39  Score=332.20  Aligned_cols=251  Identities=24%  Similarity=0.287  Sum_probs=198.7

Q ss_pred             CCCCCCccccCCceeEEEEEc----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcc
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  342 (611)
                      +|++.+.||+|+||.||++..    .+++.||+|++....    ....+.+..|+.++..+ +||||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477789999999999999854    368899999986432    23345688999999999 599999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999999854   345889999999999999999999   88999999999999999999999999999986


Q ss_pred             ccCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      +............||..|+|||++.+. .++.++||||||+++|||+||+.||........... +......      .+
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~~~------~~  227 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE-VSRRILK------CD  227 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH-HHHHHhc------CC
Confidence            544333333356789999999998765 478899999999999999999999864433222211 1111100      11


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                      +.    ++......+.+++.+|++.+|++||     +++++++
T Consensus       228 ~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         228 PP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            11    2223344578899999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.2e-39  Score=333.24  Aligned_cols=199  Identities=25%  Similarity=0.390  Sum_probs=173.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .++|+..+.||+|+||.||++... +|..+|+|.+.... ....+.+.+|+++|++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            357888999999999999999654 68899999887542 3445679999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++++|.+++...   ..+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            99999999999543   358899999999999999999993  3469999999999999999999999999987653321


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAF  476 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~  476 (611)
                         .....|+..|+|||++.+..++.++||||||+++|||++|+.|+..
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence               2345689999999999988999999999999999999999999853

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8.1e-39  Score=331.44  Aligned_cols=244  Identities=21%  Similarity=0.278  Sum_probs=198.7

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..+.||+|+||.||++... +++.||||++....   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            45778899999999999999664 68999999987542   234567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            999999999999543   35788889999999999999999   899999999999999999999999999999865432


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      .    ....|++.|+|||++.+..++.++|||||||++|||++|+.||...    ...+. +.....+.+          
T Consensus       172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~-~~~i~~~~~----------  232 (329)
T PTZ00263        172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD----TPFRI-YEKILAGRL----------  232 (329)
T ss_pred             c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC----CHHHH-HHHHhcCCc----------
Confidence            2    2356899999999999988999999999999999999999997532    11111 111111111          


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPS-----MAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt-----~~evl~  539 (611)
                      .++......+.+++..||+.||++||+     +++++.
T Consensus       233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        233 KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            112223345778999999999999997     677663

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.3e-39  Score=326.44  Aligned_cols=255  Identities=26%  Similarity=0.429  Sum_probs=204.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC------CCEEEEEEeeccchh-hHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcce
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (611)
                      ++|...+.||+|+||.||+|...+      +..||||.+...... ..+.|.+|+++++.++||||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457778899999999999996533      478999998755433 5678999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhhccC-----------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCe
Q 007248          344 LVYEYVPNRSLDQFIFDKN-----------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  412 (611)
                      +||||+++++|.+++....           ....+++..+..++.||+.||.|||   ..+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999996432           2345889999999999999999999   8899999999999999999999


Q ss_pred             EEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHh
Q 007248          413 KIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTL  490 (611)
Q Consensus       413 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~  490 (611)
                      ||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.|+..... .....    .
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-~~~~~----~  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIE----C  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHH----H
Confidence            9999999976433221 11223345788999999999999999999999999999998 9988753221 11111    1


Q ss_pred             hccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          491 YRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       491 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      ...+..         ...+......+.+++.+||+.+|++||++.||++.|.
T Consensus       237 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 ITQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            111111         1112234456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.5e-39  Score=327.01  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=202.3

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (611)
                      .+++|+..+.||+|+||.||+|...      .+..||||++.... .....+|.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4677999999999999999998642      35679999875432 2345678999999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhhccCC-------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEE
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNK-------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  414 (611)
                      .++||||+++++|.+++.....       ...+++..++.++.|+++||.|||   +.+++|+||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            9999999999999999864321       234688899999999999999999   789999999999999999999999


Q ss_pred             eeeccceeccCCCcce-eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhc
Q 007248          415 ADFGLARCFAADRTHV-STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYR  492 (611)
Q Consensus       415 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  492 (611)
                      +|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..|+.....     +.......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~~~~~~~~  235 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQVLRFVM  235 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHH
Confidence            9999987554322211 112345778999999998899999999999999999999 6777643211     11111111


Q ss_pred             cCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       493 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      ....         ...+......+.+++.+|++.+|++||++.|+++.|.
T Consensus       236 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         236 EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             cCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1111         1112233456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.6e-39  Score=332.31  Aligned_cols=254  Identities=25%  Similarity=0.405  Sum_probs=200.6

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCC----EEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGT----TVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      .+|+..+.||+|+||.||+|.+. ++.    .||||++.... ....++|.+|+.+++.++||||++++|++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            45888999999999999999753 333    48999886443 34567899999999999999999999998764 5789


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999999643  235889999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCccee-ecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          425 ADRTHVS-TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       425 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ....... ....++..|+|||++.+..++.++||||||+++|||++ |+.|+....    . ..........        
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~----~-~~~~~~~~~~--------  227 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----A-SEISSILEKG--------  227 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----H-HHHHHHHhCC--------
Confidence            4333221 12334678999999999999999999999999999998 988875321    1 1111111111        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                       .....+......+.+++..||+.+|++||++.+++..|...
T Consensus       228 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         228 -ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             11111222345678999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.9e-39  Score=324.00  Aligned_cols=264  Identities=27%  Similarity=0.397  Sum_probs=202.7

Q ss_pred             CCCCCccccCCceeEEEEE-----cCCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--CcceE
Q 007248          273 FNPSKKLGQGGAGSVYMGS-----LPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLL  344 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  344 (611)
                      |...+.||+|+||+||++.     ..++..||+|.+.... ......|.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            3778999999999998763     2467899999887543 34456789999999999999999999987654  35789


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++++|.+++..    ..+++..++.++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999943    24899999999999999999999   7899999999999999999999999999998654


Q ss_pred             CCCcce--eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCC-ChhHHHHHhhccCccccccC
Q 007248          425 ADRTHV--STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA-SPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       425 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~id  501 (611)
                      ......  .....++..|+|||.+....++.++||||||+++|||+||+.|+....... ..............+.+.++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            332211  122335667999999988899999999999999999999999875432211 11110000111112222233


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .......+...+..+.+++..||+.+|++||++++|+++|+.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~  280 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE  280 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            322223334455678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.9e-39  Score=324.79  Aligned_cols=255  Identities=25%  Similarity=0.404  Sum_probs=201.7

Q ss_pred             cCCCCCCccccCCceeEEEEEc-----CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      +.|+..+.||+|+||.||+|..     .++..+++|.+... ..+....|.+|++++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3567789999999999999963     35688999998643 33445778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCC--------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC
Q 007248          345 VYEYVPNRSLDQFIFDKNK--------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF  410 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  410 (611)
                      ||||+++++|.+++.....              ...+++..++.++.|++.||.|||   +.+++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            9999999999999853221              235889999999999999999999   78999999999999999999


Q ss_pred             CeEEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHH
Q 007248          411 TPKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVW  488 (611)
Q Consensus       411 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~  488 (611)
                      .+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..|+....    . ..+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~----~-~~~~  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS----N-QEVI  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----H-HHHH
Confidence            999999999976543221 11223345678999999988889999999999999999998 887764221    1 1111


Q ss_pred             HhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          489 TLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       489 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      ........         ...+......+.+++.+|++.+|++||++.+|.+.|.
T Consensus       237 ~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         237 EMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            11111111         1122233456788999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.2e-39  Score=327.14  Aligned_cols=258  Identities=25%  Similarity=0.408  Sum_probs=206.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc------CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++|...+.||+|+||.||++..      .++..+++|.+........+.+.+|++++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            3467778999999999999963      2356799998876666666789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccC-------------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC
Q 007248          345 VYEYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT  411 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  411 (611)
                      ||||+++++|.+++....             ....++|..++.++.||+.||+|||   ..+|+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999996432             1235899999999999999999999   899999999999999999999


Q ss_pred             eEEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHH
Q 007248          412 PKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWT  489 (611)
Q Consensus       412 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~  489 (611)
                      +||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||+| |+.|+......     ..+.
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----~~~~  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-----EVIE  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH
Confidence            99999999975543221 11223456788999999998999999999999999999999 98886533211     1112


Q ss_pred             hhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          490 LYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       490 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      ....+...         ..+...+..+.+++.+||+.+|++||++.+|+++|.+..
T Consensus       237 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         237 CITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             HHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            12222111         112223456889999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.3e-38  Score=334.82  Aligned_cols=252  Identities=22%  Similarity=0.299  Sum_probs=194.4

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .|+..+.||+|+||+||+|.. .+++.||||++....   ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            577889999999999999954 568899999986532   3445678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999853   335888999999999999999999   8999999999999999999999999999976432100


Q ss_pred             c----------------------------------------------ceeecccCCccccChhhhhcCccccccceehhH
Q 007248          428 T----------------------------------------------HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFG  461 (611)
Q Consensus       428 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~G  461 (611)
                      .                                              .......||..|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                              001234689999999999888899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHH--hcccCCCCCCCHHHHHH
Q 007248          462 ILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLL--CTQAAAALRPSMAQAIM  539 (611)
Q Consensus       462 vll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~--c~~~~p~~RPt~~evl~  539 (611)
                      |++|||++|+.||........    .........       .+...........+.+++.+  |+..+|..||++.+++.
T Consensus       236 ~il~elltG~~Pf~~~~~~~~----~~~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTET----QLKVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHH----HHHHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            999999999999864322111    111111000       01001111122345566655  66777778999999985


Q ss_pred             H
Q 007248          540 L  540 (611)
Q Consensus       540 ~  540 (611)
                      .
T Consensus       305 h  305 (381)
T cd05626         305 H  305 (381)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.5e-39  Score=333.02  Aligned_cols=252  Identities=21%  Similarity=0.249  Sum_probs=200.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|...+.||+|+||+||++.. .+|+.||||++....   .+..+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4688889999999999999954 468999999987542   234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999999543  246899999999999999999999   899999999999999999999999999999876544


Q ss_pred             CcceeecccCCccccChhhhh------cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          427 RTHVSTAVAGTLGYMAPEYLV------RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      .........||+.|+|||++.      ...++.++||||||+++|||++|+.||.....    ................ 
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~~~~i~~~~~~~~~-  230 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS----AKTYNNIMNFQRFLKF-  230 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH----HHHHHHHHcCCCccCC-
Confidence            433334457899999999986      45678899999999999999999999753321    1111111111111111 


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                            .........+.+++..|++ +|++||++.+++.
T Consensus       231 ------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         231 ------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                  0111233457788889998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.6e-39  Score=325.42  Aligned_cols=258  Identities=25%  Similarity=0.436  Sum_probs=205.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc------CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++|.+.+.||+|+||+||++..      .++..+|+|.+........+.+.+|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4677889999999999999963      2346799998876665666789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccC----------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEE
Q 007248          345 VYEYVPNRSLDQFIFDKN----------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  414 (611)
                      ||||+++++|.+++....          ....+++..++.++.||+.||+|||   +.+++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999986432          2235899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhc
Q 007248          415 ADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYR  492 (611)
Q Consensus       415 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  492 (611)
                      +|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.|+.....     ........
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-----~~~~~~i~  236 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEVIECIT  236 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH
Confidence            999999765432221 1123345678999999988899999999999999999999 8888643221     11111111


Q ss_pred             cCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       493 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      .+....         .+......+.+++.+||+.+|.+||++.+|+..|.+..
T Consensus       237 ~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         237 QGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             cCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            221111         11123345889999999999999999999998886543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-39  Score=328.42  Aligned_cols=244  Identities=22%  Similarity=0.278  Sum_probs=198.6

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..+.||+|+||.||++... +++.||+|++....   ....+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36788899999999999999654 68999999986432   234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            999999999999533   45889999999999999999999   899999999999999999999999999999765432


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                          .....|++.|+|||++.+..++.++||||||+++|||++|+.|+....    ..... .......          .
T Consensus       155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~----~~~~~-~~i~~~~----------~  215 (291)
T cd05612         155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN----PFGIY-EKILAGK----------L  215 (291)
T ss_pred             ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHH-HHHHhCC----------c
Confidence                123468999999999988889999999999999999999999975322    11111 1111111          0


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPS-----MAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt-----~~evl~  539 (611)
                      .++......+.+++..|++.||.+||+     ++++++
T Consensus       216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            122222345788999999999999995     777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=325.70  Aligned_cols=241  Identities=20%  Similarity=0.220  Sum_probs=192.7

Q ss_pred             cccCCceeEEEEEcC-CCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCCh
Q 007248          279 LGQGGAGSVYMGSLP-NGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       279 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      ||+|+||.||++... +++.||+|++...   .......+.+|++++.+++||||+++++++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999654 5889999998643   234456788999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecc
Q 007248          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV  434 (611)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  434 (611)
                      .+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  153 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF  153 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence            999954   345899999999999999999999   8999999999999999999999999999997543221 223345


Q ss_pred             cCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHH
Q 007248          435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVC  514 (611)
Q Consensus       435 ~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~  514 (611)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||....    ..+...... ...          ..++.....
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~----~~~~~~~~~-~~~----------~~~~~~~~~  218 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN----VNEMYRKIL-QEP----------LRFPDGFDR  218 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC----HHHHHHHHH-cCC----------CCCCCcCCH
Confidence            68999999999999899999999999999999999999975321    111111111 111          012223344


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          515 NVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       515 ~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      .+.+++..||+.+|++||++..+.+.|
T Consensus       219 ~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         219 DAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            578899999999999998654444444

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.3e-38  Score=318.55  Aligned_cols=253  Identities=29%  Similarity=0.454  Sum_probs=202.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      ++|+..++||+|+||.||++..+++..+|+|.+..... ..+.|.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            45778899999999999999888888999998865432 3467999999999999999999999875 456899999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +++|.+++... ....+++..+..++.+++.||.|||   +.+++||||||+||++++++.++|+|||++..+.......
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            99999999643 2345899999999999999999999   7899999999999999999999999999998764433222


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... .......    ..         .......+
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~~~----~~---------~~~~~~~~  225 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-NREVLEQ----VE---------RGYRMPCP  225 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH----HH---------cCCCCCCC
Confidence            222345678999999988899999999999999999999 888874321 1111111    11         11111223


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ......+.+++.+|++.+|++|||+.++++.|++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            3344568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.6e-39  Score=332.44  Aligned_cols=241  Identities=23%  Similarity=0.294  Sum_probs=195.0

Q ss_pred             CccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCC
Q 007248          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  352 (611)
                      +.||+|+||.||++.. .+|+.||||++....   ......+.+|++++++++||||+++++++..++..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999955 578999999987542   234467889999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceee
Q 007248          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST  432 (611)
Q Consensus       353 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  432 (611)
                      +|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~  153 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK  153 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence            99999853   346899999999999999999999   8999999999999999999999999999987532211 1223


Q ss_pred             cccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHH
Q 007248          433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQ  512 (611)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~  512 (611)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .........+.      .    .++...
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~~~~~------~----~~p~~~  218 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEE------I----RFPRTL  218 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCC------C----CCCCCC
Confidence            45689999999999988999999999999999999999999753211     11111111111      1    123334


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          513 VCNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       513 ~~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                      ...+.+++..|++.||++||     ++.++++
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            45678899999999999999     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6e-39  Score=348.30  Aligned_cols=250  Identities=20%  Similarity=0.309  Sum_probs=202.6

Q ss_pred             CCCCCccccCCceeEEEEEc-CC-CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-PN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      |...+.||+|+||.||++.. .+ +..||+|.+..........+.+|+.+|+.++|||||++++++..++..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            77789999999999999954 34 67889998766665556678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc-
Q 007248          351 NRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT-  428 (611)
Q Consensus       351 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-  428 (611)
                      +|+|.+++... .....+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++.+..... 
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            99999988543 23456889999999999999999999   78999999999999999999999999999987654322 


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.|+....    ..+...... .+..         ...
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~----~~~~~~~~~-~~~~---------~~~  291 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS----QREIMQQVL-YGKY---------DPF  291 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHH-hCCC---------CCC
Confidence            22335568999999999998899999999999999999999999975321    111111111 1110         112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +......+.+++..||+.+|++||++.+++.
T Consensus       292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            2233456889999999999999999999874

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.5e-38  Score=316.13  Aligned_cols=247  Identities=27%  Similarity=0.391  Sum_probs=198.5

Q ss_pred             CccccCCceeEEEEEcCCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCChh
Q 007248          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLD  355 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~  355 (611)
                      ++||+|+||.||+|...++..+|+|.+.... ......|.+|++++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4699999999999988889999999876543 334457899999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeeccc
Q 007248          356 QFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA  435 (611)
Q Consensus       356 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  435 (611)
                      +++...  ...+++..++.++.+++.||.|||   ..+++||||||+||++++++.+||+|||++...............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            998543  235889999999999999999999   889999999999999999999999999999754332222222233


Q ss_pred             CCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHH
Q 007248          436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVC  514 (611)
Q Consensus       436 gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~  514 (611)
                      ++..|+|||++..+.++.++||||||+++|||++ |..|+.....    .. ........         .....+.....
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~----~~-~~~~~~~~---------~~~~~~~~~~~  221 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN----QQ-AREQVEKG---------YRMSCPQKCPD  221 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH----HH-HHHHHHcC---------CCCCCCCCCCH
Confidence            4667999999988899999999999999999998 8888743211    11 11111111         11112233456


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          515 NVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       515 ~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      .+.+++.+|++.+|++||++.++++.|.
T Consensus       222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         222 DVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            6889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=341.45  Aligned_cols=253  Identities=25%  Similarity=0.318  Sum_probs=206.8

Q ss_pred             CCCCCCccccCCceeEEEEEcCCC-CEEEEEEeeccchhhHHHHHHHHHHHhcCC-CCceeeEeee-eee------CCcc
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPNG-TTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGC-SIE------GPES  342 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~~~  342 (611)
                      +.++.+.|.+|||+.||.+....+ ..+|+|++...+++..+...+||++|++|+ |+|||.+++. ...      .-+.
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            345678899999999999977665 999999998888889999999999999996 9999999993 221      1367


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      +|.||||++|.|-+++..+.... |++.++++|+.++++|+++||. .+++|||||||.+||||..+++.||||||-+..
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            89999999999999996655444 9999999999999999999994 478899999999999999999999999999864


Q ss_pred             ccCCCcce--------eecccCCccccChhhhh---cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhh
Q 007248          423 FAADRTHV--------STAVAGTLGYMAPEYLV---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY  491 (611)
Q Consensus       423 ~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~  491 (611)
                      ........        .-...-|+.|.|||.+.   +..+++|+|||+|||+||-|+....||+....            
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------------  263 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------------  263 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------------
Confidence            32222110        01233588999999874   56889999999999999999999999874321            


Q ss_pred             ccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       492 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                           ..+++....-+........+.+||..||+++|++||++-+|+..+..
T Consensus       264 -----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  264 -----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             -----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence                 23344444333345778889999999999999999999999987643

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-38  Score=319.03  Aligned_cols=254  Identities=30%  Similarity=0.442  Sum_probs=204.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      .+.|+..++||+|+||.||+|..++++.+|+|.+..... ..+.|.+|+.++++++|+||+++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            456888899999999999999988899999998875432 3467899999999999999999999874 45789999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++.... ...+++..++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999999985433 346899999999999999999999   889999999999999999999999999999776533322


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      ......++..|+|||++....++.++||||||+++|||++ |+.|+..... .....    .....         .....
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~----~~~~~---------~~~~~  224 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PEVIQ----NLERG---------YRMPR  224 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HHHHH----HHHcC---------CCCCC
Confidence            2223445678999999988889999999999999999999 9988753221 11111    11111         11111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      +......+.+++.+|++.+|++||++++++..|+.
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            22234568899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-38  Score=316.80  Aligned_cols=247  Identities=25%  Similarity=0.383  Sum_probs=195.8

Q ss_pred             CccccCCceeEEEEEc-CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCCh
Q 007248          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      +.||+|+||.||+|.. .+++.+|+|.+... ..+....|.+|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4699999999999966 46899999987543 234456799999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce-eec
Q 007248          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STA  433 (611)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~  433 (611)
                      .+++...  ...+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++.......... ...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            9998532  235899999999999999999999   8899999999999999999999999999987543221111 111


Q ss_pred             ccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHH
Q 007248          434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQ  512 (611)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~  512 (611)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..|+.....     ......         +........+...
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----~~~~~~---------~~~~~~~~~~~~~  221 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----QQTREA---------IEQGVRLPCPELC  221 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----HHHHHH---------HHcCCCCCCcccC
Confidence            223457999999998899999999999999999998 7777643211     011111         1111111223334


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          513 VCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       513 ~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      ...+.+++.+|++.+|++||++.+|+++|.
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            556889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-39  Score=297.48  Aligned_cols=247  Identities=26%  Similarity=0.366  Sum_probs=206.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|++.+.||+|.||.||.|+. +++..||+|++....   .+...++.+|+++-+.|+||||+++|++|.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            5688999999999999999955 467899999986543   233457889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||.++|+|...|.+. +...+++.....++.|+|.||.|+|   .++||||||||+|+|++.++..||+|||.+-.-.  
T Consensus       102 Eya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            999999999999643 3455888899999999999999999   8999999999999999999999999999986432  


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                       .....+.+||..|++||...+...+...|+|++|++.||++.|.+||+..... +....+..          +    +-
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-etYkrI~k----------~----~~  239 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-ETYKRIRK----------V----DL  239 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-HHHHHHHH----------c----cc
Confidence             23345678999999999999999999999999999999999999998755422 22221111          1    11


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+|........+++..|+..+|.+|.+..||+.
T Consensus       240 ~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  240 KFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             cCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence            223444556789999999999999999999875

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-38  Score=323.19  Aligned_cols=252  Identities=21%  Similarity=0.259  Sum_probs=199.7

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      -.++|+....||+|+||.||+++. ..|..+|+|+++...   ...++..+.|-.+|....+|+||+|+-.|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            356789999999999999999955 469999999998764   3456678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+|||++..+|.   +...|++....-.+.+++-|+.-||   +.|+|||||||+|+|||..|.+||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999994   4567999999999999999999999   9999999999999999999999999999985331


Q ss_pred             CC-----------------------Ccc----e-------------------eecccCCccccChhhhhcCcccccccee
Q 007248          425 AD-----------------------RTH----V-------------------STAVAGTLGYMAPEYLVRGQLTEKADVY  458 (611)
Q Consensus       425 ~~-----------------------~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~ksDV~  458 (611)
                      ..                       ...    .                   ....+||+.|||||++.+..++..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                       000    0                   0124699999999999999999999999


Q ss_pred             hhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HH
Q 007248          459 SFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPS---MA  535 (611)
Q Consensus       459 S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt---~~  535 (611)
                      |||||+||||.|.+||.....    .+....+......       +.-+-......+..++|.+|+. ||++|--   ++
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp----~~T~rkI~nwr~~-------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~  440 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETP----QETYRKIVNWRET-------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAE  440 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhhh-------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence            999999999999999864332    2222221111111       1111111122556788888888 9999975   55


Q ss_pred             HHH
Q 007248          536 QAI  538 (611)
Q Consensus       536 evl  538 (611)
                      ||-
T Consensus       441 EIK  443 (550)
T KOG0605|consen  441 EIK  443 (550)
T ss_pred             HHh
Confidence            554

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.5e-38  Score=318.61  Aligned_cols=254  Identities=28%  Similarity=0.429  Sum_probs=202.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      .++|++.++||+|+||.||+|..++...||+|++.... ...+.|.+|+++++.++||||+++++++.+ ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            35688899999999999999988777789999887432 234678999999999999999999998754 5679999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++... ....+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++.+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999999643 2345799999999999999999999   899999999999999999999999999999876543322


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      ......++..|+|||+..+..++.++||||||+++|||+| |+.|+......     .........         .....
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~~~~~~~~~---------~~~~~  224 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQVERG---------YRMPC  224 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----HHHHHHhcC---------CCCCC
Confidence            2223446778999999988899999999999999999999 77776432211     111111110         01111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      +...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            23345568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.7e-38  Score=317.31  Aligned_cols=245  Identities=27%  Similarity=0.406  Sum_probs=195.2

Q ss_pred             ccccCCceeEEEEEc---CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCC
Q 007248          278 KLGQGGAGSVYMGSL---PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (611)
Q Consensus       278 ~iG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  352 (611)
                      .||+|+||.||+|.+   +++..+|+|++....  ....++|.+|+.+++.++||||+++++++. ++..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999954   357899999886442  344678999999999999999999999875 45678999999999


Q ss_pred             ChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee-
Q 007248          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS-  431 (611)
Q Consensus       353 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-  431 (611)
                      +|.+++..   ...+++..+..++.|++.||+|||   +.+|+||||||.||++++++.+||+|||+++.......... 
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99999843   235899999999999999999999   78999999999999999999999999999986644332211 


Q ss_pred             -ecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          432 -TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       432 -~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                       ....++..|+|||.+....++.++||||||+++|||++ |+.|+.....    ... ......+         .....+
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~-~~~i~~~---------~~~~~~  220 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEV-TQMIESG---------ERMECP  220 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHH-HHHHHCC---------CCCCCC
Confidence             12234578999999988889999999999999999998 8888753221    111 1111111         111223


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ......+.+++.+||+.+|++||++.+|++.|.+
T Consensus       221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            3345568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.4e-39  Score=332.58  Aligned_cols=259  Identities=27%  Similarity=0.397  Sum_probs=201.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeeee-CC
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE-GP  340 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  340 (611)
                      .++|++.+.||+|+||.||+|...      .++.||+|++.... ....+.+..|+.++.++ +|+||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            356888999999999999999532      34789999886432 33356788999999999 89999999998764 45


Q ss_pred             cceEEEeecCCCChhhhhhccCC---------------------------------------------------------
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNK---------------------------------------------------------  363 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------  363 (611)
                      ..++++||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999999853221                                                         


Q ss_pred             -CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce-eecccCCcccc
Q 007248          364 -TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGTLGYM  441 (611)
Q Consensus       364 -~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~  441 (611)
                       ...++|..+.+++.||+.||+|||   ..+|+||||||+|||+++++.+||+|||+++.+....... .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             136899999999999999999999   8899999999999999999999999999998654332221 22344567899


Q ss_pred             ChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHH
Q 007248          442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIG  520 (611)
Q Consensus       442 aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~  520 (611)
                      |||++.+..++.++|||||||++|||++ |..|+......+    ..........         ....+......+.+++
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~---------~~~~~~~~~~~~~~l~  309 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----EFCRRLKEGT---------RMRAPEYATPEIYSIM  309 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----HHHHHHhccC---------CCCCCccCCHHHHHHH
Confidence            9999999999999999999999999998 988875322111    1111111111         1111223345688999


Q ss_pred             HHhcccCCCCCCCHHHHHHHhccC
Q 007248          521 LLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       521 ~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      .+||+.+|++||++.||+++|...
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.1e-38  Score=324.97  Aligned_cols=260  Identities=27%  Similarity=0.402  Sum_probs=205.4

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeecc-chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeC
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (611)
                      ...++|+..+.||+|+||.||++...      ....+|+|.+... ..+...++.+|++++.++ +|+||+++++++..+
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34456788899999999999999653      2368999988654 234456789999999999 899999999999999


Q ss_pred             CcceEEEeecCCCChhhhhhcc-------------CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          340 PESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                      +..+++|||+++|+|.+++...             .....+++..+++++.||+.||.|||   ..+|+||||||+|||+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence            9999999999999999998642             22356899999999999999999999   8899999999999999


Q ss_pred             CCCCCeEEeeeccceeccCCCcce-eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChh
Q 007248          407 DKDFTPKIADFGLARCFAADRTHV-STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPL  484 (611)
Q Consensus       407 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~  484 (611)
                      ++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..|+....     .
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~  240 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----V  240 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-----H
Confidence            999999999999998654332211 122335678999999988899999999999999999998 877764221     1


Q ss_pred             HHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          485 QRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       485 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      .........+         .....+......+.+++.+|++.+|++|||+.++++.|...
T Consensus       241 ~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         241 EELFKLLKEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHHHHHHHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            1111111111         11122334455688999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.1e-38  Score=329.51  Aligned_cols=247  Identities=25%  Similarity=0.347  Sum_probs=192.6

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      +|+..++||+|+||.||++.. .+++.||||++.... ....+.+.+|+++++.++|+||+++++++.+++..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            345578899999999999965 468999999986543 344567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|....       ..++..+..++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||+++.+.... .
T Consensus       155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~  223 (353)
T PLN00034        155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-D  223 (353)
T ss_pred             CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-c
Confidence            999986543       3567778899999999999999   8899999999999999999999999999998664322 1


Q ss_pred             eeecccCCccccChhhhhc-----CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVR-----GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ......|+..|+|||++..     ...+.++|||||||++|||++|+.||...... ........ ....         .
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~-~~~~---------~  292 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCA-ICMS---------Q  292 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHH-Hhcc---------C
Confidence            1234568999999998743     23356899999999999999999998632221 11111100 0000         0


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ....+......+.+++.+||+.+|++||++.||++.
T Consensus       293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111122334568899999999999999999999853

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=313.14  Aligned_cols=265  Identities=25%  Similarity=0.337  Sum_probs=202.1

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhc--CCCCceeeEeeeeeeCC----cc
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISS--IEHKNLVKLLGCSIEGP----ES  342 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~  342 (611)
                      ..++....+.||+|.||+||+|.+ .|+.||||++...+   .+.+++|.++.+.  |+|+||+.+++.-..+.    .+
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            345667789999999999999999 78999999986443   2568888888885  59999999998755443    57


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhc-----CCCCceecCCCCcccEEECCCCCeEEeee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG-----GSETRIIHRDIKTSNILLDKDFTPKIADF  417 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  417 (611)
                      +||++|.++|||.|||.    ...++....++++..+|.||+|||.     +.++.|.|||||+.|||+..++.+.|+|+
T Consensus       285 wLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            99999999999999993    3679999999999999999999994     46889999999999999999999999999


Q ss_pred             ccceeccCCCcc---eeecccCCccccChhhhhcC----cc--ccccceehhHHHHHHHHhC----------CCCCCCCC
Q 007248          418 GLARCFAADRTH---VSTAVAGTLGYMAPEYLVRG----QL--TEKADVYSFGILIIEIVCG----------RRSNAFSQ  478 (611)
Q Consensus       418 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~----~~--~~ksDV~S~Gvll~elltG----------~~p~~~~~  478 (611)
                      |||-....+...   .....+||.+|||||++...    .+  -..+||||||+++||+...          +.|+...-
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            999776554322   23467899999999998653    11  2368999999999999852          23443332


Q ss_pred             CCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          479 DSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      +....++...+..-..++.-.++...   ...+.+..+.+++..||..+|..|-|+--+-+.|.+.
T Consensus       441 p~DPs~eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             CCCCCHHHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            22223333333222222222222211   1346788899999999999999999988877776543

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.1e-38  Score=322.41  Aligned_cols=256  Identities=27%  Similarity=0.404  Sum_probs=202.3

Q ss_pred             CCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      +|...+.||+|+||.||+|...      ....+++|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3677889999999999999642      23578888876443 3345679999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccC---------------------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCccc
Q 007248          345 VYEYVPNRSLDQFIFDKN---------------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSN  403 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N  403 (611)
                      ++||+++++|.+++....                     ....+++..++.++.|++.||.|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999985321                     1235889999999999999999999   8999999999999


Q ss_pred             EEECCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCC
Q 007248          404 ILLDKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSA  481 (611)
Q Consensus       404 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~  481 (611)
                      ||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....   
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence            99999999999999999765332221 1223345678999999988889999999999999999999 888864221   


Q ss_pred             ChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          482 SPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                        .+..+......         .....+......+.+++..|++.+|++||++.++++.|++.
T Consensus       235 --~~~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         235 --PERLFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             --HHHHHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence              12222222211         11112233445688999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.4e-38  Score=325.19  Aligned_cols=200  Identities=25%  Similarity=0.402  Sum_probs=173.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .++|+..++||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367889999999999999999664 6888999988654 23445679999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++++|.+++..   ...+++..+..++.+++.||.|||+  ..+|+|+||||+|||+++++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            9999999999953   3458899999999999999999993  357999999999999999999999999998754322 


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFS  477 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~  477 (611)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.|+...
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence              122346889999999998888999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2e-38  Score=320.80  Aligned_cols=254  Identities=27%  Similarity=0.386  Sum_probs=197.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCC----EEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGT----TVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++|+..+.||+|+||+||+|.+. ++.    .+++|.+.... .....++..|+..+++++||||+++++++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            35677899999999999999753 444    47778775332 234467888999999999999999999875 456789


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ++||+++|+|.+++...  ...++|..++.++.||+.||.|||   ..+++||||||+|||+++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999999543  346899999999999999999999   7899999999999999999999999999998664


Q ss_pred             CCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          425 ADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       425 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ..... ......++..|+|||.+.++.++.++||||||+++|||++ |+.|+.....     .........+...     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~~~~-----  230 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----HEVPDLLEKGERL-----  230 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCCCcC-----
Confidence            33222 2234456778999999998999999999999999999998 8888643211     1111111111110     


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                          ..+......+.+++.+||..+|+.||++.|+++.|...
T Consensus       231 ----~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         231 ----AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence                11112234567889999999999999999999988653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.7e-38  Score=324.92  Aligned_cols=241  Identities=25%  Similarity=0.326  Sum_probs=193.3

Q ss_pred             CccccCCceeEEEEEc----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          277 KKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++||+|+||.||++..    ..++.||||++....    ......+.+|+++|+.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999964    357899999987532    22345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++..   ...+.+..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            999999999843   345788888999999999999999   8999999999999999999999999999987543222 


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      .......|++.|+|||++.+..++.++||||||+++|||++|+.||.....    ........ .+.        .  ..
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~----~~~~~~~~-~~~--------~--~~  219 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR----KKTIDKIL-KGK--------L--NL  219 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH----HHHHHHHH-cCC--------C--CC
Confidence            122345689999999999888899999999999999999999999753221    11111111 111        0  12


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                      +......+.+++..|++.+|++||     ++.++++
T Consensus       220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            223345578999999999999999     7888764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-39  Score=328.94  Aligned_cols=251  Identities=24%  Similarity=0.366  Sum_probs=211.8

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc-ceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE-SLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  346 (611)
                      ++|...++||+|+||.++..+.+ ++..+++|++....  ....+...+|+.++++++|||||.+++.|++++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56778899999999999988543 57899999987543  3334467899999999999999999999998888 89999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      +|++||+|.+.|.+.+ ...++++++++|+.||+.|+.|||   +.+|+|||||+.|||+..++.+||+|||+|+.+..+
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999996554 567999999999999999999999   899999999999999999999999999999988765


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      . .......||+.||.||.+.+.+|..|+|||||||++|||++-+++|...... .++             ..+.+....
T Consensus       160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-~Li-------------~ki~~~~~~  224 (426)
T KOG0589|consen  160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-ELI-------------LKINRGLYS  224 (426)
T ss_pred             h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-HHH-------------HHHhhccCC
Confidence            4 2344678999999999999999999999999999999999999987533211 111             112222234


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      +.+......+..++..|++.+|+.||++.+++.+
T Consensus       225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            4566677778999999999999999999999865

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2e-38  Score=320.45  Aligned_cols=257  Identities=28%  Similarity=0.373  Sum_probs=201.6

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (611)
                      .+++|...+.||+|+||.||+|...      .+..|++|.+.... ......|.+|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3567888999999999999999664      35789999876443 3345679999999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhhccCC----CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC---CeEE
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNK----TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF---TPKI  414 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl  414 (611)
                      .++||||+++++|.+++.....    ...++|..+++++.||+.||+|||   ..+++||||||+|||++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999965321    235899999999999999999999   78999999999999998754   5999


Q ss_pred             eeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhc
Q 007248          415 ADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYR  492 (611)
Q Consensus       415 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  492 (611)
                      +|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||..... ...    .....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-~~~----~~~~~  235 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEV----MEFVT  235 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHH----HHHHH
Confidence            999999865322211 1112233568999999998999999999999999999997 8888653211 111    11111


Q ss_pred             cCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       493 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      .         ......+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       236 ~---------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 G---------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             c---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1         1111223334456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.9e-38  Score=323.54  Aligned_cols=263  Identities=25%  Similarity=0.346  Sum_probs=196.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccch-hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .++|+..++||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467889999999999999999664 689999999865432 223467889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |++ ++|.+++...  ...+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            995 6777777432  345888999999999999999999   8999999999999999999999999999987543222


Q ss_pred             cceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc---c---cc--
Q 007248          428 THVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK---L---VE--  498 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~---~~--  498 (611)
                       .......++..|+|||++.+ ..++.++|||||||++|||++|+.||....+....+...........   +   ..  
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence             12233567899999999865 45788999999999999999999998654332222221111111000   0   00  


Q ss_pred             ccCCC-CCCCCCH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          499 AVDPN-LKDDFPA---------EQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       499 ~id~~-l~~~~~~---------~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..++. +....+.         .....+.+++..|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00000 0000000         11234678999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.7e-38  Score=328.22  Aligned_cols=241  Identities=23%  Similarity=0.280  Sum_probs=194.0

Q ss_pred             CccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCC
Q 007248          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  352 (611)
                      +.||+|+||.||++.. .+|..||+|++....   ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999964 568999999987542   234556788999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceee
Q 007248          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST  432 (611)
Q Consensus       353 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  432 (611)
                      +|..++..   ...+++..+..++.||+.||+|||   ..+|+||||||+|||+++++.+||+|||+++...... ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~  153 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK  153 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccc
Confidence            99988843   345899999999999999999999   7899999999999999999999999999987532221 1223


Q ss_pred             cccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHH
Q 007248          433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQ  512 (611)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~  512 (611)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.|+...... ..    ........      .    .++...
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~----~~~~~~~~------~----~~p~~~  218 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RL----FELILMEE------I----RFPRTL  218 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HH----HHHHhcCC------C----CCCCCC
Confidence            456899999999999889999999999999999999999997532211 11    11111111      0    122233


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          513 VCNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       513 ~~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                      ...+.+++..|++.+|++||     ++.++++
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            45578899999999999998     8888774

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.8e-38  Score=317.58  Aligned_cols=255  Identities=27%  Similarity=0.465  Sum_probs=203.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCC-C---CEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPN-G---TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      .++|+..+.||+|+||.||+|..+. +   ..+++|.+... .....+.+.+|++++++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3467788999999999999997642 3   37999988654 23446779999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++++|.+++...  ...+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            99999999999998543  246899999999999999999999   7899999999999999999999999999998664


Q ss_pred             CCCcceee--cccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          425 ADRTHVST--AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       425 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      ........  ....+..|+|||++....++.++||||||+++|||++ |+.|+.....    .. ........       
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~~-~~~~i~~~-------  226 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HE-VMKAINDG-------  226 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----HH-HHHHHhcC-------
Confidence            33222111  1223457999999988889999999999999999998 9999743221    11 11111111       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                        .....+......+.+++.+||+.+|++||++.+|++.|.+
T Consensus       227 --~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         227 --FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence              1111222344568899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=299.05  Aligned_cols=235  Identities=26%  Similarity=0.355  Sum_probs=197.1

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      +|+....||.|.||.|.+++.+ +|..+|+|++....   ....+...+|..+|+.+.||.++++++.+.+...+++|||
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            5677899999999999999654 68999999997653   3445678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |++||.|.++++.   .+.+++....-++.+|+.||+|||   ...|++|||||+|||||.+|.+||.|||+|+..... 
T Consensus       125 yv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  125 YVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             ccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            9999999999954   345899999999999999999999   899999999999999999999999999999876432 


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                         ..+.+||+.|+|||++....+...+|-|+|||++|||+.|..||.....    .+.. .        +++...+  .
T Consensus       198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY-~--------KI~~~~v--~  259 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIY-E--------KILEGKV--K  259 (355)
T ss_pred             ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHH-H--------HHHhCcc--c
Confidence               4578999999999999999999999999999999999999999875433    2211 1        1122222  2


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCC
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALR  531 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~R  531 (611)
                      +|.-....+.+|+...++.|-..|
T Consensus       260 fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  260 FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             CCcccCHHHHHHHHHHHhhhhHhh
Confidence            344444556778888888888888

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.6e-38  Score=320.62  Aligned_cols=261  Identities=25%  Similarity=0.347  Sum_probs=192.7

Q ss_pred             cCCCCCCccccCCceeEEEEEc--CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcC---CCCceeeEeeeee-----e
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL--PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSI---EHKNLVKLLGCSI-----E  338 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  338 (611)
                      ++|+..+.||+|+||.||++..  .++..||||++....  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688889999999999999965  346889999886442  22234566777777665   6999999999875     2


Q ss_pred             CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeec
Q 007248          339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       339 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                      ....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            446899999996 58998885432 345899999999999999999999   8999999999999999999999999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc---cCc
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR---SNK  495 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~---~~~  495 (611)
                      +++.....  .......|+..|+|||.+.+..++.++||||||+++|||++|+.||....+.. .+..+.....   ...
T Consensus       156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~  232 (290)
T cd07862         156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED  232 (290)
T ss_pred             ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhh
Confidence            99865433  22234568999999999988899999999999999999999999986443211 1111111000   000


Q ss_pred             ccc-------ccCCCCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          496 LVE-------AVDPNLKD---DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       496 ~~~-------~id~~l~~---~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +..       ...+....   .........+.+++.+|++.+|++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000       00000000   000112345678999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.3e-38  Score=324.35  Aligned_cols=237  Identities=23%  Similarity=0.285  Sum_probs=186.5

Q ss_pred             CccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHH-HHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVN-LISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      ++||+|+||.||++.. .+++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999965 468899999986432   223345566654 67889999999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      ++|..++..   ...+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT  153 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence            999988843   345788889999999999999999   7899999999999999999999999999987532211 122


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||....    ..+.... .....        +  ..+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~-i~~~~--------~--~~~~~  218 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----VSQMYDN-ILHKP--------L--QLPGG  218 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC----HHHHHHH-HhcCC--------C--CCCCC
Confidence            34568999999999998899999999999999999999999975321    1111111 11111        1  12223


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH
Q 007248          512 QVCNVLQIGLLCTQAAAALRPSMA  535 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RPt~~  535 (611)
                      ....+.+++.+|++.+|.+||+..
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         219 KTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCHHHHHHHHHHccCCHhhcCCCC
Confidence            345678999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-38  Score=346.00  Aligned_cols=260  Identities=23%  Similarity=0.299  Sum_probs=206.5

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC
Q 007248          264 ETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP  340 (611)
Q Consensus       264 ~~l~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  340 (611)
                      .+.....++|.+.+.||+|+||+||++. ..+|+.||||++...  .......+.+|+.++..++|+||+++++.+....
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            4455566799999999999999999995 457899999998654  3445567889999999999999999988765432


Q ss_pred             --------cceEEEeecCCCChhhhhhccC-CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC
Q 007248          341 --------ESLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT  411 (611)
Q Consensus       341 --------~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  411 (611)
                              ..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCC
Confidence                    3579999999999999996532 2356899999999999999999999   899999999999999999999


Q ss_pred             eEEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh
Q 007248          412 PKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL  490 (611)
Q Consensus       412 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~  490 (611)
                      +||+|||+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...    ..... ...
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~----~~~~~-~~~  256 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE----NMEEV-MHK  256 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC----CHHHH-HHH
Confidence            99999999987643221 2233467899999999999999999999999999999999999997532    11111 111


Q ss_pred             hccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          491 YRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       491 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ...+.         ....+......+.+++..||+.+|++||++.++++.
T Consensus       257 ~~~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        257 TLAGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HhcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11111         111233344568899999999999999999999853

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.5e-38  Score=322.37  Aligned_cols=253  Identities=23%  Similarity=0.379  Sum_probs=199.8

Q ss_pred             CCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccch-hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          273 FNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      |...+.||+|+||.||+|...      ++..||||++..... ...+.|.+|+.++..++||||+++++++......+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            556678999999999999653      357899999875432 3356788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccC-------------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCe
Q 007248          346 YEYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  412 (611)
                      +||+++++|.+++....             ....+++..++.++.|++.||.|||   ..+|+||||||+|||+++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence            99999999999985321             1235888999999999999999999   7899999999999999999999


Q ss_pred             EEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHh
Q 007248          413 KIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTL  490 (611)
Q Consensus       413 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~  490 (611)
                      ||+|||+++....... .......+++.|+|||.+..+.++.++||||||+++|||++ |..|+....    ..+ ....
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~~~-~~~~  238 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----NQD-VIEM  238 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----HHH-HHHH
Confidence            9999999876543221 11223445778999999988899999999999999999998 766754221    111 1111


Q ss_pred             hccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          491 YRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       491 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      ......         ...+...+..+.+++..||+.+|++||++++|+..|+
T Consensus       239 i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         239 IRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             HHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            111111         1223344556889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-38  Score=316.48  Aligned_cols=254  Identities=24%  Similarity=0.418  Sum_probs=199.3

Q ss_pred             CCCCCccccCCceeEEEEEcCC----CCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc-----
Q 007248          273 FNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE-----  341 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  341 (611)
                      |.+.+.||+|+||.||+|....    +..||||++....  ....+.+.+|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999996532    3679999987542  3445689999999999999999999998876554     


Q ss_pred             -ceEEEeecCCCChhhhhhccC---CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeee
Q 007248          342 -SLLVYEYVPNRSLDQFIFDKN---KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (611)
Q Consensus       342 -~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  417 (611)
                       .++++||+++++|..++....   ....+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             789999999999999985432   2346899999999999999999999   789999999999999999999999999


Q ss_pred             ccceeccCCCcce-eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCc
Q 007248          418 GLARCFAADRTHV-STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNK  495 (611)
Q Consensus       418 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  495 (611)
                      |+++......... .....++..|+|||.+....++.++||||||+++|||++ |..|+..... .......    ..+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~~~~~~----~~~~  232 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYL----RHGN  232 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH----HcCC
Confidence            9998764332221 112334678999999988889999999999999999999 7777643221 1111111    1111


Q ss_pred             cccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       496 ~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                               ....+......+.+++.+|++.+|++||++.||++.|.+
T Consensus       233 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         233 ---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             ---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                     111233345568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.3e-38  Score=317.87  Aligned_cols=262  Identities=26%  Similarity=0.421  Sum_probs=202.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-----CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeee--CCcce
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPESL  343 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  343 (611)
                      +.|++.+.||+|+||.||++..     .++..||||++........+.|.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4677889999999999999964     3578999999877666667789999999999999999999998653  34678


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      +|+||+++++|.+++...  ...+++..++.++.|++.||+|||   ..+|+||||||+||++++++.+||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999999532  235899999999999999999999   789999999999999999999999999999866


Q ss_pred             cCCCccee--ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC-------
Q 007248          424 AADRTHVS--TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-------  494 (611)
Q Consensus       424 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-------  494 (611)
                      ........  ....++..|+|||.+.+..++.++||||||+++|||++|..++.....  ..    .......       
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~  232 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--EF----MRMMGNDKQGQMIV  232 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--hh----hhhcccccccccch
Confidence            43322111  122334569999999888899999999999999999998766432211  00    0000000       


Q ss_pred             -ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          495 -KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       495 -~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                       .+.+.+........+......+.+++.+||+.+|++|||+.||++.|+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence             0111111111112223344568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-39  Score=313.10  Aligned_cols=245  Identities=22%  Similarity=0.342  Sum_probs=204.3

Q ss_pred             cCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      .+|++.+.||+|.||+|-++. ...|+.||||.++.+   +.+..-.+.+|++||+.|+||||+.++.+|++.+..++||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            456777889999999999994 478999999988755   3455667889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||..+|.|.+|+.   ..+.|++.+...++.||..|+.|+|   +++++|||||.+|||||+|+++||+||||+..+...
T Consensus       133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            9999999999995   4456999999999999999999999   999999999999999999999999999999877544


Q ss_pred             CcceeecccCCccccChhhhhcCcc-ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .  ..++++|++-|.+||++.+.+| .+..|-|||||+||-|+.|..||+...     .......+..+...+       
T Consensus       207 k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~lvrQIs~GaYrE-------  272 (668)
T KOG0611|consen  207 K--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRLVRQISRGAYRE-------  272 (668)
T ss_pred             c--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHHHHHhhcccccC-------
Confidence            3  3457899999999999998877 578999999999999999999986322     111222223332211       


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                          +..+....-|+.+|+..||+.|.|+.+|..
T Consensus       273 ----P~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  273 ----PETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             ----CCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence                112223456788999999999999999974

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-38  Score=333.00  Aligned_cols=256  Identities=21%  Similarity=0.229  Sum_probs=194.9

Q ss_pred             cCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      ++|...+.||+|+||.||++. ...++.||+|...      .+.+.+|+++|++++||||+++++++..+...++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            568889999999999999995 4568999999643      235779999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      . ++|..++...   ..+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++........
T Consensus       166 ~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        166 K-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             C-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            5 6888887432   35889999999999999999999   789999999999999999999999999999754332222


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCC------CChhHHHHHhhccC---------
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDS------ASPLQRVWTLYRSN---------  494 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~------~~~~~~~~~~~~~~---------  494 (611)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.|+......      ...+..+.......         
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            333467999999999999889999999999999999999999876432210      01111111100000         


Q ss_pred             -cccc---------ccCCCCCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          495 -KLVE---------AVDPNLKDDF--PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       495 -~~~~---------~id~~l~~~~--~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       .+.+         ...+..+...  .......+.+++.+|++.||++|||++|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             0000         0000000000  0123446788999999999999999999984

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-39  Score=295.35  Aligned_cols=264  Identities=22%  Similarity=0.294  Sum_probs=209.8

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC-----
Q 007248          267 EKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----  340 (611)
Q Consensus       267 ~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  340 (611)
                      -...++|.+.++||+|||+-||.+. ..++..+|+|++.....+..+..++|++..++++|||+++++++...+.     
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            3445789999999999999999994 6678999999999888888899999999999999999999999876544     


Q ss_pred             cceEEEeecCCCChhhhhhccCC-CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNK-TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  419 (611)
                      +.||+++|...|+|.+.+...+. ...+++.+++.|+.+|++||++||+. .++++||||||.|||+.+.+.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            48999999999999999966443 44799999999999999999999942 34699999999999999999999999999


Q ss_pred             ceeccCCCcce--------eecccCCccccChhhhhc---CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHH
Q 007248          420 ARCFAADRTHV--------STAVAGTLGYMAPEYLVR---GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVW  488 (611)
Q Consensus       420 a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~  488 (611)
                      +....-.-...        -.....|..|.|||.+.-   ...++++|||||||+||+|+.|.-||+.....        
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------  247 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------  247 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------
Confidence            86542111100        012346889999998854   46788999999999999999999998643221        


Q ss_pred             HhhccCcccccc-CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          489 TLYRSNKLVEAV-DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       489 ~~~~~~~~~~~i-d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                          .+.+.-.+ ...+.-+-.....+.+.+++.+|++.||.+||++.+++..+..
T Consensus       248 ----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  248 ----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             ----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                12222112 2222212222356678999999999999999999999988754

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-38  Score=329.38  Aligned_cols=245  Identities=27%  Similarity=0.315  Sum_probs=198.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC--CCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN--GTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ++|...+.||+|+||.||+|...+  +..||+|++....   ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            457888999999999999996533  3689999986432   33456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       110 ~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            9999999999999543   35889999999999999999999   89999999999999999999999999999986543


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....    ....... .....        . 
T Consensus       184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~----~~~~~~~-i~~~~--------~-  245 (340)
T PTZ00426        184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE----PLLIYQK-ILEGI--------I-  245 (340)
T ss_pred             C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC----HHHHHHH-HhcCC--------C-
Confidence            2    124568999999999998889999999999999999999999985321    1111111 11111        0 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRP-----SMAQAIML  540 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~~  540 (611)
                       .++......+.+++..|++.+|++|+     +++++++.
T Consensus       246 -~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 -YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence             11222334567899999999999995     88888753

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.4e-38  Score=327.67  Aligned_cols=242  Identities=24%  Similarity=0.293  Sum_probs=195.1

Q ss_pred             CccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCC
Q 007248          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  352 (611)
                      +.||+|+||.||++.. .+|+.||||++....   ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999954 568999999987542   334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceee
Q 007248          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST  432 (611)
Q Consensus       353 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  432 (611)
                      +|.+++..   ...+++..+..++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~  153 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMK  153 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccc
Confidence            99988843   345899999999999999999999   8999999999999999999999999999987532221 1223


Q ss_pred             cccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHH
Q 007248          433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQ  512 (611)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~  512 (611)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....    ... .......      +.    .++...
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----~~~-~~~~~~~------~~----~~p~~~  218 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL-FELILME------DI----KFPRTL  218 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH----HHH-HHHhccC------Cc----cCCCCC
Confidence            45689999999999988999999999999999999999999753211    111 1111111      11    122233


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007248          513 VCNVLQIGLLCTQAAAALRP-----SMAQAIML  540 (611)
Q Consensus       513 ~~~l~~l~~~c~~~~p~~RP-----t~~evl~~  540 (611)
                      ...+.+++..|++.+|++||     ++.++++.
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            45578899999999999997     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-38  Score=328.70  Aligned_cols=251  Identities=21%  Similarity=0.292  Sum_probs=196.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..+.||+|+||+||++.. .+|+.||||++....   ......+.+|+++|..++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4688899999999999999965 468999999987542   334556889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            999999999999543   35899999999999999999999   899999999999999999999999999998754321


Q ss_pred             Ccc-------------------------------------eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh
Q 007248          427 RTH-------------------------------------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC  469 (611)
Q Consensus       427 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt  469 (611)
                      ...                                     ......||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            100                                     0112458999999999998899999999999999999999


Q ss_pred             CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 007248          470 GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPS---MAQAIM  539 (611)
Q Consensus       470 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt---~~evl~  539 (611)
                      |+.||....    ..+..........       .+...........+.+++..|+. +|.+|++   +.++++
T Consensus       235 G~~Pf~~~~----~~~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDN----PQETYRKIINWKE-------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCC----HHHHHHHHHcCCC-------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999985332    1111111111110       00000011123346677888886 8999998   888765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.4e-38  Score=316.06  Aligned_cols=246  Identities=22%  Similarity=0.277  Sum_probs=195.3

Q ss_pred             cccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCCh
Q 007248          279 LGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       279 iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      ||+|+||+||++.. .+++.+|+|++....   ....+.+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999954 468999999986542   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhhccC-CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeec
Q 007248          355 DQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA  433 (611)
Q Consensus       355 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  433 (611)
                      .+++.... ....+++..++.++.||+.||.|||   +.+|+||||||+||++++++.+||+|||++..+..... ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            98885432 3456899999999999999999999   88999999999999999999999999999976543322 2234


Q ss_pred             ccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHH
Q 007248          434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQV  513 (611)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~  513 (611)
                      ..|+..|+|||++.+..++.++||||||+++|||++|+.||............ ...        .....  ..++....
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~--------~~~~~--~~~~~~~~  225 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-KQR--------ILNDS--VTYPDKFS  225 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH-HHh--------hcccC--CCCcccCC
Confidence            56899999999999999999999999999999999999998643322111111 110        00110  11233344


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          514 CNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       514 ~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                      ..+.+++..|++.+|++||     +++++++
T Consensus       226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            5678999999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.2e-38  Score=319.51  Aligned_cols=255  Identities=24%  Similarity=0.391  Sum_probs=202.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc------CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++|...++||+|+||.||++..      .++..+++|.+........+.|.+|+++++.++|+||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            3566788999999999999953      2356899998876666667789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCC------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCe
Q 007248          345 VYEYVPNRSLDQFIFDKNK------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  412 (611)
                      ++||+++++|.+++.....            ...+++..++.++.||+.||+|||   +.+++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            9999999999999964321            135899999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHh
Q 007248          413 KIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTL  490 (611)
Q Consensus       413 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~  490 (611)
                      ||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....    .......
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~  237 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN----TEAIECI  237 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH----HHHHHHH
Confidence            99999999765432211 1122335678999999998899999999999999999998 8888643211    1111111


Q ss_pred             hccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          491 YRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       491 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                       ....         ....+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       238 -~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         238 -TQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -HcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             1110         00112223445789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-38  Score=328.28  Aligned_cols=246  Identities=22%  Similarity=0.335  Sum_probs=203.3

Q ss_pred             CCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          272 YFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      -|+..+.||.|+-|.|-.|+ ...|+.+|||++....   ......+.+|+-+|+-+.|||++++|+++++..++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            46677899999999999995 4679999999986441   2234567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++|-|.+++..   .+.+++.+..+++.||+.|+.|+|   ..+|+||||||+|+|||..+++||+|||||..-..+ 
T Consensus        93 yv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-  165 (786)
T KOG0588|consen   93 YVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-  165 (786)
T ss_pred             ecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence            9999999999954   456999999999999999999999   899999999999999999999999999999753332 


Q ss_pred             cceeecccCCccccChhhhhcCcc-ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                       ..-.+-+|++.|.+||++++.+| ..++||||.|||||.||||+.||+.+.     +.........+..          
T Consensus       166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----ir~LLlKV~~G~f----------  229 (786)
T KOG0588|consen  166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----IRVLLLKVQRGVF----------  229 (786)
T ss_pred             -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----HHHHHHHHHcCcc----------
Confidence             23346789999999999999887 468999999999999999999987221     1111111222221          


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      +.|.....+..+|+.+|+..||+.|-|++||++.
T Consensus       230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            1234445567889999999999999999999874

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1e-37  Score=318.29  Aligned_cols=263  Identities=26%  Similarity=0.429  Sum_probs=203.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCC-----------------CCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPN-----------------GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVK  331 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  331 (611)
                      .++|+..+.||+|+||.||++...+                 +..||+|++.... ....+.|.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3568889999999999999986542                 2468999887543 345678999999999999999999


Q ss_pred             EeeeeeeCCcceEEEeecCCCChhhhhhccC--------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCccc
Q 007248          332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKN--------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSN  403 (611)
Q Consensus       332 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N  403 (611)
                      +++++..++..++++||+++++|.+++....        ....+++..++.++.|++.||.|||   +.+|+|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999996533        1236899999999999999999999   7899999999999


Q ss_pred             EEECCCCCeEEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh--CCCCCCCCCCC
Q 007248          404 ILLDKDFTPKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC--GRRSNAFSQDS  480 (611)
Q Consensus       404 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt--G~~p~~~~~~~  480 (611)
                      |++++++.++|+|||+++....... .......++..|+|||.+....++.++||||||+++|||++  |..|+.... .
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-~  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-D  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-h
Confidence            9999999999999999976543321 12234456778999999988899999999999999999998  555553221 1


Q ss_pred             CChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          481 ASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      ...+......+....      .......+...+..+.+++.+|++.+|++||++.||++.|.
T Consensus       240 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQVIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            111121111111111      11111112233456899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.1e-38  Score=313.86  Aligned_cols=246  Identities=24%  Similarity=0.392  Sum_probs=194.7

Q ss_pred             ccccCCceeEEEEEcC---CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCC
Q 007248          278 KLGQGGAGSVYMGSLP---NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRS  353 (611)
Q Consensus       278 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs  353 (611)
                      .||+|+||.||+|.+.   .+..||+|++.... ....+.|.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999653   35679999886553 334567999999999999999999999875 457899999999999


Q ss_pred             hhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee--
Q 007248          354 LDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--  431 (611)
Q Consensus       354 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~--  431 (611)
                      |.+++...  ...+++..+++++.||+.||.|||   ..+++||||||+|||++.++.+||+|||+++..........  
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            99998532  346899999999999999999999   78999999999999999999999999999976543332211  


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPA  510 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~  510 (611)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.|+.....    .. +......+         .....+.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~-~~~~~~~~---------~~~~~~~  221 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----PE-VMSFIEQG---------KRLDCPA  221 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----HH-HHHHHHCC---------CCCCCCC
Confidence            12233578999999988889999999999999999996 9888753221    11 11111111         1122333


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          511 EQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       511 ~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .....+.+++..||+.+|++||++.+|.+.|..
T Consensus       222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            445678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.3e-38  Score=314.90  Aligned_cols=253  Identities=28%  Similarity=0.433  Sum_probs=201.3

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      ++|...+.||+|+||.||++..+.+..+|+|++.... ...+.|.+|++++++++|||++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4577888999999999999988777789999876433 23467899999999999999999999875 456899999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +++|.+++... ....+++..+..++.|++.||.|||   +.+++|+||||+||++++++.++|+|||++..........
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            99999999643 2345899999999999999999999   8899999999999999999999999999998664333222


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      .....++..|+|||.+.+..++.++||||||+++|||+| |+.|+..... ....    ......         .....+
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~----~~~~~~---------~~~~~~  225 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVL----EQVERG---------YRMPCP  225 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHH----HHHHcC---------CCCCCC
Confidence            223345678999999988899999999999999999999 8888653221 1111    111111         011122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ...+..+.+++.+|++.+|++||++++|++.|++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            2344568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5e-38  Score=313.19  Aligned_cols=250  Identities=21%  Similarity=0.340  Sum_probs=203.4

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +|+..+.||+|++|.||++.. .++..|++|.+...  .....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            367788999999999999965 46899999988643  344567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++... ....+++..++.++.+++.||.|||   ..+++|+||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999999653 2356899999999999999999999   78999999999999999999999999999986654322


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                       ......++..|+|||++.+..++.++||||||+++|||++|+.|+.....    ...... ...+         .....
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~-~~~~---------~~~~~  221 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GALILK-IIRG---------VFPPV  221 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHH-HHcC---------CCCCC
Confidence             12334678899999999998999999999999999999999999754321    111111 1111         11112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      +......+.+++.+||+.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            22344568899999999999999999998853

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-38  Score=329.76  Aligned_cols=252  Identities=22%  Similarity=0.266  Sum_probs=202.0

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|.+.+.||+|+||+||++... +|+.||||++....   ......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888899999999999999654 68999999987542   234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999999543   46899999999999999999999   799999999999999999999999999999765433


Q ss_pred             C----------------------------cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCC
Q 007248          427 R----------------------------THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQ  478 (611)
Q Consensus       427 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~  478 (611)
                      .                            ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                            111234568999999999999999999999999999999999999986432


Q ss_pred             CCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 007248          479 DSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPS-MAQAIML  540 (611)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt-~~evl~~  540 (611)
                          ............       ..+...........+.+++..|++ +|++||+ ++++++.
T Consensus       235 ----~~~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 ----LQETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ----HHHHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                111111111100       001100111134557788889997 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.4e-38  Score=323.98  Aligned_cols=237  Identities=23%  Similarity=0.273  Sum_probs=187.1

Q ss_pred             CccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHH-HHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVN-LISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|+||+||++.. .+|+.||||++....   ....+.+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999965 468999999986532   223345556655 56789999999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      |+|.+++..   ...+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~  153 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTT  153 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcc
Confidence            999999853   345889999999999999999999   789999999999999999999999999998753221 1222


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||....    ..+. ........      ..+    +..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~~~~-~~~i~~~~------~~~----~~~  218 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----TAEM-YDNILNKP------LRL----KPN  218 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC----HHHH-HHHHHcCC------CCC----CCC
Confidence            34568999999999999899999999999999999999999975321    1111 11111111      011    112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH
Q 007248          512 QVCNVLQIGLLCTQAAAALRPSMA  535 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RPt~~  535 (611)
                      ....+.+++..|++.+|++||++.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         219 ISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCHHHHHHHHHHhhcCHHhCCCCC
Confidence            244578899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8.5e-38  Score=313.59  Aligned_cols=257  Identities=23%  Similarity=0.363  Sum_probs=207.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..+.||+|+||.||+|... +|+.+|+|.++..   .....+.+.+|++++++++|+||+++++++..++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999765 7899999988632   2334568999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          347 EYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       347 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      ||+++++|.+++... .....+++..++.++.++++||.|||   ..+|+||||+|+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998543 23456899999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....  ...... ......+         ..
T Consensus       159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~-~~~~~~~---------~~  225 (267)
T cd08224         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSL-CKKIEKC---------DY  225 (267)
T ss_pred             CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC--ccHHHH-HhhhhcC---------CC
Confidence            221 1223457889999999988889999999999999999999999975332  111111 1111111         11


Q ss_pred             CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          506 DDFPA-EQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       506 ~~~~~-~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ...+. .....+.+++.+||+.+|++||++.+|+++|.+
T Consensus       226 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~  264 (267)
T cd08224         226 PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE  264 (267)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence            11222 344568899999999999999999999999965

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-38  Score=318.73  Aligned_cols=256  Identities=26%  Similarity=0.406  Sum_probs=203.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (611)
                      .++|...+.||+|+||.||+|...      .+..+|+|.+.... ......|.+|+.++..++||||+++++++..+...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            356778899999999999999653      24689999986443 34456789999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCC-------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEe
Q 007248          343 LLVYEYVPNRSLDQFIFDKNK-------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA  415 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  415 (611)
                      ++||||+++++|.+++.....       ...++|..++.++.||+.||.|||   +.+++||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            999999999999999964322       234789999999999999999999   8999999999999999999999999


Q ss_pred             eeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhcc
Q 007248          416 DFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRS  493 (611)
Q Consensus       416 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  493 (611)
                      |||+++....... .......++..|+|||.+..+.++.++||||||+++|||+| |+.|+.... ...    .......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~----~~~~~~~  236 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-NEE----VLKFVID  236 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-HHH----HHHHHhc
Confidence            9999976543322 12223456788999999988899999999999999999998 888764221 111    1111111


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      +..         ...+......+.+++..||+.+|++|||+.++++.|+
T Consensus       237 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         237 GGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            111         1122333566889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.7e-38  Score=324.04  Aligned_cols=245  Identities=22%  Similarity=0.275  Sum_probs=194.0

Q ss_pred             CccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|+||.||++.. .+++.+|+|++...   .....+.+..|+.++.++ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999965 46789999998753   234456678899988876 899999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      |+|..++..   ...+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~  153 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT  153 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccc
Confidence            999988843   345899999999999999999999   8899999999999999999999999999987532211 122


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCC----ChhHHHHHhhccCccccccCCCCCCC
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA----SPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                      ....||..|+|||++.+..++.++||||||+++|||++|+.||.......    ....+.+.......          ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IR  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CC
Confidence            34568999999999999999999999999999999999999986422111    11222222221111          11


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCC------HHHHH
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPS------MAQAI  538 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt------~~evl  538 (611)
                      ++......+.+++.+|++.+|++||+      +.+++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ  260 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHh
Confidence            23334456789999999999999998      46664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.5e-38  Score=328.06  Aligned_cols=260  Identities=22%  Similarity=0.288  Sum_probs=193.1

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC-----cce
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----ESL  343 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  343 (611)
                      +|+..++||+|+||.||+|.. .+|..||||++...  .......+.+|++++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            467788999999999999964 56899999998643  2233457889999999999999999999876432     479


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      +||||+. ++|.+++..   ...+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 688888843   345899999999999999999999   889999999999999999999999999999764


Q ss_pred             cCCCcc--eeecccCCccccChhhhhc--CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHH-----------
Q 007248          424 AADRTH--VSTAVAGTLGYMAPEYLVR--GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVW-----------  488 (611)
Q Consensus       424 ~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~-----------  488 (611)
                      ......  ......|+..|+|||++.+  ..++.++|||||||++|||++|+.||...... ..+..+.           
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLITDLLGTPSPETI  232 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCHHHH
Confidence            322211  1234568999999999876  67899999999999999999999997543211 0111100           


Q ss_pred             HhhccCccc---cccCCCCCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          489 TLYRSNKLV---EAVDPNLKDDFP---AEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       489 ~~~~~~~~~---~~id~~l~~~~~---~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..+......   ..+.......+.   ......+.+++..|++.+|++||+++|+++
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            001111000   000000000000   012345678999999999999999999984

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.8e-38  Score=318.41  Aligned_cols=261  Identities=23%  Similarity=0.326  Sum_probs=196.7

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|...++||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            4688889999999999999965 468999999986443 22345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++ +|.+++...  ...+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            975 898888432  235788999999999999999999   89999999999999999999999999999976432221


Q ss_pred             ceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHH-----------HHhhc-cCc
Q 007248          429 HVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV-----------WTLYR-SNK  495 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~-----------~~~~~-~~~  495 (611)
                       ......++..|+|||.+.+ ..++.++||||+|+++|||+||+.||....... .+...           |.... ...
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhccccchh
Confidence             1223457899999999865 468899999999999999999999975432111 11111           11110 001


Q ss_pred             cccccCCCCCCCC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          496 LVEAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       496 ~~~~id~~l~~~~----~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ......+......    .........+++.+|++.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1111111110000    0112345779999999999999999999873

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.4e-37  Score=312.24  Aligned_cols=259  Identities=22%  Similarity=0.331  Sum_probs=206.7

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|++.+.||+|+||.||+|.. .+++.||||.+...   ..+....|.+|+++++.++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4688899999999999999965 47899999987542   2344567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccC-CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          347 EYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      ||+++++|.+++.... ....+++..++.++.||++||.|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999999885422 2345889999999999999999999   89999999999999999999999999999986543


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....  ...... .......     .+   
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~~~-~~~~~~~-----~~---  226 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLC-QKIEQCD-----YP---  226 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc--cHHHHH-HHHhcCC-----CC---
Confidence            221 11234578899999999888899999999999999999999999753321  111111 1111100     11   


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ..........+.+++.+||+.+|++||++.+|++.|.+.
T Consensus       227 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            111223445688999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.6e-38  Score=334.42  Aligned_cols=262  Identities=25%  Similarity=0.383  Sum_probs=204.8

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCC-CCceeeEeeeee
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE-HKNLVKLLGCSI  337 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  337 (611)
                      ++...++|...++||+|+||.||+|.+.      .+..||||++.... ....+.+.+|+++|.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3344456777899999999999999753      34689999997543 233457899999999997 999999999999


Q ss_pred             eCCcceEEEeecCCCChhhhhhccCC------------------------------------------------------
Q 007248          338 EGPESLLVYEYVPNRSLDQFIFDKNK------------------------------------------------------  363 (611)
Q Consensus       338 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------  363 (611)
                      ..+..++|+||+++|+|.++++....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999964321                                                      


Q ss_pred             -----------------------------------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcc
Q 007248          364 -----------------------------------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTS  402 (611)
Q Consensus       364 -----------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~  402 (611)
                                                               ...+++..+++++.||+.||.|||   ..+++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence                                                     124778889999999999999999   789999999999


Q ss_pred             cEEECCCCCeEEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCC
Q 007248          403 NILLDKDFTPKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDS  480 (611)
Q Consensus       403 NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~  480 (611)
                      |||+++++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.|+......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999986533221 11223456788999999988889999999999999999998 88886533221


Q ss_pred             CChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          481 ASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ..    .......         ......+......+.+++..||+.+|++||++++|++.|++
T Consensus       349 ~~----~~~~~~~---------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         349 EQ----FYNAIKR---------GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             HH----HHHHHHc---------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            11    1111111         11111223334568899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.8e-38  Score=333.84  Aligned_cols=255  Identities=20%  Similarity=0.208  Sum_probs=200.1

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcce
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (611)
                      ...++|+..++||+|+||.||++.. .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.++...+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            3456788899999999999999965 468899999986432   233456789999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      +||||+++|+|.+++..    ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            99999999999999843    24788888899999999999999   899999999999999999999999999999866


Q ss_pred             cCCCcceeecccCCccccChhhhhcC----ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVRG----QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      ............||+.|+|||++...    .++.++|||||||++|||++|+.||.....    ............    
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~----  264 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMDHKN----  264 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH----HHHHHHHHcCCC----
Confidence            54333233356789999999998653    478899999999999999999999864321    111111111110    


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAAL--RPSMAQAIML  540 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~--RPt~~evl~~  540 (611)
                         .+..+........+.+++..|++.+|++  ||++.++++.
T Consensus       265 ---~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         265 ---SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ---cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence               0110111123455778899999999987  9999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-38  Score=320.08  Aligned_cols=262  Identities=23%  Similarity=0.395  Sum_probs=199.6

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC---------------CCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN---------------GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLG  334 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~  334 (611)
                      ++|+..+.||+|+||.||++...+               ...||+|.+... .....+.|.+|++++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578889999999999999986532               235899988654 2344567999999999999999999999


Q ss_pred             eeeeCCcceEEEeecCCCChhhhhhccCC---------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEE
Q 007248          335 CSIEGPESLLVYEYVPNRSLDQFIFDKNK---------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL  405 (611)
Q Consensus       335 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl  405 (611)
                      ++......++||||+++++|.+++.....         ...+++..++.++.|++.||.|||   ..+++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            99999999999999999999999854321         124789999999999999999999   889999999999999


Q ss_pred             ECCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhC--CCCCCCCCCCCC
Q 007248          406 LDKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG--RRSNAFSQDSAS  482 (611)
Q Consensus       406 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG--~~p~~~~~~~~~  482 (611)
                      +++++.+||+|||++......... ......++..|+|||++..+.++.++||||||+++|||+++  ..|+..... ..
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~~  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-EQ  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-HH
Confidence            999999999999999765332211 11223456789999999888999999999999999999984  444432211 11


Q ss_pred             hhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          483 PLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       483 ~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      ........+....      .......+...+..+.+|+.+|++.+|++||+|++|++.|.
T Consensus       241 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1111111111100      00001112223456899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.5e-38  Score=320.14  Aligned_cols=258  Identities=24%  Similarity=0.381  Sum_probs=205.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCC-----CCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeee-CCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPN-----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-GPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  342 (611)
                      .++|...+.||+|+||.||+|...+     +..|++|++... .....+.+.+|+.++++++||||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678888999999999999997755     788999988644 23446778999999999999999999998766 5678


Q ss_pred             eEEEeecCCCChhhhhhccCCC-----ccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKT-----KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  417 (611)
                      ++++||+++++|.+++......     ..+++..++.++.||+.||+|||   +.+++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998653322     56899999999999999999999   899999999999999999999999999


Q ss_pred             ccceeccCCCcce-eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCc
Q 007248          418 GLARCFAADRTHV-STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNK  495 (611)
Q Consensus       418 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  495 (611)
                      |+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.|+....    ..+. ......+ 
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~-~~~~~~~-  235 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID----PFEM-AAYLKDG-  235 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC----HHHH-HHHHHcC-
Confidence            9998654332221 123345778999999988889999999999999999999 998875321    1111 1111111 


Q ss_pred             cccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       496 ~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                              .....+...+..+.+++.+||+.+|++||++.+|++.|...
T Consensus       236 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         236 --------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             --------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                    01011222344678999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.9e-38  Score=332.66  Aligned_cols=251  Identities=22%  Similarity=0.292  Sum_probs=193.1

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .|+..+.||+|+||.||++.. .+++.||||++....   ....+.+.+|+++|++++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            588899999999999999954 468999999986432   2334568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999954   345888888999999999999999   8999999999999999999999999999975331000


Q ss_pred             ------------------------------------------cceeecccCCccccChhhhhcCccccccceehhHHHHH
Q 007248          428 ------------------------------------------THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILII  465 (611)
Q Consensus       428 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~  465 (611)
                                                                ........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                      00011346899999999999989999999999999999


Q ss_pred             HHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 007248          466 EIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRP---SMAQAIML  540 (611)
Q Consensus       466 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RP---t~~evl~~  540 (611)
                      ||++|+.||......    ...........       .+...........+.+++..|+ .+|++|+   ++.++++.
T Consensus       236 ell~G~~Pf~~~~~~----~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADTPA----ETQLKVINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCCHH----HHHHHHhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999998643221    11111111000       0100111122334556666665 4999999   88888743

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.4e-38  Score=322.14  Aligned_cols=256  Identities=25%  Similarity=0.362  Sum_probs=199.6

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC-C--CEEEEEEeecc-chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN-G--TTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ++|++.+.||+|+||.||+|..++ +  ..+++|.++.. .....+.|.+|++++.++ +||||+++++++......++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            467888999999999999997643 3  34788887642 344556799999999999 799999999999999999999


Q ss_pred             EeecCCCChhhhhhccC-------------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCe
Q 007248          346 YEYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  412 (611)
                      +||+++++|.+++....             ....+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999996432             1135889999999999999999999   7999999999999999999999


Q ss_pred             EEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhh
Q 007248          413 KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLY  491 (611)
Q Consensus       413 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~  491 (611)
                      ||+|||++......  ........+..|+|||++....++.++||||||+++|||++ |..||.....    .+ .....
T Consensus       159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~----~~-~~~~~  231 (297)
T cd05089         159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC----AE-LYEKL  231 (297)
T ss_pred             EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HH-HHHHH
Confidence            99999998632211  11111223557999999988889999999999999999998 9888743221    11 11111


Q ss_pred             ccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       492 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                               ........+......+.+++.+||+.+|.+||++.++++.|....
T Consensus       232 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         232 ---------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             ---------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                     111111122233456789999999999999999999999886544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.4e-38  Score=316.16  Aligned_cols=253  Identities=24%  Similarity=0.409  Sum_probs=196.4

Q ss_pred             CCCCccccCCceeEEEEEcCC-CC--EEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC------Ccc
Q 007248          274 NPSKKLGQGGAGSVYMGSLPN-GT--TVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG------PES  342 (611)
Q Consensus       274 ~~~~~iG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  342 (611)
                      .+.++||+|+||.||+|...+ +.  .+|+|.+...  .....+.|..|+++++.++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999997654 32  6899987643  344567899999999999999999999987532      246


Q ss_pred             eEEEeecCCCChhhhhhcc---CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecc
Q 007248          343 LLVYEYVPNRSLDQFIFDK---NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  419 (611)
                      ++++||+++|+|.+++...   .....+++..+..++.||+.||+|||   ..+|+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999987432   12345899999999999999999999   78999999999999999999999999999


Q ss_pred             ceeccCCCcce-eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccc
Q 007248          420 ARCFAADRTHV-STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLV  497 (611)
Q Consensus       420 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (611)
                      ++.+....... .....++..|++||.+.+..++.++||||||+++|||++ |+.|+....    . ...+.....+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~-~~~~~~~~~~~~~  233 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE----N-SEIYDYLRQGNRL  233 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC----H-HHHHHHHHcCCCC
Confidence            98764332211 123345678999999998899999999999999999999 777764321    1 1112222221110


Q ss_pred             cccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       498 ~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                               ..+......+.+++.+||+.+|++||++.+|++.|++
T Consensus       234 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         234 ---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                     1122334557899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.8e-38  Score=323.91  Aligned_cols=244  Identities=25%  Similarity=0.330  Sum_probs=191.8

Q ss_pred             CCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHH---hcCCCCceeeEeeeeeeCCcceEE
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLI---SSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      |++.+.||+|+||.||++.. .+++.||||++....   ....+.+..|++++   +.++||||+++++++..++..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            56678999999999999965 468999999987542   22345566676654   567899999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++++|..++..    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999988842    35899999999999999999999   89999999999999999999999999999864322


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....    .+.... .....      .   
T Consensus       154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~----~~~~~~-i~~~~------~---  218 (324)
T cd05589         154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE----EEVFDS-IVNDE------V---  218 (324)
T ss_pred             CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHH-HHhCC------C---
Confidence            21 122345689999999999988999999999999999999999999753321    111111 11111      0   


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPS-----MAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt-----~~evl~  539 (611)
                       .++......+.+++.+|++.+|++||+     +.++++
T Consensus       219 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 -RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence             122233455788999999999999994     566553

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-39  Score=326.62  Aligned_cols=251  Identities=24%  Similarity=0.408  Sum_probs=214.2

Q ss_pred             CCCCCccccCCceeEEEEEcC---CC--CEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          273 FNPSKKLGQGGAGSVYMGSLP---NG--TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~---~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ....++||+|.||.||+|...   .|  -.||||..+.+ +.+..+.|+.|..+|++++|||||+|+|+|.+. ..++||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            344678999999999999542   23  45899988764 456678999999999999999999999999765 689999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      |.++-|.|..||..  +...|+...+..++.||..||+|||   +.++|||||..+|||+....-+||+||||++.+.++
T Consensus       470 EL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  470 ELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             ecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            99999999999954  3446888999999999999999999   899999999999999999999999999999998877


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .........-+..|||||.+.-.+++.+||||-|||.+|||+. |..||...              ++..+.-.+...-+
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv--------------kNsDVI~~iEnGeR  610 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV--------------KNSDVIGHIENGER  610 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc--------------cccceEEEecCCCC
Confidence            6666666667889999999999999999999999999999875 88886432              23344445555556


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .+.|+.++..+..|+.+||..+|.+||++.|+...|..
T Consensus       611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence            67788899999999999999999999999999877743

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-38  Score=315.09  Aligned_cols=256  Identities=30%  Similarity=0.443  Sum_probs=205.9

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ..++|.+.++||+|+||.||++..+++..+|||.+.... ...+++.+|+.++++++|+||+++++++..+...++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            346788899999999999999988888899999887543 2356799999999999999999999999998999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++.... ...+++..+..++.+|+.||.|||   +.+++|+||||+||++++++.+||+|||++..+.....
T Consensus        83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999996532 245899999999999999999999   78999999999999999999999999999986653322


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... .......    ...         .....
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-~~~~~~~----~~~---------~~~~~  224 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-NREVLEQ----VER---------GYRMP  224 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHH----HHc---------CCCCC
Confidence            22222334668999999998889999999999999999999 888874321 1111111    111         01111


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            122234568899999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.2e-38  Score=320.86  Aligned_cols=260  Identities=26%  Similarity=0.399  Sum_probs=202.4

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP  340 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  340 (611)
                      ...++|++.++||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34678889999999999999999543      24589999876443 233456889999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhhccCC-------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeE
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNK-------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK  413 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  413 (611)
                      ..++||||+++|+|.+++.....       ...+++..+.+++.||+.||.|||   +++|+||||||+|||+++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence            99999999999999999964321       234677888999999999999999   89999999999999999999999


Q ss_pred             EeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhh
Q 007248          414 IADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLY  491 (611)
Q Consensus       414 l~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~  491 (611)
                      |+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |..|+..... ..    .....
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-~~----~~~~~  234 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQ----VLKFV  234 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHHH
Confidence            9999999755332211 1122345678999999988899999999999999999999 6767542111 11    11111


Q ss_pred             ccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       492 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ..+..         ...+......+.+++.+|++.+|++||++.++++.|.+.
T Consensus       235 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         235 MDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            11110         111223345688999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-38  Score=313.12  Aligned_cols=249  Identities=28%  Similarity=0.470  Sum_probs=203.1

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      ++|+..+.||+|+||.||++.. .|+.||||.+..... ..+++.+|+.++++++|+||+++++++.++...++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            4677889999999999999987 478999999876544 46789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +++|.+++.... ...+++..+..++.|++.||.|||   ..+++|+||||+||++++++.+||+|||+++.......  
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            999999995432 236899999999999999999999   89999999999999999999999999999976532211  


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                        ....+..|+|||++..+.++.++||||||+++|||++ |+.|+....     ..........+         .....+
T Consensus       158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~~---------~~~~~~  221 (256)
T cd05039         158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPHVEKG---------YRMEAP  221 (256)
T ss_pred             --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHhcC---------CCCCCc
Confidence              2334668999999988899999999999999999997 888864221     11111111111         111112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ...+..+.+++.+|+..+|++||++.+++++|.+
T Consensus       222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            2334568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-38  Score=313.08  Aligned_cols=251  Identities=25%  Similarity=0.376  Sum_probs=201.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-----hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++|...+.||+|++|.||++.. .+++.+|+|.+....     ....+.+.+|++++++++||||+++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5688899999999999999964 568999999886432     2234578899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      |+||+++++|.+++..   ...+++..+..++.|++.||.|||   ..+|+|+||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999999853   245889999999999999999999   8999999999999999999999999999997654


Q ss_pred             CCCccee--ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          425 ADRTHVS--TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       425 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      .......  ....++..|+|||++.+..++.++||||||+++|||++|+.|+....    ...........         
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~---------  222 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE----AMAAIFKIATQ---------  222 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc----hHHHHHHHhcc---------
Confidence            3221111  23457889999999998889999999999999999999999975321    11111111111         


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ......+......+.+++..||+.+|++||++.++++.
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            11112233344567889999999999999999999854

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.5e-38  Score=330.52  Aligned_cols=257  Identities=19%  Similarity=0.212  Sum_probs=198.3

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (611)
                      +....++|+..+.||+|+||.||++... +++.+|+|.+....   ....+.+.+|+.+++.++||||+++++++.++..
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3444578999999999999999999664 57899999986432   2334568899999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .++||||+++|+|.+++..    ..+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence            9999999999999999843    24788899999999999999999   8999999999999999999999999999998


Q ss_pred             eccCCCcceeecccCCccccChhhhhcC----ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccc
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVRG----QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV  497 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (611)
                      ..............||+.|+|||++...    .++.++|||||||++|||++|+.||....    .............  
T Consensus       191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~----~~~~~~~i~~~~~--  264 (370)
T cd05621         191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS----LVGTYSKIMDHKN--  264 (370)
T ss_pred             ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCc--
Confidence            7644333233456799999999998754    37889999999999999999999985332    1111111111111  


Q ss_pred             cccCCCCCCCCCHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 007248          498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAA--LRPSMAQAIML  540 (611)
Q Consensus       498 ~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~--~RPt~~evl~~  540 (611)
                           .+..+........+.+++..|++.++.  .||++.|+++.
T Consensus       265 -----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         265 -----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                 011011112234466777888875554  38899998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.7e-38  Score=315.26  Aligned_cols=254  Identities=26%  Similarity=0.436  Sum_probs=201.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcC----CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .+|++.+.||+|+||.||+|...    .+..+|+|.+.... ....+.|.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46778899999999999999653    23479999886542 34456899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++++|.+++...  ...+++..++.++.|++.||.|||   +.+++||||||+|||++.++.++|+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999999543  245899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCcceee--cccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          426 DRTHVST--AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       426 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      .......  ...++..|+|||.+.+..++.++||||||+++||+++ |+.|+..... ......    ....        
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-~~~~~~----~~~~--------  225 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKA----IEEG--------  225 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-HHHHHH----HhCC--------
Confidence            3322222  1223568999999988899999999999999999886 9988753221 111111    1111        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                       .....+...+..+.+++.+|++.+|++||+|.++++.|..
T Consensus       226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         226 -YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             -CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence             0111122334567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-37  Score=329.56  Aligned_cols=199  Identities=26%  Similarity=0.389  Sum_probs=170.8

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .|+..++||+|+||+||+|.. .+++.+|||++....   ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            577889999999999999954 568899999987542   2345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            99999999998543   45788889999999999999999   8899999999999999999999999999975331100


Q ss_pred             ----------------------------------------------cceeecccCCccccChhhhhcCccccccceehhH
Q 007248          428 ----------------------------------------------THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFG  461 (611)
Q Consensus       428 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~G  461 (611)
                                                                    ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                          0001134689999999999988999999999999


Q ss_pred             HHHHHHHhCCCCCCC
Q 007248          462 ILIIEIVCGRRSNAF  476 (611)
Q Consensus       462 vll~elltG~~p~~~  476 (611)
                      |++|||++|+.||..
T Consensus       236 vil~elltG~~Pf~~  250 (382)
T cd05625         236 VILYEMLVGQPPFLA  250 (382)
T ss_pred             HHHHHHHhCCCCCCC
Confidence            999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-37  Score=318.16  Aligned_cols=255  Identities=21%  Similarity=0.222  Sum_probs=194.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|++.+.||+|+||.||++.. .+++.||||++....   ....+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4688899999999999999965 458999999986432   233456889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++...  ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999999532  335889999999999999999999   899999999999999999999999999999766543


Q ss_pred             CcceeecccCCccccChhhhhc-----CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVR-----GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      .........||+.|+|||++..     ..++.++|||||||++|||++|+.||...    ...+............... 
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~-  230 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHKEHFQFP-  230 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC----CHHHHHHHHHcCCCcccCC-
Confidence            3333334568999999999863     45788999999999999999999997532    1222211111111111110 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhc--ccCCCCCCCHHHHHHH
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCT--QAAAALRPSMAQAIML  540 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~--~~~p~~RPt~~evl~~  540 (611)
                      +     ........+.+++.+|+  ..++..||++.++++.
T Consensus       231 ~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         231 P-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             C-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0     01112334566666655  4455558899988754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.5e-37  Score=317.21  Aligned_cols=262  Identities=24%  Similarity=0.395  Sum_probs=200.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-----------------CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-----------------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKL  332 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l  332 (611)
                      ++|+..++||+|+||.||++...                 ++..+|+|++... .....+.|.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888999999999999998532                 2346899988754 33445789999999999999999999


Q ss_pred             eeeeeeCCcceEEEeecCCCChhhhhhccCC--------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccE
Q 007248          333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNK--------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNI  404 (611)
Q Consensus       333 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI  404 (611)
                      ++++..++..++||||+++++|.+++.....        ...+++..++.++.||+.||+|||   +.+++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            9999999999999999999999999865321        234788899999999999999999   78999999999999


Q ss_pred             EECCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh--CCCCCCCCCCCC
Q 007248          405 LLDKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC--GRRSNAFSQDSA  481 (611)
Q Consensus       405 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt--G~~p~~~~~~~~  481 (611)
                      |++.++.++|+|||+++.+...... ......++..|++||....+.++.++||||||+++|||++  |..|+..... .
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-~  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-E  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-H
Confidence            9999999999999999765432211 1122334678999999888899999999999999999998  5566542211 1


Q ss_pred             ChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          482 SPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      .........+.....      ......+......+.+++.+||+.+|++||++.+|++.|.
T Consensus       241 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QVIENTGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            111111111111100      0011112233466889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.8e-38  Score=313.42  Aligned_cols=254  Identities=28%  Similarity=0.431  Sum_probs=203.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      .++|+..++||+|+||.||++...++..+++|.+.... ...+.|.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46788899999999999999988788889999876443 345678999999999999999999999887 7789999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++.... ...+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++..+......
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            9999999996532 345889999999999999999999   789999999999999999999999999999766443322


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      ......++..|+|||++....++.++||||||+++|||+| |+.|+..... ....    ......         .....
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~~~----~~~~~~---------~~~~~  224 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVI----RALERG---------YRMPR  224 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-HHHH----HHHhCC---------CCCCC
Confidence            2223345678999999988889999999999999999999 8888653211 1111    111111         01111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      +......+.+++.+|++.+|++||++.++++.|..
T Consensus       225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            22334568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.4e-37  Score=322.25  Aligned_cols=245  Identities=20%  Similarity=0.268  Sum_probs=194.3

Q ss_pred             CccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|+||.||++.. .+++.||||++...   ..+..+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999965 46889999998753   233456688999999988 799999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      |+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~  153 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT  153 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence            999988843   245899999999999999999999   8999999999999999999999999999987432111 122


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCC----ChhHHHHHhhccCccccccCCCCCCC
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA----SPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                      ....||..|+|||++.+..++.++||||||+++|||++|+.||.......    ....+.........        .  .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~--~  223 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I--R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C--C
Confidence            34578999999999999999999999999999999999999986432211    11122222111111        1  1


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCC------HHHHH
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPS------MAQAI  538 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt------~~evl  538 (611)
                      .+......+.+++..|++.+|++||+      +.+++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence            22233445788999999999999997      56665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.9e-38  Score=324.53  Aligned_cols=243  Identities=23%  Similarity=0.292  Sum_probs=194.1

Q ss_pred             CccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCC
Q 007248          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  352 (611)
                      +.||+|+||.||++.. .+|..||+|++....   ......+.+|++++..++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999954 578999999987532   234567789999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceee
Q 007248          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST  432 (611)
Q Consensus       353 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  432 (611)
                      +|.+++..   ...+++..+..++.||+.||.|||+  ..+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~  154 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK  154 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence            99988843   3458999999999999999999992  27999999999999999999999999999875432221 223


Q ss_pred             cccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHH
Q 007248          433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQ  512 (611)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~  512 (611)
                      ...|+..|+|||++.+..++.++||||||+++|||++|+.||.....     ...........      .    .++...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i~~~~------~----~~p~~~  219 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEE------I----RFPRTL  219 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHHhcCC------C----CCCCCC
Confidence            45689999999999988999999999999999999999999753221     11111111111      0    112223


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007248          513 VCNVLQIGLLCTQAAAALRP-----SMAQAIML  540 (611)
Q Consensus       513 ~~~l~~l~~~c~~~~p~~RP-----t~~evl~~  540 (611)
                      ...+.+++.+|++.+|++|+     ++.++++.
T Consensus       220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            44578899999999999996     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.1e-38  Score=314.94  Aligned_cols=254  Identities=24%  Similarity=0.315  Sum_probs=200.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      ++|+..+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.++++++||||+++++++..++..++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            4688899999999999999965 578899999987665555667889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.++++..   ..+++..+..++.|+++||.|||   ..+|+||||+|+||+++.++.+||+|||+++...... .
T Consensus        89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~  161 (267)
T cd06646          89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-A  161 (267)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc-c
Confidence            999999998532   35889999999999999999999   7899999999999999999999999999998654221 1


Q ss_pred             eeecccCCccccChhhhh---cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLV---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      ......++..|+|||.+.   ...++.++||||||+++|||++|+.|+..........    . ......   ..+....
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----~-~~~~~~---~~~~~~~  233 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF----L-MSKSNF---QPPKLKD  233 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe----e-eecCCC---CCCCCcc
Confidence            122345788999999874   3457889999999999999999999874322111100    0 000000   0011110


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                        .......+.+++.+||+.+|++||+++++++.|
T Consensus       234 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         234 --KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              112335678999999999999999999998654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=315.35  Aligned_cols=251  Identities=24%  Similarity=0.287  Sum_probs=200.0

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      +|+..++||+|+||+||++.. .+++.||||++....   ......+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            367788999999999999965 468999999986532   2233567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++|+|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999888543 2345899999999999999999999   7899999999999999999999999999997654322


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                      .  .....|+..|+|||++.+..++.++||||||+++|||++|+.||...... .....+...         +.. ....
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~---------~~~-~~~~  223 (285)
T cd05605         157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERR---------VKE-DQEE  223 (285)
T ss_pred             c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHH---------hhh-cccc
Confidence            1  12346889999999999889999999999999999999999998643211 111111111         100 0112


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                      ++......+.+++..|++.||++||     +++++++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            2333445678999999999999999     7888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.5e-38  Score=320.52  Aligned_cols=255  Identities=26%  Similarity=0.384  Sum_probs=198.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCC--EEEEEEeecc-chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGT--TVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ++|++.+.||+|+||.||+|... ++.  .+++|++... .....+.|.+|++++.++ +||||+++++++..++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46778899999999999999753 454  4577776543 334456789999999999 899999999999999999999


Q ss_pred             EeecCCCChhhhhhccC-------------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCe
Q 007248          346 YEYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  412 (611)
                      |||+++++|.++++...             ....+++..++.++.||+.||+|||   +.+++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence            99999999999996432             1235889999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhh
Q 007248          413 KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLY  491 (611)
Q Consensus       413 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~  491 (611)
                      ||+|||+++.....  .......++..|+|||++....++.++||||||+++|||+| |..||..... .....    ..
T Consensus       164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~----~~  236 (303)
T cd05088         164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYE----KL  236 (303)
T ss_pred             EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-HHHHH----HH
Confidence            99999998632211  11112234567999999988889999999999999999998 8888743211 11111    11


Q ss_pred             ccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       492 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ..         ......+......+.+++.+|++.+|++||++.++++.|...
T Consensus       237 ~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         237 PQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             hc---------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            10         111111222334578999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-37  Score=321.20  Aligned_cols=240  Identities=25%  Similarity=0.298  Sum_probs=189.5

Q ss_pred             CccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhc-CCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISS-IEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|+||.||+|.. .+++.||||++....   ....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999965 457899999987542   2334556677777765 4899999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      |+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~  153 (316)
T cd05592          81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA  153 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence            9999998533   35889999999999999999999   7999999999999999999999999999997643222 223


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.....    .+...... ..          ...++..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----~~~~~~i~-~~----------~~~~~~~  218 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----DELFDSIL-ND----------RPHFPRW  218 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----HHHHHHHH-cC----------CCCCCCC
Confidence            345689999999999988999999999999999999999999753221    11111111 10          0112222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 007248          512 QVCNVLQIGLLCTQAAAALRPSMA-QAI  538 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RPt~~-evl  538 (611)
                      ....+.+++..||+.+|++||++. +++
T Consensus       219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         219 ISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            344577889999999999999976 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-38  Score=313.95  Aligned_cols=255  Identities=24%  Similarity=0.296  Sum_probs=199.1

Q ss_pred             HHhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccch--------------hhHHHHHHHHHHHhcCCCCceeeE
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTR--------------QWVDEFFNEVNLISSIEHKNLVKL  332 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l  332 (611)
                      +..++|++...||+|.||.|-+|+ ..+++.||||++.....              .-.+...+||.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            345789999999999999999994 45789999999854321              113467899999999999999999


Q ss_pred             eeeeee--CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC
Q 007248          333 LGCSIE--GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF  410 (611)
Q Consensus       333 ~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  410 (611)
                      +.+..+  .+.+|||+|||..|.+...=   .....+++.+..+++.++..||+|||   .++||||||||+|+||+++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCC
Confidence            999765  45789999999988875432   22223999999999999999999999   89999999999999999999


Q ss_pred             CeEEeeeccceeccCCCc----ceeecccCCccccChhhhhcCc----cccccceehhHHHHHHHHhCCCCCCCCCCCCC
Q 007248          411 TPKIADFGLARCFAADRT----HVSTAVAGTLGYMAPEYLVRGQ----LTEKADVYSFGILIIEIVCGRRSNAFSQDSAS  482 (611)
Q Consensus       411 ~~kl~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~  482 (611)
                      .+||+|||.+..+.....    .......||+.|+|||....+.    ...+.||||+||+||.|+.|+.||....    
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----  323 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----  323 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch----
Confidence            999999999987632211    1122478999999999987743    3457899999999999999999975322    


Q ss_pred             hhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          483 PLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       483 ~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      .+.. .        .++++..|.-+...+....+.+|++++|++||+.|.++.+|....
T Consensus       324 ~~~l-~--------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  324 ELEL-F--------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             HHHH-H--------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            1111 1        123333333222334566788999999999999999999987543

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=330.13  Aligned_cols=247  Identities=26%  Similarity=0.419  Sum_probs=209.4

Q ss_pred             CCccccCCceeEEEEEcC--CC--CEEEEEEeeccchh-hHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          276 SKKLGQGGAGSVYMGSLP--NG--TTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      .++||+|.||.|++|.|.  +|  -.||||.+...... ....|++|+.+|.+|+|||+++|||+..+ ....+|+|+++
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap  193 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP  193 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence            578999999999999774  34  36899999766433 56789999999999999999999999887 78899999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      .|+|.+.|++ .....+-...+..++.|||.||.||.   .+++|||||..+|+||-....+||+||||.+.+...+...
T Consensus       194 lGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  194 LGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             cchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            9999999987 45567888999999999999999999   8999999999999999999999999999999876554332


Q ss_pred             -ee-cccCCccccChhhhhcCccccccceehhHHHHHHHHhC-CCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          431 -ST-AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG-RRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       431 -~~-~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                       +. ...-.+.|+|||.+....++.++|||+|||.||||+|+ ..|              |.....-.+.+.||..-+-.
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEeP--------------W~G~~g~qIL~~iD~~erLp  335 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEP--------------WVGCRGIQILKNIDAGERLP  335 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCC--------------CCCCCHHHHHHhccccccCC
Confidence             22 34457789999999999999999999999999999985 344              33333345566677655556


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      -+..+.++++++++.||..+|++|||+..|++.+
T Consensus       336 RPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            6788899999999999999999999999997543

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.5e-37  Score=312.12  Aligned_cols=258  Identities=23%  Similarity=0.360  Sum_probs=205.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..+.||+|+||.||++.. .++..++||.+...   .....++|.+|+.+++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3577788999999999999964 57899999987643   2334568899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccC-CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          347 EYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      ||+++++|.+++.... ....+++..++.++.+|++||.|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999985422 2456899999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ... ......++..|+|||.+.+..++.++||||||+++|||++|..|+......  .... ..     .+.....+.+ 
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~-~~-----~~~~~~~~~~-  228 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSL-CK-----KIEQCDYPPL-  228 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHH-hh-----hhhcCCCCCC-
Confidence            322 122345788999999998888999999999999999999999997532211  1111 01     0111111111 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                        .+......+.+++.+||+.+|++||||.+|++++.+
T Consensus       229 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         229 --PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             --CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence              112244568899999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.7e-38  Score=323.66  Aligned_cols=238  Identities=25%  Similarity=0.267  Sum_probs=191.5

Q ss_pred             CccccCCceeEEEEEc----CCCCEEEEEEeeccch--hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          277 KKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      +.||+|+||.||++..    .+|+.+|+|++.....  .....+.+|++++++++||||+++++++..++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999853    3689999999875432  234567789999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +++|.+++..   ...+++..+..++.||++||.|||   ..+|+||||||+|||+++++.+||+|||+++...... ..
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~  154 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK  154 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence            9999999843   345899999999999999999999   8899999999999999999999999999997654322 12


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCH
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPA  510 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~  510 (611)
                      .....|+..|+|||.+....++.++||||||+++|||++|+.|+....    ..+....... ..          ...+.
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~----~~~~~~~i~~-~~----------~~~p~  219 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD----RKETMTMILK-AK----------LGMPQ  219 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC----HHHHHHHHHc-CC----------CCCCC
Confidence            234568999999999988889999999999999999999999975322    1111111111 11          01122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHH
Q 007248          511 EQVCNVLQIGLLCTQAAAALRPSMAQ  536 (611)
Q Consensus       511 ~~~~~l~~l~~~c~~~~p~~RPt~~e  536 (611)
                      .....+.+++.+|++.+|++||++.+
T Consensus       220 ~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         220 FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            23445778999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.3e-38  Score=312.26  Aligned_cols=251  Identities=24%  Similarity=0.409  Sum_probs=200.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      .+|+..+.||+|+||.||++...++..+|+|.+.... .....|.+|++++++++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            3566778999999999999988778899999886433 234578999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +++|.+++...  ...+++..++.++.+++.||+|||   +.+++|+||||+||+++.++.+||+|||++..........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            99999998543  235789999999999999999999   7899999999999999999999999999997654332222


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      .....++.+|+|||.+.++.++.++||||||+++|||++ |+.|+.....    ...... ...+         .....+
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~-~~~~---------~~~~~~  223 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----SEVVET-INAG---------FRLYKP  223 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHH-HhCC---------CCCCCC
Confidence            222334678999999988899999999999999999998 8888653221    111111 1111         000111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      ......+.+++.+||+.+|++||++.+|++.|
T Consensus       224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            12345688999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9e-38  Score=317.45  Aligned_cols=256  Identities=29%  Similarity=0.448  Sum_probs=202.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (611)
                      .++|+..+.||+|+||.||++..+      ++..+|+|++.... ....++|.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888999999999999999653      46789999886543 34456799999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccC-------------------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCccc
Q 007248          343 LLVYEYVPNRSLDQFIFDKN-------------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSN  403 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N  403 (611)
                      ++|+||+++++|.+++....                   ....+++..++.++.||+.||.|||   ..+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999996421                   1234788999999999999999999   7899999999999


Q ss_pred             EEECCCCCeEEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCC
Q 007248          404 ILLDKDFTPKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSA  481 (611)
Q Consensus       404 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~  481 (611)
                      ||+++++.+||+|||+++....... ........+..|+|||.+.+..++.++||||||+++|||++ |..|+....   
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~---  237 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA---  237 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence            9999999999999999876533221 11122334667999999988899999999999999999998 777764221   


Q ss_pred             ChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          482 SPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                       ..+ ...........         ..+......+.+++.+|++.+|++||++.||++.|+
T Consensus       238 -~~~-~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         238 -HEE-VIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             -HHH-HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence             111 11111121111         112233456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.6e-38  Score=300.68  Aligned_cols=261  Identities=25%  Similarity=0.316  Sum_probs=198.0

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhh--HHHHHHHHHHHhcCCCCceeeEeeeee--eCCcceEEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNLVKLLGCSI--EGPESLLVY  346 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~  346 (611)
                      +|+..++|++|.||.||+|+. ++++.||+|+++......  --.-++||.+|.+.+|||||.+..+..  +-+..|+||
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM  156 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM  156 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence            466789999999999999954 568999999998654211  113579999999999999999988765  345689999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      |||++ +|...+....  +.+...++.-+..|+++||+|||   ..-|+|||||++|+|+.+.|.+||+|||||+.+...
T Consensus       157 e~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  157 EYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             HHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            99976 8888885433  56888999999999999999999   899999999999999999999999999999988765


Q ss_pred             CcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhh-----------ccC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY-----------RSN  494 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-----------~~~  494 (611)
                      . ...+..+-|.+|.|||.+.+. .|+...|+||+|||+.||+++++-|.... ..+.+..+..+.           ..-
T Consensus       231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s-E~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS-EIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc-hHHHHHHHHHHhCCCccccCCCcccc
Confidence            3 344566779999999998875 68999999999999999999986653322 222233222222           111


Q ss_pred             cccc------ccCCCCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          495 KLVE------AVDPNLKDDFPAE-QVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       495 ~~~~------~id~~l~~~~~~~-~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ....      ..-..++..|+.. ....-++++...+..||.+|-|++|-++.
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            1110      0001112222222 23456788888999999999999998754

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.1e-37  Score=327.42  Aligned_cols=200  Identities=24%  Similarity=0.367  Sum_probs=173.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..+.||+|+||+||++.. .+++.||||++....   ......+.+|+.++.+++||||+++++.+.++...++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4688899999999999999954 468999999986532   233457889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999954   345899999999999999999999   899999999999999999999999999998754321


Q ss_pred             Cc----------------------------------ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCC
Q 007248          427 RT----------------------------------HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRR  472 (611)
Q Consensus       427 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~  472 (611)
                      ..                                  .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            10                                  00123468999999999999899999999999999999999999


Q ss_pred             CCCC
Q 007248          473 SNAF  476 (611)
Q Consensus       473 p~~~  476 (611)
                      ||..
T Consensus       235 Pf~~  238 (363)
T cd05628         235 PFCS  238 (363)
T ss_pred             CCCC
Confidence            9853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=312.85  Aligned_cols=249  Identities=27%  Similarity=0.396  Sum_probs=193.9

Q ss_pred             CccccCCceeEEEEEcCC-CC--EEEEEEeecc-chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSLPN-GT--TVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|+||.||+|..++ +.  .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            469999999999997644 43  4688887643 344567899999999999 899999999999999999999999999


Q ss_pred             CChhhhhhccC-------------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeec
Q 007248          352 RSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       352 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                      ++|.+++....             ....+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999996432             1235889999999999999999999   7999999999999999999999999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccc
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLV  497 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (611)
                      ++......  ........+..|+|||++....++.++||||||+++|||++ |..||..... ...    ......+   
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~----~~~~~~~---  227 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AEL----YEKLPQG---  227 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-HHH----HHHHhCC---
Confidence            98532211  11112233567999999988889999999999999999997 8888743211 111    1111111   


Q ss_pred             cccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       498 ~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                            .....+......+.+++.+|++.+|.+||++.++++.|.+.
T Consensus       228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         228 ------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             ------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                  11111222344578999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.3e-38  Score=321.69  Aligned_cols=258  Identities=27%  Similarity=0.411  Sum_probs=202.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeC
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP--------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (611)
                      .++|.+.+.||+|+||.||++...        ++..+|+|.+.... .....++.+|++++..+ +||||+++++++..+
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            356888999999999999998642        23579999887542 34456788999999999 799999999999999


Q ss_pred             CcceEEEeecCCCChhhhhhccCC-------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                      +..++||||+++++|.+++.....             ...++|..+++++.||+.||+|||   +.+++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            999999999999999999965321             235899999999999999999999   7899999999999999


Q ss_pred             CCCCCeEEeeeccceeccCCCcce-eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChh
Q 007248          407 DKDFTPKIADFGLARCFAADRTHV-STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPL  484 (611)
Q Consensus       407 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~  484 (611)
                      +.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....     .
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-----~  248 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----V  248 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----H
Confidence            999999999999987654322111 112234568999999988889999999999999999998 777764221     1


Q ss_pred             HHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          485 QRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       485 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ..........         .....+......+.+++..|++.+|++||++.+|++.|...
T Consensus       249 ~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         249 EELFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HHHHHHHHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            1111111111         11122333445688899999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.4e-38  Score=320.69  Aligned_cols=258  Identities=27%  Similarity=0.420  Sum_probs=203.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEc--------CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeC
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (611)
                      .++|.+.+.||+|+||.||++..        .++..+|+|.+... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            45677889999999999999953        13457999988643 234457799999999999 899999999999999


Q ss_pred             CcceEEEeecCCCChhhhhhccCC-------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                      ...++||||+++++|.+++.....             ...+++..++.++.||+.||.|||   +.+++||||||+|||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            999999999999999999965321             235889999999999999999999   7899999999999999


Q ss_pred             CCCCCeEEeeeccceeccCCCcce-eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChh
Q 007248          407 DKDFTPKIADFGLARCFAADRTHV-STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPL  484 (611)
Q Consensus       407 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~  484 (611)
                      ++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..|+...    . .
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~-~  245 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----P-V  245 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC----C-H
Confidence            999999999999998764332221 223345678999999988889999999999999999998 66665321    1 1


Q ss_pred             HHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          485 QRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       485 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ...........         ....+......+.+++.+||+.+|++||++.||++.|.+.
T Consensus       246 ~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         246 EELFKLLKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             HHHHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence            22222221111         1111233445688899999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-37  Score=311.13  Aligned_cols=248  Identities=28%  Similarity=0.424  Sum_probs=198.8

Q ss_pred             CccccCCceeEEEEEcCC--C--CEEEEEEeeccch-hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSLPN--G--TTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|++|.||+|.+.+  +  ..+|||.+..... ...+.|.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999997643  3  3699999876655 567789999999999999999999999888 889999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce-
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-  430 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-  430 (611)
                      ++|.+++..... ..++|..++.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||+++.+....... 
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999965432 56899999999999999999999   8899999999999999999999999999998765432221 


Q ss_pred             -eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          431 -STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       431 -~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                       .....++..|+|||.+....++.++||||||+++|||++ |+.|+.....    .+..........         ....
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~~~~---------~~~~  222 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----SQILKKIDKEGE---------RLER  222 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHhcCC---------cCCC
Confidence             113456789999999988899999999999999999999 9998743211    111111111000         0011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      +...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            2233456889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=308.48  Aligned_cols=247  Identities=29%  Similarity=0.423  Sum_probs=197.8

Q ss_pred             CccccCCceeEEEEEcCCCCEEEEEEeeccch-hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCChh
Q 007248          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLD  355 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~  355 (611)
                      ++||+|+||.||++...+++.|++|++..... +..+.|.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999877799999998875433 35678999999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee-ecc
Q 007248          356 QFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS-TAV  434 (611)
Q Consensus       356 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~~  434 (611)
                      +++...  ...+++..++.++.+++.||.|||   +.+++||||+|+|||++.++.+||+|||++........... ...
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998543  235789999999999999999999   88999999999999999999999999999976542221111 122


Q ss_pred             cCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHH
Q 007248          435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQV  513 (611)
Q Consensus       435 ~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~  513 (611)
                      ..+..|+|||.+.++.++.++||||||+++|||+| |..|+...... ..    ......         ......+....
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-~~----~~~~~~---------~~~~~~~~~~~  221 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-QT----RERIES---------GYRMPAPQLCP  221 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-HH----HHHHhc---------CCCCCCCccCC
Confidence            33567999999988899999999999999999999 77776432211 11    111111         11111223344


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          514 CNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       514 ~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      ..+.+++.+|++.+|++||++.||++.|.
T Consensus       222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            56889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.6e-38  Score=319.52  Aligned_cols=257  Identities=28%  Similarity=0.399  Sum_probs=203.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEc------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  341 (611)
                      .++|...+.||+|+||.||++..      ..+..+|||++.... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            35688899999999999999953      234579999886542 34456799999999999 89999999999999999


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .++||||+++++|.++++... ...+++.++..++.+|+.||.|||   +.+|+|+||||+|||++.++.+||+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            999999999999999996432 234899999999999999999999   7899999999999999999999999999997


Q ss_pred             eccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          422 CFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       422 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      ........ ......++..|+|||.+....++.++||||||+++|||++ |+.|+..........    .....      
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~----~~~~~------  259 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY----KLIKE------  259 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH----HHHHc------
Confidence            65433221 1122345678999999998899999999999999999998 888865332211111    11111      


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                         ......+......+.+++.+|++.+|++||++.||++.|.+
T Consensus       260 ---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         260 ---GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             ---CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence               11111122234568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8e-38  Score=314.50  Aligned_cols=253  Identities=25%  Similarity=0.442  Sum_probs=199.5

Q ss_pred             CCCCCCccccCCceeEEEEEcCC-C---CEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPN-G---TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      .|+..+.||+|+||.||+|.... +   ..||||.+... .....++|..|+.++++++||||+++++++.++...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46678899999999999997643 3   36999988654 3445678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++...  ...+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            999999999998543  345899999999999999999999   789999999999999999999999999998765432


Q ss_pred             Ccce-ee-ccc--CCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          427 RTHV-ST-AVA--GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       427 ~~~~-~~-~~~--gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      .... .. ...  .+..|+|||.+....++.++||||||+++|||++ |..|+..... ......    ....       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-~~~~~~----i~~~-------  227 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINA----IEQD-------  227 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-HHHHHH----HHcC-------
Confidence            2211 11 111  2457999999998899999999999999999886 9888743211 111111    1110       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                        .....+.+.+..+.+++..||+.+|.+||++.+|+..|+.
T Consensus       228 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         228 --YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             --CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence              1111122334557899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-37  Score=315.75  Aligned_cols=259  Identities=22%  Similarity=0.407  Sum_probs=201.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-----CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--Ccc
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PES  342 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  342 (611)
                      +.|...+.||+|+||.||++..     .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467788999999999999963     357899999986443 44456899999999999999999999998775  567


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++||||+++++|.+++...  ...++|..++.++.||+.||+|||   +.+++||||||+||++++++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccc
Confidence            8999999999999998533  235899999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCCcc--eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCC----------CCChhHHHHHh
Q 007248          423 FAADRTH--VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQD----------SASPLQRVWTL  490 (611)
Q Consensus       423 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~----------~~~~~~~~~~~  490 (611)
                      +......  ......++..|+|||++.+..++.++||||||+++|||+|++.|......          ...........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6433221  11234567789999999888899999999999999999998766432111          00011111111


Q ss_pred             hccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          491 YRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       491 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ...+         .....+......+.+++.+|++.+|++||++.++++.|..
T Consensus       239 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         239 LEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            1111         1111122345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2e-37  Score=311.39  Aligned_cols=258  Identities=26%  Similarity=0.392  Sum_probs=202.6

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++.+++++.....||+|+||.||+|.. .++..|++|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            456677787888999999999999964 4678899999877666667789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-CCCeEEeeeccceec
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCF  423 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~  423 (611)
                      |+||+++++|.+++.........++..+..++.||+.||+|||   ..+|+||||||+||+++. ++.+||+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            9999999999999964322212378888999999999999999   789999999999999986 678999999998765


Q ss_pred             cCCCcceeecccCCccccChhhhhcCc--cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVRGQ--LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      ..... ......++..|+|||++....  ++.++||||||+++|||++|+.|+........   ..+..   . ..    
T Consensus       160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~---~-~~----  227 (268)
T cd06624         160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKV---G-MF----  227 (268)
T ss_pred             ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhh---h-hh----
Confidence            33221 122345788999999986643  78899999999999999999999753221111   11110   0 00    


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       ......+......+.+++.+||+.+|++||++.||+.
T Consensus       228 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 -KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence             0111123334455788999999999999999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-37  Score=309.49  Aligned_cols=247  Identities=27%  Similarity=0.416  Sum_probs=195.0

Q ss_pred             CccccCCceeEEEEEcC--C--CCEEEEEEeeccch-hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSLP--N--GTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      ++||+|+||.||+|...  +  +..+|+|.+..... ...+++.+|+.+++++.||||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999542  2  26899998875543 34567999999999999999999999876 4568999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      ++|.+++....   .+++..++.++.|++.||.|||   ..+++|+||||+|||++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999995432   6899999999999999999999   78999999999999999999999999999986644332211


Q ss_pred             e--cccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          432 T--AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       432 ~--~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      .  ...++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ...    ........         ....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~----~~~~~~~~---------~~~~  219 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEV----IAMLESGE---------RLPR  219 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHH----HHHHHcCC---------cCCC
Confidence            1  2223567999999988899999999999999999998 8888753321 111    11111111         0112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      +......+.+++.+|++.+|++||++.+|++.|...
T Consensus       220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            223345688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.5e-37  Score=320.88  Aligned_cols=241  Identities=23%  Similarity=0.283  Sum_probs=192.4

Q ss_pred             CccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      ++||+|+||.||+|... +++.||||++....   ....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999654 57899999987542   33455678899999866 899999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      ++|..++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~  153 (321)
T cd05591          81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTT  153 (321)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccc
Confidence            9999888533   35889999999999999999999   8899999999999999999999999999987543222 122


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ....|+..|+|||++.+..++.++||||||+++|||++|+.||.....    ........ ....          .++..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~----~~~~~~i~-~~~~----------~~p~~  218 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE----DDLFESIL-HDDV----------LYPVW  218 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH----HHHHHHHH-cCCC----------CCCCC
Confidence            345689999999999988999999999999999999999999864321    11111111 1110          11222


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-------CHHHHHH
Q 007248          512 QVCNVLQIGLLCTQAAAALRP-------SMAQAIM  539 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RP-------t~~evl~  539 (611)
                      ....+.+++..|++.+|++||       ++.++++
T Consensus       219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            334578899999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2e-37  Score=309.44  Aligned_cols=249  Identities=31%  Similarity=0.468  Sum_probs=202.0

Q ss_pred             CccccCCceeEEEEEcCC----CCEEEEEEeeccchh-hHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSLPN----GTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|+||.||++....    +..+++|.+...... ..+.+.+|+++++.++|+||+++++++..+...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999996643    789999998765433 367899999999999999999999999999999999999999


Q ss_pred             CChhhhhhccCC------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          352 RSLDQFIFDKNK------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       352 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      ++|.+++.....      ...+++..++.++.|+++||+|||   +.+++|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965421      367999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          426 DRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       426 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      ... .......++..|+|||.+....++.++||||||+++|||++ |..|+....    . ...+.....+         
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~-~~~~~~~~~~---------  223 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS----N-EEVLEYLRKG---------  223 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC----H-HHHHHHHHcC---------
Confidence            321 12234557889999999988889999999999999999999 588875431    1 1111111111         


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      .....+......+.+++.+|++.+|++||++.++++.|+
T Consensus       224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            111223333556889999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.6e-37  Score=311.29  Aligned_cols=246  Identities=22%  Similarity=0.251  Sum_probs=193.2

Q ss_pred             cccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCCh
Q 007248          279 LGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       279 iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      ||+|+||.||++.. .+|+.+|+|++....   ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999965 468999999986432   12234566799999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecc
Q 007248          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV  434 (611)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  434 (611)
                      .+++.... ...+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.++|+|||++.......  .....
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~  154 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR  154 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence            98885432 345899999999999999999999   8999999999999999999999999999997654322  22345


Q ss_pred             cCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHH
Q 007248          435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVC  514 (611)
Q Consensus       435 ~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~  514 (611)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.|+..................     ..+..  .   ......
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~--~---~~~~~~  224 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-----DEVKF--E---HQNFTE  224 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-----ccccc--c---cccCCH
Confidence            6899999999999888999999999999999999999997643322221111111110     01100  0   112234


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          515 NVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       515 ~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      .+.+++..|++.+|++||++.|+++.
T Consensus       225 ~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         225 ESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             HHHHHHHHHhccCHhhCCCCccchhh
Confidence            57889999999999999999876644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.5e-37  Score=314.25  Aligned_cols=254  Identities=25%  Similarity=0.416  Sum_probs=199.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCC----EEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGT----TVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++|+..++||+|+||+||+|.+ .++.    .||+|++.... ....+.+.+|+.++..++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            4677889999999999999964 3454    48999886543 3445678999999999999999999999875 45789


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ++||+++|+|.++++..  ...+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus        86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            99999999999999543  345899999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCcce-eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          425 ADRTHV-STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       425 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ...... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.....     ...........       
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~~-------  228 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REIPDLLEKGE-------  228 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCCC-------
Confidence            433221 112334678999999988899999999999999999998 8888643211     11111111111       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                        ....+......+.+++..||+.+|+.||++.++++.|...
T Consensus       229 --~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         229 --RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             --cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence              1111223345678999999999999999999999888643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.1e-37  Score=314.89  Aligned_cols=249  Identities=24%  Similarity=0.415  Sum_probs=201.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      .+|...+.||+|+||.||+|.. .+++.+++|.+........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4677888999999999999964 578999999987665555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++..    ..+++.++..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||++........ 
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            99999999843    34789999999999999999999   78999999999999999999999999999875433221 


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......    ..........      +.+  ..+
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~~~~~~~------~~~--~~~  239 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLIATNGT------PEL--QNP  239 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHHHhcCCC------CCC--CCc
Confidence            1223467889999999988889999999999999999999999985432211    1111111100      011  112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ......+.+++.+|+..+|++||++.+|++
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            233455788999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.5e-37  Score=321.33  Aligned_cols=241  Identities=23%  Similarity=0.275  Sum_probs=192.4

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCC-ceeeEeeeeeeCCcceEEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHK-NLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  346 (611)
                      +|+..+.||+|+||.||+|... +++.||||++....   ....+.+..|++++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999654 57899999987542   33456788999999999765 5888999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999999853   235889999999999999999999   899999999999999999999999999998743221


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      . .......||..|+|||++.+..++.++||||||+++|||+||+.||.....    .+...... ...          .
T Consensus       155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~-~~~----------~  218 (324)
T cd05587         155 G-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQSIM-EHN----------V  218 (324)
T ss_pred             C-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHH-cCC----------C
Confidence            1 122345689999999999998999999999999999999999999753221    11111111 110          1


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSM  534 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~  534 (611)
                      .++......+.+++.+|++.+|++||+.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            1222334557889999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2e-37  Score=309.30  Aligned_cols=248  Identities=28%  Similarity=0.428  Sum_probs=197.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeee-eCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI-EGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~  349 (611)
                      ++|...+.||+|+||.||++.. .|..+|+|.+....  ..+.|.+|+.++++++|+|++++++++. .+...++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            3577889999999999999977 47889999876433  3467899999999999999999999764 456789999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++.... ...+++..++.++.||+.||+|||   ..+++||||||+||++++++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            9999999986432 345899999999999999999999   8899999999999999999999999999987543221  


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                        ....++..|+|||++....++.++||||||+++|||++ |+.|+...    ...+.. .....+         .....
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~----~~~~~~-~~~~~~---------~~~~~  220 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVV-PRVEKG---------YKMDA  220 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC----CHHHHH-HHHhcC---------CCCCC
Confidence              22334668999999988889999999999999999998 88886422    111111 111111         11112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      +...+..+.+++.+|++.+|++||++.++++.|.+
T Consensus       221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            22344568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=328.10  Aligned_cols=252  Identities=19%  Similarity=0.263  Sum_probs=194.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|...++||+|+||+||++.. .+++.||||++....   ....+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3678889999999999999954 578999999986532   334567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999853   345888899999999999999999   899999999999999999999999999999643211


Q ss_pred             Ccc----------------------------------------------eeecccCCccccChhhhhcCccccccceehh
Q 007248          427 RTH----------------------------------------------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSF  460 (611)
Q Consensus       427 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~  460 (611)
                      ...                                              ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000                                              0012468999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHH
Q 007248          461 GILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALR---PSMAQA  537 (611)
Q Consensus       461 Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~R---Pt~~ev  537 (611)
                      ||++|||++|+.||.....    ................     ..  .......+.+++..|++ +|.+|   |++.|+
T Consensus       235 Gvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~-----p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~  302 (377)
T cd05629         235 GAIMFECLIGWPPFCSENS----HETYRKIINWRETLYF-----PD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI  302 (377)
T ss_pred             chhhhhhhcCCCCCCCCCH----HHHHHHHHccCCccCC-----CC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence            9999999999999853221    1111111111100000     00  01123446788888887 66665   699988


Q ss_pred             HHH
Q 007248          538 IML  540 (611)
Q Consensus       538 l~~  540 (611)
                      ++.
T Consensus       303 l~h  305 (377)
T cd05629         303 KSH  305 (377)
T ss_pred             hcC
Confidence            754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.6e-37  Score=311.63  Aligned_cols=248  Identities=23%  Similarity=0.339  Sum_probs=197.2

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      +|+..+.||+|+||.||+|.. .+++.||+|++... .....+.|.+|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577788999999999999954 57899999988654 3344567999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|..+.       .+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            999997553       3678888999999999999999   8999999999999999999999999999997654321  


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChh--HHHHHhhccCccccccCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPL--QRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                       .....++..|+|||++.+..++.++||||||+++|||++|+.|+..........  ..........     ..+.+.  
T Consensus       150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~--  221 (279)
T cd06619         150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----DPPVLP--  221 (279)
T ss_pred             -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----CCCCCC--
Confidence             223568899999999998899999999999999999999999986432221110  0001111110     011111  


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                       .......+.+++.+|++.+|++||+++++++.
T Consensus       222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             11223457899999999999999999998853

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2e-37  Score=321.82  Aligned_cols=258  Identities=28%  Similarity=0.417  Sum_probs=202.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP--------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGP  340 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  340 (611)
                      .+|.+.+.||+|+||.||++...        .+..+|+|.+.... ....+++.+|+++++++ +||||+++++++..++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46788899999999999999532        12468999876432 34467899999999999 8999999999999999


Q ss_pred             cceEEEeecCCCChhhhhhccC-------------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD  407 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  407 (611)
                      ..++++||+++|+|.+++....             ....++|..++.++.||+.||.|||   ..+++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999996432             2235889999999999999999999   89999999999999999


Q ss_pred             CCCCeEEeeeccceeccCCCcce-eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhH
Q 007248          408 KDFTPKIADFGLARCFAADRTHV-STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQ  485 (611)
Q Consensus       408 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~  485 (611)
                      +++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..|+...    . .+
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----~-~~  243 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI----P-VE  243 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC----C-HH
Confidence            99999999999997654322111 122334567999999999999999999999999999998 77775322    1 11


Q ss_pred             HHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          486 RVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       486 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      .........         .....+......+.+++.+|++.+|++||++.|+++.|....
T Consensus       244 ~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         244 ELFKLLKEG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            112211111         111122333456889999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.7e-37  Score=319.47  Aligned_cols=259  Identities=29%  Similarity=0.424  Sum_probs=202.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC--------CCCEEEEEEeecc-chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeC
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP--------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (611)
                      .++|.+.++||+|+||.||++...        ....+|+|.+... ......++.+|+++++++ +||||+++++++..+
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            356778899999999999999531        2457999987644 234466789999999999 699999999999999


Q ss_pred             CcceEEEeecCCCChhhhhhccC-------------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                      ...++||||+++|+|.+++....             ....++|..+++++.||+.||.|||   +.+++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            99999999999999999996532             1245899999999999999999999   8999999999999999


Q ss_pred             CCCCCeEEeeeccceeccCCCcce-eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChh
Q 007248          407 DKDFTPKIADFGLARCFAADRTHV-STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPL  484 (611)
Q Consensus       407 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~  484 (611)
                      ++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+....     .
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-----~  242 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-----V  242 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-----H
Confidence            999999999999997654322111 112234567999999988899999999999999999999 777764221     1


Q ss_pred             HHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          485 QRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       485 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      ...........         ....+......+.+++.+|++.+|++||++.++++.|....
T Consensus       243 ~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         243 EELFKLLREGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             HHHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            11111111111         11122333456789999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4e-37  Score=306.70  Aligned_cols=249  Identities=28%  Similarity=0.407  Sum_probs=202.0

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC-CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      ++|+..+.||+|+||.||+|...+ +..+++|.+.....  .+++.+|++++++++||||+++++++..+...++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578889999999999999997754 78999998865433  678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++...  ...+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            999999998532  346899999999999999999999   78999999999999999999999999999976543321 


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      ......++..|+|||++.+..++.++||||||+++|||++|+.|+..........    . ...     ...+.+  ..+
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~----~-~~~-----~~~~~~--~~~  222 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF----M-IPN-----KPPPTL--SDP  222 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh----h-hcc-----CCCCCC--Cch
Confidence            2233457889999999988899999999999999999999999976432211100    0 000     000111  112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ......+.+++.+|++.+|++||++.||++
T Consensus       223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            223345788999999999999999999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-37  Score=323.86  Aligned_cols=259  Identities=27%  Similarity=0.376  Sum_probs=199.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEc------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeeee-CC
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE-GP  340 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  340 (611)
                      .++|+..+.||+|+||.||+|..      .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35688899999999999999952      357899999987543 33456788999999999 78999999998765 45


Q ss_pred             cceEEEeecCCCChhhhhhccCC---------------------------------------------------------
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNK---------------------------------------------------------  363 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------  363 (611)
                      ..++||||+++|+|.++++....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999999864211                                                         


Q ss_pred             -------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc-eeeccc
Q 007248          364 -------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH-VSTAVA  435 (611)
Q Consensus       364 -------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~  435 (611)
                             ...+++..+.+++.||++||+|||   +.+|+||||||+|||+++++.+||+|||++......... ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   124788899999999999999999   899999999999999999999999999999765332211 112234


Q ss_pred             CCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHH
Q 007248          436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVC  514 (611)
Q Consensus       436 gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~  514 (611)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..|+........    .......+..         ...+.....
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~~~~~~~~---------~~~~~~~~~  309 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRLKEGTR---------MRAPDYTTP  309 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH----HHHHHhccCC---------CCCCCCCCH
Confidence            5678999999988899999999999999999997 8888643221111    1111111110         011111234


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          515 NVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       515 ~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      .+.+++..||+.+|++||++.+|++.|...
T Consensus       310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            578999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.4e-36  Score=305.63  Aligned_cols=253  Identities=27%  Similarity=0.354  Sum_probs=191.3

Q ss_pred             CccccCCceeEEEEEcCC---CCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCC
Q 007248          277 KKLGQGGAGSVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  352 (611)
                      +.||+|+||.||+|...+   +..+|+|.+.... ......|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999996543   4579999886543 334457899999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCC--CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          353 SLDQFIFDKNK--TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       353 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +|.+++.....  ...+++..+..++.|+++||+|||   +.+++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999965332  235677888899999999999999   8899999999999999999999999999986543222111


Q ss_pred             -eecccCCccccChhhhhcC-------ccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          431 -STAVAGTLGYMAPEYLVRG-------QLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       431 -~~~~~gt~~y~aPE~~~~~-------~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                       .....++..|+|||++...       .++.++||||||+++|||++ |+.|+...... .....   .. ........+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-~~~~~---~~-~~~~~~~~~  232 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE-QVLTY---TV-REQQLKLPK  232 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH-HHHHH---Hh-hcccCCCCC
Confidence             1234567889999998642       35789999999999999996 99887543221 11111   11 111112222


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      +.+..    .....+.+++..|+ .+|++|||++||+..|+
T Consensus       233 ~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            22221    22334677888998 58999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.7e-37  Score=327.19  Aligned_cols=261  Identities=24%  Similarity=0.314  Sum_probs=196.8

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC-----cce
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----ESL  343 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  343 (611)
                      +|+..+.||+|+||.||++.. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999964 57899999988643  2334567889999999999999999999988776     789


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      +|+||+. ++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 578777743   345899999999999999999999   889999999999999999999999999999865


Q ss_pred             cCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcc------
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL------  496 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------  496 (611)
                      ............++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+.........      
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHh
Confidence            44333333345678899999998764 4789999999999999999999998643211 111111110000000      


Q ss_pred             ----cccc-CCCCC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          497 ----VEAV-DPNLK-------DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       497 ----~~~i-d~~l~-------~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                          ...+ .....       ..........+.+++.+|++.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                0000 00000       00111224457899999999999999999999853

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4e-37  Score=323.62  Aligned_cols=260  Identities=18%  Similarity=0.195  Sum_probs=201.1

Q ss_pred             hHHHHHHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeee
Q 007248          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIE  338 (611)
Q Consensus       263 ~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  338 (611)
                      ..++....++|+..+.||+|+||.||++... +++.+|+|++....   ....+.+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3445556688999999999999999999654 68899999986432   2334567899999999999999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeec
Q 007248          339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       339 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                      +...++||||+++|+|.+++..    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999999999999843    24788888999999999999999   8999999999999999999999999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcC----ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRG----QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN  494 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  494 (611)
                      +++..............||+.|+|||++...    .++.++|||||||++|||++|+.||....    ............
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~~~~~i~~~~  263 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYSKIMNHK  263 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC----HHHHHHHHHcCC
Confidence            9987654333333456799999999998754    37889999999999999999999985322    222211211111


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 007248          495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAAL--RPSMAQAIML  540 (611)
Q Consensus       495 ~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~--RPt~~evl~~  540 (611)
                      ......       ........+.+++..|++.++..  ||++.++++.
T Consensus       264 ~~~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         264 NSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CcccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            111111       11123445678888999844432  7899988864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.5e-37  Score=316.47  Aligned_cols=241  Identities=22%  Similarity=0.279  Sum_probs=191.8

Q ss_pred             CccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|+||+||++.. .+++.+|+|++....   .+..+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999965 467899999987542   33456688999999888 699999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      |+|..++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT  153 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence            999988843   245899999999999999999999   7899999999999999999999999999987532211 122


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCC--ChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA--SPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      ....||..|+|||++.+..++.++||||||+++|||++|+.||.......  ......+.......        .  ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~--~~p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------I--RIP  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------C--CCC
Confidence            34568999999999999999999999999999999999999986432221  12222222221111        1  122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCH
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSM  534 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~  534 (611)
                      ......+.+++.+|++.+|++||++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            2233457789999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.4e-37  Score=320.86  Aligned_cols=236  Identities=24%  Similarity=0.342  Sum_probs=189.6

Q ss_pred             CccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|+||.||++..+ +++.||||++....   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999654 58899999987432   23456778899998876 799999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      |+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~  153 (320)
T cd05590          81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT  153 (320)
T ss_pred             chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence            9999988533   35889999999999999999999   8999999999999999999999999999987543221 122


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||.....    ... .........          .++..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~-~~~i~~~~~----------~~~~~  218 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----DDL-FEAILNDEV----------VYPTW  218 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHH-HHHHhcCCC----------CCCCC
Confidence            345689999999999988999999999999999999999999853321    111 111111110          11222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH
Q 007248          512 QVCNVLQIGLLCTQAAAALRPSM  534 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RPt~  534 (611)
                      ....+.+++..|++.||++||+.
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         219 LSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCC
Confidence            34457889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.4e-37  Score=318.59  Aligned_cols=241  Identities=24%  Similarity=0.282  Sum_probs=192.7

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      +|+..+.||+|+||.||++... +++.||||++....   ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4777899999999999999654 57899999987542   23345677888888877 6899999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||   ..+|+||||||+|||+++++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            999999999988533   35889999999999999999999   789999999999999999999999999999754322


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      .. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ....   . +....          .
T Consensus       155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~---~-i~~~~----------~  218 (323)
T cd05616         155 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQ---S-IMEHN----------V  218 (323)
T ss_pred             CC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHH---H-HHhCC----------C
Confidence            21 223456899999999999999999999999999999999999998533211 1111   1 11111          1


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSM  534 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~  534 (611)
                      .++......+.+++.+|++.+|++|++.
T Consensus       219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            1233344567899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.2e-37  Score=308.71  Aligned_cols=250  Identities=28%  Similarity=0.400  Sum_probs=191.5

Q ss_pred             CccccCCceeEEEEEcC----CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeee-eCCcceEEEeecC
Q 007248          277 KKLGQGGAGSVYMGSLP----NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSI-EGPESLLVYEYVP  350 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~~  350 (611)
                      +.||+|+||.||+|...    ++..+|+|++... .....+.+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999653    2457999987543 3445678899999999999999999999765 4556899999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc-
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH-  429 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-  429 (611)
                      +++|.+++...  ...+++..++.++.||++||+|||   +.+++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999999543  234678888999999999999999   789999999999999999999999999999755432211 


Q ss_pred             --eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          430 --VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       430 --~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                        ......++..|+|||.+....++.++||||||+++|||++|..|.....+......   .......          ..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~---~~~~~~~----------~~  222 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV---YLLQGRR----------LL  222 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHhcCCC----------CC
Confidence              11133456789999999888999999999999999999996554322221111111   1111100          01


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      .+...+..+.+++..||+.+|++||++.+|++.|++.
T Consensus       223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1112234688999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.4e-37  Score=310.88  Aligned_cols=256  Identities=24%  Similarity=0.350  Sum_probs=202.2

Q ss_pred             cCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccchh-hHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcce
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (611)
                      ++|.....||+|+||.||+|..+      +...+++|.+.....+ ..+.|.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46778899999999999999753      3467999987654433 4678999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhhccCCC------ccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeee
Q 007248          344 LVYEYVPNRSLDQFIFDKNKT------KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  417 (611)
                      +||||+++++|.+++......      ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999654322      26899999999999999999999   789999999999999999999999999


Q ss_pred             ccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCcc
Q 007248          418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKL  496 (611)
Q Consensus       418 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (611)
                      |+++..............++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ..    .......+.+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-~~----~~~~~~~~~~  236 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EE----VLNRLQAGKL  236 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-HH----HHHHHHcCCc
Confidence            9987543322222233455778999999988889999999999999999999 6777642211 11    1111111111


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          497 VEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       497 ~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      .        ...+......+.+++.+|++.+|++||++.+++..|.
T Consensus       237 ~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         237 E--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             C--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1        1112223456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.6e-37  Score=310.75  Aligned_cols=238  Identities=25%  Similarity=0.369  Sum_probs=186.5

Q ss_pred             ccccCCceeEEEEEcCC-------------------------CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeE
Q 007248          278 KLGQGGAGSVYMGSLPN-------------------------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL  332 (611)
Q Consensus       278 ~iG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  332 (611)
                      .||+|+||.||+|.+..                         ...|++|++.........+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999996421                         23589998876555556789999999999999999999


Q ss_pred             eeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC--
Q 007248          333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF--  410 (611)
Q Consensus       333 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--  410 (611)
                      ++++.++...++||||+++|+|..++...  ...+++..+++++.||++||+|||   +.+|+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999998532  345889999999999999999999   78999999999999998644  


Q ss_pred             -----CeEEeeeccceeccCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHH-hCCCCCCCCCCCCCh
Q 007248          411 -----TPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIV-CGRRSNAFSQDSASP  483 (611)
Q Consensus       411 -----~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~ell-tG~~p~~~~~~~~~~  483 (611)
                           .+||+|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+....... .
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-K  230 (274)
T ss_pred             cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-H
Confidence                 3799999988643221     12346788999998865 56899999999999999995 6888865332111 1


Q ss_pred             hHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          484 LQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       484 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                       ..   .+...       ..+    +......+.+++.+||+.+|++||++.+|++.|
T Consensus       231 -~~---~~~~~-------~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         231 -ER---FYEKK-------HRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             -HH---HHHhc-------cCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence             11   11100       001    111223578899999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-37  Score=312.64  Aligned_cols=254  Identities=26%  Similarity=0.368  Sum_probs=201.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|+..+.||+|+||+||++.. ++|+.+|+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            4566778999999999999965 468899999876543 34567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++..   ...+++..+..++.+++.||.|||+  ..+++||||+|+||++++++.++|+|||++....... 
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            999999998843   3458999999999999999999993  3689999999999999999999999999986543221 


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCC-------hhHHHHHhhccCccccccC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS-------PLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~id  501 (611)
                        .....++..|+|||++.+..++.++||||||+++|||++|+.|+........       ........... .     .
T Consensus       159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~  230 (284)
T cd06620         159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-P-----P  230 (284)
T ss_pred             --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-c-----C
Confidence              1235689999999999888999999999999999999999999875433211       11111111100 0     0


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      +.+   ........+.+++.+|++.+|++||++.||+++.
T Consensus       231 ~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         231 PRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            111   0112345678899999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.5e-37  Score=343.80  Aligned_cols=258  Identities=20%  Similarity=0.282  Sum_probs=200.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..++||+|+||.||+|.. .+|+.||||++...   .....++|.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            4788899999999999999965 45899999998643   2334567999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccC--------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeec
Q 007248          347 EYVPNRSLDQFIFDKN--------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                      ||+++++|.+++....        ....+++..+++++.||++||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999985321        1234677888999999999999999   7899999999999999999999999999


Q ss_pred             cceeccCCCc-----------------ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCC
Q 007248          419 LARCFAADRT-----------------HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA  481 (611)
Q Consensus       419 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~  481 (611)
                      +++.......                 .......||+.|+|||++.+..++.++|||||||++|||+||+.|+.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621110                 01113468999999999999999999999999999999999999975422110


Q ss_pred             ChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcc
Q 007248          482 SPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRP-SMAQAIMLLTN  543 (611)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RP-t~~evl~~L~~  543 (611)
                       .   ...    ..+   .++.-. ......+..+.+++.+|++.+|++|| +++++++.|..
T Consensus       239 -i---~~~----~~i---~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        239 -I---SYR----DVI---LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             -h---hhh----hhc---cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             0   000    000   000000 00112334578899999999999996 56667666654

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.9e-37  Score=312.62  Aligned_cols=268  Identities=25%  Similarity=0.403  Sum_probs=203.8

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-----CCCEEEEEEeeccchh-hHHHHHHHHHHHhcCCCCceeeEeeeeee--CCcc
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPES  342 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  342 (611)
                      +.|...+.||+|+||.||++.+.     ++..+|||.+...... ..+.|.+|+++++.++||||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            34667789999999999999753     3689999998755443 56789999999999999999999999887  5578


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||+|||   ..+++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            99999999999999995432  35899999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCCcce--eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCCh-hHHHHHhhccCccccc
Q 007248          423 FAADRTHV--STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASP-LQRVWTLYRSNKLVEA  499 (611)
Q Consensus       423 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  499 (611)
                      ........  .....++..|++||.+....++.++||||||+++|||+||+.|+......... ............+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            65322211  11234456799999998889999999999999999999999886543211100 0000000000011111


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      +........+......+.+++.+|++.+|++||++.||+++|..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            11111112223334668899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.5e-37  Score=311.34  Aligned_cols=254  Identities=25%  Similarity=0.362  Sum_probs=198.0

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeC-----
Q 007248          267 EKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG-----  339 (611)
Q Consensus       267 ~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----  339 (611)
                      +.+++.|+..+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.++.++ +||||+++++++...     
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            34677888899999999999999965 458899999886543 3346788999999998 799999999998753     


Q ss_pred             -CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeec
Q 007248          340 -PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       340 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                       ...++||||+++++|.+++... ....+++..+..++.|++.||+|||   ..+|+|+||||+||++++++.+||+|||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCC
Confidence             3578999999999999998543 2346899999999999999999999   7899999999999999999999999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhc-----CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVR-----GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS  493 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  493 (611)
                      ++....... .......|+..|+|||++..     ..++.++||||||+++|||++|+.|+.....    ........ .
T Consensus       157 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~~~~~~~~-~  230 (272)
T cd06637         157 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRALFLIP-R  230 (272)
T ss_pred             Cceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----HHHHHHHh-c
Confidence            997653322 12234568899999999863     3578899999999999999999999753221    11111111 1


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..     ...+.   .......+.+++.+||+.+|++||++.++++
T Consensus       231 ~~-----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 NP-----APRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CC-----CCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            10     11111   1122345789999999999999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.1e-37  Score=308.89  Aligned_cols=252  Identities=23%  Similarity=0.323  Sum_probs=198.6

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      ++|...+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            3566678899999999999954 568999999987665555567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++..   ...+++.+++.++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||++....... .
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~  161 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A  161 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence            99999999853   335899999999999999999999   7899999999999999999999999999987654321 2


Q ss_pred             eeecccCCccccChhhhh---cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLV---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      ......|+..|+|||++.   ...++.++|||||||++|||++|+.|+.........    .... ....   ..+....
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~----~~~~-~~~~---~~~~~~~  233 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL----FLMT-KSNF---QPPKLKD  233 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH----Hhhh-ccCC---CCCcccc
Confidence            223456889999999874   456888999999999999999999987533221111    1110 0100   0011111


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        .......+.+++.+|++.+|++||++++|++
T Consensus       234 --~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         234 --KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             --cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence              0112235778999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.4e-37  Score=310.13  Aligned_cols=254  Identities=23%  Similarity=0.360  Sum_probs=200.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC----CCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ++|...+.||+|+||.||+|...+    ...++||...... .+..+.|.+|+.++++++||||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457778899999999999996543    2468999876554 4556789999999999999999999998875 457899


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++++|.+++...  ...+++..++.++.+++.||.|||   ..+++|+||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999543  235899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ..........++..|+|||.+....++.++||||||+++|||++ |..||...... .....   . ....         
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~---~-~~~~---------  225 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGR---I-ENGE---------  225 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHH---H-HcCC---------
Confidence            43222223344568999999988889999999999999999986 99887533221 11111   1 1111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ....+......+.+++.+|+..+|++||++.+++..|.+.
T Consensus       226 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0011223345688899999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.2e-37  Score=306.94  Aligned_cols=239  Identities=24%  Similarity=0.374  Sum_probs=187.8

Q ss_pred             CccccCCceeEEEEEcCC-------------CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcce
Q 007248          277 KKLGQGGAGSVYMGSLPN-------------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (611)
                      +.||+|+||.||+|.+..             ...+++|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997532             2358999876655556678999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC-------eEEee
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT-------PKIAD  416 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~D  416 (611)
                      +||||+++++|..++...  ...+++..+++++.||++||+|||   +.+|+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999988532  345899999999999999999999   899999999999999987664       89999


Q ss_pred             eccceeccCCCcceeecccCCccccChhhhh-cCccccccceehhHHHHHHHH-hCCCCCCCCCCCCChhHHHHHhhccC
Q 007248          417 FGLARCFAADRTHVSTAVAGTLGYMAPEYLV-RGQLTEKADVYSFGILIIEIV-CGRRSNAFSQDSASPLQRVWTLYRSN  494 (611)
Q Consensus       417 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~S~Gvll~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~  494 (611)
                      ||++......     ....++..|+|||.+. ...++.++||||||+++|||+ +|+.|+....    ..+. ..... .
T Consensus       156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~----~~~~-~~~~~-~  224 (262)
T cd05077         156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT----LAEK-ERFYE-G  224 (262)
T ss_pred             CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc----hhHH-HHHHh-c
Confidence            9998654321     2345678899999886 466889999999999999998 5776653221    1110 01111 0


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       495 ~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      ..      ..    .......+.+|+..||+.+|++||++.+|++.|
T Consensus       225 ~~------~~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         225 QC------ML----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             Cc------cC----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            00      01    111234578999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.6e-37  Score=316.21  Aligned_cols=241  Identities=24%  Similarity=0.282  Sum_probs=193.2

Q ss_pred             CccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|+||+||++... +++.||||++....   ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999654 57899999987542   23456678899999888 799999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      ++|..++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||+++...... ...
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (318)
T cd05570          81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTT  153 (318)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccc
Confidence            9999988533   35899999999999999999999   8999999999999999999999999999987532221 112


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||....    ... .........      .    .++..
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~----~~~-~~~~i~~~~------~----~~~~~  218 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD----EDE-LFQSILEDE------V----RYPRW  218 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC----HHH-HHHHHHcCC------C----CCCCc
Confidence            23468999999999999999999999999999999999999985322    111 111111111      0    11222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 007248          512 QVCNVLQIGLLCTQAAAALRPSM-----AQAIM  539 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RPt~-----~evl~  539 (611)
                      ....+.+++.+||+.+|++||++     .++++
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            34557899999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.6e-37  Score=317.20  Aligned_cols=241  Identities=22%  Similarity=0.263  Sum_probs=188.9

Q ss_pred             CccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHH-HHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVN-LISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|+||+||++.. .+|+.+|||++....   ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999954 578999999986542   233445666665 56789999999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      |+|..++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||+++...... ...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~  153 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTT  153 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCc
Confidence            999988843   345899999999999999999999   8999999999999999999999999999987532211 122


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||....    ..+...... ...      ..+    +..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~----~~~~~~~~~-~~~------~~~----~~~  218 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD----VAEMYDNIL-HKP------LVL----RPG  218 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC----HHHHHHHHH-cCC------ccC----CCC
Confidence            34568999999999999999999999999999999999999975322    111111111 111      011    112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          512 QVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ....+.+++..|++.+|++||++.+.++
T Consensus       219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         219 ASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             CCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence            3345678899999999999999864443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.5e-36  Score=305.31  Aligned_cols=253  Identities=25%  Similarity=0.346  Sum_probs=189.2

Q ss_pred             CccccCCceeEEEEEcCC---CCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCC
Q 007248          277 KKLGQGGAGSVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  352 (611)
                      +.||+|+||.||+|...+   ...+++|.+.... ......|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            359999999999996533   3578888775443 344567899999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCC--CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc-
Q 007248          353 SLDQFIFDKNK--TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH-  429 (611)
Q Consensus       353 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-  429 (611)
                      +|.+++.....  ....++.....++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||++......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999965432  234568888999999999999999   889999999999999999999999999998654322111 


Q ss_pred             eeecccCCccccChhhhhc-------CccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          430 VSTAVAGTLGYMAPEYLVR-------GQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~-------~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..|+....+    .+........ ......+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~~~~~~-~~~~~~~  232 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD----EQVLKQVVRE-QDIKLPK  232 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHHHHhhc-cCccCCC
Confidence            1123345678999998753       356789999999999999999 6667643221    1111111111 1112222


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      +.+    +......+.+++..|+ .+|++||++++|++.|.
T Consensus       233 ~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         233 PQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             Ccc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            222    2223344667788888 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=9.3e-37  Score=308.24  Aligned_cols=247  Identities=23%  Similarity=0.371  Sum_probs=201.8

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      .|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            456678899999999999965 458899999887543 345678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++..    ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06640          85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence            99999999842    35889999999999999999999   89999999999999999999999999999976643321 


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      ......++..|+|||++.+..++.++||||||+++|||++|+.|+......    ...          ..+........+
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~----------~~~~~~~~~~~~  222 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM----RVL----------FLIPKNNPPTLT  222 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH----hHh----------hhhhcCCCCCCc
Confidence            222345788999999998888999999999999999999999987532211    110          011111112234


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ......+.+++..||+.+|++||++.+++..
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            4456678899999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.4e-37  Score=312.42  Aligned_cols=246  Identities=24%  Similarity=0.385  Sum_probs=198.3

Q ss_pred             CCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      |+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            44567899999999999965 457899999886443 3445678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +++|.+++..    ..+++..+..++.||++||.|||   ..+++|+||+|+||++++++.++|+|||++........ .
T Consensus        86 ~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06642          86 GGSALDLLKP----GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence            9999998842    45889999999999999999999   89999999999999999999999999999976543221 1


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCH
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPA  510 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~  510 (611)
                      .....++..|+|||++.+..++.++||||||+++|||++|+.|+......    .....          +........+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~----------~~~~~~~~~~~  223 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM----RVLFL----------IPKNSPPTLEG  223 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh----hHHhh----------hhcCCCCCCCc
Confidence            22345788999999999888999999999999999999999986532211    11110          11111111222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          511 EQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       511 ~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      .....+.+++.+||+.+|++||++.+|++.
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            344568899999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.7e-37  Score=306.31  Aligned_cols=250  Identities=21%  Similarity=0.299  Sum_probs=201.5

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      +|+..+.||+|+||.||++.. .++..+|+|.+... .....+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            467788999999999999965 46899999988643 3344567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++... ....+++..++.++.||+.||.|||   +.+|+|+||||+||++++++.++|+|||++..+..... 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999999988532 3345789999999999999999999   89999999999999999999999999999976643221 


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      ......++..|+|||++.+..++.++||||||+++|+|++|+.|+....    ......... .+..         ...+
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~----~~~~~~~~~-~~~~---------~~~~  221 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS----WKNLILKVC-QGSY---------KPLP  221 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC----HHHHHHHHh-cCCC---------CCCC
Confidence            2234568889999999988889999999999999999999999975321    111111111 1111         1112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ......+.+++.+||+.+|++||++.+|+..
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            2234457889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9e-37  Score=309.70  Aligned_cols=250  Identities=24%  Similarity=0.294  Sum_probs=197.0

Q ss_pred             CCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      |+..+.||+|+||+||++.. .+++.+|+|.+....   ....+.+.+|+++|+.++|+||+.+++++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            55678899999999999955 568999999986442   22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            99999998885432 345899999999999999999999   8899999999999999999999999999987543221 


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                       ......|+..|+|||++.+..++.++||||||+++|||++|+.||......... .....     .+.+. ..    .+
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-~~~~~-----~~~~~-~~----~~  224 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-EEVDR-----RVLET-EE----VY  224 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHH-----hhhcc-cc----cc
Confidence             122456899999999998889999999999999999999999998643221111 11111     00000 01    11


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPS-----MAQAIM  539 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt-----~~evl~  539 (611)
                      +......+.+++..|++.+|++||+     +.++++
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            2223345778999999999999999     666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-37  Score=308.48  Aligned_cols=248  Identities=26%  Similarity=0.380  Sum_probs=201.1

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|+..+.||.|+||.||+|.. .+++.+|+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            3577788999999999999965 468999999987543 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++...    .+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            9999999998532    6899999999999999999999   8899999999999999999999999999998765432 


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      .......++..|+|||.+.+..++.++||||||+++|||+||+.|+.....    ....... ...     ..+.+... 
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~----~~~~~~~-~~~-----~~~~~~~~-  221 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP----MRVLFLI-PKN-----NPPSLEGN-  221 (274)
T ss_pred             cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch----HHHHHHh-hhc-----CCCCCccc-
Confidence            222345678899999999988899999999999999999999999753321    1111111 111     11111111 


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        .....+.+++..|+..+|++||+++++++
T Consensus       222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 --KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             --ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              03345788999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.4e-37  Score=311.03  Aligned_cols=263  Identities=23%  Similarity=0.343  Sum_probs=196.8

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +|+..+.||+|++|.||+|... ++..||||++....  ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            3677889999999999999654 68999999886432  23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      ++ ++|.+++........+++..+..++.||+.||.|||   ..+++|+||||+|||+++++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 688888865444467899999999999999999999   8899999999999999999999999999997654322 


Q ss_pred             ceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhH----------HHHHhhcc-Ccc
Q 007248          429 HVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ----------RVWTLYRS-NKL  496 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~----------~~~~~~~~-~~~  496 (611)
                      .......++..|+|||.+.+. .++.++||||||+++|||+||+.|+...........          ..|..... ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence            122234568899999988654 578899999999999999999998764321111100          00100000 000


Q ss_pred             ccccCC---CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          497 VEAVDP---NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       497 ~~~id~---~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ...++.   ............++.+++.+|++.||++|||+.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000   0000001112345678999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.8e-37  Score=333.03  Aligned_cols=260  Identities=21%  Similarity=0.303  Sum_probs=191.4

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--------
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--------  339 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  339 (611)
                      ..++|...++||+|+||.||+|.. ..++.||||++....    ....+|+.+|+.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            346789999999999999999965 468999999885432    2345799999999999999999876432        


Q ss_pred             CcceEEEeecCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC-CeEEeee
Q 007248          340 PESLLVYEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADF  417 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df  417 (611)
                      ..+++||||+++ +|.+++... .....+++..+..++.||+.||+|||   ..+|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            235689999985 676666432 23456899999999999999999999   89999999999999999665 6999999


Q ss_pred             ccceeccCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc-
Q 007248          418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK-  495 (611)
Q Consensus       418 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-  495 (611)
                      |+++.+.....  .....||+.|+|||++.+. .++.++|||||||++|||++|++||........ +........... 
T Consensus       216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVRIIQVLGTPTE  292 (440)
T ss_pred             ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCH
Confidence            99986543221  2245679999999998664 689999999999999999999999754322111 111111111000 


Q ss_pred             ---------ccc-----ccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          496 ---------LVE-----AVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       496 ---------~~~-----~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                               ..+     .....+...++......+.+++.+||+.+|++|||+.|+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                     000     00011111122233456889999999999999999999984

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.1e-37  Score=316.76  Aligned_cols=255  Identities=19%  Similarity=0.200  Sum_probs=195.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|...+.||+|+||.||++... +++.||+|.+....   ....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999654 67899999986432   233456888999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++...  ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999642  235889999999999999999999   899999999999999999999999999999876544


Q ss_pred             CcceeecccCCccccChhhhhc-----CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVR-----GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      .........|++.|+|||++..     +.++.++||||||+++|||++|+.||....    ..+.............   
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~~---  228 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHEERFQ---  228 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC----HHHHHHHHHcCCCccc---
Confidence            3333334568999999999875     467889999999999999999999985322    1121111111110000   


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAAL--RPSMAQAIML  540 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~--RPt~~evl~~  540 (611)
                        +. .........+.+++.+|+...+..  |++++++++.
T Consensus       229 --~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 --FP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             --CC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence              00 001122345677887887765433  5678887643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.8e-37  Score=309.47  Aligned_cols=249  Identities=29%  Similarity=0.434  Sum_probs=196.1

Q ss_pred             CccccCCceeEEEEEcCC-------CCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          277 KKLGQGGAGSVYMGSLPN-------GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +.||+|+||.||+|...+       +..+|||.+.... ......|.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999996543       2579999876443 24456899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccC----CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC-----CeEEeeecc
Q 007248          349 VPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-----TPKIADFGL  419 (611)
Q Consensus       349 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfGl  419 (611)
                      +++++|.+++....    ....+++..++.++.||+.||.|||   +.+++|+||||+||+++.++     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996432    2235789999999999999999999   78999999999999999877     899999999


Q ss_pred             ceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccc
Q 007248          420 ARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLV  497 (611)
Q Consensus       420 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (611)
                      ++....... .......++..|+|||++.++.++.++||||||+++|||+| |+.|+.....    .+.... ...+   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~~~~~~-~~~~---  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQH-VTAG---  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----HHHHHH-HhcC---
Confidence            975533221 11123345678999999999999999999999999999998 8888753211    111111 1111   


Q ss_pred             cccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       498 ~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                            .....+...+..+.+++.+||+.+|++||++++|++.|.
T Consensus       230 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         230 ------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                  111122334456789999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.5e-37  Score=317.26  Aligned_cols=240  Identities=25%  Similarity=0.332  Sum_probs=190.1

Q ss_pred             CccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhc-CCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISS-IEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|+||+||+|... +++.||||++....   ....+.+..|..++.. ++||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999654 57899999987542   2334567778888876 4999999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      |+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKT  153 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cce
Confidence            999999853   245889999999999999999999   8899999999999999999999999999987532211 122


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.....    .+ ........      .+.    ++..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~-~~~~i~~~------~~~----~~~~  218 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE----EE-LFQSIRMD------NPC----YPRW  218 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH----HH-HHHHHHhC------CCC----CCcc
Confidence            345689999999999988999999999999999999999999753221    11 11111111      111    1222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 007248          512 QVCNVLQIGLLCTQAAAALRPSMA-QAI  538 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RPt~~-evl  538 (611)
                      ....+.+++..|++.+|++||++. ++.
T Consensus       219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         219 LTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            334577899999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-36  Score=311.03  Aligned_cols=250  Identities=25%  Similarity=0.405  Sum_probs=202.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .++|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            35788889999999999999964 57899999999766555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++..    ..+++..+..++.|++.||.|||   +.+++||||||+|||++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            999999999843    34789999999999999999999   78999999999999999999999999999876543321


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                       ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........    ....+      .+.+  ..
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~----~~~~~------~~~~--~~  237 (297)
T cd06656         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNG------TPEL--QN  237 (297)
T ss_pred             -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----eccCC------CCCC--CC
Confidence             12234578899999999888899999999999999999999999854322111100    00000      0000  11


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +......+.+++.+||+.+|++||++.+|++
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2233445778999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1e-36  Score=312.90  Aligned_cols=260  Identities=22%  Similarity=0.329  Sum_probs=198.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|++.++||+|+||.||++.. .++..+|+|.+.... ....+.+.+|++++.+++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            3688899999999999999965 467889999886542 33456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++...   ..+++..+..++.||++||.|||+  ..+++|+||||+|||++.++.+||+|||++....... 
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            9999999999543   458899999999999999999993  3689999999999999999999999999987543221 


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhh-ccCc------------
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY-RSNK------------  495 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~------------  495 (611)
                        .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... .. ........ ....            
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KE-LEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hh-HHHhhcCccccccccCCcccccCCC
Confidence              2235678899999999888899999999999999999999999753321 11 11000000 0000            


Q ss_pred             --------cccccCCCC---CCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          496 --------LVEAVDPNL---KDDFP-AEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       496 --------~~~~id~~l---~~~~~-~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                              ..+..+...   ....+ ......+.+++.+|++.+|++||++.+|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    000000000   00000 0123457899999999999999999999854

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.1e-37  Score=317.75  Aligned_cols=240  Identities=25%  Similarity=0.323  Sum_probs=190.3

Q ss_pred             CccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|+||.||++..+ +|..||||.+....   ....+.+..|..++..+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999654 68899999987542   23345677788888754 899999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      |+|.+++..   ...+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA  153 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence            999999853   245889999999999999999999   8999999999999999999999999999987432211 122


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ....|+..|+|||++.+..++.++||||||+++|||++|+.||.....     ...+......      .+    .++..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~~~~~------~~----~~~~~  218 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFESIRVD------TP----HYPRW  218 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC------CC----CCCCC
Confidence            346689999999999999999999999999999999999999853221     1111111111      11    11222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 007248          512 QVCNVLQIGLLCTQAAAALRPSMA-QAI  538 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RPt~~-evl  538 (611)
                      ....+.+++..|++.||++||++. ++.
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         219 ITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            334577899999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-36  Score=308.91  Aligned_cols=250  Identities=23%  Similarity=0.305  Sum_probs=198.1

Q ss_pred             CCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      |+..+.||+|+||.||++.. .+++.+|||.+....   .+..+.+.+|+.++++++|+||+.+++.+.+++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            66778999999999999954 468999999886432   22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            99999999885432 345899999999999999999999   89999999999999999999999999999875433221


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                        .....|+..|+|||++.+..++.++||||||+++|||++|+.||........ ..........      +..    .+
T Consensus       158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~~~~~~~------~~~----~~  224 (285)
T cd05630         158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKE------VQE----EY  224 (285)
T ss_pred             --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHHHhhhhh------hhh----hc
Confidence              1234689999999999988999999999999999999999999864332111 0111111000      001    11


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPS-----MAQAIM  539 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt-----~~evl~  539 (611)
                      +......+.+++..|++.+|++||+     ++|+++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            2223345788999999999999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-37  Score=301.25  Aligned_cols=263  Identities=26%  Similarity=0.345  Sum_probs=198.0

Q ss_pred             CCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccch-hh-HHHHHHHHHHHhcCCCCc-eeeEeeeeeeCC------c
Q 007248          272 YFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTR-QW-VDEFFNEVNLISSIEHKN-LVKLLGCSIEGP------E  341 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~  341 (611)
                      .|...++||+|.||+||+|+ ..+|+.||+|++..... +. -....+|+.+|++|+|+| ||.|++++...+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            34456779999999999994 45789999999976643 22 234579999999999999 999999998877      7


Q ss_pred             ceEEEeecCCCChhhhhhccCCC-ccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      +++|+||+ ..+|..++...... ..++...+..++.||++||+|||   +++|+||||||.||||+++|.+||+|||+|
T Consensus        92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchH
Confidence            89999999 45999998554322 35677889999999999999999   899999999999999999999999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc---c
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK---L  496 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~  496 (611)
                      +.+.-.. ...+...+|.+|.|||++.+. .|+...||||+|||+.||++++.-|....+ .+.+..+........   +
T Consensus       168 ra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  168 RAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCCccCC
Confidence            9665332 224456679999999999886 789999999999999999998765543332 223333333222211   1


Q ss_pred             ---ccccCCCC--CCCC-CH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          497 ---VEAVDPNL--KDDF-PA-------EQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       497 ---~~~id~~l--~~~~-~~-------~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                         ..+.+-..  .... +.       .......+++..|++.+|.+|.+++..+.+
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence               11111110  0000 00       011357789999999999999999998865

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=331.87  Aligned_cols=250  Identities=28%  Similarity=0.429  Sum_probs=206.8

Q ss_pred             CCCCccccCCceeEEEEEc-CCC----CEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          274 NPSKKLGQGGAGSVYMGSL-PNG----TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       274 ~~~~~iG~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ...++||+|+||+||+|.+ ++|    .+||||++... ..+...+|++|+-+|.+++|||+++|+|+|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3468999999999999954 554    46899987644 4556789999999999999999999999998766 889999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |||.|+|.+|++.  .+..+..+..+.|..|||+||.|||   .++++||||..+|||+.....+||.|||+++....+.
T Consensus       778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            9999999999965  3456888999999999999999999   8999999999999999999999999999999887665


Q ss_pred             cceee-cccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          428 THVST-AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       428 ~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ..... ...-.+.|||=|.+....++.++|||||||.+||++| |..|.+.     ...+.         +.+++....+
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-----i~~~e---------I~dlle~geR  918 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-----IPAEE---------IPDLLEKGER  918 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-----CCHHH---------hhHHHhcccc
Confidence            54333 3344678999999999999999999999999999998 6666432     22222         2233333334


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      -..|+-+...+..++..||..|+..||+++++...+.+
T Consensus       919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence            45577788889999999999999999999999876643

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.2e-37  Score=309.04  Aligned_cols=250  Identities=26%  Similarity=0.383  Sum_probs=197.8

Q ss_pred             CCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      |+..+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            456688999999999999664 5778899988766666677899999999999999999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      ++|..++...  ...+++..+..++.||++||.|||   +.+++||||||+|||++.++.+||+|||++....... ...
T Consensus        87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~  160 (282)
T cd06643          87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR  160 (282)
T ss_pred             CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence            9999988542  346899999999999999999999   7899999999999999999999999999987543221 122


Q ss_pred             ecccCCccccChhhhh-----cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          432 TAVAGTLGYMAPEYLV-----RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      ....++..|+|||++.     ...++.++|||||||++|||++|+.|+....    ..+..........      +.+  
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----~~~~~~~~~~~~~------~~~--  228 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN----PMRVLLKIAKSEP------PTL--  228 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC----HHHHHHHHhhcCC------CCC--
Confidence            3456889999999984     3457789999999999999999999865322    1111111111100      000  


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ..+......+.+++..||+.+|++||++.++++.
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1122233457899999999999999999998743

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.6e-37  Score=342.83  Aligned_cols=258  Identities=22%  Similarity=0.330  Sum_probs=198.1

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--C
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--P  340 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  340 (611)
                      .+...++|.+.++||+|+||+||++.. ..+..+|+|.+...  .......|..|+.+|++|+|||||++++++...  .
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            344567899999999999999999965 45778999988643  234456789999999999999999999988643  4


Q ss_pred             cceEEEeecCCCChhhhhhccC-CCccCChhHHHHHHHHHHHHHHHHhcCC----CCceecCCCCcccEEECCC------
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGS----ETRIIHRDIKTSNILLDKD------  409 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~ivH~Dlkp~NIll~~~------  409 (611)
                      .++|||||+++++|.++|.... ....+++..++.|+.||+.||.|||...    ..+||||||||+||||+.+      
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            6899999999999999996432 2356999999999999999999999421    1469999999999999642      


Q ss_pred             -----------CCeEEeeeccceeccCCCcceeecccCCccccChhhhhc--CccccccceehhHHHHHHHHhCCCCCCC
Q 007248          410 -----------FTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR--GQLTEKADVYSFGILIIEIVCGRRSNAF  476 (611)
Q Consensus       410 -----------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvll~elltG~~p~~~  476 (611)
                                 +.+||+|||++..+....  ......||+.|+|||++..  ..++.++||||||||||||+||+.||..
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                       348999999997654322  2234568999999999864  4588999999999999999999999853


Q ss_pred             CCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          477 SQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ...    ...+...+....       .+.   .......+.+|+..||+.+|++||++.|++.
T Consensus       246 ~~~----~~qli~~lk~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        246 ANN----FSQLISELKRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCc----HHHHHHHHhcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            322    111111111111       110   0112345788999999999999999999983

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.4e-37  Score=316.32  Aligned_cols=242  Identities=21%  Similarity=0.256  Sum_probs=187.8

Q ss_pred             CccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHH-HHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVN-LISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|+||+||++... +++.||+|++....   ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999654 57889999986432   222334555544 56789999999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      ++|.+++..   ...+.+..+..++.||++||.|||   ..+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~  153 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT  153 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence            999999853   234778888889999999999999   8999999999999999999999999999997532221 122


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||....    ..+...... ...        +  ..+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~-~~~--------~--~~~~~  218 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----TAEMYDNIL-NKP--------L--QLKPN  218 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC----HHHHHHHHH-hCC--------c--CCCCC
Confidence            34568999999999999999999999999999999999999975322    111111111 111        0  11122


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          512 QVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ....+.+++..|++.+|.+||++.+.+..
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         219 ITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            33457788999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=319.91  Aligned_cols=245  Identities=29%  Similarity=0.433  Sum_probs=203.5

Q ss_pred             ccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCChhh
Q 007248          278 KLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQ  356 (611)
Q Consensus       278 ~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~  356 (611)
                      +||+|.||+||.|+. .+...+|||.+.....+..+.+..|+.+.++|+|+|||+++|.+.+++..-+.||-+|||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            699999999999965 4567899999987777777889999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCccC--ChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-CCCeEEeeeccceeccCCCcceeec
Q 007248          357 FIFDKNKTKLL--NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAADRTHVSTA  433 (611)
Q Consensus       357 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~  433 (611)
                      +|..+-  +++  ++..+--+..||++||.|||   ...|||||||-.|||++. .|.+||+|||.++.+..-. ....+
T Consensus       662 LLrskW--GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TET  735 (1226)
T KOG4279|consen  662 LLRSKW--GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTET  735 (1226)
T ss_pred             HHHhcc--CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC-ccccc
Confidence            996543  345  67777888999999999999   899999999999999985 5789999999998765332 23446


Q ss_pred             ccCCccccChhhhhcCc--cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          434 VAGTLGYMAPEYLVRGQ--LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       434 ~~gt~~y~aPE~~~~~~--~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ..||..|||||++..++  |...+|||||||.+.||.||++||-...+.+..      +++-+-.      ....+.|.+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA------MFkVGmy------KvHP~iPee  803 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA------MFKVGMY------KVHPPIPEE  803 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh------hhhhcce------ecCCCCcHH
Confidence            77999999999998874  788999999999999999999998644332211      1111111      122456778


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          512 QVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ...+...++++|+.++|.+||++.++++-
T Consensus       804 lsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  804 LSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             HHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            88889999999999999999999999853

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.4e-37  Score=309.95  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=199.9

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      +|+..+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5778899999999999999764 7899999988654 3344578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|..++........+++..+..++.+|+.||.|||+  +.+|+|+||||+||+++.++.+||+|||++..+....  
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  157 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--  157 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence            999999998654334468999999999999999999993  3689999999999999999999999999987553221  


Q ss_pred             eeecccCCccccChhhhhcCc------cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQ------LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~------~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                       .....++..|+|||.+.+..      ++.++||||||+++|||++|+.||...... ........         ..+. 
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~---------~~~~-  225 (286)
T cd06622         158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-NIFAQLSA---------IVDG-  225 (286)
T ss_pred             -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-hHHHHHHH---------Hhhc-
Confidence             22345788999999985543      478999999999999999999997543211 11111111         1110 


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .....+......+.+++.+|++.+|++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         226 DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            011223334556789999999999999999999885

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.9e-37  Score=304.66  Aligned_cols=251  Identities=30%  Similarity=0.494  Sum_probs=199.7

Q ss_pred             CCCCCccccCCceeEEEEEcCC-----CCEEEEEEeeccchh-hHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          273 FNPSKKLGQGGAGSVYMGSLPN-----GTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      |.+.+.||.|+||.||++...+     +..+|+|++...... ..+.+.+|++++..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3467889999999999996643     488999998755432 5678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++..... ..+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999954322 12899999999999999999999   889999999999999999999999999999876544


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .........++..|+|||.+....++.++||||+|++++||++ |+.|+... ......    .......         .
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-~~~~~~----~~~~~~~---------~  222 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-SNEEVL----EYLKKGY---------R  222 (258)
T ss_pred             cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CHHHHH----HHHhcCC---------C
Confidence            2222222346789999999988889999999999999999998 66665431 111111    1111111         1


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      ...+......+.+++.+|+..+|++|||+.++++.|
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            111222455688899999999999999999998765

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.2e-36  Score=303.50  Aligned_cols=251  Identities=21%  Similarity=0.349  Sum_probs=203.1

Q ss_pred             CCCCCCccccCCceeEEEEE-cCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +|+..+.||+|+||.||.+. ..++..+++|++...  .....+.+.+|++++++++|+||+++++++.+++..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            47778999999999999885 456889999987654  344566789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++.... ...+++..+..++.|+++||.|||   +.+++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999996432 346899999999999999999999   78999999999999999999999999999986644332


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....    ..+...... .+...         ..
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~~~~~~~~-~~~~~---------~~  221 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN----PLNLVVKIV-QGNYT---------PV  221 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHH-cCCCC---------CC
Confidence             2234568899999999988888999999999999999999999875322    112111111 11111         11


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      +......+.+++.+|++.+|++||++.++++.+
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            122345578899999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.8e-37  Score=306.41  Aligned_cols=248  Identities=28%  Similarity=0.474  Sum_probs=198.6

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch---------hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR---------QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (611)
                      +|.....||+|+||.||+|.. .+++.+|+|.+.....         +..+.+.+|+.++++++||||+++++++.++..
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            366788999999999999965 4688999998864321         223568899999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .++|+||+++++|.+++..   ...+++..+..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999943   345889999999999999999999   7899999999999999999999999999998


Q ss_pred             eccCCCcc-----eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcc
Q 007248          422 CFAADRTH-----VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL  496 (611)
Q Consensus       422 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (611)
                      ........     ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....    ........     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-----  225 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQAIFKIG-----  225 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HHHHHHHh-----
Confidence            66432111     11134578899999999888899999999999999999999999753221    11111110     


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          497 VEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       497 ~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       ...    ....+......+.+++.+||+.+|++||++.+|++
T Consensus       226 -~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 -ENA----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -ccC----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence             111    11223334456788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.3e-36  Score=305.00  Aligned_cols=250  Identities=26%  Similarity=0.411  Sum_probs=199.1

Q ss_pred             CCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccc------hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      +|...+.||+|+||+||+|...+++.+|||.+....      ....+.+.+|++++++++|+||+++++++.++...++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            367788999999999999988789999999886432      22345688999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      +||+++++|.+++...   ..+++..+..++.|++.||+|||   ..+|+|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999999532   35789999999999999999999   78999999999999999999999999999875432


Q ss_pred             CC-----cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          426 DR-----THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       426 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      ..     ........++..|+|||++.+..++.++||||||+++|||++|+.|+.......    .........    ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~----~~  226 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----AMFYIGAHR----GL  226 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH----HHHHhhhcc----CC
Confidence            11     111223457889999999988889999999999999999999999985332111    100000000    01


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+.    .+......+.+++.+||+.+|++||++.+++.
T Consensus       227 ~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 MPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111    22233455788999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.2e-37  Score=308.25  Aligned_cols=241  Identities=25%  Similarity=0.422  Sum_probs=189.1

Q ss_pred             CccccCCceeEEEEEcCC--------CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          277 KKLGQGGAGSVYMGSLPN--------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +.||+|+||.||+|....        ...+++|.+........+.|.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999996532        235888887665556667899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC--------eEEeeeccc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT--------PKIADFGLA  420 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DfGla  420 (611)
                      +++|+|.+++....  ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999996432  35899999999999999999999   899999999999999987765        599999988


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      ......     ....++..|+|||++.+. .++.++||||||+++|||++|..++....+   ..... .....      
T Consensus       156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~---~~~~~-~~~~~------  220 (258)
T cd05078         156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD---SQKKL-QFYED------  220 (258)
T ss_pred             cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc---HHHHH-HHHHc------
Confidence            654321     234578899999999764 578999999999999999999644221111   11100 00100      


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                           ....+......+.+++..||+.+|++||+++++++.|+
T Consensus       221 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 -----RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -----cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                 01122223356789999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.4e-37  Score=305.24  Aligned_cols=247  Identities=27%  Similarity=0.439  Sum_probs=197.1

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      ++|...+.||+|+||.||++.. .++.+|+|.+....  ..+.+.+|+.++++++||||+++++++..+ ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            3577889999999999999975 67889999886443  246789999999999999999999998764 4799999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +++|.+++.... ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++......   
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            999999996432 345889999999999999999999   8999999999999999999999999999987543211   


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                       .....+..|+|||.+.++.++.++||||||+++|||++ |+.|+....    ... .......+         .....+
T Consensus       155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~~~-~~~~~~~~---------~~~~~~  219 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS----LKE-VKECVEKG---------YRMEPP  219 (254)
T ss_pred             -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC----HHH-HHHHHhCC---------CCCCCC
Confidence             12234568999999988899999999999999999998 888864321    111 11111111         111122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ...+..+.+++.+|++.+|+.||++++|++.|..
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            2334567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.2e-36  Score=305.76  Aligned_cols=254  Identities=25%  Similarity=0.376  Sum_probs=200.2

Q ss_pred             CCCCCCccccCCceeEEEEEcCC--CCEEEEEEeecc----------chhhHHHHHHHHHHHhc-CCCCceeeEeeeeee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPN--GTTVAVKRLIFN----------TRQWVDEFFNEVNLISS-IEHKNLVKLLGCSIE  338 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  338 (611)
                      +|+..+.||+|+||.||+|....  ++.+|+|.+...          ......++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36778899999999999997654  688999987532          22334567889998875 799999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeee
Q 007248          339 GPESLLVYEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (611)
Q Consensus       339 ~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  417 (611)
                      ++..++||||+++++|.+++... .....+++..+++++.|++.||.|||+  ..+++|+||+|+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999988432 234568999999999999999999993  368999999999999999999999999


Q ss_pred             ccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccc
Q 007248          418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV  497 (611)
Q Consensus       418 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (611)
                      |++.......  ......++..|++||.+.+..++.++||||||+++|||++|+.|+....    ........ ......
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~----~~~~~~~~-~~~~~~  231 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN----MLSLATKI-VEAVYE  231 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC----HHHHHHHH-hhccCC
Confidence            9998654432  2334568889999999998889999999999999999999999874321    11111111 111110


Q ss_pred             cccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       498 ~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                          +    .........+.+++.+||+.+|++||++.||..+|.
T Consensus       232 ----~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         232 ----P----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ----c----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                0    001122345788999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=299.81  Aligned_cols=264  Identities=26%  Similarity=0.357  Sum_probs=200.8

Q ss_pred             HHhcCCCCCCccccCCceeEEEE-EcCCCCEEEEEEee--ccchhhHHHHHHHHHHHhcCCCCceeeEeeeeee-----C
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-----G  339 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~  339 (611)
                      .....|...+.||+|+||.|..+ ...+|+.||||++.  ....-..++-.+|+++|+.++|+||+.+++.+..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            34455666788999999999999 45678999999997  5556667888999999999999999999998765     3


Q ss_pred             CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecc
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  419 (611)
                      +..|+|+|+| ..+|...|+   ..+.|+.....-++.||++||.|+|   +.+|+||||||+|+|++.+..+||+||||
T Consensus        99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccc
Confidence            4679999999 668998884   3334889999999999999999999   89999999999999999999999999999


Q ss_pred             ceeccCC-CcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHH-----------
Q 007248          420 ARCFAAD-RTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQR-----------  486 (611)
Q Consensus       420 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~-----------  486 (611)
                      |+..... .....+..+.|.+|.|||++.. ..++...||||.|||+.||++|+.-|...... ..++.           
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v-~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV-HQLQLILELLGTPSEE  250 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH-HHHHHHHHhcCCCCHH
Confidence            9987543 1223356678999999998765 57999999999999999999999776543321 11111           


Q ss_pred             HHHhhccCccccccCC---CCC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          487 VWTLYRSNKLVEAVDP---NLK----DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       487 ~~~~~~~~~~~~~id~---~l~----~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ....+..+.....+..   .-.    ..++ ......++++.+++..||.+|+|.+|.++.
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1111221111111110   000    1111 223346788889999999999999998753

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-36  Score=303.76  Aligned_cols=238  Identities=26%  Similarity=0.420  Sum_probs=187.7

Q ss_pred             CccccCCceeEEEEEcCCCC-----------EEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          277 KKLGQGGAGSVYMGSLPNGT-----------TVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      +.||+|+||.||+|...+..           .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999775433           5788876544433 6789999999999999999999999888 778999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC-------CeEEeeec
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-------TPKIADFG  418 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~DfG  418 (611)
                      |||+++++|.+++....  ..+++..++.++.||+.||.|||   ..+|+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999995432  26899999999999999999999   89999999999999999887       79999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcC--ccccccceehhHHHHHHHHhC-CCCCCCCCCCCChhHHHHHhhccCc
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRG--QLTEKADVYSFGILIIEIVCG-RRSNAFSQDSASPLQRVWTLYRSNK  495 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~S~Gvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~  495 (611)
                      ++.....     .....++..|+|||++...  .++.++||||||+++|||++| ..|+..... . ...   ..+....
T Consensus       154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~-~~~---~~~~~~~  223 (259)
T cd05037         154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-S-EKE---RFYQDQH  223 (259)
T ss_pred             ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-h-hHH---HHHhcCC
Confidence            9976543     1233466789999998876  789999999999999999995 555433211 1 111   1111000


Q ss_pred             cccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       496 ~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                              .   .+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       224 --------~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         224 --------R---LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             --------C---CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                    0   01111256889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.4e-37  Score=311.27  Aligned_cols=250  Identities=25%  Similarity=0.433  Sum_probs=202.1

Q ss_pred             cCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      .+|...+.||.|+||.||+|. ..+++.|++|.+........+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            357788899999999999995 4578999999987665555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++..    ..+++.++..++.+++.||+|||   +.+++|+||||+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            99999998842    34899999999999999999999   88999999999999999999999999999876543322 


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....    ........... .     +.+  ..+
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~----~~~~~~~~~~~-~-----~~~--~~~  238 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYLIATNG-T-----PEL--QNP  238 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcC-C-----ccc--CCc
Confidence            12234578899999999888899999999999999999999999754322    11111111110 0     001  112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ......+.+++.+||..+|++||++.+|+..
T Consensus       239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            2233457789999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=303.81  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=203.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      ++|+..+.||+|+||.||++.. .+++.+++|.+........+.+.+|++++++++||||+++++++..+...+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            5788889999999999999965 457889999988766666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++...  ...+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++....... .
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~  156 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A  156 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence            999999998543  245889999999999999999999   7899999999999999999999999999987654321 1


Q ss_pred             eeecccCCccccChhhhhcC---ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRG---QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~---~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      ......++..|+|||.+...   .++.++||||||+++|||+||+.|+......    ...... ....+   ....+  
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~----~~~~~~-~~~~~---~~~~~--  226 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM----RALFLI-SKSNF---PPPKL--  226 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH-HhccC---CCccc--
Confidence            22334678899999998776   7889999999999999999999997532211    111111 01100   00111  


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .........+.+++.+||+.+|.+||++.+|+.
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            112334556889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=307.97  Aligned_cols=254  Identities=25%  Similarity=0.409  Sum_probs=200.1

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC-CC----EEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN-GT----TVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      .+|+..+.||+|+||.||+|..++ |.    .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            456778999999999999997542 33    58999876553 3455789999999999999999999999887 78899


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||+|||   ..+++|+||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999999543  234899999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCCccee-ecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          425 ADRTHVS-TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       425 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ....... ....++..|+|||.+....++.++||||||+++|||++ |+.|+....    ..+ .........       
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~-~~~~~~~~~-------  228 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP----AVE-IPDLLEKGE-------  228 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC----HHH-HHHHHhCCC-------
Confidence            3322211 12223568999999988889999999999999999999 998875321    111 111111111       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                        ....+......+.+++.+||..+|++||++.++++.|.+.
T Consensus       229 --~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         229 --RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence              0111222334578899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.5e-36  Score=309.08  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=199.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      +.|++.++||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56778899999999999999664 58999999988776667788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|..++...  ...+++..+..++.|++.||.|||   ..+++||||||+||+++.++.+||+|||++....... .
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~  165 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q  165 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence            999998887533  235899999999999999999999   8899999999999999999999999999987543221 1


Q ss_pred             eeecccCCccccChhhhh-----cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLV-----RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ......++..|+|||++.     ...++.++||||||+++|||++|+.|+.....    ...........      .+.+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~------~~~~  235 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAKSE------PPTL  235 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH----HHHHHHHhcCC------CccC
Confidence            223345788999999884     34567899999999999999999998753221    11111111110      0111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        ..+......+.+++.+||+.+|++||++.++++
T Consensus       236 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 --SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             --CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence              112223345788999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.9e-37  Score=314.98  Aligned_cols=241  Identities=22%  Similarity=0.286  Sum_probs=191.8

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCCcceEEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  346 (611)
                      +|+..+.||+|+||.||++.. .+|+.||||++....   ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            367788999999999999964 468999999987542   233456788999998885 577888999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999999843   245899999999999999999999   889999999999999999999999999998754322


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      . .......||..|+|||++.+..++.++||||||+++|||++|+.|+.....    ........ ...          .
T Consensus       155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~-~~~----------~  218 (323)
T cd05615         155 G-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DELFQSIM-EHN----------V  218 (323)
T ss_pred             C-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHH-hCC----------C
Confidence            1 122345689999999999988999999999999999999999999753321    11111111 111          0


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSM  534 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~  534 (611)
                      .++......+.+++.+|++.+|++|++.
T Consensus       219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            1222334557889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.9e-36  Score=303.11  Aligned_cols=252  Identities=20%  Similarity=0.327  Sum_probs=188.6

Q ss_pred             ccccCCceeEEEEEcCCC---CEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCC
Q 007248          278 KLGQGGAGSVYMGSLPNG---TTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRS  353 (611)
Q Consensus       278 ~iG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs  353 (611)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999965433   356677665433 3456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCC-CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC-ccee
Q 007248          354 LDQFIFDKNK-TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR-THVS  431 (611)
Q Consensus       354 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~  431 (611)
                      |.+++..... ...+++..+..++.||++||+|||   +.+++||||||+|||++.++.+||+|||++....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999965322 345677788899999999999999   7899999999999999999999999999985422111 1122


Q ss_pred             ecccCCccccChhhhhc-------CccccccceehhHHHHHHHHhC-CCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          432 TAVAGTLGYMAPEYLVR-------GQLTEKADVYSFGILIIEIVCG-RRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~-------~~~~~ksDV~S~Gvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      ....++..|+|||++..       ..++.++||||||+++|||+++ ..|+....    ..+...... .+......++.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~----~~~~~~~~~-~~~~~~~~~~~  233 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS----DREVLNHVI-KDQQVKLFKPQ  233 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHH-hhcccccCCCc
Confidence            24557889999998753       2457899999999999999975 55553211    111111111 12222333343


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      +...+    ...+.+++..|| .+|++||++++|++.|.
T Consensus       234 ~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         234 LELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            33222    345677888899 67999999999999884

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.5e-36  Score=312.20  Aligned_cols=255  Identities=19%  Similarity=0.206  Sum_probs=194.7

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..++||+|+||.||++..+ .++.+|+|++....   ....+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36788899999999999999664 47889999986422   223445889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999999542  235889999999999999999999   899999999999999999999999999999765443


Q ss_pred             CcceeecccCCccccChhhhh-----cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLV-----RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      .........||+.|+|||++.     ...++.++|||||||++|||++|+.||...    ...+.............   
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~----~~~~~~~~i~~~~~~~~---  228 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHKERFQ---  228 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC----CHHHHHHHHhCCCcccc---
Confidence            333333457899999999986     346788999999999999999999997532    22222222211111000   


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHH
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQA--AAALRPSMAQAIML  540 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~--~p~~RPt~~evl~~  540 (611)
                        . ..........+.+++..|+..  ++..||++.++++.
T Consensus       229 --~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 --F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              0 001112234466777776644  44447899988754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.2e-37  Score=306.51  Aligned_cols=252  Identities=30%  Similarity=0.438  Sum_probs=197.6

Q ss_pred             CCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhH--HHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWV--DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      |+..+.||+|+||+||++... +++.+|+|++........  ....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999664 467899999987654322  23456999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++.   ....+++..++.++.||++||.+||   +.+|+|+||||+||++++++.++|+|||.+.... ....
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE  153 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred             cccccccccc---ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-cccc
Confidence            9999999995   3456899999999999999999999   7899999999999999999999999999997642 2222


Q ss_pred             eeecccCCccccChhhhh-cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLV-RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      ......++..|+|||++. ....+.++||||+|+++|+|++|+.|+...... ........... .......   .   .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~~~~~~~~~~-~~~~~~~---~---~  225 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQLEIIEKILK-RPLPSSS---Q---Q  225 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HHHHHHHHHHH-THHHHHT---T---S
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccch-hhhhhhhhccc-ccccccc---c---c
Confidence            334567899999999998 788999999999999999999999997644100 11111111000 0000000   0   0


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .......+.+++..|++.+|++||++.++++
T Consensus       226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0011267889999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-37  Score=312.85  Aligned_cols=254  Identities=23%  Similarity=0.367  Sum_probs=205.3

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceE
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (611)
                      .....|++.++||+||.++||++...+.+.+|+|++...  +.+....|.+|+.+|.+| .|.+||.|++|...++.+|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            345668889999999999999999888889999987543  567788999999999999 59999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||- ..+|..+|..+.. ...+| .+..++.||+.++.++|   +.+|||.||||.|+|+-. |.+||+|||+|..+.
T Consensus       438 vmE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ  510 (677)
T ss_pred             Eeecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence            99975 5699999954432 33445 67789999999999999   899999999999999864 589999999999887


Q ss_pred             CCCcce-eecccCCccccChhhhhcC-----------ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc
Q 007248          425 ADRTHV-STAVAGTLGYMAPEYLVRG-----------QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR  492 (611)
Q Consensus       425 ~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~  492 (611)
                      .+.+.. ....+||+.||+||.+...           +.+.++||||+|||||+|+.|+.||....       ..|    
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~----  579 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQI----  579 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHH----
Confidence            766543 3467899999999998643           25678999999999999999999974211       111    


Q ss_pred             cCccccccCCCCCCCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          493 SNKLVEAVDPNLKDDFPAEQ-VCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       493 ~~~~~~~id~~l~~~~~~~~-~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                       .++..+.|+....+|+.-- ...++++++.||+.||++||++.||++.
T Consensus       580 -aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  580 -AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence             2345566665544443321 2228899999999999999999999854

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-37  Score=318.52  Aligned_cols=242  Identities=26%  Similarity=0.346  Sum_probs=200.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (611)
                      .++|....+||+|.||+|+++..+ +++.+|||.+++..   +..++..+.|.+|+... +||.++.++.+|...+.+|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            467888999999999999999654 57899999998663   45577888899988877 59999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+.||++..++    ....+++..+.-++..|+.||.|||   +++||+||||..|||||.+|.+||+||||++.--
T Consensus       447 vmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC
Confidence            99999999955444    3356899999999999999999999   8999999999999999999999999999998533


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      .. .....+.+||+.|||||++.+..|+...|.|+|||+||||+.|..||....+. +.++    .+..       |.  
T Consensus       520 ~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-e~Fd----sI~~-------d~--  584 (694)
T KOG0694|consen  520 GQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-EVFD----SIVN-------DE--  584 (694)
T ss_pred             CC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHH----HHhc-------CC--
Confidence            22 22456789999999999999999999999999999999999999997633221 1111    1111       11  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSM  534 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~  534 (611)
                       ..+|.-...+.+.|+.+.+..+|++|--+
T Consensus       585 -~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 -VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence             12455566678899999999999999877

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.8e-36  Score=301.48  Aligned_cols=256  Identities=29%  Similarity=0.404  Sum_probs=204.6

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|+..+.||.|+||+||+|.. .++..+++|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4688899999999999999965 467899999886442 33567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++........+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999965443456899999999999999999999   89999999999999999999999999999976654332


Q ss_pred             c---eeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          429 H---VSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       429 ~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      .   ......++..|+|||++... .++.++||||||+++|||++|+.|+........    ........      .+.+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~~~------~~~~  227 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV----LMLTLQND------PPSL  227 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh----HHHHhcCC------CCCc
Confidence            2   12234578899999998877 789999999999999999999999754322211    11111111      1111


Q ss_pred             CCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          505 KDDF-PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       505 ~~~~-~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .... .......+.+++..|++.+|++||++.+|++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            1111 1133456789999999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.6e-36  Score=303.10  Aligned_cols=249  Identities=26%  Similarity=0.397  Sum_probs=192.6

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-----hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--Ccc
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PES  342 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  342 (611)
                      .+|...+.||+|+||.||++.. ..+..|++|++....     .+..+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688899999999999999965 468999999886432     23345788999999999999999999988753  567


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++++||+++++|.+++...   ..+++...+.++.||+.||.|||   ..+|+||||+|+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            8999999999999999532   34889999999999999999999   78999999999999999999999999999875


Q ss_pred             ccCCCc--ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          423 FAADRT--HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       423 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      ......  .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....    ..........     ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~~~~~~-----~~  226 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQ-----PT  226 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHHHHhcC-----CC
Confidence            532111  111234578899999999888899999999999999999999999753211    1111111100     01


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+    ..+......+..++ .||..+|++||+++||++
T Consensus       227 ~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            11    22222233344554 788899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-36  Score=302.39  Aligned_cols=247  Identities=28%  Similarity=0.418  Sum_probs=200.2

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc-----hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      +|...+.||+|+||.||+|... ++..|++|.+....     .+..+.+.+|+.+++.++|+||+++++++..+...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667789999999999999765 78999999886543     34567899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      +||+++++|.+++...   ..+++..+..++.||++||.|||   ..+++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999999532   35889999999999999999999   78999999999999999999999999999876543


Q ss_pred             CCcceeecccCCccccChhhhhcCc-cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ..  ......++..|++||.+.... ++.++|+||||+++|||++|+.|+....    .....+........        
T Consensus       155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~--------  220 (258)
T cd06632         155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE----GVAAVFKIGRSKEL--------  220 (258)
T ss_pred             cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc----HHHHHHHHHhcccC--------
Confidence            32  223456788999999987766 8999999999999999999999975432    11222211110111        


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       ...+......+.+++.+||+.+|++||++.+++.
T Consensus       221 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 -PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence             1112223455788999999999999999999874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.1e-37  Score=312.86  Aligned_cols=253  Identities=27%  Similarity=0.421  Sum_probs=196.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCC----EEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGT----TVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++|+..+.||+|+||.||+|.. .+|.    .+|+|.+.... .....++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            4567788999999999999965 3443    57888876543 23345789999999999999999999998654 5679


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ++||+++|+|.+++...  ...+++..++.++.||+.||.|||   ..+|+|+||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccccc
Confidence            99999999999998543  335889999999999999999999   7899999999999999999999999999998664


Q ss_pred             CCCcce-eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          425 ADRTHV-STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       425 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ...... .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....     ..........+..      
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~~------  229 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREIPDLLEKGER------  229 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHCCCC------
Confidence            332211 122345678999999988899999999999999999997 888864321     1111111111110      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                         ...+......+.+++..||..+|++||++.+|++.|..
T Consensus       230 ---~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~  267 (303)
T cd05110         230 ---LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR  267 (303)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               01122234567899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-36  Score=324.68  Aligned_cols=259  Identities=23%  Similarity=0.278  Sum_probs=194.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ...|.+.+.||+|+||.||++..+ .++.||||...      ...+.+|+++|++++|+|||++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457888999999999999999664 47889999643      23467899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +. ++|.+++...  ...++|..++.|+.||++||.|||   ..+|+||||||+||||+.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 6888887432  236999999999999999999999   78999999999999999999999999999986543222


Q ss_pred             c-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCC---CChhHHHHHhhccCccc--cc---
Q 007248          429 H-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDS---ASPLQRVWTLYRSNKLV--EA---  499 (611)
Q Consensus       429 ~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~---~~~~~~~~~~~~~~~~~--~~---  499 (611)
                      . ......||..|+|||++.+..++.++|||||||+||||++|..++......   ......+........+.  +.   
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            1 222456899999999999999999999999999999999998765332211   01111111111111100  00   


Q ss_pred             cC------------CCCCCCCCH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          500 VD------------PNLKDDFPA-------EQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       500 id------------~~l~~~~~~-------~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ..            .........       .....+.+|+.+||+.||++|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00            000000000       112247789999999999999999999854

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-37  Score=316.78  Aligned_cols=240  Identities=23%  Similarity=0.266  Sum_probs=185.0

Q ss_pred             cccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcC---CCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          279 LGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI---EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       279 iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      ||+|+||+||+|.. .+++.||||++....   ......+..|..++...   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999965 468999999986432   22234456677777665   699999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      |+|.+++..   ...+++..+..++.||++||+|||   ..+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~  153 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT  153 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence            999998853   345899999999999999999999   8899999999999999999999999999987532221 122


Q ss_pred             ecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCH
Q 007248          432 TAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPA  510 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~  510 (611)
                      ....||..|+|||++.+. .++.++|||||||++|||++|+.||....    . ...+.....+..      .+.   ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~----~-~~~~~~i~~~~~------~~~---~~  219 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED----T-QQMYRNIAFGKV------RFP---KN  219 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC----H-HHHHHHHHcCCC------CCC---Cc
Confidence            345689999999998764 47899999999999999999999975321    1 111111111111      111   01


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 007248          511 EQVCNVLQIGLLCTQAAAALRP----SMAQAIM  539 (611)
Q Consensus       511 ~~~~~l~~l~~~c~~~~p~~RP----t~~evl~  539 (611)
                      .....+.+++.+|++.+|++||    ++.++++
T Consensus       220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            1234467889999999999998    5666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-36  Score=308.35  Aligned_cols=263  Identities=24%  Similarity=0.317  Sum_probs=202.8

Q ss_pred             cChHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeee-
Q 007248          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSI-  337 (611)
Q Consensus       261 ~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-  337 (611)
                      +.++.+..+.++|+..+.||+|+||.||++.. .+++.+|+|++.... ...+.+.+|+.+++++ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            44566777889999999999999999999955 468899999875432 2245688999999999 7999999999874 


Q ss_pred             ----eCCcceEEEeecCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCe
Q 007248          338 ----EGPESLLVYEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       338 ----~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  412 (611)
                          .++..++||||+++++|.+++... .....+++..+..++.|+++||.|||   ..+++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                345689999999999999988542 23346889999999999999999999   7899999999999999999999


Q ss_pred             EEeeeccceeccCCCcceeecccCCccccChhhhhc-----CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHH
Q 007248          413 KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR-----GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV  487 (611)
Q Consensus       413 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~  487 (611)
                      ||+|||+++....... ......|+..|+|||++..     ..++.++||||||+++|||++|+.|+.......    ..
T Consensus       164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----~~  238 (286)
T cd06638         164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----AL  238 (286)
T ss_pred             EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----HH
Confidence            9999999976543221 2223468899999998753     347889999999999999999999975432211    11


Q ss_pred             HHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          488 WTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       488 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ... .........+       +......+.+++.+|++.+|++||++.||++.
T Consensus       239 ~~~-~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         239 FKI-PRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hhc-cccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            110 0000001111       11123457889999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.7e-36  Score=312.49  Aligned_cols=256  Identities=20%  Similarity=0.270  Sum_probs=192.0

Q ss_pred             CCCccccC--CceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          275 PSKKLGQG--GAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       275 ~~~~iG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      ..++||+|  +||+||++.. ++|+.||||++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  7889999954 578999999986542  344556778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++.... ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999985432 234899999999999999999999   789999999999999999999999999875433211110


Q ss_pred             ------eeecccCCccccChhhhhc--CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          430 ------VSTAVAGTLGYMAPEYLVR--GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       430 ------~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                            ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.............     ...+...++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-----~~~~~~~~~  232 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-----NGTVPCLLD  232 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh-----cCCcccccc
Confidence                  0112346778999999876  358899999999999999999999986432211111000     000000000


Q ss_pred             -------------------CCC-----------------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          502 -------------------PNL-----------------KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       502 -------------------~~l-----------------~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                                         ..+                 ...........+.+++.+||+.||++|||++||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                               000                 00111122346789999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.6e-37  Score=320.02  Aligned_cols=200  Identities=24%  Similarity=0.368  Sum_probs=172.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..+.||+|+||.||++.. .+++.||||++....   .+..+.+.+|+.++.+++||||+++++.+.+++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3678889999999999999965 468999999986432   334567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999853   345899999999999999999999   899999999999999999999999999998754221


Q ss_pred             Cc----------------------------------ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCC
Q 007248          427 RT----------------------------------HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRR  472 (611)
Q Consensus       427 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~  472 (611)
                      ..                                  .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            00                                  00113468999999999999999999999999999999999999


Q ss_pred             CCCC
Q 007248          473 SNAF  476 (611)
Q Consensus       473 p~~~  476 (611)
                      ||..
T Consensus       235 Pf~~  238 (360)
T cd05627         235 PFCS  238 (360)
T ss_pred             CCCC
Confidence            9853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2e-36  Score=301.94  Aligned_cols=249  Identities=23%  Similarity=0.337  Sum_probs=199.0

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeee-CCcceEEEe
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-GPESLLVYE  347 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E  347 (611)
                      .|+..+.||+|++|.||++.. .+++.+|+|++....  ....+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            477889999999999999965 457899999986432  3445678999999999999999999998764 446789999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++++|.+++... ....+++.+++.++.+++.||++||   +.+++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999999643 2345899999999999999999999   8899999999999999999999999999998764322


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                      . ......++..|+|||++.+..++.++||||||++++||++|+.|+....    ......... .+.+         ..
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~----~~~~~~~~~-~~~~---------~~  221 (257)
T cd08223         157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD----MNSLVYRII-EGKL---------PP  221 (257)
T ss_pred             C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHH-hcCC---------CC
Confidence            2 2234567889999999999999999999999999999999999875321    111111111 1111         11


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+......+.+++.+|++.+|++||++.++++
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         222 MPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            22334456889999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=313.36  Aligned_cols=243  Identities=30%  Similarity=0.461  Sum_probs=196.4

Q ss_pred             CCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccch---hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTR---QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      |...+.||.|.||.||-++ ..+.+.||||++....+   +..+.+++|++.|.+++|||+|.+.||+..+...+|||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            4445679999999999994 45788999999987643   4456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      |- ||-.|++.-.  .+++-+..+..|..+.+.||+|||   +.+.||||||+.||||.+.|.+||+|||.|....+   
T Consensus       108 Cl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  108 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             Hh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            95 4666766322  346888899999999999999999   89999999999999999999999999999976543   


Q ss_pred             ceeecccCCccccChhhhh---cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLV---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                        ...++||+.|||||++.   .+.|+-|.||||||+...||...++|...... -..+   +.+..      .-.|.|.
T Consensus       179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-MSAL---YHIAQ------NesPtLq  246 (948)
T KOG0577|consen  179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSAL---YHIAQ------NESPTLQ  246 (948)
T ss_pred             --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-HHHH---HHHHh------cCCCCCC
Confidence              23578999999999985   47899999999999999999998888543321 1111   11111      1123332


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                         ..+....+.+++..|++.-|.+|||..+++.
T Consensus       247 ---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  247 ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             ---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence               3445566788899999999999999998875

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-37  Score=301.44  Aligned_cols=258  Identities=26%  Similarity=0.338  Sum_probs=194.4

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC-----cceEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----ESLLV  345 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  345 (611)
                      .|...+++|.|.||.||+|.+ ..++.||||++..+.+.    --.|+.+|+.++|||||+|+-+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            355678999999999999965 44799999998765431    236999999999999999998876432     34589


Q ss_pred             EeecCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC-CCeEEeeeccceec
Q 007248          346 YEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCF  423 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~  423 (611)
                      |||||. +|.+.++.. ..+..++...+.-+..||++||.|||   ..+|+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999987 888888542 12345777778889999999999999   7999999999999999976 89999999999988


Q ss_pred             cCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccc-----
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV-----  497 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  497 (611)
                      .......  ....|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.. .+..+.+..+.+.+....-.     
T Consensus       177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            7655442  3445889999999887 4799999999999999999999876543 33333333333333221111     


Q ss_pred             -----cccCCCCCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          498 -----EAVDPNLKDD-----FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       498 -----~~id~~l~~~-----~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                           +.-.+.+...     +......+.++++.++++.+|.+|.+..|++..
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                 1111122111     223345568899999999999999999998853

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.6e-36  Score=310.10  Aligned_cols=196  Identities=25%  Similarity=0.377  Sum_probs=159.6

Q ss_pred             CCccccCCceeEEEEEcC---CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeee--CCcceEEEeecC
Q 007248          276 SKKLGQGGAGSVYMGSLP---NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPESLLVYEYVP  350 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~  350 (611)
                      ..+||+|+||+||+|...   +++.+|+|.+....  ....+.+|+++|++++||||+++++++..  +...++|+||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999754   46789999886432  23457899999999999999999998854  456789999986


Q ss_pred             CCChhhhhhcc------CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE----CCCCCeEEeeeccc
Q 007248          351 NRSLDQFIFDK------NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLA  420 (611)
Q Consensus       351 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla  420 (611)
                      + +|.+++...      .....+++..+..++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 787776422      12235889999999999999999999   8899999999999999    45678999999999


Q ss_pred             eeccCCCcc--eeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCC
Q 007248          421 RCFAADRTH--VSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFS  477 (611)
Q Consensus       421 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~  477 (611)
                      +.+......  ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876543221  22345689999999998764 5889999999999999999999998644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.6e-36  Score=301.09  Aligned_cols=249  Identities=21%  Similarity=0.321  Sum_probs=200.8

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +|+..++||+|+||.||++.. .+|+.+|+|++...  .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            477889999999999999954 46899999998643  233456889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++.... ...+++..+++++.|++.||.|||   ..+++|+||+|+|||++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999999985432 235789999999999999999999   78999999999999999999999999999976543221


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                       ......++..|+|||++.+...+.++||||||++++||++|+.|+....    ......... .+.         ....
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~~~~~~~~-~~~---------~~~~  221 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN----MKNLVLKII-RGS---------YPPV  221 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC----HHHHHHHHh-cCC---------CCCC
Confidence             1223457889999999988889999999999999999999999875321    111111111 111         1112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +......+.+++.+||+.+|++||++.+|++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            3334456889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.3e-36  Score=306.94  Aligned_cols=260  Identities=26%  Similarity=0.345  Sum_probs=190.9

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcC---CCCceeeEeeeeee-----CC
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSI---EHKNLVKLLGCSIE-----GP  340 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  340 (611)
                      +|+..+.||+|+||+||+|.. .+++.||+|.+....  ......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            477889999999999999955 468999999886432  12223456777777655   79999999998764     23


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      ..++||||+++ +|.+++.... ...+++..+..++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999975 8888885432 245899999999999999999999   789999999999999999999999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc---Cccc
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS---NKLV  497 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~  497 (611)
                      +......  ......++..|+|||++.+..++.++|||||||++|||++|+.||....... .+.........   ..+.
T Consensus       156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhCc
Confidence            7654322  1233567889999999998899999999999999999999998875432211 11111111100   0000


Q ss_pred             c-------ccCCCCC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          498 E-------AVDPNLK---DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       498 ~-------~id~~l~---~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .       ...+...   ..........+.+++.+|++.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0       0000000   0011123345789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.7e-36  Score=309.89  Aligned_cols=262  Identities=24%  Similarity=0.353  Sum_probs=195.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|...++||+|+||.||+|..+ +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46788899999999999999654 67899999987543 22334678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++ +|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 888877433  345789999999999999999999   89999999999999999999999999999976433221


Q ss_pred             ceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCCh----------hHHHHHhhccCccc
Q 007248          429 HVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASP----------LQRVWTLYRSNKLV  497 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~----------~~~~~~~~~~~~~~  497 (611)
                       ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||.........          ....|..+......
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence             1223457889999998865 46789999999999999999999998543321110          01111111110000


Q ss_pred             cccC-CCCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          498 EAVD-PNLKD----DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       498 ~~id-~~l~~----~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ...+ +....    .........+.+++.+|++.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000 00000    000112345678999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.6e-36  Score=307.22  Aligned_cols=262  Identities=27%  Similarity=0.358  Sum_probs=203.6

Q ss_pred             cChHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeee
Q 007248          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE  338 (611)
Q Consensus       261 ~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  338 (611)
                      ++.+++..++++|+..+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            45567778899999999999999999999965 568899999886432 2345678899999999 89999999999875


Q ss_pred             C-----CcceEEEeecCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCe
Q 007248          339 G-----PESLLVYEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       339 ~-----~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  412 (611)
                      .     ...++|+||+++++|.+++... .....+++..++.++.|++.||+|||   ..+++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            4     3579999999999999988542 23356899999999999999999999   7899999999999999999999


Q ss_pred             EEeeeccceeccCCCcceeecccCCccccChhhhhcC-----ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHH
Q 007248          413 KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-----QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV  487 (611)
Q Consensus       413 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~  487 (611)
                      ||+|||++........ ......++..|+|||.+...     .++.++||||||+++|||++|+.|+......    ...
T Consensus       168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~----~~~  242 (291)
T cd06639         168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV----KTL  242 (291)
T ss_pred             EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH----HHH
Confidence            9999999876543221 12234678899999998654     3688999999999999999999997533211    111


Q ss_pred             HHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          488 WTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       488 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..... ...     +.+.  .+.+....+.+++.+|++.+|++||++.|+++
T Consensus       243 ~~~~~-~~~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         243 FKIPR-NPP-----PTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHhc-CCC-----CCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11111 111     1111  12223345889999999999999999999874

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-36  Score=305.48  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=201.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .++|++.+.||+|+||.||++.. .++..+|+|.+........+.|.+|++++++++||||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            45678889999999999999966 46899999998877666678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++...  ...+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            9999999998543  235899999999999999999999   78999999999999999999999999999865432221


Q ss_pred             ceeecccCCccccChhhhhc-----CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVR-----GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                       ......++..|+|||.+..     ..++.++||||||+++|||++|+.|+....    .......... ..     .+.
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~-~~-----~~~  227 (280)
T cd06611         159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN----PMRVLLKILK-SE-----PPT  227 (280)
T ss_pred             -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC----HHHHHHHHhc-CC-----CCC
Confidence             2223457889999999753     346789999999999999999999975321    1111111111 10     011


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +  ..+......+.+++..||+.+|.+||++.+|++
T Consensus       228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         228 L--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             c--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            1  112223345788999999999999999999974

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.2e-36  Score=301.40  Aligned_cols=254  Identities=24%  Similarity=0.349  Sum_probs=202.2

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeee--CCcceEEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPESLLVY  346 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  346 (611)
                      +|+..+.||.|+||.||++.. .++..+|+|++...  .....+.+.+|++++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            467788999999999999954 56889999988643  23445678899999999999999999998764  44578999


Q ss_pred             eecCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCC--CCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          347 EYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGS--ETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       347 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      ||+++++|.+++... .....+++..++.++.+|+.||.|||...  ..+++|+||+|+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998543 22456899999999999999999999443  678999999999999999999999999999876


Q ss_pred             cCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      ...... .....++..|+|||.+....++.++||||||+++|+|++|+.|+....    . ..........         
T Consensus       161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~-~~~~~~~~~~---------  225 (265)
T cd08217         161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----Q-LQLASKIKEG---------  225 (265)
T ss_pred             cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----H-HHHHHHHhcC---------
Confidence            543321 223468899999999988889999999999999999999999976432    1 1111111111         


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      .....+......+.+++.+|++.+|++||++.+|++.
T Consensus       226 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            1122333445668899999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.4e-36  Score=316.42  Aligned_cols=260  Identities=24%  Similarity=0.287  Sum_probs=194.4

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC------
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG------  339 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  339 (611)
                      ..++|...+.||+|+||.||++.. ..++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            456899999999999999999954 46889999998643  234456788999999999999999999987543      


Q ss_pred             CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecc
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  419 (611)
                      ...++||||+++ +|.+++.     ..+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            346999999965 6766663     23788999999999999999999   88999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc-------
Q 007248          420 ARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR-------  492 (611)
Q Consensus       420 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~-------  492 (611)
                      ++......  ......++..|+|||++.+..++.++|||||||++|||++|+.||....... .+..+.....       
T Consensus       173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHH
Confidence            97653321  2234568999999999999999999999999999999999999985432111 0000000000       


Q ss_pred             ------------c-Ccc-----ccccCCCC---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          493 ------------S-NKL-----VEAVDPNL---KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       493 ------------~-~~~-----~~~id~~l---~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                                  . ...     .+.....+   ...........+.+++.+|++.||++|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                        0 000     00000000   000111123457899999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.4e-36  Score=302.64  Aligned_cols=247  Identities=23%  Similarity=0.385  Sum_probs=199.1

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      -|...+.||+|+||.||+|.. .++..+|||.+.... ....+.|.+|+.++++++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            356778899999999999964 568899999876443 344567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++..    ..+++..+..++.+++.||.|||   ..+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            99999999842    35899999999999999999999   89999999999999999999999999999876543221 


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      ......++..|+|||.+.+..++.++||||||+++|||++|..|+.....    ....... ...         .....+
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~-~~~---------~~~~~~  222 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKVLFLI-PKN---------NPPTLE  222 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HHHHHHH-hcC---------CCCCCC
Confidence            12234578899999999888899999999999999999999998753211    1111111 111         011122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ......+.+++.+|++.+|++||++.++++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            2334557889999999999999999999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.8e-36  Score=315.45  Aligned_cols=259  Identities=25%  Similarity=0.300  Sum_probs=193.8

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC-----
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----  340 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  340 (611)
                      ..++|...+.||+|+||.||++.. ..|..||||++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457889999999999999999955 46899999998643  3344567889999999999999999999886543     


Q ss_pred             -cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecc
Q 007248          341 -ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (611)
Q Consensus       341 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  419 (611)
                       ..++||||+++ +|.+.++     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCC
Confidence             46999999975 5666553     23788899999999999999999   89999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhh--------
Q 007248          420 ARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY--------  491 (611)
Q Consensus       420 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~--------  491 (611)
                      ++......  ......+|..|+|||++.+..++.++||||||+++|||++|+.||....... .+.......        
T Consensus       170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHH
Confidence            97543221  2234567899999999999899999999999999999999999986432110 000000000        


Q ss_pred             -----------ccC-c-----cccccCCCCC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          492 -----------RSN-K-----LVEAVDPNLK---DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       492 -----------~~~-~-----~~~~id~~l~---~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                                 ... .     +.+....-..   ..........+.+++.+|++.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                       000 0     0000000000   0001112345789999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.3e-36  Score=304.51  Aligned_cols=262  Identities=24%  Similarity=0.318  Sum_probs=198.3

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ++|+..+.||+|+||.||+|..+ +|+.||+|++....  ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46788899999999999999765 58999999886442  2234568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++++|..++..   ...+++..+..++.||+.||.|||   ..+++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999998887742   235899999999999999999999   7999999999999999999999999999998764432


Q ss_pred             cceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHH----------HhhccCcc
Q 007248          428 THVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVW----------TLYRSNKL  496 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~----------~~~~~~~~  496 (611)
                      . ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............          ..+.....
T Consensus       155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence            1 1223457789999999876 4578899999999999999999999864332111111000          00000000


Q ss_pred             c-cccCCCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          497 V-EAVDPNLKDDFP-----AEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       497 ~-~~id~~l~~~~~-----~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      . ....+......+     ......+.+++.+|++.+|++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0 000011000001     112355789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.1e-36  Score=312.16  Aligned_cols=192  Identities=23%  Similarity=0.333  Sum_probs=165.9

Q ss_pred             CCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-C-----CceeeEeeeeeeCCcceE
Q 007248          272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-H-----KNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  344 (611)
                      +|++.+.||+|.||.|-++ +.++++.||||+++.. .....+-..|+.+|..|+ |     -|+|+++++|...++++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7888999999999999999 6677999999988744 444566678999999996 4     379999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC--CeEEeeecccee
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF--TPKIADFGLARC  422 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfGla~~  422 (611)
                      |+|.+ ..+|.++|... +...++...+..|+.||+.||.+||   +.+|||+||||+||||.+..  .+||+|||.+..
T Consensus       266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            99998 55999999554 3455999999999999999999999   89999999999999998654  699999999975


Q ss_pred             ccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCC
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRS  473 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p  473 (611)
                      .....   . ....+..|.|||++.+.+|+.+.||||||||+.||++|.+-
T Consensus       341 ~~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL  387 (586)
T KOG0667|consen  341 ESQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL  387 (586)
T ss_pred             cCCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc
Confidence            43321   1 44568899999999999999999999999999999999543

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.1e-36  Score=299.14  Aligned_cols=252  Identities=27%  Similarity=0.426  Sum_probs=200.4

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc------hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      +|+..+.||+|+||.||++.. .+++.+|+|++....      ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477789999999999999954 678999999886432      2235678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC-CeEEeeeccceec
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCF  423 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~  423 (611)
                      |+||+++++|.+++..   ...+++..+..++.||+.||.|||   +.+++|+||+|+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999853   345889999999999999999999   78999999999999998776 5999999999766


Q ss_pred             cCCCcc---eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          424 AADRTH---VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       424 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      ......   ......++..|+|||.+.+..++.++||||+|++++||++|+.|+...... ...........        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~--------  225 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-NHLALIFKIAS--------  225 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-chHHHHHHHhc--------
Confidence            443211   112345788999999998888999999999999999999999997533221 11111111100        


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       .......+......+.+++.+|++.+|++||++.++++
T Consensus       226 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 -ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence             01112233344556888999999999999999999873

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.9e-36  Score=299.57  Aligned_cols=252  Identities=27%  Similarity=0.385  Sum_probs=205.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccch-hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|+..+.||+|++|.||++... +++.++||++..... ...+.+.+|++.+.+++|+||+++++++..+...++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999665 589999999876543 4567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCC-CceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      +++++|.+++...   ..+++..++.++.|+++||.|||   . .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999999543   56899999999999999999999   7 999999999999999999999999999998764433


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                      .. .....++..|+|||.+....++.++||||||+++|||++|+.|+...... ...+.. ......     ..+    .
T Consensus       155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~-~~~~~~-----~~~----~  222 (264)
T cd06623         155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELM-QAICDG-----PPP----S  222 (264)
T ss_pred             Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHH-HHHhcC-----CCC----C
Confidence            22 12345788999999998888999999999999999999999997654321 111111 111111     111    1


Q ss_pred             CCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          508 FPAE-QVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       508 ~~~~-~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      .+.. ....+.+++..|++.+|++||++.++++.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1222 44568899999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.9e-36  Score=300.58  Aligned_cols=250  Identities=25%  Similarity=0.384  Sum_probs=201.4

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      +|+..+.||+|+||.||++... +++.+++|++.... .+..+++.+|++++++++||||+++++++..+...++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5677889999999999999664 68999999887553 345677999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCC-CceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      ++++|.+++....  ..+++..+..++.|++.||+|||   . .+++|+||||+||++++++.++|+|||++........
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            9999999995432  56889999999999999999999   6 8999999999999999999999999999865532221


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCC-CChhHHHHHhhccCccccccCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDS-ASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                      .   ...++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... ....+.........      .+.+   
T Consensus       157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~---  224 (265)
T cd06605         157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP------PPRL---  224 (265)
T ss_pred             h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC------CCCC---
Confidence            1   256788999999998889999999999999999999999997644321 12222211111110      0111   


Q ss_pred             CCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          508 FPAE-QVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       508 ~~~~-~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       +.. ....+.+++..|+..+|++||++.+++.
T Consensus       225 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 -PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence             111 3445789999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.2e-36  Score=308.73  Aligned_cols=261  Identities=26%  Similarity=0.370  Sum_probs=197.6

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ++|+..++||+|+||.||++..+ +++.+|+|++....  ....+.+.+|+++++.++||||+++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36778899999999999999765 58999999875432  2235678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++++|.++...   ...++|..++.++.||++||.|||   +.+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999887743   234899999999999999999999   7899999999999999999999999999997654332


Q ss_pred             cceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh-----------hccCc
Q 007248          428 THVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL-----------YRSNK  495 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-----------~~~~~  495 (611)
                       .......++..|+|||++.+ ..++.++||||||+++|||++|+.|+...... ..+......           +....
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccch
Confidence             22233457889999999875 35678999999999999999999887533211 111111100           00000


Q ss_pred             cc-cccCCCCCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          496 LV-EAVDPNLKDD-----FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       496 ~~-~~id~~l~~~-----~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +. ....+.....     ........+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00 0000000000     01123456889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=310.13  Aligned_cols=251  Identities=23%  Similarity=0.287  Sum_probs=209.1

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcCC-CCEEEEEEeeccch---hhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCCcce
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTR---QWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  343 (611)
                      ....|+..+.||+|.||.||++..+. |+.+|+|.+.....   ...+...+|+.+|+++. |||||.+++.+++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34567888999999999999996655 99999999875533   34568899999999998 999999999999999999


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC----CCeEEeeecc
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD----FTPKIADFGL  419 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGl  419 (611)
                      +|||++.||.|.+.|...    .+++.....++.||+.++.|||   ..+|+||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999655    2999999999999999999999   8999999999999999643    4799999999


Q ss_pred             ceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          420 ARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       420 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      +.....  .......+||+.|+|||++....++...||||+|+++|.|++|..||....+......     ...+.+   
T Consensus       186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-----i~~~~~---  255 (382)
T KOG0032|consen  186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-----ILRGDF---  255 (382)
T ss_pred             ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-----HHcCCC---
Confidence            988765  3455678899999999999999999999999999999999999999875544333221     111111   


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                         ....+.-......+.+++..++..||..|+|+.++++
T Consensus       256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence               2222223334556788999999999999999999986

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.7e-36  Score=316.12  Aligned_cols=262  Identities=25%  Similarity=0.281  Sum_probs=195.4

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC----
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP----  340 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  340 (611)
                      ...++|...+.||+|+||.||++.. ..++.||||++...  .....+.+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3457899999999999999999954 46889999998643  2344567889999999999999999999876433    


Q ss_pred             --cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeec
Q 007248          341 --ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       341 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                        ..++||||+++ +|.+++.     ..+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCc
Confidence              46899999965 6666663     23788999999999999999999   8999999999999999999999999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHH----------HH
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQR----------VW  488 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~----------~~  488 (611)
                      +++.....  .......+|..|+|||++.+..++.++||||||+++|||++|+.||............          .+
T Consensus       165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99764322  1223456899999999999889999999999999999999999998543211100000          00


Q ss_pred             Hh-------h-cc-CccccccCC-----CCC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          489 TL-------Y-RS-NKLVEAVDP-----NLK---DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       489 ~~-------~-~~-~~~~~~id~-----~l~---~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ..       + .. ........+     .+.   ...+......+.+++.+|++.||++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            00       0 00 000000000     000   01111223457899999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.2e-36  Score=300.65  Aligned_cols=249  Identities=25%  Similarity=0.350  Sum_probs=195.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-----hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--Ccc
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PES  342 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  342 (611)
                      ++|+..++||+|+||.||+|.. .++..||||.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4688889999999999999965 458999999885321     23456788999999999999999999988764  457


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      +++|||+++++|.+++...   ..+++...++++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            8999999999999998532   34788999999999999999999   78999999999999999999999999999875


Q ss_pred             ccCCCc--ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          423 FAADRT--HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       423 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      ......  .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....    .........        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~~--------  223 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIAT--------  223 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHHHHHHhc--------
Confidence            532211  112234578899999999888899999999999999999999999753211    111111110        


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       .......+......+.+++..|+. +|+.||++++|++
T Consensus       224 -~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         224 -QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence             011122244444567788888884 8999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.1e-36  Score=301.24  Aligned_cols=253  Identities=24%  Similarity=0.391  Sum_probs=197.2

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc----------hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT----------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP  340 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  340 (611)
                      +|...+.||+|+||.||+|.. .+|+.+|+|.+....          ....+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            356778999999999999954 468999999875321          112356889999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      ..++||||+++++|.+++...   ..+++..+..++.||+.||.|||   +.+++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999999543   46899999999999999999999   789999999999999999999999999999


Q ss_pred             eeccCCCcc-eeecccCCccccChhhhhcCc--cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccc
Q 007248          421 RCFAADRTH-VSTAVAGTLGYMAPEYLVRGQ--LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV  497 (611)
Q Consensus       421 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (611)
                      +........ ......++..|+|||.+....  ++.++||||||+++|||++|+.|+....    ............ ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~-~~  230 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----AIAAMFKLGNKR-SA  230 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----hHHHHHHhhccc-cC
Confidence            765432211 122345788999999987654  7899999999999999999999974321    112112111111 11


Q ss_pred             cccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       498 ~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..+...    ........+.+++..|++.+|++||++.+|++
T Consensus       231 ~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         231 PPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            111111    11223456788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.9e-36  Score=305.56  Aligned_cols=261  Identities=23%  Similarity=0.333  Sum_probs=195.5

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +|+..+.||+|+||.||++.. .+|+.+|+|++....  ......+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            467788999999999999965 468999999986432  22335678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      ++ ++|.+++...  ...+++..+..++.||++||.|||   ..+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            97 4787777432  345899999999999999999999   78999999999999999999999999999976543221


Q ss_pred             ceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC------ccccccC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN------KLVEAVD  501 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~id  501 (611)
                       ......++..|+|||.+.+. .++.++||||||+++|||+||+.|+....+....+..........      .+.+..+
T Consensus       155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence             12234568899999998765 468999999999999999999998654333222221111110000      0000111


Q ss_pred             CCCCC---------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          502 PNLKD---------DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       502 ~~l~~---------~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .....         .........+.+++.+|++.+|.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00000         011123356778999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-35  Score=300.70  Aligned_cols=259  Identities=24%  Similarity=0.305  Sum_probs=200.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--CcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  346 (611)
                      ++|+..+.||.|++|.||++.. .+++.+|+|.+.... ......+.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            3577889999999999999966 468899999887543 34456799999999999999999999988653  3679999


Q ss_pred             eecCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          347 EYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       347 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      ||+++++|.+++... .....+++..+..++.||+.||.|||   ..+++|+||+|.||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999987532 23455889999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCC-CChhHHHHHhhccCccccccCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDS-ASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ..   .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ....+.... ..........+ ..
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~  232 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPNPELKD-EP  232 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH-HhcCCchhhcc-CC
Confidence            21   12345688999999999889999999999999999999999998754221 112221111 11111111110 00


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .  ........+.+++.+||+.+|++|||+.||++
T Consensus       233 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         233 G--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             C--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0  01123456889999999999999999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.4e-36  Score=308.16  Aligned_cols=196  Identities=25%  Similarity=0.376  Sum_probs=159.1

Q ss_pred             CCccccCCceeEEEEEcC---CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeee--CCcceEEEeecC
Q 007248          276 SKKLGQGGAGSVYMGSLP---NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPESLLVYEYVP  350 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~  350 (611)
                      ..+||+|+||.||+|...   ++..||+|.+....  ....+.+|++++++++||||+++++++..  +...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            368999999999999754   45789999886432  23467899999999999999999998853  456789999987


Q ss_pred             CCChhhhhhcc------CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE----CCCCCeEEeeeccc
Q 007248          351 NRSLDQFIFDK------NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLA  420 (611)
Q Consensus       351 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla  420 (611)
                      + +|.+++...      .....+++..+..++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 777766321      12235889999999999999999999   8899999999999999    56678999999999


Q ss_pred             eeccCCCcc--eeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCC
Q 007248          421 RCFAADRTH--VSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFS  477 (611)
Q Consensus       421 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~  477 (611)
                      +........  ......+|..|+|||++.+. .++.++||||||+++|||+||+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876443221  12245678999999998764 5789999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.6e-36  Score=302.23  Aligned_cols=254  Identities=24%  Similarity=0.392  Sum_probs=196.3

Q ss_pred             CCCCCccccCCceeEEEEEcC----CCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC------
Q 007248          273 FNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------  340 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  340 (611)
                      |.+.+.||+|+||.||+|.+.    .++.+|||++...  .....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456788999999999999643    3688999988654  3345677899999999999999999999876532      


Q ss_pred             cceEEEeecCCCChhhhhhccC---CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeee
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKN---KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  417 (611)
                      ..++++||+++|+|.+++....   ....+++..+++++.||+.||+|||   +.+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            2378899999999998875321   2235789999999999999999999   789999999999999999999999999


Q ss_pred             ccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCc
Q 007248          418 GLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNK  495 (611)
Q Consensus       418 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  495 (611)
                      |+++........ ......++..|++||.+....++.++||||||+++|||++ |+.|+..... ......    .....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~----~~~~~  232 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNY----LIKGN  232 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHH----HHcCC
Confidence            999865432211 1223345678999999988889999999999999999999 7777642211 111111    11111


Q ss_pred             cccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       496 ~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .       +  ..+......+.+++.+|++.+|++||++.+|++.|.+
T Consensus       233 ~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         233 R-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             c-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            0       0  1112334568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-36  Score=309.40  Aligned_cols=246  Identities=26%  Similarity=0.426  Sum_probs=196.9

Q ss_pred             CCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCC
Q 007248          275 PSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRS  353 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs  353 (611)
                      ....||+|+||.||++.. .++..||||.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++++
T Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            346799999999999965 4688999999876655666789999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeec
Q 007248          354 LDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA  433 (611)
Q Consensus       354 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  433 (611)
                      |.+++..    ..+++..+..++.||+.||.|||   ..+|+||||||+||++++++.+||+|||++........ ....
T Consensus       106 L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~  177 (292)
T cd06658         106 LTDIVTH----TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS  177 (292)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence            9998832    34889999999999999999999   78999999999999999999999999999875433221 1223


Q ss_pred             ccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHH
Q 007248          434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQV  513 (611)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~  513 (611)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.|+....    ........      ...+.+.+..  .....
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----~~~~~~~~------~~~~~~~~~~--~~~~~  245 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP----PLQAMRRI------RDNLPPRVKD--SHKVS  245 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH------HhcCCCcccc--ccccC
Confidence            457889999999988889999999999999999999999975321    11111110      1111111111  11223


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          514 CNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       514 ~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ..+.+++..|++.+|++|||+.++++.
T Consensus       246 ~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         246 SVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            356788889999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.6e-36  Score=303.85  Aligned_cols=259  Identities=25%  Similarity=0.351  Sum_probs=200.8

Q ss_pred             ChHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeee-
Q 007248          262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE-  338 (611)
Q Consensus       262 ~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  338 (611)
                      +..++..+.+.|+..+.||+|+||.||+|.. .+++.+|+|++.... ....++..|+.++.++ +||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            4556667788999999999999999999965 568899999886543 3346788999999998 79999999999853 


Q ss_pred             -----CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeE
Q 007248          339 -----GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK  413 (611)
Q Consensus       339 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  413 (611)
                           ....+++|||+++|+|.+++... ....+++..+..++.||+.||.|||   ..+|+|+||+|+||++++++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence                 45679999999999999998543 2345888889999999999999999   78999999999999999999999


Q ss_pred             EeeeccceeccCCCcceeecccCCccccChhhhh-----cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHH
Q 007248          414 IADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV-----RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVW  488 (611)
Q Consensus       414 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~  488 (611)
                      |+|||++........ ......++..|+|||.+.     ...++.++||||||+++|||++|+.|+.........    .
T Consensus       162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----~  236 (282)
T cd06636         162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----F  236 (282)
T ss_pred             EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh----h
Confidence            999999875432211 122356888999999875     345788999999999999999999997533211111    1


Q ss_pred             HhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          489 TLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       489 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..      .....+.+.   .......+.+++..||+.+|.+||++.|+++
T Consensus       237 ~~------~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         237 LI------PRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hH------hhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            00      000111111   1123446889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-36  Score=319.25  Aligned_cols=259  Identities=23%  Similarity=0.275  Sum_probs=196.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC---CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP---NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ..+|++.+.||+|+||.||++...   .+..||||.+...     +.+.+|+++|++++||||+++++++..+...++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357889999999999999999542   3578999987543     23568999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      |++. ++|.+++.   ....+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||++......
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9995 68888882   3356899999999999999999999   789999999999999999999999999999765433


Q ss_pred             Ccc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCC--hhHHHHHhhccCccc------
Q 007248          427 RTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS--PLQRVWTLYRSNKLV------  497 (611)
Q Consensus       427 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~------  497 (611)
                      ... ......||..|+|||++....++.++|||||||++|||++|+.|+........  .+..+..........      
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            221 22345789999999999988999999999999999999999999864432211  111111111100000      


Q ss_pred             -------cccCCCCCCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          498 -------EAVDPNLKDDFP-------AEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       498 -------~~id~~l~~~~~-------~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                             .......+..+.       ......+.+++..|++.+|++||++.|++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                   000000111110       0112356788999999999999999999854

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.6e-36  Score=298.41  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=198.5

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +|+..+.||+|+||.||++.. .+++.+|||++...  ..+..+.+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477789999999999999955 46889999998654  234467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC-CeEEeeeccceeccCCC
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAADR  427 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~  427 (611)
                      +++++|.+++.... ...+++..+.+++.++++||.|||   ..+++|+||+|+||++++++ .+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999996432 345899999999999999999999   78999999999999998654 58999999998664332


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                      .  .....++..|+|||.+....++.++||||||+++|+|++|+.|+......    ....... ...         ...
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~~~-~~~---------~~~  220 (256)
T cd08220         157 K--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVLKIM-SGT---------FAP  220 (256)
T ss_pred             c--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH----HHHHHHH-hcC---------CCC
Confidence            1  22345788999999998888999999999999999999999987533211    1111111 110         011


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+......+.+++.+||+.+|++|||+.|+++
T Consensus       221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            12223445789999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.1e-36  Score=307.56  Aligned_cols=246  Identities=27%  Similarity=0.398  Sum_probs=197.2

Q ss_pred             CCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCC
Q 007248          275 PSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRS  353 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs  353 (611)
                      ...+||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            345799999999999965 4689999999876555556778999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeec
Q 007248          354 LDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA  433 (611)
Q Consensus       354 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  433 (611)
                      |.+++..    ..+++..++.++.||+.||.|||   ..+++||||||+||+++.++.+||+|||++..+..... ....
T Consensus       105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~  176 (297)
T cd06659         105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS  176 (297)
T ss_pred             HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence            9988732    35899999999999999999999   78999999999999999999999999999875543221 1223


Q ss_pred             ccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHH
Q 007248          434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQV  513 (611)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~  513 (611)
                      ..++..|+|||++.+..++.++||||||+++|||++|+.|+....    ..+..... ....     .....  ......
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~~~~~-~~~~-----~~~~~--~~~~~~  244 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS----PVQAMKRL-RDSP-----PPKLK--NAHKIS  244 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH-hccC-----CCCcc--ccCCCC
Confidence            567899999999988889999999999999999999999975322    11111111 1110     00000  011223


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          514 CNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       514 ~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ..+.+++..|++.+|++||++.+|++.
T Consensus       245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         245 PVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            447789999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.3e-36  Score=303.29  Aligned_cols=262  Identities=25%  Similarity=0.355  Sum_probs=199.8

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +|+..+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            467788999999999999965 468999999987543  33456799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      + +++|.+++....  ..+++..++.++.||++||.|||   +.+++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999985433  56899999999999999999999   78999999999999999999999999999987654332


Q ss_pred             ceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC------------c
Q 007248          429 HVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN------------K  495 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------------~  495 (611)
                      .......++..|+|||.+.+. .++.++||||+|++++||++|++++....+ ...+..........            .
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCCChHHHhhccCcch
Confidence            223345688899999988654 468899999999999999999766543221 11111111111000            0


Q ss_pred             cccccCCCCC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          496 LVEAVDPNLK----DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       496 ~~~~id~~l~----~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      +.....+...    .....+....+.+++.+|++.+|++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000000    00011223668899999999999999999998853

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3e-36  Score=306.00  Aligned_cols=263  Identities=25%  Similarity=0.321  Sum_probs=200.8

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ++|+..+.||+|+||.||+|..+ +++.|+||++...  .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36788899999999999999665 5889999987643  23345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |++++.+..++..   ...+++..+..++.+|+.||.|||   ..+++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            9998777766532   234899999999999999999999   7899999999999999999999999999998765544


Q ss_pred             cceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHH----------HHhhccCcc
Q 007248          428 THVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV----------WTLYRSNKL  496 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~----------~~~~~~~~~  496 (611)
                      ........++..|+|||++.+. .++.++||||||+++|||++|+.|+.............          +..+.....
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence            3233345678899999999887 78999999999999999999998875332211110000          000000000


Q ss_pred             c---cccCCCC----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          497 V---EAVDPNL----KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       497 ~---~~id~~l----~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .   +..+...    ...++......+.+++.+||+.+|++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0   0000000    00112223566889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.2e-35  Score=303.30  Aligned_cols=261  Identities=26%  Similarity=0.335  Sum_probs=197.1

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch-----hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR-----QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      +|+..+.||+|+||.||+|.. .+++.||||++.....     .....+..|++++++++|+||+++++++.+++..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            467788999999999999965 4689999999875432     2345677899999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+ +++|.+++....  ..+++..++.++.||++||.|||   ..+|+|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 999999995432  36899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC---------c
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN---------K  495 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---------~  495 (611)
                      ... ......++..|+|||.+.+ ..++.++||||||+++|||++|..++....+ ...+..........         .
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhccc
Confidence            322 1223345788999998865 4578899999999999999999766543221 11111111100000         0


Q ss_pred             cccccCCCCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          496 LVEAVDPNLKDDF-----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       496 ~~~~id~~l~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      +............     .......+.+++.+|++.+|++||++.||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000000111     11234568899999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-36  Score=303.61  Aligned_cols=262  Identities=25%  Similarity=0.357  Sum_probs=195.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccch-hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|+..+.||+|++|.||+|..+ +++.||||.+..... .....+.+|++++++++|+||+++++++.++...++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56788899999999999999654 689999999865432 2234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++ +|.+++....  ..+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 8999885432  36889999999999999999999   78999999999999999999999999999865432211


Q ss_pred             ceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc---cc------c
Q 007248          429 HVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK---LV------E  498 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~------~  498 (611)
                       ......++..|+|||++.+ ..++.++||||||+++|||++|+.|+.........+...+.......   +.      +
T Consensus       159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             1122346788999999875 45788999999999999999999998544322122221111111100   00      0


Q ss_pred             ccC--------CCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          499 AVD--------PNLKDDF-PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       499 ~id--------~~l~~~~-~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ...        ..+.... .......+.+++..|++.+|++||++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000        0000000 0011255778999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1e-35  Score=303.19  Aligned_cols=250  Identities=25%  Similarity=0.405  Sum_probs=201.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      ++|...+.||+|+||.||++.. .++..+++|.+........+.+.+|+.++++++||||+++++++..++..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5788889999999999999964 468899999987555555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++..    ..+++..+..++.+++.||.|||   +.+++|+||+|+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            99999999843    34789999999999999999999   88999999999999999999999999999876543322 


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      ......++..|++||.+....++.++||||||+++|||++|+.||.........    ......+.      +.  ...+
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~----~~~~~~~~------~~--~~~~  238 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YLIATNGT------PE--LQNP  238 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe----eehhcCCC------CC--CCCc
Confidence            122345788999999998888999999999999999999999998543221111    00000000      00  0112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ......+.+++..||+.+|++||++.+++..
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2234457889999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.4e-36  Score=298.59  Aligned_cols=251  Identities=27%  Similarity=0.456  Sum_probs=200.1

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch--hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +|...+.||+|+||.||+|.. .+++.+++|.+.....  ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            467789999999999999965 4689999999876543  3677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++...   ..+++..+..++.++++||.|||   +.+++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            9999999998542   34789999999999999999999   89999999999999999999999999999987654332


Q ss_pred             ceee---cccCCccccChhhhhcCc---cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          429 HVST---AVAGTLGYMAPEYLVRGQ---LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       429 ~~~~---~~~gt~~y~aPE~~~~~~---~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ....   ...++..|+|||++....   .+.++||||||+++|||++|+.|+......   ......... .     ..+
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~~~~~~~-~-----~~~  225 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQIMFHVGA-G-----HKP  225 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHHHHHHhc-C-----CCC
Confidence            2211   345788999999998766   889999999999999999999998533211   111111100 0     011


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+..  .......+.+++..|++.+|++||++.+++.
T Consensus       226 ~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         226 PIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111  1112445678999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=305.79  Aligned_cols=252  Identities=22%  Similarity=0.255  Sum_probs=199.2

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccch---hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR---QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..+.||+|+||.||++... ++..+|+|.+.....   ...+.+.+|+++++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36778899999999999999664 489999999875432   34567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+.+++|.+++... ....+++..+..++.||++||.|||   ..+++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999998533 2356899999999999999999999   789999999999999999999999999998754322


Q ss_pred             Ccc----------------------------eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCC
Q 007248          427 RTH----------------------------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQ  478 (611)
Q Consensus       427 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~  478 (611)
                      ...                            ......|+..|+|||++.+..++.++||||||+++|||++|+.|+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                            0112357889999999998889999999999999999999999975332


Q ss_pred             CCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 007248          479 DSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPS----MAQAIM  539 (611)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt----~~evl~  539 (611)
                      ... .   ....         .+..............+.+++.+|++.+|++||+    +.|++.
T Consensus       237 ~~~-~---~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDE-T---FSNI---------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHH-H---HHHH---------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            211 1   1111         1111111111114556889999999999999999    666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-36  Score=311.92  Aligned_cols=258  Identities=24%  Similarity=0.314  Sum_probs=193.9

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC----
Q 007248          267 EKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG----  339 (611)
Q Consensus       267 ~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  339 (611)
                      .+..++|...+.||+|+||.||++.. .++..||||++....  ....+.+.+|++++++++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            34567899999999999999999954 568899999986432  23345688999999999999999999987643    


Q ss_pred             --CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeee
Q 007248          340 --PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (611)
Q Consensus       340 --~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  417 (611)
                        ...++++|++ +++|.+++.    ...+++..+..++.||+.||.|||   ..+|+||||||+|||+++++.+||+||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCC
Confidence              3468999987 789988873    235899999999999999999999   899999999999999999999999999


Q ss_pred             ccceeccCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc----
Q 007248          418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR----  492 (611)
Q Consensus       418 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~----  492 (611)
                      |+++.....    .....|+..|+|||++.+ ..++.++||||||+++|||++|+.||....... .+........    
T Consensus       163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~  237 (343)
T cd07878         163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSP  237 (343)
T ss_pred             ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCH
Confidence            999865432    223468999999999876 568899999999999999999999975432111 1111100000    


Q ss_pred             -------cCccccccCCCCCCCCCH--------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          493 -------SNKLVEAVDPNLKDDFPA--------EQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       493 -------~~~~~~~id~~l~~~~~~--------~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                             .......+. .+. ..+.        .....+.+++.+|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         238 EVLKKISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHHhcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   000000000 000 0000        11224678999999999999999999984

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=300.33  Aligned_cols=247  Identities=27%  Similarity=0.427  Sum_probs=197.5

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCC---CCceeeEeeeeeeCCcceEEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIE---HKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  346 (611)
                      .|+..+.||+|+||.||+|.. .++..+|+|.+... .....+++.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999965 57899999988654 2344567889999999986   999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++..    ..+++..++.++.|++.||.|||   ..+|+|+||+|+||++++++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999999843    26899999999999999999999   899999999999999999999999999999876543


Q ss_pred             CcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .. ......|+..|+|||.+..+ .++.++||||||+++|||++|+.|+.....    ..... ....     ...+.+.
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~-~~~~-----~~~~~~~  223 (277)
T cd06917         155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA----FRAMM-LIPK-----SKPPRLE  223 (277)
T ss_pred             cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh----hhhhh-cccc-----CCCCCCC
Confidence            32 22344688899999998654 468899999999999999999999753221    11110 0000     0111111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..   .....+.+++.+|++.+|++||++.+++.
T Consensus       224 ~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         224 DN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             cc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            11   13445788999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.7e-36  Score=313.01  Aligned_cols=191  Identities=27%  Similarity=0.398  Sum_probs=163.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ..+|+..+.||+|+||.||+|... ++..||+|.....      ....|+.++++++||||+++++++..+...++|+||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            457999999999999999999664 5678999974322      235699999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +. ++|.+++..  ....+++..++.|+.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       139 ~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  211 (357)
T PHA03209        139 YS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-  211 (357)
T ss_pred             cC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence            95 688888753  3346899999999999999999999   7899999999999999999999999999997533221 


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSN  474 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~  474 (611)
                       ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence             122456899999999999999999999999999999999976664

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.1e-35  Score=304.29  Aligned_cols=261  Identities=25%  Similarity=0.340  Sum_probs=195.8

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|...++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46788899999999999999654 68899999986443 23345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      ++ ++|.+++...  ...+++..+..++.||++||.|||   ..+|+|+||||+|||+++++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 5888888543  335889999999999999999999   89999999999999999999999999999975432221


Q ss_pred             ceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHH-----------HHHhhccC-c
Q 007248          429 HVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQR-----------VWTLYRSN-K  495 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~-----------~~~~~~~~-~  495 (611)
                       ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ..+..           .|..+... .
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhchhhhcccc
Confidence             11233568899999988654 5788999999999999999999987543211 11111           11111000 0


Q ss_pred             cccccCCCCCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          496 LVEAVDPNLKDD----FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       496 ~~~~id~~l~~~----~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ....-.+.....    ........+.+++.+|++.+|.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000110000    01122345778999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-35  Score=300.40  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=192.7

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc-hhhHHHHHHHHHH-HhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-RQWVDEFFNEVNL-ISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ++|++.+.||+|+||.||++... +|..||+|++.... .+....+..|+.+ ++.++||||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46788899999999999999654 68999999987542 2334456667765 566799999999999999999999999


Q ss_pred             ecCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCC-ceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          348 YVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       348 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |++ ++|.+++... .....+++..++.++.||+.||+|||   +. +++||||||+|||++.++.+||+|||++..+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6888887542 23356899999999999999999999   55 899999999999999999999999999976533


Q ss_pred             CCcceeecccCCccccChhhhhc----CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVR----GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      ..  ......++..|+|||.+.+    ..++.++||||||+++|||++|+.|+.....   ..+....... +     ..
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~-~-----~~  225 (283)
T cd06617         157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---PFQQLKQVVE-E-----PS  225 (283)
T ss_pred             cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---CHHHHHHHHh-c-----CC
Confidence            21  1223457889999998865    3468899999999999999999999753221   1121111111 0     11


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +.+.   .......+.+++..|++.+|++||++.+|++
T Consensus       226 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 PQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111   1112345788999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=299.13  Aligned_cols=255  Identities=28%  Similarity=0.373  Sum_probs=200.1

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCC-----
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGP-----  340 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  340 (611)
                      .++++|+..+.||+|+||.||+|... +++.+++|++..... ..+.|.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            45788999999999999999999764 578999998875543 346799999999999 7999999999987654     


Q ss_pred             -cceEEEeecCCCChhhhhhccC-CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeec
Q 007248          341 -ESLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       341 -~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                       ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence             4799999999999999985432 2456899999999999999999999   8999999999999999999999999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhc-----CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVR-----GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS  493 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  493 (611)
                      ++....... .......++..|+|||++..     ..++.++||||||+++|||++|+.|+..........    ... .
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~-~  232 (275)
T cd06608         159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF----KIP-R  232 (275)
T ss_pred             cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH----Hhh-c
Confidence            987653322 22234557889999998754     246789999999999999999999975322111111    110 0


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .     ..+.+.  .+......+.+++.+|+..+|++|||+.+|++
T Consensus       233 ~-----~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         233 N-----PPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             c-----CCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0     111111  12224456889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.5e-36  Score=324.87  Aligned_cols=263  Identities=19%  Similarity=0.187  Sum_probs=190.8

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCC------CceeeEeeee
Q 007248          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH------KNLVKLLGCS  336 (611)
Q Consensus       264 ~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~  336 (611)
                      +++...+++|++.++||+|+||+||+|.. ..++.||||++.... ...+.+..|+.++++++|      .+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            44555678899999999999999999965 467899999986432 233455667777776654      4589999988


Q ss_pred             eeC-CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCC-CceecCCCCcccEEECCCC----
Q 007248          337 IEG-PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNILLDKDF----  410 (611)
Q Consensus       337 ~~~-~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~----  410 (611)
                      ..+ ...++|||++ +++|.+++..   ...+++..+..|+.||+.||.|||   . .+||||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccc
Confidence            764 4678999988 7788888853   246899999999999999999999   5 5999999999999998765    


Q ss_pred             ------------CeEEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCC
Q 007248          411 ------------TPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQ  478 (611)
Q Consensus       411 ------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~  478 (611)
                                  .+||+|||++....    .......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                        49999999875322    22335678999999999999999999999999999999999999986433


Q ss_pred             CCCChhHHHHHhhc-----------cCccccccCC--CCCCCCCH---------------HHHHHHHHHHHHhcccCCCC
Q 007248          479 DSASPLQRVWTLYR-----------SNKLVEAVDP--NLKDDFPA---------------EQVCNVLQIGLLCTQAAAAL  530 (611)
Q Consensus       479 ~~~~~~~~~~~~~~-----------~~~~~~~id~--~l~~~~~~---------------~~~~~l~~l~~~c~~~~p~~  530 (611)
                      ... .+..+.....           .....+..+.  .+......               .....+.+|+..||+.||++
T Consensus       350 ~~~-~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        350 NLE-HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             hHH-HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            211 1110000000           0000000000  00000000               01234679999999999999


Q ss_pred             CCCHHHHHH
Q 007248          531 RPSMAQAIM  539 (611)
Q Consensus       531 RPt~~evl~  539 (611)
                      |||++|+++
T Consensus       429 R~ta~e~L~  437 (467)
T PTZ00284        429 RLNARQMTT  437 (467)
T ss_pred             CCCHHHHhc
Confidence            999999985

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.1e-36  Score=303.19  Aligned_cols=264  Identities=24%  Similarity=0.318  Sum_probs=195.2

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch-hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++++|...+.||+|+||.||+|.. .+|..||+|++..... .....+.+|+.+++.++|+||+++++++..+...++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            457788899999999999999954 4689999999865432 22346789999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+. ++|.+++...  ...+.+..+..++.||+.||.|||   ..+|+|+||||+|||++.++++||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 6777776432  235788889999999999999999   789999999999999999999999999998754322


Q ss_pred             CcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC-----------
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-----------  494 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----------  494 (611)
                      .. ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....+....+...|......           
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence            11 11233468899999998654 578899999999999999999999864432212222222111100           


Q ss_pred             -ccccccCCCC-CCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          495 -KLVEAVDPNL-KDDF-----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       495 -~~~~~id~~l-~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       .......+.. ....     .......+.+++.+|++.+|++|||+.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence             0000000000 0000     0012345778899999999999999999873

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.1e-35  Score=300.47  Aligned_cols=243  Identities=27%  Similarity=0.343  Sum_probs=198.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|...+.||+|+||.||++.. .+++.+|+|++....   .+..+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            3677889999999999999965 468999999886532   234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++...   ..+++..+..++.||+.||.|||   ..+++|+||+|+|||+++++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999998543   46899999999999999999999   799999999999999999999999999999765443


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                          .....+++.|+|||.+.+...+.++||||||+++|||++|+.|+....    .. ........+.      .    
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~-~~~~~~~~~~------~----  215 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN----PI-QIYEKILEGK------V----  215 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----HH-HHHHHHhcCC------c----
Confidence                224467899999999988888999999999999999999999975332    11 1111111111      1    


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRP-----SMAQAI  538 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl  538 (611)
                      .++......+.+++.+||+.+|++||     +++|++
T Consensus       216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            11222345678899999999999999     677765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-38  Score=294.26  Aligned_cols=248  Identities=28%  Similarity=0.405  Sum_probs=206.3

Q ss_pred             CCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      |.+.++||+|.||.||++.+ ..|+.+|||++....  ..+++.+|+.+|++.+.|++|++||.+.....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            55678999999999999954 579999999886543  468899999999999999999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      |++.+.++  .++++|++.++..++..-++||+|||   ...-||||||+.||||+.+|.+||+|||.+..+.+ .....
T Consensus       113 GSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKR  186 (502)
T KOG0574|consen  113 GSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKR  186 (502)
T ss_pred             CcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh-hHHhh
Confidence            99999995  45678999999999999999999999   78889999999999999999999999999987653 23344


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ..+.||+.|||||++..-.|..+.||||||+...||..|++|+..-..    ..-+..      +.....|.++  -|..
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP----MRAIFM------IPT~PPPTF~--KPE~  254 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP----MRAIFM------IPTKPPPTFK--KPEE  254 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc----cceeEe------ccCCCCCCCC--ChHh
Confidence            567899999999999999999999999999999999999999643211    110000      0111112222  2556


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          512 QVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ...++-+++..|+-.+|++|-|+.++++.
T Consensus       255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  255 WSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            67778999999999999999999988763

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2e-35  Score=302.87  Aligned_cols=255  Identities=21%  Similarity=0.269  Sum_probs=199.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..+.||+|+||.||++.. ..++.|++|.+....   ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            3678889999999999999965 457899999887543   233567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++...   ..+++..+..++.+++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            999999999999432   45899999999999999999999   789999999999999999999999999998642111


Q ss_pred             Cc--------------ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc
Q 007248          427 RT--------------HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR  492 (611)
Q Consensus       427 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~  492 (611)
                      ..              .......++..|+|||.+....++.++||||||+++|||++|+.|+....    ..+. .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~----~~~~-~~~~~  229 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT----PEEL-FGQVI  229 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHH-HHHHH
Confidence            00              01112356889999999988889999999999999999999999975221    1111 11111


Q ss_pred             cCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       493 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ...   ...+...    ......+.+++.+||+.+|++||+..++.+.|..
T Consensus       230 ~~~---~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         230 SDD---IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hcc---cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            111   0011111    1233457899999999999999998777777754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-36  Score=281.34  Aligned_cols=254  Identities=22%  Similarity=0.325  Sum_probs=201.1

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccc--------hhhHHHHHHHHHHHhcC-CCCceeeEeeee
Q 007248          267 EKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT--------RQWVDEFFNEVNLISSI-EHKNLVKLLGCS  336 (611)
Q Consensus       267 ~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  336 (611)
                      ....+.|+..+.||.|..++|-+.. .+.|..+|+|++....        .+..++-.+|+.+|+++ .||+|+.+.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            3445678888999999999998884 4568899999885321        23345567899999998 799999999999


Q ss_pred             eeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEee
Q 007248          337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD  416 (611)
Q Consensus       337 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  416 (611)
                      +.+...++|+|.|+.|.|.++|.   ..-.++++...+|+.|+.+|+.|||   ..+||||||||+|||+|++.++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEec
Confidence            99999999999999999999994   3456999999999999999999999   89999999999999999999999999


Q ss_pred             eccceeccCCCcceeecccCCccccChhhhhc------CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh
Q 007248          417 FGLARCFAADRTHVSTAVAGTLGYMAPEYLVR------GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL  490 (611)
Q Consensus       417 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~  490 (611)
                      ||++..+....  .-...+||++|+|||.+..      ..|+...|+|+.|||+|.|+.|.+||-...  +.+   ...+
T Consensus       167 FGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--Qml---MLR~  239 (411)
T KOG0599|consen  167 FGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QML---MLRM  239 (411)
T ss_pred             cceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHH---HHHH
Confidence            99998775443  3346789999999999864      247788999999999999999999962110  000   0011


Q ss_pred             hccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          491 YRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       491 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +..++.      ....+--.+......+++.+|++.||++|-|.+|++.
T Consensus       240 ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  240 IMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            111111      1111222234455789999999999999999999984

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.3e-35  Score=292.54  Aligned_cols=248  Identities=29%  Similarity=0.461  Sum_probs=201.8

Q ss_pred             CCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      |+..+.||+|++|.||++... ++..+++|++........+.+.+|++++++++|+|++++++++..+...++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            667789999999999999764 6899999998766555667899999999999999999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      ++|.+++....  ..+++..+..++.+++.||.+||   ..+++||||+|+||++++++.++|+|||.+........  .
T Consensus        82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  154 (253)
T cd05122          82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R  154 (253)
T ss_pred             CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence            99999985432  46899999999999999999999   79999999999999999999999999999876654322  2


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ....++..|++||.+.....+.++||||||+++++|++|+.|+.....    ........ ......     +..  +..
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~-----~~~--~~~  222 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP----MKALFKIA-TNGPPG-----LRN--PEK  222 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch----HHHHHHHH-hcCCCC-----cCc--ccc
Confidence            345678899999999888899999999999999999999998753321    11111111 011001     110  111


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          512 QVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ....+.+++.+|++.+|++|||+.++++
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1455889999999999999999999874

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.2e-35  Score=299.59  Aligned_cols=254  Identities=28%  Similarity=0.435  Sum_probs=204.2

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ..++.|+..+.||+|++|.||++..+ ++..+++|++..... ..+.+.+|+++++.++|+|++++++++..+...++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            35667888899999999999999765 688999999876554 5677899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++....  ..+++..++.++.+++.||.|||   ..+++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999996533  36999999999999999999999   899999999999999999999999999998654332


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      .. ......++..|++||.+.+..++.++||||||+++|||++|+.|+.....    ........ ......     +  
T Consensus       170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~-----~--  236 (286)
T cd06614         170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP----LRALFLIT-TKGIPP-----L--  236 (286)
T ss_pred             hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH-hcCCCC-----C--
Confidence            21 12234578899999999888899999999999999999999999753221    11111111 111100     0  


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ..+......+.+++.+|++.+|..||++.+|++.
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            0111134568899999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.1e-35  Score=300.78  Aligned_cols=262  Identities=25%  Similarity=0.372  Sum_probs=197.6

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--CcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  345 (611)
                      ++|+..+.||+|+||.||+|..+ +++.+++|.+....  ......+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46778899999999999999765 58899999987543  22334678899999999999999999998877  789999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++ +|.+++....  ..+++..+..++.||+.||.|||   ..+++|+||||+|||+++++.+||+|||++..+..
T Consensus        85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999974 8988885432  36899999999999999999999   78999999999999999999999999999986654


Q ss_pred             CCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCC----------hhHHHHHhhcc-
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS----------PLQRVWTLYRS-  493 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~----------~~~~~~~~~~~-  493 (611)
                      ... ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........          +....|..+.. 
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            321 12234568889999998764 468899999999999999999998764322110          00011111100 


Q ss_pred             -----CccccccCCCCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          494 -----NKLVEAVDPNLKDDFPAE-QVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       494 -----~~~~~~id~~l~~~~~~~-~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                           ..........+...++.. ....+.+++..|++.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                 001111111112222222 3455788999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3e-35  Score=301.81  Aligned_cols=246  Identities=28%  Similarity=0.435  Sum_probs=194.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      +.|...+.||+|+||.||+|.. .+++.||+|++...   ..+..+.+.+|+++++.++||||+++++++.+++..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4577889999999999999965 46899999988643   2344567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||++ |+|.+++...  ...+++..+..++.||+.||.|||   ..+|+|+||+|+||++++++.+||+|||++......
T Consensus        95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 5776666432  235899999999999999999999   789999999999999999999999999998754322


Q ss_pred             CcceeecccCCccccChhhhh---cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLV---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                           ....++..|+|||++.   .+.++.++||||||+++|||+||+.|+....    ............      .+.
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~----~~~~~~~~~~~~------~~~  233 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHIAQND------SPT  233 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc----HHHHHHHHhcCC------CCC
Confidence                 2345788999999874   3568899999999999999999999874321    111111111110      011


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      +   .+......+.+++.+||+.+|++||++.+|+..
T Consensus       234 ~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         234 L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            1   122234568899999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.6e-36  Score=302.14  Aligned_cols=261  Identities=25%  Similarity=0.350  Sum_probs=194.9

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +|+..+.||+|++|.||+|.. .+|+.||||++....  ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            477889999999999999965 468999999886442  22345788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +. ++|.+++.... ...+++..+..++.||+.||+|||   ..+++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 68888885432 346899999999999999999999   78999999999999999999999999999876543221


Q ss_pred             ceeecccCCccccChhhhhcCc-cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHH----------HHhhcc----
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV----------WTLYRS----  493 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~----------~~~~~~----  493 (611)
                       ......++..|+|||.+.+.. ++.++||||||+++|||+||+.|+.............          |.....    
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence             122334678899999886644 5889999999999999999999976433211111110          000000    


Q ss_pred             -CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          494 -NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       494 -~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       ..........+. .........+.+++.+|++.||++||+++++++
T Consensus       235 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         235 KPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence             000000000000 000112234678999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.4e-35  Score=299.28  Aligned_cols=247  Identities=28%  Similarity=0.433  Sum_probs=199.2

Q ss_pred             CCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      |...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            44457899999999999964 56899999998766555567789999999999999999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      ++|.+++..    ..+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++........ ..
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~  172 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR  172 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence            999999854    35899999999999999999999   88999999999999999999999999998875543221 22


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ....|+..|+|||.+.+..++.++||||||+++|||++|+.|+...    ......... ...     ..+.+..  +..
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~----~~~~~~~~~-~~~-----~~~~~~~--~~~  240 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE----PPLQAMKRI-RDN-----LPPKLKN--LHK  240 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC----CHHHHHHHH-Hhc-----CCCCCcc--ccc
Confidence            2345889999999998888999999999999999999999997532    122211111 111     1111111  112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          512 QVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ....+.+++.+|++.+|++||++.++++
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         241 VSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            3346889999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.7e-35  Score=298.47  Aligned_cols=262  Identities=25%  Similarity=0.378  Sum_probs=197.9

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccch-hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      +|+..++||+|++|.||+|... +|..||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999764 689999999875532 23466789999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++ +|.+++........+++..+..++.||+.||.|||   ..+++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 88888865544456899999999999999999999   78999999999999999999999999999976543221 


Q ss_pred             eeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHH-----------HHhhcc-Ccc
Q 007248          430 VSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV-----------WTLYRS-NKL  496 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~-----------~~~~~~-~~~  496 (611)
                      ......++..|++||.+.+. .++.++||||||+++|||++|+.|+......+ .....           |..+.. ..+
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCchh
Confidence            12234568899999988664 56889999999999999999999876432211 11111           110000 000


Q ss_pred             ccccCCCC---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          497 VEAVDPNL---KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       497 ~~~id~~l---~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ........   ...........+.+++..|++.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000   00001122345779999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=300.58  Aligned_cols=260  Identities=26%  Similarity=0.354  Sum_probs=196.7

Q ss_pred             CCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--CcceEEEe
Q 007248          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLLVYE  347 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E  347 (611)
                      |+..+.||+|+||.||+|... +++.+|+|++....  ....+.+.+|++++++++|||++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            556789999999999999665 58899999997653  33456788999999999999999999999887  78999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++ +|.+++...  ...+++..++.++.||++||+|||   ..+++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 888888543  246899999999999999999999   7899999999999999999999999999998765443


Q ss_pred             cceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC---cccc-----
Q 007248          428 THVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN---KLVE-----  498 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~-----  498 (611)
                      ........++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ..+..........   ....     
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccch
Confidence            222233456788999997765 45789999999999999999999997543321 1111111100000   0000     


Q ss_pred             ---------ccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          499 ---------AVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       499 ---------~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                               .....+...+.......+.+++.+|++.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                     00000000011112556889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=299.31  Aligned_cols=260  Identities=26%  Similarity=0.365  Sum_probs=194.8

Q ss_pred             CCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      |+..+.||+|++|.||+|.. .+|..||+|++....  ....+.+.+|++++++++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            56678999999999999965 479999999987543  223457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      + ++|.+++..... ..+++..++.++.||++||.|||   +.+++||||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 689998854332 45899999999999999999999   78999999999999999999999999999975533221 


Q ss_pred             eeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhH----------HHHHhhcc-Cccc
Q 007248          430 VSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ----------RVWTLYRS-NKLV  497 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~----------~~~~~~~~-~~~~  497 (611)
                      ......++..|+|||++.+. .++.++||||||+++|||++|+.||...........          ..|..... ....
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            11223467899999987654 568899999999999999999998754322111111          00100000 0000


Q ss_pred             ----cccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          498 ----EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       498 ----~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                          ....... ..........+.+++.+|++.+|++||+++|+++
T Consensus       235 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         235 PTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                0000000 0011122356789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.2e-34  Score=288.66  Aligned_cols=250  Identities=27%  Similarity=0.399  Sum_probs=204.7

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--CcceEEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLLVY  346 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  346 (611)
                      +|...+.||+|++|.||+|... ++..+++|++....  ....+.+.+|++++++++||||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667789999999999999765 68999999886554  24567899999999999999999999999988  8899999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++....   .+++..++.++.++++||+|||   +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999995432   6899999999999999999999   799999999999999999999999999999876544


Q ss_pred             Ccc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ... ......++..|+|||.+.....+.++||||||+++++|++|+.|+....   ......+....         ....
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~---------~~~~  222 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG---NPMAALYKIGS---------SGEP  222 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHhccc---------cCCC
Confidence            321 1234567889999999988889999999999999999999999976543   22222222111         1111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ...+......+.+++.+|++.+|++||++.+++.
T Consensus       223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            1223333566889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=303.39  Aligned_cols=264  Identities=22%  Similarity=0.317  Sum_probs=195.6

Q ss_pred             CCCCCCccccCCceeEEEEEcC---CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--Ccce
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP---NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESL  343 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  343 (611)
                      +|+..++||+|+||.||+|...   ++..||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3677889999999999999664   47899999987632   34456788999999999999999999999988  7899


Q ss_pred             EEEeecCCCChhhhhhccC--CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC----CCCeEEeee
Q 007248          344 LVYEYVPNRSLDQFIFDKN--KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK----DFTPKIADF  417 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df  417 (611)
                      +||||+++ +|.+++....  ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 6666664322  2236889999999999999999999   889999999999999999    899999999


Q ss_pred             ccceeccCCCc--ceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCC---Ch-----hHH
Q 007248          418 GLARCFAADRT--HVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSA---SP-----LQR  486 (611)
Q Consensus       418 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~---~~-----~~~  486 (611)
                      |++........  .......++..|+|||++.+. .++.++||||||++++||++|+.|+.......   .+     +..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986543322  112244678899999988764 57899999999999999999999986543322   00     000


Q ss_pred             HHHhhc------------cCccccccCCCCCCCCC---------H--HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          487 VWTLYR------------SNKLVEAVDPNLKDDFP---------A--EQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       487 ~~~~~~------------~~~~~~~id~~l~~~~~---------~--~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +.....            ........+......++         .  .....+.+++.+|++.+|++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000            00000000000001111         0  22345789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6e-37  Score=281.58  Aligned_cols=251  Identities=21%  Similarity=0.284  Sum_probs=198.8

Q ss_pred             hcCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      +++|+..+.||+|.|+.||+. ..+.|+.+|+|++...  .....+++.+|++|-+.|+||||++|.+...+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            456677789999999999998 5678999999987533  2335678899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC---CCeEEeeeccceec
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD---FTPKIADFGLARCF  423 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~~~  423 (611)
                      |+|.|++|..-|..+   ..+++...-..+.||+++|.|.|   ..+|||||+||.|+||-..   --+||+|||+|...
T Consensus        90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999997665332   45778888899999999999999   8999999999999999643   34899999999887


Q ss_pred             cCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      ..  ...-...+||++|||||++...+++..+|||+-|||||-|+.|.+||... +...+    +..+..+..  .+++.
T Consensus       164 ~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-~~~rl----ye~I~~g~y--d~~~~  234 (355)
T KOG0033|consen  164 ND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-DQHRL----YEQIKAGAY--DYPSP  234 (355)
T ss_pred             CC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-cHHHH----HHHHhcccc--CCCCc
Confidence            62  22334568999999999999999999999999999999999999997431 11112    222222221  11111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .    -....+...+++.+|+..||.+|.|..|.++
T Consensus       235 ~----w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  235 E----WDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             c----cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            1    1122334678888999999999999999873

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.3e-35  Score=293.56  Aligned_cols=247  Identities=24%  Similarity=0.289  Sum_probs=200.7

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      +|+..+.||.|+||.||++... ++..+|+|.+....   ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4777899999999999999664 58999999986442   2446789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++++|.+++...   ..+++..+..++.||++||.|||   ..+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999998433   46899999999999999999999   7899999999999999999999999999987654322


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                        ......++..|+|||.+....++.++||||||+++|+|++|+.|+......  ...........          ....
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~----------~~~~  220 (258)
T cd05578         155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET----------ADVL  220 (258)
T ss_pred             --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc----------cccc
Confidence              223456788999999998888999999999999999999999997644321  11111111110          1112


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSM--AQAI  538 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~--~evl  538 (611)
                      .+......+.+++.+||+.+|.+||++  +|++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            233344668899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.7e-35  Score=295.12  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=198.4

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +|+..+.||+|+||.||++... +|..+|+|.+....  ....+.+.+|+.+++.++|+||+++++.+..+...++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677889999999999999664 58899999886542  23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC-CeEEeeeccceeccCCC
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAADR  427 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~  427 (611)
                      +++++|.+++.... ...+++..+..++.|+++||.|||   ..+++|+||||+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999985432 235799999999999999999999   78999999999999999886 46999999997654322


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                       .......|+..|+|||++....++.++||||||+++|||++|+.|+....    ..+...... ...+         ..
T Consensus       157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~-~~~~---------~~  221 (257)
T cd08225         157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN----LHQLVLKIC-QGYF---------AP  221 (257)
T ss_pred             -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHh-cccC---------CC
Confidence             12223458889999999988889999999999999999999999975321    112221111 1111         11


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ........+.+++.+|++.+|++|||+.+|+.
T Consensus       222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            11223345888999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.9e-35  Score=297.98  Aligned_cols=254  Identities=25%  Similarity=0.353  Sum_probs=192.9

Q ss_pred             CCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCCcceEEEeec
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      |...+.||+|+||.||++.. .+++.+|+|++.... ......+.+|+.++.++. |+||+++++++..+...+++|||+
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~   85 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM   85 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence            44567899999999999954 468999999986542 344567899999999996 999999999999999999999998


Q ss_pred             CCCChhhhhhc--cCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          350 PNRSLDQFIFD--KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       350 ~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      .. +|.++...  ......+++..+..++.+++.||+|||+  ..+++||||||+||+++.++.+||+|||+++......
T Consensus        86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            64 55443311  1123568999999999999999999993  3589999999999999999999999999997554322


Q ss_pred             cceeecccCCccccChhhhhcC---ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRG---QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      .  .....++..|+|||++...   .++.++||||||+++|||++|+.|+....   ...+........      ..+.+
T Consensus       163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~------~~~~~  231 (288)
T cd06616         163 A--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVKG------DPPIL  231 (288)
T ss_pred             c--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhhcCC------CCCcC
Confidence            1  1234578899999998776   68899999999999999999999975332   111111111110      11122


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ....+......+.+++.+|++.+|++||++.+|+..
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            222222345568899999999999999999999853

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.5e-35  Score=293.58  Aligned_cols=248  Identities=26%  Similarity=0.390  Sum_probs=201.7

Q ss_pred             CCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +|+..++||+|+||.||++. ..+++.+++|.+....  .....++.+|++++++++|+||+++++++..+...++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            46778899999999999995 4578899999987542  34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccC-CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          349 VPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       349 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      +++++|.+++.... ....+++..++.++.+++.||.|||   ..+++|+||+|.||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999985522 2356899999999999999999999   889999999999999999999999999999776543 


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                        ......++..|++||.+.+..++.++|+||||+++|||++|+.|+.....    .. ........         ....
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~-~~~~~~~~---------~~~~  220 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----QD-LRYKVQRG---------KYPP  220 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HH-HHHHHhcC---------CCCC
Confidence              12234578899999999888899999999999999999999999753221    11 11111111         1112


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+......+.+++..|++.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            23344566899999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.2e-35  Score=291.75  Aligned_cols=242  Identities=24%  Similarity=0.312  Sum_probs=195.0

Q ss_pred             cccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCCh
Q 007248          279 LGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       279 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      ||.|+||.||++... +++.+|+|++....   ....+.+.+|+++++.++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999664 48999999986432   23456799999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecc
Q 007248          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV  434 (611)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  434 (611)
                      .+++...   ..+++..+..++.||+.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~  152 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF  152 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence            9999543   34899999999999999999999   8999999999999999999999999999998664432  22334


Q ss_pred             cCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHH
Q 007248          435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVC  514 (611)
Q Consensus       435 ~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~  514 (611)
                      .++..|++||.+....++.++|+||||+++|||++|+.|+.....  +.........         +......++.....
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~---------~~~~~~~~~~~~~~  221 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE--DPMEIYNDIL---------KGNGKLEFPNYIDK  221 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC--CHHHHHHHHh---------ccCCCCCCCcccCH
Confidence            678899999999888899999999999999999999999865432  1111111111         11111122333355


Q ss_pred             HHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007248          515 NVLQIGLLCTQAAAALRPS-----MAQAIM  539 (611)
Q Consensus       515 ~l~~l~~~c~~~~p~~RPt-----~~evl~  539 (611)
                      .+.+++..||+.+|++||+     +.|+++
T Consensus       222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            6889999999999999999     666653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-36  Score=312.04  Aligned_cols=246  Identities=24%  Similarity=0.352  Sum_probs=193.0

Q ss_pred             CCCCccccCCceeEEEEEc-CCCCEEEEEEeecc----chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc--ceEEE
Q 007248          274 NPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN----TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE--SLLVY  346 (611)
Q Consensus       274 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  346 (611)
                      ....+||+|+|-+||||.. ..|..||--.++..    ..+..++|..|+++|+.|+|||||++|.++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4457899999999999944 45777776655422    34556899999999999999999999999887665  77899


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC-CCeEEeeeccceeccC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCFAA  425 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~~~  425 (611)
                      |.+..|+|..|+.+.   +.++.+.+.+|+.||++||.|||++ .++|||||||-.||+|+.+ |.+||+|+|||.....
T Consensus       123 EL~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            999999999999543   4588899999999999999999975 6899999999999999865 7999999999987643


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ..   ...+.||+.|||||... ..|+...||||||+.++||+|+..|+.-   ...+.+...+ ...+.....+..   
T Consensus       199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE---C~n~AQIYKK-V~SGiKP~sl~k---  267 (632)
T KOG0584|consen  199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE---CTNPAQIYKK-VTSGIKPAALSK---  267 (632)
T ss_pred             cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh---hCCHHHHHHH-HHcCCCHHHhhc---
Confidence            32   23478999999999986 8899999999999999999999988643   2233332222 222211111110   


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                        ..   -.++.+||..|+.. .++||++.|++..
T Consensus       268 --V~---dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  268 --VK---DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             --cC---CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence              01   12367889999999 9999999999853

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8.2e-35  Score=296.02  Aligned_cols=251  Identities=24%  Similarity=0.297  Sum_probs=196.6

Q ss_pred             CCCCCCccccCCceeEEEEEc----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcc
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  342 (611)
                      +|+..+.||+|+||.||++..    .+|..||+|++....    ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            367788999999999999965    478999999986532    22346788999999999 699999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++|+||+++++|.+++...   ..+++..+..++.||++||.|||   +.+++||||+|+|||+++++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            9999999999999998532   45888999999999999999999   89999999999999999999999999999987


Q ss_pred             ccCCCcceeecccCCccccChhhhhcC--ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLVRG--QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      .............++..|+|||.+...  .++.++||||||+++|||++|+.|+...................       
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------  227 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------  227 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-------
Confidence            644332223345688899999998753  46789999999999999999999986433322222211111110       


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                      .+    .++......+.+++..|++.+|++||     +.++++.
T Consensus       228 ~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            01    12223345578899999999999997     6666653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7.1e-35  Score=296.18  Aligned_cols=255  Identities=24%  Similarity=0.305  Sum_probs=199.8

Q ss_pred             CCCCCCccccCCceeEEEEEc----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcc
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  342 (611)
                      +|+..+.||+|+||.||++..    .++..+|||.+....    ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            366778999999999999853    357889999886432    23345688999999999 699999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++||||+++++|.+++..   ...+++..+..++.|+++||.|||   ..+++||||+|+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999999853   245889999999999999999999   79999999999999999999999999999976


Q ss_pred             ccCCCcceeecccCCccccChhhhhcCc--cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLVRGQ--LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      +............++..|+|||.+.+..  .+.++||||||+++|||++|..|+..................       .
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-------~  227 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-------S  227 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-------c
Confidence            5543322223456789999999987655  788999999999999999999997543222111111111100       0


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .+    ..+......+.+++.+|++.+|++|||+.++.+.|..
T Consensus       228 ~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            11    1122233457889999999999999999998887754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7e-35  Score=300.52  Aligned_cols=245  Identities=28%  Similarity=0.431  Sum_probs=193.2

Q ss_pred             CCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      |...+.||+|+||.||++.. .++..+|+|++...   ..+..+.+.+|++++++++|||++++++++.++...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            56678899999999999965 46889999998643   233456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++ +|.+++...  ...++|..+..++.+|+.||.|||   ..+|+||||+|+||+++.++.+||+|||++......  
T Consensus       107 ~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         107 CLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             CCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            975 777776432  345899999999999999999999   889999999999999999999999999998654321  


Q ss_pred             ceeecccCCccccChhhhh---cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLV---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                         ....++..|+|||++.   .+.++.++||||||+++|||++|+.|+.....    ............      +   
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~~~~~~~~------~---  242 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNES------P---  242 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHhccC------C---
Confidence               2345788999999974   45788999999999999999999998653211    111111111110      0   


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      ..........+.+++.+|++.+|++||++.+|++.+
T Consensus       243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            011122344578899999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.2e-34  Score=292.72  Aligned_cols=244  Identities=24%  Similarity=0.306  Sum_probs=191.8

Q ss_pred             cccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCCh
Q 007248          279 LGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       279 iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      ||+|+||+||++.. .+|+.+|+|.+....   ....+.+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999954 468999999886432   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecc
Q 007248          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV  434 (611)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  434 (611)
                      .+++..... ..+++..++.++.|++.||.|||   ..+++||||+|+||++++++.+||+|||++.......  .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~  154 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR  154 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence            999965432 46899999999999999999999   8899999999999999999999999999987654321  12234


Q ss_pred             cCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHH
Q 007248          435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVC  514 (611)
Q Consensus       435 ~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~  514 (611)
                      .++..|+|||.+.+..++.++||||||+++++|++|+.|+......... ......    .. .     .....+.....
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~----~~-~-----~~~~~~~~~~~  223 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-EELKRR----TL-E-----MAVEYPDKFSP  223 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-HHHHhc----cc-c-----ccccCCccCCH
Confidence            5778999999998888999999999999999999999998644321111 111110    00 0     01112222345


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          515 NVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       515 ~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                      .+.+++..||+.+|++||     +..+++.
T Consensus       224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         224 EAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            578999999999999999     6565653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.4e-34  Score=292.61  Aligned_cols=242  Identities=21%  Similarity=0.252  Sum_probs=186.0

Q ss_pred             ccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHH---hcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          278 KLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLI---SSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       278 ~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      .||+|+||.||++.. .+++.+|+|.+....   ......+.+|..++   ...+||||+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999965 468999999886432   12223344554433   34579999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +++|.+++...   ..+++..+..++.|++.||.|||   ..+|+||||||+|||+++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            99999998533   45899999999999999999999   7899999999999999999999999999987553322   


Q ss_pred             eecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      .....|+..|+|||.+.. ..++.++||||||+++|||++|+.||....... . .......      ...+.    ..+
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~-~~~~~~~------~~~~~----~~~  219 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-K-HEIDRMT------LTVNV----ELP  219 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-H-HHHHHHh------hcCCc----CCc
Confidence            123468999999999864 457899999999999999999999986433211 1 1111110      01111    122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRP-----SMAQAIML  540 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~~  540 (611)
                      ......+.+++..|++.+|++||     +++++++.
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            33345678899999999999999     59998864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=327.00  Aligned_cols=264  Identities=27%  Similarity=0.377  Sum_probs=209.5

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEcC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEee
Q 007248          265 TLEKATNYFNPSKKLGQGGAGSVYMGSLP--------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLG  334 (611)
Q Consensus       265 ~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~  334 (611)
                      .++...++..+.+.||+|.||.|++|...        ....||||.++... ....+.+..|+++|+.+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34444555566679999999999999542        14579999987543 34567899999999998 6999999999


Q ss_pred             eeeeCCcceEEEeecCCCChhhhhhccC-----------CC--ccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCc
Q 007248          335 CSIEGPESLLVYEYVPNRSLDQFIFDKN-----------KT--KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKT  401 (611)
Q Consensus       335 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  401 (611)
                      +|...+..++|.||+..|+|.+||+...           ..  ..++...++.++.|||.||+||+   +.++|||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence            9999999999999999999999996544           00  24889999999999999999999   88999999999


Q ss_pred             ccEEECCCCCeEEeeeccceeccCCCcceeeccc--CCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCC
Q 007248          402 SNILLDKDFTPKIADFGLARCFAADRTHVSTAVA--GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQD  479 (611)
Q Consensus       402 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~  479 (611)
                      +|||+.++..+||+|||+++..............  -...|||||.+....++.|+|||||||+||||+|...+....  
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~--  524 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG--  524 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC--
Confidence            9999999999999999999865554433322222  356799999999999999999999999999999954432211  


Q ss_pred             CCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          480 SASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                       ......++.         .+....+.+.|..+..++.+|++.||+.+|++||++.++++.+..
T Consensus       525 -~~~~~~l~~---------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  525 -IPPTEELLE---------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             -CCcHHHHHH---------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence             110111122         233333445566677889999999999999999999999999876

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.3e-35  Score=298.07  Aligned_cols=260  Identities=24%  Similarity=0.341  Sum_probs=193.6

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCCc-----
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPE-----  341 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  341 (611)
                      ++|+..+.||+|+||.||+|.. .+++.||||++....  ......+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4688889999999999999965 468999999876442  223457889999999994 6999999999887665     


Q ss_pred             ceEEEeecCCCChhhhhhccCC--CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-CCCeEEeeec
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNK--TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFG  418 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG  418 (611)
                      .++||||+++ +|.+++.....  ...+++..++.++.||++||.|||   ..+|+||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 78888854332  346899999999999999999999   789999999999999998 8899999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc---cC
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR---SN  494 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~---~~  494 (611)
                      +++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..|+....+    .........   ..
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~  231 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE----LQQLLHIFKLLGTP  231 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHHhCCC
Confidence            9976543221 1223346788999998865 4578999999999999999999988754322    111111111   00


Q ss_pred             c------cccccC----CCCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          495 K------LVEAVD----PNLKD----DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       495 ~------~~~~id----~~l~~----~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .      ..+..+    +....    .........+.+++..|++.+|++||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0      000000    00000    000123455789999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=310.13  Aligned_cols=216  Identities=26%  Similarity=0.422  Sum_probs=185.3

Q ss_pred             CCCCCCccccCCceeEEEEE-cCCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC------cce
Q 007248          272 YFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------ESL  343 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  343 (611)
                      .|...+.||+|+||.||+|+ ...|+.||||.+... .....+....|+++|++|+|+|||++++.-++..      ..+
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            35567889999999999997 567999999988653 2345678899999999999999999999866544      568


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC--CCC--CeEEeeecc
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD--KDF--TPKIADFGL  419 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DfGl  419 (611)
                      +|||||.+|||...|.+..+...|++.+.+.+..++..||.|||   +++|+||||||.||++-  ++|  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999998888888999999999999999999999   89999999999999984  333  479999999


Q ss_pred             ceeccCCCcceeecccCCccccChhhhh-cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc
Q 007248          420 ARCFAADRTHVSTAVAGTLGYMAPEYLV-RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR  492 (611)
Q Consensus       420 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~  492 (611)
                      |+.+.++.  ......||..|++||... .+.++...|.|||||++||.+||..||..........+..|....
T Consensus       171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t  242 (732)
T KOG4250|consen  171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT  242 (732)
T ss_pred             cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence            99876654  566789999999999998 488999999999999999999999999877665555555555443

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-34  Score=297.53  Aligned_cols=263  Identities=25%  Similarity=0.337  Sum_probs=193.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch--hhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--CcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  344 (611)
                      .++|+..++||+|+||.||+|.. .+|+.||+|++.....  .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            45788899999999999999965 4689999999864432  2233567899999999999999999998755  46799


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+.+ +|.+++...  ...+++..+..++.||++||+|||   ..+++||||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999964 788887532  246899999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh-----------hc
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL-----------YR  492 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-----------~~  492 (611)
                      .... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ..+..+...           ..
T Consensus       160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         160 LPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             CccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChhhchhhh
Confidence            3321 1222345778999999865 45789999999999999999999987533211 111111110           00


Q ss_pred             cCccccccC--CCCCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          493 SNKLVEAVD--PNLKDDFP---AEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       493 ~~~~~~~id--~~l~~~~~---~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      .........  ........   ......+.+++..|++.||++|||+++++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000000000  00000000   0123456789999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.5e-35  Score=290.11  Aligned_cols=250  Identities=23%  Similarity=0.376  Sum_probs=203.4

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +|...+.||+|+||.||++... ++..+++|++....  ....+.+.+|+++++.++|||++++++.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4677889999999999999654 68999999987553  25567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccC-CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          349 VPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       349 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      +++++|.+++.... ....+++..+..++.+++.||.|||   ..+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999996532 2367999999999999999999999   7899999999999999999999999999998664433


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                       .......++..|+|||.+....++.++||||+|+++++|++|+.|+....    ......... ...         ...
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~~~-~~~---------~~~  222 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN----LLELALKIL-KGQ---------YPP  222 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc----HHHHHHHHh-cCC---------CCC
Confidence             22234567889999999988889999999999999999999999975332    111111111 111         111


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+......+.+++.+|+..+|++||++.++++
T Consensus       223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            22234456889999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.1e-34  Score=303.61  Aligned_cols=260  Identities=24%  Similarity=0.292  Sum_probs=196.0

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC----
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP----  340 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  340 (611)
                      ...++|+..+.||+|+||.||++.. .+++.||||++...  .....+.+.+|+.++++++||||+++++++....    
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            3457899999999999999999954 57899999988532  3344567889999999999999999999876433    


Q ss_pred             --cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeec
Q 007248          341 --ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       341 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                        ..++||||+. ++|.+.+..     .+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence              4699999996 488877732     2888999999999999999999   7899999999999999999999999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc------
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR------  492 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~------  492 (611)
                      +++......  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+.....      
T Consensus       164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHH
Confidence            998654322  122345788999999999999999999999999999999999997543211 00000000000      


Q ss_pred             ------------c-------CccccccCCCC----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          493 ------------S-------NKLVEAVDPNL----KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       493 ------------~-------~~~~~~id~~l----~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                                  .       ..+.+.....+    ....+......+.+++.+|++.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                        0       00001111100    01111233556789999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-35  Score=320.65  Aligned_cols=266  Identities=20%  Similarity=0.288  Sum_probs=187.6

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcCC--CCEEEEE------------------EeeccchhhHHHHHHHHHHHhcCCCCc
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLPN--GTTVAVK------------------RLIFNTRQWVDEFFNEVNLISSIEHKN  328 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n  328 (611)
                      ..++|++.++||+|+||+||++..+.  +...++|                  .+. ........+.+|+.+|++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            35689999999999999999985432  2222222                  111 11233456889999999999999


Q ss_pred             eeeEeeeeeeCCcceEEEeecCCCChhhhhhccCC--CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK--TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       329 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                      |+++++++...+..++|+|++. ++|.+++.....  ........+..++.||+.||.|||   ..+|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence            9999999999999999999985 577777643211  122345667789999999999999   7899999999999999


Q ss_pred             CCCCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHH
Q 007248          407 DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQR  486 (611)
Q Consensus       407 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~  486 (611)
                      +.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++....... ....
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~-~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK-PGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC-HHHH
Confidence            999999999999998775544333345678999999999999999999999999999999999986433222111 1111


Q ss_pred             HHHhhcc-----C-------ccccccCCCCC----CCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          487 VWTLYRS-----N-------KLVEAVDPNLK----DDFPA-----EQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       487 ~~~~~~~-----~-------~~~~~id~~l~----~~~~~-----~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      .......     .       .+.+.++....    ...+.     .....+.+++.+|++.||++||++.|++..
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1111000     0       00001100000    00000     012235677889999999999999999853

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1e-34  Score=296.94  Aligned_cols=264  Identities=24%  Similarity=0.347  Sum_probs=196.6

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC----
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP----  340 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  340 (611)
                      ...++|++.+.||+|+||.||+|..+ +|+.||||++....  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678899999999999999999764 58899999987543  223456788999999999999999999887654    


Q ss_pred             ------cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEE
Q 007248          341 ------ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (611)
Q Consensus       341 ------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  414 (611)
                            ..++|+||+++ +|..++...  ...+++..+..++.||+.||+|||   +.+|+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 676666432  346899999999999999999999   789999999999999999999999


Q ss_pred             eeeccceeccCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc
Q 007248          415 ADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS  493 (611)
Q Consensus       415 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  493 (611)
                      +|||++...............++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ..+..+......
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~  236 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGS  236 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence            99999986654332222233457789999988653 5788999999999999999999887643221 111111111110


Q ss_pred             Cc---cccc--------cCC------CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          494 NK---LVEA--------VDP------NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       494 ~~---~~~~--------id~------~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..   ....        .+.      ..... ....+..+.+++..||+.+|++||++.+|+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00   0000        000      00000 0112456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.7e-34  Score=294.37  Aligned_cols=258  Identities=19%  Similarity=0.205  Sum_probs=184.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCC----CCEEEEEEeeccchhh-----------HHHHHHHHHHHhcCCCCceeeEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFNTRQW-----------VDEFFNEVNLISSIEHKNLVKLLG  334 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~  334 (611)
                      .++|.+.++||+|+||.||+|...+    +..+|+|.........           ......+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4678899999999999999997644    3456666543222111           011233445566789999999999


Q ss_pred             eeeeCC----cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC
Q 007248          335 CSIEGP----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF  410 (611)
Q Consensus       335 ~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  410 (611)
                      +.....    ..++++|++.. ++.+.+..   ....++..+..++.|+++||.|||   +.+|+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence            766543    33677887643 55555532   223578888999999999999999   78999999999999999999


Q ss_pred             CeEEeeeccceeccCCCcc------eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChh
Q 007248          411 TPKIADFGLARCFAADRTH------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPL  484 (611)
Q Consensus       411 ~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~  484 (611)
                      .++|+|||+++.+......      ......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999999876432211      1123468999999999999999999999999999999999999987553333222


Q ss_pred             HHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          485 QRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       485 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      ......+    +..+....+.   .......+.+++..|++.+|++||++.++++.|
T Consensus       244 ~~~~~~~----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCDF----IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHHH----HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            2111100    0011111111   111245578999999999999999999999876

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=287.94  Aligned_cols=247  Identities=28%  Similarity=0.442  Sum_probs=201.7

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccch--hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +|+..+.||+|++|.||++... +++.+++|.+.....  ...+.+.+|++++++++|||++++++++.+++..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677899999999999999654 678999999876543  4567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++...   ..+++..+..++.|++.||.|||   ..+|+||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999998433   56899999999999999999999   88999999999999999999999999999987654332


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      . .....++..|+|||.......+.++|||++|+++|+|++|+.|+....    .....+..... .         ....
T Consensus       155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~-~---------~~~~  219 (254)
T cd06627         155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRIVQD-D---------HPPL  219 (254)
T ss_pred             c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHhcc-C---------CCCC
Confidence            1 233467889999999988888999999999999999999999875322    12222221111 0         1112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +......+.+++.+|++.+|++||++.+++.
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            2233456789999999999999999999873

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-34  Score=299.81  Aligned_cols=262  Identities=23%  Similarity=0.349  Sum_probs=194.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC-----cc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----ES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  342 (611)
                      +++|++.++||+|+||.||+|.. .+|+.||||++... .......+.+|+.++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46889999999999999999954 57899999998643 3344567889999999999999999999866443     47


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++|+||+++ +|.+++.    ...+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999965 7777773    235899999999999999999999   88999999999999999999999999999976


Q ss_pred             ccCCCcc--eeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC---cc
Q 007248          423 FAADRTH--VSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN---KL  496 (611)
Q Consensus       423 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~  496 (611)
                      .......  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .............   .+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCHHHH
Confidence            5432221  1123467889999998755 46889999999999999999999987532210 0111111111100   00


Q ss_pred             ccccCCC-------C--CCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          497 VEAVDPN-------L--KDDFP-----AEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       497 ~~~id~~-------l--~~~~~-----~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ..+.+..       +  ....+     ......+.+++.+|++.+|++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000000       0  00000     1123457899999999999999999999865

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1e-34  Score=295.94  Aligned_cols=262  Identities=23%  Similarity=0.326  Sum_probs=193.1

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ++|+..+.||+|++|.||+|..+ +|+.||+|++....  ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999654 68899999886432  2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-CCCeEEeeeccceeccCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAAD  426 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~  426 (611)
                      |++ ++|.+++.... ...+++..+..++.||+.||+|||   ..+++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 57877774322 234678888899999999999999   789999999999999985 557999999999765432


Q ss_pred             CcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc---------c
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK---------L  496 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------~  496 (611)
                      . .......++..|+|||++.+. .++.++||||||+++|||+||+.|+........... ....+....         +
T Consensus       157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        157 V-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK-IFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             c-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChhhccccccc
Confidence            1 112234568899999998664 578899999999999999999999864322111111 001000000         0


Q ss_pred             cccc--CCCCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          497 VEAV--DPNLKD----DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       497 ~~~i--d~~l~~----~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ....  -+....    .........+.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000  000000    001122344788999999999999999999985

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.5e-35  Score=286.35  Aligned_cols=251  Identities=24%  Similarity=0.258  Sum_probs=203.8

Q ss_pred             CCCCCCccccCCceeEEEEEcCC-CCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .|+..++||.|.-|+||++.+.+ +..+|+|++....   ++...+...|-+||+.++||.++.||+.++.++..+++||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            34456789999999999998754 5899999997653   3445567789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC--
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA--  425 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~--  425 (611)
                      ||+||+|....+.+ ..+.+++..+.-++.+|+-||+|||   -.|||.|||||+||||.++|.+-|+||.|+.....  
T Consensus       158 yCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             cCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            99999999988654 4456899999999999999999999   89999999999999999999999999998743210  


Q ss_pred             --------------------------------CCc---------------------ceeecccCCccccChhhhhcCccc
Q 007248          426 --------------------------------DRT---------------------HVSTAVAGTLGYMAPEYLVRGQLT  452 (611)
Q Consensus       426 --------------------------------~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~  452 (611)
                                                      ...                     ..+...+||-.|+|||++.+.-.+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                            000                     011235689999999999999999


Q ss_pred             cccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 007248          453 EKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRP  532 (611)
Q Consensus       453 ~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RP  532 (611)
                      .+.|.|+|||+||||+.|+.||......+++...+             -..+.-.........+.+||...|.+||++|-
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv-------------~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl  380 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV-------------GQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL  380 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh-------------cCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence            99999999999999999999998766665544332             11221111224456688999999999999999


Q ss_pred             C----HHHHHH
Q 007248          533 S----MAQAIM  539 (611)
Q Consensus       533 t----~~evl~  539 (611)
                      .    +.||-+
T Consensus       381 g~~rGA~eIK~  391 (459)
T KOG0610|consen  381 GSKRGAAEIKR  391 (459)
T ss_pred             ccccchHHhhc
Confidence            8    777754

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.7e-35  Score=296.96  Aligned_cols=243  Identities=27%  Similarity=0.417  Sum_probs=194.8

Q ss_pred             CccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCChh
Q 007248          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLD  355 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~  355 (611)
                      .+||+|+||.||++.. .++..||||++........+.+.+|+.+++.++|+||+++++++..++..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            5799999999999966 578999999986555555677999999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeeccc
Q 007248          356 QFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA  435 (611)
Q Consensus       356 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  435 (611)
                      +++..    ..+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++....... .......
T Consensus       106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~  177 (292)
T cd06657         106 DIVTH----TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV  177 (292)
T ss_pred             HHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence            98732    34789999999999999999999   7899999999999999999999999999987554322 1223345


Q ss_pred             CCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHH
Q 007248          436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCN  515 (611)
Q Consensus       436 gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~  515 (611)
                      ++..|+|||.+.+..++.++||||||+++|||++|+.|+.....    ..... ....     ...+.+..  .......
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~----~~~~~-~~~~-----~~~~~~~~--~~~~~~~  245 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMK-MIRD-----NLPPKLKN--LHKVSPS  245 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHH-HHHh-----hCCcccCC--cccCCHH
Confidence            78899999999888889999999999999999999999753211    11111 1110     01111110  1122345


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 007248          516 VLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       516 l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +.+++.+||+.+|.+||++.+|+.
T Consensus       246 l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         246 LKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHhCCcccCcCHHHHhc
Confidence            778899999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.5e-35  Score=291.07  Aligned_cols=244  Identities=23%  Similarity=0.336  Sum_probs=195.6

Q ss_pred             cccCCceeEEEEEcC-CCCEEEEEEeeccch---hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCCh
Q 007248          279 LGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR---QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       279 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      ||+|+||.||++... +|+.+++|.+.....   ...+.+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999765 489999998865432   4566789999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc------
Q 007248          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT------  428 (611)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~------  428 (611)
                      .+++...   ..+++..+..++.||++||+|||   ..+++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9999543   26899999999999999999999   89999999999999999999999999999875433211      


Q ss_pred             -ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          429 -HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       429 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                       .......++..|++||.......+.++||||||+++|||++|+.|+....    ......... .+..          .
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~~~-~~~~----------~  219 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET----PEEIFQNIL-NGKI----------E  219 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHh-cCCc----------C
Confidence             12223457889999999988889999999999999999999999975332    111111111 1110          0


Q ss_pred             CCHH--HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          508 FPAE--QVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       508 ~~~~--~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .+..  ....+.+++.+|++.+|++|||+.++.+.|..
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            1111  24567899999999999999999777776643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.8e-35  Score=302.01  Aligned_cols=263  Identities=22%  Similarity=0.334  Sum_probs=196.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeee----CCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIE----GPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  342 (611)
                      .++|+..+.||+|+||.||++.. .+|..||+|++....  ....+.+.+|+.+|++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            46788899999999999999964 468999999986542  2345678899999999999999999998753    3467


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++|+||+. ++|.+++..   ...+++..+..++.||+.||.|||   ..+|+||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999995 689888843   334899999999999999999999   78999999999999999999999999999976


Q ss_pred             ccCCCcc---eeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHH-----------H
Q 007248          423 FAADRTH---VSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQR-----------V  487 (611)
Q Consensus       423 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~-----------~  487 (611)
                      .......   ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+..           .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLILSVLGSPSEEV  235 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHHHHhCCChhHh
Confidence            5432221   1123468889999999865 46889999999999999999999998543211 00000           0


Q ss_pred             HHhhccCccccccCC-CCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          488 WTLYRSNKLVEAVDP-NLKDDFP-----AEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       488 ~~~~~~~~~~~~id~-~l~~~~~-----~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      +.....+.+.+.++. ......+     ......+.+++.+|++.+|++||++.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            000001111111110 0001111     1234568899999999999999999998864

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-34  Score=289.22  Aligned_cols=249  Identities=24%  Similarity=0.342  Sum_probs=195.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc-----chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--Ccc
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PES  342 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  342 (611)
                      .+|+..+.||+|+||.||+|.. .++..+|+|++...     ..+....|.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688899999999999999965 46899999987532     233456789999999999999999999998764  457


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++++||+++++|.+++...   ..+++..+.+++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            8999999999999998532   34789999999999999999999   88999999999999999999999999999976


Q ss_pred             ccCCCc--ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          423 FAADRT--HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       423 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      ......  .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....    .......         .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~---------~  222 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAIFKI---------A  222 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHHHHH---------H
Confidence            532111  111234578899999999888899999999999999999999999753211    1111111         1


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ........+......+.+++.+|++ +|..||+..+++.
T Consensus       223 ~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1111122344445668889999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-36  Score=305.88  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=203.6

Q ss_pred             CCCCCCccccCCceeEEEEEcCC-CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      .|++...||.|+||+||++..++ +-..|-|++.....+..+.|+-|++||...+||+||+|++.|..++.++++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            45566789999999999996654 55667888877778888999999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      ||-.+..+.+-  ...|.+.++.-++.+++.||.|||   +.+|||||||+.|||+.-+|.++|+|||.+.-.. .....
T Consensus       113 GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qk  186 (1187)
T KOG0579|consen  113 GGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQK  186 (1187)
T ss_pred             CchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch-hHHhh
Confidence            99999888543  346999999999999999999999   8999999999999999999999999999985322 11223


Q ss_pred             eecccCCccccChhhhhc-----CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVR-----GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ...+.||+.|||||+.+.     .+|+.++||||||+.|.||..+.+|..    .-.+...+....+.+.      |.|.
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh----elnpMRVllKiaKSeP------PTLl  256 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH----ELNPMRVLLKIAKSEP------PTLL  256 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc----ccchHHHHHHHhhcCC------Cccc
Confidence            346789999999998754     578999999999999999999988732    2223333333222221      2222


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        .|......+.++...|+..||..||+..++++
T Consensus       257 --qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  257 --QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             --CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence              24555667889999999999999999999885

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-35  Score=291.87  Aligned_cols=247  Identities=23%  Similarity=0.352  Sum_probs=207.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .-|...+.||+|.|..|-++++ -.|..||||++....  ......+++|++.|+.++|||||+||.+......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            3456678899999999999843 489999999986543  3334578899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC-CCCCeEEeeeccceeccCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~  426 (611)
                      .-.+|+|.+||-+..  ..+.+....+++.||..|+.|+|   +..+|||||||+||.+- .-|-+||.|||++..+...
T Consensus        98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            999999999995443  34888999999999999999999   99999999999998765 4578999999999766543


Q ss_pred             CcceeecccCCccccChhhhhcCccc-cccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLT-EKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .  .-+..+|+..|-|||++.+..|+ ++.||||||||||-|++|+.||....+.++             +..++|-.. 
T Consensus       173 ~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------------LTmImDCKY-  236 (864)
T KOG4717|consen  173 K--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------------LTMIMDCKY-  236 (864)
T ss_pred             c--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------hhhhhcccc-
Confidence            3  34567899999999999998875 588999999999999999999986665543             333444332 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       ..|.....++.+|+..|+..||++|.+.+||+.
T Consensus       237 -tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  237 -TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence             346677788999999999999999999999984

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=290.46  Aligned_cols=255  Identities=27%  Similarity=0.395  Sum_probs=199.2

Q ss_pred             hcCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccc-------hhhHHHHHHHHHHHhcCCCCceeeEeeeee-eCC
Q 007248          270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT-------RQWVDEFFNEVNLISSIEHKNLVKLLGCSI-EGP  340 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~  340 (611)
                      .++|-..++||+|||+.||++ .+...+.||||+-..+.       ....+...+|.+|.+.|.||.||++|+++. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            345666789999999999999 66778999999754332       112344678999999999999999999986 556


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC---CCeEEeee
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD---FTPKIADF  417 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Df  417 (611)
                      .++.|+|||+|.+|+-||   +..+.+++++...|+.||+.||.||.+ .+++|||-||||.||||.+.   |.+||.||
T Consensus       542 sFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             cceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeec
Confidence            789999999999999999   345679999999999999999999984 57899999999999999654   67999999


Q ss_pred             ccceeccCCCcc------eeecccCCccccChhhhhcC----ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHH
Q 007248          418 GLARCFAADRTH------VSTAVAGTLGYMAPEYLVRG----QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV  487 (611)
Q Consensus       418 Gla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~  487 (611)
                      ||++.+..+...      .....+||.+|++||.+.-+    +++.|.||||.|||+|+.+.|++||..+....+.++. 
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe-  696 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE-  696 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh-
Confidence            999998765432      33467899999999987644    5788999999999999999999999876655444432 


Q ss_pred             HHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 007248          488 WTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQA  537 (611)
Q Consensus       488 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~ev  537 (611)
                            +.+.....-.+.  .-+....+...++.+|++..-++|....++
T Consensus       697 ------NTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  697 ------NTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             ------hchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence                  222222211111  111233446678899999999999876554

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.1e-34  Score=299.62  Aligned_cols=263  Identities=25%  Similarity=0.360  Sum_probs=195.1

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeecc--chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeC--Ccc
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG--PES  342 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  342 (611)
                      ..++|+..+.||+|+||.||+|... +++.+|||++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3467888899999999999999654 6889999988532  233445678899999999 999999999988653  367


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++||||++ ++|..++..    ..++|..+..++.||+.||.|||   ..+|+|+||||+||++++++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 599888843    26889999999999999999999   78999999999999999999999999999986


Q ss_pred             ccCCCcc----eeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh-------
Q 007248          423 FAADRTH----VSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL-------  490 (611)
Q Consensus       423 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-------  490 (611)
                      .......    ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ........       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~  235 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSAE  235 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHH
Confidence            6433221    2223457889999998755 457889999999999999999999875322111 11110000       


Q ss_pred             ----hccCccccccC---CCCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          491 ----YRSNKLVEAVD---PNLKD---DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       491 ----~~~~~~~~~id---~~l~~---~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                          ........+++   ..-..   .........+.+++.+|++.+|++||++.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                00000000110   00000   0011134568899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.8e-34  Score=296.47  Aligned_cols=259  Identities=22%  Similarity=0.294  Sum_probs=191.2

Q ss_pred             CccccC--CceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQG--GAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      ..||+|  +||+||++.. ..|+.||||++...  ..+..+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            457776  9999999965 57999999998643  234457889999999999999999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce-
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-  430 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-  430 (611)
                      ++|.+++.... ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999985432 235889999999999999999999   7899999999999999999999999998654322111100 


Q ss_pred             -----eecccCCccccChhhhhcC--ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHH--------------
Q 007248          431 -----STAVAGTLGYMAPEYLVRG--QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWT--------------  489 (611)
Q Consensus       431 -----~~~~~gt~~y~aPE~~~~~--~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~--------------  489 (611)
                           .....++..|+|||++.+.  .++.++||||||+++|||++|+.|+...............              
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                 0112345679999998764  4789999999999999999999997643221111000000              


Q ss_pred             --hh----------------ccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          490 --LY----------------RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       490 --~~----------------~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        ..                .........+..+...........+.+++.+||+.+|++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence              00                000000111111122222334567899999999999999999999984

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=331.65  Aligned_cols=257  Identities=26%  Similarity=0.388  Sum_probs=205.5

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (611)
                      +...+-+|....+||.|.||.||.+ ...+|...|||.+....  ....+.+.+|+.++..++|||+|+++|+-.+.+..
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            3444567788899999999999998 56679999999886543  34456678999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      +|.||||++|+|.+.+.   ....+++.....+..|++.|+.|||   +.+||||||||.||||+.+|.+|++|||.|..
T Consensus      1310 ~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeE
Confidence            99999999999999993   3344667777778899999999999   89999999999999999999999999999987


Q ss_pred             ccCCCcc---eeecccCCccccChhhhhcCc---cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcc
Q 007248          423 FAADRTH---VSTAVAGTLGYMAPEYLVRGQ---LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL  496 (611)
Q Consensus       423 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~---~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (611)
                      .......   .-....||+.|||||++.+..   ..-+.||||+||+++||+||++||...+..       |..      
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aI------ 1450 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAI------ 1450 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHH------
Confidence            7554321   122567999999999997644   345789999999999999999997543322       111      


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          497 VEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       497 ~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      .-.+-..-...+|......-.+++..|++.||+.|-++.|+++.=
T Consensus      1451 My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1451 MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            111111223345555666677899999999999999888887653

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.7e-34  Score=285.36  Aligned_cols=247  Identities=21%  Similarity=0.249  Sum_probs=189.5

Q ss_pred             HHHHHhcCCCCCCcc--ccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCC
Q 007248          265 TLEKATNYFNPSKKL--GQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGP  340 (611)
Q Consensus       265 ~l~~~~~~f~~~~~i--G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  340 (611)
                      ++....++|++.+.+  |+|+||.||++.. .++..+|+|.+.......     .|+.....+ +||||+++++++..++
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            344455677777776  9999999999964 568889999876432111     122222222 7999999999999999


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC-CeEEeeecc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGL  419 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl  419 (611)
                      ..++||||+++++|.+++...   ..+++..+..++.||++||.|||   +.+++||||||+||+++.++ .++|+|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            999999999999999999533   36899999999999999999999   78999999999999999998 999999999


Q ss_pred             ceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          420 ARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       420 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      +.......     ...++..|+|||++.+..++.++||||||+++|||++|+.|+................. .      
T Consensus       157 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------  224 (267)
T PHA03390        157 CKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q------  224 (267)
T ss_pred             ceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c------
Confidence            87654322     24578899999999988999999999999999999999999874332211111111111 0      


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHH
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPS-MAQAI  538 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt-~~evl  538 (611)
                        ...  ..+......+.+++..|++.+|.+||+ +++++
T Consensus       225 --~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l  260 (267)
T PHA03390        225 --KKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEII  260 (267)
T ss_pred             --ccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence              000  111234455788999999999999996 68887

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.8e-35  Score=321.54  Aligned_cols=255  Identities=28%  Similarity=0.408  Sum_probs=191.9

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeee------
Q 007248          267 EKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE------  338 (611)
Q Consensus       267 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  338 (611)
                      .....+|++.+.||+||||.|||++.+ ||+.||||++... +......+.+|+++|++|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456778899999999999999999553 8999999998765 34445678899999999999999999743210      


Q ss_pred             -----------------------------------------------------------C--------------------
Q 007248          339 -----------------------------------------------------------G--------------------  339 (611)
Q Consensus       339 -----------------------------------------------------------~--------------------  339 (611)
                                                                                 +                    
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                       0                    


Q ss_pred             ----------------------------------CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHH
Q 007248          340 ----------------------------------PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY  385 (611)
Q Consensus       340 ----------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~  385 (611)
                                                        ..+|+-||||+..+|.+++.+.....  .-...++++.+|++||.|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence                                              01478899999988888885433221  456779999999999999


Q ss_pred             HhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc---C--------------CCcceeecccCCccccChhhhhc
Q 007248          386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA---A--------------DRTHVSTAVAGTLGYMAPEYLVR  448 (611)
Q Consensus       386 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~---~--------------~~~~~~~~~~gt~~y~aPE~~~~  448 (611)
                      +|   +.+||||||||.||+||++..+||+|||+|....   .              ......+...||.-|+|||++.+
T Consensus       713 IH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99   8899999999999999999999999999998621   0              01112346789999999999976


Q ss_pred             C---ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 007248          449 G---QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQ  525 (611)
Q Consensus       449 ~---~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~  525 (611)
                      .   +|+.|+|+||+||||+||+.   ||....+....    ....+.+.+...      ..+..+.+..-.+++.++++
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~i----L~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASI----LTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHH----HHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence            5   49999999999999999995   44433222111    112222222211      12233344445688999999


Q ss_pred             cCCCCCCCHHHHHH
Q 007248          526 AAAALRPSMAQAIM  539 (611)
Q Consensus       526 ~~p~~RPt~~evl~  539 (611)
                      .||.+|||+.|+++
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999884

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.5e-34  Score=290.93  Aligned_cols=257  Identities=21%  Similarity=0.269  Sum_probs=190.1

Q ss_pred             CCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeC--CcceEEEe
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEG--PESLLVYE  347 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E  347 (611)
                      |+..++||+|+||.||+|.. .+++.+|+|++.... ........+|+.++.++. |+||+++++++.++  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            45678899999999999964 468999999886532 222234567999999885 99999999999887  88999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |++ ++|.+++...  ...++|..+..++.||+.||+|||   ..+++||||+|+||+++. +.+||+|||+++......
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 5787777432  246899999999999999999999   789999999999999999 999999999997654322


Q ss_pred             cceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh-----------hccCc
Q 007248          428 THVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL-----------YRSNK  495 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-----------~~~~~  495 (611)
                      .  .....++..|+|||.+.. +.++.++|||||||++|||++|+.|+...... ..+......           .....
T Consensus       154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-DQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-HHHHHHHHHcCCCCHHHHHhhcccc
Confidence            2  123457889999997654 55788999999999999999999987543211 111111110           00000


Q ss_pred             cccccCCCCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          496 LVEAVDPNLKD----DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       496 ~~~~id~~l~~----~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ......+....    .........+.+++.+|++.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00000000000    001123567899999999999999999999874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.6e-34  Score=293.32  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=192.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC-CCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ++|+..+.||+|+||.||+|..++ ++.||||++.... .....++..|+.++.+. .||||+++++++.++...+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            457778999999999999997764 8999999987543 23445677788877766 49999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |++ ++|.+++...  ...+++..+..++.||++||+|||+  ..+|+||||+|+||++++++.+||+|||++..+....
T Consensus        95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            985 4777666432  2368999999999999999999993  3589999999999999999999999999987654322


Q ss_pred             cceeecccCCccccChhhhhcCc----cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQ----LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      .  .....++..|+|||.+....    ++.++||||||+++|||++|+.|+......   .+..........      +.
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~------~~  238 (296)
T cd06618         170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVLTKILQEEP------PS  238 (296)
T ss_pred             c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---HHHHHHHhcCCC------CC
Confidence            1  12345778999999987553    788999999999999999999997542211   111111111110      00


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      +.  ........+.+++.+||+.+|++||++.++++.
T Consensus       239 ~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            10  011234568899999999999999999999854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.1e-34  Score=294.32  Aligned_cols=260  Identities=20%  Similarity=0.232  Sum_probs=192.0

Q ss_pred             CCccccCCceeEEEEEcCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCC
Q 007248          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRS  353 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs  353 (611)
                      .+.+|.|+++.||++.. +++.||||++...  ..+..+.+.+|+++++.++||||+++++++.+++..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455556666666655 7899999998754  34556789999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc----
Q 007248          354 LDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH----  429 (611)
Q Consensus       354 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~----  429 (611)
                      |.+++.... ...+++..+..++.|+++||+|||   ..+|+||||||+||+++.++.+||+|||.+.........    
T Consensus        86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999996432 235888999999999999999999   789999999999999999999999999998754322110    


Q ss_pred             --eeecccCCccccChhhhhcC--ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh----hccCc------
Q 007248          430 --VSTAVAGTLGYMAPEYLVRG--QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL----YRSNK------  495 (611)
Q Consensus       430 --~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~----~~~~~------  495 (611)
                        ......++..|+|||++...  .++.++||||||+++|||++|+.||.........++.....    +....      
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence              11234567789999998763  57889999999999999999999986543222111111000    00000      


Q ss_pred             -ccc----ccCCCC----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          496 -LVE----AVDPNL----KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       496 -~~~----~id~~l----~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                       ...    ..++..    ...........+.+++.+||+.+|++|||++++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence             000    000000    011122234567889999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-34  Score=286.06  Aligned_cols=244  Identities=23%  Similarity=0.241  Sum_probs=188.8

Q ss_pred             CccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHH-hcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLI-SSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      +.||+|+||.||+|.. .+++.||||++....   ......+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4699999999999965 468999999886442   12223445555544 456899999999999999999999999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      ++|.+++..   ...+++..+..++.||+.||.|||   ..+++|+||+|+||++++++.+||+|||+++....     .
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~  150 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N  150 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence            999999843   245889999999999999999999   78999999999999999999999999999875432     2


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                      ....++..|++||.+.+..++.++||||||+++|||++|..|+.....     ...+.........      ........
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~------~~~~~~~~  219 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSRRIN------WPEEVKEF  219 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcccC------CCCccccc
Confidence            234578899999999888889999999999999999999999753221     1111111111110      01111112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          512 QVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       512 ~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      ....+.+++.+|++.+|++||++.++.+.|.
T Consensus       220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             CCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            3455889999999999999998876666664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.3e-34  Score=299.18  Aligned_cols=261  Identities=23%  Similarity=0.325  Sum_probs=195.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC-----Cc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----PE  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  341 (611)
                      .++|...+.||+|+||+||++.. .++..||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788899999999999999954 56899999988643  233455678999999999999999999987654     24


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .++|+||+. ++|.+++..   ...+++..+..++.||+.||.|||   ..+++||||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 688888843   345899999999999999999999   7899999999999999999999999999997


Q ss_pred             eccCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhh---------
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY---------  491 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~---------  491 (611)
                      ...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||..... ...........         
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhh
Confidence            654322 22233457889999998865 4688999999999999999999999753321 11111111100         


Q ss_pred             --ccCcccccc-------CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          492 --RSNKLVEAV-------DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       492 --~~~~~~~~i-------d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                        ......+.+       +..+.. ........+.+++.+|++.+|++||+++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence              000000000       000000 011234557899999999999999999999854

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.5e-34  Score=293.15  Aligned_cols=263  Identities=24%  Similarity=0.337  Sum_probs=190.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc-----
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE-----  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  341 (611)
                      .++|+..++||+|+||.||++.. .+++.||||++....  ......+.+|++++++++||||+++++++.....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            34688899999999999999965 468999999886432  2223456789999999999999999998876543     


Q ss_pred             ---ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeec
Q 007248          342 ---SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       342 ---~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                         .++||||+.+ +|.+++...  ...+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCC
Confidence               4999999965 787777432  235899999999999999999999   7899999999999999999999999999


Q ss_pred             cceeccCCCcc---eeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc-
Q 007248          419 LARCFAADRTH---VSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS-  493 (611)
Q Consensus       419 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~-  493 (611)
                      ++..+......   ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ..+......... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~~~~~~~  243 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLISQLCGSI  243 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence            99766432221   11234567889999988664 4688999999999999999999887543211 111111110000 


Q ss_pred             --Ccc-----ccccCC-CCCCCC---------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          494 --NKL-----VEAVDP-NLKDDF---------PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       494 --~~~-----~~~id~-~l~~~~---------~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        ...     ....+. .+....         +......+.+++.+|++.+|++||+++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence              000     000000 000000         0011234678999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-35  Score=284.73  Aligned_cols=264  Identities=22%  Similarity=0.326  Sum_probs=211.4

Q ss_pred             hHHHHHHhcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeee
Q 007248          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGC  335 (611)
Q Consensus       263 ~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~  335 (611)
                      ..+|.....++.....+-+|.||.||.|.|.      +.+.|-||.++... .-....|+.|.-++..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3445555677888889999999999999553      34667888776553 3446678999999999999999999998


Q ss_pred             eeeC-CcceEEEeecCCCChhhhhh-----ccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC
Q 007248          336 SIEG-PESLLVYEYVPNRSLDQFIF-----DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD  409 (611)
Q Consensus       336 ~~~~-~~~~lv~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  409 (611)
                      +.++ ...+++|.++.-|+|..||.     +....+.++..++..++.|++.|++|||   +++|||.||..+|++||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhh
Confidence            7654 56789999999999999997     5556678899999999999999999999   8999999999999999999


Q ss_pred             CCeEEeeeccceeccCCC-cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHH
Q 007248          410 FTPKIADFGLARCFAADR-THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRV  487 (611)
Q Consensus       410 ~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~  487 (611)
                      .++||+|=.|++.+-+.. .-.......+..||+||.+.+..++..+|||||||+||||+| |+.|..    ..++.+..
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya----eIDPfEm~  508 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA----EIDPFEME  508 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc----ccCHHHHH
Confidence            999999999998653322 222233445779999999999999999999999999999998 666642    22233322


Q ss_pred             HHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          488 WTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       488 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                       ...+         ...+-..|.+++.+++.++.-||...|++||+++|++.-|.+
T Consensus       509 -~ylk---------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  509 -HYLK---------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             -HHHh---------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence             1112         222334466788889999999999999999999999988854

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.6e-34  Score=293.16  Aligned_cols=245  Identities=28%  Similarity=0.425  Sum_probs=191.9

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .|...+.||+|+||.||+|.. .++..+|+|.+...   .....+++.+|+++++.++|+|++++++++..+...++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            355667899999999999965 46789999988642   23345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+. |+|.+++...  ...+++..+..++.|++.||.|||   ..+++||||+|+||+++.++.+||+|||++...... 
T Consensus        96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            996 5777776432  245889999999999999999999   789999999999999999999999999998765322 


Q ss_pred             cceeecccCCccccChhhhh---cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLV---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                          ....++..|+|||.+.   .+..+.++||||||+++|||++|+.|+......    ....... ....     +..
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~-~~~~-----~~~  234 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIA-QNES-----PAL  234 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH----HHHHHHh-hcCC-----CCc
Confidence                2345788999999975   356788999999999999999999986432111    1111111 1100     111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                         ........+.+++.+||+.+|++||++.+|++.
T Consensus       235 ---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         235 ---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence               112234457889999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-34  Score=287.76  Aligned_cols=259  Identities=26%  Similarity=0.344  Sum_probs=192.0

Q ss_pred             CCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcC---CCCceeeEeeeeeeCCc-----
Q 007248          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSI---EHKNLVKLLGCSIEGPE-----  341 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  341 (611)
                      |++.+.||+|+||.||+|..+ +++.+|+|++....  ......+.+|+.++.++   +||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            556789999999999999775 48999999986432  22234566788777665   69999999999988776     


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .+++|||+.+ +|.+++.... ...+++..++.++.||++||.|||   +.+++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 8888885432 235899999999999999999999   7899999999999999999999999999997


Q ss_pred             eccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccc---
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE---  498 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  498 (611)
                      .......  .....++..|+|||++.+..++.++||||||+++|||++|+.|+...... ..+..+........-..   
T Consensus       156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCC
Confidence            7643321  12334688899999999889999999999999999999998887532211 11111111110000000   


Q ss_pred             -------ccCCCCC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          499 -------AVDPNLK---DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       499 -------~id~~l~---~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                             .......   ..........+.+++.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                   0000000   0011123455778999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-34  Score=287.98  Aligned_cols=259  Identities=24%  Similarity=0.350  Sum_probs=197.2

Q ss_pred             CCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccch--hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      |+..+.||+|++|.||++... +++.+++|++.....  .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456788999999999999664 689999998865432  34567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++ +|.+++....  ..+++..+..++.||++||.|||   ..+|+|+||+|+||+++.++.+||+|||.+....... .
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~  153 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R  153 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence            75 8888875432  46899999999999999999999   8899999999999999999999999999998765443 1


Q ss_pred             eeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc---CccccccC----
Q 007248          430 VSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS---NKLVEAVD----  501 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~id----  501 (611)
                      ......++..|+|||.+.+. .++.++||||||+++|+|+||+.|+...... +.+.........   ..+....+    
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCchHhcccchhhhhh
Confidence            22234577889999998776 7899999999999999999999887543221 111111000000   00000000    


Q ss_pred             -----CCCC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          502 -----PNLK----DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       502 -----~~l~----~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                           +...    ..........+.+++..||+.+|.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                 0000    0111223456889999999999999999999874

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.6e-33  Score=284.70  Aligned_cols=241  Identities=22%  Similarity=0.255  Sum_probs=185.8

Q ss_pred             ccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHH---HHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          278 KLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVN---LISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       278 ~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      .||+|+||.||++.. .+++.||+|.+....   ......+..|..   .++...||||+++++++..++..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999965 468899999886432   122223444443   4445689999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +++|.+++..   ...+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||++..+....   
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            9999998843   346999999999999999999999   7899999999999999999999999999987553222   


Q ss_pred             eecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      .....|+..|+|||.+.++ .++.++||||||+++|||++|+.|+........  ........      ..+..    .+
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~------~~~~~----~~  219 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTL------TMAVE----LP  219 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhh------ccCCC----CC
Confidence            1234689999999998754 688999999999999999999999864322111  11111100      01111    12


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                      ......+.+++.+|+..+|++||     ++.++++
T Consensus       220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            22345688899999999999999     9999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-34  Score=296.89  Aligned_cols=245  Identities=23%  Similarity=0.340  Sum_probs=201.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ...|.+...||+|.|++|..|+. ..+..||||.+....  ....+.+.+|+++|..|+|||||+++.+.+....+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            56788899999999999999954 469999999886542  334456889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+.+|.+.+++....+   +.+.....++.|+.+|++|||   .+.|+|||||++||||+.+.++||+|||++..+...
T Consensus       135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc
Confidence            99999999999965544   455777889999999999999   899999999999999999999999999999887633


Q ss_pred             CcceeecccCCccccChhhhhcCcc-ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                        ......+|++.|.|||++.+..+ .++.|+||+|++||-|+.|..||+...-                 .++-++.++
T Consensus       209 --~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-----------------k~Lr~rvl~  269 (596)
T KOG0586|consen  209 --LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-----------------KELRPRVLR  269 (596)
T ss_pred             --ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-----------------ccccchhee
Confidence              34456789999999999988765 6799999999999999999999863211                 111111111


Q ss_pred             CC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DD--FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~--~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..  .+.-....+.+++...+-.+|.+|++++++.+
T Consensus       270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            11  12223445778888999999999999999975

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.8e-34  Score=291.46  Aligned_cols=247  Identities=24%  Similarity=0.320  Sum_probs=199.8

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeecc---chhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  345 (611)
                      ++|...+.||+|+||.||++... +++.+|+|++...   .....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46788899999999999999654 7899999988643   2333467889999999998 99999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++++|.+++...   ..+++..++.++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            9999999999999543   36999999999999999999999   78999999999999999999999999999986644


Q ss_pred             CCc-------------------ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHH
Q 007248          426 DRT-------------------HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQR  486 (611)
Q Consensus       426 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~  486 (611)
                      ...                   .......++..|+|||......++.++||||||++++|+++|+.|+.....    ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~  230 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YLT  230 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----HHH
Confidence            321                   112234578899999999888899999999999999999999999764321    111


Q ss_pred             HHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHH
Q 007248          487 VWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSM----AQAI  538 (611)
Q Consensus       487 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~----~evl  538 (611)
                      .....         +  ....++......+.+++.+|++.+|++||++    ++++
T Consensus       231 ~~~~~---------~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll  275 (280)
T cd05581         231 FQKIL---------K--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK  275 (280)
T ss_pred             HHHHH---------h--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence            11111         0  1112223334568899999999999999999    6665

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.2e-34  Score=293.77  Aligned_cols=263  Identities=23%  Similarity=0.321  Sum_probs=195.8

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeee-CCc
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-GPE  341 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  341 (611)
                      +...+++|+..+.||+|+||.||++. ..++..||||++...  .....+.+.+|++++++++||||+++++++.. +..
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            34567889999999999999999995 457899999987532  22345678899999999999999999998865 557


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .++|+||+ +++|.+++.    ...+++..+..++.||++||.|||   ..+|+||||+|+|||+++++.+||+|||++.
T Consensus        85 ~~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          85 IYFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            88999998 568988873    234788888899999999999999   8899999999999999999999999999987


Q ss_pred             eccCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCC----------hhHHHHHh
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS----------PLQRVWTL  490 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~----------~~~~~~~~  490 (611)
                      .....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........          +.+.+...
T Consensus       157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            54321    123456788999998766 5688999999999999999999988754321000          00000100


Q ss_pred             hccCccccccC-CCCCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          491 YRSNKLVEAVD-PNLKDDFPA-----EQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       491 ~~~~~~~~~id-~~l~~~~~~-----~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      .......+.+. .......+.     .....+.+++.+|++.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000011100 001111111     123568899999999999999999998744

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.1e-34  Score=292.93  Aligned_cols=263  Identities=25%  Similarity=0.377  Sum_probs=191.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch--hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC------
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------  340 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  340 (611)
                      .++|+..++||+|+||.||+|.. .+++.+|||++.....  .....+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            46788999999999999999965 4689999998865432  22346778999999999999999999875433      


Q ss_pred             --cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeec
Q 007248          341 --ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       341 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                        ..++|+||+.+ +|...+...  ...+++..+..++.||++||.|||   ..+|+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCc
Confidence              45999999965 676666432  346899999999999999999999   7899999999999999999999999999


Q ss_pred             cceeccCCCcc----------eeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHH
Q 007248          419 LARCFAADRTH----------VSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV  487 (611)
Q Consensus       419 la~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~  487 (611)
                      +++........          ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~  239 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLI  239 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence            99765432211          11233567889999988654 5789999999999999999999887533221 111111


Q ss_pred             HHhhccC---------ccccccCCCCCCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          488 WTLYRSN---------KLVEAVDPNLKDDFP-------AEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       488 ~~~~~~~---------~~~~~id~~l~~~~~-------~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +......         .+....+.......+       ......+.+++.+|++.+|++|||+.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1111100         000000000000011       112245789999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.7e-34  Score=295.43  Aligned_cols=266  Identities=24%  Similarity=0.321  Sum_probs=197.5

Q ss_pred             ChHHHHHHhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeee
Q 007248          262 KYETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIE  338 (611)
Q Consensus       262 ~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  338 (611)
                      ...++..++++|...+.||+|+||.||++. ..+++.||+|++....  ....+.+.+|+.++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            345677788999999999999999999995 4578999999986432  2334678899999999999999999998764


Q ss_pred             C------CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCe
Q 007248          339 G------PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       339 ~------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  412 (611)
                      .      ...+++++++ +++|.+++..    ..+++..+..++.||++||+|||   +.+|+||||||+||++++++.+
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCE
Confidence            3      2357788876 7899888732    34899999999999999999999   8899999999999999999999


Q ss_pred             EEeeeccceeccCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh-
Q 007248          413 KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL-  490 (611)
Q Consensus       413 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-  490 (611)
                      ||+|||++......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .+...... 
T Consensus       160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~  234 (345)
T cd07877         160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLV  234 (345)
T ss_pred             EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence            99999998754321    223457889999998866 467889999999999999999999875322111 11110000 


Q ss_pred             ----------hccCc---cccccCCCCCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          491 ----------YRSNK---LVEAVDPNLKDDF---PAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       491 ----------~~~~~---~~~~id~~l~~~~---~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                                +....   ....+.......+   .......+.+++..|++.+|++||++.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                      00000   0000000000000   00123457899999999999999999998853

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-34  Score=287.89  Aligned_cols=259  Identities=27%  Similarity=0.385  Sum_probs=196.3

Q ss_pred             CCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      |+..+.||+|+||.||+|... +++.+|+|++....  ....+.+.+|+.++++++|+||+++++++......++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456688999999999999665 58999999987653  334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      + ++|.+++....  ..+++..+..++.++++||.|||   ..+|+||||+|+||++++++.+||+|||+++....... 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            7 58999995432  46899999999999999999999   78999999999999999999999999999976543322 


Q ss_pred             eeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCCh----------hHHHHHhhccCc---
Q 007248          430 VSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASP----------LQRVWTLYRSNK---  495 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~----------~~~~~~~~~~~~---  495 (611)
                      ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.........          ....|..+..-.   
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            12233457789999998776 7899999999999999999998887543211100          011111111000   


Q ss_pred             --cccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          496 --LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       496 --~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        ............+ ......+.+++..|++.+|++||++.+|+.
T Consensus       234 ~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence              0000000000001 112456889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-34  Score=286.99  Aligned_cols=259  Identities=27%  Similarity=0.346  Sum_probs=193.3

Q ss_pred             CCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccch-hhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCCcceEEEeec
Q 007248          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      |.+.+.||+|++|+||+|... +++.|+||++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999765 578999998864422 22234567999999998 999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                       +++|.+++.... ...+++..++.++.|++.+|.|||   +.+++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             889998885433 246899999999999999999999   78999999999999999999999999999976543221 


Q ss_pred             eeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc---------Cccccc
Q 007248          430 VSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS---------NKLVEA  499 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~  499 (611)
                       .....++..|+|||++.. ..++.++||||||++++||++|+.|+........ +.........         ..+...
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCCCChhhhhhHhhhhcc
Confidence             223457889999998754 4578999999999999999999988743321110 0000000000         000001


Q ss_pred             cCCCCC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          500 VDPNLK-------DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       500 id~~l~-------~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ++..+.       ..........+.+++.+|++.+|++||+++|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            110000       0001112456889999999999999999999874

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.2e-34  Score=295.31  Aligned_cols=256  Identities=24%  Similarity=0.376  Sum_probs=189.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC------
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------  340 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  340 (611)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            47888899999999999999965 46899999988643  2223456889999999999999999999887543      


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      ..++|+||+.. +|..++     ...+++..+..++.|++.||+|||   ..+++||||||+|||++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            45899999964 676654     124889999999999999999999   789999999999999999999999999998


Q ss_pred             eeccCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh---------
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL---------  490 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~---------  490 (611)
                      +.....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+...+..         
T Consensus       165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFV  239 (342)
T ss_pred             cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHH
Confidence            754321    123456788999999876 468899999999999999999999986432111 11111110         


Q ss_pred             --hccCccccccC--CCC-CCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          491 --YRSNKLVEAVD--PNL-KDDF---PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       491 --~~~~~~~~~id--~~l-~~~~---~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        .........+.  +.. ....   .......+.+++.+|++.+|++||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              00000000000  000 0000   0112345789999999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-34  Score=296.02  Aligned_cols=261  Identities=23%  Similarity=0.292  Sum_probs=198.3

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC-----cce
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----ESL  343 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  343 (611)
                      +|...+.||+|+||.||++... ++..+|||++....  ....+.+.+|+++++.++||||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999764 48999999886543  344567899999999999999999999988765     789


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      +||||++ ++|.+++...   ..+++..+..++.+|++||.|||   ..+|+||||||.|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 4888888432   36999999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCc--ceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh----------
Q 007248          424 AADRT--HVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL----------  490 (611)
Q Consensus       424 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~----------  490 (611)
                      .....  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ........          
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHhcCCCChhHhh
Confidence            54331  112334578899999999887 78999999999999999999999975432110 00000000          


Q ss_pred             -hccCccccccCC-CCCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          491 -YRSNKLVEAVDP-NLKD-----DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       491 -~~~~~~~~~id~-~l~~-----~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                       .......+.+.. ....     .........+.+++.+||+.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             000000001000 0000     0011134557899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.6e-33  Score=289.83  Aligned_cols=243  Identities=29%  Similarity=0.447  Sum_probs=190.0

Q ss_pred             CCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      |...++||+|+||+||+|.. .++..|++|++....   ....+.+.+|+++++.++|||++++++++.++...++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            45567899999999999965 468899999986432   23446788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +. ++|.+++...  ...+++..++.++.||+.||.|||   ..+++|+||+|+||+++.++.+||+|||++.....   
T Consensus       103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 5777776432  345899999999999999999999   78999999999999999999999999999854321   


Q ss_pred             ceeecccCCccccChhhhh---cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLV---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                        .....++..|+|||++.   .+.++.++||||||+++|||++|..|+.....    .......... ..     +...
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~----~~~~~~~~~~-~~-----~~~~  241 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQN-DS-----PTLQ  241 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhc-CC-----CCCC
Confidence              12346788999999984   45688899999999999999999998653321    1111111111 10     1111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                         .......+.+++.+|++.+|++||++.+++.
T Consensus       242 ---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         242 ---SNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               1112234778999999999999999999884

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-33  Score=294.79  Aligned_cols=262  Identities=23%  Similarity=0.346  Sum_probs=195.4

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC--
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP--  340 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  340 (611)
                      +....++|...+.||+|+||.||++. ..++..||||++...  .....+.+.+|+++|++++||||+++++++..+.  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            34457789999999999999999995 457899999988543  2333456889999999999999999999887654  


Q ss_pred             ----cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEee
Q 007248          341 ----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD  416 (611)
Q Consensus       341 ----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  416 (611)
                          ..++||||+ +++|.+++.    ...+++..+..++.||++||+|||   ..+|+||||||+||++++++.+||+|
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEee
Confidence                348999998 779988873    235899999999999999999999   89999999999999999999999999


Q ss_pred             eccceeccCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhH----------
Q 007248          417 FGLARCFAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ----------  485 (611)
Q Consensus       417 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~----------  485 (611)
                      ||++.......    ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+...........          
T Consensus       162 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07880         162 FGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK  237 (343)
T ss_pred             cccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            99997553321    23456889999999876 4578899999999999999999999764321110000          


Q ss_pred             HHHHhhccCccccccC--CCCC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          486 RVWTLYRSNKLVEAVD--PNLK----DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       486 ~~~~~~~~~~~~~~id--~~l~----~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .++..+........+.  +...    ..........+.+++.+|++.+|++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0001000000000000  0000    0001122334789999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.4e-33  Score=293.20  Aligned_cols=262  Identities=23%  Similarity=0.297  Sum_probs=193.0

Q ss_pred             cCCCC-CCccccCCceeEEEEEc-CCCCEEEEEEeeccchhh--------------HHHHHHHHHHHhcCCCCceeeEee
Q 007248          271 NYFNP-SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQW--------------VDEFFNEVNLISSIEHKNLVKLLG  334 (611)
Q Consensus       271 ~~f~~-~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  334 (611)
                      ++|.. .+.||+|+||+||+|.. .+++.||||++.......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            34543 46799999999999964 468999999886432211              125779999999999999999999


Q ss_pred             eeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEE
Q 007248          335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (611)
Q Consensus       335 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  414 (611)
                      ++..++..++||||+. ++|.+++..   ...+++.....++.||+.||+|||   +.+|+|+||+|+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEE
Confidence            9999999999999996 689888843   345889999999999999999999   899999999999999999999999


Q ss_pred             eeeccceeccCCC-------------cceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCC
Q 007248          415 ADFGLARCFAADR-------------THVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDS  480 (611)
Q Consensus       415 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~  480 (611)
                      +|||+++......             ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999998664111             1111123467889999998764 4688999999999999999999987644321


Q ss_pred             CChhHHHHHhhccCc---cccc--------cCCCCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          481 ASPLQRVWTLYRSNK---LVEA--------VDPNLKD---DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       481 ~~~~~~~~~~~~~~~---~~~~--------id~~l~~---~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                       ..+..+........   +...        .......   .........+.+++..|++.+|++||+++|++..
T Consensus       241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        241 -DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             -HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence             11111111111000   0000        0000000   0011224457899999999999999999999853

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8e-34  Score=295.76  Aligned_cols=262  Identities=23%  Similarity=0.313  Sum_probs=192.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC---------
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG---------  339 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  339 (611)
                      ..+|...+.||.|+||.||+|.. .+|..||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36788899999999999999955 56899999998766656667889999999999999999999876543         


Q ss_pred             -----CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC-CCCCeE
Q 007248          340 -----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPK  413 (611)
Q Consensus       340 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k  413 (611)
                           ...++|+||++ ++|.+++.    ...+++..+..++.||+.||.|||   +.+|+||||||+||+++ +++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEE
Confidence                 34689999997 58888873    235889999999999999999999   78999999999999997 456789


Q ss_pred             EeeeccceeccCCCcce--eecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh
Q 007248          414 IADFGLARCFAADRTHV--STAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL  490 (611)
Q Consensus       414 l~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~  490 (611)
                      |+|||+++.........  .....++..|+|||.+.. ..++.++|||||||++|||++|+.||................
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999997654322111  123356889999998755 467889999999999999999999985432211100000000


Q ss_pred             h-----ccCccc----cccC-CCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          491 Y-----RSNKLV----EAVD-PNLKDDFP-----AEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       491 ~-----~~~~~~----~~id-~~l~~~~~-----~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .     ......    .... .......+     ......+.+++..|++.+|++|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0     000000    0000 00000001     112345778999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.4e-34  Score=283.69  Aligned_cols=249  Identities=26%  Similarity=0.372  Sum_probs=192.9

Q ss_pred             CCCCCCccccCCceeEEEEEcCC-CCEEEEEEeecc-----chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      +|.+.+.||+|+||.||++.... +..+++|.++..     .......+..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47778999999999999996533 444555554321     122334577899999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          346 YEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      +||+++++|.+++... .....+++..++.++.|++.||.|||   +.+++|+||+|+||++++ +.+||+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988642 23456999999999999999999999   899999999999999976 569999999997654


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      .... ......++..|+|||.+....++.++||||||+++|+|++|..|+...    .......... ..     ..+  
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~----~~~~~~~~~~-~~-----~~~--  223 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ----NFLSVVLRIV-EG-----PTP--  223 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHHHHH-cC-----CCC--
Confidence            3221 223455788999999998888899999999999999999999987422    1222111111 11     111  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        ..+......+.+++.+|++.+|++||++.++++
T Consensus       224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 --SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             --CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence              123334456889999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-34  Score=266.50  Aligned_cols=248  Identities=21%  Similarity=0.328  Sum_probs=193.4

Q ss_pred             CCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          275 PSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      ....||.|..|.|++.+. ..|..+|||.+.... .+..++++..++++..- ..|.||+.+|||..+...++.||.| .
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence            356799999999999965 458999999987653 45567788888877655 5899999999999999999999988 3


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      .-++.++..  -.+++++..+=++...+.+||.||.+  +++|+|||+||+|||+|+.|++||+|||++..+.+..  ..
T Consensus       175 ~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Ah  248 (391)
T KOG0983|consen  175 TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AH  248 (391)
T ss_pred             HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--cc
Confidence            455666632  23458888888999999999999997  8999999999999999999999999999997765433  23


Q ss_pred             ecccCCccccChhhhhc---CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          432 TAVAGTLGYMAPEYLVR---GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      +..+|-+.|||||.+.-   ..|+.++||||||+.|+||.||+.|+......-+.+.   ....++.      |.|..  
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt---kvln~eP------P~L~~--  317 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT---KVLNEEP------PLLPG--  317 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH---HHHhcCC------CCCCc--
Confidence            45678899999999864   3688899999999999999999999865433322222   2222111      22221  


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ...-...+.+++..|++.|+.+||...++++.
T Consensus       318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            11134457889999999999999999998753

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-33  Score=294.80  Aligned_cols=259  Identities=24%  Similarity=0.335  Sum_probs=195.2

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc---
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE---  341 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  341 (611)
                      +..++|...+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.++++++||||+++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            45678889999999999999999664 5789999988643  23345667889999999999999999998776554   


Q ss_pred             ---ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeec
Q 007248          342 ---SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       342 ---~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                         .++|+||+ +++|.+++..    ..+++..+..++.||++||.|||   ..+|+||||||+||++++++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccc
Confidence               89999998 6699988843    45899999999999999999999   7899999999999999999999999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHH----------
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV----------  487 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~----------  487 (611)
                      ++......    .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... .+...          
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~  238 (343)
T cd07851         164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEE  238 (343)
T ss_pred             cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHH
Confidence            99765432    2234578889999998653 67889999999999999999999875332111 11110          


Q ss_pred             -HHhhccCccccccC---CCCCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          488 -WTLYRSNKLVEAVD---PNLKDDF---PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       488 -~~~~~~~~~~~~id---~~l~~~~---~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       +..+........+.   ......+   .......+.+++.+|++.+|++|||+.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence             00000000000000   0000000   0112456889999999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=283.86  Aligned_cols=245  Identities=24%  Similarity=0.302  Sum_probs=199.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .+.|..-++||+|+||.||-.+. ..|+.+|.|++....   ++...--++|-.+|.+++.+.||.+--.++..+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            35678889999999999998844 469999999885432   23334567899999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      +..|.||+|.-+|..... ..+++...+-++.+|+-||++||   +.+||.|||||+|||||+.|+++|+|.|||..+..
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999966543 56999999999999999999999   89999999999999999999999999999987765


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC-
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL-  504 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l-  504 (611)
                      ....  ...+||.+|||||++.++.|+...|.|||||+||||+.|+.||....+...              .+.+|... 
T Consensus       340 g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk--------------~eEvdrr~~  403 (591)
T KOG0986|consen  340 GKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK--------------REEVDRRTL  403 (591)
T ss_pred             CCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh--------------HHHHHHHHh
Confidence            4433  234899999999999999999999999999999999999999754332211              11111111 


Q ss_pred             --CCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 007248          505 --KDDFPAEQVCNVLQIGLLCTQAAAALRPSM  534 (611)
Q Consensus       505 --~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~  534 (611)
                        ..+++..-.++...|....++.||++|---
T Consensus       404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             cchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence              123444445567788888999999988543

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-33  Score=277.66  Aligned_cols=236  Identities=26%  Similarity=0.311  Sum_probs=191.4

Q ss_pred             cccCCceeEEEEEcC-CCCEEEEEEeeccch---hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCCh
Q 007248          279 LGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR---QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       279 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      ||+|+||.||++... +++.+++|++.....   ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999664 589999998865432   2456789999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecc
Q 007248          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV  434 (611)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  434 (611)
                      .+++...   ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~  153 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF  153 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence            9999433   35899999999999999999999   7999999999999999999999999999997654332 122345


Q ss_pred             cCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHH
Q 007248          435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVC  514 (611)
Q Consensus       435 ~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~  514 (611)
                      .++..|++||.+.+...+.++|+||||+++|||++|+.|+.....    ........ ..          ...++.....
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~-~~----------~~~~~~~~~~  218 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKIL-KD----------PLRFPEFLSP  218 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHh-cC----------CCCCCCCCCH
Confidence            678899999999888889999999999999999999999753321    11111111 10          0112223345


Q ss_pred             HHHHHHHHhcccCCCCCCCHHH
Q 007248          515 NVLQIGLLCTQAAAALRPSMAQ  536 (611)
Q Consensus       515 ~l~~l~~~c~~~~p~~RPt~~e  536 (611)
                      .+.+++.+|+..+|++||++.+
T Consensus       219 ~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         219 EARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHHhcCCHhhCCCccc
Confidence            6789999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.3e-32  Score=285.50  Aligned_cols=260  Identities=25%  Similarity=0.293  Sum_probs=188.9

Q ss_pred             CCCCCCccccCCceeEEEEEcC-C--CCEEEEEEeecc--chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeC----Cc
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-N--GTTVAVKRLIFN--TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG----PE  341 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  341 (611)
                      +|+..+.||+|+||.||++... .  +..||+|++...  .....+.+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999654 3  789999988643  223356788999999999 599999999875432    34


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .++++||+. ++|.+++..   ...+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888885 689888843   345899999999999999999999   8899999999999999999999999999998


Q ss_pred             eccCCCcc---eeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhH-----------H
Q 007248          422 CFAADRTH---VSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ-----------R  486 (611)
Q Consensus       422 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~-----------~  486 (611)
                      .+......   ......|+..|+|||++.+ ..++.++||||||+++|+|++|+.|+....... .+.           .
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~  232 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEE  232 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHH
Confidence            65432211   1123468899999998766 468899999999999999999999875432110 010           0


Q ss_pred             HHHhhccCccccc---cCCCCC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          487 VWTLYRSNKLVEA---VDPNLK---DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       487 ~~~~~~~~~~~~~---id~~l~---~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+..+........   ....-.   ..........+.+++.+|++.+|++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000000   000000   0001112345789999999999999999999873

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8.8e-34  Score=269.11  Aligned_cols=202  Identities=27%  Similarity=0.379  Sum_probs=167.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC-----CCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeee-CCcc
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN-----GTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-GPES  342 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  342 (611)
                      ..|+....||+|.||.||+|.-.+     ...+|||+++...  ........+|+.++++++||||+.|..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            457888999999999999994322     2379999886542  1223457799999999999999999998877 7789


Q ss_pred             eEEEeecCCCChhhhhhc--cCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC----CCeEEee
Q 007248          343 LLVYEYVPNRSLDQFIFD--KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD----FTPKIAD  416 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D  416 (611)
                      ++++||.+. +|...|+-  ..+...++...+..|++||+.|+.|||   +.=|+||||||.|||+..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999977 78777743  334467899999999999999999999   7889999999999999887    8999999


Q ss_pred             eccceeccCCCcce--eecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCC
Q 007248          417 FGLARCFAADRTHV--STAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAF  476 (611)
Q Consensus       417 fGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~  476 (611)
                      ||+++.+...-...  ...++-|.+|.|||.+.+. .||.+.|||+.|||+.||+|-.+-|.-
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            99999886544332  3356679999999999875 689999999999999999998766543

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=305.81  Aligned_cols=259  Identities=22%  Similarity=0.227  Sum_probs=206.9

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC
Q 007248          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG  339 (611)
Q Consensus       264 ~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  339 (611)
                      .++....++|++.++||+|+||.|..++.+ .++.||+|++..-.   +....-|..|-++|..-+.+-|+.+.-.|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344555678889999999999999999764 58899999987532   33445688999999999999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecc
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  419 (611)
                      ..+|+|||||+||+|..++....   .+++....-++..|.-||.-||   +.|+|||||||.|||||..|.+||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchh
Confidence            99999999999999999995443   5888888889999999999999   89999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccCCccccChhhhhc-----CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC
Q 007248          420 ARCFAADRTHVSTAVAGTLGYMAPEYLVR-----GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN  494 (611)
Q Consensus       420 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  494 (611)
                      +-.+..+....+...+|||.|.+||++..     +.|...+|.||+||++|||+.|..||..    ..+++....+....
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa----dslveTY~KIm~hk  297 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA----DSLVETYGKIMNHK  297 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH----HHHHHHHHHHhchh
Confidence            98888787777888899999999999863     5788999999999999999999999853    33444444433332


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 007248          495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPS---MAQAIML  540 (611)
Q Consensus       495 ~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt---~~evl~~  540 (611)
                      ....+.+       ..+......+||...+. +|+.|-.   ++++-..
T Consensus       298 ~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  298 ESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             hhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            2222221       12234455666655443 5666666   8887643

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=267.91  Aligned_cols=262  Identities=26%  Similarity=0.344  Sum_probs=196.5

Q ss_pred             ccccChHHHHHHhcCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccc-hhhHHHHHHHHHHHh-cCCCCceeeEee
Q 007248          258 CLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT-RQWVDEFFNEVNLIS-SIEHKNLVKLLG  334 (611)
Q Consensus       258 ~~~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~-~l~h~niv~l~~  334 (611)
                      ...|+.++|+.       ...||.|+||+|+|- ..+.|+.+|||++.... ....++++.|.+... .-+.||||++||
T Consensus        58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG  130 (361)
T KOG1006|consen   58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG  130 (361)
T ss_pred             ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence            34566666665       457999999999998 45679999999998664 356678889998555 458999999999


Q ss_pred             eeeeCCcceEEEeecCCCChhhhhhc--cCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCe
Q 007248          335 CSIEGPESLLVYEYVPNRSLDQFIFD--KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       335 ~~~~~~~~~lv~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  412 (611)
                      .+..++..++.||.| ..||+.+-..  ..+...+++.-+-.|.....+||.||.+  ...|||||+||+|||||..|.+
T Consensus       131 a~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~v  207 (361)
T KOG1006|consen  131 ALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDV  207 (361)
T ss_pred             hhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCE
Confidence            999999999999999 4466554311  1223458888888899999999999996  7899999999999999999999


Q ss_pred             EEeeeccceeccCCCcceeecccCCccccChhhhhcC--ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh
Q 007248          413 KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG--QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL  490 (611)
Q Consensus       413 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~  490 (611)
                      ||+|||++..+.+.  ...+.-+|-..|||||.+...  -++.+|||||||+.|+|+.||+.|.....+   .++.+...
T Consensus       208 KLCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~V  282 (361)
T KOG1006|consen  208 KLCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQV  282 (361)
T ss_pred             eeecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHH
Confidence            99999998765432  122345678899999998643  388999999999999999999999654332   22222221


Q ss_pred             hccCccccccCCCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          491 YRSNKLVEAVDPNLKDDF-PAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       491 ~~~~~~~~~id~~l~~~~-~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ...+.      |.+..+. .......+..++..|+..|..+||...++.++
T Consensus       283 v~gdp------p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  283 VIGDP------PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HcCCC------CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            11111      1111110 12244568899999999999999999998754

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-33  Score=264.97  Aligned_cols=263  Identities=26%  Similarity=0.316  Sum_probs=203.7

Q ss_pred             ccChHHHHHHhcCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeee
Q 007248          260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSI  337 (611)
Q Consensus       260 ~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  337 (611)
                      .-+++++.+.|.     +.||+|+|+.|-.+ .+.+|..+|||++.........+.++|++++.+. .|+||+.|+++|+
T Consensus        72 ~g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE  146 (463)
T KOG0607|consen   72 SGKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE  146 (463)
T ss_pred             cchHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence            345788888774     67999999999887 6778999999999877777788899999999988 5999999999999


Q ss_pred             eCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC---eEE
Q 007248          338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT---PKI  414 (611)
Q Consensus       338 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl  414 (611)
                      ++...|||||-|.||+|..+|+++   ..+++.+..++..+|+.||.|||   .++|.||||||+|||-.....   +||
T Consensus       147 dd~~FYLVfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             ccceEEEEEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceee
Confidence            999999999999999999999643   45899999999999999999999   899999999999999876544   799


Q ss_pred             eeeccceecc--CCC----cceeecccCCccccChhhhhc-----CccccccceehhHHHHHHHHhCCCCCCCCCCC---
Q 007248          415 ADFGLARCFA--ADR----THVSTAVAGTLGYMAPEYLVR-----GQLTEKADVYSFGILIIEIVCGRRSNAFSQDS---  480 (611)
Q Consensus       415 ~DfGla~~~~--~~~----~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~---  480 (611)
                      +||.|..-..  .+-    +..-.+.+|+..|||||+..-     ..|+.+.|.||||||||-|++|.+||-..-..   
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG  300 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG  300 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence            9998875432  111    112235678999999998642     35788999999999999999999998654321   


Q ss_pred             ---CChhHHHHHhhccCccccccCCCCCCCCCHHH----HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          481 ---ASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQ----VCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       481 ---~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~----~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                         +..-..     -.+.+.+.|...-. +||.++    .....+++...+-.++.+|-+..++++
T Consensus       301 WdrGe~Cr~-----CQ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  301 WDRGEVCRV-----CQNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ccCCCccHH-----HHHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence               111100     01123333322222 344433    334556777777899999999988875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.1e-32  Score=306.01  Aligned_cols=145  Identities=26%  Similarity=0.367  Sum_probs=129.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|.+.++||+|+||.||+|... +++.||||++....   ......+..|+.++..++||||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56888899999999999999664 68999999986432   334567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      ||+++++|.+++...   ..+++..++.++.||+.||.|||   ..+|+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999532   35888999999999999999999   7899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=1.4e-32  Score=241.54  Aligned_cols=260  Identities=24%  Similarity=0.360  Sum_probs=195.7

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch--hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +|...++||+|.||+||+|+. ..++.||+|++..++.  ..-...++|+-+|++++|+|||+++++...++.+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            355567899999999999954 5689999999876532  2234578999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      |.. +|..|...  -++.++.+....++.|+++||.|.|   .+++.||||||.|.||+.+|+.||+|||+++.+.-.-.
T Consensus        83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            954 77777632  3456889999999999999999999   89999999999999999999999999999998764432


Q ss_pred             ceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc---Cc---cccccC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS---NK---LVEAVD  501 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~---~~~~id  501 (611)
                      -. ...+-|.+|.+|.++.+. -++...|+||-|||+.||....+|.....+..+.+..+......   +.   +..+.|
T Consensus       157 cy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  157 CY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             ee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence            22 234458999999999875 47889999999999999998777876665554444444333321   12   223333


Q ss_pred             CCCCCCCCHH-----HHH----HHHHHHHHhcccCCCCCCCHHHHH
Q 007248          502 PNLKDDFPAE-----QVC----NVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       502 ~~l~~~~~~~-----~~~----~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                      -.....++..     .+.    .=.++....+.-+|..|.++++.+
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal  281 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL  281 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence            3333333321     111    123444456666888888888765

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=3.1e-32  Score=268.62  Aligned_cols=220  Identities=19%  Similarity=0.101  Sum_probs=174.9

Q ss_pred             CCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCChhhhhhc
Q 007248          282 GGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD  360 (611)
Q Consensus       282 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~  360 (611)
                      |.||.||++.. .+++.+|+|++....     .+.+|...+....||||+++++++.++...++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999954 578999999986543     233455566667899999999999999999999999999999999854


Q ss_pred             cCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecccCCccc
Q 007248          361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY  440 (611)
Q Consensus       361 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y  440 (611)
                      .   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++......    .....++..|
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y  148 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY  148 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence            3   34899999999999999999999   899999999999999999999999999988654332    1223456789


Q ss_pred             cChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHH
Q 007248          441 MAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIG  520 (611)
Q Consensus       441 ~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~  520 (611)
                      +|||.+....++.++||||+|+++|||++|+.|+.......               .....    ...+......+.+++
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~----~~~~~~~~~~~~~li  209 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTT----LNIPEWVSEEARSLL  209 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccccc----cCCcccCCHHHHHHH
Confidence            99999988888999999999999999999997754221100               00000    011222334578899


Q ss_pred             HHhcccCCCCCCCHH
Q 007248          521 LLCTQAAAALRPSMA  535 (611)
Q Consensus       521 ~~c~~~~p~~RPt~~  535 (611)
                      .+|++.||++||++.
T Consensus       210 ~~~l~~dp~~R~~~~  224 (237)
T cd05576         210 QQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHccCCHHHhcCCC
Confidence            999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=2.1e-32  Score=291.57  Aligned_cols=262  Identities=24%  Similarity=0.341  Sum_probs=212.6

Q ss_pred             cChHHHHHHhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeee
Q 007248          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE  338 (611)
Q Consensus       261 ~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  338 (611)
                      ..++.+...++.|++.+.||+|.+|.||+++ .++++..|||++..... ..+++..|.++|+.+ .|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            3455666778889999999999999999994 46789999998765543 346788899999988 79999999998863


Q ss_pred             -----CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeE
Q 007248          339 -----GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK  413 (611)
Q Consensus       339 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  413 (611)
                           ++.++||||||.+||..|++.... ...+.|..+..|+..++.||.+||   ...++|||||-.|||++.++.+|
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEE
Confidence                 568999999999999999996655 667999999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceeccCCCcceeecccCCccccChhhhhcC-----ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHH
Q 007248          414 IADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-----QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVW  488 (611)
Q Consensus       414 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~  488 (611)
                      |.|||++..+.... ....+..||+.|||||++...     .++..+|+||||++..||.-|.+|......--.++    
T Consensus       164 LvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF----  238 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF----  238 (953)
T ss_pred             Eeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc----
Confidence            99999998765433 233467799999999998653     46779999999999999999999865433221111    


Q ss_pred             HhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          489 TLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       489 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                            .+.....+.|  .-+....+++.+++..|+..|-+.||++.++++.
T Consensus       239 ------~IpRNPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  239 ------LIPRNPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ------cCCCCCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                  1111122222  2366778889999999999999999999988753

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=1e-31  Score=287.28  Aligned_cols=259  Identities=23%  Similarity=0.275  Sum_probs=179.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-----------------CCCCEEEEEEeeccchhhHHHHH--------------HHH
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-----------------PNGTTVAVKRLIFNTRQWVDEFF--------------NEV  318 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~~--------------~E~  318 (611)
                      .++|++.++||+|+||+||+|..                 .+++.||||++........++|.              .|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56789999999999999999953                 24578999998755433333343              466


Q ss_pred             HHHhcCCCCce-----eeEeeeeee--------CCcceEEEeecCCCChhhhhhccCC---------------------C
Q 007248          319 NLISSIEHKNL-----VKLLGCSIE--------GPESLLVYEYVPNRSLDQFIFDKNK---------------------T  364 (611)
Q Consensus       319 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~  364 (611)
                      ..+.+++|.++     ++++++|..        ++..+|||||+++++|.++++....                     .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777776654     677777653        3568999999999999999864211                     1


Q ss_pred             ccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecccCCccccChh
Q 007248          365 KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE  444 (611)
Q Consensus       365 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE  444 (611)
                      ..++|..+..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||++...............+++.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            23577889999999999999999   789999999999999999999999999999755432221112233478999999


Q ss_pred             hhhcCcc----------------------ccccceehhHHHHHHHHhCCC-CCCCCCCCCC------hhHHHHHhhccCc
Q 007248          445 YLVRGQL----------------------TEKADVYSFGILIIEIVCGRR-SNAFSQDSAS------PLQRVWTLYRSNK  495 (611)
Q Consensus       445 ~~~~~~~----------------------~~ksDV~S~Gvll~elltG~~-p~~~~~~~~~------~~~~~~~~~~~~~  495 (611)
                      .+.....                      ..+.||||+||+++||++|.. |+........      .....|..+....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            8754321                      134799999999999999875 4431110000      0011122221111


Q ss_pred             cccccCCCCCCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 007248          496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAA---ALRPSMAQAIM  539 (611)
Q Consensus       496 ~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p---~~RPt~~evl~  539 (611)
                      .    +-..    .........+++..++..+|   .+|+|++|+++
T Consensus       461 ~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        461 Y----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             C----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            1    1111    11223446778888888765   68999999873

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=9.1e-32  Score=264.80  Aligned_cols=238  Identities=25%  Similarity=0.325  Sum_probs=191.7

Q ss_pred             CceeEEEEEcC-CCCEEEEEEeeccchhh-HHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCChhhhhhc
Q 007248          283 GAGSVYMGSLP-NGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD  360 (611)
Q Consensus       283 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~  360 (611)
                      +||.||+|... +|+.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999775 48999999987654433 67899999999999999999999999999999999999999999999854


Q ss_pred             cCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecccCCccc
Q 007248          361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY  440 (611)
Q Consensus       361 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y  440 (611)
                      ..   .+++..++.++.+++++|.+||   +.+++|+||+|+||++++++.++|+|||++.......  ......++..|
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~  152 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY  152 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence            32   2889999999999999999999   7899999999999999999999999999998765432  22345678899


Q ss_pred             cChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHH
Q 007248          441 MAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIG  520 (611)
Q Consensus       441 ~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~  520 (611)
                      ++||.+....++.++|||+||+++++|++|..|+....+.....+    .........       ..........+.+++
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~----~~~~~~~~~-------~~~~~~~~~~~~~~i  221 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFK----KIGKPKPPF-------PPPEWKISPEAKDLI  221 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH----HHhccCCCC-------ccccccCCHHHHHHH
Confidence            999999888899999999999999999999988754322211111    111111000       000000345688999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 007248          521 LLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       521 ~~c~~~~p~~RPt~~evl~  539 (611)
                      .+|+..+|++||++.++++
T Consensus       222 ~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      222 RKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHccCCchhccCHHHHhh
Confidence            9999999999999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=283.75  Aligned_cols=240  Identities=25%  Similarity=0.276  Sum_probs=193.0

Q ss_pred             HhcCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEE
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      .++.|+....+|.|+|+.|-.+ ...+++..+||++.....    +-.+|+.++... +||||+++.+.+.++.+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3677888889999999999888 456789999999865522    223677666655 8999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE-CCCCCeEEeeeccceeccC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL-DKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGla~~~~~  425 (611)
                      |++.++-|.+-+....    ....++..|+.+|+.|+.|||   .+++|||||||+|||+ ++.++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            9999998888774332    222677789999999999999   7999999999999999 5889999999999987654


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      +    ....+-|..|.|||++....+++++|+||||++||+|++|+.|+...+.+..+.    ..+..+           
T Consensus       469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~----~~i~~~-----------  529 (612)
T KOG0603|consen  469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH----TRIQMP-----------  529 (612)
T ss_pred             h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH----HhhcCC-----------
Confidence            4    223456889999999999999999999999999999999999987666552221    111111           


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       .+.........+|+.+|++.+|.+||+|+++..
T Consensus       530 -~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 -KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence             222334455678888999999999999999874

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-32  Score=260.78  Aligned_cols=241  Identities=24%  Similarity=0.295  Sum_probs=195.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .++|+..++||+|.||+|-+.+- ..|+.+|+|+++..   .+..+..-+.|-++|+.-+||.+..|.-.|...+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            35678889999999999999954 46899999998755   234455667899999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||..||.|.-+|.   +...+++....-+-..|..||.|||   ..+||.||||.+|.|||.+|.+||.||||++.--.
T Consensus       247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999998883   4456788877778899999999999   89999999999999999999999999999974322


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                       ........+||+.|+|||++....|....|.|.+||++|||++|+.||.... .+.+++.+.    .        ..+ 
T Consensus       321 -~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-h~kLFeLIl----~--------ed~-  385 (516)
T KOG0690|consen  321 -YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-HEKLFELIL----M--------EDL-  385 (516)
T ss_pred             -ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-hhHHHHHHH----h--------hhc-
Confidence             1234557899999999999999999999999999999999999999986432 222222211    0        111 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCC
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRP  532 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RP  532 (611)
                       .+|.....+...+....+..+|++|-
T Consensus       386 -kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  386 -KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -cCCccCCHHHHHHHHHHhhcChHhhc
Confidence             23444444566777788899999995

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.9e-31  Score=292.49  Aligned_cols=258  Identities=22%  Similarity=0.235  Sum_probs=167.8

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcC-C----CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeee------ee
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLP-N----GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC------SI  337 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  337 (611)
                      ..++|+..++||+|+||.||+|... +    +..||||++.....  .+.+.+|  .+....+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999664 4    68999998754321  1112222  1122222222222211      24


Q ss_pred             eCCcceEEEeecCCCChhhhhhccCCC-----------------ccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 007248          338 EGPESLLVYEYVPNRSLDQFIFDKNKT-----------------KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK  400 (611)
Q Consensus       338 ~~~~~~lv~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  400 (611)
                      .+...++||||+++++|.+++......                 ....+..+..++.||+.||+|||   +.+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            566789999999999999998543210                 01123345679999999999999   7899999999


Q ss_pred             cccEEECC-CCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcC----------------------ccccccce
Q 007248          401 TSNILLDK-DFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG----------------------QLTEKADV  457 (611)
Q Consensus       401 p~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksDV  457 (611)
                      |+|||+++ ++.+||+|||+++.+............+++.|+|||.+...                      .+..++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57899999999986544333334456789999999976432                      23446799


Q ss_pred             ehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC-----ccccccCCCCC----CCC--CHHHHHHHHHHHHHhccc
Q 007248          458 YSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-----KLVEAVDPNLK----DDF--PAEQVCNVLQIGLLCTQA  526 (611)
Q Consensus       458 ~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~id~~l~----~~~--~~~~~~~l~~l~~~c~~~  526 (611)
                      |||||+||||+++..+.+..     .... ...+...     .+...+.+...    ..+  .........+|+.+|++.
T Consensus       363 wSlGviL~el~~~~~~~~~~-----~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSN-----LIQF-NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchH-----HHHH-HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            99999999999976653211     1110 0000000     01111111100    000  000112345799999999


Q ss_pred             CCCCCCCHHHHHH
Q 007248          527 AAALRPSMAQAIM  539 (611)
Q Consensus       527 ~p~~RPt~~evl~  539 (611)
                      ||++|||++++++
T Consensus       437 dP~kR~ta~e~L~  449 (566)
T PLN03225        437 KGRQRISAKAALA  449 (566)
T ss_pred             CcccCCCHHHHhC
Confidence            9999999999985

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=4.8e-32  Score=272.77  Aligned_cols=243  Identities=25%  Similarity=0.323  Sum_probs=191.2

Q ss_pred             CCccccCCceeEEEEE-cCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCC
Q 007248          276 SKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  352 (611)
                      .+.||+|.||+||-|. .++|+.||||++.+-  ..+....+.+|+.||+++.||.||.+.-.|+..+..++|||-+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            4789999999999995 467999999988533  2333477899999999999999999999999999999999999 55


Q ss_pred             ChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC---CCeEEeeeccceeccCCCcc
Q 007248          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD---FTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       353 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~~~~~~~~~  429 (611)
                      +..++|... +.+.|++....-++.||+.||.|||   .++|+|+||||+||||...   .++||+|||.|+.+....  
T Consensus       648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--  721 (888)
T KOG4236|consen  648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--  721 (888)
T ss_pred             hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence            666666443 3345888877888999999999999   8999999999999999654   479999999999886543  


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      ....++||+.|+|||++.+.-|...-|+||.|||+|--++|..||..+.+-.+.++.+.-++-...+             
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW-------------  788 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPW-------------  788 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCch-------------
Confidence            3346789999999999999999999999999999999999999986555443333322211111111             


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                      .+.....++++...+|..-.+|-+.++-+
T Consensus       789 ~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  789 SEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            12233456777777888777887776554

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=253.87  Aligned_cols=248  Identities=21%  Similarity=0.248  Sum_probs=191.7

Q ss_pred             hcCCCCC-CccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeee----CCcc
Q 007248          270 TNYFNPS-KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE----GPES  342 (611)
Q Consensus       270 ~~~f~~~-~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  342 (611)
                      +++|.+. ++||-|-.|+|-.... ..|+.+|+|++....     ...+|+++.-.. .|||||.+++++++    ...+
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            4555554 5799999999998844 468999999875432     345788866554 79999999998764    3457


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC---CCCeEEeeecc
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGL  419 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGl  419 (611)
                      ++|||.|+||.|...+.++ +...+++.+.-.|+.||+.|+.|||   ..+|.||||||+|+|...   |-.+||+|||+
T Consensus       135 LiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             EeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            8999999999999999654 4467999999999999999999999   899999999999999975   44689999999


Q ss_pred             ceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          420 ARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       420 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      |+....  .....+.+-|+.|.|||++...+++...|+||+||++|-|++|.+||..... ...-......+..+.    
T Consensus       211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aispgMk~rI~~gq----  283 (400)
T KOG0604|consen  211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKRRIRTGQ----  283 (400)
T ss_pred             ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCChhHHhHhhccC----
Confidence            986432  2233456679999999999999999999999999999999999999865432 111111111111111    


Q ss_pred             cCCCCCCCCCHH----HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          500 VDPNLKDDFPAE----QVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       500 id~~l~~~~~~~----~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                            -.||.+    ..+...+++...+..+|++|-|+.+++.
T Consensus       284 ------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  284 ------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             ------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence                  123333    3455678889999999999999999984

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-31  Score=258.19  Aligned_cols=260  Identities=20%  Similarity=0.265  Sum_probs=198.1

Q ss_pred             hcCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-C-Cc----eeeEeeeeeeCCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-H-KN----LVKLLGCSIEGPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~n----iv~l~~~~~~~~~~  342 (611)
                      +++|.+..++|+|.||.|-.. ....+..||||+++. .....+.-+-|+++|.++. + |+    +|.+.++|.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            788999999999999999988 344579999998763 3344566778999999993 2 33    78888999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC--------------
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK--------------  408 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--------------  408 (611)
                      ++|+|.+ |-|+.++|.. +...+++...+..|+.|++++++|||   +.+++|-||||+|||+.+              
T Consensus       167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence            9999988 6699999943 34567889999999999999999999   899999999999999932              


Q ss_pred             ------CCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCC
Q 007248          409 ------DFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS  482 (611)
Q Consensus       409 ------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~  482 (611)
                            +..+||+|||-|..-....    ..++.|..|.|||++.+..++.++||||+||||.||.||..-|....+.+.
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                  3358999999997644332    456779999999999999999999999999999999999988776654332


Q ss_pred             h--hHHH--------------HHhhccCccc-----------cccCCC--C--CCCCCHHHHHHHHHHHHHhcccCCCCC
Q 007248          483 P--LQRV--------------WTLYRSNKLV-----------EAVDPN--L--KDDFPAEQVCNVLQIGLLCTQAAAALR  531 (611)
Q Consensus       483 ~--~~~~--------------~~~~~~~~~~-----------~~id~~--l--~~~~~~~~~~~l~~l~~~c~~~~p~~R  531 (611)
                      +  .+.+              .+.+..+++.           ...++-  +  .......+...+++|+..++..||.+|
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R  397 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR  397 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence            1  0100              0001111110           000000  0  001123456679999999999999999


Q ss_pred             CCHHHHHH
Q 007248          532 PSMAQAIM  539 (611)
Q Consensus       532 Pt~~evl~  539 (611)
                      +|+.|++.
T Consensus       398 iTl~EAL~  405 (415)
T KOG0671|consen  398 ITLREALS  405 (415)
T ss_pred             ccHHHHhc
Confidence            99999874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=238.52  Aligned_cols=208  Identities=28%  Similarity=0.385  Sum_probs=168.3

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccc-hhhHHHHHHHHHHHh-cCCCCceeeEeeeeeeCCcc
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT-RQWVDEFFNEVNLIS-SIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~  342 (611)
                      ++...+.......||+|++|.|-+-+ .++|+.+|+|++...- .+..++.+.|+.+.. ....|.+|.+||...++...
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            33334444456789999999998774 4689999999987542 345567888888655 45899999999999999999


Q ss_pred             eEEEeecCCCChhhhhhc-cCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          343 LLVYEYVPNRSLDQFIFD-KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      ++.||.| ..||+.|-.+ -.+...+++..+=+|+..|.+||.|||+  +..+||||+||+|||++.+|++|++|||.+.
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999 5588777533 2345678888999999999999999997  7899999999999999999999999999997


Q ss_pred             eccCCCcceeecccCCccccChhhhhc----CccccccceehhHHHHHHHHhCCCCCCCCC
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVR----GQLTEKADVYSFGILIIEIVCGRRSNAFSQ  478 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDV~S~Gvll~elltG~~p~~~~~  478 (611)
                      .+.+.-  ..+...|-..|||||.+..    ..|+.|+||||||+.+.||.+++.|++...
T Consensus       198 ~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  198 YLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             eehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            664322  1123457789999998864    368899999999999999999999976543

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-31  Score=259.86  Aligned_cols=240  Identities=25%  Similarity=0.298  Sum_probs=192.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .+|+...+||+|+||+|.++.. -..+.+|||+++.+.   ....+--+.|-++|... +-|.++.+..+|..-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            4688899999999999999954 456889999987652   23344456788888876 567899999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+.||+|-..|++-.   .+.+....-++.+||-||-|||   .++||.||||..|||||.+|.+||+|||+++.---
T Consensus       429 MEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            99999999998885443   3677788889999999999999   89999999999999999999999999999974322


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      + .....+.+||+.|+|||++...+|....|.|||||+||||+.|++||+...+. ++++.+            .+..  
T Consensus       503 ~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-elF~aI------------~ehn--  566 (683)
T KOG0696|consen  503 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQAI------------MEHN--  566 (683)
T ss_pred             C-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHH------------HHcc--
Confidence            1 12334689999999999999999999999999999999999999998643321 222211            1111  


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCC
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRP  532 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RP  532 (611)
                      -.+|.....+...|+...+...|.+|-
T Consensus       567 vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             CcCcccccHHHHHHHHHHhhcCCcccc
Confidence            135666666777888888999998884

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=4e-31  Score=280.50  Aligned_cols=244  Identities=27%  Similarity=0.433  Sum_probs=186.8

Q ss_pred             CCCCCccccCCcee-EEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEeecC
Q 007248          273 FNPSKKLGQGGAGS-VYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       273 f~~~~~iG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      |...+++|.|.-|+ ||+|.. +|+.||||++-..   ...-..+|+..|+.- +|||||++++...+....|+..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            45567899999985 799998 6789999988533   233456899999987 7999999999999999999999999 


Q ss_pred             CCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC---C--CCeEEeeeccceecc
Q 007248          351 NRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---D--FTPKIADFGLARCFA  424 (611)
Q Consensus       351 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DfGla~~~~  424 (611)
                      .-+|.+++... .......-...+.+..|+++||++||   ..+||||||||.||||+.   +  .+++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            55999999553 11111111445778999999999999   899999999999999976   3  479999999999876


Q ss_pred             CCCcce--eecccCCccccChhhhhcCccccccceehhHHHHHHHHhC-CCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          425 ADRTHV--STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG-RRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       425 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      .+....  .....||.+|+|||++....-+...||||+||++|+.++| .+||+..-..+      ........-...+.
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~------~NIl~~~~~L~~L~  736 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ------ANILTGNYTLVHLE  736 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh------hhhhcCccceeeec
Confidence            655433  3357799999999999998888899999999999999997 88986443221      11111111111111


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                      +      ..++  ...+|+.+|+.++|..||++.+|+
T Consensus       737 ~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  737 P------LPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             c------CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            0      1111  567889999999999999999997

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.7e-32  Score=251.94  Aligned_cols=263  Identities=22%  Similarity=0.382  Sum_probs=190.8

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc-hh-hHHHHHHHHHHHhcCCCCceeeEeeeeee--------CC
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-RQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIE--------GP  340 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~  340 (611)
                      .|+...+||+|.||+||+|+.+ .|+.||+|++.... ++ .-..-++|+++|..|+|+|++.++..|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            3445678999999999999654 47788999765432 21 22356799999999999999999987653        23


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      .+++|+.+|+. +|.-+|.+.  ...++...+.+++.++..||.|+|   ...|+|||+||.|+||+.++.+||+|||++
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence            47999999976 777777433  345888899999999999999999   899999999999999999999999999999


Q ss_pred             eeccCCCcc---eeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCCh----------hHH
Q 007248          421 RCFAADRTH---VSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASP----------LQR  486 (611)
Q Consensus       421 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~----------~~~  486 (611)
                      +.+......   ..+..+-|.+|.+||.+.+. .++++.|||.-|||+.||.|+.+-+..+.+...+          -..
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            877543322   23345569999999998874 7899999999999999999998765433321111          112


Q ss_pred             HHHhhccCccccccCCC-CC-CCC--CHHHH------HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          487 VWTLYRSNKLVEAVDPN-LK-DDF--PAEQV------CNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       487 ~~~~~~~~~~~~~id~~-l~-~~~--~~~~~------~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      +|.....-.+.+.+... +. +.+  -.+..      ...++++..++..||.+|+..++++..
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            23322222222222111 10 000  00111      135678889999999999999999854

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.7e-30  Score=263.42  Aligned_cols=205  Identities=25%  Similarity=0.397  Sum_probs=172.4

Q ss_pred             CCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          272 YFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      -|-.++.||-|+||+|.++. .+....+|+|.+...+   +..+...+.|-+||.+...+-||+||-.|.+++.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            35667889999999999994 4456789999987654   3345567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC--
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA--  425 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~--  425 (611)
                      |++||++-.+|.   +.+.+.+....-++.++..|+++.|   +.|+|||||||.|||||.+|.+||.||||+.-+..  
T Consensus       710 YIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  710 YIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             ccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecc
Confidence            999999999984   4456788888888999999999999   99999999999999999999999999999853310  


Q ss_pred             C------Ccce---------------------------------eecccCCccccChhhhhcCccccccceehhHHHHHH
Q 007248          426 D------RTHV---------------------------------STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIE  466 (611)
Q Consensus       426 ~------~~~~---------------------------------~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~e  466 (611)
                      +      ..+.                                 ....+||..|+|||++...-++..+|.||.||||||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence            0      0000                                 012469999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCCCC
Q 007248          467 IVCGRRSNAFSQDSAS  482 (611)
Q Consensus       467 lltG~~p~~~~~~~~~  482 (611)
                      |+.|+.||-.....++
T Consensus       864 m~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGET  879 (1034)
T ss_pred             HhhCCCCccCCCCCcc
Confidence            9999999876655544

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.7e-28  Score=235.43  Aligned_cols=210  Identities=33%  Similarity=0.570  Sum_probs=182.3

Q ss_pred             cccCCceeEEEEEcCC-CCEEEEEEeeccchh-hHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCChhh
Q 007248          279 LGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQ  356 (611)
Q Consensus       279 iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~  356 (611)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999997754 899999998755432 45679999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-CCCeEEeeeccceeccCCCcceeeccc
Q 007248          357 FIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAADRTHVSTAVA  435 (611)
Q Consensus       357 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~  435 (611)
                      ++....  ..+++..+..++.+++++|.+||   ..+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  154 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV  154 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence            985432  45899999999999999999999   789999999999999999 89999999999986654321 122345


Q ss_pred             CCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHH
Q 007248          436 GTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVC  514 (611)
Q Consensus       436 gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~  514 (611)
                      +...|++||.+... ..+.+.|+|++|+++++|                                              .
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------~  188 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------P  188 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------H
Confidence            68899999999877 888999999999999998                                              4


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          515 NVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       515 ~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      .+.+++..|++.+|++||++.++++.
T Consensus       189 ~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         189 ELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            47789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-30  Score=260.21  Aligned_cols=241  Identities=23%  Similarity=0.308  Sum_probs=195.2

Q ss_pred             CCCCCCccccCCceeEEEEEcCCCC-EEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPNGT-TVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      +++....||-|+||.|-+...++.. .+|+|.++..   +....+....|-.+|.+.+.|.||++|..|.++...|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            4455678999999999988664433 4888877543   34456778899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      -|-||.|...|.++   +.++.....-++..+.+|++|||   .++||.|||||+|.+||.+|-+||.|||+|+.+....
T Consensus       501 aClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  501 ACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            99999999999654   45777778888999999999999   8999999999999999999999999999999776543


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                        ...+.+||+.|.|||++.+.-.+...|.||||+++|||++|++||....    +.......      .+-+|.   -.
T Consensus       575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d----pmktYn~I------LkGid~---i~  639 (732)
T KOG0614|consen  575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD----PMKTYNLI------LKGIDK---IE  639 (732)
T ss_pred             --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc----hHHHHHHH------Hhhhhh---hh
Confidence              3457899999999999999999999999999999999999999986432    22221111      111111   13


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCC
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPS  533 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt  533 (611)
                      +|........++++.....+|.+|--
T Consensus       640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  640 FPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             cccccchhHHHHHHHHHhcCcHhhhc
Confidence            45555556778888888899999876

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.1e-29  Score=239.22  Aligned_cols=246  Identities=20%  Similarity=0.268  Sum_probs=191.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeecc---chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (611)
                      .+.|....+||+|.|.+|..++++ ..+.+|+|+++..   +.+..+=...|-.+..+. +||.+|.+..+|..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            356888999999999999999764 5789999988643   333334445666676665 79999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      |.||+++|+|--++.   +...|+++...-+...|.-||.|||   ..+||.||||..|||||..|.+||.|||+.+.--
T Consensus       329 vieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999987774   3344888888888999999999999   8999999999999999999999999999997533


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCC---CChhHHHHHhhccCccccccC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDS---ASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~id  501 (611)
                      .+ .....+.+||+.|.|||++.+..|....|.|++||+++||+.|+.||+.....   ...-.+....+-        .
T Consensus       403 ~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil--------e  473 (593)
T KOG0695|consen  403 GP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL--------E  473 (593)
T ss_pred             CC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh--------h
Confidence            22 22345789999999999999999999999999999999999999999865321   111111222111        1


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRP  532 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RP  532 (611)
                      ..+  ..|.....+...+.+.-+..||++|-
T Consensus       474 kqi--riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  474 KQI--RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             hcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence            111  12333444556777888999998874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.9e-30  Score=237.35  Aligned_cols=260  Identities=25%  Similarity=0.349  Sum_probs=191.5

Q ss_pred             CCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC-----CcceEE
Q 007248          274 NPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----PESLLV  345 (611)
Q Consensus       274 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv  345 (611)
                      +..+-||-|+||.||.... .+|+.||+|++..-  .-..-+.+.+|+++|.-++|.|++..++...-.     .++|+|
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            4567899999999999855 47999999988532  233456889999999999999999988865533     257899


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      +|.| ..+|...|..   .+.|+...+.-+..||++||.|||   ..+|.||||||.|.|++.|-.+||+|||+++....
T Consensus       136 TELm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence            9998 4588888743   345888888889999999999999   89999999999999999999999999999998776


Q ss_pred             CCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcc--------
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL--------  496 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------  496 (611)
                      +....++..+-|..|.|||++++. .|+...||||.|||+.||+..+.-|..... ...++.+.++.....+        
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-iqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-IEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-HHHHHHHHHHhCCCcHHHHHHHhh
Confidence            666666666678999999999885 689999999999999999976655432221 1122222222221111        


Q ss_pred             ---ccccCCCCCC-C--------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          497 ---VEAVDPNLKD-D--------FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       497 ---~~~id~~l~~-~--------~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                         .-++....+. .        -+...-...+.+...++..+|..|.+..+.+..+
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence               1111111110 0        0111222345666678899999999988887654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=6.2e-29  Score=226.71  Aligned_cols=255  Identities=20%  Similarity=0.342  Sum_probs=193.2

Q ss_pred             hcCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCC--cceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGP--ESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv  345 (611)
                      .++|++.+++|+|.|++|+.| ...+.+.++||+++.-.   .+.+.+|+++|..|. ||||++|++...+..  ...||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            356777889999999999999 45678999999987543   357889999999996 999999999887654  56799


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC-CCeEEeeeccceecc
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCFA  424 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~~  424 (611)
                      +||+.+.+...+-      ..|+...+...+.++++||.|+|   +.||.|||+||.|++||.. ..++|+|+|||.++.
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998876554      34677778889999999999999   8999999999999999965 469999999998765


Q ss_pred             CCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccc-----
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE-----  498 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  498 (611)
                      ....  ....+.+..|--||.+..- .++..-|+|||||+|..|+..+.||....++.+.+..+........+..     
T Consensus       185 p~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  185 PGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             CCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            4332  2223346677889998764 5778889999999999999999999888776655444333322221111     


Q ss_pred             --ccCCCCCC-----------CC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007248          499 --AVDPNLKD-----------DF-----PAEQVCNVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       499 --~id~~l~~-----------~~-----~~~~~~~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                        .+|+.+.+           .+     ..-...+.++++...+..|-.+|||++|.+
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam  320 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM  320 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence              12222110           00     001124567888889999999999999976

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=8.5e-28  Score=234.04  Aligned_cols=199  Identities=34%  Similarity=0.495  Sum_probs=171.4

Q ss_pred             CCCCCccccCCceeEEEEEcCC-CCEEEEEEeeccchh-hHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          273 FNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      |...+.||+|++|.||++...+ +..+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999997765 899999998765544 57789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +++|.+++.....  .+++..+..++.+++++|.+||   ..+++|+||+|.||+++.++.++|+|||++..........
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence            9999999854322  1789999999999999999999   7899999999999999999999999999998765443112


Q ss_pred             eecccCCccccChhhh-hcCccccccceehhHHHHHHHHhCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYL-VRGQLTEKADVYSFGILIIEIVCGRRSNAF  476 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~-~~~~~~~ksDV~S~Gvll~elltG~~p~~~  476 (611)
                      .....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            2334567889999998 666788899999999999999999999843

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.3e-27  Score=236.12  Aligned_cols=131  Identities=27%  Similarity=0.413  Sum_probs=110.6

Q ss_pred             cCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-----C---CceeeEeeeeee---
Q 007248          271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-----H---KNLVKLLGCSIE---  338 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~---  338 (611)
                      .+|...++||.|.|++||++ ...+.+.||+|+++. .....+.-+.||++|++++     |   .+||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            57788899999999999999 566788999998864 3444567889999999883     3   359999999874   


Q ss_pred             -CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          339 -GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       339 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                       +.+.++|+|++ |.+|..+|... ..+-++...+.+|+.||+.||.|||.  +.+|||.||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence             55789999999 66888888543 44568999999999999999999997  6799999999999999

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=5.2e-28  Score=250.60  Aligned_cols=252  Identities=24%  Similarity=0.340  Sum_probs=200.9

Q ss_pred             hcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .++|+...++|.|.||.|||++ ...+...|||.++........-..+|+-+++.-+|||||.++|-+.....+++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            4567788999999999999995 457899999999887777777788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      |.+|+|.+.-|   ...++++.++..+.....+||+|||   ..+=+|||||-.|||+.+.|.+|++|||.+..+... .
T Consensus        94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i  166 (829)
T KOG0576|consen   94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-I  166 (829)
T ss_pred             cCCCcccceee---ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh-h
Confidence            99999998764   4567999999999999999999999   788899999999999999999999999998665432 2


Q ss_pred             ceeecccCCccccChhhhh---cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccC-CCC
Q 007248          429 HVSTAVAGTLGYMAPEYLV---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD-PNL  504 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id-~~l  504 (611)
                      .......||+.|||||+..   .+-+..++|||++|+...|+-.-+.|....    .+.+.....-+     ...+ +.+
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl----hpmr~l~LmTk-----S~~qpp~l  237 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL----HPMRALFLMTK-----SGFQPPTL  237 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc----chHHHHHHhhc-----cCCCCCcc
Confidence            3344678999999999863   467899999999999999998777663211    11111111111     1111 122


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ++  .......+-++++.|+..+|++||+.+.++.
T Consensus       238 kD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 KD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            21  2233445778999999999999999987653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=5.2e-27  Score=239.44  Aligned_cols=196  Identities=26%  Similarity=0.388  Sum_probs=162.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHH-----HHHHHHHHHhcCC---CCceeeEeeeee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVD-----EFFNEVNLISSIE---HKNLVKLLGCSI  337 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~-----~~~~E~~~l~~l~---h~niv~l~~~~~  337 (611)
                      ...|...+.+|+|+||.|+.+..+ +...|+||.+.+..   ..|.+     ..--|+.||..|+   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            345778899999999999999664 45678888775432   11211     2345999999997   999999999999


Q ss_pred             eCCcceEEEeec-CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEee
Q 007248          338 EGPESLLVYEYV-PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD  416 (611)
Q Consensus       338 ~~~~~~lv~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  416 (611)
                      +++.+||+||-. ++-+|.++|.   ....+++....-|+.||+-|+++||   ..+|||||||-+||.++.+|-+||+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEee
Confidence            999999999975 4568889983   3455999999999999999999999   89999999999999999999999999


Q ss_pred             eccceeccCCCcceeecccCCccccChhhhhcCccc-cccceehhHHHHHHHHhCCCCC
Q 007248          417 FGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT-EKADVYSFGILIIEIVCGRRSN  474 (611)
Q Consensus       417 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~S~Gvll~elltG~~p~  474 (611)
                      ||.+.......   ....+||.+|.|||++.+.+|- ..-|||++|++||.++....|+
T Consensus       714 fgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  714 FGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             ccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            99987654332   3357899999999999888774 4579999999999998776664

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-26  Score=216.08  Aligned_cols=253  Identities=17%  Similarity=0.261  Sum_probs=185.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeee-eeeCCcceEEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGC-SIEGPESLLVY  346 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~  346 (611)
                      .+.|.+.+.||+|.||.+-++.+. ..+.+++|-+... ....++|.+|...--.| .|.||+.-|++ |+..+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            456888899999999999999664 5778999976533 33467899998865556 58999998874 66777888999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC--CCCCeEEeeeccceecc
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD--KDFTPKIADFGLARCFA  424 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGla~~~~  424 (611)
                      ||+|.|+|.+-+..    ..+.+....+++.|++.||.|||   +.++||||||.+||||-  +..++||+|||+.+..+
T Consensus       102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999988833    44788888999999999999999   89999999999999994  34589999999986432


Q ss_pred             CCCcceeecccCCccccChhhhhcC-----ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRG-----QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      ..    .....-+..|.+||.....     ...+.+|||.||++++..+||+.||.... ..+.-.|-|..|........
T Consensus       175 ~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~~~~  249 (378)
T KOG1345|consen  175 TT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKNPAL  249 (378)
T ss_pred             ce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccCccC
Confidence            11    1122235678999976432     35778999999999999999999997432 22222333444544433221


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                        |.....+..    ++.++...-+.++|++|-.+.++-++.
T Consensus       250 --P~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  250 --PKKFNPFSE----KALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             --chhhcccCH----HHHHHHHHhcCCcccccchhHHHHHHH
Confidence              112222332    355666678899999997777766554

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=4.1e-26  Score=226.51  Aligned_cols=263  Identities=23%  Similarity=0.354  Sum_probs=196.6

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEcC----CCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCC
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGP  340 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  340 (611)
                      +....+.|...++||+|.|++||++...    .++.||+|.+....  .-....+|++.|..+ .+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3444567888999999999999999543    46889999886543  235688999999999 6999999999999999


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC-CCeEEeeecc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGL  419 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl  419 (611)
                      ...+|+||+++-...++..      .++...+...+..+.+||.++|   ..+||||||||+|+|.+.. +.-.|.||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechh
Confidence            9999999999999988883      3668888999999999999999   9999999999999999854 5689999999


Q ss_pred             ceeccCCC-------------------------------------------cceeecccCCccccChhhhhc-Ccccccc
Q 007248          420 ARCFAADR-------------------------------------------THVSTAVAGTLGYMAPEYLVR-GQLTEKA  455 (611)
Q Consensus       420 a~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ks  455 (611)
                      |.......                                           .......+||+||.|||++.. ...++++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            97211100                                           000113469999999999865 5678999


Q ss_pred             ceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc----------cCc--ccc---------------ccC-CCCCC-
Q 007248          456 DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR----------SNK--LVE---------------AVD-PNLKD-  506 (611)
Q Consensus       456 DV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~----------~~~--~~~---------------~id-~~l~~-  506 (611)
                      ||||.|||++-+++++.||....++...+..+...+.          .++  +.+               -++ ..+.. 
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            9999999999999999999877655443322111111          011  000               000 00000 


Q ss_pred             CC--------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          507 DF--------PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       507 ~~--------~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +.        ..-....++++..+|+..||.+|-|+++.++
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            00        0111225788999999999999999999874

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=2.2e-26  Score=220.35  Aligned_cols=257  Identities=26%  Similarity=0.305  Sum_probs=185.1

Q ss_pred             CCCCCCccccCCceeEEEE-EcCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC------cc
Q 007248          272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------ES  342 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  342 (611)
                      +|-....+|.|.- .|-.+ ..-.++.||+|++...  .....++..+|..++..++|+||++++.++.-..      +.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4555667888887 44444 4446899999987533  2334566778999999999999999999987443      56


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      |+|||+| ..+|...++.     .++-..+..|..|++.|+.|||   ..+|+||||||+||++..+..+||.|||+++.
T Consensus        97 y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   97 YLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence            9999999 5588888852     3667788899999999999999   89999999999999999999999999999975


Q ss_pred             ccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCC----------CCChhH-------
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQD----------SASPLQ-------  485 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~----------~~~~~~-------  485 (611)
                      -..+  -..+....+..|.|||++.+..+.+..||||+||++.||++|+.-|.....          .+++-.       
T Consensus       168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            4333  345567788999999999988899999999999999999999865531110          000000       


Q ss_pred             -HHHHhhcc------Ccccccc-CCCCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          486 -RVWTLYRS------NKLVEAV-DPNLK--DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       486 -~~~~~~~~------~~~~~~i-d~~l~--~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                       .+......      -...+.+ |....  .+.+........+++..|+-.+|++|-+.++++..
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence             00000000      0001111 11111  01111233446788889999999999999999864

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=1.2e-26  Score=267.03  Aligned_cols=196  Identities=19%  Similarity=0.254  Sum_probs=139.2

Q ss_pred             hcCCC-CceeeEeeee-------eeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCc
Q 007248          322 SSIEH-KNLVKLLGCS-------IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR  393 (611)
Q Consensus       322 ~~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  393 (611)
                      +.++| +||++++++|       .+....++++||+ +++|.++|...  ...+++..++.++.||++||.|||   ..+
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~g  100 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAH---SQG  100 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHH---hCC
Confidence            34556 6888888877       3334677889987 66999999532  345999999999999999999999   899


Q ss_pred             eecCCCCcccEEECC-------------------CCCeEEeeeccceeccCCCc---------------ceeecccCCcc
Q 007248          394 IIHRDIKTSNILLDK-------------------DFTPKIADFGLARCFAADRT---------------HVSTAVAGTLG  439 (611)
Q Consensus       394 ivH~Dlkp~NIll~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~  439 (611)
                      |+||||||+||||+.                   ++.+||+|||+++.......               .......||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999954                   44566677777654211000               00112357889


Q ss_pred             ccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHH
Q 007248          440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQI  519 (611)
Q Consensus       440 y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l  519 (611)
                      |||||++.+..++.++|||||||+||||++|..|+....   ....   . ...    ....+.     ..........+
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~---~-~~~----~~~~~~-----~~~~~~~~~~~  244 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMS---S-LRH----RVLPPQ-----ILLNWPKEASF  244 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHH---H-HHH----hhcChh-----hhhcCHHHHHH
Confidence            999999999999999999999999999999887643110   0000   0 000    001111     11122345678


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 007248          520 GLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       520 ~~~c~~~~p~~RPt~~evl~  539 (611)
                      +.+||+.+|.+||+|.||++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHhCCCChhhCcChHHHhh
Confidence            88999999999999999985

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=1.6e-26  Score=233.03  Aligned_cols=202  Identities=20%  Similarity=0.211  Sum_probs=171.1

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC------CCceeeEeeeeeeC
Q 007248          267 EKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE------HKNLVKLLGCSIEG  339 (611)
Q Consensus       267 ~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~  339 (611)
                      +....+|......|+|-|++|.+|.. ..|+.||||+|..+. ...+.=+.|+++|++|+      --|+++|+..|...
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            34457888888999999999999944 458899999987653 23345568999999995      34789999999999


Q ss_pred             CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC-CeEEeeec
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFG  418 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG  418 (611)
                      ++++||+|-+ ..+|.+.|...+..-.|....+..++.|+.-||..|.   +.+|+|.||||.|||+++.. .+||||||
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCc
Confidence            9999999987 5699999988777778999999999999999999999   89999999999999999765 58999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCC
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAF  476 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~  476 (611)
                      -|........   +...-+..|.|||++.+..|+...|+||.||.||||.||+..|..
T Consensus       583 SA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  583 SASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             cccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            9976654332   233446689999999999999999999999999999999976643

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=5.3e-25  Score=206.53  Aligned_cols=165  Identities=21%  Similarity=0.199  Sum_probs=123.6

Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      |+|.+++...  ...++|..++.|+.||++||.|||   +.+      ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc----
Confidence            6899999542  346999999999999999999999   444      999999999999999  99998654322    


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE  511 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~  511 (611)
                        ..|++.|||||++.+..++.++|||||||++|||+||+.|+.........+.........      .++.. ...+..
T Consensus        64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~------~~~~~-~~~~~~  134 (176)
T smart00750       64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA------DDPRD-RSNLES  134 (176)
T ss_pred             --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc------CCccc-cccHHH
Confidence              257899999999999999999999999999999999999975433222222211111000      00000 011122


Q ss_pred             HHH--HHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          512 QVC--NVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       512 ~~~--~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      ...  .+.+++.+|++.+|++||++.|+++.+.
T Consensus       135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      135 VSAARSFADFMRVCASRLPQRREAANHYLAHCR  167 (176)
T ss_pred             HHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence            222  5889999999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=3.6e-24  Score=219.99  Aligned_cols=169  Identities=20%  Similarity=0.194  Sum_probs=131.8

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEcC--CCCEEEEEEeecc-----chhhHHHHHHHHHHHhcCCCCceee-Eeee
Q 007248          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLP--NGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLVK-LLGC  335 (611)
Q Consensus       264 ~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~  335 (611)
                      +......++|...+.||+|+||+||+|...  +++.+|||++...     .....+.|.+|+++|++++|+|++. ++++
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~   90 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT   90 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence            344556778999999999999999999654  5778899986532     2234567999999999999999985 4432


Q ss_pred             eeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCC-CcccEEECCCCCeEE
Q 007248          336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDI-KTSNILLDKDFTPKI  414 (611)
Q Consensus       336 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl  414 (611)
                          +..++||||+++++|....    ...      ...++.+++++|.|||   ..+|+|||| ||+|||++.++++||
T Consensus        91 ----~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             ----CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEE
Confidence                4679999999999996321    111      1467889999999999   899999999 999999999999999


Q ss_pred             eeeccceeccCCCcce-------eecccCCccccChhhhhcC
Q 007248          415 ADFGLARCFAADRTHV-------STAVAGTLGYMAPEYLVRG  449 (611)
Q Consensus       415 ~DfGla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~  449 (611)
                      +|||+++.+.......       -....++..|+|||.+...
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999999775432111       1245678889999988653

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=4.5e-24  Score=199.59  Aligned_cols=245  Identities=22%  Similarity=0.365  Sum_probs=188.8

Q ss_pred             CCCccccCCceeEEEEEcCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCC
Q 007248          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  352 (611)
                      ...+|.+...|+.|+|++ .|..+++|++...  .....+.|..|.-.|+.+.||||+.++|.|.....+.+|..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            345788999999999999 5667777877543  2334467999999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEe--eeccceeccCCCcce
Q 007248          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA--DFGLARCFAADRTHV  430 (611)
Q Consensus       353 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--DfGla~~~~~~~~~~  430 (611)
                      +|...||+.. .-..+-.+..+++.+||+|++|||+- ++-|.-.-|.+..|++|++.+++|+  |--++  +.      
T Consensus       273 slynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs--fq------  342 (448)
T KOG0195|consen  273 SLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS--FQ------  342 (448)
T ss_pred             HHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee--ee------
Confidence            9999998653 34578889999999999999999952 3334445799999999999998875  22111  10      


Q ss_pred             eecccCCccccChhhhhcCcc---ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVRGQL---TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~---~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                      .....-.+.||+||.+...+-   -...|+|||.++||||.|...||.....-+--             .++.-..++..
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------------mkialeglrv~  409 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------------MKIALEGLRVH  409 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------------hhhhhcccccc
Confidence            111223678999999977643   34789999999999999999997643321110             11112345555


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .|+.....+.+++..|...||.+||.++.|+-.|+.
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            677777788999999999999999999999988864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=4.2e-22  Score=205.22  Aligned_cols=259  Identities=20%  Similarity=0.221  Sum_probs=191.1

Q ss_pred             CCCCCCccccCCceeEEEEEcCCC--CEEEEEEeeccchhhHHHHHHHHHHHhcCCC----CceeeEeeee-eeCCcceE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPNG--TTVAVKRLIFNTRQWVDEFFNEVNLISSIEH----KNLVKLLGCS-IEGPESLL  344 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  344 (611)
                      +|.+.++||+|+||.||++...+.  ..+|+|............+..|+.++..+.+    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            788999999999999999975443  4788887665433322367889999998873    5888888888 57778899


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC-----CCeEEeeecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-----FTPKIADFGL  419 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DfGl  419 (611)
                      ||+.+ |.+|.++..... .+.++....++|+.|++.+|.+||   +.+++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99987 889999774443 567999999999999999999999   8999999999999999865     4699999999


Q ss_pred             ce--eccCCCcc------e-eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh
Q 007248          420 AR--CFAADRTH------V-STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL  490 (611)
Q Consensus       420 a~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~  490 (611)
                      ++  .+......      . .....||..|.++....+...+.+.|+||++.++.|++.|..||........ ...... 
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~-  251 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEK-  251 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHH-
Confidence            98  33222111      1 1235699999999999999999999999999999999999999854433221 111111 


Q ss_pred             hccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          491 YRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       491 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                         .........     .....+..+.++...+-..+..++|....+...|....
T Consensus       252 ---~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  252 ---DPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             ---Hhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence               000111111     11112233455555555689999999999988875443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=2.9e-21  Score=198.28  Aligned_cols=261  Identities=28%  Similarity=0.392  Sum_probs=196.1

Q ss_pred             CCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchh---hHHHHHHHHHHHhcCCCC-ceeeEeeeeeeCCcceEEEee
Q 007248          273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ---WVDEFFNEVNLISSIEHK-NLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~  348 (611)
                      |.....||.|+||.||++...  ..+++|.+......   ....|.+|+.+++.+.|+ +++++++++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556778999999999999775  78999988655322   467899999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC-CeEEeeeccceeccCCC
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAADR  427 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~  427 (611)
                      +.++++.+++........+.......++.|++.++.|+|   ..+++|||+||+||+++..+ .+++.|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977743221136888999999999999999999   78899999999999999988 79999999998655433


Q ss_pred             cc-----eeecccCCccccChhhhhc---CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          428 TH-----VSTAVAGTLGYMAPEYLVR---GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       428 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      ..     ......|+..|++||.+..   .......|+|++|++++++++|..|+...... ......+......... .
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~-~  234 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTP-S  234 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCc-c
Confidence            22     2356779999999999987   57889999999999999999999995443321 0111111111111100 0


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ................+.+++..|+..+|..|.++.+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00011111112223457788889999999999999887653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=4e-22  Score=218.25  Aligned_cols=253  Identities=24%  Similarity=0.311  Sum_probs=185.2

Q ss_pred             CCCCccccCCceeEEEEEc-CCCCEEEEEEee----cc-ch-hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          274 NPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLI----FN-TR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       274 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~----~~-~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ...+.+|.|++|.|+.... ......+.|...    .. .. .....+..|+-+-..++|||++..+....+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3467899999997776632 233334444322    11 11 11222566777888899999998888777777666669


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      |||++ +|..++...   ..+....+..++.|+..|+.|||   ..+|.|||||++|+++..++.+||+|||.+..+...
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 999998433   34777888899999999999999   899999999999999999999999999999877544


Q ss_pred             Cc---ceeecccCCccccChhhhhcCcccc-ccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          427 RT---HVSTAVAGTLGYMAPEYLVRGQLTE-KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       427 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ..   .......|+..|+|||++...+|.+ ..||||.|+++..|++|+.||............  ..... .  ..+..
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~--~~~~~-~--~~~~~  548 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT--NNYSD-Q--RNIFE  548 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh--hcccc-c--ccccc
Confidence            33   3455678999999999999999887 579999999999999999998766544332100  00000 0  00000


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      . ........+.+...++.++++.+|.+|-||++|++
T Consensus       549 ~-~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  549 G-PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             C-hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0 01112344556788899999999999999999984

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=3.6e-21  Score=182.06  Aligned_cols=139  Identities=17%  Similarity=0.155  Sum_probs=108.1

Q ss_pred             CCccccCCceeEEEEEcCCCCEEEEEEeeccchh--h-------HHH-----------------HHHHHHHHhcCCCCce
Q 007248          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ--W-------VDE-----------------FFNEVNLISSIEHKNL  329 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni  329 (611)
                      ...||+|+||.||+|..++|+.||||+++.....  .       ...                 ...|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999998889999999998654211  0       112                 2359999999988776


Q ss_pred             eeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHH-hcCCCCceecCCCCcccEEECC
Q 007248          330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL-HGGSETRIIHRDIKTSNILLDK  408 (611)
Q Consensus       330 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlkp~NIll~~  408 (611)
                      .....+..  ...++||||++++++...+.   ....+++.....++.|++.+|.+| |   ..+|+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-
Confidence            43332222  23489999999987765532   224588999999999999999999 7   78999999999999998 


Q ss_pred             CCCeEEeeeccceec
Q 007248          409 DFTPKIADFGLARCF  423 (611)
Q Consensus       409 ~~~~kl~DfGla~~~  423 (611)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=2.5e-21  Score=185.13  Aligned_cols=171  Identities=12%  Similarity=0.181  Sum_probs=133.6

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccch---hhHHH------HHHHHHHHhcCCCCceeeEeeeeeeC
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR---QWVDE------FFNEVNLISSIEHKNLVKLLGCSIEG  339 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~  339 (611)
                      ..++|...++||.|+||.||.... ++..+|||.+.....   .....      |.+|+..+.+++|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            467899999999999999999766 577899999864422   22222      67999999999999999998886533


Q ss_pred             --------CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC
Q 007248          340 --------PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT  411 (611)
Q Consensus       340 --------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  411 (611)
                              ...++||||++|.+|.++..       ++.    ....+|+.+|..||   ..+++|||++|+||+++.++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-
Confidence                    35789999999999988741       222    24569999999999   89999999999999999988 


Q ss_pred             eEEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHH
Q 007248          412 PKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIV  468 (611)
Q Consensus       412 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ell  468 (611)
                      ++|+|||.......+...             ..+.....+..++|+|+||+.+..+.
T Consensus       173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999988654322110             11344455668999999999988765

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=6.7e-21  Score=199.19  Aligned_cols=215  Identities=27%  Similarity=0.429  Sum_probs=162.9

Q ss_pred             HhcCCCCceeeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 007248          321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK  400 (611)
Q Consensus       321 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  400 (611)
                      |+.+.|.|+.+++|.+.+++..++|.+||..|+|.+.+..  ....++|.....++.+|++||+|||+  .+-..|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeec
Confidence            4678999999999999999999999999999999999954  44569999999999999999999994  3333999999


Q ss_pred             cccEEECCCCCeEEeeeccceeccCC-CcceeecccCCccccChhhhhcC-------ccccccceehhHHHHHHHHhCCC
Q 007248          401 TSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVRG-------QLTEKADVYSFGILIIEIVCGRR  472 (611)
Q Consensus       401 p~NIll~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDV~S~Gvll~elltG~~  472 (611)
                      ++|+++|....+||+|||+....... .........-..-|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998765421 11111122235579999998763       14678999999999999999999


Q ss_pred             CCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          473 SNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       473 p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ||..........+.+....+  .....+.|.+....  +....+..++..||..+|++||++++|-..+..
T Consensus       157 ~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~  223 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT  223 (484)
T ss_pred             ccccccccCChHHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence            99876555544333333222  11111222222110  233358899999999999999999999877753

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=6.1e-20  Score=174.21  Aligned_cols=140  Identities=19%  Similarity=0.172  Sum_probs=110.4

Q ss_pred             CCccccCCceeEEEEEcCCCCEEEEEEeeccchh--------------------------hHHHHHHHHHHHhcCCCCce
Q 007248          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ--------------------------WVDEFFNEVNLISSIEHKNL  329 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  329 (611)
                      ...||+|+||.||+|...+|+.||||++......                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999998778999999998754210                          01224578999999999987


Q ss_pred             eeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCC-CceecCCCCcccEEECC
Q 007248          330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNILLDK  408 (611)
Q Consensus       330 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~  408 (611)
                      .....+...  ..++||||++++++.....   ....++......++.+++.+|.+||   . .+|+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-
Confidence            544433332  3489999999886544321   1234778889999999999999999   6 8999999999999999 


Q ss_pred             CCCeEEeeeccceecc
Q 007248          409 DFTPKIADFGLARCFA  424 (611)
Q Consensus       409 ~~~~kl~DfGla~~~~  424 (611)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            7899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=1.2e-20  Score=174.15  Aligned_cols=257  Identities=19%  Similarity=0.283  Sum_probs=189.2

Q ss_pred             hcCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCC-CceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH-KNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ...|...++||.|+||.+|.| ...+|..||||.-.....  ..++..|.++.+.|+| ..|..+..|..+...-.+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            457888999999999999999 677899999997543322  2457789999999975 678888889999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC---CCeEEeeeccceecc
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD---FTPKIADFGLARCFA  424 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~~~~  424 (611)
                      .+ |-||+++..--  ...++.++++-++-|++.-++|+|   ..++|||||||.|+|..-+   ..+.|+||||++.+.
T Consensus        92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            98 78999887322  234788899999999999999999   8999999999999999743   468999999998775


Q ss_pred             CCCcce------eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccc
Q 007248          425 ADRTHV------STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE  498 (611)
Q Consensus       425 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (611)
                      +..+..      .....||.+|.+--...+...+.+.|+-|+|.+|....-|..||...... +..+.... +.+.++..
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~-tk~QKyEk-I~EkK~s~  243 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA-TKKQKYEK-ISEKKMST  243 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh-hHHHHHHH-HHHhhcCC
Confidence            543322      23567999999888777778889999999999999999999998643221 11111111 11111111


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          499 AVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       499 ~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      .+.. |-..+|.    ++...+.-|-..--++-|...-+-+..
T Consensus       244 ~ie~-LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  244 PIEV-LCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             CHHH-HhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            1111 1122333    355566678888888888876555443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=5e-20  Score=177.47  Aligned_cols=199  Identities=21%  Similarity=0.308  Sum_probs=165.9

Q ss_pred             cCCCCCCccccCCceeEEEE-EcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      -.|...++||+|.||..+.| .+-+++.||||--...+  ...++..|.+..+.| ..++|..++-|-.++..-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            46888999999999999999 56689999999543222  234677788888877 568999999888889899999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC-----CCeEEeeeccceec
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-----FTPKIADFGLARCF  423 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DfGla~~~  423 (611)
                      + |-||+|+..-  -...++.+.++-+|.|++.-++|+|   .+.+|.|||||+|+||...     ..+.|+|||||+.+
T Consensus       106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 7788887621  1234889999999999999999999   8999999999999999743     35899999999987


Q ss_pred             cCCCcce------eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCC
Q 007248          424 AADRTHV------STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFS  477 (611)
Q Consensus       424 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~  477 (611)
                      -+..+..      .....||.+||+--...+.+.+.+.|+-|||-++...|-|..||...
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            6554432      23567999999999888999999999999999999999999998643

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.3e-19  Score=167.86  Aligned_cols=185  Identities=15%  Similarity=0.098  Sum_probs=139.4

Q ss_pred             CCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhH-----HHHHHHHHHHhcCC-CCceeeEeeeeeeCCcceEEEe
Q 007248          274 NPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       274 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .....|++|+||+||.+.- .+.+++.+.+..... +.     ..|.+|+++|++|+ |+++++++++    ...+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~-~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPW-WLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchh-hhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3467899999999998766 678888887764432 22     25789999999995 5889999886    34699999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCC-CcccEEECCCCCeEEeeeccceeccCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDI-KTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      |+.|.+|...+..          ....++.+++++|.++|   ..+|+|||| ||.|||++.++.++|+|||++......
T Consensus        79 yI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         79 YLAGAAMYQRPPR----------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             eecCccHHhhhhh----------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            9999998654310          11357789999999999   899999999 799999999999999999999865433


Q ss_pred             Ccc----e--------eecccCCccccChhhhhcC-ccc-cccceehhHHHHHHHHhCCCCCCCC
Q 007248          427 RTH----V--------STAVAGTLGYMAPEYLVRG-QLT-EKADVYSFGILIIEIVCGRRSNAFS  477 (611)
Q Consensus       427 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~ksDV~S~Gvll~elltG~~p~~~~  477 (611)
                      ...    .        ......++.|+.|+...-. ..+ ...+.++.|.-+|.++|++.+.-.+
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            210    0        0112357788888865332 233 4668889999999999999875433

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=5.7e-19  Score=168.55  Aligned_cols=136  Identities=17%  Similarity=0.245  Sum_probs=106.5

Q ss_pred             CCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-----CCCceeeEeeeeeeCC---c-ceE
Q 007248          274 NPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-----EHKNLVKLLGCSIEGP---E-SLL  344 (611)
Q Consensus       274 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l  344 (611)
                      ...+.||+|+||.||.  .++....+||++........+.+.+|+++++.+     .||||++++|+++++.   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4467899999999996  443333479988765444567899999999999     5799999999998764   3 337


Q ss_pred             EEee--cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHH-HHHhcCCCCceecCCCCcccEEECC----CCCeEEeee
Q 007248          345 VYEY--VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL-AYLHGGSETRIIHRDIKTSNILLDK----DFTPKIADF  417 (611)
Q Consensus       345 v~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df  417 (611)
                      |+||  +++++|.+++.+.    .+++.  ..++.+++.++ +|||   +.+|+||||||+|||++.    +.+++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  6689999999432    24544  35678888888 9999   899999999999999974    347999995


Q ss_pred             ccc
Q 007248          418 GLA  420 (611)
Q Consensus       418 Gla  420 (611)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.77  E-value=2.6e-19  Score=195.73  Aligned_cols=244  Identities=23%  Similarity=0.241  Sum_probs=178.4

Q ss_pred             CCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccc-hhhHHHHHHHHHH--HhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT-RQWVDEFFNEVNL--ISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++...+.||++.|=+|.+++.++|. |+||++.... .-..+.|.++++-  ...++|||.+++.-+...+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5667789999999999999998887 9999886554 3345556555443  4455999999999888888888999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec--cCC
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF--AAD  426 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~--~~~  426 (611)
                      +.+ +|.|.|.   -+.-|...+..=|+.|++.||..+|   +.+|+|||||.+||||..=..+.|+||.--+..  ..+
T Consensus       103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            965 8887773   2334556666668999999999999   899999999999999999999999999876543  222


Q ss_pred             Cccee----ecccCCccccChhhhhcC-----------ccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHh
Q 007248          427 RTHVS----TAVAGTLGYMAPEYLVRG-----------QLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTL  490 (611)
Q Consensus       427 ~~~~~----~~~~gt~~y~aPE~~~~~-----------~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~  490 (611)
                      .....    .+...-..|+|||.+...           ..+++.||||+||++.||++ |+++|+..+    ++.     
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~a-----  246 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLA-----  246 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHh-----
Confidence            22211    122344579999987542           26789999999999999987 466654321    111     


Q ss_pred             hccC------ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          491 YRSN------KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       491 ~~~~------~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ++.+      .+.+.|    .+       ..+.++++.|++.||+.|-++++.++.-.+
T Consensus       247 Yr~~~~~~~e~~Le~I----ed-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  247 YRSGNADDPEQLLEKI----ED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             HhccCccCHHHHHHhC----cC-------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            1111      111111    10       136789999999999999999999987443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.77  E-value=3.2e-18  Score=168.69  Aligned_cols=232  Identities=20%  Similarity=0.246  Sum_probs=148.4

Q ss_pred             CCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCC----------CceeeEee----
Q 007248          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEH----------KNLVKLLG----  334 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~----  334 (611)
                      +...+.||.|+++.||.+... .|+.+|||+.....   ....+++.+|.-....+.+          -.++.-++    
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            344678999999999999664 58999999876443   3346677777765555432          12222111    


Q ss_pred             -----eeeeCC--------cceEEEeecCCCChhhhhh---ccC-CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecC
Q 007248          335 -----CSIEGP--------ESLLVYEYVPNRSLDQFIF---DKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR  397 (611)
Q Consensus       335 -----~~~~~~--------~~~lv~E~~~~gsL~~~l~---~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  397 (611)
                           ++....        ..+++|+-+ .++|.+++.   ... ....+....++.+..|+++.+++||   ..+++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence                 111111        236677776 568877753   221 1234566677888899999999999   8999999


Q ss_pred             CCCcccEEECCCCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcC--------ccccccceehhHHHHHHHHh
Q 007248          398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG--------QLTEKADVYSFGILIIEIVC  469 (611)
Q Consensus       398 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~ksDV~S~Gvll~ellt  469 (611)
                      ||+|+|+|++.+|.++|+||+.....+...   . ....+..|.+||.....        .++.+.|.|++|+++|.|.+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY---R-CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEE---E-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCcee---e-ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            999999999999999999998876443211   1 12345789999987542        57889999999999999999


Q ss_pred             CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 007248          470 GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALR  531 (611)
Q Consensus       470 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~R  531 (611)
                      |+.|++..........                 .+ .... +.++.+..|+..+++.+|++|
T Consensus       246 ~~lPf~~~~~~~~~~~-----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW-----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG-----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc-----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999875432211100                 11 1223 556678899999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=2.5e-18  Score=191.89  Aligned_cols=198  Identities=24%  Similarity=0.255  Sum_probs=157.8

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC---CCceeeEeeeeeeCCcc
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE---HKNLVKLLGCSIEGPES  342 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~  342 (611)
                      ++.-.+.|.+.+.||+|+||+||+|...+|+.||+|+-+....   -+|.--.+++.+|+   -+-|+.+..++.-.+.-
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            3444567888899999999999999888899999997654322   12322334444554   23455555566667788


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-------CCCeEEe
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-------DFTPKIA  415 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~~kl~  415 (611)
                      +||+||.+.|+|.+++.   ..+.++|...+-++.|+++.+++||   ..+|||+||||.|.||..       ...++|+
T Consensus       770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEE
Confidence            99999999999999994   5667999999999999999999999   899999999999999942       3458999


Q ss_pred             eeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCC
Q 007248          416 DFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRR  472 (611)
Q Consensus       416 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~  472 (611)
                      |||-+-.+..-.. ......++|-.+-.+|...+..++.+.|-|.+.-+++-||.|+.
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9999965432222 24456778999999999999999999999999999999999974

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=7.7e-18  Score=164.78  Aligned_cols=145  Identities=17%  Similarity=0.117  Sum_probs=112.7

Q ss_pred             HHhcCCCCCCccccCCceeEEEEE--cCCCCEEEEEEeeccchh------------------------hHHHHHHHHHHH
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGS--LPNGTTVAVKRLIFNTRQ------------------------WVDEFFNEVNLI  321 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l  321 (611)
                      +-...|.+.+.||+|+||.||+|.  ..+|+.||||++......                        ....+..|++++
T Consensus        25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L  104 (237)
T smart00090       25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL  104 (237)
T ss_pred             hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence            333457788999999999999997  678999999988643210                        112356899999


Q ss_pred             hcCCCC--ceeeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCc-eecCC
Q 007248          322 SSIEHK--NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR-IIHRD  398 (611)
Q Consensus       322 ~~l~h~--niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~D  398 (611)
                      .++.+.  .+++++++    ...++||||+++.+|..+...   ...+.......++.||+.+|.+||   ..+ |+|||
T Consensus       105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~D  174 (237)
T smart00090      105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLY---KEGELVHGD  174 (237)
T ss_pred             HHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCC
Confidence            999753  34455543    235899999999888766522   223556667899999999999999   788 99999


Q ss_pred             CCcccEEECCCCCeEEeeeccceec
Q 007248          399 IKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       399 lkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      |||+||+++ +++++|+|||++...
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhcc
Confidence            999999999 789999999998644

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=5.1e-19  Score=184.86  Aligned_cols=186  Identities=26%  Similarity=0.276  Sum_probs=154.2

Q ss_pred             ccccCCceeEEEE----EcCCCCEEEEEEeeccchh--hHHHHHHHHHHHhcCC-CCceeeEeeeeeeCCcceEEEeecC
Q 007248          278 KLGQGGAGSVYMG----SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       278 ~iG~G~~g~Vy~~----~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      .+|+|.||.|+..    ..+.|..+|+|.++.....  .......|..++...+ ||.+|++.-.+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            3799999999865    3345788999987654321  1124567888888886 9999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +|.|...+.   .....++.........++-+++++|   +.+|+|||+|++||+++.+|.+|+.|||+++..-..... 
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            999987773   3334666666778888999999999   999999999999999999999999999999876543322 


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAF  476 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~  476 (611)
                          +||..|||||++.  ......|-||||++++||+||-.||..
T Consensus       154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                8899999999997  567889999999999999999998753

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=6.7e-19  Score=180.61  Aligned_cols=173  Identities=25%  Similarity=0.408  Sum_probs=131.3

Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      .+++.|++|...+|.+||..+......+|...+.++.|++.|+.|      ++.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999766666778999999999999999999      67899999999999999999999999999


Q ss_pred             eeccCCC-----cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhC-CCCCCCCCCCCChhHHHHHhhccC
Q 007248          421 RCFAADR-----THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG-RRSNAFSQDSASPLQRVWTLYRSN  494 (611)
Q Consensus       421 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~  494 (611)
                      .......     ....+...||..||+||.+.+..++.|+|||+||+||+||++- ...++    ...    ....++++
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~----t~~d~r~g  475 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIA----TLTDIRDG  475 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHH----hhhhhhcC
Confidence            7665544     2234567899999999999999999999999999999999972 11110    000    00111111


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 007248          495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ  536 (611)
Q Consensus       495 ~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~e  536 (611)
                      .    +++....++|.+     ..+..+++.+.|.+||+..+
T Consensus       476 ~----ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  476 I----IPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             C----CChHHhhcCcHH-----HHHHHHhcCCCcccCchHHH
Confidence            1    111222223322     46778999999999995444

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=1.9e-17  Score=158.30  Aligned_cols=146  Identities=21%  Similarity=0.198  Sum_probs=113.8

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccch----------------------hhHHHHHHHHHHH
Q 007248          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR----------------------QWVDEFFNEVNLI  321 (611)
Q Consensus       264 ~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l  321 (611)
                      .++......|...+.||+|+||.||++..++|+.||||++.....                      .....+..|+.++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            344444445778899999999999999888899999998754321                      0112366789999


Q ss_pred             hcCCCCc--eeeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 007248          322 SSIEHKN--LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDI  399 (611)
Q Consensus       322 ~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  399 (611)
                      ..+.|++  ++..++.    ...++||||+++++|......         .....++.+++.++.++|   ..+|+||||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl  151 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAY---KHGIIHGDL  151 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHH---HCCCCcCCC
Confidence            9998874  4444442    356899999999998765420         234678899999999999   799999999


Q ss_pred             CcccEEECCCCCeEEeeeccceeccC
Q 007248          400 KTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       400 kp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      ||+||++++++.++|+|||++..+..
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999999965543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.3e-17  Score=161.20  Aligned_cols=134  Identities=22%  Similarity=0.325  Sum_probs=113.1

Q ss_pred             CccccCCceeEEEEEcCCCCEEEEEEeeccch--------hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR--------QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +.||+|++|.||+|.. .|..++||+......        .....+.+|++++..+.|+|++....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 678899997653221        1124578999999999999988777777777888999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      +++++|.+++...      .+ .+..++.+++.+|.+||   ..+++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998432      12 78899999999999999   89999999999999999 78899999999864

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=9.4e-18  Score=165.31  Aligned_cols=195  Identities=24%  Similarity=0.293  Sum_probs=135.5

Q ss_pred             CCCceeeEeeeeee---------------------------CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHH
Q 007248          325 EHKNLVKLLGCSIE---------------------------GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL  377 (611)
Q Consensus       325 ~h~niv~l~~~~~~---------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  377 (611)
                      +|||||+++++|.+                           ...+|+||..++. +|..++..+    ..+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence            59999999987653                           2346889887754 888888432    355566677899


Q ss_pred             HHHHHHHHHhcCCCCceecCCCCcccEEEC--CCC--CeEEeeeccceeccCCC-----cceeecccCCccccChhhhhc
Q 007248          378 GTAEGLAYLHGGSETRIIHRDIKTSNILLD--KDF--TPKIADFGLARCFAADR-----THVSTAVAGTLGYMAPEYLVR  448 (611)
Q Consensus       378 ~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~  448 (611)
                      |+++|..|||   +++|.|||+|+.||||.  +|+  .+.|+|||++-.-....     .......-|...-||||+...
T Consensus       349 QlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999   99999999999999994  443  47899999984322110     111123446777899999864


Q ss_pred             C--c----cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHH
Q 007248          449 G--Q----LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLL  522 (611)
Q Consensus       449 ~--~----~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~  522 (611)
                      .  +    ...|.|.|+.|-+.||+++...||...  ++..++.  ..+.+.++     |.+    +...+..+.+++..
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r--Gem~L~~--r~Yqe~qL-----Pal----p~~vpp~~rqlV~~  492 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR--GEMLLDT--RTYQESQL-----PAL----PSRVPPVARQLVFD  492 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCccccc--chheech--hhhhhhhC-----CCC----cccCChHHHHHHHH
Confidence            3  1    245899999999999999999887642  2212111  11222222     222    33444557889999


Q ss_pred             hcccCCCCCCCHHHHHHH
Q 007248          523 CTQAAAALRPSMAQAIML  540 (611)
Q Consensus       523 c~~~~p~~RPt~~evl~~  540 (611)
                      .++.||++||+..=..+.
T Consensus       493 lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  493 LLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             HhcCCccccCCccHHHhH
Confidence            999999999987544433

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=2e-17  Score=182.03  Aligned_cols=144  Identities=21%  Similarity=0.314  Sum_probs=115.6

Q ss_pred             hHHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEe-ecc-------chhhHHHHHHHHHHHhcCCCCceeeEee
Q 007248          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRL-IFN-------TRQWVDEFFNEVNLISSIEHKNLVKLLG  334 (611)
Q Consensus       263 ~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~  334 (611)
                      +.........|...+.||+|+||+||+|.+... .+++|+. ...       .....+.+.+|++++..++|++++....
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            333344455567789999999999999987544 3444432 211       1112356889999999999999998888


Q ss_pred             eeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEE
Q 007248          335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (611)
Q Consensus       335 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  414 (611)
                      ++......++||||+++++|.+++.           ....++.+++++|.+||   +.+++||||||+|||+ +++.++|
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~l  468 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYL  468 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEE
Confidence            8777778899999999999999883           35679999999999999   8999999999999999 5779999


Q ss_pred             eeecccee
Q 007248          415 ADFGLARC  422 (611)
Q Consensus       415 ~DfGla~~  422 (611)
                      +|||+++.
T Consensus       469 iDFGla~~  476 (535)
T PRK09605        469 IDFGLGKY  476 (535)
T ss_pred             EeCccccc
Confidence            99999965

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=3.3e-17  Score=156.85  Aligned_cols=130  Identities=23%  Similarity=0.394  Sum_probs=106.5

Q ss_pred             ccccCCceeEEEEEcCCCCEEEEEEeeccc--------hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       278 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      .||+|+||.||+|.+ +|..+++|+.....        ....+++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999986 67889999864321        112356789999999999887665555556667789999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++++|.+++....    .      .++.+++.+|.+||   ..+++|+|++|.||+++ ++.+++.|||++..
T Consensus        80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998873321    0      78999999999999   89999999999999999 78999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.71  E-value=1.1e-17  Score=142.16  Aligned_cols=75  Identities=35%  Similarity=0.659  Sum_probs=59.7

Q ss_pred             cchhhhcccC--CCceeee-ecCCCCcceEEEEecCCCCChhhHHHHHHHHHhhccc-cCCCCceEEEcceeeEEEeccc
Q 007248            2 EILSQLITAN--THFATFN-LNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPR-CLPSLSATIFFDGCFLRYDIYS   77 (611)
Q Consensus         2 ~~l~~~~~~~--~~f~~~~-~~~~~~~~vy~l~~C~~d~~~~~C~~Cl~~~~~~~~~-c~~~~~~~~~~~~C~~ry~~~~   77 (611)
                      +.|.+.++..  .+|++++ +..++  +||||+||++|+++.+|..||+.++..++. |+.+++|++++++|+|||++++
T Consensus        28 ~~l~~~a~~~~~~~f~~~~~~~~~~--~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~~~C~lRY~~~~  105 (106)
T PF01657_consen   28 SSLVSNAASSSSKGFATGSAGSGPD--TVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGRVWYDSCFLRYENYP  105 (106)
T ss_dssp             HHHHHHGGGTT-TEEEEEE--ST-----EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEEEEESSEEEEEESS-
T ss_pred             HHHHHHHhhccccCcEEeecCCCCC--eEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEEEECCCEEEEEECCC
Confidence            4566666543  5899998 55555  999999999999999999999999999999 8899999999999999999999


Q ss_pred             c
Q 007248           78 F   78 (611)
Q Consensus        78 f   78 (611)
                      |
T Consensus       106 F  106 (106)
T PF01657_consen  106 F  106 (106)
T ss_dssp             -
T ss_pred             C
Confidence            8

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.64  E-value=1.9e-16  Score=134.62  Aligned_cols=84  Identities=29%  Similarity=0.559  Sum_probs=71.2

Q ss_pred             hHHHHHHHHHHHHHHHHhhc-CCccccccc----ceEEEEEeccccCCccChhhHHHhhhhhhhcccCCCCCCeEEeeee
Q 007248          110 GFVESVGYAVGNVSRIAVEK-GGGFGAVKV----MGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGC  184 (611)
Q Consensus       110 ~f~~~v~~ll~~l~~~a~~~-~~~f~~~~~----~~~yglaQC~~dls~~~C~~Cl~~~~~~~~~~c~~~~~g~~~~~~C  184 (611)
                      .|...+..+|..+...++.+ ..+|+++..    .+||||+||++||++.+|..||..++..++..|.++.+|++++.+|
T Consensus        18 ~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~~~C   97 (106)
T PF01657_consen   18 TFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGRVWYDSC   97 (106)
T ss_dssp             THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEEEEESSE
T ss_pred             hHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEEEECCCE
Confidence            38999999999999998876 468988753    3899999999999999999999999999999899999999999999


Q ss_pred             eeeccCCcc
Q 007248          185 YLRYSTDKF  193 (611)
Q Consensus       185 ~~ry~~~~f  193 (611)
                      ++||+.++|
T Consensus        98 ~lRY~~~~F  106 (106)
T PF01657_consen   98 FLRYENYPF  106 (106)
T ss_dssp             EEEEESS--
T ss_pred             EEEEECCCC
Confidence            999999887

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=1.5e-15  Score=143.77  Aligned_cols=137  Identities=20%  Similarity=0.194  Sum_probs=98.1

Q ss_pred             CCccccCCceeEEEEEcCCCCEEEEEEeeccchh--hHHH----------------------HHHHHHHHhcCCCCc--e
Q 007248          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ--WVDE----------------------FFNEVNLISSIEHKN--L  329 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i  329 (611)
                      .+.||+|+||.||+|...+|+.||||++......  ....                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999998888999999987653211  1111                      134555566554432  4


Q ss_pred             eeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCC-CceecCCCCcccEEECC
Q 007248          330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNILLDK  408 (611)
Q Consensus       330 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~  408 (611)
                      .+.+++    ...++||||++++.+.........   .. .....++.+++.++.++|   . .+|+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-
Confidence            444443    246899999999654322111000   11 567789999999999999   6 8999999999999999 


Q ss_pred             CCCeEEeeeccceecc
Q 007248          409 DFTPKIADFGLARCFA  424 (611)
Q Consensus       409 ~~~~kl~DfGla~~~~  424 (611)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8899999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=1.9e-15  Score=137.11  Aligned_cols=135  Identities=23%  Similarity=0.218  Sum_probs=113.8

Q ss_pred             CCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCC--CceeeEeeeeeeCCcceEEEeecCCC
Q 007248          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH--KNLVKLLGCSIEGPESLLVYEYVPNR  352 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~g  352 (611)
                      +.+.||+|.++.||++...+ ..++||.......  ...+.+|+.++..++|  .++++++++...++..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35679999999999998854 7899998765433  4678899999999976  58999999888888899999999988


Q ss_pred             ChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       353 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      .+..+          +......++.+++++|++||.....+++|+|++|.||++++.+.+++.|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77643          4566678899999999999954346899999999999999989999999998863

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=8.9e-15  Score=143.48  Aligned_cols=135  Identities=19%  Similarity=0.268  Sum_probs=104.8

Q ss_pred             CCccc-cCCceeEEEEEcCCCCEEEEEEeeccc-------------hhhHHHHHHHHHHHhcCCCCce--eeEeeeeeeC
Q 007248          276 SKKLG-QGGAGSVYMGSLPNGTTVAVKRLIFNT-------------RQWVDEFFNEVNLISSIEHKNL--VKLLGCSIEG  339 (611)
Q Consensus       276 ~~~iG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  339 (611)
                      ...|| .|+.|+||+.... +..++||+.....             ......+.+|++++.+|+|++|  +..+++...+
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45788 8999999999874 7789999774311             1223467889999999998875  6777764433


Q ss_pred             C-c---ceEEEeecCC-CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEE
Q 007248          340 P-E---SLLVYEYVPN-RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (611)
Q Consensus       340 ~-~---~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  414 (611)
                      . .   .++|+||+++ .+|.+++..    ..++..    .+.+|+.+|.+||   ..+|+||||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEE
Confidence            2 2   2599999997 689888743    224433    3678999999999   899999999999999999889999


Q ss_pred             eeecccee
Q 007248          415 ADFGLARC  422 (611)
Q Consensus       415 ~DfGla~~  422 (611)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.57  E-value=2.1e-15  Score=165.44  Aligned_cols=207  Identities=21%  Similarity=0.278  Sum_probs=136.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      .+|+.++.|..|+||.||..+++ ..+.+|+| +..+.-     +.+-  ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee-------------------
Confidence            46788899999999999999765 36778885 332211     0000  22222333333                   


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc-
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT-  428 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-  428 (611)
                        |+=...+   +..+.++.        +++.+++|||   ..+|+|||+||.|.+|..-|.+|+.|||+.+....... 
T Consensus       136 --gDc~tll---k~~g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 --GDCATLL---KNIGPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             --chhhhhc---ccCCCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence              2323333   11122222        2278999999   89999999999999999999999999999875322110 


Q ss_pred             -------------ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC-
Q 007248          429 -------------HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-  494 (611)
Q Consensus       429 -------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-  494 (611)
                                   .....++||+.|.|||++...-|....|.|++|+|+||.+-|+.||+.... +.++..+.   ... 
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~vi---sd~i  275 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVI---SDDI  275 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhh---hhhc
Confidence                         112356899999999999999999999999999999999999999864322 22222211   111 


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 007248          495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPS  533 (611)
Q Consensus       495 ~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt  533 (611)
                      .+.+- |        .....+..+++.+.++.+|.+|--
T Consensus       276 ~wpE~-d--------ea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  276 EWPEE-D--------EALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             ccccc-C--------cCCCHHHHHHHHHHHHhChHhhcc
Confidence            11111 1        112233567777888999988853

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=3.5e-15  Score=163.78  Aligned_cols=254  Identities=24%  Similarity=0.261  Sum_probs=184.6

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC--CCEEEEEEeeccc--hhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN--GTTVAVKRLIFNT--RQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  345 (611)
                      ..|...+.||+|.|+.|-......  ...+|+|.+....  ....+....|..+-..+. |+|++.+++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456667789999999998775533  4556666654332  233344555777777776 99999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC-CeEEeeeccceecc
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFA  424 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~  424 (611)
                      .||..++++.+.+... .....+....-....|+..++.|+|.  ..++.|+||||+|.+++..+ ..+++|||+|..+.
T Consensus       100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999998888321 11134555566789999999999994  67899999999999999999 99999999998776


Q ss_pred             C--CCcceeecccC-CccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCCh-hHHHHHhhccCccccc
Q 007248          425 A--DRTHVSTAVAG-TLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASP-LQRVWTLYRSNKLVEA  499 (611)
Q Consensus       425 ~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  499 (611)
                      .  ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........ ..|     ....  ..
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~-----~~~~--~~  249 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW-----KSNK--GR  249 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee-----cccc--cc
Confidence            5  22233345667 9999999998874 5577899999999999999999998766443321 111     1111  00


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                      .    .............++...++..+|..|.+.+++.
T Consensus       250 ~----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  250 F----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             c----ccCccccCChhhhhcccccccCCchhcccccccc
Confidence            0    0011112223345666778889999999988875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=9.8e-14  Score=147.84  Aligned_cols=145  Identities=21%  Similarity=0.206  Sum_probs=102.3

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhH------------------------------H--------
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV------------------------------D--------  312 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~--------  312 (611)
                      ..|+ .+.||.|++|.||+|++++|+.||||+......+..                              +        
T Consensus       118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            3444 367999999999999999999999999865421110                              0        


Q ss_pred             --HHHHHHHHHhcC----CCCceeeEeeee-eeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHH-HHH
Q 007248          313 --EFFNEVNLISSI----EHKNLVKLLGCS-IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE-GLA  384 (611)
Q Consensus       313 --~~~~E~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~  384 (611)
                        .|.+|++.+.++    +|.+-+.+-.++ ......+|||||++|++|.++......  .+   .+.+++..+++ .+.
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~  271 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLN  271 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHH
Confidence              144455555544    233323332222 224467999999999999988642211  11   24456776666 478


Q ss_pred             HHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       385 ~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      .+|   ..+++|+|++|.||+++++++++|.|||++..+.
T Consensus       272 ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       272 QVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            889   7999999999999999999999999999997664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=5.4e-13  Score=140.16  Aligned_cols=248  Identities=23%  Similarity=0.281  Sum_probs=180.7

Q ss_pred             cCCCCCCcccc--CCceeEEEEEc---CCCCEEEEEEee--ccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcc
Q 007248          271 NYFNPSKKLGQ--GGAGSVYMGSL---PNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       271 ~~f~~~~~iG~--G~~g~Vy~~~~---~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  342 (611)
                      ..|.....+|.  |.+|.||.+..   .++..+|+|+-+  .........=.+|+....++ .|+|.++.+..+...+.+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34667788999  99999999965   467889999733  22223333335677777777 599999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHH----HHHHHhcCCCCceecCCCCcccEEECCC-CCeEEeee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE----GLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADF  417 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df  417 (611)
                      ++-+|++. .+|..+.+..  ...++...++....+...    ||.++|   ..+++|-|+||.||++..+ ...++.||
T Consensus       194 fiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCc
Confidence            99999985 7888887543  334666777777777777    999999   8999999999999999999 88999999


Q ss_pred             ccceeccCCCcce----eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc
Q 007248          418 GLARCFAADRTHV----STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS  493 (611)
Q Consensus       418 Gla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  493 (611)
                      |+...+.......    .....+...|++||.. .+.++..+|||++|.+++|-.+|..........      .|...+.
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~~r~  340 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQLRQ  340 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------Ccccccc
Confidence            9998876554221    2233678899999987 567889999999999999999987654322111      1222111


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..        +..++-.....++..+..++++.+|-.|++.+.+..
T Consensus       341 ~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  341 GY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            11        111121122233445788899999999999877653

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.35  E-value=1.2e-12  Score=141.18  Aligned_cols=147  Identities=18%  Similarity=0.222  Sum_probs=95.1

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcCC-CCEEEEEEeeccchh----------------------------------hHH
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQ----------------------------------WVD  312 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~  312 (611)
                      +....|+. +.||+|++|.||+|++++ |+.||||++.....+                                  ..+
T Consensus       117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~  195 (537)
T PRK04750        117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK  195 (537)
T ss_pred             HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence            33456776 789999999999999887 999999998754211                                  111


Q ss_pred             H------HHHHHHHHhcC----CCCceeeEeeeeee-CCcceEEEeecCCCChhhhhh--ccC-CCccCChhHHHHHHHH
Q 007248          313 E------FFNEVNLISSI----EHKNLVKLLGCSIE-GPESLLVYEYVPNRSLDQFIF--DKN-KTKLLNWNKRFNIILG  378 (611)
Q Consensus       313 ~------~~~E~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~--~~~-~~~~l~~~~~~~i~~~  378 (611)
                      .      |.+|+..+.++    .+.+.+.+-.++.+ ....+|||||+.|+.+.++-.  ..+ ....+.......++  
T Consensus       196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~--  273 (537)
T PRK04750        196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF--  273 (537)
T ss_pred             HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH--
Confidence            1      33344444333    23333433333322 456789999999999987531  111 00112222222222  


Q ss_pred             HHHHHHHHhcCCCCceecCCCCcccEEECCCC----CeEEeeeccceeccC
Q 007248          379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDF----TPKIADFGLARCFAA  425 (611)
Q Consensus       379 ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGla~~~~~  425 (611)
                           ..++   ..+++|+|+||.||+++.++    ++++.|||+...++.
T Consensus       274 -----~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 -----TQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 3334   57999999999999999888    999999999987654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=2.1e-12  Score=125.20  Aligned_cols=202  Identities=20%  Similarity=0.294  Sum_probs=136.5

Q ss_pred             HHHhcCCCCceeeEeeeeeeCC-----cceEEEeecCCCChhhhhhccCC-CccCChhHHHHHHHHHHHHHHHHhcCCCC
Q 007248          319 NLISSIEHKNLVKLLGCSIEGP-----ESLLVYEYVPNRSLDQFIFDKNK-TKLLNWNKRFNIILGTAEGLAYLHGGSET  392 (611)
Q Consensus       319 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~  392 (611)
                      .-|-++-|-|||++..|+.+.+     ...++.|||..|+|..+|.+..+ ...+......+|+.||..||.|||+ +.+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence            3455567999999999876543     46899999999999999976433 3457777778899999999999995 589


Q ss_pred             ceecCCCCcccEEECCCCCeEEeeeccceeccC----CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHH
Q 007248          393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAA----DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIV  468 (611)
Q Consensus       393 ~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ell  468 (611)
                      +|+|+++.-.-|++..++-+||.--- ...+..    ..........+.++|.+||.=...+.+..+|||+||+-.+||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            99999999999999999888875211 111100    0011111234678999999877777888999999999999998


Q ss_pred             hCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          469 CGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       469 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      -|..-......... .+..    ....+. .....+.           ..++..|++..|..||+|.+++.
T Consensus       277 ilEiq~tnseS~~~-~ee~----ia~~i~-~len~lq-----------r~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNSESKVE-VEEN----IANVII-GLENGLQ-----------RGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCCcceee-hhhh----hhhhee-eccCccc-----------cCcCcccccCCCCCCcchhhhhc
Confidence            77543211111100 0000    000011 1111111           23455799999999999998764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.31  E-value=6.9e-12  Score=116.58  Aligned_cols=130  Identities=19%  Similarity=0.113  Sum_probs=95.1

Q ss_pred             CCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCcee-eEeeeeeeCCcceEEEeecCCCCh
Q 007248          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV-KLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      .+.|+.|.++.||++... +..+++|....... ....+.+|+++++.+.+.+++ +++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            356899999999999874 77899998654322 123467899999988665544 455443  3346899999999887


Q ss_pred             hhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCC--CCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS--ETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      ....        .   ....++.+++++|+.||...  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            6431        1   11245688999999999422  22369999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.21  E-value=3.1e-10  Score=106.56  Aligned_cols=135  Identities=13%  Similarity=0.083  Sum_probs=98.2

Q ss_pred             CccccCCceeEEEEEcCC-------CCEEEEEEeeccc------h----------------hhHHHHH----HHHHHHhc
Q 007248          277 KKLGQGGAGSVYMGSLPN-------GTTVAVKRLIFNT------R----------------QWVDEFF----NEVNLISS  323 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------~----------------~~~~~~~----~E~~~l~~  323 (611)
                      ..||.|.-+.||.|...+       +..+|||+.+...      .                .+.+.+.    +|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999996543       5799999764211      0                1122333    79999998


Q ss_pred             CCC--CceeeEeeeeeeCCcceEEEeecCCCChhh-hhhccCCCccCChhHHHHHHHHHHHHHHHH-hcCCCCceecCCC
Q 007248          324 IEH--KNLVKLLGCSIEGPESLLVYEYVPNRSLDQ-FIFDKNKTKLLNWNKRFNIILGTAEGLAYL-HGGSETRIIHRDI  399 (611)
Q Consensus       324 l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dl  399 (611)
                      +..  -+++.++++    ...+|||||+.+..+.. .+.    ...++......+..+++.+|..| |   +.+|||+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence            853  466677765    46789999997754422 221    12244556677889999999999 7   789999999


Q ss_pred             CcccEEECCCCCeEEeeeccceec
Q 007248          400 KTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       400 kp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      ++.|||+++ +.+.|+|||.+-..
T Consensus       152 s~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEEC-CcEEEEECCCceeC
Confidence            999999974 68999999988644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.21  E-value=9.1e-11  Score=124.57  Aligned_cols=168  Identities=17%  Similarity=0.223  Sum_probs=126.8

Q ss_pred             EcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChh
Q 007248          291 SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWN  370 (611)
Q Consensus       291 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~  370 (611)
                      +..++.+|.|...+....++.+...+-++-|+.++||||++++..++.++..|||+|-+  ..|..++.+      +...
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~  104 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKE  104 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHH
Confidence            45578889998887665555666778899999999999999999999999999999987  345555522      2344


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcCc
Q 007248          371 KRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ  450 (611)
Q Consensus       371 ~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  450 (611)
                      ...--+.||+.||.|||+  +.+++|++|.-..|+++..|.-||++|.++........ .......--.|..|+.+....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence            556678999999999986  78999999999999999999999999998754332221 001111122456666543222


Q ss_pred             cccccceehhHHHHHHHHhCC
Q 007248          451 LTEKADVYSFGILIIEIVCGR  471 (611)
Q Consensus       451 ~~~ksDV~S~Gvll~elltG~  471 (611)
                        -..|.|-||++++|++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              3459999999999999993

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=2.2e-11  Score=128.10  Aligned_cols=245  Identities=21%  Similarity=0.219  Sum_probs=172.2

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc--CCCCEEEEEEeeccchhhHHH--HHHHHHHHhcC-CCCceeeEeeeeeeCCcc
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSL--PNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSI-EHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  342 (611)
                      ..+.+|.....||.|.|+.|++...  .++..|++|.+.........+  -+.|+-+...+ .|.++++.+..+......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3455788889999999999998743  468899999876543222222  23566666555 688999988888888888


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC-CCeEEeeeccce
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLAR  421 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~  421 (611)
                      ++--||+.++++...+   .-...++...++++..|++.++.++|   .+.++|+|+||+||++..+ +..++.|||++.
T Consensus       342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence            8999999999987766   22345788889999999999999999   8999999999999999886 788999999986


Q ss_pred             eccCCCcceeecccCCcccc--ChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          422 CFAADRTHVSTAVAGTLGYM--APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      .+.-    .........+++  +|+......+..+.|++|||+-+.|.++|..-....      .+  |..+..+.+   
T Consensus       416 ~~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~------~~--~~~i~~~~~---  480 (524)
T KOG0601|consen  416 RLAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG------VQ--SLTIRSGDT---  480 (524)
T ss_pred             ccce----ecccccccccccccchhhccccccccccccccccccccccccCcccCccc------cc--ceeeecccc---
Confidence            3211    111222334445  455555567888999999999999999987532110      11  111111111   


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                            ...+.. ...+..+..-++..++..||.+.++..+
T Consensus       481 ------p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  481 ------PNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             ------cCCCch-HHhhhhhhhhhcCCccccchhhhhhccc
Confidence                  111111 1445566677888999999998877644

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.17  E-value=2.3e-10  Score=111.18  Aligned_cols=141  Identities=20%  Similarity=0.266  Sum_probs=110.1

Q ss_pred             CccccCCceeEEEEEcCCCCEEEEEEeeccch-hhHHHHHHHHHHHhcCCC--CceeeEeeeeeeCC---cceEEEeecC
Q 007248          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEH--KNLVKLLGCSIEGP---ESLLVYEYVP  350 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~E~~~  350 (611)
                      +.|+.|..+.||++...+|..+++|....... .....+..|+++++.+.+  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999887778999998654322 134578899999999975  44577777766542   5689999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG-----------------------------------------  389 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----------------------------------------  389 (611)
                      +.++.+.+..    ..++...+..++.+++++|..||+.                                         
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988876521    3467778888889999999999841                                         


Q ss_pred             ------------CCCceecCCCCcccEEECC--CCCeEEeeeccce
Q 007248          390 ------------SETRIIHRDIKTSNILLDK--DFTPKIADFGLAR  421 (611)
Q Consensus       390 ------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~  421 (611)
                                  ....++|+|++|.||++++  ++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                        1356799999999999998  5668999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.15  E-value=4.4e-10  Score=101.83  Aligned_cols=131  Identities=21%  Similarity=0.329  Sum_probs=100.6

Q ss_pred             CccccCCceeEEEEEcCCCCEEEEEEeecc---ch-----hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFN---TR-----QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ..|++|+-..+|.+.+. |..+++|.-...   .+     -..+.-.+|++++.+++--.|.--+=+..+.....++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45889999999999774 445777743221   11     1234567899999998765555444455677788999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++|..|.+.+...          ...++..|-.-+.-||   ..+|+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888432          3567888888899999   89999999999999998764 99999999964

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.12  E-value=5.1e-10  Score=100.78  Aligned_cols=143  Identities=22%  Similarity=0.286  Sum_probs=107.2

Q ss_pred             CCCccccCCceeEEEEEcCCCCEEEEEEee-cc-------chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRLI-FN-------TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~-~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ....|-+|+-+.|+++.+ .|+...||.-. ..       ..-..++.++|+++|.++.--.|.--.=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            467889999999999998 67777777432 11       1223456789999999886555544444566777788999


Q ss_pred             eecCC-CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC---eEEeeecccee
Q 007248          347 EYVPN-RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT---PKIADFGLARC  422 (611)
Q Consensus       347 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla~~  422 (611)
                      ||+++ .++.+++...-... .+......++..|-+.+.-||   ...|||+||..+||+|..++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 57888886543332 223333788999999999999   899999999999999976653   58999999853

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.08  E-value=1.2e-09  Score=112.54  Aligned_cols=169  Identities=20%  Similarity=0.299  Sum_probs=129.2

Q ss_pred             ceeEEEE-EcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeee----eCCcceEEEeecCC-CChhhh
Q 007248          284 AGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI----EGPESLLVYEYVPN-RSLDQF  357 (611)
Q Consensus       284 ~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~E~~~~-gsL~~~  357 (611)
                      -.+.||+ ..-||..|++|++..+..........-++.++++.|+|+|++..++.    .+..+++||+|.|+ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3578999 44589999999995444333334456788999999999999999876    34568999999987 567665


Q ss_pred             hhcc------------CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          358 IFDK------------NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       358 l~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      -+..            ......++..+|.++.|+..||.++|   +.|+.-+-|.+.+||++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            5432            12234778899999999999999999   88999999999999999999999999888766544


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRS  473 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p  473 (611)
                      +..               |-+.   --.+-|.-.||.+++.|.||...
T Consensus       446 d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            431               1111   12356888899999999999643

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.94  E-value=1e-08  Score=96.00  Aligned_cols=125  Identities=24%  Similarity=0.252  Sum_probs=83.4

Q ss_pred             eEEEEEcCCCCEEEEEEeeccch--------------------------hhHHHHHHHHHHHhcCCCC--ceeeEeeeee
Q 007248          286 SVYMGSLPNGTTVAVKRLIFNTR--------------------------QWVDEFFNEVNLISSIEHK--NLVKLLGCSI  337 (611)
Q Consensus       286 ~Vy~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  337 (611)
                      .||.|..++|..+|||.......                          .......+|.+.|.++..-  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            38999988999999997642210                          0112356899999999765  567777553 


Q ss_pred             eCCcceEEEeecC--CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHH-HhcCCCCceecCCCCcccEEECCCCCeEE
Q 007248          338 EGPESLLVYEYVP--NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY-LHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (611)
Q Consensus       338 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  414 (611)
                         ..+|||||++  +..+..+.. .    .++......++.+++..+.. +|   ..+|+|+||.+.|||++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~-~----~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKD-V----DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHH-C----GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHh-c----cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEE
Confidence               4689999998  555544331 1    12244556778888885555 57   8999999999999999988 9999


Q ss_pred             eeeccceec
Q 007248          415 ADFGLARCF  423 (611)
Q Consensus       415 ~DfGla~~~  423 (611)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.90  E-value=2.1e-08  Score=99.54  Aligned_cols=140  Identities=16%  Similarity=0.100  Sum_probs=99.9

Q ss_pred             CccccCCceeEEEEEcCCCCEEEEEEeeccch-hhHH----------HHHHHHHHHhcCCCCc--eeeEeeeeee-----
Q 007248          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR-QWVD----------EFFNEVNLISSIEHKN--LVKLLGCSIE-----  338 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~----------~~~~E~~~l~~l~h~n--iv~l~~~~~~-----  338 (611)
                      +.+-.-....|.+..+ +|+.+.||+...... +..+          .+.+|...+.++...+  .+.++++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444445677766 678999997643321 1122          3778999888885433  3455555543     


Q ss_pred             CCcceEEEeecCCC-ChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-------CC
Q 007248          339 GPESLLVYEYVPNR-SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-------DF  410 (611)
Q Consensus       339 ~~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~~  410 (611)
                      ...-+||+|++++. +|.+++.... ....+......++.+++..+.-||   ..+|+|+|++++|||++.       +.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCc
Confidence            22468999999986 8998874321 233455677789999999999999   899999999999999985       46


Q ss_pred             CeEEeeeccce
Q 007248          411 TPKIADFGLAR  421 (611)
Q Consensus       411 ~~kl~DfGla~  421 (611)
                      .+.|+||+.+.
T Consensus       183 ~~~LIDl~r~~  193 (268)
T PRK15123        183 KLSVIDLHRAQ  193 (268)
T ss_pred             eEEEEECCccc
Confidence            79999999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.82  E-value=2.8e-09  Score=118.21  Aligned_cols=248  Identities=19%  Similarity=0.195  Sum_probs=160.7

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ..+.|.+.+-+-+|.++.+..+.-. .|...++|......   ....+....+-.++-..+||-++....-+.-....+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4456677777888999988866322 23334444332211   1111122222223333345666655555556778899


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      +++|+.+++|...||...   .++..-....+..+...+++||   ...++|+|++|.|+|+..++..++.|||+.....
T Consensus       882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccc
Confidence            999999999999986543   3454455566777888999999   6669999999999999999999999998432211


Q ss_pred             C------C---------------C----c-----ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCC
Q 007248          425 A------D---------------R----T-----HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSN  474 (611)
Q Consensus       425 ~------~---------------~----~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~  474 (611)
                      .      .               .    .     .......+|+.|.+||...+.......|.|++|+.++|.++|..|+
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            0      0               0    0     0112456899999999999999999999999999999999999987


Q ss_pred             CCCCCCCChhHHHHHhhccCccccccCCCC-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 007248          475 AFSQDSASPLQRVWTLYRSNKLVEAVDPNL-KDDFPAEQVCNVLQIGLLCTQAAAALRPSMA  535 (611)
Q Consensus       475 ~~~~~~~~~~~~~~~~~~~~~~~~~id~~l-~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~  535 (611)
                      ......    +.+..         ++.... ....+.+......+++..-+..+|.+|-.+.
T Consensus      1036 na~tpq----~~f~n---------i~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQ----QIFEN---------ILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcchh----hhhhc---------cccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            543221    11111         010000 0112333344456667777888999887776

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.73  E-value=7.6e-08  Score=92.64  Aligned_cols=133  Identities=22%  Similarity=0.229  Sum_probs=96.0

Q ss_pred             CCCCccccCCceeEEEEEcCCCCEEEEEEeeccch------------------h----hHHHHHHHHHHHhcCCCC--ce
Q 007248          274 NPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR------------------Q----WVDEFFNEVNLISSIEHK--NL  329 (611)
Q Consensus       274 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~----~~~~~~~E~~~l~~l~h~--ni  329 (611)
                      .+.++||.|.-+.||.|..++|.++|||.-.....                  .    ......+|.++|.+|.-.  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            45688999999999999999999999994321110                  1    122356799999998654  66


Q ss_pred             eeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC
Q 007248          330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD  409 (611)
Q Consensus       330 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  409 (611)
                      .+.+++    +...+||||+++-.|...-        ++....-.++..|++-+.-+-   ..+|||+|+.+-||+++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~d  238 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecC
Confidence            666654    3557999999886664332        123333345555555555554   5789999999999999999


Q ss_pred             CCeEEeeeccce
Q 007248          410 FTPKIADFGLAR  421 (611)
Q Consensus       410 ~~~kl~DfGla~  421 (611)
                      |.+.++||--+.
T Consensus       239 g~~~vIDwPQ~v  250 (304)
T COG0478         239 GDIVVIDWPQAV  250 (304)
T ss_pred             CCEEEEeCcccc
Confidence            999999997654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.65  E-value=1.7e-07  Score=100.76  Aligned_cols=148  Identities=18%  Similarity=0.197  Sum_probs=95.9

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhH------------------------------HH----
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV------------------------------DE----  313 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~~----  313 (611)
                      +....|+ .+-|+.++-|.||+|++++|+.||||+..++-.+..                              ++    
T Consensus       123 e~F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~  201 (517)
T COG0661         123 ELFSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKR  201 (517)
T ss_pred             HHHHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHH
Confidence            3344454 267899999999999999999999998765432211                              11    


Q ss_pred             ------HHHHHHHHhcC----C-CCceeeEee-eeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHH
Q 007248          314 ------FFNEVNLISSI----E-HKNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE  381 (611)
Q Consensus       314 ------~~~E~~~l~~l----~-h~niv~l~~-~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~  381 (611)
                            +.+|..-+.++    + .+++ ++=. |..-....+|+|||++|-.+.+...-+.  ...+-+.   ++..+++
T Consensus       202 l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~  275 (517)
T COG0661         202 LREELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVR  275 (517)
T ss_pred             HHHHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHH
Confidence                  23344444433    1 2332 2222 2233567899999999999988852221  2244333   3333322


Q ss_pred             H-HHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          382 G-LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       382 ~-L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      + +..+-   ..+++|.|..|.||+++.++++.+.|||+...+..
T Consensus       276 ~f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         276 AFLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            2 22222   46899999999999999999999999999876654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.61  E-value=1.8e-08  Score=107.82  Aligned_cols=153  Identities=20%  Similarity=0.318  Sum_probs=102.1

Q ss_pred             HHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc--------ceeecccCCccccChhhhh
Q 007248          376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT--------HVSTAVAGTLGYMAPEYLV  447 (611)
Q Consensus       376 ~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~--------~~~~~~~gt~~y~aPE~~~  447 (611)
                      +.+++.||.|+|.  +.++||++|.|++|.++.++..||+.|+.+........        ....-..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            4456699999996  78999999999999999999999999998754332111        0111122456899999999


Q ss_pred             cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccC
Q 007248          448 RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAA  527 (611)
Q Consensus       448 ~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~  527 (611)
                      ....+.++|+||+|+++|-+..|..+....... .. .....        ...+..-...+..+.+.++.+=+.+.+..+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~-~~~~~--------~~~~~~~~~~~s~~~p~el~~~l~k~l~~~  252 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LL-SYSFS--------RNLLNAGAFGYSNNLPSELRESLKKLLNGD  252 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCC-cc-hhhhh--------hcccccccccccccCcHHHHHHHHHHhcCC
Confidence            988899999999999999999554442211111 11 00000        000000011123344555666677889999


Q ss_pred             CCCCCCHHHHHHH
Q 007248          528 AALRPSMAQAIML  540 (611)
Q Consensus       528 p~~RPt~~evl~~  540 (611)
                      +..||++.++...
T Consensus       253 ~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  253 SAVRPTLDLLLSI  265 (700)
T ss_pred             cccCcchhhhhcc
Confidence            9999988887644

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.60  E-value=3.2e-07  Score=88.07  Aligned_cols=105  Identities=22%  Similarity=0.260  Sum_probs=82.7

Q ss_pred             HHHHHHHHHHhcCCCC--ceeeEeeeeeeCC----cceEEEeecCCC-ChhhhhhccCCCccCChhHHHHHHHHHHHHHH
Q 007248          312 DEFFNEVNLISSIEHK--NLVKLLGCSIEGP----ESLLVYEYVPNR-SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA  384 (611)
Q Consensus       312 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~  384 (611)
                      ....+|...+..+...  .+++.+++.+...    ..++|+|++++. +|.+++.....   ++......++.++++.+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            3577888888877533  3556666665432    348999999984 79998854222   566677889999999999


Q ss_pred             HHhcCCCCceecCCCCcccEEECCCC---CeEEeeecccee
Q 007248          385 YLHGGSETRIIHRDIKTSNILLDKDF---TPKIADFGLARC  422 (611)
Q Consensus       385 ~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~  422 (611)
                      -||   ..+|+|+|+++.|||++.+.   .+.|+||+-++.
T Consensus       133 ~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999   89999999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.58  E-value=7.9e-07  Score=83.79  Aligned_cols=138  Identities=17%  Similarity=0.161  Sum_probs=101.7

Q ss_pred             cccCCceeEEEEEcCCCCEEEEEEeeccc------hhhHHHHHHHHHHHhcCCCCc--eeeEeeeeeeCC----cceEEE
Q 007248          279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNT------RQWVDEFFNEVNLISSIEHKN--LVKLLGCSIEGP----ESLLVY  346 (611)
Q Consensus       279 iG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~  346 (611)
                      -|+||-+.|++-.+ +|..+-+|+-...-      +-....|.+|+..|.+|..-+  +++...+.....    .-+||+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            57789999999877 44578899764211      234578999999999885433  444442221111    247999


Q ss_pred             eecCC-CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC--eEEeeeccce
Q 007248          347 EYVPN-RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT--PKIADFGLAR  421 (611)
Q Consensus       347 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~  421 (611)
                      |-+++ -+|.+++.+. ....++...+..++.+|+..+.-||   ..++.|+|+.+.|||++.++.  ++++||.-++
T Consensus       105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97764 5888887432 2235677778899999999999999   899999999999999986666  9999998664

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.55  E-value=1.2e-06  Score=88.73  Aligned_cols=255  Identities=17%  Similarity=0.195  Sum_probs=149.7

Q ss_pred             CCCccccCCceeEEEE-EcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeee----e--eeCCc-ceEE
Q 007248          275 PSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGC----S--IEGPE-SLLV  345 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~----~--~~~~~-~~lv  345 (611)
                      ...-||+|+-+.+|.. ..   ..-+-|+..........   +.+..|... .||-+-.-+.+    .  -++.. .-+.
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            4567999999999954 22   12234554433222111   222333333 55543321111    0  11222 4466


Q ss_pred             EeecCCCC-hhhhh---hccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          346 YEYVPNRS-LDQFI---FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       346 ~E~~~~gs-L~~~l---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      |..+++.- +..+.   +.+......+|...++.+..++.+.+.||   ..+.+-+|++++|+|+.+++.+.|.|-.--.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccccee
Confidence            77666542 22222   12233456899999999999999999999   7899999999999999999999998744332


Q ss_pred             eccCCCcceeecccCCccccChhhhhc-----CccccccceehhHHHHHHHHhC-CCCCCCCCC---CCChhHHHHHhhc
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVR-----GQLTEKADVYSFGILIIEIVCG-RRSNAFSQD---SASPLQRVWTLYR  492 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvll~elltG-~~p~~~~~~---~~~~~~~~~~~~~  492 (611)
                      ...  .....--.+|...|++||.-.-     -.-+..+|.|.||+++++++.| ++|+..-..   ...+.+.   .+.
T Consensus       166 i~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~Ia  240 (637)
T COG4248         166 INA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DIA  240 (637)
T ss_pred             ecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hhh
Confidence            221  1222234568889999997652     3456789999999999999887 888754321   1222221   111


Q ss_pred             cCccccccC--CCCC---CCCCHH-HHHHHHHHHHHhccc--CCCCCCCHHHHHHHhcc
Q 007248          493 SNKLVEAVD--PNLK---DDFPAE-QVCNVLQIGLLCTQA--AAALRPSMAQAIMLLTN  543 (611)
Q Consensus       493 ~~~~~~~id--~~l~---~~~~~~-~~~~l~~l~~~c~~~--~p~~RPt~~evl~~L~~  543 (611)
                      .+.....-|  +.++   ...|-. .+..+.-+..+|+..  ++.-|||.+-.+..|..
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence            122111111  1111   111211 122344555678764  46789999998877643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.41  E-value=2.9e-06  Score=82.51  Aligned_cols=132  Identities=17%  Similarity=0.142  Sum_probs=84.2

Q ss_pred             CccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc--eeeEeeeeeeCCcceEEEeecCCCC-
Q 007248          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN--LVKLLGCSIEGPESLLVYEYVPNRS-  353 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gs-  353 (611)
                      ..||+|..+.||+.   .|..+++|......  ......+|.++++.+..-+  +.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            56899999999984   24567788765432  2345678999999886443  4667777777777889999999963 


Q ss_pred             hhhhhhccCCCccCChhHHHHHHHHHHHH---------------------------------------HHHHhc-CCCCc
Q 007248          354 LDQFIFDKNKTKLLNWNKRFNIILGTAEG---------------------------------------LAYLHG-GSETR  393 (611)
Q Consensus       354 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~---------------------------------------L~~LH~-~~~~~  393 (611)
                      +...+.       .+......++..+++.                                       ..+|.. .....
T Consensus        82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            211110       0000011111111111                                       122221 12345


Q ss_pred             eecCCCCcccEEECCCCCeEEeeeccce
Q 007248          394 IIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       394 ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      ++|+|+.|.||++++++ +.|+||+.+.
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            78999999999999888 9999999874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.35  E-value=5.5e-06  Score=78.45  Aligned_cols=137  Identities=17%  Similarity=0.166  Sum_probs=88.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHH---------HHHHHHHhcCC---CCceeeEeeeee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEF---------FNEVNLISSIE---HKNLVKLLGCSI  337 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---h~niv~l~~~~~  337 (611)
                      .++|...+++-......|.+-.. +|..+++|..........+.|         .+++..+.+++   -..+..++.+.+
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            45666666666666666666665 678999997765433322222         23333333332   223333333222


Q ss_pred             -----eCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCe
Q 007248          338 -----EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       338 -----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  412 (611)
                           .....+++|||++|-.|.++..       ++.    .++..|.++|.-||   +.|++|+|..|+|+++.++ .+
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GI  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cE
Confidence                 2234578999999988876541       222    25567788899999   8999999999999999865 59


Q ss_pred             EEeeecccee
Q 007248          413 KIADFGLARC  422 (611)
Q Consensus       413 kl~DfGla~~  422 (611)
                      ++.||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.34  E-value=8.1e-06  Score=78.10  Aligned_cols=154  Identities=21%  Similarity=0.235  Sum_probs=101.6

Q ss_pred             cccChHHHHHHhcCCCCCCccc---cCCceeEEEEEcCCCCEEEEEEeeccchhhHH---------H-------------
Q 007248          259 LSFKYETLEKATNYFNPSKKLG---QGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---------E-------------  313 (611)
Q Consensus       259 ~~~~~~~l~~~~~~f~~~~~iG---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~-------------  313 (611)
                      ...+.+.|....++..+....|   .|.-..||+|...++..+|||+.........+         .             
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            3456677777777777766555   56666899998888999999987644321110         1             


Q ss_pred             --HHHHHHHHhcCC--CCceeeEeeeeeeCCcceEEEeecCCCCh-hhhhhccCCCccCChhHHHHHHHHHHHHHHHHhc
Q 007248          314 --FFNEVNLISSIE--HKNLVKLLGCSIEGPESLLVYEYVPNRSL-DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG  388 (611)
Q Consensus       314 --~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~  388 (611)
                        -.+|+.-|.++.  +-.+.+-+++.    .-.|||||+...-+ .-.|    +.-.+.......+..++++.+.-|-.
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~  184 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYK  184 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHH
Confidence              124566666553  33344444443    45799999965411 1111    11122333566777888888888872


Q ss_pred             CCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       389 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                        ..++||+||..-|||+. ++.+.|+|||-+-..
T Consensus       185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             --hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence              48999999999999999 789999999988543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.29  E-value=4e-06  Score=89.93  Aligned_cols=160  Identities=18%  Similarity=0.205  Sum_probs=100.8

Q ss_pred             cccccccChHHHH------------HHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhh------------
Q 007248          255 KKSCLSFKYETLE------------KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQW------------  310 (611)
Q Consensus       255 ~~~~~~~~~~~l~------------~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------  310 (611)
                      ...+++++++++.            .....|+ .+-||.-..|.||+|++++|+.||||+-+..-++.            
T Consensus       134 qD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~  212 (538)
T KOG1235|consen  134 QDQAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLA  212 (538)
T ss_pred             hccCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHH
Confidence            3455666666643            3333443 36799999999999999999999999765432111            


Q ss_pred             -------------------HH------HHHHHHHHHhc----CCCCc------eeeEeeeeeeCCcceEEEeecCCCChh
Q 007248          311 -------------------VD------EFFNEVNLISS----IEHKN------LVKLLGCSIEGPESLLVYEYVPNRSLD  355 (611)
Q Consensus       311 -------------------~~------~~~~E~~~l~~----l~h~n------iv~l~~~~~~~~~~~lv~E~~~~gsL~  355 (611)
                                         .+      .|.+|.+-..+    +.|-+      |.+++-  .-....+|+||||+|..+.
T Consensus       213 ~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~  290 (538)
T KOG1235|consen  213 KVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKIN  290 (538)
T ss_pred             HHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCC
Confidence                               01      13444433332    34555      223322  2344789999999998887


Q ss_pred             hhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC----CCCeEEeeeccceecc
Q 007248          356 QFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK----DFTPKIADFGLARCFA  424 (611)
Q Consensus       356 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DfGla~~~~  424 (611)
                      +.-.-  ....++...+..-+.++..-+-+     ..|++|+|=.|.||+++.    ++++.+-|||+.....
T Consensus       291 Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf-----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  291 DLDAI--DKRGISPHDILNKLVEAYLEQIF-----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             CHHHH--HHcCCCHHHHHHHHHHHHHHHHH-----hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            76421  12224545444444443322222     457999999999999993    6689999999987554

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.27  E-value=6.9e-06  Score=80.19  Aligned_cols=142  Identities=20%  Similarity=0.207  Sum_probs=83.9

Q ss_pred             CccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCC--ceeeEeeeeee---CCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK--NLVKLLGCSIE---GPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~E~~~~  351 (611)
                      +.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+.+++.+...   ....+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            568999999999998877 69999976543  4456777888888887433  35566664432   3346899999999


Q ss_pred             CChhh----------------hh---hcc-CCCccCChhH---------HHHH------------HHHHHH-HHHHHhc-
Q 007248          352 RSLDQ----------------FI---FDK-NKTKLLNWNK---------RFNI------------ILGTAE-GLAYLHG-  388 (611)
Q Consensus       352 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~~LH~-  388 (611)
                      ..+..                .+   |.. .......+..         ....            ...+.+ .+..++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88877                11   111 0111111110         0000            111222 2333332 


Q ss_pred             ---CCCCceecCCCCcccEEEC-CCCCeEEeeeccce
Q 007248          389 ---GSETRIIHRDIKTSNILLD-KDFTPKIADFGLAR  421 (611)
Q Consensus       389 ---~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~  421 (611)
                         .....++|+|+.|.|||++ +++.+-|.||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               2367799999999999999 55666799998874

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.23  E-value=2e-07  Score=98.75  Aligned_cols=194  Identities=16%  Similarity=0.101  Sum_probs=136.8

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc-eeeEeeeeeeCCcc
Q 007248          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN-LVKLLGCSIEGPES  342 (611)
Q Consensus       264 ~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~  342 (611)
                      -.++..+..+..-+-.++|+++++||.+-...+...++.+...     ....-++++|.+++||| .+..++-+..+...
T Consensus       235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~  309 (829)
T KOG0576|consen  235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL  309 (829)
T ss_pred             CcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence            3344445555555678999999999986544444445544332     34456899999999999 66677777777788


Q ss_pred             eEEEeecCCC-ChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          343 LLVYEYVPNR-SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       343 ~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      +++++++..+ +-..-..  .....+..-+...+...-+++|++||   +-.=+|+|    ||+..+ +..|..||+...
T Consensus       310 ~i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~  379 (829)
T KOG0576|consen  310 WIPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPP  379 (829)
T ss_pred             chhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCc
Confidence            9999999877 2211110  01112333444556667788999999   44458888    777766 578999999987


Q ss_pred             eccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCC
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSN  474 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~  474 (611)
                      .+....  ......+++.|+|||+...+.+..+.|+|++|+--.++--|-+|.
T Consensus       380 ~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  380 QLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            665432  234567899999999999999999999999999877887776663

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.21  E-value=1.5e-05  Score=78.81  Aligned_cols=140  Identities=14%  Similarity=0.138  Sum_probs=85.8

Q ss_pred             ccccCCc-eeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCCcceEEEeecCCCChh
Q 007248          278 KLGQGGA-GSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVPNRSLD  355 (611)
Q Consensus       278 ~iG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~  355 (611)
                      .|-.|.. ..||+.... +..+.||+.....   .....+|+++++.+. +--+.+++++...++..++|||+++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3555655 688999774 4788888765432   345668888888873 444667888777767789999999998776


Q ss_pred             hhh-------------------hccCC-CccCC--hhHHHHHHH--------------------HHHHHHHHHh----cC
Q 007248          356 QFI-------------------FDKNK-TKLLN--WNKRFNIIL--------------------GTAEGLAYLH----GG  389 (611)
Q Consensus       356 ~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~~L~~LH----~~  389 (611)
                      ...                   |.... .....  ....+....                    .+...+..|-    ..
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            432                   11100 00110  000010000                    0111122221    11


Q ss_pred             CCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          390 SETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       390 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      ....++|+|+.|.|||++++..+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            24568999999999999998778899999774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.19  E-value=6.7e-06  Score=77.35  Aligned_cols=104  Identities=25%  Similarity=0.225  Sum_probs=83.3

Q ss_pred             HHHHHHHhcCCC-CceeeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCc
Q 007248          315 FNEVNLISSIEH-KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR  393 (611)
Q Consensus       315 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  393 (611)
                      .+|.-+|..+++ +++++++|+|    ..++|.||.+.+++...-..-......+|..|.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            368888898876 6999999999    45889999987766421100011124789999999999999999999766667


Q ss_pred             eecCCCCcccEEECCCCCeEEeeecccee
Q 007248          394 IIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       394 ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      +.-.|++++|+-+++++++|+.|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            88899999999999999999999987754

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.01  E-value=5.4e-05  Score=87.89  Aligned_cols=147  Identities=15%  Similarity=0.240  Sum_probs=91.6

Q ss_pred             CCccccCCceeEEEEEcCCC---CEEEEEEeeccc-hhhHHHHHHHHHHHhcCC-CCce--eeEeeeeeeC---CcceEE
Q 007248          276 SKKLGQGGAGSVYMGSLPNG---TTVAVKRLIFNT-RQWVDEFFNEVNLISSIE-HKNL--VKLLGCSIEG---PESLLV  345 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  345 (611)
                      .+.|+.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  .+++.++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999876554   467778654322 122356889999999995 6665  7788887664   457899


Q ss_pred             EeecCCCChhhh-----------------------hhccCCC--------ccCCh--hHHHHHH---------------H
Q 007248          346 YEYVPNRSLDQF-----------------------IFDKNKT--------KLLNW--NKRFNII---------------L  377 (611)
Q Consensus       346 ~E~~~~gsL~~~-----------------------l~~~~~~--------~~l~~--~~~~~i~---------------~  377 (611)
                      |||+++..+.+-                       ||.-...        .+.++  .++-.|.               -
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            999998654321                       1111000        01111  1111111               1


Q ss_pred             HHHHHHHHHhcCC--------CCceecCCCCcccEEECCC-CC-eEEeeecccee
Q 007248          378 GTAEGLAYLHGGS--------ETRIIHRDIKTSNILLDKD-FT-PKIADFGLARC  422 (611)
Q Consensus       378 ~ia~~L~~LH~~~--------~~~ivH~Dlkp~NIll~~~-~~-~kl~DfGla~~  422 (611)
                      .+.+.+.+|....        ...+||+|+++.|||++.+ .. +-|.||+++..
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence            2334456674321        2459999999999999853 33 57899998754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.96  E-value=0.00011  Score=69.37  Aligned_cols=129  Identities=17%  Similarity=0.250  Sum_probs=90.1

Q ss_pred             CCCccccCCceeEEEEEcCCCCEEEEEEeeccc----------------hhhHHHHHHHHHHHhcCC------CCceeeE
Q 007248          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT----------------RQWVDEFFNEVNLISSIE------HKNLVKL  332 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l  332 (611)
                      ....||+|+.-.||.  +++.....||+.....                ....+++.+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            456899999999985  4566678888876554                122345666666555554      7889999


Q ss_pred             eeeeeeCCcceEEEeecCC------CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          333 LGCSIEGPESLLVYEYVPN------RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       333 ~~~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                      +|+.+.+...-+|+|.+.+      -+|.+++.    ...++. ...+.+.+.   ..||-   ...|+.+||+|.||++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEEE
Confidence            9999999999999998754      35777773    223554 444444444   44555   5679999999999999


Q ss_pred             CCCC----CeEEee
Q 007248          407 DKDF----TPKIAD  416 (611)
Q Consensus       407 ~~~~----~~kl~D  416 (611)
                      ....    .+.|+|
T Consensus       152 ~~~~~~~~~lvlID  165 (199)
T PF10707_consen  152 QRRDSGEFRLVLID  165 (199)
T ss_pred             EecCCCceEEEEEe
Confidence            6432    477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.87  E-value=0.00028  Score=71.76  Aligned_cols=78  Identities=9%  Similarity=-0.015  Sum_probs=56.7

Q ss_pred             CCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCC---CceeeEeeeeee---CCcceEEEe
Q 007248          274 NPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH---KNLVKLLGCSIE---GPESLLVYE  347 (611)
Q Consensus       274 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~E  347 (611)
                      ...+.||.|..+.||+....++ .+++|..+...  ....|..|.+.|+.|..   ..++++++++..   .+..++|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3456799999999999977666 46667543211  22478899999988843   367888887754   356899999


Q ss_pred             ecCCCCh
Q 007248          348 YVPNRSL  354 (611)
Q Consensus       348 ~~~~gsL  354 (611)
                      ++++.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.80  E-value=0.00018  Score=70.65  Aligned_cols=73  Identities=15%  Similarity=0.282  Sum_probs=45.3

Q ss_pred             CccccCCce-eEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCC---ceeeEeeeeeeC---CcceEEEeec
Q 007248          277 KKLGQGGAG-SVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK---NLVKLLGCSIEG---PESLLVYEYV  349 (611)
Q Consensus       277 ~~iG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~E~~  349 (611)
                      +.|+.|+.. .||+.    +..+++|.....  .....+.+|.+++..+...   -+.++++.....   ...+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457777776 48875    235777754332  2235788899999877532   234444433322   2348899999


Q ss_pred             CCCChh
Q 007248          350 PNRSLD  355 (611)
Q Consensus       350 ~~gsL~  355 (611)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            997774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.78  E-value=0.00014  Score=72.32  Aligned_cols=137  Identities=12%  Similarity=0.088  Sum_probs=78.6

Q ss_pred             cccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCce-eeEeeeeeeCCcceEEEeecCCCChhhh
Q 007248          279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEYVPNRSLDQF  357 (611)
Q Consensus       279 iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~~~  357 (611)
                      +..|-...+|+... ++..+++|..........-...+|.++++.+...++ .++++...    .++||||++|..+..-
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            55677889998874 567888886543322211135678888888854333 34444432    3689999998776431


Q ss_pred             -----------------hhccCC-CccCChhHH-HHHHHH---------HHHHHHHHhc-----CCCCceecCCCCcccE
Q 007248          358 -----------------IFDKNK-TKLLNWNKR-FNIILG---------TAEGLAYLHG-----GSETRIIHRDIKTSNI  404 (611)
Q Consensus       358 -----------------l~~~~~-~~~l~~~~~-~~i~~~---------ia~~L~~LH~-----~~~~~ivH~Dlkp~NI  404 (611)
                                       ||.... ...++.... .....+         +.+.+..+-.     .....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             121111 111222111 111111         1111222211     1134689999999999


Q ss_pred             EECCCCCeEEeeeccce
Q 007248          405 LLDKDFTPKIADFGLAR  421 (611)
Q Consensus       405 ll~~~~~~kl~DfGla~  421 (611)
                      ++++++ +.|+||..+.
T Consensus       159 l~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEeCCC-CEEEeccccC
Confidence            999876 7899999874

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.75  E-value=0.00022  Score=66.88  Aligned_cols=125  Identities=26%  Similarity=0.390  Sum_probs=90.5

Q ss_pred             cCCCCCCccccCCc-eeEEEEEcCCCCEEEEEEeec---cch------------------hhHHHHHHHHHHHhcCC---
Q 007248          271 NYFNPSKKLGQGGA-GSVYMGSLPNGTTVAVKRLIF---NTR------------------QWVDEFFNEVNLISSIE---  325 (611)
Q Consensus       271 ~~f~~~~~iG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~---  325 (611)
                      ..++..+.||.|.- |.||++.+ +|+.+|+|.+..   ...                  .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888999999999 99999999 678999998321   100                  11235888998888774   


Q ss_pred             CCce--eeEeeeeeeC------------------CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHH
Q 007248          326 HKNL--VKLLGCSIEG------------------PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY  385 (611)
Q Consensus       326 h~ni--v~l~~~~~~~------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~  385 (611)
                      +.++  |+.+||..-.                  ....||.||++...                ....+-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence            4456  8999986422                  11246777765532                1123346777888899


Q ss_pred             HhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       386 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      +|   +.+|+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HH---HCCeeeccCcccccc-----CCEEEecccC
Confidence            99   999999999999986     3589999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.71  E-value=0.00025  Score=64.37  Aligned_cols=127  Identities=21%  Similarity=0.278  Sum_probs=86.9

Q ss_pred             CCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCcee-eEeeeeeeCCcceEEEeecCCCCh
Q 007248          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV-KLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      .+.|++|.+|.||+|.+. |..+|+|+-..++  ....+..|+++|..++--++. +++.|-    .-++.|||+.|-.|
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L   99 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence            467999999999999994 4588888665443  346788999999998766654 344443    23455999999888


Q ss_pred             hhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCC-cccEEECCCCCeEEeeecccee
Q 007248          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK-TSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~DfGla~~  422 (611)
                      .++-...      +-    +-+..+++.---|.   ..+|-|+.|. |...+|-+++.+.|+||.-|..
T Consensus       100 ~~~~~~~------~r----k~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIGG------DR----KHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcc------cH----HHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            7665211      22    23344444433444   6789999887 4444444555999999998863

>PRK05231 homoserine kinase; Provisional

Probab=97.69  E-value=0.00075  Score=69.47  Aligned_cols=156  Identities=14%  Similarity=0.182  Sum_probs=83.2

Q ss_pred             ChHHHHHHhcCCCC-----CCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc--eeeEee
Q 007248          262 KYETLEKATNYFNP-----SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN--LVKLLG  334 (611)
Q Consensus       262 ~~~~l~~~~~~f~~-----~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~  334 (611)
                      +.+++...-..|..     .+.|+.|....+|+....+| .+++|+......   +....|+.++..|...+  +.+.+.
T Consensus         8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~   83 (319)
T PRK05231          8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVA   83 (319)
T ss_pred             CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCccee
Confidence            34445444445543     34566777789999877555 688897652222   23334455555442211  333332


Q ss_pred             ------eeeeCCcceEEEeecCCCChhh-----------h---hhccCC--------CccCCh-hHHHHHH---------
Q 007248          335 ------CSIEGPESLLVYEYVPNRSLDQ-----------F---IFDKNK--------TKLLNW-NKRFNII---------  376 (611)
Q Consensus       335 ------~~~~~~~~~lv~E~~~~gsL~~-----------~---l~~~~~--------~~~l~~-~~~~~i~---------  376 (611)
                            +...++..++++||++|..+..           .   +|....        ...+.| .....-.         
T Consensus        84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (319)
T PRK05231         84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA  163 (319)
T ss_pred             CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence                  1233556789999999975421           1   111110        011112 2211111         


Q ss_pred             ----HHHHHHHHHHhc----CCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          377 ----LGTAEGLAYLHG----GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       377 ----~~ia~~L~~LH~----~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                          ..+...+..+..    ....+++|+|+.|.|||++++...-|+||+.+.
T Consensus       164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                111112223221    134689999999999999976556899999874

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.65  E-value=0.00035  Score=68.45  Aligned_cols=140  Identities=19%  Similarity=0.237  Sum_probs=80.9

Q ss_pred             CccccCCceeEEEEEcCC--CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc-eeeEeeeeeeCCcceEEEeecCCCC
Q 007248          277 KKLGQGGAGSVYMGSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN-LVKLLGCSIEGPESLLVYEYVPNRS  353 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~~~~gs  353 (611)
                      +.|..|-...+|+....+  +..+++|+....... .-.-.+|+.++..+...+ .+++++...    ..+||||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            457778888999998764  678889966433221 112246888888884333 344554432    248999999977


Q ss_pred             hhhh-----------------hhccCCC--------ccC-ChhHHHHHHH----------------------HHHHHHHH
Q 007248          354 LDQF-----------------IFDKNKT--------KLL-NWNKRFNIIL----------------------GTAEGLAY  385 (611)
Q Consensus       354 L~~~-----------------l~~~~~~--------~~l-~~~~~~~i~~----------------------~ia~~L~~  385 (611)
                      +...                 +|.....        ... -|..+..+..                      .+.+-+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6321                 1111111        011 1222212211                      11111111


Q ss_pred             H----hc-CCCCceecCCCCcccEEECC-CCCeEEeeeccce
Q 007248          386 L----HG-GSETRIIHRDIKTSNILLDK-DFTPKIADFGLAR  421 (611)
Q Consensus       386 L----H~-~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~  421 (611)
                      |    .. .....++|+|+.+.|||+++ ++.+.|+||..+.
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            1    11 12457999999999999998 5789999998774

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.60  E-value=0.0008  Score=68.44  Aligned_cols=142  Identities=15%  Similarity=0.172  Sum_probs=85.3

Q ss_pred             CCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc--eeeEee------eeeeCCcceEEEe
Q 007248          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN--LVKLLG------CSIEGPESLLVYE  347 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~E  347 (611)
                      .+.|..|....+|+....+ ..+++|+....   ..+....|++++..+.+.+  +++++.      +...++..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567778778999987644 47888876532   2345667788777774332  444443      1233456789999


Q ss_pred             ecCCCChhh----hh----------hccC--------CCccCChhHHH----------HHHHHHHHHHHHHhc----CCC
Q 007248          348 YVPNRSLDQ----FI----------FDKN--------KTKLLNWNKRF----------NIILGTAEGLAYLHG----GSE  391 (611)
Q Consensus       348 ~~~~gsL~~----~l----------~~~~--------~~~~l~~~~~~----------~i~~~ia~~L~~LH~----~~~  391 (611)
                      |++|..+..    ..          |...        ......|....          .....+...+.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999977643    01          1100        00112222211          011123344455442    224


Q ss_pred             CceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          392 TRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       392 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      ..++|+|+.|.|||+++++.+.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            579999999999999998777899999874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.60  E-value=0.0008  Score=70.57  Aligned_cols=75  Identities=17%  Similarity=0.181  Sum_probs=54.2

Q ss_pred             CccccCCceeEEEEEcCCC-CEEEEEEeeccc-------hhhHHHHHHHHHHHhcCC---CCceeeEeeeeeeCCcceEE
Q 007248          277 KKLGQGGAGSVYMGSLPNG-TTVAVKRLIFNT-------RQWVDEFFNEVNLISSIE---HKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  345 (611)
                      +.||.|.+..||+....+| +.++||.-....       ....+.+..|.+.|..+.   -.++++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5689999999999988777 489999743111       123456777888888762   2457778777  34557899


Q ss_pred             EeecCCCC
Q 007248          346 YEYVPNRS  353 (611)
Q Consensus       346 ~E~~~~gs  353 (611)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998744

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.53  E-value=0.0012  Score=67.71  Aligned_cols=156  Identities=17%  Similarity=0.211  Sum_probs=88.3

Q ss_pred             hHHHHHHhcCCCC-----CCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc--eeeEeee
Q 007248          263 YETLEKATNYFNP-----SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN--LVKLLGC  335 (611)
Q Consensus       263 ~~~l~~~~~~f~~-----~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~  335 (611)
                      .++|....+.|..     ...++.|....+|+....+| .+++|+......  .+....|++++..|...+  +++++..
T Consensus         9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t   85 (307)
T TIGR00938         9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKS   85 (307)
T ss_pred             HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccC
Confidence            3555555445544     34567777789999876555 577887644211  234455666666663222  3444331


Q ss_pred             ------eeeCCcceEEEeecCCCChhhh--------------hhccCCC---------ccCChhHHHH------------
Q 007248          336 ------SIEGPESLLVYEYVPNRSLDQF--------------IFDKNKT---------KLLNWNKRFN------------  374 (611)
Q Consensus       336 ------~~~~~~~~lv~E~~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~~------------  374 (611)
                            ...++..++++||++|..+...              +|.....         ..-.|.....            
T Consensus        86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~  165 (307)
T TIGR00938        86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH  165 (307)
T ss_pred             CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence                  1234567899999998654211              1211000         0112221111            


Q ss_pred             HHHHHHHHHHHHhc----CCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          375 IILGTAEGLAYLHG----GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       375 i~~~ia~~L~~LH~----~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      ....+.+.++++..    ....+++|+|+.+.||++++++...|.||+.+.
T Consensus       166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            11123344555532    235789999999999999988767899999873

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.34  E-value=0.001  Score=76.03  Aligned_cols=197  Identities=18%  Similarity=0.154  Sum_probs=131.0

Q ss_pred             HHHHHHHHHhcCCCCceeeEeeeeeeCCcc----eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhc
Q 007248          313 EFFNEVNLISSIEHKNLVKLLGCSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG  388 (611)
Q Consensus       313 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~  388 (611)
                      ....|++.+.++.|+|++.++.|-.+....    .+..|++..-++...+.   .-..++......+..++..||.|+| 
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h-  303 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLH-  303 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHH-
Confidence            345677788889999999999987654332    34567888888877773   3345788888889999999999999 


Q ss_pred             CCCCceecCCCCcc---cEEECCCCCeEEe--eeccceeccCCCcceeecccCCccccChhhhhcCcccc--ccceehhH
Q 007248          389 GSETRIIHRDIKTS---NILLDKDFTPKIA--DFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE--KADVYSFG  461 (611)
Q Consensus       389 ~~~~~ivH~Dlkp~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--ksDV~S~G  461 (611)
                        .....|.-|..+   +--.+..+...++  ||+..+.+......  ....-+..|.+||.........  ..|+|.+|
T Consensus       304 --~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  304 --SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             --HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHH
Confidence              444444444444   4444555666666  88887765443322  1223355677888776655444  47999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007248          462 ILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL  541 (611)
Q Consensus       462 vll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L  541 (611)
                      .++..+..|..+......                ....++..    ...    .+.+....|+..++++|+...+++...
T Consensus       380 ll~~~~~~~~~i~~~~~~----------------~~~~l~~~----~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAV----------------PVSLLDVL----STS----ELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             HHHhhhhhcCcccccccc----------------hhhhhccc----cch----hhhhhhhhhcchhhhhccchhhhhhch
Confidence            999999988755221110                01111111    010    345666789999999999999998664

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.33  E-value=0.001  Score=67.88  Aligned_cols=140  Identities=24%  Similarity=0.289  Sum_probs=82.3

Q ss_pred             CccccCCceeEEEEEcCC-------CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCce-eeEeeeeeeCCcceEEEee
Q 007248          277 KKLGQGGAGSVYMGSLPN-------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~  348 (611)
                      +.|..|--..+|+....+       +..+++|+..... .......+|.+++..+...++ .++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            345556667899887655       5789999865432 222345678888887743333 455555532    368999


Q ss_pred             cCCCChhhh-----------------hhccCCCc--------cCChhHHHH--------------------------HHH
Q 007248          349 VPNRSLDQF-----------------IFDKNKTK--------LLNWNKRFN--------------------------IIL  377 (611)
Q Consensus       349 ~~~gsL~~~-----------------l~~~~~~~--------~l~~~~~~~--------------------------i~~  377 (611)
                      ++|..+...                 +|......        ..-|..+-+                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998776431                 11111110        001111111                          111


Q ss_pred             HHHHHHHHHhc------CCCCceecCCCCcccEEECCC----CCeEEeeeccce
Q 007248          378 GTAEGLAYLHG------GSETRIIHRDIKTSNILLDKD----FTPKIADFGLAR  421 (611)
Q Consensus       378 ~ia~~L~~LH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~  421 (611)
                      .+..-+.+|..      .....++|+|+.+.|||++++    +.++|+||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22223334431      245679999999999999985    789999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02236 choline kinase

Probab=97.05  E-value=0.0039  Score=64.77  Aligned_cols=139  Identities=22%  Similarity=0.332  Sum_probs=81.2

Q ss_pred             ccccCCceeEEEEEcCC-----CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCce-eeEeeeeeeCCcceEEEeecCC
Q 007248          278 KLGQGGAGSVYMGSLPN-----GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       278 ~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      .|-.|-.-.+|+....+     +..+++|+.........+ -.+|..++..+..-++ .++++.+..+    .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            45456777889886533     367888876544332222 2578888888854444 3556665433    58999988


Q ss_pred             CChhhh-----------------hhccCC---CccCChhHHHHHHHHH-----------------HHHHHHH----hc-C
Q 007248          352 RSLDQF-----------------IFDKNK---TKLLNWNKRFNIILGT-----------------AEGLAYL----HG-G  389 (611)
Q Consensus       352 gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~~i-----------------a~~L~~L----H~-~  389 (611)
                      .+|...                 +|....   ....-|.++.++..++                 ...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            776421                 122110   1112233333332221                 1111122    21 2


Q ss_pred             CCCceecCCCCcccEEECC-CCCeEEeeeccce
Q 007248          390 SETRIIHRDIKTSNILLDK-DFTPKIADFGLAR  421 (611)
Q Consensus       390 ~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~  421 (611)
                      ....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            2457899999999999986 4689999999875

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.05  E-value=0.0071  Score=61.31  Aligned_cols=128  Identities=17%  Similarity=0.207  Sum_probs=79.3

Q ss_pred             eEEEEEcCCCCEEEEEEee-ccchhhHHHHHHHHHHHhcCCC--CceeeEeeeeeeCC--cceEEEeecCCCChhhhhhc
Q 007248          286 SVYMGSLPNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEH--KNLVKLLGCSIEGP--ESLLVYEYVPNRSLDQFIFD  360 (611)
Q Consensus       286 ~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~E~~~~gsL~~~l~~  360 (611)
                      .+|..... ++.+++++-. ...........+|+++|+.+.-  --+...+++|.++.  ..+.||+|++|..+.+.+..
T Consensus        40 ~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~  118 (321)
T COG3173          40 DTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP  118 (321)
T ss_pred             ceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence            34444333 7788888221 1223344556678888887743  23445677777666  66999999998544433311


Q ss_pred             cCCCccCChhHHHHHH-HHHHHHHHHHhc---------------------------------------------------
Q 007248          361 KNKTKLLNWNKRFNII-LGTAEGLAYLHG---------------------------------------------------  388 (611)
Q Consensus       361 ~~~~~~l~~~~~~~i~-~~ia~~L~~LH~---------------------------------------------------  388 (611)
                      ..    ..    -+++ ..+++.|.-||+                                                   
T Consensus       119 ~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~  190 (321)
T COG3173         119 ES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN  190 (321)
T ss_pred             cc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence            00    00    1112 244444444442                                                   


Q ss_pred             ----CCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          389 ----GSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       389 ----~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                          .....++|+|+.+.||+++++.-+=|.||+++..
T Consensus       191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                2245699999999999999998899999999864

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.02  E-value=0.007  Score=60.90  Aligned_cols=73  Identities=15%  Similarity=0.186  Sum_probs=47.6

Q ss_pred             CCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC---CCCceeeEeeeeeeCCcceEEEeecCCC
Q 007248          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI---EHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~g  352 (611)
                      .+.|+-|....+|+.. .+++.+.||.-.   ......|..|.+-|+.|   .--.+++++++...++..+||+||++.+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            4578889999999988 577899999765   22235677888888877   3456788888887777789999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.01  E-value=0.0081  Score=60.31  Aligned_cols=31  Identities=29%  Similarity=0.545  Sum_probs=25.6

Q ss_pred             CceecCCCCcccEEECCCCC-eEEeeecccee
Q 007248          392 TRIIHRDIKTSNILLDKDFT-PKIADFGLARC  422 (611)
Q Consensus       392 ~~ivH~Dlkp~NIll~~~~~-~kl~DfGla~~  422 (611)
                      ..++|+|+++.|||++++++ .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 46999998853

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.93  E-value=0.001  Score=66.10  Aligned_cols=132  Identities=17%  Similarity=0.238  Sum_probs=90.4

Q ss_pred             CCCCCccccCCceeEEEEEcCCCCEEEEEEeeccc------------------hhhH----HHHHHHHHHHhcCCCC--c
Q 007248          273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT------------------RQWV----DEFFNEVNLISSIEHK--N  328 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~----~~~~~E~~~l~~l~h~--n  328 (611)
                      +...++||-|.-+-||.+-.++|++.++|.-....                  ..|.    -...+|...|+.|...  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            56689999999999999999999999999432110                  0111    1235688888877432  2


Q ss_pred             eeeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC
Q 007248          329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK  408 (611)
Q Consensus       329 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~  408 (611)
                      +++.+++    +..++|||++.+-.|...-+      ..+...+..   .+..-+.-|-   ..|+||+|..-=||++++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~---~lm~~Iv~la---~~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYD---DLMGLIVRLA---NHGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHH---HHHHHHHHHH---HcCceecccchheeEEec
Confidence            4445544    35589999998888765431      123333333   3333344455   789999999999999999


Q ss_pred             CCCeEEeeeccc
Q 007248          409 DFTPKIADFGLA  420 (611)
Q Consensus       409 ~~~~kl~DfGla  420 (611)
                      +..++++||--.
T Consensus       238 d~~i~vIDFPQm  249 (465)
T KOG2268|consen  238 DDKIVVIDFPQM  249 (465)
T ss_pred             CCCEEEeechHh
Confidence            999999999654

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.54  E-value=0.00041  Score=80.94  Aligned_cols=159  Identities=11%  Similarity=-0.007  Sum_probs=114.0

Q ss_pred             HHHHHHHHhcCCCCceeeEeeeee--eCCcceEEEeecCCCChhhhhhccC-CCccCChhHHHHHHHHHHHHHHHHhc--
Q 007248          314 FFNEVNLISSIEHKNLVKLLGCSI--EGPESLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHG--  388 (611)
Q Consensus       314 ~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~--  388 (611)
                      ...|...+++..|+++.....-..  +..+.+.+++|+..|.+.+.|.+.. +...++..-+...-.+......-.|.  
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            345666667789999887765443  3446789999999999999885543 23344444433333332444444442  


Q ss_pred             CCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHH
Q 007248          389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIV  468 (611)
Q Consensus       389 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ell  468 (611)
                      ....-.+|++||+-|.+|..+.++|+.++|+.+...+. ........+++.|+.|+....-.++.++|+|..|+.+|++.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            22345789999999999999999999999999843322 22334456788899999998889999999999999999998


Q ss_pred             hCCCC
Q 007248          469 CGRRS  473 (611)
Q Consensus       469 tG~~p  473 (611)
                      -|..+
T Consensus      1435 ~~n~~ 1439 (2724)
T KOG1826|consen 1435 DGNAY 1439 (2724)
T ss_pred             cccHH
Confidence            87655

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.43  E-value=0.014  Score=56.09  Aligned_cols=123  Identities=23%  Similarity=0.194  Sum_probs=60.2

Q ss_pred             CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCce-eeEeeeeeeCCcceEEEeecCCCChhhh-------h--------
Q 007248          295 GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEYVPNRSLDQF-------I--------  358 (611)
Q Consensus       295 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~~~-------l--------  358 (611)
                      .+.|+||+....+ +..-.-..|..+++.+..-++ .++++++.+    ..|+||+++.+|..-       +        
T Consensus         2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence            4578888766553 333445678888888855444 556665533    267799977664321       0        


Q ss_pred             --hcc----CCCccCChhHHHHH----------------------HHHHHHHHHHHhc-----CCCCceecCCCCcccEE
Q 007248          359 --FDK----NKTKLLNWNKRFNI----------------------ILGTAEGLAYLHG-----GSETRIIHRDIKTSNIL  405 (611)
Q Consensus       359 --~~~----~~~~~l~~~~~~~i----------------------~~~ia~~L~~LH~-----~~~~~ivH~Dlkp~NIl  405 (611)
                        |..    .....--|..+..+                      ...+..-+..+..     ....-+.|+||.+.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence              110    01111112222222                      0111111222210     12356899999999999


Q ss_pred             E-CCCCCeEEeeecccee
Q 007248          406 L-DKDFTPKIADFGLARC  422 (611)
Q Consensus       406 l-~~~~~~kl~DfGla~~  422 (611)
                      + +.++.++|+||..+..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8888999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.22  E-value=0.045  Score=56.01  Aligned_cols=31  Identities=23%  Similarity=0.312  Sum_probs=28.2

Q ss_pred             CCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       391 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      ..+++|+|+.+.|||+++++.+.|+||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            5579999999999999999999999998875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.17  E-value=0.023  Score=58.67  Aligned_cols=139  Identities=17%  Similarity=0.237  Sum_probs=77.6

Q ss_pred             ccccCCceeEEEEEcCC----CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCce-eeEeeeeeeCCcceEEEeecCCC
Q 007248          278 KLGQGGAGSVYMGSLPN----GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEYVPNR  352 (611)
Q Consensus       278 ~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~g  352 (611)
                      .|..|-...+|+....+    +..|++|+........ -.-.+|..+++.+..-++ +++++++.. +   +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcCC
Confidence            44446666788876433    2478888765433221 123578888888865555 456666532 2   589999876


Q ss_pred             Chhhh-----------------hhccCC---CccCChhHHHHHHHHH----------------------HHHHHHHh---
Q 007248          353 SLDQF-----------------IFDKNK---TKLLNWNKRFNIILGT----------------------AEGLAYLH---  387 (611)
Q Consensus       353 sL~~~-----------------l~~~~~---~~~l~~~~~~~i~~~i----------------------a~~L~~LH---  387 (611)
                      .|..-                 +|....   ...--|..+.++..++                      .+-+..+.   
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            65321                 122110   0111233332222221                      11111111   


Q ss_pred             c--CCCCceecCCCCcccEEECC-CCCeEEeeeccce
Q 007248          388 G--GSETRIIHRDIKTSNILLDK-DFTPKIADFGLAR  421 (611)
Q Consensus       388 ~--~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~  421 (611)
                      .  ....-++|.|+.+.|||+++ ++.++++||..+.
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            1  12335799999999999975 5689999999874

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.80  E-value=0.11  Score=49.67  Aligned_cols=75  Identities=21%  Similarity=0.303  Sum_probs=52.0

Q ss_pred             CccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC---CCCceeeEeeeeeeCCcceEEEeecCCCC
Q 007248          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI---EHKNLVKLLGCSIEGPESLLVYEYVPNRS  353 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~gs  353 (611)
                      +.+.-|..-..|.... ...++-||+   +..+....|..|+.-|..+   +--++.+++.+-......|+|+||++-+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~---n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKC---NQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEe---cchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            3444444444454433 456788885   3344556788888777666   44567888888888899999999999877


Q ss_pred             hh
Q 007248          354 LD  355 (611)
Q Consensus       354 L~  355 (611)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            75

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.78  E-value=0.15  Score=52.11  Aligned_cols=30  Identities=27%  Similarity=0.325  Sum_probs=26.1

Q ss_pred             CCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       391 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      ..+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            468999999999999988 578999999663

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.77  E-value=0.27  Score=50.63  Aligned_cols=96  Identities=13%  Similarity=0.049  Sum_probs=56.1

Q ss_pred             ccccChHHHHHHhcCCCCC---C-ccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc--eee
Q 007248          258 CLSFKYETLEKATNYFNPS---K-KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN--LVK  331 (611)
Q Consensus       258 ~~~~~~~~l~~~~~~f~~~---~-~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~  331 (611)
                      ...++.+.+..+...+...   + ..=.+.-..||+....+|..+++|..... .....+...|++.+..|....  ++.
T Consensus         8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~   86 (325)
T PRK11768          8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVA   86 (325)
T ss_pred             CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCC
Confidence            4456667777776665332   1 11234456799998888889999976432 223445666777776663211  222


Q ss_pred             Ee---e--eeeeCCcceEEEeecCCCCh
Q 007248          332 LL---G--CSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       332 l~---~--~~~~~~~~~lv~E~~~~gsL  354 (611)
                      ..   |  ....++..+.++++++|...
T Consensus        87 p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         87 PLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             CccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            11   2  22334567889999988654

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.76  E-value=0.16  Score=53.34  Aligned_cols=73  Identities=12%  Similarity=0.176  Sum_probs=49.0

Q ss_pred             CCccccCCceeEEEEEcCCCCEEEEEEeeccc----h---hhHHHHHHHHHHHhcCC---CCceeeEeeeeeeCCcceEE
Q 007248          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT----R---QWVDEFFNEVNLISSIE---HKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  345 (611)
                      .+.||-|....||+...+ +..++||+-....    .   ....+-..|++.|+.+.   ..++++++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            457899999999998764 4568999754111    1   12333344566666553   357888888877  456889


Q ss_pred             EeecCC
Q 007248          346 YEYVPN  351 (611)
Q Consensus       346 ~E~~~~  351 (611)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.68  E-value=0.048  Score=51.59  Aligned_cols=153  Identities=18%  Similarity=0.189  Sum_probs=90.5

Q ss_pred             CCceeEEEEEcCCCCEEEEEEeeccchh-hHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCChhhhhhc
Q 007248          282 GGAGSVYMGSLPNGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD  360 (611)
Q Consensus       282 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~  360 (611)
                      ++..+.-++..+-| +..+|++....-. ...-|.++.++++++.  .|+++..-  ++-..-+|.|+|-.-.       
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------  140 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------
Confidence            34444444443333 3445555433222 3456788999998874  46777622  3334568889882211       


Q ss_pred             cCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecccCCccc
Q 007248          361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY  440 (611)
Q Consensus       361 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y  440 (611)
                           ...    ..++.-=++.|.-.|++ ..+.+|||..|+||+-|..|.+||.|=+..-  ..           +..|
T Consensus       141 -----i~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~-----------~V~~  197 (308)
T PF07387_consen  141 -----INF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--EN-----------QVNM  197 (308)
T ss_pred             -----cch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--hh-----------eeeE
Confidence                 011    12222224678888843 5789999999999999999999999966431  11           1112


Q ss_pred             cChhhhhcCccccccceehhHHHHHHHHhCCC
Q 007248          441 MAPEYLVRGQLTEKADVYSFGILIIEIVCGRR  472 (611)
Q Consensus       441 ~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~  472 (611)
                      .--|   ....++++.+-+|=.-++++..-.+
T Consensus       198 vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  198 VNIE---YESLTQEAEVKVFVKSCLKLVEKQR  226 (308)
T ss_pred             Eeee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence            1111   2345667777788777787776443

The function of this family is unknown.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.67  E-value=0.095  Score=54.07  Aligned_cols=73  Identities=14%  Similarity=0.103  Sum_probs=47.1

Q ss_pred             ccccCCceeEEEEEcCCC-CEEEEEEeecc-------chhhHHHHHHHHHHHhcCC--CC-ceeeEeeeeeeCCcceEEE
Q 007248          278 KLGQGGAGSVYMGSLPNG-TTVAVKRLIFN-------TRQWVDEFFNEVNLISSIE--HK-NLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       278 ~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~  346 (611)
                      .||.|...-||++..++| +.++||.-...       -+-..++..-|.+.|+...  -| .+++++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            479999999999987765 58999964211       1222345556777776652  24 34555543  445667999


Q ss_pred             eecCCC
Q 007248          347 EYVPNR  352 (611)
Q Consensus       347 E~~~~g  352 (611)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.60  E-value=0.07  Score=54.39  Aligned_cols=139  Identities=18%  Similarity=0.198  Sum_probs=91.2

Q ss_pred             CCCccccCCceeEEEEEcCCCCEEEEEEeecc-----chh--------------------hHHH-HHHHHHHHhcCCCCc
Q 007248          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN-----TRQ--------------------WVDE-FFNEVNLISSIEHKN  328 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~~--------------------~~~~-~~~E~~~l~~l~h~n  328 (611)
                      +...|..|.-..||.+.-.+|..+|||+.+-+     +++                    -++. ...|++-|.+++.-.
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            34578889999999999999999999976421     110                    1111 134666666665433


Q ss_pred             eeeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC
Q 007248          329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK  408 (611)
Q Consensus       329 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~  408 (611)
                      |.----...  ...+|||+|+....   |-...-+.-.++...+..+-.+++.-|.-|..  ..++||.||.=-|+|+- 
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh-  299 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH-  299 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE-
Confidence            321111111  13479999985322   22112233457777788888888888888875  67899999999999986 


Q ss_pred             CCCeEEeeeccce
Q 007248          409 DFTPKIADFGLAR  421 (611)
Q Consensus       409 ~~~~kl~DfGla~  421 (611)
                      +|.+.|+|.+-+-
T Consensus       300 dG~lyiIDVSQSV  312 (520)
T KOG2270|consen  300 DGKLYIIDVSQSV  312 (520)
T ss_pred             CCEEEEEEccccc
Confidence            4589999988664

>PRK06148 hypothetical protein; Provisional

Probab=95.60  E-value=0.14  Score=60.90  Aligned_cols=141  Identities=18%  Similarity=0.228  Sum_probs=78.6

Q ss_pred             CccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-------CCCceeeEe-e----eeee-CC--c
Q 007248          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-------EHKNLVKLL-G----CSIE-GP--E  341 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~l~-~----~~~~-~~--~  341 (611)
                      +.|+ |..-.+|+....+|..+++|+.......  .....|.++|..|       .-|.+++-. |    .... ++  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            3454 4567889988888889999988654322  2333444555443       233444322 1    1111 22  3


Q ss_pred             ceEEEeecCCCChhhhh-----------------hc-------cCCCccCChhH-----------------HHHHHHHHH
Q 007248          342 SLLVYEYVPNRSLDQFI-----------------FD-------KNKTKLLNWNK-----------------RFNIILGTA  380 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l-----------------~~-------~~~~~~l~~~~-----------------~~~i~~~ia  380 (611)
                      .+.+++|++|..|.+..                 +.       ......+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            56789999998775511                 10       00112233422                 112222232


Q ss_pred             HHHH-----HHhcCCCCceecCCCCcccEEECCCC--CeE-Eeeeccce
Q 007248          381 EGLA-----YLHGGSETRIIHRDIKTSNILLDKDF--TPK-IADFGLAR  421 (611)
Q Consensus       381 ~~L~-----~LH~~~~~~ivH~Dlkp~NIll~~~~--~~k-l~DfGla~  421 (611)
                      +.+.     .|. ....++||+|+.+.|||++.+.  ++. |+|||-+.
T Consensus       188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            2221     121 2356799999999999999875  555 99999874

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.34  E-value=0.0073  Score=63.67  Aligned_cols=47  Identities=23%  Similarity=0.340  Sum_probs=36.8

Q ss_pred             HHHHHHHHHHhcCCCCceeeEeeeeeeCCc-ceEEEeecCCCChhhhhh
Q 007248          312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPE-SLLVYEYVPNRSLDQFIF  359 (611)
Q Consensus       312 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~E~~~~gsL~~~l~  359 (611)
                      .+++.....++.++|+|+-..+.+...... ..+|+|++ +.||++.+.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~   74 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK   74 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence            356667788999999999999988764443 57889988 678988874

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.24  E-value=0.063  Score=54.64  Aligned_cols=111  Identities=17%  Similarity=0.186  Sum_probs=73.5

Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      ..|++|++. +++|..       ...-.|.+.+.|+++-+..+.-+..  +.+.-|||+.-.||||+ +|++-|+||-++
T Consensus       300 y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         300 YLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             EEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeee
Confidence            446677764 445432       2335789999999999888888874  67899999999999999 999999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCC
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRR  472 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~  472 (611)
                      +.-......      .....--|-.+. |.-+.+=+||-+--.   |+.|+.
T Consensus       369 Rl~~~q~~i------sy~rldhp~lF~-G~dd~QFeIYrlMr~---l~~g~w  410 (488)
T COG5072         369 RLSYSQGII------SYNRLDHPDLFN-GVDDYQFEIYRLMRR---LLKGRW  410 (488)
T ss_pred             ecccCCcee------eccccCchhhhc-CccceeeeHHHHHHH---HhcCcH
Confidence            853322211      111223455554 444566667654333   344544

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.97  E-value=0.65  Score=47.72  Aligned_cols=140  Identities=24%  Similarity=0.300  Sum_probs=81.0

Q ss_pred             ccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc------eeeEee----eeeeCCcceEEEe
Q 007248          278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN------LVKLLG----CSIEGPESLLVYE  347 (611)
Q Consensus       278 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~----~~~~~~~~~lv~E  347 (611)
                      .|.+ .-..+|+....+|.. ++|.....  ....+..-|+..|..|.-.+      +..+=|    ........+.+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 455789888877776 88866544  33455666777777663222      222222    1112236788999


Q ss_pred             ecCCCChhh-hh--------------hc---------cCCCccCChhH-------------HHHHHHHHHHHHHHHhc--
Q 007248          348 YVPNRSLDQ-FI--------------FD---------KNKTKLLNWNK-------------RFNIILGTAEGLAYLHG--  388 (611)
Q Consensus       348 ~~~~gsL~~-~l--------------~~---------~~~~~~l~~~~-------------~~~i~~~ia~~L~~LH~--  388 (611)
                      |++|..+.. ..              |.         ........|..             -.....++...+..+.+  
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999988872 11              11         01112334431             01122334444444442  


Q ss_pred             --CCCCc---eecCCCCcccEEECCCCC-eEEeeeccce
Q 007248          389 --GSETR---IIHRDIKTSNILLDKDFT-PKIADFGLAR  421 (611)
Q Consensus       389 --~~~~~---ivH~Dlkp~NIll~~~~~-~kl~DfGla~  421 (611)
                        .....   +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence              11222   999999999999999875 8999999763

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.66  E-value=0.092  Score=54.25  Aligned_cols=61  Identities=18%  Similarity=0.116  Sum_probs=44.0

Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK  408 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~  408 (611)
                      ..++=+|.++-++..++....    .++..+.+++.-.++||..+--  -.+++|.|+.|.||++.-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence            456667888889988884322    3445566677767777765552  568999999999999953

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	611
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-54
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-52
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-46
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-45
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-37
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-26
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-24
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-24
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-24
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-24
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-24
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-24
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-24
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-24
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-24
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-24
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-24
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-24
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-24
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-23
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-23
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-18
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-18
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-18
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-18
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-18
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-18
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-16
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-16
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-16
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-16
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-16
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-16
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-16
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-15
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-13
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-13
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-13
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-13
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-12
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-12
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-12
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-12
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-12
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-12
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-12
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-12
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-12
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		9e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		9e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-10
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		8e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		9e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		6e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		8e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
3soa_A	444	Full-Length Human Camkii Length = 444		3e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		4e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-05
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		4e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  209 bits (531), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 113/287 (39%), Positives = 176/287 (61%), Gaps = 6/287 (2%)
Query: 261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD-EFFNEVN 319
           F    L+ A++ F+    LG+GG G VY G L +GT VAVKRL     Q  + +F  EV 
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILG 378
           +IS   H+NL++L G  +   E LLVY Y+ N S+   + ++ +++  L+W KR  I LG
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 147
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +A GLAYLH   + +IIHRD+K +NILLD++F   + DFGLA+       HV  AV GT+
Sbjct: 148 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTI 207
Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQ----DSASPLQRVWTLYRSN 494
           G++APEYL  G+ +EK DV+ +G++++E++ G+R+   ++    D    L  V  L +  
Sbjct: 208 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 267
Query: 495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           KL   VD +L+ ++  E+V  ++Q+ LLCTQ++   RP M++ + +L
Sbjct: 268 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  204 bits (518), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 111/287 (38%), Positives = 173/287 (60%), Gaps = 6/287 (2%)
Query: 261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD-EFFNEVN 319
           F    L+ A++ F     LG+GG G VY G L +G  VAVKRL     Q  + +F  EV 
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILG 378
           +IS   H+NL++L G  +   E LLVY Y+ N S+   + ++ +++  L+W KR  I LG
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +A GLAYLH   + +IIHRD+K +NILLD++F   + DFGLA+       HV  AV G +
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXI 199
Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQ----DSASPLQRVWTLYRSN 494
           G++APEYL  G+ +EK DV+ +G++++E++ G+R+   ++    D    L  V  L +  
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           KL   VD +L+ ++  E+V  ++Q+ LLCTQ++   RP M++ + +L
Sbjct: 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  182 bits (461), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 109/281 (38%), Positives = 162/281 (57%), Gaps = 9/281 (3%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
           LE+ATN F+    +G G  G VY G L +G  VA+KR    + Q ++EF  E+  +S   
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLA 384
           H +LV L+G   E  E +L+Y+Y+ N +L + ++  +  T  ++W +R  I +G A GL 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 385 YLHGGSETR-IIHRDIKTSNILLDKDFTPKIADFGLA-RCFAADRTHVSTAVAGTLGYMA 442
           YLH    TR IIHRD+K+ NILLD++F PKI DFG++ +    D+TH+   V GTLGY+ 
Sbjct: 154 YLH----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN--KLVEAV 500
           PEY ++G+LTEK+DVYSFG+++ E++C R +   S          W +   N  +L + V
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           DPNL D    E +       + C   ++  RPSM   +  L
Sbjct: 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  178 bits (452), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 108/281 (38%), Positives = 161/281 (57%), Gaps = 9/281 (3%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
           LE+ATN F+    +G G  G VY G L +G  VA+KR    + Q ++EF  E+  +S   
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLA 384
           H +LV L+G   E  E +L+Y+Y+ N +L + ++  +  T  ++W +R  I +G A GL 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 385 YLHGGSETR-IIHRDIKTSNILLDKDFTPKIADFGLA-RCFAADRTHVSTAVAGTLGYMA 442
           YLH    TR IIHRD+K+ NILLD++F PKI DFG++ +     +TH+   V GTLGY+ 
Sbjct: 154 YLH----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN--KLVEAV 500
           PEY ++G+LTEK+DVYSFG+++ E++C R +   S          W +   N  +L + V
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           DPNL D    E +       + C   ++  RPSM   +  L
Sbjct: 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  162 bits (410), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 97/224 (43%), Positives = 139/224 (62%), Gaps = 20/224 (8%)
Query: 260 SFKYETLEKATNYFNP------SKKLGQGGAGSVYMGSLPNGTTVAVKRLI----FNTRQ 309
           SF +  L+  TN F+         K+G+GG G VY G + N TTVAVK+L       T +
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
              +F  E+ +++  +H+NLV+LLG S +G +  LVY Y+PN SL   +   + T  L+W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC---FAAD 426
           + R  I  G A G+ +LH   E   IHRDIK++NILLD+ FT KI+DFGLAR    FA  
Sbjct: 133 HMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA-- 187
Query: 427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           +T + + + GT  YMAPE L RG++T K+D+YSFG++++EI+ G
Sbjct: 188 QTVMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  161 bits (408), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 97/224 (43%), Positives = 138/224 (61%), Gaps = 20/224 (8%)
Query: 260 SFKYETLEKATNYFNP------SKKLGQGGAGSVYMGSLPNGTTVAVKRLI----FNTRQ 309
           SF +  L+  TN F+         K+G+GG G VY G + N TTVAVK+L       T +
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
              +F  E+ +++  +H+NLV+LLG S +G +  LVY Y+PN SL   +   + T  L+W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC---FAAD 426
           + R  I  G A G+ +LH   E   IHRDIK++NILLD+ FT KI+DFGLAR    FA  
Sbjct: 133 HMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA-- 187
Query: 427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           +T +   + GT  YMAPE L RG++T K+D+YSFG++++EI+ G
Sbjct: 188 QTVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  159 bits (402), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 96/224 (42%), Positives = 137/224 (61%), Gaps = 20/224 (8%)
Query: 260 SFKYETLEKATNYFNP------SKKLGQGGAGSVYMGSLPNGTTVAVKRLI----FNTRQ 309
           SF +  L+  TN F+         K+G+GG G VY G + N TTVAVK+L       T +
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 66
Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
              +F  E+ +++  +H+NLV+LLG S +G +  LVY Y+PN SL   +   + T  L+W
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC---FAAD 426
           + R  I  G A G+ +LH   E   IHRDIK++NILLD+ FT KI+DFGLAR    FA  
Sbjct: 127 HMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA-- 181
Query: 427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           +  +   + GT  YMAPE L RG++T K+D+YSFG++++EI+ G
Sbjct: 182 QXVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  154 bits (388), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 94/222 (42%), Positives = 131/222 (59%), Gaps = 16/222 (7%)
Query: 260 SFKYETLEKATNYFNP------SKKLGQGGAGSVYMGSLPNGTTVAVKRLI----FNTRQ 309
           SF +  L+  TN F+         K G+GG G VY G + N TTVAVK+L       T +
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 63
Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
              +F  E+ + +  +H+NLV+LLG S +G +  LVY Y PN SL   +   + T  L+W
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           + R  I  G A G+ +LH   E   IHRDIK++NILLD+ FT KI+DFGLAR        
Sbjct: 124 HXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 430 VSTA-VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           V  + + GT  Y APE L RG++T K+D+YSFG++++EI+ G
Sbjct: 181 VXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITG 221

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 140/286 (48%), Gaps = 23/286 (8%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLI---FNTRQWVDEFFNEVNLISSIEHKNL 329
            N  +K+G G  G+V+     +G+ VAVK L+   F+  + V+EF  EV ++  + H N+
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHPNI 96
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V  +G   + P   +V EY+   SL + +      + L+  +R ++    A+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
           +   I+HRD+K+ N+L+DK +T K+ DFGL+R   A     S   AGT  +MAPE L   
Sbjct: 157 NPP-IVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 450 QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD-DF 508
              EK+DVYSFG+++ E+                LQ+ W      ++V AV    K  + 
Sbjct: 215 PSNEKSDVYSFGVILWELAT--------------LQQPWGNLNPAQVVAAVGFKCKRLEI 260
Query: 509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV-CEIPTPSQ 553
           P      V  I   C       RPS A  + LL   +   +P P++
Sbjct: 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/287 (31%), Positives = 145/287 (50%), Gaps = 25/287 (8%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLI---FNTRQWVDEFFNEVNLISSIEHKNL 329
            N  +K+G G  G+V+     +G+ VAVK L+   F+  + V+EF  EV ++  + H N+
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHPNI 96
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V  +G   + P   +V EY+   SL + +      + L+  +R ++    A+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST-AVAGTLGYMAPEYLVR 448
           +   I+HR++K+ N+L+DK +T K+ DFGL+R  A+  T +S+ + AGT  +MAPE L  
Sbjct: 157 NPP-IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRD 213
Query: 449 GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD-D 507
               EK+DVYSFG+++ E+                LQ+ W      ++V AV    K  +
Sbjct: 214 EPSNEKSDVYSFGVILWELAT--------------LQQPWGNLNPAQVVAAVGFKCKRLE 259
Query: 508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV-CEIPTPSQ 553
            P      V  I   C       RPS A  + LL   +   +P P++
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G AG V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 78  TQEP-IYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+    + KIADFGLAR                + + APE +  G  T K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 457 VYSFGILIIEIVCGRR 472
           V+SFGIL+ EIV   R
Sbjct: 193 VWSFGILLTEIVTHGR 208

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/196 (36%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 86  TQEP-IYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIH 140
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+    + KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 200
Query: 457 VYSFGILIIEIVCGRR 472
           V+SFGIL+ EIV   R
Sbjct: 201 VWSFGILLTEIVTHGR 216

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/196 (36%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 84  TQEP-IYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIH 138
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+    + KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 457 VYSFGILIIEIVCGRR 472
           V+SFGIL+ EIV   R
Sbjct: 199 VWSFGILLTEIVTHGR 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 124/257 (48%), Gaps = 19/257 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 78  TQEP-IYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+    + KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNV 516
           V+SFGIL+ EIV   R       +   +Q    L R  ++V        D+ P E    +
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQ---NLERGYRMVRP------DNCPEE----L 239
Query: 517 LQIGLLCTQAAAALRPS 533
            Q+  LC +     RP+
Sbjct: 240 YQLMRLCWKERPEDRPT 256

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/196 (36%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 87  TQEP-IYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIH 141
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+    + KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 201
Query: 457 VYSFGILIIEIVCGRR 472
           V+SFGIL+ EIV   R
Sbjct: 202 VWSFGILLTEIVTHGR 217

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 124/257 (48%), Gaps = 19/257 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 21  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 80  TQEP-IYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIH 134
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+    + KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 194
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNV 516
           V+SFGIL+ EIV   R       +   +Q    L R  ++V        D+ P E    +
Sbjct: 195 VWSFGILLTEIVTHGRIPYPGMTNPEVIQ---NLERGYRMVRP------DNCPEE----L 241
Query: 517 LQIGLLCTQAAAALRPS 533
            Q+  LC +     RP+
Sbjct: 242 YQLMRLCWKERPEDRPT 258

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 124/257 (48%), Gaps = 19/257 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 20  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 79  TQEP-IYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIH 133
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+    + KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 193
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNV 516
           V+SFGIL+ EIV   R       +   +Q    L R  ++V        D+ P E    +
Sbjct: 194 VWSFGILLTEIVTHGRIPYPGMTNPEVIQ---NLERGYRMVRP------DNCPEE----L 240
Query: 517 LQIGLLCTQAAAALRPS 533
            Q+  LC +     RP+
Sbjct: 241 YQLMRLCWKERPEDRPT 257

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 124/257 (48%), Gaps = 19/257 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 78  TQEP-IYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+    + KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNV 516
           V+SFGIL+ EIV   R       +   +Q    L R  ++V        D+ P E    +
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQ---NLERGYRMVRP------DNCPEE----L 239
Query: 517 LQIGLLCTQAAAALRPS 533
            Q+  LC +     RP+
Sbjct: 240 YQLMRLCWKERPEDRPT 256

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 124/257 (48%), Gaps = 19/257 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 78  TQEP-IYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+    + KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNV 516
           V+SFGIL+ EIV   R       +   +Q    L R  ++V        D+ P E    +
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQ---NLERGYRMVRP------DNCPEE----L 239
Query: 517 LQIGLLCTQAAAALRPS 533
            Q+  LC +     RP+
Sbjct: 240 YQLMRLCWKERPEDRPT 256

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 124/257 (48%), Gaps = 19/257 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 83  TQEP-IYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIH 137
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+    + KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 197
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNV 516
           V+SFGIL+ EIV   R       +   +Q    L R  ++V        D+ P E    +
Sbjct: 198 VWSFGILLTEIVTHGRIPYPGMTNPEVIQ---NLERGYRMVRP------DNCPEE----L 244
Query: 517 LQIGLLCTQAAAALRPS 533
            Q+  LC +     RP+
Sbjct: 245 YQLMRLCWKERPEDRPT 261

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 124/257 (48%), Gaps = 19/257 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 84  TQEP-IYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIH 138
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+    + KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNV 516
           V+SFGIL+ EIV   R       +   +Q    L R  ++V        D+ P E    +
Sbjct: 199 VWSFGILLTEIVTHGRIPYPGMTNPEVIQ---NLERGYRMVRP------DNCPEE----L 245
Query: 517 LQIGLLCTQAAAALRPS 533
            Q+  LC +     RP+
Sbjct: 246 YQLMRLCWKERPEDRPT 262

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/196 (36%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 88  TQEP-IYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFI---EERNYIH 142
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+    + KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 202
Query: 457 VYSFGILIIEIVCGRR 472
           V+SFGIL+ EIV   R
Sbjct: 203 VWSFGILLTEIVTHGR 218

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 124/257 (48%), Gaps = 19/257 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 14  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 73  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 127
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+    + KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 187
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNV 516
           V+SFGIL+ EIV   R       +   +Q +   YR       V P   D+ P E    +
Sbjct: 188 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------MVRP---DNCPEE----L 234
Query: 517 LQIGLLCTQAAAALRPS 533
            Q+  LC +     RP+
Sbjct: 235 YQLMRLCWKERPEDRPT 251

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 124/257 (48%), Gaps = 19/257 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 15  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 74  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 128
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           R+++ +NIL+    + KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 188
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNV 516
           V+SFGIL+ EIV   R       +   +Q +   YR       V P   D+ P E    +
Sbjct: 189 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------MVRP---DNCPEE----L 235
Query: 517 LQIGLLCTQAAAALRPS 533
            Q+  LC +     RP+
Sbjct: 236 YQLMRLCWKERPEDRPT 252

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/192 (35%), Positives = 97/192 (50%), Gaps = 5/192 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V+MG   N T VAVK L   T   V  F  E NL+ +++H  LV+L    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
                  ++ EY+   SL  F+      K+L   K  +     AEG+AY+        IH
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIAEGMAYIE---RKNYIH 133
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +N+L+ +    KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 457 VYSFGILIIEIV 468
           V+SFGIL+ EIV
Sbjct: 194 VWSFGILLYEIV 205

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 98/192 (51%), Gaps = 5/192 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KKLG G  G V+MG   N T VAVK L   T   V  F  E NL+ +++H  LV+L    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ E++   SL  F+      K+L   K  +     AEG+AY+        IH
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +N+L+ +    KIADFGLAR    +           + + APE +  G  T K++
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSN 192
Query: 457 VYSFGILIIEIV 468
           V+SFGIL+ EIV
Sbjct: 193 VWSFGILLYEIV 204

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 6/216 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V+MG+    T VA+K L   T    + F  E  ++  ++H  LV+L    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMS-PESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            E P   +V EY+   SL  F+ D  + + L      ++    A G+AY+        IH
Sbjct: 74  SEEP-IYIVTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 128
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++++NIL+      KIADFGLAR    +           + + APE  + G+ T K+D
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR 492
           V+SFGIL+ E+V   R      ++   L++V   YR
Sbjct: 189 VWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 224

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 141/297 (47%), Gaps = 36/297 (12%)
Query: 268 KATNYFNPS-----KKLGQGGAGSVYMGSLPNGT-----TVAVKRLI--FNTRQWVDEFF 315
           K T   +PS     K +G G  G VY G L   +      VA+K L   +  +Q VD F 
Sbjct: 36  KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FL 94
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
            E  ++    H N+++L G   +    +++ EY+ N +LD+F+ +K+     +  +   +
Sbjct: 95  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGM 152
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           + G A G+ YL   +    +HRD+   NIL++ +   K++DFGL+R    D     T   
Sbjct: 153 LRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 436 GTLG--YMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYR 492
           G +   + APE +   + T  +DV+SFGI++ E++  G R               W L  
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-------------YWEL-S 255
Query: 493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIP 549
           ++++++A++   +   P +    + Q+ + C Q   A RP  A  + +L +K+   P
Sbjct: 256 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL-DKLIRAP 311

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 101/196 (51%), Gaps = 8/196 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 74  EEP-IXIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+D
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 457 VYSFGILIIEIVCGRR 472
           V+SFGIL+ E+    R
Sbjct: 188 VWSFGILLTELTTKGR 203

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 101/196 (51%), Gaps = 8/196 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 77  EEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 130
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+D
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 457 VYSFGILIIEIVCGRR 472
           V+SFGIL+ E+    R
Sbjct: 191 VWSFGILLTELTTKGR 206

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 101/196 (51%), Gaps = 8/196 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 457 VYSFGILIIEIVCGRR 472
           V+SFGIL+ E+    R
Sbjct: 364 VWSFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 101/196 (51%), Gaps = 8/196 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 457 VYSFGILIIEIVCGRR 472
           V+SFGIL+ E+    R
Sbjct: 364 VWSFGILLTELTTKGR 379

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 98/195 (50%), Gaps = 6/195 (3%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  I H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 458 YSFGILIIEIVCGRR 472
           +SFGIL+ E+    R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 101/196 (51%), Gaps = 8/196 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 333 EEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 457 VYSFGILIIEIVCGRR 472
           V+SFGIL+ E+    R
Sbjct: 447 VWSFGILLTELTTKGR 462

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 6/195 (3%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 458 YSFGILIIEIVCGRR 472
           +SFGIL+ E+    R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 101/196 (51%), Gaps = 8/196 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 250 EEP-IYIVGEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 457 VYSFGILIIEIVCGRR 472
           V+SFGIL+ E+    R
Sbjct: 364 VWSFGILLTELTTKGR 379

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 101/196 (51%), Gaps = 8/196 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 81  EEP-IYIVTEYMNKGSLLDFL--KGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+D
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 457 VYSFGILIIEIVCGRR 472
           V+SFGIL+ E+    R
Sbjct: 195 VWSFGILLTELTTKGR 210

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            KKLG G  G V+M +    T VAVK +   +   V+ F  E N++ +++H  LVKL   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 336 SIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             + P   ++ E++   SL  F+  D+   + L   K  +     AEG+A++    +   
Sbjct: 79  VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNY 132
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK 454
           IHRD++ +NIL+      KIADFGLAR    +           + + APE +  G  T K
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 455 ADVYSFGILIIEIVC-GR 471
           +DV+SFGIL++EIV  GR
Sbjct: 193 SDVWSFGILLMEIVTYGR 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 6/195 (3%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 73  EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+DV
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 458 YSFGILIIEIVCGRR 472
           +SFGIL+ E+    R
Sbjct: 188 WSFGILLTELTTKGR 202

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            KKLG G  G V+M +    T VAVK +   +   V+ F  E N++ +++H  LVKL   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 336 SIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             + P   ++ E++   SL  F+  D+   + L   K  +     AEG+A++    +   
Sbjct: 252 VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNY 305
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK 454
           IHRD++ +NIL+      KIADFGLAR    +           + + APE +  G  T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 455 ADVYSFGILIIEIVC 469
           +DV+SFGIL++EIV 
Sbjct: 366 SDVWSFGILLMEIVT 380

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 137/290 (47%), Gaps = 35/290 (12%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQW-------VDEFFNEVNL 320
           A N     K++G+GG G V+ G L  + + VA+K LI    +          EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           +S++ H N+VKL G     P   +V E+VP   L   + DK     + W+ +  ++L  A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILL-----DKDFTPKIADFGLARCFAADRTHVSTAVA 435
            G+ Y+   +   I+HRD+++ NI L     +     K+ADFGL++       H  + + 
Sbjct: 133 LGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLL 187
Query: 436 GTLGYMAPEYL--VRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
           G   +MAPE +       TEKAD YSF +++  I+ G     F + S   ++ +  + R 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG--EGPFDEYSYGKIKFI-NMIRE 244
Query: 494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
               E + P + +D P  ++ NV++   LC       RP  +  +  L+ 
Sbjct: 245 ----EGLRPTIPEDCPP-RLRNVIE---LCWSGDPKKRPHFSYIVKELSE 286

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 101/196 (51%), Gaps = 8/196 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 81  EEP-IYIVTEYMNKGSLLDFL--KGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+D
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 457 VYSFGILIIEIVCGRR 472
           V+SFGIL+ E+    R
Sbjct: 195 VWSFGILLTELTTKGR 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 6/195 (3%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 458 YSFGILIIEIVCGRR 472
           +SFGIL+ E+    R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 6/195 (3%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 458 YSFGILIIEIVCGRR 472
           +SFGIL+ E+    R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 6/195 (3%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 75  EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+DV
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 458 YSFGILIIEIVCGRR 472
           +SFGIL+ E+    R
Sbjct: 190 WSFGILLTELTTKGR 204

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 6/195 (3%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 458 YSFGILIIEIVCGRR 472
           +SFGIL+ E+    R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D+  +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+DV
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 458 YSFGILIIEIVCGRR 472
           +SFGIL+ E+    R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 16  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 76  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 128
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQ---- 450
           HRD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE ++R Q    
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 187
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + ++DVY+FGI++ E++ G+
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQ 208

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 41  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 101 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 153
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQ---- 450
           HRD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE ++R Q    
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 212
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + ++DVY+FGI++ E++ G+
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQ 233

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+    L  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 458 YSFGILIIEIVCGRR 472
           +SFGIL+ E+    R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 110/200 (55%), Gaps = 12/200 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 18  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P+  +V ++    SL   +   ++TK     K  +I   TA G+ YLH  S   IIH
Sbjct: 78  TK-PQLAIVTQWCEGSSLYHHLH-ASETKF-EMKKLIDIARQTARGMDYLHAKS---IIH 131
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQLTE-- 453
           RD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE ++R Q +   
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSNPY 190
Query: 454 --KADVYSFGILIIEIVCGR 471
             ++DVY+FGI++ E++ G+
Sbjct: 191 SFQSDVYAFGIVLYELMTGQ 210

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 131
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQ---- 450
           HRD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE ++R Q    
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 190
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + ++DVY+FGI++ E++ G+
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 154
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQ---- 450
           HRD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE ++R Q    
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 213
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + ++DVY+FGI++ E++ G+
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQ 234

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 131
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQ---- 450
           HRD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE ++R Q    
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 190
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + ++DVY+FGI++ E++ G+
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQ---- 450
           HRD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE ++R Q    
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 185
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + ++DVY+FGI++ E++ G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 111/201 (55%), Gaps = 14/201 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
              P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 74  T-APQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQ---- 450
           HRD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE ++R Q    
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 185
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + ++DVY+FGI++ E++ G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+    L  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 458 YSFGILIIEIVCGRR 472
           +SFGIL+ E+    R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 136/289 (47%), Gaps = 35/289 (12%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQW-------VDEFFNEVNL 320
           A N     K++G+GG G V+ G L  + + VA+K LI    +          EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           +S++ H N+VKL G     P   +V E+VP   L   + DK     + W+ +  ++L  A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILL-----DKDFTPKIADFGLARCFAADRTHVSTAVA 435
            G+ Y+   +   I+HRD+++ NI L     +     K+ADFG ++       H  + + 
Sbjct: 133 LGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGLL 187
Query: 436 GTLGYMAPEYL--VRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
           G   +MAPE +       TEKAD YSF +++  I+ G     F + S   ++ +  + R 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG--EGPFDEYSYGKIKFI-NMIRE 244
Query: 494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT 542
               E + P + +D P  ++ NV++   LC       RP  +  +  L+
Sbjct: 245 ----EGLRPTIPEDCPP-RLRNVIE---LCWSGDPKKRPHFSYIVKELS 285

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 126/263 (47%), Gaps = 25/263 (9%)
Query: 278 KLGQGGAGSVYMGSLPNGT-TVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           KLG G  G VY+G     + TVAVK L  +T + V+EF  E  ++  I+H NLV+LLG C
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT--AEGLAYLHGGSETR 393
           ++E P   +V EY+P  +L  ++ + N+ ++        + + T  +  + YL    +  
Sbjct: 98  TLE-PPFYIVTEYMPYGNLLDYLRECNREEV---TAVVLLYMATQISSAMEYL---EKKN 150
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
            IHRD+   N L+ ++   K+ADFGL+R    D           + + APE L     + 
Sbjct: 151 FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSI 210
Query: 454 KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQV 513
           K+DV++FG+L+ EI     +   S      L +V+ L      +E          P    
Sbjct: 211 KSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYDLLEKGYRMEQ---------PEGCP 257
Query: 514 CNVLQIGLLCTQAAAALRPSMAQ 536
             V ++   C + + A RPS A+
Sbjct: 258 PKVYELMRACWKWSPADRPSFAE 280

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 136/290 (46%), Gaps = 35/290 (12%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQW-------VDEFFNEVNL 320
           A N     K++G+GG G V+ G L  + + VA+K LI    +          EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           +S++ H N+VKL G     P   +V E+VP   L   + DK     + W+ +  ++L  A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILL-----DKDFTPKIADFGLARCFAADRTHVSTAVA 435
            G+ Y+   +   I+HRD+++ NI L     +     K+ADF L++       H  + + 
Sbjct: 133 LGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGLL 187
Query: 436 GTLGYMAPEYL--VRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
           G   +MAPE +       TEKAD YSF +++  I+ G     F + S   ++ +  + R 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE--GPFDEYSYGKIKFI-NMIRE 244
Query: 494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
               E + P + +D P  ++ NV++   LC       RP  +  +  L+ 
Sbjct: 245 ----EGLRPTIPEDCPP-RLRNVIE---LCWSGDPKKRPHFSYIVKELSE 286

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 154
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQ---- 450
           HRD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE ++R Q    
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 213
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + ++DVY+FGI++ E++ G+
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQ 234

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 34  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 94  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 146
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQ---- 450
           HRD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE ++R Q    
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 205
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + ++DVY+FGI++ E++ G+
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQ 226

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQ---- 450
           HRD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE ++R Q    
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 185
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + ++DVY+FGI++ E++ G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 110/200 (55%), Gaps = 12/200 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P+  +V ++    SL   +   ++TK     K  +I   TA G+ YLH  S   IIH
Sbjct: 90  TK-PQLAIVTQWCEGSSLYHHLH-ASETKF-EMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQLTE-- 453
           RD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE ++R Q +   
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSNPY 202
Query: 454 --KADVYSFGILIIEIVCGR 471
             ++DVY+FGI++ E++ G+
Sbjct: 203 SFQSDVYAFGIVLYELMTGQ 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 109/200 (54%), Gaps = 12/200 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
              P+  +V ++    SL   +   ++TK     K  +I   TA G+ YLH  S   IIH
Sbjct: 90  T-APQLAIVTQWCEGSSLYHHLH-ASETKF-EMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQLTE-- 453
           RD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE ++R Q +   
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSNPY 202
Query: 454 --KADVYSFGILIIEIVCGR 471
             ++DVY+FGI++ E++ G+
Sbjct: 203 SFQSDVYAFGIVLYELMTGQ 222

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 140/306 (45%), Gaps = 31/306 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G L        +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFGLAR    D     T   G +   + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWT 217
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           +PE +   + T  +DV+S+GI++ E++  G R               W +   + +++AV
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMSNQD-VIKAV 263
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSS 560
           D   +   P +    + Q+ L C Q     RP   Q + +L +K+  I  P     + S+
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL-DKL--IRNPGSLKIITSA 320
Query: 561 VMEPGN 566
              P N
Sbjct: 321 AARPSN 326

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 96/195 (49%), Gaps = 6/195 (3%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L        + F  E  ++  + H+ LV+L     
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 251 EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D++ +NIL+ ++   K+ADFGL R    +           + + APE  + G+ T K+DV
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 458 YSFGILIIEIVCGRR 472
           +SFGIL+ E+    R
Sbjct: 366 WSFGILLTELTTKGR 380

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 140/306 (45%), Gaps = 31/306 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G L        +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +   + 
Sbjct: 161 KYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           +PE +   + T  +DV+S+GI++ E++  G R               W +   + +++AV
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMSNQD-VIKAV 263
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSS 560
           D   +   P +    + Q+ L C Q     RP   Q + +L +K+  I  P     + S+
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL-DKL--IRNPGSLKIITSA 320
Query: 561 VMEPGN 566
              P N
Sbjct: 321 AARPSN 326

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 140/306 (45%), Gaps = 31/306 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G L        +VA+K L +  T +   +F  E +++  
Sbjct: 15  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 131
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +   + 
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           +PE +   + T  +DV+S+GI++ E++  G R               W +   + +++AV
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMSNQD-VIKAV 234
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSS 560
           D   +   P +    + Q+ L C Q     RP   Q + +L +K+  I  P     + S+
Sbjct: 235 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL-DKL--IRNPGSLKIITSA 291
Query: 561 VMEPGN 566
              P N
Sbjct: 292 AARPSN 297

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 140/306 (45%), Gaps = 31/306 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G L        +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +   + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           +PE +   + T  +DV+S+GI++ E++  G R               W +   + +++AV
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMSNQD-VIKAV 263
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSS 560
           D   +   P +    + Q+ L C Q     RP   Q + +L +K+  I  P     + S+
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL-DKL--IRNPGSLKIITSA 320
Query: 561 VMEPGN 566
              P N
Sbjct: 321 AARPSN 326

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 140/306 (45%), Gaps = 31/306 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G L        +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +   + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           +PE +   + T  +DV+S+GI++ E++  G R               W +   + +++AV
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMSNQD-VIKAV 263
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSS 560
           D   +   P +    + Q+ L C Q     RP   Q + +L +K+  I  P     + S+
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL-DKL--IRNPGSLKIITSA 320
Query: 561 VMEPGN 566
              P N
Sbjct: 321 AARPSN 326

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 140/306 (45%), Gaps = 31/306 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G L        +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +   + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           +PE +   + T  +DV+S+GI++ E++  G R               W +   + +++AV
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMSNQD-VIKAV 263
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSS 560
           D   +   P +    + Q+ L C Q     RP   Q + +L +K+  I  P     + S+
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL-DKL--IRNPGSLKIITSA 320
Query: 561 VMEPGN 566
              P N
Sbjct: 321 AARPSN 326

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 140/306 (45%), Gaps = 31/306 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G L        +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +   + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           +PE +   + T  +DV+S+GI++ E++  G R               W +   + +++AV
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMSNQD-VIKAV 263
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSS 560
           D   +   P +    + Q+ L C Q     RP   Q + +L +K+  I  P     + S+
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL-DKL--IRNPGSLKIITSA 320
Query: 561 VMEPGN 566
              P N
Sbjct: 321 AARPSN 326

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 140/306 (45%), Gaps = 31/306 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G L        +VA+K L +  T +   +F  E +++  
Sbjct: 32  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 90
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 91  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 148
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +   + 
Sbjct: 149 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 205
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           +PE +   + T  +DV+S+GI++ E++  G R               W +   + +++AV
Sbjct: 206 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMSNQD-VIKAV 251
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSS 560
           D   +   P +    + Q+ L C Q     RP   Q + +L +K+  I  P     + S+
Sbjct: 252 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL-DKL--IRNPGSLKIITSA 308
Query: 561 VMEPGN 566
              P N
Sbjct: 309 AARPSN 314

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 140/306 (45%), Gaps = 31/306 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G L        +VA+K L +  T +   +F  E +++  
Sbjct: 42  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 100
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 101 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 158
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +   + 
Sbjct: 159 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 215
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           +PE +   + T  +DV+S+GI++ E++  G R               W +   + +++AV
Sbjct: 216 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMSNQD-VIKAV 261
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSS 560
           D   +   P +    + Q+ L C Q     RP   Q + +L +K+  I  P     + S+
Sbjct: 262 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL-DKL--IRNPGSLKIITSA 318
Query: 561 VMEPGN 566
              P N
Sbjct: 319 AARPSN 324

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 131/288 (45%), Gaps = 33/288 (11%)
Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLI--FNTRQWVDEFFNEV 318
           T E   +  +  K +G G +G V  G L         VA+K L   +  RQ  D F +E 
Sbjct: 43  TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEA 101
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
           +++   +H N+++L G    G  +++V EY+ N SLD F+  +         +   ++ G
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRG 159
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
              G+ YL   S+   +HRD+   N+L+D +   K++DFGL+R    D     T   G +
Sbjct: 160 VGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI 216
Query: 439 G--YMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNK 495
              + APE +     +  +DV+SFG+++ E++  G R               W +  +  
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP-------------YWNMT-NRD 262
Query: 496 LVEAVDPNLKDDFPAEQVC--NVLQIGLLCTQAAAALRPSMAQAIMLL 541
           ++ +V+   +   PA   C   + Q+ L C     A RP  +Q + +L
Sbjct: 263 VISSVEEGYR--LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 31/306 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G L        +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFGL R    D     T   G +   + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           +PE +   + T  +DV+S+GI++ E++  G R               W +   + +++AV
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMSNQD-VIKAV 263
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSS 560
           D   +   P +    + Q+ L C Q     RP   Q + +L +K+  I  P     + S+
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL-DKL--IRNPGSLKIITSA 320
Query: 561 VMEPGN 566
              P N
Sbjct: 321 AARPSN 326

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 133/288 (46%), Gaps = 25/288 (8%)
Query: 252 TSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQW 310
           TSM  S  S  Y+  E          KLG G  G VY G       TVAVK L  +T + 
Sbjct: 1   TSMDPS--SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME- 57
Query: 311 VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWN 370
           V+EF  E  ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV---N 114
Query: 371 KRFNIILGT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
               + + T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D  
Sbjct: 115 AVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 171
Query: 429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVW 488
                    + + APE L   + + K+DV++FG+L+ EI     +   S      L +V+
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVY 227
Query: 489 TLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
            L   +  +E      + +   E+V  +++    C Q   + RPS A+
Sbjct: 228 ELLEKDYRME------RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 266

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 133/288 (46%), Gaps = 25/288 (8%)
Query: 252 TSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQW 310
           TSM  S  S  Y+  E          KLG G  G VY G       TVAVK L  +T + 
Sbjct: 1   TSMDPS--SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME- 57
Query: 311 VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWN 370
           V+EF  E  ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---N 114
Query: 371 KRFNIILGT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
               + + T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D  
Sbjct: 115 AVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 171
Query: 429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVW 488
                    + + APE L   + + K+DV++FG+L+ EI     +   S      L +V+
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVY 227
Query: 489 TLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
            L   +  +E      + +   E+V  +++    C Q   + RPS A+
Sbjct: 228 ELLEKDYRME------RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 266

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 131/288 (45%), Gaps = 33/288 (11%)
Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLI--FNTRQWVDEFFNEV 318
           T E   +  +  K +G G +G V  G L         VA+K L   +  RQ  D F +E 
Sbjct: 43  TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEA 101
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
           +++   +H N+++L G    G  +++V EY+ N SLD F+  +         +   ++ G
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRG 159
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
              G+ YL   S+   +HRD+   N+L+D +   K++DFGL+R    D     T   G +
Sbjct: 160 VGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 439 G--YMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNK 495
              + APE +     +  +DV+SFG+++ E++  G R               W +  +  
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP-------------YWNMT-NRD 262
Query: 496 LVEAVDPNLKDDFPAEQVC--NVLQIGLLCTQAAAALRPSMAQAIMLL 541
           ++ +V+   +   PA   C   + Q+ L C     A RP  +Q + +L
Sbjct: 263 VISSVEEGYR--LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 118/263 (44%), Gaps = 21/263 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           K+LG G  G V +G       VAVK +I       DEFF E   +  + H  LVK  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           S E P   +V EY+ N  L  ++  ++  K L  ++   +     EG+A+L      + I
Sbjct: 73  SKEYP-IYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HRD+   N L+D+D   K++DFG+ R    D+   S      + + APE     + + K+
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 456 DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCN 515
           DV++FGIL+ E+        FS          + LY ++++V  V    +   P      
Sbjct: 187 DVWAFGILMWEV--------FSLGKMP-----YDLYTNSEVVLKVSQGHRLYRPHLASDT 233
Query: 516 VLQIGLLCTQAAAALRPSMAQAI 538
           + QI   C       RP+  Q +
Sbjct: 234 IYQIMYSCWHELPEKRPTFQQLL 256

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 161
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 448 RGQLTEKADVYSFGILIIEI 467
             + +  +DV+SFG+++ E+
Sbjct: 222 ESKFSVASDVWSFGVVLYEL 241

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 101/195 (51%), Gaps = 18/195 (9%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            KKLG G  G V+M +    T VAVK +   +   V+ F  E N++ +++H  LVKL   
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 336 SIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             + P   ++ E++   SL  F+  D+   + L   K  +     AEG+A++    +   
Sbjct: 246 VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNY 299
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK 454
           IHRD++ +NIL+      KIADFGLAR  A             + + APE +  G  T K
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARVGA----------KFPIKWTAPEAINFGSFTIK 349
Query: 455 ADVYSFGILIIEIVC 469
           +DV+SFGIL++EIV 
Sbjct: 350 SDVWSFGILLMEIVT 364

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 135
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 448 RGQLTEKADVYSFGILIIEI 467
             + +  +DV+SFG+++ E+
Sbjct: 196 ESKFSVASDVWSFGVVLYEL 215

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 20/216 (9%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 148
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 448 RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASP 483
             + +  +DV+SFG+++ E+        + + S SP
Sbjct: 209 ESKFSVASDVWSFGVVLYELF------TYIEKSKSP 238

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 136
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 448 RGQLTEKADVYSFGILIIEI 467
             + +  +DV+SFG+++ E+
Sbjct: 197 ESKFSVASDVWSFGVVLYEL 216

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 130/281 (46%), Gaps = 23/281 (8%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
           +S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E
Sbjct: 3   MSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 61
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + +
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYM 118
Query: 378 GT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D         
Sbjct: 119 ATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAK 175
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK 495
             + + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   + 
Sbjct: 176 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDY 231
Query: 496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
            +E      + +   E+V  +++    C Q   + RPS A+
Sbjct: 232 RME------RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 263

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 128
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 448 RGQLTEKADVYSFGILIIEI 467
             + +  +DV+SFG+++ E+
Sbjct: 189 ESKFSVASDVWSFGVVLYEL 208

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 130/281 (46%), Gaps = 23/281 (8%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
           +S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E
Sbjct: 3   MSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 61
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + +
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYM 118
Query: 378 GT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D         
Sbjct: 119 ATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 175
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK 495
             + + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   + 
Sbjct: 176 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDY 231
Query: 496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
            +E      + +   E+V  +++    C Q   + RPS A+
Sbjct: 232 RME------RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 263

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 20/216 (9%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 130
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 448 RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASP 483
             + +  +DV+SFG+++ E+        + + S SP
Sbjct: 191 ESKFSVASDVWSFGVVLYELF------TYIEKSKSP 220

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 128/277 (46%), Gaps = 23/277 (8%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLI 321
           Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E  ++
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 68
Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-- 379
             I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + + T  
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYMATQI 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D           + 
Sbjct: 126 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 182
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   +  +E 
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDYRME- 237
Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
                + +   E+V  +++    C Q   + RPS A+
Sbjct: 238 -----RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 266

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 10/212 (4%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
           +S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E
Sbjct: 2   MSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 60
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + +
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYM 117
Query: 378 GT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D         
Sbjct: 118 ATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAK 174
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
             + + APE L   + + K+DV++FG+L+ EI
Sbjct: 175 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 134
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 448 RGQLTEKADVYSFGILIIEI 467
             + +  +DV+SFG+++ E+
Sbjct: 195 ESKFSVASDVWSFGVVLYEL 214

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 133
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 448 RGQLTEKADVYSFGILIIEI 467
             + +  +DV+SFG+++ E+
Sbjct: 194 ESKFSVASDVWSFGVVLYEL 213

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 129
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 448 RGQLTEKADVYSFGILIIEI 467
             + +  +DV+SFG+++ E+
Sbjct: 190 ESKFSVASDVWSFGVVLYEL 209

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 130
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 448 RGQLTEKADVYSFGILIIEI 467
             + +  +DV+SFG+++ E+
Sbjct: 191 ESKFSVASDVWSFGVVLYEL 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 137
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 448 RGQLTEKADVYSFGILIIEI 467
             + +  +DV+SFG+++ E+
Sbjct: 198 ESKFSVASDVWSFGVVLYEL 217

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 128/277 (46%), Gaps = 23/277 (8%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLI 321
           Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E  ++
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 64
Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-- 379
             I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + + T  
Sbjct: 65  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV---NAVVLLYMATQI 121
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D           + 
Sbjct: 122 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 178
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   +  +E 
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDYRME- 233
Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
                + +   E+V  +++    C Q   + RPS A+
Sbjct: 234 -----RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 262

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 130
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 448 RGQLTEKADVYSFGILIIEI 467
             + +  +DV+SFG+++ E+
Sbjct: 191 ESKFSVASDVWSFGVVLYEL 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 20/216 (9%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 148
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 448 RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASP 483
             + +  +DV+SFG+++ E+        + + S SP
Sbjct: 209 ESKFSVASDVWSFGVVLYELF------TYIEKSKSP 238

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 106/200 (53%), Gaps = 14/200 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ E++P  SL +++  K+K ++ +  K         +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 133
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 448 RGQLTEKADVYSFGILIIEI 467
             + +  +DV+SFG+++ E+
Sbjct: 194 ESKFSVASDVWSFGVVLYEL 213

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 131/281 (46%), Gaps = 23/281 (8%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGT-TVAVKRLIFNTRQWVDEFFNE 317
           +S  Y+  E          KLG G  G VY G     + TVAVK L  +T + V+EF  E
Sbjct: 1   VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 59
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + +
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYM 116
Query: 378 GT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D         
Sbjct: 117 ATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK 495
             + + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   + 
Sbjct: 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDY 229
Query: 496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
            +E      + +   E+V  +++    C Q   + RPS A+
Sbjct: 230 RME------RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 261

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 119/261 (45%), Gaps = 34/261 (13%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIEHK 327
           F+  +++G G  G+VY    + N   VA+K++ ++ +Q    W D    EV  +  + H 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 114
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           N ++  GC +    + LV EY    + D     K   K L   +   +  G  +GLAYLH
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH 171
Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV 447
             +   +IHRD+K  NILL +    K+ DFG A   A      +    GT  +MAPE ++
Sbjct: 172 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVIL 223
Query: 448 ---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV------------WTLYR 492
               GQ   K DV+S GI  IE+   R+   F+ ++ S L  +            W+ Y 
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIEL-AERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 282
Query: 493 SNKLVEAVDPNLKDDFPAEQV 513
            N  V++    +  D P  +V
Sbjct: 283 RN-FVDSCLQKIPQDRPTSEV 302

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 10/212 (4%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
           +S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E
Sbjct: 1   VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 59
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + +
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYM 116
Query: 378 GT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D         
Sbjct: 117 ATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
             + + APE L   + + K+DV++FG+L+ EI
Sbjct: 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 129/277 (46%), Gaps = 23/277 (8%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGT-TVAVKRLIFNTRQWVDEFFNEVNLI 321
           Y+  E          KLG G  G VY G     + TVAVK L  +T + V+EF  E  ++
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 67
Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-- 379
             I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + + T  
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYMATQI 124
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D           + 
Sbjct: 125 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   +  +E 
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDYRME- 236
Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
                + +   E+V  +++    C Q   + RPS A+
Sbjct: 237 -----RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 265

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 107/223 (47%), Gaps = 21/223 (9%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIEHK 327
           F+  +++G G  G+VY    + N   VA+K++ ++ +Q    W D    EV  +  + H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 75
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           N ++  GC +    + LV EY    + D     K   K L   +   +  G  +GLAYLH
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH 132
Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV 447
             +   +IHRD+K  NILL +    K+ DFG A   A      +    GT  +MAPE ++
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVIL 184
Query: 448 ---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
               GQ   K DV+S GI  IE+   R+   F+ ++ S L  +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL-AERKPPLFNMNAMSALYHI 226

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 128/277 (46%), Gaps = 23/277 (8%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLI 321
           Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E  ++
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 65
Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-- 379
             I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + + T  
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYMATQI 122
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D           + 
Sbjct: 123 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   +  +E 
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDYRME- 234
Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
                + +   E+V  +++    C Q   + RPS A+
Sbjct: 235 -----RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 263

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 111/216 (51%), Gaps = 20/216 (9%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K + ++  K         +G+ YL   
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKER-IDHIKLLQYTSQICKGMEYL--- 131
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHR++ T NIL++ +   KI DFGL +    D+ +      G   + + APE L 
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 448 RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASP 483
             + +  +DV+SFG+++ E+        + + S SP
Sbjct: 192 ESKFSVASDVWSFGVVLYELF------TYIEKSKSP 221

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 131/286 (45%), Gaps = 35/286 (12%)
Query: 276 SKKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
            ++LG+G  G V++    N         VAVK L   +     +F  E  L+++++H+++
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI----------FDKNKTKLLNWNKRFNIILGT 379
           VK  G  +EG   ++V+EY+ +  L++F+           + N    L  ++  +I    
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTL 438
           A G+ YL   +    +HRD+ T N L+ ++   KI DFG++R  ++ D   V       +
Sbjct: 138 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLV 497
            +M PE ++  + T ++DV+S G+++ EI   G++               W    +N+++
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--------------WYQLSNNEVI 240
Query: 498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           E +        P      V ++ L C Q    +R ++     LL N
Sbjct: 241 ECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 128/277 (46%), Gaps = 23/277 (8%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLI 321
           Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E  ++
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 68
Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-- 379
             I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + + T  
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYMATQI 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D           + 
Sbjct: 126 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   +  +E 
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDYRME- 237
Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
                + +   E+V  +++    C Q   + RPS A+
Sbjct: 238 -----RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 266

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  +   + ++  K         +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYL--- 133
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G   + + APE L 
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 448 RGQLTEKADVYSFGILIIEI 467
             + +  +DV+SFG+++ E+
Sbjct: 194 ESKFSVASDVWSFGVVLYEL 213

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 129/277 (46%), Gaps = 23/277 (8%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGT-TVAVKRLIFNTRQWVDEFFNEVNLI 321
           Y+  E          KLG G  G VY G     + TVAVK L  +T + V+EF  E  ++
Sbjct: 18  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 76
Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-- 379
             I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + + T  
Sbjct: 77  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYMATQI 133
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D           + 
Sbjct: 134 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   +  +E 
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDYRME- 245
Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
                + +   E+V  +++    C Q   + RPS A+
Sbjct: 246 -----RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 274

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 278 KLGQGGAGSVYMG--SLPNGTTVAVKRLIFNTRQ---WVDEFFNEVNLISSIEHKNLVKL 332
           KLG GG  +VY+   ++ N   VA+K +    R+    +  F  EV+  S + H+N+V +
Sbjct: 18  KLGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           +    E     LV EY+   +L ++I        L+ +   N      +G+ + H   + 
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DM 130
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
           RI+HRDIK  NIL+D + T KI DFG+A+  +      +  V GT+ Y +PE   +G+ T
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ-AKGEAT 189
Query: 453 EK-ADVYSFGILIIEIVCGR 471
           ++  D+YS GI++ E++ G 
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 126/275 (45%), Gaps = 27/275 (9%)
Query: 279 LGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           +G G  G V  G L         VA+K L +  T +   +F  E +++   +H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G    G   ++V E++ N +LD F+  +         +   ++ G A G+ YL   ++  
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFL--RKHDGQFTVIQLVGMLRGIAAGMRYL---ADMG 165
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YMAPEYLVRGQL 451
            +HRD+   NIL++ +   K++DFGL+R    D   V T   G +   + APE +   + 
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKF 225
Query: 452 TEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPA 510
           T  +DV+S+GI++ E++  G R               W +  +  +++A++   +   P 
Sbjct: 226 TSASDVWSYGIVMWEVMSYGERP-------------YWDM-SNQDVIKAIEEGYRLPAPM 271
Query: 511 EQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV 545
           +    + Q+ L C Q   A RP   Q + +L   +
Sbjct: 272 DCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMI 306

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVI 138
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HRDIK+ NILL  D + K+ DFG       +++  ST V GT  +MAPE + R     K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 456 DVYSFGILIIEIVCGR 471
           D++S GI+ IE++ G 
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 139/306 (45%), Gaps = 31/306 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G L        +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V E + N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +   + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           +PE +   + T  +DV+S+GI++ E++  G R               W +   + +++AV
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMSNQD-VIKAV 263
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSS 560
           D   +   P +    + Q+ L C Q     RP   Q + +L +K+  I  P     + S+
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL-DKL--IRNPGSLKIITSA 320
Query: 561 VMEPGN 566
              P N
Sbjct: 321 AARPSN 326

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 139/306 (45%), Gaps = 31/306 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G L        +VA+K L +  T +   +F  E +++  
Sbjct: 15  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V E + N SLD F+  +         +   ++ G A G+
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 131
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +   + 
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           +PE +   + T  +DV+S+GI++ E++  G R               W +   + +++AV
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMSNQD-VIKAV 234
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSS 560
           D   +   P +    + Q+ L C Q     RP   Q + +L +K+  I  P     + S+
Sbjct: 235 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL-DKL--IRNPGSLKIITSA 291
Query: 561 VMEPGN 566
              P N
Sbjct: 292 AARPSN 297

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 125/268 (46%), Gaps = 21/268 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G V++G   N   VA+K +   +    D+F  E  ++  + H  LV+L G  
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS-EDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +E     LV+E++ +  L  ++  + +  L        + L   EG+AYL    E  +IH
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 146
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD+   N L+ ++   K++DFG+ R    D+   ST     + + +PE     + + K+D
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-KLVEAVDPNLKDDFPAEQVCN 515
           V+SFG+L+ E+        FS+    P +      RSN ++VE +    +   P     +
Sbjct: 207 VWSFGVLMWEV--------FSEGKI-PYEN-----RSNSEVVEDISTGFRLYKPRLASTH 252
Query: 516 VLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           V QI   C +     RP+ ++ +  L  
Sbjct: 253 VYQIMNHCWKERPEDRPAFSRLLRQLAE 280

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 139/306 (45%), Gaps = 31/306 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G L        +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V E + N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +   + 
Sbjct: 161 KYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           +PE +   + T  +DV+S+GI++ E++  G R               W +   + +++AV
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMSNQD-VIKAV 263
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSS 560
           D   +   P +    + Q+ L C Q     RP   Q + +L +K+  I  P     + S+
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL-DKL--IRNPGSLKIITSA 320
Query: 561 VMEPGN 566
              P N
Sbjct: 321 AARPSN 326

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 124/262 (47%), Gaps = 23/262 (8%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KLG G  G VY G       TVAVK L  +T + V+EF  E  ++  I+H NLV+LLG  
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT--AEGLAYLHGGSETRI 394
              P   ++ E++   +L  ++ + N+ ++   +    + + T  +  + YL    +   
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYLRECNRQEV---SAVVLLYMATQISSAMEYL---EKKNF 130
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK 454
           IHRD+   N L+ ++   K+ADFGL+R    D           + + APE L   + + K
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 455 ADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVC 514
           +DV++FG+L+ EI         +    SP   +      +++ E ++ + + + P     
Sbjct: 191 SDVWAFGVLLWEI---------ATYGMSPYPGI----DPSQVYELLEKDYRMERPEGCPE 237
Query: 515 NVLQIGLLCTQAAAALRPSMAQ 536
            V ++   C Q   + RPS A+
Sbjct: 238 KVYELMRACWQWNPSDRPSFAE 259

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 129/277 (46%), Gaps = 23/277 (8%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGT-TVAVKRLIFNTRQWVDEFFNEVNLI 321
           Y+  E          KLG G  G VY G     + TVAVK L  +T + V+EF  E  ++
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-- 379
             I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   +    + + T  
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV---SAVVLLYMATQI 120
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D           + 
Sbjct: 121 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   +  +E 
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDYRME- 232
Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
                + +   E+V  +++    C Q   + RPS A+
Sbjct: 233 -----RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 261

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 23/277 (8%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLI 321
           Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E  ++
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-- 379
             I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   +    + + T  
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---SAVVLLYMATQI 120
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D           + 
Sbjct: 121 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   +  +E 
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDYRME- 232
Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
                + +   E+V  +++    C Q   + RPS A+
Sbjct: 233 -----RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 261

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 23/277 (8%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLI 321
           Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E  ++
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-- 379
             I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   +    + + T  
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV---SAVVLLYMATQI 120
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D           + 
Sbjct: 121 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   +  +E 
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDYRME- 232
Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
                + +   E+V  +++    C Q   + RPS A+
Sbjct: 233 -----RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 261

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 23/277 (8%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLI 321
           Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E  ++
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-- 379
             I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   +    + + T  
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---SAVVLLYMATQI 120
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D           + 
Sbjct: 121 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   +  +E 
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDYRME- 232
Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
                + +   E+V  +++    C Q   + RPS A+
Sbjct: 233 -----RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 261

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 9/201 (4%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +Y +   K+G+G  G V + ++  +G  VAVK++    +Q  +  FNEV ++   +H+N+
Sbjct: 29  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V++    + G E  +V E++   +L   +        +N  +   + L   + L+ LH  
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 144
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
               +IHRDIK+ +ILL  D   K++DFG     + +       V GT  +MAPE + R 
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRL 200
Query: 450 QLTEKADVYSFGILIIEIVCG 470
               + D++S GI++IE+V G
Sbjct: 201 PYGPEVDIWSLGIMVIEMVDG 221

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 9/201 (4%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +Y +   K+G+G  G V + ++  +G  VAVK++    +Q  +  FNEV ++   +H+N+
Sbjct: 31  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V++    + G E  +V E++   +L   +        +N  +   + L   + L+ LH  
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 146
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
               +IHRDIK+ +ILL  D   K++DFG     + +       V GT  +MAPE + R 
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRL 202
Query: 450 QLTEKADVYSFGILIIEIVCG 470
               + D++S GI++IE+V G
Sbjct: 203 PYGPEVDIWSLGIMVIEMVDG 223

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 9/201 (4%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +Y +   K+G+G  G V + ++  +G  VAVK++    +Q  +  FNEV ++   +H+N+
Sbjct: 20  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V++    + G E  +V E++   +L   +        +N  +   + L   + L+ LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 135
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
               +IHRDIK+ +ILL  D   K++DFG     + +       V GT  +MAPE + R 
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRL 191
Query: 450 QLTEKADVYSFGILIIEIVCG 470
               + D++S GI++IE+V G
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDG 212

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 23/281 (8%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGT-TVAVKRLIFNTRQWVDEFFNE 317
           +S  Y+  E          KLG G  G VY G     + TVAVK L  +T + V+EF  E
Sbjct: 247 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 305
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + +
Sbjct: 306 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYM 362
Query: 378 GT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            T  +  + YL    +   IHR++   N L+ ++   K+ADFGL+R    D         
Sbjct: 363 ATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 419
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK 495
             + + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   + 
Sbjct: 420 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDY 475
Query: 496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
            +E      + +   E+V  +++    C Q   + RPS A+
Sbjct: 476 RME------RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 507

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 9/201 (4%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +Y +   K+G+G  G V + ++  +G  VAVK++    +Q  +  FNEV ++   +H+N+
Sbjct: 24  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V++    + G E  +V E++   +L   +        +N  +   + L   + L+ LH  
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 139
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
               +IHRDIK+ +ILL  D   K++DFG     + +       V GT  +MAPE + R 
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRL 195
Query: 450 QLTEKADVYSFGILIIEIVCG 470
               + D++S GI++IE+V G
Sbjct: 196 PYGPEVDIWSLGIMVIEMVDG 216

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 124/262 (47%), Gaps = 23/262 (8%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KLG G  G VY G       TVAVK L  +T + V+EF  E  ++  I+H NLV+LLG  
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT--AEGLAYLHGGSETRI 394
              P   ++ E++   +L  ++ + N+ ++   +    + + T  +  + YL    +   
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQEV---SAVVLLYMATQISSAMEYL---EKKNF 130
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK 454
           IHRD+   N L+ ++   K+ADFGL+R    D           + + APE L   + + K
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 455 ADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVC 514
           +DV++FG+L+ EI         +    SP   +      +++ E ++ + + + P     
Sbjct: 191 SDVWAFGVLLWEI---------ATYGMSPYPGI----DPSQVYELLEKDYRMERPEGCPE 237
Query: 515 NVLQIGLLCTQAAAALRPSMAQ 536
            V ++   C Q   + RPS A+
Sbjct: 238 KVYELMRACWQWNPSDRPSFAE 259

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 129/277 (46%), Gaps = 23/277 (8%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGT-TVAVKRLIFNTRQWVDEFFNEVNLI 321
           Y+  E          KLG G  G VY G     + TVAVK L  +T + V+EF  E  ++
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 68
Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-- 379
             I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   +    + + T  
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---SAVVLLYMATQI 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D           + 
Sbjct: 126 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   +  +E 
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDYRME- 237
Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
                + +   E+V  +++    C Q   + RPS A+
Sbjct: 238 -----RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 266

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 101/194 (52%), Gaps = 9/194 (4%)
Query: 278 KLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+G+G  G V + ++  +G  VAVK++    +Q  +  FNEV ++   +H+N+V++    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           + G E  +V E++   +L   +        +N  +   + L   + L+ LH      +IH
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIH 270
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RDIK+ +ILL  D   K++DFG     + +       V GT  +MAPE + R     + D
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVD 329
Query: 457 VYSFGILIIEIVCG 470
           ++S GI++IE+V G
Sbjct: 330 IWSLGIMVIEMVDG 343

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 124/262 (47%), Gaps = 23/262 (8%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KLG G  G VY G       TVAVK L  +T + V+EF  E  ++  I+H NLV+LLG  
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT--AEGLAYLHGGSETRI 394
              P   ++ E++   +L  ++ + N+ ++   +    + + T  +  + YL    +   
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQEV---SAVVLLYMATQISSAMEYL---EKKNF 130
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK 454
           IHRD+   N L+ ++   K+ADFGL+R    D           + + APE L   + + K
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 455 ADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVC 514
           +DV++FG+L+ EI         +    SP   +      +++ E ++ + + + P     
Sbjct: 191 SDVWAFGVLLWEI---------ATYGMSPYPGI----DPSQVYELLEKDYRMERPEGCPE 237
Query: 515 NVLQIGLLCTQAAAALRPSMAQ 536
            V ++   C Q   + RPS A+
Sbjct: 238 KVYELMRACWQWNPSDRPSFAE 259

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 9/201 (4%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +Y +   K+G+G  G V + ++  +G  VAVK++    +Q  +  FNEV ++   +H+N+
Sbjct: 74  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V++    + G E  +V E++   +L   +        +N  +   + L   + L+ LH  
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 189
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
               +IHRDIK+ +ILL  D   K++DFG     + +       V GT  +MAPE + R 
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRL 245
Query: 450 QLTEKADVYSFGILIIEIVCG 470
               + D++S GI++IE+V G
Sbjct: 246 PYGPEVDIWSLGIMVIEMVDG 266

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 124/266 (46%), Gaps = 21/266 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G V++G   N   VA+K  I       ++F  E  ++  + H  LV+L G  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +E     LV+E++ +  L  ++  + +  L        + L   EG+AYL    E  +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIH 126
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD+   N L+ ++   K++DFG+ R    D+   ST     + + +PE     + + K+D
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-KLVEAVDPNLKDDFPAEQVCN 515
           V+SFG+L+ E+        FS+    P +      RSN ++VE +    +   P     +
Sbjct: 187 VWSFGVLMWEV--------FSEGKI-PYEN-----RSNSEVVEDISTGFRLYKPRLASTH 232
Query: 516 VLQIGLLCTQAAAALRPSMAQAIMLL 541
           V QI   C +     RP+ ++ +  L
Sbjct: 233 VYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           F+  +KLG+G  GSVY       G  VA+K++   +   + E   E++++   +  ++VK
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
             G   +  +  +V EY    S+   I  +NKT  L  ++   I+  T +GL YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYLHF--- 143
Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
            R IHRDIK  NILL+ +   K+ADFG+A     D       V GT  +MAPE +     
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 452 TEKADVYSFGILIIEIVCGR 471
              AD++S GI  IE+  G+
Sbjct: 203 NCVADIWSLGITAIEMAEGK 222

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 10/211 (4%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+G+G  G V +    + G  VAVK +    +Q  +  FNEV ++   +H N+V++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           + G E  ++ E++   +L   +        LN  +   +     + LAYLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RDIK+ +ILL  D   K++DFG     + D       + GT  +MAPE + R     + D
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKXLVGTPYWMAPEVISRSLYATEVD 223
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
           ++S GI++IE+V G     FS      ++R+
Sbjct: 224 IWSLGIMVIEMVDG-EPPYFSDSPVQAMKRL 253

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVI 138
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HRDIK+ NILL  D + K+ DFG       +++  S  V GT  +MAPE + R     K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 456 DVYSFGILIIEIVCGR 471
           D++S GI+ IE++ G 
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVI 138
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HRDIK+ NILL  D + K+ DFG       +++  S  V GT  +MAPE + R     K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 456 DVYSFGILIIEIVCGR 471
           D++S GI+ IE++ G 
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVI 139
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HRDIK+ NILL  D + K+ DFG       +++  S  V GT  +MAPE + R     K 
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKV 198
Query: 456 DVYSFGILIIEIVCGR 471
           D++S GI+ IE++ G 
Sbjct: 199 DIWSLGIMAIEMIEGE 214

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G V++G   N   VA+K +        ++F  E  ++  + H  LV+L G  
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +E     LV+E++ +  L  ++  + +  L        + L   EG+AYL    E  +IH
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 129
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD+   N L+ ++   K++DFG+ R    D+   ST     + + +PE     + + K+D
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-KLVEAVDPNLKDDFPAEQVCN 515
           V+SFG+L+ E+        FS+    P +      RSN ++VE +    +   P     +
Sbjct: 190 VWSFGVLMWEV--------FSEGKI-PYEN-----RSNSEVVEDISTGFRLYKPRLASTH 235
Query: 516 VLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           V QI   C +     RP+ ++ +  L  
Sbjct: 236 VYQIMNHCWRERPEDRPAFSRLLRQLAE 263

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVI 139
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HR+IK+ NILL  D + K+ DFG       +++  ST V GT  +MAPE + R     K 
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 198
Query: 456 DVYSFGILIIEIVCGR 471
           D++S GI+ IE++ G 
Sbjct: 199 DIWSLGIMAIEMIEGE 214

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 127/293 (43%), Gaps = 23/293 (7%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE 338
           +G+G  G V          VA+K++   + +    F  E+  +S + H N+VKL G  + 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
                LV EY    SL   +               +  L  ++G+AYLH      +IHRD
Sbjct: 74  --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 399 IKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           +K  N+LL    T  KI DFG A      +TH+ T   G+  +MAPE       +EK DV
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTA---CDIQTHM-TNNKGSAAWMAPEVFEGSNYSEKCDV 187
Query: 458 YSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVL 517
           +S+GI++ E++  R+   F +      + +W ++   +      P L  + P      + 
Sbjct: 188 FSWGIILWEVITRRKP--FDEIGGPAFRIMWAVHNGTR------PPLIKNLPKP----IE 235
Query: 518 QIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQP-PFLNSSVMEPGNSSR 569
            +   C     + RPSM + + ++T+ +   P   +P  +     + PG   R
Sbjct: 236 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGR 288

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 127/293 (43%), Gaps = 23/293 (7%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE 338
           +G+G  G V          VA+K++   + +    F  E+  +S + H N+VKL G  + 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
                LV EY    SL   +               +  L  ++G+AYLH      +IHRD
Sbjct: 73  --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 399 IKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           +K  N+LL    T  KI DFG A      +TH+ T   G+  +MAPE       +EK DV
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTA---CDIQTHM-TNNKGSAAWMAPEVFEGSNYSEKCDV 186
Query: 458 YSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVL 517
           +S+GI++ E++  R+   F +      + +W ++   +      P L  + P      + 
Sbjct: 187 FSWGIILWEVITRRKP--FDEIGGPAFRIMWAVHNGTR------PPLIKNLPKP----IE 234
Query: 518 QIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQP-PFLNSSVMEPGNSSR 569
            +   C     + RPSM + + ++T+ +   P   +P  +     + PG   R
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGR 287

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G V++G   N   VA+K  I       ++F  E  ++  + H  LV+L G  
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +E     LV+E++ +  L  ++  + +  L        + L   EG+AYL    E  +IH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 124
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD+   N L+ ++   K++DFG+ R    D+   ST     + + +PE     + + K+D
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-KLVEAVDPNLKDDFPAEQVCN 515
           V+SFG+L+ E+        FS+    P +      RSN ++VE +    +   P     +
Sbjct: 185 VWSFGVLMWEV--------FSEGKI-PYEN-----RSNSEVVEDISTGFRLYKPRLASTH 230
Query: 516 VLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           V QI   C +     RP+ ++ +  L  
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQLAE 258

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G V++G   N   VA+K  I       ++F  E  ++  + H  LV+L G  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +E     LV+E++ +  L  ++  + +  L        + L   EG+AYL    E  +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 126
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD+   N L+ ++   K++DFG+ R    D+   ST     + + +PE     + + K+D
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-KLVEAVDPNLKDDFPAEQVCN 515
           V+SFG+L+ E+        FS+    P +      RSN ++VE +    +   P     +
Sbjct: 187 VWSFGVLMWEV--------FSEGKI-PYEN-----RSNSEVVEDISTGFRLYKPRLASTH 232
Query: 516 VLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           V QI   C +     RP+ ++ +  L  
Sbjct: 233 VYQIMNHCWKERPEDRPAFSRLLRQLAE 260

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 138/309 (44%), Gaps = 42/309 (13%)
Query: 242 EDRNN-LGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLP----NGT 296
           ED N  +  +A  ++ SC+     T+E+          +G G  G V  G L        
Sbjct: 6   EDPNQAVHEFAKEIEASCI-----TIERV---------IGAGEFGEVCSGRLKLPGKREL 51
Query: 297 TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLD 355
            VA+K L +  T +   +F  E +++   +H N++ L G   +    ++V EY+ N SLD
Sbjct: 52  PVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 111
Query: 356 QFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA 415
            F+  K         +   ++ G + G+ YL   S+   +HRD+   NIL++ +   K++
Sbjct: 112 TFL--KKNDGQFTVIQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 166
Query: 416 DFGLARCFAADRTHVSTAVAGTLG--YMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRR 472
           DFGL+R    D     T   G +   + APE +   + T  +DV+S+GI++ E+V  G R
Sbjct: 167 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGER 226
Query: 473 SNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRP 532
                          W +   + +++AV+   +   P +    + Q+ L C Q     RP
Sbjct: 227 P-------------YWEMTNQD-VIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRP 272
Query: 533 SMAQAIMLL 541
              + + +L
Sbjct: 273 KFDEIVNML 281

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 113/230 (49%), Gaps = 19/230 (8%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+G+G  G V + +  + G  VAVK++    +Q  +  FNEV ++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           + G E  +V E++   +L   +        +N  +   + L     L+YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RDIK+ +ILL  D   K++DFG     + +       V GT  +MAPE + R     + D
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV-GTPYWMAPEVISRLPYGTEVD 223
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD 506
           ++S GI++IE++ G     F++    PLQ +       ++ +++ P +KD
Sbjct: 224 IWSLGIMVIEMIDG-EPPYFNE---PPLQAM------RRIRDSLPPRVKD 263

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 131/281 (46%), Gaps = 23/281 (8%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGT-TVAVKRLIFNTRQWVDEFFNE 317
           +S  Y+  E          KLG G  G VY G     + TVAVK L  +T + V+EF  E
Sbjct: 208 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 266
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   +    + +
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---SAVVLLYM 323
Query: 378 GT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            T  +  + YL    +   IHR++   N L+ ++   K+ADFGL+R    D         
Sbjct: 324 ATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 380
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK 495
             + + APE L   + + K+DV++FG+L+ EI     +   S      L +V+ L   + 
Sbjct: 381 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDLSQVYELLEKDY 436
Query: 496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
            +E      + +   E+V  +++    C Q   + RPS A+
Sbjct: 437 RME------RPEGCPEKVYELMRA---CWQWNPSDRPSFAE 468

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 279 LGQGGAG-SVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           LG+G  G ++ +     G  + +K LI    +    F  EV ++  +EH N++K +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           +      + EY+   +L   I  K+      W++R +     A G+AYLH      IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVST-------------AVAGTLGYMAPE 444
           D+ + N L+ ++    +ADFGLAR    ++T                  V G   +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 445 YLVRGQLTEKADVYSFGILIIEIV 468
            +      EK DV+SFGI++ EI+
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII 216

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 120/263 (45%), Gaps = 29/263 (11%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           + +G+G  G V +G    G  VAVK            F  E ++++ + H NLV+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 337 IEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           +E    L +V EY+   SL  ++  + ++ +L  +      L   E + YL G +    +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL--GYMAPEYLVRGQLTE 453
           HRD+   N+L+ +D   K++DFGL +  +      ST   G L   + APE L   + + 
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFST 193
Query: 454 KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQV 513
           K+DV+SFGIL+ EI    R          P  R+        +V  V+   K D P    
Sbjct: 194 KSDVWSFGILLWEIYSFGR---------VPYPRI----PLKDVVPRVEKGYKMDAPDGCP 240
Query: 514 CNVLQIGLLCTQAAAALRPSMAQ 536
             V ++   C    AA+RPS  Q
Sbjct: 241 PAVYEVMKNCWHLDAAMRPSFLQ 263

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTV----AVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G  +P G TV    A+K L   T    + EF +E  +++S++H +LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEGLAYL 386
           +LLG  +  P   LV + +P+  L +++ +         LLNW       +  A+G+ YL
Sbjct: 81  RLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 133
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEY 445
               E R++HRD+   N+L+      KI DFGLAR    D + + +      + +MA E 
Sbjct: 134 ---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 446 LVRGQLTEKADVYSFGILIIEIV 468
           +   + T ++DV+S+G+ I E++
Sbjct: 191 IHYRKFTHQSDVWSYGVTIWELM 213

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTV----AVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G  +P G TV    A+K L   T    + EF +E  +++S++H +LV
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEGLAYL 386
           +LLG  +  P   LV + +P+  L +++ +         LLNW       +  A+G+ YL
Sbjct: 104 RLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 156
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEY 445
               E R++HRD+   N+L+      KI DFGLAR    D + + +      + +MA E 
Sbjct: 157 ---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 446 LVRGQLTEKADVYSFGILIIEIV 468
           +   + T ++DV+S+G+ I E++
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELM 236

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 122/263 (46%), Gaps = 29/263 (11%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           + +G+G  G V +G    G  VAVK +  +       F  E ++++ + H NLV+LLG  
Sbjct: 12  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 337 IEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           +E    L +V EY+   SL  ++  + ++ +L  +      L   E + YL G +    +
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FV 124
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL--GYMAPEYLVRGQLTE 453
           HRD+   N+L+ +D   K++DFGL +  +      ST   G L   + APE L   + + 
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFST 178
Query: 454 KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQV 513
           K+DV+SFGIL+ EI    R          P  R+        +V  V+   K D P    
Sbjct: 179 KSDVWSFGILLWEIYSFGR---------VPYPRI----PLKDVVPRVEKGYKMDAPDGCP 225
Query: 514 CNVLQIGLLCTQAAAALRPSMAQ 536
             V ++   C    AA+RPS  Q
Sbjct: 226 PAVYEVMKNCWHLDAAMRPSFLQ 248

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFN----TRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G GG G VY  +   G  VAVK    +      Q ++    E  L + ++H N++ L G
Sbjct: 15  IGIGGFGKVYR-AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTK--LLNWNKRFNIILGTAEGLAYLHGGSET 392
             ++ P   LV E+     L++ +  K      L+NW  +       A G+ YLH  +  
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMNYLHDEAIV 127
Query: 393 RIIHRDIKTSNILL-----DKDFTP---KIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
            IIHRD+K+SNIL+     + D +    KI DFGLAR +   RT   +A AG   +MAPE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSA-AGAYAWMAPE 184
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGR 471
            +     ++ +DV+S+G+L+ E++ G 
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 119/263 (45%), Gaps = 29/263 (11%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           + +G+G  G V +G    G  VAVK            F  E ++++ + H NLV+LLG  
Sbjct: 18  QTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 337 IEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           +E    L +V EY+   SL  ++  + ++ +L  +      L   E + YL G +    +
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FV 130
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL--GYMAPEYLVRGQLTE 453
           HRD+   N+L+ +D   K++DFGL +  +      ST   G L   + APE L     + 
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREAAFST 184
Query: 454 KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQV 513
           K+DV+SFGIL+ EI    R          P  R+        +V  V+   K D P    
Sbjct: 185 KSDVWSFGILLWEIYSFGR---------VPYPRI----PLKDVVPRVEKGYKMDAPDGCP 231
Query: 514 CNVLQIGLLCTQAAAALRPSMAQ 536
             V ++   C    AA+RPS  Q
Sbjct: 232 PAVYEVMKNCWHLDAAMRPSFLQ 254

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 123/268 (45%), Gaps = 21/268 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G V++G   N   VA+K +        ++F  E  ++  + H  LV+L G  
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +E     LV E++ +  L  ++  + +  L        + L   EG+AYL    E  +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 127
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD+   N L+ ++   K++DFG+ R    D+   ST     + + +PE     + + K+D
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-KLVEAVDPNLKDDFPAEQVCN 515
           V+SFG+L+ E+        FS+    P +      RSN ++VE +    +   P     +
Sbjct: 188 VWSFGVLMWEV--------FSEGKI-PYEN-----RSNSEVVEDISTGFRLYKPRLASTH 233
Query: 516 VLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           V QI   C +     RP+ ++ +  L  
Sbjct: 234 VYQIMNHCWRERPEDRPAFSRLLRQLAE 261

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 278 KLGQGGAGSVYMGS----LP--NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           +LG+G  G V++      LP  +   VAVK L   +     +F  E  L++ ++H+++V+
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKN-KTKL-----------LNWNKRFNIILGT 379
             G   EG   L+V+EY+ +  L++F+       KL           L   +   +    
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTL 438
           A G+ YL G      +HRD+ T N L+ +    KI DFG++R  ++ D   V       +
Sbjct: 139 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEI 467
            +M PE ++  + T ++DV+SFG+++ EI
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEI 224

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 39/279 (13%)
Query: 277 KKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLV 330
           K +G G  G V  G L         VA+K L   +  +Q  D F +E +++   +H N++
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNII 72
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL------GTAEGLA 384
            L G   +    +++ EY+ N SLD F+  KN       + RF +I       G   G+ 
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFL-RKN-------DGRFTVIQLVGMLRGIGSGMK 124
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YMA 442
           YL   S+   +HRD+   NIL++ +   K++DFG++R    D     T   G +   + A
Sbjct: 125 YL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 181
Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP 502
           PE +   + T  +DV+S+GI++ E++             S  +R +    +  +++A++ 
Sbjct: 182 PEAIAYRKFTSASDVWSYGIVMWEVM-------------SYGERPYWDMSNQDVIKAIEE 228
Query: 503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
             +   P +    + Q+ L C Q   + RP   Q + +L
Sbjct: 229 GYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 128/281 (45%), Gaps = 41/281 (14%)
Query: 276 SKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNL 329
            K +G G  G V  G L         VA+K L   +  +Q  D F +E +++   +H N+
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNI 92
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL------GTAEGL 383
           + L G   +    +++ EY+ N SLD F+  KN       + RF +I       G   G+
Sbjct: 93  IHLEGVVTKCKPVMIITEYMENGSLDAFL-RKN-------DGRFTVIQLVGMLRGIGSGM 144
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFG++R    D     T   G +   + 
Sbjct: 145 KYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT 201
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           APE +   + T  +DV+S+GI++ E++  G R               W +   + +++A+
Sbjct: 202 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWDMSNQD-VIKAI 247
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           +   +   P +    + Q+ L C Q   + RP   Q + +L
Sbjct: 248 EEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 278 KLGQGGAGSVYMGS----LP--NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           +LG+G  G V++      LP  +   VAVK L   +     +F  E  L++ ++H+++V+
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKN-KTKL-----------LNWNKRFNIILGT 379
             G   EG   L+V+EY+ +  L++F+       KL           L   +   +    
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTL 438
           A G+ YL G      +HRD+ T N L+ +    KI DFG++R  ++ D   V       +
Sbjct: 145 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEI 467
            +M PE ++  + T ++DV+SFG+++ EI
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEI 230

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 128/281 (45%), Gaps = 41/281 (14%)
Query: 276 SKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNL 329
            K +G G  G V  G L         VA+K L   +  +Q  D F +E +++   +H N+
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNI 77
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL------GTAEGL 383
           + L G   +    +++ EY+ N SLD F+  KN       + RF +I       G   G+
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFL-RKN-------DGRFTVIQLVGMLRGIGSGM 129
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--YM 441
            YL   S+   +HRD+   NIL++ +   K++DFG++R    D     T   G +   + 
Sbjct: 130 KYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT 186
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           APE +   + T  +DV+S+GI++ E++  G R               W +   + +++A+
Sbjct: 187 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWDMSNQD-VIKAI 232
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           +   +   P +    + Q+ L C Q   + RP   Q + +L
Sbjct: 233 EEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 278 KLGQGGAGSVYMGS----LP--NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           +LG+G  G V++      LP  +   VAVK L   +     +F  E  L++ ++H+++V+
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK-TKL-----------LNWNKRFNIILGT 379
             G   EG   L+V+EY+ +  L++F+       KL           L   +   +    
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTL 438
           A G+ YL G      +HRD+ T N L+ +    KI DFG++R  ++ D   V       +
Sbjct: 168 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEI 467
            +M PE ++  + T ++DV+SFG+++ EI
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEI 253

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           LG+G  G VY G  L N   +A+K +     ++      E+ L   ++HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 338 EGPESLLVYEYVPNRSLDQFIFDK------NKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           E     +  E VP  SL   +  K      N+  +  + K+        EGL YLH   +
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI------LEGLKYLH---D 140
Query: 392 TRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
            +I+HRDIK  N+L++      KI+DFG ++  A       T   GTL YMAPE + +G 
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGP 199
Query: 451 --LTEKADVYSFGILIIEIVCGR 471
               + AD++S G  IIE+  G+
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           LG+G  G VY G  L N   +A+K +     ++      E+ L   ++HKN+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 338 EGPESLLVYEYVPNRSLDQFIFDK------NKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           E     +  E VP  SL   +  K      N+  +  + K+        EGL YLH   +
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI------LEGLKYLH---D 126
Query: 392 TRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
            +I+HRDIK  N+L++      KI+DFG ++  A       T   GTL YMAPE + +G 
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGP 185
Query: 451 --LTEKADVYSFGILIIEIVCGR 471
               + AD++S G  IIE+  G+
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGK 208

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 92  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 148
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 206
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAGTLGYM 441
           +L   +  + +HRD+   N +LD+ FT K+ADFGLAR       D  H  T     + +M
Sbjct: 207 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA-- 499
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQGRR 314
Query: 500 -VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            + P    D        + ++ L C    A +RPS ++ +
Sbjct: 315 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELV 347

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 38  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 94
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 95  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 152
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAGTLGYM 441
           +L   +  + +HRD+   N +LD+ FT K+ADFGLAR       D  H  T     + +M
Sbjct: 153 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA-- 499
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQGRR 260
Query: 500 -VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            + P    D        + ++ L C    A +RPS ++ +
Sbjct: 261 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELV 293

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 33  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 89
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 147
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAGTLGYM 441
           +L   +  + +HRD+   N +LD+ FT K+ADFGLAR       D  H  T     + +M
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA-- 499
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQGRR 255
Query: 500 -VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            + P    D        + ++ L C    A +RPS ++ +
Sbjct: 256 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 133/277 (48%), Gaps = 31/277 (11%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 34  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 90
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 148
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAGTLGYM 441
           +L   +  + +HRD+   N +LD+ FT K+ADFGLAR       D  H  T     + +M
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD 501
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQG-R 255
Query: 502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
             L+ ++  + +  V+   L C    A +RPS ++ +
Sbjct: 256 RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 289

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 133/277 (48%), Gaps = 31/277 (11%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 34  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 90
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 148
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAGTLGYM 441
           +L   +  + +HRD+   N +LD+ FT K+ADFGLAR       D  H  T     + +M
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD 501
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQG-R 255
Query: 502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
             L+ ++  + +  V+   L C    A +RPS ++ +
Sbjct: 256 RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 289

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 33  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 89
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 147
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAGTLGYM 441
           +L   +  + +HRD+   N +LD+ FT K+ADFGLAR       D  H  T     + +M
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA-- 499
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQGRR 255
Query: 500 -VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            + P    D        + ++ L C    A +RPS ++ +
Sbjct: 256 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 276 SKKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
            ++LG+G  G V++    N         VAVK L   T     +F  E  L+++++H+++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-------------LNWNKRFNII 376
           VK  G   +G   ++V+EY+ +  L++F+       +             L  ++  +I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVA 435
              A G+ YL   +    +HRD+ T N L+  +   KI DFG++R  ++ D   V     
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
             + +M PE ++  + T ++DV+SFG+++ EI
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F+  + LG+G  G+VY+        +   +++F T   +  V+ +   EV + S + H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA--------TYITELANAL 125
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL  +   KIADFG +    + R    T + GTL Y+ P
Sbjct: 126 SYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 179
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCG 470
           E ++ G++  EK D++S G+L  E + G
Sbjct: 180 E-MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 31  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 87
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 145
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAGTLGYM 441
           +L   +  + +HRD+   N +LD+ FT K+ADFGLAR       D  H  T     + +M
Sbjct: 146 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA-- 499
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQGRR 253
Query: 500 -VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            + P    D        + ++ L C    A +RPS ++ +
Sbjct: 254 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 26/211 (12%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIF--------------NTRQWVDEFFNEVNLIS 322
           +KLG G  G V +    NG +    ++I               N  ++ +E +NE++L+ 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 323 SIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           S++H N++KL     +     LV E+     L + I +++K    +     NI+     G
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSG 158
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKD---FTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           + YLH   +  I+HRDIK  NILL+        KI DFGL+  F+ D  +      GT  
Sbjct: 159 ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTAY 213
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y+APE L + +  EK DV+S G+++  ++CG
Sbjct: 214 YIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 31  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 87
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 145
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR---THVSTAVAGTLGYM 441
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR          H  T     + +M
Sbjct: 146 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 202
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA-- 499
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQGRR 253
Query: 500 -VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            + P    D        + ++ L C    A +RPS ++ +
Sbjct: 254 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 25  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 81
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 82  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 139
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR---THVSTAVAGTLGYM 441
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR          H  T     + +M
Sbjct: 140 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 196
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA-- 499
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 197 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQGRR 247
Query: 500 -VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            + P    D        + ++ L C    A +RPS ++ +
Sbjct: 248 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELV 280

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 120/263 (45%), Gaps = 29/263 (11%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           + +G+G  G V +G    G  VAVK +  +       F  E ++++ + H NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 337 IEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           +E    L +V EY+   SL  ++  + ++ +L  +      L   E + YL G +    +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL--GYMAPEYLVRGQLTE 453
           HRD+   N+L+ +D   K++DFGL +  +      ST   G L   + APE L   + + 
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFST 365
Query: 454 KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQV 513
           K+DV+SFGIL+ EI    R          P  R+        +V  V+   K D P    
Sbjct: 366 KSDVWSFGILLWEIYSFGR---------VPYPRI----PLKDVVPRVEKGYKMDAPDGCP 412
Query: 514 CNVLQIGLLCTQAAAALRPSMAQ 536
             V  +   C    AA RP+  Q
Sbjct: 413 PAVYDVMKNCWHLDAATRPTFLQ 435

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 93/190 (48%), Gaps = 16/190 (8%)
Query: 293 PNGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
           P    VA+KR+     Q  +DE   E+  +S   H N+V      +   E  LV + +  
Sbjct: 33  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 92
Query: 352 RSLDQFIFD-----KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL 406
            S+   I       ++K+ +L+ +    I+    EGL YLH   +   IHRD+K  NILL
Sbjct: 93  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 149
Query: 407 DKDFTPKIADFGLARCFAA----DRTHVSTAVAGTLGYMAPEYL--VRGQLTEKADVYSF 460
            +D + +IADFG++   A      R  V     GT  +MAPE +  VRG    KAD++SF
Sbjct: 150 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSF 208
Query: 461 GILIIEIVCG 470
           GI  IE+  G
Sbjct: 209 GITAIELATG 218

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 33  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 89
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 147
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR---THVSTAVAGTLGYM 441
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR          H  T     + +M
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA-- 499
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQGRR 255
Query: 500 -VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            + P    D        + ++ L C    A +RPS ++ +
Sbjct: 256 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 30  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 86
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 87  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 144
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR---THVSTAVAGTLGYM 441
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR          H  T     + +M
Sbjct: 145 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 201
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA-- 499
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQGRR 252
Query: 500 -VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            + P    D        + ++ L C    A +RPS ++ +
Sbjct: 253 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELV 285

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 32  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 88
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 146
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR---THVSTAVAGTLGYM 441
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR          H  T     + +M
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 203
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA-- 499
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQGRR 254
Query: 500 -VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            + P    D        + ++ L C    A +RPS ++ +
Sbjct: 255 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 93/190 (48%), Gaps = 16/190 (8%)
Query: 293 PNGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
           P    VA+KR+     Q  +DE   E+  +S   H N+V      +   E  LV + +  
Sbjct: 38  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97
Query: 352 RSLDQFIFD-----KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL 406
            S+   I       ++K+ +L+ +    I+    EGL YLH   +   IHRD+K  NILL
Sbjct: 98  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 154
Query: 407 DKDFTPKIADFGLARCFAA----DRTHVSTAVAGTLGYMAPEYL--VRGQLTEKADVYSF 460
            +D + +IADFG++   A      R  V     GT  +MAPE +  VRG    KAD++SF
Sbjct: 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSF 213
Query: 461 GILIIEIVCG 470
           GI  IE+  G
Sbjct: 214 GITAIELATG 223

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 28  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 84
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 142
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR---THVSTAVAGTLGYM 441
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR          H  T     + +M
Sbjct: 143 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA-- 499
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQGRR 250
Query: 500 -VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            + P    D        + ++ L C    A +RPS ++ +
Sbjct: 251 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELV 283

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 132/277 (47%), Gaps = 31/277 (11%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 51  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 107
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 108 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 165
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR---THVSTAVAGTLGYM 441
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR          H  T     + +M
Sbjct: 166 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 222
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD 501
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQG-R 272
Query: 502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
             L+ ++  + +  V+   L C    A +RPS ++ +
Sbjct: 273 RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 306

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 32  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 88
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 146
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAGTLGYM 441
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR          H  T     + +M
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWM 203
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA-- 499
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQGRR 254
Query: 500 -VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            + P    D        + ++ L C    A +RPS ++ +
Sbjct: 255 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 33  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 89
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 147
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR---THVSTAVAGTLGYM 441
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR          H  T     + +M
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA-- 499
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQGRR 255
Query: 500 -VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            + P    D        + ++ L C    A +RPS ++ +
Sbjct: 256 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 52  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 108
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 109 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 166
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR---THVSTAVAGTLGYM 441
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR          H  T     + +M
Sbjct: 167 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 223
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA-- 499
           A E L   + T K+DV+SFG+L+ E++            A P   V T   +  L++   
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVNTFDITVYLLQGRR 274
Query: 500 -VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            + P    D        + ++ L C    A +RPS ++ +
Sbjct: 275 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELV 307

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 110/228 (48%), Gaps = 29/228 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+    N   +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     ++IHRDIK  N+LL      KIADFG +    + R     A+ GTL Y+ P
Sbjct: 122 SYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLPP 175
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR---RSNAFSQDSASPLQRV 487
           E ++ G++  EK D++S G+L  E + G+    +N + QD+   + RV
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-QDTYKRISRV 221

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 138/292 (47%), Gaps = 35/292 (11%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNL 320
           E   +Y    + +G G  G V  G L       + VA+K L   +  RQ   EF +E ++
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASI 68
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGT 379
           +   EH N+++L G        +++ E++ N +LD F+  +  +  ++   +   ++ G 
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGI 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAG 436
           A G+ YL   +E   +HRD+   NIL++ +   K++DFGL+R     ++D T+ S+ + G
Sbjct: 126 ASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSS-LGG 181
Query: 437 TLG--YMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRS 493
            +   + APE +   + T  +D +S+GI++ E++  G R               W +   
Sbjct: 182 KIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP-------------YWDMSNQ 228
Query: 494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV 545
           + ++ A++ + +   P +   ++ Q+ L C Q     RP   Q +  L   +
Sbjct: 229 D-VINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 279

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 122
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG + C A   +   T ++GTL Y+ P
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-CHAP--SSRRTTLSGTLDYLPP 176
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 177 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 30/218 (13%)
Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFN 316
           KY+ LEK          +G+G  G VY      G  VA+KR+  +     DE        
Sbjct: 22  KYQKLEK----------VGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIR 68
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           E++L+  + H N+V L+   I     L LV+E++  + L + + D+NKT L +   +   
Sbjct: 69  EISLLKELHHPNIVSLIDV-IHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKI-Y 124
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
           +     G+A+ H   + RI+HRD+K  N+L++ D   K+ADFGLAR F    R++    V
Sbjct: 125 LYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV 181
Query: 435 AGTLGYMAPEYLV-RGQLTEKADVYSFGILIIEIVCGR 471
             TL Y AP+ L+   + +   D++S G +  E++ G+
Sbjct: 182 --TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G TV+V     K  + +  + +D+F  EVN + S++H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +       LL    R+ +    AEG+ YL   
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--- 137
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLGYMAPEYLV 447
              R IHRD+   N+LL      KI DFGL R    +  H  +         + APE L 
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 448 RGQLTEKADVYSFGILIIEI 467
               +  +D + FG+ + E+
Sbjct: 198 TRTFSHASDTWMFGVTLWEM 217

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 108/204 (52%), Gaps = 20/204 (9%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           S ++G G  G+VY G       V + +++  T +    F NEV ++    H N++  +G 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 336 SIEGPESLLVYEYVPNRSLDQFIF-DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             +   ++ V ++    SL + +   + K ++    +  +I   TA+G+ YLH  +   I
Sbjct: 101 MTKDNLAI-VTQWCEGSSLYKHLHVQETKFQMF---QLIDIARQTAQGMDYLHAKN---I 153
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLA----RCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
           IHRD+K++NI L +  T KI DFGLA    R   + +    T   G++ +MAPE ++R Q
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT---GSVLWMAPE-VIRMQ 209
Query: 451 ----LTEKADVYSFGILIIEIVCG 470
                + ++DVYS+GI++ E++ G
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G TV+V     K  + +  + +D+F  EVN + S++H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +       LL    R+ +    AEG+ YL   
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--- 137
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLGYMAPEYLV 447
              R IHRD+   N+LL      KI DFGL R    +  H  +         + APE L 
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 448 RGQLTEKADVYSFGILIIEI 467
               +  +D + FG+ + E+
Sbjct: 198 TRTFSHASDTWMFGVTLWEM 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 112/219 (51%), Gaps = 32/219 (14%)
Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFN 316
           KY+ LEK          +G+G  G VY      G  VA+KR+  +     DE        
Sbjct: 22  KYQKLEK----------VGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIR 68
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           E++L+  + H N+V L+   I     L LV+E++  + L + + D+NKT L +   +  I
Sbjct: 69  EISLLKELHHPNIVSLIDV-IHSERCLTLVFEFM-EKDLKK-VLDENKTGLQD--SQIKI 123
Query: 376 IL-GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTA 433
            L     G+A+ H   + RI+HRD+K  N+L++ D   K+ADFGLAR F    R++    
Sbjct: 124 YLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV 180
Query: 434 VAGTLGYMAPEYLV-RGQLTEKADVYSFGILIIEIVCGR 471
           V  TL Y AP+ L+   + +   D++S G +  E++ G+
Sbjct: 181 V--TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G TV+V     K  + +  + +D+F  EVN + S++H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +       LL    R+ +    AEG+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--- 127
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLGYMAPEYLV 447
              R IHRD+   N+LL      KI DFGL R    +  H  +         + APE L 
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 448 RGQLTEKADVYSFGILIIEI 467
               +  +D + FG+ + E+
Sbjct: 188 TRTFSHASDTWMFGVTLWEM 207

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G TV+V     K  + +  + +D+F  EVN + S++H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +       LL    R+ +    AEG+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--- 127
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLGYMAPEYLV 447
              R IHRD+   N+LL      KI DFGL R    +  H  +         + APE L 
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 448 RGQLTEKADVYSFGILIIEI 467
               +  +D + FG+ + E+
Sbjct: 188 TRTFSHASDTWMFGVTLWEM 207

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G TV+V     K  + +  + +D+F  EVN + S++H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +       LL    R+ +    AEG+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--- 127
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLGYMAPEYLV 447
              R IHRD+   N+LL      KI DFGL R    +  H  +         + APE L 
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 448 RGQLTEKADVYSFGILIIEI 467
               +  +D + FG+ + E+
Sbjct: 188 TRTFSHASDTWMFGVTLWEM 207

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G TV+V     K  + +  + +D+F  EVN + S++H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +       LL    R+ +    AEG+ YL   
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--- 131
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLGYMAPEYLV 447
              R IHRD+   N+LL      KI DFGL R    +  H  +         + APE L 
Sbjct: 132 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 448 RGQLTEKADVYSFGILIIEI 467
               +  +D + FG+ + E+
Sbjct: 192 TRTFSHASDTWMFGVTLWEM 211

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G TV+V     K  + +  + +D+F  EVN + S++H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +       LL    R+ +    AEG+ YL   
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--- 131
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLGYMAPEYLV 447
              R IHRD+   N+LL      KI DFGL R    +  H  +         + APE L 
Sbjct: 132 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 448 RGQLTEKADVYSFGILIIEI 467
               +  +D + FG+ + E+
Sbjct: 192 TRTFSHASDTWMFGVTLWEM 211

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 281 QGGAGSVYMGSLPNGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEG 339
           +G  G V+   L N   VAVK      +Q W +E+  EV  +  ++H+N+++ +G    G
Sbjct: 34  RGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRG 90
Query: 340 P----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH-------G 388
                +  L+  +    SL  F+    K  +++WN+  +I    A GLAYLH        
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST-AVAGTLGYMAPEYLV 447
           G +  I HRDIK+ N+LL  + T  IADFGLA  F A ++   T    GT  YMAPE L 
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL- 205
Query: 448 RGQLT------EKADVYSFGILIIEI 467
            G +        + D+Y+ G+++ E+
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 124
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 178
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 126
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 180
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 181 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 87  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 138
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 139 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 192
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 193 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 137/292 (46%), Gaps = 35/292 (11%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNL 320
           E   +Y    + +G G  G V  G L       + VA+K L   +  RQ   EF +E ++
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASI 70
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGT 379
           +   EH N+++L G        +++ E++ N +LD F+  +  +  ++   +   ++ G 
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGI 127
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAG 436
           A G+ YL   +E   +HRD+   NIL++ +   K++DFGL+R     ++D T  S+ + G
Sbjct: 128 ASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSS-LGG 183
Query: 437 TLG--YMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRS 493
            +   + APE +   + T  +D +S+GI++ E++  G R               W +   
Sbjct: 184 KIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP-------------YWDMSNQ 230
Query: 494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV 545
           + ++ A++ + +   P +   ++ Q+ L C Q     RP   Q +  L   +
Sbjct: 231 D-VINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 281

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 124
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R     A+ GTL Y+ P
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLPP 178
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 25/208 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F+  + LG+G  G+VY+        +   +++F T   +  V+ +   EV + S + H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA--------TYITELANAL 125
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL  +   KIADFG +    + R      + GTL Y+ P
Sbjct: 126 SYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RDTLCGTLDYLPP 179
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCG 470
           E ++ G++  EK D++S G+L  E + G
Sbjct: 180 E-MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 124
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 178
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 126
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 180
Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGR 471
           E +      EK D++S G+L  E + G+
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 175
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTELCGTLDYLPP 175
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 120
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 121 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 174
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 175 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 147
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 148 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 201
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 202 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 125
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 126 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 179
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 180 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P   + + +     FD+ +T           I   A  L
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTA--------TYITELANAL 126
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 180
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 181 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTXLCGTLDYLPP 175
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 122
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPP 176
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 177 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R     A+ GTL Y+ P
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLPP 175
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPP 175
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNL 329
           + +G+G  G V+    P        T VAVK L       +  +F  E  L++  ++ N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL---------------------LN 368
           VKLLG    G    L++EY+    L++F+   +   +                     L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 369 WNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADR 427
             ++  I    A G+AYL   SE + +HRD+ T N L+ ++   KIADFGL+R  ++AD 
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
                  A  + +M PE +   + T ++DV+++G+++ EI
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 126
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPP 180
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 181 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPP 175
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 118
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL Y+ P
Sbjct: 119 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 172
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 173 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 109/220 (49%), Gaps = 37/220 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 94  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR    D  H+  
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDX 205
Query: 433 AVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEI 467
               T G     +MAPE L     T ++DV+SFG+L+ EI
Sbjct: 206 XKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 125/270 (46%), Gaps = 26/270 (9%)
Query: 273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   KK+G+G    VY  + L +G  VA+K++    + + +   D    E++L+  + H 
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHP 92
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFNIILGTAEGLAY 385
           N++K     IE  E  +V E      L + I  F K K +L+     +   +     L +
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTVWKYFVQLCSALEH 151
Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEY 445
           +H     R++HRDIK +N+ +      K+ D GL R F++ +T  + ++ GT  YM+PE 
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPER 207
Query: 446 LVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD-PNL 504
           +       K+D++S G L+ E+   +  + F  D  +       LY   K +E  D P L
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMN-------LYSLCKKIEQCDYPPL 258
Query: 505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSM 534
             D  +E+   + Q+  +C       RP +
Sbjct: 259 PSDHYSEE---LRQLVNMCINPDPEKRPDV 285

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 37/217 (17%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNL--ISSIEHKNLVKLL--- 333
           +G+G  G+VY GSL +   VAVK   F  RQ    F NE N+  +  +EH N+ + +   
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGD 76
Query: 334 -GCSIEGP-ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG--- 388
              + +G  E LLV EY PN SL +++         +W     +      GLAYLH    
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 389 -GSETR--IIHRDIKTSNILLDKDFTPKIADFGLARCFAADR-------THVSTAVAGTL 438
            G   +  I HRD+ + N+L+  D T  I+DFGL+     +R        + + +  GT+
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192
Query: 439 GYMAPEYLVRGQLT--------EKADVYSFGILIIEI 467
            YMAPE L  G +         ++ D+Y+ G++  EI
Sbjct: 193 RYMAPEVL-EGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 131/286 (45%), Gaps = 28/286 (9%)
Query: 272 YFNPSKKLGQGGAG--SVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE 325
           Y    + LG+G  G  S+Y     N   G  VAVK L  +   Q    +  E++++ ++ 
Sbjct: 15  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY 74
Query: 326 HKNLVKLLGC-SIEGPESL-LVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFNIILGTAE 381
           H++++K  GC   +G +SL LV EYVP  SL  ++        +LL + ++        E
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI------CE 128
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG--TLG 439
           G+AYLH       IHR++   N+LLD D   KI DFGLA+       +      G   + 
Sbjct: 129 GMAYLHA---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 185
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN----K 495
           + APE L   +    +DV+SFG+ + E++    S   SQ   +    +  + +      +
Sbjct: 186 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDS---SQSPPTKFLELIGIAQGQMTVLR 242
Query: 496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           L E ++   +   P +  C V  +   C +  A+ RP+    I +L
Sbjct: 243 LTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPIL 288

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 131/286 (45%), Gaps = 28/286 (9%)
Query: 272 YFNPSKKLGQGGAG--SVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE 325
           Y    + LG+G  G  S+Y     N   G  VAVK L  +   Q    +  E++++ ++ 
Sbjct: 15  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY 74
Query: 326 HKNLVKLLGC-SIEGPESL-LVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFNIILGTAE 381
           H++++K  GC   +G +SL LV EYVP  SL  ++        +LL + ++        E
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI------CE 128
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG--TLG 439
           G+AYLH       IHR++   N+LLD D   KI DFGLA+       +      G   + 
Sbjct: 129 GMAYLHS---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 185
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN----K 495
           + APE L   +    +DV+SFG+ + E++    S   SQ   +    +  + +      +
Sbjct: 186 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDS---SQSPPTKFLELIGIAQGQMTVLR 242
Query: 496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           L E ++   +   P +  C V  +   C +  A+ RP+    I +L
Sbjct: 243 LTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPIL 288

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLLG 334
           K++G+G  G V+MG    G  VAVK + F T +    +F E  +  ++   H+N++  + 
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVK-VFFTTEE--ASWFRETEIYQTVLMRHENILGFIA 98
Query: 335 CSIEGPESL----LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG-- 388
             I+G  S     L+ +Y  N SL    +D  K+  L+      +   +  GL +LH   
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 389 ---GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS---TAVAGTLGYMA 442
                +  I HRD+K+ NIL+ K+ T  IAD GLA  F +D   V        GT  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 443 PEYLVRG------QLTEKADVYSFGILIIEI 467
           PE L         Q    AD+YSFG+++ E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 109/220 (49%), Gaps = 37/220 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 94  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR    D  H+  
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 205
Query: 433 AVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEI 467
               T G     +MAPE L     T ++DV+SFG+L+ EI
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 128/277 (46%), Gaps = 29/277 (10%)
Query: 279 LGQGGAGSVYMG--SLPNGTT--VAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           +G G  G V  G   LP      VA+K L    T +   +F +E +++   +H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   +    +++ E++ N SLD F+  +         +   ++ G A G+ YL   ++  
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 155
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLG--YMAPEYLVRG 449
            +HRD+   NIL++ +   K++DFGL+R    D +    ++A+ G +   + APE +   
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 450 QLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF 508
           + T  +DV+S+GI++ E++  G R               W +   + ++ A++ + +   
Sbjct: 216 KFTSASDVWSYGIVMWEVMSYGERP-------------YWDMTNQD-VINAIEQDYRLPP 261
Query: 509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV 545
           P +    + Q+ L C Q     RP   Q +  L   +
Sbjct: 262 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 298

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 123
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIA+FG +    + R    T + GTL Y+ P
Sbjct: 124 SYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTLDYLPP 177
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 178 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 109/220 (49%), Gaps = 37/220 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 79  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR    D  H+  
Sbjct: 138 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 190
Query: 433 AVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEI 467
               T G     +MAPE L     T ++DV+SFG+L+ EI
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/197 (33%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G AG V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 14  LGEGAAGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 109/220 (49%), Gaps = 37/220 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 94  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR    D  H+  
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 205
Query: 433 AVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEI 467
               T G     +MAPE L     T ++DV+SFG+L+ EI
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 109/220 (49%), Gaps = 37/220 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 87  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR    D  H+  
Sbjct: 146 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 198
Query: 433 AVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEI 467
               T G     +MAPE L     T ++DV+SFG+L+ EI
Sbjct: 199 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 20/223 (8%)
Query: 261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVD 312
           F  +  E A      S++LGQG  G VY G           T VA+K +    + R+ + 
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI- 64
Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD-----KNKTKLL 367
           EF NE +++      ++V+LLG   +G  +L++ E +    L  ++       +N   L 
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 368 --NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFA 424
             + +K   +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R  + 
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
            D           + +M+PE L  G  T  +DV+SFG+++ EI
Sbjct: 182 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 109/220 (49%), Gaps = 37/220 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 94  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR    D  H+  
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 205
Query: 433 AVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEI 467
               T G     +MAPE L     T ++DV+SFG+L+ EI
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 122
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R      + GTL Y+ P
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDTLCGTLDYLPP 176
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 177 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 109/220 (49%), Gaps = 37/220 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 83  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR    D  H+  
Sbjct: 142 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 194
Query: 433 AVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEI 467
               T G     +MAPE L     T ++DV+SFG+L+ EI
Sbjct: 195 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 123
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R      + GTL Y+ P
Sbjct: 124 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLPP 177
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 178 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 124
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIA+FG +    + R    T + GTL Y+ P
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTLDYLPP 178
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 109/220 (49%), Gaps = 37/220 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 86  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR    D  H+  
Sbjct: 145 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 197
Query: 433 AVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEI 467
               T G     +MAPE L     T ++DV+SFG+L+ EI
Sbjct: 198 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 126/274 (45%), Gaps = 27/274 (9%)
Query: 278 KLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           +LG+G  GSV +          G  VAVK+L  +      +F  E+ ++ ++    +VK 
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 333 LGCSI-EGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            G S   G +SL LV EY+P+  L  F+  +     L+ ++         +G+ YL  GS
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GS 132
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLVR 448
             R +HRD+   NIL++ +   KIADFGLA+    D+ +      G   + + APE L  
Sbjct: 133 R-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 191
Query: 449 GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK--- 505
              + ++DV+SFG+++ E+        +   S SP      +  S + V A+   L+   
Sbjct: 192 NIFSRQSDVWSFGVVLYELF------TYCDKSCSPSAEFLRMMGSERDVPALSRLLELLE 245
Query: 506 --DDFPAEQVC--NVLQIGLLCTQAAAALRPSMA 535
                PA   C   V ++  LC   +   RPS +
Sbjct: 246 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFS 279

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E+V ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 68  VKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 180
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 222

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 20/220 (9%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFF 315
           +  E A      S++LGQG  G VY G           T VA+K +    + R+ + EF 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 70
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD-----KNKTKLL--N 368
           NE +++      ++V+LLG   +G  +L++ E +    L  ++       +N   L   +
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 369 WNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADR 427
            +K   +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R  +  D 
Sbjct: 131 LSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 187
Query: 428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
                     + +M+PE L  G  T  +DV+SFG+++ EI
Sbjct: 188 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 20/220 (9%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFF 315
           +  E A      S++LGQG  G VY G           T VA+K +    + R+ + EF 
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 66
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLN 368
           NE +++      ++V+LLG   +G  +L++ E +         RSL   + +       +
Sbjct: 67  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 369 WNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADR 427
            +K   +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R  +  D 
Sbjct: 127 LSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 183
Query: 428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
                     + +M+PE L  G  T  +DV+SFG+++ EI
Sbjct: 184 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 79
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNK 371
           +++      ++V+LLG   +G  +L++ E +         RSL   + +       + +K
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHV 430
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R  +  D    
Sbjct: 140 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
                  + +M+PE L  G  T  +DV+SFG+++ EI
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 13/210 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEF-FNEVNLISSIEH 326
           +++ F   +KLG G   +VY G +   G  VA+K +  ++ +        E++L+  ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPN---RSLDQFIFDKNKTKL-LNWNKRFNIILGTAEG 382
           +N+V+L        +  LV+E++ N   + +D          L LN  K F   L   +G
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQG 120
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           LA+ H   E +I+HRD+K  N+L++K    K+ DFGLAR F       S+ V  TL Y A
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRA 176
Query: 443 PEYLVRGQ-LTEKADVYSFGILIIEIVCGR 471
           P+ L+  +  +   D++S G ++ E++ G+
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 124
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R      + GTL Y+ P
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLPP 178
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 132/291 (45%), Gaps = 50/291 (17%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 135 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR    D  H+  
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 246
Query: 433 AVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
               T G     +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF----TLGGSPYPGVPVEEL 302
Query: 488 WTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           + L +    +         D P+     +  +   C  A  + RP+  Q +
Sbjct: 303 FKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 344

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P   + + +     FD+ +T           I   A  L
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTA--------TYITELANAL 126
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R      + GTL Y+ P
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLXGTLDYLPP 180
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 181 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 72
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD-----KNKTKLL--NWNK 371
           +++      ++V+LLG   +G  +L++ E +    L  ++       +N   L   + +K
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHV 430
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R  +  D    
Sbjct: 133 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
                  + +M+PE L  G  T  +DV+SFG+++ EI
Sbjct: 190 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 79
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD-----KNKTKLL--NWNK 371
           +++      ++V+LLG   +G  +L++ E +    L  ++       +N   L   + +K
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 139
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHV 430
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R  +  D    
Sbjct: 140 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
                  + +M+PE L  G  T  +DV+SFG+++ EI
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 177
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 219

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 66
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD-----KNKTKLL--NWNK 371
           +++      ++V+LLG   +G  +L++ E +    L  ++       +N   L   + +K
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHV 430
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R  +  D    
Sbjct: 127 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
                  + +M+PE L  G  T  +DV+SFG+++ EI
Sbjct: 184 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 130 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 184
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 226

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R      + GTL Y+ P
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLPP 175
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 72
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD-----KNKTKLL--NWNK 371
           +++      ++V+LLG   +G  +L++ E +    L  ++       +N   L   + +K
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHV 430
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R  +  D    
Sbjct: 133 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
                  + +M+PE L  G  T  +DV+SFG+++ EI
Sbjct: 190 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 122/271 (45%), Gaps = 35/271 (12%)
Query: 276 SKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLV 330
            + +G+G  G VY G       N    A+K L   T  Q V+ F  E  L+  + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 331 KLLGCSIEGPESL--LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
            L+G  +  PE L  ++  Y+ +  L QFI    +   +     F   L  A G+ YL  
Sbjct: 86  ALIGIMLP-PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG--LQVARGMEYL-- 140
Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA----VAGTLGYMAPE 444
            +E + +HRD+   N +LD+ FT K+ADFGLAR    DR + S          + + A E
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARLPVKWTALE 198
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL 504
            L   + T K+DV+SFG+L+ E++      A       P      L +  +L        
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT---RGAPPYRHIDPFDLTHFLAQGRRL-------- 247
Query: 505 KDDFPAEQVC--NVLQIGLLCTQAAAALRPS 533
               P  + C  ++ Q+   C +A  A+RP+
Sbjct: 248 ----PQPEYCPDSLYQVMQQCWEADPAVRPT 274

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVS 431
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR     D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
           T     + +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ ++ L 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELFKLL 272
Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +    +         D PA     +  +   C  A  + RP+  Q +
Sbjct: 273 KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVS 431
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR     D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
           T     + +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ ++ L 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELFKLL 272
Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +    +         D PA     +  +   C  A  + RP+  Q +
Sbjct: 273 KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 43  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 101
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD-----KNKTKLL--NWNK 371
           +++      ++V+LLG   +G  +L++ E +    L  ++       +N   L   + +K
Sbjct: 102 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 161
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHV 430
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R  +  D    
Sbjct: 162 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 218
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
                  + +M+PE L  G  T  +DV+SFG+++ EI
Sbjct: 219 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 28/221 (12%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 73
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD-----KNKTKLL--NWNK 371
           +++      ++V+LLG   +G  +L++ E +    L  ++       +N   L   + +K
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R    D     
Sbjct: 134 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETD 186
Query: 432 TAVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEI 467
               G  G     +M+PE L  G  T  +DV+SFG+++ EI
Sbjct: 187 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 130 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 184
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 226

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 147
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R      + GTL Y+ P
Sbjct: 148 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDDLCGTLDYLPP 201
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 202 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 114/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E+V ++ L  F+ D +    +      + +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 176
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 218

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 116/226 (51%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 177
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 219

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 116/226 (51%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 176
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 218

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 176
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 218

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVS 431
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR     D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
           T     + +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ ++ L 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELFKLL 272
Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +    +         D PA     +  +   C  A  + RP+  Q +
Sbjct: 273 KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 28/221 (12%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 64
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD-----KNKTKLL--NWNK 371
           +++      ++V+LLG   +G  +L++ E +    L  ++       +N   L   + +K
Sbjct: 65  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 124
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R    D     
Sbjct: 125 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETD 177
Query: 432 TAVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEI 467
               G  G     +M+PE L  G  T  +DV+SFG+++ EI
Sbjct: 178 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 177
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 219

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 177
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 219

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 125 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 179
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 221

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 101 KNIIHLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVS 431
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR     D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
           T     + +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ ++ L 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELFKLL 272
Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +    +         D PA     +  +   C  A  + RP+  Q +
Sbjct: 273 KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 178
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 220

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 116/226 (51%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 176
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 218

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 14  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 179
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 221

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 116/226 (51%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 177
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 219

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 127 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 181
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 223

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 176
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 218

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 116/226 (51%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 177
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 219

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 124 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 178
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 220

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 180
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 222

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 124
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R      + GTL Y+ P
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDDLCGTLDYLPP 178
Query: 444 EYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           E ++ G++  EK D++S G+L  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 178
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 220

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 177
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 219

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 127 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 181
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 223

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 178
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 220

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 180
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 222

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 179
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 221

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 14  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 119/255 (46%), Gaps = 38/255 (14%)
Query: 277 KKLGQGGAGSV------YMGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           K LG+G  G V      ++      TTVAVK L  N +   + +  +E N++  + H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 330 VKLLG-CSIEGPESLLVYEYVPNRSLDQFI---------------------FDKNKTKLL 367
           +KL G CS +GP  LL+ EY    SL  F+                      D    + L
Sbjct: 89  IKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
                 +     ++G+ YL   +E +++HRD+   NIL+ +    KI+DFGL+R    + 
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 428 THVSTAVAGT-LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQR 486
           ++V  +     + +MA E L     T ++DV+SFG+L+ EIV     N +      P +R
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-LGGNPY---PGIPPER 260
Query: 487 VWTLYRSNKLVEAVD 501
           ++ L ++   +E  D
Sbjct: 261 LFNLLKTGHRMERPD 275

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 272 YFNPSKKLGQGGAG--SVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE 325
           Y    + LG+G  G  S+Y     N   G  VAVK L      Q    +  E+ ++ ++ 
Sbjct: 10  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 69
Query: 326 HKNLVKLLGC-SIEGPESL-LVYEYVPNRSLDQFIFDK--NKTKLLNWNKRFNIILGTAE 381
           H+++VK  GC   +G +S+ LV EYVP  SL  ++        +LL + ++        E
Sbjct: 70  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQI------CE 123
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG--TLG 439
           G+AYLH       IHR +   N+LLD D   KI DFGLA+       +      G   + 
Sbjct: 124 GMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 180
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPL----QRVWTLYRSNK 495
           + APE L   +    +DV+SFG+ + E++    SN       + L    Q   T+ R  +
Sbjct: 181 WYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTE 240
Query: 496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           L+E  +   +   P    C +  +   C +  A+ RP+    + +L
Sbjct: 241 LLERGE---RLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 283

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 101 KNIITLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVS 431
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR     D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
           T     + +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ ++ L 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELFKLL 272
Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +    +         D PA     +  +   C  A  + RP+  Q +
Sbjct: 273 KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 101/225 (44%), Gaps = 25/225 (11%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
           E  E   N     K LG G  G V       +G       VAVK L   +    DE    
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 96
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
            +E+ ++S + +H+N+V LLG    G   L++ EY     L  F+  + K+++L  +  F
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAF 154
Query: 374 NIILGTAEGLAYLHGGSET----------RIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
            I   TA     LH  S+             IHRD+   N+LL      KI DFGLAR  
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 424 AADRTHVSTAVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
             D  ++    A   + +MAPE +     T ++DV+S+GIL+ EI
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 15  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 127
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 187
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 272 YFNPSKKLGQGGAG--SVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE 325
           Y    + LG+G  G  S+Y     N   G  VAVK L      Q    +  E+ ++ ++ 
Sbjct: 9   YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 68
Query: 326 HKNLVKLLGC-SIEGPESL-LVYEYVPNRSLDQFIFDK--NKTKLLNWNKRFNIILGTAE 381
           H+++VK  GC   +G +S+ LV EYVP  SL  ++        +LL + ++        E
Sbjct: 69  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQI------CE 122
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG--TLG 439
           G+AYLH       IHR +   N+LLD D   KI DFGLA+       +      G   + 
Sbjct: 123 GMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 179
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPL----QRVWTLYRSNK 495
           + APE L   +    +DV+SFG+ + E++    SN       + L    Q   T+ R  +
Sbjct: 180 WYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTE 239
Query: 496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           L+E  +   +   P    C +  +   C +  A+ RP+    + +L
Sbjct: 240 LLERGE---RLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 282

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVS 431
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR     D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNT 216
Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
           T     + +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ ++ L 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELFKLL 272
Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +    +         D PA     +  +   C  A  + RP+  Q +
Sbjct: 273 KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 27/274 (9%)
Query: 278 KLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           +LG+G  GSV +          G  VAVK+L  +      +F  E+ ++ ++    +VK 
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 333 LGCSI-EGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            G S   G +SL LV EY+P+  L  F+  +     L+ ++         +G+ YL  GS
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GS 145
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGYMAPEYLVR 448
             R +HRD+   NIL++ +   KIADFGLA+    D+ +      G   + + APE L  
Sbjct: 146 R-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 449 GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD-----PN 503
              + ++DV+SFG+++ E+        +   S SP      +    + V A+        
Sbjct: 205 NIFSRQSDVWSFGVVLYELF------TYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258
Query: 504 LKDDFPAEQVC--NVLQIGLLCTQAAAALRPSMA 535
                PA   C   V ++  LC   +   RPS +
Sbjct: 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFS 292

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 114/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L  F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 123 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 177
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 219

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 14  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 66
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD-----KNKTKLL--NWNK 371
           +++      ++V+LLG   +G  +L++ E +    L  ++       +N   L   + +K
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHV 430
              +    A+G+AYL+     + +HRD+   N  + +DFT KI DFG+ R  +  D    
Sbjct: 127 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
                  + +M+PE L  G  T  +DV+SFG+++ EI
Sbjct: 184 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 15  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 127
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ + + + H+N+VK  
Sbjct: 13  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 125
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL- 451
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 452 TEKADVYSFGILIIEIVCG 470
            E  DV+S GI++  ++ G
Sbjct: 186 AEPVDVWSCGIVLTAMLAG 204

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 278 KLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           +LG+G  GSV +          G  VAVK+L  +      +F  E+ ++ ++    +VK 
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 333 LGCSI-EGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            G S   G +SL LV EY+P+  L  F+  +     L+ ++         +G+ YL  GS
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GS 133
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG--TLGYMAPEYLVR 448
             R +HRD+   NIL++ +   KIADFGLA+    D+ +      G   + + APE L  
Sbjct: 134 R-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 192
Query: 449 GQLTEKADVYSFGILIIEI 467
              + ++DV+SFG+++ E+
Sbjct: 193 NIFSRQSDVWSFGVVLYEL 211

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 99/222 (44%), Gaps = 23/222 (10%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
           E  E   N     K LG G  G V       +G       VAVK L   +    DE    
Sbjct: 31  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 88
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-------FDKNKTKL 366
            +E+ ++S + +H+N+V LLG    G   L++ EY     L  F+        DK   + 
Sbjct: 89  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP 148
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           L      +     A+G+A+L   +    IHRD+   N+LL      KI DFGLAR    D
Sbjct: 149 LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 205
Query: 427 RTHVSTAVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
             ++    A   + +MAPE +     T ++DV+S+GIL+ EI
Sbjct: 206 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 247

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 15  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 127
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 15  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 127
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 15  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 127
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 278 KLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           +LG+G  GSV +          G  VAVK+L  +      +F  E+ ++ ++    +VK 
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 333 LGCSIEG--PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            G S     PE  LV EY+P+  L  F+  +     L+ ++         +G+ YL  GS
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GS 129
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG--TLGYMAPEYLVR 448
             R +HRD+   NIL++ +   KIADFGLA+    D+        G   + + APE L  
Sbjct: 130 R-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSD 188
Query: 449 GQLTEKADVYSFGILIIEI 467
              + ++DV+SFG+++ E+
Sbjct: 189 NIFSRQSDVWSFGVVLYEL 207

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 90  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVS 431
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR     D    +
Sbjct: 149 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 205
Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
           T     + +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ ++ L 
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELFKLL 261
Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +    +         D PA     +  +   C  A  + RP+  Q +
Sbjct: 262 KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 299

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 114/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ +  L +F+ D +    +      + +    +GLA+ H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 126 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 180
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 222

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GL++ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 177
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 219

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 99/222 (44%), Gaps = 23/222 (10%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
           E  E   N     K LG G  G V       +G       VAVK L   +    DE    
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 96
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-------FDKNKTKL 366
            +E+ ++S + +H+N+V LLG    G   L++ EY     L  F+        DK   + 
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP 156
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           L      +     A+G+A+L   +    IHRD+   N+LL      KI DFGLAR    D
Sbjct: 157 LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 213
Query: 427 RTHVSTAVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
             ++    A   + +MAPE +     T ++DV+S+GIL+ EI
Sbjct: 214 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 255

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 13  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 125
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 186 PVDVWSCGIVLTAMLAG 202

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 14  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 114/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L  F+ D +    +      + +    +GLA+ H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 180
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 222

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 114/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ +  L +F+ D +    +      + +    +GLA+ H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 124 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 178
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 220

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 14  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 15  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 127
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 12  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 124
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL- 451
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 452 TEKADVYSFGILIIEIVCG 470
            E  DV+S GI++  ++ G
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 88  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVS 431
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR     D    +
Sbjct: 147 VSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKT 203
Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
           T     + +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ ++ L 
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELFKLL 259
Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +    +         D PA     +  +   C  A  + RP+  Q +
Sbjct: 260 KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 297

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 14  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVS 431
            +     A G+ YL   +  + IHRD+   N+L+ ++   +IADFGLAR     D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKT 216
Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
           T     + +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ ++ L 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELFKLL 272
Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +    +         D PA     +  +   C  A  + RP+  Q +
Sbjct: 273 KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 93  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVS 431
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR     D    +
Sbjct: 152 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 208
Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
           T     + +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ ++ L 
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELFKLL 264
Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +    +         D PA     +  +   C  A  + RP+  Q +
Sbjct: 265 KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 302

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 13  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 125
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL- 451
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 452 TEKADVYSFGILIIEIVCG 470
            E  DV+S GI++  ++ G
Sbjct: 186 AEPVDVWSCGIVLTAMLAG 204

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 133/285 (46%), Gaps = 33/285 (11%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 80
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN-------WNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +  L  ++         N         +   +    A+
Sbjct: 81  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 140
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           G+AYL+     + +HRD+   N ++  DFT KI DFG+ R  +  D           + +
Sbjct: 141 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           MAPE L  G  T  +D++SFG+++ EI         +  +  P Q +        +++  
Sbjct: 198 MAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQPYQGLSNEQVLKFVMDGG 248
Query: 501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV 545
             +  D+ P E+V ++++   +C Q    +RP+  + + LL + +
Sbjct: 249 YLDQPDNCP-ERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDDL 289

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 131/287 (45%), Gaps = 37/287 (12%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN-------WNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +  L  ++         N         +   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           G+AYL+     + +HRD+   N ++  DFT KI DFG+ R  +  D           + +
Sbjct: 142 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV 500
           MAPE L  G  T  +D++SFG+++ EI         +  +  P Q    L     L   +
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQPYQ---GLSNEQVLKFVM 246
Query: 501 DPNLKD--DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV 545
           D    D  D   E+V ++++   +C Q    +RP+  + + LL + +
Sbjct: 247 DGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 14  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 14  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL-TE 453
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +   E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 454 KADVYSFGILIIEIVCG 470
             DV+S GI++  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
           E  E   N     K LG G  G V       +G       VAVK L   +    DE    
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 96
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
            +E+ ++S + +H+N+V LLG    G   L++ EY     L  F+  + K+++L  +  F
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAF 154
Query: 374 NIILGT-------------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            I   T             A+G+A+L   +    IHRD+   N+LL      KI DFGLA
Sbjct: 155 AIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 421 RCFAADRTHVSTAVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
           R    D  ++    A   + +MAPE +     T ++DV+S+GIL+ EI
Sbjct: 212 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 12  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 124
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL- 451
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 452 TEKADVYSFGILIIEIVCG 470
            E  DV+S GI++  ++ G
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 12  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 124
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLVRGQL- 451
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL Y+APE L R +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 452 TEKADVYSFGILIIEIVCG 470
            E  DV+S GI++  ++ G
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 118/255 (46%), Gaps = 38/255 (14%)
Query: 277 KKLGQGGAGSV------YMGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           K LG+G  G V      ++      TTVAVK L  N +   + +  +E N++  + H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 330 VKLLG-CSIEGPESLLVYEYVPNRSLDQFI---------------------FDKNKTKLL 367
           +KL G CS +GP  LL+ EY    SL  F+                      D    + L
Sbjct: 89  IKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
                 +     ++G+ YL   +E +++HRD+   NIL+ +    KI+DFGL+R    + 
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 428 THVSTAVAGT-LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQR 486
           + V  +     + +MA E L     T ++DV+SFG+L+ EIV     N +      P +R
Sbjct: 205 SXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-LGGNPY---PGIPPER 260
Query: 487 VWTLYRSNKLVEAVD 501
           ++ L ++   +E  D
Sbjct: 261 LFNLLKTGHRMERPD 275

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 147 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVS 431
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR     D    +
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
           T     + +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ ++ L 
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELFKLL 318
Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +    +         D PA     +  +   C  A  + RP+  Q +
Sbjct: 319 KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 113/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ +  L  F+ D +    +      + +    +GLA+ H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 180
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 222

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 113/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ +  L  F+ D +    +      + +    +GLA+ H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 179
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 221

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 128/293 (43%), Gaps = 42/293 (14%)
Query: 272 YFNPSKKLGQGGAG--SVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE 325
           Y    + LG+G  G  S+Y     N   G  VAVK L  +   Q    +  E++++ ++ 
Sbjct: 32  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY 91
Query: 326 HKNLVKLLGCSIE-GPESL-LVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFNIILGTAE 381
           H++++K  GC  + G  SL LV EYVP  SL  ++        +LL + ++        E
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI------CE 145
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG--TLG 439
           G+AYLH       IHRD+   N+LLD D   KI DFGLA+              G   + 
Sbjct: 146 GMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVF 202
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSN-----------AFSQDSASPLQRVW 488
           + APE L   +    +DV+SFG+ + E++    S+             +Q   + L+   
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 489 TLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
            L R  +L         D  PAE    V  +   C +  A+ RP+    I +L
Sbjct: 263 LLERGERLPRP------DKCPAE----VYHLMKNCWETEASFRPTFENLIPIL 305

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 130/286 (45%), Gaps = 40/286 (13%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLV--------YEYVPNRSLD--QFIFDKNKT--KLLNWNKRF 373
           KN++ LLG C+ +GP  ++V         EY+  R     ++ +D N+   + + +    
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVST 432
           +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR     D    +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR 492
                + +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ ++ L +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELFKLLK 273
Query: 493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
               +         D PA     +  +   C  A  + RP+  Q +
Sbjct: 274 EGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 131/291 (45%), Gaps = 45/291 (15%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 78
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN-------WNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +  L  ++         N         +   +    A+
Sbjct: 79  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 138
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG-- 439
           G+AYL+     + +HRD+   N ++  DFT KI DFG+ R    D         G  G  
Sbjct: 139 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLL 191
Query: 440 ---YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL 496
              +MAPE L  G  T  +D++SFG+++ EI         +  +  P Q    L     L
Sbjct: 192 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQPYQ---GLSNEQVL 239
Query: 497 VEAVDPNLKD--DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV 545
              +D    D  D   E+V ++++   +C Q    +RP+  + + LL + +
Sbjct: 240 KFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDDL 287

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+ ++  +T           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 177
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 219

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+ ++  +T           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V  TL Y APE L+ 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 176
Query: 449 GQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +    A D++S G +  E+V   R   F  DS   + +++ ++R+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE--IDQLFRIFRT 218

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 127/277 (45%), Gaps = 29/277 (10%)
Query: 279 LGQGGAGSVYMG--SLPNGTT--VAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           +G G  G V  G   LP      VA+K L    T +   +F +E +++   +H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   +    +++ E++ N SLD F+  +         +   ++ G A G+ YL   ++  
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 129
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLG--YMAPEYLVRG 449
            +HR +   NIL++ +   K++DFGL+R    D +    ++A+ G +   + APE +   
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 450 QLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF 508
           + T  +DV+S+GI++ E++  G R               W +   + ++ A++ + +   
Sbjct: 190 KFTSASDVWSYGIVMWEVMSYGERP-------------YWDMTNQD-VINAIEQDYRLPP 235
Query: 509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV 545
           P +    + Q+ L C Q     RP   Q +  L   +
Sbjct: 236 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 272

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN-------WNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +  L  ++         N         +   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG-- 439
           G+AYL+     + +HRD+   N ++  DFT KI DFG+ R    D         G  G  
Sbjct: 142 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLL 194
Query: 440 ---YMAPEYLVRGQLTEKADVYSFGILIIEI 467
              +MAPE L  G  T  +D++SFG+++ EI
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 131/291 (45%), Gaps = 45/291 (15%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN-------WNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +  L  ++         N         +   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG-- 439
           G+AYL+     + +HRD+   N ++  DFT KI DFG+ R    D         G  G  
Sbjct: 142 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLL 194
Query: 440 ---YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL 496
              +MAPE L  G  T  +D++SFG+++ EI         +  +  P Q    L     L
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQPYQ---GLSNEQVL 242
Query: 497 VEAVDPNLKD--DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV 545
              +D    D  D   E+V ++++   +C Q    +RP+  + + LL + +
Sbjct: 243 KFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 130/286 (45%), Gaps = 40/286 (13%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLV--------YEYVPNRSLD--QFIFDKNKT--KLLNWNKRF 373
           KN++ LLG C+ +GP  ++V         EY+  R     ++ +D N+   + + +    
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVST 432
           +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR     D    +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR 492
                + +MAPE L     T ++DV+SFG+L+ EI     +   S     P++ ++ L +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELFKLLK 273
Query: 493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
               +         D PA     +  +   C  A  + RP+  Q +
Sbjct: 274 EGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 132/288 (45%), Gaps = 39/288 (13%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN-------WNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +  L  ++         N         +   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG-- 439
           G+AYL+     + +HRD+   N ++  DFT KI DFG+ R    +  +      G L   
Sbjct: 142 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETAYYRKGGKGLLPVR 197
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           +MAPE L  G  T  +D++SFG+++ EI         +  +  P Q    L     L   
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQPYQ---GLSNEQVLKFV 245
Query: 500 VDPNLKD--DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV 545
           +D    D  D   E+V ++++   +C Q    +RP+  + + LL + +
Sbjct: 246 MDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 6/191 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V  G       VA+K +I       DEF  E  ++ ++ H+ LV+L G  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+ N  L  ++  +         +   +     E + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD+   N L++     K++DFGL+R    D    S      + +  PE L+  + + K+D
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 457 VYSFGILIIEI 467
           +++FG+L+ EI
Sbjct: 204 IWAFGVLMWEI 214

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 117/255 (45%), Gaps = 38/255 (14%)
Query: 277 KKLGQGGAGSV------YMGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           K LG+G  G V      ++      TTVAVK L  N +   + +  +E N++  + H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 330 VKLLG-CSIEGPESLLVYEYVPNRSLDQFI---------------------FDKNKTKLL 367
           +KL G CS +GP  LL+ EY    SL  F+                      D    + L
Sbjct: 89  IKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
                 +     ++G+ YL   +E  ++HRD+   NIL+ +    KI+DFGL+R    + 
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 428 THVSTAVAGT-LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQR 486
           + V  +     + +MA E L     T ++DV+SFG+L+ EIV     N +      P +R
Sbjct: 205 SXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-LGGNPY---PGIPPER 260
Query: 487 VWTLYRSNKLVEAVD 501
           ++ L ++   +E  D
Sbjct: 261 LFNLLKTGHRMERPD 275

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 6/191 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V  G       VA+K +I       DEF  E  ++ ++ H+ LV+L G  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+ N  L  ++  +         +   +     E + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 123
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD+   N L++     K++DFGL+R    D    S      + +  PE L+  + + K+D
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 457 VYSFGILIIEI 467
           +++FG+L+ EI
Sbjct: 184 IWAFGVLMWEI 194

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 6/191 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V  G       VA+K +I       DEF  E  ++ ++ H+ LV+L G  
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+ N  L  ++  +         +   +     E + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 127
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD+   N L++     K++DFGL+R    D    S      + +  PE L+  + + K+D
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 187
Query: 457 VYSFGILIIEI 467
           +++FG+L+ EI
Sbjct: 188 IWAFGVLMWEI 198

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 6/191 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V  G       VA+K +I       DEF  E  ++ ++ H+ LV+L G  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+ N  L  ++  +         +   +     E + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD+   N L++     K++DFGL+R    D    S      + +  PE L+  + + K+D
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 457 VYSFGILIIEI 467
           +++FG+L+ EI
Sbjct: 204 IWAFGVLMWEI 214

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           + LG G  G VY G +      P+   VAVK L  +++ +  +D F  E  +IS   H+N
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELD-FLMEALIISKFNHQN 109
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLA 384
           +V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           YL    E   IHRDI   N LL         KI DFG+AR  + A            + +
Sbjct: 170 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEI 467
           M PE  + G  T K D +SFG+L+ EI
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 6/191 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V  G       VA+K +I       DEF  E  ++ ++ H+ LV+L G  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+ N  L  ++  +         +   +     E + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 128
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD+   N L++     K++DFGL+R    D    S      + +  PE L+  + + K+D
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 457 VYSFGILIIEI 467
           +++FG+L+ EI
Sbjct: 189 IWAFGVLMWEI 199

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 6/191 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V  G       VA+K +I       DEF  E  ++ ++ H+ LV+L G  
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+ N  L  ++  +         +   +     E + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 134
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD+   N L++     K++DFGL+R    D    S      + +  PE L+  + + K+D
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 194
Query: 457 VYSFGILIIEI 467
           +++FG+L+ EI
Sbjct: 195 IWAFGVLMWEI 205

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 6/191 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V  G       VA+K +I       DEF  E  ++ ++ H+ LV+L G  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+ N  L  ++  +         +   +     E + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 128
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD+   N L++     K++DFGL+R    D    S      + +  PE L+  + + K+D
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 457 VYSFGILIIEI 467
           +++FG+L+ EI
Sbjct: 189 IWAFGVLMWEI 199

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN-------WNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +  L  ++         N         +   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           G+AYL+     + +HR++   N ++  DFT KI DFG+ R  +  D           + +
Sbjct: 142 GMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEI 467
           MAPE L  G  T  +D++SFG+++ EI
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLV 330
           + LG+G  G V +          G  VAVK L   +    + +   E+ ++ ++ H+N+V
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 331 KLLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           K  G C+ +G   + L+ E++P+ SL +++  KNK K+ N  ++    +   +G+ YL  
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKI-NLKQQLKYAVQICKGMDYL-- 130
Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLGYMAPEYL 446
           GS  + +HRD+   N+L++ +   KI DFGL +    D+    V       + + APE L
Sbjct: 131 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 447 VRGQLTEKADVYSFGILIIEIV 468
           ++ +    +DV+SFG+ + E++
Sbjct: 190 MQSKFYIASDVWSFGVTLHELL 211

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLV 330
           + LG+G  G V +          G  VAVK L   +    + +   E+ ++ ++ H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 331 KLLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           K  G C+ +G   + L+ E++P+ SL +++  KNK K+ N  ++    +   +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKI-NLKQQLKYAVQICKGMDYL-- 142
Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLGYMAPEYL 446
           GS  + +HRD+   N+L++ +   KI DFGL +    D+    V       + + APE L
Sbjct: 143 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 447 VRGQLTEKADVYSFGILIIEIV 468
           ++ +    +DV+SFG+ + E++
Sbjct: 202 MQSKFYIASDVWSFGVTLHELL 223

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 82
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN-------WNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +  L  ++         N         +   +    A+
Sbjct: 83  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 142
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           G+AYL+     + +HR++   N ++  DFT KI DFG+ R  +  D           + +
Sbjct: 143 GMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEI 467
           MAPE L  G  T  +D++SFG+++ EI
Sbjct: 200 MAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 34/209 (16%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEHKNLVK 331
           +K+G+G  G VY      G T A+K++        DE        E++++  ++H N+VK
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVK 64
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN---------WNKRFNIILGTAEG 382
           L          +LV+E++          D++  KLL+           K F  +L    G
Sbjct: 65  LYDVIHTKKRLVLVFEHL----------DQDLKKLLDVCEGGLESVTAKSF--LLQLLNG 112
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           +AY H   + R++HRD+K  N+L++++   KIADFGLAR F       +  V  TL Y A
Sbjct: 113 IAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRA 168
Query: 443 PEYLV-RGQLTEKADVYSFGILIIEIVCG 470
           P+ L+   + +   D++S G +  E+V G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 34/209 (16%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEHKNLVK 331
           +K+G+G  G VY      G T A+K++        DE        E++++  ++H N+VK
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVK 64
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN---------WNKRFNIILGTAEG 382
           L          +LV+E++          D++  KLL+           K F  +L    G
Sbjct: 65  LYDVIHTKKRLVLVFEHL----------DQDLKKLLDVCEGGLESVTAKSF--LLQLLNG 112
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           +AY H   + R++HRD+K  N+L++++   KIADFGLAR F       +  V  TL Y A
Sbjct: 113 IAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRA 168
Query: 443 PEYLV-RGQLTEKADVYSFGILIIEIVCG 470
           P+ L+   + +   D++S G +  E+V G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKN 328
           F     LG+G    VY   S+  G  VA+K +          V    NEV +   ++H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           +++L     +     LV E   N  +++++  KN+ K  + N+  + +     G+ YLH 
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
                I+HRD+  SN+LL ++   KIADFGLA           T + GT  Y++PE   R
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATR 186
Query: 449 GQLTEKADVYSFGILIIEIVCGR 471
                ++DV+S G +   ++ GR
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 116/253 (45%), Gaps = 51/253 (20%)
Query: 237 LSKMKEDRNNLGLYATSMKKSCLSF--KYETLEKATNYFNPSKKLGQGGAGSV---YMGS 291
           +S+ K D N    Y+  +  S  +   +Y+ L          K +G G  G V   Y   
Sbjct: 1   MSRSKRDNN---FYSVEIGDSTFTVLKRYQNL----------KPIGSGAQGIVVAAYDAI 47
Query: 292 LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
           L     VA+K+L   F  +      + E+ L+  + HKN++ LL              + 
Sbjct: 48  LERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV------------FT 93
Query: 350 PNRSLDQF--------IFDKNKTKLLNW---NKRFNIIL-GTAEGLAYLHGGSETRIIHR 397
           P +SL++F        + D N ++++     ++R + +L     G+ +LH      IIHR
Sbjct: 94  PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHR 150
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D+K SNI++  D T KI DFGLAR   A  + + T    T  Y APE ++     E  D+
Sbjct: 151 DLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 458 YSFGILIIEIVCG 470
           +S G+++ E++ G
Sbjct: 209 WSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 116/253 (45%), Gaps = 51/253 (20%)
Query: 237 LSKMKEDRNNLGLYATSMKKSCLSF--KYETLEKATNYFNPSKKLGQGGAGSV---YMGS 291
           +S+ K D N    Y+  +  S  +   +Y+ L          K +G G  G V   Y   
Sbjct: 1   MSRSKRDNN---FYSVEIGDSTFTVLKRYQNL----------KPIGSGAQGIVCAAYDAI 47
Query: 292 LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
           L     VA+K+L   F  +      + E+ L+  + HKN++ LL              + 
Sbjct: 48  LERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV------------FT 93
Query: 350 PNRSLDQF--------IFDKNKTKLLNW---NKRFNIIL-GTAEGLAYLHGGSETRIIHR 397
           P +SL++F        + D N ++++     ++R + +L     G+ +LH      IIHR
Sbjct: 94  PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHR 150
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D+K SNI++  D T KI DFGLAR   A  + + T    T  Y APE ++     E  D+
Sbjct: 151 DLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 458 YSFGILIIEIVCG 470
           +S G+++ E++ G
Sbjct: 209 WSVGVIMGEMIKG 221

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 34/209 (16%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEHKNLVK 331
           +K+G+G  G VY      G T A+K++        DE        E++++  ++H N+VK
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVK 64
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN---------WNKRFNIILGTAEG 382
           L          +LV+E++          D++  KLL+           K F  +L    G
Sbjct: 65  LYDVIHTKKRLVLVFEHL----------DQDLKKLLDVCEGGLESVTAKSF--LLQLLNG 112
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           +AY H   + R++HRD+K  N+L++++   KIADFGLAR F       +  +  TL Y A
Sbjct: 113 IAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRA 168
Query: 443 PEYLV-RGQLTEKADVYSFGILIIEIVCG 470
           P+ L+   + +   D++S G +  E+V G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 18/206 (8%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS + H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGYM 441
           L    E   IHRDI   N LL         KI DFG+AR  + A            + +M
Sbjct: 171 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 442 APEYLVRGQLTEKADVYSFGILIIEI 467
            PE  + G  T K D +SFG+L+ EI
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 42/228 (18%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLV 330
           F P + LG+GG G V+   +  +    A+KR+    R+   E    EV  ++ +EH  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 331 KLLGCSIEG-------PESLLVYEYVPNRSLDQFIFDKNKTKLLNW-NKR---------- 372
           +     +E        P S  VY Y+  +          K  L +W N R          
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLC-------RKENLKDWMNGRCTIEERERSV 119
Query: 373 -FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
             +I L  AE + +LH      ++HRD+K SNI    D   K+ DFGL      D    +
Sbjct: 120 CLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 432 -----------TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIV 468
                      T   GT  YM+PE +     + K D++S G+++ E++
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           + LG G  G VY G +      P+   VAVK L  + + +  +D F  E  +IS + H+N
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKLNHQN 95
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLA 384
           +V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           YL    E   IHRDI   N LL         KI DFG+AR  + A            + +
Sbjct: 156 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEI 467
           M PE  + G  T K D +SFG+L+ EI
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 20/225 (8%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRL-IFNTRQWVD-EFFNEVNLI---S 322
           AT+ + P  ++G G  G+VY    P+ G  VA+K + + N  + +      EV L+    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 323 SIEHKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
           + EH N+V+L+  C+    +      LV+E+V ++ L  ++ DK     L      +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
               GL +LH      I+HRD+K  NIL+    T K+ADFGLAR ++         V  T
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV--T 174
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS 482
           L Y APE L++       D++S G +  E+   RR   F  +S +
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEA 217

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 28  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 87
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGYM 441
           L    E   IHRDI   N LL         KI DFG+AR  + A            + +M
Sbjct: 148 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 204
Query: 442 APEYLVRGQLTEKADVYSFGILIIEI 467
            PE  + G  T K D +SFG+L+ EI
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEI 230

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGYM 441
           L    E   IHRDI   N LL         KI DFG+AR  + A            + +M
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 442 APEYLVRGQLTEKADVYSFGILIIEI 467
            PE  + G  T K D +SFG+L+ EI
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 108/229 (47%), Gaps = 16/229 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV--DEFFNEVNLISSIEHKNLVKLLG 334
           +KLG G  G V++    +     V + I   R  V  ++   E+ ++ S++H N++K+  
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 335 CSIEGPESLLVYEYVPN-RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
              +     +V E       L++ +  + + K L+      ++      LAY H      
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QH 144
Query: 394 IIHRDIKTSNILLDKDFTP----KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
           ++H+D+K  NIL  +D +P    KI DFGLA  F +D    ST  AGT  YMAPE   R 
Sbjct: 145 VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPEVFKR- 200
Query: 450 QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE 498
            +T K D++S G+++  ++ G     F+  S   +Q+  T    N  VE
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTG--CLPFTGTSLEEVQQKATYKEPNYAVE 247

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           + LG G  G VY G +      P+   VAVK L  + + +  +D F  E  +IS   H+N
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 94
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLA 384
           +V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  
Sbjct: 95  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           YL    E   IHRDI   N LL         KI DFG+AR  + A            + +
Sbjct: 155 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEI 467
           M PE  + G  T K D +SFG+L+ EI
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 137/293 (46%), Gaps = 33/293 (11%)
Query: 256 KSCLSFKYETLEKATNYFNPSKKLGQGGAGSV-YMGSLPNGTTVAVKRL--IFNTRQWVD 312
           K+C+S   +  E   +   P  +LG+G  G V  M  +P+G  +AVKR+    N+++   
Sbjct: 36  KACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKR 95
Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF---IFDKNKTKLLNW 369
              +    + +++    V   G      +  +  E + + SLD+F   + DK +T  +  
Sbjct: 96  LLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQT--IPE 152
Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           +    I +   + L +LH  S+  +IHRD+K SN+L++     K+ DFG++  +  D   
Sbjct: 153 DILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDSV- 208
Query: 430 VSTAVAGTLGYMAPEY----LVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDS-ASPL 484
             T  AG   YMAPE     L +   + K+D++S GI +IE+   R    F  DS  +P 
Sbjct: 209 AKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR----FPYDSWGTPF 264
Query: 485 QRVWTLYRSNKLVEAVDPNLK-DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
           Q++       ++VE   P L  D F AE V    Q    C +  +  RP+  +
Sbjct: 265 QQL------KQVVEEPSPQLPADKFSAEFVDFTSQ----CLKKNSKERPTYPE 307

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           + LG G  G VY G +      P+   VAVK L  + + +  +D F  E  +IS   H+N
Sbjct: 53  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 111
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLA 384
           +V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  
Sbjct: 112 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 171
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           YL    E   IHRDI   N LL         KI DFG+AR  + A            + +
Sbjct: 172 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 228
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEI 467
           M PE  + G  T K D +SFG+L+ EI
Sbjct: 229 MPPEAFMEGIFTSKTDTWSFGVLLWEI 255

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 110
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGYM 441
           L    E   IHRDI   N LL         KI DFG+AR  + A            + +M
Sbjct: 171 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 442 APEYLVRGQLTEKADVYSFGILIIEI 467
            PE  + G  T K D +SFG+L+ EI
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTV----AVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G  +P+G  V    A+K L  NT    + E  +E  +++ +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDK----NKTKLLNWNKRFNIILGTAEGLAYL 386
           +LLG  +     L V + +P   L   + +         LLNW       +  A+G++YL
Sbjct: 83  RLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYL 135
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT-LGYMAPEY 445
               + R++HRD+   N+L+      KI DFGLAR    D T          + +MA E 
Sbjct: 136 E---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 446 LVRGQLTEKADVYSFGILIIEIV 468
           ++R + T ++DV+S+G+ + E++
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELM 215

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 20/225 (8%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRL-IFNTRQWVD-EFFNEVNLI---S 322
           AT+ + P  ++G G  G+VY    P+ G  VA+K + + N  + +      EV L+    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 323 SIEHKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
           + EH N+V+L+  C+    +      LV+E+V ++ L  ++ DK     L      +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
               GL +LH      I+HRD+K  NIL+    T K+ADFGLAR ++         V  T
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV--T 174
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS 482
           L Y APE L++       D++S G +  E+   RR   F  +S +
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEA 217

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           + LG G  G VY G +      P+   VAVK L  + + +  +D F  E  +IS   H+N
Sbjct: 54  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 112
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLA 384
           +V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  
Sbjct: 113 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 172
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           YL    E   IHRDI   N LL         KI DFG+AR  + A            + +
Sbjct: 173 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 229
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEI 467
           M PE  + G  T K D +SFG+L+ EI
Sbjct: 230 MPPEAFMEGIFTSKTDTWSFGVLLWEI 256

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 82/158 (51%), Gaps = 14/158 (8%)
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           EV L+  ++H N++KL     +     +V E Y      D+ I    K K  + +    I
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARI 126
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVST 432
           I     G+ Y+H  +   I+HRD+K  NILL   +KD   KI DFGL+ CF  + T +  
Sbjct: 127 IKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKD 182
Query: 433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            + GT  Y+APE L RG   EK DV+S G+++  ++ G
Sbjct: 183 RI-GTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSG 218

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGYM 441
           L    E   IHRDI   N LL         KI DFG+AR  + A            + +M
Sbjct: 157 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 442 APEYLVRGQLTEKADVYSFGILIIEI 467
            PE  + G  T K D +SFG+L+ EI
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           + LG G  G VY G +      P+   VAVK L  + + +  +D F  E  +IS   H+N
Sbjct: 63  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 121
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLA 384
           +V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  
Sbjct: 122 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 181
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           YL    E   IHRDI   N LL         KI DFG+AR  + A            + +
Sbjct: 182 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 238
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEI 467
           M PE  + G  T K D +SFG+L+ EI
Sbjct: 239 MPPEAFMEGIFTSKTDTWSFGVLLWEI 265

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           K +G G  G V        G  VAVK+L   F  +      + E+ L+  + HKN++ LL
Sbjct: 28  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 87
Query: 334 GCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTAE- 381
                         + P ++L++F        + D N  ++++    ++R + +L     
Sbjct: 88  NV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC 135
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A    + T    T  Y 
Sbjct: 136 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMMTPYVVTRYYR 190
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCG 470
           APE ++     E  D++S G ++ E+V G
Sbjct: 191 APEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           + LG G  G VY G +      P+   VAVK L  + + +  +D F  E  +IS   H+N
Sbjct: 43  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 101
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLA 384
           +V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  
Sbjct: 102 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 161
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           YL    E   IHRDI   N LL         KI DFG+AR  + A            + +
Sbjct: 162 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 218
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEI 467
           M PE  + G  T K D +SFG+L+ EI
Sbjct: 219 MPPEAFMEGIFTSKTDTWSFGVLLWEI 245

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 36/212 (16%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 24  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 81
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 82  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 184
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           Y APE ++     E  D++S G ++ E+VC +
Sbjct: 185 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 36/212 (16%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 35  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 92
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 93  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 140
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 141 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 195
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           Y APE ++     E  D++S G ++ E+VC +
Sbjct: 196 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           + LG G  G VY G +      P+   VAVK L  + + +  +D F  E  +IS   H+N
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 135
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLA 384
           +V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           YL    E   IHRDI   N LL         KI DFG+AR  + A            + +
Sbjct: 196 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEI 467
           M PE  + G  T K D +SFG+L+ EI
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 18/224 (8%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL--PNGTT--VAVKRLIFN--TRQWVD 312
           L  K E +    N     K LG+G  GSV  G+L   +GT+  VAVK +  +  +++ ++
Sbjct: 22  LQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE 81
Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEG-----PESLLVYEYVPNRSLDQFI-FDKNKT-- 364
           EF +E   +    H N+++LLG  IE      P+ +++  ++    L  ++ + + +T  
Sbjct: 82  EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141
Query: 365 KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA-RCF 423
           K +        ++  A G+ YL   S    +HRD+   N +L  D T  +ADFGL+ + +
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY 198
Query: 424 AADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
           + D           + ++A E L     T K+DV++FG+ + EI
Sbjct: 199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 277 KKLGQGGAGSVYMGSL----PNGTT--VAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNL 329
           ++LG+   G VY G L    P   T  VA+K L       + +EF +E  L + ++H N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIF-------------DKNKTKLLNWNKRFNII 376
           V LLG   +     +++ Y  +  L +F+              D+     L      +++
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVA 435
              A G+ YL   S   ++H+D+ T N+L+      KI+D GL R  +AAD   +     
Sbjct: 152 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
             + +MAPE ++ G+ +  +D++S+G+++ E+
Sbjct: 209 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 23/228 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRL-IFNTRQWVDEF----FNEVNLI- 321
           AT+ + P  ++G G  G+VY    P+ G  VA+K + + N              EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 322 --SSIEHKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
              + EH N+V+L+  C+    +      LV+E+V ++ L  ++ DK     L      +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           ++     GL +LH      I+HRD+K  NIL+    T K+ADFGLAR ++       T V
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPV 179
Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS 482
             TL Y APE L++       D++S G +  E+   RR   F  +S +
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEA 225

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 315 FNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRF 373
             EV L+  ++H N++KL     +     +V E Y      D+ I    K K  + +   
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAA 124
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHV 430
            II     G+ Y+H   +  I+HRD+K  NILL   +KD   KI DFGL+ CF  + T +
Sbjct: 125 RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKM 180
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWT 489
              + GT  Y+APE L RG   EK DV+S G+++  ++ G     + ++    L+RV T
Sbjct: 181 KDRI-GTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSG-TPPFYGKNEYDILKRVET 236

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 110/233 (47%), Gaps = 29/233 (12%)
Query: 248 GLYATSMKKSCLSFKYETLEKATNYFNPSK------KLGQGGAGSVYMGSLPNGTTVAVK 301
            LY  SMK+          E  T   NP        +LG G  G VY       + +A  
Sbjct: 17  NLYFQSMKQ---------YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 302 RLI-FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD 360
           ++I   + + ++++  E+++++S +H N+VKLL          ++ E+    ++D  + +
Sbjct: 68  KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE 127
Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             +   L  ++   +   T + L YLH   + +IIHRD+K  NIL   D   K+ADFG++
Sbjct: 128 LERP--LTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 421 RCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTE-----KADVYSFGILIIEI 467
                 RT     +  GT  +MAPE ++     +     KADV+S GI +IE+
Sbjct: 183 A--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 99/235 (42%), Gaps = 36/235 (15%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
           E  E   N     K LG G  G V       +G       VAVK L   +    DE    
Sbjct: 24  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 81
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI--------------- 358
            +E+ ++S + +H+N+V LLG    G   L++ EY     L  F+               
Sbjct: 82  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPG 141
Query: 359 -----FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK 413
                 DK   + L      +     A+G+A+L   +    IHRD+   N+LL      K
Sbjct: 142 QDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAK 198
Query: 414 IADFGLARCFAADRTHVSTAVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
           I DFGLAR    D  ++    A   + +MAPE +     T ++DV+S+GIL+ EI
Sbjct: 199 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 253

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 315 FNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRF 373
             EV L+  ++H N++KL     +     +V E Y      D+ I    K K  + +   
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAA 124
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHV 430
            II     G+ Y+H   +  I+HRD+K  NILL   +KD   KI DFGL+ CF  + T +
Sbjct: 125 RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKM 180
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWT 489
              + GT  Y+APE L RG   EK DV+S G+++  ++ G     + ++    L+RV T
Sbjct: 181 KDRI-GTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSG-TPPFYGKNEYDILKRVET 236

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  AEG
Sbjct: 74  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEG 126
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 127 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 184 ALESILHRIYTHQSDVWSYGVTVWELM 210

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 277 KKLGQGGAGSVYMGSL----PNGTT--VAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNL 329
           ++LG+   G VY G L    P   T  VA+K L       + +EF +E  L + ++H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIF-------------DKNKTKLLNWNKRFNII 376
           V LLG   +     +++ Y  +  L +F+              D+     L      +++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVA 435
              A G+ YL   S   ++H+D+ T N+L+      KI+D GL R  +AAD   +     
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
             + +MAPE ++ G+ +  +D++S+G+++ E+
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 100/228 (43%), Gaps = 29/228 (12%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
           E  E   N     K LG G  G V       +G       VAVK L   +    DE    
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 96
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDK------------ 361
            +E+ ++S + +H+N+V LLG    G   L++ EY     L  F+  K            
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPS 156
Query: 362 -NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            N  + L+     +     A+G+A+L   +    IHRD+   N+LL      KI DFGLA
Sbjct: 157 HNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 213
Query: 421 RCFAADRTHVSTAVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
           R    D  ++    A   + +MAPE +     T ++DV+S+GIL+ EI
Sbjct: 214 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 261

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 27/232 (11%)
Query: 248 GLYATSMKKSCLSFKYETLEKATNYFNPSK------KLGQGGAGSVYMGSLPNGTTVAVK 301
            LY  SMK+          E  T   NP        +LG G  G VY       + +A  
Sbjct: 17  NLYFQSMKQ---------YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 302 RLI-FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD 360
           ++I   + + ++++  E+++++S +H N+VKLL          ++ E+    ++D  + +
Sbjct: 68  KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE 127
Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             +   L  ++   +   T + L YLH   + +IIHRD+K  NIL   D   K+ADFG++
Sbjct: 128 LERP--LTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE-----KADVYSFGILIIEI 467
                       +  GT  +MAPE ++     +     KADV+S GI +IE+
Sbjct: 183 -AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 20/225 (8%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRL-IFNTRQWVD-EFFNEVNLI---S 322
           AT+ + P  ++G G  G+VY    P+ G  VA+K + + N  + +      EV L+    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 323 SIEHKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
           + EH N+V+L+  C+    +      LV+E+V ++ L  ++ DK     L      +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
               GL +LH      I+HRD+K  NIL+    T K+ADFGLAR ++         V  T
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV--T 174
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS 482
           L Y APE L++       D++S G +  E+   RR   F  +S +
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEA 217

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 115/253 (45%), Gaps = 51/253 (20%)
Query: 237 LSKMKEDRNNLGLYATSMKKSCLSF--KYETLEKATNYFNPSKKLGQGGAGSV---YMGS 291
           +S+ K D N    Y+  +  S  +   +Y+ L          K +G G  G V   Y   
Sbjct: 1   MSRSKRDNN---FYSVEIGDSTFTVLKRYQNL----------KPIGSGAQGIVCAAYDAI 47
Query: 292 LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
           L     VA+K+L   F  +      + E+ L+  + HKN++ LL              + 
Sbjct: 48  LERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV------------FT 93
Query: 350 PNRSLDQF--------IFDKNKTKLLNW---NKRFNIIL-GTAEGLAYLHGGSETRIIHR 397
           P +SL++F        + D N ++++     ++R + +L     G+ +LH      IIHR
Sbjct: 94  PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHR 150
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADV 457
           D+K SNI++  D T KI DFGLAR   A  + + T    T  Y APE ++     E  D+
Sbjct: 151 DLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 458 YSFGILIIEIVCG 470
           +S G ++ E++ G
Sbjct: 209 WSVGCIMGEMIKG 221

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 131/302 (43%), Gaps = 30/302 (9%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYM----GSLPNGTTVAVKRLI-FNTRQWVDEF-FN 316
           ++++EK  N       LG  G GS  M     +   G  VA+K+ +  +  + V +    
Sbjct: 21  FQSMEKYEN-------LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR 73
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E+ L+  + H+NLV LL    +     LV+E+V +  LD      N    L++      +
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYL 130
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
                G+ + H  +   IIHRDIK  NIL+ +    K+ DFG AR  AA        VA 
Sbjct: 131 FQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA- 186
Query: 437 TLGYMAPEYLVRGQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK 495
           T  Y APE LV      KA DV++ G L+ E+  G     F  DS      +  LY    
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG--EPLFPGDSD-----IDQLYHIMM 239
Query: 496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALR-PSMAQAIMLLTNKVCEIPTPSQP 554
            +  + P  ++ F    V   +++  +  +     R P +++ ++ L  K   I  P + 
Sbjct: 240 CLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHI-DPDKR 298
Query: 555 PF 556
           PF
Sbjct: 299 PF 300

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 27/232 (11%)
Query: 248 GLYATSMKKSCLSFKYETLEKATNYFNPSK------KLGQGGAGSVYMGSLPNGTTVAVK 301
            LY  SMK+          E  T   NP        +LG G  G VY       + +A  
Sbjct: 17  NLYFQSMKQ---------YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 302 RLI-FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD 360
           ++I   + + ++++  E+++++S +H N+VKLL          ++ E+    ++D  + +
Sbjct: 68  KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE 127
Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             +   L  ++   +   T + L YLH   + +IIHRD+K  NIL   D   K+ADFG++
Sbjct: 128 LERP--LTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE-----KADVYSFGILIIEI 467
                          GT  +MAPE ++     +     KADV+S GI +IE+
Sbjct: 183 -AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 16/198 (8%)
Query: 279 LGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFN-----EVNLISSIEHKNLVKL 332
           LG+G   +VY     N    VA+K++    R    +  N     E+ L+  + H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           L          LV++++     D  +  K+ + +L  +     +L T +GL YLH   + 
Sbjct: 78  LDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 131
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQL 451
            I+HRD+K +N+LLD++   K+ADFGLA+ F + +R +    V  T  Y APE L   ++
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLFGARM 189
Query: 452 TE-KADVYSFGILIIEIV 468
                D+++ G ++ E++
Sbjct: 190 YGVGVDMWAVGCILAELL 207

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 111 PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 163
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 164 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 220
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 221 ALESILHRIYTHQSDVWSYGVTVWELM 247

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIIL-GT 379
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 136 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRY 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG GG   V++   L +   VAVK L   +     +   F  E    +++ H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 335 C----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                +  GP   +V EYV   +L   +  +     +   +   +I    + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH--- 133
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGTLGYMAPEYLVR 448
           +  IIHRD+K +NIL+      K+ DFG+AR  A     V  + AV GT  Y++PE    
Sbjct: 134 QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 449 GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL 496
             +  ++DVYS G ++ E++ G     F+ D  SP+   +   R + +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGE--PPFTGD--SPVSVAYQHVREDPI 237

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSI--EHKNLVKLLG 334
           +G+G  G V+ GS   G  VAVK  IF++R   DE  +F E  L +++   H+N++  + 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVK--IFSSR---DEKSWFRETELYNTVMLRHENILGFIA 69
Query: 335 CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH--- 387
             +    S     L+  Y    SL    +D  +   L+      I+L  A GLA+LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 388 GGSETR--IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA---VAGTLGYMA 442
            G++ +  I HRD+K+ NIL+ K+    IAD GLA   +     +        GT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 443 PEYLVRGQLTE------KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
           PE L      +      + D+++FG+++ E+     SN   +D   P   V
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSI--EHKNLVKLLG 334
           +G+G  G V+ GS   G  VAVK  IF++R   DE  +F E  L +++   H+N++  + 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVK--IFSSR---DEKSWFRETELYNTVMLRHENILGFIA 69
Query: 335 CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH--- 387
             +    S     L+  Y    SL    +D  +   L+      I+L  A GLA+LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 388 GGSETR--IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA---VAGTLGYMA 442
            G++ +  I HRD+K+ NIL+ K+    IAD GLA   +     +        GT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 443 PEYLVRGQLTE------KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
           PE L      +      + D+++FG+++ E+     SN   +D   P   V
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 38/238 (15%)
Query: 254 MKKSCLSFKYETLEKATNYFNPSKKLGQ-----GGAGSVYMGSLPN--GTTVAVKRL--I 304
           M KS +  ++ ++E A + F   K+  Q      GA  +   +     G  VAVK+L   
Sbjct: 1   MSKSKVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP 60
Query: 305 FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF------- 357
           F  +      + E+ L+  + HKN++ LL              + P ++L++F       
Sbjct: 61  FQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVM 108
Query: 358 -IFDKNKTKLLNW---NKRFNIILGTAE-GLAYLHGGSETRIIHRDIKTSNILLDKDFTP 412
            + D N  ++++    ++R + +L     G+ +LH      IIHRD+K SNI++  D T 
Sbjct: 109 ELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 165
Query: 413 KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           KI DFGLAR   A    + T    T  Y APE ++        D++S G ++ E+V G
Sbjct: 166 KILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 36/211 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N ++++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRY 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y APE ++     E  D++S G ++ E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL  C  +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 145
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 146 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 281 QGGAGSVYMGSLPNGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEG 339
           +G  G V+   L N   VAVK      +Q W  E   E+     ++H+NL++ +     G
Sbjct: 25  RGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQSE--REIFSTPGMKHENLLQFIAAEKRG 81
Query: 340 P----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG------- 388
                E  L+  +    SL  ++    K  ++ WN+  ++    + GL+YLH        
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 389 -GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST-AVAGTLGYMAPEYL 446
            G +  I HRD K+ N+LL  D T  +ADFGLA  F   +    T    GT  YMAPE L
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVL 197
Query: 447 VRGQLT------EKADVYSFGILIIEIV 468
             G +        + D+Y+ G+++ E+V
Sbjct: 198 -EGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VA+K  I +  Q     + + F EV ++  + H N+VK
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L L+ EY     +  ++    + K      +F  I+   +   Y H   
Sbjct: 79  LFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCH--- 131
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
           + RI+HRD+K  N+LLD D   KIADFG +  F         A  G   Y APE L +G+
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGAPPYAAPE-LFQGK 188
Query: 451 LTE--KADVYSFGILIIEIVCG 470
             +  + DV+S G+++  +V G
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSG 210

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 36/211 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N ++++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRY 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y APE ++     E  D++S G ++ E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           + LG G  G VY G +      P+   VAVK L  + + +  +D F  E  +IS   H+N
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 95
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLA 384
           +V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
           YL    E   IHRDI   N LL         KI DFG+A+  + A            + +
Sbjct: 156 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKW 212
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEI 467
           M PE  + G  T K D +SFG+L+ EI
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIIL-GT 379
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 136 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRY 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSI--EHKNLVKLLG 334
           +G+G  G V+ GS   G  VAVK  IF++R   DE  +F E  L +++   H+N++  + 
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVK--IFSSR---DEKSWFRETELYNTVMLRHENILGFIA 98
Query: 335 CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH--- 387
             +    S     L+  Y    SL    +D  +   L+      I+L  A GLA+LH   
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 388 GGSETR--IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA---VAGTLGYMA 442
            G++ +  I HRD+K+ NIL+ K+    IAD GLA   +     +        GT  YMA
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 443 PEYLVRGQLTE------KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
           PE L      +      + D+++FG+++ E+     SN   +D   P   V
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 265

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 36/212 (16%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + +      T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRY 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           Y APE ++     E  D++S G ++ E+VC +
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 130 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIIL-GT 379
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 81  LLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 128
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 129 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRY 183
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 36/211 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N ++++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y APE ++     E  D++S G ++ E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 78  PHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 131 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELM 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 81  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 134 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELM 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 78  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 131 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELM 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 133 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 132 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVK----RLIFNTRQWVDEFFNEVNLISSIEHK 327
           F   + LG G  G V++  S  NG   A+K     ++   +Q V+   +E  ++S + H 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHP 66
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLA 384
            ++++ G   +  +  ++ +Y+    L  F   +   +  N   +F      AE    L 
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFY----AAEVCLALE 120
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      II+RD+K  NILLDK+   KI DFG A+ +  D   V+  + GT  Y+APE
Sbjct: 121 YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-YVPD---VTYXLCGTPDYIAPE 173
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            +      +  D +SFGILI E++ G
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIF-----NTRQWVDEFFNEVNLISSIEHKNLV 330
           K LG G  G+V+ G  +P G ++ +   I      + RQ      + +  I S++H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDK----NKTKLLNWNKRFNIILGTAEGLAYL 386
           +LLG    G    LV +Y+P  SL   +           LLNW  +       A+G+ YL
Sbjct: 97  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 149
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT-LGYMAPEY 445
               E  ++HR++   N+LL      ++ADFG+A     D   +  + A T + +MA E 
Sbjct: 150 ---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 206
Query: 446 LVRGQLTEKADVYSFGILIIEIV 468
           +  G+ T ++DV+S+G+ + E++
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWELM 229

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 87  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 139
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 140 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 196
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 197 ALESILHRIYTHQSDVWSYGVTVWELM 223

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG GG   V++   L +   VAVK L   +     +   F  E    +++ H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 335 C----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                +  GP   +V EYV   +L   +  +     +   +   +I    + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH--- 133
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGTLGYMAPEYLVR 448
           +  IIHRD+K +NI++      K+ DFG+AR  A     V  + AV GT  Y++PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 449 GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL 496
             +  ++DVYS G ++ E++ G     F+ D  SP+   +   R + +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGE--PPFTGD--SPVSVAYQHVREDPI 237

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIF-----NTRQWVDEFFNEVNLISSIEHKNLV 330
           K LG G  G+V+ G  +P G ++ +   I      + RQ      + +  I S++H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDK----NKTKLLNWNKRFNIILGTAEGLAYL 386
           +LLG    G    LV +Y+P  SL   +           LLNW  +       A+G+ YL
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 131
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT-LGYMAPEY 445
               E  ++HR++   N+LL      ++ADFG+A     D   +  + A T + +MA E 
Sbjct: 132 ---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 446 LVRGQLTEKADVYSFGILIIEIV 468
           +  G+ T ++DV+S+G+ + E++
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELM 211

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 130 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 133 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 83  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 135
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 136 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 192
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 193 ALESILHRIYTHQSDVWSYGVTVWELM 219

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 71  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 123
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 124 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELM 207

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 137 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 132 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 133 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 133 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 130 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 130 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNKT----KLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 97  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 143
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR  A +     T    T  Y 
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYR 196
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 125/297 (42%), Gaps = 43/297 (14%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
           K LG G  G V   +           TVAVK L  +      E   +E+ ++S +  H N
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 329 LVKLLG-CSIEGPESLLVYEY--------VPNRSLDQFIFDKNKTKLLNWNKRF------ 373
           +V LLG C+I GP +L++ EY           R  D FI  K    ++  ++        
Sbjct: 112 IVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 374 -NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A+G+A+L   +    IHRD+   NILL      KI DFGLAR    D  +V  
Sbjct: 171 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVK 227
Query: 433 AVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS-PLQRVWTL 490
             A   + +MAPE +     T ++DV+S+GI + E+        FS  S+  P   V   
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL--------FSLGSSPYPGMPV--- 276
Query: 491 YRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCE 547
              +K  + +    +   P      +  I   C  A    RP+  Q + L+  ++ E
Sbjct: 277 --DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 331

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 102 PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 154
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 155 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 211
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 212 ALESILHRIYTHQSDVWSYGVTVWELM 238

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +LG G  G VY   +   G   A K +   + + ++++  E+ ++++ +H  +VKLLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
               +  ++ E+ P  ++D  + + ++   L   +   +     E L +LH     RIIH
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHS---KRIIH 140
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE--- 453
           RD+K  N+L+  +   ++ADFG++            +  GT  +MAPE ++   + +   
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 199
Query: 454 --KADVYSFGILIIEI 467
             KAD++S GI +IE+
Sbjct: 200 DYKADIWSLGITLIEM 215

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 36/212 (16%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + +      T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRY 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           Y APE ++     E  D++S G ++ E+VC +
Sbjct: 191 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 117/239 (48%), Gaps = 22/239 (9%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +++G+G  G V+ G + N T   VA+K + +      +++   E+ ++S  +   +
Sbjct: 25  FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            K  G  ++G +  ++ EY+   S      D  +    +  +   ++    +GL YLH  
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLH-- 137
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
           SE +I HRDIK +N+LL +    K+ADFG+A      +   +T V GT  +MAPE + + 
Sbjct: 138 SEKKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 195
Query: 450 QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF 508
               KAD++S GI  IE+  G   N+       P++ ++ + ++N       P L  DF
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPPNS----DMHPMRVLFLIPKNNP------PTLVGDF 244

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 97  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 143
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR  A +     T    T  Y 
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYR 196
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 128/306 (41%), Gaps = 41/306 (13%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVN 319
           E   N  +  K LG G  G V   +           TVAVK L  +      E   +E+ 
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 320 LISSI-EHKNLVKLLG-CSIEGPESLLVYEY--------VPNRSLDQFIFDKNKTKLLNW 369
           ++S +  H N+V LLG C+I GP +L++ EY           R  D FI  K    ++  
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 370 NKRF-------NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
           ++         +     A+G+A+L   +    IHRD+   NILL      KI DFGLAR 
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 423 FAADRTHVSTAVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA 481
              D  +V    A   + +MAPE +     T ++DV+S+GI + E+        FS  S 
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL--------FSLGS- 245
Query: 482 SPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           SP      +   +K  + +    +   P      +  I   C  A    RP+  Q + L+
Sbjct: 246 SPYP---GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 542 TNKVCE 547
             ++ E
Sbjct: 303 EKQISE 308

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRY 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 35/222 (15%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIE-HKNLVKL 332
           KKLG+G  G V+       G  VAVK++   F         F E+ +++ +  H+N+V L
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 333 LGC--SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    +    +  LV++Y+    L   I    +  +L    +  ++    + + YLH G 
Sbjct: 75  LNVLRADNDRDVYLVFDYMET-DLHAVI----RANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA--------------------ADRTHV 430
              ++HRD+K SNILL+ +   K+ADFGL+R F                      D   +
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 431 STAVAGTLGYMAPEYLV-RGQLTEKADVYSFGILIIEIVCGR 471
            T    T  Y APE L+   + T+  D++S G ++ EI+CG+
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 68  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 126 LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 174 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 228
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y APE ++     E  D++S G ++ E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 97  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 143
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR  A +     T    T  Y 
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYR 196
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 31  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 88
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 89  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 191
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y APE ++     E  D++S G ++ E++ G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VA+K  I +  Q     + + F EV ++  + H N+VK
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 75
Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L L+ EY     +  ++    + K      +F  I+   +   Y H   
Sbjct: 76  LFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCH--- 128
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
           + RI+HRD+K  N+LLD D   KIADFG +  F            G+  Y APE L +G+
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDTFCGSPPYAAPE-LFQGK 185
Query: 451 LTE--KADVYSFGILIIEIVCG 470
             +  + DV+S G+++  +V G
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSG 207

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F +   ++ V+ +   E+ + + + H N
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L     +     L+ EY P   L + +     FD+ +T          I+   A+ L
Sbjct: 85  ILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTA--------TIMEELADAL 136
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
            Y HG    ++IHRDIK  N+LL      KIADFG +    + R      + GTL Y+ P
Sbjct: 137 MYCHG---KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLR---RKTMCGTLDYLPP 190
Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCG 470
           E +      EK D++  G+L  E++ G
Sbjct: 191 EMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +LG G  G VY   +   G   A K +   + + ++++  E+ ++++ +H  +VKLLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
               +  ++ E+ P  ++D  + + ++   L   +   +     E L +LH     RIIH
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHS---KRIIH 132
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE--- 453
           RD+K  N+L+  +   ++ADFG++            +  GT  +MAPE ++   + +   
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 191
Query: 454 --KADVYSFGILIIEI 467
             KAD++S GI +IE+
Sbjct: 192 DYKADIWSLGITLIEM 207

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 41/296 (13%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
           K LG G  G V   +           TVAVK L  +      E   +E+ ++S +  H N
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 329 LVKLLG-CSIEGPESLLVYEY--------VPNRSLDQFIFDKNKTKLLNWNKRF------ 373
           +V LLG C+I GP +L++ EY           R  D FI  K    ++  ++        
Sbjct: 112 IVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 374 -NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A+G+A+L   +    IHRD+   NILL      KI DFGLAR    D  +V  
Sbjct: 171 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 433 AVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
             A   + +MAPE +     T ++DV+S+GI + E+        FS  S SP      + 
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL--------FSLGS-SPYP---GMP 275
Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCE 547
             +K  + +    +   P      +  I   C  A    RP+  Q + L+  ++ E
Sbjct: 276 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 331

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG GG   V++   L +   VAVK L   +     +   F  E    +++ H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 335 C----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                +  GP   +V EYV   +L   +  +     +   +   +I    + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH--- 133
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGTLGYMAPEYLVR 448
           +  IIHRD+K +NI++      K+ DFG+AR  A     V  + AV GT  Y++PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 449 GQLTEKADVYSFGILIIEIVCGRRSNAFSQDS 480
             +  ++DVYS G ++ E++ G     F+ DS
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGE--PPFTGDS 223

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y APE ++     E  D++S G ++ E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRY 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y APE ++     E  D++S G ++ E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 41/296 (13%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
           K LG G  G V   +           TVAVK L  +      E   +E+ ++S +  H N
Sbjct: 45  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 104
Query: 329 LVKLLG-CSIEGPESLLVYEY--------VPNRSLDQFIFDKNKTKLLNWNKRF------ 373
           +V LLG C+I GP +L++ EY           R  D FI  K    ++  ++        
Sbjct: 105 IVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 163
Query: 374 -NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A+G+A+L   +    IHRD+   NILL      KI DFGLAR    D  +V  
Sbjct: 164 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 220
Query: 433 AVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
             A   + +MAPE +     T ++DV+S+GI + E+        FS  S SP      + 
Sbjct: 221 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL--------FSLGS-SPYP---GMP 268
Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCE 547
             +K  + +    +   P      +  I   C  A    RP+  Q + L+  ++ E
Sbjct: 269 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 324

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 41/296 (13%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
           K LG G  G V   +           TVAVK L  +      E   +E+ ++S +  H N
Sbjct: 47  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 106
Query: 329 LVKLLG-CSIEGPESLLVYEY--------VPNRSLDQFIFDKNKTKLLNWNKRF------ 373
           +V LLG C+I GP +L++ EY           R  D FI  K    ++  ++        
Sbjct: 107 IVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 165
Query: 374 -NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +     A+G+A+L   +    IHRD+   NILL      KI DFGLAR    D  +V  
Sbjct: 166 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 222
Query: 433 AVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
             A   + +MAPE +     T ++DV+S+GI + E+        FS  S SP      + 
Sbjct: 223 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL--------FSLGS-SPYP---GMP 270
Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCE 547
             +K  + +    +   P      +  I   C  A    RP+  Q + L+  ++ E
Sbjct: 271 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 326

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 68  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 126 LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 174 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 228
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 44/214 (20%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG---TL 438
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR       H    +AG   T 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATR 186
Query: 439 GYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            Y APE ++      +  D++S G ++ E++ GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 138
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     + A  GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 44/214 (20%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG---TL 438
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR       H    +AG   T 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATR 186
Query: 439 GYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            Y APE ++      +  D++S G ++ E++ GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           K LG+G  G V +      G  VA+K   + +            E++ +  + H +++KL
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
                   E ++V EY  N   D +I  ++K       + F  I+   E   Y H     
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIISAVE---YCH---RH 132
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
           +I+HRD+K  N+LLD+    KIADFGL+     D   + T+  G+  Y APE ++ G+L 
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYAAPE-VISGKLY 189
Query: 453 --EKADVYSFGILIIEIVCGR 471
              + DV+S G+++  ++C R
Sbjct: 190 AGPEVDVWSCGVILYVMLCRR 210

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           K LG+G  G V +      G  VA+K   + +            E++ +  + H +++KL
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
                   E ++V EY  N   D +I  ++K       + F  I+   E   Y H     
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIISAVE---YCH---RH 131
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
           +I+HRD+K  N+LLD+    KIADFGL+     D   + T+  G+  Y APE ++ G+L 
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYAAPE-VISGKLY 188
Query: 453 --EKADVYSFGILIIEIVCGR 471
              + DV+S G+++  ++C R
Sbjct: 189 AGPEVDVWSCGVILYVMLCRR 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 6/159 (3%)
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLL--VYEYVPNRSLDQFIFDKNKTK-LLNWN 370
             +EVNL+  ++H N+V+     I+   + L  V EY     L   I    K +  L+  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 371 KRFNIILGTAEGLAYLHGGSE--TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
               ++      L   H  S+    ++HRD+K +N+ LD     K+ DFGLAR    D T
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-T 170
Query: 429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
             + A  GT  YM+PE + R    EK+D++S G L+ E+
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 31  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 88
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 89  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 191
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VAVK  I +  Q     + + F EV ++  + H N+VK
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L LV EY     +  ++    + K      +F  I+   +   Y H   
Sbjct: 78  LFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCH--- 130
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
           +  I+HRD+K  N+LLD D   KIADFG +  F         A  G   Y APE L +G+
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDAFCGAPPYAAPE-LFQGK 187
Query: 451 LTE--KADVYSFGILIIEIVCG 470
             +  + DV+S G+++  +V G
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSG 209

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 24  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 81
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 82  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 184
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           K LG+G  G V +      G  VA+K   + +            E++ +  + H +++KL
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
                   E ++V EY  N   D +I  ++K       + F  I+   E   Y H     
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIISAVE---YCH---RH 126
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
           +I+HRD+K  N+LLD+    KIADFGL+     D   + T+  G+  Y APE ++ G+L 
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYAAPE-VISGKLY 183
Query: 453 --EKADVYSFGILIIEIVCGR 471
              + DV+S G+++  ++C R
Sbjct: 184 AGPEVDVWSCGVILYVMLCRR 204

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 31  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 88
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 89  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 191
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 24  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 81
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 82  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 184
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 29  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 86
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 87  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 134
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 135 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 189
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 190 YRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 81  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 128
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T  
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 183
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           Y APE ++     E  D++S G ++ E+V
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 112
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 113 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 169
Query: 432 TAVAGT--LGYMAPEYLVRGQLTEKADVYSFGILIIE 466
               G   + + APE +   + + K+DV+SFG+L+ E
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           K LG+G  G V +      G  VA+K   + +            E++ +  + H +++KL
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
                   E ++V EY  N   D +I  ++K       + F  I+   E   Y H     
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIISAVE---YCH---RH 122
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
           +I+HRD+K  N+LLD+    KIADFGL+     D   + T+  G+  Y APE ++ G+L 
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYAAPE-VISGKLY 179
Query: 453 --EKADVYSFGILIIEIVCGR 471
              + DV+S G+++  ++C R
Sbjct: 180 AGPEVDVWSCGVILYVMLCRR 200

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 36/222 (16%)
Query: 277 KKLGQGGAGSVYMGSLPNG---TTVAVKRLIFNTRQWVDE-----FFNEVNLISSI-EHK 327
           K LG G  G V M +   G   T V+++  +   ++  D        +E+ +++ +  H+
Sbjct: 51  KVLGSGAFGKV-MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 328 NLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNK-----------TKLLNWNKRFNI 375
           N+V LLG C++ GP   L++EY     L  ++  K +            K L   +  N+
Sbjct: 110 NIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 376 I---------LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           +            A+G+ +L   S    +HRD+   N+L+      KI DFGLAR   +D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 427 RTHVSTAVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
             +V    A   + +MAPE L  G  T K+DV+S+GIL+ EI
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 108
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 109 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165
Query: 432 TAVAGT--LGYMAPEYLVRGQLTEKADVYSFGILIIE 466
               G   + + APE +   + + K+DV+SFG+L+ E
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 44/214 (20%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNKT----KLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 86  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 132
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG---TL 438
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR       H    +AG   T 
Sbjct: 133 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATR 182
Query: 439 GYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            Y APE ++      +  D++S G ++ E++ GR
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 51  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 106
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 107 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 163
Query: 432 TAVAGT--LGYMAPEYLVRGQLTEKADVYSFGILIIE 466
               G   + + APE +   + + K+DV+SFG+L+ E
Sbjct: 164 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 200

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH----------- 326
           LGQG  G V    +  +    A+K+ I +T + +    +EV L++S+ H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 327 --KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
             +N VK +    +     +  EY  NR+L   I  +N  +    ++ + +     E L+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQ--QRDEYWRLFRQILEALS 130
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-------CFAADRTHVS------ 431
           Y+H      IIHRD+K  NI +D+    KI DFGLA+           D  ++       
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 432 TAVAGTLGYMAPEYLV-RGQLTEKADVYSFGILIIEIV 468
           T+  GT  Y+A E L   G   EK D+YS GI+  E++
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG GG   V++   L     VAVK L   +     +   F  E    +++ H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 335 C----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                +  GP   +V EYV   +L   +  +     +   +   +I    + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH--- 133
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGTLGYMAPEYLVR 448
           +  IIHRD+K +NI++      K+ DFG+AR  A     V  + AV GT  Y++PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 449 GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL 496
             +  ++DVYS G ++ E++ G     F+ D  SP+   +   R + +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGE--PPFTGD--SPVSVAYQHVREDPI 237

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 126
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 127 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 183
Query: 432 TAVAGT--LGYMAPEYLVRGQLTEKADVYSFGILIIE 466
               G   + + APE +   + + K+DV+SFG+L+ E
Sbjct: 184 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 95  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 142 GLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRWYR 194
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 118
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 119 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 432 TAVAGT--LGYMAPEYLVRGQLTEKADVYSFGILIIE 466
               G   + + APE +   + + K+DV+SFG+L+ E
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 128
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 129 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 432 TAVAGT--LGYMAPEYLVRGQLTEKADVYSFGILIIE 466
               G   + + APE +   + + K+DV+SFG+L+ E
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 128
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 129 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 432 TAVAGT--LGYMAPEYLVRGQLTEKADVYSFGILIIE 466
               G   + + APE +   + + K+DV+SFG+L+ E
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 101 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 147
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 148 GLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRWYR 200
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 81  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFG A+   A ++ + +      + +M
Sbjct: 134 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELM 217

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 85/315 (26%), Positives = 127/315 (40%), Gaps = 44/315 (13%)
Query: 254 MKKSCLSFKYET--LEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIF 305
           + + C    Y+    E   +  N  K LG+G  G V       +       TVAVK L  
Sbjct: 8   LDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKE 67
Query: 306 N-TRQWVDEFFNEVNLISSI-EHKNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN 362
             T        +E+ ++  I  H N+V LLG C+  G   +++ E+    +L  ++  K 
Sbjct: 68  GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127
Query: 363 K---------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK 413
                        L            A+G+ +L   +  + IHRD+   NILL +    K
Sbjct: 128 NEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVK 184
Query: 414 IADFGLARCFAADRTHVSTAVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRR 472
           I DFGLAR    D  +V    A   L +MAPE +     T ++DV+SFG+L+ EI     
Sbjct: 185 IXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI----- 239
Query: 473 SNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAA 528
              FS   ASP       Y   K+ E     LK+      P      + Q  L C     
Sbjct: 240 ---FSL-GASP-------YPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 288
Query: 529 ALRPSMAQAIMLLTN 543
           + RP+ ++ +  L N
Sbjct: 289 SQRPTFSELVEHLGN 303

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 16/212 (7%)
Query: 267 EKAT-NYFNPSKKLGQGGAGSVYMG---SLPN-GTTVAVKRLIFNTRQWVDEFFN--EVN 319
           EKA  ++F   K LGQG  G V++    + P+ G   A+K L   T +  D      E +
Sbjct: 23  EKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERD 82
Query: 320 LISSIEHKNLVKL-LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
           +++ + H  +VKL      EG +  L+ +++  R  D F     +      + +F  +  
Sbjct: 83  ILADVNHPFVVKLHYAFQTEG-KLYLILDFL--RGGDLFTRLSKEVMFTEEDVKF-YLAE 138
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            A GL +LH      II+RD+K  NILLD++   K+ DFGL++  A D    + +  GT+
Sbjct: 139 LALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-AIDHEKKAYSFCGTV 194
Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            YMAPE + R   +  AD +S+G+L+ E++ G
Sbjct: 195 EYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 470
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 471 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527
Query: 432 TAVAGT--LGYMAPEYLVRGQLTEKADVYSFGILIIE 466
               G   + + APE +   + + K+DV+SFG+L+ E
Sbjct: 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 564

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 115/254 (45%), Gaps = 48/254 (18%)
Query: 236 RLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPN 294
           R S M ++R     Y   + K+     +E  E+  N  +P   +G G  GSV        
Sbjct: 17  RGSHMSQERPTF--YRQELNKTI----WEVPERYQN-LSP---VGSGAYGSVCAAFDTKT 66
Query: 295 GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR 352
           G  VAVK+L   F +       + E+ L+  ++H+N++ LL              + P R
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPAR 114
Query: 353 SLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
           SL++F  ++        D N      KL + + +F +I     GL Y+H      IIHRD
Sbjct: 115 SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSAD---IIHRD 170
Query: 399 IKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADV 457
           +K SN+ +++D   KI DFGLAR    +     T    T  Y APE ++      +  D+
Sbjct: 171 LKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDI 226
Query: 458 YSFGILIIEIVCGR 471
           +S G ++ E++ GR
Sbjct: 227 WSVGCIMAELLTGR 240

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 95  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 142 GLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRWYR 194
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 115/254 (45%), Gaps = 48/254 (18%)
Query: 236 RLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPN 294
           R S M ++R     Y   + K+     +E  E+  N  +P   +G G  GSV        
Sbjct: 16  RGSHMSQERPTF--YRQELNKTI----WEVPERYQN-LSP---VGSGAYGSVCAAFDTKT 65
Query: 295 GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR 352
           G  VAVK+L   F +       + E+ L+  ++H+N++ LL              + P R
Sbjct: 66  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPAR 113
Query: 353 SLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
           SL++F  ++        D N      KL + + +F +I     GL Y+H      IIHRD
Sbjct: 114 SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSAD---IIHRD 169
Query: 399 IKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADV 457
           +K SN+ +++D   KI DFGLAR    +     T    T  Y APE ++      +  D+
Sbjct: 170 LKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDI 225
Query: 458 YSFGILIIEIVCGR 471
           +S G ++ E++ GR
Sbjct: 226 WSVGCIMAELLTGR 239

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFG A+   A ++ + +      + +M
Sbjct: 132 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 36/211 (17%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 32  KPIGSGAQGIVCAAYDAILER--NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 89
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 90  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 137
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR        V   V  T  
Sbjct: 138 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV--TRY 192
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y APE ++     E  D++S G ++ E++ G
Sbjct: 193 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 115/254 (45%), Gaps = 48/254 (18%)
Query: 236 RLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPN 294
           R S M ++R     Y   + K+     +E  E+  N  +P   +G G  GSV        
Sbjct: 16  RGSHMSQERPTF--YRQELNKTI----WEVPERYQN-LSP---VGSGAYGSVCAAFDTKT 65
Query: 295 GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR 352
           G  VAVK+L   F +       + E+ L+  ++H+N++ LL              + P R
Sbjct: 66  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPAR 113
Query: 353 SLDQF--IF--------DKNKT----KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
           SL++F  ++        D N      KL + + +F +I     GL Y+H      IIHRD
Sbjct: 114 SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSAD---IIHRD 169
Query: 399 IKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADV 457
           +K SN+ +++D   KI DFGLAR    +     T    T  Y APE ++      +  D+
Sbjct: 170 LKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDI 225
Query: 458 YSFGILIIEIVCGR 471
           +S G ++ E++ GR
Sbjct: 226 WSVGCIMAELLTGR 239

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 471
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 472 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 528
Query: 432 TAVAGT--LGYMAPEYLVRGQLTEKADVYSFGILIIE 466
               G   + + APE +   + + K+DV+SFG+L+ E
Sbjct: 529 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 565

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 115/254 (45%), Gaps = 48/254 (18%)
Query: 236 RLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPN 294
           R S M ++R     Y   + K+     +E  E+  N  +P   +G G  GSV        
Sbjct: 17  RGSHMSQERPTF--YRQELNKTI----WEVPERYQN-LSP---VGSGAYGSVCAAFDTKT 66
Query: 295 GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR 352
           G  VAVK+L   F +       + E+ L+  ++H+N++ LL              + P R
Sbjct: 67  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPAR 114
Query: 353 SLDQF--IF--------DKNKT----KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
           SL++F  ++        D N      KL + + +F +I     GL Y+H      IIHRD
Sbjct: 115 SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSAD---IIHRD 170
Query: 399 IKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADV 457
           +K SN+ +++D   KI DFGLAR    +     T    T  Y APE ++      +  D+
Sbjct: 171 LKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDI 226
Query: 458 YSFGILIIEIVCGR 471
           +S G ++ E++ GR
Sbjct: 227 WSVGCIMAELLTGR 240

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 137
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     + +  GT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           F   + +G GG G V+      +G T  ++R+ +N  +       EV  ++ ++H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE----REVKALAKLDHVNIVH 69
Query: 332 LLGC-------------SIEG----PES------------LLVYEYVPNRSLDQFIFDKN 362
             GC             S+E     PE+             +  E+    +L+Q+I +K 
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKR 128
Query: 363 KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
           + + L+      +     +G+ Y+H     ++IHRD+K SNI L      KI DFGL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 423 FAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIV 468
              D     T   GTL YM+PE +      ++ D+Y+ G+++ E++
Sbjct: 186 LKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K L  G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 137 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 6/159 (3%)
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLL--VYEYVPNRSLDQFIFDKNKTK-LLNWN 370
             +EVNL+  ++H N+V+     I+   + L  V EY     L   I    K +  L+  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 371 KRFNIILGTAEGLAYLHGGSE--TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
               ++      L   H  S+    ++HRD+K +N+ LD     K+ DFGLAR    D +
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
              T V GT  YM+PE + R    EK+D++S G L+ E+
Sbjct: 172 FAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFG A+   A ++ + +      + +M
Sbjct: 132 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 113/225 (50%), Gaps = 16/225 (7%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G V+ G + N T   VA+K + +      +++   E+ ++S  +   +
Sbjct: 29  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 87
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            K  G  ++  +  ++ EY+   S      D  +   L+  +   I+    +GL YLH  
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLH-- 141
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
           SE +I HRDIK +N+LL +    K+ADFG+A      +   +T V GT  +MAPE + + 
Sbjct: 142 SEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 199
Query: 450 QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN 494
               KAD++S GI  IE+  G   ++       P++ ++ + ++N
Sbjct: 200 AYDSKADIWSLGITAIELARGEPPHS----ELHPMKVLFLIPKNN 240

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG GG   V++   L     VAVK L   +     +   F  E    +++ H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 335 C----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                +  GP   +V EYV   +L   +  +     +   +   +I    + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH--- 133
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGTLGYMAPEYLVR 448
           +  IIHRD+K +NI++      K+ DFG+AR  A     V  + AV GT  Y++PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 449 GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL 496
             +  ++DVYS G ++ E++ G     F+ D  SP+   +   R + +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGE--PPFTGD--SPVSVAYQHVREDPI 237

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFY-----------TAE 140
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     + +  GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L     ++ +D+++ G +I ++V G
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 96  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 142
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 143 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 195
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 116/257 (45%), Gaps = 54/257 (21%)
Query: 236 RLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPN 294
           R S M ++R     Y   + K+     +E  E+  N  +P   +G G  GSV        
Sbjct: 17  RGSHMSQERPTF--YRQELNKTI----WEVPERYQN-LSP---VGSGAYGSVCAAFDTKT 66
Query: 295 GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR 352
           G  VAVK+L   F +       + E+ L+  ++H+N++ LL              + P R
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPAR 114
Query: 353 SLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
           SL++F  ++        D N      KL + + +F +I     GL Y+H      IIHRD
Sbjct: 115 SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSAD---IIHRD 170
Query: 399 IKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG---TLGYMAPEYLVRG-QLTEK 454
           +K SN+ +++D   KI DFGLAR       H    + G   T  Y APE ++      + 
Sbjct: 171 LKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATRWYRAPEIMLNWMHYNQT 223
Query: 455 ADVYSFGILIIEIVCGR 471
            D++S G ++ E++ GR
Sbjct: 224 VDIWSVGCIMAELLTGR 240

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 96  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 142
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 143 GLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM----TGYVATRWYR 195
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 92  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 138
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 139 GLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM----TGYVATRWYR 191
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 84/309 (27%), Positives = 129/309 (41%), Gaps = 44/309 (14%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWV 311
           L +     E   +  N  K LG+G  G V       +       TVAVK L    T    
Sbjct: 15  LPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH 74
Query: 312 DEFFNEVNLISSI-EHKNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
               +E+ ++  I  H N+V LLG C+  G   +++ E+    +L  ++  K + + + +
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPY 133
Query: 370 NKRFNIIL----------GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL 419
              +   L            A+G+ +L   +  + IHRD+   NILL +    KI DFGL
Sbjct: 134 KDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGL 190
Query: 420 ARCFAADRTHVSTAVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQ 478
           AR    D  +V    A   L +MAPE +     T ++DV+SFG+L+ EI        FS 
Sbjct: 191 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL 242
Query: 479 DSASPLQRVWTLYRSNKLVEAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSM 534
             ASP       Y   K+ E     LK+      P      + Q  L C     + RP+ 
Sbjct: 243 -GASP-------YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 294
Query: 535 AQAIMLLTN 543
           ++ +  L N
Sbjct: 295 SELVEHLGN 303

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VAVK  I +  Q     + + F EV ++  + H N+VK
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L LV EY     +  ++    + K      +F  I+   +   Y H   
Sbjct: 78  LFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCH--- 130
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
           +  I+HRD+K  N+LLD D   KIADFG +  F            G+  Y APE L +G+
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDTFCGSPPYAAPE-LFQGK 187
Query: 451 LTE--KADVYSFGILIIEIVCG 470
             +  + DV+S G+++  +V G
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSG 209

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 279 LGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+G  G VY G   N       VAVK    + T    ++F +E  ++ +++H ++VKL+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLAYLHGGS 390
           G   E P + ++ E  P   L  ++ ++NK  L    K   ++L + +    +AYL    
Sbjct: 76  GIIEEEP-TWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQICKAMAYLES-- 127
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
               +HRDI   NIL+      K+ DFGL+R    +  + ++     + +M+PE +   +
Sbjct: 128 -INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 186
Query: 451 LTEKADVYSFGILIIEIV 468
            T  +DV+ F + + EI+
Sbjct: 187 FTTASDVWMFAVCMWEIL 204

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFG A+   A ++ + +      + +M
Sbjct: 132 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VAVK  I +  Q     + + F EV ++  + H N+VK
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L LV EY     +  ++    + K      +F  I+   +   Y H   
Sbjct: 78  LFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCH--- 130
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
           +  I+HRD+K  N+LLD D   KIADFG +  F            G+  Y APE L +G+
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDTFCGSPPYAAPE-LFQGK 187
Query: 451 LTE--KADVYSFGILIIEIVCG 470
             +  + DV+S G+++  +V G
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSG 209

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 279 LGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+G  G VY G   N       VAVK    + T    ++F +E  ++ +++H ++VKL+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLAYLHGGS 390
           G   E P + ++ E  P   L  ++ ++NK  L    K   ++L + +    +AYL    
Sbjct: 92  GIIEEEP-TWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQICKAMAYLES-- 143
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
               +HRDI   NIL+      K+ DFGL+R    +  + ++     + +M+PE +   +
Sbjct: 144 -INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 202
Query: 451 LTEKADVYSFGILIIEIV 468
            T  +DV+ F + + EI+
Sbjct: 203 FTTASDVWMFAVCMWEIL 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 279 LGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+G  G VY G   N       VAVK    + T    ++F +E  ++ +++H ++VKL+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLAYLHGGS 390
           G   E P + ++ E  P   L  ++ ++NK  L    K   ++L + +    +AYL    
Sbjct: 80  GIIEEEP-TWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQICKAMAYLES-- 131
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
               +HRDI   NIL+      K+ DFGL+R    +  + ++     + +M+PE +   +
Sbjct: 132 -INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 190
Query: 451 LTEKADVYSFGILIIEIV 468
            T  +DV+ F + + EI+
Sbjct: 191 FTTASDVWMFAVCMWEIL 208

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 100 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 146
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 147 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 199
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G V+ G + N T   VA+K + +      +++   E+ ++S  +   +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            K  G  ++  +  ++ EY+   S      D  +   L+  +   I+    +GL YLH  
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLH-- 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
           SE +I HRDIK +N+LL +    K+ADFG+A      +   +T V GT  +MAPE + + 
Sbjct: 122 SEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 179
Query: 450 QLTEKADVYSFGILIIEIVCGRRSNA 475
               KAD++S GI  IE+  G   ++
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHS 205

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTR---QWVDEFFNEVNLISSIEHKNLVKL 332
           K +G+G    V +   +  G  VAV R+I  T+     + + F EV ++  + H N+VKL
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
               IE  ++L LV EY     +  ++    + K      +F  I+   +   Y H   +
Sbjct: 79  FEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCH---Q 131
Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
             I+HRD+K  N+LLD D   KIADFG +  F            G+  Y APE L +G+ 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDTFCGSPPYAAPE-LFQGKK 188
Query: 452 TE--KADVYSFGILIIEIVCG 470
            +  + DV+S G+++  +V G
Sbjct: 189 YDGPEVDVWSLGVILYTLVSG 209

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 96  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 142
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 143 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 195
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 96  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 142
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 143 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 195
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K L  G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 137 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 92  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 138
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 139 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 191
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 102 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 148
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 149 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 201
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 102 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 148
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 149 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 201
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 86  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQF-LIYQILR 132
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 133 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 185
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG GG   V++   L     VAVK L   +     +   F  E    +++ H  +V +  
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 335 C----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                +  GP   +V EYV   +L   +  +     +   +   +I    + L + H   
Sbjct: 97  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH--- 150
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGTLGYMAPEYLVR 448
           +  IIHRD+K +NI++      K+ DFG+AR  A     V  + AV GT  Y++PE    
Sbjct: 151 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 210
Query: 449 GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL 496
             +  ++DVYS G ++ E++ G     F+ D  SP+   +   R + +
Sbjct: 211 DSVDARSDVYSLGCVLYEVLTG--EPPFTGD--SPVSVAYQHVREDPI 254

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 95  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 142 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 194
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNKT----KLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGXVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 89  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 135
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 136 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 188
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 141
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     + +  GT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 97  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 143
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 196
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 102 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 148
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 149 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYR 201
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFG A+   A ++ + +      + +M
Sbjct: 130 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K L  G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +M
Sbjct: 130 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 92  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 138
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 139 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 191
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYM 441
           + YL    + R++HRD+   N+L+      KI DFG A+   A ++ + +      + +M
Sbjct: 137 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           A E ++    T ++DV+S+G+ + E++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 49/307 (15%)
Query: 279 LGQGGAGSVYMGSLPNG---TTVAVKRLI-FNTRQWVDEFFNEVNLISSI-EHKNLVKLL 333
           +G+G  G V    +         A+KR+  + ++    +F  E+ ++  +  H N++ LL
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA------------- 380
           G         L  EY P+ +L  F+    K+++L  +  F I   TA             
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 381 ---EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG- 436
               G+ YL   S+ + IHRD+   NIL+ +++  KIADFGL+R       +V   +   
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 437 TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL 496
            + +MA E L     T  +DV+S+G+L+ EIV    +       A   +++   YR  K 
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 263
Query: 497 VEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPF 556
           +   D              V  +   C +     RPS AQ I++  N++ E     +  +
Sbjct: 264 LNCDD-------------EVYDLMRQCWREKPYERPSFAQ-ILVSLNRMLE----ERKTY 305
Query: 557 LNSSVME 563
           +N+++ E
Sbjct: 306 VNTTLYE 312

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 112
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD     
Sbjct: 113 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK 169
Query: 432 TAVAGT--LGYMAPEYLVRGQLTEKADVYSFGILIIE 466
               G   + + APE +   + + K+DV+SFG+L+ E
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTR---QWVDEFFNEVNLISSIEHKNLVKL 332
           K +G+G    V +   +  G  VAV R+I  T+     + + F EV ++  + H N+VKL
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
               IE  ++L LV EY     +  ++    + K      +F  I+   +   Y H   +
Sbjct: 79  FEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCH---Q 131
Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
             I+HRD+K  N+LLD D   KIADFG +  F            G+  Y APE L +G+ 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDEFCGSPPYAAPE-LFQGKK 188
Query: 452 TE--KADVYSFGILIIEIVCG 470
            +  + DV+S G+++  +V G
Sbjct: 189 YDGPEVDVWSLGVILYTLVSG 209

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 29/214 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           F   + +G GG G V+      +G T  +KR+ +N     ++   EV  ++ ++H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVH 68
Query: 332 LLGCSIEG----PES-------------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
             GC  +G    PE+              +  E+    +L+Q+I +K + + L+      
Sbjct: 69  YNGC-WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           +     +G+ Y+H     ++I+RD+K SNI L      KI DFGL      D     +  
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK- 182
Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIV 468
            GTL YM+PE +      ++ D+Y+ G+++ E++
Sbjct: 183 -GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLV 330
            K +G+G    V +   +  G  VAVK  I +  Q     + + F EV ++  + H N+V
Sbjct: 20  QKTIGKGNFAKVKLARHVLTGREVAVK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 331 KLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           KL    IE  ++L LV EY     +  ++    + K      +F  I+   +   Y H  
Sbjct: 78  KLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCH-- 131
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
            +  I+HRD+K  N+LLD D   KIADFG +  F            G+  Y APE L +G
Sbjct: 132 -QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK--LDTFCGSPPYAAPE-LFQG 187
Query: 450 QLTE--KADVYSFGILIIEIVCG 470
           +  +  + DV+S G+++  +V G
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNKT----KLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 95  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 142 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 194
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 122
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 123 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 100/215 (46%), Gaps = 10/215 (4%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFN 316
           L+ K +  E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   
Sbjct: 56  LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 115
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E+ ++       +V   G      E  +  E++   SLDQ +    K   +       + 
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVS 172
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           +   +GL YL    + +I+HRD+K SNIL++     K+ DFG++         ++ +  G
Sbjct: 173 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVG 227
Query: 437 TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           T  YM+PE L     + ++D++S G+ ++E+  GR
Sbjct: 228 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 92  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 138
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 139 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 191
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNKT----KLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNKT----KLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 113 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 159
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 160 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 212
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 49/307 (15%)
Query: 279 LGQGGAGSVYMGSLPNG---TTVAVKRLI-FNTRQWVDEFFNEVNLISSI-EHKNLVKLL 333
           +G+G  G V    +         A+KR+  + ++    +F  E+ ++  +  H N++ LL
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA------------- 380
           G         L  EY P+ +L  F+    K+++L  +  F I   TA             
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 381 ---EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG- 436
               G+ YL   S+ + IHRD+   NIL+ +++  KIADFGL+R       +V   +   
Sbjct: 140 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 193
Query: 437 TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL 496
            + +MA E L     T  +DV+S+G+L+ EIV    +       A   +++   YR  K 
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 253
Query: 497 VEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPF 556
           +   D              V  +   C +     RPS AQ I++  N++ E     +  +
Sbjct: 254 LNCDD-------------EVYDLMRQCWREKPYERPSFAQ-ILVSLNRMLE----ERKTY 295
Query: 557 LNSSVME 563
           +N+++ E
Sbjct: 296 VNTTLYE 302

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 137
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNKT----KLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 87  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 133
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 134 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 186
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 138
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 116
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 117 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNKT----KLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 86  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 132
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 133 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 185
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 118
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 119 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 115
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 116 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 101 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 147
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 148 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 200
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNKT----KLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 86  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 132
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 133 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 185
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 117
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 118 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 140
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 21/221 (9%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMG-SLPNGTT-VAVKRLIFNTRQWVDEF--FNEVNLI-- 321
           +A   +    ++G+G  G V+    L NG   VA+KR+   T +         EV ++  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 322 -SSIEHKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
             + EH N+V+L   C++   +      LV+E+V ++ L  ++ DK     +      ++
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDM 125
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           +     GL +LH     R++HRD+K  NIL+      K+ADFGLAR ++      S  V 
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV- 181
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAF 476
            TL Y APE L++       D++S G +  E+   RR   F
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLF 219

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNKT----KLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 87  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 133
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 134 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 186
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 138
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 21/221 (9%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMG-SLPNGTT-VAVKRLIFNTRQWVDEF--FNEVNLI-- 321
           +A   +    ++G+G  G V+    L NG   VA+KR+   T +         EV ++  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 322 -SSIEHKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
             + EH N+V+L   C++   +      LV+E+V ++ L  ++ DK     +      ++
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDM 125
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           +     GL +LH     R++HRD+K  NIL+      K+ADFGLAR ++      S  V 
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV- 181
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAF 476
            TL Y APE L++       D++S G +  E+   RR   F
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLF 219

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 140
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNKT----KLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 88  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 134
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y 
Sbjct: 135 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYR 187
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 134/285 (47%), Gaps = 35/285 (12%)
Query: 265 TLEKATNYFNPSKKLGQGGAGSV-YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLI 321
           ++E   +   P  +LG+G  G V  M  +P+G  +AVKR+    N+++      +    +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF---IFDKNKTKLLNWNKRFNIILG 378
            +++    V   G      +  +  E + + SLD+F   + DK +T  +  +    I + 
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQT--IPEDILGKIAVS 117
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV-AGT 437
             + L +LH  S+  +IHRD+K SN+L++     K+ DFG++     D   V+  + AG 
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGC 172
Query: 438 LGYMAPE----YLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDS-ASPLQRVWTLYR 492
             YMAPE     L +   + K+D++S GI +IE+   R    F  DS  +P Q++     
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR----FPYDSWGTPFQQL----- 223
Query: 493 SNKLVEAVDPNLK-DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
             ++VE   P L  D F AE V    Q    C +  +  RP+  +
Sbjct: 224 -KQVVEEPSPQLPADKFSAEFVDFTSQ----CLKKNSKERPTYPE 263

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F+  + LG+G  G+VY+        +   +++F +   ++ V+ +   E+ + S + H N
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           ++++     +     L+ E+ P   L + +    K    +  +    +   A+ L Y H 
Sbjct: 77  ILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCH- 132
Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
             E ++IHRDIK  N+L+      KIADFG +    + R      + GTL Y+ PE +  
Sbjct: 133 --ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRXMCGTLDYLPPEMIEG 187
Query: 449 GQLTEKADVYSFGILIIEIVCG 470
               EK D++  G+L  E + G
Sbjct: 188 KTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 100/215 (46%), Gaps = 10/215 (4%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFN 316
           L+ K +  E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   
Sbjct: 21  LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E+ ++       +V   G      E  +  E++   SLDQ +    K   +       + 
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVS 137
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           +   +GL YL    + +I+HRD+K SNIL++     K+ DFG++         ++ +  G
Sbjct: 138 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVG 192
Query: 437 TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           T  YM+PE L     + ++D++S G+ ++E+  GR
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNL 329
           F    ++G+G  G VY G + N T   VA+K + +      +++   E+ ++S  +   +
Sbjct: 21  FTKLDRIGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            +  G  ++  +  ++ EY+   S      D  K   L       I+    +GL YLH  
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHS- 134
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
              R IHRDIK +N+LL +    K+ADFG+A     D         GT  +MAPE + + 
Sbjct: 135 --ERKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQS 191
Query: 450 QLTEKADVYSFGILIIEIVCGRRSNA 475
               KAD++S GI  IE+  G   N+
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPNS 217

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 22/200 (11%)
Query: 277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEHKNLV 330
           +++G+G  G V+ G L  + T VAVK    + R+ +      +F  E  ++    H N+V
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +L+G   +     +V E V  +  D   F + +   L       ++   A G+ YL    
Sbjct: 176 RLIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG----TLGYMAPEYL 446
               IHRD+   N L+ +    KI+DFG++R    +   V  A  G     + + APE L
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGLRQVPVKWTAPEAL 287
Query: 447 VRGQLTEKADVYSFGILIIE 466
             G+ + ++DV+SFGIL+ E
Sbjct: 288 NYGRYSSESDVWSFGILLWE 307

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISS 323
           +E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                +V   G      E  +  E++   SLDQ +    K   +       + +   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
            YL    + +I+HRD+K SNIL++     K+ DFG++         ++ +  GT  YM+P
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGR 471
           E L     + ++D++S G+ ++E+  GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISS 323
           +E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                +V   G      E  +  E++   SLDQ +    K   +       + +   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
            YL    + +I+HRD+K SNIL++     K+ DFG++         ++ +  GT  YM+P
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGR 471
           E L     + ++D++S G+ ++E+  GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 21/221 (9%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMG-SLPNGTT-VAVKRLIFNTRQWVDEF--FNEVNLI-- 321
           +A   +    ++G+G  G V+    L NG   VA+KR+   T +         EV ++  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 322 -SSIEHKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
             + EH N+V+L   C++   +      LV+E+V ++ L  ++ DK     +      ++
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDM 125
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           +     GL +LH     R++HRD+K  NIL+      K+ADFGLAR ++      S  V 
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV- 181
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAF 476
            TL Y APE L++       D++S G +  E+   RR   F
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLF 219

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 100/215 (46%), Gaps = 10/215 (4%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFN 316
           L+ K +  E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   
Sbjct: 13  LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 72
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E+ ++       +V   G      E  +  E++   SLDQ +    +       K   + 
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 129
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           +   +GL YL    + +I+HRD+K SNIL++     K+ DFG++         ++ +  G
Sbjct: 130 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVG 184
Query: 437 TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           T  YM+PE L     + ++D++S G+ ++E+  GR
Sbjct: 185 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 140
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 135/295 (45%), Gaps = 25/295 (8%)
Query: 277 KKLGQGGAG-SVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           +K+G+G  G ++ + S  +G    +K +  +  + +  +E   EV ++++++H N+V+  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
               E     +V +Y     L + I +  K  L   ++  +  +     L ++H   + +
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH---DRK 145
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
           I+HRDIK+ NI L KD T ++ DFG+AR   +    ++ A  GT  Y++PE         
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELARACIGTPYYLSPEICENKPYNN 204
Query: 454 KADVYSFGILIIEIVCGRRSNAFSQDSAS-----------PLQRVWTLYRSNKLVEAVDP 502
           K+D+++ G ++ E+   +  +AF   S             P   +   Y    LV  +  
Sbjct: 205 KSDIWALGCVLYELCTLK--HAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFK 262
Query: 503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSM-AQAIMLLT-NKVCEIPTPSQPP 555
               D P+  V ++L+ G +  +    L P + A+   L T +K    P P++ P
Sbjct: 263 RNPRDRPS--VNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRP 315

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISS 323
           +E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                +V   G      E  +  E++   SLDQ +    K   +       + +   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
            YL    + +I+HRD+K SNIL++     K+ DFG++         ++ +  GT  YM+P
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGR 471
           E L     + ++D++S G+ ++E+  GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISS 323
           +E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                +V   G      E  +  E++   SLDQ +    K   +       + +   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
            YL    + +I+HRD+K SNIL++     K+ DFG++         ++ +  GT  YM+P
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGR 471
           E L     + ++D++S G+ ++E+  GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 44/214 (20%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 113 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 159
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG---TL 438
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR       H    + G   T 
Sbjct: 160 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVATR 209
Query: 439 GYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            Y APE ++      +  D++S G ++ E++ GR
Sbjct: 210 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 140
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 143
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 144 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 141
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 140
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F+  + LG+G  G+VY+        +   +++F +   ++ V+ +   E+ + S + H N
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           ++++     +     L+ E+ P   L + +    K    +  +    +   A+ L Y H 
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCH- 131
Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
             E ++IHRDIK  N+L+      KIADFG +    + R      + GTL Y+ PE +  
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRXMCGTLDYLPPEMIEG 186
Query: 449 GQLTEKADVYSFGILIIEIVCG 470
               EK D++  G+L  E + G
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVG 208

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VAVK  I +  Q     + + F EV +   + H N+VK
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIXKVLNHPNIVK 77
Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L LV EY     +  ++    + K      +F  I+   +   Y H   
Sbjct: 78  LFEV-IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ---YCH--- 130
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
           +  I+HRD+K  N+LLD D   KIADFG +  F         A  G   Y APE L +G+
Sbjct: 131 QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK--LDAFCGAPPYAAPE-LFQGK 187
Query: 451 LTE--KADVYSFGILIIEIVCG 470
             +  + DV+S G+++  +V G
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSG 209

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMGSL---PNGTTVAVKRLIFNTRQW-VDEFFNEVNLISS 323
           K  N      +LG G  GSV  G          VA+K L   T +   +E   E  ++  
Sbjct: 7   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 66
Query: 324 IEHKNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           +++  +V+L+G C  E    +LV E      L +F+  K +   +  +    ++   + G
Sbjct: 67  LDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMG 122
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT--LGY 440
           + YL    E   +HRD+   N+LL      KI+DFGL++   AD ++ +   AG   L +
Sbjct: 123 MKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIE 466
            APE +   + + ++DV+S+G+ + E
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWE 205

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISS 323
           +E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                +V   G      E  +  E++   SLDQ +    +       K   + +   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGL 117
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
            YL    + +I+HRD+K SNIL++     K+ DFG++         ++ +  GT  YM+P
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGR 471
           E L     + ++D++S G+ ++E+  GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISS 323
           ++ +   + LG+G  G V +      G   AVK  + + RQ       +    EV L+  
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQ 82
Query: 324 IEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           ++H N++KL     +     LV E Y      D+ I  K  +++        II     G
Sbjct: 83  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAARIIRQVLSG 138
Query: 383 LAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           + Y+H   + +I+HRD+K  N+LL+   KD   +I DFGL+  F A +        GT  
Sbjct: 139 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTAY 193
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y+APE L  G   EK DV+S G+++  ++ G
Sbjct: 194 YIAPEVL-HGTYDEKCDVWSTGVILYILLSG 223

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL---DQFIF--DKNKTKL 366
           D+F NE+ +I+ I+++  +   G      E  ++YEY+ N S+   D++ F  DKN T  
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           +       II       +Y+H   E  I HRD+K SNIL+DK+   K++DFG +      
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 427 RTHVSTAVAGTLGYMAPEYLVRGQLTE--KADVYSFGI 462
           +   S    GT  +M PE+          K D++S GI
Sbjct: 206 KIKGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 35/194 (18%)
Query: 294 NGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
            G  VA+K+L   F +  +    + E+ L+  + H+N++ LL              + P+
Sbjct: 49  TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV------------FTPD 96
Query: 352 RSLDQF--------IFDKNKTKLLNWNK----RFN-IILGTAEGLAYLHGGSETRIIHRD 398
            +LD F            +  KL+   K    R   ++    +GL Y+H      IIHRD
Sbjct: 97  ETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRD 153
Query: 399 IKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADV 457
           +K  N+ +++D   KI DFGLAR   AD       V  T  Y APE ++   + T+  D+
Sbjct: 154 LKPGNLAVNEDCELKILDFGLAR--QADSEMXGXVV--TRWYRAPEVILNWMRYTQTVDI 209
Query: 458 YSFGILIIEIVCGR 471
           +S G ++ E++ G+
Sbjct: 210 WSVGCIMAEMITGK 223

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 127/303 (41%), Gaps = 45/303 (14%)
Query: 180 FNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSK 239
            + G + ++S +++  H               +   V S  A  + SL   +AA    S+
Sbjct: 18  LSRGAHEKFSVEEYLVH--------------ALQGSVSSGQAHSLTSLAKTWAARGSRSR 63
Query: 240 MKEDR--NNLGLYATSMKKSCLSFKY-ETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNG 295
               +  +N G+  T   K  + ++Y E +  AT+      +LG+G  G V+ M     G
Sbjct: 64  EPSPKTEDNEGVLLTEKLKP-VDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTG 118
Query: 296 TTVAVKRLIFNTRQWVDEFFNEVNLIS--SIEHKNLVKLLGCSIEGPESLLVYEYVPNRS 353
              AVK++         E F    L++   +    +V L G   EGP   +  E +   S
Sbjct: 119 FQCAVKKVRL-------EVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGS 171
Query: 354 LDQFIFDKNKTKLLNWNKRFNIILGTA-EGLAYLHGGSETRIIHRDIKTSNILLDKDFT- 411
           L Q + ++          R    LG A EGL YLH     RI+H D+K  N+LL  D + 
Sbjct: 172 LGQLVKEQGCLP----EDRALYYLGQALEGLEYLH---SRRILHGDVKADNVLLSSDGSH 224
Query: 412 PKIADFGLARCFAADRTHVSTA----VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
             + DFG A C   D    S      + GT  +MAPE ++      K DV+S   +++ +
Sbjct: 225 AALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHM 284
Query: 468 VCG 470
           + G
Sbjct: 285 LNG 287

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 22/200 (11%)
Query: 277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEHKNLV 330
           +++G+G  G V+ G L  + T VAVK    + R+ +      +F  E  ++    H N+V
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +L+G   +     +V E V  +  D   F + +   L       ++   A G+ YL    
Sbjct: 176 RLIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG----TLGYMAPEYL 446
               IHRD+   N L+ +    KI+DFG++R    +   V  A  G     + + APE L
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 447 VRGQLTEKADVYSFGILIIE 466
             G+ + ++DV+SFGIL+ E
Sbjct: 288 NYGRYSSESDVWSFGILLWE 307

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 10/218 (4%)
Query: 256 KSCLSFKYETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DE 313
           ++ L+ K +  E   + F    +LG G  G V  +   P+G  +A K +    +  + ++
Sbjct: 1   EAFLTQKAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQ 60
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
              E+ ++       +V   G      E  +  E++   SLDQ + +  +       K  
Sbjct: 61  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK-- 118
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
            + +    GLAYL    + +I+HRD+K SNIL++     K+ DFG++         ++ +
Sbjct: 119 -VSIAVLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS 172
Query: 434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
             GT  YMAPE L     + ++D++S G+ ++E+  GR
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISS 323
           ++ +   + LG+G  G V +      G   AVK  + + RQ       +    EV L+  
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQ 106
Query: 324 IEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           ++H N++KL     +     LV E Y      D+ I  K  +++        II     G
Sbjct: 107 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAARIIRQVLSG 162
Query: 383 LAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           + Y+H   + +I+HRD+K  N+LL+   KD   +I DFGL+  F A +        GT  
Sbjct: 163 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTAY 217
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y+APE L  G   EK DV+S G+++  ++ G
Sbjct: 218 YIAPEVL-HGTYDEKCDVWSTGVILYILLSG 247

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 18/216 (8%)
Query: 264 ETLEKA-TNYFNPSKKLGQGGAGSVYMGSLPNGTTV-------AVKRLIFNTRQWVDEFF 315
           E  EKA  + F   K LGQG  G V++    +G+          +K+     R  V    
Sbjct: 16  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM 75
Query: 316 NEVNLISSIEHKNLVKL-LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            E +++  + H  +VKL      EG +  L+ +++  R  D F     +      + +F 
Sbjct: 76  -ERDILVEVNHPFIVKLHYAFQTEG-KLYLILDFL--RGGDLFTRLSKEVMFTEEDVKF- 130
Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
            +   A  L +LH      II+RD+K  NILLD++   K+ DFGL++  + D    + + 
Sbjct: 131 YLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSF 186
Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            GT+ YMAPE + R   T+ AD +SFG+L+ E++ G
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISS 323
           ++ +   + LG+G  G V +      G   AVK  + + RQ       +    EV L+  
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQ 88
Query: 324 IEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           ++H N++KL     +     LV E Y      D+ I  K  +++        II     G
Sbjct: 89  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAARIIRQVLSG 144
Query: 383 LAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           + Y+H   + +I+HRD+K  N+LL+   KD   +I DFGL+  F A +        GT  
Sbjct: 145 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTAY 199
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y+APE L  G   EK DV+S G+++  ++ G
Sbjct: 200 YIAPEVL-HGTYDEKCDVWSTGVILYILLSG 229

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 267 EKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISSI 324
           E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   E+ ++   
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
               +V   G      E  +  E++   SLDQ +    +       K   + +   +GL 
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLT 121
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YL    + +I+HRD+K SNIL++     K+ DFG++     +   ++    GT  YM+PE
Sbjct: 122 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE---MANEFVGTRSYMSPE 176
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGR 471
            L     + ++D++S G+ ++E+  GR
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISS 323
           ++ +   + LG+G  G V +      G   AVK  + + RQ       +    EV L+  
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQ 105
Query: 324 IEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           ++H N++KL     +     LV E Y      D+ I  K  +++        II     G
Sbjct: 106 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAARIIRQVLSG 161
Query: 383 LAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           + Y+H   + +I+HRD+K  N+LL+   KD   +I DFGL+  F A +        GT  
Sbjct: 162 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTAY 216
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y+APE L  G   EK DV+S G+++  ++ G
Sbjct: 217 YIAPEVL-HGTYDEKCDVWSTGVILYILLSG 246

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI D+GLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 109/236 (46%), Gaps = 27/236 (11%)
Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FF 315
           KYE LEK          +G+G  G+V+   +      VA+KR+  +     DE       
Sbjct: 3   KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSAL 49
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
            E+ L+  ++HKN+V+L        +  LV+E+  ++ L ++    N        K F  
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSF-- 106
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           +    +GL + H  +   ++HRD+K  N+L++++   K+ADFGLAR F       S  V 
Sbjct: 107 LFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV 163
Query: 436 GTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL 490
            TL Y  P+ L   +L +   D++S G +  E+    R      D    L+R++ L
Sbjct: 164 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRL 218

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           NE+ ++  I+H N+V L      G    L+ + V    L   I +K             +
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRL 121
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNIL---LDKDFTPKIADFGLARCFAADRTHVST 432
           I    + + YLH   +  I+HRD+K  N+L   LD+D    I+DFGL++    D   V +
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLS 176
Query: 433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              GT GY+APE L +   ++  D +S G++   ++CG
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 18/216 (8%)
Query: 264 ETLEKAT-NYFNPSKKLGQGGAGSVYMGSLPNGTTV-------AVKRLIFNTRQWVDEFF 315
           E  EKA  + F   K LGQG  G V++    +G+          +K+     R  V    
Sbjct: 16  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM 75
Query: 316 NEVNLISSIEHKNLVKL-LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            E +++  + H  +VKL      EG +  L+ +++  R  D F     +      + +F 
Sbjct: 76  -ERDILVEVNHPFIVKLHYAFQTEG-KLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFY 131
Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           +    A  L +LH      II+RD+K  NILLD++   K+ DFGL++  + D    + + 
Sbjct: 132 LA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSF 186
Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            GT+ YMAPE + R   T+ AD +SFG+L+ E++ G
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLGC 335
           KLG+G   +VY G S      VA+K +     +        EV+L+  ++H N+V L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 336 SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I   +SL LV+EY+ ++ L Q++ D     ++N +     +     GLAY H     ++
Sbjct: 69  -IHTEKSLTLVFEYL-DKDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCH---RQKV 121
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV-RGQLTE 453
           +HRD+K  N+L+++    K+ADFGLAR  +         V  TL Y  P+ L+     + 
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYST 180
Query: 454 KADVYSFGILIIEIVCGR 471
           + D++  G +  E+  GR
Sbjct: 181 QIDMWGVGCIFYEMATGR 198

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 18/216 (8%)
Query: 264 ETLEKAT-NYFNPSKKLGQGGAGSVYMGSLPNGTTV-------AVKRLIFNTRQWVDEFF 315
           E  EKA  + F   K LGQG  G V++    +G+          +K+     R  V    
Sbjct: 17  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM 76
Query: 316 NEVNLISSIEHKNLVKL-LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            E +++  + H  +VKL      EG +  L+ +++  R  D F     +      + +F 
Sbjct: 77  -ERDILVEVNHPFIVKLHYAFQTEG-KLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFY 132
Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           +    A  L +LH      II+RD+K  NILLD++   K+ DFGL++  + D    + + 
Sbjct: 133 LA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSF 187
Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            GT+ YMAPE + R   T+ AD +SFG+L+ E++ G
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 121/279 (43%), Gaps = 29/279 (10%)
Query: 216 VLSTTAFLMLSLFAAYAA-YARLSKM-KEDRNNLGLYATSMKKSCLSFKYETLEKATNYF 273
           V S  A  + SL   +++  A+L ++  E  +N G+  T   K      YE  E+  ++ 
Sbjct: 19  VSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKP---VDYEYREE-VHWM 74
Query: 274 NPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS--SIEHKNLV 330
               +LG+G  G V+ M     G   AVK++         E F    L++   +    +V
Sbjct: 75  THQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIV 127
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            L G   EGP   +  E +   SL Q I    +   L  ++    +    EGL YLH   
Sbjct: 128 PLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLH--- 181
Query: 391 ETRIIHRDIKTSNILLDKDFT-PKIADFGLARCFAADRTHVSTA----VAGTLGYMAPEY 445
             RI+H D+K  N+LL  D +   + DFG A C   D    S      + GT  +MAPE 
Sbjct: 182 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 241
Query: 446 LVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPL 484
           ++      K D++S   +++ ++ G   + ++Q    PL
Sbjct: 242 VMGKPCDAKVDIWSSCCMMLHMLNG--CHPWTQYFRGPL 278

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 279 LGQGGAGSVYMGSLP-NGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG G  G V +G     G  VAVK   R    +   V +   E+  +    H +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                 +  +V EYV    L  +I    + + +   + F  IL   +   Y H      +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD---YCH---RHMV 132
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL--T 452
           +HRD+K  N+LLD     KIADFGL+    +D   + T+  G+  Y APE ++ G+L   
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTS-CGSPNYAAPE-VISGRLYAG 189
Query: 453 EKADVYSFGILIIEIVCG 470
            + D++S G+++  ++CG
Sbjct: 190 PEVDIWSCGVILYALLCG 207

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 104/239 (43%), Gaps = 46/239 (19%)
Query: 248 GLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT 307
           G++ TS KK  LS  Y+ +          KKLG G  G V    L       V+R I   
Sbjct: 25  GMFITS-KKGHLSEMYQRV----------KKLGSGAYGEVL---LCRDKVTHVERAIKII 70
Query: 308 RQWV------DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFD 360
           R+         +   EV ++  ++H N++KL     +     LV E Y      D+ I  
Sbjct: 71  RKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH- 129
Query: 361 KNKTKLLNWNKRFN------IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFT 411
                      +FN      II     G+ YLH   +  I+HRD+K  N+LL   +KD  
Sbjct: 130 ---------RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDAL 177
Query: 412 PKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            KI DFGL+  F   +        GT  Y+APE L R +  EK DV+S G+++  ++ G
Sbjct: 178 IKIVDFGLSAVFENQKKMKER--LGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAG 233

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 273 FNPSKKLGQGG-AGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G  + +V    L      A+K  I   R  + E        E +++S ++H
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 138
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     +    GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             Y++PE L      + +D+++ G +I ++V G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 6/159 (3%)
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLL--VYEYVPNRSLDQFIFDKNKTK-LLNWN 370
             +EVNL+  ++H N+V+     I+   + L  V EY     L   I    K +  L+  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 371 KRFNIILGTAEGLAYLHGGSE--TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
               ++      L   H  S+    ++HRD+K +N+ LD     K+ DFGLAR    D  
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED 171
Query: 429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
                V GT  YM+PE + R    EK+D++S G L+ E+
Sbjct: 172 FAKEFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G V+ G + N T   VA+K + +      +++   E+ ++S  +   +
Sbjct: 24  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            K  G  ++  +  ++ EY+   S      D  +   L+  +   I+    +GL YLH  
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLH-- 136
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
           SE +I HRDIK +N+LL +    K+ADFG+A     D         GT  +MAPE + + 
Sbjct: 137 SEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQS 194
Query: 450 QLTEKADVYSFGILIIEIVCGRRSNA 475
               KAD++S GI  IE+  G   ++
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHS 220

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           NE+ ++  I+H N+V L      G    L+ + V    L   I +K             +
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRL 121
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNIL---LDKDFTPKIADFGLARCFAADRTHVST 432
           I    + + YLH   +  I+HRD+K  N+L   LD+D    I+DFGL++    D   V +
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLS 176
Query: 433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              GT GY+APE L +   ++  D +S G++   ++CG
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 38/220 (17%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           LGQG  G V    +  +    A+K+ I +T + +    +EV L++S+ H+ +V+     +
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 338 E-----GPES--------LLVYEYVPNRSLDQFIFDKNKTKLLN--WNKRFNIILGTAEG 382
           E      P +         +  EY  NR+L   I  +N  +  +  W + F  IL   E 
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW-RLFRQIL---EA 128
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-------CFAADRTHVS---- 431
           L+Y+H      IIHR++K  NI +D+    KI DFGLA+           D  ++     
Sbjct: 129 LSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 432 --TAVAGTLGYMAPEYLV-RGQLTEKADVYSFGILIIEIV 468
             T+  GT  Y+A E L   G   EK D YS GI+  E +
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G V+ G + N T   VA+K + +      +++   E+ ++S  +   +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            K  G  ++  +  ++ EY+   S      D  +   L+  +   I+    +GL YLH  
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLH-- 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
           SE +I HRDIK +N+LL +    K+ADFG+A     D         GT  +MAPE + + 
Sbjct: 122 SEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 450 QLTEKADVYSFGILIIEIVCGRRSNA 475
               KAD++S GI  IE+  G   ++
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHS 205

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VAVK  I +  Q     + + F EV ++  + H N+VK
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 70
Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L LV EY     +  ++      K      +F  I+   +   Y H   
Sbjct: 71  LFEV-IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ---YCH--- 123
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
           +  I+HRD+K  N+LLD D   KIADFG +  F            G+  Y APE L +G+
Sbjct: 124 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDTFCGSPPYAAPE-LFQGK 180
Query: 451 LTE--KADVYSFGILIIEIVCG 470
             +  + DV+S G+++  +V G
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSG 202

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DFGL R    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM----TGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 279 LGQGGAGSVYMGSL-PNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           LG+G  G V   +  P G  VA+K++  F+   +      E+ ++   +H+N++ +   +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF--N 76
Query: 337 IEGPESLLVYE--YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
           I+ P+S   +   Y+    +   +     T++L+ +     I  T   +  LHG +   +
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---V 133
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVS------TAVAGTLGYMAPE- 444
           IHRD+K SN+L++ +   K+ DFGLAR     AAD +  +      T    T  Y APE 
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEV 193
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGR 471
            L   + +   DV+S G ++ E+   R
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 90/211 (42%), Gaps = 24/211 (11%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL-----IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           ++LG GG G V        G  VA+K+        N  +W      E+ ++  + H N+V
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC----LEIQIMKKLNHPNVV 75
Query: 331 KLL----GCSIEGPESL--LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                  G     P  L  L  EY     L +++        L       ++   +  L 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           YLH   E RIIHRD+K  NI+L    +    KI D G A+    D+  + T   GTL Y+
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQYL 190
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRR 472
           APE L + + T   D +SFG L  E + G R
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           NE+ ++  I+H N+V L      G    L+ + V    L   I +K             +
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRL 121
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNIL---LDKDFTPKIADFGLARCFAADRTHVST 432
           I    + + YLH   +  I+HRD+K  N+L   LD+D    I+DFGL++    D   V +
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLS 176
Query: 433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              GT GY+APE L +   ++  D +S G++   ++CG
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           NE+ ++  I+H N+V L      G    L+ + V    L   I +K             +
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRL 121
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNIL---LDKDFTPKIADFGLARCFAADRTHVST 432
           I    + + YLH   +  I+HRD+K  N+L   LD+D    I+DFGL++    D   V +
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLS 176
Query: 433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              GT GY+APE L +   ++  D +S G++   ++CG
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 90/211 (42%), Gaps = 24/211 (11%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL-----IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           ++LG GG G V        G  VA+K+        N  +W      E+ ++  + H N+V
Sbjct: 21  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC----LEIQIMKKLNHPNVV 76
Query: 331 KLL----GCSIEGPESL--LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                  G     P  L  L  EY     L +++        L       ++   +  L 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           YLH   E RIIHRD+K  NI+L    +    KI D G A+    D+  + T   GTL Y+
Sbjct: 137 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQYL 191
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRR 472
           APE L + + T   D +SFG L  E + G R
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 279 LGQGGAGSVYMGSL-PNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           LG+G  G V   +  P G  VA+K++  F+   +      E+ ++   +H+N++ +   +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF--N 76
Query: 337 IEGPESLLVYE--YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
           I+ P+S   +   Y+    +   +     T++L+ +     I  T   +  LHG +   +
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---V 133
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVS------TAVAGTLGYMAPE- 444
           IHRD+K SN+L++ +   K+ DFGLAR     AAD +  +      T    T  Y APE 
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEV 193
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGR 471
            L   + +   DV+S G ++ E+   R
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 133/307 (43%), Gaps = 49/307 (15%)
Query: 279 LGQGGAGSVYMGSLPNG---TTVAVKRLI-FNTRQWVDEFFNEVNLISSI-EHKNLVKLL 333
           +G+G  G V    +         A+KR+  + ++    +F  E+ ++  +  H N++ LL
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA------------- 380
           G         L  EY P+ +L  F+    K+++L  +  F I   TA             
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 381 ---EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG- 436
               G+ YL   S+ + IHR++   NIL+ +++  KIADFGL+R       +V   +   
Sbjct: 147 DVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 200
Query: 437 TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL 496
            + +MA E L     T  +DV+S+G+L+ EIV    +       A   +++   YR  K 
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 260
Query: 497 VEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPF 556
           +   D              V  +   C +     RPS AQ I++  N++ E     +  +
Sbjct: 261 LNCDD-------------EVYDLMRQCWREKPYERPSFAQ-ILVSLNRMLE----ERKTY 302
Query: 557 LNSSVME 563
           +N+++ E
Sbjct: 303 VNTTLYE 309

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 115/267 (43%), Gaps = 31/267 (11%)
Query: 216 VLSTTAFLMLSLFAAYAAYARLSKMKEDR--NNLGLYATSMKKSCLSFKY-ETLEKATNY 272
           V S  A  + SL   +AA    S+    +  +N G+  T   K  + ++Y E +  AT+ 
Sbjct: 21  VSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKP-VDYEYREEVHWATHQ 79
Query: 273 FNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS--SIEHKNL 329
                +LG+G  G V+ M     G   AVK++         E F    L++   +    +
Sbjct: 80  L----RLGRGSFGEVHRMEDKQTGFQCAVKKVRL-------EVFRAEELMACAGLTSPRI 128
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA-EGLAYLHG 388
           V L G   EGP   +  E +   SL Q + ++          R    LG A EGL YLH 
Sbjct: 129 VPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP----EDRALYYLGQALEGLEYLH- 183
Query: 389 GSETRIIHRDIKTSNILLDKDFT-PKIADFGLARCFAADRTH----VSTAVAGTLGYMAP 443
               RI+H D+K  N+LL  D +   + DFG A C   D           + GT  +MAP
Sbjct: 184 --SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAP 241
Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCG 470
           E ++      K DV+S   +++ ++ G
Sbjct: 242 EVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 278 KLGQGGAGSVYMGSL---PNGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIEHKNLVKLL 333
           +LG G  GSV  G          VA+K L   T +   +E   E  ++  +++  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 334 G-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           G C  E    +LV E      L +F+  K +   +  +    ++   + G+ YL    E 
Sbjct: 403 GVCQAEA--LMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEK 455
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG--TLGYMAPEYLVRGQ 450
             +HR++   N+LL      KI+DFGL++   AD ++ +   AG   L + APE +   +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 451 LTEKADVYSFGILIIEIV 468
            + ++DV+S+G+ + E +
Sbjct: 516 FSSRSDVWSYGVTMWEAL 533

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 123/311 (39%), Gaps = 45/311 (14%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWV 311
           L +     E   +  N  K LG+G  G V       +       TVAVK L    T    
Sbjct: 16  LPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 75
Query: 312 DEFFNEVNLISSI-EHKNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNK------ 363
               +E+ ++  I  H N+V LLG C+  G   +++ E+    +L  ++  K        
Sbjct: 76  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 135
Query: 364 ------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF 417
                    L            A+G+ +L   +  + IHRD+   NILL +    KI DF
Sbjct: 136 TPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 418 GLARCFAADRTHVSTAVAG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAF 476
           GLAR    D   V    A   L +MAPE +     T ++DV+SFG+L+ EI        F
Sbjct: 193 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------F 244
Query: 477 SQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRP 532
           S   ASP       Y   K+ E     LK+      P      + Q  L C     + RP
Sbjct: 245 SL-GASP-------YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296
Query: 533 SMAQAIMLLTN 543
           + ++ +  L N
Sbjct: 297 TFSELVEHLGN 307

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLL-- 333
           +G G  GSV     + +G  +AVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 334 ---GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                S+E    + +  ++    L+  +      KL + + +F +I     GL Y+H   
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLKYIHSAD 174
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG- 449
              IIHRD+K SN+ +++D   KI DFGLAR    +     T    T  Y APE ++   
Sbjct: 175 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWM 227
Query: 450 QLTEKADVYSFGILIIEIVCGR 471
                 D++S G ++ E++ GR
Sbjct: 228 HYNMTVDIWSVGCIMAELLTGR 249

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH----------- 326
           LGQG  G V    +  +    A+K+ I +T + +    +EV L++S+ H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 327 --KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
             +N VK +    +     +  EY  N +L   I  +N  +    ++ + +     E L+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ--QRDEYWRLFRQILEALS 130
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-------CFAADRTHVS------ 431
           Y+H      IIHRD+K  NI +D+    KI DFGLA+           D  ++       
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 432 TAVAGTLGYMAPEYLV-RGQLTEKADVYSFGILIIEIV 468
           T+  GT  Y+A E L   G   EK D+YS GI+  E++
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 279 LGQGGAGSVYMGSLPNGTTV-----AVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    +  S  +   V       K L+    Q  ++   E+++  S+ H+++V   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 87
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLAYLHGGS 390
           G   +     +V E    RSL +    K +  L     R+    I+LG      YLH   
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGCQ----YLH--- 138
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
             R+IHRD+K  N+ L++D   KI DFGLA     D     T + GT  Y+APE L +  
Sbjct: 139 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKG 197
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + + DV+S G ++  ++ G+
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGK 218

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 87/172 (50%), Gaps = 13/172 (7%)
Query: 305 FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL--VYEYVPNRSLDQFIFDKN 362
              R  +++ + E+ ++  ++H N+VKL+    +  E  L  V+E V        + +  
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP----VMEVP 129
Query: 363 KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
             K L+ ++         +G+ YLH     +IIHRDIK SN+L+ +D   KIADFG++  
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 423 FAADRTHVSTAVAGTLGYMAPEYL--VRGQLTEKA-DVYSFGILIIEIVCGR 471
           F      +S  V GT  +MAPE L   R   + KA DV++ G+ +   V G+
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++ +  H+N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI-N 89
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ- 450
           ++HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  + 
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            T+  D++S G ++ E++  R
Sbjct: 207 YTKSIDIWSVGCILAEMLSNR 227

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 279 LGQGGAGSVYMGSL-PNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           LG+G  G V   +  P G  VA+K++  F+   +      E+ ++   +H+N++ +   +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF--N 76
Query: 337 IEGPESLLVYE--YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
           I+ P+S   +   Y+    +   +     T++L+ +     I  T   +  LHG +   +
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---V 133
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAG------TLGYMAPE- 444
           IHRD+K SN+L++ +   K+ DFGLAR     AAD +  +   +G      T  Y APE 
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV 193
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGR 471
            L   + +   DV+S G ++ E+   R
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 87
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ- 450
           ++HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  + 
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            T+  D++S G ++ E++  R
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR 225

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++ +  H+N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 91  I-IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ- 450
           ++HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  + 
Sbjct: 147 VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            T+  D++S G ++ E++  R
Sbjct: 207 YTKSIDIWSVGCILAEMLSNR 227

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 115/265 (43%), Gaps = 27/265 (10%)
Query: 216 VLSTTAFLMLSLFAAYAA-YARLSKM-KEDRNNLGLYATSMKKSCLSFKYETLEKATNYF 273
           V S  A  + SL   +++  A+L ++  E  +N G+  T   K      YE  E+  ++ 
Sbjct: 5   VSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKP---VDYEYREE-VHWM 60
Query: 274 NPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS--SIEHKNLV 330
               ++G+G  G V+ M     G   AVK++         E F    L++   +    +V
Sbjct: 61  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIV 113
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            L G   EGP   +  E +   SL Q I    +   L  ++    +    EGL YLH   
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLH--- 167
Query: 391 ETRIIHRDIKTSNILLDKDFT-PKIADFGLARCFAADRTHVSTA----VAGTLGYMAPEY 445
             RI+H D+K  N+LL  D +   + DFG A C   D    S      + GT  +MAPE 
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 446 LVRGQLTEKADVYSFGILIIEIVCG 470
           ++      K D++S   +++ ++ G
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 279 LGQGGAGSVYMGSLPNGTTV-----AVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    +  S  +   V       K L+    Q  ++   E+++  S+ H+++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 83
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLAYLHGGS 390
           G   +     +V E    RSL +    K +  L     R+    I+LG      YLH   
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGCQ----YLH--- 134
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
             R+IHRD+K  N+ L++D   KI DFGLA     D     T + GT  Y+APE L +  
Sbjct: 135 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKG 193
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + + DV+S G ++  ++ G+
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGK 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 279 LGQGGAGSVYMGSLPNGTTV-----AVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    +  S  +   V       K L+    Q  ++   E+++  S+ H+++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 83
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLAYLHGGS 390
           G   +     +V E    RSL +    K +  L     R+    I+LG      YLH   
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGCQ----YLH--- 134
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
             R+IHRD+K  N+ L++D   KI DFGLA     D     T + GT  Y+APE L +  
Sbjct: 135 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKG 193
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + + DV+S G ++  ++ G+
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGK 214

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 87
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ- 450
           ++HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  + 
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            T+  D++S G ++ E++  R
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR 225

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 121/277 (43%), Gaps = 25/277 (9%)
Query: 216 VLSTTAFLMLSLFAAYAA-YARLSKM-KEDRNNLGLYATSMKKSCLSFKYETLEKATNYF 273
           V S  A  + SL   +++  A+L ++  E  +N G+  T   K      YE  E+  ++ 
Sbjct: 21  VSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKP---VDYEYREE-VHWM 76
Query: 274 NPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
               ++G+G  G V+ M     G   AVK++     + V+E      L S      +V L
Sbjct: 77  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-VEELVACAGLSSP----RIVPL 131
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
            G   EGP   +  E +   SL Q I    +   L  ++    +    EGL YLH     
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLH---TR 185
Query: 393 RIIHRDIKTSNILLDKDFT-PKIADFGLARCFAADRTHVSTA----VAGTLGYMAPEYLV 447
           RI+H D+K  N+LL  D +   + DFG A C   D    S      + GT  +MAPE ++
Sbjct: 186 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 245
Query: 448 RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPL 484
                 K D++S   +++ ++ G   + ++Q    PL
Sbjct: 246 GKPCDAKVDIWSSCCMMLHMLNG--CHPWTQYFRGPL 280

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI-ND 92
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 149
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ-L 451
           +HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  +  
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 452 TEKADVYSFGILIIEIVCGR 471
           T+  D++S G ++ E++  R
Sbjct: 210 TKSIDIWSVGCILAEMLSNR 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 92
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 149
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ-L 451
           +HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  +  
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 452 TEKADVYSFGILIIEIVCGR 471
           T+  D++S G ++ E++  R
Sbjct: 210 TKSIDIWSVGCILAEMLSNR 229

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI DF LAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 87
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ- 450
           ++HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  + 
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            T+  D++S G ++ E++  R
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR 225

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNG----TTVAVKRLIFN--TRQWVD 312
           L  K E +      F   + LG+G  GSV    L         VAVK L  +      ++
Sbjct: 11  LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEG------PESLLVYEYVPNRSLDQFIFDKNKTKL 366
           EF  E   +   +H ++ KL+G S+        P  +++  ++ +  L  F+      + 
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE- 129
Query: 367 LNWNKRFNIILGT--------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG 418
                 FN+ L T        A G+ YL   S    IHRD+   N +L +D T  +ADFG
Sbjct: 130 ----NPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFG 182
Query: 419 LAR-CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           L+R  ++ D      A    + ++A E L     T  +DV++FG+ + EI+
Sbjct: 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 118/292 (40%), Gaps = 44/292 (15%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNK-----------TKLLNWNKRFNII 376
           +V LLG C+  G   +++ E+    +L  ++  K                L         
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D   V    A 
Sbjct: 155 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 437 -TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK 495
             L +MAPE +     T ++DV+SFG+L+ EI        FS   ASP       Y   K
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL-GASP-------YPGVK 255
Query: 496 LVEAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           + E     LK+      P      + Q  L C     + RP+ ++ +  L N
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI  FGLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLL 333
            + +G+G  G V+ G    G  VAVK  IF++R+    +F E  +  ++   H+N++  +
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFI 63
Query: 334 GCSIEG----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG- 388
               +      +  LV +Y  + SL    FD      +       + L TA GLA+LH  
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 119
Query: 389 --GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA--RCFAADRTHVS-TAVAGTLGYM 441
             G++ +  I HRD+K+ NIL+ K+ T  IAD GLA     A D   ++     GT  YM
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 442 APEYLVRG------QLTEKADVYSFGILIIEI 467
           APE L         +  ++AD+Y+ G++  EI
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 89
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ- 450
           ++HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  + 
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            T+  D++S G ++ E++  R
Sbjct: 207 YTKSIDIWSVGCILAEMLSNR 227

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI D GLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 19/212 (8%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNLVKLLG 334
           KLG+G  G VY         TVA+KR+     +         EV+L+  ++H+N+++L  
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                    L++EY  N  L +++ DKN    +   K F  +     G+ + H     R 
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSF--LYQLINGVNFCHS---RRC 153
Query: 395 IHRDIKTSNILL---DKDFTP--KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG 449
           +HRD+K  N+LL   D   TP  KI DFGLAR F       +  +  TL Y  PE L+  
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGS 212
Query: 450 -QLTEKADVYSFGILIIEIVCGRRSNAFSQDS 480
              +   D++S   +  E++   ++  F  DS
Sbjct: 213 RHYSTSVDIWSIACIWAEMLM--KTPLFPGDS 242

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLL 333
            + +G+G  G V+ G    G  VAVK  IF++R+    +F E  +  ++   H+N++  +
Sbjct: 9   QESIGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFI 64
Query: 334 GCSIEG----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG- 388
               +      +  LV +Y  + SL    FD      +       + L TA GLA+LH  
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 120
Query: 389 --GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA--RCFAADRTHVS-TAVAGTLGYM 441
             G++ +  I HRD+K+ NIL+ K+ T  IAD GLA     A D   ++     GT  YM
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 180
Query: 442 APEYLVRG------QLTEKADVYSFGILIIEI 467
           APE L         +  ++AD+Y+ G++  EI
Sbjct: 181 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISS 323
           ++ +   + LG+G  G V +      G   AVK  + + RQ       +    EV L+  
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQ 82
Query: 324 IEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           ++H N+ KL     +     LV E Y      D+ I  K  +++        II     G
Sbjct: 83  LDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAARIIRQVLSG 138
Query: 383 LAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           + Y H   + +I+HRD+K  N+LL+   KD   +I DFGL+  F A +        GT  
Sbjct: 139 ITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK--IGTAY 193
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y+APE L  G   EK DV+S G+++  ++ G
Sbjct: 194 YIAPEVL-HGTYDEKCDVWSTGVILYILLSG 223

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 87
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ- 450
           ++HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  + 
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            T+  D++S G ++ E++  R
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 29  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 86
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 143
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ-L 451
           +HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  +  
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 203
Query: 452 TEKADVYSFGILIIEIVCGR 471
           T+  D++S G ++ E++  R
Sbjct: 204 TKSIDIWSVGCILAEMLSNR 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 39  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 95
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 152
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ- 450
           ++HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  + 
Sbjct: 153 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 212
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            T+  D++S G ++ E++  R
Sbjct: 213 YTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 87
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ- 450
           ++HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  + 
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            T+  D++S G ++ E++  R
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR 225

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 123/294 (41%), Gaps = 46/294 (15%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 435 AG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
           A   L +MAPE +     T ++DV+SFG+L+ EI        FS   ASP       Y  
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL-GASP-------YPG 244
Query: 494 NKLVEAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
            K+ E     LK+      P      + Q  L C     + RP+ ++ +  L N
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 298

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI D GLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 36  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 93
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 150
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ-L 451
           +HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  +  
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 210
Query: 452 TEKADVYSFGILIIEIVCGR 471
           T+  D++S G ++ E++  R
Sbjct: 211 TKSIDIWSVGCILAEMLSNR 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 29  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 86
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 143
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ-L 451
           +HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  +  
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 203
Query: 452 TEKADVYSFGILIIEIVCGR 471
           T+  D++S G ++ E++  R
Sbjct: 204 TKSIDIWSVGCILAEMLSNR 223

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 37  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 94
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 95  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 151
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ-L 451
           +HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  +  
Sbjct: 152 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 211
Query: 452 TEKADVYSFGILIIEIVCGR 471
           T+  D++S G ++ E++  R
Sbjct: 212 TKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 28  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 85
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 86  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 142
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ-L 451
           +HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  +  
Sbjct: 143 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 202
Query: 452 TEKADVYSFGILIIEIVCGR 471
           T+  D++S G ++ E++  R
Sbjct: 203 TKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 92
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 149
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ-L 451
           +HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  +  
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 452 TEKADVYSFGILIIEIVCGR 471
           T+  D++S G ++ E++  R
Sbjct: 210 TKSIDIWSVGCILAEMLSNR 229

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLL 333
            + +G+G  G V+ G    G  VAVK  IF++R+    +F E  +  ++   H+N++  +
Sbjct: 14  QESIGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFI 69
Query: 334 GCSIEG----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG- 388
               +      +  LV +Y  + SL    FD      +       + L TA GLA+LH  
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 125
Query: 389 --GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA--RCFAADRTHVS-TAVAGTLGYM 441
             G++ +  I HRD+K+ NIL+ K+ T  IAD GLA     A D   ++     GT  YM
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 185
Query: 442 APEYLVRG------QLTEKADVYSFGILIIEI 467
           APE L         +  ++AD+Y+ G++  EI
Sbjct: 186 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLL 333
            + +G+G  G V+ G    G  VAVK  IF++R+    +F E  +  ++   H+N++  +
Sbjct: 11  QESIGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFI 66
Query: 334 GCSIEG----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG- 388
               +      +  LV +Y  + SL    FD      +       + L TA GLA+LH  
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 122
Query: 389 --GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA--RCFAADRTHVS-TAVAGTLGYM 441
             G++ +  I HRD+K+ NIL+ K+ T  IAD GLA     A D   ++     GT  YM
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 182
Query: 442 APEYLVRG------QLTEKADVYSFGILIIEI 467
           APE L         +  ++AD+Y+ G++  EI
Sbjct: 183 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 107
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 164
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ- 450
           ++HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  + 
Sbjct: 165 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            T+  D++S G ++ E++  R
Sbjct: 225 YTKSIDIWSVGCILAEMLSNR 245

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLL 333
            + +G+G  G V+ G    G  VAVK  IF++R+    +F E  +  ++   H+N++  +
Sbjct: 34  QESIGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFI 89
Query: 334 GCSIEG----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG- 388
               +      +  LV +Y  + SL    FD      +       + L TA GLA+LH  
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 145
Query: 389 --GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA--RCFAADRTHVS-TAVAGTLGYM 441
             G++ +  I HRD+K+ NIL+ K+ T  IAD GLA     A D   ++     GT  YM
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 205
Query: 442 APEYLVRG------QLTEKADVYSFGILIIEI 467
           APE L         +  ++AD+Y+ G++  EI
Sbjct: 206 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLL 333
            + +G+G  G V+ G    G  VAVK  IF++R+    +F E  +  ++   H+N++  +
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFI 102
Query: 334 GCSIEG----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG- 388
               +      +  LV +Y  + SL    FD      +       + L TA GLA+LH  
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 389 --GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA--RCFAADRTHVS-TAVAGTLGYM 441
             G++ +  I HRD+K+ NIL+ K+ T  IAD GLA     A D   ++     GT  YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 442 APEYLVRG------QLTEKADVYSFGILIIEI 467
           APE L         +  ++AD+Y+ G++  EI
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 123/294 (41%), Gaps = 46/294 (15%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 435 AG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
           A   L +MAPE +     T ++DV+SFG+L+ EI        FS   ASP       Y  
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL-GASP-------YPG 253
Query: 494 NKLVEAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
            K+ E     LK+      P      + Q  L C     + RP+ ++ +  L N
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 279 LGQGGAGSVYMGSLP-NGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG G  G V +G     G  VAVK   R    +   V +   E+  +    H +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                 +  +V EYV    L  +I    + + +   + F  IL   +   Y H      +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD---YCH---RHMV 132
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL--T 452
           +HRD+K  N+LLD     KIADFGL+    +D   +  +  G+  Y APE ++ G+L   
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRDS-CGSPNYAAPE-VISGRLYAG 189
Query: 453 EKADVYSFGILIIEIVCG 470
            + D++S G+++  ++CG
Sbjct: 190 PEVDIWSCGVILYALLCG 207

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 27/236 (11%)
Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FF 315
           KYE LEK          +G+G  G+V+   +      VA+KR+  +     DE       
Sbjct: 3   KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSAL 49
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
            E+ L+  ++HKN+V+L        +  LV+E+  ++ L ++    N        K F  
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSF-- 106
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           +    +GL + H  +   ++HRD+K  N+L++++   K+A+FGLAR F       S  V 
Sbjct: 107 LFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV 163
Query: 436 GTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL 490
            TL Y  P+ L   +L +   D++S G +  E+    R      D    L+R++ L
Sbjct: 164 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 279 LGQGGAGSVYMGSLPNGTTV-----AVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    +  S  +   V       K L+    Q  ++   E+++  S+ H+++V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 81
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLAYLHGGS 390
           G   +     +V E    RSL +    K +  L     R+    I+LG      YLH   
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGCQ----YLH--- 132
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
             R+IHRD+K  N+ L++D   KI DFGLA     D       + GT  Y+APE L +  
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPEVLSKKG 191
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + + DV+S G ++  ++ G+
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKL-- 332
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 333 --LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                +IE  + + +  ++    L + +    KT+ L+ +     +     GL Y+H  +
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVR 448
              ++HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++ 
Sbjct: 165 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 449 GQ-LTEKADVYSFGILIIEIVCGR 471
            +  T+  D++S G ++ E++  R
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 279 LGQGGAGSVYMGSLPNGTTV-----AVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    +  S  +   V       K L+    Q  ++   E+++  S+ H+++V   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 107
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLAYLHGGS 390
           G   +     +V E    RSL +    K +  L     R+    I+LG      YLH   
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGCQ----YLH--- 158
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
             R+IHRD+K  N+ L++D   KI DFGLA     D       + GT  Y+APE L +  
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPEVLSKKG 217
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + + DV+S G ++  ++ G+
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 123/294 (41%), Gaps = 46/294 (15%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 435 AG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
           A   L +MAPE +     T ++DV+SFG+L+ EI        FS   ASP       Y  
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL-GASP-------YPG 244
Query: 494 NKLVEAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
            K+ E     LK+      P      + Q  L C     + RP+ ++ +  L N
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 298

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 123/294 (41%), Gaps = 46/294 (15%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 70  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    
Sbjct: 190 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 435 AG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
           A   L +MAPE +     T ++DV+SFG+L+ EI        FS   ASP       Y  
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL-GASP-------YPG 290
Query: 494 NKLVEAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
            K+ E     LK+      P      + Q  L C     + RP+ ++ +  L N
Sbjct: 291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 279 LGQGGAGSVYMGSLPNGTTV-----AVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    +  S  +   V       K L+    Q  ++   E+++  S+ H+++V   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 105
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLAYLHGGS 390
           G   +     +V E    RSL +    K +  L     R+    I+LG      YLH   
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGCQ----YLH--- 156
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
             R+IHRD+K  N+ L++D   KI DFGLA     D       + GT  Y+APE L +  
Sbjct: 157 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPEVLSKKG 215
Query: 451 LTEKADVYSFGILIIEIVCGR 471
            + + DV+S G ++  ++ G+
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGK 236

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 123/294 (41%), Gaps = 46/294 (15%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    
Sbjct: 155 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 435 AG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
           A   L +MAPE +     T ++DV+SFG+L+ EI        FS   ASP       Y  
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL-GASP-------YPG 255
Query: 494 NKLVEAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
            K+ E     LK+      P      + Q  L C     + RP+ ++ +  L N
Sbjct: 256 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 309

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSI--EHKNLVKLLG 334
           +G+G  G V+ G L +G +VAVK  IF++R   DE  +F E  + +++   H N++  + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVK--IFSSR---DEQSWFRETEIYNTVLLRHDNILGFIA 69
Query: 335 CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG-- 388
             +    S     L+  Y  + SL  F+    + + L  +    + +  A GLA+LH   
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVEI 125
Query: 389 -GSETR--IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV---STAVAGTLGYMA 442
            G++ +  I HRD K+ N+L+  +    IAD GLA   +    ++   +    GT  YMA
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMA 185
Query: 443 PEYL---VRGQLTEK---ADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
           PE L   +R    E     D+++FG+++ EI      N   +D   P   V
Sbjct: 186 PEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDV 236

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K SN+ +++D   KI D GLAR    +     T    T  Y 
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLARHTDDE----MTGYVATRWYR 189
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           APE ++      +  D++S G ++ E++ GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 279 LGQGGAGSVYMGSLPN-----GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    Y  +  +        V  K ++    Q  ++   E+ +  S+++ ++V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGFH 108
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   +     +V E    RSL +    K +  +     R+  +  T +G+ YLH     R
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLEL--HKRRKAVTEPEARY-FMRQTIQGVQYLHN---NR 162
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
           +IHRD+K  N+ L+ D   KI DFGLA     D     T + GT  Y+APE L +   + 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAPEVLCKKGHSF 221
Query: 454 KADVYSFGILIIEIVCGR 471
           + D++S G ++  ++ G+
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTV----AVKRLIFNTRQWVDEFFNEVNLIS-SIEHK 327
           F   K LG+G  G V++             A+K+ +      V+    E  ++S + EH 
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 328 NLVKLLGCSIEGPESLL-VYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
            L  +  C+ +  E+L  V EY+    L   I     FD ++           IILG   
Sbjct: 80  FLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY----AAEIILG--- 131
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGY 440
            L +LH      I++RD+K  NILLDKD   KIADFG+ +     D    +    GT  Y
Sbjct: 132 -LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFCGTPDY 185
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           +APE L+  +     D +SFG+L+ E++ G+
Sbjct: 186 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLI-SSIEHKNLVK 331
           F P   LG G  G++    + +   VAVKR++     + D    EV L+  S EH N+++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIR 82
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
              C+ +  +   +   +   +L +++  K+   L    +   ++  T  GLA+LH    
Sbjct: 83  YF-CTEKDRQFQYIAIELCAATLQEYVEQKDFAHL--GLEPITLLQQTTSGLAHLHS--- 136
Query: 392 TRIIHRDIKTSNILLDK-----DFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPE 444
             I+HRD+K  NIL+            I+DFGL +  A  R   S  + V GT G++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 445 YL---VRGQLTEKADVYSFGILIIEIV 468
            L    +   T   D++S G +   ++
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVI 223

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L YLH  SE  +++RD+K  N++LDKD   KI DFGL +    D   + T   GT  Y+
Sbjct: 263 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 319
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L         D +  G+++ E++CGR
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L YLH  SE  +++RD+K  N++LDKD   KI DFGL +    D   + T   GT  Y+
Sbjct: 260 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 316
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L         D +  G+++ E++CGR
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 279 LGQGGAGSVYMGSLP-NGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG G  G V +G     G  VAVK   R    +   V +   E+  +    H +++KL  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                 +  +V EYV    L  +I    +       + F  IL    G+ Y H      +
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS---GVDYCH---RHMV 137
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT-- 452
           +HRD+K  N+LLD     KIADFGL+    +D   +  +  G+  Y APE ++ G+L   
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRXS-CGSPNYAAPE-VISGRLYAG 194
Query: 453 EKADVYSFGILIIEIVCG 470
            + D++S G+++  ++CG
Sbjct: 195 PEVDIWSSGVILYALLCG 212

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 122/294 (41%), Gaps = 46/294 (15%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D   V    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 435 AG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
           A   L +MAPE +     T ++DV+SFG+L+ EI        FS   ASP       Y  
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL-GASP-------YPG 244
Query: 494 NKLVEAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
            K+ E     LK+      P      + Q  L C     + RP+ ++ +  L N
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 298

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 122/294 (41%), Gaps = 46/294 (15%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D   V    
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 435 AG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
           A   L +MAPE +     T ++DV+SFG+L+ EI        FS   ASP       Y  
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL-GASP-------YPG 253
Query: 494 NKLVEAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
            K+ E     LK+      P      + Q  L C     + RP+ ++ +  L N
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 78  GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLES---KR 131
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-TLGYMAPEYLVRGQLT 452
            +HRDI   N+L+  +   K+ DFGL+R +  D T+   +     + +MAPE +   + T
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 453 EKADVYSFGILIIEIV 468
             +DV+ FG+ + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA++++  F  + +      E+ ++    H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 92
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 149
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ-L 451
           +HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++  +  
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 452 TEKADVYSFGILIIEIVCGR 471
           T+  D++S G ++ E++  R
Sbjct: 210 TKSIDIWSVGCILAEMLSNR 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 92
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN-----IILGTAEGLAYLHGGS 390
            I  P      E + +  + Q + + +  KLL      N      +     GL Y+H  +
Sbjct: 93  IIRAP----TIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVR 448
              ++HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE ++ 
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 449 GQ-LTEKADVYSFGILIIEIVCGR 471
            +  T+  D++S G ++ E++  R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 75  GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLES---KR 128
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-TLGYMAPEYLVRGQLT 452
            +HRDI   N+L+  +   K+ DFGL+R +  D T+   +     + +MAPE +   + T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 453 EKADVYSFGILIIEIV 468
             +DV+ FG+ + EI+
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 270 TNYFNPSKKLGQGGAGSVYMGSLPNGTT--VAVKRLIFNTRQWVDEFF--NEVNLISSIE 325
           +++F    +LG+G    VY      GT    A+K L    ++ VD+     E+ ++  + 
Sbjct: 52  SDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLS 106
Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           H N++KL        E  LV E V    L   I +K      +       IL   E +AY
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL---EAVAY 163
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           LH   E  I+HRD+K  N+L      D   KIADFGL++    +   +   V GT GY A
Sbjct: 164 LH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVCGTPGYCA 218
Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCG 470
           PE L       + D++S GI+   ++CG
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 80  GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLES---KR 133
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-TLGYMAPEYLVRGQLT 452
            +HRDI   N+L+  +   K+ DFGL+R +  D T+   +     + +MAPE +   + T
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 453 EKADVYSFGILIIEIV 468
             +DV+ FG+ + EI+
Sbjct: 193 SASDVWMFGVCMWEIL 208

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 122/294 (41%), Gaps = 46/294 (15%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D   V    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 435 AG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
           A   L +MAPE +     T ++DV+SFG+L+ EI        FS   ASP       Y  
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL-GASP-------YPG 244
Query: 494 NKLVEAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
            K+ E     LK+      P      + Q  L C     + RP+ ++ +  L N
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 298

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 11/195 (5%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 83  GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLES---KR 136
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
            +HRDI   N+L+  +   K+ DFGL+R       + ++     + +MAPE +   + T 
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 454 KADVYSFGILIIEIV 468
            +DV+ FG+ + EI+
Sbjct: 197 ASDVWMFGVCMWEIL 211

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 78  GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLES---KR 131
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-TLGYMAPEYLVRGQLT 452
            +HRDI   N+L+  +   K+ DFGL+R +  D T+   +     + +MAPE +   + T
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 453 EKADVYSFGILIIEIV 468
             +DV+ FG+ + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 81  GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLES---KR 134
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-TLGYMAPEYLVRGQLT 452
            +HRDI   N+L+  +   K+ DFGL+R +  D T+   +     + +MAPE +   + T
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 453 EKADVYSFGILIIEIV 468
             +DV+ FG+ + EI+
Sbjct: 194 SASDVWMFGVCMWEIL 209

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 11/195 (5%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 106 GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLES---KR 159
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
            +HRDI   N+L+  +   K+ DFGL+R       + ++     + +MAPE +   + T 
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 219
Query: 454 KADVYSFGILIIEIV 468
            +DV+ FG+ + EI+
Sbjct: 220 ASDVWMFGVCMWEIL 234

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 122/294 (41%), Gaps = 46/294 (15%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D   V    
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 435 AG-TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
           A   L +MAPE +     T ++DV+SFG+L+ EI        FS   ASP       Y  
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL-GASP-------YPG 253
Query: 494 NKLVEAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
            K+ E     LK+      P      + Q  L C     + RP+ ++ +  L N
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 19/228 (8%)
Query: 248 GLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--I 304
           G Y   + K+         E    Y +P+  +G G  GSV       +G  VA+K+L   
Sbjct: 27  GFYKQDVNKTAW-------ELPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRP 78
Query: 305 FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT 364
           F +  +    + E+ L+  ++H+N++ LL            Y++       Q    K   
Sbjct: 79  FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG 138
Query: 365 KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
              +  K   ++    +GL Y+H      ++HRD+K  N+ +++D   KI DFGLAR   
Sbjct: 139 MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195
Query: 425 ADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           A+     T    T  Y APE ++      +  D++S G ++ E++ G+
Sbjct: 196 AEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 105/248 (42%), Gaps = 27/248 (10%)
Query: 234 YARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLP 293
           +  L K K   N L  Y   +KK         L+     ++  K +G+G  G V +    
Sbjct: 44  FPALRKNKNIDNFLNRYEKIVKK------IRGLQMKAEDYDVVKVIGRGAFGEVQLVRHK 97
Query: 294 NGTTVAVKRLI--FNTRQWVDE-FFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYV 349
               V   +L+  F   +  D  FF E   I +  +   V  L C+ +  + L +V EY+
Sbjct: 98  ASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 157
Query: 350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD 409
           P   L   +   N      W K +     TAE +  L       +IHRD+K  N+LLDK 
Sbjct: 158 PGGDLVNLM--SNYDVPEKWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKH 210
Query: 410 FTPKIADFGLARCFAADRT---HVSTAVAGTLGYMAPEYLVR----GQLTEKADVYSFGI 462
              K+ADFG   C   D T   H  TAV GT  Y++PE L      G    + D +S G+
Sbjct: 211 GHLKLADFG--TCMKMDETGMVHCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGV 267
Query: 463 LIIEIVCG 470
            + E++ G
Sbjct: 268 FLFEMLVG 275

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTV----AVKRLIFNTRQWVDEFFNEVNLIS-SIEHKNLVK 331
           K LG+G  G V++             A+K+ +      V+    E  ++S + EH  L  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 332 LLGCSIEGPESLL-VYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAEGLAY 385
           +  C+ +  E+L  V EY+    L   I     FD ++           IILG    L +
Sbjct: 83  MF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY----AAEIILG----LQF 133
Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTLGYMAPE 444
           LH      I++RD+K  NILLDKD   KIADFG+ +     D    +    GT  Y+APE
Sbjct: 134 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCGTPDYIAPE 188
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGR 471
            L+  +     D +SFG+L+ E++ G+
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 19/228 (8%)
Query: 248 GLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--I 304
           G Y   + K+         E    Y +P+  +G G  GSV       +G  VA+K+L   
Sbjct: 9   GFYKQDVNKTAW-------ELPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRP 60
Query: 305 FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT 364
           F +  +    + E+ L+  ++H+N++ LL            Y++       Q    K   
Sbjct: 61  FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG 120
Query: 365 KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
              +  K   ++    +GL Y+H      ++HRD+K  N+ +++D   KI DFGLAR   
Sbjct: 121 LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 177
Query: 425 ADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
           A+     T    T  Y APE ++      +  D++S G ++ E++ G+
Sbjct: 178 AEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 279 LGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDE------FFNEVNLISSIEHKNLVK 331
           LG+G  G V + +       VA+K   F +RQ + +         E++ +  + H +++K
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           L        + ++V EY      D +I +K +       + F  I+   E   Y H    
Sbjct: 74  LYDVITTPTDIVMVIEYAGGELFD-YIVEKKRMTEDEGRRFFQQIICAIE---YCH---R 126
Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
            +I+HRD+K  N+LLD +   KIADFGL+     D   + T+  G+  Y APE ++ G+L
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYAAPE-VINGKL 183
Query: 452 T--EKADVYSFGILIIEIVCGR 471
               + DV+S GI++  ++ GR
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 279 LGQGGAGSVYMGSLPN-----GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    Y  +  +        V  K ++    Q  ++   E+ +  S+++ ++V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGFH 108
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   +     +V E    RSL +    K +  +     R+  +  T +G+ YLH     R
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLEL--HKRRKAVTEPEARY-FMRQTIQGVQYLHN---NR 162
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
           +IHRD+K  N+ L+ D   KI DFGLA     D       + GT  Y+APE L +   + 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKXLCGTPNYIAPEVLCKKGHSF 221
Query: 454 KADVYSFGILIIEIVCGR 471
           + D++S G ++  ++ G+
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 92
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 149
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ-L 451
           +HRD+K SN+LL+     KI DFGLAR    D  H         T  Y APE ++  +  
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGY 209
Query: 452 TEKADVYSFGILIIEIVCGR 471
           T+  D++S G ++ E++  R
Sbjct: 210 TKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 36  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 93
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 150
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ-L 451
           +HRD+K SN+LL+     KI DFGLAR    D  H         T  Y APE ++  +  
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGY 210
Query: 452 TEKADVYSFGILIIEIVCGR 471
           T+  D++S G ++ E++  R
Sbjct: 211 TKSIDIWSVGCILAEMLSNR 230

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 52/90 (57%), Gaps = 4/90 (4%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL +LH   +  II+RD+K  N+LLD D   +I+D GLA    A +T  +   AGT G+M
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFM 356
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L+  +     D ++ G+ + E++  R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 52/90 (57%), Gaps = 4/90 (4%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL +LH   +  II+RD+K  N+LLD D   +I+D GLA    A +T  +   AGT G+M
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFM 356
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L+  +     D ++ G+ + E++  R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 52/90 (57%), Gaps = 4/90 (4%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL +LH   +  II+RD+K  N+LLD D   +I+D GLA    A +T  +   AGT G+M
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFM 356
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L+  +     D ++ G+ + E++  R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 87/195 (44%), Gaps = 11/195 (5%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 78  GVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLES---KR 131
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
            +HRDI   N+L+  +   K+ DFGL+R         ++     + +MAPE +   + T 
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTS 191
Query: 454 KADVYSFGILIIEIV 468
            +DV+ FG+ + EI+
Sbjct: 192 ASDVWMFGVCMWEIL 206

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 52/90 (57%), Gaps = 4/90 (4%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL +LH   +  II+RD+K  N+LLD D   +I+D GLA    A +T  +   AGT G+M
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFM 356
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L+  +     D ++ G+ + E++  R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 279 LGQGGAGSVYMGSLPNGTT--------VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           LG+GG G V+      G          V  K +I    +       E N++  ++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            L+     G +  L+ EY+   S  +      +  +   +     +   +  L +LH   
Sbjct: 85  DLIYAFQTGGKLYLILEYL---SGGELFMQLEREGIFMEDTACFYLAEISMALGHLH--- 138
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
           +  II+RD+K  NI+L+     K+ DFGL +    D T V+    GT+ YMAPE L+R  
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEILMRSG 197
Query: 451 LTEKADVYSFGILIIEIVCG 470
                D +S G L+ +++ G
Sbjct: 198 HNRAVDWWSLGALMYDMLTG 217

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 32/212 (15%)
Query: 278 KLGQGGAGSV-YMGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLI-SSIEHKNLV 330
           ++G+G  GSV  M   P+G  +AVKR+    R  VDE        +++++  S +   +V
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRI----RSTVDEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQF-------IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +  G      +  +  E + + S D+F       + D    ++L       I L T + L
Sbjct: 85  QFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKAL 138
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
            +L      +IIHRDIK SNILLD+    K+ DFG++       +   T  AG   YMAP
Sbjct: 139 NHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDAGCRPYMAP 194
Query: 444 EYL----VRGQLTEKADVYSFGILIIEIVCGR 471
           E +     R     ++DV+S GI + E+  GR
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + +G G  GSV   Y   L     VAVK+L   F +       + E+ L+  ++H+N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 332 LL-----GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
           LL       SIE    + +   +    L+  +    K++ L+      ++     GL Y+
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KSQALSDEHVQFLVYQLLRGLKYI 147
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL 446
           H      IIHRD+K SN+ +++D   +I DFGLAR   AD     T    T  Y APE +
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEE--MTGYVATRWYRAPEIM 200
Query: 447 VRG-QLTEKADVYSFGILIIEIVCGR 471
           +      +  D++S G ++ E++ G+
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 279 LGQGGAGSVYMGSLPN-----GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    Y  +  +        V  K ++    Q  ++   E+ +  S+++ ++V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGFH 108
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   +     +V E    RSL +    K +  +     R+  +  T +G+ YLH     R
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLEL--HKRRKAVTEPEARY-FMRQTIQGVQYLHN---NR 162
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
           +IHRD+K  N+ L+ D   KI DFGLA     D       + GT  Y+APE L +   + 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAPEVLCKKGHSF 221
Query: 454 KADVYSFGILIIEIVCGR 471
           + D++S G ++  ++ G+
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 278 KLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSIEHKNLVKLLG 334
           K+G+G  G V+   +   G  VA+K+ + +    V +     E+ ++  ++H NLV LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 335 CSIEGPESLLVYEYVPN---RSLDQFI--FDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
                    LV+EY  +     LD++     ++  K + W         T + + + H  
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAVNFCHKH 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV-R 448
           +    IHRD+K  NIL+ K    K+ DFG AR       +    VA T  Y +PE LV  
Sbjct: 122 N---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGD 177
Query: 449 GQLTEKADVYSFGILIIEIVCG 470
            Q     DV++ G +  E++ G
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSG 199

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIE 325
           ++ +   KKLG G  G V +      G   A+K   +    T        +EV ++  ++
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 326 HKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++KL     +     LV E Y      D+ I  +  +++        I+     G  
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV----DAAVIMKQVLSGTT 135
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           YLH   +  I+HRD+K  N+LL+   +D   KI DFGL+  F            GT  Y+
Sbjct: 136 YLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL--GTAYYI 190
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCG 470
           APE L R +  EK DV+S G+++  ++CG
Sbjct: 191 APEVL-RKKYDEKCDVWSCGVILYILLCG 218

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 279 LGQGGAGSVYMGSLPNGTT--------VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           LG+GG G V+      G          V  K +I    +       E N++  ++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            L+     G +  L+ EY+   S  +      +  +   +     +   +  L +LH   
Sbjct: 85  DLIYAFQTGGKLYLILEYL---SGGELFMQLEREGIFMEDTACFYLAEISMALGHLH--- 138
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
           +  II+RD+K  NI+L+     K+ DFGL +    D T V+    GT+ YMAPE L+R  
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIEYMAPEILMRSG 197
Query: 451 LTEKADVYSFGILIIEIVCG 470
                D +S G L+ +++ G
Sbjct: 198 HNRAVDWWSLGALMYDMLTG 217

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 279 LGQGGAGSVYMGSLPN-----GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    Y  +  +        V  K ++    Q  ++   E+ +  S+++ ++V   
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGFH 92
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   +     +V E    RSL +    K +  +     R+  +  T +G+ YLH     R
Sbjct: 93  GFFEDDDFVYVVLEICRRRSLLEL--HKRRKAVTEPEARY-FMRQTIQGVQYLHN---NR 146
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
           +IHRD+K  N+ L+ D   KI DFGLA     D       + GT  Y+APE L +   + 
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAPEVLCKKGHSF 205
Query: 454 KADVYSFGILIIEIVCGR 471
           + D++S G ++  ++ G+
Sbjct: 206 EVDIWSLGCILYTLLVGK 223

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 78  GVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLES---KR 131
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-TLGYMAPEYLVRGQLT 452
            +HRDI   N+L+      K+ DFGL+R +  D T+   +     + +MAPE +   + T
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 453 EKADVYSFGILIIEIV 468
             +DV+ FG+ + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 11/195 (5%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 458 GVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLES---KR 511
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
            +HRDI   N+L+  +   K+ DFGL+R       + ++     + +MAPE +   + T 
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 454 KADVYSFGILIIEIV 468
            +DV+ FG+ + EI+
Sbjct: 572 ASDVWMFGVCMWEIL 586

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIE 325
           ++ +   KKLG G  G V +      G   A+K   +    T        +EV ++  ++
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 326 HKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++KL     +     LV E Y      D+ I  +  +++        I+     G  
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV----DAAVIMKQVLSGTT 118
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           YLH   +  I+HRD+K  N+LL+   +D   KI DFGL+  F            GT  Y+
Sbjct: 119 YLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL--GTAYYI 173
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCG 470
           APE L R +  EK DV+S G+++  ++CG
Sbjct: 174 APEVL-RKKYDEKCDVWSCGVILYILLCG 201

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 30/244 (12%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAV-------KRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           ++G+G   +VY G L   TTV V       ++L  + RQ    F  E   +  ++H N+V
Sbjct: 33  EIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIV 88
Query: 331 KLLGC---SIEGPESL-LVYEYVPNRSLDQFI--FDKNKTKLL-NWNKRFNIILGTAEGL 383
           +       +++G + + LV E   + +L  ++  F   K K+L +W ++        +GL
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGL 142
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
            +LH  +   IIHRD+K  NI +     + KI D GLA      R   + AV GT  + A
Sbjct: 143 QFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFXA 198
Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP 502
           PE     +  E  DVY+FG   +E        +  Q++A   +RV +  +     +   P
Sbjct: 199 PEXY-EEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 503 NLKD 506
            +K+
Sbjct: 258 EVKE 261

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 277 KKLGQGGAGSVYMGSLPNG--TTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL-- 332
           K LG GG G V+  ++ N     VA+K+++    Q V     E+ +I  ++H N+VK+  
Sbjct: 17  KPLGCGGNGLVF-SAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFE 75
Query: 333 ------------LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
                       +G   E     +V EY+     +       +  LL  + R   +    
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL----EQGPLLEEHARL-FMYQLL 130
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTHVSTAVAG--T 437
            GL Y+H  +   ++HRD+K +N+ ++ +D   KI DFGLAR      +H      G  T
Sbjct: 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 438 LGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGR 471
             Y +P  L+     T+  D+++ G +  E++ G+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L YLH  SE  +++RD+K  N++LDKD   KI DFGL +    D   +     GT  Y+
Sbjct: 121 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-XFCGTPEYL 177
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L         D +  G+++ E++CGR
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L YLH  SE  +++RD+K  N++LDKD   KI DFGL +    D   +     GT  Y+
Sbjct: 122 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-XFCGTPEYL 178
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L         D +  G+++ E++CGR
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L YLH  SE  +++RD+K  N++LDKD   KI DFGL +    D   +     GT  Y+
Sbjct: 120 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-XFCGTPEYL 176
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L         D +  G+++ E++CGR
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + +G G  GSV   Y   L     VAVK+L   F +       + E+ L+  ++H+N++ 
Sbjct: 26  RPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 83
Query: 332 LL-----GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
           LL       SIE    + +   +    L+  +    K + L+      ++     GL Y+
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYI 139
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL 446
           H      IIHRD+K SN+ +++D   +I DFGLAR   AD     T    T  Y APE +
Sbjct: 140 HSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADEE--MTGYVATRWYRAPEIM 192
Query: 447 VRG-QLTEKADVYSFGILIIEIVCGR 471
           +      +  D++S G ++ E++ G+
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + +G G  GSV   Y   L     VAVK+L   F +       + E+ L+  ++H+N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 332 LL-----GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
           LL       SIE    + +   +    L+  +    K + L+      ++     GL Y+
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYI 147
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL 446
           H      IIHRD+K SN+ +++D   +I DFGLAR   AD     T    T  Y APE +
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEE--MTGYVATRWYRAPEIM 200
Query: 447 VRG-QLTEKADVYSFGILIIEIVCGR 471
           +      +  D++S G ++ E++ G+
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVK----L 332
           +G+G  G V         T VA+K++  F  + +      E+ ++    H+N++     L
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
              ++E    +    Y+    ++  ++   K++ L+ +     +     GL Y+H  +  
Sbjct: 111 RASTLEAMRDV----YIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEYLVRGQ 450
            ++HRD+K SN+L++     KI DFGLAR    +  H    T    T  Y APE ++  +
Sbjct: 165 -VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSK 223
Query: 451 -LTEKADVYSFGILIIEIVCGR 471
             T+  D++S G ++ E++  R
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNR 245

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 35/213 (16%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS-SIEHKNLVKLLGC 335
           K LG G +G+V       G  VAVKR++ +   + D    E+ L++ S +H N+++   C
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY-C 76
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFN---IILGTAEGLAYLHGGSE 391
           S      L +   + N +L   +  KN + + L   K +N   ++   A G+A+LH    
Sbjct: 77  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133
Query: 392 TRIIHRDIKTSNILLDKD--FTPK-----------IADFGLARCFAADRTHVSTAV---A 435
            +IIHRD+K  NIL+     FT             I+DFGL +   + ++   T +   +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 436 GTLGYMAPEYL-------VRGQLTEKADVYSFG 461
           GT G+ APE L        + +LT   D++S G
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 28/166 (16%)
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP-----NRSLDQFIFDKNKTKLLNWN 370
           NE+ ++  I+H+N+V L           LV + V      +R L++ ++ +    L    
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---- 110
Query: 371 KRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK------IADFGLARCFA 424
               +I      + YLH   E  I+HRD+K  N+L     TP+      I DFGL++   
Sbjct: 111 ----VIQQVLSAVKYLH---ENGIVHRDLKPENLLY---LTPEENSKIMITDFGLSK--- 157
Query: 425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            ++  + +   GT GY+APE L +   ++  D +S G++   ++CG
Sbjct: 158 MEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 87/195 (44%), Gaps = 11/195 (5%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 458 GVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLES---KR 511
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
            +HRDI   N+L+      K+ DFGL+R       + ++     + +MAPE +   + T 
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 454 KADVYSFGILIIEIV 468
            +DV+ FG+ + EI+
Sbjct: 572 ASDVWMFGVCMWEIL 586

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L YLH      +++RDIK  N++LDKD   KI DFGL +   +D   + T   GT  Y+
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 172
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L         D +  G+++ E++CGR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L YLH      +++RDIK  N++LDKD   KI DFGL +   +D   + T   GT  Y+
Sbjct: 120 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 175
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L         D +  G+++ E++CGR
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L YLH      +++RDIK  N++LDKD   KI DFGL +   +D   + T   GT  Y+
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 172
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L         D +  G+++ E++CGR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/91 (42%), Positives = 57/91 (62%), Gaps = 7/91 (7%)
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           L +LH   +  II+RDIK  NILLD +    + DFGL++ F AD T  +    GT+ YMA
Sbjct: 172 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 443 PEYLVRGQLT--EKA-DVYSFGILIIEIVCG 470
           P+ +VRG  +  +KA D +S G+L+ E++ G
Sbjct: 229 PD-IVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
           NE+ ++  I+H+N+V L     E P  L LV + V    L   I +K             
Sbjct: 69  NEIAVLRKIKHENIVALEDI-YESPNHLYLVMQLVSGGELFDRIVEKG---FYTEKDAST 124
Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVS 431
           +I    + + YLH      I+HRD+K  N+L    D++    I+DFGL++     +  V 
Sbjct: 125 LIRQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVM 179
Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           +   GT GY+APE L +   ++  D +S G++   ++CG
Sbjct: 180 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 67/127 (52%), Gaps = 11/127 (8%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL ++H      +++RD+K +NILLD+    +I+D GLA  F+  + H S    GT GYM
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 357
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV--WTLYRSNKLVE 498
           APE L +G      AD +S G ++ +++ G   + F Q        +   TL  + +L +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH--SPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 499 AVDPNLK 505
           +  P L+
Sbjct: 416 SFSPELR 422

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 67/127 (52%), Gaps = 11/127 (8%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL ++H      +++RD+K +NILLD+    +I+D GLA  F+  + H S    GT GYM
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 357
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV--WTLYRSNKLVE 498
           APE L +G      AD +S G ++ +++ G   + F Q        +   TL  + +L +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH--SPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 499 AVDPNLK 505
           +  P L+
Sbjct: 416 SFSPELR 422

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 67/127 (52%), Gaps = 11/127 (8%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL ++H      +++RD+K +NILLD+    +I+D GLA  F+  + H S    GT GYM
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 357
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV--WTLYRSNKLVE 498
           APE L +G      AD +S G ++ +++ G   + F Q        +   TL  + +L +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH--SPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 499 AVDPNLK 505
           +  P L+
Sbjct: 416 SFSPELR 422

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 256 KSCLSFKYETLEK-ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV--D 312
           +S +   YE  E+  +  F   +K  Q G G  Y            KR + ++R+ V  +
Sbjct: 21  QSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIK------KRRLXSSRRGVSRE 74
Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKR 372
           E   EVN++  I H N++ L        + +L+ E V    L  F+ +K     L  ++ 
Sbjct: 75  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEA 131
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNI-LLDKDF-TPKIA--DFGLARCFAADRT 428
              +    +G+ YLH     RI H D+K  NI LLDK+   P+I   DFG+A    A   
Sbjct: 132 TQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 188
Query: 429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             +  + GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 189 FKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 67/127 (52%), Gaps = 11/127 (8%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL ++H      +++RD+K +NILLD+    +I+D GLA  F+  + H S    GT GYM
Sbjct: 303 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 356
Query: 442 APEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV--WTLYRSNKLVE 498
           APE L +G      AD +S G ++ +++ G   + F Q        +   TL  + +L +
Sbjct: 357 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH--SPFRQHKTKDKHEIDRMTLTMAVELPD 414
Query: 499 AVDPNLK 505
           +  P L+
Sbjct: 415 SFSPELR 421

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/267 (22%), Positives = 96/267 (35%), Gaps = 75/267 (28%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLV 330
           F P + +G+GG G V+   +  +    A+KR+    R+   E    EV  ++ +EH  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 331 KLLGCSIEGPESLLVYEY------------------------VPNRSLDQFIFDKN---- 362
           +     +E P      E                         V  R +D F   KN    
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQ 126
Query: 363 ------------------KTKLLNWNKR------------FNIILGTAEGLAYLHGGSET 392
                             K  L +W  R             +I +  AE + +LH     
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG-- 184
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV-----------AGTLGYM 441
            ++HRD+K SNI    D   K+ DFGL      D    +               GT  YM
Sbjct: 185 -LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYM 243
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIV 468
           +PE +     + K D++S G+++ E++
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN----EVNLISS 323
           K ++ ++  ++LG+G A SV    +   T +     I NT++     F     E  +   
Sbjct: 3   KFSDNYDVKEELGKG-AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           ++H N+V+L     E     LV++ V    L + I  +      + +     IL   E +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ESI 118
Query: 384 AYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLGY 440
           AY H      I+HR++K  N+LL    K    K+ADFGLA     + +      AGT GY
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGY 173
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           ++PE L +   ++  D+++ G+++  ++ G
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS-SIEHKNLVKLLGC 335
           K LG G +G+V       G  VAVKR++ +   + D    E+ L++ S +H N+++   C
Sbjct: 39  KILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY-C 94
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFN---IILGTAEGLAYLHGGSE 391
           S      L +   + N +L   +  KN + + L   K +N   ++   A G+A+LH    
Sbjct: 95  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 151
Query: 392 TRIIHRDIKTSNILLDKD--FTPK-----------IADFGLARCFAADRTHVSTAV---A 435
            +IIHRD+K  NIL+     FT             I+DFGL +   + +      +   +
Sbjct: 152 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPS 211
Query: 436 GTLGYMAPEYL---VRGQLTEKADVYSFGILIIEIV 468
           GT G+ APE L    + +LT   D++S G +   I+
Sbjct: 212 GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYIL 247

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 15/220 (6%)
Query: 256 KSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTV--AVKRLIFNTRQWVDE 313
           +  L F+  T      Y+     +G+G  G V + ++  GT +  A K++     + VD 
Sbjct: 11  RENLYFQGSTKGDINQYYTLENTIGRGSWGEVKI-AVQKGTRIRRAAKKIPKYFVEDVDR 69
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
           F  E+ ++ S++H N+++L     +  +  LV E      L + +  K   ++   +   
Sbjct: 70  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAA 126
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILL--DKDFTP-KIADFGLARCFAADRTHV 430
            I+      +AY H   +  + HRD+K  N L   D   +P K+ DFGLA  F   +  +
Sbjct: 127 RIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-M 182
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            T V GT  Y++P+ L  G    + D +S G+++  ++CG
Sbjct: 183 RTKV-GTPYYVSPQVL-EGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS-SIEHKNLVKLLGC 335
           K LG G +G+V       G  VAVKR++ +   + D    E+ L++ S +H N+++   C
Sbjct: 39  KILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY-C 94
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFN---IILGTAEGLAYLHGGSE 391
           S      L +   + N +L   +  KN + + L   K +N   ++   A G+A+LH    
Sbjct: 95  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 151
Query: 392 TRIIHRDIKTSNILLDKD--FTPK-----------IADFGLARCFAADRTHVSTAV---A 435
            +IIHRD+K  NIL+     FT             I+DFGL +   + +      +   +
Sbjct: 152 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPS 211
Query: 436 GTLGYMAPEYL---VRGQLTEKADVYSFGILIIEIV 468
           GT G+ APE L    + +LT   D++S G +   I+
Sbjct: 212 GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYIL 247

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN----EVNLISS 323
           K ++ ++  ++LG+G A SV    +   T +     I NT++     F     E  +   
Sbjct: 2   KFSDNYDVKEELGKG-AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           ++H N+V+L     E     LV++ V    L + I  +      + +     IL   E +
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ESI 117
Query: 384 AYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLGY 440
           AY H      I+HR++K  N+LL    K    K+ADFGLA     + +      AGT GY
Sbjct: 118 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGY 172
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           ++PE L +   ++  D+++ G+++  ++ G
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 82/189 (43%), Gaps = 39/189 (20%)
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-T 437
            A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    A   
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV 497
           L +MAPE +     T ++DV+SFG+L+ EI        FS   ASP              
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL-GASPY------------- 294
Query: 498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFL 557
               P +K D   E+ C  L+ G    +A     P M Q ++      C    PSQ P  
Sbjct: 295 ----PGVKID---EEFCRRLKEGTR-MRAPDYTTPEMYQTML-----DCWHGEPSQRPTF 341
Query: 558 NSSVMEPGN 566
           +  V   GN
Sbjct: 342 SELVEHLGN 350

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 129/299 (43%), Gaps = 61/299 (20%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS 322
           E  E   +   P  +LG+G  G V     +P+G   AVKR+                 ++
Sbjct: 27  ENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRI--------------RATVN 72
Query: 323 SIEHKNLVKLLGCS---IEGPESLLVY------------EYVPNRSLDQF---IFDKNKT 364
           S E K L+  L  S   ++ P ++  Y              + + SLD+F   + DK +T
Sbjct: 73  SQEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQT 132
Query: 365 KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
             +  +    I +   + L +LH  S+  +IHRD+K SN+L++     K  DFG++    
Sbjct: 133 --IPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLV 188
Query: 425 ADRTHVSTAV-AGTLGYMAPE----YLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQD 479
            D   V+  + AG   Y APE     L +   + K+D++S GI  IE+   R    F  D
Sbjct: 189 DD---VAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILR----FPYD 241
Query: 480 S-ASPLQRVWTLYRSNKLVEAVDPNLK-DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQ 536
           S  +P Q++       ++VE   P L  D F AE V    Q    C +  +  RP+  +
Sbjct: 242 SWGTPFQQL------KQVVEEPSPQLPADKFSAEFVDFTSQ----CLKKNSKERPTYPE 290

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN----EVNLISS 323
           K ++ ++  ++LG+G A SV    +   T +     I NT++     F     E  +   
Sbjct: 26  KFSDNYDVKEELGKG-AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 84
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           ++H N+V+L     E     LV++ V    L + I  +      + +     IL   E +
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ESI 141
Query: 384 AYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLGY 440
           AY H      I+HR++K  N+LL    K    K+ADFGLA     + +      AGT GY
Sbjct: 142 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGY 196
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           ++PE L +   ++  D+++ G+++  ++ G
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 21/221 (9%)
Query: 257 SCLSFKYETLEK-ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV--DE 313
           S +   YE  E+  +  F   +K  Q G G  Y            KR + ++R+ V  +E
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIK------KRRLSSSRRGVSREE 54
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
              EVN++  I H N++ L        + +L+ E V    L  F+ +K     L  ++  
Sbjct: 55  IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEAT 111
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNI-LLDKDF-TPKIA--DFGLARCFAADRTH 429
             +    +G+ YLH     RI H D+K  NI LLDK+   P+I   DFG+A    A    
Sbjct: 112 QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168
Query: 430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            +  + GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 169 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 24/170 (14%)
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-T 437
            A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    A   
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV 497
           L +MAPE +     T ++DV+SFG+L+ EI        FS   ASP       Y   K+ 
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL-GASP-------YPGVKID 302
Query: 498 EAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           E     LK+      P      + Q  L C     + RP+ ++ +  L N
Sbjct: 303 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 24/170 (14%)
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-T 437
            A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    A   
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV 497
           L +MAPE +     T ++DV+SFG+L+ EI        FS   ASP       Y   K+ 
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL-GASP-------YPGVKID 309
Query: 498 EAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           E     LK+      P      + Q  L C     + RP+ ++ +  L N
Sbjct: 310 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 359

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 24/170 (14%)
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG-T 437
            A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    A   
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV 497
           L +MAPE +     T ++DV+SFG+L+ EI        FS   ASP       Y   K+ 
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL-GASP-------YPGVKID 307
Query: 498 EAVDPNLKDDF----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           E     LK+      P      + Q  L C     + RP+ ++ +  L N
Sbjct: 308 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 357

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 21/226 (9%)
Query: 252 TSMKKSCLSFKYETLEK-ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQW 310
           ++ ++  +   YE  E+  +  F   +K  Q G G  Y            KR + ++R+ 
Sbjct: 3   STFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIK------KRRLSSSRRG 56
Query: 311 V--DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN 368
           V  +E   EVN++  I H N++ L        + +L+ E V    L  F+ +K     L 
Sbjct: 57  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LT 113
Query: 369 WNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNI-LLDKDF-TPKIA--DFGLARCFA 424
            ++    +    +G+ YLH     RI H D+K  NI LLDK+   P+I   DFG+A    
Sbjct: 114 EDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 170
Query: 425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           A     +  + GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 171 AGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN----EVNLISS 323
           K ++ ++  ++LG+G A SV    +   T +     I NT++     F     E  +   
Sbjct: 3   KFSDNYDVKEELGKG-AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           ++H N+V+L     E     LV++ V    L + I  +      + +     IL   E +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ESI 118
Query: 384 AYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLGY 440
           AY H      I+HR++K  N+LL    K    K+ADFGLA     + +      AGT GY
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGY 173
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           ++PE L +   ++  D+++ G+++  ++ G
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L YLH      +++RDIK  N++LDKD   KI DFGL +   +D   +     GT  Y+
Sbjct: 122 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-XFCGTPEYL 177
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L         D +  G+++ E++CGR
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L YLH      +++RDIK  N++LDKD   KI DFGL +   +D   +     GT  Y+
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-XFCGTPEYL 172
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L         D +  G+++ E++CGR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 279 LGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEF---FNEVNLISSIEHKNLVKLLG 334
           LG+G  G V +  +   G   AVK L  +     D+      E  ++S   +   +  L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 335 CSIEGPESLL-VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           C  + P+ L  V E+V    L   +F   K++  +  +           L +LH   +  
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISALMFLH---DKG 144
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV-AGTLGYMAPEYLVRGQLT 452
           II+RD+K  N+LLD +   K+ADFG+  C       V+TA   GT  Y+APE L      
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGM--CKEGICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 453 EKADVYSFGILIIEIVCGR 471
              D ++ G+L+ E++CG 
Sbjct: 203 PAVDWWAMGVLLYEMLCGH 221

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L YLH      +++RDIK  N++LDKD   KI DFGL +   +D   +     GT  Y+
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-XFCGTPEYL 172
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L         D +  G+++ E++CGR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            L YLH      +++RDIK  N++LDKD   KI DFGL +   +D   +     GT  Y+
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-XFCGTPEYL 172
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE L         D +  G+++ E++CGR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 113/247 (45%), Gaps = 25/247 (10%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFF--NEVNLISSIEHKN 328
           +Y++  ++LG G  G V+         V V + I NT   +D++   NE+++++ + H  
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDK--NKTKLLNWNKRFNIILGTAEGLAYL 386
           L+ L     +  E +L+ E++    L    FD+   +   ++  +  N +    EGL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 387 HGGSETRIIHRDIKTSNILLD--KDFTPKIADFGLARCFAADR-THVSTAVAGTLGYMAP 443
           H   E  I+H DIK  NI+ +  K  + KI DFGLA     D    V+TA A    + AP
Sbjct: 166 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA---EFAAP 219
Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV----WTLYRSNKLVEA 499
           E + R  +    D+++ G+L   ++ G    A  +D    LQ V    W          +
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRCDWEF--DEDAFSS 276
Query: 500 VDPNLKD 506
           V P  KD
Sbjct: 277 VSPEAKD 283

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSI 337
           +G G  G VY G       +A  +++  T    +E   E+N++     H+N+    G  I
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 338 E-GPESL-----LVYEYVPNRSLDQFIFD-KNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +  P  +     LV E+    S+   I + K  T    W     I      GL++LH   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH--- 146
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRG 449
           + ++IHRDIK  N+LL ++   K+ DFG++     DRT        GT  +MAPE +   
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACD 204
Query: 450 QLTE-----KADVYSFGILIIEIVCG 470
           +  +     K+D++S GI  IE+  G
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSLPNGTTV--AVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
            Y+     +G+G  G V + ++  GT +  A K++     + VD F  E+ ++ S++H N
Sbjct: 9   QYYTLENTIGRGSWGEVKI-AVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           +++L     +  +  LV E      L + +  K   ++   +    I+      +AY H 
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCH- 123
Query: 389 GSETRIIHRDIKTSNILL--DKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEY 445
             +  + HRD+K  N L   D   +P K+ DFGLA  F   +  + T V GT  Y++P+ 
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTPYYVSPQV 179
Query: 446 LVRGQLTEKADVYSFGILIIEIVCG 470
           L  G    + D +S G+++  ++CG
Sbjct: 180 L-EGLYGPECDEWSAGVMMYVLLCG 203

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K +G G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    K+ADFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 35/213 (16%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS-SIEHKNLVKLLGC 335
           K LG G +G+V       G  VAVKR++ +   + D    E+ L++ S +H N+++   C
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY-C 76
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFN---IILGTAEGLAYLHGGSE 391
           S      L +   + N +L   +  KN + + L   K +N   ++   A G+A+LH    
Sbjct: 77  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133
Query: 392 TRIIHRDIKTSNILLDKD--FTPK-----------IADFGLARCFAADRTHVSTAV---A 435
            +IIHRD+K  NIL+     FT             I+DFGL +   + +      +   +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPS 193
Query: 436 GTLGYMAPEYL-------VRGQLTEKADVYSFG 461
           GT G+ APE L        + +LT   D++S G
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K +G G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EY+P    D F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    K+ADFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K +G G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EY+P    D F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    K+ADFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL  LH     RI++RD+K  NILLD     +I+D GLA      +T       GT+GYM
Sbjct: 298 GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYM 352
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE +   + T   D ++ G L+ E++ G+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL  LH     RI++RD+K  NILLD     +I+D GLA      +T       GT+GYM
Sbjct: 298 GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYM 352
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE +   + T   D ++ G L+ E++ G+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 279 LGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWVD--EFFNEVNLISSIEHKNLVKLLGC 335
           LG G  G V+       G  +A K  I  TR   D  E  NE+++++ ++H NL++L   
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAK--IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDK--NKTKLLNWNKRFNIIL---GTAEGLAYLHGGS 390
                + +LV EYV    L   I D+  N T+L       + IL      EG+ ++H   
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTEL-------DTILFMKQICEGIRHMH--- 204
Query: 391 ETRIIHRDIKTSNIL-LDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
           +  I+H D+K  NIL +++D    KI DFGLAR +   R  +     GT  ++APE +  
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-REKLKVNF-GTPEFLAPEVVNY 262
Query: 449 GQLTEKADVYSFGILIIEIVCG 470
             ++   D++S G++   ++ G
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSG 284

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 102
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHARFYAAQIVLT----FE 156
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 209
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA-VAGT 437
            A G+ +L   S  + IHRD+   NILL ++   KI DFGLAR    +  +V        
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEI 467
           L +MAPE +     + K+DV+S+G+L+ EI
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEI 294

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 102
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 156
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WTLCGTPEYLAPE 209
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 20/222 (9%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTV----AVKRLIFNTRQWVDEFFNEVNLISSI-EHK 327
           F+  + +G+G    V +  L     +     VK+ + N  + +D    E ++      H 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLA 384
            LV L  C         V EYV    L      + + KL   + RF     +AE    L 
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFY----SAEISLALN 167
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV-AGTLGYMAP 443
           YLH   E  II+RD+K  N+LLD +   K+ D+G+  C    R   +T+   GT  Y+AP
Sbjct: 168 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM--CKEGLRPGDTTSTFCGTPNYIAP 222
Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ 485
           E L         D ++ G+L+ E++ GR        S +P Q
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 20/222 (9%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTV----AVKRLIFNTRQWVDEFFNEVNLISSI-EHK 327
           F+  + +G+G    V +  L     +     VK+ + N  + +D    E ++      H 
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLA 384
            LV L  C         V EYV    L      + + KL   + RF     +AE    L 
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFY----SAEISLALN 135
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA-VAGTLGYMAP 443
           YLH   E  II+RD+K  N+LLD +   K+ D+G+  C    R   +T+   GT  Y+AP
Sbjct: 136 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM--CKEGLRPGDTTSXFCGTPNYIAP 190
Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ 485
           E L         D ++ G+L+ E++ GR        S +P Q
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 232

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 87/190 (45%), Gaps = 17/190 (8%)
Query: 294 NGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLV---KLLGCSIEGPESLLVYEY 348
            G  VA+K++   F+          E+ ++   +H N++    +L  ++   E   VY  
Sbjct: 79  TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 138
Query: 349 VP--NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL 406
           +      L Q I       L +       +L    GL Y+H     ++IHRD+K SN+L+
Sbjct: 139 LDLMESDLHQIIHSSQPLTLEHVRYFLYQLL---RGLKYMHSA---QVIHRDLKPSNLLV 192
Query: 407 DKDFTPKIADFGLARCF---AADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGI 462
           +++   KI DFG+AR      A+  +  T    T  Y APE ++   + T+  D++S G 
Sbjct: 193 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 252
Query: 463 LIIEIVCGRR 472
           +  E++  R+
Sbjct: 253 IFGEMLARRQ 262

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 102
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 156
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 209
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 36/237 (15%)
Query: 279 LGQGGAGSVYMGSLPNGT-TVAVKRLIFNTRQWVD--EFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G VY+    N    VA+K++       +D      E+ +++ ++   +++L   
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDL 95
Query: 336 SIEGPESLLVYE--YVPNRSLDQFIFDKNKTKLLNWNKRFNIIL-GTAEGLAYLHGGSET 392
            I  PE LL ++  Y+     D  +    KT +    +    IL     G  ++H   E+
Sbjct: 96  II--PEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIH---ES 150
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR-THVS-------------------- 431
            IIHRD+K +N LL++D + KI DFGLAR   +D+  H+                     
Sbjct: 151 GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLK 210
Query: 432 ---TAVAGTLGYMAPEY-LVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPL 484
              T+   T  Y APE  L++   T   D++S G +  E++   +S+  +  +  PL
Sbjct: 211 KQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPL 267

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 87
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 88  FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 141
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 142 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WTLCGTPEYLAPE 194
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 195 IILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 110
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 167
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 168 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 222
Query: 441 MAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            APE +      T   DV+S G ++ E++ G+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 25/213 (11%)
Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW---VDEFFNEVNLISSIEHKNLVK 331
           S  LGQG   +V+ G     G   A+K  +FN   +   VD    E  ++  + HKN+VK
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 332 LLGCSIEGP--ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           L     E      +L+ E+ P  SL   + + +    L  ++   ++     G+ +L   
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL--- 128
Query: 390 SETRIIHRDIKTSNILL----DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEY 445
            E  I+HR+IK  NI+     D     K+ DFG AR    D   VS  + GT  Y+ P+ 
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDM 186
Query: 446 LVRGQLTEK--------ADVYSFGILIIEIVCG 470
             R  L +          D++S G+       G
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 88/190 (46%), Gaps = 17/190 (8%)
Query: 294 NGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLV---KLLGCSIEGPESLLVYEY 348
            G  VA+K++   F+          E+ ++   +H N++    +L  ++   E   VY  
Sbjct: 78  TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 137
Query: 349 VP--NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL 406
           +      L Q I   + ++ L        +     GL Y+H     ++IHRD+K SN+L+
Sbjct: 138 LDLMESDLHQII---HSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLV 191
Query: 407 DKDFTPKIADFGLARCF---AADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGI 462
           +++   KI DFG+AR      A+  +  T    T  Y APE ++   + T+  D++S G 
Sbjct: 192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 251
Query: 463 LIIEIVCGRR 472
           +  E++  R+
Sbjct: 252 IFGEMLARRQ 261

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 88
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 145
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 146 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 200
Query: 441 MAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            APE +      T   DV+S G ++ E++ G+
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/307 (21%), Positives = 120/307 (39%), Gaps = 42/307 (13%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE 338
           +G+G  G VY G       + +  +  +    +  F  EV       H+N+V  +G  + 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
            P   ++      R+L   + D     +L+ NK   I     +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 399 IKTSNILLDKDFTPKIADFGL---ARCFAADRTHVSTAVA-GTLGYMAPEYLV------- 447
           +K+ N+  D      I DFGL   +    A R      +  G L ++APE +        
Sbjct: 156 LKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 448 --RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK 505
             +   ++ +DV++ G +  E+    R   F    A  +  +W      ++   + PNL 
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHA--REWPFKTQPAEAI--IW------QMGTGMKPNLS 264
Query: 506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSSVMEPG 565
                +++ ++L   L C       RP+  + + +L           + P  N  +  PG
Sbjct: 265 QIGMGKEISDIL---LFCWAFEQEERPTFTKLMDML----------EKLPKRNRRLSHPG 311
Query: 566 NSSRSCS 572
           +  +S  
Sbjct: 312 HFWKSAE 318

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 48/83 (57%), Gaps = 7/83 (8%)
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
           +IHRD+K SNILLD+    K+ DFG++     D+    +  AG   YMAPE +     T+
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS--AGCAAYMAPERIDPPDPTK 203
Query: 454 -----KADVYSFGILIIEIVCGR 471
                +ADV+S GI ++E+  G+
Sbjct: 204 PDYDIRADVWSLGISLVELATGQ 226

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 133
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 188
Query: 441 MAPEYLVRG--QLTEKADVYSFGILIIEIVCGR 471
            APE L+ G    T   DV+S G ++ E++ G+
Sbjct: 189 RAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 133
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 188
Query: 441 MAPEYLVRG--QLTEKADVYSFGILIIEIVCGR 471
            APE L+ G    T   DV+S G ++ E++ G+
Sbjct: 189 RAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 76/172 (44%), Gaps = 19/172 (11%)
Query: 308 RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP----NRSLDQFIFDKNK 363
           R  V   F E+ ++  +EH  LV L     +  +  +V + +        L Q +  K +
Sbjct: 56  RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE 115
Query: 364 TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
           T  L        I      L YL      RIIHRD+K  NILLD+     I DF +A   
Sbjct: 116 TVKL-------FICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165
Query: 424 AADRTHVSTAVAGTLGYMAPEYLVRGQ---LTEKADVYSFGILIIEIVCGRR 472
             + T ++T +AGT  YMAPE     +    +   D +S G+   E++ GRR
Sbjct: 166 PRE-TQITT-MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EY P   +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFXEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+++D+    K+ DFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 84
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 142 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 196
Query: 441 MAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            APE +      T   DV+S G ++ E++ G+
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 20/222 (9%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTV----AVKRLIFNTRQWVDEFFNEVNLISSI-EHK 327
           F+  + +G+G    V +  L     +     VK+ + N  + +D    E ++      H 
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLA 384
            LV L  C         V EYV    L      + + KL   + RF     +AE    L 
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFY----SAEISLALN 120
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA-VAGTLGYMAP 443
           YLH   E  II+RD+K  N+LLD +   K+ D+G+  C    R   +T+   GT  Y+AP
Sbjct: 121 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM--CKEGLRPGDTTSXFCGTPNYIAP 175
Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ 485
           E L         D ++ G+L+ E++ GR        S +P Q
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 217

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 95
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 152
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 153 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 207
Query: 441 MAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            APE +      T   DV+S G ++ E++ G+
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 77
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 134
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 135 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 189
Query: 441 MAPEYLVRG--QLTEKADVYSFGILIIEIVCGR 471
            APE L+ G    T   DV+S G ++ E++ G+
Sbjct: 190 RAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 20/222 (9%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTV----AVKRLIFNTRQWVDEFFNEVNLISSI-EHK 327
           F+  + +G+G    V +  L     +     VK+ + N  + +D    E ++      H 
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLA 384
            LV L  C         V EYV    L      + + KL   + RF     +AE    L 
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFY----SAEISLALN 124
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA-VAGTLGYMAP 443
           YLH   E  II+RD+K  N+LLD +   K+ D+G+  C    R   +T+   GT  Y+AP
Sbjct: 125 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM--CKEGLRPGDTTSXFCGTPNYIAP 179
Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ 485
           E L         D ++ G+L+ E++ GR        S +P Q
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 104
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 161
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 162 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 216
Query: 441 MAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            APE +      T   DV+S G ++ E++ G+
Sbjct: 217 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 88
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 145
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 146 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 200
Query: 441 MAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            APE +      T   DV+S G ++ E++ G+
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 80
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 137
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 138 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 192
Query: 441 MAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            APE +      T   DV+S G ++ E++ G+
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 110
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 167
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 168 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 222
Query: 441 MAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            APE +      T   DV+S G ++ E++ G+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 81
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 138
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 139 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 193
Query: 441 MAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            APE +      T   DV+S G ++ E++ G+
Sbjct: 194 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 114
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 171
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 172 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 226
Query: 441 MAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            APE +      T   DV+S G ++ E++ G+
Sbjct: 227 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 133
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 188
Query: 441 MAPEYLVRG--QLTEKADVYSFGILIIEIVCGR 471
            APE L+ G    T   DV+S G ++ E++ G+
Sbjct: 189 RAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 89
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 146
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 147 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 201
Query: 441 MAPEYLVRG--QLTEKADVYSFGILIIEIVCGR 471
            APE L+ G    T   DV+S G ++ E++ G+
Sbjct: 202 RAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 112
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 169
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 170 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 224
Query: 441 MAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            APE +      T   DV+S G ++ E++ G+
Sbjct: 225 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 133
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 188
Query: 441 MAPEYLVRG--QLTEKADVYSFGILIIEIVCGR 471
            APE L+ G    T   DV+S G ++ E++ G+
Sbjct: 189 RAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              +AGT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 196 -WXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 4/90 (4%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL +LH   +  II+RD+K  N++LD +   KIADFG+ +    D    +    GT  Y+
Sbjct: 132 GLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV-TTREFCGTPDYI 187
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           APE +      +  D +++G+L+ E++ G+
Sbjct: 188 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +      G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 94
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 95  FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHARFYAAQIVLT----FE 148
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 201
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EY P   +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+++D+    K+ DFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 155
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 212
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGY 440
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +    Y
Sbjct: 213 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 267
Query: 441 MAPEYLVRG-QLTEKADVYSFGILIIEIVCGR 471
            APE +      T   DV+S G ++ E++ G+
Sbjct: 268 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   ++ ++   NE  ++ ++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKE-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EY P   +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+++D+    K+ DFGLA+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 277 KKLGQGGAGSV-YMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +KLG+GG   V  +  L +G   A+KR++ + +Q  +E   E ++     H N+++L+  
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 336 SIE----GPESLLVYEYVPNRSL-DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            +       E+ L+  +    +L ++    K+K   L  ++   ++LG   GL  +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR--CFAADRTHVSTAVAG------TLGYMA 442
                HRD+K +NILL  +  P + D G     C   + +  +  +        T+ Y A
Sbjct: 155 YA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 443 PE-YLVRGQ--LTEKADVYSFGILIIEIVCG 470
           PE + V+    + E+ DV+S G ++  ++ G
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +      G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +      G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           E   +Y++  ++LG G    V         L        KR   ++R+ V  ++   EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  I+H N++ L        + +L+ E V    L  F+ +K         +    IL  
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN- 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK----IADFGLARCFAADRTHVSTAVA 435
             G+ YLH     +I H D+K  NI+L     PK    I DFGLA     D  +    + 
Sbjct: 126 --GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +      G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 102
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 156
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 209
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +      G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 102
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 156
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 209
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +      G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 94
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 95  FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 148
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 201
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +      G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 102
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 156
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 209
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 262 KYETLEKATNY---FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+E+  + T +   F   K LG G  G V +      G   A+K L    +   +Q ++ 
Sbjct: 50  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEH 108
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYVP   +  F   +   +    + RF
Sbjct: 109 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARF 166
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 167 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 216
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 217 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +      G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYVP   +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 25/213 (11%)
Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW---VDEFFNEVNLISSIEHKNLVK 331
           S  LGQG   +V+ G     G   A+K  +FN   +   VD    E  ++  + HKN+VK
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 332 LLGCSIEGP--ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           L     E      +L+ E+ P  SL   + + +    L  ++   ++     G+ +L   
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 390 SETRIIHRDIKTSNILL----DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEY 445
            E  I+HR+IK  NI+     D     K+ DFG AR    D   V   + GT  Y+ P+ 
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--XLYGTEEYLHPDM 186
Query: 446 LVRGQLTEK--------ADVYSFGILIIEIVCG 470
             R  L +          D++S G+       G
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 196 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 102
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            L KL     +     +V EY P   +  F   +   +    + RF    I+L       
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFXEPHARFYAAQIVLT----FE 156
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+++D+    K+ DFG A+     RT     + GT  Y+APE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 209
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 50  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 108
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 109 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF 166
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+         
Sbjct: 167 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----A 215
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           +  + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 216 TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           +H N++ L     +G    LV E +    L   I    + K  +  +   ++    + + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL---RQKFFSEREASFVLHTIGKTVE 135
Query: 385 YLHGGSETRIIHRDIKTSNIL-LDKDFTP---KIADFGLARCFAADRTHVSTAVAGTLGY 440
           YLH      ++HRD+K SNIL +D+   P   +I DFG A+   A+   + T    T  +
Sbjct: 136 YLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANF 191
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           +APE L R    E  D++S GIL+  ++ G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           +H N++ L     +G    LV E +    L   I    + K  +  +   ++    + + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL---RQKFFSEREASFVLHTIGKTVE 135
Query: 385 YLHGGSETRIIHRDIKTSNIL-LDKDFTP---KIADFGLARCFAADRTHVSTAVAGTLGY 440
           YLH      ++HRD+K SNIL +D+   P   +I DFG A+   A+   + T    T  +
Sbjct: 136 YLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANF 191
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           +APE L R    E  D++S GIL+  ++ G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 50  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 108
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 109 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARF 166
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 167 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 216
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 217 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 20/184 (10%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNLVKLLG 334
           K+GQG  G V+       G  VA+K+++    +  +      E+ ++  ++H+N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 335 -CSIEGPES-------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
            C  +            LV+++     L   + +      L+  KR   +L    GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQML--LNGLYYI 141
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG---TLGYMAP 443
           H     +I+HRD+K +N+L+ +D   K+ADFGLAR F+  +            TL Y  P
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 444 EYLV 447
           E L+
Sbjct: 199 ELLL 202

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EY P   +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+++D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 196 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 20/184 (10%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNLVKLLG 334
           K+GQG  G V+       G  VA+K+++    +  +      E+ ++  ++H+N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 335 -CSIEG-------PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
            C  +            LV+++  +           K  L    +   ++L    GL Y+
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---GLYYI 141
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG---TLGYMAP 443
           H     +I+HRD+K +N+L+ +D   K+ADFGLAR F+  +            TL Y  P
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 444 EYLV 447
           E L+
Sbjct: 199 ELLL 202

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           E   +Y++  ++LG G    V         L        KR   ++R+ V  ++   EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  I+H N++ L        + +L+ E V    L  F+ +K         +    IL  
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN- 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK----IADFGLARCFAADRTHVSTAVA 435
             G+ YLH     +I H D+K  NI+L     PK    I DFGLA     D  +    + 
Sbjct: 126 --GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 20/184 (10%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNLVKLLG 334
           K+GQG  G V+       G  VA+K+++    +  +      E+ ++  ++H+N+V L+ 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 335 -CSIEGPES-------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
            C  +            LV+++     L   + +      L+  KR   +L    GL Y+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQML--LNGLYYI 140
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG---TLGYMAP 443
           H     +I+HRD+K +N+L+ +D   K+ADFGLAR F+  +            TL Y  P
Sbjct: 141 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 444 EYLV 447
           E L+
Sbjct: 198 ELLL 201

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 196 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 10/149 (6%)
Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           H N+VKL     +   + LV E +    L + I    K K  +  +   I+      +++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERI---KKKKHFSETEASYIMRKLVSAVSH 121
Query: 386 LHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           +H   +  ++HRD+K  N+L    + +   KI DFG AR    D   + T    TL Y A
Sbjct: 122 MH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAA 177
Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           PE L +    E  D++S G+++  ++ G+
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 24  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 82
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 83  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARF 140
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 141 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 190
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 191 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   ++ ++   NE  ++ ++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKE-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EY P   +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+++D+    ++ DFGLA+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 102
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            L KL     +     +V EY P   +  F   +   +    + RF    I+L       
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 156
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+++D+    K+ DFG A+     RT     + GT  Y+APE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 209
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSI 324
           T+ +   ++LG+G    V     +P G   A K  I NT++       +   E  +   +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAK--IINTKKLSARDHQKLEREARICRLL 60
Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           +H N+V+L     E     LV++ V    L + I  +      + +     IL +     
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH-C 119
Query: 385 YLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           +L+G     I+HRD+K  N+LL    K    K+ADFGLA     D+       AGT GY+
Sbjct: 120 HLNG-----IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGYL 173
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCG 470
           +PE L +    +  D+++ G+++  ++ G
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 20/184 (10%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNLVKLLG 334
           K+GQG  G V+       G  VA+K+++    +  +      E+ ++  ++H+N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 335 -CSIEGPES-------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
            C  +            LV+++     L   + +      L+  KR   +L    GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQML--LNGLYYI 141
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG---TLGYMAP 443
           H     +I+HRD+K +N+L+ +D   K+ADFGLAR F+  +            TL Y  P
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 444 EYLV 447
           E L+
Sbjct: 199 ELLL 202

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 196 -WXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 102
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            L KL     +     +V EY P   +  F   +   +    + RF    I+L       
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 156
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+++D+    K+ DFG A+     RT     + GT  Y+APE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 209
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFAEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 196 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSI 324
           T+ +   ++LG+G    V     +P G   A K  I NT++       +   E  +   +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAK--IINTKKLSARDHQKLEREARICRLL 60
Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           +H N+V+L     E     LV++ V    L + I  +      + +     IL +     
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH-C 119
Query: 385 YLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           +L+G     I+HRD+K  N+LL    K    K+ADFGLA     D+       AGT GY+
Sbjct: 120 HLNG-----IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGYL 173
Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCG 470
           +PE L +    +  D+++ G+++  ++ G
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +      G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 102
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EY P   +  F   +   +    + RF    I+L       
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 156
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+++D+    K+ DFG A+     RT     + GT  Y+APE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 209
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 196 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%), Gaps = 1/78 (1%)
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
           II+RD+K  N++LD +   KIADFG+ +    D    +    GT  Y+APE +      +
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTPDYIAPEIIAYQPYGK 521
Query: 454 KADVYSFGILIIEIVCGR 471
             D ++FG+L+ E++ G+
Sbjct: 522 SVDWWAFGVLLYEMLAGQ 539

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 36/167 (21%)
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-----LNWNK 371
           E+ ++S +EH N++K+L           ++E   N+   Q + +K+ + L     ++ + 
Sbjct: 79  EIAILSRVEHANIIKVLD----------IFE---NQGFFQLVMEKHGSGLDLFAFIDRHP 125
Query: 372 RFNIILGT------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
           R +  L +         + YL       IIHRDIK  NI++ +DFT K+ DFG A     
Sbjct: 126 RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL-- 180
Query: 426 DRTHVSTAVAGTLGYMAPEYLV----RGQLTEKADVYSFGILIIEIV 468
           +R  +     GT+ Y APE L+    RG    + +++S G+ +  +V
Sbjct: 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLV 224

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 196 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           E   +Y++  ++LG G    V         L        KR   ++R+ V  ++   EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  I+H N++ L        + +L+ E V    L  F+ +K         +    IL  
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN- 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK----IADFGLARCFAADRTHVSTAVA 435
             G+ YLH     +I H D+K  NI+L     PK    I DFGLA     D  +    + 
Sbjct: 126 --GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 30  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 88
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF 146
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 147 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 196
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 197 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+++D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 196 -WXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 196 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           E   +Y++  ++LG G    V         L        KR   ++R+ V  ++   EV+
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  I+H N++ L        + +L+ E V    L  F+ +K         +    IL  
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN- 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK----IADFGLARCFAADRTHVSTAVA 435
             G+ YLH     +I H D+K  NI+L     PK    I DFGLA     D  +    + 
Sbjct: 126 --GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   + LG G  G V +      G   A+K L    +   +Q ++   NE  +  ++   
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRIQQAVNFP 102
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EY P   +  F   +   +    + RF    I+L       
Sbjct: 103 FLVKLEFSFKDNSNLYMVLEYAPGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 156
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    K+ADFG A+     RT     + GT  Y+APE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-RT---WXLCGTPEYLAPE 209
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           E   +Y++  ++LG G    V         L        KR   ++R+ V  ++   EV+
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  I+H N++ L        + +L+ E V    L  F+ +K         +    IL  
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN- 124
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK----IADFGLARCFAADRTHVSTAVA 435
             G+ YLH     +I H D+K  NI+L     PK    I DFGLA     D  +    + 
Sbjct: 125 --GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 177
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           E   +Y++  ++LG G    V         L        KR   ++R+ V  ++   EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  I+H N++ L        + +L+ E V    L  F+ +K         +    IL  
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN- 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK----IADFGLARCFAADRTHVSTAVA 435
             G+ YLH     +I H D+K  NI+L     PK    I DFGLA     D  +    + 
Sbjct: 126 --GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           A GL +L       II+RD+K  N++LD +   KIADFG+ +    D    +    GT  
Sbjct: 131 AIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTPD 186
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           Y+APE +      +  D ++FG+L+ E++ G+
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           E   +Y++  ++LG G    V         L        KR   ++R+ V  ++   EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  I+H N++ L        + +L+ E V    L  F+ +K         +    IL  
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN- 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK----IADFGLARCFAADRTHVSTAVA 435
             G+ YLH     +I H D+K  NI+L     PK    I DFGLA     D  +    + 
Sbjct: 126 --GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 196 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 196 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           E   +Y++  ++LG G    V         L        KR   ++R+ V  ++   EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  I+H N++ L        + +L+ E V    L  F+ +K         +    IL  
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN- 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK----IADFGLARCFAADRTHVSTAVA 435
             G+ YLH     +I H D+K  NI+L     PK    I DFGLA     D  +    + 
Sbjct: 126 --GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKLLGC 335
           K +G G  G V+   L     VA+K+++ + R     F N E+ ++  ++H N+V L   
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAF 100
Query: 336 SIEGPESL------LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
                +        LV EYVP    R+   +   K    +L        +L     LAY+
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL---RSLAYI 157
Query: 387 HGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEY 445
           H      I HRDIK  N+LLD      K+ DFG A+   A   +VS   +    Y APE 
Sbjct: 158 HS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY--YRAPEL 212
Query: 446 LVRG-QLTEKADVYSFGILIIEIVCGR 471
           +      T   D++S G ++ E++ G+
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           E   +Y++  ++LG G    V         L        KR   ++R+ V  ++   EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  I+H N++ L        + +L+ E V    L  F+ +K         +    IL  
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN- 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK----IADFGLARCFAADRTHVSTAVA 435
             G+ YLH     +I H D+K  NI+L     PK    I DFGLA     D  +    + 
Sbjct: 126 --GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           E   +Y++  ++LG G    V         L        KR   ++R+ V  ++   EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  I+H N++ L        + +L+ E V    L  F+ +K         +    IL  
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN- 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK----IADFGLARCFAADRTHVSTAVA 435
             G+ YLH     +I H D+K  NI+L     PK    I DFGLA     D  +    + 
Sbjct: 126 --GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           E   +Y++  ++LG G    V         L        KR   ++R+ V  ++   EV+
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  I+H N++ L        + +L+ E V    L  F+ +K         +    IL  
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN- 124
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK----IADFGLARCFAADRTHVSTAVA 435
             G+ YLH     +I H D+K  NI+L     PK    I DFGLA     D  +    + 
Sbjct: 125 --GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 177
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 16  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 74
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 75  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF 132
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 133 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG-RT-- 182
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI E+  G
Sbjct: 183 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLI----FNTRQWVDEFFNEVNLISSIEHK 327
           +  +K +G G  G VY   L  +G  VA+K+++    F  R        E+ ++  ++H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHC 73
Query: 328 NLVKL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILG 378
           N+V+L      S E  + +   LV +YVP    R    +   K    ++ + K +   L 
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL- 131
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGT 437
               LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +  
Sbjct: 132 -FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 438 LGYMAPEYLVRG--QLTEKADVYSFGILIIEIVCGR 471
             Y APE L+ G    T   DV+S G ++ E++ G+
Sbjct: 188 --YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +   +  G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLA 384
            LVKL     +     +V EYV    +  F   +   +    + RF    I+L       
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT---WXLCGTPEYLAPE 208
Query: 445 YLVRGQLTEKADVYSFGILIIEIVCG 470
            ++     +  D ++ G+LI E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLI----FNTRQWVDEFFNEVNLISSIEHK 327
           +  +K +G G  G VY   L  +G  VA+K+++    F  R        E+ ++  ++H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHC 73
Query: 328 NLVKL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILG 378
           N+V+L      S E  + +   LV +YVP    R    +   K    ++ + K +   L 
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL- 131
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGT 437
               LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +  
Sbjct: 132 -FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 438 LGYMAPEYLVRG--QLTEKADVYSFGILIIEIVCGR 471
             Y APE L+ G    T   DV+S G ++ E++ G+
Sbjct: 188 --YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           E   +Y++  ++LG G    V         L        KR   ++R+ V  ++   EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  I+H N++ L        + +L+ E V    L  F+ +K         +    IL  
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN- 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK----IADFGLARCFAADRTHVSTAVA 435
             G+ YLH     +I H D+K  NI+L     PK    I DFGLA     D  +    + 
Sbjct: 126 --GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLI----FNTRQWVDEFFNEVNLISSIEHK 327
           +  +K +G G  G VY   L  +G  VA+K+++    F  R        E+ ++  ++H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHC 73
Query: 328 NLVKL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILG 378
           N+V+L      S E  + +   LV +YVP    R    +   K    ++ + K +   L 
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI-YVKLYMYQL- 131
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGT 437
               LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS   +  
Sbjct: 132 -FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 438 LGYMAPEYLVRG--QLTEKADVYSFGILIIEIVCGR 471
             Y APE L+ G    T   DV+S G ++ E++ G+
Sbjct: 188 --YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           E   +Y++  ++LG G    V         L        KR   ++R+ V  ++   EV+
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  I+H N++ L        + +L+ E V    L  F+ +K         +    IL  
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN- 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK----IADFGLARCFAADRTHVSTAVA 435
             G+ YLH     +I H D+K  NI+L     PK    I DFGLA     D  +    + 
Sbjct: 126 --GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           E   +Y++  ++LG G    V         L        KR   ++R+ V  ++   EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  I+H N++ L        + +L+ E V    L  F+ +K         +    IL  
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILN- 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK----IADFGLARCFAADRTHVSTAVA 435
             G+ YLH     +I H D+K  NI+L     PK    I DFGLA     D  +    + 
Sbjct: 126 --GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 78/174 (44%), Gaps = 25/174 (14%)
Query: 300 VKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIF 359
           VKR I N R              S+ H N+V+     +      +V EY     L + I 
Sbjct: 62  VKREIINHR--------------SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 107
Query: 360 DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP--KIADF 417
             N  +      RF        G++Y H     ++ HRD+K  N LLD    P  KIADF
Sbjct: 108 --NAGRFSEDEARF-FFQQLISGVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADF 161
Query: 418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK-ADVYSFGILIIEIVCG 470
           G ++  +   +   +AV GT  Y+APE L++ +   K ADV+S G+ +  ++ G
Sbjct: 162 GYSKA-SVLHSQPKSAV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+APE ++     +  D ++ G+LI ++  G
Sbjct: 196 -WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 161
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 215
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 35/233 (15%)
Query: 273 FNPSKKLGQGGAGSVYMG--------SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI 324
           FN S  LGQG    ++ G           + T V +K L    R + + FF   +++S +
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII--LGTAEG 382
            HK+LV   G    G E++LV E+V   SLD ++  KNK  +       NI+  L  A+ 
Sbjct: 70  SHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKNCI-------NILWKLEVAKQ 121
Query: 383 LAY-LHGGSETRIIHRDIKTSNILL-----DKDFTP---KIADFGLARCFAADRTHVSTA 433
           LA+ +H   E  +IH ++   NILL      K   P   K++D G++             
Sbjct: 122 LAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----KDI 176
Query: 434 VAGTLGYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ 485
           +   + ++ PE +   + L    D +SFG  + EI  G      + DS   LQ
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 162
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 216
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 15/213 (7%)
Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNL 320
           T  + T+ +   ++LG+G A SV    +    T      I NT++       +   E  +
Sbjct: 25  TCTRFTDDYQLFEELGKG-AFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARI 83
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
              ++H N+V+L     E     LV++ V    L + I  +      + +   + IL   
Sbjct: 84  CRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQIL--- 140
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           E + ++H   +  I+HRD+K  N+LL    K    K+ADFGLA     ++       AGT
Sbjct: 141 ESVNHIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ-QAWFGFAGT 196
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            GY++PE L +    +  D+++ G+++  ++ G
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 161
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 215
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 91  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 148
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 149 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 202
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 203 HRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 69/151 (45%), Gaps = 11/151 (7%)
Query: 323 SIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           S+ H N+V+     +      ++ EY     L + I +  +         F  +L    G
Sbjct: 72  SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS---G 128
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTP--KIADFGLARCFAADRTHVSTAVAGTLGY 440
           ++Y H     +I HRD+K  N LLD    P  KI DFG ++         ST   GT  Y
Sbjct: 129 VSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAY 183
Query: 441 MAPEYLVRGQLTEK-ADVYSFGILIIEIVCG 470
           +APE L+R +   K ADV+S G+ +  ++ G
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 162
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 216
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCG 239

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 176
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 177 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 230
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 162
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 216
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 91  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 148
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 149 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 202
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 203 HRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 134
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 188
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 16/92 (17%)
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--- 439
           LA+LH      ++H D+K +NI L      K+ DFGL          + TA AG +    
Sbjct: 170 LAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLL-------VELGTAGAGEVQEGD 219
Query: 440 --YMAPEYLVRGQLTEKADVYSFGILIIEIVC 469
             YMAPE L++G     ADV+S G+ I+E+ C
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILEVAC 250

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 162
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 216
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 161
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 215
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 149
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 150 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 203
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 124 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 181
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 182 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 235
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 236 HRYHGRSAAVWSLGILLYDMVCG 258

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 149
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 150 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 203
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 149
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 150 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 203
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 161
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 215
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 176
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 177 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 230
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCG 253

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEHK 327
           F   K +G+G  G V +  L N   V   + I N  + +       F  E +++ + + K
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMK-ILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
            +  L     +     LV +Y     L   +  K + +L     RF +    AE +  + 
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYL----AEMVIAID 189
Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV 447
              +   +HRDIK  NIL+D +   ++ADFG       D T  S+   GT  Y++PE L 
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 448 -----RGQLTEKADVYSFGILIIEIVCGR 471
                +G+   + D +S G+ + E++ G 
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 134
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 188
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNX 129
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 107/251 (42%), Gaps = 46/251 (18%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ-------WVDEFF-----NEVNLISSIEH 326
           +  G  G+V  G    G  VA+KR +FNT           D F       E+ L++   H
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKR-VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNR----SLDQFIFDKNKTKLLNWNKRF--NIILGTA 380
            N++ L    +   E  +   Y+        L Q I D+         + F  +I+LG  
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG-- 146
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD--RTHVSTAVAGTL 438
                LH   E  ++HRD+   NILL  +    I DF LAR   AD  +TH  T      
Sbjct: 147 -----LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----R 197
Query: 439 GYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS-NKL 496
            Y APE +++ +  T+  D++S G ++ E+   R++          L R  T Y   NK+
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKA----------LFRGSTFYNQLNKI 246
Query: 497 VEAV-DPNLKD 506
           VE V  P ++D
Sbjct: 247 VEVVGTPKIED 257

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 107/251 (42%), Gaps = 46/251 (18%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ-------WVDEFF-----NEVNLISSIEH 326
           +  G  G+V  G    G  VA+KR +FNT           D F       E+ L++   H
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKR-VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNR----SLDQFIFDKNKTKLLNWNKRF--NIILGTA 380
            N++ L    +   E  +   Y+        L Q I D+         + F  +I+LG  
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG-- 146
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD--RTHVSTAVAGTL 438
                LH   E  ++HRD+   NILL  +    I DF LAR   AD  +TH  T      
Sbjct: 147 -----LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----R 197
Query: 439 GYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS-NKL 496
            Y APE +++ +  T+  D++S G ++ E+   R++          L R  T Y   NK+
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKA----------LFRGSTFYNQLNKI 246
Query: 497 VEAV-DPNLKD 506
           VE V  P ++D
Sbjct: 247 VEVVGTPKIED 257

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 76  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 133
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 134 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 187
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 188 HRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 134
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 188
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 168
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 169 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 222
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 129
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLIS 322
           E   K  + F   +  GQG  G+V +G   + G +VA+K++I + R + +     +  ++
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLA 74
Query: 323 SIEHKNLVKL------LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
            + H N+V+L      LG        L +V EYVP+ +L +   +  + ++        +
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKV 133
Query: 376 IL-GTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAADRTHVSTA 433
            L      +  LH  S   + HRDIK  N+L+++ D T K+ DFG A+  +    +V  A
Sbjct: 134 FLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV--A 190
Query: 434 VAGTLGYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCG 470
              +  Y APE +   Q  T   D++S G +  E++ G
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 75  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 132
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 133 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 186
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 187 HRYHGRSAAVWSLGILLYDMVCG 209

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 35/233 (15%)
Query: 273 FNPSKKLGQGGAGSVYMG--------SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI 324
           FN S  LGQG    ++ G           + T V +K L    R + + FF   +++S +
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII--LGTAEG 382
            HK+LV   G  + G E++LV E+V   SLD ++  KNK  +       NI+  L  A+ 
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCI-------NILWKLEVAKQ 121
Query: 383 L-AYLHGGSETRIIHRDIKTSNILL-----DKDFTP---KIADFGLARCFAADRTHVSTA 433
           L A +H   E  +IH ++   NILL      K   P   K++D G++             
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----KDI 176
Query: 434 VAGTLGYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ 485
           +   + ++ PE +   + L    D +SFG  + EI  G      + DS   LQ
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 129
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++LL    E P+S ++    P    D F F   +  L     R +      E + + H  
Sbjct: 99  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 156
Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++  
Sbjct: 157 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 210
Query: 449 GQLTEK-ADVYSFGILIIEIVCG 470
            +   + A V+S GIL+ ++VCG
Sbjct: 211 HRYHGRSAAVWSLGILLYDMVCG 233

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT  Y+AP  ++     +  D ++ G+LI E+  G
Sbjct: 196 -WXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 107/234 (45%), Gaps = 33/234 (14%)
Query: 279 LGQGGAGSVYMGSLPNG-TTVAVKRLIFNTRQWVD--EFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G VY+    N    VA+K++       +D      E+ +++ ++   +++L   
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 336 SIEGPESLLVYE--YVPNRSLDQFIFDKNKTKLLNWNKRFNIIL-GTAEGLAYLHGGSET 392
            I  P+ LL ++  Y+     D  +    KT +    +    IL     G  ++H   E+
Sbjct: 94  II--PDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH---ES 148
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR-THVS-------------------- 431
            IIHRD+K +N LL++D + K+ DFGLAR   +++ T++                     
Sbjct: 149 GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208
Query: 432 TAVAGTLGYMAPEY-LVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPL 484
           T+   T  Y APE  L++   T+  D++S G +  E++   +S+     +  PL
Sbjct: 209 TSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 74/174 (42%), Gaps = 25/174 (14%)
Query: 300 VKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIF 359
           VKR I N R              S+ H N+V+     +      +V EY     L + I 
Sbjct: 61  VKREIINHR--------------SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 106
Query: 360 DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP--KIADF 417
             N  +      RF        G++Y H     ++ HRD+K  N LLD    P  KI DF
Sbjct: 107 --NAGRFSEDEARF-FFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDF 160
Query: 418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK-ADVYSFGILIIEIVCG 470
           G ++         ST   GT  Y+APE L++ +   K ADV+S G+ +  ++ G
Sbjct: 161 GYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 74/174 (42%), Gaps = 25/174 (14%)
Query: 300 VKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIF 359
           VKR I N R              S+ H N+V+     +      +V EY     L + I 
Sbjct: 62  VKREIINHR--------------SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 107
Query: 360 DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP--KIADF 417
             N  +      RF        G++Y H     ++ HRD+K  N LLD    P  KI DF
Sbjct: 108 --NAGRFSEDEARF-FFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDF 161
Query: 418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK-ADVYSFGILIIEIVCG 470
           G ++         ST   GT  Y+APE L++ +   K ADV+S G+ +  ++ G
Sbjct: 162 GYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 11/150 (7%)
Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           +H N++ L     +G    +V E +    L   I    + K  +  +   ++    + + 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVE 130
Query: 385 YLHGGSETRIIHRDIKTSNIL-LDKDFTP---KIADFGLARCFAADRTHVSTAVAGTLGY 440
           YLH      ++HRD+K SNIL +D+   P   +I DFG A+   A+   + T    T  +
Sbjct: 131 YLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TANF 186
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           +APE L R       D++S G+L+  ++ G
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E  +   ++H N+V+L     E     LV++ V    L + I  +      + +     I
Sbjct: 53  EARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI 112
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTA 433
           L   E + + H   +  ++HRD+K  N+LL    K    K+ADFGLA     D+      
Sbjct: 113 L---EAVLHCH---QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-QAWFG 165
Query: 434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            AGT GY++PE L +    +  D+++ G+++  ++ G
Sbjct: 166 FAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 279 LGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIE----HK 327
           LG+GG G+V+ G  L +   VA+K +  N         +      EV L+  +     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
            +++LL    E  E  ++    P  + D F +   K  L     R        + +A + 
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF----GQVVAAIQ 153
Query: 388 GGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL 446
                 ++HRDIK  NIL+D +    K+ DFG +     D  +  T   GT  Y  PE++
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPY--TDFDGTRVYSPPEWI 210
Query: 447 VRGQLTE-KADVYSFGILIIEIVCG 470
            R Q     A V+S GIL+ ++VCG
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 104/249 (41%), Gaps = 29/249 (11%)
Query: 234 YARLSKMKEDRNNLGLYATSMKK-SCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL 292
           +  L K K   N L  Y  ++ K   L  K E  E         K +G+G  G V +   
Sbjct: 38  FPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVV-------KVIGRGAFGEVQLVRH 90
Query: 293 PNGTTVAVKRLI--FNTRQWVDE--FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY 348
            +   V   +L+  F   +  D   F+ E ++++      +V+L     +     +V EY
Sbjct: 91  KSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150
Query: 349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK 408
           +P   L   +   N      W + +     TAE +  L        IHRD+K  N+LLDK
Sbjct: 151 MPGGDLVNLM--SNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDK 203
Query: 409 DFTPKIADFGLARCFAADRTHV---STAVAGTLGYMAPEYLVR----GQLTEKADVYSFG 461
               K+ADFG   C   ++  +    TAV GT  Y++PE L      G    + D +S G
Sbjct: 204 SGHLKLADFGT--CMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVG 260
Query: 462 ILIIEIVCG 470
           + + E++ G
Sbjct: 261 VFLYEMLVG 269

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLI--FNTRQWVDE--FFNEVNLISS 323
           KA +Y    K +G+G  G V +    +   V   +L+  F   +  D   F+ E ++++ 
Sbjct: 72  KAEDY-EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 130
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                +V+L     +     +V EY+P   L   +   N      W + +     TAE +
Sbjct: 131 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY-----TAEVV 183
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV---STAVAGTLGY 440
             L        IHRD+K  N+LLDK    K+ADFG   C   ++  +    TAV GT  Y
Sbjct: 184 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT--CMKMNKEGMVRCDTAV-GTPDY 240
Query: 441 MAPEYLVR----GQLTEKADVYSFGILIIEIVCG 470
           ++PE L      G    + D +S G+ + E++ G
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE------ 325
           ++P   +G+G +  V        G   AVK +     +   E   EV   +  E      
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 326 ---HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
              H +++ L+          LV++ +  R  + F +   K  L     R +I+    E 
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLM--RKGELFDYLTEKVALSEKETR-SIMRSLLEA 212
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           +++LH  +   I+HRD+K  NILLD +   +++DFG + C       +   + GT GY+A
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEKLRE-LCGTPGYLA 267
Query: 443 PEYL------VRGQLTEKADVYSFGILIIEIVCG 470
           PE L            ++ D+++ G+++  ++ G
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLI--FNTRQWVDE--FFNEVNLISS 323
           KA +Y    K +G+G  G V +    +   V   +L+  F   +  D   F+ E ++++ 
Sbjct: 72  KAEDY-EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 130
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                +V+L     +     +V EY+P   L   +   N      W + +     TAE +
Sbjct: 131 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY-----TAEVV 183
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV---STAVAGTLGY 440
             L        IHRD+K  N+LLDK    K+ADFG   C   ++  +    TAV GT  Y
Sbjct: 184 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT--CMKMNKEGMVRCDTAV-GTPDY 240
Query: 441 MAPEYLVR----GQLTEKADVYSFGILIIEIVCG 470
           ++PE L      G    + D +S G+ + E++ G
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/281 (22%), Positives = 114/281 (40%), Gaps = 65/281 (23%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMGS--LPNG--TTVAVKRLIFNTRQWVDEFFNEV 318
           YE + + +N F    K+G+G   SVY+ +  L  G    +A+K LI  +        + +
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--------HPI 64
Query: 319 NLISSIE-------HKNLVKLLGCSIEGPESLLVYEYVPNRS----LDQFIFDKNKTKLL 367
            + + ++         N++ +  C  +    ++   Y+ + S    L+   F + +  +L
Sbjct: 65  RIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYML 124
Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLA------ 420
           N  K           L  +H   +  I+HRD+K SN L ++      + DFGLA      
Sbjct: 125 NLFK----------ALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171
Query: 421 ---------------RC------FAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVY 458
                          RC          R       AGT G+ APE L +    T   D++
Sbjct: 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231
Query: 459 SFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           S G++ + ++ GR     + D  + L ++ T+  S + ++A
Sbjct: 232 SAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQA 272

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 262 KYETLEKAT---NYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDE 313
           K+ET  + T   + F+  K LG G  G V +     +G   A+K L    +   +Q ++ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             NE  ++ ++    LVKL     +     +V EYV    +  F   +   +    + RF
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF 145
Query: 374 ---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
               I+L       YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT  
Sbjct: 146 YAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RT-- 195
Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
              + GT   +APE ++     +  D ++ G+LI E+  G
Sbjct: 196 -WXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 27/228 (11%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNE 317
           L  K+E + K T     S+ LG+G    V    SL NG   AVK +           F E
Sbjct: 6   LPGKFEDMYKLT-----SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFRE 60
Query: 318 VNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           V  +   + +KN+++L+    +     LV+E +   S+   I    K K  N  +   ++
Sbjct: 61  VETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVV 117
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLD--KDFTP-KIADFGLARCFAADR------ 427
              A  L +LH      I HRD+K  NIL +  +  +P KI DF L      +       
Sbjct: 118 RDVAAALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPIT 174
Query: 428 THVSTAVAGTLGYMAPEY--LVRGQLT---EKADVYSFGILIIEIVCG 470
           T   T   G+  YMAPE   +   Q T   ++ D++S G+++  ++ G
Sbjct: 175 TPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 12/104 (11%)
Query: 365 KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF---TPKIADFGLAR 421
           ++++ N    +I    EG+ YLH   +  I+H D+K  NILL   +     KI DFG++R
Sbjct: 126 EMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
Query: 422 CFAADRTHVST--AVAGTLGYMAPEYLVRGQLTEKADVYSFGIL 463
                  H      + GT  Y+APE L    +T   D+++ GI+
Sbjct: 183 KIG----HACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 11/150 (7%)
Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           +H N++ L     +G    +V E      L   I    + K  +  +   ++    + + 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL---RQKFFSEREASAVLFTITKTVE 130
Query: 385 YLHGGSETRIIHRDIKTSNIL-LDKDFTP---KIADFGLARCFAADRTHVSTAVAGTLGY 440
           YLH      ++HRD+K SNIL +D+   P   +I DFG A+   A+   + T    T  +
Sbjct: 131 YLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TANF 186
Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           +APE L R       D++S G+L+   + G
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           +K  ++++  ++LG G    V         L        KR    +R+ V  +E   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  + H N++ L        + +L+ E V    L  F+  K     L+  +  + I   
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNI-LLDKDF-TP--KIADFGLARCFAADRTHVSTAVA 435
            +G+ YLH     +I H D+K  NI LLDK+   P  K+ DFGLA     D       + 
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN-IF 179
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 15/163 (9%)
Query: 315 FNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             EV+++  +  H N+++L           LV++ +    L  ++ +K     L+  +  
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETR 127
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
            I+    E +  LH   +  I+HRD+K  NILLD D   K+ DFG + C   D      +
Sbjct: 128 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS-C-QLDPGEKLRS 182
Query: 434 VAGTLGYMAPEYLV------RGQLTEKADVYSFGILIIEIVCG 470
           V GT  Y+APE +            ++ D++S G+++  ++ G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E  +   ++H N+V+L     E     L+++ V    L + I  +      + +     I
Sbjct: 71  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI 130
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTA 433
           L   E + + H   +  ++HRD+K  N+LL    K    K+ADFGLA     ++      
Sbjct: 131 L---EAVLHCH---QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFG 183
Query: 434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            AGT GY++PE L +    +  D+++ G+++  ++ G
Sbjct: 184 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN------EVNLISSIEH--KNL 329
           LG GG GSVY G  + +   VA+K +  +      E  N      EV L+  +      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 330 VKLLGCSIEGPES--LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           ++LL    E P+S  L++    P + L  FI ++   +       F  +L   E + + H
Sbjct: 76  IRLLDW-FERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVL---EAVRHCH 131
Query: 388 GGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL 446
                 ++HRDIK  NIL+D +    K+ DFG     A  +  V T   GT  Y  PE++
Sbjct: 132 NCG---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWI 185
Query: 447 VRGQLTEK-ADVYSFGILIIEIVCG 470
              +   + A V+S GIL+ ++VCG
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           +K  ++++  ++LG G    V         L        KR    +R+ V  +E   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  + H N++ L        + +L+ E V    L  F+  K     L+  +  + I   
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNI-LLDKDF-TP--KIADFGLARCFAADRTHVSTAVA 435
            +G+ YLH     +I H D+K  NI LLDK+   P  K+ DFGLA     D       + 
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN-IF 179
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           +K  ++++  ++LG G    V         L        KR    +R+ V  +E   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  + H N++ L        + +L+ E V    L  F+  K     L+  +  + I   
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNI-LLDKDF-TP--KIADFGLARCFAADRTHVSTAVA 435
            +G+ YLH     +I H D+K  NI LLDK+   P  K+ DFGLA     D       + 
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN-IF 179
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 315 FNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             EV+++  +  H N+++L           LV++ +    L  ++ +K     L+  +  
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETR 114
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
            I+    E +  LH   +  I+HRD+K  NILLD D   K+ DFG + C   D       
Sbjct: 115 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS-C-QLDPGEKLRE 169
Query: 434 VAGTLGYMAPEYLV------RGQLTEKADVYSFGILIIEIVCG 470
           V GT  Y+APE +            ++ D++S G+++  ++ G
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 81/183 (44%), Gaps = 24/183 (13%)
Query: 290 GSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
           G LPNGT V ++ ++      V   F+ V           ++LL    E P+S ++    
Sbjct: 93  GELPNGTRVPMEVVLLKK---VSSGFSGV-----------IRLLDW-FERPDSFVLILER 137
Query: 350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD 409
           P    D F F   +  L     R +      E + + H      ++HRDIK  NIL+D +
Sbjct: 138 PEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN 193
Query: 410 FTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK-ADVYSFGILIIEI 467
               K+ DFG     A  +  V T   GT  Y  PE++   +   + A V+S GIL+ ++
Sbjct: 194 RGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 250
Query: 468 VCG 470
           VCG
Sbjct: 251 VCG 253

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 5/82 (6%)
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV-----RG 449
           +HRDIK  N+LLD +   ++ADFG       D T  S+   GT  Y++PE L       G
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 450 QLTEKADVYSFGILIIEIVCGR 471
           +   + D +S G+ + E++ G 
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGE 294

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           +K  ++++  ++LG G    V         L        KR    +R+ V  +E   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  + H N++ L        + +L+ E V    L  F+  K     L+  +  + I   
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNI-LLDKDF-TP--KIADFGLARCFAADRTHVSTAVA 435
            +G+ YLH     +I H D+K  NI LLDK+   P  K+ DFGLA     D       + 
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN-IF 179
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 44/91 (48%), Gaps = 4/91 (4%)
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
           A  L YLH      I++RD+K  NILLD      + DFGL +      +  ST   GT  
Sbjct: 149 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPE 204
Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           Y+APE L +       D +  G ++ E++ G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 5/82 (6%)
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV-----RG 449
           +HRDIK  N+LLD +   ++ADFG       D T  S+   GT  Y++PE L       G
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 450 QLTEKADVYSFGILIIEIVCGR 471
           +   + D +S G+ + E++ G 
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGE 278

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 315 FNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             EV+++  +  H N+++L           LV++ +    L  ++ +K     L+  +  
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETR 127
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
            I+    E +  LH   +  I+HRD+K  NILLD D   K+ DFG + C   D       
Sbjct: 128 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS-C-QLDPGEKLRE 182
Query: 434 VAGTLGYMAPEYLV------RGQLTEKADVYSFGILIIEIVCG 470
           V GT  Y+APE +            ++ D++S G+++  ++ G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           +K  ++++  ++LG G    V         L        KR    +R+ V  +E   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  + H N++ L        + +L+ E V    L  F+  K     L+  +  + I   
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNI-LLDKDF-TP--KIADFGLARCFAADRTHVSTAVA 435
            +G+ YLH     +I H D+K  NI LLDK+   P  K+ DFGLA     D       + 
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN-IF 179
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYM-----GSLPNGTTVAVKRLIFNTRQWV--DEFFNEVN 319
           +K  ++++  ++LG G    V         L        KR    +R+ V  +E   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           ++  + H N++ L        + +L+ E V    L  F+  K     L+  +  + I   
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNI-LLDKDF-TP--KIADFGLARCFAADRTHVSTAVA 435
            +G+ YLH     +I H D+K  NI LLDK+   P  K+ DFGLA     D       + 
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN-IF 179
Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVK-----RLIFNTRQWVDEFFN---EVNLISSIEH 326
           SK LG G  G V +         VA+K     +    + +  D   N   E+ ++  + H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
             ++K+     +  +  +V E +    L   +    + K       F  +L   +   YL
Sbjct: 75  PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ---YL 130
Query: 387 HGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           H   E  IIHRD+K  N+LL   ++D   KI DFG ++      T +   + GT  Y+AP
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAP 185
Query: 444 EYLVR---GQLTEKADVYSFGILIIEIVCG 470
           E LV           D +S G+++   + G
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVK-----RLIFNTRQWVDEFFN---EVNLISSIEH 326
           SK LG G  G V +         VA+K     +    + +  D   N   E+ ++  + H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
             ++K+     +  +  +V E +    L   +    + K       F  +L   +   YL
Sbjct: 75  PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ---YL 130
Query: 387 HGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           H   E  IIHRD+K  N+LL   ++D   KI DFG ++      T +   + GT  Y+AP
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAP 185
Query: 444 EYLVR---GQLTEKADVYSFGILIIEIVCG 470
           E LV           D +S G+++   + G
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVK-----RLIFNTRQWVDEFFN---EVNLISSIEH 326
           SK LG G  G V +         VA+K     +    + +  D   N   E+ ++  + H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
             ++K+     +  +  +V E +    L   +    + K       F  +L   +   YL
Sbjct: 75  PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ---YL 130
Query: 387 HGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           H   E  IIHRD+K  N+LL   ++D   KI DFG ++      T +   + GT  Y+AP
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAP 185
Query: 444 EYLVR---GQLTEKADVYSFGILIIEIVCG 470
           E LV           D +S G+++   + G
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVK-----RLIFNTRQWVDEFFN---EVNLISSIEH 326
           SK LG G  G V +         VA+K     +    + +  D   N   E+ ++  + H
Sbjct: 21  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 80
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
             ++K+     +  +  +V E +    L   +    + K       F  +L   +   YL
Sbjct: 81  PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ---YL 136
Query: 387 HGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           H   E  IIHRD+K  N+LL   ++D   KI DFG ++      T +   + GT  Y+AP
Sbjct: 137 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAP 191
Query: 444 EYLVR---GQLTEKADVYSFGILIIEIVCG 470
           E LV           D +S G+++   + G
Sbjct: 192 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVK-----RLIFNTRQWVDEFFN---EVNLISSIEH 326
           SK LG G  G V +         VA+K     +    + +  D   N   E+ ++  + H
Sbjct: 14  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 73
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
             ++K+     +  +  +V E +    L   +    + K       F  +L   +   YL
Sbjct: 74  PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ---YL 129
Query: 387 HGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           H   E  IIHRD+K  N+LL   ++D   KI DFG ++      T +   + GT  Y+AP
Sbjct: 130 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAP 184
Query: 444 EYLVR---GQLTEKADVYSFGILIIEIVCG 470
           E LV           D +S G+++   + G
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 27/236 (11%)
Query: 261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVN 319
           F  +T+E         + L +GG   VY    + +G   A+KRL+ N  +       EV 
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVC 77
Query: 320 LISSIE-HKNLVKLLGCSIEGPES--------LLVYEYVPNRSLDQFIFDKNKTKLLNWN 370
            +  +  H N+V+    +  G E         LL+ E    + L +F+        L+ +
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ-LVEFLKKMESRGPLSCD 136
Query: 371 KRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF------- 423
               I   T   + ++H   +  IIHRD+K  N+LL    T K+ DFG A          
Sbjct: 137 TVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195
Query: 424 --AADRTHVSTAVA--GTLGYMAPEYL---VRGQLTEKADVYSFGILIIEIVCGRR 472
             A  R  V   +    T  Y  PE +       + EK D+++ G  I+ ++C R+
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGC-ILYLLCFRQ 250

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV-------DEFFN---EVNLISSIE 325
           SK LG G  G V + +    T   V   I + R++        D   N   E+ ++  + 
Sbjct: 154 SKTLGSGACGEVKL-AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 212
Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           H  ++K+     +  +  +V E +    L   +    + K       F  +L   +   Y
Sbjct: 213 HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ---Y 268
Query: 386 LHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           LH   E  IIHRD+K  N+LL   ++D   KI DFG ++      T +   + GT  Y+A
Sbjct: 269 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLA 323
Query: 443 PEYLVR---GQLTEKADVYSFGILIIEIVCG 470
           PE LV           D +S G+++   + G
Sbjct: 324 PEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV-------DEFFN---EVNLISSIE 325
           SK LG G  G V + +    T   V   I + R++        D   N   E+ ++  + 
Sbjct: 140 SKTLGSGACGEVKL-AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           H  ++K+     +  +  +V E +    L   +    + K       F  +L   +   Y
Sbjct: 199 HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ---Y 254
Query: 386 LHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           LH   E  IIHRD+K  N+LL   ++D   KI DFG ++      T +   + GT  Y+A
Sbjct: 255 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLA 309
Query: 443 PEYLVR---GQLTEKADVYSFGILIIEIVCG 470
           PE LV           D +S G+++   + G
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 73/174 (41%), Gaps = 25/174 (14%)
Query: 300 VKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIF 359
           VKR I N R              S+ H N+V+     +      +V EY     L + I 
Sbjct: 62  VKREIINHR--------------SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 107
Query: 360 DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP--KIADF 417
             N  +      RF        G++Y H     ++ HRD+K  N LLD    P  KI  F
Sbjct: 108 --NAGRFSEDEARF-FFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAF 161
Query: 418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK-ADVYSFGILIIEIVCG 470
           G ++         ST   GT  Y+APE L++ +   K ADV+S G+ +  ++ G
Sbjct: 162 GYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 16/163 (9%)
Query: 316 NEVNLISSIEHKNLVKLLGC--SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
            E+ L+  + HKN+++L+    + E  +  +V EY       Q + D    K     +  
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEKRFPVCQAH 112
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC---FAADRTHV 430
                  +GL YLH      I+H+DIK  N+LL    T KI+  G+A     FAAD T  
Sbjct: 113 GYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 431 STAVAGTLGYMAPEYLVRGQLT---EKADVYSFGILIIEIVCG 470
           ++   G+  +  PE +  G  T    K D++S G+ +  I  G
Sbjct: 170 TS--QGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/75 (33%), Positives = 37/75 (49%)
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HRD+K  NIL+  D    + DFG+A     ++        GTL Y APE       T +A
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 456 DVYSFGILIIEIVCG 470
           D+Y+   ++ E + G
Sbjct: 217 DIYALTCVLYECLTG 231

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E  +   ++H N+V+L     E     L+++ V    L + I  +      + +     I
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI 119
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTA 433
           L   E + + H   +  ++HR++K  N+LL    K    K+ADFGLA     ++      
Sbjct: 120 L---EAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFG 172
Query: 434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            AGT GY++PE L +    +  D+++ G+++  ++ G
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 105/231 (45%), Gaps = 20/231 (8%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +KLG+G    V+   ++ N   V VK L    +   ++   E+ ++ ++     +  L  
Sbjct: 43  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---NKIKREIKILENLRGGPNIITLAD 99
Query: 336 SIEGPES---LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
            ++ P S    LV+E+V N    Q         L +++ RF  +    + L Y H     
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYEILKALDYCHSMG-- 151
Query: 393 RIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
            I+HRD+K  N+++D +    ++ D+GLA  +   + + +  VA    +  PE LV  Q+
Sbjct: 152 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQM 208
Query: 452 TEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD 501
            + + D++S G ++  ++  +       D+   L R+  +  +  L + +D
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 259

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 328 NLVKLLGCSIEGPES---LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           N++KL+  +++ P S    LV+EY+ N    Q         L +++ RF  +    + L 
Sbjct: 94  NIIKLID-TVKDPVSKTPALVFEYINNTDFKQLY-----QILTDFDIRF-YMYELLKALD 146
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           Y H      I+HRD+K  N+++D      ++ D+GLA  +   + + +  VA    +  P
Sbjct: 147 YCHSKG---IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEY-NVRVASRY-FKGP 201
Query: 444 EYLVRGQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
           E LV  Q+ + + D++S G ++  ++  R      QD+   L R+
Sbjct: 202 ELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRI 246

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 7/93 (7%)
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILL--DKDFTP-KIADFGLARCFAADRTHVSTAVAGT 437
           E L Y H   +  IIHRD+K  N+LL   ++  P K+ DFG+A     +   V+    GT
Sbjct: 141 EALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG-ESGLVAGGRVGT 196
Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
             +MAPE + R    +  DV+  G+++  ++ G
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 328 NLVKLLGCSIEGPES---LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           N++KL+  +++ P S    LV+EY+ N    Q         L +++ RF  +    + L 
Sbjct: 99  NIIKLID-TVKDPVSKTPALVFEYINNTDFKQLY-----QILTDFDIRF-YMYELLKALD 151
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           Y H      I+HRD+K  N+++D      ++ D+GLA  +   + + +  VA    +  P
Sbjct: 152 YCHSKG---IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEY-NVRVASRY-FKGP 206
Query: 444 EYLVRGQLTEKA-DVYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
           E LV  Q+ + + D++S G ++  ++  R      QD+   L R+
Sbjct: 207 ELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRI 251

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 56/130 (43%), Gaps = 12/130 (9%)
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL-------V 447
           +HRDIK  NILLD+    ++ADFG      AD T  S    GT  Y++PE L        
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 448 RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD---PNL 504
            G    + D ++ G+   E+  G+    F  DS +        Y+ +  +  VD   P  
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQ--TPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEE 301
Query: 505 KDDFPAEQVC 514
             DF    +C
Sbjct: 302 ARDFIQRLLC 311

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 72/174 (41%), Gaps = 25/174 (14%)
Query: 300 VKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIF 359
           VKR I N R              S+ H N+V+     +      +V EY     L + I 
Sbjct: 62  VKREIINHR--------------SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 107
Query: 360 DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP--KIADF 417
             N  +      RF        G++Y H     ++ HRD+K  N LLD    P  KI  F
Sbjct: 108 --NAGRFSEDEARF-FFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAF 161
Query: 418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK-ADVYSFGILIIEIVCG 470
           G ++          T   GT  Y+APE L++ +   K ADV+S G+ +  ++ G
Sbjct: 162 GYSKSSVLHSQPKDT--VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	611
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-146
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-129
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-125
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-82
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-68
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-64
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-57
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-57
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-56
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-54
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-50
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-43
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-41
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-40
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-39
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-39
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-39
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-38
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-38
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-37
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-37
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-36
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-36
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-36
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-35
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-35
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-35
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-35
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-34
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-34
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-34
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-33
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-27
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-27
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-26
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-26
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-25
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-25
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-25
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-24
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-23
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-20
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-20
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-18
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-16
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	4e-16
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	2e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  426 bits (1097), Expect = e-146
 Identities = 115/289 (39%), Positives = 178/289 (61%), Gaps = 6/289 (2%)

Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD-EFFNEV 318
            F    L+ A++ F+    LG+GG G VY G L +GT VAVKRL     Q  + +F  EV
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIIL 377
            +IS   H+NL++L G  +   E LLVY Y+ N S+   + ++ +++  L+W KR  I L
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           G+A GLAYLH   + +IIHRD+K +NILLD++F   + DFGLA+      THV+TAV GT
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198

Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRR----SNAFSQDSASPLQRVWTLYRS 493
           +G++APEYL  G+ +EK DV+ +G++++E++ G+R    +   + D    L  V  L + 
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT 542
            KL   VD +L+ ++  E+V  ++Q+ LLCTQ++   RP M++ + +L 
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  380 bits (979), Expect = e-129
 Identities = 105/294 (35%), Positives = 162/294 (55%), Gaps = 18/294 (6%)

Query: 260 SFKYETLEKATNYFNPSK------KLGQGGAGSVYMGSLPNGTTVAVKRL----IFNTRQ 309
           SF +  L+  TN F+         K+G+GG G VY G + N TTVAVK+L       T +
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72

Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
              +F  E+ +++  +H+NLV+LLG S +G +  LVY Y+PN SL   +   + T  L+W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132

Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRT 428
           + R  I  G A G+ +LH   E   IHRDIK++NILLD+ FT KI+DFGLAR      +T
Sbjct: 133 HMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189

Query: 429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVW 488
            +++ + GT  YMAPE L RG++T K+D+YSFG++++EI+ G  +    ++    L    
Sbjct: 190 VMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248

Query: 489 TLYRSNK-LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
            +    K + + +D  + +D  +  V  +  +   C       RP + +   LL
Sbjct: 249 EIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  371 bits (956), Expect = e-125
 Identities = 108/310 (34%), Positives = 172/310 (55%), Gaps = 7/310 (2%)

Query: 236 RLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNG 295
           + SK     N+    +  +           LE+ATN F+    +G G  G VY G L +G
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63

Query: 296 TTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLD 355
             VA+KR    + Q ++EF  E+  +S   H +LV L+G   E  E +L+Y+Y+ N +L 
Sbjct: 64  AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123

Query: 356 QFIFDKNKTKL-LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI 414
           + ++  +   + ++W +R  I +G A GL YLH  +   IIHRD+K+ NILLD++F PKI
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180

Query: 415 ADFGLARCF-AADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRR- 472
            DFG+++     D+TH+ST V GTLGY+ PEY ++G+LTEK+DVYSFG+++ E++C R  
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

Query: 473 -SNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALR 531
              +  ++  +  +     + + +L + VDPNL D    E +       + C   ++  R
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300

Query: 532 PSMAQAIMLL 541
           PSM   +  L
Sbjct: 301 PSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  261 bits (668), Expect = 1e-82
 Identities = 79/313 (25%), Positives = 128/313 (40%), Gaps = 33/313 (10%)

Query: 257 SCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ-WVDEFF 315
           S +    E L   +      +   +G  G V+         VAVK      +Q W +E+ 
Sbjct: 10  SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEY- 67

Query: 316 NEVNLISSIEHKNLVKLLGCSIEGP----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
            EV  +  ++H+N+++ +G    G     +  L+  +    SL  F+    K  +++WN+
Sbjct: 68  -EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNE 122

Query: 372 RFNIILGTAEGLAYLH-------GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
             +I    A GLAYLH        G +  I HRDIK+ N+LL  + T  IADFGLA  F 
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 425 ADRTHV-STAVAGTLGYMAPEYL-----VRGQLTEKADVYSFGILIIEIVCGRRSNAFSQ 478
           A ++   +    GT  YMAPE L      +     + D+Y+ G+++ E+     +     
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 479 DS-ASPLQ-RVWTLYRSNKLVEAV-----DPNLKDDFPAEQVCNVL-QIGLLCTQAAAAL 530
           D    P +  +        + E V      P L+D +       +L +    C    A  
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302

Query: 531 RPSMAQAIMLLTN 543
           R S       +T 
Sbjct: 303 RLSAGCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  223 bits (570), Expect = 5e-68
 Identities = 73/336 (21%), Positives = 120/336 (35%), Gaps = 48/336 (14%)

Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEV 318
           +           +     + +G+G  G+VY GSL +   VAVK     +      F NE 
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEK 56

Query: 319 N--LISSIEHKNLVKLLGCSIEGPES-----LLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           N   +  +EH N+ + +              LLV EY PN SL +++         +W  
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVS 112

Query: 372 RFNIILGTAEGLAYLH------GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
              +      GLAYLH         +  I HRD+ + N+L+  D T  I+DFGL+     
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 426 DR-------THVSTAVAGTLGYMAPEYL-------VRGQLTEKADVYSFGILIIEIVCGR 471
           +R        + + +  GT+ YMAPE L             ++ D+Y+ G++  EI   R
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-R 231

Query: 472 RSNAFSQDSASPLQ-----RVWTLYRSNKLVEAVD-----PNLKDDFPAEQVCNVLQIGL 521
            ++ F  +S    Q      V        +   V      P   + +    +        
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291

Query: 522 L--CTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPP 555
           +  C    A  R +   A   +   +          
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  213 bits (544), Expect = 2e-64
 Identities = 75/296 (25%), Positives = 125/296 (42%), Gaps = 23/296 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           + +G+G  G V          VA+K     +      F  E+  +S + H N+VKL G  
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +      LV EY    SL   +               +  L  ++G+AYLH      +IH
Sbjct: 71  LNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128

Query: 397 RDIKTSNILLDKDFT-PKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           RD+K  N+LL    T  KI DFG A     D     T   G+  +MAPE       +EK 
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184

Query: 456 DVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCN 515
           DV+S+GI++ E++  R+   F +      + +W ++   +      P L  + P + + +
Sbjct: 185 DVFSWGIILWEVITRRK--PFDEIGGPAFRIMWAVHNGTR------PPLIKNLP-KPIES 235

Query: 516 VLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQP-PFLNSSVMEPGNSSRS 570
           ++     C     + RPSM + + ++T+ +   P   +P  +     + PG   R 
Sbjct: 236 LMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRV 288

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  209 bits (534), Expect = 5e-63
 Identities = 67/197 (34%), Positives = 110/197 (55%), Gaps = 5/197 (2%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +K+G G  G+V+     +G+ VAVK L+      + V+EF  EV ++  + H N+V  +G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
              + P   +V EY+   SL + +      + L+  +R ++    A+G+ YLH      I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPI 160

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK 454
           +HR++K+ N+L+DK +T K+ DFGL+R   A     S + AGT  +MAPE L      EK
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219

Query: 455 ADVYSFGILIIEIVCGR 471
           +DVYSFG+++ E+   +
Sbjct: 220 SDVYSFGVILWELATLQ 236

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  203 bits (518), Expect = 7e-61
 Identities = 74/282 (26%), Positives = 127/282 (45%), Gaps = 35/282 (12%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIF-------NTRQWVDEFFNEVNLISSIEHKN 328
           K++G+GG G V+ G  + + + VA+K LI           +   EF  EV ++S++ H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           +VKL G     P   +V E+VP   L   +   +K   + W+ +  ++L  A G+ Y+  
Sbjct: 85  IVKLYGLMHNPP--RMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQN 140

Query: 389 GSETRIIHRDIKTSNILLDK-----DFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
                I+HRD+++ NI L           K+ADFGL++       H  + + G   +MAP
Sbjct: 141 -QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAP 195

Query: 444 EYLVRGQL--TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD 501
           E +   +   TEKAD YSF +++  I+ G     F + S   ++ +  +           
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEG--PFDEYSYGKIKFINMIREEGLR----- 248

Query: 502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           P + +D P      +  +  LC       RP  +  +  L+ 
Sbjct: 249 PTIPEDCPPR----LRNVIELCWSGDPKKRPHFSYIVKELSE 286

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  193 bits (492), Expect = 2e-57
 Identities = 43/203 (21%), Positives = 86/203 (42%), Gaps = 18/203 (8%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLG 334
            KL +  +G ++ G    G  + VK L     + +   +F  E   +    H N++ +LG
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 335 CSIEGPESLL--VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
                P      +  ++P  SL   +  +    +++ ++     L  A G+A+LH   E 
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHT-LEP 132

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ-- 450
            I    + + ++++D+D T +I+   +   F       S        ++APE L + +  
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEAL-QKKPE 185

Query: 451 --LTEKADVYSFGILIIEIVCGR 471
                 AD++SF +L+ E+V   
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE 208

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  192 bits (489), Expect = 6e-57
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 20/207 (9%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIF----NTRQWVDEFFNEVNLISSIEHKNLVKL 332
           + +G GG G VY      G  VAVK        +  Q ++    E  L + ++H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
            G  ++ P   LV E+     L++ +  K     +  +   N  +  A G+ YLH  +  
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 393 RIIHRDIKTSNILLDKDFTP--------KIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
            IIHRD+K+SNIL+ +            KI DFGLAR +         + AG   +MAPE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPE 184

Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGR 471
            +     ++ +DV+S+G+L+ E++ G 
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE 211

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  192 bits (489), Expect = 2e-56
 Identities = 74/306 (24%), Positives = 120/306 (39%), Gaps = 37/306 (12%)

Query: 277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           + LG+G  G     +    G  + +K LI    +    F  EV ++  +EH N++K +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             +      + EY+   +L   I  K+      W++R +     A G+AYLH      II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLH---SMNII 130

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTH-------------VSTAVAGTLGYMA 442
           HRD+ + N L+ ++    +ADFGLAR    ++T                  V G   +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP 502
           PE +      EK DV+SFGI++ EI+        +     P    + L     +   +D 
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN----ADPDYLPRTMDFGL----NVRGFLDR 242

Query: 503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM-----LLTNKVCEIPTPSQPPFL 557
               + P         I + C       RPS  + +      L  +    +P   Q   L
Sbjct: 243 YCPPNCPPS----FFPITVRCCDLDPEKRPSFVK-LEHWLETLRMHLAGHLPLGPQLEQL 297

Query: 558 NSSVME 563
           +    E
Sbjct: 298 DRGFWE 303

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  185 bits (472), Expect = 2e-54
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 27/273 (9%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +++G G  G+VY G   +G  VAVK L     T Q +  F NEV ++    H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            S     ++ V ++    SL   +            K  +I   TA G+ YLH      I
Sbjct: 88  YSTAPQLAI-VTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLH---AKSI 141

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQL-- 451
           IHRD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE ++R Q   
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSN 200

Query: 452 --TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV-WTLYRSNKLVEAVDPNLKDDF 508
             + ++DVY+FGI++ E++ G+        + +   ++   + R +   +     ++ + 
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ----LPYSNINNRDQIIEMVGRGSLSPDL--SKVRSNC 254

Query: 509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           P      + ++   C +     RPS  + +  +
Sbjct: 255 PKR----MKRLMAECLKKKRDERPSFPRILAEI 283

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  186 bits (475), Expect = 4e-54
 Identities = 76/295 (25%), Positives = 124/295 (42%), Gaps = 37/295 (12%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNE--VNLISSIEHKNLVKLLG 334
           K++G+G  G V+MG    G  VAVK  +F T +    +F E  +     + H+N++  + 
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVK--VFFTTE-EASWFRETEIYQTVLMRHENILGFIA 98

Query: 335 CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
             I+G  S     L+ +Y  N SL  ++    K+  L+      +   +  GL +LH   
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 391 ETR-----IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV---STAVAGTLGYMA 442
            +      I HRD+K+ NIL+ K+ T  IAD GLA  F +D   V        GT  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 443 PE------YLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS-NK 495
           PE           Q    AD+YSFG+++ E+     S    ++   P   +     S   
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274

Query: 496 LVEAVD-----PNLKDDFPAEQVCNVLQIGLL--CTQAAAALRPSMAQAIMLLTN 543
           + E V      P+  + + +++    +   L+  C     A R +  +    L  
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQM-GKLMTECWAHNPASRLTALRVKKTLAK 328

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  185 bits (471), Expect = 1e-53
 Identities = 63/309 (20%), Positives = 117/309 (37%), Gaps = 46/309 (14%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIF--NTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           + +G+G  G VY G   +G  VA++ +    +    +  F  EV       H+N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             +  P   ++      R+L   +  ++   +L+ NK   I     +G+ YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLAR----CFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
           +H+D+K+ N+  D      I DFGL        A  R        G L ++APE + +  
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 451 L---------TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD 501
                     ++ +DV++ G +  E+        +   +      +W +    K      
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE----WPFKTQPAEAIIWQMGTGMKP----- 261

Query: 502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSSV 561
              +     E    +  I L C       RP+  + + +L     ++P        N  +
Sbjct: 262 NLSQIGMGKE----ISDILLFCWAFEQEERPTFTKLMDMLE----KLPK------RNRRL 307

Query: 562 MEPGNSSRS 570
             PG+  +S
Sbjct: 308 SHPGHFWKS 316

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  182 bits (464), Expect = 5e-53
 Identities = 74/296 (25%), Positives = 124/296 (41%), Gaps = 39/296 (13%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNE--VNLISSIEHKNLVKLLG 334
           + +G+G  G V+ GS   G  VAVK  IF++R     +F E  +     + H+N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVK--IFSSRD-EKSWFRETELYNTVMLRHENILGFIA 69

Query: 335 CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
             +    S     L+  Y    SL  ++    +   L+      I+L  A GLA+LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 391 ETR-----IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV---STAVAGTLGYMA 442
                   I HRD+K+ NIL+ K+    IAD GLA   +     +   +    GT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 443 PEYLVRGQL-------TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS-N 494
           PE L    +        ++ D+++FG+++ E+     SN   +D   P   V     S  
Sbjct: 186 PEVL-DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 495 KLVEAVD-----PNLKDDFPAEQVCNVLQIGLL--CTQAAAALRPSMAQAIMLLTN 543
            + + V      PN+ + + ++     L   L+  C     + R +  +    LT 
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSL-AKLMKECWYQNPSARLTALRIKKTLTK 299

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  176 bits (449), Expect = 2e-50
 Identities = 69/298 (23%), Positives = 118/298 (39%), Gaps = 43/298 (14%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNE--VNLISSIEHKNLVKLLG 334
           + +G+G  G V+ G    G  VAVK  IF++R+    +F E  +     + H+N++  + 
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFIA 103

Query: 335 CSI----EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH--- 387
                     +  LV +Y  + SL  ++        +       + L TA GLA+LH   
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 388 --GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV---STAVAGTLGYMA 442
                +  I HRD+K+ NIL+ K+ T  IAD GLA    +    +        GT  YMA
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 443 PEYLVRGQL-------TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQR-VWTLYRSN 494
           PE L    +        ++AD+Y+ G++  EI          +D   P    V +     
Sbjct: 220 PEVL-DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278

Query: 495 KLVEAV---------DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           ++ + V             +       +  +++    C  A  A R +  +    L+ 
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLSQ 333

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  155 bits (395), Expect = 2e-43
 Identities = 63/278 (22%), Positives = 114/278 (41%), Gaps = 31/278 (11%)

Query: 272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKN 328
           +     ++G+G   +VY G        VA    +    T+     F  E  ++  ++H N
Sbjct: 27  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86

Query: 329 LVKLLGC---SIEGPESLLVY-EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           +V+       +++G + +++  E + + +L  ++    + K++      +      +GL 
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQ 143

Query: 385 YLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +LH      IIHRD+K  NI +     + KI D GLA    A       AV GT  +MAP
Sbjct: 144 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAP 199

Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN 503
           E     +  E  DVY+FG+ ++E+       +  Q++A   +RV +  +     +   P 
Sbjct: 200 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258

Query: 504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           +K+            I   C +     R S      LL
Sbjct: 259 VKE------------IIEGCIRQNKDERYS---IKDLL 281

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  151 bits (382), Expect = 7e-41
 Identities = 65/358 (18%), Positives = 150/358 (41%), Gaps = 36/358 (10%)

Query: 250 YATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN-- 306
           +++ +     +  ++++EK    +   +K+G+G  G   +  S  +G    +K +  +  
Sbjct: 7   HSSGVDLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM 62

Query: 307 TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL 366
           + +  +E   EV ++++++H N+V+      E     +V +Y     L + I +  K  L
Sbjct: 63  SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVL 121

Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
              ++  +  +     L ++H   + +I+HRDIK+ NI L KD T ++ DFG+AR   + 
Sbjct: 122 FQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178

Query: 427 RTHVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ 485
                  + GT  Y++PE +   +    K+D+++ G ++ E+   +   AF   S   L 
Sbjct: 179 VELARACI-GTPYYLSPE-ICENKPYNNKSDIWALGCVLYELCTLKH--AFEAGSMKNLV 234

Query: 486 RVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM--LLTN 543
                    K++    P +   +  + + +++       +     RPS+   +    +  
Sbjct: 235 --------LKIISGSFPPVSLHYSYD-LRSLVS---QLFKRNPRDRPSVNSILEKGFIAK 282

Query: 544 KVCEIPTPSQ------PPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSSSESSS 595
           ++ +  +P            +    +P  + R  S  + IS +  +     ++     
Sbjct: 283 RIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIP 340

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  150 bits (380), Expect = 3e-40
 Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 12/230 (5%)

Query: 244 RNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKR 302
                L   S      +   +            +++G+G  G V+ G L  + T VAVK 
Sbjct: 87  STQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS 146

Query: 303 L-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFD 360
                      +F  E  ++    H N+V+L+G C+ + P   +V E V       F+  
Sbjct: 147 CRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP-IYIVMELVQGGDFLTFL-- 203

Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           + +   L       ++   A G+ YL        IHRD+   N L+ +    KI+DFG++
Sbjct: 204 RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMS 260

Query: 421 RCFAADRTHVSTAVAGTLGY--MAPEYLVRGQLTEKADVYSFGILIIEIV 468
           R   AD  + ++     +     APE L  G+ + ++DV+SFGIL+ E  
Sbjct: 261 R-EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  150 bits (381), Expect = 8e-40
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 19/201 (9%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           + +G+G  G V +G    G  VAVK +  +       F  E ++++ + H NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             E     +V EY+   SL  ++  + +  +L  +      L   E + YL        +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL---EGNNFV 311

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT---LGYMAPEYLVRGQLT 452
           HRD+   N+L+ +D   K++DFGL +         S+        + + APE L   + +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364

Query: 453 EKADVYSFGILIIEIV-CGRR 472
            K+DV+SFGIL+ EI   GR 
Sbjct: 365 TKSDVWSFGILLWEIYSFGRV 385

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  147 bits (372), Expect = 9e-40
 Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 32/218 (14%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +KLG+GG   V +   L +G   A+KR++ + +Q  +E   E ++     H N+++L+  
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 336 SIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIILGTAEGLAY 385
            +    +     L+  +    +L   I      +L +            ++LG   GL  
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA--------GT 437
           +H        HRD+K +NILL  +  P + D G              A+          T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 438 LGYMAPEYLVRGQ----LTEKADVYSFGILIIEIVCGR 471
           + Y APE L   Q    + E+ DV+S G ++  ++ G 
Sbjct: 207 ISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  144 bits (366), Expect = 4e-39
 Identities = 66/266 (24%), Positives = 117/266 (43%), Gaps = 22/266 (8%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL-IFN--TRQWVDEFFNEVNLISSIEHKNLVKL 332
           KK+G+G    VY    L +G  VA+K++ IF+    +   +   E++L+  + H N++K 
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
               IE  E  +V E      L + I   K + +L+     +   +     L ++H    
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
            R++HRDIK +N+ +      K+ D GL R F++  T   + V GT  YM+PE  +    
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE-RIHENG 212

Query: 452 -TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPA 510
              K+D++S G L+ E+   +    F  D  +            K+ +   P L  D  +
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQS--PFYGDKMNLYSLC------KKIEQCDYPPLPSDHYS 264

Query: 511 EQVCNVLQIGLLCTQAAAALRPSMAQ 536
           E++  ++    +C       RP +  
Sbjct: 265 EELRQLVN---MCINPDPEKRPDVTY 287

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  143 bits (364), Expect = 6e-39
 Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 14/203 (6%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
             LG+G  G VY G  L N   +A+K +     ++      E+ L   ++HKN+V+ LG 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF--NIILGTAEGLAYLHGGSETR 393
             E     +  E VP  SL   +  ++K   L  N++          EGL YLH   + +
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQ 142

Query: 394 IIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL- 451
           I+HRDIK  N+L++      KI+DFG ++  A       T   GTL YMAPE ++     
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPE-IIDKGPR 200

Query: 452 --TEKADVYSFGILIIEIVCGRR 472
              + AD++S G  IIE+  G+ 
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKP 223

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  147 bits (373), Expect = 9e-39
 Identities = 69/200 (34%), Positives = 103/200 (51%), Gaps = 13/200 (6%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KKLG G  G V+M +    T VAVK +   +   V+ F  E N++ +++H  LVKL    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ E++   SL  F+   ++       K  +     AEG+A++    +   IH
Sbjct: 253 TKEP-IYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG---YMAPEYLVRGQLTE 453
           RD++ +NIL+      KIADFGLAR    +     TA  G      + APE +  G  T 
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTI 364

Query: 454 KADVYSFGILIIEIV-CGRR 472
           K+DV+SFGIL++EIV  GR 
Sbjct: 365 KSDVWSFGILLMEIVTYGRI 384

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  147 bits (374), Expect = 1e-38
 Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 6/193 (3%)

Query: 277 KKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            KLG G  G VY G       TVAVK L  +T + V+EF  E  ++  I+H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
               P   ++ E++   +L  ++ + N+ + ++      +    +  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKA 455
           HR++   N L+ ++   K+ADFGL+R    D           + + APE L   + + K+
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400

Query: 456 DVYSFGILIIEIV 468
           DV++FG+L+ EI 
Sbjct: 401 DVWAFGVLLWEIA 413

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  146 bits (370), Expect = 2e-38
 Identities = 63/192 (32%), Positives = 96/192 (50%), Gaps = 6/192 (3%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
            KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            E P   +V EY+   SL  F       K L   +  ++    A G+AY+        +H
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 457 VYSFGILIIEIV 468
           V+SFGIL+ E+ 
Sbjct: 364 VWSFGILLTELT 375

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  144 bits (364), Expect = 2e-38
 Identities = 73/354 (20%), Positives = 146/354 (41%), Gaps = 50/354 (14%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNL--VKL 332
           K++G GG+  V+          A+K +       Q +D + NE+  ++ ++  +   ++L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
                   + + +V E   N  L+ ++  K     ++  +R +      E +  +H   +
Sbjct: 75  YD-YEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH---Q 126

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS-TAVAGTLGYMAPEYLV--- 447
             I+H D+K +N L+      K+ DFG+A     D T V   +  GT+ YM PE +    
Sbjct: 127 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 448 --------RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
                   + +++ K+DV+S G ++  +  G+          +P Q++      +KL   
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK----------TPFQQIINQI--SKLHAI 233

Query: 500 VDPNLKDDFPA---EQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN---KVCEIPTPSQ 553
           +DPN + +FP    + + +VL+    C +     R S+ +   LL +   ++   P    
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPE---LLAHPYVQIQTHPVNQM 287

Query: 554 PPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSSSESSSTHSSDAHSRSRE 607
                  +          ++ + I   AK +   YS  ES ++ SS    + R 
Sbjct: 288 AKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 341

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  141 bits (358), Expect = 3e-38
 Identities = 72/195 (36%), Positives = 102/195 (52%), Gaps = 12/195 (6%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+        L  NK  ++    AEG+A++    E   IH
Sbjct: 78  TQEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL---GYMAPEYLVRGQLTE 453
           RD++ +NIL+    + KIADFGLAR    +     TA  G      + APE +  G  T 
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 454 KADVYSFGILIIEIV 468
           K+DV+SFGIL+ EIV
Sbjct: 190 KSDVWSFGILLTEIV 204

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  142 bits (359), Expect = 4e-38
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 14/201 (6%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVK 331
           + +G+G  G VY G   +        A+K L      Q V+ F  E  L+  + H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 332 LLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L+G          ++  Y+ +  L QFI  ++  +        +  L  A G+ YL   +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL---A 141

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARC-FAADRTHVSTAVAGTL--GYMAPEYLV 447
           E + +HRD+   N +LD+ FT K+ADFGLAR     +   V       L   + A E L 
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201

Query: 448 RGQLTEKADVYSFGILIIEIV 468
             + T K+DV+SFG+L+ E++
Sbjct: 202 TYRFTTKSDVWSFGVLLWELL 222

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  147 bits (372), Expect = 4e-38
 Identities = 63/192 (32%), Positives = 96/192 (50%), Gaps = 6/192 (3%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
            KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            E P   +V EY+   SL  F       K L   +  ++    A G+AY+        +H
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 457 VYSFGILIIEIV 468
           V+SFGIL+ E+ 
Sbjct: 447 VWSFGILLTELT 458

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  141 bits (358), Expect = 5e-38
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 14/201 (6%)

Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  +   + ++  K         +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL--GYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+        G     + APE L 
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190

Query: 448 RGQLTEKADVYSFGILIIEIV 468
             + +  +DV+SFG+++ E+ 
Sbjct: 191 ESKFSVASDVWSFGVVLYELF 211

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  141 bits (358), Expect = 5e-38
 Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 48/309 (15%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIEHKNLV 330
           F P + LG+GG G V+   +  +    A+KR+    R+   ++   EV  ++ +EH  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 331 KLLGCSIEGPE---------SLLVY---EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
           +     +E             + +Y   +     +L  ++  +   +    +   +I L 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-----------CFAADR 427
            AE + +LH      ++HRD+K SNI    D   K+ DFGL                   
Sbjct: 127 IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
               T   GT  YM+PE +     + K D++S G+++ E++       FS  +     R 
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-----PFS--TQMERVRT 236

Query: 488 WTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK-VC 546
            T  R+ K      P     +P E    ++Q        +   RP       ++ N    
Sbjct: 237 LTDVRNLKF----PPLFTQKYPCEY--VMVQ---DMLSPSPMERPEAIN---IIENAVFE 284

Query: 547 EIPTPSQPP 555
           ++  P +  
Sbjct: 285 DLDFPGKTV 293

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  140 bits (356), Expect = 6e-38
 Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 18/196 (9%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           + +G+G  G V +G    G  VAVK +  +       F  E ++++ + H NLV+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             E     +V EY+   SL  ++       +L  +      L   E + YL        +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 139

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT---LGYMAPEYLVRGQLT 452
           HRD+   N+L+ +D   K++DFGL +         S+        + + APE L   + +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 192

Query: 453 EKADVYSFGILIIEIV 468
            K+DV+SFGIL+ EI 
Sbjct: 193 TKSDVWSFGILLWEIY 208

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  141 bits (357), Expect = 7e-38
 Identities = 50/220 (22%), Positives = 103/220 (46%), Gaps = 16/220 (7%)

Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           + LG+G  G V +          G  VAVK L   +    + +   E+ ++ ++ H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 331 KLLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           K  G C+ +G   + L+ E++P+ SL +++        +N  ++    +   +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL-- 142

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL--GYMAPEYL 446
               + +HRD+   N+L++ +   KI DFGL +    D+ + +          + APE L
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201

Query: 447 VRGQLTEKADVYSFGILIIEIV-CGRRSNAFSQDSASPLQ 485
           ++ +    +DV+SFG+ + E++      ++        + 
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  141 bits (358), Expect = 1e-37
 Identities = 62/201 (30%), Positives = 103/201 (51%), Gaps = 14/201 (6%)

Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  +   + ++  K         +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL--GYMAPEYLV 447
              R IHRD+ T NIL++ +   KI DFGL +    D+ +      G     + APE L 
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221

Query: 448 RGQLTEKADVYSFGILIIEIV 468
             + +  +DV+SFG+++ E+ 
Sbjct: 222 ESKFSVASDVWSFGVVLYELF 242

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  140 bits (355), Expect = 1e-37
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 15/201 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           K+LG G  G V  G       VA+K +   +    DEF  E  ++ ++ H+ LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           + + P   ++ EY+ N  L  ++  +         +   +     E + YL      + +
Sbjct: 89  TKQRP-IFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL---GYMAPEYLVRGQLT 452
           HRD+   N L++     K++DFGL+R    D     T+  G+     +  PE L+  + +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLMYSKFS 199

Query: 453 EKADVYSFGILIIEIV-CGRR 472
            K+D+++FG+L+ EI   G+ 
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKM 220

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  141 bits (358), Expect = 1e-37
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 13/199 (6%)

Query: 277 KKLGQGGAGSVYMGSLPNG-----TTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G            VA+K L   T  +   E  +E  +++S+++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +LLG  +      L+ + +P   L  ++  +     +      N  +  A+G+ YL    
Sbjct: 81  RLLGICLTST-VQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT-LGYMAPEYLVRG 449
           + R++HRD+   N+L+      KI DFGLA+   A+            + +MA E ++  
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 450 QLTEKADVYSFGILIIEIV 468
             T ++DV+S+G+ + E++
Sbjct: 195 IYTHQSDVWSYGVTVWELM 213

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  140 bits (354), Expect = 1e-37
 Identities = 60/251 (23%), Positives = 106/251 (42%), Gaps = 34/251 (13%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           F   + +G GG G V+      +G T  +KR+ +N     ++   EV  ++ ++H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVH 68

Query: 332 LLGCSIEGPESL----------------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
             GC                        +  E+    +L+Q+I +K + + L+      +
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
                +G+ Y+H     ++I+RD+K SNI L      KI DFGL      D     T   
Sbjct: 128 FEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSK 182

Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK 495
           GTL YM+PE +      ++ D+Y+ G+++ E++    + AF           +T  R   
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-AFETSK------FFTDLRDGI 235

Query: 496 LVEAVDPNLKD 506
           + +  D   K 
Sbjct: 236 ISDIFDKKEKT 246

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  140 bits (356), Expect = 1e-37
 Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 17/202 (8%)

Query: 277 KKLGQGGAGSVYMGSLPN-----GTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           + LG+G  G V +          G  VAVK L      Q    +  E++++ ++ H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 331 KLLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           K  G C   G  SL LV EYVP  SL  ++        +   +         EG+AYLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH- 151

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL--GYMAPEYL 446
                 IHRD+   N+LLD D   KI DFGLA+       +      G     + APE L
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 447 VRGQLTEKADVYSFGILIIEIV 468
              +    +DV+SFG+ + E++
Sbjct: 210 KEYKFYYASDVWSFGVTLYELL 231

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  139 bits (352), Expect = 2e-37
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 15/201 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           +++G G  G V++G   N   VA+K +        ++F  E  ++  + H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             + P   LV E++ +  L  ++  + +  L        + L   EG+AYL    E  +I
Sbjct: 73  LEQAP-ICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL---GYMAPEYLVRGQLT 452
           HRD+   N L+ ++   K++DFG+ R    D     T+  GT     + +PE     + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKWASPEVFSFSRYS 183

Query: 453 EKADVYSFGILIIEIV-CGRR 472
            K+DV+SFG+L+ E+   G+ 
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKI 204

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  139 bits (352), Expect = 2e-37
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           K+LG G  G V +G       VAVK +   +    DEFF E   +  + H  LVK  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           S E P   +V EY+ N  L  ++  ++  K L  ++   +     EG+A+L      + I
Sbjct: 73  SKEYP-IYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL---GYMAPEYLVRGQLT 452
           HRD+   N L+D+D   K++DFG+ R    D+     +  GT     + APE     + +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFKYS 183

Query: 453 EKADVYSFGILIIEIV-CGRR 472
            K+DV++FGIL+ E+   G+ 
Sbjct: 184 SKSDVWAFGILMWEVFSLGKM 204

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  141 bits (358), Expect = 3e-37
 Identities = 72/354 (20%), Positives = 145/354 (40%), Gaps = 50/354 (14%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNL--VKL 332
           K++G GG+  V+          A+K +       Q +D + NE+  ++ ++  +   ++L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
                   + + +V E   N  L+ ++  K     ++  +R +      E +  +H   +
Sbjct: 122 YD-YEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH---Q 173

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS-TAVAGTLGYMAPEYLV--- 447
             I+H D+K +N L+      K+ DFG+A     D T V   +  G + YM PE +    
Sbjct: 174 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 448 --------RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
                   + +++ K+DV+S G ++  +  G+          +P Q++      +KL   
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK----------TPFQQIINQI--SKLHAI 280

Query: 500 VDPNLKDDFPA---EQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN---KVCEIPTPSQ 553
           +DPN + +FP    + + +VL+    C +     R S+ +   LL +   ++   P    
Sbjct: 281 IDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPE---LLAHPYVQIQTHPVNQM 334

Query: 554 PPFLNSSVMEPGNSSRSCSANSFISNVAKRIEVSYSSSESSSTHSSDAHSRSRE 607
                  +          ++ + I   AK +   YS  ES ++ SS    + R 
Sbjct: 335 AKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 388

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  137 bits (348), Expect = 1e-36
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)

Query: 277 KKLGQGGAGSVYMGSLPNG---TTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVK 331
           K+LG G  G+V  G         TVAVK L          DE   E N++  +++  +V+
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 332 LLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           ++G C  E    +LV E      L++++    + + +       ++   + G+ YL    
Sbjct: 83  MIGICEAESW--MLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL--GYMAPEYLVR 448
           E+  +HRD+   N+LL      KI+DFGL++   AD  +      G     + APE +  
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194

Query: 449 GQLTEKADVYSFGILIIEIV-CGRR 472
            + + K+DV+SFG+L+ E    G++
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQK 219

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  137 bits (347), Expect = 1e-36
 Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 14/197 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNGTT-VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG- 334
            KLG G  G VY G     +  VAVK L  +T + V+EF  E  ++  I+H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
           C+ E P   ++ E++   +L  ++ + N+ ++ +      +    +  + YL    +   
Sbjct: 78  CTREPP-FYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYL---EKKNF 132

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL---GYMAPEYLVRGQL 451
           IHRD+   N L+ ++   K+ADFGL+R    D     TA AG      + APE L   + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKF 189

Query: 452 TEKADVYSFGILIIEIV 468
           + K+DV++FG+L+ EI 
Sbjct: 190 SIKSDVWAFGVLLWEIA 206

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  138 bits (349), Expect = 2e-36
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 29/208 (13%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            ++G+G  G V+       G   AVK++     +       E+   + +    +V L G 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIILGTAEGLAYLHGG 389
             EGP   +  E +   SL          +L+              +    EGL YLH  
Sbjct: 119 VREGPWVNIFMELLEGGSL---------GQLIKQMGCLPEDRALYYLGQALEGLEYLH-- 167

Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTA----VAGTLGYMAPE 444
              RI+H D+K  N+LL  D +   + DFG A C   D    S      + GT  +MAPE
Sbjct: 168 -TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGRR 472
            ++      K D++S   +++ ++ G  
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  137 bits (348), Expect = 2e-36
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 20/204 (9%)

Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
            +LG+G  GSV +          G  VAVK+L  +      +F  E+ ++ ++    +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G     G +SL LV EY+P+  L  F+  +     L+ ++         +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 143

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG-----YMAPE 444
              R +HRD+   NIL++ +   KIADFGLA+    D+      V    G     + APE
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVREPGQSPIFWYAPE 200

Query: 445 YLVRGQLTEKADVYSFGILIIEIV 468
            L     + ++DV+SFG+++ E+ 
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELF 224

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  136 bits (344), Expect = 3e-36
 Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 15/201 (7%)

Query: 277 KKLGQGGAGSVYMGSL--PNGTT--VAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G T  VAVK L   + +  + +D+F  EVN + S++H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +  +               +  AEG+ YL   
Sbjct: 84  IRLYGVVLTPP-MKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYL--- 137

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY--MAPEYLV 447
              R IHRD+   N+LL      KI DFGL R    +  H        + +   APE L 
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197

Query: 448 RGQLTEKADVYSFGILIIEIV 468
               +  +D + FG+ + E+ 
Sbjct: 198 TRTFSHASDTWMFGVTLWEMF 218

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  136 bits (345), Expect = 4e-36
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 26/211 (12%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           K LG+G  GSV  G+L         VAVK +    ++++ ++EF +E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 331 KLLG-CSIEGPES----LLVYEYVPNRSLDQFI---FDKNKTKLLNWNKRFNIILGTAEG 382
           +LLG C     +     +++  ++    L  ++     +   K +        ++  A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG--- 439
           + YL   S    +HRD+   N +L  D T  +ADFGL++              G +    
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQGRIAKMP 212

Query: 440 --YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
             ++A E L     T K+DV++FG+ + EI 
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  136 bits (345), Expect = 5e-36
 Identities = 45/212 (21%), Positives = 93/212 (43%), Gaps = 26/212 (12%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL--VKL 332
           K++G GG+  V+          A+K +         +D + NE+  ++ ++  +   ++L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
                   + + +V E   N  L+ ++  K     ++  +R +      E +  +H   +
Sbjct: 94  YDY-EITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH---Q 145

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS-TAVAGTLGYMAPEYLV--- 447
             I+H D+K +N L+      K+ DFG+A     D T V   +  GT+ YM PE +    
Sbjct: 146 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 448 --------RGQLTEKADVYSFGILIIEIVCGR 471
                   + +++ K+DV+S G ++  +  G+
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  136 bits (345), Expect = 5e-36
 Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 13/199 (6%)

Query: 277 KKLGQGGAGSVYMGSL-----PNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           K LG G  G+V+ G            V +K +   + RQ      + +  I S++H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +LLG         LV +Y+P  SL   +  +     L      N  +  A+G+ YL    
Sbjct: 79  RLLGLCPGSS-LQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYL---E 132

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT-LGYMAPEYLVRG 449
           E  ++HR++   N+LL      ++ADFG+A     D   +  + A T + +MA E +  G
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192

Query: 450 QLTEKADVYSFGILIIEIV 468
           + T ++DV+S+G+ + E++
Sbjct: 193 KYTHQSDVWSYGVTVWELM 211

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  136 bits (344), Expect = 7e-36
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 13/199 (6%)

Query: 277 KKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G            VA+K L   T  +   E  +E  +++S+++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +LLG  +      L+ + +P   L  ++  +     +      N  +  A+G+ YL    
Sbjct: 81  RLLGICLTST-VQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT-LGYMAPEYLVRG 449
           + R++HRD+   N+L+      KI DFGLA+   A+            + +MA E ++  
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 450 QLTEKADVYSFGILIIEIV 468
             T ++DV+S+G+ + E++
Sbjct: 195 IYTHQSDVWSYGVTVWELM 213

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  135 bits (342), Expect = 7e-36
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 33/217 (15%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           ++LG+G  G V++    N         VAVK L   T     +F  E  L+++++H+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 331 KLLG-CSIEGPESLLVYEYVPNRSLDQF-------------IFDKNKTKLLNWNKRFNII 376
           K  G C    P  ++V+EY+ +  L++F                +     L  ++  +I 
Sbjct: 81  KFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              A G+ YL   +    +HRD+ T N L+  +   KI DFG++R    D         G
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 192

Query: 437 TLG-----YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
                   +M PE ++  + T ++DV+SFG+++ EI 
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  135 bits (342), Expect = 8e-36
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 16/202 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           + +G+G  G VY G+L +        AVK L  I +  + V +F  E  ++    H N++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFSHPNVL 89

Query: 331 KLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            LLG C       L+V  Y+ +  L  FI  +N+T            L  A+G+ YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL--- 144

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTL--GYMAPEYL 446
           +  + +HRD+   N +LD+ FT K+ADFGLAR  +  +   V       L   +MA E L
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 447 VRGQLTEKADVYSFGILIIEIV 468
              + T K+DV+SFG+L+ E++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELM 226

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  138 bits (350), Expect = 8e-36
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 22/210 (10%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVN-LISSIEHKNLVK 331
           F P   LG G  G++    + +   VAVKR++    +       EV  L  S EH N+++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL---PECFSFADREVQLLRESDEHPNVIR 82

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
              C+ +  +   +  E     +L +++  + K       +   ++  T  GLA+LH   
Sbjct: 83  YF-CTEKDRQFQYIAIELCAA-TLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLH--- 135

Query: 391 ETRIIHRDIKTSNILL-----DKDFTPKIADFGLARCFAADR--THVSTAVAGTLGYMAP 443
              I+HRD+K  NIL+            I+DFGL +  A  R      + V GT G++AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 444 EYL---VRGQLTEKADVYSFGILIIEIVCG 470
           E L    +   T   D++S G +   ++  
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  134 bits (340), Expect = 1e-35
 Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 39/215 (18%)

Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
           + LGQG    ++ G           + T V +K L    R + + FF   +++S + HK+
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           LV   G  + G E++LV E+V   SLD ++  K     +N   +  +    A  + +L  
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFL-- 129

Query: 389 GSETRIIHRDIKTSNILLDKDFTP--------KIADFGLARCFAADRTHVSTAVAGTLGY 440
             E  +IH ++   NILL ++           K++D G++             V      
Sbjct: 130 -EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-----------TVLPKDIL 177

Query: 441 ------MAPEYLV-RGQLTEKADVYSFGILIIEIV 468
                 + PE +     L    D +SFG  + EI 
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  135 bits (342), Expect = 1e-35
 Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 27/212 (12%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           + LG+G  GSV    L         VAVK L         ++EF  E   +   +H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 331 KLLG-CSIEGPES-----LLVYEYVPNRSLDQFIFD---KNKTKLLNWNKRFNIILGTAE 381
           KL+G       +      +++  ++ +  L  F+           L        ++  A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG-- 439
           G+ YL   S    IHRD+   N +L +D T  +ADFGL+R              G     
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCASKL 201

Query: 440 ---YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
              ++A E L     T  +DV++FG+ + EI+
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  135 bits (341), Expect = 1e-35
 Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 27/220 (12%)

Query: 271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW---VDEFFNEVNLISSIEH 326
           + +  S  LGQG   +V+ G     G   A+K  +FN   +   VD    E  ++  + H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 327 KNLVKLLGCSIEGPESLLVY---EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           KN+VKL     E   +       E+ P  SL   + + +    L  ++   ++     G+
Sbjct: 67  KNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 384 AYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
            +L    E  I+HR+IK  NI+     D     K+ DFG AR    D     +   GT  
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEE 180

Query: 440 YMAPEYLVRGQL--------TEKADVYSFGILIIEIVCGR 471
           Y+ P+   R  L            D++S G+       G 
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  133 bits (338), Expect = 2e-35
 Identities = 65/271 (23%), Positives = 106/271 (39%), Gaps = 25/271 (9%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLL 333
             +G G  G         +G  +  K L +   T        +EVNL+  ++H N+V+  
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 334 GCSIEGPESLL--VYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLH--G 388
              I+   + L  V EY     L   I     + + L+      ++      L   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
                ++HRD+K +N+ LD     K+ DFGLAR    D +   T V GT  YM+PE  + 
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPE-QMN 189

Query: 449 GQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD 507
                EK+D++S G L+ E+        F+  S   L          K+ E     +   
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMP--PFTAFSQKELAG--------KIREGKFRRIPYR 239

Query: 508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +  E   N +   +L  +     RPS+ + +
Sbjct: 240 YSDE--LNEIITRMLNLK--DYHRPSVEEIL 266

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  134 bits (340), Expect = 2e-35
 Identities = 61/226 (26%), Positives = 89/226 (39%), Gaps = 16/226 (7%)

Query: 253 SMKKSCLSFKYETLEKATNY---FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTR 308
              ++  S  Y+     + +   F    +LG G  G V+   S  +G   AVKR +   R
Sbjct: 36  EASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR 95

Query: 309 QWVD--EFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTK 365
              D      EV     + +H   V+L     EG    L  E     SL Q    +    
Sbjct: 96  GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGA 152

Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
            L   + +  +  T   LA+LH      ++H D+K +NI L      K+ DFGL      
Sbjct: 153 SLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-- 207

Query: 426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
                     G   YMAPE L++G     ADV+S G+ I+E+ C  
Sbjct: 208 GTAGAGEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  133 bits (338), Expect = 3e-35
 Identities = 63/231 (27%), Positives = 99/231 (42%), Gaps = 44/231 (19%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           F     LGQG  G V    +  +    A+K+ I +T + +    +EV L++S+ H+ +V+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYVVR 66

Query: 332 LLGCSIEGPESL-------------LVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFN 374
                +E    +             +  EY  N +L   I  +N    + +       F 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL---FR 123

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV---- 430
            IL   E L+Y+H      IIHRD+K  NI +D+    KI DFGLA+        +    
Sbjct: 124 QIL---EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 431 ----------STAVAGTLGYMAPEYLV-RGQLTEKADVYSFGILIIEIVCG 470
                     ++A+ GT  Y+A E L   G   EK D+YS GI+  E++  
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  133 bits (338), Expect = 4e-35
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           ++LGQG  G VY G           T VA+K +    + +   EF NE +++      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQF-------IFDKNKTKLLNWNKRFNIILGTAEG 382
           V+LLG   +G  +L++ E +    L  +       + +       + +K   +    A+G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY-- 440
           +AYL   +  + +HRD+   N ++ +DFT KI DFG+ R    D         G  G   
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 203

Query: 441 ---MAPEYLVRGQLTEKADVYSFGILIIEIV 468
              M+PE L  G  T  +DV+SFG+++ EI 
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  135 bits (341), Expect = 4e-35
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 16/202 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           + +G+G  G VY G+L +        AVK L  I +  +    F  E  ++    H N++
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVL 153

Query: 331 KLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            LLG C       L+V  Y+ +  L  FI  +N+T            L  A+G+ +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL--- 208

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVSTAVAGTL--GYMAPEYL 446
           +  + +HRD+   N +LD+ FT K+ADFGLAR  +  +   V       L   +MA E L
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 447 VRGQLTEKADVYSFGILIIEIV 468
              + T K+DV+SFG+L+ E++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELM 290

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  135 bits (342), Expect = 5e-35
 Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 27/220 (12%)

Query: 271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE---FFNEVNLISSIEH 326
           + +  S  LGQG   +V+ G     G   A+K  +FN   ++        E  ++  + H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 327 KNLVKLLGCSIEGPESLLVY---EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           KN+VKL     E   +       E+ P  SL   + + +    L  ++   ++     G+
Sbjct: 67  KNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 384 AYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
            +L    E  I+HR+IK  NI+     D     K+ DFG AR    D     +   GT  
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLY-GTEE 180

Query: 440 YMAPEYLVRGQL--------TEKADVYSFGILIIEIVCGR 471
           Y+ P+   R  L            D++S G+       G 
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  132 bits (335), Expect = 6e-35
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 12/197 (6%)

Query: 278 KLGQGGAGSVYMGSLPNG---TTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLL 333
           +LG G  GSV  G          VA+K L   T +   +E   E  ++  +++  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G        +LV E      L +F+    K + +  +    ++   + G+ YL    E  
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL--GYMAPEYLVRGQL 451
            +HRD+   N+LL      KI+DFGL++   AD ++ +   AG     + APE +   + 
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190

Query: 452 TEKADVYSFGILIIEIV 468
           + ++DV+S+G+ + E +
Sbjct: 191 SSRSDVWSYGVTMWEAL 207

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  132 bits (335), Expect = 6e-35
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 34/218 (15%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           ++LG+   G VY G L           VA+K L         +EF +E  L + ++H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 330 VKLLG-CSIEGPESLLVYEYVPNRSLDQF-------------IFDKNKTKLLNWNKRFNI 375
           V LLG  + + P   +++ Y  +  L +F               D+     L      ++
Sbjct: 75  VCLLGVVTKDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           +   A G+ YL   S   ++H+D+ T N+L+      KI+D GL R    +         
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKL 186

Query: 436 GTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
                    +MAPE ++ G+ +  +D++S+G+++ E+ 
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  133 bits (336), Expect = 1e-34
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 32/216 (14%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
            +LG+G  G V++    N         VAVK L   +     +F  E  L++ ++H+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 331 KLLG-CSIEGPESLLVYEYVPNRSLDQF------------IFDKNKTKLLNWNKRFNIIL 377
           +  G C+   P  L+V+EY+ +  L++F              +      L   +   +  
Sbjct: 107 RFFGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
             A G+ YL   +    +HRD+ T N L+ +    KI DFG++R    D         G 
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGG 218

Query: 438 LG-----YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
                  +M PE ++  + T ++DV+SFG+++ EI 
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  131 bits (332), Expect = 1e-34
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 17/200 (8%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVK 331
           + LG+G  G VY G   N       VAVK    +      ++F +E  ++ +++H ++VK
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           L+G   E P + ++ E  P   L  ++  +     L         L   + +AYL     
Sbjct: 78  LIGIIEEEP-TWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYL---ES 131

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL---GYMAPEYLVR 448
              +HRDI   NIL+      K+ DFGL+R    +        + T     +M+PE +  
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINF 188

Query: 449 GQLTEKADVYSFGILIIEIV 468
            + T  +DV+ F + + EI+
Sbjct: 189 RRFTTASDVWMFAVCMWEIL 208

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  132 bits (333), Expect = 2e-34
 Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 34/219 (15%)

Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V               TVAVK L    T        +E+ ++  I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-------- 379
           +V LLG C+  G   +++ E+    +L  ++  K    +       ++            
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 380 -----AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D       V
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYV 205

Query: 435 AGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
                     +MAPE +     T ++DV+SFG+L+ EI 
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  131 bits (332), Expect = 2e-34
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 37/221 (16%)

Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG G  G V   +           TVAVK L  +      +   +E+ ++S +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-------- 379
           +V LLG C+I GP +L++ EY     L  F+  K  + + +      +            
Sbjct: 89  IVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 380 -------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
                  A+G+A+L   +    IHRD+   NILL      KI DFGLAR    D  + S 
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSN 200

Query: 433 AVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
            V          +MAPE +     T ++DV+S+GI + E+ 
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  132 bits (333), Expect = 3e-34
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 14/200 (7%)

Query: 277 KKLGQGGAGSVYMGSLP----NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G +G V  G L         VA+K L      +   +F +E +++   +H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 332 LLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L G  +     +++V EY+ N SLD F+  +         +   ++ G   G+ YL   S
Sbjct: 115 LEGVVTRGRL-AMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY--MAPEYLVR 448
           +   +HRD+   N+L+D +   K++DFGL+R    D     T   G +     APE +  
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 449 GQLTEKADVYSFGILIIEIV 468
              +  +DV+SFG+++ E++
Sbjct: 229 RTFSSASDVWSFGVVMWEVL 248

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  131 bits (331), Expect = 5e-34
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 35/216 (16%)

Query: 277 KKLGQGGAGSVYMGSLPNG---TTVAVKRL--IFNTRQWVDEFFNEVNLISSI-EHKNLV 330
             +G+G  G V    +         A+KR+    +     D F  E+ ++  +  H N++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 89

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT----------- 379
            LLG         L  EY P+ +L  F+      +        N    T           
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 380 --AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
             A G+ YL   S+ + IHRD+   NIL+ +++  KIADFGL+R            V  T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 199

Query: 438 LG-----YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
           +G     +MA E L     T  +DV+S+G+L+ EIV
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  131 bits (331), Expect = 5e-34
 Identities = 62/212 (29%), Positives = 88/212 (41%), Gaps = 28/212 (13%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           + LG G  G VY G +           VAVK L  + + +  +D F  E  +IS   H+N
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 94

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI----FDKNKTKLLNWNKRFNIILGTAEGLA 384
           +V+ +G S++     ++ E +    L  F+       ++   L      ++    A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 385 YLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLARCFAADRTHVSTAVAGTLGY- 440
           YL    E   IHRDI   N LL         KI DFG+AR    D    S    G     
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAML 207

Query: 441 ----MAPEYLVRGQLTEKADVYSFGILIIEIV 468
               M PE  + G  T K D +SFG+L+ EI 
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  131 bits (331), Expect = 6e-34
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 16/206 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNGT-----TVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLV 330
           K +G G  G VY G L   +      VA+K L      +   +F  E  ++    H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 331 KLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           +L G  S   P  +++ EY+ N +LD+F+  + K    +  +   ++ G A G+ YL   
Sbjct: 110 RLEGVISKYKP-MMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL--- 163

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY--MAPEYLV 447
           +    +HRD+   NIL++ +   K++DFGL+R    D     T   G +     APE + 
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 448 RGQLTEKADVYSFGILIIEIV-CGRR 472
             + T  +DV+SFGI++ E++  G R
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGER 249

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  135 bits (342), Expect = 6e-34
 Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 13/203 (6%)

Query: 277 KKLGQGGAGSVYMGSLPNG---TTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKL 332
            +LG G  GSV  G          VA+K L   T +   +E   E  ++  +++  +V+L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           +G        +LV E      L +F+    K + +  +    ++   + G+ YL    E 
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEK 455

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY--MAPEYLVRGQ 450
             +HR++   N+LL      KI+DFGL++   AD ++ +   AG       APE +   +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515

Query: 451 LTEKADVYSFGILIIEIV-CGRR 472
            + ++DV+S+G+ + E +  G++
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQK 538

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  131 bits (332), Expect = 7e-34
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 12/199 (6%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V  G L        +VA+K L +  T +   +F  E +++   +H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+ YL   S+
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SD 165

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY--MAPEYLVRG 449
              +HRD+   NIL++ +   K++DFGL R    D     T   G +     +PE +   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225

Query: 450 QLTEKADVYSFGILIIEIV 468
           + T  +DV+S+GI++ E++
Sbjct: 226 KFTSASDVWSYGIVLWEVM 244

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  132 bits (335), Expect = 8e-34
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 37/229 (16%)

Query: 271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVN-LISSIEHKNL 329
           N     K LG G +G+V       G  VAVKR++     + D    E+  L  S +H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71

Query: 330 VKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNK----TKLLNWNKRFNIILGTAEGLA 384
           ++   CS      L +  E     +L   +  KN      KL       +++   A G+A
Sbjct: 72  IRYY-CSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 385 YLHGGSETRIIHRDIKTSNILLD-------------KDFTPKIADFGLARCFAADRTHVS 431
           +LH     +IIHRD+K  NIL+              ++    I+DFGL +   + ++   
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 432 TA---VAGTLGYMAPEYL-------VRGQLTEKADVYSFGILIIEIVCG 470
           T     +GT G+ APE L        + +LT   D++S G +   I+  
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  131 bits (332), Expect = 8e-34
 Identities = 61/212 (28%), Positives = 87/212 (41%), Gaps = 28/212 (13%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           + LG G  G VY G +           VAVK L  + + +  +D F  E  +IS   H+N
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 135

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI----FDKNKTKLLNWNKRFNIILGTAEGLA 384
           +V+ +G S++     ++ E +    L  F+       ++   L      ++    A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 385 YLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLARCFAADRTHVSTAVAGTLGY- 440
           YL    E   IHRDI   N LL         KI DFG+AR    D         G     
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAML 248

Query: 441 ----MAPEYLVRGQLTEKADVYSFGILIIEIV 468
               M PE  + G  T K D +SFG+L+ EI 
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  130 bits (328), Expect = 1e-33
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 40/225 (17%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           K LG+G  G V   +  +       TTVAVK L  N +   + +  +E N++  + H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT---------- 379
           +KL G   +    LL+ EY    SL  F+ +  K          +    +          
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 380 -----------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
                      ++G+ YL   +E +++HRD+   NIL+ +    KI+DFGL+R    D  
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR----DVY 201

Query: 429 HVSTAVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
              + V  + G     +MA E L     T ++DV+SFG+L+ EIV
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  130 bits (328), Expect = 1e-33
 Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 33/217 (15%)

Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG G  G V   +            VAVK L         +   +E+ ++S + +H+N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-------- 379
           +V LLG C+  GP  L++ EY     L  F+  K++    +          +        
Sbjct: 112 IVNLLGACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 380 ---AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              A+G+A+L   +    IHRD+   N+LL      KI DFGLAR    D    S  +  
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SNYIVK 223

Query: 437 TLG-----YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
                   +MAPE +     T ++DV+S+GIL+ EI 
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  128 bits (324), Expect = 1e-33
 Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 17/200 (8%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVK 331
           + +G+G  G V+ G   +       VA+K     T     ++F  E   +   +H ++VK
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           L+G   E P   ++ E      L  F+  + +   L+           +  LAYL     
Sbjct: 81  LIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---ES 134

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL---GYMAPEYLVR 448
            R +HRDI   N+L+  +   K+ DFGL+R             +       +MAPE +  
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY---YKASKGKLPIKWMAPESINF 191

Query: 449 GQLTEKADVYSFGILIIEIV 468
            + T  +DV+ FG+ + EI+
Sbjct: 192 RRFTSASDVWMFGVCMWEIL 211

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  128 bits (324), Expect = 2e-33
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 12/209 (5%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
            KLG GG  +VY+         VA+K +        + +  F  EV+  S + H+N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           +    E     LV EY+   +L ++I        L+ +   N      +G+ + H   + 
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DM 130

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
           RI+HRDIK  NIL+D + T KI DFG+A+  +      +  V GT+ Y +PE        
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 453 EKADVYSFGILIIEIVCGRRSNAFSQDSA 481
           E  D+YS GI++ E++ G     F+ ++A
Sbjct: 191 ECTDIYSIGIVLYEMLVGEP--PFNGETA 217

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  129 bits (326), Expect = 3e-33
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 35/220 (15%)

Query: 277 KKLGQGGAGSVYMGSLP--------NGTTVAVKRL-IFNTRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L    T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT------- 379
           KN++ LLG   +     ++ EY    +L +++  +    +        +           
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 380 ------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
                 A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR    D  ++   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYY 213

Query: 434 VAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
              T G     +MAPE L     T ++DV+SFG+L+ EI 
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  127 bits (320), Expect = 7e-33
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 15/215 (6%)

Query: 263 YETLEKATNYFNPSK------KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFF 315
            E L    +  +P K      K+GQG +G+VY    +  G  VA++++    +   +   
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65

Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           NE+ ++   ++ N+V  L   + G E  +V EY+   SL   +        ++  +   +
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAV 121

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
                + L +LH     ++IHRDIK+ NILL  D + K+ DFG       +++  ST V 
Sbjct: 122 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 177

Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           GT  +MAPE + R     K D++S GI+ IE++ G
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  128 bits (324), Expect = 9e-33
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 35/220 (15%)

Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L    T + + +  +E+ ++  I +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT------- 379
           KN++ LLG   +     ++ EY    +L +++  +    +        +           
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 380 ------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
                 A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR    D  ++   
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYY 259

Query: 434 VAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
              T G     +MAPE L     T ++DV+SFG+L+ EI 
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  127 bits (322), Expect = 1e-32
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 40/225 (17%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           + +G+G  G V+    P        T VAVK L    +     +F  E  L++  ++ N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQF---------------------IFDKNKTKLLN 368
           VKLLG    G    L++EY+    L++F                              L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 369 WNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
             ++  I    A G+AYL   SE + +HRD+ T N L+ ++   KIADFGL+R    +  
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NIY 225

Query: 429 HVSTAVAGTLGY-----MAPEYLVRGQLTEKADVYSFGILIIEIV 468
                 A          M PE +   + T ++DV+++G+++ EI 
Sbjct: 226 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  127 bits (322), Expect = 1e-32
 Identities = 62/226 (27%), Positives = 93/226 (41%), Gaps = 42/226 (18%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG G  G V   +            VAVK L         +   +E+ +++ +  H+N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-------- 379
           +V LLG C++ GP   L++EY     L  ++  K +    +  +  N             
Sbjct: 111 IVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 380 ------------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
                       A+G+ +L        +HRD+   N+L+      KI DFGLAR    D 
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR----DI 222

Query: 428 THVSTAVAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
              S  V          +MAPE L  G  T K+DV+S+GIL+ EI 
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  127 bits (322), Expect = 2e-32
 Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 35/220 (15%)

Query: 277 KKLGQGGAGSVYMGSLPN--------GTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +              T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT------- 379
           KN++ LLG   +     ++ EY    +L +++  +    L       +            
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 380 ------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
                 A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR    D  H+   
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247

Query: 434 VAGTLG-----YMAPEYLVRGQLTEKADVYSFGILIIEIV 468
              T G     +MAPE L     T ++DV+SFG+L+ EI 
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  131 bits (331), Expect = 2e-32
 Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 11/197 (5%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVK 331
           + +G+G  G V+ G   +       VA+K      +    ++F  E   +   +H ++VK
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           L+G   E P   ++ E      L  F+  + +   L+           +  LAYL     
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ES 509

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
            R +HRDI   N+L+  +   K+ DFGL+R       + ++     + +MAPE +   + 
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569

Query: 452 TEKADVYSFGILIIEIV 468
           T  +DV+ FG+ + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  125 bits (315), Expect = 4e-32
 Identities = 55/196 (28%), Positives = 96/196 (48%), Gaps = 10/196 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLG 334
           +K+G+G  G V+ G        VA+K +     +  +++   E+ ++S  +   + K  G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             ++  +  ++ EY+   S    +    +   L+  +   I+    +GL YLH     + 
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---SEKK 140

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK 454
           IHRDIK +N+LL +    K+ADFG+A      +   +T V GT  +MAPE + +     K
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 199

Query: 455 ADVYSFGILIIEIVCG 470
           AD++S GI  IE+  G
Sbjct: 200 ADIWSLGITAIELARG 215

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  124 bits (314), Expect = 5e-32
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 27/207 (13%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK----RLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + LG+GG    +           A K     L+    Q  ++   E+++  S+ H+++V 
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVG 79

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLA 384
             G   E  + + +V E    RSL     + +K +     K          +     G  
Sbjct: 80  FHGF-FEDNDFVFVVLELCRRRSL----LELHKRR-----KALTEPEARYYLRQIVLGCQ 129

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH     R+IHRD+K  N+ L++D   KI DFGLA     D       + GT  Y+APE
Sbjct: 130 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE 185

Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGR 471
            L +   + + DV+S G ++  ++ G+
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  125 bits (316), Expect = 5e-32
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 9/202 (4%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
               +   K+G+G  G V +     +G  VAVK +    +Q  +  FNEV ++   +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           +V++    + G E  ++ E++   +L   +        LN  +   +     + LAYLH 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLH- 158

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
                +IHRDIK+ +ILL  D   K++DFG     + D     + V GT  +MAPE + R
Sbjct: 159 --AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR 215

Query: 449 GQLTEKADVYSFGILIIEIVCG 470
                + D++S GI++IE+V G
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDG 237

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  125 bits (315), Expect = 5e-32
 Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 9/202 (4%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
              F+  +KLG+G  GSVY       G  VA+K         + E   E++++   +  +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDSPH 85

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           +VK  G   +  +  +V EY    S+   I  + + K L  ++   I+  T +GL YLH 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLH- 142

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               R IHRDIK  NILL+ +   K+ADFG+A          +T + GT  +MAPE +  
Sbjct: 143 --FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQE 199

Query: 449 GQLTEKADVYSFGILIIEIVCG 470
                 AD++S GI  IE+  G
Sbjct: 200 IGYNCVADIWSLGITAIEMAEG 221

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  123 bits (312), Expect = 8e-32
 Identities = 47/225 (20%), Positives = 85/225 (37%), Gaps = 35/225 (15%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSI-EHKN 328
           F+  +K+G G  GSV+      +G   A+KR        VDE     EV   + + +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLH 387
           +V+      E    L+  EY    SL   I +  +        +  +++L    GL Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 388 GGSETRIIHRDIKTSNILLDKD-------------------FTPKIADFGLARCFAADRT 428
                 ++H DIK SNI + +                       KI D G     ++ + 
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189

Query: 429 HVSTAVAGTLGYMAPEYLVRGQL--TEKADVYSFGILIIEIVCGR 471
                  G   ++A E +++       KAD+++  + ++      
Sbjct: 190 EE-----GDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  126 bits (317), Expect = 1e-31
 Identities = 43/208 (20%), Positives = 77/208 (37%), Gaps = 17/208 (8%)

Query: 277 KKLGQGGA--GSVYMG-SLPNGTTVAVKR--LIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
             +G+G     +V +    P G  V V+R  L   + + V     E+++     H N+V 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
                I   E  +V  ++   S    +   +    +N      I+ G  + L Y+H    
Sbjct: 91  YRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIH---H 146

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST------AVAGTLGYMAPEY 445
              +HR +K S+IL+  D    ++         +                  L +++PE 
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206

Query: 446 LVRGQL--TEKADVYSFGILIIEIVCGR 471
           L +       K+D+YS GI   E+  G 
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGH 234

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  124 bits (314), Expect = 1e-31
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 27/207 (13%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK----RLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + LG+GG    +           A K     L+    Q  ++   E+++  S+ H+++V 
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVG 105

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLA 384
             G   E  + + +V E    RSL     + +K +     K          +     G  
Sbjct: 106 FHGF-FEDNDFVFVVLELCRRRSL----LELHKRR-----KALTEPEARYYLRQIVLGCQ 155

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH     R+IHRD+K  N+ L++D   KI DFGLA     D       + GT  Y+APE
Sbjct: 156 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE 211

Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGR 471
            L +   + + DV+S G ++  ++ G+
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  129 bits (324), Expect = 2e-31
 Identities = 59/210 (28%), Positives = 87/210 (41%), Gaps = 22/210 (10%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQW---VDEFFNEVNLISSIEHKNLVKL 332
           ++LG GG G V        G  VA+K             + +  E+ ++  + H N+V  
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 333 LGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
                +G + L       L  EY     L +++        L       ++   +  L Y
Sbjct: 78  REV-PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136

Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           LH   E RIIHRD+K  NI+L    +    KI D G A+         +  V GTL Y+A
Sbjct: 137 LH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQYLA 191

Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCGRR 472
           PE L + + T   D +SFG L  E + G R
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (310), Expect = 2e-31
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 28/220 (12%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRL--------IFNTRQWVDEFFNEVNLISSIEHK 327
           + LG GG   V++   L +   VAVK L         F  R     F  E    +++ H 
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-----FRREAQNAAALNHP 72

Query: 328 NLVKLL--GCSIEGPESL--LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +V +   G +      L  +V EYV   +L   +  +     +   +   +I    + L
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQAL 129

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGTLGYM 441
            + H   +  IIHRD+K +NI++      K+ DFG+AR  A     V  + AV GT  Y+
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA 481
           +PE      +  ++DVYS G ++ E++ G     F+ DS 
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEP--PFTGDSP 224

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  122 bits (308), Expect = 2e-31
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 26/207 (12%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK----RLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
             LG+G    VY   S+  G  VA+K    + ++     V    NEV +   ++H ++++
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM-VQRVQNEVKIHCQLKHPSILE 75

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLA 384
           L     E    + LV E   N  +        K +     K F+       +     G+ 
Sbjct: 76  LYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNR----VKPFSENEARHFMHQIITGML 126

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           YLH      I+HRD+  SN+LL ++   KIADFGLA           T + GT  Y++PE
Sbjct: 127 YLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE 182

Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGR 471
              R     ++DV+S G +   ++ GR
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGR 209

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  123 bits (310), Expect = 4e-31
 Identities = 50/218 (22%), Positives = 86/218 (39%), Gaps = 24/218 (11%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLG 334
           + L +GG   VY    + +G   A+KRL+ N  +       EV  +  +  H N+V+   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 335 CSIEGPES-------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
            +  G E         L+   +    L +F+        L+ +    I   T   + ++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA-----------G 436
              +  IIHRD+K  N+LL    T K+ DFG A   +    +  +A              
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 437 TLGYMAPE--YLVRGQ-LTEKADVYSFGILIIEIVCGR 471
           T  Y  PE   L     + EK D+++ G ++  +   +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  121 bits (306), Expect = 6e-31
 Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 17/208 (8%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           + +G G    V      P    VA+KR+ +   +  +DE   E+  +S   H N+V    
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLAYLHG 388
             +   E  LV + +   S+   I      K  + +   +      I+    EGL YLH 
Sbjct: 81  SFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH- 138

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFG----LARCFAADRTHVSTAVAGTLGYMAPE 444
             +   IHRD+K  NILL +D + +IADFG    LA      R  V     GT  +MAPE
Sbjct: 139 --KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196

Query: 445 YLVRGQL-TEKADVYSFGILIIEIVCGR 471
            + + +    KAD++SFGI  IE+  G 
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGA 224

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  122 bits (308), Expect = 9e-31
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 34/221 (15%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVK-----------------RLIFNTRQWVDEFFNEVN 319
           + L QG    + +    +    A+K                     + +   D+F NE+ 
Sbjct: 37  RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 320 LISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRF 373
           +I+ I+++  +   G  I   + + ++YEY+ N S+ +F       DKN T  +      
Sbjct: 96  IITDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
            II       +Y+H  +E  I HRD+K SNIL+DK+   K++DFG +      +   S  
Sbjct: 155 CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS-- 210

Query: 434 VAGTLGYMAPEYLVRGQLT---EKADVYSFGILIIEIVCGR 471
             GT  +M PE     + +    K D++S GI +  +    
Sbjct: 211 -RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  121 bits (305), Expect = 1e-30
 Identities = 48/217 (22%), Positives = 79/217 (36%), Gaps = 26/217 (11%)

Query: 277 KKLGQGGAGSVYMGSLPN-GTTVAVKRL--------IFNTRQWVDEFFNEVNLISSIEHK 327
           + +G+GG G VY          VA+K +        +F TR        E      ++  
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR-----MQREARTAGRLQEP 94

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           ++V +        +  +    +    L   +  +     L   +   I+      L   H
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH 151

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST--AVAGTLGYMAPEY 445
                   HRD+K  NIL+  D    + DFG+A   A     ++      GTL YMAPE 
Sbjct: 152 ---AAGATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPER 206

Query: 446 LVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS 482
                 T +AD+Y+   ++ E + G     +  D  S
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSP--PYQGDQLS 241

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  120 bits (302), Expect = 1e-30
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 29/207 (14%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + LG+G  G+VY+     +   +A+K L    +        +   EV + S + H N+++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLRHPNILR 73

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLA 384
           L G        + L+ EY P  ++    + +     L    +F+       I   A  L+
Sbjct: 74  LYGY-FHDATRVYLILEYAPLGTV----YRE-----LQKLSKFDEQRTATYITELANALS 123

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           Y H     R+IHRDIK  N+LL      KIADFG +    + R      + GTL Y+ PE
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPE 177

Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGR 471
            +      EK D++S G+L  E + G+
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  125 bits (316), Expect = 2e-30
 Identities = 47/218 (21%), Positives = 86/218 (39%), Gaps = 27/218 (12%)

Query: 278 KLGQGGAGSVYMG---SLPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLL 333
            +  GG G +Y+    ++ NG  V +K L+ +   +       E   ++ + H ++V++ 
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 334 -----GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
                      P   +V EYV  +SL +    K     L   +    +L     L+YLH 
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH- 199

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
                +++ D+K  NI+L ++   K+ D G       +       + GT G+ APE +VR
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSF---GYLYGTPGFQAPE-IVR 250

Query: 449 GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQR 486
              T   D+Y+ G  +  +         +      L  
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLP--TRNGRYVDGLPE 286

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  120 bits (302), Expect = 3e-30
 Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 12/200 (6%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            +LG G  G VY   +   G   A K +   + + ++++  E+ ++++ +H  +VKLLG 
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
                +  ++ E+ P  ++D  +      + L   +   +     E L +LH     RII
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLH---SKRII 139

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE-- 453
           HRD+K  N+L+  +   ++ADFG++           + + GT  +MAPE ++   + +  
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTP 198

Query: 454 ---KADVYSFGILIIEIVCG 470
              KAD++S GI +IE+   
Sbjct: 199 YDYKADIWSLGITLIEMAQI 218

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  119 bits (301), Expect = 7e-30
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 18/205 (8%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFF---NEVNLISSIEHKN 328
           F+  +++G G  G+VY    + N   VA+K++ ++ +Q  +++     EV  +  + H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
            ++  GC +    + LV EY    + D     +   K L   +   +  G  +GLAYLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLAYLH- 171

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE---Y 445
                +IHRD+K  NILL +    K+ DFG     A+     ++ V GT  +MAPE    
Sbjct: 172 --SHNMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANSFV-GTPYWMAPEVILA 224

Query: 446 LVRGQLTEKADVYSFGILIIEIVCG 470
           +  GQ   K DV+S GI  IE+   
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAER 249

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  116 bits (294), Expect = 2e-29
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 29/207 (14%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + LG+G  G+VY+     N   +A+K L    +        +   E+ + S + H N+++
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILR 78

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLA 384
           +        + + L+ E+ P   L    + +     L  + RF+       +   A+ L 
Sbjct: 79  MYN-YFHDRKRIYLMLEFAPRGEL----YKE-----LQKHGRFDEQRSATFMEELADALH 128

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           Y H   E ++IHRDIK  N+L+      KIADFG +    + R        GTL Y+ PE
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM---CGTLDYLPPE 182

Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGR 471
            +      EK D++  G+L  E + G 
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  118 bits (296), Expect = 2e-29
 Identities = 60/327 (18%), Positives = 103/327 (31%), Gaps = 47/327 (14%)

Query: 233 AYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL 292
                +K K D      YA  +K+  L  +    EK         KL   G    +   L
Sbjct: 20  GVVFEAKNKVDDC---NYA--IKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL 74

Query: 293 PNGTTVAVKRLIFNTRQW------------VDEFFNEVNLISSIEHKNLVKLLGCSIEGP 340
                   + +     +             +D    ++  +     KN V  L  S    
Sbjct: 75  ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKV 134

Query: 341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK 400
              +  +     +L  ++  +   +        +I +  AE + +LH      ++HRD+K
Sbjct: 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLK 191

Query: 401 TSNILLDKDFTPKIADFGLAR-----------CFAADRTHVSTAVAGTLGYMAPEYLVRG 449
            SNI    D   K+ DFGL                       T   GT  YM+PE +   
Sbjct: 192 PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN 251

Query: 450 QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP 509
             + K D++S G+++ E++       FS  +     R+ T  R+ K            +P
Sbjct: 252 NYSHKVDIFSLGLILFELLYS-----FS--TQMERVRIITDVRNLKF----PLLFTQKYP 300

Query: 510 AEQVCNVLQIGLLCTQAAAALRPSMAQ 536
            E       +       +   RP    
Sbjct: 301 QEH-----MMVQDMLSPSPTERPEATD 322

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  117 bits (295), Expect = 6e-29
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 22/224 (9%)

Query: 256 KSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWV-DE 313
           ++ L+ K +  E   + F    +LG G  G V+  S  P+G  +A K +    +  + ++
Sbjct: 18  EAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ 77

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
              E+ ++       +V   G      E  +  E++   SLD         ++L    R 
Sbjct: 78  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD---------QVLKKAGRI 128

Query: 374 N------IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
                  + +   +GL YL    + +I+HRD+K SNIL++     K+ DFG++       
Sbjct: 129 PEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185

Query: 428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
             ++ +  GT  YM+PE L     + ++D++S G+ ++E+  GR
Sbjct: 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  114 bits (287), Expect = 2e-28
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 23/220 (10%)

Query: 265 TLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNT-RQWVDEFFNEVN-LI 321
           ++E   +   P  +LG+G  G V  M  +P+G  +AVKR+      Q       +++  +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------I 375
            +++    V   G      +  +  E + + SLD+F       ++++  +         I
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKI 114

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            +   + L +LH  S+  +IHRD+K SN+L++     K+ DFG++              A
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDA 170

Query: 436 GTLGYMAPE----YLVRGQLTEKADVYSFGILIIEIVCGR 471
           G   YMAPE     L +   + K+D++S GI +IE+   R
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (286), Expect = 6e-28
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)

Query: 277 KKLGQGGAGSVY-MGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVN-LISSIEHKNLVKLL 333
            ++G+G  GSV  M   P+G  +AVKR+      +   +   +++ ++ S +   +V+  
Sbjct: 28  GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLAYLH 387
           G      +  +  E + + S D+F     K      +          I L T + L +L 
Sbjct: 88  GALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV 447
                +IIHRDIK SNILLD+    K+ DFG++       +   T  AG   YMAPE + 
Sbjct: 143 --ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERID 198

Query: 448 RGQL----TEKADVYSFGILIIEIVCGR 471
                     ++DV+S GI + E+  GR
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGR 226

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  114 bits (287), Expect = 6e-28
 Identities = 45/291 (15%), Positives = 84/291 (28%), Gaps = 36/291 (12%)

Query: 235 ARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG---- 290
           + LSK      N   +   +            +  +        LG+G    VY      
Sbjct: 32  SGLSKPVSSYPNTFEWQCKLPAIK---PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGD 88

Query: 291 --SLPNGTTVAVKRLIFNTRQWVDEFF---NEVNLISSIEHKNLVKLLGCSIEGPESLLV 345
                N     +K +      W  EF+     +  +        +K     +    S+LV
Sbjct: 89  LNDAKNKQKFVLK-VQKPANPW--EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145

Query: 346 YEYVPNRSLDQFI--FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSN 403
            E     +L   I  +     K++      +  +     +  +H   +  IIH DIK  N
Sbjct: 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDN 202

Query: 404 ILLDKDFTP-----------KIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEYLVRGQL 451
            +L   F              + D G +       +  + TA   T G+   E L     
Sbjct: 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW 262

Query: 452 TEKADVYSFGILIIEIVCGR----RSNAFSQDSASPLQRVWTLYRSNKLVE 498
             + D +     +  ++ G     ++           +R+  L   N+   
Sbjct: 263 NYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFH 313

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  115 bits (290), Expect = 1e-27
 Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 30/234 (12%)

Query: 252 TSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLI---FNT 307
             +  +   F   +    ++ +   + LG+G  G V +      G   AVK +       
Sbjct: 7   DHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ 66

Query: 308 RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKL 366
           +   +    EV L+  ++H N++KL     E      LV E      L    FD+  ++ 
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIMKLYE-FFEDKGYFYLVGEVYTGGEL----FDEIISR- 120

Query: 367 LNWNKRFN------IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADF 417
               KRF+      II     G+ Y+H   + +I+HRD+K  N+LL    KD   +I DF
Sbjct: 121 ----KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDF 173

Query: 418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           GL+  F  + +       GT  Y+APE L  G   EK DV+S G+++  ++ G 
Sbjct: 174 GLSTHF--EASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGC 224

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  114 bits (288), Expect = 2e-27
 Identities = 64/235 (27%), Positives = 98/235 (41%), Gaps = 33/235 (14%)

Query: 253 SMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW- 310
            ++ +   F        +  +   KKLG G  G V +          A+K  I       
Sbjct: 19  DLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK--IIRKTSVS 76

Query: 311 ---VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKL 366
                +   EV ++  ++H N++KL     E   +  LV E      L    FD+   + 
Sbjct: 77  TSSNSKLLEEVAVLKLLDHPNIMKLYD-FFEDKRNYYLVMECYKGGEL----FDEIIHR- 130

Query: 367 LNWNKRFN------IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADF 417
                +FN      II     G+ YLH   +  I+HRD+K  N+LL   +KD   KI DF
Sbjct: 131 ----MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDF 183

Query: 418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRR 472
           GL+  F  +         GT  Y+APE L R +  EK DV+S G+++  ++ G  
Sbjct: 184 GLSAVF--ENQKKMKERLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYP 235

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  112 bits (282), Expect = 3e-27
 Identities = 30/296 (10%), Positives = 67/296 (22%), Gaps = 48/296 (16%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLI---FNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           + L  G    V++   +      A+K       N+R  ++         + +  ++  + 
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 333 LG----------CSIEG----------------PESLLVYEYVP---NRSLDQFIFDKNK 363
                        +++                    LL+                F    
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 364 TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
                      +        A L       ++H      N+ +  D    + D       
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 424 AADRTHVSTAVAGTLGYMAPEYLVRG--QLTEKADVYSFGILIIEIVCGRRSNAFSQDSA 481
                    A +  + Y   E+L       T   + +  G+ I  + C      F   + 
Sbjct: 245 GTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL--PFGLVTP 298

Query: 482 SPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQA 537
                           +++        P   V  ++    L        R    +A
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDF-VKTLIG-RFLNFDRRR--RLLPLEA 350

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (282), Expect = 3e-27
 Identities = 50/307 (16%), Positives = 90/307 (29%), Gaps = 72/307 (23%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTR--------------------------- 308
             LGQ    +         G +  V    F  R                           
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 309 -QWVDEFFNEVNLISSIEHKNLVKLLGC-SIEGPESLLVYEYVPNRSLDQF---IFDKNK 363
            +    F    +L+   + K ++++          S          +L  F   +   + 
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 364 T-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
           T K L  + R  + L     LA LH      ++H  ++  +I+LD+     +  F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 423 FAADRTHVSTAVAGTLGYMAPEYLV-----------RGQLTEKADVYSFGILIIEIVCGR 471
             A         + + G+  PE              R  +T   D ++ G++I  I C  
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 472 RSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALR 531
                ++D+A        ++RS             + P   V  +L+ G L        R
Sbjct: 311 L--PITKDAALGGSEW--IFRS-----------CKNIPQP-VRALLE-GFLRYPKED--R 351

Query: 532 PSMAQAI 538
               QA+
Sbjct: 352 LLPLQAM 358

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  109 bits (276), Expect = 9e-27
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 31/224 (13%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           +YE + +          +G G  G+VY      +G  VA+K +                 
Sbjct: 10  RYEPVAE----------IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV 59

Query: 317 -EVNL---ISSIEHKNLVKLL----GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLL 367
            EV L   + + EH N+V+L+        +    + LV+E+V ++ L  ++ DK     L
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGL 117

Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
                 +++     GL +LH      I+HRD+K  NIL+    T K+ADFGLAR ++   
Sbjct: 118 PAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174

Query: 428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
                 V  TL Y APE L++       D++S G +  E+   +
Sbjct: 175 ALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  112 bits (283), Expect = 1e-26
 Identities = 67/218 (30%), Positives = 95/218 (43%), Gaps = 33/218 (15%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSI 324
              +N    LG+G  G V            AVK  + N              EV L+  +
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK--VINKASAKNKDTSTILREVELLKKL 78

Query: 325 EHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IIL 377
           +H N++KL    +E   S  +V E      L    FD+   +     KRF+      II 
Sbjct: 79  DHPNIMKLFE-ILEDSSSFYIVGELYTGGEL----FDEIIKR-----KRFSEHDAARIIK 128

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAV 434
               G+ Y+H   +  I+HRD+K  NILL   +KD   KI DFGL+ CF   +       
Sbjct: 129 QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDR 183

Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRR 472
            GT  Y+APE L RG   EK DV+S G+++  ++ G  
Sbjct: 184 IGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTP 220

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  111 bits (280), Expect = 1e-26
 Identities = 56/224 (25%), Positives = 89/224 (39%), Gaps = 40/224 (17%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ----------WVDEFFNEV 318
            + +  SK LG G  G V +         VA++  I + R+                 E+
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR--IISKRKFAIGSAREADPALNVETEI 191

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK-----TKLLNWNKRF 373
            ++  + H  ++K+     +  +  +V E +    L   +    +      KL      F
Sbjct: 192 EILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----F 245

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHV 430
             +L     + YLH   E  IIHRD+K  N+LL   ++D   KI DFG ++      T +
Sbjct: 246 YQML---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 297

Query: 431 STAVAGTLGYMAPEYLVRGQL---TEKADVYSFG-ILIIEIVCG 470
              + GT  Y+APE LV           D +S G IL I  + G
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI-CLSG 340

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  112 bits (283), Expect = 1e-26
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 40/237 (16%)

Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL-------------IF 305
            +  +   K    +   +KLG G  G V +       +  A+K +               
Sbjct: 25  MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84

Query: 306 NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKT 364
           N  ++ +E +NE++L+ S++H N++KL     E  +   LV E+     L    F++   
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFD-VFEDKKYFYLVTEFYEGGEL----FEQIIN 139

Query: 365 KLLNWNKRFN------IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIA 415
           +      +F+      I+     G+ YLH   +  I+HRDIK  NILL   +     KI 
Sbjct: 140 R-----HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIV 191

Query: 416 DFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRR 472
           DFGL+  F   + +      GT  Y+APE L + +  EK DV+S G+++  ++CG  
Sbjct: 192 DFGLSSFF--SKDYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYP 245

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (273), Expect = 1e-26
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 30/216 (13%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW---VDEFFNEVNLISSIE 325
            + F   +KLG G  G V++     +G    +K    N  +    +++   E+ ++ S++
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK--TINKDRSQVPMEQIEAEIEVLKSLD 78

Query: 326 HKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILG 378
           H N++K+     E   ++ +V E      L     ++  +      K  +      ++  
Sbjct: 79  HPNIIKIFEV-FEDYHNMYIVMETCEGGEL----LERIVSAQAR-GKALSEGYVAELMKQ 132

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVA 435
               LAY H      ++H+D+K  NIL          KI DFGLA  F       ST  A
Sbjct: 133 MMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAA 187

Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFG-ILIIEIVCG 470
           GT  YMAPE   +  +T K D++S G ++   ++ G
Sbjct: 188 GTALYMAPEVF-KRDVTFKCDIWSAGVVMYF-LLTG 221

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  109 bits (274), Expect = 2e-26
 Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 33/208 (15%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSIEHKNLVKLL 333
           + LG G    V++      G   A+K           +    NE+ ++  I+H+N+V L 
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALK--CIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 334 GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIILGTAEGLAYL 386
               E      LV + V    L    FD+   +       +       +I      + YL
Sbjct: 73  D-IYESTTHYYLVMQLVSGGEL----FDRILER-----GVYTEKDASLVIQQVLSAVKYL 122

Query: 387 HGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           H   E  I+HRD+K  N+L    +++    I DFGL++     +  + +   GT GY+AP
Sbjct: 123 H---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPGYVAP 176

Query: 444 EYLVRGQLTEKADVYSFG-ILIIEIVCG 470
           E L +   ++  D +S G I  I ++CG
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYI-LLCG 203

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  109 bits (274), Expect = 2e-26
 Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 29/218 (13%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           KYE + K          +G+G  G V+   +   G  VA+K+ + +     D        
Sbjct: 4   KYEKIGK----------IGEGSYGVVFKCRNRDTGQIVAIKKFLESED---DPVIKKIAL 50

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            E+ ++  ++H NLV LL         L LV+EY  + ++   +    +    +  K   
Sbjct: 51  REIRMLKQLKHPNLVNLLEV-FRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSI- 107

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
               T + + + H   +   IHRD+K  NIL+ K    K+ DFG AR       +    V
Sbjct: 108 -TWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163

Query: 435 AGTLGYMAPEYLVRGQLTEKA-DVYSFGILIIEIVCGR 471
           A T  Y +PE LV         DV++ G +  E++ G 
Sbjct: 164 A-TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  108 bits (273), Expect = 2e-26
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 15/203 (7%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT-RQWVDEFFNEVN-LISSIEHKNLVKLL 333
            ++G G  G V+       G  +AVK++  +  ++       +++ ++ S +   +V+  
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G  I   +  +  E +     ++    K     +       + +   + L YL    +  
Sbjct: 91  GTFITNTDVFIAMELM-GTCAEKLK--KRMQGPIPERILGKMTVAIVKALYYLK--EKHG 145

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
           +IHRD+K SNILLD+    K+ DFG++              AG   YMAPE +     T+
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPDPTK 203

Query: 454 -----KADVYSFGILIIEIVCGR 471
                +ADV+S GI ++E+  G+
Sbjct: 204 PDYDIRADVWSLGISLVELATGQ 226

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  108 bits (272), Expect = 3e-26
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLG 334
           + +G G  G VY G  +  G   A+K ++  T    +E   E+N++     H+N+    G
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88

Query: 335 CSIEGPESL------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
             I+           LV E+    S+   +    K   L       I      GL++LH 
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLH- 146

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
             + ++IHRDIK  N+LL ++   K+ DFG++          +T + GT  +MAPE +  
Sbjct: 147 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIAC 203

Query: 449 GQLTE-----KADVYSFGILIIEIVCG 470
            +  +     K+D++S GI  IE+  G
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEG 230

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  107 bits (270), Expect = 4e-26
 Identities = 70/217 (32%), Positives = 95/217 (43%), Gaps = 35/217 (16%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSI 324
              +N    LG+G  G V            AVK  + N              EV L+  +
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK--VINKASAKNKDTSTILREVELLKKL 78

Query: 325 EHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IIL 377
           +H N++KL    +E   S  +V E      L    FD+   +     KRF+      II 
Sbjct: 79  DHPNIMKLFE-ILEDSSSFYIVGELYTGGEL----FDEIIKR-----KRFSEHDAARIIK 128

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAV 434
               G+ Y+H   +  I+HRD+K  NILL   +KD   KI DFGL+ CF   +       
Sbjct: 129 QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDR 183

Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFG-ILIIEIVCG 470
            GT  Y+APE L RG   EK DV+S G IL I ++ G
Sbjct: 184 IGTAYYIAPEVL-RGTYDEKCDVWSAGVILYI-LLSG 218

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  108 bits (273), Expect = 5e-26
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 25/192 (13%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           +YE L+           LG+G   +VY          VA+K++    R    +  N    
Sbjct: 11  RYEKLDF----------LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
            E+ L+  + H N++ LL          LV++++    L+  I D +     +  K +  
Sbjct: 61  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY-- 117

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAV 434
           +L T +GL YLH   +  I+HRD+K +N+LLD++   K+ADFGLA+ F + +R +    V
Sbjct: 118 MLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 174

Query: 435 AGTLGYMAPEYL 446
             T  Y APE L
Sbjct: 175 --TRWYRAPELL 184

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  106 bits (267), Expect = 6e-26
 Identities = 52/220 (23%), Positives = 86/220 (39%), Gaps = 33/220 (15%)

Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDE--FFNEVNLI 321
           T      Y+     +G+G  G V +          A K          D   F  E+ ++
Sbjct: 3   TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAK--KIPKYFVEDVDRFKQEIEIM 60

Query: 322 SSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------ 374
            S++H N+++L   + E    + LV E      L    F++   K     + F       
Sbjct: 61  KSLDHPNIIRLYE-TFEDNTDIYLVMELCTGGEL----FERVVHK-----RVFRESDAAR 110

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVS 431
           I+      +AY H   +  + HRD+K  N L      D   K+ DFGLA  F      + 
Sbjct: 111 IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMM 165

Query: 432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFG-ILIIEIVCG 470
               GT  Y++P+ L  G    + D +S G ++ + ++CG
Sbjct: 166 RTKVGTPYYVSPQVL-EGLYGPECDEWSAGVMMYV-LLCG 203

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  106 bits (267), Expect = 1e-25
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 29/219 (13%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           KYE LEK          +G+G  G+V+   +      VA+KR+  +     DE       
Sbjct: 3   KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSAL 49

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            E+ L+  ++HKN+V+L    +   + L LV+E+     L ++    N        K F 
Sbjct: 50  REICLLKELKHKNIVRLHDV-LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF- 106

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
            +    +GL + H      ++HRD+K  N+L++++   K+A+FGLAR F       S  V
Sbjct: 107 -LFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162

Query: 435 AGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRR 472
             TL Y  P+ L   +L +   D++S G +  E+    R
Sbjct: 163 V-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  108 bits (270), Expect = 2e-25
 Identities = 44/301 (14%), Positives = 87/301 (28%), Gaps = 61/301 (20%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIF---NTRQWVDEFFNEVNLISS--------- 323
             LGQ    +         G +  V    F        + +   EV  +           
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 324 -------------IEHKNLVKLLGCSIEGPESLLVYEYVP-------NRSLDQFIFDKNK 363
                        ++     K++   ++  +  ++  +          ++  + +   + 
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 364 T-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
           T K L  + R  + L     LA LH      ++H  ++  +I+LD+     +  F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 423 FAADRTHVSTAVAGTLGYMAPEYLVRGQ-----LTEKADVYSFGILIIEIVCGRRSNAFS 477
             A                A   L  GQ     +T   D ++ G+ I  I C       +
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL--PNT 318

Query: 478 QDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQA 537
            D+A              +  +       + P + V  +L+ G L        R    QA
Sbjct: 319 DDAALGGSE--------WIFRSC-----KNIP-QPVRALLE-GFLRYPKED--RLLPLQA 361

Query: 538 I 538
           +
Sbjct: 362 M 362

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  105 bits (265), Expect = 2e-25
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 28/217 (12%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN----- 316
           KY  LEK          +G+G  G VY      G T A+K++        DE        
Sbjct: 3   KYHGLEK----------IGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIR 49

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           E++++  ++H N+VKL    I   + L LV+E++    L + +            K F  
Sbjct: 50  EISILKELKHSNIVKLYDV-IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF-- 105

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           +L    G+AY H   + R++HRD+K  N+L++++   KIADFGLAR F       +  + 
Sbjct: 106 LLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162

Query: 436 GTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
            TL Y AP+ L+  +  +   D++S G +  E+V G 
Sbjct: 163 -TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  104 bits (263), Expect = 3e-25
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 34/217 (15%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSI 324
           ++ ++  ++LG+G    V        G   A K  I NT++       +   E  +   +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK--IINTKKLSARDFQKLEREARICRKL 62

Query: 325 EHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIIL 377
           +H N+V+L   SI+      LV++ V    L    F+    +     + +      + I 
Sbjct: 63  QHPNIVRLHD-SIQEESFHYLVFDLVTGGEL----FEDIVAR-----EFYSEADASHCIQ 112

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAV 434
              E +AY H      I+HR++K  N+LL    K    K+ADFGLA     + +      
Sbjct: 113 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGF 167

Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFG-ILIIEIVCG 470
           AGT GY++PE L +   ++  D+++ G IL I ++ G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYI-LLVG 203

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  105 bits (265), Expect = 3e-25
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 28/217 (12%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN----- 316
           KY+ LEK          +G+G  G VY      G  VA+KR+  +     DE        
Sbjct: 22  KYQKLEK----------VGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIR 68

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           E++L+  + H N+V L+   I     L LV+E++    L + + +       +  K +  
Sbjct: 69  EISLLKELHHPNIVSLIDV-IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY-- 124

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           +     G+A+ H   + RI+HRD+K  N+L++ D   K+ADFGLAR F       +  V 
Sbjct: 125 LYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV 181

Query: 436 GTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
            TL Y AP+ L+  +  +   D++S G +  E++ G+
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  106 bits (266), Expect = 3e-25
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 29/218 (13%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           KYE L            +G+G  G V    +   G  VA+K+ + +     D+       
Sbjct: 26  KYENLGL----------VGEGSYGMVMKCRNKDTGRIVAIKKFLESDD---DKMVKKIAM 72

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            E+ L+  + H+NLV LL    +  +   LV+E+V + ++   +            +++ 
Sbjct: 73  REIKLLKQLRHENLVNLLEV-CKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKY- 129

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
            +     G+ + H      IIHRDIK  NIL+ +    K+ DFG AR  AA        V
Sbjct: 130 -LFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV 185

Query: 435 AGTLGYMAPEYLVRGQLTEKA-DVYSFGILIIEIVCGR 471
           A T  Y APE LV      KA DV++ G L+ E+  G 
Sbjct: 186 A-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  105 bits (265), Expect = 3e-25
 Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 40/227 (17%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQ----------WVDEFF 315
           +   + +  SK LG G  G V +         VA+K  I + R+                
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIK--IISKRKFAIGSAREADPALNVE 63

Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK-----TKLLNWN 370
            E+ ++  + H  ++K+     +  +  +V E +    L   +    +      KL    
Sbjct: 64  TEIEILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY--- 119

Query: 371 KRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADR 427
             F  +L     + YLH   E  IIHRD+K  N+LL   ++D   KI DFG ++      
Sbjct: 120 --FYQML---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GE 169

Query: 428 THVSTAVAGTLGYMAPEYLV---RGQLTEKADVYSFG-ILIIEIVCG 470
           T +   + GT  Y+APE LV           D +S G IL I  + G
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI-CLSG 215

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  105 bits (264), Expect = 5e-25
 Identities = 57/271 (21%), Positives = 89/271 (32%), Gaps = 55/271 (20%)

Query: 252 TSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVK-----RLIF 305
            S  +  L F+  +L +    ++    +GQG  G V +          A+K     ++  
Sbjct: 7   HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66

Query: 306 NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKT 364
              + V+    EV L+  + H N+ +L     E  + + LV E      L   +      
Sbjct: 67  INPKDVERIKTEVRLMKKLHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDD 125

Query: 365 KLLNWNKRFNIILGTA-------------------------------------EGLAYLH 387
                                                                  L YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185

Query: 388 GGSETRIIHRDIKTSNILL--DKDFTPKIADFGLARCFAADRT---HVSTAVAGTLGYMA 442
                 I HRDIK  N L   +K F  K+ DFGL++ F        +  T  AGT  ++A
Sbjct: 186 ---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242

Query: 443 PEYLVRGQL--TEKADVYSFGILIIEIVCGR 471
           PE L         K D +S G+L+  ++ G 
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  103 bits (259), Expect = 2e-24
 Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 36/229 (15%)

Query: 254 MKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD 312
           MK S     Y+            K LG+G            +    AVK  I + R    
Sbjct: 1   MKDSPFYQHYD-------LDLKDKPLGEGSFSICRKCVHKKSNQAFAVK--IISKRM-EA 50

Query: 313 EFFNEVNLISSI-EHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWN 370
               E+  +     H N+VKL            LV E +    L    F++ K K     
Sbjct: 51  NTQKEITALKLCEGHPNIVKLHE-VFHDQLHTFLVMELLNGGEL----FERIKKK----- 100

Query: 371 KRFN------IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLAR 421
           K F+      I+      ++++H   +  ++HRD+K  N+L    + +   KI DFG AR
Sbjct: 101 KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157

Query: 422 CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
               D   + T    TL Y APE L +    E  D++S G+++  ++ G
Sbjct: 158 LKPPDNQPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  103 bits (260), Expect = 2e-24
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 34/227 (14%)

Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQW----VDEF 314
            F      K ++ ++  ++LG+G    V        G   A K  I NT++       + 
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK--IINTKKLSARDFQKL 75

Query: 315 FNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             E  +   ++H N+V+L   SI+      LV++ V    L    F+    +     + +
Sbjct: 76  EREARICRKLQHPNIVRLHD-SIQEESFHYLVFDLVTGGEL----FEDIVAR-----EFY 125

Query: 374 ------NIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFA 424
                 + I    E +AY H      I+HR++K  N+LL    K    K+ADFGLA    
Sbjct: 126 SEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV- 181

Query: 425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFG-ILIIEIVCG 470
            + +      AGT GY++PE L +   ++  D+++ G IL I ++ G
Sbjct: 182 -NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYI-LLVG 226

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  103 bits (259), Expect = 2e-24
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 35/225 (15%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG--SLPNGTTVAVKRLIFNTRQWVDEFFN--- 316
           +YE + +          +G+G  G V+        G  VA+KR+   T    +E      
Sbjct: 12  QYECVAE----------IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---EEGMPLST 58

Query: 317 --EVNL---ISSIEHKNLVKLL----GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKL 366
             EV +   + + EH N+V+L         +    L LV+E+V ++ L  ++ DK     
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPG 116

Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           +      +++     GL +LH     R++HRD+K  NIL+      K+ADFGLAR ++  
Sbjct: 117 VPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173

Query: 427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
               S  V  TL Y APE L++       D++S G +  E+   +
Sbjct: 174 MALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  103 bits (258), Expect = 2e-24
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 20/203 (9%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VA+K  I +  Q     + + F EV ++  + H N+VK
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L L+ EY     +  ++    + K      +F  I+     + Y H   
Sbjct: 79  LFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV---SAVQYCH--- 131

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
           + RI+HRD+K  N+LLD D   KIADFG +  F      +     G   Y APE L +G+
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFC-GAPPYAAPE-LFQGK 188

Query: 451 LTE--KADVYSFGILIIEIVCGR 471
             +  + DV+S G+++  +V G 
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGS 211

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  103 bits (259), Expect = 2e-24
 Identities = 48/220 (21%), Positives = 85/220 (38%), Gaps = 28/220 (12%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVK-----RLIFNTRQWVDEFFNEVNLISS 323
            + +   + +G+G    V        G   AVK     +   +     ++   E ++   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 324 IEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NII 376
           ++H ++V+LL  +      L +V+E++    L   I  +           +      + +
Sbjct: 83  LKHPHIVELLE-TYSSDGMLYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYM 136

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTA 433
               E L Y H   +  IIHRD+K   +LL   +     K+  FG+A             
Sbjct: 137 RQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193

Query: 434 VAGTLGYMAPEYLVRGQLTEKADVYSFG-ILIIEIVCGRR 472
           V GT  +MAPE + R    +  DV+  G IL I ++ G  
Sbjct: 194 V-GTPHFMAPEVVKREPYGKPVDVWGCGVILFI-LLSGCL 231

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  103 bits (258), Expect = 3e-24
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 30/218 (13%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
            Y  L+K          LG+G   +VY G S      VA+K +        +E       
Sbjct: 3   TYIKLDK----------LGEGTYATVYKGKSKLTDNLVALKEIRLEH----EEGAPCTAI 48

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            EV+L+  ++H N+V L    I   +SL LV+EY+ ++ L Q++ D      ++  K F 
Sbjct: 49  REVSLLKDLKHANIVTLHDI-IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF- 105

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
            +     GLAY H     +++HRD+K  N+L+++    K+ADFGLAR  +         V
Sbjct: 106 -LFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV 161

Query: 435 AGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
             TL Y  P+ L+     + + D++  G +  E+  GR
Sbjct: 162 V-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  103 bits (258), Expect = 4e-24
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 30/213 (14%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
           +++F    +LG+G    VY           A+K  +            E+ ++  + H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALK--VLKKTVDKKIVRTEIGVLLRLSHPN 109

Query: 329 LVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIILGTAE 381
           ++KL     E P  + LV E V    L    FD+   K       +      + +    E
Sbjct: 110 IIKLKE-IFETPTEISLVLELVTGGEL----FDRIVEK-----GYYSERDAADAVKQILE 159

Query: 382 GLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            +AYLH   E  I+HRD+K  N+L      D   KIADFGL++    +   +   V GT 
Sbjct: 160 AVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTP 214

Query: 439 GYMAPEYLVRGQLTEKADVYSFG-ILIIEIVCG 470
           GY APE L       + D++S G I  I ++CG
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYI-LLCG 246

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (260), Expect = 7e-24
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 33/217 (15%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSI 324
           T  +   ++LG+G    V     +  G   A    I NT++       +   E  +   +
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAM--IINTKKLSARDHQKLEREARICRLL 67

Query: 325 EHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIIL 377
           +H N+V+L   SI       L+++ V    L    F+    +     + +      + I 
Sbjct: 68  KHPNIVRLHD-SISEEGHHYLIFDLVTGGEL----FEDIVAR-----EYYSEADASHCIQ 117

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAV 434
              E + + H   +  ++HR++K  N+LL    K    K+ADFGLA     ++       
Sbjct: 118 QILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174

Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFG-ILIIEIVCG 470
            GT GY++PE L +    +  D+++ G IL I ++ G
Sbjct: 175 -GTPGYLSPEVLRKDPYGKPVDLWACGVILYI-LLVG 209

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  101 bits (255), Expect = 1e-23
 Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 22/223 (9%)

Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLI 321
            E   K  + F   +  GQG  G+V +G     G +VA+K+ +    ++ +     +  +
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK-VIQDPRFRNRELQIMQDL 73

Query: 322 SSIEHKNLVKLLGC----SIEGPESL---LVYEYVPNRSLDQFI--FDKNKTKLLNWNKR 372
           + + H N+V+L              +   +V EYVP+ +L +    + + +        +
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIK 132

Query: 373 FNI--ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAADRTH 429
             +  ++     +  LH  S   + HRDIK  N+L+++ D T K+ DFG A+  +    +
Sbjct: 133 VFLFQLI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188

Query: 430 VSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           V+     +  Y APE +   Q  T   D++S G +  E++ G 
Sbjct: 189 VAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  101 bits (253), Expect = 1e-23
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 35/223 (15%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           +Y  + K          LG+G  G VY         TVA+KR+        +E       
Sbjct: 35  RYRRITK----------LGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAI 81

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            EV+L+  ++H+N+++L    I     L L++EY     L +++ DKN    +   K F 
Sbjct: 82  REVSLLKELQHRNIIELKSV-IHHNHRLHLIFEYA-ENDLKKYM-DKNPDVSMRVIKSF- 137

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP-----KIADFGLARCFAADRTH 429
            +     G+ + H     R +HRD+K  N+LL           KI DFGLAR F      
Sbjct: 138 -LYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ 193

Query: 430 VSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
            +  +  TL Y  PE L+  +  +   D++S   +  E++   
Sbjct: 194 FTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  102 bits (255), Expect = 2e-23
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 16/210 (7%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD--EFFNEVNLISS 323
               +Y++  ++LG G  G V+       G     K    NT   +D     NE+++++ 
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK--FINTPYPLDKYTVKNEISIMNQ 104

Query: 324 IEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           + H  L+ L   + E    + L+ E++    L   I  ++    ++  +  N +    EG
Sbjct: 105 LHHPKLINLHD-AFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEG 161

Query: 383 LAYLHGGSETRIIHRDIKTSNILL--DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY 440
           L ++H   E  I+H DIK  NI+    K  + KI DFGLA     +   +      T  +
Sbjct: 162 LKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEF 216

Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            APE + R  +    D+++ G+L   ++ G
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  100 bits (251), Expect = 2e-23
 Identities = 61/221 (27%), Positives = 109/221 (49%), Gaps = 31/221 (14%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           +++ LEK          LG G   +VY G +   G  VA+K +  ++    +E       
Sbjct: 6   QFKQLEK----------LGNGTYATVYKGLNKTTGVYVALKEVKLDS----EEGTPSTAI 51

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            E++L+  ++H+N+V+L    I     L LV+E++ N  L +++  +         +   
Sbjct: 52  REISLMKELKHENIVRLYDV-IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNL 109

Query: 375 I---ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
           +        +GLA+ H   E +I+HRD+K  N+L++K    K+ DFGLAR F       S
Sbjct: 110 VKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS 166

Query: 432 TAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           + V  TL Y AP+ L+  +  +   D++S G ++ E++ G+
Sbjct: 167 SEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 99.6 bits (249), Expect = 3e-23
 Identities = 54/228 (23%), Positives = 87/228 (38%), Gaps = 45/228 (19%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWV-----------DEFFNE 317
              + P + LG+G +  V      P     AVK  I +                +    E
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVK--IIDVTGGGSFSAEEVQELREATLKE 73

Query: 318 VNLISSI-EHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF-- 373
           V+++  +  H N+++L   + E      LV++ +    L    FD    K          
Sbjct: 74  VDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGEL----FDYLTEK-----VTLSE 123

Query: 374 ----NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
                I+    E +  LH   +  I+HRD+K  NILLD D   K+ DFG +     D   
Sbjct: 124 KETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGE 178

Query: 430 VSTAVAGTLGYMAPEYLVRGQL------TEKADVYSFG-ILIIEIVCG 470
               V GT  Y+APE +            ++ D++S G I+   ++ G
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT-LLAG 225

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  101 bits (253), Expect = 3e-23
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 27/221 (12%)

Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN-EVNLIS 322
           +T E+    +   K +G G  G V+   L     VA+K+++ + R     F N E+ ++ 
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMR 87

Query: 323 SIEHKNLVKLLGCSIEGPESL------LVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFN 374
            ++H N+V L        +        LV EYVP  ++ +    + K K  +     +  
Sbjct: 88  IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKLY 146

Query: 375 I--ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           +  +L     LAY+H      I HRDIK  N+LLD      K+ DFG A+   A   +VS
Sbjct: 147 MYQLL---RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200

Query: 432 TAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
                +  Y APE +      T   D++S G ++ E++ G+
Sbjct: 201 YIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  101 bits (253), Expect = 3e-23
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 28/213 (13%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY      +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 110

Query: 331 KLLGCSIEGPESL------LVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFNI--ILGTA 380
           +L        E        LV +YVP  ++ +    + + K  L     +  +  +    
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF--- 166

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTLG 439
             LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS     +  
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 221

Query: 440 YMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           Y APE +      T   DV+S G ++ E++ G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 52/233 (22%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK----------------RLIFNTRQWVDEFFNEVN 319
            ++G+G  G V +  +  + T  A+K                     TR           
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 320 LISSIE----------HKNLVKLLGCSIEGPESL---LVYEYVPNRSLDQFIFDK-NKTK 365
            I  +           H N+VKL+   ++ P      +V+E V    +     +      
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKP 133

Query: 366 LLNWNKRF---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
           L     RF   ++I G    + YLH     +IIHRDIK SN+L+ +D   KIADFG++  
Sbjct: 134 LSEDQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 423 FAADRTHVSTAVAGTLGYMAPEYLVRGQLTE----KADVYSFGILIIEIVCGR 471
           F      +S    GT  +MAPE  +            DV++ G+ +   V G+
Sbjct: 187 FKGSDALLSNT-VGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 98.5 bits (246), Expect = 9e-23
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 21/216 (9%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVK----RLIFNTRQWVD--EFFNEVN 319
           +K  ++++  ++LG G    V        G   A K    R    +R+ V   E   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 320 LISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
           ++  + H N++ L     E    + L+ E V    L  F+  K     L+  +  + I  
Sbjct: 68  ILRQVLHHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQ 123

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILL-DKDFTP---KIADFGLARCFAADRTHVSTAV 434
             +G+ YLH     +I H D+K  NI+L DK+      K+ DFGLA     +       +
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNI 178

Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 99.4 bits (248), Expect = 1e-22
 Identities = 56/266 (21%), Positives = 103/266 (38%), Gaps = 40/266 (15%)

Query: 229 AAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVY 288
           A   A A+     + +    LY  SM        +   ++    ++P   +G+G +  V 
Sbjct: 52  ANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVR 111

Query: 289 MGS-LPNGTTVAVKRL--------IFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE 338
                  G   AVK +             +  +    E +++  +  H +++ L+  S E
Sbjct: 112 RCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID-SYE 170

Query: 339 GPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIILGTAEGLAYLHGGSE 391
               + LV++ +    L    FD    K              +I+    E +++LH    
Sbjct: 171 SSSFMFLVFDLMRKGEL----FDYLTEK-----VALSEKETRSIMRSLLEAVSFLH---A 218

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
             I+HRD+K  NILLD +   +++DFG +             + GT GY+APE L     
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMD 276

Query: 452 ------TEKADVYSFG-ILIIEIVCG 470
                  ++ D+++ G IL   ++ G
Sbjct: 277 ETHPGYGKEVDLWACGVILFT-LLAG 301

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 28/225 (12%)

Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--------W 310
           +FK + +E    +++  ++LG G    V        G   A K      RQ         
Sbjct: 4   TFKQQKVED---FYDIGEELGSGQFAIVKKCREKSTGLEYAAK--FIKKRQSRASRRGVC 58

Query: 311 VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNW 369
            +E   EV+++  + H N++ L     E    + L+ E V    L  F+  K     L+ 
Sbjct: 59  REEIEREVSILRQVLHPNIITLHD-VYENRTDVVLILELVSGGELFDFLAQKES---LSE 114

Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL-DKDFTP---KIADFGLARCFAA 425
            +  + I    +G+ YLH     +I H D+K  NI+L DK+      K+ DFGLA     
Sbjct: 115 EEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-- 169

Query: 426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           +       + GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 21/207 (10%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVK----RLIFNTRQWVD--EFFNEVNLIS 322
            +++   ++LG G    V        G   A K    R + ++R+ V   E   EVN++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 323 SIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
            I H N++ L     E    + L+ E V    L  F+ +K     L  ++    +    +
Sbjct: 64  EIRHPNIITLHD-IFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILD 119

Query: 382 GLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           G+ YLH     RI H D+K  NI+L      +   K+ DFG+A    A        + GT
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGT 174

Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILI 464
             ++APE +    L  +AD++S G++ 
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVIT 201

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 96.5 bits (241), Expect = 4e-22
 Identities = 44/201 (21%), Positives = 81/201 (40%), Gaps = 13/201 (6%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
           ++    +  ++ LG+G  G V+      +  T   K  +            E+++++   
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIAR 59

Query: 326 HKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H+N++ L   S E  E L +++E++    + + I        LN  +  + +    E L 
Sbjct: 60  HRNILHLHE-SFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQ 116

Query: 385 YLHGGSETRIIHRDIKTSNILL--DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           +LH      I H DI+  NI+    +  T KI +FG AR            +     Y A
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYA 171

Query: 443 PEYLVRGQLTEKADVYSFGIL 463
           PE      ++   D++S G L
Sbjct: 172 PEVHQHDVVSTATDMWSLGTL 192

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 96.9 bits (242), Expect = 4e-22
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 50/209 (23%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           KYE L K          +GQG  G V+       G  VA+K+++        E F     
Sbjct: 18  KYEKLAK----------IGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITAL 64

Query: 317 -EVNLISSIEHKNLVKLLG-------CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLL 367
            E+ ++  ++H+N+V L+               S+ LV+++           + +   LL
Sbjct: 65  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC----------EHDLAGLL 114

Query: 368 -NWNKRFN------IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            N   +F       ++     GL Y+H     +I+HRD+K +N+L+ +D   K+ADFGLA
Sbjct: 115 SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171

Query: 421 RCFAADRTHVS---TAVAGTLGYMAPEYL 446
           R F+  +       T    TL Y  PE L
Sbjct: 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELL 200

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 21/216 (9%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVK----RLIFNTRQWVD--EFFNEVN 319
           E   +Y++  ++LG G    V        G   A K    R   ++R+ V   +   EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 320 LISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
           ++  I+H N++ L     E    + L+ E V    L  F+ +K     L   +    +  
Sbjct: 67  ILKEIQHPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQ 122

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLARCFAADRTHVSTAV 434
              G+ YLH     +I H D+K  NI+L          KI DFGLA             +
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNI 177

Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            GT  ++APE +    L  +AD++S G++   ++ G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 96.6 bits (241), Expect = 6e-22
 Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 31/214 (14%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVN-LISSIEHK 327
           T+ +   + +G G                 AVK  I +  +   +   E+  L+   +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK--IIDKSK--RDPTEEIEILLRYGQHP 76

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAE 381
           N++ L     +G    +V E +    L     DK   +     K F+      ++    +
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQ-----KFFSEREASAVLFTITK 127

Query: 382 GLAYLHGGSETRIIHRDIKTSNILL-DKDFTP---KIADFGLARCFAADRTHVSTAVAGT 437
            + YLH      ++HRD+K SNIL  D+   P   +I DFG A+   A+   + T    T
Sbjct: 128 TVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YT 183

Query: 438 LGYMAPEYLVRGQLTEKADVYSFG-ILIIEIVCG 470
             ++APE L R       D++S G +L   ++ G
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYT-MLTG 216

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 97.2 bits (242), Expect = 7e-22
 Identities = 44/187 (23%), Positives = 74/187 (39%), Gaps = 25/187 (13%)

Query: 278 KLGQGGAGSVYMG---SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           K+G+G  G VY        +    A+K+              E+ L+  ++H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQ--IEGTGISMSACREIALLRELKHPNVISLQK 85

Query: 335 CSIE-GPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLAYL 386
             +      + L+++Y     L   I     +K      +        ++    +G+ YL
Sbjct: 86  VFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTP----KIADFGLARCFAA---DRTHVSTAVAGTLG 439
           H      ++HRD+K +NIL+  +       KIAD G AR F +       +   V  T  
Sbjct: 145 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200

Query: 440 YMAPEYL 446
           Y APE L
Sbjct: 201 YRAPELL 207

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 95.9 bits (239), Expect = 8e-22
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 23/208 (11%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVK---RLIFNTRQWVDE-----FFNEVNLISSIEHK 327
             LG G  G V+          V VK   +       W+++        E+ ++S +EH 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 328 NLVKLLGCSIEGPESL-LVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           N++K+L    E      LV E +     L  FI    +      +  F  ++     + Y
Sbjct: 90  NIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS---AVGY 145

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEY 445
           L       IIHRDIK  NI++ +DFT K+ DFG A           T   GT+ Y APE 
Sbjct: 146 LRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFC-GTIEYCAPE- 199

Query: 446 LVRGQLTE--KADVYSFGILIIEIVCGR 471
           ++ G      + +++S G+ +  +V   
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 96.3 bits (240), Expect = 1e-21
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 28/220 (12%)

Query: 252 TSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW 310
            + K+  ++  Y          + ++ LG G  G V+       G  +A K  I  TR  
Sbjct: 78  VTAKQGAVNSFYT--------VSKTEILGGGRFGQVHKCEETATGLKLAAK--IIKTRGM 127

Query: 311 VD--EFFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDK--NKTK 365
            D  E  NE+++++ ++H NL++L   + E    + LV EYV    L    FD+  +++ 
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGEL----FDRIIDESY 182

Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL-DKDFTP-KIADFGLARCF 423
            L        +    EG+ ++H   +  I+H D+K  NIL  ++D    KI DFGLAR +
Sbjct: 183 NLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239

Query: 424 AADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGIL 463
                       GT  ++APE +    ++   D++S G++
Sbjct: 240 --KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 98.0 bits (244), Expect = 1e-21
 Identities = 44/208 (21%), Positives = 88/208 (42%), Gaps = 12/208 (5%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
           +   ++++  ++LG G  G V+       G   A K ++       +    E+  +S + 
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212

Query: 326 HKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H  LV L   + E    + ++YE++    L + + D++    ++ ++    +    +GL 
Sbjct: 213 HPTLVNLHD-AFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLC 269

Query: 385 YLHGGSETRIIHRDIKTSNILL--DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMA 442
           ++H   E   +H D+K  NI+    +    K+ DFGL      D         GT  + A
Sbjct: 270 HMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAA 324

Query: 443 PEYLVRGQLTEKADVYSFGILIIEIVCG 470
           PE      +    D++S G+L   ++ G
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 28/208 (13%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---EVNLISSIEHKNLVKL 332
           + LG+G  G V +  +      VAVK  I + ++ VD   N   E+ +   + H+N+VK 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDK--NKTKLLNWNKR--FNIILGTAEGLAYLH 387
            G          L  EY     L    FD+      +   + +  F+ ++    G+ YLH
Sbjct: 71  YGH-RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH 122

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT--HVSTAVAGTLGYMAPEY 445
           G     I HRDIK  N+LLD+    KI+DFGLA  F  +     ++    GTL Y+APE 
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE- 177

Query: 446 LVRGQL--TEKADVYSFGILIIEIVCGR 471
           L++ +    E  DV+S GI++  ++ G 
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 52/224 (23%), Positives = 85/224 (37%), Gaps = 31/224 (13%)

Query: 255 KKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ---- 309
            ++      E       Y   SK+LG+G    V    S   G   A K      R+    
Sbjct: 15  TENLYFQSMENFNN--FYILTSKELGRGKFAVVRQCISKSTGQEYAAK--FLKKRRRGQD 70

Query: 310 WVDEFFNEVNLISSIEH-KNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLL 367
              E  +E+ ++   +    ++ L     E    + L+ EY     +      +    + 
Sbjct: 71  CRAEILHEIAVLELAKSCPRVINLHE-VYENTSEIILILEYAAGGEIFSLCLPELAEMV- 128

Query: 368 NWNKR-----FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGL 419
             ++         IL   EG+ YLH   +  I+H D+K  NILL         KI DFG+
Sbjct: 129 --SENDVIRLIKQIL---EGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180

Query: 420 ARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGIL 463
           +R        +   + GT  Y+APE L    +T   D+++ GI+
Sbjct: 181 SRKIG-HACELREIM-GTPEYLAPEILNYDPITTATDMWNIGII 222

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 23/210 (10%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG+G   +V +   L      A+K L    I    + V     E +++S ++H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 90

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGL 383
             VKL   + +  E L     Y  N  L    + +          RF    I+      L
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTAEIVSA----L 143

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA-VAGTLGYMA 442
            YLHG     IIHRD+K  NILL++D   +I DFG A+  + +          GT  Y++
Sbjct: 144 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200

Query: 443 PEYLVRGQLTEKA-DVYSFGILIIEIVCGR 471
           PE L+  +   K+ D+++ G +I ++V G 
Sbjct: 201 PE-LLTEKSACKSSDLWALGCIIYQLVAGL 229

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 17/202 (8%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
             LG G  G V +G     G  VAVK   R    +   V +   E+  +    H +++KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
               I  P    +V EYV    L  +I    + + +   + F  IL     + Y H    
Sbjct: 77  YQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL---SAVDYCH---R 129

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
             ++HRD+K  N+LLD     KIADFGL+   +     + T+  G+  Y APE ++ G+L
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTS-CGSPNYAAPE-VISGRL 186

Query: 452 TE--KADVYSFGILIIEIVCGR 471
               + D++S G+++  ++CG 
Sbjct: 187 YAGPEVDIWSCGVILYALLCGT 208

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 30/209 (14%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---EVNLISSIEHKNLVKL 332
           + LG+G  G V +  +      VAVK  I + ++ VD   N   E+ +   + H+N+VK 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDK--NKTKLLNWNKRF---NIILGTAEGLAYL 386
            G          L  EY     L    FD+      +   + +     ++     G+ YL
Sbjct: 71  YGH-RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLM----AGVVYL 121

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT--HVSTAVAGTLGYMAPE 444
           HG     I HRDIK  N+LLD+    KI+DFGLA  F  +     ++    GTL Y+APE
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177

Query: 445 YLVRGQL--TEKADVYSFGILIIEIVCGR 471
            L++ +    E  DV+S GI++  ++ G 
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 93.2 bits (232), Expect = 7e-21
 Identities = 55/220 (25%), Positives = 89/220 (40%), Gaps = 47/220 (21%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFN---------EVNLISSIEH 326
             LG GG GSVY G  + +   VA+K +    +  + ++           EV L+  +  
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHV---EKDRISDWGELPNGTRVPMEVVLLKKVSS 105

Query: 327 K--NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN--------- 374
               +++LL    E P+S  L+ E        Q +FD      +                
Sbjct: 106 GFSGVIRLLDW-FERPDSFVLILERPEP---VQDLFDF-----ITERGALQEELARSFFW 156

Query: 375 -IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCFAADRTHVST 432
            ++    E + + H      ++HRDIK  NIL+D +    K+ DFG         T  + 
Sbjct: 157 QVL----EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTD 207

Query: 433 AVAGTLGYMAPEYLVRGQLT-EKADVYSFGILIIEIVCGR 471
              GT  Y  PE++   +     A V+S GIL+ ++VCG 
Sbjct: 208 FD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 95.2 bits (237), Expect = 9e-21
 Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 34/231 (14%)

Query: 259 LSFKYETLEKAT-NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRL---IFNTRQWVDE 313
           L +K+   +    ++F   + LG+GG G V+   +   G   A K+L       R+    
Sbjct: 172 LQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG 231

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVP---------NRSLDQFIFDKNK 363
              E  +++ +  + +V L   + E    L LV   +          N   D   F + +
Sbjct: 232 AMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290

Query: 364 TKLLNWNKRF---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
                    F    I+ G    L +LH   +  II+RD+K  N+LLD D   +I+D GLA
Sbjct: 291 A-------IFYTAQIVSG----LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

Query: 421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
               A +T       GT G+MAPE L+  +     D ++ G+ + E++  R
Sbjct: 337 VELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 53/217 (24%), Positives = 83/217 (38%), Gaps = 39/217 (17%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK----RLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
             LG+G  G V            AVK    + +            E+ L+  + HKN+++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN----------IILGT 379
           L+     E  + + +V EY      +  + D          KRF           +I   
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVP------EKRFPVCQAHGYFCQLI--- 119

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT--HVSTAVAGT 437
            +GL YLH      I+H+DIK  N+LL    T KI+  G+A             T+  G+
Sbjct: 120 -DGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGS 174

Query: 438 LGYMAPEYLVRGQLT---EKADVYSFGILIIEIVCGR 471
             +  PE +  G  T    K D++S G+ +  I  G 
Sbjct: 175 PAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 92.8 bits (231), Expect = 2e-20
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 24/213 (11%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEH 326
              +   K +G G  G V           VA+K+L   F  +      + E+ L+  + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 327 KNLVKLL-----GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILG 378
           KN++ LL       S+E  + + +V E +   +L Q I    + +L +    + +  +L 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSYLLYQML- 137

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
              G+ +LH      IIHRD+K SNI++  D T KI DFGLAR   A  + + T    T 
Sbjct: 138 --CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 190

Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
            Y APE ++     E  D++S G ++ E++ G 
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 91.7 bits (228), Expect = 4e-20
 Identities = 53/252 (21%), Positives = 103/252 (40%), Gaps = 60/252 (23%)

Query: 266 LEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFN-EVNLISS 323
           LE ++  ++  K LG G  G V     + +G   A+K+++ + R     + N E++++  
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKV 56

Query: 324 IEHKNLVKLLGC-------------------------------SIEGPESL-------LV 345
           ++H N++KL+                                       +        ++
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 346 YEYVPNRSLDQFI--FDKNKTKLLNWNKRFNI--ILGTAEGLAYLHGGSETRIIHRDIKT 401
            EYVP+ +L + +  F ++   +        I  +      + ++H      I HRDIK 
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF---RAVGFIHSL---GICHRDIKP 169

Query: 402 SNILLD-KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL-TEKADVYS 459
            N+L++ KD T K+ DFG A+        V+     +  Y APE ++     T   D++S
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWS 227

Query: 460 FGILIIEIVCGR 471
            G +  E++ G+
Sbjct: 228 IGCVFGELILGK 239

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 57/217 (26%), Positives = 86/217 (39%), Gaps = 35/217 (16%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   + +G+G  G V +          A+K +         + V   F E+ ++  +EH 
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLEHP 75

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIILGTAE 381
            LV L   S +  E + +V + +    L         F +   KL              E
Sbjct: 76  FLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF-----------ICE 123

Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
               L YL      RIIHRD+K  NILLD+     I DF +A     +    +  +AGT 
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTK 178

Query: 439 GYMAPEYLVRGQL---TEKADVYSFGILIIEIVCGRR 472
            YMAPE     +    +   D +S G+   E++ GRR
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 91.2 bits (227), Expect = 4e-20
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 31/216 (14%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEH 326
              +     +G G  GSV       +G  VA+K+L   F +  +    + E+ L+  ++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 327 KNLVKLLGCSIEGPESL--------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--I 376
           +N++ LL   +  P S         LV  ++    L + +      K      ++ +  +
Sbjct: 83  ENVIGLL--DVFTPASSLRNFYDFYLVMPFMQT-DLQKIM----GLKFSEEKIQYLVYQM 135

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           L   +GL Y+H      ++HRD+K  N+ +++D   KI DFGLAR   A+ T     V  
Sbjct: 136 L---KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY---VV- 185

Query: 437 TLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           T  Y APE ++      +  D++S G ++ E++ G+
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 55/245 (22%), Positives = 89/245 (36%), Gaps = 49/245 (20%)

Query: 251 ATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ 309
           +T          Y+  E           LG+G    V    +L      AVK  I   + 
Sbjct: 2   STDSFSGRFEDVYQLQEDV---------LGEGAHARVQTCINLITSQEYAVK--IIEKQP 50

Query: 310 WVDE--FFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL 366
                  F EV ++   + H+N+++L+    E     LV+E +   S+          + 
Sbjct: 51  GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKR- 105

Query: 367 LNWNKRFN------IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADF 417
               + FN      ++   A  L +LH      I HRD+K  NIL    ++    KI DF
Sbjct: 106 ----RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDF 158

Query: 418 GLARCFAADRTHVSTA------VAGTLGYMAPEYLVRGQLT-----EKADVYSFG-ILII 465
            L      +      +        G+  YMAPE +           ++ D++S G IL I
Sbjct: 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYI 218

Query: 466 EIVCG 470
            ++ G
Sbjct: 219 -LLSG 222

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 90.5 bits (225), Expect = 6e-20
 Identities = 49/211 (23%), Positives = 83/211 (39%), Gaps = 35/211 (16%)

Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVN-LISSIEHKNLVKLL 333
            + LG G  G V        G   A+K  +        +   EV+    +    ++V +L
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALK--LLYDSP---KARQEVDHHWQASGGPHIVCIL 88

Query: 334 GC---SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGL 383
                   G   L ++ E +    L   I ++        ++ F       I+      +
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRIQERG-------DQAFTEREAAEIMRDIGTAI 141

Query: 384 AYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGY 440
            +LH      I HRD+K  N+L    +KD   K+ DFG A+     +  + T    T  Y
Sbjct: 142 QFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPYY 195

Query: 441 MAPEYLVRGQLTEKADVYSFG-ILIIEIVCG 470
           +APE L   +  +  D++S G I+ I ++CG
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYI-LLCG 225

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 26/206 (12%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           + LG+G  G V + +       VA+K   R +            E++ +  + H +++KL
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDK--NKTKLLNWNKR--FNIILGTAEGLAYLH 387
               I  P  + +V EY         +FD    K ++     R  F  I+     + Y H
Sbjct: 75  YDV-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQII---CAIEYCH 125

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV 447
                +I+HRD+K  N+LLD +   KIADFGL+         + T+  G+  Y APE ++
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTS-CGSPNYAAPE-VI 179

Query: 448 RGQLTE--KADVYSFGILIIEIVCGR 471
            G+L    + DV+S GI++  ++ GR
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGR 205

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 91.8 bits (228), Expect = 1e-19
 Identities = 64/229 (27%), Positives = 98/229 (42%), Gaps = 33/229 (14%)

Query: 259 LSFKYETLEKAT-NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRL---IFNTRQWVDE 313
           L +K+   +  T N F   + LG+GG G V    +   G   A K+L       R+    
Sbjct: 171 LQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSL-------DQFIFDKNKTK 365
             NE  ++  +  + +V L   + E  ++L LV   +    L        Q  F + +  
Sbjct: 231 ALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA- 288

Query: 366 LLNWNKRFNIILGTAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
                  F      AE   GL  LH     RI++RD+K  NILLD     +I+D GLA  
Sbjct: 289 ------VFY----AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVH 335

Query: 423 FAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
               +T       GT+GYMAPE +   + T   D ++ G L+ E++ G+
Sbjct: 336 VPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 33/223 (14%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRL--IFNTRQWVDEFFN---------EV 318
            + +   + +  G  G+V  G    G  VA+KR+    +  + V+   +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 319 NLISSIEHKNLVKLLGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
            L++   H N++ L    I             LV E +    L Q I    +  +   + 
Sbjct: 81  RLLNHFHHPNILGLR--DIFVHFEEPAMHKLYLVTELMRT-DLAQVI-HDQRIVISPQHI 136

Query: 372 RFNI--ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           ++ +  IL    GL  LH      ++HRD+   NILL  +    I DF LAR   AD   
Sbjct: 137 QYFMYHIL---LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD--A 188

Query: 430 VSTAVAGTLGYMAPEYLV-RGQLTEKADVYSFGILIIEIVCGR 471
             T       Y APE ++     T+  D++S G ++ E+   +
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 91.0 bits (226), Expect = 1e-19
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 17/202 (8%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
             LG G  G V +G     G  VAVK   R    +   V +   E+  +    H +++KL
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
               I  P  + +V EYV    L  +I    +       + F  IL    G+ Y H    
Sbjct: 82  YQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL---SGVDYCHR--- 134

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
             ++HRD+K  N+LLD     KIADFGL+   +     + T+  G+  Y APE ++ G+L
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNYAAPE-VISGRL 191

Query: 452 TE--KADVYSFGILIIEIVCGR 471
               + D++S G+++  ++CG 
Sbjct: 192 YAGPEVDIWSSGVILYALLCGT 213

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 91.9 bits (228), Expect = 2e-19
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)

Query: 271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVN---LISS 323
           N F+  + +G+GG G VY       G   A+K L       +Q      NE     L+S+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 324 IEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGT 379
            +   +V +   +   P+ L  + + +    L               + RF    IILG 
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRFYAAEIILG- 304

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
              L ++H      +++RD+K +NILLD+    +I+D GLA  F+  + H   A  GT G
Sbjct: 305 ---LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHG 355

Query: 440 YMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           YMAPE L +G      AD +S G ++ +++ G 
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 90.3 bits (224), Expect = 2e-19
 Identities = 66/236 (27%), Positives = 111/236 (47%), Gaps = 30/236 (12%)

Query: 253 SMKKSCLSFKYETLEKATNYFNPSKK------LGQGGAGSVYMGS-LPNGTTVAVKRL-- 303
           +M KS +  ++ ++E   + F   K+      +G G  G V           VA+K+L  
Sbjct: 38  NMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR 97

Query: 304 IFNTRQWVDEFFNEVNLISSIEHKNLVKLL-----GCSIEGPESL-LVYEYVPNRSLDQF 357
            F  +      + E+ L+  + HKN++ LL       ++E  + + LV E +   +L Q 
Sbjct: 98  PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQV 156

Query: 358 IFDKNKTKLLNWNKRFNI--ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA 415
           I    + +L +    + +  +L    G+ +LH      IIHRD+K SNI++  D T KI 
Sbjct: 157 I----QMELDHERMSYLLYQML---CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 206

Query: 416 DFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           DFGLAR   A  + + T    T  Y APE ++     E  D++S G ++ E+V  +
Sbjct: 207 DFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 39/212 (18%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLLG 334
           K +G G  G   +         VAVK         +DE    E+    S+ H N+V+   
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVK--YIERGAAIDENVQREIINHRSLRHPNIVRFKE 83

Query: 335 CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN----------IILGTAEGL 383
             I  P  L ++ EY     L    +++     +    RF+          ++ G    +
Sbjct: 84  V-ILTPTHLAIIMEYASGGEL----YER-----ICNAGRFSEDEARFFFQQLLSG----V 129

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTP--KIADFGLARCFAADRTHVSTAVAGTLGYM 441
           +Y H     +I HRD+K  N LLD    P  KI DFG ++      +   + V GT  Y+
Sbjct: 130 SYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYI 184

Query: 442 APEYLVRGQLTE--KADVYSFGILIIEIVCGR 471
           APE ++  Q  +   ADV+S G+ +  ++ G 
Sbjct: 185 APE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 89.0 bits (221), Expect = 4e-19
 Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 34/216 (15%)

Query: 271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVN-LISSIEHKN 328
           +Y   S+ LG G  G V    +       A+K  +        +   EV     + +  +
Sbjct: 62  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCP---KARREVELHWRASQCPH 116

Query: 329 LVKLLGC---SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIILG 378
           +V+++        G + L +V E +    L    F + + +    ++ F       I+  
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDR---GDQAFTEREASEIMKS 169

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVA 435
             E + YLH      I HRD+K  N+L      +   K+ DFG A+   +  + ++T   
Sbjct: 170 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC- 224

Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFG-ILIIEIVCG 470
            T  Y+APE L   +  +  D++S G I+ I ++CG
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI-LLCG 259

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 87.4 bits (217), Expect = 4e-19
 Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 35/215 (16%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLI-------------S 322
             LG+GG G+V+ G  L +   VA+K +    R  V  +    + +             +
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVI---PRNRVLGWSPLSDSVTCPLEVALLWKVGA 93

Query: 323 SIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLL-NWNKRF--NIILG 378
              H  +++LL    E  E   LV E  P  + D F +   K  L    ++ F   ++  
Sbjct: 94  GGGHPGVIRLLDW-FETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFFGQVV-- 149

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCFAADRTHVSTAVAGT 437
               + + H      ++HRDIK  NIL+D      K+ DFG            +    GT
Sbjct: 150 --AAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD-GT 201

Query: 438 LGYMAPEYLVRGQLT-EKADVYSFGILIIEIVCGR 471
             Y  PE++ R Q     A V+S GIL+ ++VCG 
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 87.0 bits (216), Expect = 9e-19
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 24/208 (11%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F+  K LG G  G V +     +G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGL 383
            LVKL   S +   +L +V EYV    +  F   +   +    + RF    I+L      
Sbjct: 102 FLVKLE-FSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----F 154

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
            YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT     + GT   +AP
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTW---TLCGTPEALAP 207

Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGR 471
           E ++     +  D ++ G+LI E+  G 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY 235

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 53/225 (23%), Positives = 102/225 (45%), Gaps = 31/225 (13%)

Query: 261 FKYETL----EKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFF 315
           + YE+         +Y    +KLG+G    V+    + N   V VK L         +  
Sbjct: 23  WDYESHVVEWGNQDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIK 78

Query: 316 NEVNLISSI-EHKNLVKLLGCSIEGPES---LLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
            E+ ++ ++    N++ L    ++ P S    LV+E+V N    Q         L +++ 
Sbjct: 79  REIKILENLRGGPNIITLADI-VKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDI 132

Query: 372 RFNI--ILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRT 428
           RF +  IL   + L Y H      I+HRD+K  N+++D +    ++ D+GLA  +   + 
Sbjct: 133 RFYMYEIL---KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186

Query: 429 HVSTAVAGTLGYMAPEYLVRGQLTEKA-DVYSFGILIIEIVCGRR 472
           + +  VA +  +  PE LV  Q+ + + D++S G ++  ++  + 
Sbjct: 187 Y-NVRVA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 50/249 (20%), Positives = 99/249 (39%), Gaps = 45/249 (18%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEH 326
            + +     +G+G  G VY+         VA+K++  +F           E+ +++ ++ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84

Query: 327 KNLVKLLGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--IL 377
             +++L    +  P+ L       +V E      L +    K    L   + +  +  +L
Sbjct: 85  DYIIRLY--DLIIPDDLLKFDELYIVLEIAD-SDLKKLF--KTPIFLTEEHIKTILYNLL 139

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
               G  ++H      IIHRD+K +N LL++D + K+ DFGLAR   +++          
Sbjct: 140 ---LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 438 LG---------------------YMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNA 475
                                  Y APE ++  +  T+  D++S G +  E++   +S+ 
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253

Query: 476 FSQDSASPL 484
               +  PL
Sbjct: 254 NDPTNRFPL 262

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 33/224 (14%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
            + +   K LG GG G V+          VA+K+++    Q V     E+ +I  ++H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 329 LVKLL----------GCSIEGPESL----LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
           +VK+              +     L    +V EY+    L   +    +  LL  + R  
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLLEEHARLF 125

Query: 375 I--ILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTHVS 431
           +  +L    GL Y+H  +   ++HRD+K +N+ ++ +D   KI DFGLAR      +H  
Sbjct: 126 MYQLL---RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 432 TA---VAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
                +  T  Y +P  L+     T+  D+++ G +  E++ G+
Sbjct: 180 HLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.7 bits (208), Expect = 8e-18
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 24/208 (11%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   + LG G  G V++  S  NG   A+K L    +   +Q V+   +E  ++S + H 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHP 66

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGL 383
            ++++   + +  + + ++ +Y+    L  F   +   +  N   +F    + L     L
Sbjct: 67  FIIRMW-GTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAEVCLA----L 119

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
            YLH      II+RD+K  NILLDK+   KI DFG A+ +  D T+  T + GT  Y+AP
Sbjct: 120 EYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK-YVPDVTY--T-LCGTPDYIAP 172

Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGR 471
           E +      +  D +SFGILI E++ G 
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGY 200

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)

Query: 273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNL 329
           +   + +G G  G+V        G  VA+K+L   F +  +    + E+ L+  + H+N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 330 VKLL-----GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILGTAE 381
           + LL       +++      LV  ++    L + +      KL     +F +  +L   +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM---KHEKLGEDRIQFLVYQML---K 139

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
           GL Y+H      IIHRD+K  N+ +++D   KI DFGLAR   ++ T     V  T  Y 
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG---YVV-TRWYR 192

Query: 442 APEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           APE ++     T+  D++S G ++ E++ G+
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 26/216 (12%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHK 327
              +     +G+G  G V       N   VA+K++  F  + +      E+ ++    H+
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85

Query: 328 NLVKLLGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILG 378
           N++ +    I    ++       +V + +    L + +       L N +  + +  IL 
Sbjct: 86  NIIGIN--DIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQIL- 138

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAG 436
              GL Y+H  +   ++HRD+K SN+LL+     KI DFGLAR    D  H    T    
Sbjct: 139 --RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 437 TLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
           T  Y APE ++  +  T+  D++S G ++ E++  R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 84.9 bits (210), Expect = 1e-17
 Identities = 42/199 (21%), Positives = 77/199 (38%), Gaps = 29/199 (14%)

Query: 273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNL 329
           +     +G G  G V           VA+K++  +F           E+ +++ + H ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114

Query: 330 VKLLGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILGTA 380
           VK+L   I  P+ +       +V E        +    +    L   + +  +  +L   
Sbjct: 115 VKVL--DIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKTLLYNLL--- 166

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG---- 436
            G+ Y+H      I+HRD+K +N L+++D + K+ DFGLAR         S         
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 437 --TLGYMAPEYLVRGQLTE 453
              L        ++ QLT 
Sbjct: 224 DMNLVTFPHTKNLKRQLTG 242

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 24/213 (11%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K +G+G  G V +          A+K L    +    +    F  E +++ + + K
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE-TACFREERDVLVNGDSK 134

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GL 383
            +  L   + +   +L LV +Y     L   +  K + +L     RF +    AE    +
Sbjct: 135 WITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYL----AEMVIAI 188

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
             +H   +   +HRDIK  NIL+D +   ++ADFG       D T  S+   GT  Y++P
Sbjct: 189 DSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245

Query: 444 EYLVRGQLTEK-----ADVYSFGILIIEIVCGR 471
           E L   +  +       D +S G+ + E++ G 
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 84.4 bits (209), Expect = 2e-17
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 28/212 (13%)

Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKN 328
           F   K LG+G  G V +      G   A+K L   +   +  V     E  ++ +  H  
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209

Query: 329 LVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIILGTAE- 381
           L  L   S +  + L  V EY     L      + +F +++ +              AE 
Sbjct: 210 LTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY-----------GAEI 257

Query: 382 --GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
              L YLH  SE  +++RD+K  N++LDKD   KI DFGL +    D   + T   GT  
Sbjct: 258 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPE 314

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           Y+APE L         D +  G+++ E++CGR
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 31/286 (10%), Positives = 70/286 (24%), Gaps = 56/286 (19%)

Query: 278 KLGQGGAGSVYMG---SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
             G       +     +L     VA+  +          + E  +    +S I+   + +
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           +L         L+V E++   SL +           +       +   A      H    
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---R 147

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
             +       S + +  D    +A                         M          
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA------- 179

Query: 452 TEKADVYSFGILIIEIVCGRRSNAFSQDSA-SPLQRVWTLYRSNKLVEAVDP-NLKDDFP 509
             + D+   G  +  ++  R      +    S L             + ++P ++  D P
Sbjct: 180 NPQDDIRGIGASLYALLVNRW--PLPEAGVRSGLAPAERDTAG----QPIEPADIDRDIP 233

Query: 510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPP 555
            +    +  +     Q    +R +     ++         T    P
Sbjct: 234 FQ----ISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGP 275

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 83.2 bits (206), Expect = 3e-17
 Identities = 52/215 (24%), Positives = 86/215 (40%), Gaps = 26/215 (12%)

Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K +G+G    V +  +   G   A+K +    +    + V  F  E +++ + + +
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE-VSCFREERDVLVNGDRR 121

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GL 383
            + +L   + +    L LV EY     L   +  K   ++     RF +    AE    +
Sbjct: 122 WITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYL----AEIVMAI 175

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
             +H       +HRDIK  NILLD+    ++ADFG      AD T  S    GT  Y++P
Sbjct: 176 DSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232

Query: 444 EYLVRGQLTEKADVY-------SFGILIIEIVCGR 471
           E L           Y       + G+   E+  G+
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 81.9 bits (203), Expect = 5e-17
 Identities = 54/229 (23%), Positives = 100/229 (43%), Gaps = 33/229 (14%)

Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL-IFNTRQWVDEFFNEVNLI 321
             +   ++ F     LG+G  G V   +  P G  VA+K++  F+   +      E+ ++
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL 63

Query: 322 SSIEHKNLVKLLGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
              +H+N++ +   +I+ P+S        ++ E +    L + I   +   L + + ++ 
Sbjct: 64  KHFKHENIITIF--NIQRPDSFENFNEVYIIQELMQ-TDLHRVI---STQMLSDDHIQYF 117

Query: 375 I--ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
           I   L     +  LHG +   +IHRD+K SN+L++ +   K+ DFGLAR         S 
Sbjct: 118 IYQTL---RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

Query: 433 AVAGTLG---------YMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
                 G         Y APE ++     +   DV+S G ++ E+   R
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 81.7 bits (202), Expect = 9e-17
 Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 35/217 (16%)

Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           +   K +G+G  G V +          A+K L    +         F+ E ++++     
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD-SAFFWEERDIMAFANSP 129

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPN----RSLDQFIFDKNKTKLLNWNKRFNIILGTAE- 381
            +V+L   + +    L +V EY+P       +  +   +          RF      AE 
Sbjct: 130 WVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-------RFYT----AEV 177

Query: 382 --GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA-RCFAADRTHVSTAVAGTL 438
              L  +H       IHRD+K  N+LLDK    K+ADFG   +          TAV GT 
Sbjct: 178 VLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTP 233

Query: 439 GYMAPEYL----VRGQLTEKADVYSFGILIIEIVCGR 471
            Y++PE L      G    + D +S G+ + E++ G 
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 36/90 (40%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT-L 438
           A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    A   L
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259

Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEIV 468
            +MAPE +     T ++DV+SFG+L+ EI 
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 33/156 (21%), Positives = 56/156 (35%), Gaps = 19/156 (12%)

Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V               TVAVK L    T        +E+ ++  I  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           +V LLG C+  G   +++ E+    +L  ++           +KR   +    +G  +  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
           G      I  D+K     +    +   + F   +  
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 28/215 (13%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEH 326
              +     +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 327 KNLVKLLGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--IL 377
           +N++ LL        SL       LV   +    L+  +      KL + + +F I  IL
Sbjct: 88  ENVIGLLDV-FTPARSLEEFNDVYLVTHLMGA-DLNNIV---KCQKLTDDHVQFLIYQIL 142

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
               GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR  A + T     VA T
Sbjct: 143 ---RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG---YVA-T 192

Query: 438 LGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGR 471
             Y APE ++      +  D++S G ++ E++ GR
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 51/192 (26%), Positives = 90/192 (46%), Gaps = 24/192 (12%)

Query: 273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSI-EHKN 328
           +   KKLG+G  G V+       G  VAVK++   F         F E+ +++ +  H+N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70

Query: 329 LVKLLGCSIEGPESL----LVYEYVPNRSLDQFIFDKNKTKLL-NWNKRFNI--ILGTAE 381
           +V LL  ++   ++     LV++Y+    L   I    +  +L   +K++ +  ++   +
Sbjct: 71  IVNLL--NVLRADNDRDVYLVFDYMET-DLHAVI----RANILEPVHKQYVVYQLI---K 120

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            + YLH G    ++HRD+K SNILL+ +   K+ADFGL+R F   R   +          
Sbjct: 121 VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 442 APEYLVRGQLTE 453
                 +  LT+
Sbjct: 178 ENFDDDQPILTD 189

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 76.4 bits (189), Expect = 2e-15
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 35/217 (16%)

Query: 273 FNPSKKLGQGGAGSVYM----GSLPNGTTVAVK-----RLIFNTRQWVDEFFNEVNLISS 323
           F   + LG+GG G V+          G   A+K      ++ N +        E N++  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD-TAHTKAERNILEE 77

Query: 324 IEHKNLVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIIL 377
           ++H  +V L+  + +    L L+ EY+    L      + IF ++          F +  
Sbjct: 78  VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-------CFYL-- 127

Query: 378 GTAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
             AE    L +LH   +  II+RD+K  NI+L+     K+ DFGL +    D T   T  
Sbjct: 128 --AEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-F 181

Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
            GT+ YMAPE L+R       D +S G L+ +++ G 
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 29/212 (13%)

Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKN 328
           F+  K LG+G  G V +      G   A+K L   +   +  V     E  ++ +  H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 329 LVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIILGTAE- 381
           L  L   + +  + L  V EY     L      + +F + + +              AE 
Sbjct: 67  LTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----------GAEI 114

Query: 382 --GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
              L YLH      +++RDIK  N++LDKD   KI DFGL +   +D   + T   GT  
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPE 170

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           Y+APE L         D +  G+++ E++CGR
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 35/219 (15%)

Query: 273 FNPSKKLGQGGAGSVYM----GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSI 324
           F   K LG G  G V++         G   A+K L    I    +  +    E  ++  I
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115

Query: 325 EHKN-LVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIIL 377
                LV L   + +    L L+ +Y+    L      +  F +++        +  +  
Sbjct: 116 RQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-------QIYV-- 165

Query: 378 GTAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
              E    L +LH   +  II+RDIK  NILLD +    + DFGL++ F AD T  +   
Sbjct: 166 --GEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 220

Query: 435 AGTLGYMAPEYLVRGQL--TEKADVYSFGILIIEIVCGR 471
            GT+ YMAP+ +  G     +  D +S G+L+ E++ G 
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 74.5 bits (184), Expect = 1e-14
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 37/217 (17%)

Query: 273 FNPSKKLGQGGAGSVYM----GSLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIE 325
           F   K LGQG  G V++             A+K L       R  V     E +++  + 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMERDILVEVN 84

Query: 326 HKNLVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIILGT 379
           H  +VKL   + +    L L+ +++    L      + +F +          +F +    
Sbjct: 85  HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-------KFYL---- 132

Query: 380 AE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR--CFAADRTHVSTAV 434
           AE    L +LH      II+RD+K  NILLD++   K+ DFGL++       + +   + 
Sbjct: 133 AELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SF 186

Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
            GT+ YMAPE + R   T+ AD +SFG+L+ E++ G 
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 75.4 bits (185), Expect = 2e-14
 Identities = 57/213 (26%), Positives = 84/213 (39%), Gaps = 30/213 (14%)

Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRL---IFNTRQWVDEFFNEVN-LISSIEHK 327
           FN    LG+G  G V +          AVK L   +      V+    E   L    +  
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIILGTAE 381
            L +L  C  +  + L  V EYV    L         F +                  AE
Sbjct: 403 FLTQLHSCF-QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY-----------AAE 450

Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
              GL +L       II+RD+K  N++LD +   KIADFG+ +    D     T   GT 
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTP 506

Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
            Y+APE +      +  D ++FG+L+ E++ G+
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 57/214 (26%), Positives = 88/214 (41%), Gaps = 32/214 (14%)

Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRL----IFNTRQWVDEFFNEVN-LISSIEH 326
           F+  K +G+G  G V +          AVK L    I   ++      +E N L+ +++H
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKH 98

Query: 327 KNLVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRF---NIIL 377
             LV L   S +  + L  V +Y+    L      +  F + +        RF    I  
Sbjct: 99  PFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RFYAAEIAS 150

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
                L YLH      I++RD+K  NILLD      + DFGL +      +  ST   GT
Sbjct: 151 A----LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGT 202

Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
             Y+APE L +       D +  G ++ E++ G 
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 72.6 bits (179), Expect = 6e-14
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 7/96 (7%)

Query: 379 TAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           +AE    L YLH   E  II+RD+K  N+LLD +   K+ D+G+ +         ST   
Sbjct: 116 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FC 171

Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           GT  Y+APE L         D ++ G+L+ E++ GR
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 11/98 (11%)

Query: 379 TAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR--CFAADRTHVSTA 433
            AE   GL +L       II+RD+K  N++LD +   KIADFG+ +   +    T     
Sbjct: 127 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK---T 180

Query: 434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
             GT  Y+APE +      +  D ++FG+L+ E++ G+
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 72.8 bits (179), Expect = 7e-14
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 7/96 (7%)

Query: 379 TAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           +AE    L YLH   E  II+RD+K  N+LLD +   K+ D+G+ +         ST   
Sbjct: 159 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FC 214

Query: 436 GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           GT  Y+APE L         D ++ G+L+ E++ GR
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 72.3 bits (178), Expect = 7e-14
 Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 11/98 (11%)

Query: 379 TAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA--RCFAADRTHVSTA 433
            AE    L +LH   +  II+RD+K  N+LLD +   K+ADFG+          T     
Sbjct: 130 AAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA---T 183

Query: 434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
             GT  Y+APE L         D ++ G+L+ E++CG 
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 71.9 bits (177), Expect = 9e-14
 Identities = 39/98 (39%), Positives = 56/98 (57%), Gaps = 11/98 (11%)

Query: 379 TAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR--CFAADRTHVSTA 433
            AE   GL +LH      I++RD+K  NILLDKD   KIADFG+ +       +T  +T 
Sbjct: 124 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NT- 177

Query: 434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
             GT  Y+APE L+  +     D +SFG+L+ E++ G+
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 72.0 bits (177), Expect = 9e-14
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 35/219 (15%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI----------- 324
           +KLG G   +V++   + N T VA+K ++   + + +   +E+ L+  +           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 325 EHKNLVKLLGC-SIEGPESL---LVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNI-ILG 378
              +++KLL   + +GP  +   +V+E V   +L   I       + L + K+ +  +L 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLL- 141

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLD------KDFTPKIADFGLARCFAADRTHVST 432
              GL Y+H      IIH DIK  N+L++           KIAD G A C+  +  H + 
Sbjct: 142 --LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDE--HYTN 194

Query: 433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           ++  T  Y +PE L+       AD++S   LI E++ G 
Sbjct: 195 SIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 71.1 bits (173), Expect = 2e-13
 Identities = 48/301 (15%), Positives = 95/301 (31%), Gaps = 69/301 (22%)

Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--------RQWVDEFFNEVNL 320
            T      +K+G+G  G V+     + T VA+K +            ++  +E   E+ +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 321 ISSIE---------HKNLVKLLGCSI---EGPESLL-VYEY----------VPNRSLDQF 357
              +           +  + L          P  LL  +++           P+   D  
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 358 IF------------DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL 405
           +F            ++ +TKL +     +I+      LA     +  R  HRD+   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVL 194

Query: 406 LDKDFTPKIADFGLAR--------------CFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
           L K    K+      +               +   R      V      M  + L  G  
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED-LFTGDG 253

Query: 452 TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE 511
             + D+Y            + +N    +       +W  Y ++K+++ +    K + PA 
Sbjct: 254 DYQFDIYRL--------MKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAM 305

Query: 512 Q 512
           +
Sbjct: 306 K 306

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 69.6 bits (170), Expect = 8e-13
 Identities = 57/260 (21%), Positives = 89/260 (34%), Gaps = 75/260 (28%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEF-FNEVNLISSIE--------H 326
           +KLG G   +V++   +     VA+K  +  + +   E   +E+ L+ S+          
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMK--VVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100

Query: 327 KNLVKLLGC-SIEGPESL---LVYEYVPNR-SLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           + +V+LL    I G       +V+E       L ++I  K+  + L       II    +
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWI-IKSNYQGLPLPCVKKIIQQVLQ 157

Query: 382 GLAYLHGGSETRIIHRDIKTSNILL----------------------------------- 406
           GL YLH  ++ RIIH DIK  NILL                                   
Sbjct: 158 GLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 407 --------------DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
                          +    KIAD G A       T        T  Y + E L+     
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYN 271

Query: 453 EKADVYSFGILIIEIVCGRR 472
             AD++S   +  E+  G  
Sbjct: 272 TPADIWSTACMAFELATGDY 291

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 39/182 (21%), Positives = 67/182 (36%), Gaps = 39/182 (21%)

Query: 254 MKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVD 312
           +KK+ +   Y+   +          LG G  G V            A+K L     Q   
Sbjct: 10  IKKNAIIDDYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKML-----QDCP 55

Query: 313 EFFNEVN-LISSIEHKNLVKLLGC---SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLL 367
           +   EV     + +  ++V+++        G + L +V E +    L    F + + +  
Sbjct: 56  KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDR-- 109

Query: 368 NWNKRF------NIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFG 418
             ++ F       I+    E + YLH      I HRD+K  N+L      +   K+ DFG
Sbjct: 110 -GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 165

Query: 419 LA 420
            A
Sbjct: 166 FA 167

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 27/195 (13%), Positives = 65/195 (33%), Gaps = 37/195 (18%)

Query: 277 KKLGQGGAGSVYMG---------SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK 327
               +   G +Y           S P     ++K    + R + ++ F +      ++  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ-RAAKPLQVN 106

Query: 328 NLVKLLGCSIEG-PESLLVYEYVPNRSLDQFI----FDKNKTKLLNWNKRFNIILGTAEG 382
              KL    +   P       +  ++   +F+      ++    L+ + +  +   +   
Sbjct: 107 KWKKLYSTPLLAIPT---CMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQ 163

Query: 383 LA--------YLHGGSETRIIHRDIKTSNILLDKDFTPKI--ADFGLARCFAADRTHV-- 430
           +A        +LH   E   +H ++   NI +D +   ++  A +G A  +     HV  
Sbjct: 164 VACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220

Query: 431 ----STAVAGTLGYM 441
                +   G L ++
Sbjct: 221 VEGSRSPHEGDLEFI 235

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 46/218 (21%), Positives = 78/218 (35%), Gaps = 60/218 (27%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH-KNLVKLLG 334
           KK+G G  G + +G +L     VA+K     +R    +   E      +     + ++  
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYY 72

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA--------YL 386
               G  + +V E +   SL+  +FD         ++ F+  L T   +A        Y+
Sbjct: 73  FGPCGKYNAMVLELL-GPSLED-LFDLC-------DRTFS--LKTVLMIAIQLISRMEYV 121

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPK-----IADFGLARCFAADRTHV------STAVA 435
           H      +I+RD+K  N L+ +          I DF LA+ +    T          ++ 
Sbjct: 122 H---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178

Query: 436 GT----------------------LGYMAPEYLVRGQL 451
           GT                      LG+M   Y +RG L
Sbjct: 179 GTARYMSINTHLGKEQSRRDDLEALGHMFM-YFLRGSL 215

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 39/202 (19%), Positives = 67/202 (33%), Gaps = 51/202 (25%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIF------NTRQWVDE--FFNEVNLISSIEHKN 328
             +GQGG G +Y+  + +  +V             +      E  F+        I+   
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 329 LV---------KLLGCSIEGPESL----LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
                      K  G  +          ++ +      L Q I++ N        KRF+ 
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDL-QKIYEAN-------AKRFS- 150

Query: 376 ILGTAEGLA--------YLHGGSETRIIHRDIKTSNILLDKDFTPKI--ADFGLARCFAA 425
              T   L+        Y+H   E   +H DIK SN+LL+     ++   D+GLA  +  
Sbjct: 151 -RKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206

Query: 426 DRTHV------STAVAGTLGYM 441
           +  H            GT+ + 
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFT 228

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 36/194 (18%), Positives = 67/194 (34%), Gaps = 38/194 (19%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           KK+G GG G +Y+          A   +    ++     F+E+        + + K    
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQE-NGPLFSELKFY-----QRVAKKDCI 96

Query: 336 SIEGPESLLVYEYVPN-----RSLDQ------FIFD---KNKTKLLNWNKRFNI--ILGT 379
                   L Y  +P       +  +       + +    +  K+   N  F    +L  
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156

Query: 380 A----EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI--ADFGLARCFAADRTHV--- 430
                + L Y+H   E   +H DIK +N+LL      ++  AD+GL+  +  +  H    
Sbjct: 157 GIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213

Query: 431 ---STAVAGTLGYM 441
                   GT+ + 
Sbjct: 214 ENPRKGHNGTIEFT 227

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 31/166 (18%), Positives = 69/166 (41%), Gaps = 27/166 (16%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV-KLLG 334
           +++G+G  G ++ G +L N   VA+K     +     +  +E      +     +  +  
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 73

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILGTAE----GLAYLHG 388
              EG  ++LV + +   SL+  + D          ++F++  +   A+     +  +H 
Sbjct: 74  FGQEGLHNVLVIDLLG-PSLED-LLDLC-------GRKFSVKTVAMAAKQMLARVQSIHE 124

Query: 389 GSETRIIHRDIKTSNILLDKDFTPK-----IADFGLARCFAADRTH 429
            S   +++RDIK  N L+ +  +       + DFG+ + +    T 
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.6 bits (138), Expect = 1e-08
 Identities = 84/574 (14%), Positives = 155/574 (27%), Gaps = 198/574 (34%)

Query: 65  FFDGCFLRYDIYSF-----YQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAV 119
           F +   LR + Y F       E   PS+       +   + N+N+            +A 
Sbjct: 82  FVEEV-LRIN-YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV-----------FAK 128

Query: 120 GNVSR-------------------IAVEKGGGFG----AVKVM-----------GVYALA 145
            NVSR                   + ++   G G    A+ V             ++   
Sbjct: 129 YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF--- 185

Query: 146 QCWESLGRDGCRE---------CLDKAGMRVRRSCRMRKEGRGFNAGCY--LRYSTDKFF 194
             W +L      E                   RS          ++      R    K +
Sbjct: 186 --WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243

Query: 195 NH-----DD----ETGD--DRGSSRLGVMIAIVLSTTAF--LMLSLFAAYAAYARLSKMK 241
            +      +    +  +  +  S +       +L TT F  +   L AA   +  L    
Sbjct: 244 ENCLLVLLNVQNAKAWNAFN-LSCK-------ILLTTRFKQVTDFLSAATTTHISLDHHS 295

Query: 242 ---EDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTV 298
                     L         L  + + L +     NP ++L           S+ +G   
Sbjct: 296 MTLTPDEVKSLLL-----KYLDCRPQDLPREVLTTNP-RRLSIIAE------SIRDGL-- 341

Query: 299 AVKRLIFNTRQ-WVDEFFNEVNLI--SSI------EHKNLVKLLGCSI--EG---PESLL 344
                   T   W     +++  I  SS+      E++ +   L  S+       P  LL
Sbjct: 342 -------ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL--SVFPPSAHIPTILL 392

Query: 345 VY------EYVPNRSLDQFIFDKNKTKLLNWNKRFNI--------ILGTAEGLAYLHGGS 390
                   +      +++       + +    K   I        +    E    LH   
Sbjct: 393 SLIWFDVIKSDVMVVVNKLH---KYSLVEKQPKESTISIPSIYLELKVKLENEYALH--- 446

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIAD---FGLARCFAADRTHVSTAVAGTLGYMAPEYLV 447
              I+           D D  P   D   +          +H        +G+    +L 
Sbjct: 447 -RSIVDHYNIPKTFDSD-DLIPPYLDQYFY----------SH--------IGH----HLK 482

Query: 448 RGQLTEKAD----VY-SFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP 502
             +  E+      V+  F  L  +I     +   S    + LQ++   Y+    +   DP
Sbjct: 483 NIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQL-KFYK--PYICDNDP 539

Query: 503 N----LKD--DF---PAEQV-----CNVLQIGLL 522
                +    DF     E +      ++L+I L+
Sbjct: 540 KYERLVNAILDFLPKIEENLICSKYTDLLRIALM 573

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 50/235 (21%), Positives = 100/235 (42%), Gaps = 55/235 (23%)

Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNE 317
           ++++YE L+           +G+G  G V           VA+K ++ N +++  +   E
Sbjct: 95  VAYRYEVLKV----------IGKGSFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQAAEE 143

Query: 318 VNLISSI------EHKNLVKLLG--------CSIEGPESLLVYEYVPNRSLDQFIFD--- 360
           + ++  +         N++ +L         C        + +E      L   +++   
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHIC--------MTFE-----LLSMNLYELIK 190

Query: 361 KNKTKLLNWN--KRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP--KIAD 416
           KNK +  +    ++F   +   + L  LH   + RIIH D+K  NILL +      K+ D
Sbjct: 191 KNKFQGFSLPLVRKFAHSI--LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVID 245

Query: 417 FGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           FG + C+  +   V T +  +  Y APE ++  +     D++S G ++ E++ G 
Sbjct: 246 FGSS-CY--EHQRVYTYIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 25/165 (15%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV-KLLG 334
           +K+G G  G +Y+G  +  G  VA+K     T+    +   E  +   ++    +  +  
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 72

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILGTA----EGLAYLHG 388
           C  EG  +++V E +   SL+  +F+         +++F++  +L  A      + Y+H 
Sbjct: 73  CGAEGDYNVMVMELL-GPSLED-LFNFC-------SRKFSLKTVLLLADQMISRIEYIH- 122

Query: 389 GSETRIIHRDIKTSNILLDKDFTPK---IADFGLARCFAADRTHV 430
                 IHRD+K  N L+          I DFGLA+ +   RTH 
Sbjct: 123 --SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 48/215 (22%), Positives = 85/215 (39%), Gaps = 39/215 (18%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI------EHKNL 329
             +G+G  G V           VA+K +I N + ++++   EV L+  +          +
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118

Query: 330 VKLLG--------CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWN--KRFNI-ILG 378
           V L          C        LV+E + + +L   +      + ++ N  ++F   +  
Sbjct: 119 VHLKRHFMFRNHLC--------LVFEML-SYNLYDLL-RNTNFRGVSLNLTRKFAQQMC- 167

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP--KIADFGLARCFAADRTHVSTAVAG 436
               L +L    E  IIH D+K  NILL        KI DFG + C       +   +  
Sbjct: 168 --TALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQ--RIYQYIQ- 220

Query: 437 TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
           +  Y +PE L+        D++S G +++E+  G 
Sbjct: 221 SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 39/167 (23%), Positives = 71/167 (42%), Gaps = 29/167 (17%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV-KLLG 334
           +K+G G  G +Y+G ++     VA+K     T+    +   E  +   ++    +  +  
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA--------YL 386
             +EG  ++LV + +   SL+  +F+         +++ +  L T   LA        ++
Sbjct: 71  FGVEGDYNVLVMDLL-GPSLED-LFNFC-------SRKLS--LKTVLMLADQMINRVEFV 119

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPK---IADFGLARCFAADRTHV 430
           H  S    +HRDIK  N L+          I DFGLA+ +    TH 
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 31/109 (28%), Positives = 44/109 (40%), Gaps = 26/109 (23%)

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTP-------------------KIADFGLAR 421
             L +LH   E ++ H D+K  NIL                          ++ADFG A 
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189

Query: 422 CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            F  D  H +T VA T  Y  PE ++     +  DV+S G ++ E   G
Sbjct: 190 TF--DHEHHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 30/111 (27%), Positives = 47/111 (42%), Gaps = 30/111 (27%)

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILL-DKDFTP------------------KIADFGLAR 421
           + + +LH     ++ H D+K  NIL    D+T                   K+ DFG A 
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184

Query: 422 CFAADR--THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
            +  +   T VST       Y APE ++    ++  DV+S G ++IE   G
Sbjct: 185 TYDDEHHSTLVSTRH-----YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.2 bits (97), Expect = 7e-04
 Identities = 52/238 (21%), Positives = 91/238 (38%), Gaps = 67/238 (28%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-----EHKNLV 330
           +K+G G  G V +   + N    AVK ++ N +++      E +++  I      + N+V
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVK-VVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 331 KLLG--------CSIEGPESLLVYEYVPNRSLDQFIFD---KNKTKLLNWN--KRFNIIL 377
           K  G        C        L++E      L   +++   +N     +    K + I +
Sbjct: 100 KYHGKFMYYDHMC--------LIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEI 146

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP------------------------- 412
             A  L YL    +  + H D+K  NILLD  +                           
Sbjct: 147 LKA--LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 413 KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG 470
           K+ DFG A  F     +  + +  T  Y APE ++       +D++SFG ++ E+  G
Sbjct: 202 KLIDFGCA-TF--KSDYHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	611
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.73
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.73
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.68
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.67
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.66
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.22
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.04
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.95
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.69
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.53
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.46
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.41
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.32
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.29
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.08
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.0
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.89
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.84
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.62
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.44
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.38
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.35
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.3
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.23
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.15
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.07
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.88
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.61
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.6
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.4
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.9
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.49
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	90.77
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	90.51
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	88.96
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.38

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.4e-56  Score=450.59  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=212.1

Q ss_pred             cCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++|.+.++||+|+||+||+|.+.      ++..||||+++....+..++|.+|+++|++++|||||+++|++.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            35667789999999999999753      478899999987777778899999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccC----------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEE
Q 007248          345 VYEYVPNRSLDQFIFDKN----------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  414 (611)
                      |||||++|+|.++|+...          ....++|.++++|+.||++||+|||   +++||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999996532          2356999999999999999999999   789999999999999999999999


Q ss_pred             eeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhc
Q 007248          415 ADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYR  492 (611)
Q Consensus       415 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  492 (611)
                      +|||+++........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||....    ..+.. ..+.
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~----~~~~~-~~i~  244 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS----NNEVI-ECIT  244 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----HHHHH-HHHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----HHHHH-HHHH
Confidence            999999876543322 2234568999999999999999999999999999999999 899975322    11211 1111


Q ss_pred             cCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       493 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      .+.         ....|...+..+.+|+.+||+.||++||||+||+++|++.
T Consensus       245 ~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          245 QGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             HTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            221         1123444556789999999999999999999999999754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.5e-55  Score=451.93  Aligned_cols=257  Identities=24%  Similarity=0.383  Sum_probs=206.2

Q ss_pred             cCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++|...++||+|+||+||+|.+.      +++.||||++........++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            34566788999999999999764      478999999987777778899999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCC------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCe
Q 007248          345 VYEYVPNRSLDQFIFDKNK------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  412 (611)
                      |||||++|+|.++|+....            ...++|.++++|+.||++||+|||   +++||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            9999999999999975432            246999999999999999999999   7899999999999999999999


Q ss_pred             EEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHh
Q 007248          413 KIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTL  490 (611)
Q Consensus       413 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~  490 (611)
                      ||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||....    ..+. ...
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~----~~~~-~~~  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS----NTEA-IDC  272 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC----HHHH-HHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC----HHHH-HHH
Confidence            9999999987644332 23345679999999999999999999999999999999999 899975322    1121 111


Q ss_pred             hccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          491 YRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       491 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      +..+.         +.+.|...+..+.+|+.+||+.||++||||+||+++|+..
T Consensus       273 i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          273 ITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             HHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            11111         1123444556788999999999999999999999999754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.7e-55  Score=447.46  Aligned_cols=254  Identities=23%  Similarity=0.362  Sum_probs=209.0

Q ss_pred             CCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          273 FNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      +++.++||+|+||+||+|.+.      +++.||||++.... ....++|.+|+.+|++++|||||+++|+|.+++..++|
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            455788999999999999762      46889999986543 34467899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCC-------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCe
Q 007248          346 YEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  412 (611)
                      ||||++|+|.++|+....             ...++|..+++|+.|||+||+|||   +.+||||||||+||||++++.+
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCE
Confidence            999999999999965321             246999999999999999999999   7899999999999999999999


Q ss_pred             EEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHh
Q 007248          413 KIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTL  490 (611)
Q Consensus       413 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~  490 (611)
                      ||+|||+++....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||....    ..+. ...
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~----~~~~-~~~  259 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----NQDV-VEM  259 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC----HHHH-HHH
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC----HHHH-HHH
Confidence            9999999987643322 23345679999999999999999999999999999999999 888875321    1111 111


Q ss_pred             hccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          491 YRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       491 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      +..+         ...+.|...+..+.+|+.+||+.||++||||.||++.|+.
T Consensus       260 i~~~---------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          260 IRNR---------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHcC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            2221         1223345566678999999999999999999999999964

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.5e-55  Score=440.49  Aligned_cols=263  Identities=25%  Similarity=0.399  Sum_probs=205.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .+++.+.++||+|+||+||+|.+.+  .||||+++..  ..+..+.|.+|+++|++++|||||+++|++.+ +..+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            3566778999999999999998754  6999998643  34567889999999999999999999998865 56899999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      ||++|+|.++|+..  ...++|.++++|+.|||+||+|||   +++||||||||+||||++++.+||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            99999999999643  346999999999999999999999   7899999999999999999999999999998765332


Q ss_pred             -cceeecccCCccccChhhhhc---CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          428 -THVSTAVAGTLGYMAPEYLVR---GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       428 -~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                       ........||+.|||||++.+   +.++.++|||||||+||||+||+.||.....    ...+......+.    ..+.
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~----~~~~~~~~~~~~----~~p~  258 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN----RDQIIFMVGRGY----ASPD  258 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HHHHHHHHHTTC----CCCC
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh----HHHHHHHHhcCC----CCCC
Confidence             223446789999999999964   4689999999999999999999999853322    111111111111    1111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCC
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIP  549 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~~~~  549 (611)
                      + ...+...+..+.+|+.+||+.+|++||||.||++.|+....++|
T Consensus       259 ~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          259 L-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             S-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             c-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            1 12233455668899999999999999999999998865544443

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-52  Score=432.35  Aligned_cols=268  Identities=25%  Similarity=0.355  Sum_probs=217.2

Q ss_pred             ccChHHHHHHhcCCCCCCccccCCceeEEEEEcCC------CCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCC-Cceee
Q 007248          260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEH-KNLVK  331 (611)
Q Consensus       260 ~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~  331 (611)
                      .+..+.++...++|++.+.||+|+||+||+|.+..      ++.||||++.... ....+.|.+|+++|.+++| ||||+
T Consensus        53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            44556666777889999999999999999996532      3679999997553 3446789999999999965 89999


Q ss_pred             EeeeeeeC-CcceEEEeecCCCChhhhhhccCC-------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecC
Q 007248          332 LLGCSIEG-PESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR  397 (611)
Q Consensus       332 l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  397 (611)
                      ++|+|.+. +.+++|||||++|+|.++|+....             ...++|..++.++.|||+||+|||   +++||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecC
Confidence            99998764 568999999999999999965321             345899999999999999999999   7899999


Q ss_pred             CCCcccEEECCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCC
Q 007248          398 DIKTSNILLDKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNA  475 (611)
Q Consensus       398 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~  475 (611)
                      ||||+||||++++.+||+|||+|+.+..+... ......||+.|||||++.+..++.++|||||||+||||+| |+.||.
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999876554433 3345678999999999999999999999999999999998 899975


Q ss_pred             CCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          476 FSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       476 ~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ......    .+......+         .+...|......+.+++..||+.||++|||+.||++.|.+
T Consensus       290 ~~~~~~----~~~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          290 GVKIDE----EFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             TCCCSH----HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCHHH----HHHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            432221    122222221         1122334445668899999999999999999999998864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.2e-53  Score=432.87  Aligned_cols=250  Identities=22%  Similarity=0.334  Sum_probs=202.1

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ++|++.++||+|+||+||+|.. .+|+.||||++...  .....+.|.+|+++|++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5788999999999999999964 57999999999754  34456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      ||++|+|.++|... +...+++..++.|+.||+.||+|||   +.+||||||||+||||+.++.+||+|||+++.+....
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            99999999999643 3345789999999999999999999   7999999999999999999999999999998654321


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                       .......||+.|||||++.+..++.++|||||||+||||+||+.||...    ...+....... +..     +    .
T Consensus       180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~----~~~~~~~~i~~-~~~-----~----~  244 (350)
T 4b9d_A          180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG----SMKNLVLKIIS-GSF-----P----P  244 (350)
T ss_dssp             -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHH-TCC-----C----C
T ss_pred             -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHHHHHHc-CCC-----C----C
Confidence             1233567999999999999999999999999999999999999998532    22222222221 111     1    1


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+......+.+|+.+||+.||++|||+.|+++
T Consensus       245 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            12233456889999999999999999999985

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.4e-51  Score=419.26  Aligned_cols=267  Identities=25%  Similarity=0.322  Sum_probs=200.1

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC----cceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP----ESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  346 (611)
                      ++|...++||+|+||+||+|.+ +|+.||||++...... ...+..|+..+.+++|||||+++|++.+++    .++|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3466678999999999999988 6899999998654322 223345666677899999999999998754    479999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcC-----CCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG-----SETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      |||++|+|.++|+.    ..++|..+++++.|+++||+|||+.     ..++||||||||+||||+.++++||+|||+++
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999954    3589999999999999999999943     13499999999999999999999999999998


Q ss_pred             eccCCCcce---eecccCCccccChhhhhcC------ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh-h
Q 007248          422 CFAADRTHV---STAVAGTLGYMAPEYLVRG------QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL-Y  491 (611)
Q Consensus       422 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-~  491 (611)
                      .........   .....||+.|||||++.+.      .++.++|||||||+||||+||+.|+........+....... .
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            775543322   2245799999999999754      47889999999999999999998875544332221100000 0


Q ss_pred             ccCccc-cccCCCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          492 RSNKLV-EAVDPNLKDDFP-----AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       492 ~~~~~~-~~id~~l~~~~~-----~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ....+. ...+..++...+     .+.+..+.+|+.+||+.||++||||.||++.|++
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            000000 111222222222     2456778999999999999999999999999865

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.8e-52  Score=422.08  Aligned_cols=251  Identities=22%  Similarity=0.290  Sum_probs=203.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      +.|...++||+|+||+||+|.. .+|+.||||++.....     +.+|+.+|++++|||||++++++.+++..|||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            4577788999999999999965 5699999999975432     247999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC-CeEEeeeccceeccCCCc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAADRT  428 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~~  428 (611)
                      ++|+|.++|...   ..+++..+..++.||+.||+|||   +++||||||||+||||+.++ .+||+|||+|+.+..+..
T Consensus       133 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            999999999543   45999999999999999999999   89999999999999999987 699999999998754432


Q ss_pred             c----eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          429 H----VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       429 ~----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      .    .....+||+.|||||++.+..++.++|||||||+||||+||+.||........ ...+   .......       
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i---~~~~~~~-------  275 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKI---ASEPPPI-------  275 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHH---HHSCCGG-------
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHH---HcCCCCc-------
Confidence            2    12346799999999999999999999999999999999999999865433322 2211   1111100       


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                       ...+......+.+++.+||+.||++|||+.||++.|...
T Consensus       276 -~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          276 -REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             -GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence             012233445678999999999999999999999887543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.6e-51  Score=421.68  Aligned_cols=249  Identities=27%  Similarity=0.421  Sum_probs=207.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      +.|+..++||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            4588889999999999999965 579999999997665555667899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++|+|.+++..    ..+++..+..++.||+.||+|||   +.+||||||||+||||+.++.+||+|||+++.+.... .
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~  225 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P  225 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-C
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-C
Confidence            99999999953    34899999999999999999999   7999999999999999999999999999998765433 2


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      .....+||+.|||||++.+..++.++|||||||++|||++|+.||...    ...+.... +...     ..+.+  ...
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~~~~~~-i~~~-----~~~~~--~~~  293 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----PPLKAMKM-IRDN-----LPPRL--KNL  293 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHH-HHHS-----SCCCC--SCG
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHHHH-HHcC-----CCCCC--Ccc
Confidence            334678999999999999999999999999999999999999998532    22222211 1111     11111  112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ......+.+|+.+||+.||++|||+.|+++
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            234456889999999999999999999874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.8e-51  Score=410.80  Aligned_cols=244  Identities=25%  Similarity=0.336  Sum_probs=194.6

Q ss_pred             CCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeee----CCcceEEE
Q 007248          274 NPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE----GPESLLVY  346 (611)
Q Consensus       274 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  346 (611)
                      +..++||+|+||+||+|.. .++..||||++...  .....+.|.+|+++|++++|||||++++++.+    +...++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            4556899999999999965 56899999998654  34456789999999999999999999999865    34579999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCc--eecCCCCcccEEECC-CCCeEEeeeccceec
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLDK-DFTPKIADFGLARCF  423 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~  423 (611)
                      |||++|+|.++|..   ...+++..+..|+.||+.||+|||   .++  ||||||||+||||+. ++.+||+|||+|+..
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            99999999999954   346899999999999999999999   566  999999999999984 789999999999754


Q ss_pred             cCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      ...   ......||+.|||||++. +.++.++|||||||+||||+||+.||.....    ...+......+....     
T Consensus       183 ~~~---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~~i~~~~~~~-----  249 (290)
T 3fpq_A          183 RAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGVKPA-----  249 (290)
T ss_dssp             CTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTCCCG-----
T ss_pred             CCC---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HHHHHHHHHcCCCCC-----
Confidence            322   234578999999999886 4699999999999999999999999853222    111122222111111     


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                         .++......+.+|+.+||+.||++|||+.|+++
T Consensus       250 ---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               111122345788999999999999999999874

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.9e-51  Score=410.93  Aligned_cols=247  Identities=23%  Similarity=0.294  Sum_probs=206.7

Q ss_pred             cCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|++.+.||+|+||+||++. ..+|+.||||++...   .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            468899999999999999995 457999999999754   2344678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.++|...   +.+++..+..++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            999999999999543   45999999999999999999999   799999999999999999999999999999987543


Q ss_pred             Cc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .. ......+||+.|||||++.+..++.++||||+||++|||+||+.||...    +..+..... ....+         
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~~~~~~i-~~~~~---------  251 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NEGLIFAKI-IKLEY---------  251 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHH-HHTCC---------
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHH-HcCCC---------
Confidence            32 3345678999999999999999999999999999999999999998532    222211111 11111         


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                       .++......+.+++.+|++.||++|||++|++
T Consensus       252 -~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 -DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence             12233345578999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.7e-50  Score=422.73  Aligned_cols=250  Identities=27%  Similarity=0.423  Sum_probs=208.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .+.|+..++||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++.+||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            35688899999999999999965 56999999999866555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      |++|+|.+++..    ..+++..+..++.||+.||+|||   +++||||||||+||||+.++.+||+|||+++.+.... 
T Consensus       230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            999999999843    34899999999999999999999   7899999999999999999999999999998765433 


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      ......+||+.|||||++.+..++.++|||||||++|||++|+.||...    ...+.... +..+     ..+.+.  .
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~~~~~~-i~~~-----~~~~~~--~  369 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----PPLKAMKM-IRDN-----LPPRLK--N  369 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHH-HHHS-----CCCCCS--C
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHHHH-HHcC-----CCCCCc--c
Confidence            2334578999999999999999999999999999999999999998532    22222221 1111     111111  1


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .......+.+|+.+||+.||++|||+.|+++
T Consensus       370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2223455788999999999999999999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.4e-50  Score=397.17  Aligned_cols=245  Identities=22%  Similarity=0.333  Sum_probs=189.7

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++....   ....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999965 569999999986542   334567999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+ +|+|.+++...   ..+++..+..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 68999998543   45999999999999999999999   799999999999999999999999999999865432


Q ss_pred             CcceeecccCCccccChhhhhcCcc-ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .  ......||+.|||||++.+..+ +.++||||+||++|||+||+.||...    .... .......+..         
T Consensus       166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~----~~~~-~~~~i~~~~~---------  229 (275)
T 3hyh_A          166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE----SIPV-LFKNISNGVY---------  229 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHH-HHHHHHHTCC---------
T ss_pred             C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC----CHHH-HHHHHHcCCC---------
Confidence            2  2345689999999999988776 57999999999999999999998532    2211 1122222111         


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       .++......+.+++.+|++.||++|||++|+++
T Consensus       230 -~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 -TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             122223455788999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.5e-50  Score=404.31  Aligned_cols=247  Identities=24%  Similarity=0.251  Sum_probs=195.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc----CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++|++.+.||+|+||+||+|+.    ..++.||||++....  ......+.+|+++|++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4688999999999999999964    247899999986432  2233468899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++|+|.++|...   ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999999543   45999999999999999999999   7999999999999999999999999999998654


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ... .......||+.|||||++.+..++.++|||||||++|||+||+.||...    +..+...... ...         
T Consensus       178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~----~~~~~~~~i~-~~~---------  242 (304)
T 3ubd_A          178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK----DRKETMTMIL-KAK---------  242 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHH-HCC---------
T ss_pred             CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc----CHHHHHHHHH-cCC---------
Confidence            322 2234578999999999999999999999999999999999999998532    2222222211 111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPS-----MAQAIM  539 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt-----~~evl~  539 (611)
                       ..++......+.+++.+||+.||++|||     ++|+++
T Consensus       243 -~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 -LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence             1123334456789999999999999998     567763

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-49  Score=402.88  Aligned_cols=250  Identities=22%  Similarity=0.361  Sum_probs=188.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc-------
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE-------  341 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  341 (611)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            3588899999999999999964 578999999987543 3445789999999999999999999999875543       


Q ss_pred             -----ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEee
Q 007248          342 -----SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD  416 (611)
Q Consensus       342 -----~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  416 (611)
                           +|+||||+++|+|.+++.........++..++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                 6899999999999999976655556777888999999999999999   78999999999999999999999999


Q ss_pred             eccceeccCCCcc-----------eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhH
Q 007248          417 FGLARCFAADRTH-----------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ  485 (611)
Q Consensus       417 fGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~  485 (611)
                      ||+|+.+......           ..+..+||+.|||||++.+..++.++|||||||++|||++   ||....   ....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---ERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---HHHH
Confidence            9999877543321           1224579999999999999999999999999999999996   543110   0111


Q ss_pred             HHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          486 RVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       486 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      . ........        . ..........+.+++.+||+.||++|||+.|+++
T Consensus       236 ~-~~~~~~~~--------~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          236 T-LTDVRNLK--------F-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             H-HHHHHTTC--------C-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H-HHHHhcCC--------C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1 11111111        0 0011222344678999999999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7e-47  Score=389.88  Aligned_cols=290  Identities=39%  Similarity=0.667  Sum_probs=249.7

Q ss_pred             cccccChHHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccch-hhHHHHHHHHHHHhcCCCCceeeEeee
Q 007248          257 SCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGC  335 (611)
Q Consensus       257 ~~~~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~  335 (611)
                      ....|+++++..++++|+..+.||+|+||.||+|...+|+.||||++..... .....|.+|++++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            3457899999999999999999999999999999988899999999875432 223368999999999999999999999


Q ss_pred             eeeCCcceEEEeecCCCChhhhhhccC-CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEE
Q 007248          336 SIEGPESLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (611)
Q Consensus       336 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  414 (611)
                      +...+..++||||+++|+|.+++.... ....++|..++.++.||+.||.|||+....+|+||||||+|||+++++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999997643 3346999999999999999999999433339999999999999999999999


Q ss_pred             eeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCC----CCCCChhHHHHHh
Q 007248          415 ADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFS----QDSASPLQRVWTL  490 (611)
Q Consensus       415 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~----~~~~~~~~~~~~~  490 (611)
                      +|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||...    ........+....
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            999999887655555555667999999999999999999999999999999999999998632    2333455555566


Q ss_pred             hccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          491 YRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       491 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                      .....+....+..+...++......+.+++.+||+.+|++|||+.||+++|++...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            66677778888888888899999999999999999999999999999999986443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.7e-46  Score=384.71  Aligned_cols=283  Identities=37%  Similarity=0.633  Sum_probs=241.9

Q ss_pred             cccChHHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeee
Q 007248          259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE  338 (611)
Q Consensus       259 ~~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  338 (611)
                      ..+++.+++.++++|+..+.||+|+||.||+|...+++.||||++........+.|.+|++++++++||||+++++++.+
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            34556667788999999999999999999999988899999999877666667889999999999999999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhhccCC-CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeee
Q 007248          339 GPESLLVYEYVPNRSLDQFIFDKNK-TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (611)
Q Consensus       339 ~~~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  417 (611)
                      ++..++||||+++|+|.+++..... ...++|..++.++.||++||.|||   ..+|+||||||+|||++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeec
Confidence            9999999999999999999965432 236899999999999999999999   789999999999999999999999999


Q ss_pred             ccceeccCCC-cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCC--CChhHHHHHhhccC
Q 007248          418 GLARCFAADR-THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDS--ASPLQRVWTLYRSN  494 (611)
Q Consensus       418 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~--~~~~~~~~~~~~~~  494 (611)
                      |+++...... ........||..|+|||++.+..++.++||||||+++|||++|+.|+......  .....+.......+
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            9998654322 22233456899999999999999999999999999999999999998754332  23444444455566


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       495 ~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      .+...+++.+....+......+.+++.+||+.+|++||++.||++.|+..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            67777888888788888999999999999999999999999999998753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.1e-46  Score=386.77  Aligned_cols=204  Identities=24%  Similarity=0.394  Sum_probs=172.9

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEc----CCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeC
Q 007248          265 TLEKATNYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (611)
Q Consensus       265 ~l~~~~~~f~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (611)
                      .+....+.|++.++||+|+||+||+|..    ..++.||||++....  ....+.+|+++|+.+ +|||||++++++.++
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            3344568899999999999999999954    246889999986543  235688999999998 699999999999999


Q ss_pred             CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC-CCeEEeeec
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFG  418 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG  418 (611)
                      +..++||||+++|+|.+++.      .+++..+..++.||+.||+|||   +.+|+||||||+|||++.+ +.+||+|||
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            99999999999999999982      3889999999999999999999   8999999999999999877 799999999


Q ss_pred             cceeccCCCc---------------------------ceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhC
Q 007248          419 LARCFAADRT---------------------------HVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCG  470 (611)
Q Consensus       419 la~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG  470 (611)
                      +|+.......                           ......+||+.|+|||++.+. .++.++||||+||++|||+||
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            9986543221                           112245799999999999775 589999999999999999999


Q ss_pred             CCCCCCCCC
Q 007248          471 RRSNAFSQD  479 (611)
Q Consensus       471 ~~p~~~~~~  479 (611)
                      +.||....+
T Consensus       244 ~~Pf~~~~~  252 (361)
T 4f9c_A          244 RYPFYKASD  252 (361)
T ss_dssp             CSSSSCCSS
T ss_pred             CCCCCCCCC
Confidence            999865443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=386.69  Aligned_cols=261  Identities=21%  Similarity=0.295  Sum_probs=198.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeee------CCc
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE------GPE  341 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  341 (611)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++...  .....+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5788999999999999999954 57999999999643  23445678999999999999999999998764      357


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .|||||||+ |+|.+++..   ...+++..+..++.||+.||.|||   +.+||||||||+|||++.++.+||+|||+++
T Consensus       134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceee
Confidence            899999995 689999843   456999999999999999999999   8999999999999999999999999999998


Q ss_pred             eccCCC---cceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc--
Q 007248          422 CFAADR---THVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK--  495 (611)
Q Consensus       422 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--  495 (611)
                      .+....   ........||+.|||||++.+. .++.++||||+||++|||++|+.||...... ..+..+........  
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCChH
Confidence            764332   2233467899999999998875 5689999999999999999999998533211 11111111111100  


Q ss_pred             ---------cccccCCC-CCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          496 ---------LVEAVDPN-LKDDFPA-----EQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       496 ---------~~~~id~~-l~~~~~~-----~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                               ....+... -....+.     .....+.+|+.+||+.||++|||+.|+++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                     00000000 0000111     12345788999999999999999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.6e-44  Score=363.86  Aligned_cols=282  Identities=36%  Similarity=0.588  Sum_probs=234.3

Q ss_pred             cccccChHHHHHHhcCCCCC------CccccCCceeEEEEEcCCCCEEEEEEeecc----chhhHHHHHHHHHHHhcCCC
Q 007248          257 SCLSFKYETLEKATNYFNPS------KKLGQGGAGSVYMGSLPNGTTVAVKRLIFN----TRQWVDEFFNEVNLISSIEH  326 (611)
Q Consensus       257 ~~~~~~~~~l~~~~~~f~~~------~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h  326 (611)
                      ....|+++++..++++|...      +.||+|+||.||+|.. +++.||||++...    ..+..+.|.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34678999999999999988      8999999999999987 6889999998643    23456789999999999999


Q ss_pred             CceeeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       327 ~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                      |||+++++++.+++..++||||+++++|.+++........+++..++.++.||+.||.|||   ..+|+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence            9999999999999999999999999999999976555567999999999999999999999   7899999999999999


Q ss_pred             CCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhH
Q 007248          407 DKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ  485 (611)
Q Consensus       407 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~  485 (611)
                      +.++.+||+|||++......... ......|+..|+|||.+. +.++.++||||||+++|||++|+.|+...........
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            99999999999999876543322 223457899999999875 4689999999999999999999999876554433333


Q ss_pred             HHHHhhc-cCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          486 RVWTLYR-SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       486 ~~~~~~~-~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ....... ...+.+.+++.+ ...+......+.+++..||+.+|++||++.+|++.|.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            2222222 223344555544 345677788899999999999999999999999999754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.2e-45  Score=399.69  Aligned_cols=252  Identities=20%  Similarity=0.265  Sum_probs=207.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .++|++.+.||+|+||+||++.. .+|+.||||++........+.+.+|+++|+.++|||||++++++.++..+++||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            36799999999999999999954 57999999999876666677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC--CCeEEeeeccceeccCC
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD--FTPKIADFGLARCFAAD  426 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla~~~~~~  426 (611)
                      |++|+|.++|..  +...+++..+..++.||+.||.|||   +++|+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999853  2346999999999999999999999   8999999999999999854  78999999999987543


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      .  ......||+.|||||++.+..++.++|||||||++|||++|+.||....    ..+..... ....      ..+..
T Consensus       311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~----~~~~~~~i-~~~~------~~~~~  377 (573)
T 3uto_A          311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----DDETLRNV-KSCD------WNMDD  377 (573)
T ss_dssp             S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHH-HTTC------CCCCS
T ss_pred             C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHH-HhCC------CCCCc
Confidence            3  2345679999999999999999999999999999999999999985322    22211111 1111      01111


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .........+.+|+..||+.||++|||+.|+++
T Consensus       378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111123345788999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.8e-44  Score=392.46  Aligned_cols=248  Identities=21%  Similarity=0.225  Sum_probs=199.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHH---HHHHHHHHHhcCCCCceeeEeeeeeeCCcce
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVD---EFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (611)
                      ++|++.++||+|+||+||++.. .+|+.||||++....   .....   ....++.+++.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            5688999999999999999955 569999999996432   12222   3344577788899999999999999999999


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      +||||++||+|.++|...   ..+++..+..++.||+.||+|||   ..+||||||||+||||+.+|.+||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            999999999999999543   45999999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ....   ....+||+.|||||++.. ..++.++|||||||+||||++|+.||...... ..... ........       
T Consensus       343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-~~~~i-~~~i~~~~-------  410 (689)
T 3v5w_A          343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEI-DRMTLTMA-------  410 (689)
T ss_dssp             SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-CHHHH-HHHHHHCC-------
T ss_pred             CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHH-HHhhcCCC-------
Confidence            5433   235689999999999975 47899999999999999999999998643222 11111 11111111       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPS-----MAQAIM  539 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt-----~~evl~  539 (611)
                         ..++......+.+|+..||+.||++|++     ++||++
T Consensus       411 ---~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          411 ---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ---CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence               1123333455789999999999999998     677764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-44  Score=370.11  Aligned_cols=265  Identities=31%  Similarity=0.454  Sum_probs=205.9

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc
Q 007248          265 TLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       265 ~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (611)
                      ++....++|++.+.||+|+||+||+|.. +|+.||||++....  .+..+.|.+|++++++++||||+++++++.+.+..
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            3344456788899999999999999987 68899999986543  44567899999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCc--eecCCCCcccEEECCCCCeEEeeeccc
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      ++||||+++++|.+++........+++..++.++.||+.||+|||   +.+  |+||||||+|||++.++.+||+|||++
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            999999999999999976544456999999999999999999999   778  999999999999999999999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      +...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....    ..+.........      
T Consensus       187 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~----~~~~~~~~~~~~------  255 (309)
T 3p86_A          187 RLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN----PAQVVAAVGFKC------  255 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC----HHHHHHHHHHSC------
T ss_pred             ccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcC------
Confidence            7543322 22334678999999999999999999999999999999999999985332    111111110010      


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCC
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCE  547 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~~  547 (611)
                         .....+......+.+++.+||+.+|++||++.+|++.|+.....
T Consensus       256 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          256 ---KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ---CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence               11122333445688999999999999999999999999765543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=361.34  Aligned_cols=258  Identities=26%  Similarity=0.404  Sum_probs=209.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      ++|...++||+|+||+||++.. .+++.||+|++........+.|.+|++++++++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            4677889999999999999965 568999999987777777889999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++...  ...+++..++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus        90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            999999999643  345899999999999999999999   789999999999999999999999999999876443221


Q ss_pred             e-------------eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcc
Q 007248          430 V-------------STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL  496 (611)
Q Consensus       430 ~-------------~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (611)
                      .             .....||+.|+|||++.+..++.++||||||+++|||++|..|+............        ..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--------~~  236 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------NV  236 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--------CH
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--------hh
Confidence            1             11457899999999999999999999999999999999999887643322111000        00


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          497 VEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       497 ~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      ....+...    +......+.+++.+||+.+|++||++.+|++.|+...
T Consensus       237 ~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          237 RGFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             HHHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            00111111    1122234788999999999999999999999987543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.7e-43  Score=371.03  Aligned_cols=258  Identities=27%  Similarity=0.403  Sum_probs=209.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc--------CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeC
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (611)
                      .++|...+.||+|+||.||+|..        .++..||||++... .....+.+.+|+++|+++ +||||+++++++.++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            35678889999999999999964        24567999998754 344567899999999999 899999999999999


Q ss_pred             CcceEEEeecCCCChhhhhhccCC-------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||++||.|||   ..+|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            999999999999999999965431             245899999999999999999999   7899999999999999


Q ss_pred             CCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChh
Q 007248          407 DKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPL  484 (611)
Q Consensus       407 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~  484 (611)
                      +.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||+| |+.|+..... ... 
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-~~~-  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EEL-  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGH-
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHH-
Confidence            99999999999999876543322 2234457889999999999999999999999999999999 8888753221 111 


Q ss_pred             HHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          485 QRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       485 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                         ......+         .....+......+.+++..||+.+|++||++.|+++.|...
T Consensus       315 ---~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          315 ---FKLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             ---HHHHHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               1111111         11223344455688999999999999999999999998753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=365.25  Aligned_cols=256  Identities=25%  Similarity=0.441  Sum_probs=205.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcC----CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ++|.+.+.||+|+||.||+|...    .+..||||++... .....+.|.+|++++++++||||+++++++.+++..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            45677899999999999999763    3456999999754 344567899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++++|.+++...  ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++....
T Consensus       129 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          129 TEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             eeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            9999999999999543  346999999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCcce--eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          426 DRTHV--STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       426 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      .....  .....+|..|+|||++.+..++.++||||||+++|||++ |+.||.....    ... .....         .
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~~-~~~~~---------~  269 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----RDV-ISSVE---------E  269 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHH-HHHHH---------T
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----HHH-HHHHH---------c
Confidence            33222  223446778999999999999999999999999999999 9998743221    111 11111         1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      ......+......+.+++..||+.+|++||++.+|++.|....
T Consensus       270 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1122233344566889999999999999999999999997643

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.7e-43  Score=357.31  Aligned_cols=250  Identities=25%  Similarity=0.434  Sum_probs=208.6

Q ss_pred             hcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .++|+..+.||+|+||+||+|. ..+++.||||++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            4679999999999999999996 467899999999876666677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++...    .+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999999542    4899999999999999999999   78999999999999999999999999999987654332


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                       ......||+.|+|||++.+..++.++||||||+++|||++|+.||....    .............      +.  ...
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~------~~--~~~  238 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN----PLRALYLIATNGT------PE--LQN  238 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHHCS------CC--CSC
T ss_pred             -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCC------CC--CCC
Confidence             2335679999999999999999999999999999999999999985322    2222221111111      11  112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +......+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            3344556889999999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.9e-44  Score=373.11  Aligned_cols=256  Identities=26%  Similarity=0.436  Sum_probs=197.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC----CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      .++|...+.||+|+||.||+|...    ++..||||++... .....+.|.+|+.++++++||||+++++++.+++..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357888999999999999999764    5778999998754 34456789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++++|.+++...  ...+++..++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999643  346899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCccee--ecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          425 ADRTHVS--TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       425 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      .......  ....++..|+|||++.+..++.++||||||+++|||++ |+.|+....    ..+ .....         .
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~----~~~-~~~~i---------~  264 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS----NQD-VIKAV---------D  264 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC----HHH-HHHHH---------H
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC----HHH-HHHHH---------H
Confidence            4332211  12335678999999999999999999999999999998 999975321    111 11111         1


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      .......+......+.+++.+||+.+|++||++.+|++.|...
T Consensus       265 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence            1111222334556688999999999999999999999998654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1e-42  Score=357.99  Aligned_cols=261  Identities=26%  Similarity=0.380  Sum_probs=214.5

Q ss_pred             cccChHHHHHHhcC----------CCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCC
Q 007248          259 LSFKYETLEKATNY----------FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK  327 (611)
Q Consensus       259 ~~~~~~~l~~~~~~----------f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  327 (611)
                      ..++++++..+++.          |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            46788898888875          566679999999999999765 7999999999876666678899999999999999


Q ss_pred             ceeeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC
Q 007248          328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD  407 (611)
Q Consensus       328 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  407 (611)
                      ||+++++++..++..++||||+++++|.+++..    ..+++..+..++.||+.||.|||   ..+|+||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEC
Confidence            999999999999999999999999999999842    35899999999999999999999   78999999999999999


Q ss_pred             CCCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHH
Q 007248          408 KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV  487 (611)
Q Consensus       408 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~  487 (611)
                      .++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.|+....    ..+..
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~----~~~~~  250 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS----PVQAM  250 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHH
T ss_pred             CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHH
Confidence            999999999999987654322 2335679999999999999999999999999999999999999985321    22211


Q ss_pred             HHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          488 WTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       488 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ... ..     ...+.+.  ........+.+++.+||+.+|++||++.|+++
T Consensus       251 ~~~-~~-----~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          251 KRL-RD-----SPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHH-HH-----SSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHH-hc-----CCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111 11     1111111  12223455788999999999999999999985

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8e-43  Score=359.02  Aligned_cols=266  Identities=26%  Similarity=0.346  Sum_probs=205.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc----ceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE----SLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv  345 (611)
                      .++|+..++||+|+||+||+|... ++.||||++..... ....+..|+.++++++||||+++++++.+...    .++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            457888899999999999999874 79999999865433 33456679999999999999999999987554    6999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCC----------ceecCCCCcccEEECCCCCeEEe
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET----------RIIHRDIKTSNILLDKDFTPKIA  415 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~----------~ivH~Dlkp~NIll~~~~~~kl~  415 (611)
                      |||+++|+|.+++..    ..++|..++.++.||+.||.|||   +.          +|+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            999999999999954    34899999999999999999999   67          99999999999999999999999


Q ss_pred             eeccceeccCCCcc-eeecccCCccccChhhhhc-----CccccccceehhHHHHHHHHhCCCCCCCCCCCCC-hhHHHH
Q 007248          416 DFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVR-----GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS-PLQRVW  488 (611)
Q Consensus       416 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~-~~~~~~  488 (611)
                      |||+++.+...... ......||+.|+|||++.+     ..++.++||||||+++|||+||+.||....+... +.....
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999876544322 2234678999999999976     3567899999999999999999999875433221 111000


Q ss_pred             -HhhccCccccc-cCCCCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          489 -TLYRSNKLVEA-VDPNLKDDF-----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       489 -~~~~~~~~~~~-id~~l~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                       .......+.+. .........     .......+.+++.+||+.||++|||+.||++.|+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             00000000111 111111111     224456689999999999999999999999998653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-43  Score=354.41  Aligned_cols=253  Identities=25%  Similarity=0.400  Sum_probs=208.0

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      ++|+..+.||+|+||.||++...+++.||||++.... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            4677889999999999999988889999999987543 234679999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +++|.+++...  ...+++..++.++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus        89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence            99999999543  346899999999999999999999   7899999999999999999999999999998654433233


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....    .... .......         .....+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~----~~~~-~~~~~~~---------~~~~~~  229 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEV-VEDISTG---------FRLYKP  229 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHH-HHHHHTT---------CCCCCC
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC----HHHH-HHHHhcC---------ccCCCC
Confidence            334556788999999999999999999999999999999 888875321    1111 1111111         111122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ......+.+++..||+.+|++||++.++++.|.+
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  263 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence            2334558899999999999999999999999865

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.7e-44  Score=383.98  Aligned_cols=263  Identities=27%  Similarity=0.402  Sum_probs=213.0

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcce
Q 007248          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       264 ~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (611)
                      +.++...++|...+.||+|+||.||+|.++++..||||++.... ...+.|.+|+++|++++||||+++++++. ++..+
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            34455567788899999999999999999888999999987543 34678999999999999999999999986 56789


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      +||||+++|+|.+++.... ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       259 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            9999999999999996432 235889999999999999999999   789999999999999999999999999999866


Q ss_pred             cCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ............++..|+|||++..+.++.++||||||++||||+| |+.|+....    ..+. ......+        
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~----~~~~-~~~i~~~--------  401 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----NPEV-IRALERG--------  401 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHH-HHHHHHT--------
T ss_pred             CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC----HHHH-HHHHHcC--------
Confidence            4322222233456789999999999999999999999999999999 999875321    1111 1111111        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                       .....+...+..+.+++.+||+.+|++|||+++|++.|+....
T Consensus       402 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          402 -YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence             1112233445668899999999999999999999999986543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.7e-43  Score=351.48  Aligned_cols=256  Identities=26%  Similarity=0.389  Sum_probs=210.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      .++|+..+.||+|+||.||++...++..||||++.... ...+++.+|++++.+++||||+++++++.++...++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            45688889999999999999998888899999987543 23467999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++++|.+++...  ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999999543  345899999999999999999999   789999999999999999999999999999876655444


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....    ....... ....         ....
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~-~~~~---------~~~~  226 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN----SEVVLKV-SQGH---------RLYR  226 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHHH-HTTC---------CCCC
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh----HHHHHHH-HcCC---------CCCC
Confidence            4444556788999999999999999999999999999999 9988753321    1111111 1110         1111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      +......+.+++..||+.+|++|||+.++++.|+...
T Consensus       227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            2223345889999999999999999999999997643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1e-43  Score=373.78  Aligned_cols=255  Identities=25%  Similarity=0.350  Sum_probs=206.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .++|...+.||+|+||.||+|... +++.||||++.... ....+.|.+|+++|++++||||+++++++..++..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            456778899999999999999775 78999999987542 3445678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++|+|.+++...  ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999999543  345899999999999999999999   7899999999999999999999999999998644322


Q ss_pred             ccee-ecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          428 THVS-TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       428 ~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .... ....++..|+|||.+..+.++.++||||||+++|||+| |+.|+.....     ........         ....
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----~~~~~~~~---------~~~~  333 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----QQTREFVE---------KGGR  333 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----HHHHHHHH---------TTCC
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH---------cCCC
Confidence            1111 12234678999999999999999999999999999998 8888753221     11111111         1112


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ...+...+..+.+++.+||+.+|++|||+.+|++.|..
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            22333445568899999999999999999999999865

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-42  Score=352.06  Aligned_cols=262  Identities=24%  Similarity=0.360  Sum_probs=204.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhc--CCCCceeeEeeeeeeC----Ccce
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISS--IEHKNLVKLLGCSIEG----PESL  343 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~  343 (611)
                      .++|...+.||+|+||+||+|.. +++.||||++....   .+.+..|.+++..  ++||||+++++++...    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46788899999999999999987 78999999986443   3456667777666  7999999999986543    4578


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCC-----CCceecCCCCcccEEECCCCCeEEeeec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS-----ETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                      +||||+++|+|.+++.    ...+++..++.++.||+.||+|||...     +.+|+||||||+|||++.++.+||+|||
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence            9999999999999993    345999999999999999999999321     5799999999999999999999999999


Q ss_pred             cceeccCCCcce---eecccCCccccChhhhhcC------ccccccceehhHHHHHHHHhC----------CCCCCCCCC
Q 007248          419 LARCFAADRTHV---STAVAGTLGYMAPEYLVRG------QLTEKADVYSFGILIIEIVCG----------RRSNAFSQD  479 (611)
Q Consensus       419 la~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~ksDV~S~Gvll~elltG----------~~p~~~~~~  479 (611)
                      +++.........   .....||+.|+|||++.+.      .++.++||||||+++|||+||          +.||.....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            998765544332   2234789999999999876      567899999999999999999          666654433


Q ss_pred             CCChhHHHHHhhccCccccccCCCCCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          480 SASPLQRVWTLYRSNKLVEAVDPNLKD-DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~id~~l~~-~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ................    ..+.+.. ..+......+.+++.+||+.||++|||+.+|++.|++
T Consensus       239 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          239 NDPSFEDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             SSCCHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcchhhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            3333332222221111    1111110 1123466789999999999999999999999999975

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.6e-43  Score=356.84  Aligned_cols=265  Identities=26%  Similarity=0.413  Sum_probs=207.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-----CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeee--CCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  342 (611)
                      .++|+..+.||+|+||+||++.+     .+++.||||++........+.|.+|++++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35678889999999999999973     3688999999987777777889999999999999999999999864  3568


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999999543  235899999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCCcc--eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC------
Q 007248          423 FAADRTH--VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN------  494 (611)
Q Consensus       423 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------  494 (611)
                      .......  ......++..|+|||.+.+..++.++||||||+++|||+||..|+.....      .........      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~~  237 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI  237 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH------HHHHHHCTTCCTHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH------HHHhhhcCccccchh
Confidence            6543321  22244577789999999999999999999999999999999988653211      000000000      


Q ss_pred             --ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          495 --KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       495 --~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                        .+.+.+........+......+.+++..||+.+|++|||+.||++.|....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence              111112222222334445567889999999999999999999999987543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.8e-43  Score=382.33  Aligned_cols=258  Identities=26%  Similarity=0.399  Sum_probs=212.7

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcCC-CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ..++|...++||+|+||.||+|.+.. +..||||++.... ...++|.+|+.+|++++||||+++++++.+++..++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            34567888999999999999997754 8899999987543 346789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++|+|.+++.... ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       297 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          297 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             ccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            999999999996532 345899999999999999999999   7899999999999999999999999999998765443


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      ........++..|+|||++....++.++||||||++||||+| |+.|+..... ..    +..         .+....+.
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-~~----~~~---------~~~~~~~~  438 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQ----VYE---------LLEKDYRM  438 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GG----HHH---------HHHTTCCC
T ss_pred             eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-HH----HHH---------HHHcCCCC
Confidence            333334456789999999999999999999999999999999 8888753221 11    111         11122222


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      ..+......+.+|+.+||+.+|++||++.+|++.|+...
T Consensus       439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            334445567889999999999999999999999997643

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.8e-43  Score=379.31  Aligned_cols=261  Identities=27%  Similarity=0.406  Sum_probs=206.2

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          267 EKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       267 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      +...++|...++||+|+||.||+|.+.++..||||++.... ...+.|.+|+++|++++||||+++++++.+ +..++||
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~  257 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  257 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence            34456788889999999999999998888889999987543 235689999999999999999999999876 6789999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++... ....+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus       258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            999999999999532 2245899999999999999999999   789999999999999999999999999999876543


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .........++..|+|||.+..+.++.++||||||+++|||+| |+.|+....    ..+. .....         ...+
T Consensus       334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~----~~~~-~~~i~---------~~~~  399 (452)
T 1fmk_A          334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREV-LDQVE---------RGYR  399 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHH-HHHHH---------TTCC
T ss_pred             ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC----HHHH-HHHHH---------cCCC
Confidence            3222334456789999999999999999999999999999999 888875321    1111 11111         1112


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCC
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCE  547 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~~  547 (611)
                      ...+...+..+.+++.+||+.+|++|||+++|++.|......
T Consensus       400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            223444556788999999999999999999999999875543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.9e-43  Score=364.91  Aligned_cols=269  Identities=26%  Similarity=0.362  Sum_probs=215.2

Q ss_pred             cccChHHHHHHhcCCCCCCccccCCceeEEEEE------cCCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCcee
Q 007248          259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGS------LPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLV  330 (611)
Q Consensus       259 ~~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~------~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv  330 (611)
                      ..+....++...++|...+.||+|+||.||+|.      ..+++.||||++.... ....+.+.+|++++.++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            345666777778899999999999999999995      2356899999997543 34457899999999999 899999


Q ss_pred             eEeeeeeeCCc-ceEEEeecCCCChhhhhhccCC----------------------------------------------
Q 007248          331 KLLGCSIEGPE-SLLVYEYVPNRSLDQFIFDKNK----------------------------------------------  363 (611)
Q Consensus       331 ~l~~~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------  363 (611)
                      ++++++.+.+. .++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            99999887654 8999999999999999965432                                              


Q ss_pred             -----------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          364 -----------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       364 -----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                                       ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                             122899999999999999999999   789999999999999999999999999999866443


Q ss_pred             Cc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          427 RT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       427 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      .. .......||..|+|||++.+..++.++||||||+++|||+| |+.|+.........    ........         
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~~~~~~~---------  313 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----CRRLKEGT---------  313 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH----HHHHHHTC---------
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH----HHHHHcCC---------
Confidence            32 23335567899999999999999999999999999999999 99997543322111    11111111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ....+......+.+++..||+.+|++||++.||++.|..
T Consensus       314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  352 (359)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            111222334558899999999999999999999999865

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=351.87  Aligned_cols=263  Identities=26%  Similarity=0.409  Sum_probs=203.8

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      ++|+..+.||+|+||.||++.. .++.||||++...  ...+.|.+|++++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            4677889999999999999987 4789999988643  34578999999999999999999999887  35899999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC-eEEeeeccceeccCCCcc
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT-PKIADFGLARCFAADRTH  429 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfGla~~~~~~~~~  429 (611)
                      +++|.+++........+++..++.++.||++||.|||+....+|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999976555556889999999999999999999432289999999999999998886 799999999754322   


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                       .....||..|+|||++.+..++.++||||||+++|||++|+.|+.....  ......+......      .+    ..+
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~------~~----~~~  226 (307)
T 2eva_A          160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG--PAFRIMWAVHNGT------RP----PLI  226 (307)
T ss_dssp             ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS--SHHHHHHHHHTTC------CC----CCB
T ss_pred             -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc--cHHHHHHHHhcCC------CC----Ccc
Confidence             2234589999999999999999999999999999999999999864322  2222222211111      11    112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCCCCCC
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQP  554 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~~~~~p~~~  554 (611)
                      ......+.+++.+||+.+|++|||+.++++.|.......+.+..|
T Consensus       227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~  271 (307)
T 2eva_A          227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP  271 (307)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence            223445789999999999999999999999998765555544433

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.7e-42  Score=355.12  Aligned_cols=252  Identities=26%  Similarity=0.333  Sum_probs=201.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .++|+..+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            35788899999999999999965 478999999986543 2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++++|.+++..   ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            9999999999843   345899999999999999999999   7899999999999999999999999999998664332


Q ss_pred             c-ceeecccCCccccChhhhhcCcc-ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          428 T-HVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       428 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      . .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||............    +....        ..
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~----~~~~~--------~~  227 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKK--------TY  227 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH----HHTTC--------TT
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH----Hhccc--------cc
Confidence            2 22335679999999999988765 78999999999999999999998654332221111    11110        00


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..........+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1111233455788999999999999999999874

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.5e-42  Score=351.24  Aligned_cols=272  Identities=20%  Similarity=0.265  Sum_probs=215.6

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC--cceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP--ESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  346 (611)
                      ++|...++||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888899999999999999654 58999999987543 344677889999999999999999999988765  679999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE----CCCCCeEEeeecccee
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLARC  422 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla~~  422 (611)
                      ||+++++|.+++........+++..++.++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999976555555999999999999999999999   7899999999999999    7888899999999987


Q ss_pred             ccCCCcceeecccCCccccChhhhh--------cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLV--------RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN  494 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  494 (611)
                      ......  .....||..|+|||++.        +..++.++||||||+++|||++|+.||....................
T Consensus       166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            654332  23456899999999986        46889999999999999999999999865443333233222222211


Q ss_pred             c---cccc---c--------CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCC
Q 007248          495 K---LVEA---V--------DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCE  547 (611)
Q Consensus       495 ~---~~~~---i--------d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~~  547 (611)
                      .   +...   .        +.......+......+.+++..||+.||++|||++|+++...+....
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            1   0000   0        01111234566777789999999999999999999999998765543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.2e-43  Score=353.32  Aligned_cols=255  Identities=23%  Similarity=0.357  Sum_probs=206.1

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ..++|+..+.||+|+||.||++...++..||||++..... ..+++.+|++++.+++||||+++++++.+++..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            3457888899999999999999988888999999875432 346799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus       101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            9999999999542  345899999999999999999999   78999999999999999999999999999976544332


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                      .......++..|+|||++.+..++.++||||||+++|||+| |+.||.....    ...... ...         .....
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----~~~~~~-~~~---------~~~~~  241 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETAEH-IAQ---------GLRLY  241 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHH-HHT---------TCCCC
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh----hHHHHH-Hhc---------ccCCC
Confidence            22334456788999999999999999999999999999998 9988753321    111111 111         11111


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .+......+.+++..||+.+|++||++.++++.|..
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            222334568899999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.3e-42  Score=350.87  Aligned_cols=261  Identities=25%  Similarity=0.378  Sum_probs=205.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .++|+..+.||+|+||.||++.. .+++.||||++...   ..+..+.|.+|+.++++++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            35688899999999999999964 57899999998543   344567899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++++|.+++...   ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999999543   35899999999999999999999   78999999999999999999999999999986654


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ..........||+.|+|||.+.+..++.++||||||+++|||++|+.||....    ............ ...     ..
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~----~~~~~~~~~~~~-~~~-----~~  233 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET----AVSIAIKHIQDS-VPN-----VT  233 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC----HHHHHHHHHSSC-CCC-----HH
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhhcc-CCC-----cc
Confidence            43333445678999999999999999999999999999999999999985322    222211111111 000     00


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhccCCC
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRP-SMAQAIMLLTNKVC  546 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RP-t~~evl~~L~~~~~  546 (611)
                      ...+...+..+.+++.+|++.+|++|| +++++.+.|.....
T Consensus       234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            011222345688999999999999998 89999999976543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.9e-42  Score=353.70  Aligned_cols=247  Identities=22%  Similarity=0.328  Sum_probs=204.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+++|+.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45788899999999999999965 67999999998754  3445677899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            999999999999543   34899999999999999999999   789999999999999999999999999999766433


Q ss_pred             CcceeecccCCccccChhhhhcCccc-cccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLT-EKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .  ......||+.|+|||++.+..+. .++||||||+++|||++|+.||....    ..+. ......+..         
T Consensus       168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~-~~~i~~~~~---------  231 (328)
T 3fe3_A          168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN----LKEL-RERVLRGKY---------  231 (328)
T ss_dssp             C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH-HHHHHHCCC---------
T ss_pred             C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC----HHHH-HHHHHhCCC---------
Confidence            2  23456799999999999887765 79999999999999999999985321    1111 111111111         


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       ..+......+.+++.+|++.||++|||++|+++
T Consensus       232 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          232 -RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             122233455788999999999999999999874

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.5e-42  Score=353.59  Aligned_cols=258  Identities=27%  Similarity=0.397  Sum_probs=209.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc------CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (611)
                      .++|...+.||+|+||.||++..      .++..||||++... .....+.+.+|++++++++||||+++++++.+++..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46788889999999999999964      34588999998754 345567899999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCC---------------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCc
Q 007248          343 LLVYEYVPNRSLDQFIFDKNK---------------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKT  401 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  401 (611)
                      ++||||+++++|.+++.....                     ...+++..++.++.||++||.|||   +.+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            999999999999999965432                     234899999999999999999999   78999999999


Q ss_pred             ccEEECCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCC
Q 007248          402 SNILLDKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQD  479 (611)
Q Consensus       402 ~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~  479 (611)
                      +|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999876543322 2224457889999999999999999999999999999999 9988753321


Q ss_pred             CCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          480 SASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      . .    ........         .....+......+.+++.+||+.+|++||++.+|++.|...
T Consensus       259 ~-~----~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          259 E-R----LFNLLKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             G-G----HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H-H----HHHHhhcC---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1 1    11111111         11122333455688999999999999999999999998653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.1e-43  Score=361.22  Aligned_cols=271  Identities=25%  Similarity=0.350  Sum_probs=212.7

Q ss_pred             cCCCCCCccccCCceeEEEEE-----cCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeee--eCCcce
Q 007248          271 NYFNPSKKLGQGGAGSVYMGS-----LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI--EGPESL  343 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  343 (611)
                      ++|+..+.||+|+||.||++.     ..+++.||||++........+.+.+|++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            467788999999999999997     3468899999998777777788999999999999999999999886  455689


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      +||||+++++|.+++...  ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus       103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            999999999999999543  235899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCcc--eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHH---HHhhccCcccc
Q 007248          424 AADRTH--VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV---WTLYRSNKLVE  498 (611)
Q Consensus       424 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~---~~~~~~~~~~~  498 (611)
                      ......  ......++..|+|||++.+..++.++||||||+++|||++|+.|+......  .....   ........+.+
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE--FLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HHHHCC----CCHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch--hhhhcccccccccHHHHHH
Confidence            544332  222456788899999999999999999999999999999999986532110  00000   00000011122


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCC
Q 007248          499 AVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEI  548 (611)
Q Consensus       499 ~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~~~  548 (611)
                      .+........+......+.+++..||+.+|++||++.||++.|+......
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            22222333344455667899999999999999999999999998665433

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.8e-43  Score=361.64  Aligned_cols=251  Identities=23%  Similarity=0.386  Sum_probs=198.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCC--CceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEH--KNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  345 (611)
                      .++|++.+.||+|+||.||++...+++.||||++...  ..+..+.|.+|+.+|.+++|  |||+++++++.++...++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4568889999999999999998888999999998754  34456789999999999976  9999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      || +.+++|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.+..
T Consensus        88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 5688999999643   45899999999999999999999   78999999999999997 57899999999987654


Q ss_pred             CCcc-eeecccCCccccChhhhhc-----------CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc
Q 007248          426 DRTH-VSTAVAGTLGYMAPEYLVR-----------GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS  493 (611)
Q Consensus       426 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  493 (611)
                      .... ......||+.|+|||++.+           ..++.++||||||+++|||++|+.||.....   .....      
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~------  230 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISKL------  230 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---HHHHH------
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---HHHHH------
Confidence            3322 2335679999999999875           6788999999999999999999999853221   11111      


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                         ...+++.....++......+.+++..||+.||++|||+.|+++.
T Consensus       231 ---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          231 ---HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ---HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence               12222222223333334567899999999999999999999854

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.6e-42  Score=355.00  Aligned_cols=251  Identities=22%  Similarity=0.355  Sum_probs=200.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc------
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE------  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  341 (611)
                      .++|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            456888999999999999999765 79999999987543 3456789999999999999999999999866542      


Q ss_pred             ---------------------------------------------------ceEEEeecCCCChhhhhhccCCCccCChh
Q 007248          342 ---------------------------------------------------SLLVYEYVPNRSLDQFIFDKNKTKLLNWN  370 (611)
Q Consensus       342 ---------------------------------------------------~~lv~E~~~~gsL~~~l~~~~~~~~l~~~  370 (611)
                                                                         .++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               78999999999999999876666667888


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc-----------ceeecccCCcc
Q 007248          371 KRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT-----------HVSTAVAGTLG  439 (611)
Q Consensus       371 ~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~~  439 (611)
                      .++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999   78999999999999999999999999999987754421           11234568999


Q ss_pred             ccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHH
Q 007248          440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQI  519 (611)
Q Consensus       440 y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l  519 (611)
                      |+|||++.+..++.++||||||+++|||++|..|+..      . ..........         ............+.++
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~------~-~~~~~~~~~~---------~~~~~~~~~~~~~~~l  305 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME------R-VRIITDVRNL---------KFPLLFTQKYPQEHMM  305 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH------H-HHHHHHHHTT---------CCCHHHHHHCHHHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH------H-HHHHHHhhcc---------CCCcccccCChhHHHH
Confidence            9999999999999999999999999999998765210      0 0001111111         0011112334557889


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 007248          520 GLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       520 ~~~c~~~~p~~RPt~~evl~  539 (611)
                      +..||+.||++||++.|+++
T Consensus       306 i~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          306 VQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHccCCCCcCCCHHHHhh
Confidence            99999999999999999985

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=359.21  Aligned_cols=262  Identities=27%  Similarity=0.415  Sum_probs=211.5

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC
Q 007248          267 EKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG  339 (611)
Q Consensus       267 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  339 (611)
                      ....++|+..+.||+|+||.||+|...      +++.||||++... .....+.|.+|++++++++||||+++++++.++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            344678999999999999999999763      3488999998754 344567899999999999999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhhccCC---------------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCC
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNK---------------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD  398 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  398 (611)
                      +..++||||+++++|.+++.....                     ...+++..++.++.||++||.|||   +.+|+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence            999999999999999999965321                     256999999999999999999999   78999999


Q ss_pred             CCcccEEECCCCCeEEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCC
Q 007248          399 IKTSNILLDKDFTPKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAF  476 (611)
Q Consensus       399 lkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~  476 (611)
                      |||+|||++.++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||+| |+.|+..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999976543221 12234567899999999999999999999999999999999 9888753


Q ss_pred             CCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          477 SQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      ..    ..+ .......+..         ...+......+.+++..||+.+|++||++.+|++.|.+..
T Consensus       280 ~~----~~~-~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          280 MA----HEE-VIYYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             SC----HHH-HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CC----hHH-HHHHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            21    111 1111112211         1123334456889999999999999999999999998654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.3e-43  Score=365.08  Aligned_cols=257  Identities=27%  Similarity=0.370  Sum_probs=206.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (611)
                      .++|...+.||+|+||+||+|.+.      ++..||||++... .......+.+|+.++++++||||+++++++.++...
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            356788899999999999999742      4678999998644 344556799999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccC----CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC---CeEEe
Q 007248          343 LLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF---TPKIA  415 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  415 (611)
                      ++||||+++|+|.+++....    ....+++..++.++.||++||.|||   ..+|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999996543    2245899999999999999999999   78999999999999999554   59999


Q ss_pred             eeccceeccCCC-cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhcc
Q 007248          416 DFGLARCFAADR-THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRS  493 (611)
Q Consensus       416 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  493 (611)
                      |||+++...... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||....    ..+. ......
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~----~~~~-~~~i~~  301 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS----NQEV-LEFVTS  301 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHH-HHHHHT
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHH-HHHHHc
Confidence            999997553221 122334567899999999999999999999999999999998 888875321    1111 111111


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      +         .....+......+.+++.+||+.+|++||++.+|++.|..
T Consensus       302 ~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          302 G---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C---------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1         1112233344568899999999999999999999998864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=363.72  Aligned_cols=259  Identities=27%  Similarity=0.415  Sum_probs=210.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEc--------CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeC
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (611)
                      .++|...+.||+|+||.||+|..        ..+..||||++... .....+.+.+|+++++++ +||||+++++++.++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            46788889999999999999964        23467999998754 344567899999999999 999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhhccCC-------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||   +.+|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            999999999999999999965432             245999999999999999999999   7899999999999999


Q ss_pred             CCCCCeEEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChh
Q 007248          407 DKDFTPKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPL  484 (611)
Q Consensus       407 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~  484 (611)
                      +.++.+||+|||+++....... .......+|..|+|||++.+..++.++||||||+++|||++ |+.|+....     .
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-----~  299 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----V  299 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----H
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-----H
Confidence            9999999999999986654322 22334567889999999999999999999999999999999 888875321     1


Q ss_pred             HHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          485 QRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       485 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      ..........         .....+......+.+++..||+.+|++||++.||++.|....
T Consensus       300 ~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          300 EELFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             HHHHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1122222211         111223334456889999999999999999999999997654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-42  Score=358.67  Aligned_cols=254  Identities=24%  Similarity=0.409  Sum_probs=198.6

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCE----EEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTT----VAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++|+..++||+|+||+||+|.. .+++.    ||+|.+... .....+.|.+|+.++++++||||+++++++.++. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            4678889999999999999974 34443    588877543 2345678999999999999999999999998754 789


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            99999999999999653  345899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          425 ADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       425 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ..... ......+|..|+|||++.+..++.++||||||+++|||+| |+.||...... ..             ...+..
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~-------------~~~~~~  234 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EI-------------SSILEK  234 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GH-------------HHHHHT
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-HH-------------HHHHHc
Confidence            44332 2234456889999999999999999999999999999999 99997533211 11             111111


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ......+......+.+++.+||+.+|++||++.+|++.|...
T Consensus       235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          235 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            112223444556788999999999999999999999998654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.5e-42  Score=370.52  Aligned_cols=249  Identities=28%  Similarity=0.430  Sum_probs=204.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC-cceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-ESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~  348 (611)
                      .++|+..+.||+|+||.||+|... |+.||||+++...  ..+.|.+|+++|++++||||+++++++.+.. ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            456778899999999999999884 7899999987543  4578999999999999999999999987665 78999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++|+|.+++.... ...+++..++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence            99999999996542 334789999999999999999999   7899999999999999999999999999998543221 


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                         ....++..|+|||++.+..++.++||||||+++|||+| |+.|+...... .....    ..         ...+..
T Consensus       344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~----i~---------~~~~~~  406 (450)
T 1k9a_A          344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPR----VE---------KGYKMD  406 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-THHHH----HH---------TTCCCC
T ss_pred             ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH----HH---------cCCCCC
Confidence               22356889999999999999999999999999999998 99987643221 12111    11         111222


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .+...+..+.+++..||+.+|++|||+.+|++.|+.
T Consensus       407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            344455678899999999999999999999998865

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.2e-42  Score=348.55  Aligned_cols=255  Identities=21%  Similarity=0.323  Sum_probs=194.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCC----CCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      .++|+..+.||+|+||.||+|....    +..||||++... .....+.|.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4678888999999999999996532    457999988653 3445678999999999999999999999984 567899


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++++|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999999543  345899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      ...........+++.|+|||++....++.++||||||+++|||++ |+.||...... .....    .....        
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-~~~~~----i~~~~--------  234 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGR----IENGE--------  234 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHH----HHTTC--------
T ss_pred             cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-HHHHH----HHcCC--------
Confidence            443333334556789999999999999999999999999999997 88887543221 11111    11111        


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                       ....+......+.+++..|++.+|++||++.+|++.|...
T Consensus       235 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          235 -RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             1122333455688999999999999999999999998653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.1e-42  Score=350.23  Aligned_cols=258  Identities=30%  Similarity=0.420  Sum_probs=208.4

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ...++|+..+.||+|+||.||+|...++..||||++.... ...+.|.+|++++++++||||+++++++. ++..++|||
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   87 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE   87 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence            3456788899999999999999998888899999987543 23578999999999999999999999986 456899999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++++|.+++... ....+++..++.++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||++.......
T Consensus        88 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             cCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            99999999999532 1235899999999999999999999   7899999999999999999999999999998765443


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.|+....    ..+. .......         ...
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~~-~~~~~~~---------~~~  229 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEV-IQNLERG---------YRM  229 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHH-HHHHHTT---------CCC
T ss_pred             cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC----HHHH-HHHHhcc---------cCC
Confidence            333334556789999999999999999999999999999999 888875321    1111 1111111         111


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      ..+......+.+++..|++.+|++||++.++++.|++..
T Consensus       230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            122333456889999999999999999999999987643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-42  Score=356.78  Aligned_cols=264  Identities=27%  Similarity=0.385  Sum_probs=210.1

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEc------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeeee
Q 007248          267 EKATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE  338 (611)
Q Consensus       267 ~~~~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  338 (611)
                      +...++|...+.||+|+||.||+|..      .++..||||++.... ....+.+.+|+.++.++ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            33457888899999999999999974      245689999987542 33456899999999999 99999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhhccCCC--------------------ccCChhHHHHHHHHHHHHHHHHhcCCCCceecCC
Q 007248          339 GPESLLVYEYVPNRSLDQFIFDKNKT--------------------KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD  398 (611)
Q Consensus       339 ~~~~~lv~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  398 (611)
                      ++..++||||+++|+|.+++......                    ..+++..++.++.||+.||.|||   ..+|+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence            99999999999999999999654321                    34899999999999999999999   78999999


Q ss_pred             CCcccEEECCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCC
Q 007248          399 IKTSNILLDKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAF  476 (611)
Q Consensus       399 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~  476 (611)
                      |||+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            9999999999999999999999876544332 2234557889999999999999999999999999999998 9988754


Q ss_pred             CCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          477 SQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                      .......    .......         .....+......+.+++.+||+.+|++||++.+|++.|.....
T Consensus       278 ~~~~~~~----~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          278 IPVDANF----YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             CCCSHHH----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCcHHHH----HHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            4322111    1111111         1112233345568899999999999999999999999976544

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-42  Score=345.70  Aligned_cols=254  Identities=25%  Similarity=0.393  Sum_probs=207.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      ++|...+.||+|+||.||++...+++.||||++..... ..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            46778899999999999999888889999999875432 34679999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +++|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++..........
T Consensus        87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence            99999999543  345899999999999999999999   7899999999999999999999999999997654322222


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      .....++..|+|||++.+..++.++||||||+++|||++ |+.|+....    ..+.. .....+         .....+
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~-~~i~~~---------~~~~~~  227 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVV-EDISTG---------FRLYKP  227 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHH-HHHHTT---------CCCCCC
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC----HHHHH-HHHhcC---------CcCCCC
Confidence            234456788999999998999999999999999999999 888875321    11111 111111         111122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ......+.+++.+||+.+|++||++.++++.|.+.
T Consensus       228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            23345688999999999999999999999998653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=381.86  Aligned_cols=263  Identities=27%  Similarity=0.407  Sum_probs=211.7

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcce
Q 007248          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       264 ~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (611)
                      +.++...++|...++||+|+||.||+|.+.++..||||++.... ...+.|.+|+++|++++||||+++++++.+ +..+
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            33444556788889999999999999999888899999987543 235789999999999999999999999876 6789


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      +||||+++|+|.+++... ....+++..++.|+.||+.||+|||   ..+|+||||||+||||++++.+||+|||+++..
T Consensus       338 lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             EEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             EeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            999999999999999532 2235899999999999999999999   789999999999999999999999999999765


Q ss_pred             cCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ............++..|+|||++..+.++.++||||||++||||++ |+.|+....    ..+. ......         
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~----~~~~-~~~i~~---------  479 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREV-LDQVER---------  479 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC----HHHH-HHHHHT---------
T ss_pred             CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHH-HHHHHc---------
Confidence            4322222223456789999999999999999999999999999999 888875321    1111 111111         


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                      ..+...+......+.+|+.+||+.+|++|||+.+|++.|+....
T Consensus       480 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          480 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            11122233445668899999999999999999999999986543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.9e-42  Score=356.27  Aligned_cols=263  Identities=25%  Similarity=0.383  Sum_probs=194.7

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEcCCC----CEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGSLPNG----TTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG  339 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  339 (611)
                      +....++|+..+.||+|+||.||+|.....    ..||||++...  .....+.|.+|++++++++||||+++++++...
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            334456889999999999999999976543    27999998654  344567899999999999999999999999877


Q ss_pred             Ccc------eEEEeecCCCChhhhhhccC---CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC
Q 007248          340 PES------LLVYEYVPNRSLDQFIFDKN---KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF  410 (611)
Q Consensus       340 ~~~------~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  410 (611)
                      ...      ++||||+++++|.+++....   ....+++..++.++.||++||.|||   +.+|+||||||+|||+++++
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTS
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCC
Confidence            655      99999999999999995432   1225899999999999999999999   78999999999999999999


Q ss_pred             CeEEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHH
Q 007248          411 TPKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVW  488 (611)
Q Consensus       411 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~  488 (611)
                      .+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... ...    
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~----  249 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-EIY----  249 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHH----
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-HHH----
Confidence            999999999986644322 22224456789999999999999999999999999999999 88887533221 111    


Q ss_pred             HhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          489 TLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       489 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      .......         ....+......+.+++.+||+.+|++||++.++++.|++..
T Consensus       250 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          250 NYLIGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             HHHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111111         11223334456889999999999999999999999987643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.5e-42  Score=350.80  Aligned_cols=257  Identities=27%  Similarity=0.394  Sum_probs=212.0

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ...++|+..+.||+|+||.||+|... ++..||||++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            34667888999999999999999665 48899999987543 34678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++... ....+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            999999999999653 3356899999999999999999999   789999999999999999999999999999876655


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ...    ..         +.....
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~~----~~---------~~~~~~  230 (288)
T 3kfa_A          165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVY----EL---------LEKDYR  230 (288)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHH----HH---------HHTTCC
T ss_pred             ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHH----HH---------HhccCC
Confidence            4444445567889999999999999999999999999999999 88887532211 111    11         111112


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ...+......+.+++..|++.+|++||++.++++.|..
T Consensus       231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence            22233445568899999999999999999999998864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-41  Score=348.10  Aligned_cols=263  Identities=23%  Similarity=0.321  Sum_probs=202.3

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ..++|+..++||+|+||+||+|...+|+.||||++....  ....+.+.+|++++++++||||+++++++.++...++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            346788899999999999999988889999999986442  233567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++ +|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        99 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99985 788877542  345899999999999999999999   789999999999999999999999999999876433


Q ss_pred             CcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcc---cc----
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL---VE----  498 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~----  498 (611)
                      .. ......+|..|+|||++.+ ..++.++||||||+++|||++|+.||....... .+..+.........   ..    
T Consensus       173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhcc
Confidence            22 2334568999999999876 568999999999999999999999986544332 22222221111100   00    


Q ss_pred             --ccCCC--CCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          499 --AVDPN--LKDDF-----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       499 --~id~~--l~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        ..+..  .....     .......+.+++.+|++.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              00000  00000     1112345789999999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.5e-42  Score=357.41  Aligned_cols=255  Identities=25%  Similarity=0.371  Sum_probs=199.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCE----EEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTT----VAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++|+..+.||+|+||.||+|.. .+++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            4577789999999999999965 34544    7788765332 233456789999999999999999999986 567899


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++|+|.+++...  ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999999543  356999999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          425 ADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       425 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ..... ......++..|+|||++.+..++.++||||||+++|||+| |+.||...... ..    ........       
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~----~~~~~~~~-------  234 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EV----PDLLEKGE-------  234 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-HH----HHHHHTTC-------
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-HH----HHHHHcCC-------
Confidence            44322 2334567889999999999999999999999999999999 99997643221 11    11111111       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                        ....+......+.+++..||+.+|++||++.+|++.|....
T Consensus       235 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          235 --RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             --BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             --CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              11112222334678999999999999999999999997654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.1e-42  Score=342.68  Aligned_cols=253  Identities=28%  Similarity=0.405  Sum_probs=194.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccc----hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .++|+..+.||+|+||.||+|.. .++.||||++....    ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            35678889999999999999987 48899999886543    23356789999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC--------CCCeEEeee
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK--------DFTPKIADF  417 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~Df  417 (611)
                      |||+++++|.+++.    ...+++..++.++.||++||.|||+....+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999983    346899999999999999999999422223999999999999986        678999999


Q ss_pred             ccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccc
Q 007248          418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV  497 (611)
Q Consensus       418 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (611)
                      |++.......   .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....    ..........     
T Consensus       161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~-----  228 (271)
T 3dtc_A          161 GLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID----GLAVAYGVAM-----  228 (271)
T ss_dssp             CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC----HHHHHHHHHT-----
T ss_pred             Cccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHhhhc-----
Confidence            9997654322   224568999999999999999999999999999999999999975322    1111111111     


Q ss_pred             cccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       498 ~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                          .......+......+.+++.+||+.+|++||++.|+++.|++
T Consensus       229 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          229 ----NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             ----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             ----CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                111122233445568899999999999999999999999964

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.4e-41  Score=342.96  Aligned_cols=262  Identities=22%  Similarity=0.332  Sum_probs=202.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ++|+..++||+|+||+||+|.. .+++.||||++....  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            4688889999999999999965 468999999987543  3445778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++ +|.+++..  ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9976 55555532  2345999999999999999999999   7899999999999999999999999999998764332


Q ss_pred             cceeecccCCccccChhhhhcCc-cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc------ccccc
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK------LVEAV  500 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~i  500 (611)
                       .......||..|+|||++.+.. ++.++||||||+++|||++|..|+....+....+..+........      ..+..
T Consensus       156 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             -ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence             2233456899999999997765 799999999999999999999986544332222222222111110      00000


Q ss_pred             CC---------CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          501 DP---------NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       501 d~---------~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +.         .............+.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00         0001112234456789999999999999999999984

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2e-41  Score=349.74  Aligned_cols=260  Identities=17%  Similarity=0.225  Sum_probs=206.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .++|...+.||+|+||.||+|.. .+|+.||||++.....  .+.+.+|+++++++ +||||+++++++..++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            35788899999999999999964 6789999999865432  24688999999999 99999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC-----eEEeeecccee
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT-----PKIADFGLARC  422 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGla~~  422 (611)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999999643  346999999999999999999999   789999999999999998887     99999999987


Q ss_pred             ccCCCcce------eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcc
Q 007248          423 FAADRTHV------STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL  496 (611)
Q Consensus       423 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (611)
                      +.......      .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+..... .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~-~~~~~~~~~i-~~~~~  237 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-DTLKERYQKI-GDTKR  237 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-SSHHHHHHHH-HHHHH
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc-ccHHHHHHHH-Hhhhc
Confidence            65433221      2356799999999999999999999999999999999999999865432 2222211111 11000


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          497 VEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       497 ~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      .... ..+...    .+ .+.+++..||+.+|++||++++|++.|.+..
T Consensus       238 ~~~~-~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          238 ATPI-EVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HSCH-HHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             cCCH-HHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            0000 000011    12 6889999999999999999999999887543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.6e-41  Score=354.21  Aligned_cols=251  Identities=20%  Similarity=0.277  Sum_probs=203.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch------hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR------QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (611)
                      .+.|+..+.||+|+||.||++.. .+|+.||||++.....      ...+.+.+|+.+|++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            46788899999999999999965 4689999999875432      1357899999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC----CeEEeeec
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF----TPKIADFG  418 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG  418 (611)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||.|||   ..+|+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999943   346999999999999999999999   78999999999999998877    79999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccc
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE  498 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (611)
                      +++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||....    ..+.. ..+.....  
T Consensus       165 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~----~~~~~-~~i~~~~~--  235 (361)
T 2yab_A          165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETL-ANITAVSY--  235 (361)
T ss_dssp             SCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHH-HHHHTTCC--
T ss_pred             CceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----HHHHH-HHHHhcCC--
Confidence            998765432  2235679999999999998899999999999999999999999985322    11111 11111110  


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          499 AVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       499 ~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                          .+...........+.+++..|++.||++|||+.|+++
T Consensus       236 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 ----DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             ----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                0000001122345789999999999999999999884

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.1e-41  Score=348.74  Aligned_cols=247  Identities=23%  Similarity=0.286  Sum_probs=203.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..+.||+|+||+||++.. .+|+.||||++...   .....+.+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            5688899999999999999965 46899999999754   2334567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            999999999998543   45899999999999999999999   789999999999999999999999999999754322


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      . .......||+.|+|||++.+..++.++||||||+++|||++|+.||....    .... ........        +  
T Consensus       159 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~-~~~i~~~~--------~--  222 (337)
T 1o6l_A          159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERL-FELILMEE--------I--  222 (337)
T ss_dssp             T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHH-HHHHHHCC--------C--
T ss_pred             C-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC----HHHH-HHHHHcCC--------C--
Confidence            2 22345678999999999999999999999999999999999999985321    1111 11111111        0  


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                      .++......+.+++..||+.+|++||     +++||++
T Consensus       223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            12333345678999999999999999     8999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2e-42  Score=355.47  Aligned_cols=266  Identities=26%  Similarity=0.388  Sum_probs=207.8

Q ss_pred             CCCCCccccCCceeEEEEEc-----CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--CcceE
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLL  344 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  344 (611)
                      |+..++||+|+||+||++.+     .+++.||||++.... ....+.|.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            47889999999999998854     267899999997553 35567899999999999999999999999874  56799


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++++|.+++..    ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999943    23899999999999999999999   7899999999999999999999999999998775


Q ss_pred             CCCcc--eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCC-hhHHHHHhhccCccccccC
Q 007248          425 ADRTH--VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS-PLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       425 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~id  501 (611)
                      .....  ......++..|+|||++.+..++.++||||||+++|||++|+.|+........ ...+.........+.+.++
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            44322  22345678889999999999999999999999999999999998753211000 0000000000111222333


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      .......+......+.+++.+||+.+|++||++.|+++.|....
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            33333344555667899999999999999999999999987543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-41  Score=347.34  Aligned_cols=260  Identities=27%  Similarity=0.396  Sum_probs=210.4

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCC
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGP  340 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  340 (611)
                      ..++|...+.||+|+||.||+|..      .+++.||||++.... ....+.+.+|+++++++ +||||+++++++.+++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346788899999999999999963      356899999987543 34467899999999999 9999999999999999


Q ss_pred             cceEEEeecCCCChhhhhhccCC---------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEE
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNK---------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL  405 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl  405 (611)
                      ..++||||+++|+|.+++.....               ...+++..++.++.||++||.|||   +.+|+||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence            99999999999999999965432               225899999999999999999999   789999999999999


Q ss_pred             ECCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCCh
Q 007248          406 LDKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASP  483 (611)
Q Consensus       406 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~  483 (611)
                      ++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||+| |+.|+.........
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            999999999999999876544332 2224456789999999999999999999999999999999 99887543322111


Q ss_pred             hHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          484 LQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       484 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                          .......         .....+......+.+++.+|++.+|++||++.||++.|.+.
T Consensus       258 ----~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          258 ----YKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             ----HHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence                1111111         11111223345688999999999999999999999999754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.6e-42  Score=360.53  Aligned_cols=250  Identities=22%  Similarity=0.386  Sum_probs=198.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCC--CCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIE--HKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  346 (611)
                      +.|.+.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.+|.+++  ||||+++++++..++..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            458889999999999999998888999999998654  3455678999999999996  599999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      | +.+++|.+++...   ..+++..+..++.||+.||.|||   ..+|+||||||+|||++ ++.+||+|||+++.+...
T Consensus       136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 6788999999643   35889999999999999999999   88999999999999996 578999999999876543


Q ss_pred             Ccc-eeecccCCccccChhhhhc-----------CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC
Q 007248          427 RTH-VSTAVAGTLGYMAPEYLVR-----------GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN  494 (611)
Q Consensus       427 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  494 (611)
                      ... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....   ......      
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~~------  278 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISKLH------  278 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHHH------
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH---HHHHHH------
Confidence            322 2335679999999999875           3688999999999999999999999853221   111111      


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       495 ~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                         ..+++.....++......+.+++..||+.||++||++.||++.
T Consensus       279 ---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          279 ---AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ---HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence               1222222222233334567899999999999999999999854

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-41  Score=345.44  Aligned_cols=263  Identities=26%  Similarity=0.406  Sum_probs=200.1

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC--CCCceeeEeeeeeeC----C
Q 007248          267 EKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLLGCSIEG----P  340 (611)
Q Consensus       267 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~  340 (611)
                      ....++|+..+.||+|+||.||+|... ++.||||++....   ...+..|.+++..+  +||||+++++++...    .
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            445578999999999999999999874 8999999986443   24455666666654  999999999999887    6


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCC--------ceecCCCCcccEEECCCCCe
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET--------RIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~--------~ivH~Dlkp~NIll~~~~~~  412 (611)
                      ..++||||+++|+|.+++..    ..+++..++.++.||+.||.|||   ..        +|+||||||+|||++.++.+
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCE
Confidence            78999999999999999943    35899999999999999999999   55        99999999999999999999


Q ss_pred             EEeeeccceeccCCCcce---eecccCCccccChhhhhcCccccc------cceehhHHHHHHHHhCC----------CC
Q 007248          413 KIADFGLARCFAADRTHV---STAVAGTLGYMAPEYLVRGQLTEK------ADVYSFGILIIEIVCGR----------RS  473 (611)
Q Consensus       413 kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------sDV~S~Gvll~elltG~----------~p  473 (611)
                      ||+|||+++.+.......   .....||..|+|||++.+.....+      +||||||+++|||+||.          .|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999997765433221   124578999999999987766554      99999999999999994          44


Q ss_pred             CCCCCCCCChhHHHHHhhccCccccccCCCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          474 NAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF-PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       474 ~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~-~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      +.....................    ..+.+.... +......+.+++.+||+.||++|||+.+|++.|...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhhhcCCCCchhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence            4332222222222222111111    111111111 125677799999999999999999999999999754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.5e-42  Score=354.02  Aligned_cols=268  Identities=26%  Similarity=0.386  Sum_probs=213.7

Q ss_pred             cChHHHHHHhcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEe
Q 007248          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLL  333 (611)
Q Consensus       261 ~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~  333 (611)
                      +..++++...++|...+.||+|+||.||+|...      .++.||||++.... ......|.+|++++++++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            344555666788999999999999999999653      36889999987543 34456799999999999999999999


Q ss_pred             eeeeeCCcceEEEeecCCCChhhhhhccC-------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          334 GCSIEGPESLLVYEYVPNRSLDQFIFDKN-------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       334 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                      +++.+++..++||||+++++|.+++....       ....+++..++.++.||+.||.|||   +.+|+||||||+|||+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEE
Confidence            99999999999999999999999996422       1245789999999999999999999   7899999999999999


Q ss_pred             CCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChh
Q 007248          407 DKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPL  484 (611)
Q Consensus       407 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~  484 (611)
                      +.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.|+....    ..
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~  247 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----NE  247 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----HH
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC----HH
Confidence            99999999999999765433221 1223456889999999999999999999999999999999 788764321    11


Q ss_pred             HHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          485 QRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       485 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      + ..........         ...+......+.+++.+||+.+|++||++.|+++.|.+..
T Consensus       248 ~-~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          248 Q-VLRFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             H-HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             H-HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            1 1111111111         1122334456889999999999999999999999997654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.1e-41  Score=356.66  Aligned_cols=268  Identities=16%  Similarity=0.228  Sum_probs=205.9

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcCC------CCEEEEEEeeccchhhH-----------HHHHHHHHHHhcCCCCceee
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWV-----------DEFFNEVNLISSIEHKNLVK  331 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~  331 (611)
                      ..++|.+.+.||+|+||.||+|...+      ++.||||++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35678899999999999999997654      47899999875542211           12445677788889999999


Q ss_pred             EeeeeeeC----CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC
Q 007248          332 LLGCSIEG----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD  407 (611)
Q Consensus       332 l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  407 (611)
                      +++++...    ...++||||+ +++|.+++...  ...+++..++.|+.||+.||.|||   ..+|+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEe
Confidence            99998765    4479999999 99999999643  346999999999999999999999   78999999999999999


Q ss_pred             --CCCCeEEeeeccceeccCCCcce------eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCC
Q 007248          408 --KDFTPKIADFGLARCFAADRTHV------STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQD  479 (611)
Q Consensus       408 --~~~~~kl~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~  479 (611)
                        .++.+||+|||+++.+.......      .....||+.|+|||++.+..++.++||||||+++|||+||+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              88999999999998765332211      1234599999999999999999999999999999999999999875433


Q ss_pred             CCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          480 SASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                      ...........+ ...+.+.+++.+..   ...+..+.+++..||+.+|++||++.+|++.|.+...
T Consensus       267 ~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          267 DPKYVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             CHHHHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            322222221111 12233333333221   1223457889999999999999999999999876543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.5e-41  Score=351.40  Aligned_cols=258  Identities=27%  Similarity=0.423  Sum_probs=207.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc--------CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeC
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (611)
                      .++|...+.||+|+||.||+|..        .++..||||++... .....+.+.+|+++++++ +||||+++++++.++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            46788899999999999999965        35678999998754 344567899999999999 999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhhccCC-------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                      +..++||||+++++|.+++.....             ...+++..++.++.||++||.|||   ..+|+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            999999999999999999965432             234899999999999999999999   7899999999999999


Q ss_pred             CCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChh
Q 007248          407 DKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPL  484 (611)
Q Consensus       407 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~  484 (611)
                      +.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.|+....     .
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~  265 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V  265 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----H
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-----H
Confidence            99999999999999876543322 2224456889999999999999999999999999999999 988875321     1


Q ss_pred             HHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          485 QRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       485 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ...........         ....+......+.+++..||+.+|++||++.||++.|...
T Consensus       266 ~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          266 EELFKLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             HHHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11111111111         1112333445688999999999999999999999998754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-41  Score=363.15  Aligned_cols=265  Identities=20%  Similarity=0.198  Sum_probs=211.0

Q ss_pred             cChHHHHHHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccch---hhHHHHHHHHHHHhcCCCCceeeEeeee
Q 007248          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR---QWVDEFFNEVNLISSIEHKNLVKLLGCS  336 (611)
Q Consensus       261 ~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~  336 (611)
                      +.+.++...+++|+..++||+|+||+||++... +++.||||++.....   ...+.+.+|+.++..++||||+++++++
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345566677889999999999999999999765 478999999875321   2233488999999999999999999999


Q ss_pred             eeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEee
Q 007248          337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD  416 (611)
Q Consensus       337 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  416 (611)
                      .+++..++||||+++|+|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+||||+.++.+||+|
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcc
Confidence            9999999999999999999999642  345899999999999999999999   78999999999999999999999999


Q ss_pred             eccceeccCCCcceeecccCCccccChhhhh-----cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhh
Q 007248          417 FGLARCFAADRTHVSTAVAGTLGYMAPEYLV-----RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY  491 (611)
Q Consensus       417 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~  491 (611)
                      ||+++..............||+.|+|||++.     .+.++.++|||||||++|||++|+.||...    ...+......
T Consensus       219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~----~~~~~~~~i~  294 (437)
T 4aw2_A          219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIM  294 (437)
T ss_dssp             CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHH
T ss_pred             hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC----ChhHHHHhhh
Confidence            9999877655554455678999999999997     567899999999999999999999998532    2222222211


Q ss_pred             ccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 007248          492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAAL--RPSMAQAIML  540 (611)
Q Consensus       492 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~--RPt~~evl~~  540 (611)
                      ....  ...-+..    .......+.+++.+|+..+|+.  ||+++|+++.
T Consensus       295 ~~~~--~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          295 NHKE--RFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             THHH--HCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hccc--cccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            1100  0000111    1113345778888999888877  9999999853

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=349.40  Aligned_cols=251  Identities=20%  Similarity=0.280  Sum_probs=202.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch------hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR------QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (611)
                      .++|...+.||+|+||.||++.. .+|+.||||++.....      ...+.+.+|+.+|++++||||+++++++.++...
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            35688889999999999999965 4689999999875432      1357899999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC----CeEEeeec
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF----TPKIADFG  418 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG  418 (611)
                      ++||||+++++|.+++..   ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999943   346999999999999999999999   78999999999999999887    79999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccc
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE  498 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (611)
                      +++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||....    ..+..... ....   
T Consensus       164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~~-~~~~---  233 (326)
T 2y0a_A          164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANV-SAVN---  233 (326)
T ss_dssp             TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHH-HHTC---
T ss_pred             CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC----HHHHHHHH-HhcC---
Confidence            998765332  2234578999999999998899999999999999999999999975322    11111111 1100   


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          499 AVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       499 ~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                         ..............+.+++..||+.||++|||+.|+++
T Consensus       234 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          234 ---YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             ---CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               00100001122345788999999999999999999985

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=344.50  Aligned_cols=256  Identities=22%  Similarity=0.357  Sum_probs=206.1

Q ss_pred             CCCCCC-ccccCCceeEEEEEcC---CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          272 YFNPSK-KLGQGGAGSVYMGSLP---NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       272 ~f~~~~-~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      +|...+ .||+|+||.||+|...   ++..||||++... .....+.+.+|++++++++||||+++++++ ..+..++||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence            444555 8999999999999643   5788999999764 345567899999999999999999999999 556789999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++..  ....+++..++.++.||++||.|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus        89 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           89 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             ECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            99999999999953  3346899999999999999999999   789999999999999999999999999999876544


Q ss_pred             Ccce--eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          427 RTHV--STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       427 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      ....  .....+|..|+|||++.+..++.++||||||+++|||++ |+.|+.....    .+ .......+         
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~-~~~~i~~~---------  229 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PE-VMAFIEQG---------  229 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HH-HHHHHHTT---------
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----HH-HHHHHhcC---------
Confidence            3322  223456889999999998999999999999999999999 9999754321    11 11111111         


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCC
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCE  547 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~~  547 (611)
                      .....+......+.+++..||+.+|++||++.+|++.|......
T Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          230 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            11223334456688999999999999999999999998765433

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.3e-41  Score=342.61  Aligned_cols=260  Identities=27%  Similarity=0.427  Sum_probs=196.0

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ..++|...++||+|+||.||+|...+  .+|||++...  .....+.|.+|++++++++||||++++++. .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            35678889999999999999998743  5999998644  345567899999999999999999999965 556789999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++...  ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||++......
T Consensus        99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence            999999999999533  356899999999999999999999   789999999999999999999999999999765432


Q ss_pred             C-cceeecccCCccccChhhhh---cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          427 R-THVSTAVAGTLGYMAPEYLV---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       427 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      . ........||..|+|||++.   ...++.++||||||+++|||++|+.||.........    ............+  
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~--  247 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI----IEMVGRGSLSPDL--  247 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH----HHHHHHTSCCCCT--
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH----HHHhcccccCcch--
Confidence            2 22233456899999999986   567888999999999999999999998643322211    2222222111111  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                         .......+..+.+++..||+.+|++||++.+|++.|++..
T Consensus       248 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          248 ---SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             ---TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ---hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence               1112233456889999999999999999999999997643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5e-41  Score=353.57  Aligned_cols=253  Identities=22%  Similarity=0.253  Sum_probs=206.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++..........+.+|+++|++++||||+++++++.++...++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            46788999999999999999965 46899999999876655667899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC--CCCeEEeeeccceeccCC
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK--DFTPKIADFGLARCFAAD  426 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~  426 (611)
                      +++|+|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.  ++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            9999999998532  345899999999999999999999   789999999999999974  467999999999876543


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      ..  .....||+.|+|||++.+..++.++||||||+++|||++|+.||....    ......... ...+  ..+.    
T Consensus       205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~~~i~-~~~~--~~~~----  271 (387)
T 1kob_A          205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED----DLETLQNVK-RCDW--EFDE----  271 (387)
T ss_dssp             SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHHH-HCCC--CCCS----
T ss_pred             cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC----HHHHHHHHH-hCCC--CCCc----
Confidence            32  234568999999999999999999999999999999999999985422    112111111 1110  0111    


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      .........+.+++..||+.||++|||+.|+++.
T Consensus       272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            1112234557899999999999999999999853

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7e-42  Score=353.53  Aligned_cols=262  Identities=28%  Similarity=0.383  Sum_probs=209.4

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEcCC------CCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeee
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSI  337 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  337 (611)
                      ++...++|...+.||+|+||.||+|....      ...||||.+.... ....+.+.+|+++++++ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            44456788899999999999999996532      2479999987543 34567899999999999 8999999999999


Q ss_pred             eCCcceEEEeecCCCChhhhhhccCC-----------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          338 EGPESLLVYEYVPNRSLDQFIFDKNK-----------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       338 ~~~~~~lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                      +++..++||||+++|+|.+++.....           ...+++..++.++.||+.||.|||   ..+|+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence            99999999999999999999964321           345899999999999999999999   7899999999999999


Q ss_pred             CCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChh
Q 007248          407 DKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPL  484 (611)
Q Consensus       407 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~  484 (611)
                      +.++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|||+| |..|+......... 
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-  276 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-  276 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-
Confidence            99999999999999866443322 2234456789999999999999999999999999999999 88887543222111 


Q ss_pred             HHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          485 QRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       485 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                         .......         .....+......+.+++..||+.+|++||++.+|++.|..
T Consensus       277 ---~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          277 ---YKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             ---HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence               1111111         1111122234568899999999999999999999999864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.3e-41  Score=338.81  Aligned_cols=252  Identities=29%  Similarity=0.505  Sum_probs=201.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchh-------hHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQ-------WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (611)
                      .++|+..+.||+|+||.||+|.. .+++.||||++......       ..+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            35788889999999999999965 57899999998643321       1267899999999999999999999986654 


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCc--eecCCCCcccEEECCCCC-----eEE
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLDKDFT-----PKI  414 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~kl  414 (611)
                       ++||||+++++|.+++...  ...+++..++.++.||+.||+|||   ..+  |+||||||+|||++.++.     +||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence             7999999999999988543  346999999999999999999999   777  999999999999988776     999


Q ss_pred             eeeccceeccCCCcceeecccCCccccChhhh--hcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc
Q 007248          415 ADFGLARCFAADRTHVSTAVAGTLGYMAPEYL--VRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR  492 (611)
Q Consensus       415 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~  492 (611)
                      +|||+++....    ......||+.|+|||++  ....++.++||||||+++|||++|+.||.......  ....... .
T Consensus       171 ~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~-~  243 (287)
T 4f0f_A          171 ADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK--IKFINMI-R  243 (287)
T ss_dssp             CCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH--HHHHHHH-H
T ss_pred             CCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH--HHHHHHH-h
Confidence            99999974332    23446789999999998  44567899999999999999999999986433221  1111111 1


Q ss_pred             cCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       493 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .        .......+......+.+++..||+.+|++||++.||++.|++
T Consensus       244 ~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          244 E--------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             H--------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             c--------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            1        111122233445568899999999999999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=345.01  Aligned_cols=249  Identities=23%  Similarity=0.314  Sum_probs=194.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch--------------------------hhHHHHHHHHHHHh
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR--------------------------QWVDEFFNEVNLIS  322 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  322 (611)
                      .++|...+.||+|+||.||+|.. .+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            35788899999999999999964 5689999999865421                          12356899999999


Q ss_pred             cCCCCceeeEeeeeee--CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 007248          323 SIEHKNLVKLLGCSIE--GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK  400 (611)
Q Consensus       323 ~l~h~niv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  400 (611)
                      +++||||+++++++.+  +...++||||+++++|.+++    ....+++..++.++.||++||.|||   ..+|+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence            9999999999999986  56789999999999998876    2346999999999999999999999   7899999999


Q ss_pred             cccEEECCCCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcCc---cccccceehhHHHHHHHHhCCCCCCCC
Q 007248          401 TSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ---LTEKADVYSFGILIIEIVCGRRSNAFS  477 (611)
Q Consensus       401 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDV~S~Gvll~elltG~~p~~~~  477 (611)
                      |+|||++.++.+||+|||+++.+..... ......||+.|+|||++.+..   .+.++||||||+++|||++|+.||...
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999987654322 233567899999999987654   477899999999999999999997532


Q ss_pred             CCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          478 QDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                          ..... .........        ...........+.+++.+||+.||++||++.|+++
T Consensus       244 ----~~~~~-~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 ----RIMCL-HSKIKSQAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             ----SHHHH-HHHHHHCCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----cHHHH-HHHHhcccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence                11111 111111111        00011123345889999999999999999999863

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3e-41  Score=337.74  Aligned_cols=250  Identities=21%  Similarity=0.349  Sum_probs=202.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--CcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  346 (611)
                      ++|...+.||+|+||.||+|.. +++.||||++...  .....+.|.+|+.++++++||||+++++++.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            4678889999999999999988 4889999998754  345567899999999999999999999999877  7789999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCc--eecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||+++|+|.+++... ....+++..++.++.||+.||.|||   +.+  |+||||||+|||++.++.++|+|||++....
T Consensus        89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999653 2336899999999999999999999   677  9999999999999999999999999875432


Q ss_pred             CCCcceeecccCCccccChhhhhcCcccc---ccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTE---KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      .      ....+|+.|+|||.+.+...+.   ++||||||+++|||++|+.|+....    ...........        
T Consensus       165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~--------  226 (271)
T 3kmu_A          165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS----NMEIGMKVALE--------  226 (271)
T ss_dssp             C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC----HHHHHHHHHHS--------
T ss_pred             c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC----hHHHHHHHHhc--------
Confidence            2      2346799999999998766554   7999999999999999999975322    11111111111        


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                       ......+......+.+++..||+.+|++|||+.++++.|...
T Consensus       227 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          227 -GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             -CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence             111122333445688999999999999999999999999753

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.2e-42  Score=350.00  Aligned_cols=262  Identities=23%  Similarity=0.402  Sum_probs=206.3

Q ss_pred             cCCCCCCccccCCceeEEEEE-----cCCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC--Ccc
Q 007248          271 NYFNPSKKLGQGGAGSVYMGS-----LPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PES  342 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  342 (611)
                      ++|+..+.||+|+||.||++.     ..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            457788999999999999997     3468999999987443 34457899999999999999999999999876  668


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++||||+++++|.+++....  ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccc
Confidence            99999999999999995432  35899999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCCcc--eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhh-------cc
Q 007248          423 FAADRTH--VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY-------RS  493 (611)
Q Consensus       423 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~  493 (611)
                      .......  ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+....      .......       ..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLKMIGPTHGQMTV  249 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHHHHCSCCGGGHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhhccCCcccccCH
Confidence            7554332  2234567888999999999999999999999999999999998753221      0000000       00


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ..+...+........+......+.+++..||+.+|++|||+.++++.|+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            01111122222223344455678899999999999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=350.40  Aligned_cols=266  Identities=18%  Similarity=0.245  Sum_probs=199.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC----CCCEEEEEEeeccchh-----------hHHHHHHHHHHHhcCCCCceeeEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFNTRQ-----------WVDEFFNEVNLISSIEHKNLVKLLG  334 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  334 (611)
                      .++|...+.||+|+||.||+|...    .+..+|||++......           ..+.+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357888999999999999999764    5789999998754321           1224678899999999999999999


Q ss_pred             eeee----CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC
Q 007248          335 CSIE----GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF  410 (611)
Q Consensus       335 ~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  410 (611)
                      ++..    +...++||||+ +++|.+++...   ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCC
Confidence            9887    67889999999 99999999543   36999999999999999999999   78999999999999999887


Q ss_pred             --CeEEeeeccceeccCCCcc------eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCC
Q 007248          411 --TPKIADFGLARCFAADRTH------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS  482 (611)
Q Consensus       411 --~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~  482 (611)
                        .+||+|||+++.+......      ......||..|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999876432211      11345789999999999999999999999999999999999999864322222


Q ss_pred             hhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          483 PLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       483 ~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                      ............ +...+.....   .......+.+++..||+.+|++||++.+|++.|.+...
T Consensus       269 ~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          269 AVQTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            221111111110 1010000000   01233458899999999999999999999999986554

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.4e-41  Score=347.93  Aligned_cols=253  Identities=23%  Similarity=0.360  Sum_probs=194.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc---
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES---  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  342 (611)
                      .++|+..+.||+|+||.||++.. .+++.||||++...   .....+.|.+|++++++++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46788899999999999999964 67899999998754   334456789999999999999999999998876554   


Q ss_pred             -eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          343 -LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       343 -~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                       ++||||+++++|.+++...   ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             9999999999999999643   35899999999999999999999   7899999999999999999999999999998


Q ss_pred             eccCCCcc--eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          422 CFAADRTH--VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       422 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      .+......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...    ......+...........
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~----~~~~~~~~~~~~~~~~~~  240 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD----SPVSVAYQHVREDPIPPS  240 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHCCCCCHH
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHhcCCCCCcc
Confidence            66543221  223456899999999999999999999999999999999999997532    222222222222111000


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                             .........+.+++.+||+.||++||+..+++.
T Consensus       241 -------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          241 -------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             -------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             -------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence                   001112345789999999999999997776664

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-41  Score=347.41  Aligned_cols=251  Identities=18%  Similarity=0.208  Sum_probs=203.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .++|...+.||+|+||.||++.. .+++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            46788899999999999999965 468899999887543 3456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC--CCCeEEeeeccceeccCC
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK--DFTPKIADFGLARCFAAD  426 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~  426 (611)
                      +++++|.+++..  ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.  ++.+||+|||+++.+...
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999943  2346899999999999999999999   789999999999999997  789999999999876543


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      .  ......||+.|+|||++.+..++.++||||||+++|||++|+.||....    ..+...... ....      ....
T Consensus       158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~-~~~~------~~~~  224 (321)
T 1tki_A          158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----NQQIIENIM-NAEY------TFDE  224 (321)
T ss_dssp             C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHH-HTCC------CCCH
T ss_pred             C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC----HHHHHHHHH-cCCC------CCCh
Confidence            2  2334568999999999998889999999999999999999999985322    111111111 1110      0000


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .........+.+++.+|++.||++|||+.|+++
T Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            000122345789999999999999999999996

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=347.03  Aligned_cols=261  Identities=21%  Similarity=0.287  Sum_probs=204.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeee----CCcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE----GPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  344 (611)
                      .++|+..+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46788899999999999999965 6789999999977767777889999999999999999999999873    346789


Q ss_pred             EEeecCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          345 VYEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      ||||+++++|.+++... .....+++..++.++.||++||.|||   ..+|+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999999642 23456999999999999999999999   789999999999999999999999999998764


Q ss_pred             cCCCcc--------eeecccCCccccChhhhhcCc---cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc
Q 007248          424 AADRTH--------VSTAVAGTLGYMAPEYLVRGQ---LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR  492 (611)
Q Consensus       424 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~  492 (611)
                      ......        ......|+..|+|||++....   ++.++||||||+++|||++|+.||..............    
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----  260 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV----  260 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH----
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh----
Confidence            321110        011345799999999987543   68899999999999999999999753211111111110    


Q ss_pred             cCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       493 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                              ........+......+.+++..||+.+|++||++.+|++.|....
T Consensus       261 --------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          261 --------QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             --------HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             --------hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence                    001111112233456889999999999999999999999998654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.3e-41  Score=342.86  Aligned_cols=254  Identities=22%  Similarity=0.341  Sum_probs=201.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCC----CCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      .++|...+.||+|+||.||+|...+    +..||||++... .....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4678888999999999999996532    346999998755 34456789999999999999999999999865 45789


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++++|.+++...  ...+++..++.++.||++||.|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            99999999999999543  245899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .....    .....        
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-~~~~~----~~~~~--------  231 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVIGV----LEKGD--------  231 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-GHHHH----HHHTC--------
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-HHHHH----HhcCC--------
Confidence            443333344567889999999999999999999999999999998 99997543221 11111    11110        


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                       ....+......+.+++.+||+.+|++||++.|+++.|.+
T Consensus       232 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          232 -RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence             011122234558899999999999999999999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=351.82  Aligned_cols=255  Identities=26%  Similarity=0.454  Sum_probs=198.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC-----CCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN-----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++|...+.||+|+||.||+|....     +..||||++... .......|.+|++++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            345567899999999999996542     246999998754 33445679999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++++|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999999543  346899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCcce--eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          425 ADRTHV--STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       425 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      ......  .....++..|+|||++.+..++.++||||||+++|||++ |+.|+.....    .+ .......+       
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----~~-~~~~~~~~-------  266 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HE-VMKAINDG-------  266 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HH-HHHHHHTT-------
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH----HH-HHHHHHCC-------
Confidence            432211  123346788999999999999999999999999999999 9998743211    11 11111111       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                        .....+......+.+++.+||+.+|++||++.+|++.|...
T Consensus       267 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          267 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             --CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              11122334455688999999999999999999999998654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.5e-41  Score=345.33  Aligned_cols=269  Identities=25%  Similarity=0.349  Sum_probs=214.0

Q ss_pred             ccChHHHHHHhcCCCCCCccccCCceeEEEEEc------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceee
Q 007248          260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVK  331 (611)
Q Consensus       260 ~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~  331 (611)
                      .+....++...++|...+.||+|+||.||+|..      .+++.||||++.... ....+.+.+|++++.++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            345555666678899999999999999999963      356899999987543 34456899999999999 7999999


Q ss_pred             EeeeeeeCC-cceEEEeecCCCChhhhhhccCC-------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecC
Q 007248          332 LLGCSIEGP-ESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR  397 (611)
Q Consensus       332 l~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  397 (611)
                      +++++...+ ..++||||+++++|.+++.....             ...+++..++.++.||++||.|||   +.+|+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence            999987655 48999999999999999965432             123889999999999999999999   7899999


Q ss_pred             CCCcccEEECCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCC
Q 007248          398 DIKTSNILLDKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNA  475 (611)
Q Consensus       398 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~  475 (611)
                      ||||+|||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |+.|+.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999999999999999876543332 2234567889999999999999999999999999999998 998875


Q ss_pred             CCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          476 FSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       476 ~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ........    ......+..         ...+......+.+++.+||+.+|++||++.||++.|...
T Consensus       253 ~~~~~~~~----~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          253 GVKIDEEF----CRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             TCCCSHHH----HHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccchhHHH----HHHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            43322111    111111111         111222345588999999999999999999999998653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.1e-41  Score=354.49  Aligned_cols=248  Identities=21%  Similarity=0.270  Sum_probs=198.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (611)
                      .++|+..++||+|+||+||+++.+ +++.||||++....   .+..+.+..|..++.++ +||||+++++++.+++..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            356888999999999999999654 57899999997542   23345688999999887 89999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999999543   45899999999999999999999   7899999999999999999999999999997533


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCC----hhHHHHHhhccCcccccc
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS----PLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~i  500 (611)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........    .............     
T Consensus       205 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-----  278 (396)
T 4dc2_A          205 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----  278 (396)
T ss_dssp             CTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred             cCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence            222 223456799999999999999999999999999999999999999864432211    1111222111111     


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSM  534 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~  534 (611)
                           ..++......+.+++..||+.||++||+.
T Consensus       279 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -----cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                 11233344567899999999999999985

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.1e-41  Score=344.71  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=201.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC-C-------CEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN-G-------TTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (611)
                      ++|...+.||+|+||.||+|.... +       ..||+|++........+.|.+|++++++++||||+++++++.+++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            467788999999999999996543 3       47999999777667778899999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC--------eEE
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT--------PKI  414 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl  414 (611)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.        +||
T Consensus        88 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             EEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeee
Confidence            9999999999999999543  334899999999999999999999   789999999999999998887        999


Q ss_pred             eeeccceeccCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc
Q 007248          415 ADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS  493 (611)
Q Consensus       415 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  493 (611)
                      +|||++......     ....++..|+|||++.+ ..++.++||||||+++|||++|..|+.........    ......
T Consensus       163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~----~~~~~~  233 (289)
T 4fvq_A          163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK----LQFYED  233 (289)
T ss_dssp             CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----HHHHHT
T ss_pred             ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH----HHHhhc
Confidence            999998644321     23457889999999987 67899999999999999999976654322221111    111111


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                      .       ..+    +......+.+++..||+.+|++|||+.++++.|.+...
T Consensus       234 ~-------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          234 R-------HQL----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             T-------CCC----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             c-------CCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            0       011    11112336789999999999999999999999986543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-40  Score=348.53  Aligned_cols=252  Identities=20%  Similarity=0.277  Sum_probs=203.5

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ..++|+..+.||+|+||.||++.. .+|+.||||++...  .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            356788999999999999999965 46899999998754  234557789999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC---CeEEeeecccee
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF---TPKIADFGLARC  422 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~  422 (611)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||   ..+|+||||||+|||++.++   .+||+|||++..
T Consensus       107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            999999999999853   346899999999999999999999   78999999999999998654   599999999986


Q ss_pred             ccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      .....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||....    ... .+..+..+..      
T Consensus       181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~----~~~-~~~~i~~~~~------  247 (362)
T 2bdw_A          181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHR-LYAQIKAGAY------  247 (362)
T ss_dssp             CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHH-HHHHHHHTCC------
T ss_pred             ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HHH-HHHHHHhCCC------
Confidence            65332  2234679999999999999899999999999999999999999975321    111 1111111111      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .............+.+++..||+.||++||++.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          248 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0000011123456789999999999999999999985

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.5e-42  Score=350.01  Aligned_cols=244  Identities=25%  Similarity=0.315  Sum_probs=192.8

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeecc--chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..++||+|+||+||+|... +|+.||||++...  .......+..|+..+.++ +||||+++++++.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57889999999999999999665 7999999987643  233344566677666655 9999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+ +++|.+++....  ..++|..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus       137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 779998885542  45999999999999999999999   789999999999999999999999999999866433


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      .  ......||+.|+|||++.+ .++.++||||||+++|||++|..|+...        ..+.........        .
T Consensus       211 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~--------~~~~~~~~~~~~--------~  271 (311)
T 3p1a_A          211 G--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG--------EGWQQLRQGYLP--------P  271 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH--------HHHHHHTTTCCC--------H
T ss_pred             C--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHHHHHhccCCC--------c
Confidence            2  2334568999999998865 7899999999999999999997664321        112222221111        1


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .++......+.+++..|++.+|++|||+.|+++
T Consensus       272 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            111223456889999999999999999999985

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.9e-41  Score=339.99  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=198.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|+..+.||+|+||.||+|...+|+.||||++....  ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4688889999999999999988889999999986543  22346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++ +|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            975 898888543  345899999999999999999999   7899999999999999999999999999997654322 


Q ss_pred             ceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc------cc--cc
Q 007248          429 HVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK------LV--EA  499 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~--~~  499 (611)
                      .......+|+.|+|||++.+. .++.++||||||+++|||++|+.||....... .+...........      ..  ..
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhcccc
Confidence            122345689999999998764 58999999999999999999999985432211 1111111111100      00  00


Q ss_pred             cCCCCC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          500 VDPNLK-------DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       500 id~~l~-------~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .++.+.       ..........+.+++.+|++.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111111       0111223456789999999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.9e-41  Score=339.76  Aligned_cols=260  Identities=17%  Similarity=0.195  Sum_probs=208.0

Q ss_pred             hcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .++|+..+.||+|+||.||+|. ..+|+.||||++....  ..+.+.+|+.++..+ +|+|++++++++.++...++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            4578889999999999999996 4678999999886443  234678999999999 89999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC-----eEEeeecccee
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT-----PKIADFGLARC  422 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGla~~  422 (611)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999999643  235899999999999999999999   899999999999999987776     99999999987


Q ss_pred             ccCCCcc------eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc---c
Q 007248          423 FAADRTH------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR---S  493 (611)
Q Consensus       423 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~---~  493 (611)
                      .......      ......||..|+|||++.+..++.++||||||+++|||++|+.||........ .........   .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~  239 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQKYERIGEKKQS  239 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-HHHHHHHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-HHHHHHHHhhccC
Confidence            6544321      22356789999999999999999999999999999999999999875432221 111111110   1


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCC
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCE  547 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~~  547 (611)
                      ....+.         .......+.+++..||+.+|++||++++|++.|.+....
T Consensus       240 ~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          240 TPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             SCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            111111         112234588999999999999999999999998765443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-40  Score=340.54  Aligned_cols=244  Identities=25%  Similarity=0.314  Sum_probs=202.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..+.||+|+||.||++.. .+|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            5688889999999999999965 468999999987542   234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            999999999999543   35899999999999999999999   899999999999999999999999999999865432


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                          .....||+.|+|||++.+..++.++||||||+++|||++|+.||....    ........... .        +  
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~-~--------~--  220 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----TMKTYEKILNA-E--------L--  220 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHC-C--------C--
T ss_pred             ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhC-C--------C--
Confidence                234679999999999999999999999999999999999999985321    22221121111 1        1  


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                      .++......+.+++.+|++.+|++||     +++++++
T Consensus       221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            12223345678999999999999999     8888874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.5e-41  Score=344.89  Aligned_cols=263  Identities=25%  Similarity=0.400  Sum_probs=208.7

Q ss_pred             cCCCCCCccccCCceeEEEEE-----cCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC--cce
Q 007248          271 NYFNPSKKLGQGGAGSVYMGS-----LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP--ESL  343 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~  343 (611)
                      ++|+..+.||+|+||.||++.     ..+++.||||++........+.|.+|++++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            457788999999999999997     3468999999998776667788999999999999999999999887654  789


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      +||||+++++|.+++...  ...+++..++.++.||++||.|||   ..+|+||||||+|||++.++.+||+|||++...
T Consensus       121 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            999999999999999643  235899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCcce--eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc--------
Q 007248          424 AADRTHV--STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS--------  493 (611)
Q Consensus       424 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~--------  493 (611)
                      .......  .....++..|+|||.+.+..++.++||||||+++|||+||+.|+....      .........        
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~------~~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP------AEFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH------HHHHHHHCTTCCTHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH------HHHHHhhccccchhhhH
Confidence            5443321  223456778999999999999999999999999999999998865321      000000000        


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ..+.+.+........+......+.+++.+||+.+|++||++.||++.|++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            011112222222223344556788999999999999999999999998653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.5e-41  Score=352.04  Aligned_cols=254  Identities=20%  Similarity=0.247  Sum_probs=202.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch-----hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcce
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR-----QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (611)
                      .+.|+..+.||+|+||.||++.. .+|+.||||++.....     ...+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            35688899999999999999965 5689999999864321     23578999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhhccC-CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC---eEEeeecc
Q 007248          344 LVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT---PKIADFGL  419 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGl  419 (611)
                      +||||+++++|.+++.... ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999998885432 2345899999999999999999999   789999999999999987655   99999999


Q ss_pred             ceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          420 ARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       420 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      +........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||....      .........+...  
T Consensus       180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~i~~~~~~--  250 (351)
T 3c0i_A          180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------ERLFEGIIKGKYK--  250 (351)
T ss_dssp             CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------HHHHHHHHHTCCC--
T ss_pred             eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------HHHHHHHHcCCCC--
Confidence            987654322 2334579999999999999999999999999999999999999985421      1111111111110  


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..+..    .......+.+++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00000    0112345789999999999999999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.6e-41  Score=352.72  Aligned_cols=246  Identities=23%  Similarity=0.289  Sum_probs=195.7

Q ss_pred             CCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCCh
Q 007248          276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      .+.||+|+||.||+|.. .+|+.||||++........+.|.+|+++|++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56799999999999964 57899999999876666678899999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE--CCCCCeEEeeeccceeccCCCcceee
Q 007248          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL--DKDFTPKIADFGLARCFAADRTHVST  432 (611)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfGla~~~~~~~~~~~~  432 (611)
                      .+++...  ...+++..++.++.||++||.|||   +.+|+||||||+|||+  ++++.+||+|||+++.......  ..
T Consensus       174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~  246 (373)
T 2x4f_A          174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK  246 (373)
T ss_dssp             HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred             HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence            9988542  345899999999999999999999   7899999999999999  5678899999999987654322  23


Q ss_pred             cccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHH
Q 007248          433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQ  512 (611)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~  512 (611)
                      ...||+.|+|||++....++.++||||||+++|||++|+.||.....    .+........ ..      .+........
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~~-~~------~~~~~~~~~~  315 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND----AETLNNILAC-RW------DLEDEEFQDI  315 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHT-CC------CSCSGGGTTS
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhc-cC------CCChhhhccC
Confidence            45689999999999989999999999999999999999999854321    1111111111 10      0000001122


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          513 VCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       513 ~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ...+.+++..|++.+|++||++.|+++
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            345789999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=352.87  Aligned_cols=270  Identities=21%  Similarity=0.263  Sum_probs=213.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC--cceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP--ESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  345 (611)
                      .++|...++||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            356888899999999999999654 58999999987543 334677889999999999999999999988765  67999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE----CCCCCeEEeeeccce
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLAR  421 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla~  421 (611)
                      |||+++|+|.+++........+++..++.++.||+.||.|||   ..+|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999966544455999999999999999999999   7899999999999999    777889999999998


Q ss_pred             eccCCCcceeecccCCccccChhhhhc--------CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVR--------GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS  493 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  493 (611)
                      ......  ......||..|+|||++..        ..++.++||||||+++|||++|+.||..........+........
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            764432  2234568999999999875        577889999999999999999999987554433333333332222


Q ss_pred             Ccc---ccc---c--------CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          494 NKL---VEA---V--------DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       494 ~~~---~~~---i--------d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ...   ...   .        +.......+......+.+++..||+.||++||+++|+++.|...
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            110   000   0        01111234466777788999999999999999999999887654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.8e-41  Score=348.99  Aligned_cols=251  Identities=25%  Similarity=0.301  Sum_probs=188.3

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ..++|+..+.||+|+||.||+|... +++.||||++....  ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4567888999999999999999765 57899999987543  34678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC---CCCeEEeeeccceecc
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLARCFA  424 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~~~  424 (611)
                      |+++++|.+++..   ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999999953   345899999999999999999999   789999999999999975   8899999999998654


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ...  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........    ...+.....      ..
T Consensus       203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~i~~~~~------~~  270 (349)
T 2w4o_A          203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM----FRRILNCEY------YF  270 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH----HHHHHTTCC------CC
T ss_pred             ccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH----HHHHHhCCC------cc
Confidence            322  223456899999999999989999999999999999999999997543221111    111111111      01


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ...........+.+++.+|++.||++|||+.|+++
T Consensus       271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11112233456889999999999999999999985

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.8e-41  Score=349.74  Aligned_cols=262  Identities=22%  Similarity=0.196  Sum_probs=203.6

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc-----chhhHHHHHHHHHHHhcCCCCceeeEeeeee
Q 007248          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLVKLLGCSI  337 (611)
Q Consensus       264 ~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  337 (611)
                      .++....++|+..+.||+|+||.||+|.. .++..||||++...     .....+.+.+|++++++++||||+++++++.
T Consensus        19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   98 (345)
T 3hko_A           19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE   98 (345)
T ss_dssp             BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence            34667788999999999999999999965 56889999998644     2345678999999999999999999999999


Q ss_pred             eCCcceEEEeecCCCChhhhhhccC-------------------------------------CCccCChhHHHHHHHHHH
Q 007248          338 EGPESLLVYEYVPNRSLDQFIFDKN-------------------------------------KTKLLNWNKRFNIILGTA  380 (611)
Q Consensus       338 ~~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia  380 (611)
                      +++..++||||+++|+|.+++....                                     ....+++..++.++.||+
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A           99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            9999999999999999999984210                                     022346778889999999


Q ss_pred             HHHHHHhcCCCCceecCCCCcccEEECCCC--CeEEeeeccceeccCCCcc---eeecccCCccccChhhhhc--Ccccc
Q 007248          381 EGLAYLHGGSETRIIHRDIKTSNILLDKDF--TPKIADFGLARCFAADRTH---VSTAVAGTLGYMAPEYLVR--GQLTE  453 (611)
Q Consensus       381 ~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~  453 (611)
                      .||+|||   ..+|+||||||+|||++.++  .+||+|||+++.+......   ......||+.|+|||++.+  ..++.
T Consensus       179 ~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          179 SALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            9999999   78999999999999998776  8999999999876432221   2335678999999999975  67889


Q ss_pred             ccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 007248          454 KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPS  533 (611)
Q Consensus       454 ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt  533 (611)
                      ++||||||+++|||++|+.||.....    .+...........       ............+.+++..||+.+|++||+
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVND----ADTISQVLNKKLC-------FENPNYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCC-------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCh----HHHHHHHHhcccc-------cCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence            99999999999999999999753321    1222222111110       000111123456889999999999999999


Q ss_pred             HHHHHH
Q 007248          534 MAQAIM  539 (611)
Q Consensus       534 ~~evl~  539 (611)
                      +.++++
T Consensus       325 ~~~~l~  330 (345)
T 3hko_A          325 AMRALQ  330 (345)
T ss_dssp             HHHHHH
T ss_pred             HHHHhc
Confidence            999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.3e-41  Score=348.45  Aligned_cols=265  Identities=23%  Similarity=0.386  Sum_probs=199.1

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEcC----CCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeee
Q 007248          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSI  337 (611)
Q Consensus       264 ~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  337 (611)
                      +++....++|...+.||+|+||.||+|...    .+..||||++...  .....+.+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            344445677888899999999999999653    3458999998654  3445678999999999999999999999988


Q ss_pred             eCCc-----ceEEEeecCCCChhhhhhcc---CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC
Q 007248          338 EGPE-----SLLVYEYVPNRSLDQFIFDK---NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD  409 (611)
Q Consensus       338 ~~~~-----~~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  409 (611)
                      +...     .++||||+++++|.+++...   .....+++..++.++.||++||.|||   ..+|+||||||+|||++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCC
Confidence            7553     49999999999999998532   23456999999999999999999999   8899999999999999999


Q ss_pred             CCeEEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHH
Q 007248          410 FTPKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRV  487 (611)
Q Consensus       410 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~  487 (611)
                      +.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... ..... 
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~-  261 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-EMYDY-  261 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHH-
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-HHHHH-
Confidence            9999999999986643322 12234457889999999999999999999999999999999 77776533211 11111 


Q ss_pred             HHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          488 WTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       488 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                         ....         .....+......+.+++..||+.+|++||++.+|++.|....
T Consensus       262 ---~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          262 ---LLHG---------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             ---HHTT---------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHcC---------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               1111         111223334456889999999999999999999999997654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=377.09  Aligned_cols=247  Identities=23%  Similarity=0.374  Sum_probs=197.7

Q ss_pred             ccccCCceeEEEEEcC---CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCCCC
Q 007248          278 KLGQGGAGSVYMGSLP---NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRS  353 (611)
Q Consensus       278 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs  353 (611)
                      .||+|+||.||+|.+.   ++..||||+++... ....++|.+|+++|++++|||||++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999653   46789999987643 3456889999999999999999999999876 56899999999999


Q ss_pred             hhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce--e
Q 007248          354 LDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--S  431 (611)
Q Consensus       354 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~--~  431 (611)
                      |.+++...  ...+++..++.++.||+.||+|||   ..+|+||||||+||||++++.+||+|||+++.........  .
T Consensus       422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            99999543  456999999999999999999999   7899999999999999999999999999998664332221  1


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCH
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPA  510 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~  510 (611)
                      ....++..|+|||++....++.++||||||++||||++ |+.|+......    + +...+..         ..+...+.
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~-~~~~i~~---------~~~~~~p~  562 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----E-VMAFIEQ---------GKRMECPP  562 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----H-HHHHHHT---------TCCCCCCT
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----H-HHHHHHc---------CCCCCCCC
Confidence            22345689999999999999999999999999999998 99997543221    1 1111111         11223344


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          511 EQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       511 ~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      .....+.+|+..||+.+|++||++.+|++.|...
T Consensus       563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            4556789999999999999999999999998753

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.8e-40  Score=342.65  Aligned_cols=271  Identities=25%  Similarity=0.327  Sum_probs=210.6

Q ss_pred             ChHHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhc--CCCCceeeEeeeeeeC
Q 007248          262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISS--IEHKNLVKLLGCSIEG  339 (611)
Q Consensus       262 ~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~  339 (611)
                      +...-....++|...+.||+|+||.||+|.. +|+.||||++...   ..+.+.+|++++..  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3333455667899999999999999999987 5899999998643   34567889998887  7999999999999877


Q ss_pred             C----cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCC-----CCceecCCCCcccEEECCCC
Q 007248          340 P----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS-----ETRIIHRDIKTSNILLDKDF  410 (611)
Q Consensus       340 ~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~  410 (611)
                      .    ..++||||+++|+|.+++..    ..+++..++.++.||+.||.|||...     +.+|+||||||+|||++.++
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred             CCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence            6    78999999999999999953    35899999999999999999999321     47899999999999999999


Q ss_pred             CeEEeeeccceeccCCCcc---eeecccCCccccChhhhhcC------ccccccceehhHHHHHHHHhC----------C
Q 007248          411 TPKIADFGLARCFAADRTH---VSTAVAGTLGYMAPEYLVRG------QLTEKADVYSFGILIIEIVCG----------R  471 (611)
Q Consensus       411 ~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDV~S~Gvll~elltG----------~  471 (611)
                      .+||+|||++.........   ......||..|+|||++.+.      .++.++||||||+++|||+||          +
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            9999999999876554332   12345789999999999765      445789999999999999999          5


Q ss_pred             CCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          472 RSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD-FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       472 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~-~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      .|+.....................    ..+.+... ...+....+.+++.+||+.+|++||++.+|++.|.+.
T Consensus       265 ~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          265 LPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCccccCcCcccHHHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            565443332222222222221111    11111111 1235667899999999999999999999999999754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.7e-41  Score=348.52  Aligned_cols=248  Identities=23%  Similarity=0.300  Sum_probs=199.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (611)
                      .++|+..+.||+|+||+||++.. .+|+.||||++...   .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            46788999999999999999965 46899999999754   234456788999999988 79999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++...
T Consensus       102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999999543   35899999999999999999999   7899999999999999999999999999997533


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....    ..+..... ....         
T Consensus       176 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~~~~i-~~~~---------  240 (353)
T 3txo_A          176 CNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN----EDDLFEAI-LNDE---------  240 (353)
T ss_dssp             C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHH-HHCC---------
T ss_pred             cCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC----HHHHHHHH-HcCC---------
Confidence            222 22345679999999999999899999999999999999999999985332    11111111 1111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSM------AQAIM  539 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~------~evl~  539 (611)
                       ..++......+.+++..|++.+|++||++      .|+++
T Consensus       241 -~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 -VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence             11233334557889999999999999998      77764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.7e-41  Score=357.79  Aligned_cols=260  Identities=19%  Similarity=0.200  Sum_probs=207.9

Q ss_pred             hHHHHHHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeee
Q 007248          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIE  338 (611)
Q Consensus       263 ~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  338 (611)
                      ..++....++|+..++||+|+||+||++... +++.||||++....   ....+.+.+|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3445556788999999999999999999654 58999999986532   1223458899999999999999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeec
Q 007248          339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       339 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                      +...++||||+++|+|.+++..    ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccc
Confidence            9999999999999999999853    24899999999999999999999   7899999999999999999999999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcCc----cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ----LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN  494 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  494 (611)
                      +++..............||+.|+|||++.+..    ++.++|||||||++|||++|+.||...    .............
T Consensus       214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~~i~~~~  289 (410)
T 3v8s_A          214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKIMNHK  289 (410)
T ss_dssp             TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTHH
T ss_pred             eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC----ChhhHHHHHHhcc
Confidence            99877655444445678999999999998655    889999999999999999999998532    2222211111110


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 007248          495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAAL--RPSMAQAIML  540 (611)
Q Consensus       495 ~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~--RPt~~evl~~  540 (611)
                      .....       +........+.+++..|++.+|++  ||+++||++.
T Consensus       290 ~~~~~-------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          290 NSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHCCC-------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ccccC-------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            00000       001122345788999999999988  9999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=351.44  Aligned_cols=255  Identities=24%  Similarity=0.402  Sum_probs=197.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCE----EEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTT----VAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++|+..+.||+|+||.||+|.. .+++.    ||+|.+... .....+.+.+|+.++++++||||+++++++..+. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            5688889999999999999964 34554    577776533 3345678999999999999999999999998754 889


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        94 v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            99999999999999643  345899999999999999999999   7899999999999999999999999999998764


Q ss_pred             CCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          425 ADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       425 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ..... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...    .         .+..
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~----~---------~~~~  234 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EIS----S---------ILEK  234 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHH----H---------HHHT
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHH----H---------HHHc
Confidence            43322 2223456789999999999999999999999999999999 99997533211 111    1         1111


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      ......+......+.+++..||+.+|++||++.|+++.|....
T Consensus       235 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          235 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1122223344556889999999999999999999999997643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9e-41  Score=357.66  Aligned_cols=254  Identities=19%  Similarity=0.243  Sum_probs=203.4

Q ss_pred             HHhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ...++|+..+.||+|+||.||++. ..+|+.+|+|++....  ....+.+.+|++++++++||||+++++++.+++..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            345678899999999999999995 4578999999987543  3445678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC---CCCCeEEeeeccce
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR  421 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~  421 (611)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++   +++.+||+|||++.
T Consensus        88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            99999999999998543   45899999999999999999999   78999999999999998   46789999999997


Q ss_pred             eccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      ....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....    ... .......+.. ... 
T Consensus       162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~----~~~-~~~~i~~~~~-~~~-  233 (444)
T 3soa_A          162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED----QHR-LYQQIKAGAY-DFP-  233 (444)
T ss_dssp             CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHH-HHHHHHHTCC-CCC-
T ss_pred             EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc----HHH-HHHHHHhCCC-CCC-
Confidence            6654322 2234679999999999999899999999999999999999999975321    111 1121211111 000 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                          ..........+.+++..|++.||++|||+.|+++
T Consensus       234 ----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          234 ----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             ----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                0111123345789999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-41  Score=357.75  Aligned_cols=264  Identities=19%  Similarity=0.188  Sum_probs=208.5

Q ss_pred             cChHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeee
Q 007248          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCS  336 (611)
Q Consensus       261 ~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~  336 (611)
                      +.++++....++|+..+.||+|+||+||++.. .+|+.||||++....   ....+.+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            34455556678999999999999999999966 468999999997532   22334588999999999999999999999


Q ss_pred             eeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEee
Q 007248          337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD  416 (611)
Q Consensus       337 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  416 (611)
                      .+++..++||||+++|+|.+++....  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEee
Confidence            99999999999999999999996432  35899999999999999999999   78999999999999999999999999


Q ss_pred             eccceeccCCCcceeecccCCccccChhhhh-------cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHH
Q 007248          417 FGLARCFAADRTHVSTAVAGTLGYMAPEYLV-------RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWT  489 (611)
Q Consensus       417 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~  489 (611)
                      ||+++..............||+.|+|||++.       ...++.++|||||||++|||++|+.||....    ..+....
T Consensus       206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~----~~~~~~~  281 (412)
T 2vd5_A          206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS----TAETYGK  281 (412)
T ss_dssp             CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHH
T ss_pred             chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC----HHHHHHH
Confidence            9999877655443444568999999999997       3578999999999999999999999985322    1111111


Q ss_pred             hhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 007248          490 LYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALR---PSMAQAIML  540 (611)
Q Consensus       490 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~R---Pt~~evl~~  540 (611)
                      ......  ...-+.+    +......+.+++.+|++ +|++|   |+++|+++.
T Consensus       282 i~~~~~--~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          282 IVHYKE--HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHhccc--CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            111000  0000111    12233457889999999 99998   689998753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=349.25  Aligned_cols=249  Identities=23%  Similarity=0.326  Sum_probs=203.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|++.+.||+|+||.||++.. .+++.||||++....   ....+.+.+|+++|+.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            5688899999999999999965 468899999986542   334578899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999954   345899999999999999999999   789999999999999999999999999999876433


Q ss_pred             CcceeecccCCccccChhhhhc---CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVR---GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      .  ......||+.|+|||++..   ..++.++|||||||++|||++|+.||.......  ............        
T Consensus       169 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~~~--------  236 (384)
T 4fr4_A          169 T--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTFETTV--------  236 (384)
T ss_dssp             C--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHHHHCC--------
T ss_pred             C--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhhcc--------
Confidence            2  2345679999999999864   458999999999999999999999986433221  111111111111        


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPS-MAQAIM  539 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt-~~evl~  539 (611)
                        ..++......+.+++..||+.+|++||+ +++|.+
T Consensus       237 --~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 --VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence              1123334456889999999999999998 777764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.4e-40  Score=345.24  Aligned_cols=247  Identities=21%  Similarity=0.276  Sum_probs=199.8

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeecc---chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ++|+..+.||+|+||.||++..+ +++.||||++...   .....+.+.+|+.++.++ +||||+++++++.+++..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46788899999999999999654 6899999999754   334566788999999988 899999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            9999999999999543   35899999999999999999999   78999999999999999999999999999975432


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCC----ChhHHHHHhhccCccccccC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA----SPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~id  501 (611)
                      .. .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......    ..............      
T Consensus       163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------  235 (345)
T 3a8x_A          163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------  235 (345)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------
T ss_pred             CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------
Confidence            22 22345679999999999999999999999999999999999999986432211    11111111111111      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSM  534 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~  534 (611)
                          ..++......+.+++.+||+.||++||+.
T Consensus       236 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 ----IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ----CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                11233344567899999999999999995

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.7e-41  Score=347.10  Aligned_cols=261  Identities=28%  Similarity=0.417  Sum_probs=196.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHH--HhcCCCCceeeEeeeeee-----CCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNL--ISSIEHKNLVKLLGCSIE-----GPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~  342 (611)
                      .++|+..+.||+|+||.||+|.. +++.||||++.....   ..+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            35788889999999999999977 789999999875432   344445554  456899999999985432     2356


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCC---------ceecCCCCcccEEECCCCCeE
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET---------RIIHRDIKTSNILLDKDFTPK  413 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~---------~ivH~Dlkp~NIll~~~~~~k  413 (611)
                      ++||||+++|+|.+++...    ..++..++.++.||++||.|||   ..         +|+||||||+|||++.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEE
Confidence            8999999999999999433    3589999999999999999999   66         999999999999999999999


Q ss_pred             EeeeccceeccCCCc-------ceeecccCCccccChhhhhc-------CccccccceehhHHHHHHHHhCCCCCCCCCC
Q 007248          414 IADFGLARCFAADRT-------HVSTAVAGTLGYMAPEYLVR-------GQLTEKADVYSFGILIIEIVCGRRSNAFSQD  479 (611)
Q Consensus       414 l~DfGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDV~S~Gvll~elltG~~p~~~~~~  479 (611)
                      |+|||+++.+.....       .......||..|+|||++.+       ..++.++||||||+++|||++|+.|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987654321       11224568999999999976       4677899999999999999999887655433


Q ss_pred             CCChhH-------------HHHHhhccCccccccCCCCCCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          480 SASPLQ-------------RVWTLYRSNKLVEAVDPNLKDD--FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       480 ~~~~~~-------------~~~~~~~~~~~~~~id~~l~~~--~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ......             ..........    ..+.+...  ........+.+++.+||+.||++|||+.||++.|...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            221110             0001111111    11111111  1223566799999999999999999999999998764


Q ss_pred             C
Q 007248          545 V  545 (611)
Q Consensus       545 ~  545 (611)
                      .
T Consensus       317 l  317 (336)
T 3g2f_A          317 M  317 (336)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=350.28  Aligned_cols=258  Identities=22%  Similarity=0.262  Sum_probs=190.3

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-CCceeeEeeeee--------
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSI--------  337 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------  337 (611)
                      ....+|+..++||+|+||.||++.. .+++.||||++........+.+.+|+.++.++. ||||+++++++.        
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            3345788899999999999999964 578999999997777777788999999999996 999999999984        


Q ss_pred             eCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCc--eecCCCCcccEEECCCCCeEEe
Q 007248          338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLDKDFTPKIA  415 (611)
Q Consensus       338 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~  415 (611)
                      .....++||||+. |+|.+++........+++..++.++.||+.||.|||   ..+  |+||||||+|||++.++.+||+
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEe
Confidence            3334789999995 799999865444557999999999999999999999   777  9999999999999999999999


Q ss_pred             eeccceeccCCCcce-----------eecccCCccccChhhh---hcCccccccceehhHHHHHHHHhCCCCCCCCCCCC
Q 007248          416 DFGLARCFAADRTHV-----------STAVAGTLGYMAPEYL---VRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA  481 (611)
Q Consensus       416 DfGla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~  481 (611)
                      |||++..........           .....||+.|+|||++   .+..++.++||||||+++|||++|+.||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            999998765432211           1134589999999998   56678999999999999999999999975322110


Q ss_pred             ChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          482 SPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                                       .++.......+......+.+++..||+.+|++||++.|+++.|.....
T Consensus       261 -----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          261 -----------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                             001111111111122336789999999999999999999999976543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.9e-41  Score=340.91  Aligned_cols=258  Identities=27%  Similarity=0.386  Sum_probs=201.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC----CCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeee-eCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSI-EGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~l  344 (611)
                      .+|+..+.||+|+||.||+|...+    +..+|||.+... .....+.+.+|+.++++++||||+++++++. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457778999999999999997532    236899988653 3455678999999999999999999999854 5567899


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus       105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            9999999999999954  3345899999999999999999999   7899999999999999999999999999998664


Q ss_pred             CCCc---ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          425 ADRT---HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       425 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      ....   .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+...............    ..      
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~------  249 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----GR------  249 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT----TC------
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc----CC------
Confidence            3321   1223455788999999999999999999999999999999966554333333222221111    10      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                         ....+......+.+++..||+.+|++||++.|+++.|.....
T Consensus       250 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          250 ---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               111122234468899999999999999999999999976543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.8e-40  Score=350.76  Aligned_cols=262  Identities=19%  Similarity=0.249  Sum_probs=203.4

Q ss_pred             hcCCCCCCccccC--CceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          270 TNYFNPSKKLGQG--GAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      .++|++.++||+|  +||.||++... +|+.||||++....  .+..+.+.+|++++++++||||+++++++.+++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4578889999999  99999999654 79999999997543  4456778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++++|.+++.... ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999996532 345899999999999999999999   7899999999999999999999999999986543


Q ss_pred             CCCc------ceeecccCCccccChhhhhc--CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcc
Q 007248          425 ADRT------HVSTAVAGTLGYMAPEYLVR--GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL  496 (611)
Q Consensus       425 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (611)
                      ....      .......||..|+|||++.+  ..++.++|||||||++|||++|+.||..............     +.+
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-----~~~  254 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-----GTV  254 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----CCC
Confidence            2211      11123468999999999987  5789999999999999999999999865433222111100     000


Q ss_pred             ccccCC-----------------------C-------------CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          497 VEAVDP-----------------------N-------------LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       497 ~~~id~-----------------------~-------------l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ...++.                       .             .....+......+.+++.+||+.||++|||+.|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            000000                       0             0001122334568899999999999999999999853

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-41  Score=341.05  Aligned_cols=256  Identities=26%  Similarity=0.346  Sum_probs=202.8

Q ss_pred             CCCCCccccCCceeEEEEEcC-C---CCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc-eEEE
Q 007248          273 FNPSKKLGQGGAGSVYMGSLP-N---GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES-LLVY  346 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~~-~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~  346 (611)
                      |...++||+|+||.||+|... +   +..+|+|++... .....+.|.+|+.++++++||||+++++++.+.+.. ++||
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            445688999999999999643 2   237999998653 345567899999999999999999999999876665 9999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+.+++|.+++..  ....+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus       103 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          103 PYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             ecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            99999999999954  3356899999999999999999999   789999999999999999999999999999765432


Q ss_pred             Cc---ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          427 RT---HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       427 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      ..   .......++..|+|||.+.+..++.++||||||+++|||++|..|+....+........    ...         
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~----~~~---------  244 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL----AQG---------  244 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH----HTT---------
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh----hcC---------
Confidence            21   12234567889999999999999999999999999999999777754333222221111    111         


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                      .....+......+.+++..|++.+|++|||+.++++.|.+...
T Consensus       245 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1111223334568899999999999999999999999876543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-41  Score=353.99  Aligned_cols=256  Identities=27%  Similarity=0.392  Sum_probs=192.1

Q ss_pred             CCCCCCccccCCceeEEEEEcC--CC--CEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeee-CCcceEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP--NG--TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-GPESLLV  345 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  345 (611)
                      .|...+.||+|+||.||+|...  ++  ..||||.+... .....+.|.+|+.++++++||||+++++++.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3556688999999999999653  22  46899988643 34556789999999999999999999998654 5678999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++|+|.+++..  ....+++..++.++.||++||.|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999954  3345889999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCcc---eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhC-CCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          426 DRTH---VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCG-RRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       426 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      ....   ......++..|+|||.+.+..++.++||||||+++|||+|| ..|+... .........    ..+.      
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-~~~~~~~~~----~~~~------  313 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYL----LQGR------  313 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CSSCHHHHH----HTTC------
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-CHHHHHHHH----HcCC------
Confidence            3211   12234577899999999999999999999999999999994 5554332 222222211    1111      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                         ....+......+.+++..||+.+|++||++.||++.|.....
T Consensus       314 ---~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          314 ---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               111122334568899999999999999999999999976543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.4e-40  Score=341.48  Aligned_cols=264  Identities=25%  Similarity=0.401  Sum_probs=188.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            45788899999999999999965 468999999987543 2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccC---CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          348 YVPNRSLDQFIFDKN---KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      |++ ++|.+++....   ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999885432   2245899999999999999999999   7899999999999999999999999999998764


Q ss_pred             CCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC--c-c---c
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN--K-L---V  497 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~-~---~  497 (611)
                      .... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ..+..+.......  . +   .
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHhhhhh
Confidence            3322 2234568999999999976 46899999999999999999999998643221 1111111111000  0 0   0


Q ss_pred             c--ccCCCCCC------------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          498 E--AVDPNLKD------------DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       498 ~--~id~~l~~------------~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .  ...+.+..            .........+.+++.+|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0  00000000            001112345889999999999999999999874

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.6e-40  Score=347.17  Aligned_cols=252  Identities=21%  Similarity=0.254  Sum_probs=193.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .++|...+.||+|+||+||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467888999999999999999654 78999999987543 2336688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC--eEEeeeccceeccCC
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT--PKIADFGLARCFAAD  426 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~~~~~  426 (611)
                      +++|+|.+++...   ..+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999999999543   35899999999999999999999   789999999999999987765  999999999743322


Q ss_pred             CcceeecccCCccccChhhhhcCccccc-cceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEK-ADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .  ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||...................         ...
T Consensus       172 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~---------~~~  240 (361)
T 3uc3_A          172 S--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV---------KYS  240 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT---------CCC
T ss_pred             C--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC---------CCC
Confidence            1  2234568999999999988877655 899999999999999999987654444333322221111         111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..........+.+++.+||+.+|++|||+.|+++
T Consensus       241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          241 IPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            1111122345789999999999999999999985

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.7e-41  Score=346.50  Aligned_cols=245  Identities=22%  Similarity=0.310  Sum_probs=200.6

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|.+.+.||+|+||.||+|.. .+++.||||++....   ....+.+.+|+.+++.++||||+++++++......++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5788889999999999999964 678999999986432   223457899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+ +|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||++......
T Consensus        89 E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 78999988543   35899999999999999999999   789999999999999999999999999999865433


Q ss_pred             CcceeecccCCccccChhhhhcCcc-ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .  ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......              +...+.... 
T Consensus       162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--------------~~~~i~~~~-  224 (336)
T 3h4j_B          162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--------------LFKKVNSCV-  224 (336)
T ss_dssp             B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--------------CBCCCCSSC-
T ss_pred             c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--------------HHHHHHcCC-
Confidence            2  2234578999999999988776 689999999999999999999986432211              111111111 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ...+......+.+++.+|++.||++|||+.|+++
T Consensus       225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1123334456789999999999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.1e-41  Score=341.95  Aligned_cols=254  Identities=25%  Similarity=0.400  Sum_probs=202.6

Q ss_pred             hcCCCCCC-ccccCCceeEEEEEc---CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcce
Q 007248          270 TNYFNPSK-KLGQGGAGSVYMGSL---PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       270 ~~~f~~~~-~iG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (611)
                      .++|...+ .||+|+||.||+|..   ..++.||||++....  ....+.|.+|+++++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            34566666 899999999999943   346889999986542  33467899999999999999999999999 667789


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      +||||+++++|.+++...   ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            999999999999999643   35899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCccee--ecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          424 AADRTHVS--TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       424 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      ........  ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....     ...........     
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~~-----  237 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKGE-----  237 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTC-----
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC-----
Confidence            54433222  23446788999999999999999999999999999999 9999753221     11111111111     


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                          ....+......+.+++..||+.+|++||++.+|++.|++.
T Consensus       238 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          238 ----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                1122334456688999999999999999999999999754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3e-40  Score=335.00  Aligned_cols=252  Identities=27%  Similarity=0.387  Sum_probs=200.0

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      +|.....||+|+||.||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            344556899999999999964 5789999999987666667889999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-CCCeEEeeeccceeccCCCcc
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~  429 (611)
                      +++|.+++........+++..+..++.||+.||.|||   ..+|+||||||+|||++. ++.+||+|||++....... .
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-P  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-C
Confidence            9999999976544456788999999999999999999   789999999999999987 8899999999998664322 1


Q ss_pred             eeecccCCccccChhhhhcCc--cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQ--LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                      ......|+..|+|||++.+..  ++.++||||||+++|||++|+.|+.......   ........     ....+    .
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~-----~~~~~----~  246 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGM-----FKVHP----E  246 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HHHHHHHH-----HCCCC----C
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HHHHhhcc-----ccccc----c
Confidence            223456899999999997654  7889999999999999999999975322111   11111000     00111    2


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+......+.+++.+||+.+|++||++.++++
T Consensus       247 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          247 IPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            23334456789999999999999999999984

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.7e-40  Score=342.36  Aligned_cols=263  Identities=20%  Similarity=0.287  Sum_probs=205.3

Q ss_pred             ccChHHHHHHhcCCCCC-CccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcC-CCCceeeEee
Q 007248          260 SFKYETLEKATNYFNPS-KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSI-EHKNLVKLLG  334 (611)
Q Consensus       260 ~~~~~~l~~~~~~f~~~-~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~  334 (611)
                      ...+...+...+.|... +.||+|+||.||++.. .+++.||||++....  ......+.+|+.++..+ +||||+++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            34445556667777777 8899999999999965 468999999987543  33467899999999999 5699999999


Q ss_pred             eeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC---CCC
Q 007248          335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFT  411 (611)
Q Consensus       335 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~  411 (611)
                      ++.+.+..++||||+++|+|.+++... ....+++..++.++.||+.||+|||   ..+|+||||||+|||++.   ++.
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCC
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCc
Confidence            999999999999999999999998543 2356899999999999999999999   789999999999999998   789


Q ss_pred             eEEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhh
Q 007248          412 PKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY  491 (611)
Q Consensus       412 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~  491 (611)
                      +||+|||+++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....    ........
T Consensus       173 ~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~  246 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN----QETYLNIS  246 (327)
T ss_dssp             EEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH
T ss_pred             EEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHH
Confidence            9999999998764332  22345789999999999999999999999999999999999999754321    11111111


Q ss_pred             ccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       492 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       ..      ...............+.+++..||+.+|++|||+.++++
T Consensus       247 -~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          247 -QV------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             -HT------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -hc------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence             10      011111112233455789999999999999999999874

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.7e-40  Score=343.65  Aligned_cols=244  Identities=22%  Similarity=0.280  Sum_probs=203.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..+.||+|+||.||++.. .+|+.||||++....   ....+.+.+|+++|+.++||||+++++++.++...++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            5688889999999999999965 468999999986542   234567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999999643   35899999999999999999999   799999999999999999999999999999876432


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                          .....||+.|+|||++.+..++.++||||||+++|||++|+.||...    ...+.... +..+.+          
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~~~~~~~-i~~~~~----------  255 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----QPIQIYEK-IVSGKV----------  255 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHH-HHHCCC----------
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC----CHHHHHHH-HHcCCC----------
Confidence                23457899999999999999999999999999999999999998532    22222111 111111          


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPS-----MAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt-----~~evl~  539 (611)
                      .++......+.+++..||+.||++||+     +++|++
T Consensus       256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            122333456889999999999999998     888874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-41  Score=349.72  Aligned_cols=254  Identities=24%  Similarity=0.296  Sum_probs=205.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCc
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  341 (611)
                      ++|+..+.||+|+||.||++..    .+++.||||++....    ....+.+.+|+++|+++ +||||+++++++..+..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5688899999999999999976    478999999986432    23345677899999999 69999999999999999


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .++||||+++++|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999999643   35899999999999999999999   7899999999999999999999999999998


Q ss_pred             eccCCCcceeecccCCccccChhhhhcC--ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVRG--QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      .+............||+.|+|||++.+.  .++.++||||||+++|||++|+.||...................      
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------  281 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------  281 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC------
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc------
Confidence            7654444344456799999999999863  47889999999999999999999987554433332222111111      


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRP-----SMAQAIMLL  541 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~~L  541 (611)
                       .    ..++......+.+++.+||+.||++||     +++|+++..
T Consensus       282 -~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 -E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -C----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence             1    112333445578999999999999999     999998653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.8e-40  Score=345.35  Aligned_cols=211  Identities=24%  Similarity=0.302  Sum_probs=182.3

Q ss_pred             cccccChHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-----CCcee
Q 007248          257 SCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-----HKNLV  330 (611)
Q Consensus       257 ~~~~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv  330 (611)
                      ....+++++-....++|...++||+|+||.||+|.. .+++.||||++... ....+.+..|+++++.++     ||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            344566666667788999999999999999999965 57899999998643 344567788999999886     99999


Q ss_pred             eEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC--
Q 007248          331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK--  408 (611)
Q Consensus       331 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--  408 (611)
                      ++++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.  
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPY  174 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccc
Confidence            9999999999999999999 999999996433 345899999999999999999999   789999999999999986  


Q ss_pred             -----------------------CCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHH
Q 007248          409 -----------------------DFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILII  465 (611)
Q Consensus       409 -----------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~  465 (611)
                                             ++.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  250 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence                                   788999999999865432    23457899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCC
Q 007248          466 EIVCGRRSNAFS  477 (611)
Q Consensus       466 elltG~~p~~~~  477 (611)
                      ||++|+.||...
T Consensus       251 ell~g~~pf~~~  262 (360)
T 3llt_A          251 ELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHSSCSCCCS
T ss_pred             HHHHCCCCCCCC
Confidence            999999998643

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.7e-41  Score=348.75  Aligned_cols=246  Identities=27%  Similarity=0.439  Sum_probs=199.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      +.|...+.||+|+||.||+|.. .+|+.||||++...   .....+.|.+|++++++++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4577889999999999999964 67899999998754   2344567999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+. |+|.+++...  ...+++..+..++.||++||.|||   ..+|+||||||+|||++.++.+||+|||++......
T Consensus       134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 6888887433  246899999999999999999999   789999999999999999999999999999765432


Q ss_pred             CcceeecccCCccccChhhhh---cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLV---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                           ....||+.|+|||++.   .+.++.++||||||+++|||++|+.|+....    ............      .+.
T Consensus       208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~----~~~~~~~~~~~~------~~~  272 (348)
T 1u5q_A          208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHIAQNE------SPA  272 (348)
T ss_dssp             -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHSC------CCC
T ss_pred             -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcC------CCC
Confidence                 2456899999999985   5678999999999999999999999975322    222222221111      111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      +.   +......+.+++..||+.+|++|||+.++++.
T Consensus       273 ~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          273 LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11   11223457889999999999999999999853

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-40  Score=338.61  Aligned_cols=259  Identities=17%  Similarity=0.188  Sum_probs=198.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .++|...+.||+|+||.||++.. .+++.||||++....   ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            46788999999999999999965 468899999986542   33457899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++++|.+++...   ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            9999999999999643   35899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ..........|+..|+|||++.+..++.++||||||+++|||++|+.||.....     ............ .   +   
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~-~---~---  254 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-----SVMGAHINQAIP-R---P---  254 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-----HHHHHHHHSCCC-C---G---
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-----HHHHHHhccCCC-C---c---
Confidence            433333456789999999999999999999999999999999999999753221     111111111100 0   0   


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhccCCC
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRP-SMAQAIMLLTNKVC  546 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RP-t~~evl~~L~~~~~  546 (611)
                      ...+......+.+++.+||+.+|++|| +++++++.|.....
T Consensus       255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            011122234578899999999999999 99999999976543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.8e-40  Score=352.75  Aligned_cols=250  Identities=22%  Similarity=0.337  Sum_probs=204.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|...+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            46788899999999999999654 79999999987542   234567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999953   346999999999999999999999   899999999999999999999999999999876543


Q ss_pred             CcceeecccCCccccChhhhhcCcc-ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .  ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....    .. .......+.        . 
T Consensus       170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~-~~~~i~~~~--------~-  233 (476)
T 2y94_A          170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV----PT-LFKKICDGI--------F-  233 (476)
T ss_dssp             C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS----HH-HHHHHHTTC--------C-
T ss_pred             c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH----HH-HHHHHhcCC--------c-
Confidence            2  2334579999999999988765 6899999999999999999999863221    11 111111111        1 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--Hhcc
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM--LLTN  543 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~--~L~~  543 (611)
                       ..+......+.+++..||+.||++|||+.|+++  ++.+
T Consensus       234 -~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          234 -YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             -CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence             112223345788999999999999999999996  4543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.7e-41  Score=344.52  Aligned_cols=257  Identities=28%  Similarity=0.392  Sum_probs=202.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEc------CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (611)
                      .++|...+.||+|+||.||+|..      .++..||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46788999999999999999974      35778999998644 344566899999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCC----CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC---CCCeEEe
Q 007248          343 LLVYEYVPNRSLDQFIFDKNK----TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIA  415 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~  415 (611)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999965432    245899999999999999999999   789999999999999994   4469999


Q ss_pred             eeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhcc
Q 007248          416 DFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRS  493 (611)
Q Consensus       416 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  493 (611)
                      |||++........ .......+++.|+|||++.+..++.++||||||+++|||+| |+.|+....    ... .......
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~~-~~~~~~~  260 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS----NQE-VLEFVTS  260 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHH-HHHHHHT
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC----HHH-HHHHHhc
Confidence            9999976543322 22234567889999999999999999999999999999998 888875321    111 1111111


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ..         ....+......+.+++..||+.+|++||++.+|++.|..
T Consensus       261 ~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          261 GG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            11         111223344568899999999999999999999998864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6e-41  Score=337.43  Aligned_cols=250  Identities=28%  Similarity=0.416  Sum_probs=196.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC-CcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-PESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~  348 (611)
                      .++|+..+.||+|+||.||++.. +|+.||||++....  ..+.|.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            45788889999999999999987 58899999986543  457899999999999999999999987654 478999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++... ....+++..++.++.||++||.|||   +.+|+||||||+|||++.++.+||+|||++....... 
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            9999999999543 2234889999999999999999999   7899999999999999999999999999987543321 


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                         ....++..|+|||.+.+..++.++||||||+++|||+| |+.|+..... ...    .....         ......
T Consensus       172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~----~~~~~---------~~~~~~  234 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDV----VPRVE---------KGYKMD  234 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GGH----HHHHT---------TTCCCC
T ss_pred             ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-HHH----HHHHh---------cCCCCC
Confidence               23356889999999999999999999999999999998 9988753321 111    11111         111122


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      .+......+.+++..||+.+|++||++.++++.|+..
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            2334455688999999999999999999999998653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.5e-41  Score=374.92  Aligned_cols=246  Identities=26%  Similarity=0.405  Sum_probs=196.6

Q ss_pred             CccccCCceeEEEEEc---CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSL---PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      ++||+|+||.||+|.+   ..++.||||+++...  ....++|.+|+++|++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999954   346789999987543  3446789999999999999999999999864 568899999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc--
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--  429 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~--  429 (611)
                      |+|.+++..   ...+++..++.|+.||+.||+|||   ..+|+||||||+||||+.++.+||+|||+++.+......  
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999953   345899999999999999999999   789999999999999999999999999999876543321  


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      ......+|..|+|||++....++.++||||||+++|||++ |+.||.....     ..+......         ......
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~~~~i~~---------~~~~~~  593 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEK---------GERMGC  593 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHT---------TCCCCC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHc---------CCCCCC
Confidence            2223456789999999999999999999999999999998 9999753221     111111111         112223


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      +......+.+|+..||+.+|++||++.+|++.|.+
T Consensus       594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            44455678999999999999999999999999865

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=332.31  Aligned_cols=249  Identities=24%  Similarity=0.356  Sum_probs=182.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .++|...+.||+|+||.||+|.. .+|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35688889999999999999965 578999999986442   22357789999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++++|.+++...  ...+++..++.++.||++||.|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            9999999999999542  356899999999999999999999   78999999999999999999999999999987643


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+......... .            ....... 
T Consensus       165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~------------~~~~~~~-  229 (278)
T 3cok_A          165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-N------------KVVLADY-  229 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSSCC-
T ss_pred             CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-H------------HHhhccc-
Confidence            222 222456899999999999889999999999999999999999998643322111 0            0000000 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       ..+......+.+++.+|++.||++||++.++++
T Consensus       230 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 -EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence             122233456789999999999999999999874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=343.46  Aligned_cols=243  Identities=23%  Similarity=0.294  Sum_probs=200.8

Q ss_pred             HhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccch--------hhHHHHHHHHHHHhcCCCCceeeEeeeeeeC
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTR--------QWVDEFFNEVNLISSIEHKNLVKLLGCSIEG  339 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  339 (611)
                      ..++|...+.||+|+||.||+|. ..+++.||||++.....        ...+.+.+|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            45689999999999999999996 56789999999875421        1334677899999999999999999999999


Q ss_pred             CcceEEEeecCCC-ChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeec
Q 007248          340 PESLLVYEYVPNR-SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       340 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                      +..++||||+.+| +|.+++...   ..+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 999998533   35899999999999999999999   7899999999999999999999999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcCcc-ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccc
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV  497 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (611)
                      ++........  .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....                  
T Consensus       176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------  235 (335)
T 3dls_A          176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------  235 (335)
T ss_dssp             TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------------
T ss_pred             cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------------
Confidence            9987654332  234568999999999988776 7899999999999999999999753110                  


Q ss_pred             cccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       498 ~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                       .+....  ..+......+.+++..||+.+|++||++.++++.
T Consensus       236 -~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 -TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             011111  1122234457899999999999999999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-40  Score=343.61  Aligned_cols=256  Identities=26%  Similarity=0.390  Sum_probs=201.7

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCE--EEEEEeecc-chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTT--VAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ++|+..+.||+|+||.||+|... ++..  +|||++... .....+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            56888899999999999999654 4554  499988643 234456789999999999 999999999999999999999


Q ss_pred             EeecCCCChhhhhhccC-------------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCe
Q 007248          346 YEYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  412 (611)
                      |||+++++|.+++....             ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999996542             2346899999999999999999999   7899999999999999999999


Q ss_pred             EEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhh
Q 007248          413 KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLY  491 (611)
Q Consensus       413 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~  491 (611)
                      ||+|||+++.....  .......++..|+|||++.+..++.++||||||+++|||+| |+.||....    ..+ .....
T Consensus       182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~----~~~-~~~~~  254 (327)
T 1fvr_A          182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAE-LYEKL  254 (327)
T ss_dssp             EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHH-HHHHG
T ss_pred             EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc----HHH-HHHHh
Confidence            99999999743211  11223456889999999999999999999999999999998 999975321    111 11111


Q ss_pred             ccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       492 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      ..+         .....+......+.+++.+||+.+|++||++.++++.|....
T Consensus       255 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          255 PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             GGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            111         111223334456889999999999999999999999887543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.3e-40  Score=345.19  Aligned_cols=249  Identities=24%  Similarity=0.303  Sum_probs=202.3

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcc
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  342 (611)
                      ...++|...+.||+|+||.||++.. .+|+.||||++....   ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            3457889999999999999999966 468999999997542   23456788999999877 999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            9999999999999999543   35899999999999999999999   78999999999999999999999999999975


Q ss_pred             ccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....    ..+. ...+....      +
T Consensus       168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~-~~~i~~~~------~  235 (345)
T 1xjd_A          168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEEL-FHSIRMDN------P  235 (345)
T ss_dssp             CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH-HHHHHHCC------C
T ss_pred             cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC----HHHH-HHHHHhCC------C
Confidence            43222 22345679999999999999999999999999999999999999985321    1111 11111111      1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMA-QAI  538 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~-evl  538 (611)
                          .++......+.+++..||+.+|++||++. +|+
T Consensus       236 ----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          236 ----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                12223345578999999999999999997 665

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.7e-40  Score=329.11  Aligned_cols=252  Identities=26%  Similarity=0.329  Sum_probs=203.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            456888999999999999999654 78999999987543 3445789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++++|.+++..   ...+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999999843   345899999999999999999999   7899999999999999999999999999998654332


Q ss_pred             c-ceeecccCCccccChhhhhcCcc-ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          428 T-HVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       428 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      . .......|+..|+|||.+.+..+ +.++||||||+++|||++|+.||...........    .+.....        .
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~--------~  227 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS----DWKEKKT--------Y  227 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH----HHHTTCT--------T
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH----Hhhhccc--------c
Confidence            2 12334678999999999987665 7899999999999999999999865433222111    1111110        0


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..........+.+++..|++.+|++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            0111223445788999999999999999999874

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5e-40  Score=359.20  Aligned_cols=253  Identities=24%  Similarity=0.288  Sum_probs=207.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .++|+..+.||+|+||.||++.. .+|+.||||++....   ....+.+.+|+++|++++||||+++++++.+++..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            45688889999999999999965 479999999986542   23456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++|+|.+++.... ...+++..+..++.||+.||.|||   ..+|+||||||+||||+.++.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999996533 345899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ...  .....||+.|+|||++.+..++.++|||||||++|||++|+.||........... +........          
T Consensus       339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~-i~~~i~~~~----------  405 (576)
T 2acx_A          339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-VERLVKEVP----------  405 (576)
T ss_dssp             TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH-HHHHHHHCC----------
T ss_pred             Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH-HHHHhhccc----------
Confidence            322  2345799999999999999999999999999999999999999875443322211 111111111          


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                      ..++......+.+++..||+.||++||     ++.||++
T Consensus       406 ~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            112233345688999999999999999     7888874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.8e-40  Score=340.82  Aligned_cols=248  Identities=23%  Similarity=0.304  Sum_probs=192.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (611)
                      .++|+..+.||+|+||.||++..    .+|+.||||++....    ......+.+|+++|++++||||+++++++..++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35688899999999999999975    478999999987542    2334568899999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .++||||+++++|.+++...   ..+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999999543   35889999999999999999999   7899999999999999999999999999997


Q ss_pred             eccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      ...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....    .......... ..      
T Consensus       170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~-~~------  237 (327)
T 3a62_A          170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN----RKKTIDKILK-CK------  237 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHH-TC------
T ss_pred             ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHh-CC------
Confidence            543222 12335678999999999998899999999999999999999999985322    1111111111 11      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                          ..++......+.+++.+||+.+|++||     ++.|+++
T Consensus       238 ----~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 ----LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                112233345678999999999999999     7778775

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.2e-40  Score=339.58  Aligned_cols=254  Identities=22%  Similarity=0.302  Sum_probs=197.0

Q ss_pred             cCCCCC-CccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPS-KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~-~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      +.|.+. +.||+|+||.||++.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            456664 7899999999999964 57899999999766555677899999999985 79999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC---eEEeeeccceecc
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT---PKIADFGLARCFA  424 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla~~~~  424 (611)
                      |+++++|.+++...   ..+++..+..++.||+.||+|||   ..+|+||||||+|||++.++.   +||+|||++....
T Consensus        92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            99999999999643   35899999999999999999999   789999999999999998776   9999999997654


Q ss_pred             CCCc------ceeecccCCccccChhhhhc-----CccccccceehhHHHHHHHHhCCCCCCCCCCCCChh---------
Q 007248          425 ADRT------HVSTAVAGTLGYMAPEYLVR-----GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPL---------  484 (611)
Q Consensus       425 ~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~---------  484 (611)
                      ....      .......||..|+|||++..     ..++.++||||||+++|||++|+.||..........         
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            2211      11223458999999999875     568899999999999999999999986543221100         


Q ss_pred             -HHHHHhhccCccccccCCCCCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          485 -QRVWTLYRSNKLVEAVDPNLKDDFPA----EQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       485 -~~~~~~~~~~~~~~~id~~l~~~~~~----~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                       ...........        .  .++.    .....+.+++.+|++.||++|||+.|+++.
T Consensus       246 ~~~~~~~i~~~~--------~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          246 QNMLFESIQEGK--------Y--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHCC--------C--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHhccC--------c--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             00111111111        1  1121    123458899999999999999999999863

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=349.47  Aligned_cols=263  Identities=15%  Similarity=0.182  Sum_probs=203.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC---------CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceee---------
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP---------NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK---------  331 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  331 (611)
                      .++|...+.||+|+||.||+|...         +++.||||++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            367888999999999999999765         3789999998744     35789999999999999987         


Q ss_pred             ------Eeeeeee-CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccE
Q 007248          332 ------LLGCSIE-GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNI  404 (611)
Q Consensus       332 ------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI  404 (611)
                            +++++.. +...++||||+ +++|.+++... ....+++..++.++.||+.||.|||   +.+|+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHE
Confidence                  5667765 67889999999 99999999643 2356999999999999999999999   78999999999999


Q ss_pred             EECCCC--CeEEeeeccceeccCCCcc------eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCC
Q 007248          405 LLDKDF--TPKIADFGLARCFAADRTH------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAF  476 (611)
Q Consensus       405 ll~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~  476 (611)
                      |++.++  .+||+|||+++.+......      ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  8999999999866433211      11345789999999999998999999999999999999999999875


Q ss_pred             CCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          477 SQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                      .......+......+.. ......+....   .......+.+++..||+.+|++||++.+|++.|.+...
T Consensus       271 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVD-KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             GTTCHHHHHHHHHHHHH-SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCcCHHHHHHHHHhccC-Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            44222222211111111 11111111111   01123558899999999999999999999999876543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.8e-40  Score=332.70  Aligned_cols=247  Identities=25%  Similarity=0.359  Sum_probs=199.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .++|+..+.||+|+||.||++.. .++..||||++....   ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            45788889999999999999954 467899999986542   23356789999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++++|.+++...   ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999999543   35899999999999999999999   89999999999999999999999999999854432


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .   ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....    ... ........      .    
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~-~~~~~~~~------~----  223 (279)
T 3fdn_A          162 S---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----YQE-TYKRISRV------E----  223 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHH-HHHHHHHT------C----
T ss_pred             c---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc----HHH-HHHHHHhC------C----
Confidence            2   2234568999999999999999999999999999999999999975321    111 11111111      1    


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      ..++......+.+++..||+.+|++||++.|+++.
T Consensus       224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          224 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            11222334557889999999999999999999953

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.4e-41  Score=360.01  Aligned_cols=248  Identities=23%  Similarity=0.270  Sum_probs=193.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .++|+..+.||+|+||.||++.. .+|+.||||++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            35688889999999999999954 57899999998753   234456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCC-CceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||   . .+|+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            9999999999998543   45899999999999999999999   6 899999999999999999999999999997543


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....    .... ........      .  
T Consensus       301 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~-~~~i~~~~------~--  366 (446)
T 4ejn_A          301 KDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKL-FELILMEE------I--  366 (446)
T ss_dssp             C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH-HHHHHHCC------C--
T ss_pred             CCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC----HHHH-HHHHHhCC------C--
Confidence            222 22345679999999999999999999999999999999999999985322    1111 11111111      0  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                        .++......+.+++..||+.||++||     ++.|+++
T Consensus       367 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 --RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence              12223345678999999999999999     9999985

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2e-40  Score=334.68  Aligned_cols=246  Identities=22%  Similarity=0.319  Sum_probs=198.3

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeecc--chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceE
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (611)
                      ..++|+..+.||+|+||.||+|... +++.||||++...  .......+.+|+..+..+ +||||+++++++.+++..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3567888999999999999999664 7999999998754  234456788999999999 99999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCC-CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC--------------
Q 007248          345 VYEYVPNRSLDQFIFDKNK-TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD--------------  409 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--------------  409 (611)
                      ||||+++++|.+++..... ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999964322 246899999999999999999999   7899999999999999844              


Q ss_pred             -----CCeEEeeeccceeccCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCCh
Q 007248          410 -----FTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASP  483 (611)
Q Consensus       410 -----~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~  483 (611)
                           ..+||+|||++.......     ...||..|+|||++.+. .++.++||||||+++|||++|..++...    ..
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQ  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HH
T ss_pred             ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hH
Confidence                 479999999998765332     23589999999999776 6678999999999999999998764321    11


Q ss_pred             hHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          484 LQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       484 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                          +.....+..         ...+......+.+++..||+.||++||++.|+++
T Consensus       237 ----~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 ----WHEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ----HHHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                111111111         1122233456889999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.8e-40  Score=337.97  Aligned_cols=262  Identities=22%  Similarity=0.332  Sum_probs=198.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35688899999999999999964 57899999998742   345567899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          346 YEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      |||+++++|.+++... .....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999998542 22456899999999999999999999   7899999999999999999999999999997654


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....  ...... .........     .+
T Consensus       188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~-~~~~~~~~~-----~~  258 (310)
T 2wqm_A          188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLC-KKIEQCDYP-----PL  258 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C--CHHHHH-HHHHTTCSC-----CC
T ss_pred             CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch--hHHHHH-HHhhcccCC-----CC
Confidence            3221 22345689999999999999999999999999999999999999753321  111111 111111111     11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                         ........+.+++..||+.||++||++.+|++.|.+...
T Consensus       259 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          259 ---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             ---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence               112234458899999999999999999999999976543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.6e-40  Score=337.03  Aligned_cols=248  Identities=25%  Similarity=0.415  Sum_probs=204.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      +.|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            4688889999999999999964 578999999987553 34567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++.    ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||++........
T Consensus       102 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          102 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             CTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            99999999984    245899999999999999999999   78999999999999999999999999999987654322


Q ss_pred             ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                       ......|+..|+|||++.+..++.++||||||+++|||++|+.|+....    ........ ...     ..+.+..  
T Consensus       175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~-~~~-----~~~~~~~--  241 (303)
T 3a7i_A          175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH----PMKVLFLI-PKN-----NPPTLEG--  241 (303)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHH-HHS-----CCCCCCS--
T ss_pred             -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC----HHHHHHHh-hcC-----CCCCCcc--
Confidence             2234568999999999999999999999999999999999999975321    11111111 111     1111222  


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                        .....+.+++..||+.+|++|||+.++++.
T Consensus       242 --~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          242 --NYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             --SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             --ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              233458899999999999999999999853

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.5e-40  Score=332.57  Aligned_cols=246  Identities=22%  Similarity=0.353  Sum_probs=202.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .++|...+.||+|+||.||+|.. .++..+|+|++........+.+.+|++++++++||||+++++++.++...++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            45788899999999999999965 45789999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE---CCCCCeEEeeeccceeccC
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~~~  425 (611)
                      +++++|.+++...   ..+++..++.++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||++..+..
T Consensus        88 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            9999999998543   35899999999999999999999   7899999999999999   7888999999999987654


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ..  ......||+.|+|||++.+ .++.++||||||+++|||++|+.||.....    .+.... ...+..         
T Consensus       162 ~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~-~~~~~~---------  224 (277)
T 3f3z_A          162 GK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD----SEVMLK-IREGTF---------  224 (277)
T ss_dssp             TS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH-HHHCCC---------
T ss_pred             cc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH----HHHHHH-HHhCCC---------
Confidence            33  2234568999999999865 489999999999999999999999854321    111111 111110         


Q ss_pred             CCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPA----EQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~----~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       .++.    .....+.+++..|++.+|++||++.++++
T Consensus       225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          225 -TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             1111    12456789999999999999999999974

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.9e-40  Score=333.07  Aligned_cols=249  Identities=24%  Similarity=0.386  Sum_probs=202.7

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeee---------
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE---------  338 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  338 (611)
                      ..++|+..+.||+|+||.||+|... +++.||||++....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3457888999999999999999764 78999999987654    346789999999999999999998754         


Q ss_pred             -------CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC
Q 007248          339 -------GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT  411 (611)
Q Consensus       339 -------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  411 (611)
                             ....++||||+++++|.+++... ....+++..++.++.||+.||.|||   ..+|+||||||+|||+++++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCC
Confidence                   44579999999999999999643 2346899999999999999999999   789999999999999999999


Q ss_pred             eEEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhh
Q 007248          412 PKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY  491 (611)
Q Consensus       412 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~  491 (611)
                      +||+|||++........  .....+++.|+|||.+.+..++.++||||||+++|||++|..|+...       ...+...
T Consensus       161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~~~  231 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFTDL  231 (284)
T ss_dssp             EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHHHH
T ss_pred             EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHHHh
Confidence            99999999987654322  23456899999999999999999999999999999999998874210       1111111


Q ss_pred             ccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       492 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                      ..        ..+...+    ...+.+++..||+.+|++||++.|+++.|.....
T Consensus       232 ~~--------~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          232 RD--------GIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             HT--------TCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             hc--------ccccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            11        1111222    3347789999999999999999999999876543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.4e-40  Score=341.01  Aligned_cols=248  Identities=23%  Similarity=0.247  Sum_probs=202.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (611)
                      .++|+..+.||+|+||.||++... +|+.||||++....   ....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            467888999999999999999765 47899999987542   23456788999999988 89999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999999543   35899999999999999999999   7899999999999999999999999999997543


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....    ..+...... ...         
T Consensus       173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~~~~i~-~~~---------  237 (353)
T 2i0e_A          173 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----EDELFQSIM-EHN---------  237 (353)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHH-HCC---------
T ss_pred             cCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC----HHHHHHHHH-hCC---------
Confidence            222 22345679999999999999999999999999999999999999985321    111111111 111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPS-----MAQAIM  539 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt-----~~evl~  539 (611)
                       ..++......+.+++..|++.+|++||+     +++|++
T Consensus       238 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence             1123334456889999999999999995     467664

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.9e-40  Score=339.78  Aligned_cols=251  Identities=21%  Similarity=0.273  Sum_probs=202.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch------hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR------QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (611)
                      .++|+..+.||+|+||.||++.. .+|+.||||++.....      ...+.+.+|+.++++++||||+++++++.++...
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            45688899999999999999965 4689999999875432      1367899999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC----CeEEeeec
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF----TPKIADFG  418 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG  418 (611)
                      ++||||+++++|.+++..   ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999954   345899999999999999999999   78999999999999999888    79999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccc
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE  498 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (611)
                      ++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||....    ..+.... ......  
T Consensus       165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~-i~~~~~--  235 (321)
T 2a2a_A          165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLAN-ITSVSY--  235 (321)
T ss_dssp             TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHH-HHTTCC--
T ss_pred             cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC----HHHHHHH-HHhccc--
Confidence            998765432  2234568999999999999999999999999999999999999975322    1111111 111100  


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          499 AVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       499 ~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                          .............+.+++..|++.+|++|||+.|+++
T Consensus       236 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          236 ----DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             ----CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             ----ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                0000001122345789999999999999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.6e-40  Score=330.70  Aligned_cols=251  Identities=20%  Similarity=0.275  Sum_probs=202.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++...  .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            56788999999999999999965 46899999998654  3345577899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC---eEEeeeccceec
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT---PKIADFGLARCF  423 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla~~~  423 (611)
                      ||+++++|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            999999999988543   45899999999999999999999   789999999999999987655   999999999766


Q ss_pred             cCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      ....  ......|++.|+|||++.+..++.++||||||+++|||++|+.|+....    .... ......... ....  
T Consensus       159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~-~~~~~~~~~-~~~~--  228 (284)
T 3kk8_A          159 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRL-YAQIKAGAY-DYPS--  228 (284)
T ss_dssp             CSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH-HHHHHHTCC-CCCT--
T ss_pred             ccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc----hhHH-HHHHHhccc-cCCc--
Confidence            5332  2234578999999999999999999999999999999999999975322    1111 111111111 0000  


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                         .........+.+++..|++.+|++|||+.|+++
T Consensus       229 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          229 ---PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ---TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               011123345789999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=341.79  Aligned_cols=252  Identities=16%  Similarity=0.145  Sum_probs=201.7

Q ss_pred             HHHhcCCCCCCccccCCceeEEEE------EcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC---CCceeeEeeeee
Q 007248          267 EKATNYFNPSKKLGQGGAGSVYMG------SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE---HKNLVKLLGCSI  337 (611)
Q Consensus       267 ~~~~~~f~~~~~iG~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  337 (611)
                      +...++|...++||+|+||+||+|      ....++.||||++....   ..++..|++++..++   |+||+++++++.
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            344577888999999999999999      34568999999987544   346777888877776   999999999999


Q ss_pred             eCCcceEEEeecCCCChhhhhhccC--CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-------
Q 007248          338 EGPESLLVYEYVPNRSLDQFIFDKN--KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-------  408 (611)
Q Consensus       338 ~~~~~~lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------  408 (611)
                      .++..++||||+++|+|.+++....  ....++|..++.|+.||++||+|||   ..+|+||||||+||||+.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence            9999999999999999999996422  3456999999999999999999999   889999999999999998       


Q ss_pred             ----CCCeEEeeeccceeccCC-CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCCh
Q 007248          409 ----DFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASP  483 (611)
Q Consensus       409 ----~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~  483 (611)
                          ++.+||+|||+++.+... .........||..|+|||++.+..++.++||||||+++|||+||+.|+.......  
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--  292 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--  292 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence                899999999999865422 2334456779999999999999999999999999999999999999974332211  


Q ss_pred             hHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHhcc
Q 007248          484 LQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALR-PSMAQAIMLLTN  543 (611)
Q Consensus       484 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~R-Pt~~evl~~L~~  543 (611)
                                    ..+...+....   ....+.+++..|++.+|.+| |++.++.+.|..
T Consensus       293 --------------~~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          293 --------------CKPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             --------------EEECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             --------------eeechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                          01111121111   23446678889999999998 678888777754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.5e-41  Score=338.31  Aligned_cols=255  Identities=23%  Similarity=0.321  Sum_probs=202.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeee--CCcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  344 (611)
                      .++|+..+.||+|+||.||++.. .+++.||+|++...  .....+.+.+|++++++++||||+++++++.+  +...++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            45788889999999999999965 47899999998754  34456789999999999999999999998754  567899


Q ss_pred             EEeecCCCChhhhhhccC-CCccCChhHHHHHHHHHHHHHHHHhcCCCCc-----eecCCCCcccEEECCCCCeEEeeec
Q 007248          345 VYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETR-----IIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                      ||||+++++|.+++.... ....+++..++.++.||+.||.|||   ..+     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999996532 2345899999999999999999999   566     9999999999999999999999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccc
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE  498 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (611)
                      ++........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....    ..+ .......+..  
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~-~~~~i~~~~~--  233 (279)
T 2w5a_A          162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----QKE-LAGKIREGKF--  233 (279)
T ss_dssp             HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHH-HHHHHHHTCC--
T ss_pred             hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC----HHH-HHHHHhhccc--
Confidence            9976543321 1224568999999999999899999999999999999999999975432    111 1111111111  


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          499 AVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       499 ~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                             ...+......+.+++.+||+.+|++||++.||++.+.
T Consensus       234 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          234 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             -------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                   1122233456889999999999999999999997653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1e-39  Score=355.97  Aligned_cols=253  Identities=22%  Similarity=0.302  Sum_probs=206.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|...+.||+|+||.||++.. .+|+.||||++....   ....+.+.+|+++|++++||||+++++++.+....++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            5688889999999999999976 469999999997542   234567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCC-CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          347 EYVPNRSLDQFIFDKNK-TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      ||+++|+|.+++..... ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            99999999999965432 446999999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ... ......||+.|+|||++.+..++.++|||||||++|||++|+.||................. ...          
T Consensus       342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~-~~~----------  409 (543)
T 3c4z_A          342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL-EQA----------  409 (543)
T ss_dssp             TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH-HCC----------
T ss_pred             CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh-hcc----------
Confidence            322 22345799999999999999999999999999999999999999875433322222211111 111          


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSM-----AQAI  538 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~-----~evl  538 (611)
                      ..++......+.+++..||+.+|++||++     ++|+
T Consensus       410 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~  447 (543)
T 3c4z_A          410 VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR  447 (543)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred             cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence            11233344567899999999999999976     5665

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=337.57  Aligned_cols=262  Identities=23%  Similarity=0.313  Sum_probs=197.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ++|+..++||+|+||.||+|... +|+.||||++....  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57888999999999999999664 58999999886443  3445678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999998843   345899999999999999999999   7899999999999999999999999999998765332


Q ss_pred             cceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhH----------HHHHhhccCcc
Q 007248          428 THVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ----------RVWTLYRSNKL  496 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~----------~~~~~~~~~~~  496 (611)
                      . ......||..|+|||++.+ ..++.++||||||+++|||++|+.||...........          ..+..+.....
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence            2 2234568999999999976 5689999999999999999999999854332111100          00111111111


Q ss_pred             cccc---CCCCCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          497 VEAV---DPNLKDDF---PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       497 ~~~i---d~~l~~~~---~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ....   ++.-....   .......+.+++..||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            1110   11000000   0123445789999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.6e-40  Score=339.74  Aligned_cols=248  Identities=23%  Similarity=0.313  Sum_probs=203.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .++|...+.||+|+||.||++.. .+++.+|+|++...   .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            35677889999999999999965 45789999998654   234567899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++++|.+++...   ..+++..++.++.||++||.|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            9999999999998543   45899999999999999999999   78999999999999999999999999999987643


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ... ......|+..|+|||++.+..++.++||||||+++|||++|+.||....    ..+. +.......      ..  
T Consensus       194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~-~~~~~~~~------~~--  259 (335)
T 2owb_A          194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKET-YLRIKKNE------YS--  259 (335)
T ss_dssp             TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS----HHHH-HHHHHHTC------CC--
T ss_pred             Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC----HHHH-HHHHhcCC------CC--
Confidence            322 2234568999999999999899999999999999999999999975322    1111 11111111      11  


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        .+......+.+++.+||+.||++||++.|+++
T Consensus       260 --~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          260 --IPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              12223345788999999999999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.1e-40  Score=330.23  Aligned_cols=245  Identities=23%  Similarity=0.325  Sum_probs=202.0

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|...+.||+|+||.||+|... +++.||||++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56888899999999999999654 67899999986542   223567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++...   ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            999999999999543   35899999999999999999999   899999999999999999999999999999765432


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      .   .....|+..|+|||++.+..++.++||||||+++|||++|+.|+....    ....... ....      +.    
T Consensus       168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~-~~~~------~~----  229 (284)
T 2vgo_A          168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS----HTETHRR-IVNV------DL----  229 (284)
T ss_dssp             C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHH-HHTT------CC----
T ss_pred             c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC----HhHHHHH-Hhcc------cc----
Confidence            2   234568999999999999999999999999999999999999975332    1111111 1111      11    


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .++......+.+++..|++.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            122333456789999999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.4e-41  Score=352.56  Aligned_cols=242  Identities=17%  Similarity=0.156  Sum_probs=189.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHH---HHHhcCCCCceeeEe-------ee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEV---NLISSIEHKNLVKLL-------GC  335 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  335 (611)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...   .....+.|.+|+   ++|++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788889999999999999975 56999999998743   344567899999   555666899999998       55


Q ss_pred             eeeCC-----------------cceEEEeecCCCChhhhhhccC----CCccCChhHHHHHHHHHHHHHHHHhcCCCCce
Q 007248          336 SIEGP-----------------ESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEGLAYLHGGSETRI  394 (611)
Q Consensus       336 ~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  394 (611)
                      +...+                 ..++||||+ +|+|.+++....    ....+++..++.|+.||+.||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            55443                 278999999 689999996431    1234556889999999999999999   7899


Q ss_pred             ecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcC-----------ccccccceehhHHH
Q 007248          395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-----------QLTEKADVYSFGIL  463 (611)
Q Consensus       395 vH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDV~S~Gvl  463 (611)
                      +||||||+|||++.++.+||+|||+++....    ......| ..|+|||++.+.           .++.++||||||++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999985322    2345567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          464 IIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       464 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +|||++|+.||.........             .... ... ...    ...+.+++.+||+.||++||++.|+++
T Consensus       303 l~elltg~~Pf~~~~~~~~~-------------~~~~-~~~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGS-------------EWIF-RSC-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC------CCS-------------GGGG-SSC-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCcccccccch-------------hhhh-hhc-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999997543221110             0111 100 122    345788999999999999999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.7e-40  Score=350.59  Aligned_cols=253  Identities=22%  Similarity=0.272  Sum_probs=192.1

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--------hhhHHHHHHHHHHHhcCCCCceeeEeeeeee
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIE  338 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  338 (611)
                      ...++|...+.||+|+||.||+|.. .+++.||||++....        ......+.+|+++|++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            4567899999999999999999954 568999999987532        112235889999999999999999999975 


Q ss_pred             CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC---CeEEe
Q 007248          339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF---TPKIA  415 (611)
Q Consensus       339 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  415 (611)
                      .+..++||||+++|+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++   .+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEe
Confidence            4558999999999999999843   346899999999999999999999   78999999999999997544   59999


Q ss_pred             eeccceeccCCCcceeecccCCccccChhhhhc---CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc
Q 007248          416 DFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR---GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR  492 (611)
Q Consensus       416 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~  492 (611)
                      |||+++.....  .......||+.|+|||++.+   ..++.++||||||+++|||++|+.||..............    
T Consensus       285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~----  358 (419)
T 3i6u_A          285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT----  358 (419)
T ss_dssp             CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH----
T ss_pred             ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh----
Confidence            99999865432  22335678999999999853   5788999999999999999999999865443333322211    


Q ss_pred             cCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       493 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+...      ............+.+++.+||+.+|++||++.|+++
T Consensus       359 ~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          359 SGKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             TTCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            11100      000000112455889999999999999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.9e-40  Score=332.93  Aligned_cols=249  Identities=23%  Similarity=0.307  Sum_probs=204.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .++|...+.||+|+||.||++... +++.+|+|++...   .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            356788899999999999999654 5889999998654   234567889999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++++|.+++...   ..+++..++.++.||++||.|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            9999999999988543   35899999999999999999999   78999999999999999999999999999987643


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      ... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....    ..+. +.......      .   
T Consensus       168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~-~~~~~~~~------~---  232 (294)
T 2rku_A          168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKET-YLRIKKNE------Y---  232 (294)
T ss_dssp             TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS----HHHH-HHHHHTTC------C---
T ss_pred             Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHH-HHHHhhcc------C---
Confidence            322 2234568999999999998889999999999999999999999975432    1111 11111111      0   


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                       ..+......+.+++.+|++.+|++||++.|+++.
T Consensus       233 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 -SIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence             1122233457889999999999999999999863

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9.1e-40  Score=330.18  Aligned_cols=251  Identities=25%  Similarity=0.324  Sum_probs=195.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|...++||+|+||.||++.. .++..+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            5688899999999999999965 568999999987553 33467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE---CCCCCeEEeeeccceecc
Q 007248          349 VPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFA  424 (611)
Q Consensus       349 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~~  424 (611)
                      +++++|.+++... .....+++..++.++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||++..+.
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999998543 22356999999999999999999999   7899999999999999   456789999999997654


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ...  ......|+..|+|||++. +.++.++||||||+++|||++|+.||....    ............       +..
T Consensus       179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~----~~~~~~~~~~~~-------~~~  244 (285)
T 3is5_A          179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEVQQKATYKE-------PNY  244 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCC-------CCC
T ss_pred             Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC----HHHHHhhhccCC-------ccc
Confidence            332  233456899999999885 578999999999999999999999975322    111111111010       000


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ... .......+.+++.+|++.||++||++.||++
T Consensus       245 ~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          245 AVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000 0012345778999999999999999999984

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.2e-40  Score=340.00  Aligned_cols=247  Identities=21%  Similarity=0.249  Sum_probs=177.9

Q ss_pred             CCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCCcceEEEeecCCCC
Q 007248          276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVPNRS  353 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gs  353 (611)
                      .+.||+|+||.||++.. .+++.||||++...   ....+.+|+.++..+. ||||+++++++.++...++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            47899999999999965 46899999998643   3456789999999997 9999999999999999999999999999


Q ss_pred             hhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC---CeEEeeeccceeccCCCcce
Q 007248          354 LDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF---TPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       354 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~~~~~~~~~  430 (611)
                      |.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++   .+||+|||+++....... .
T Consensus        93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~  165 (325)
T 3kn6_A           93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P  165 (325)
T ss_dssp             HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence            99999543   45899999999999999999999   78999999999999998765   799999999986543322 2


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCC--ChhHHHHHhhccCccccccCCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA--SPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......  .........+..+..      ......
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~  239 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEA  239 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHH
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCccc
Confidence            334568999999999999999999999999999999999999986543211  111111111111111      000000


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                      .......+.+++..|++.||++|||+.|++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            112345688999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.2e-40  Score=335.24  Aligned_cols=256  Identities=26%  Similarity=0.378  Sum_probs=196.1

Q ss_pred             cCCCCCCccccCCceeEEEEEcC--CCC--EEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcce
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP--NGT--TVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (611)
                      ++|+..+.||+|+||.||+|.+.  +++  .||||++...   ..+..+.|.+|++++++++||||+++++++..+. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            56888899999999999999642  333  6899988643   2345678999999999999999999999988765 89


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      +|+||+++++|.+++...  ...+++..++.++.||++||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        97 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            999999999999999643  245899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCcce--eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          424 AADRTHV--STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       424 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      .......  .....++..|+|||++.+..++.++||||||+++|||++ |+.|+....    ..+.........      
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~~~~~~------  241 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN----GSQILHKIDKEG------  241 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTSC------
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC----HHHHHHHHHccC------
Confidence            5443321  224457889999999999999999999999999999999 999875332    111111111111      


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                         .....+......+.+++.+|++.+|++||++.++++.|.+..
T Consensus       242 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          242 ---ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ---CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence               111122334456889999999999999999999999997643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.5e-40  Score=331.45  Aligned_cols=260  Identities=20%  Similarity=0.287  Sum_probs=203.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeee-eeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS-IEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~E  347 (611)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++.....  .+.+.+|+++++.++|++++..+.++ .++...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46788999999999999999964 6789999998865432  24688999999999988866655554 66777899999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE---CCCCCeEEeeeccceecc
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFA  424 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~~  424 (611)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||++....
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999999532  245899999999999999999999   7899999999999999   488899999999998765


Q ss_pred             CCCcc------eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCC--ChhHHHHHhhccCcc
Q 007248          425 ADRTH------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA--SPLQRVWTLYRSNKL  496 (611)
Q Consensus       425 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~  496 (611)
                      .....      ......||..|+|||.+.+..++.++||||||+++|||++|+.||.......  .....+.........
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            44321      1235578999999999999999999999999999999999999987543221  222221111101000


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 007248          497 VEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVC  546 (611)
Q Consensus       497 ~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~  546 (611)
                       ..    +    .......+.+++.+||+.+|++||++.+|++.|.+...
T Consensus       240 -~~----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  280 (296)
T 3uzp_A          240 -EV----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             -HH----H----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             -HH----H----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence             00    0    11123458899999999999999999999999976543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.9e-40  Score=330.95  Aligned_cols=246  Identities=26%  Similarity=0.351  Sum_probs=195.3

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeee----CCcceE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE----GPESLL  344 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  344 (611)
                      .|...+.||+|+||.||+|.. .++..||+|++...  .....+.+.+|+.++++++||||+++++++..    +...++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            466677899999999999955 56889999998754  34456789999999999999999999998875    345799


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCc--eecCCCCcccEEEC-CCCCeEEeeeccce
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLD-KDFTPKIADFGLAR  421 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfGla~  421 (611)
                      ||||+++++|.+++...   ..+++..++.++.||+.||.|||   ..+  |+||||||+|||++ +++.+||+|||++.
T Consensus       107 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            99999999999999543   45899999999999999999999   677  99999999999998 78899999999996


Q ss_pred             eccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      .....   ......|++.|+|||++. +.++.++||||||+++|||++|+.||.......   . ............   
T Consensus       181 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~-~~~~~~~~~~~~---  249 (290)
T 1t4h_A          181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA---Q-IYRRVTSGVKPA---  249 (290)
T ss_dssp             GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---H-HHHHHTTTCCCG---
T ss_pred             ccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH---H-HHHHHhccCCcc---
Confidence            54332   223456899999999886 568999999999999999999999985432211   1 111111111111   


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                           .++......+.+++..||+.+|++||++.|+++
T Consensus       250 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                 111122345889999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-39  Score=339.06  Aligned_cols=266  Identities=24%  Similarity=0.334  Sum_probs=196.5

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccch-----hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC
Q 007248          267 EKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR-----QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP  340 (611)
Q Consensus       267 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  340 (611)
                      ....++|...+.||+|+||.||+|... +|+.||||++.....     ...+.+.+|++++++++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344578999999999999999999764 589999999864322     11246889999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      ..++||||+++ +|.+++..  ....+++..+..++.||++||.|||   ..+|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            99999999986 88888843  2346899999999999999999999   789999999999999999999999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc---c
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK---L  496 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~  496 (611)
                      +.+.... .......+|+.|+|||++.+. .++.++||||||+++|||++|..|+...... ..+..+........   +
T Consensus       160 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          160 KSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             STTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTS
T ss_pred             eeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhh
Confidence            8664332 223345789999999998764 5789999999999999999999887543211 11111111111110   0


Q ss_pred             c---cccCC---CCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          497 V---EAVDP---NLKDDFP-----AEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       497 ~---~~id~---~l~~~~~-----~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      .   ...+.   ......+     ......+.+++..|++.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0   00000   0001111     1223568899999999999999999999865

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.8e-40  Score=339.26  Aligned_cols=252  Identities=21%  Similarity=0.305  Sum_probs=199.9

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEE
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ..++|+..+.||+|+||.||++.. .+|+.||||++.....    .+.+|++++.++ +||||+++++++.++...++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            356788899999999999999965 4689999999875432    245788888887 7999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC----CCeEEeeecccee
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD----FTPKIADFGLARC  422 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~  422 (611)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||+.++    +.+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999999999999543   45899999999999999999999   7899999999999998543    2499999999987


Q ss_pred             ccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ... ..+...+..+..      
T Consensus       170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~-~~~~~~i~~~~~------  240 (342)
T 2qr7_A          170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTP-EEILARIGSGKF------  240 (342)
T ss_dssp             CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-SCH-HHHHHHHHHCCC------
T ss_pred             CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-CCH-HHHHHHHccCCc------
Confidence            654322 23346789999999999888899999999999999999999999864322 111 122222222211      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .+...........+.+++..|++.||++||++.++++
T Consensus       241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1111122233456789999999999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-39  Score=330.56  Aligned_cols=261  Identities=20%  Similarity=0.291  Sum_probs=200.2

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeee-eeCCcceEE
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS-IEGPESLLV  345 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv  345 (611)
                      ...++|+..+.||+|+||.||+|.. .+++.||||++.....  .+.+.+|+++++.++|++++..++.+ .++...++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3457899999999999999999964 6789999998754432  24588999999999988877666654 667788999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE---CCCCCeEEeeecccee
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARC  422 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~  422 (611)
                      |||+ +++|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||+   ++++.+||+|||+++.
T Consensus        84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            9999 99999998532  235899999999999999999999   7899999999999999   7889999999999987


Q ss_pred             ccCCCcc------eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCC--ChhHHHHHhhccC
Q 007248          423 FAADRTH------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA--SPLQRVWTLYRSN  494 (611)
Q Consensus       423 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~--~~~~~~~~~~~~~  494 (611)
                      .......      ......||..|+|||.+.+..++.++||||||+++|||++|+.||.......  .............
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            6544321      2235678999999999999999999999999999999999999987543322  1221111110000


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       495 ~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      .. ...    ...    ....+.+++..||+.+|++||++.+|++.|.+..
T Consensus       238 ~~-~~~----~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          238 PI-EVL----CKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             CH-HHH----TTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             hh-hhh----hcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence            00 000    011    2345889999999999999999999999987543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.8e-40  Score=334.42  Aligned_cols=263  Identities=26%  Similarity=0.334  Sum_probs=196.5

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-----hhhHHHHHHHHHHHhcC---CCCceeeEeeeeeeC
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-----RQWVDEFFNEVNLISSI---EHKNLVKLLGCSIEG  339 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~  339 (611)
                      .+++|+..++||+|+||+||+|.. .+++.||||++....     ......+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999975 578999999986432     11234566777777766   499999999999876


Q ss_pred             C-----cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEE
Q 007248          340 P-----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (611)
Q Consensus       340 ~-----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  414 (611)
                      .     ..++||||+. ++|.+++.... ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence            5     4789999997 59999986433 234899999999999999999999   789999999999999999999999


Q ss_pred             eeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC
Q 007248          415 ADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN  494 (611)
Q Consensus       415 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  494 (611)
                      +|||+++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .+..+.......
T Consensus       162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~  238 (308)
T 3g33_A          162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLP  238 (308)
T ss_dssp             CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            9999997654322  2345678999999999999999999999999999999999999975432211 111111111110


Q ss_pred             c---ccccc---CCCCC--CC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          495 K---LVEAV---DPNLK--DD-----FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       495 ~---~~~~i---d~~l~--~~-----~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .   +....   ...+.  ..     ...+....+.+++.+|++.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0   00000   00000  00     01123456789999999999999999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9e-40  Score=337.18  Aligned_cols=255  Identities=19%  Similarity=0.284  Sum_probs=199.3

Q ss_pred             cCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-CCceeeEeeeeee--CCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIE--GPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  346 (611)
                      ++|+..++||+|+||.||+|. ..+++.||||++....   .+.+.+|++++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            568889999999999999995 4678999999986443   467889999999997 9999999999987  66789999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC-CeEEeeeccceeccC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAA  425 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~  425 (611)
                      ||+++++|.+++.      .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++ .+||+|||+++....
T Consensus       113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            9999999999883      3889999999999999999999   78999999999999999776 899999999987654


Q ss_pred             CCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccc------
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE------  498 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  498 (611)
                      ...  .....++..|+|||++.+ ..++.++||||||+++|||++|+.|+.........+...........+.+      
T Consensus       184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            322  234568999999999877 67899999999999999999999998644332221111111111000000      


Q ss_pred             ---------cc--------CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          499 ---------AV--------DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       499 ---------~i--------d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                               .+        ........+......+.+++..||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                     00        000111112223556889999999999999999999985

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.2e-40  Score=342.13  Aligned_cols=263  Identities=26%  Similarity=0.377  Sum_probs=198.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      .++|+..+.||+|+||.||++... +|+.||||++....  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            356888899999999999999654 58999999986443  344567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++...   ..+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||++......
T Consensus       104 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            999999999887432   35899999999999999999999   789999999999999999999999999999765433


Q ss_pred             CcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHH----------HHHhhccCc
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQR----------VWTLYRSNK  495 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~----------~~~~~~~~~  495 (611)
                      .. ......|+..|+|||++.+. .++.++||||||+++|||++|+.||............          .+..+....
T Consensus       178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            22 22345689999999999775 7899999999999999999999998644321111110          011111111


Q ss_pred             c-ccccCCCCCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          496 L-VEAVDPNLKDDFPA-----EQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       496 ~-~~~id~~l~~~~~~-----~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      . .....+.+....+.     .....+.+++.+||+.||++|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1 11111111111111     23456889999999999999999999884

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.5e-40  Score=345.37  Aligned_cols=201  Identities=30%  Similarity=0.490  Sum_probs=162.7

Q ss_pred             HHhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCC--c
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGP--E  341 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  341 (611)
                      ...++|+..+.||+|+||.||+|. ..+|+.||||++...  .....+.+.+|+.++.++. ||||+++++++..++  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            345789999999999999999995 457899999998543  3455677889999999997 999999999987544  6


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .++||||++ ++|.+++..    ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999997 589988853    35899999999999999999999   7899999999999999999999999999998


Q ss_pred             eccCCC--------------------cceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCC
Q 007248          422 CFAADR--------------------THVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAF  476 (611)
Q Consensus       422 ~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~  476 (611)
                      .+....                    ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            754311                    112234579999999999976 6789999999999999999999999854

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.6e-40  Score=336.63  Aligned_cols=261  Identities=27%  Similarity=0.381  Sum_probs=185.4

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ...++|+..+.||+|+||.||++.. .+++.||||++.... ....+++.+|+.++++++||||+++++++..++..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            3457889999999999999999965 468999999886443 34456789999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhcc-----CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          346 YEYVPNRSLDQFIFDK-----NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      |||+++++|.+++...     .....+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            9999999999998531     12456899999999999999999999   789999999999999999999999999999


Q ss_pred             eeccCCCc----ceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc
Q 007248          421 RCFAADRT----HVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK  495 (611)
Q Consensus       421 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  495 (611)
                      ........    .......|++.|+|||++.. ..++.++||||||+++|||++|+.|+........    .........
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~  244 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV----LMLTLQNDP  244 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----HHHHHTSSC
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH----HHHHhccCC
Confidence            76543221    11234568999999999876 4689999999999999999999999864332211    111111110


Q ss_pred             --cc-cccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          496 --LV-EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       496 --~~-~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        +. ...++.+...    ....+.+++.+||+.||++||++.++++
T Consensus       245 ~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          245 PSLETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCTTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             Cccccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence              00 0111112222    2345788999999999999999999984

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.1e-39  Score=343.31  Aligned_cols=252  Identities=21%  Similarity=0.235  Sum_probs=189.0

Q ss_pred             cCCCCC-CccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHh-cCCCCceeeEeeeeee----CCcce
Q 007248          271 NYFNPS-KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLIS-SIEHKNLVKLLGCSIE----GPESL  343 (611)
Q Consensus       271 ~~f~~~-~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~~  343 (611)
                      ++|... +.||+|+||+||++.. .+|+.||||++...     ..+.+|++++. ..+||||+++++++..    +...+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            345554 6899999999999965 46899999998632     35678888874 4589999999998875    56789


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC---CCCeEEeeeccc
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLA  420 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla  420 (611)
                      +||||+++|+|.+++.... ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            9999999999999996532 346999999999999999999999   789999999999999997   788999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      +......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....+..+.. .  
T Consensus       212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~i~~~~~-~--  285 (400)
T 1nxk_A          212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRIRMGQY-E--  285 (400)
T ss_dssp             EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-HHHHHHHTCC-C--
T ss_pred             cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-HHHHHHcCcc-c--
Confidence            8654322  22356789999999999999999999999999999999999999865432221100 0111111111 0  


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                         +...........+.+++..||+.||++|||+.|+++.
T Consensus       286 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          286 ---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             ---CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               0000112234557899999999999999999999964

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-39  Score=350.71  Aligned_cols=259  Identities=25%  Similarity=0.281  Sum_probs=192.7

Q ss_pred             hcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC------
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------  340 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  340 (611)
                      .++|+..++||+|+||+||+|. ..+|+.||||++...  .....+.+.+|+.+|+.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            4678889999999999999995 456899999999754  3445678899999999999999999999987554      


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      ..++||||++++ |.+.+.     ..+++..+..++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            469999999764 666652     13889999999999999999999   789999999999999999999999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC------
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN------  494 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------  494 (611)
                      +.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+.......      
T Consensus       212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          212 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             -----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHT
T ss_pred             eecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence            865432  2234567899999999999999999999999999999999999998543211 1111111100000      


Q ss_pred             ----ccccccCC---------------CCCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          495 ----KLVEAVDP---------------NLKDDF---PAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       495 ----~~~~~id~---------------~l~~~~---~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                          .....++.               .+....   .......+.+|+.+||+.||++|||++|+++.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                00000000               000000   01124568899999999999999999999863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7.4e-40  Score=342.94  Aligned_cols=246  Identities=21%  Similarity=0.252  Sum_probs=190.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHH-HhcCCCCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNL-ISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ++|+..+.||+|+||.||+++.+ +++.||||++....   ....+.+..|..+ ++.++||||+++++++.+.+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            56888999999999999999654 58899999997543   2334567778776 5778999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       118 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          118 LDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            9999999999999543   35889999999999999999999   78999999999999999999999999999975432


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....    ..+. +..+....        + 
T Consensus       192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~-~~~i~~~~--------~-  256 (373)
T 2r5t_A          192 HN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----TAEM-YDNILNKP--------L-  256 (373)
T ss_dssp             CC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB----HHHH-HHHHHHSC--------C-
T ss_pred             CC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----HHHH-HHHHHhcc--------c-
Confidence            22 22345679999999999999999999999999999999999999985321    1111 11111111        1 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                       .++......+.+++..||+.||++||++.+.+
T Consensus       257 -~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          257 -QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             -CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence             11222334578899999999999999985433

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=7.7e-40  Score=343.57  Aligned_cols=254  Identities=11%  Similarity=0.063  Sum_probs=182.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcC--CCCceeeEe-------eee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI--EHKNLVKLL-------GCS  336 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  336 (611)
                      ...|...+.||+|+||.||+|.. .+|+.||||++....   ....+.+.+|+++++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            34577889999999999999975 478999999998643   24456677885444444  799988855       444


Q ss_pred             eeC-----------------CcceEEEeecCCCChhhhhhccCCCccCChhHH------HHHHHHHHHHHHHHhcCCCCc
Q 007248          337 IEG-----------------PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKR------FNIILGTAEGLAYLHGGSETR  393 (611)
Q Consensus       337 ~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~  393 (611)
                      ...                 ...++||||++ |+|.+++...  ...+++..+      +.++.||+.||+|||   +.+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQ---SKG  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCC
Confidence            332                 23799999998 8999999653  224566666      788899999999999   789


Q ss_pred             eecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecccCCccccChhhhhc--CccccccceehhHHHHHHHHhCC
Q 007248          394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR--GQLTEKADVYSFGILIIEIVCGR  471 (611)
Q Consensus       394 ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvll~elltG~  471 (611)
                      |+||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||++.+  ..++.++||||||+++|||++|+
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999865321    224556799999999987  67899999999999999999999


Q ss_pred             CCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          472 RSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       472 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .||.........      .+............+...........+.+++.+||+.||++|||+.++++
T Consensus       291 ~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          291 LPFGLVTPGIKG------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CSTTBCCTTCTT------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCcCccccc------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            998654322110      01111111111111111112234556889999999999999999999873

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.7e-40  Score=330.48  Aligned_cols=250  Identities=22%  Similarity=0.278  Sum_probs=199.2

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccch------hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcce
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR------QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (611)
                      ++|+..+.||+|+||.||++... +++.||||++.....      ...+.+.+|+.++++++||||+++++++.++...+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56888999999999999999664 689999999875421      13678999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC----CeEEeeecc
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF----TPKIADFGL  419 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGl  419 (611)
                      +||||+++++|.+++...   ..+++..++.++.||+.||.|||   ..+|+||||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            999999999999999543   45899999999999999999999   78999999999999999877    799999999


Q ss_pred             ceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          420 ARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       420 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      +.......  ......+++.|+|||++.+..++.++||||||+++|||++|+.|+....    .... ........    
T Consensus       159 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~-~~~~~~~~----  227 (283)
T 3bhy_A          159 AHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET----KQET-LTNISAVN----  227 (283)
T ss_dssp             CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS----HHHH-HHHHHTTC----
T ss_pred             ceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc----hHHH-HHHhHhcc----
Confidence            98664332  2234568999999999998999999999999999999999999975322    1111 11111110    


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        ..............+.+++.+|++.+|++||++.|+++
T Consensus       228 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          228 --YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             --CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence              00000001122345789999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.8e-39  Score=337.59  Aligned_cols=258  Identities=22%  Similarity=0.302  Sum_probs=204.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhh-----------------HHHHHHHHHHHhcCCCCceeeE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQW-----------------VDEFFNEVNLISSIEHKNLVKL  332 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  332 (611)
                      .++|...+.||+|+||.||++.. +|+.||||++.......                 .+.|.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            45788899999999999999988 89999999987543211                 2789999999999999999999


Q ss_pred             eeeeeeCCcceEEEeecCCCChhhh------hhccCCCccCChhHHHHHHHHHHHHHHHHhcCCC-CceecCCCCcccEE
Q 007248          333 LGCSIEGPESLLVYEYVPNRSLDQF------IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNIL  405 (611)
Q Consensus       333 ~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIl  405 (611)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..++.++.||+.||.|||   . .+|+||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence            9999999999999999999999999      532 22467999999999999999999999   6 89999999999999


Q ss_pred             ECCCCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcC-cccc-ccceehhHHHHHHHHhCCCCCCCCCCCCCh
Q 007248          406 LDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTE-KADVYSFGILIIEIVCGRRSNAFSQDSASP  483 (611)
Q Consensus       406 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDV~S~Gvll~elltG~~p~~~~~~~~~~  483 (611)
                      ++.++.+||+|||++......   ......|+..|+|||++.+. .++. ++||||||+++|||++|+.|+.........
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            999999999999999876433   33456789999999999877 6666 999999999999999999998654332222


Q ss_pred             hHHHHHhhccCccccccC--CCC-------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          484 LQRVWTLYRSNKLVEAVD--PNL-------KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       484 ~~~~~~~~~~~~~~~~id--~~l-------~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..    ........-..+  ...       ...........+.+++.+||+.+|++||++.|+++
T Consensus       262 ~~----~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          262 FN----NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HH----HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HH----HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11    111111100000  000       00001233456889999999999999999999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.7e-39  Score=339.59  Aligned_cols=259  Identities=22%  Similarity=0.340  Sum_probs=200.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .++|+..+.||+|+||.||++.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            35688889999999999999965 46899999998765 34456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCC-ceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      |+++++|.+++...   ..+++..+..++.+|+.||.|||   .. +|+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999999999543   35899999999999999999999   54 8999999999999999999999999999754321


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh-------------hc-
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL-------------YR-  492 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-------------~~-  492 (611)
                         ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......  .......             .. 
T Consensus       186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE--LELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH--HHHHHC-----------------
T ss_pred             ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccCCCCCCCcccC
Confidence               2234578999999999999999999999999999999999999986432110  0000000             00 


Q ss_pred             -------------cCcccc----ccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          493 -------------SNKLVE----AVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       493 -------------~~~~~~----~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                                   .....+    .................+.+++..||+.||++|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                         000000    00000000111123445889999999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-39  Score=347.58  Aligned_cols=199  Identities=25%  Similarity=0.389  Sum_probs=166.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC-----Cc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----PE  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  341 (611)
                      .++|...+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+++|++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46788999999999999999954 56889999999643  344567899999999999999999999998776     56


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .++||||+. ++|.+++..   ...+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 599999853   345999999999999999999999   7899999999999999999999999999998


Q ss_pred             eccCCCcc---------------------eeecccCCccccChhhh-hcCccccccceehhHHHHHHHHhCCCCCC
Q 007248          422 CFAADRTH---------------------VSTAVAGTLGYMAPEYL-VRGQLTEKADVYSFGILIIEIVCGRRSNA  475 (611)
Q Consensus       422 ~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~ksDV~S~Gvll~elltG~~p~~  475 (611)
                      ........                     ..+...||..|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            76543211                     22456789999999986 45679999999999999999998765543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-39  Score=331.91  Aligned_cols=250  Identities=21%  Similarity=0.314  Sum_probs=200.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .++|...+.||+|+||.||++.. .+|+.||||++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            45788899999999999999965 47899999999866554556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE---CCCCCeEEeeeccceeccC
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~~~  425 (611)
                      +++++|.+++...   ..+++..++.++.||+.||.|||   ..+|+||||||+|||+   ++++.+||+|||++.....
T Consensus        88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            9999999998543   35899999999999999999999   7899999999999999   7888999999999875432


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .   ......|++.|+|||++.+..++.++||||||+++|||++|+.|+.....    .. ....+..+..      ...
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~-~~~~i~~~~~------~~~  227 (304)
T 2jam_A          162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE----SK-LFEKIKEGYY------EFE  227 (304)
T ss_dssp             B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH----HH-HHHHHHHCCC------CCC
T ss_pred             C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HH-HHHHHHcCCC------CCC
Confidence            2   12234689999999999999999999999999999999999999753221    11 1111111111      011


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..........+.+++..|++.+|++||++.|+++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1112233456889999999999999999999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-39  Score=349.40  Aligned_cols=195  Identities=25%  Similarity=0.378  Sum_probs=154.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC-----Cc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----PE  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  341 (611)
                      .++|++.+.||+|+||+||+|.. .+++.||||++...  .....+.+.+|+++|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            36789999999999999999954 47899999998643  344567899999999999999999999998543     46


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .++||||+ +++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 5789998853   345999999999999999999999   7899999999999999999999999999998


Q ss_pred             eccCCCc--------------------------ceeecccCCccccChhhh-hcCccccccceehhHHHHHHHHhCC
Q 007248          422 CFAADRT--------------------------HVSTAVAGTLGYMAPEYL-VRGQLTEKADVYSFGILIIEIVCGR  471 (611)
Q Consensus       422 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDV~S~Gvll~elltG~  471 (611)
                      .......                          ...+...||+.|+|||++ ....++.++|||||||+||||++|.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            7643221                          122345689999999986 4567999999999999999999953

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=324.33  Aligned_cols=251  Identities=21%  Similarity=0.222  Sum_probs=197.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc----hhhHHHHHHHHHHHhcCCCCceeeEeeeee--eCCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSIEHKNLVKLLGCSI--EGPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  342 (611)
                      .++|...+.||+|+||.||++.. .+++.||||++....    ....+.+.+|++++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            46899999999999999999965 468999999986542    234578999999999999999999999984  45678


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++||||++++ |.+++... ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999876 66666443 2356899999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCC-cceeecccCCccccChhhhhcCc--cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          423 FAADR-THVSTAVAGTLGYMAPEYLVRGQ--LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       423 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      ..... ........|+..|+|||++.+..  .+.++||||||+++|||++|+.|+....    ... ..........   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~-~~~~i~~~~~---  230 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN----IYK-LFENIGKGSY---  230 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS----HHH-HHHHHHHCCC---
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch----HHH-HHHHHhcCCC---
Confidence            65322 22233556899999999987643  4779999999999999999999975321    111 1111111111   


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                             ..+......+.+++.+|++.||++||++.|+++.
T Consensus       231 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 -------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   1122334557899999999999999999999963

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.7e-40  Score=337.05  Aligned_cols=261  Identities=23%  Similarity=0.343  Sum_probs=192.0

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchh-hHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|...+.||+|+||+||+|... +++.||||++...... ....+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888899999999999999654 7899999998654322 122456899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      ++ ++|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            97 5898888543  345899999999999999999999   7899999999999999999999999999997654322 


Q ss_pred             ceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc---ccccc----
Q 007248          429 HVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK---LVEAV----  500 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~i----  500 (611)
                      .......+|..|+|||++.+ ..++.++||||||+++|||++|+.||...... ..+..+........   +....    
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHhchhhhcchh
Confidence            22234567999999999876 56899999999999999999999998643211 11111111111000   00000    


Q ss_pred             -----CCCCCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          501 -----DPNLKDD----FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       501 -----d~~l~~~----~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                           .+.....    ........+.+++.+|++.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                 0000000    01122345789999999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.3e-40  Score=341.68  Aligned_cols=263  Identities=22%  Similarity=0.310  Sum_probs=191.4

Q ss_pred             HHhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ...++|...++||+|+||+||++. ..+++.||||++....  ....+.+.+|++++++++||||+++++++.+++..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            445689999999999999999995 4578999999986543  2335578899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC-----CCCCeEEeeecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-----KDFTPKIADFGL  419 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~DfGl  419 (611)
                      ||||+++ +|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++     +++.+||+|||+
T Consensus       111 v~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9999974 999998543   34899999999999999999999   78999999999999994     555699999999


Q ss_pred             ceeccCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC---c
Q 007248          420 ARCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN---K  495 (611)
Q Consensus       420 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~  495 (611)
                      ++.+.... .......+|..|+|||++.+. .++.++||||||+++|||++|+.||........... ........   .
T Consensus       184 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~  261 (329)
T 3gbz_A          184 ARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK-IFEVLGLPDDTT  261 (329)
T ss_dssp             HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCCCTTT
T ss_pred             ccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH-HHHHhCCCchhh
Confidence            98664332 222345679999999999874 489999999999999999999999854322111111 11110000   0


Q ss_pred             c---cccc-----CCCCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          496 L---VEAV-----DPNLKDDF-----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       496 ~---~~~i-----d~~l~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +   ....     .+......     +......+.+++..||+.||++|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0   0000     00000000     0112355789999999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.5e-39  Score=348.25  Aligned_cols=260  Identities=19%  Similarity=0.292  Sum_probs=203.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCC-CceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH-KNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .++|.+.++||+|+||.||+|.. .+++.||||++.....  .+.+.+|+++++.++| +++..+..++.++...++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46789999999999999999964 6789999998765432  2458899999999977 556666777778888999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE---CCCCCeEEeeeccceecc
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFA  424 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~~  424 (611)
                      |+ +++|.+++...  ...+++..++.|+.||+.||.|||   ..+|+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999999532  245999999999999999999999   7899999999999999   688899999999998765


Q ss_pred             CCCcc------eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccc
Q 007248          425 ADRTH------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE  498 (611)
Q Consensus       425 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (611)
                      .....      ......||..|+|||++.+..++.++||||||++||||++|+.||....... ..+.+... ....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~i-~~~~~~~  235 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKI-SEKKVAT  235 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-HHHHHHHH-HHHHHHS
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh-HHHHHHHH-hhccccc
Confidence            44322      1225679999999999999999999999999999999999999986543322 11111111 1111111


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          499 AVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       499 ~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      .+. .+...    ....+.+++..||+.+|++||++.+|+++|...
T Consensus       236 ~~~-~l~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          236 SIE-ALCRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             CHH-HHHTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cHH-HHhcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            110 00011    234588999999999999999999999988643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.8e-40  Score=337.50  Aligned_cols=260  Identities=22%  Similarity=0.382  Sum_probs=200.5

Q ss_pred             ccChHHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCC--CCceeeEeee
Q 007248          260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIE--HKNLVKLLGC  335 (611)
Q Consensus       260 ~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~  335 (611)
                      .+.++.+....++|+..+.||+|+||.||++...+++.||||++...  .....+.+.+|++++.+++  ||||++++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            34444455566789999999999999999998888999999998654  3455678999999999997  5999999999


Q ss_pred             eeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEe
Q 007248          336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA  415 (611)
Q Consensus       336 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  415 (611)
                      +..++..++||| +.+++|.+++...   ..+++..++.++.||++||.|||   +.+|+||||||+|||+++ +.+||+
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~  168 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLI  168 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEEC
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEe
Confidence            999999999999 6688999999543   35899999999999999999999   789999999999999965 799999


Q ss_pred             eeccceeccCCCcc-eeecccCCccccChhhhhc-----------CccccccceehhHHHHHHHHhCCCCCCCCCCCCCh
Q 007248          416 DFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVR-----------GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASP  483 (611)
Q Consensus       416 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~  483 (611)
                      |||++......... ......|+..|+|||.+.+           ..++.++||||||+++|||++|+.|+.....   .
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~  245 (313)
T 3cek_A          169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---Q  245 (313)
T ss_dssp             CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS---H
T ss_pred             eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH---H
Confidence            99999866443222 2234568999999999875           4678899999999999999999999753221   1


Q ss_pred             hHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          484 LQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       484 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .....         ..+++.....++......+.+++.+||+.+|++||++.|+++
T Consensus       246 ~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          246 ISKLH---------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHHHH---------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHH---------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            11111         112222222223333456788999999999999999999985

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.8e-39  Score=336.59  Aligned_cols=257  Identities=19%  Similarity=0.332  Sum_probs=204.3

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--------hhhHHHHHHHHHHHhcC-CCCceeeEe
Q 007248          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--------RQWVDEFFNEVNLISSI-EHKNLVKLL  333 (611)
Q Consensus       264 ~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~  333 (611)
                      +......++|...+.||+|+||.||+|... +|+.||||++....        .+..+.+.+|+.++.++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            334555678999999999999999999764 79999999986543        12345788999999999 899999999


Q ss_pred             eeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeE
Q 007248          334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK  413 (611)
Q Consensus       334 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  413 (611)
                      +++......++||||+++++|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+|
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEE
Confidence            9999999999999999999999999543   35899999999999999999999   78999999999999999999999


Q ss_pred             EeeeccceeccCCCcceeecccCCccccChhhhhcC------ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHH
Q 007248          414 IADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG------QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV  487 (611)
Q Consensus       414 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~  487 (611)
                      |+|||++..+....  ......||+.|+|||++.+.      .++.++||||||+++|||++|+.||....    .....
T Consensus       241 l~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~  314 (365)
T 2y7j_A          241 LSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR----QILML  314 (365)
T ss_dssp             ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHH
T ss_pred             EEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC----HHHHH
Confidence            99999998765432  22346789999999998643      58889999999999999999999975321    11111


Q ss_pred             HHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          488 WTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       488 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       .........      ............+.+++..|++.+|++||++.|+++
T Consensus       315 -~~i~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          315 -RMIMEGQYQ------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             -HHHHHTCCC------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HHHHhCCCC------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             111111100      000000012345789999999999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.3e-39  Score=340.60  Aligned_cols=270  Identities=22%  Similarity=0.249  Sum_probs=199.5

Q ss_pred             cChHHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccc-----------hhhHHHHHHHHHHHhcCCCCce
Q 007248          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT-----------RQWVDEFFNEVNLISSIEHKNL  329 (611)
Q Consensus       261 ~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~ni  329 (611)
                      ...+++....++|...+.||+|+||.||+|...+|+.||||++....           ....+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            34567888999999999999999999999988889999999985421           2234789999999999999999


Q ss_pred             eeEeeeeeeC-----CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccE
Q 007248          330 VKLLGCSIEG-----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNI  404 (611)
Q Consensus       330 v~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI  404 (611)
                      +++++++...     ...++||||++ |+|.+++..  ....+++..+..++.||+.||.|||   ..+|+||||||+||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NI  165 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNI  165 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHE
Confidence            9999998543     35799999997 688888853  3346899999999999999999999   78999999999999


Q ss_pred             EECCCCCeEEeeeccceeccCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCCh
Q 007248          405 LLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASP  483 (611)
Q Consensus       405 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~  483 (611)
                      |++.++.+||+|||+++......  ......+|..|+|||++.+ ..++.++||||||+++|||++|+.||....... .
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~  242 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-Q  242 (362)
T ss_dssp             EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H
T ss_pred             EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-H
Confidence            99999999999999997543322  2234568999999999877 678999999999999999999999986432111 1


Q ss_pred             hHHHHHhhccC-----------ccccccCCCCCCC-------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          484 LQRVWTLYRSN-----------KLVEAVDPNLKDD-------FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       484 ~~~~~~~~~~~-----------~~~~~id~~l~~~-------~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +..+.......           ...+.+...+...       ........+.+++..|++.+|++|||+.|+++
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            11111111000           0111111111100       01122345789999999999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.9e-39  Score=322.91  Aligned_cols=247  Identities=22%  Similarity=0.341  Sum_probs=194.2

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|...+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            56888899999999999999764 78999999986542   234568899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++...   ..+++..++.++.||+.||.|||   +.+|+|+||||+|||++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           91 EYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            999999999999543   35899999999999999999999   789999999999999999999999999999765432


Q ss_pred             CcceeecccCCccccChhhhhcCcc-ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .  ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.|+....    . ............         
T Consensus       165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~-~~~~~~~~~~~~---------  228 (276)
T 2h6d_A          165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH----V-PTLFKKIRGGVF---------  228 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS----H-HHHHHHHHHCCC---------
T ss_pred             c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc----H-HHHHHHhhcCcc---------
Confidence            2  2234568999999999987665 689999999999999999999975321    1 111111111110         


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                       ..+......+.+++.+|++.+|++||++.++++.
T Consensus       229 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 -YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             1122233457889999999999999999999863

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-39  Score=338.81  Aligned_cols=257  Identities=23%  Similarity=0.353  Sum_probs=193.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC------
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------  340 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  340 (611)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+++|++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46788889999999999999965 57999999998543  3444678899999999999999999999988653      


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      ..++||||+ +++|.+++..    ..+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 8899999853    35899999999999999999999   789999999999999999999999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc------
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS------  493 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~------  493 (611)
                      +.....    .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..+......      
T Consensus       176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred             cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence            875432    234578999999999887 67999999999999999999999998643211 111111110000      


Q ss_pred             -----Cc-------cccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          494 -----NK-------LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       494 -----~~-------~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                           ..       +.......+ ..........+.+++.+|++.||++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                 00       000000000 01112234557899999999999999999999863

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.6e-39  Score=332.76  Aligned_cols=252  Identities=22%  Similarity=0.269  Sum_probs=196.1

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--------hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG  339 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  339 (611)
                      ..++|...+.||+|+||.||+|.. .+++.||||++....        ......+.+|++++++++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            346788999999999999999965 468999999986432        12234588999999999999999999998765


Q ss_pred             CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC---eEEee
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT---PKIAD  416 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D  416 (611)
                      . .++||||+++++|.+++..   ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 8999999999999999843   346899999999999999999999   789999999999999987664   99999


Q ss_pred             eccceeccCCCcceeecccCCccccChhhhh---cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc
Q 007248          417 FGLARCFAADRTHVSTAVAGTLGYMAPEYLV---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS  493 (611)
Q Consensus       417 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  493 (611)
                      ||+++......  ......|+..|+|||++.   ...++.++||||||+++|||++|+.||............+..    
T Consensus       161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----  234 (322)
T 2ycf_A          161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS----  234 (322)
T ss_dssp             CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH----
T ss_pred             Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh----
Confidence            99998764322  223456899999999974   457889999999999999999999998654443333222211    


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +...      ............+.+++.+||+.||++||++.++++
T Consensus       235 ~~~~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          235 GKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             TCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Cccc------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1100      000000122455789999999999999999999984

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=8.3e-40  Score=333.01  Aligned_cols=252  Identities=24%  Similarity=0.382  Sum_probs=197.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++..++..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467888999999999999999764 5899999998776666678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++++|.+++...  ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||++...... .
T Consensus        98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~  171 (302)
T 2j7t_A           98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-L  171 (302)
T ss_dssp             CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-H
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-c
Confidence            9999999998543  235899999999999999999999   789999999999999999999999999997543211 1


Q ss_pred             ceeecccCCccccChhhhh-----cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          429 HVSTAVAGTLGYMAPEYLV-----RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      .......|+..|+|||++.     ...++.++||||||+++|||++|+.|+....    .............      +.
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~------~~  241 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVLLKIAKSDP------PT  241 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHSCC------CC
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC----HHHHHHHHhccCC------cc
Confidence            1122356899999999984     5678899999999999999999999975332    1111111111110      00


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        ...+......+.+++..||+.+|++|||+.++++
T Consensus       242 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 --LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              0112333456889999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.7e-40  Score=366.19  Aligned_cols=258  Identities=21%  Similarity=0.299  Sum_probs=202.4

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEcC----CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc
Q 007248          267 EKATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       267 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (611)
                      +...++|+..+.||+|+||.||+|...    .+..||||++... .....+.|.+|+.++++++||||+++++++. ++.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            334567888899999999999999653    2467999988654 3445578999999999999999999999985 456


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .++||||+++|+|.+++...  ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            89999999999999999543  335899999999999999999999   7899999999999999999999999999998


Q ss_pred             eccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      ..............+++.|+|||++.+..++.++||||||+++|||++ |+.||....    ..+.... +..+.     
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~----~~~~~~~-i~~~~-----  609 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----NNDVIGR-IENGE-----  609 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHH-HHHTC-----
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHH-HHcCC-----
Confidence            765443333334557889999999999999999999999999999997 888875321    1111111 11111     


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                          ....+......+.+++..||+.+|++||++.+|++.|...
T Consensus       610 ----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          610 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                1112333445688999999999999999999999998653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-39  Score=343.31  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=194.7

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC-----
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----  339 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  339 (611)
                      ++...++|...+.||+|+||.||+|. ..+|+.||||++.....    ...+|+++|+.++||||+++++++...     
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34567789999999999999999995 46799999999865432    234799999999999999999998543     


Q ss_pred             ---------------------------------CcceEEEeecCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHH
Q 007248          340 ---------------------------------PESLLVYEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAY  385 (611)
Q Consensus       340 ---------------------------------~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~  385 (611)
                                                       ...++||||++ ++|.+.+... .....+++..+..++.||++||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             33789999998 5877777532 234569999999999999999999


Q ss_pred             HhcCCCCceecCCCCcccEEEC-CCCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcC-ccccccceehhHHH
Q 007248          386 LHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGIL  463 (611)
Q Consensus       386 LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvl  463 (611)
                      ||   +.+|+||||||+|||++ .++.+||+|||+++.+.....  .....+|..|+|||++.+. .++.++||||||++
T Consensus       157 LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            99   89999999999999998 688999999999987644332  2345679999999998765 48999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCChhHHHHHhhccC----------ccccccCCCCC-----CCCCHHHHHHHHHHHHHhcccCC
Q 007248          464 IIEIVCGRRSNAFSQDSASPLQRVWTLYRSN----------KLVEAVDPNLK-----DDFPAEQVCNVLQIGLLCTQAAA  528 (611)
Q Consensus       464 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~id~~l~-----~~~~~~~~~~l~~l~~~c~~~~p  528 (611)
                      +|||++|+.||........ +..+.......          ...+..-+.+.     ..++......+.+++..||+.+|
T Consensus       232 l~ell~g~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            9999999999864322111 11111111100          00000000110     01222344568899999999999


Q ss_pred             CCCCCHHHHHH
Q 007248          529 ALRPSMAQAIM  539 (611)
Q Consensus       529 ~~RPt~~evl~  539 (611)
                      ++|||+.|+++
T Consensus       311 ~~R~t~~e~l~  321 (383)
T 3eb0_A          311 DLRINPYEAMA  321 (383)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hhCCCHHHHhc
Confidence            99999999984

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2e-39  Score=328.13  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=186.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      .++|+..+.||+|+||.||++.. .+|+.||||++....  ....+.+..+...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46788899999999999999965 578999999986542  223334555556688899999999999999999999999


Q ss_pred             eecCCCChhhhhhcc-CCCccCChhHHHHHHHHHHHHHHHHhcCCCC-ceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          347 EYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       347 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||++ |+|.+++... .....+++..++.++.||+.||.|||   .. +|+||||||+|||++.++.+||+|||++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 5888877432 23456999999999999999999999   66 99999999999999999999999999997654


Q ss_pred             CCCcceeecccCCccccChhhh----hcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYL----VRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      ...  ......||+.|+|||++    ....++.++||||||+++|||++|+.|+.....   .............     
T Consensus       162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~-----  231 (290)
T 3fme_A          162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT---PFQQLKQVVEEPS-----  231 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC---HHHHHHHHHHSCC-----
T ss_pred             ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc---hHHHHHHHhccCC-----
Confidence            332  22334689999999996    456789999999999999999999999864222   2222222111111     


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       +.   .........+.+++.+|++.+|++|||+.|+++
T Consensus       232 -~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          232 -PQ---LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -CC---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -CC---cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence             11   111223445789999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=334.83  Aligned_cols=268  Identities=21%  Similarity=0.336  Sum_probs=201.0

Q ss_pred             ChHHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC
Q 007248          262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG  339 (611)
Q Consensus       262 ~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  339 (611)
                      ..++++...++|+..+.||+|+||.||+|...+  .+|+|++....  ....+.|.+|+.++++++||||+++++++.+.
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            334445556788999999999999999998743  59999886432  23345678999999999999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecc
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  419 (611)
                      +..++||||+++++|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             CceEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCC
Confidence            9999999999999999999542  346899999999999999999999   78999999999999998 67999999999


Q ss_pred             ceeccCCCc----ceeecccCCccccChhhhhc---------CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHH
Q 007248          420 ARCFAADRT----HVSTAVAGTLGYMAPEYLVR---------GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQR  486 (611)
Q Consensus       420 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~  486 (611)
                      +........    .......|+..|+|||++..         ..++.++||||||+++|||++|+.||....    ....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~  251 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP----AEAI  251 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC----HHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHH
Confidence            875432111    11223458899999999864         357889999999999999999999975322    1111


Q ss_pred             HHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCC
Q 007248          487 VWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPT  550 (611)
Q Consensus       487 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~~~~~  550 (611)
                      .+.. ..+.     .+.+.   .......+.+++..||+.+|++||++.+|+++|.........
T Consensus       252 ~~~~-~~~~-----~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~  306 (319)
T 2y4i_B          252 IWQM-GTGM-----KPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR  306 (319)
T ss_dssp             HHHH-HTTC-----CCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred             HHHh-ccCC-----CCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            1111 1111     11111   111223478899999999999999999999999876544333

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.7e-39  Score=328.78  Aligned_cols=252  Identities=29%  Similarity=0.424  Sum_probs=199.3

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ...++|+..+.||+|+||.||+|... +|+.||||++....  ..+.+.+|++++++++||||+++++++..++..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34567889999999999999999654 58999999987543  3467899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++...  ...+++..++.++.||+.||.|||   ..+|+|+||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999998532  346899999999999999999999   789999999999999999999999999999876543


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      .. ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....    ............      .+.+  
T Consensus       179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~------~~~~--  245 (314)
T 3com_A          179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH----PMRAIFMIPTNP------PPTF--  245 (314)
T ss_dssp             BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHSC------CCCC--
T ss_pred             cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCC------Cccc--
Confidence            22 2234568999999999999899999999999999999999999975322    112111111110      0111  


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..+......+.+++..||+.+|++||++.++++
T Consensus       246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            112233456889999999999999999999975

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.2e-39  Score=326.18  Aligned_cols=252  Identities=26%  Similarity=0.371  Sum_probs=193.1

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeee---------
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE---------  338 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  338 (611)
                      ..++|+..+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            346788899999999999999965 57899999998643 4456789999999999999999999998765         


Q ss_pred             ----CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEE
Q 007248          339 ----GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (611)
Q Consensus       339 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  414 (611)
                          ....++||||+++++|.+++...  ...+++..++.++.||+.||+|||   ..+|+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEE
Confidence                34678999999999999999643  345788999999999999999999   789999999999999999999999


Q ss_pred             eeeccceeccCCC-------------cceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCC
Q 007248          415 ADFGLARCFAADR-------------THVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDS  480 (611)
Q Consensus       415 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~  480 (611)
                      +|||++.......             ........|+..|+|||++.+. .++.++||||||+++|||++   |+....  
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--  232 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--  232 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence            9999997654321             1112345689999999999764 78999999999999999998   332111  


Q ss_pred             CChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          481 ASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       ..... ......      ....+...++......+.+++.+||+.||++|||+.++++
T Consensus       233 -~~~~~-~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          233 -ERVNI-LKKLRS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             -HHHHH-HHHHHS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -hHHHH-HHhccc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence             01111 111111      1112222334445566889999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=344.19  Aligned_cols=200  Identities=25%  Similarity=0.377  Sum_probs=153.0

Q ss_pred             CCCC-CCccccCCceeEEEEEcC---CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeee--CCcceEE
Q 007248          272 YFNP-SKKLGQGGAGSVYMGSLP---NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPESLLV  345 (611)
Q Consensus       272 ~f~~-~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  345 (611)
                      .|+. .++||+|+||+||+|...   +++.||||++....  ..+.+.+|+++|++++||||+++++++..  +...++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            3544 468999999999999754   57899999986442  23568899999999999999999999954  6678999


Q ss_pred             EeecCCCChhhhhhcc------CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE----CCCCCeEEe
Q 007248          346 YEYVPNRSLDQFIFDK------NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIA  415 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~  415 (611)
                      |||+. ++|.+++...      .....+++..++.++.||+.||.|||   ..+|+||||||+||||    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99996 4787777421      12235899999999999999999999   7899999999999999    778899999


Q ss_pred             eeccceeccCCCc--ceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCC
Q 007248          416 DFGLARCFAADRT--HVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFS  477 (611)
Q Consensus       416 DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~  477 (611)
                      |||+++.+.....  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            9999987653322  222356789999999999874 5899999999999999999999998644

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.5e-39  Score=332.99  Aligned_cols=262  Identities=22%  Similarity=0.327  Sum_probs=196.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeee--------C
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--------G  339 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  339 (611)
                      ++|+..+.||+|+||.||+|.. .+|+.||||++....  ......+.+|++++++++||||+++++++..        +
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5788899999999999999965 578999999886442  2334578899999999999999999999887        4


Q ss_pred             CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecc
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  419 (611)
                      +..++||||+++ +|.+.+...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            468999999975 777777433  345899999999999999999999   78999999999999999999999999999


Q ss_pred             ceeccCCCc---ceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc---
Q 007248          420 ARCFAADRT---HVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR---  492 (611)
Q Consensus       420 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~---  492 (611)
                      ++.+.....   .......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...... ..+..+.....   
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSIT  249 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCC
Confidence            987653222   22235578999999999876 45799999999999999999999997643211 11111111100   


Q ss_pred             --------cCccccccCCCCCCCCCH-HH------HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          493 --------SNKLVEAVDPNLKDDFPA-EQ------VCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       493 --------~~~~~~~id~~l~~~~~~-~~------~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                              .....+.+.......... ..      ...+.+++.+|++.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence                    000001000000000011 11      234778999999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=336.26  Aligned_cols=261  Identities=25%  Similarity=0.376  Sum_probs=199.1

Q ss_pred             ccChHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeee
Q 007248          260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSI  337 (611)
Q Consensus       260 ~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  337 (611)
                      .+.+.++....++|+..+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            445556666788999999999999999999965 578999999987543 2346788999999999 8999999999988


Q ss_pred             e------CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC
Q 007248          338 E------GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT  411 (611)
Q Consensus       338 ~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  411 (611)
                      .      ....++||||+++++|.+++... ....+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCC
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCC
Confidence            6      45789999999999999999643 2356899999999999999999999   789999999999999999999


Q ss_pred             eEEeeeccceeccCCCcceeecccCCccccChhhhh-----cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHH
Q 007248          412 PKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV-----RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQR  486 (611)
Q Consensus       412 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~  486 (611)
                      +||+|||++....... .......|+..|+|||++.     ...++.++||||||+++|||++|+.|+....    ....
T Consensus       168 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~  242 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH----PMRA  242 (326)
T ss_dssp             EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC----HHHH
T ss_pred             EEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc----HHHH
Confidence            9999999997654322 1223456899999999987     5678899999999999999999999975322    1121


Q ss_pred             HHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          487 VWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       487 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ....... ..     +.+.   +......+.+++.+||+.+|++||++.++++
T Consensus       243 ~~~~~~~-~~-----~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          243 LFLIPRN-PA-----PRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHS-CC-----CCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhhcC-cc-----ccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1111111 11     1111   1122345788999999999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.8e-39  Score=325.14  Aligned_cols=253  Identities=21%  Similarity=0.305  Sum_probs=202.5

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---------hhhHHHHHHHHHHHhcCC-CCceeeEeeee
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---------RQWVDEFFNEVNLISSIE-HKNLVKLLGCS  336 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  336 (611)
                      ...++|+..+.||+|+||.||++.. .+|+.||||++....         ....+.+.+|+++++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            3456888999999999999999965 468999999986542         233567889999999995 99999999999


Q ss_pred             eeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEee
Q 007248          337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD  416 (611)
Q Consensus       337 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  416 (611)
                      ..+...++||||+++++|.+++...   ..+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEec
Confidence            9999999999999999999999543   45899999999999999999999   78999999999999999999999999


Q ss_pred             eccceeccCCCcceeecccCCccccChhhhh------cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh
Q 007248          417 FGLARCFAADRTHVSTAVAGTLGYMAPEYLV------RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL  490 (611)
Q Consensus       417 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~  490 (611)
                      ||++.......  ......++..|+|||++.      ...++.++||||||+++|||++|+.|+....    .... ...
T Consensus       168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~-~~~  240 (298)
T 1phk_A          168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK----QMLM-LRM  240 (298)
T ss_dssp             CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH-HHH
T ss_pred             ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc----HHHH-HHH
Confidence            99998765432  223456899999999985      4567889999999999999999999975322    1111 111


Q ss_pred             hccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          491 YRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       491 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ......      .............+.+++.+|++.+|++||++.|+++
T Consensus       241 ~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          241 IMSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HhcCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            111111      0111111234456889999999999999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-38  Score=358.68  Aligned_cols=248  Identities=23%  Similarity=0.247  Sum_probs=203.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (611)
                      .++|+..+.||+|+||.||++.. .+++.||||++...   .....+.+..|..+|..+ +||||+++++++.+.+..++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            46788889999999999999965 46889999998754   233456788999999988 79999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++...
T Consensus       420 V~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            99999999999999643   35899999999999999999999   7899999999999999999999999999998643


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ... .......||+.|+|||++.+..++.++||||||++||||++|+.||....    ..+...... ...         
T Consensus       494 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~----~~~~~~~i~-~~~---------  558 (674)
T 3pfq_A          494 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----EDELFQSIM-EHN---------  558 (674)
T ss_dssp             CTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHH-SSC---------
T ss_pred             cCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC----HHHHHHHHH-hCC---------
Confidence            322 22345679999999999999999999999999999999999999985322    111111111 111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSM-----AQAIM  539 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~-----~evl~  539 (611)
                       ..++......+.+|+..||+.||++||++     +||++
T Consensus       559 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence             12333445568899999999999999997     66663

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.6e-39  Score=343.66  Aligned_cols=260  Identities=22%  Similarity=0.284  Sum_probs=193.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc------ceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE------SLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~l  344 (611)
                      .+|...+.||+|+||.||+|....+..+|+|++.....    ...+|+++|+.++||||+++++++.....      .++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            45788899999999999999887777799998865432    12369999999999999999999865443      789


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC-CCCCeEEeeeccceec
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCF  423 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~  423 (611)
                      ||||++++.+............+++..+..++.||++||+|||   ..+|+||||||+|||++ .++.+||+|||+++..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            9999987655444432333456999999999999999999999   78999999999999999 7899999999999876


Q ss_pred             cCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC--------
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN--------  494 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~--------  494 (611)
                      .....  .....+|..|+|||++.+. .++.++|||||||++|||++|+.||........+ ..+.......        
T Consensus       193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l-~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL-VEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHHHHH
T ss_pred             cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHhh
Confidence            44332  2345689999999998765 5899999999999999999999998643221111 1111111000        


Q ss_pred             --ccccccCCCCCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          495 --KLVEAVDPNLKD-----DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       495 --~~~~~id~~l~~-----~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                        ...+..-+....     .++......+.+++.+||+.||++|||+.|+++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence              000000011110     1112234568899999999999999999999863

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9.7e-39  Score=347.96  Aligned_cols=250  Identities=25%  Similarity=0.311  Sum_probs=196.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      .+.|...++||+|+||+||++.. .++..||||++....  ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            45688899999999999999965 468999999987542  333567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC---CCeEEeeeccceec
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD---FTPKIADFGLARCF  423 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~~~  423 (611)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++..   +.+||+|||++..+
T Consensus       116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            999999999988543   35899999999999999999999   7899999999999999764   45999999999876


Q ss_pred             cCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      ....  ......||+.|+|||++. +.++.++|||||||++|||++|+.||....    ..+. ......+...  .+..
T Consensus       190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~-~~~i~~~~~~--~~~~  259 (494)
T 3lij_A          190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT----DQEI-LRKVEKGKYT--FDSP  259 (494)
T ss_dssp             BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH-HHHHHHTCCC--CCSG
T ss_pred             CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHH-HHHHHhCCCC--CCch
Confidence            5432  233467999999999885 579999999999999999999999985322    1111 1111111110  0000


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .    .......+.+++..||+.+|++|||+.|+++
T Consensus       260 ~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          260 E----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             G----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             h----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            0    0122345789999999999999999999984

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.6e-39  Score=344.95  Aligned_cols=257  Identities=23%  Similarity=0.317  Sum_probs=190.8

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC------cceE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------ESLL  344 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  344 (611)
                      +|+..+.||+|+||.||+|.. .+|+.||||++.....    .+.+|+++|++++||||+++++++....      ..++
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            577788999999999999976 4689999999865432    2347999999999999999999885422      3579


Q ss_pred             EEeecCCCChhhhhhc-cCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC-CCeEEeeecccee
Q 007248          345 VYEYVPNRSLDQFIFD-KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARC  422 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~  422 (611)
                      ||||+++ +|.+.+.. ......+++..+..++.||++||.|||   ..+|+||||||+||||+.+ +.+||+|||+++.
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            9999986 56555532 123456999999999999999999999   8999999999999999965 5689999999987


Q ss_pred             ccCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC-------
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-------  494 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-------  494 (611)
                      +.....  .....+|..|+|||++.+. .++.++|||||||++|||++|+.||........+.. +.......       
T Consensus       207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~-i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE-IIKVLGTPTREQIRE  283 (420)
T ss_dssp             CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCSCCHHHHHH
T ss_pred             cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCCHHHHHh
Confidence            644322  2345689999999998765 789999999999999999999999864322111111 11111100       


Q ss_pred             ---ccccccCCCCCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          495 ---KLVEAVDPNLKDD-----FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       495 ---~~~~~id~~l~~~-----~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                         ...+..-+.+...     ++......+.+|+.+||+.||++||++.|+++
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence               0011101111100     12223456889999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.1e-39  Score=338.88  Aligned_cols=260  Identities=24%  Similarity=0.307  Sum_probs=200.2

Q ss_pred             hcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC--------CCceeeEeeeee---
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE--------HKNLVKLLGCSI---  337 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  337 (611)
                      .++|...++||+|+||+||+|. ..+++.||||++... ....+.+.+|++++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            3678899999999999999995 456899999998644 345677899999999885        788999999987   


Q ss_pred             -eCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCC-ceecCCCCcccEEECCCC-----
Q 007248          338 -EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLDKDF-----  410 (611)
Q Consensus       338 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~-----  410 (611)
                       .+...++||||+ +++|.+++... ....+++..++.++.||+.||.|||   .. +|+||||||+|||++.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhh
Confidence             556789999999 55666666433 2346899999999999999999999   66 999999999999999775     


Q ss_pred             --------------------------------------------CeEEeeeccceeccCCCcceeecccCCccccChhhh
Q 007248          411 --------------------------------------------TPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL  446 (611)
Q Consensus       411 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~  446 (611)
                                                                  .+||+|||++......    .....||..|+|||++
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence                                                        7999999999876432    2345689999999999


Q ss_pred             hcCccccccceehhHHHHHHHHhCCCCCCCCCCCCCh-----hHHHHHhhcc--------Ccc-ccccCC-----CC---
Q 007248          447 VRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASP-----LQRVWTLYRS--------NKL-VEAVDP-----NL---  504 (611)
Q Consensus       447 ~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~-----~~~~~~~~~~--------~~~-~~~id~-----~l---  504 (611)
                      .+..++.++|||||||++|||++|+.||.........     +.........        ... .+....     .+   
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            9999999999999999999999999998754332211     1111110000        000 000000     00   


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          505 -----------KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       505 -----------~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                                 ....+......+.+|+.+||+.||++|||+.|+++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                       01235566778999999999999999999999984

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.8e-39  Score=347.29  Aligned_cols=252  Identities=25%  Similarity=0.312  Sum_probs=200.4

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ..++|++.++||+|+||+||++.. .+++.||||++....  ....+.+.+|+++|++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            345788999999999999999965 478999999986432  23457899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC---CCCCeEEeeecccee
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARC  422 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~~  422 (611)
                      |||+++++|.+++...   ..+++..+..++.||+.||.|||   ..+|+||||||+|||++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999999988543   35899999999999999999999   78999999999999995   456799999999976


Q ss_pred             ccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      +....  ......||+.|+|||++.+ .++.++||||||+++|||++|+.||....    ..+.... ...+...     
T Consensus       174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~-i~~~~~~-----  240 (486)
T 3mwu_A          174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN----EYDILKR-VETGKYA-----  240 (486)
T ss_dssp             BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHH-HHHTCCC-----
T ss_pred             CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHH-HHhCCCC-----
Confidence            54332  2334579999999999865 68999999999999999999999975322    1111111 1111110     


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                       ...+........+.+++..||+.+|++|||+.|+++.
T Consensus       241 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          241 -FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             0001112234567899999999999999999999863

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.9e-39  Score=350.39  Aligned_cols=250  Identities=25%  Similarity=0.323  Sum_probs=202.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      .++|+..+.||+|+||.||++.. .+|+.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            45788899999999999999965 478999999986432   34567899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE---CCCCCeEEeeecccee
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARC  422 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~  422 (611)
                      |||+.+++|.+++...   ..+++..+..++.||+.||.|||   ..+|+||||||+|||+   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            9999999999998543   45899999999999999999999   7899999999999999   5678999999999986


Q ss_pred             ccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      +.....  .....||+.|+|||++.+ .++.++||||||+++|||++|+.||....    ..+.... +..+...     
T Consensus       179 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~-i~~~~~~-----  245 (484)
T 3nyv_A          179 FEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN----EYDILKK-VEKGKYT-----  245 (484)
T ss_dssp             BCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHH-HHHCCCC-----
T ss_pred             cccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC----HHHHHHH-HHcCCCC-----
Confidence            654322  234568999999999865 78999999999999999999999985322    1111111 1111110     


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       ...+........+.+++..||+.+|++|||+.|+++
T Consensus       246 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 -FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence             000111233456889999999999999999999984

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.6e-39  Score=330.76  Aligned_cols=258  Identities=22%  Similarity=0.322  Sum_probs=192.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeee-----------
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI-----------  337 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  337 (611)
                      .++|...+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            357888899999999999999665 58999999998777777788999999999999999999999874           


Q ss_pred             ---eCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC-CCCCeE
Q 007248          338 ---EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPK  413 (611)
Q Consensus       338 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k  413 (611)
                         +....++||||++ |+|.+++.    ...+++..++.++.||+.||+|||   +.+|+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEE
Confidence               3457799999997 69999984    245899999999999999999999   78999999999999997 567999


Q ss_pred             EeeeccceeccCCCc--ceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh
Q 007248          414 IADFGLARCFAADRT--HVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL  490 (611)
Q Consensus       414 l~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~  490 (611)
                      |+|||+++.......  .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.....    .......
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~~  237 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE----LEQMQLI  237 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence            999999986543221  12234457899999998876 6789999999999999999999999864322    1111111


Q ss_pred             hccCc-------------cccccCCCCC-CC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          491 YRSNK-------------LVEAVDPNLK-DD-----FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       491 ~~~~~-------------~~~~id~~l~-~~-----~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .....             +...+..... ..     ........+.+++.+|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            10000             0000000000 00     01123456889999999999999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.7e-38  Score=331.80  Aligned_cols=256  Identities=24%  Similarity=0.282  Sum_probs=190.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC------
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------  340 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  340 (611)
                      .++|...+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            35788899999999999999954 56899999998753  3445677899999999999999999999987665      


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      ..++||||+++ +|.+++.     ..+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999975 7888873     23889999999999999999999   789999999999999999999999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc-------
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS-------  493 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~-------  493 (611)
                      +......  ......||..|+|||++.+..++.++||||||+++|||++|+.||.....    ..........       
T Consensus       175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~  248 (371)
T 2xrw_A          175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVIEQLGTPCPE  248 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHC-CCCCCHH
T ss_pred             ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHH
Confidence            7654321  22345789999999999999999999999999999999999999854321    1111111100       


Q ss_pred             ---------------C------ccccccCCCCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          494 ---------------N------KLVEAVDPNLKDD---FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       494 ---------------~------~~~~~id~~l~~~---~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                                     .      .+.......+...   ........+.+++.+||+.||++|||++|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                           0      0000000000000   011225568899999999999999999999863

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.8e-39  Score=342.58  Aligned_cols=198  Identities=20%  Similarity=0.252  Sum_probs=170.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcC------CCCceeeEeeeeeeCCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI------EHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  342 (611)
                      ..+|+..++||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            45688899999999999999954 56899999998654 34456778888888876      577999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC--eEEeeeccc
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT--PKIADFGLA  420 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla  420 (611)
                      ++||||+. ++|.+++.... ...+++..+..++.||+.||+|||   +.+|+||||||+||||+.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 68999885432 345899999999999999999999   789999999999999999887  999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCC
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFS  477 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~  477 (611)
                      ......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            764332    23457899999999999999999999999999999999999997543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.4e-39  Score=335.15  Aligned_cols=258  Identities=24%  Similarity=0.317  Sum_probs=181.9

Q ss_pred             hcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC------C
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG------P  340 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  340 (611)
                      .++|...+.||+|+||.||+|. ..+|+.||||++...  .....+.+.+|+++|+.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            4678889999999999999995 567899999998643  334567889999999999999999999998754      5


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      ..++|+||+ +++|.+++..    ..+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 7899998843    45999999999999999999999   789999999999999999999999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC-----
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-----  494 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----  494 (611)
                      +.....    .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..+.......     
T Consensus       180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHH
T ss_pred             cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            765432    234578999999999877 67899999999999999999999998543211 1111111111100     


Q ss_pred             ------ccccccCCCC-CCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          495 ------KLVEAVDPNL-KDDFP-----AEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       495 ------~~~~~id~~l-~~~~~-----~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                            .....+.... ....+     ......+.+|+.+||+.||++|||+.|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                  0000000000 00001     1123457899999999999999999999853

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-38  Score=328.13  Aligned_cols=255  Identities=26%  Similarity=0.369  Sum_probs=178.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHH-HHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVN-LISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      .++|...+.||+|+||.||++.. .+|+.||||++.... .....++..|+. +++.++||||+++++++.+++..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            35788889999999999999966 478999999987543 334456666666 778889999999999999999999999


Q ss_pred             eecCCCChhhhhhc--cCCCccCChhHHHHHHHHHHHHHHHHhcCCCC-ceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          347 EYVPNRSLDQFIFD--KNKTKLLNWNKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       347 E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      ||+++ +|.+++..  ......+++..+..++.|++.||.|||   .. +|+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 88777742  122456899999999999999999999   66 9999999999999999999999999999765


Q ss_pred             cCCCcceeecccCCccccChhhh----hcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYL----VRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      ....  ......|+..|+|||++    .+..++.++||||||+++|||++|+.|+.........   ..      .+...
T Consensus       177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~------~~~~~  245 (327)
T 3aln_A          177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---LT------QVVKG  245 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------C------CCCCS
T ss_pred             cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---HH------HHhcC
Confidence            4322  12234689999999998    4567899999999999999999999998643221110   00      00111


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..+.+...........+.+++..||+.+|++||++.+|++
T Consensus       246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            1111111112233456889999999999999999999974

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.4e-38  Score=333.07  Aligned_cols=261  Identities=21%  Similarity=0.311  Sum_probs=198.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC-----Ccc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----PES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  342 (611)
                      .++|...+.||+|+||.||++.. .+++.||||++... .....+.+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            46788999999999999999954 57889999998743 344457899999999999999999999998754     367


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++||||+. ++|.+++..    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++..
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 599998843    34899999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCCcce--eecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcc---
Q 007248          423 FAADRTHV--STAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL---  496 (611)
Q Consensus       423 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---  496 (611)
                      ........  .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+..+.........   
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDL  256 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHH
Confidence            65332221  234578999999998765 458999999999999999999999985433221 11111111110000   


Q ss_pred             --------cccc-CCCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          497 --------VEAV-DPNLKDDFP-----AEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       497 --------~~~i-d~~l~~~~~-----~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                              .... ........+     ......+.+++.+|++.||++|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                    0000 000000111     122345789999999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.8e-38  Score=346.69  Aligned_cols=251  Identities=26%  Similarity=0.351  Sum_probs=198.6

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch-------------hhHHHHHHHHHHHhcCCCCceeeEee
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR-------------QWVDEFFNEVNLISSIEHKNLVKLLG  334 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  334 (611)
                      ..++|...++||+|+||+||++.. .+++.||||++.....             ...+.+.+|+.+|++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            457788999999999999999965 4688999999864321             33567899999999999999999999


Q ss_pred             eeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC---C
Q 007248          335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF---T  411 (611)
Q Consensus       335 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~  411 (611)
                      ++.++...++||||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999999998543   35899999999999999999999   78999999999999999776   6


Q ss_pred             eEEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhh
Q 007248          412 PKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY  491 (611)
Q Consensus       412 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~  491 (611)
                      +||+|||++..+....  ......||+.|+|||++. +.++.++||||||+++|||++|+.||....    ..+. ....
T Consensus       188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~-~~~i  259 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN----DQDI-IKKV  259 (504)
T ss_dssp             EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH-HHHH
T ss_pred             EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC----HHHH-HHHH
Confidence            9999999998765432  233457999999999986 568999999999999999999999985322    1111 1111


Q ss_pred             ccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       492 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..+...      ............+.+++..|++.+|++|||+.|+++
T Consensus       260 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          260 EKGKYY------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHCCCC------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HcCCCC------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111110      000000112345789999999999999999999984

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.4e-38  Score=331.36  Aligned_cols=261  Identities=21%  Similarity=0.293  Sum_probs=196.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC-----Ccc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----PES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  342 (611)
                      .++|...+.||+|+||.||+|.. .+|+.||||++... .......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            46788899999999999999965 46899999998643 344566788999999999999999999987754     678


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++||||+. ++|.+++..    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 689998853    35899999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCCcc---------eeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc
Q 007248          423 FAADRTH---------VSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR  492 (611)
Q Consensus       423 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~  492 (611)
                      .......         ......||..|+|||++.. ..++.++||||||+++|||++|+.||....... .+........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~  240 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIG  240 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhC
Confidence            6532211         1123468999999998765 678999999999999999999999986432111 1111111110


Q ss_pred             cCc------------cccccCCC-CCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          493 SNK------------LVEAVDPN-LKDDF-----PAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       493 ~~~------------~~~~id~~-l~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ...            ..+.+... .....     .......+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000            00000000 00000     1123455789999999999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.2e-38  Score=332.79  Aligned_cols=271  Identities=21%  Similarity=0.288  Sum_probs=191.4

Q ss_pred             hHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc
Q 007248          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       263 ~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (611)
                      .+......++|...+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|++.+..++||||+++++++.....
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            345667788999999999999999999965 468999999886543 233466788889999999999999999876443


Q ss_pred             -------ceEEEeecCCCChhhhhh-ccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-CCCe
Q 007248          342 -------SLLVYEYVPNRSLDQFIF-DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTP  412 (611)
Q Consensus       342 -------~~lv~E~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~  412 (611)
                             .++||||++++ |.+.+. .......+++..+..++.||+.||.|||. ...+|+||||||+|||++. ++.+
T Consensus        94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEE
T ss_pred             ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcE
Confidence                   78999999874 444332 22345568999999999999999999993 2578999999999999997 8999


Q ss_pred             EEeeeccceeccCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhh
Q 007248          413 KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY  491 (611)
Q Consensus       413 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~  491 (611)
                      ||+|||+++......  ......||..|+|||++.+. .++.++||||||+++|||++|+.||........ +..+....
T Consensus       172 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~~  248 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LHEIVRVL  248 (360)
T ss_dssp             EECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHH
T ss_pred             EEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HHHHHHHc
Confidence            999999998665433  22345689999999998665 489999999999999999999999864332111 11111100


Q ss_pred             ccC--ccccccCCC----------------CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          492 RSN--KLVEAVDPN----------------LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       492 ~~~--~~~~~id~~----------------l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ...  .....+++.                ............+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            000  000000000                001112234567899999999999999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.2e-38  Score=327.97  Aligned_cols=264  Identities=25%  Similarity=0.342  Sum_probs=198.8

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc--CCCCEEEEEEeeccch--hhHHHHHHHHHHHhcC---CCCceeeEeeeee---
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSL--PNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSI---EHKNLVKLLGCSI---  337 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---  337 (611)
                      .+.++|+..+.||+|+||.||++..  .+|+.||||++.....  .....+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            4557899999999999999999976  4688999999864431  2223566777777766   8999999999987   


Q ss_pred             --eCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEe
Q 007248          338 --EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA  415 (611)
Q Consensus       338 --~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  415 (611)
                        .....++||||++ |+|.+++.... ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEe
Confidence              5567899999998 69999986433 335899999999999999999999   7899999999999999999999999


Q ss_pred             eeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC-
Q 007248          416 DFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-  494 (611)
Q Consensus       416 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-  494 (611)
                      |||+++......  ......|+..|+|||++.+..++.++||||||+++|||++|+.||....... .+..+....... 
T Consensus       163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~  239 (326)
T 1blx_A          163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPG  239 (326)
T ss_dssp             SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred             cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCC
Confidence            999997654322  2234568999999999999999999999999999999999999976432211 111111111100 


Q ss_pred             --cccc-------ccC---CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          495 --KLVE-------AVD---PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       495 --~~~~-------~id---~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        .+..       ...   ......+.......+.+++.+||+.+|++||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              0000       000   00001112233456789999999999999999999984

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.1e-38  Score=323.63  Aligned_cols=259  Identities=19%  Similarity=0.247  Sum_probs=200.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc--CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc------eeeEeeeeeeCCc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL--PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN------LVKLLGCSIEGPE  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  341 (611)
                      .++|++.+.||+|+||.||++..  .+++.||||++... ....+.+.+|+++++.++|+|      ++++++++.+++.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35788899999999999999964  46889999998644 344577889999999987765      9999999999999


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-------------
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-------------  408 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------------  408 (611)
                      .++||||+ +++|.+++.... ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 889999986432 346889999999999999999999   789999999999999987             


Q ss_pred             ------CCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCC
Q 007248          409 ------DFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS  482 (611)
Q Consensus       409 ------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~  482 (611)
                            ++.+||+|||++......    .....||..|+|||++.+..++.++||||||+++|||++|+.||....... 
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE-  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-
T ss_pred             ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-
Confidence                  668999999999864432    234578999999999999899999999999999999999999986432211 


Q ss_pred             hhHHHHHhhcc-----------Ccccc--ccC---------------CCC--CCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 007248          483 PLQRVWTLYRS-----------NKLVE--AVD---------------PNL--KDDFPAEQVCNVLQIGLLCTQAAAALRP  532 (611)
Q Consensus       483 ~~~~~~~~~~~-----------~~~~~--~id---------------~~l--~~~~~~~~~~~l~~l~~~c~~~~p~~RP  532 (611)
                      ...........           .....  ..+               ..+  ....+......+.+++.+||+.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            11111110000           00000  000               000  0112334567789999999999999999


Q ss_pred             CHHHHHH
Q 007248          533 SMAQAIM  539 (611)
Q Consensus       533 t~~evl~  539 (611)
                      |+.|+++
T Consensus       322 t~~ell~  328 (339)
T 1z57_A          322 TLREALK  328 (339)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.1e-38  Score=336.45  Aligned_cols=251  Identities=24%  Similarity=0.360  Sum_probs=186.2

Q ss_pred             CCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEeecC
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      .|...++||+|+||+||.+...+|+.||||++....   .+.+.+|+++|.++ +||||+++++++.+++..++||||+.
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            344567899999999987766689999999986543   35678999999886 89999999999999999999999995


Q ss_pred             CCChhhhhhccCCC----ccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC-------------CCeE
Q 007248          351 NRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-------------FTPK  413 (611)
Q Consensus       351 ~gsL~~~l~~~~~~----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~k  413 (611)
                       |+|.+++......    ...++..++.++.||+.||+|||   +.+|+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             6999999654321    11245567889999999999999   7899999999999999754             4899


Q ss_pred             EeeeccceeccCCCcc---eeecccCCccccChhhhhc-------CccccccceehhHHHHHHHHh-CCCCCCCCCCCCC
Q 007248          414 IADFGLARCFAADRTH---VSTAVAGTLGYMAPEYLVR-------GQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSAS  482 (611)
Q Consensus       414 l~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~  482 (611)
                      |+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||+| |+.|+......  
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--  246 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--  246 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH--
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh--
Confidence            9999999876543322   1234579999999999975       578999999999999999999 89887532211  


Q ss_pred             hhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          483 PLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       483 ~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      . .   .... +.. .  .+.+....+......+.+++.+||+.||++||++.+|++
T Consensus       247 ~-~---~i~~-~~~-~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 E-S---NIIR-GIF-S--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H-H---HHHH-TCC-C--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H-H---HHhc-CCC-C--cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            0 0   1111 000 0  011111223455677899999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.2e-38  Score=331.22  Aligned_cols=257  Identities=22%  Similarity=0.330  Sum_probs=194.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc----
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES----  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  342 (611)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            45788889999999999999954 56899999998753  334467889999999999999999999999877655    


Q ss_pred             --eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          343 --LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       343 --~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                        ++||||+. ++|.+++.     ..+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 68888772     23899999999999999999999   789999999999999999999999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC-----
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-----  494 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----  494 (611)
                      +.....    .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+..........     
T Consensus       192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHH
T ss_pred             cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCcHHHH
Confidence            755332    234568999999999987 688999999999999999999999986432111 111110000000     


Q ss_pred             ------c---cccccCCCCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          495 ------K---LVEAVDPNLKDD---FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       495 ------~---~~~~id~~l~~~---~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                            .   ....+.......   ........+.+++..|++.||++|||+.|+++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                  0   000000000000   011224568899999999999999999999853

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=325.11  Aligned_cols=255  Identities=22%  Similarity=0.327  Sum_probs=194.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc-----
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE-----  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  341 (611)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            35688889999999999999965 56899999998653  33446788999999999999999999999987654     


Q ss_pred             -ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          342 -SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       342 -~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                       .++||||+. ++|.+++.     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 68888873     23899999999999999999999   789999999999999999999999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC-----
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN-----  494 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----  494 (611)
                      +.....    .....+|..|+|||++.+ ..++.++||||||+++|||++|+.||....... .+..+.......     
T Consensus       174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHH
T ss_pred             cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence            764322    234568999999999877 678999999999999999999999986432111 111111100000     


Q ss_pred             -------------ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          495 -------------KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       495 -------------~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                                   .+.......+ ..........+.+++.+|++.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                         0000000111 1112234556889999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.9e-38  Score=324.13  Aligned_cols=252  Identities=21%  Similarity=0.224  Sum_probs=171.1

Q ss_pred             hcCCCCCC-ccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeee----CCcce
Q 007248          270 TNYFNPSK-KLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE----GPESL  343 (611)
Q Consensus       270 ~~~f~~~~-~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  343 (611)
                      .++|...+ .||+|+||.||++... +|+.||||++.... ...+   .....++.++||||+++++++..    +...+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            45777754 6999999999999654 68999999986532 1112   22334566799999999999876    44589


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC---CCCeEEeeeccc
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLA  420 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla  420 (611)
                      +||||+++|+|.+++.... ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.   ++.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            9999999999999996542 346999999999999999999999   789999999999999986   445999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      +......   .....+|+.|+|||++....++.++||||||+++|||++|+.||............ .......      
T Consensus       179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~------  248 (336)
T 3fhr_A          179 KETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-KRRIRLG------  248 (336)
T ss_dssp             EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             eeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH-HHhhhcc------
Confidence            8654322   23456799999999998899999999999999999999999998644322110000 0000000      


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ...+...........+.+++..|++.+|++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            001111111233456889999999999999999999996

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-37  Score=327.01  Aligned_cols=203  Identities=24%  Similarity=0.276  Sum_probs=171.5

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-CC-----ceeeEeeeeeeC
Q 007248          267 EKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HK-----NLVKLLGCSIEG  339 (611)
Q Consensus       267 ~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~  339 (611)
                      +...++|+..+.||+|+||+||+|.. .+++.||||++... ....+++..|+.+++.++ |+     +|+++++++...
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            34567899999999999999999964 46889999998743 344567788999888874 44     499999999999


Q ss_pred             CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC--CCCCeEEeee
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD--KDFTPKIADF  417 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Df  417 (611)
                      +..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||.+ +.+|+||||||+|||++  .++.+||+||
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             CceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            99999999996 59999986543 24589999999999999999999942 46899999999999995  4778999999


Q ss_pred             ccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCC
Q 007248          418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFS  477 (611)
Q Consensus       418 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~  477 (611)
                      |+++.....    .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999876432    23457899999999999999999999999999999999999998643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.7e-38  Score=318.61  Aligned_cols=252  Identities=25%  Similarity=0.317  Sum_probs=200.2

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          268 KATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       268 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ...++|+..+.||+|+||.||++... +++.||||++....  ....+.+.+|++++++++||||+++++++.+....++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            44568999999999999999999664 78999999986542  3446789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC---CCeEEeeeccce
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD---FTPKIADFGLAR  421 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~  421 (611)
                      |+||+++++|.+++...   ..+++..++.++.||+.||.|||   ..+|+||||||+|||++.+   +.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            99999999999988543   35899999999999999999999   7899999999999999764   469999999997


Q ss_pred             eccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccC
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD  501 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  501 (611)
                      .......  .....++..|+|||.+.+ .++.++||||||+++|||++|+.|+....    ..+. ......+....  +
T Consensus       173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~-~~~~~~~~~~~--~  242 (287)
T 2wei_A          173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN----EYDI-LKRVETGKYAF--D  242 (287)
T ss_dssp             TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH-HHHHHHCCCCC--C
T ss_pred             eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC----HHHH-HHHHHcCCCCC--C
Confidence            6543321  223457889999998865 58999999999999999999999975322    1111 11111111100  0


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       502 ~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                        +  .........+.+++.+|++.+|++|||+.|+++
T Consensus       243 --~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          243 --L--PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             --S--GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --c--hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence              0  000122345789999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=325.14  Aligned_cols=246  Identities=26%  Similarity=0.369  Sum_probs=190.3

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch------hhHHHHHHHHHHHhcC----CCCceeeEe
Q 007248          265 TLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR------QWVDEFFNEVNLISSI----EHKNLVKLL  333 (611)
Q Consensus       265 ~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~  333 (611)
                      +.+...++|...+.||+|+||.||+|.. .+++.||||++.....      .....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3455677899999999999999999965 5689999999865432      1223466799999988    899999999


Q ss_pred             eeeeeCCcceEEEee-cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC-CCCC
Q 007248          334 GCSIEGPESLLVYEY-VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFT  411 (611)
Q Consensus       334 ~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~  411 (611)
                      +++...+..++|+|| +.+++|.+++...   ..+++..++.++.||+.||.|||   +.+|+||||||+|||++ .++.
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCe
Confidence            999999999999999 7899999999643   35899999999999999999999   78999999999999999 8899


Q ss_pred             eEEeeeccceeccCCCcceeecccCCccccChhhhhcCcc-ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHh
Q 007248          412 PKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL  490 (611)
Q Consensus       412 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~  490 (611)
                      +||+|||++.......   .....|+..|+|||++.+..+ +.++||||||+++|||++|+.|+....       ..   
T Consensus       179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~---  245 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EI---  245 (312)
T ss_dssp             EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HH---
T ss_pred             EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HH---
Confidence            9999999998765432   234568999999999987766 458999999999999999999975211       00   


Q ss_pred             hccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          491 YRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       491 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      .. ..      .    .++......+.+++.+||+.+|++||++.|+++.
T Consensus       246 ~~-~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          246 LE-AE------L----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HH-TC------C----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             hh-hc------c----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00 00      0    1222334557899999999999999999999863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-37  Score=326.82  Aligned_cols=259  Identities=22%  Similarity=0.276  Sum_probs=198.1

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-----------CCceeeEeeeeee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-----------HKNLVKLLGCSIE  338 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  338 (611)
                      ++|...+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            5788899999999999999964 57899999998643 334567889999999886           8999999999886


Q ss_pred             CC----cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCC-ceecCCCCcccEEEC------
Q 007248          339 GP----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLD------  407 (611)
Q Consensus       339 ~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~------  407 (611)
                      .+    ..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||   .. +|+||||||+|||++      
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            54    689999999 899999996532 345899999999999999999999   66 999999999999994      


Q ss_pred             CCCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCC--Ch--
Q 007248          408 KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSA--SP--  483 (611)
Q Consensus       408 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~--~~--  483 (611)
                      ..+.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......  ..  
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            4457999999999876432    234568999999999999999999999999999999999999987543211  00  


Q ss_pred             -hHHHHHhhc------------------cCccccccCCC----------CCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 007248          484 -LQRVWTLYR------------------SNKLVEAVDPN----------LKDDFPAEQVCNVLQIGLLCTQAAAALRPSM  534 (611)
Q Consensus       484 -~~~~~~~~~------------------~~~~~~~id~~----------l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~  534 (611)
                       +..+.....                  .......+...          -...++......+.+++..||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence             111111000                  00000000000          0113456677889999999999999999999


Q ss_pred             HHHHH
Q 007248          535 AQAIM  539 (611)
Q Consensus       535 ~evl~  539 (611)
                      .|+++
T Consensus       329 ~ell~  333 (373)
T 1q8y_A          329 GGLVN  333 (373)
T ss_dssp             HHHHT
T ss_pred             HHHhh
Confidence            99985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.3e-37  Score=320.01  Aligned_cols=259  Identities=20%  Similarity=0.249  Sum_probs=197.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEcC-CC-CEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc------eeeEeeeeeeCCc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLP-NG-TTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN------LVKLLGCSIEGPE  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  341 (611)
                      .++|++.+.||+|+||.||++... ++ +.||||++... ....+.+.+|+.++++++|+|      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            367888999999999999999653 34 68999998643 344577889999999998776      8999999999999


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE---------------
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---------------  406 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---------------  406 (611)
                      .++||||+ +++|.+++... ....+++..++.++.||+.||.|||   +.+|+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccc
Confidence            99999999 66777776443 2346899999999999999999999   8899999999999999               


Q ss_pred             ----CCCCCeEEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCC
Q 007248          407 ----DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS  482 (611)
Q Consensus       407 ----~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~  482 (611)
                          +.++.+||+|||+++.....    .....||..|+|||++.+..++.++||||||+++|||++|+.||....... 
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred             cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence                56789999999999864432    234578999999999999999999999999999999999999986433211 


Q ss_pred             hhHHHHHhhcc-----------Cccc------------------cccCC-CCCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 007248          483 PLQRVWTLYRS-----------NKLV------------------EAVDP-NLKDDFPAEQVCNVLQIGLLCTQAAAALRP  532 (611)
Q Consensus       483 ~~~~~~~~~~~-----------~~~~------------------~~id~-~l~~~~~~~~~~~l~~l~~~c~~~~p~~RP  532 (611)
                      .+.........           ....                  +...+ .............+.+++.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            11111111000           0000                  00000 000011223456788999999999999999


Q ss_pred             CHHHHHH
Q 007248          533 SMAQAIM  539 (611)
Q Consensus       533 t~~evl~  539 (611)
                      |+.|+++
T Consensus       327 t~~e~l~  333 (355)
T 2eu9_A          327 TLAEALL  333 (355)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999873

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.4e-38  Score=322.67  Aligned_cols=244  Identities=24%  Similarity=0.337  Sum_probs=197.6

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccch------hhHHHHHHHHHHHhcCC--CCceeeEeeee
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTR------QWVDEFFNEVNLISSIE--HKNLVKLLGCS  336 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~  336 (611)
                      .+...++|...+.||+|+||.||+|. ..+++.||||++.....      ...+.+.+|+.++++++  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            34456778899999999999999995 46789999999875432      12245778999999996  59999999999


Q ss_pred             eeCCcceEEEeecCC-CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC-CCCCeEE
Q 007248          337 IEGPESLLVYEYVPN-RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPKI  414 (611)
Q Consensus       337 ~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl  414 (611)
                      .+++..++|+|++.+ ++|.+++...   ..+++..++.++.||++||.|||   +.+|+||||||+|||++ +++.+||
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEE
Confidence            999999999999976 8999999543   45899999999999999999999   78999999999999999 7889999


Q ss_pred             eeeccceeccCCCcceeecccCCccccChhhhhcCcc-ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc
Q 007248          415 ADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS  493 (611)
Q Consensus       415 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  493 (611)
                      +|||+++......   .....||..|+|||++.+..+ +.++||||||+++|||++|+.||....      .    ... 
T Consensus       192 ~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~----~~~-  257 (320)
T 3a99_A          192 IDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E----IIR-  257 (320)
T ss_dssp             CCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHH-
T ss_pred             eeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------h----hhc-
Confidence            9999998765332   234568999999999987765 788999999999999999999975321      0    000 


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..      ..+    +......+.+++.+||+.+|++||++.||++
T Consensus       258 ~~------~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 GQ------VFF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CC------CCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc------ccc----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00      001    1222345789999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=318.34  Aligned_cols=251  Identities=22%  Similarity=0.325  Sum_probs=177.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-h-hhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-R-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++.... . ...+.+..+..+++.++||||+++++++.+++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            45678889999999999999966 478999999987543 2 22334455556788899999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCC-ceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      ||+ ++.+..+....  ...+++..++.++.||++||.|||   .. +|+||||||+|||++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 45555554321  345899999999999999999999   64 899999999999999999999999999976543


Q ss_pred             CCcceeecccCCccccChhhhh-----cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLV-----RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      ..  ......++..|+|||++.     ...++.++||||||+++|||++|+.||.....   .............     
T Consensus       178 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~-----  247 (318)
T 2dyl_A          178 DK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT---DFEVLTKVLQEEP-----  247 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS---HHHHHHHHHHSCC-----
T ss_pred             Cc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc---cHHHHHHHhccCC-----
Confidence            22  223456899999999984     45688899999999999999999999864322   1111111111110     


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       +.+..  .......+.+++.+||+.+|++||++.++++
T Consensus       248 -~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 -PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             11110  1122345788999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.8e-38  Score=345.25  Aligned_cols=260  Identities=24%  Similarity=0.309  Sum_probs=199.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeee------CCc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE------GPE  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  341 (611)
                      .++|+..++||+|+||.||+|.. .+|+.||||++... .....+.|.+|++++++++||||+++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36799999999999999999965 56899999988654 34556789999999999999999999998765      667


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC---eEEeeec
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT---PKIADFG  418 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG  418 (611)
                      .++||||+++|+|.+++........+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976555557999999999999999999999   789999999999999997765   8999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc---
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK---  495 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---  495 (611)
                      ++.......  ......|+..|+|||++.+..++.++||||||+++|||++|+.||.....   ...|.........   
T Consensus       170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~---~~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ---PVQWHGKVREKSNEHI  244 (676)
T ss_dssp             CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH---HHHSSTTCC------C
T ss_pred             ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc---hhhhhhhhhcccchhh
Confidence            998764432  22346789999999999999999999999999999999999999864311   1111000000000   


Q ss_pred             -cccccCC--------CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 007248          496 -LVEAVDP--------NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQA  537 (611)
Q Consensus       496 -~~~~id~--------~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~ev  537 (611)
                       ..+....        .............+.+++..|++.||++|||+.++
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence             0000000        01122344567789999999999999999999663

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=332.73  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=184.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ..+|...++||+|+||+||.....+|+.||||++.....   ..+.+|+++|+++ +|||||++++++.++...++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            345778899999999996655555889999999864432   2356899999999 899999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-----CCCeEEeeeccceec
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-----DFTPKIADFGLARCF  423 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla~~~  423 (611)
                      +. |+|.+++....  ..+.+..++.++.||+.||.|||   ..+|+||||||+|||++.     ...+||+|||+++..
T Consensus       100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 59999996432  33556677899999999999999   789999999999999953     335889999999876


Q ss_pred             cCCCc--ceeecccCCccccChhhhh---cCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccc
Q 007248          424 AADRT--HVSTAVAGTLGYMAPEYLV---RGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLV  497 (611)
Q Consensus       424 ~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (611)
                      .....  .......||+.|+|||++.   ...++.++|||||||++|||++ |+.|+.....     ............ 
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----~~~~~~~~~~~~-  247 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----RQANILLGACSL-  247 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----HHHHHHTTCCCC-
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----HHHHHHhccCCc-
Confidence            54322  2233567999999999997   4567889999999999999999 8888743211     111111111000 


Q ss_pred             cccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       498 ~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..    +  .........+.+++.+||+.||++|||+.||++
T Consensus       248 ~~----~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          248 DC----L--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TT----S--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc----c--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00    0  112233445778999999999999999999984

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9e-37  Score=345.03  Aligned_cols=236  Identities=20%  Similarity=0.279  Sum_probs=189.6

Q ss_pred             cCCCCCCccccCCceeEEEEEcC--CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc-----c
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP--NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE-----S  342 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~  342 (611)
                      ++|.+.+.||+|+||.||++...  +|+.||||++... ..+..+.|.+|++++++++||||+++++++.+.+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67888999999999999999764  6899999988643 34556789999999999999999999999987765     6


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++||||+++++|.+++..     .++|..++.|+.||+.||.|||   +.+|+||||||+|||++.+ .+||+|||+++.
T Consensus       160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            999999999999988732     5899999999999999999999   7899999999999999986 899999999987


Q ss_pred             ccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ....     ....||+.|+|||++.++. +.++||||||+++|||++|..|+......              .    +  
T Consensus       231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------------~----~--  284 (681)
T 2pzi_A          231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------------G----L--  284 (681)
T ss_dssp             TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------------S----C--
T ss_pred             cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------------c----c--
Confidence            6433     3456899999999987664 88999999999999999998775421100              0    0  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhc
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPS-MAQAIMLLT  542 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt-~~evl~~L~  542 (611)
                       ............+.+++.+||+.+|++||+ ++++...|.
T Consensus       285 -~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          285 -PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             -CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             -cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence             000011122356789999999999999995 555555554

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.7e-36  Score=306.33  Aligned_cols=228  Identities=11%  Similarity=0.054  Sum_probs=180.6

Q ss_pred             cCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|+..+.||+|+||.||+|... +++.||||++....   .+..+.|.+|+.++.+++||||+++++++.+++..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56888899999999999999664 58999999987542   345578999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++++|.+++..    . ....++.+++.||+.||+|||   ..+|+||||||+|||++.++.+||+++|        
T Consensus       111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            99999999999932    2 345578899999999999999   7899999999999999999999998543        


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC-
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK-  505 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~-  505 (611)
                                   |++|       ++.++||||||+++|||+||+.||........... .         ...+..... 
T Consensus       175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-~---------~~~~~~~~~~  224 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-A---------ERDTAGQPIE  224 (286)
T ss_dssp             -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-C---------CBCTTSCBCC
T ss_pred             -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-H---------HHHhccCCCC
Confidence                         3333       67899999999999999999999865432211100 0         000000000 


Q ss_pred             -CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          506 -DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       506 -~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                       ..........+.+++.+||+.||++| |+.|+++.|....
T Consensus       225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence             00111234458899999999999999 9999999997644

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-36  Score=321.64  Aligned_cols=241  Identities=18%  Similarity=0.178  Sum_probs=178.2

Q ss_pred             hcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCC-Ccee--------------
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEH-KNLV--------------  330 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv--------------  330 (611)
                      ++.|...+.||+|+||.||+|. ..+|+.||||++....   ....+.|.+|+.+++.++| +|..              
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            4456677899999999999996 5679999999987432   2335779999999999987 2211              


Q ss_pred             -e------Eeeeeee-----CCcceEEEeecCCCChhhhhhc----cCCCccCChhHHHHHHHHHHHHHHHHhcCCCCce
Q 007248          331 -K------LLGCSIE-----GPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI  394 (611)
Q Consensus       331 -~------l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  394 (611)
                       .      ++.+...     ....+++|+++ +++|.+++..    ......+++..++.++.||++||+|||   +.+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence             1      1111111     12346666655 6899988831    223456889999999999999999999   7899


Q ss_pred             ecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecccCCccccChhhh----------hcCccccccceehhHHHH
Q 007248          395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL----------VRGQLTEKADVYSFGILI  464 (611)
Q Consensus       395 vH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDV~S~Gvll  464 (611)
                      +||||||+||||+.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||||++
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            99999999999999999999999999765432    344567 999999999          555688899999999999


Q ss_pred             HHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007248          465 IEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       465 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                      |||++|+.||........             ....+.. . ...+    ..+.+++..||+.+|++||++.+++
T Consensus       308 ~elltg~~Pf~~~~~~~~-------------~~~~~~~-~-~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG-------------SEWIFRS-C-KNIP----QPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC-------------SGGGGSS-C-CCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhhh-------------HHHHHhh-c-ccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999854321110             0011110 0 1222    4588999999999999999987775

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4e-35  Score=298.27  Aligned_cols=226  Identities=20%  Similarity=0.267  Sum_probs=176.1

Q ss_pred             cCCCCC-CccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHH-hcCCCCceeeEeeeeee----CCcce
Q 007248          271 NYFNPS-KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLI-SSIEHKNLVKLLGCSIE----GPESL  343 (611)
Q Consensus       271 ~~f~~~-~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~  343 (611)
                      ++|... +.||+|+||.||++.. .+++.||||++...     ..+.+|++++ +.++||||+++++++..    +...+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            455555 6799999999999955 57899999998643     3567888887 56699999999999876    66789


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC---CCCeEEeeeccc
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLA  420 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla  420 (611)
                      +||||+++++|.+++... ....+++..++.++.||+.||.|||   ..+|+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            999999999999999653 2346999999999999999999999   789999999999999998   788999999998


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      ....                       +..++.++||||||+++|||++|+.||.........          ..+...+
T Consensus       168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----------~~~~~~~  214 (299)
T 3m2w_A          168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------PGMKTRI  214 (299)
T ss_dssp             EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCSCCSS
T ss_pred             cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----------HHHHHHH
Confidence            6432                       245678999999999999999999998543221100          0000111


Q ss_pred             CCCCCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          501 DPNLKDDFP----AEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       501 d~~l~~~~~----~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .... ...+    ......+.+++..||+.+|++|||+.|+++
T Consensus       215 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          215 RMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CTTC-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcc-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0000 1112    123456889999999999999999999985

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.1e-35  Score=307.46  Aligned_cols=241  Identities=17%  Similarity=0.180  Sum_probs=181.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccc--------hhhHHHHHHHHHHHhcCC---------CCceeeE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--------RQWVDEFFNEVNLISSIE---------HKNLVKL  332 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l  332 (611)
                      .++|+..++||+|+||+||+|.. +|+.||||++....        ....+.+.+|+.++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35677889999999999999987 78999999997542        223477889999998886         6666666


Q ss_pred             eeee-----------------ee-------------CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHH
Q 007248          333 LGCS-----------------IE-------------GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG  382 (611)
Q Consensus       333 ~~~~-----------------~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~  382 (611)
                      .+++                 .+             +...++||||+++|++.+.+..    ..+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            6653                 32             6789999999999987777632    458999999999999999


Q ss_pred             HHHHhcCCCCceecCCCCcccEEECCCC--------------------CeEEeeeccceeccCCCcceeecccCCccccC
Q 007248          383 LAYLHGGSETRIIHRDIKTSNILLDKDF--------------------TPKIADFGLARCFAADRTHVSTAVAGTLGYMA  442 (611)
Q Consensus       383 L~~LH~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a  442 (611)
                      |.|||.  +.+|+||||||+||||+.++                    .+||+|||+++.....      ...||+.|+|
T Consensus       174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a  245 (336)
T 2vuw_A          174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred             HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence            999992  37899999999999999887                    8999999999876532      3468999999


Q ss_pred             hhhhhcCccccccceehhHHH-HHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc--CCCCCCCCCHHHHHHHHHH
Q 007248          443 PEYLVRGQLTEKADVYSFGIL-IIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV--DPNLKDDFPAEQVCNVLQI  519 (611)
Q Consensus       443 PE~~~~~~~~~ksDV~S~Gvl-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i--d~~l~~~~~~~~~~~l~~l  519 (611)
                      ||++.+.. +.++||||+|++ .+++++|..|+..         ..|.......+...+  ...............+.++
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl  315 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEF  315 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHH
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHH
Confidence            99998666 889999998776 7788889888521         111000001111100  1111111233456778999


Q ss_pred             HHHhcccCCCCCCCHHHHH
Q 007248          520 GLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       520 ~~~c~~~~p~~RPt~~evl  538 (611)
                      +.+||+.+     |+.|++
T Consensus       316 i~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          316 HRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHGGGSS-----SHHHHH
T ss_pred             HHHHhccC-----CHHHHH
Confidence            99999966     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1e-29  Score=279.92  Aligned_cols=185  Identities=15%  Similarity=0.159  Sum_probs=130.0

Q ss_pred             ccccCCceeEEEE-EcCCCCEEEEEEeeccc----------hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEE
Q 007248          278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT----------RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       278 ~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ..+.|++|.+..+ +.--|+.++||.+....          ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3566666666554 23348899999986431          23456799999999999 799999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||++|++|.++|...   ..++..   +|+.||+.||+|||   +++||||||||+||||++++.+||+|||+++....
T Consensus       321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999999543   345554   58899999999999   89999999999999999999999999999987654


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRS  473 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p  473 (611)
                      +.. ......||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            332 2335679999999999864 567789999999999888766443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=2.1e-27  Score=260.05  Aligned_cols=183  Identities=20%  Similarity=0.239  Sum_probs=145.4

Q ss_pred             CCCCccccCCceeEEEEEcCCCCEEEEEEeeccc--------hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          274 NPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       274 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ...++||+|+||.||++.. .+..+++|+.....        ....+.|.+|+++|++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4567899999999999965 57889999864321        12245689999999999999999776666678888999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++++|.+++..           ++.++.||++||.|||   +.+|+||||||+|||+++  ++||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           4689999999999999   789999999999999999  999999999997754


Q ss_pred             CCcce------eecccCCccccChhhhhc--CccccccceehhHHHHHHHHhCCCC
Q 007248          426 DRTHV------STAVAGTLGYMAPEYLVR--GQLTEKADVYSFGILIIEIVCGRRS  473 (611)
Q Consensus       426 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvll~elltG~~p  473 (611)
                      .....      .....||+.|||||++..  ..|+...|+|+..+-.++-+.++.+
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r  537 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR  537 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence            32211      235678999999999987  5688889999999999988877655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.2e-23  Score=211.21  Aligned_cols=152  Identities=16%  Similarity=0.095  Sum_probs=121.7

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccch------------------hhHHHHHHHHHHHhcCCC
Q 007248          265 TLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR------------------QWVDEFFNEVNLISSIEH  326 (611)
Q Consensus       265 ~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h  326 (611)
                      .+......|...+.||+|+||.||+|...+|+.||||.+.....                  .....+.+|+++|++++ 
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            34444556667799999999999999887899999999864321                  13567899999999999 


Q ss_pred             CceeeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       327 ~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                       | +++.+++.. +..++||||+++++|.+ +.         ......++.||+.||.|||   +.+|+||||||+|||+
T Consensus       163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl  226 (282)
T 1zar_A          163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLV  226 (282)
T ss_dssp             -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred             -C-CCcCeEEec-cceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEE
Confidence             4 666665433 56799999999999988 41         1234579999999999999   8999999999999999


Q ss_pred             CCCCCeEEeeeccceeccCCCcceeecccCCccccChhhhhc
Q 007248          407 DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR  448 (611)
Q Consensus       407 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~  448 (611)
                      + ++.+||+|||+++.              +..++|||++..
T Consensus       227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r  253 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE--------------VGEEGWREILER  253 (282)
T ss_dssp             E-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred             E-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence            9 99999999999863              335789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=4.2e-19  Score=175.83  Aligned_cols=137  Identities=17%  Similarity=0.168  Sum_probs=106.7

Q ss_pred             CCCCCccccCCceeEEEEEc-CCCCE--EEEEEeeccch------------------------hhHHHHHHHHHHHhcCC
Q 007248          273 FNPSKKLGQGGAGSVYMGSL-PNGTT--VAVKRLIFNTR------------------------QWVDEFFNEVNLISSIE  325 (611)
Q Consensus       273 f~~~~~iG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~  325 (611)
                      |+..+.||+|+||.||+|.. .+|+.  ||||++.....                        .....+.+|+.+|.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56678999999999999977 68888  99998653311                        11236789999999998


Q ss_pred             CCce--eeEeeeeeeCCcceEEEeecCC-C----ChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCC
Q 007248          326 HKNL--VKLLGCSIEGPESLLVYEYVPN-R----SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD  398 (611)
Q Consensus       326 h~ni--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  398 (611)
                      |+|+  +.++++    ...+|||||+.+ |    +|.++...      .++..+..++.||+.||.|||.  ..+|+|||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~--~~givHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ--EAELVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH--TSCEECSS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH--HCCEEeCC
Confidence            8764  444443    367899999942 4    56555421      2356778999999999999994  47899999


Q ss_pred             CCcccEEECCCCCeEEeeeccceec
Q 007248          399 IKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       399 lkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      |||+|||+++  .++|+|||++...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  9999999999754

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.73  E-value=3e-18  Score=144.19  Aligned_cols=77  Identities=22%  Similarity=0.433  Sum_probs=63.9

Q ss_pred             cchhhhcccCC-CceeeeecCCCCcceEEEEecCCCCChhhHHHHHHHHHhhccc-cCCCCceEEEcceeeEEEecccc
Q 007248            2 EILSQLITANT-HFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPR-CLPSLSATIFFDGCFLRYDIYSF   78 (611)
Q Consensus         2 ~~l~~~~~~~~-~f~~~~~~~~~~~~vy~l~~C~~d~~~~~C~~Cl~~~~~~~~~-c~~~~~~~~~~~~C~~ry~~~~f   78 (611)
                      +.|+++++.+. +|+++.....+..+||||+|||||+++.+|..||+.|+..+++ |+++++|++|+++|++|||+++|
T Consensus        30 ~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           30 ADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence            45666665543 5666652222334999999999999999999999999999988 88999999999999999999998

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.68  E-value=3.8e-17  Score=137.44  Aligned_cols=86  Identities=17%  Similarity=0.370  Sum_probs=76.4

Q ss_pred             hhhHHHHHHHHHHHHHHHHhhcCCccccccc-----ceEEEEEeccccCCccChhhHHHhhhhhhhcccCCCCCCeEEee
Q 007248          108 VDGFVESVGYAVGNVSRIAVEKGGGFGAVKV-----MGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNA  182 (611)
Q Consensus       108 ~~~f~~~v~~ll~~l~~~a~~~~~~f~~~~~-----~~~yglaQC~~dls~~~C~~Cl~~~~~~~~~~c~~~~~g~~~~~  182 (611)
                      -..|..++..+|..|...++.++.+|+++..     ++||||+||++||++.+|+.||..++.+++..|.+.++|+++..
T Consensus        18 ~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C~~~~g~~i~~~   97 (108)
T 3a2e_A           18 GSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSICNNAIGARVQLV   97 (108)
T ss_dssp             TCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHTTSBSSEEEEET
T ss_pred             CChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHCCCCceEEEECC
Confidence            3458889999999999988887767765443     27999999999999999999999999999998999999999999


Q ss_pred             eeeeeccCCcc
Q 007248          183 GCYLRYSTDKF  193 (611)
Q Consensus       183 ~C~~ry~~~~f  193 (611)
                      +|++||+.++|
T Consensus        98 ~C~lRY~~~~F  108 (108)
T 3a2e_A           98 DCFIQYEQRSF  108 (108)
T ss_dssp             TEEEEEESSCC
T ss_pred             CEEEEEeCCcC
Confidence            99999999887

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.67  E-value=3.1e-17  Score=169.11  Aligned_cols=135  Identities=13%  Similarity=0.196  Sum_probs=97.4

Q ss_pred             CCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccch--------------hhHHHHH--------HHHHHHhcCCCCce
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR--------------QWVDEFF--------NEVNLISSIEHKNL  329 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~~--------~E~~~l~~l~h~ni  329 (611)
                      -|++.+.||+|+||.||+|..++|+.||||+++....              .......        +|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3788899999999999999988999999998753210              0111222        34455555533332


Q ss_pred             e--eEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC
Q 007248          330 V--KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD  407 (611)
Q Consensus       330 v--~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  407 (611)
                      .  ..+++    ...+|||||+++++|.++..         ......++.||+.+|.+||   +.+||||||||.|||++
T Consensus       176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~  239 (397)
T 4gyi_A          176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIR  239 (397)
T ss_dssp             SCCCEEEE----ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred             CCCeeeec----cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEe
Confidence            1  12221    23479999999998876541         1234568899999999999   78999999999999998


Q ss_pred             CCCC----------eEEeeecccee
Q 007248          408 KDFT----------PKIADFGLARC  422 (611)
Q Consensus       408 ~~~~----------~kl~DfGla~~  422 (611)
                      +++.          +.|+||+-+-.
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCCcccccccccceEEEEeCCccc
Confidence            8763          89999997753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.36  E-value=1.9e-12  Score=128.04  Aligned_cols=147  Identities=17%  Similarity=0.066  Sum_probs=114.3

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCCcceE
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  344 (611)
                      +......|.....++.|+.+.||+.... ++.+++|+...........+.+|+++++.+. |.++.+++++..+.+..++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            3444556777778888889999999764 6899999886432222345889999999884 6778899999998889999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG-----------------------------------  389 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----------------------------------  389 (611)
                      ||||++|.+|.+.+.        +......++.+++++|..||.-                                   
T Consensus        88 v~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            999999999987641        1233457889999999999961                                   


Q ss_pred             ---------------------CCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          390 ---------------------SETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       390 ---------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                                           ....++|+|++|.|||++++..+.|+||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 01559999999999999876566799999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.22  E-value=1.4e-11  Score=121.31  Aligned_cols=128  Identities=18%  Similarity=0.150  Sum_probs=97.1

Q ss_pred             ccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc--eeeEeeeeeeCCcceEEEeecCCCChhhh
Q 007248          280 GQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN--LVKLLGCSIEGPESLLVYEYVPNRSLDQF  357 (611)
Q Consensus       280 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~  357 (611)
                      +.|..+.||+....+|..+++|.....   ....+..|+++++.+.+.+  +.+++++...++..++||||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            455669999998877889999986543   2245778999999885544  566888888877889999999998884  


Q ss_pred             hhccCCCccCChhHHHHHHHHHHHHHHHHhcCC-----------------------------------------------
Q 007248          358 IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS-----------------------------------------------  390 (611)
Q Consensus       358 l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----------------------------------------------  390 (611)
                      ...      .   ....++.++++.|..||...                                               
T Consensus       104 ~~~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (264)
T 1nd4_A          104 SSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  174 (264)
T ss_dssp             TSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             cCc------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence            211      1   12357788888888888421                                               


Q ss_pred             --------CCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          391 --------ETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       391 --------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                              ...++|+|++|.|||++++..+.|+|||.+.
T Consensus       175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                    1239999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.04  E-value=6.4e-10  Score=115.19  Aligned_cols=141  Identities=14%  Similarity=0.167  Sum_probs=106.2

Q ss_pred             CCccccCCceeEEEEEcCCCCEEEEEEee--ccc-hhhHHHHHHHHHHHhcCC--CCceeeEeeeeeeC---CcceEEEe
Q 007248          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLI--FNT-RQWVDEFFNEVNLISSIE--HKNLVKLLGCSIEG---PESLLVYE  347 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~E  347 (611)
                      .+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|+.+++.+.  +..+++++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4678999999999998754 678888765  322 122346788999999886  45688899888776   34799999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS-------------------------------------  390 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------  390 (611)
                      |++|..+.+..     ...++...+..++.++++.|..||...                                     
T Consensus       122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99998885422     123677888899999999999999520                                     


Q ss_pred             ------------------CCceecCCCCcccEEECCCCC--eEEeeecccee
Q 007248          391 ------------------ETRIIHRDIKTSNILLDKDFT--PKIADFGLARC  422 (611)
Q Consensus       391 ------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~  422 (611)
                                        ...++|+|+++.|||++.++.  +.|.||+++..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              257999999999999997753  68999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.95  E-value=7.5e-10  Score=111.84  Aligned_cols=184  Identities=20%  Similarity=0.203  Sum_probs=120.5

Q ss_pred             CCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCc--eeeEeeeeeeCC---cceEEEeec
Q 007248          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKN--LVKLLGCSIEGP---ESLLVYEYV  349 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~E~~  349 (611)
                      .+.++.|....||+..    ..+++|+...  ......+.+|+++|+.+ .+..  +.+++.....+.   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999864    4688887542  23456788999999887 3332  445555543333   348999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG----------------------------------------  389 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------------------  389 (611)
                      +|.+|.+...     ..++..++..++.++++.|..||..                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998875432     2356677778888888888888841                                        


Q ss_pred             ---------------CCCceecCCCCcccEEECC--CCCeEEeeeccceeccCCCcceeecc--------------cCCc
Q 007248          390 ---------------SETRIIHRDIKTSNILLDK--DFTPKIADFGLARCFAADRTHVSTAV--------------AGTL  438 (611)
Q Consensus       390 ---------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~--------------~gt~  438 (611)
                                     ....++|+|++|.||++++  +..+.|+||+.+..-... .......              ....
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHc
Confidence                           1245899999999999998  456789999998653221 0000000              0000


Q ss_pred             cccC-hhhhhcCccccccceehhHHHHHHHHhCCCC
Q 007248          439 GYMA-PEYLVRGQLTEKADVYSFGILIIEIVCGRRS  473 (611)
Q Consensus       439 ~y~a-PE~~~~~~~~~ksDV~S~Gvll~elltG~~p  473 (611)
                      +... |+...  ......+.|+++.++|++.+|..+
T Consensus       253 ~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          253 KHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             TCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             CCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHH
Confidence            1112 22221  112235889999999999999765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.46  E-value=1e-06  Score=86.85  Aligned_cols=134  Identities=16%  Similarity=0.154  Sum_probs=96.7

Q ss_pred             ccccCCce-eEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCCcceEEEeecCCCCh
Q 007248          278 KLGQGGAG-SVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       278 ~iG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      .+..|..| .||+.... ++..+++|+-...   ....+..|...|+.+. +--+.++++++.+++..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556555 68987654 4678899975433   3456788999988773 33477889999999999999999999888


Q ss_pred             hhhhhccCCCccCChhHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 007248          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG----------------------------------------------  388 (611)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~----------------------------------------------  388 (611)
                      .+....       .......+..++++.|..||.                                              
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            765421       122334566677777777773                                              


Q ss_pred             ---------CCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          389 ---------GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       389 ---------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                               .....++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                     012237999999999999987777799999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.41  E-value=1.4e-06  Score=87.72  Aligned_cols=135  Identities=20%  Similarity=0.198  Sum_probs=93.4

Q ss_pred             CccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCC---ceeeEeeeee-eCCcceEEEeecCCC
Q 007248          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK---NLVKLLGCSI-EGPESLLVYEYVPNR  352 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~E~~~~g  352 (611)
                      +.++.|....||+.    |..++||+..  .......+..|+++|+.+.+.   .+.+++.+.. ..+..++||||++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            46788888899988    5678888742  233456788999999998652   3566666664 445678999999998


Q ss_pred             ChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 007248          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG-------------------------------------------  389 (611)
Q Consensus       353 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------------  389 (611)
                      +|.+....     .++......++.++++.|..||..                                           
T Consensus        99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            88763211     133444445555555555555521                                           


Q ss_pred             --------------CCCceecCCCCcccEEECC---CCC-eEEeeecccee
Q 007248          390 --------------SETRIIHRDIKTSNILLDK---DFT-PKIADFGLARC  422 (611)
Q Consensus       390 --------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DfGla~~  422 (611)
                                    ....++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          2346799999999999997   455 48999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.29  E-value=1.2e-06  Score=90.14  Aligned_cols=80  Identities=6%  Similarity=0.012  Sum_probs=55.4

Q ss_pred             Ccc-ccCCceeEEEEEcC-------CCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCC-C--CceeeEeeeeeeC---
Q 007248          277 KKL-GQGGAGSVYMGSLP-------NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIE-H--KNLVKLLGCSIEG---  339 (611)
Q Consensus       277 ~~i-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~---  339 (611)
                      +.| +.|....+|+....       ++..+++|+.....   ......+..|+.+++.+. +  ..+.+++.+..++   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78888999988664       26788888754322   001245678888888874 2  3567788877655   


Q ss_pred             CcceEEEeecCCCChhh
Q 007248          340 PESLLVYEYVPNRSLDQ  356 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~  356 (611)
                      +..++||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.08  E-value=1.6e-05  Score=83.14  Aligned_cols=75  Identities=11%  Similarity=0.113  Sum_probs=49.9

Q ss_pred             CCccccCCceeEEEEEcC-CCCEEEEEEeeccch-------hhHHHHHHHHHHHhcCCC--C-ceeeEeeeeeeCCcceE
Q 007248          276 SKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR-------QWVDEFFNEVNLISSIEH--K-NLVKLLGCSIEGPESLL  344 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l  344 (611)
                      .+.||.|..+.||++... +++.++||.......       ...+.+..|.++|+.+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999754 468899997643211       123456778888887732  3 34456654  4456789


Q ss_pred             EEeecCCC
Q 007248          345 VYEYVPNR  352 (611)
Q Consensus       345 v~E~~~~g  352 (611)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.00  E-value=1.8e-05  Score=80.69  Aligned_cols=140  Identities=18%  Similarity=0.230  Sum_probs=79.8

Q ss_pred             CccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCC--CceeeEee------eeeeCCcceEEEee
Q 007248          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH--KNLVKLLG------CSIEGPESLLVYEY  348 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~E~  348 (611)
                      +.|+.|..+.||+....+| .+++|+.... .   ..+..|+.+++.|..  -.+++++.      +...++..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3466677889999977555 5899987642 2   233345555554421  12333332      22345677999999


Q ss_pred             cCCCChh--------------hhhhccCC-----------CccCChhHHH------------------------------
Q 007248          349 VPNRSLD--------------QFIFDKNK-----------TKLLNWNKRF------------------------------  373 (611)
Q Consensus       349 ~~~gsL~--------------~~l~~~~~-----------~~~l~~~~~~------------------------------  373 (611)
                      ++|..+.              ..+|....           .....|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9987653              01121100           0112232211                              


Q ss_pred             -HHHHHHHHHHHHHhc----------CCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          374 -NIILGTAEGLAYLHG----------GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       374 -~i~~~ia~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                       .+...+.+++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             111223445666652          125789999999999999888889999999874

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.89  E-value=2.8e-05  Score=77.34  Aligned_cols=79  Identities=19%  Similarity=0.184  Sum_probs=57.1

Q ss_pred             CCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCC---CceeeEeeeeeeCCcceEEEee
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH---KNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .....+.+|.|..+.||+.++.+|+.++||+-..........|..|++.|+.|.-   --+++++++    +..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            3445677999999999999999999999997654433333457889998887732   224555554    235899999


Q ss_pred             cCCCCh
Q 007248          349 VPNRSL  354 (611)
Q Consensus       349 ~~~gsL  354 (611)
                      ++.+..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.84  E-value=0.00011  Score=73.68  Aligned_cols=138  Identities=17%  Similarity=0.140  Sum_probs=92.6

Q ss_pred             CCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC---CCceeeEeeeeeeCCcceEEEeecCCC
Q 007248          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE---HKNLVKLLGCSIEGPESLLVYEYVPNR  352 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~g  352 (611)
                      .+.|+.|....+|+... ++..++||+....   ....|..|.+.|+.|.   ...+++++++....+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            45789999999999987 5678889976533   3466888999888873   356888888888778899999999998


Q ss_pred             Chhh-----------hhhccCC---C----------------ccCChhHHH---HHHH----------------HHHH-H
Q 007248          353 SLDQ-----------FIFDKNK---T----------------KLLNWNKRF---NIIL----------------GTAE-G  382 (611)
Q Consensus       353 sL~~-----------~l~~~~~---~----------------~~l~~~~~~---~i~~----------------~ia~-~  382 (611)
                      .+..           -||....   .                -.-+|...+   ++..                .+.. .
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            7532           1232211   0                012454322   1111                1111 1


Q ss_pred             HHHHhc-CCCCceecCCCCcccEEECCCCCeEEeeec
Q 007248          383 LAYLHG-GSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (611)
Q Consensus       383 L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  418 (611)
                      ...|.. ...+.++|+|+.+.||+++.++ +.|.||.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            223421 2367899999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.62  E-value=0.00025  Score=74.62  Aligned_cols=79  Identities=13%  Similarity=0.117  Sum_probs=47.3

Q ss_pred             CCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcceeecc-cCCccccChhhhhcC---ccccccceehhHHHHHH
Q 007248          391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV-AGTLGYMAPEYLVRG---QLTEKADVYSFGILIIE  466 (611)
Q Consensus       391 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~ksDV~S~Gvll~e  466 (611)
                      ...++|+|+++.|||++.++ ++|+||+.+..-... ....... .-...|++|+.....   ......++......+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            67899999999999999876 999999988643211 0000000 001235555544211   11223455677777887


Q ss_pred             HHhCC
Q 007248          467 IVCGR  471 (611)
Q Consensus       467 lltG~  471 (611)
                      .++++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.44  E-value=0.001  Score=67.00  Aligned_cols=159  Identities=12%  Similarity=0.131  Sum_probs=89.7

Q ss_pred             ccChHHHHHHhcCCCCC-----CccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc--eeeE
Q 007248          260 SFKYETLEKATNYFNPS-----KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN--LVKL  332 (611)
Q Consensus       260 ~~~~~~l~~~~~~f~~~-----~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l  332 (611)
                      .++.+++......|...     +.|+.|....+|+....+| .+++|+.....  ..+.+..|+.++..+...+  +.++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            34566677766667652     3466788889999987665 68889775421  1234556777777663222  2333


Q ss_pred             eee------eeeCCcceEEEeecCCCChhh--------------hhhccCC----C-----ccCChhHHHHH--------
Q 007248          333 LGC------SIEGPESLLVYEYVPNRSLDQ--------------FIFDKNK----T-----KLLNWNKRFNI--------  375 (611)
Q Consensus       333 ~~~------~~~~~~~~lv~E~~~~gsL~~--------------~l~~~~~----~-----~~l~~~~~~~i--------  375 (611)
                      +..      ...++..+++++|++|..+..              .+|....    .     ....|...+.-        
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            321      123456789999999866432              0121100    0     11123321110        


Q ss_pred             ----HHHHHHHHHHHhc----CCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          376 ----ILGTAEGLAYLHG----GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       376 ----~~~ia~~L~~LH~----~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                          ...+.+.+..|+.    .....++|+|+.+.|||++++..+.|+||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                0123445555542    124679999999999999987556899999774

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.38  E-value=0.00045  Score=72.70  Aligned_cols=72  Identities=18%  Similarity=0.290  Sum_probs=49.2

Q ss_pred             CccccCCceeEEEEEcCC--------CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCce-eeEeeeeeeCCcceEEEe
Q 007248          277 KKLGQGGAGSVYMGSLPN--------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E  347 (611)
                      +.|+.|....+|+...++        +..+++|+.....  ..+.+.+|+.+++.+...++ +++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            567888889999997653        4788888763311  11455679988888754344 567776543    38999


Q ss_pred             ecCCCCh
Q 007248          348 YVPNRSL  354 (611)
Q Consensus       348 ~~~~gsL  354 (611)
                      |++|.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9987555

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.35  E-value=0.0029  Score=63.72  Aligned_cols=159  Identities=16%  Similarity=0.127  Sum_probs=90.0

Q ss_pred             ccChHHHHHHhcCCCC-----CCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc--eeeE
Q 007248          260 SFKYETLEKATNYFNP-----SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN--LVKL  332 (611)
Q Consensus       260 ~~~~~~l~~~~~~f~~-----~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l  332 (611)
                      ..+.+.+..+.+.|..     ...|+ |....||+....+|+.+++|...... ...+.+..|..++..+....  ++++
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence            3455556555555533     23466 77889999987778889999875321 12345667888777764222  3444


Q ss_pred             eee-----eeeCCcceEEEeecCCCChhh----h----------hhcc----C--CCccCChhHH----HHH--------
Q 007248          333 LGC-----SIEGPESLLVYEYVPNRSLDQ----F----------IFDK----N--KTKLLNWNKR----FNI--------  375 (611)
Q Consensus       333 ~~~-----~~~~~~~~lv~E~~~~gsL~~----~----------l~~~----~--~~~~l~~~~~----~~i--------  375 (611)
                      +..     ...++..+++|||++|..+..    .          +|..    .  ....+++...    ..+        
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            443     223445678999998865431    0          1110    0  0111222211    000        


Q ss_pred             -------HHHHHHHHHHHhc----CCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          376 -------ILGTAEGLAYLHG----GSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       376 -------~~~ia~~L~~LH~----~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                             ...+.+.+..+..    .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                   1111122333321    1256789999999999999 4 899999987753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.30  E-value=0.0013  Score=66.62  Aligned_cols=141  Identities=13%  Similarity=0.093  Sum_probs=72.4

Q ss_pred             CccccCCcee-EEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCC--CceeeEeeeeeeCCcceEEEeecCCCC
Q 007248          277 KKLGQGGAGS-VYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH--KNLVKLLGCSIEGPESLLVYEYVPNRS  353 (611)
Q Consensus       277 ~~iG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gs  353 (611)
                      +.|+.|.... +|+....+|..+++|.......   +.+..|+.+++.+..  -.+.+++.+..+.  -+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence            4465554444 6677664467787775433221   223456666665532  2355666654333  378999998766


Q ss_pred             hhhhhhc---------------------cCC--CccCChhHHH-------HH-------------HHHHHHHHHHHh---
Q 007248          354 LDQFIFD---------------------KNK--TKLLNWNKRF-------NI-------------ILGTAEGLAYLH---  387 (611)
Q Consensus       354 L~~~l~~---------------------~~~--~~~l~~~~~~-------~i-------------~~~ia~~L~~LH---  387 (611)
                      +.+++..                     ...  ...++.....       .+             ...+.+.+..|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            6543321                     000  0011111000       00             011112222221   


Q ss_pred             cCCCCceecCCCCcccEEECCC----CCeEEeeecccee
Q 007248          388 GGSETRIIHRDIKTSNILLDKD----FTPKIADFGLARC  422 (611)
Q Consensus       388 ~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~  422 (611)
                      ......++|||+.+.|||++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1125689999999999999875    6789999998864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.23  E-value=0.00095  Score=66.59  Aligned_cols=138  Identities=12%  Similarity=0.059  Sum_probs=74.9

Q ss_pred             CCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCce-eeEeeeeeeCCcceEEEeec-CCCC
Q 007248          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEYV-PNRS  353 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~-~~gs  353 (611)
                      .+.|+.|....+|+.     ..+++|+........ -...+|+.+++.+...++ .+++++.  .+.-++|+||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            577888999999998     568888765332111 122467777776643222 4555543  33457999999 6655


Q ss_pred             hhhh------------------hhccCCC--ccCC-hhHHHHHHHH--------------HHHHH----HHHh-cCCCCc
Q 007248          354 LDQF------------------IFDKNKT--KLLN-WNKRFNIILG--------------TAEGL----AYLH-GGSETR  393 (611)
Q Consensus       354 L~~~------------------l~~~~~~--~~l~-~~~~~~i~~~--------------ia~~L----~~LH-~~~~~~  393 (611)
                      |...                  +|.....  ...+ +..+..+...              +.+.+    ..|. ......
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            5321                  1111100  0001 1111111000              11111    1111 122456


Q ss_pred             eecCCCCcccEEECCCCCeEEeeecccee
Q 007248          394 IIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       394 ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5566789999998753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.15  E-value=0.0012  Score=69.81  Aligned_cols=74  Identities=11%  Similarity=0.025  Sum_probs=47.2

Q ss_pred             CccccCCceeEEEEEcCC-CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCce-eeEeeeeeeCCcceEEEeecCCCCh
Q 007248          277 KKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      +.|+.|-...+|+....+ +..+++|+......... ....|..++..|...++ .++++++..    .+|+||+++.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence            567888889999998765 47788887643221111 12478888888865444 567777632    359999998665


Q ss_pred             h
Q 007248          355 D  355 (611)
Q Consensus       355 ~  355 (611)
                      .
T Consensus       189 ~  189 (458)
T 2qg7_A          189 S  189 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.07  E-value=0.0018  Score=66.64  Aligned_cols=141  Identities=21%  Similarity=0.241  Sum_probs=83.9

Q ss_pred             CCccccCCceeEEEEEcCC--------CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc-eeeEeeeeeeCCcceEEE
Q 007248          276 SKKLGQGGAGSVYMGSLPN--------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN-LVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  346 (611)
                      .+.|..|-...+|+...++        +..+++|+... .......+.+|.++++.|.-.+ ..++++++.++    +||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEE
Confidence            3467778888899997753        47899987532 1223455668999888774222 35677766542    999


Q ss_pred             eecCCCChhhh-----------------hhccC--CCccC--ChhHHHHHHHHHHH-------------------HHHHH
Q 007248          347 EYVPNRSLDQF-----------------IFDKN--KTKLL--NWNKRFNIILGTAE-------------------GLAYL  386 (611)
Q Consensus       347 E~~~~gsL~~~-----------------l~~~~--~~~~l--~~~~~~~i~~~ia~-------------------~L~~L  386 (611)
                      ||++|.+|..-                 ||...  -....  -|.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998766421                 12111  01112  24455555544322                   22333


Q ss_pred             h----c-CCCCceecCCCCcccEEECCC----CCeEEeeeccce
Q 007248          387 H----G-GSETRIIHRDIKTSNILLDKD----FTPKIADFGLAR  421 (611)
Q Consensus       387 H----~-~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~  421 (611)
                      .    . .....++|+|+.+.|||++++    +.+.|+||..+.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2    1 234579999999999999876    689999999875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.88  E-value=0.0014  Score=67.32  Aligned_cols=73  Identities=14%  Similarity=0.140  Sum_probs=43.5

Q ss_pred             CccccCCceeEEEEEcCC---------CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc-eeeEeeeeeeCCcceEEE
Q 007248          277 KKLGQGGAGSVYMGSLPN---------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN-LVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  346 (611)
                      ..|+.|....+|+....+         +..+++|+....... ......|.++++.+...+ ..++++..    .-++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence            457778888999987654         267888875433221 112357888887774333 34666544    237899


Q ss_pred             eecCCCCh
Q 007248          347 EYVPNRSL  354 (611)
Q Consensus       347 E~~~~gsL  354 (611)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99998654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.60  E-value=0.014  Score=59.03  Aligned_cols=32  Identities=22%  Similarity=0.316  Sum_probs=28.1

Q ss_pred             CCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       391 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      ...++|+|+.+.||++++++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            46799999999999999888899999987753

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.40  E-value=0.0077  Score=56.06  Aligned_cols=103  Identities=17%  Similarity=0.101  Sum_probs=65.4

Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCccee
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  431 (611)
                      -||.+.|..  ...++++.++|.++.|.+.+|.-+-.. ..+ ..+=+.|..|+|..+|++.+.+ +.+.          
T Consensus        33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc----------
Confidence            378888853  346899999999999999998877210 011 1333457899999999887764 1110          


Q ss_pred             ecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCC
Q 007248          432 TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRS  473 (611)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p  473 (611)
                         .....+.|||... ...+.+.=|||+|++||.-+--..|
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence               0122456788652 3456788899999999998854333

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.90  E-value=0.09  Score=54.75  Aligned_cols=140  Identities=11%  Similarity=0.128  Sum_probs=82.9

Q ss_pred             CccccCCceeEEEEEcCC--------CCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCc-eeeEeeeeeeCCcceEEEe
Q 007248          277 KKLGQGGAGSVYMGSLPN--------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN-LVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E  347 (611)
                      +.|..|-...+|+...++        +..+++|+....... .-...+|..+++.+...+ ..++++.+.    -++|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            456677788899997753        578899875432211 112346888887774222 345565432    378999


Q ss_pred             ecCCCChhhh-----------------hhcc-------C---CCccCChhHHHHHHHHH-------------------HH
Q 007248          348 YVPNRSLDQF-----------------IFDK-------N---KTKLLNWNKRFNIILGT-------------------AE  381 (611)
Q Consensus       348 ~~~~gsL~~~-----------------l~~~-------~---~~~~l~~~~~~~i~~~i-------------------a~  381 (611)
                      |++|.+|..-                 ||..       .   ...+.-|.++.++..++                   ..
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            9999765320                 1110       0   11112244444444332                   12


Q ss_pred             HHHHHhc---------------------CCCCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          382 GLAYLHG---------------------GSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       382 ~L~~LH~---------------------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      .+.+|..                     .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            2333321                     12456899999999999 7788999999998853

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.49  E-value=0.28  Score=50.64  Aligned_cols=30  Identities=27%  Similarity=0.387  Sum_probs=25.0

Q ss_pred             ceecCCCCcccEEE------CCCCCeEEeeecccee
Q 007248          393 RIIHRDIKTSNILL------DKDFTPKIADFGLARC  422 (611)
Q Consensus       393 ~ivH~Dlkp~NIll------~~~~~~kl~DfGla~~  422 (611)
                      .++|+|+.+.|||+      +++..++++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      4566799999998853

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=90.77  E-value=0.012  Score=39.13  Aligned_cols=16  Identities=25%  Similarity=0.285  Sum_probs=8.6

Q ss_pred             CCCcceeEeeeehhhH
Q 007248          206 SSRLGVMIAIVLSTTA  221 (611)
Q Consensus       206 ~~~~~~~i~i~~~~~~  221 (611)
                      .+....++++++|+++
T Consensus         8 ~~~~~~Ia~~vVGvll   23 (44)
T 2jwa_A            8 ASPLTSIISAVVGILL   23 (44)
T ss_dssp             CCSHHHHHHHHHHHHH
T ss_pred             CCcccchHHHHHHHHH
Confidence            3444456666666443

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=90.51  E-value=0.018  Score=38.46  Aligned_cols=30  Identities=7%  Similarity=0.079  Sum_probs=13.8

Q ss_pred             CcceeEeeeehhhHHHHHhhhheeeeeeec
Q 007248          208 RLGVMIAIVLSTTAFLMLSLFAAYAAYARL  237 (611)
Q Consensus       208 ~~~~~i~i~~~~~~~l~l~~~~~~~~~~~~  237 (611)
                      ....|.+.+++++++++++++++|+++||+
T Consensus         9 ~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr   38 (44)
T 2ks1_B            9 KIPSIATGMVGALLLLLVVALGIGLFMRRR   38 (44)
T ss_dssp             CSSSSTHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CcceEEeehhHHHHHHHHHHHHHHHHhhhh
Confidence            334444455554444444444444444443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=88.96  E-value=0.019  Score=38.30  Aligned_cols=30  Identities=17%  Similarity=0.069  Sum_probs=14.5

Q ss_pred             CcceeEeeeehhhHHHHHhhhheeeeeeec
Q 007248          208 RLGVMIAIVLSTTAFLMLSLFAAYAAYARL  237 (611)
Q Consensus       208 ~~~~~i~i~~~~~~~l~l~~~~~~~~~~~~  237 (611)
                      ....+.+.+++++++++++++++|+++||+
T Consensus         8 ~~~aIA~gVVgGv~~v~ii~~~~~~~~RRR   37 (44)
T 2l2t_A            8 RTPLIAAGVIGGLFILVIVGLTFAVYVRRK   37 (44)
T ss_dssp             SSHHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CcceEEEeehHHHHHHHHHHHHHHHHhhhh
Confidence            334455555555555444444444444443

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.38  E-value=0.12  Score=54.56  Aligned_cols=60  Identities=7%  Similarity=0.023  Sum_probs=18.1

Q ss_pred             CCCccccCCceeEEEEEcCC-CCEEEE------EEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeee
Q 007248          275 PSKKLGQGGAGSVYMGSLPN-GTTVAV------KRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSI  337 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  337 (611)
                      ..++||   ||.||+|.+.. ..+|||      |.....  ..+....|.+|..++..++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            456777   99999998754 367888      766532  2334457889999999999999999988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	611
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-65
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-64
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-63
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-63
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-61
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-61
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-60
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-58
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-56
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-54
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-50
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-50
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-47
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-42
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-21

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 3e-66
 Identities = 67/269 (24%), Positives = 125/269 (46%), Gaps = 19/269 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
              P+  +V ++    SL   +            K  +I   TA+G+ YLH      IIH
Sbjct: 74  -TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH---AKSIIH 127

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTLGYMAPEYLV---RGQLT 452
           RD+K++NI L +D T KI DFGLA   +    +H    ++G++ +MAPE +    +   +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 453 EKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQ 512
            ++DVY+FGI++ E++ G+    +   + +   ++  +     L   +   ++ + P   
Sbjct: 188 FQSDVYAFGIVLYELMTGQL--PY--SNINNRDQIIFMVGRGYLSPDL-SKVRSNCPKA- 241

Query: 513 VCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
              + ++   C +     RP   Q +  +
Sbjct: 242 ---MKRLMAECLKKKRDERPLFPQILASI 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 2e-65
 Identities = 83/265 (31%), Positives = 123/265 (46%), Gaps = 19/265 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L        D F  E NL+  ++H+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 132

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+    + KIADFGLAR    +           + + APE +  G  T K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192

Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNV 516
           V+SFGIL+ EIV   R       +   +Q +   YR             D+ P E    +
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---------MVRPDNCPEE----L 239

Query: 517 LQIGLLCTQAAAALRPSMAQAIMLL 541
            Q+  LC +     RP+      +L
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 5e-64
 Identities = 64/269 (23%), Positives = 120/269 (44%), Gaps = 19/269 (7%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
               +++G G  G V++G   N   VA+K  I       ++F  E  ++  + H  LV+L
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
            G  +E     LV+E++ +  L  +   + +  L        + L   EG+AYL    E 
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDY--LRTQRGLFAAETLLGMCLDVCEGMAYLE---EA 120

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
            +IHRD+   N L+ ++   K++DFG+ R    D+   ST     + + +PE     + +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 453 EKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQ 512
            K+DV+SFG+L+ E+    +    ++ ++             ++VE +    +   P   
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNS-------------EVVEDISTGFRLYKPRLA 227

Query: 513 VCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
             +V QI   C +     RP+ ++ +  L
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 1e-63
 Identities = 69/278 (24%), Positives = 120/278 (43%), Gaps = 19/278 (6%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
            KLGQG  G V+MG+    T VA+K  +       + F  E  ++  + H+ LV+L    
Sbjct: 23  VKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 80

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +      +V EY+   SL  F+  +   K L   +  ++    A G+AY+        +H
Sbjct: 81  VSEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVH 136

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKAD 456
           RD++ +NIL+ ++   K+ADFGLAR    +           + + APE  + G+ T K+D
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 196

Query: 457 VYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNV 516
           V+SFGIL+ E+    R               +    + ++++ V+   +   P E   ++
Sbjct: 197 VWSFGILLTELTTKGR-------------VPYPGMVNREVLDQVERGYRMPCPPECPESL 243

Query: 517 LQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQP 554
             +   C +     RP+       L +         QP
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 8e-63
 Identities = 60/270 (22%), Positives = 108/270 (40%), Gaps = 20/270 (7%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
               K+LG G  G V  G       VA+K  I       DEF  E  ++ ++ H+ LV+L
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
            G   +     ++ EY+ N  L  ++ +          +   +     E + YL      
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLE---SK 119

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
           + +HRD+   N L++     K++DFGL+R    D    S      + +  PE L+  + +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 453 EKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQ 512
            K+D+++FG+L+ EI    +               +  + +++  E +   L+   P   
Sbjct: 180 SKSDIWAFGVLMWEIYSLGK-------------MPYERFTNSETAEHIAQGLRLYRPHLA 226

Query: 513 VCNVLQIGLLCTQAAAALRPSMAQAI-MLL 541
              V  I   C    A  RP+    +  +L
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  203 bits (518), Expect = 2e-61
 Identities = 77/318 (24%), Positives = 132/318 (41%), Gaps = 46/318 (14%)

Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWV- 311
           L+ K  +LE   N     + +G+G  G V+    P        T VAVK L       + 
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL----- 366
            +F  E  L++  ++ N+VKLLG    G    L++EY+    L++F+   +   +     
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 367 ----------------LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF 410
                           L+  ++  I    A G+AYL    E + +HRD+ T N L+ ++ 
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENM 177

Query: 411 TPKIADFGLAR-CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC 469
             KIADFGL+R  ++AD        A  + +M PE +   + T ++DV+++G+++ EI  
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 470 GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAA 529
                 +       +  V                  ++ P E    +  +  LC     A
Sbjct: 238 YGLQPYYGMAHEEVIYYVRDGNI---------LACPENCPLE----LYNLMRLCWSKLPA 284

Query: 530 LRPSMAQAIMLLTNKVCE 547
            RPS      +L  ++CE
Sbjct: 285 DRPSFCSIHRIL-QRMCE 301

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 2e-61
 Identities = 53/235 (22%), Positives = 100/235 (42%), Gaps = 12/235 (5%)

Query: 266 LEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISS 323
           +E   + F    +LG G  G V+     P+G  +A K +    +  + ++   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                +V   G      E  +  E++   SLDQ +    +   +       + +   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
            YL    + +I+HRD+K SNIL++     K+ DFG++            +  GT  YM+P
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSP 172

Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE 498
           E L     + ++D++S G+ ++E+  GR         A  L+ ++         E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRY--PIPPPDAKELELMFGCQVEGDAAE 225

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 6e-61
 Identities = 71/270 (26%), Positives = 116/270 (42%), Gaps = 25/270 (9%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
               + +G+G  G V +G    G  VAVK +          F  E ++++ + H NLV+L
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQL 65

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           LG  +E    L +V EY+   SL  ++  + +  +L  +      L   E + YL     
Sbjct: 66  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---G 121

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
              +HRD+   N+L+ +D   K++DFGL +  ++ +          + + APE L   + 
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKKF 177

Query: 452 TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE 511
           + K+DV+SFGIL+ EI    R           + RV   Y+          +  D  P  
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---------MDAPDGCPPA 228

Query: 512 QVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
               V ++   C    AA+RPS  Q    L
Sbjct: 229 ----VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  201 bits (511), Expect = 2e-60
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 19/283 (6%)

Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
           S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E 
Sbjct: 6   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 64

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++ +      +   
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQ 123

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D           +
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 439 GYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE 498
            + APE L   + + K+DV++FG+L+ EI                    +     +++ E
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM-------------SPYPGIDLSQVYE 227

Query: 499 AVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
            ++ + + + P      V ++   C Q   + RPS A+     
Sbjct: 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  198 bits (503), Expect = 3e-59
 Identities = 66/299 (22%), Positives = 126/299 (42%), Gaps = 36/299 (12%)

Query: 261 FKYETLEKATNYFNPS---------KKLGQGGAGSVYMGSLP----NGTTVAVKRLIFN- 306
           F +E   +A   F            + +G G  G V  G L         VA+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 307 TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL 366
           T +   +F +E +++   +H N++ L G   +    +++ E++ N SLD F+   +    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               +   ++ G A G+ YL    +   +HRD+   NIL++ +   K++DFGL+R    D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 427 RTHV----STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS 482
            +      +      + + APE +   + T  +DV+S+GI++ E++              
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 483 PLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
              R +    +  ++ A++ + +   P +    + Q+ L C Q     RP   Q +  L
Sbjct: 232 ---RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (502), Expect = 6e-59
 Identities = 73/276 (26%), Positives = 116/276 (42%), Gaps = 31/276 (11%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ---WVDEFFNEVNLISSIE 325
              F+  +++G G  G+VY    + N   VA+K++ ++ +Q      +   EV  +  + 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           H N ++  GC +    + LV EY    + D     K     L   +   +  G  +GLAY
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEY 445
           LH      +IHRD+K  NILL +    K+ DFG A   A   + V     GT  +MAPE 
Sbjct: 131 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEV 182

Query: 446 LV---RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP 502
           ++    GQ   K DV+S GI  IE+   +           PL  +  +     + +   P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKP----------PLFNMNAMSALYHIAQNESP 232

Query: 503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
            L+    +E   N +     C Q     RP+    +
Sbjct: 233 ALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLL 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 4e-58
 Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 35/292 (11%)

Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN---GTTVAVKRL--IFNTRQWVDE 313
           L  K  TLE         K+LG G  G+V  G         TVAVK L    N     DE
Sbjct: 3   LDRKLLTLE--------DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 54

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
              E N++  +++  +V+++G   E    +LV E      L++++        +      
Sbjct: 55  LLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNII 110

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST- 432
            ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +    
Sbjct: 111 ELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167

Query: 433 -AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLY 491
                 + + APE +   + + K+DV+SFG+L+ E     +             + +   
Sbjct: 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ-------------KPYRGM 214

Query: 492 RSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           + +++   ++   +   PA     +  +  LC       RP  A   + L N
Sbjct: 215 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 7e-58
 Identities = 68/285 (23%), Positives = 131/285 (45%), Gaps = 26/285 (9%)

Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMGSLPNGT-----TVAVKRL-IFNTRQWVDEFFNEV 318
           T E   +     K +G G  G VY G L   +      VA+K L    T +   +F  E 
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++    H N+++L G   +    +++ EY+ N +LD+F+ +K+     +  +   ++ G
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRG 118

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD--RTHVSTAVAG 436
            A G+ YL        +HRD+   NIL++ +   K++DFGL+R    D   T+ ++    
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 437 TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL 496
            + + APE +   + T  +DV+SFGI++ E++       +                ++++
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------NHEV 222

Query: 497 VEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
           ++A++   +   P +    + Q+ + C Q   A RP  A  + +L
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 3e-57
 Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 33/293 (11%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFF-NEVNLISSIEHKNLVKLLGC 335
           + +G+G  G V+ G    G  VAVK    ++R+    F   E+     + H+N++  +  
Sbjct: 9   ESIGKGRFGEVWRGKW-RGEEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 336 SIEGPESL----LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH---- 387
             +   +     LV +Y  + SL  ++        +       + L TA GLA+LH    
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121

Query: 388 -GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA---VAGTLGYMAP 443
               +  I HRD+K+ NIL+ K+ T  IAD GLA    +    +  A     GT  YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 444 EYL------VRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV 497
           E L         +  ++AD+Y+ G++  EI          +D   P   +     S + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 498 ------EAVDPNLKDDF-PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
                 + + PN+ + +   E +  + +I   C  A  A R +  +    L+ 
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 7e-57
 Identities = 63/275 (22%), Positives = 112/275 (40%), Gaps = 28/275 (10%)

Query: 272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKN 328
           +     ++G+G   +VY G        VA   L     T+     F  E  ++  ++H N
Sbjct: 10  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69

Query: 329 LVKLLGCSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           +V+         +     +LV E + + +L  ++    + K++      +      +GL 
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQ 126

Query: 385 YLHGGSETRIIHRDIKTSNILL-DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
           +LH  +   IIHRD+K  NI +     + KI D GLA      R   + AV GT  +MAP
Sbjct: 127 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAP 182

Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN 503
           E     +  E  DVY+FG+ ++E+       +  Q++A   +RV +  +     +   P 
Sbjct: 183 EMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241

Query: 504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
           +K+            I   C +     R S+   +
Sbjct: 242 VKE------------IIEGCIRQNKDERYSIKDLL 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 8e-57
 Identities = 68/279 (24%), Positives = 108/279 (38%), Gaps = 24/279 (8%)

Query: 268 KATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSI 324
           +A +Y      +G G  G         +G  +  K L     T        +EVNL+  +
Sbjct: 2   RAEDY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 325 EHKNLVKLLGCSIEGPESLL--VYEYVPNRSLDQFIFDKNKTK-LLNWNKRFNIILGTAE 381
           +H N+V+     I+   + L  V EY     L   I    K +  L+      ++     
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 382 GLAYLH--GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
            L   H        ++HRD+K +N+ LD     K+ DFGLAR    D T  + A  GT  
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPY 179

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           YM+PE + R    EK+D++S G L+ E+        F+  S   L          K+ E 
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP--PFTAFSQKELAG--------KIREG 229

Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
               +   +  E    + +I           RPS+ + +
Sbjct: 230 KFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEIL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 9e-57
 Identities = 65/285 (22%), Positives = 125/285 (43%), Gaps = 27/285 (9%)

Query: 263 YETLEKATN---YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEV 318
           YE + +  N   ++    +LG G  G VY   +       A K +   + + ++++  E+
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
           ++++S +H N+VKLL          ++ E+    ++D  + +  +   L  ++   +   
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQ 118

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           T + L YLH   + +IIHRD+K  NIL   D   K+ADFG++           + + GT 
Sbjct: 119 TLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTP 174

Query: 439 GYMAPEYLV-----RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
            +MAPE ++           KADV+S GI +IE+      +       +P++ +  + +S
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH----HELNPMRVLLKIAKS 230

Query: 494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
                A       +F      + L+    C +     R + +Q +
Sbjct: 231 EPPTLAQPSRWSSNF-----KDFLK---KCLEKNVDARWTTSQLL 267

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 2e-56
 Identities = 57/297 (19%), Positives = 118/297 (39%), Gaps = 25/297 (8%)

Query: 268 KATNYFNPSKKLGQGGAGSVYMG---SLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           K  N      +LG G  GSV  G          VA+K L     +   +E   E  ++  
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++  +V+L+G   +    +LV E      L +F+  K +   +  +    ++   + G+
Sbjct: 66  LDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLGYM 441
            YL    E   +HRD+   N+LL      KI+DFGL++   AD ++    +A    L + 
Sbjct: 123 KYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 442 APEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD 501
           APE +   + + ++DV+S+G+ + E +   +             + +   +  +++  ++
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ-------------KPYKKMKGPEVMAFIE 226

Query: 502 PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLN 558
              + + P E    +  +   C       RP        +      + +  +    +
Sbjct: 227 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHH 283

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 5e-56
 Identities = 73/292 (25%), Positives = 127/292 (43%), Gaps = 27/292 (9%)

Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFNTRQ-WVDEF 314
           + ++  +  ++   + ++ +G+G  G VY G+L +        AVK L   T    V +F
Sbjct: 16  AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75

Query: 315 FNEVNLISSIEHKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             E  ++    H N++ LLG  +    S L+V  Y+ +  L  FI   N+T         
Sbjct: 76  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLI 133

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA---ADRTHV 430
              L  A+G+ +L      + +HRD+   N +LD+ FT K+ADFGLAR       D  H 
Sbjct: 134 GFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190

Query: 431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTL 490
            T     + +MA E L   + T K+DV+SFG+L+ E++          ++      +   
Sbjct: 191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 250

Query: 491 YRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT 542
            R             +  P      + ++ L C    A +RPS ++ +  ++
Sbjct: 251 RR---------LLQPEYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 6e-55
 Identities = 65/270 (24%), Positives = 112/270 (41%), Gaps = 28/270 (10%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+     +   +A+K L            +   EV + S + H N
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           +++L G   +     L+ EY P  ++ + +   +K    +  +    I   A  L+Y H 
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH- 123

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
               R+IHRDIK  N+LL      KIADFG +    + R      + GTL Y+ PE +  
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEG 178

Query: 449 GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF 508
               EK D++S G+L  E + G+    F  ++              K +  V+    D  
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKP--PFEANTYQETY---------KRISRVEFTFPDFV 227

Query: 509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
             E   +++       +   + RP + + +
Sbjct: 228 T-EGARDLIS---RLLKHNPSQRPMLREVL 253

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-54
 Identities = 71/289 (24%), Positives = 110/289 (38%), Gaps = 39/289 (13%)

Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIE-HKN 328
           K LG G  G V   +           TVAVK L  +      +   +E+ ++S +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL---------------LNWNKRF 373
           +V LLG    G  +L++ EY     L  F+  K  + +               L+     
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH-VST 432
           +     A+G+A+L        IHRD+   NILL      KI DFGLAR    D  + V  
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 433 AVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR 492
                + +MAPE +     T ++DV+S+GI + E+     S        S   ++     
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM----- 260

Query: 493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
                  +    +   P      +  I   C  A    RP+  Q + L+
Sbjct: 261 -------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 1e-54
 Identities = 68/269 (25%), Positives = 103/269 (38%), Gaps = 22/269 (8%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           ++  + LG+G  G V +  +      VAVK + +       +    E+ +   + H+N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           K  G   EG    L  EY     L   I        +              G+ YLH   
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLH--- 120

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLVRG 449
              I HRDIK  N+LLD+    KI+DFGLA  F  + R  +   + GTL Y+APE L R 
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 450 QL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF 508
           +   E  DV+S GI++  ++ G        DS                 + +D       
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA-- 238

Query: 509 PAEQVCNVLQIGLLCTQAAAALRPSMAQA 537
                   L   +L    +A  R ++   
Sbjct: 239 --------LLHKILVENPSA--RITIPDI 257

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 4e-54
 Identities = 69/314 (21%), Positives = 126/314 (40%), Gaps = 41/314 (13%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNG---TTVAVKRL-IFNTRQWVDEFFNEVNLISSIE-HK 327
                 +G+G  G V    +         A+KR+  + ++    +F  E+ ++  +  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-------------FDKNKTKLLNWNKRFN 374
           N++ LLG         L  EY P+ +L  F+                +    L+  +  +
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A G+ YL    + + IHRD+   NIL+ +++  KIADFGL+R          T  
Sbjct: 132 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMG 186

Query: 435 AGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN 494
              + +MA E L     T  +DV+S+G+L+ EIV    +              +      
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-------------PYCGMTCA 233

Query: 495 KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQP 554
           +L E +    + + P      V  +   C +     RPS AQ ++ L N++ E     + 
Sbjct: 234 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL-NRMLE----ERK 288

Query: 555 PFLNSSVMEPGNSS 568
            ++N+++ E    +
Sbjct: 289 TYVNTTLYEKFTYA 302

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 8e-54
 Identities = 69/279 (24%), Positives = 109/279 (39%), Gaps = 27/279 (9%)

Query: 273 FNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIE 325
               +KLG G  G V  G          +VAVK L   + +  + +D+F  EVN + S++
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           H+NL++L G  +  P   +V E  P  SL   +       LL    R    +  AEG+ Y
Sbjct: 70  HRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGY 126

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTLGYMAP 443
           L      R IHRD+   N+LL      KI DFGL R    +  H  +         + AP
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN 503
           E L     +  +D + FG+ + E+    +      + +  L ++          E     
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--------EGERLP 235

Query: 504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT 542
             +D P +    +  + + C       RP+       L 
Sbjct: 236 RPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 2e-53
 Identities = 76/304 (25%), Positives = 132/304 (43%), Gaps = 28/304 (9%)

Query: 264 ETLEKATNYFNPSKK------LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN 316
           E L    +  +P KK      +GQG +G+VY    +  G  VA++++    +   +   N
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E+ ++   ++ N+V  L   + G E  +V EY+   SL   + +          +   + 
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVC 122

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
               + L +LH     ++IHRDIK+ NILL  D + K+ DFG       +++  ST V G
Sbjct: 123 RECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-G 178

Query: 437 TLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKL 496
           T  +MAPE + R     K D++S GI+ IE++ G     +  ++     R   L  +N  
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP--PYLNENP---LRALYLIATNGT 233

Query: 497 VEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPF 556
            E  +P   +   A    + L     C       R S  + +     K+ + P  S  P 
Sbjct: 234 PELQNP---EKLSAI-FRDFLN---RCLDMDVEKRGSAKELLQHQFLKIAK-PLSSLTPL 285

Query: 557 LNSS 560
           + ++
Sbjct: 286 IAAA 289

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 1e-52
 Identities = 69/301 (22%), Positives = 108/301 (35%), Gaps = 47/301 (15%)

Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIE-HKN 328
           K LG G  G V   +            VAVK L         +   +E+ +++ +  H+N
Sbjct: 43  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT--------------------KLLN 368
           +V LLG         L++EY     L  ++  K +                      +L 
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 369 WNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
           +          A+G+ +L        +HRD+   N+L+      KI DFGLAR   +D  
Sbjct: 163 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219

Query: 429 HVS-TAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV 487
           +V        + +MAPE L  G  T K+DV+S+GIL+ EI      N +           
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPVDAN--- 275

Query: 488 WTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCE 547
                     + +    K D P      +  I   C    +  RPS       L    C+
Sbjct: 276 --------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG---CQ 324

Query: 548 I 548
           +
Sbjct: 325 L 325

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 5e-52
 Identities = 64/317 (20%), Positives = 133/317 (41%), Gaps = 40/317 (12%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTT----VAVKRL-IFNTRQWVDEFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G      VA+K L    + +   E  +E  +++S+++
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
            ++ +LLG  +      L+ + +P   L  ++ +             N  +  A+G+ YL
Sbjct: 71  PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYL 127

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTLGYMAPEY 445
               + R++HRD+   N+L+      KI DFGLA+   A ++ + +      + +MA E 
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 446 LVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK 505
           ++    T ++DV+S+G+ + E++                 + +    ++++   ++   +
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS-------------KPYDGIPASEISSILEKGER 231

Query: 506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT--------------NKVCEIPTP 551
              P     +V  I + C    A  RP   + I+  +              ++   +P+P
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSP 291

Query: 552 SQPPFLNSSVMEPGNSS 568
           +   F  + + E     
Sbjct: 292 TDSNFYRALMDEEDMDD 308

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-50
 Identities = 58/272 (21%), Positives = 106/272 (38%), Gaps = 24/272 (8%)

Query: 277 KKLGQGGAGSVYMGSLPN----GTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLVK 331
           + +G+G  G V+ G   +       VA+K     T   V ++F  E   +   +H ++VK
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           L+G   E P   ++ E      L  F+  +  +  L+           +  LAYL     
Sbjct: 73  LIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLE---S 126

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
            R +HRDI   N+L+  +   K+ DFGL+R       + ++     + +MAPE +   + 
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186

Query: 452 TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAE 511
           T  +DV+ FG+ + EI+           +   + R+    R           +  + P  
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---------LPMPPNCPPT 237

Query: 512 QVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
               +  +   C     + RP   +    L+ 
Sbjct: 238 ----LYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  176 bits (446), Expect = 2e-50
 Identities = 62/318 (19%), Positives = 120/318 (37%), Gaps = 23/318 (7%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           ++LG G  G V+       G   A K ++       +    E+  +S + H  LV L   
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             +  E +++YE++    L + + D++    ++ ++    +    +GL ++H   E   +
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH---ENNYV 146

Query: 396 HRDIKTSNILL--DKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
           H D+K  NI+    +    K+ DFGL       ++   T   GT  + APE      +  
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGY 204

Query: 454 KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQV 513
             D++S G+L   ++ G     F  ++     R          V++ D N+ D   +   
Sbjct: 205 YTDMWSVGVLSYILLSGLSP--FGGENDDETLR---------NVKSCDWNMDDSAFSGIS 253

Query: 514 CNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFLNSSVMEPGNSSRSCSA 573
            +          A    R ++ QA  L    +     P +   + SS       S     
Sbjct: 254 EDGKDFIRKLLLADPNTRMTIHQA--LEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKY 311

Query: 574 NSFISNVAKRIEVSYSSS 591
           +++   +     +S  SS
Sbjct: 312 DAWPEPLPPLGRISNYSS 329

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 8e-50
 Identities = 70/302 (23%), Positives = 126/302 (41%), Gaps = 33/302 (10%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL-IFNTRQWVDEFFNEVNLISSIE 325
              S++LGQG  G VY G           T VA+K +    + +   EF NE +++    
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-------LNWNKRFNIILG 378
             ++V+LLG   +G  +L++ E +    L  ++                + +K   +   
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVSTAVAGT 437
            A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R     D           
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV 497
           + +M+PE L  G  T  +DV+SFG+++ EI                  + +    + +++
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------------QPYQGLSNEQVL 245

Query: 498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFL 557
             V      D P      + ++  +C Q    +RPS  + I  +  ++   P   +  F 
Sbjct: 246 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME--PGFREVSFY 303

Query: 558 NS 559
            S
Sbjct: 304 YS 305

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 3e-48
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 11/205 (5%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKN 328
           F   K LG+G   +V +   L      A+K L          V     E +++S ++H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
            VKL     +  +      Y  N  L ++I         +              L YLH 
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH- 125

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTLGYMAPEYLV 447
                IIHRD+K  NILL++D   +I DFG A+  + + +   + +  GT  Y++PE L 
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 448 RGQLTEKADVYSFGILIIEIVCGRR 472
                + +D+++ G +I ++V G  
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLP 208

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 6e-48
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 40/289 (13%)

Query: 277 KKLGQGGAGSVYMGSLP--------NGTTVAVKRL-IFNTRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +              T VAVK L    T + + +  +E+ ++  I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKRF 373
           KN++ LLG   +     ++ EY    +L +++  +             N  + L+     
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
           +     A G+ YL      + IHRD+   N+L+ +D   KIADFGLAR       +  T 
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 434 VA-GTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR 492
                + +MAPE L     T ++DV+SFG+L+ EI     S         P++ ++    
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP----YPGVPVEELF---- 247

Query: 493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLL 541
              L E    +   +   E    +  +   C  A  + RP+  Q +  L
Sbjct: 248 -KLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 6e-47
 Identities = 72/290 (24%), Positives = 106/290 (36%), Gaps = 38/290 (13%)

Query: 277 KKLGQGGAGSVYMG------SLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNL 329
           K LG+G  G V               TVAVK L    T        +E+ ++  I H   
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 330 VKLLG--CSIEGPESLLVYEYVPNRSLDQFIFDKNKT-------------KLLNWNKRFN 374
           V  L   C+  G   +++ E+    +L  ++  K                  L       
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STA 433
                A+G+ +L      + IHRD+   NILL +    KI DFGLAR    D  +V    
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 434 VAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS 493
               L +MAPE +     T ++DV+SFG+L+ EI     S            R       
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR------- 248

Query: 494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
            +L E       D    E    + Q  L C     + RP+ ++ +  L N
Sbjct: 249 -RLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  164 bits (417), Expect = 2e-46
 Identities = 68/344 (19%), Positives = 126/344 (36%), Gaps = 38/344 (11%)

Query: 271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +Y++  ++LG G  G V+       G     K +            NE+++++ + H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           + L     +  E +L+ E++    L   I  ++    ++  +  N +    EGL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH-- 144

Query: 390 SETRIIHRDIKTSNILLDKDFTP--KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV 447
            E  I+H DIK  NI+ +       KI DFGLA     D     T    T  + APE + 
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVD 201

Query: 448 RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD 507
           R  +    D+++ G+L   ++ G     F+ +       + TL    +     D +    
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLS--PFAGED-----DLETLQNVKRCDWEFDEDAFSS 254

Query: 508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCEIPTPSQPPFL---NSSVMEP 564
              E   + ++      Q     R ++  A+              + P+L   +S++   
Sbjct: 255 VSPE-AKDFIK---NLLQKEPRKRLTVHDAL--------------EHPWLKGDHSNLTSR 296

Query: 565 GNSSRSCSANSFISNVAKRIEVSYSSSESSSTHSSDAHSRSREL 608
             SSR       I            +    +  SS    R +E 
Sbjct: 297 IPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEY 340

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  156 bits (396), Expect = 3e-44
 Identities = 62/280 (22%), Positives = 114/280 (40%), Gaps = 27/280 (9%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIE 325
           ++ +   + LG GG   V++   L     VAVK L   +     +   F  E    +++ 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 326 HKNLVKLLGCSIE----GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           H  +V +          GP   +V EYV   +L   +  +     +   +   +I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGTLG 439
            L + H   +  IIHRD+K +NI++      K+ DFG+AR  A     V  + AV GT  
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 440 YMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA 499
           Y++PE      +  ++DVYS G ++ E++ G     F+ DS        ++   +   + 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP--PFTGDSPV------SVAYQHVREDP 231

Query: 500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM 539
           + P+ + +  +  +  V+             R   A  + 
Sbjct: 232 IPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMR 268

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  159 bits (402), Expect = 4e-44
 Identities = 57/246 (23%), Positives = 102/246 (41%), Gaps = 21/246 (8%)

Query: 271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLIS---S 323
           N F+  + +G+GG G VY       G   A+K L       +Q      NE  ++S   +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +   +V +        +   + + +    L   +         +             GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
            ++H      +++RD+K +NILLD+    +I+D GLA  F+  + H S    GT GYMAP
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 174

Query: 444 EYLVRGQ-LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN--KLVEAV 500
           E L +G      AD +S G ++ +++ G   + F Q        +  +  +   +L ++ 
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGH--SPFRQHKTKDKHEIDRMTLTMAVELPDSF 232

Query: 501 DPNLKD 506
            P L+ 
Sbjct: 233 SPELRS 238

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 5e-44
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 8/207 (3%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHK 327
              +     +G+G  G V       N   VA+K++  F  + +      E+ ++    H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           N++ +           +   Y+    +   ++   KT+ L+ +     +     GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS--TAVAGTLGYMAPEY 445
                 ++HRD+K SN+LL+     KI DFGLAR    D  H    T    T  Y APE 
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 446 LVRGQL-TEKADVYSFGILIIEIVCGR 471
           ++  +  T+  D++S G ++ E++  R
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (395), Expect = 1e-43
 Identities = 63/281 (22%), Positives = 112/281 (39%), Gaps = 24/281 (8%)

Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-FFNEVNL 320
           ++  E   + ++    LG G    V +         VA+K +     +  +    NE+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           +  I+H N+V L      G    L+ + V    L   I +K             +I    
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVL 117

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           + + YLH   +  I+HRD+K  N+L    D+D    I+DFGL++    D   V +   GT
Sbjct: 118 DAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGT 172

Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLV 497
            GY+APE L +   ++  D +S G++   ++CG     F  ++ + L       +  K  
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP--PFYDENDAKL-----FEQILKAE 225

Query: 498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
              D    DD       + ++      +     R +  QA+
Sbjct: 226 YEFDSPYWDDISDS-AKDFIR---HLMEKDPEKRFTCEQAL 262

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  153 bits (387), Expect = 6e-43
 Identities = 57/283 (20%), Positives = 107/283 (37%), Gaps = 36/283 (12%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---------IFNTRQWVDEFFNEVNLIS 322
           + P + LG+G +  V      P     AVK +             ++  +    EV+++ 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 323 SI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
            +  H N+++L           LV++ +    L  ++ +K     L+  +   I+    E
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLE 121

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYM 441
            +  LH   +  I+HRD+K  NILLD D   K+ DFG +     D       V GT  Y+
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYL 176

Query: 442 APEYL------VRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK 495
           APE +            ++ D++S G+++  ++ G     F         ++  L     
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP--PFWHRK-----QMLMLRMIMS 229

Query: 496 LVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
                     DD+    V +++             R +  +A+
Sbjct: 230 GNYQFGSPEWDDYSDT-VKDLVS---RFLVVQPQKRYTAEEAL 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 1e-42
 Identities = 66/274 (24%), Positives = 101/274 (36%), Gaps = 31/274 (11%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLIS-SIEHK 327
           F   K LG+G  G V++          A+K L   +      V+    E  ++S + EH 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
            L  +            V EY+    L   I   +K    + ++          GL +LH
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH 120

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLV 447
                 I++RD+K  NILLDKD   KIADFG+ +         +T   GT  Y+APE L+
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILL 176

Query: 448 RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD 507
             +     D +SFG+L+ E++ G+    F       L        +      ++   KD 
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQS--PFHGQDEEELFH-SIRMDNPFYPRWLEKEAKD- 232

Query: 508 FPAEQVCNVLQIGLL--CTQAAAALRPSMAQAIM 539
                        LL          R  +   I 
Sbjct: 233 -------------LLVKLFVREPEKRLGVRGDIR 253

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (386), Expect = 1e-42
 Identities = 56/278 (20%), Positives = 101/278 (36%), Gaps = 26/278 (9%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG- 334
           +K+G G  G +Y+G  +  G  VA+K     T+    +   E  +   ++    +  +  
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
           C  EG  +++V E +     D F F   K    +      +       + Y+H       
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIH---SKNF 124

Query: 395 IHRDIKTSNIL---LDKDFTPKIADFGLARCFAADRTHV------STAVAGTLGYMAPEY 445
           IHRD+K  N L     K     I DFGLA+ +   RTH       +  + GT  Y +   
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 446 LVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK 505
            +  + + + D+ S G +++    G     +    A+  ++ +      K+       L 
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLP--WQGLKAATKRQKYERISEKKM-STPIEVLC 241

Query: 506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
             +P+E           C       +P  +    L  N
Sbjct: 242 KGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRN 275

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  152 bits (385), Expect = 3e-42
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           + LG G  G V++  S  NG   A+K L   I    + V+   +E  ++S + H  ++++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
            G   +  +  ++ +Y+    L   +    +                   L YLH     
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYLH---SK 123

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLT 452
            II+RD+K  NILLDK+   KI DFG A+        V+  + GT  Y+APE +      
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 453 EKADVYSFGILIIEIVCGRR 472
           +  D +SFGILI E++ G  
Sbjct: 180 KSIDWWSFGILIYEMLAGYT 199

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 4e-42
 Identities = 57/331 (17%), Positives = 118/331 (35%), Gaps = 33/331 (9%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           + LG+G  G V+      +  T   K +             E+++++   H+N++ L   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHES 69

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
                E ++++E++    + + I        LN  +  + +    E L +LH      I 
Sbjct: 70  FESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLH---SHNIG 124

Query: 396 HRDIKTSNILLD--KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
           H DI+  NI+    +  T KI +FG AR            +     Y APE      ++ 
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVST 182

Query: 454 KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQV 513
             D++S G L+  ++ G     F  ++   +            +   +    ++   E  
Sbjct: 183 ATDMWSLGTLVYVLLSGIN--PFLAETNQQIIE---------NIMNAEYTFDEEAFKEIS 231

Query: 514 CNVLQIGLLCTQAAAALRPSMAQA---------IMLLTNKVCEIPTPSQPPFLNSSVMEP 564
              +             R + ++A         I  ++ KV  I T     + ++ + + 
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV--IRTLKHRRYYHTLIKKD 289

Query: 565 GNSSRSCSANSFISNVAKRIEVSYSSSESSS 595
            N   S +  S    +  +  VS +  + +S
Sbjct: 290 LNMVVSAARISCGGAIRSQKGVSVAKVKVAS 320

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (378), Expect = 2e-41
 Identities = 71/284 (25%), Positives = 117/284 (41%), Gaps = 24/284 (8%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++          D +    +      + +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE-YLVR 448
              R++HRD+K  N+L++ +   K+ADFGLAR F       +  V  TL Y APE  L  
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 177

Query: 449 GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD---PNLK 505
              +   D++S G +  E+V  R       +     +   TL   +++V       P+ K
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 506 DDFPAEQVCNVLQIGLLCTQAAAAL-----------RPSMAQAI 538
             FP     +  ++     +   +L           R S   A+
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  148 bits (374), Expect = 6e-41
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 8/197 (4%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +K+G+G  G VY      G T A+K  RL             E++++  ++H N+VKL  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                   +LV+E++           +     L      + +L    G+AY H   + R+
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH---DRRV 121

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEK 454
           +HRD+K  N+L++++   KIADFGLAR F       +  +           +   + +  
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181

Query: 455 ADVYSFGILIIEIVCGR 471
            D++S G +  E+V G 
Sbjct: 182 IDIWSVGCIFAEMVNGT 198

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 8e-41
 Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 15/215 (6%)

Query: 268 KATNYFNPSKKLGQGGAGSVYMG--SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL--- 320
           +A   +    ++G+G  G V+        G  VA+KR+               EV +   
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQ---FIFDKNKTKLLNWNKRFNIIL 377
           + + EH N+V+L                +    +DQ      DK     +      +++ 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
               GL +LH     R++HRD+K  NIL+      K+ADFGLAR +        T+V  T
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVT 178

Query: 438 LGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRR 472
           L Y APE L++       D++S G +  E+   + 
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 1e-40
 Identities = 65/306 (21%), Positives = 121/306 (39%), Gaps = 40/306 (13%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEHKNLV 330
             LG+G   +VY          VA+K++    R    +        E+ L+  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            LL          LV++++           K+ + +L  +     +L T +GL YLH   
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLH--- 117

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQ 450
           +  I+HRD+K +N+LLD++   K+ADFGLA+ F +     +  V  T  Y APE L   +
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176

Query: 451 L-TEKADVYSFGILIIEIVCGRR--------------SNAFSQDSASPLQRVWTLYRSNK 495
           +     D+++ G ++ E++                         +      + +L     
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 496 LVEAVDPNLKDDFPA--EQVCNVLQIGLLCTQAAAALRPSMAQAIM--LLTNK-----VC 546
                   L   F A  + + +++Q            R +  QA+     +N+      C
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKMKYFSNRPGPTPGC 293

Query: 547 EIPTPS 552
           ++P P+
Sbjct: 294 QLPRPN 299

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  147 bits (371), Expect = 1e-40
 Identities = 43/280 (15%), Positives = 94/280 (33%), Gaps = 28/280 (10%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH-KNLVKLLG 334
           +++G+G  G ++ G +L N   VA+K      R    +  +E      +     +  +  
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
              EG  ++LV + +               +  +              +  +H   E  +
Sbjct: 69  FGQEGLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSL 122

Query: 395 IHRDIKTSNILLDKDFTP-----KIADFGLARCFAADRTHV------STAVAGTLGYMAP 443
           ++RDIK  N L+ +  +       + DFG+ + +    T           ++GT  YM+ 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN 503
              +  + + + D+ + G + +  + G     +    A+  ++ +      K    +   
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGS--LPWQGLKAATNKQKYERIGEKKQSTPL-RE 239

Query: 504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN 543
           L   FP E      +        A    P       L + 
Sbjct: 240 LCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSK 275

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-40
 Identities = 61/289 (21%), Positives = 112/289 (38%), Gaps = 33/289 (11%)

Query: 261 FKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL------IFNTRQWVDE 313
           F+ E ++   +Y++  ++LG G    V        G   A K +              ++
Sbjct: 3   FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
              EV+++  I+H N++ L        + +L+ E V    L  F+ +K     L   +  
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 116

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP----KIADFGLARCFAADRTH 429
             +     G+ YLH     +I H D+K  NI+L     P    KI DFGLA     D  +
Sbjct: 117 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGN 171

Query: 430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWT 489
               + GT  ++APE +    L  +AD++S G++   ++ G   + F  D+         
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETLA--- 226

Query: 490 LYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI 538
                  V AV+   +D++ +                    R ++  ++
Sbjct: 227 ------NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 8e-40
 Identities = 62/338 (18%), Positives = 122/338 (36%), Gaps = 38/338 (11%)

Query: 254 MKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD 312
           +KK+ +   Y+   +          LG G  G V    +       A+K L     Q   
Sbjct: 4   IKKNAIIDDYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKML-----QDCP 49

Query: 313 EFFNEVN-LISSIEHKNLVKLLGC----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLL 367
           +   EV     + +  ++V+++             L+V E +    L   I D+      
Sbjct: 50  KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF- 108

Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLARCFA 424
              +   I+    E + YLH      I HRD+K  N+L      +   K+ DFG A+   
Sbjct: 109 TEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165

Query: 425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPL 484
           +  +  +     T  Y+APE L   +  +  D++S G+++  ++CG     F  +    L
Sbjct: 166 SHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSN--HGL 219

Query: 485 QRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK 544
                +    ++ +   PN +    +E+V  +++      +     R ++ +   +    
Sbjct: 220 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEF--MNHPW 274

Query: 545 VCEIPTPSQPPFLNSSVMEPGNSSRSCSANSFISNVAK 582
           + +     Q P   S V++              S +A 
Sbjct: 275 IMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALAT 312

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 2e-38
 Identities = 52/208 (25%), Positives = 81/208 (38%), Gaps = 16/208 (7%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           +  +K +G G  G VY      +G  VA+K++     Q       E+ ++  ++H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77

Query: 332 LLGCSIEGPES------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           L        E        LV +YVP              + L        +      LAY
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 386 LHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPE 444
           +H      I HRDIK  N+LLD D    K+ DFG A+       +VS  +          
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPEL 193

Query: 445 YLVRGQLTEKADVYSFGILIIEIVCGRR 472
                  T   DV+S G ++ E++ G+ 
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQP 221

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 3e-37
 Identities = 59/238 (24%), Positives = 92/238 (38%), Gaps = 14/238 (5%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKN 328
           F+  K LG+G  G V +      G   A+K L   +   +  V     E  ++ +  H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           L  L            V EY     L   +   ++ ++    +           L YLH 
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH- 122

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVR 448
                +++RDIK  N++LDKD   KI DFGL +   +D   + T   GT  Y+APE L  
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLED 179

Query: 449 GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD 506
                  D +  G+++ E++CGR    F       L  +  L    +    + P  K 
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRL--PFYNQDHERLFELI-LMEEIRFPRTLSPEAKS 234

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 3e-37
 Identities = 55/279 (19%), Positives = 103/279 (36%), Gaps = 24/279 (8%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           +K+G+G  G+V+   +      VA+K  RL  +          E+ L+  ++HKN+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
                  +  LV+E+        F          +     + +    +GL + H      
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH---SRN 121

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTE 453
           ++HRD+K  N+L++++   K+A+FGLAR F       S  V                 + 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 454 KADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVD----PNLKDDFP 509
             D++S G +  E+    R      D    L+R++ L  +    +       P+ K    
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 510 AEQVCNVLQIGLLCTQAAAAL-----------RPSMAQA 537
                +++ +          L           R S  +A
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 3e-37
 Identities = 56/294 (19%), Positives = 103/294 (35%), Gaps = 44/294 (14%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL------IFNTRQWVDEFFNEVNLISSI--EHK 327
             LG GG GSVY G  + +   VA+K +       +           EV L+  +     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
            +++LL         +L+ E             +     L      +      E + + H
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCH 127

Query: 388 GGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL 446
                 ++HRDIK  NIL+D +    K+ DFG        +  V T   GT  Y  PE++
Sbjct: 128 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181

Query: 447 VRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK 505
              +     A V+S GIL+ ++VCG                    +  ++ +       +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI-----------------PFEHDEEIIRGQVFFR 224

Query: 506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK-VCEIPTPSQPPFLN 558
               +E       +   C     + RP+  +   +  +  + ++  P +   ++
Sbjct: 225 QRVSSE----CQHLIRWCLALRPSDRPTFEE---IQNHPWMQDVLLPQETAEIH 271

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-36
 Identities = 66/294 (22%), Positives = 114/294 (38%), Gaps = 40/294 (13%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
            K+GQG  G V+       G  VA+K+++       +      E+ ++  ++H+N+V L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 334 GCSIEGPES--------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
                             LV+++  +           K      ++   ++     GL Y
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYY 132

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT---HVSTAVAGTLGYMA 442
           +H     +I+HRD+K +N+L+ +D   K+ADFGLAR F+  +    +  T    TL Y  
Sbjct: 133 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 443 PEYLVRGQL-TEKADVYSFGILIIEIVCGRRS----------NAFSQDSASPLQRVW--- 488
           PE L+  +      D++  G ++ E+                   SQ   S    VW   
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249

Query: 489 ---TLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLL--CTQAAAALRPSMAQA 537
               LY   +LV+     +KD   A  V +   + L+        A R     A
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAY-VRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  131 bits (330), Expect = 3e-34
 Identities = 54/240 (22%), Positives = 92/240 (38%), Gaps = 26/240 (10%)

Query: 237 LSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNG 295
           L+K KED           K    S     L++    F+  K LG G  G V +     +G
Sbjct: 19  LAKAKEDFLK--------KWETPSQNTAQLDQ----FDRIKTLGTGSFGRVMLVKHKESG 66

Query: 296 TTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR 352
              A+K L        + ++   NE  ++ ++    LVKL     +     +V EYV   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP 412
            +   +    +    +                YLH      +I+RD+K  N+L+D+    
Sbjct: 127 EMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180

Query: 413 KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRR 472
           ++ DFG A+        +     GT   +APE ++     +  D ++ G+LI E+  G  
Sbjct: 181 QVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-32
 Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 12/213 (5%)

Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNL 320
           +T  +    +   + +G G  G+V        G  VA+K+L   F +  +    + E+ L
Sbjct: 11  KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70

Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           +  + H+N++ LL             + Y+    +   +    K + L  ++   ++   
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
            +GL Y+H      IIHRD+K  N+ +++D   KI DFGLAR   ++ T        T  
Sbjct: 131 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG----YVVTRW 183

Query: 440 YMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGR 471
           Y APE ++     T+  D++S G ++ E++ G+
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 4e-32
 Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 17/211 (8%)

Query: 273 FNPSKKLGQGGAGSVYMG----SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSI 324
           F   K LG G  G V++         G   A+K L    I    +  +    E  ++  I
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 325 EHK-NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                LV L        +  L+ +Y+    L   +  + +                 E +
Sbjct: 86  RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GEIV 139

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
             L    +  II+RDIK  NILLD +    + DFGL++ F AD T  +    GT+ YMAP
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 444 EYLVRGQ--LTEKADVYSFGILIIEIVCGRR 472
           + +  G     +  D +S G+L+ E++ G  
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 5e-30
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 20/208 (9%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNL 329
           +   K +G G  G V           VA+K+L   F  +      + E+ L+  + HKN+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 330 VKLLGCSI------EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           + LL          E  +  LV E +          + +        +   ++     G+
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGI 132

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAP 443
            +LH      IIHRD+K SNI++  D T KI DFGLAR      + + T    T  Y AP
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAP 187

Query: 444 EYLVRGQLTEKADVYSFGILIIEIVCGR 471
           E ++     E  D++S G ++ E+V  +
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  118 bits (295), Expect = 9e-30
 Identities = 42/202 (20%), Positives = 83/202 (41%), Gaps = 20/202 (9%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLG 334
           +KLG+G    V+   ++ N   V VK L         +   E+ ++ ++    N++ L  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLAD 97

Query: 335 CSIEGPESL--LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
              +       LV+E+V N    Q        + L        +    + L Y H     
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH---SM 148

Query: 393 RIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL 451
            I+HRD+K  N+++D +    ++ D+GLA  +   + +       +  +  PE LV  Q+
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQM 206

Query: 452 -TEKADVYSFGILIIEIVCGRR 472
                D++S G ++  ++  + 
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKE 228

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 3e-29
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 12/213 (5%)

Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 321 ISSIEHKNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           +  ++H+N++ LL   +           Y+    +   + +  K + L  +    +I   
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLG 439
             GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    + T        T  
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRW 183

Query: 440 YMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGR 471
           Y APE ++      +  D++S G ++ E++ GR
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (268), Expect = 4e-26
 Identities = 45/211 (21%), Positives = 78/211 (36%), Gaps = 19/211 (9%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +KLG G   +V++   + N T VA+K  +   + + +   +E+ L+  +   +  K    
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKI-VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 336 SIEGPESLLVYEYVPNRSLDQF-------------IFDKNKTKLLNWNKRFNIILGTAEG 382
                  LL +      +                 +  K + + +       I      G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAADRTHVS-TAVAGTLGY 440
           L Y+H      IIH DIK  N+L++  D    +    +A    A       T    T  Y
Sbjct: 138 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 441 MAPEYLVRGQLTEKADVYSFGILIIEIVCGR 471
            +PE L+       AD++S   LI E++ G 
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 89.8 bits (222), Expect = 2e-21
 Identities = 36/210 (17%), Positives = 66/210 (31%), Gaps = 44/210 (20%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVK---------RLIFNTRQWVD-EFFNEVNLISSIEH 326
           K +G+G   +V+           VK         + +   R + D  F       +  E 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
           + L KL G ++        Y +  N  L + I  K   ++   N    ++    E +A  
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYL 446
           +      I+H D+   N+L+  +    I DF  +     +                 E L
Sbjct: 120 Y---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV----EVGEE----------GWREIL 161

Query: 447 VRG----------QLTEKADVYSFGILIIE 466
            R               + D+ S    I++
Sbjct: 162 ERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	611
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.66
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.14
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.43
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.41
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.54
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.52
d1cjaa_	342	Actin-fragmin kinase, catalytic domain {Physarum p	80.95

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=421.40  Aligned_cols=255  Identities=24%  Similarity=0.397  Sum_probs=199.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      ++|+..+.||+|+||+||+|.+.+++.||||++.... ...++|.+|++++++++|||||+++|++.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4677889999999999999999888999999987543 345789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +|+|.+++...  ...++|..++.++.||++||.|||   +.+|+||||||+|||+++++.+||+|||+++.........
T Consensus        84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            99999998543  356899999999999999999999   7899999999999999999999999999998776554444


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCH
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPA  510 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~  510 (611)
                      .....||..|+|||++.+..++.++|||||||++|||+|+..|+.........+.    ....+         .+...+.
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~----~i~~~---------~~~~~p~  225 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTG---------FRLYKPR  225 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH----HHHHT---------CCCCCCT
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHH----HHHhc---------CCCCCcc
Confidence            4456789999999999999999999999999999999996655433222111111    11111         1112233


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          511 EQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       511 ~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      .....+.+++..||+.||++||||+||++.|++.
T Consensus       226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            3445688999999999999999999999998753

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=422.06  Aligned_cols=255  Identities=30%  Similarity=0.438  Sum_probs=209.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      .++|+..++||+|+||+||+|.+++++.||||++.... ...+.|.+|+++|++++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            45678889999999999999999888999999987543 345789999999999999999999998765 5679999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++|+|.+++.... ...++|..+++|+.||++||.|||   ..+|+||||||+||||++++.+||+|||+++........
T Consensus        90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence            9999999885432 235899999999999999999999   789999999999999999999999999999987655444


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      ......||+.|+|||++..+.++.++|||||||++|||+||..|+...........    ....         ..+...+
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~----~i~~---------~~~~~~p  232 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ----NLER---------GYRMVRP  232 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHT---------TCCCCCC
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH----HHHh---------cCCCCCc
Confidence            44566789999999999999999999999999999999997776543322211111    1111         1112223


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ...+..+.+|+.+||+.+|++||||+||+++|+.
T Consensus       233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            3445568899999999999999999999998864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-53  Score=419.32  Aligned_cols=261  Identities=28%  Similarity=0.431  Sum_probs=203.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .++|+..++||+|+||+||+|++++  .||||++...  ..+..+.|.+|+++|++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            4678889999999999999998743  6999998643  34567889999999999999999999998754 56899999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++|+|.+++...  ...++|..++.|+.||++||+|||   +++||||||||+||||+.++.+||+|||+++......
T Consensus        84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999999643  345999999999999999999999   7899999999999999999999999999998765433


Q ss_pred             c-ceeecccCCccccChhhhhc---CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          428 T-HVSTAVAGTLGYMAPEYLVR---GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       428 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      . .......||+.|||||++..   +.++.++|||||||+||||+||+.||......    ..+......+..    .+.
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~----~~~~~~~~~~~~----~p~  230 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR----DQIIFMVGRGYL----SPD  230 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----HHHHHHHHHTSC----CCC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH----HHHHHHHhcCCC----CCc
Confidence            2 23345679999999999864   35789999999999999999999998543221    111221111111    111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCC
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCE  547 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~~  547 (611)
                      + ...+...+..+.+++.+||+.+|++|||++||++.|+.....
T Consensus       231 ~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         231 L-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             G-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             c-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            1 112233445688999999999999999999999998764433

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-52  Score=422.81  Aligned_cols=266  Identities=25%  Similarity=0.437  Sum_probs=203.6

Q ss_pred             ccChHHHHHHhcCC---------CCCCccccCCceeEEEEEcCC-C---CEEEEEEeecc-chhhHHHHHHHHHHHhcCC
Q 007248          260 SFKYETLEKATNYF---------NPSKKLGQGGAGSVYMGSLPN-G---TTVAVKRLIFN-TRQWVDEFFNEVNLISSIE  325 (611)
Q Consensus       260 ~~~~~~l~~~~~~f---------~~~~~iG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~  325 (611)
                      .++++++.+++.+|         +..++||+|+||+||+|..+. +   ..||||++... .....++|.+|+++|++++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   85 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD   85 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence            45666666666554         345789999999999997642 3   36899988654 4455678999999999999


Q ss_pred             CCceeeEeeeeeeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEE
Q 007248          326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL  405 (611)
Q Consensus       326 h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl  405 (611)
                      |||||+++|++.+++..++||||+++|+|.+++...  ...++|.++++++.||++||+|||   +++|+||||||+|||
T Consensus        86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NIL  160 (299)
T d1jpaa_          86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNIL  160 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEE
Confidence            999999999999999999999999999999988543  346999999999999999999999   789999999999999


Q ss_pred             ECCCCCeEEeeeccceeccCCCcce----eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCC
Q 007248          406 LDKDFTPKIADFGLARCFAADRTHV----STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDS  480 (611)
Q Consensus       406 l~~~~~~kl~DfGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~  480 (611)
                      |+.++.+||+|||+++.+.......    .....||+.|||||.+.++.++.++|||||||++|||+| |+.||....  
T Consensus       161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--  238 (299)
T d1jpaa_         161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--  238 (299)
T ss_dssp             ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred             ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--
Confidence            9999999999999998765433221    123457899999999999999999999999999999998 888875321  


Q ss_pred             CChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          481 ASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                        ..+.. ..         +....+.+.+...+..+.+|+.+||+.+|++||||.||++.|++.
T Consensus       239 --~~~~~-~~---------i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         239 --NQDVI-NA---------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             --HHHHH-HH---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --HHHHH-HH---------HHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              11111 11         111222233445566788999999999999999999999998653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.8e-53  Score=422.03  Aligned_cols=261  Identities=27%  Similarity=0.390  Sum_probs=216.5

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEcC-CCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          266 LEKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       266 l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      ++...++|+..++||+|+||+||+|.+. +|+.||||++..+. ...++|.+|+++|++++|||||+++|++.+++..++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            3334567888899999999999999764 58899999987543 345789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++|+|.+++... ....++|..++.|+.||++||+|||   +.+|+||||||+||||++++.+||+|||+++...
T Consensus        91 v~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence            99999999999999653 3456999999999999999999999   7899999999999999999999999999998776


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ...........|++.|+|||++.++.++.++|||||||++|||++|..|+....+.    ..+.....         ...
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----~~~~~~i~---------~~~  233 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYELLE---------KDY  233 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHH---------TTC
T ss_pred             CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----HHHHHHHh---------cCC
Confidence            65555455566899999999999999999999999999999999988776433221    11222221         122


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ....+...+..+.+|+..||+.||++|||++||++.|+..
T Consensus       234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2233444556788999999999999999999999998653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=407.50  Aligned_cols=253  Identities=23%  Similarity=0.357  Sum_probs=213.0

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      ++|+..++||+|+||+||+|++++++.||||+++... ...++|++|++++++++||||++++|++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            5788999999999999999999888899999987643 345789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +|+|.+++...  ...+++..+++++.||++||.|||   +.+|+||||||+|||+++++.+||+|||+++.........
T Consensus        83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            99999997543  346899999999999999999999   7899999999999999999999999999998766554444


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      .....+|..|+|||.+.+..++.++||||||+++|||+| |+.||....    ..+.... +..         ..+...|
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~----~~~~~~~-i~~---------~~~~~~p  223 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT----NSETAEH-IAQ---------GLRLYRP  223 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----HHHHHHH-HHT---------TCCCCCC
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC----HHHHHHH-HHh---------CCCCCCc
Confidence            445678999999999999999999999999999999998 788875332    1111111 111         1122233


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ......+.+++..||+.+|++|||+++|++.|.+
T Consensus       224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            4445668899999999999999999999998853

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-52  Score=415.89  Aligned_cols=258  Identities=27%  Similarity=0.412  Sum_probs=205.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  350 (611)
                      ++|++.+.||+|+||+||+|.+++++.||||++.... ...+.|.+|+.+|++++|||||+++|++.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            5688899999999999999999888899999986543 345789999999999999999999999854 56899999999


Q ss_pred             CCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce
Q 007248          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (611)
Q Consensus       351 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  430 (611)
                      +|+|..++... ....++|.+++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++.........
T Consensus        95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            99999998543 2345999999999999999999999   7899999999999999999999999999998775554444


Q ss_pred             eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCCH
Q 007248          431 STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPA  510 (611)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~  510 (611)
                      .....||+.|+|||++..+.++.++||||||+++|||+||..|+.........+..    +..         ....+.+.
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~----i~~---------~~~~~~~~  237 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VER---------GYRMPCPP  237 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHT---------TCCCCCCT
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH----HHh---------cCCCCCCc
Confidence            45567899999999999999999999999999999999987776543332222221    111         11222334


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCC
Q 007248          511 EQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKVCE  547 (611)
Q Consensus       511 ~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~~~  547 (611)
                      .....+.+++.+||+.||++||+|++|+++|......
T Consensus       238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            4456688999999999999999999999999765443

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-51  Score=404.59  Aligned_cols=250  Identities=26%  Similarity=0.337  Sum_probs=202.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|+..++||+|+||+||+|.. .+|+.||||++.... .+..+.|.+|+++|++++|||||++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            4688899999999999999965 578999999987543 33456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +++|+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++.+.....
T Consensus        85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999999943   346999999999999999999999   78999999999999999999999999999987654332


Q ss_pred             -ceeecccCCccccChhhhhcCcc-ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          429 -HVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       429 -~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                       .......||+.|||||++.+..+ +.++|||||||++|||+||+.||....+.......    .....        ...
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~----~~~~~--------~~~  226 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKK--------TYL  226 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH----HHTTC--------TTS
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH----HhcCC--------CCC
Confidence             23345789999999999988776 67899999999999999999998654432222111    11111        111


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                      .........+.+++.+||+.||++|||++|++
T Consensus       227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil  258 (271)
T d1nvra_         227 NPWKKIDSAPLALLHKILVENPSARITIPDIK  258 (271)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence            11122345577899999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-51  Score=408.48  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=205.0

Q ss_pred             CCCCCC-ccccCCceeEEEEEcC---CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          272 YFNPSK-KLGQGGAGSVYMGSLP---NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       272 ~f~~~~-~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      +|...+ +||+|+||+||+|.+.   ++..||||++... .....++|.+|+++|++++|||||+++|++.. +..++||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm   87 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM   87 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence            445556 4999999999999653   3557999998754 34556789999999999999999999999865 5689999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++..  ....+++..+++++.||++||+|||   +.+|+||||||+||||+.++.+||+|||+++.+...
T Consensus        88 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          88 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             ECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            99999999999843  2346999999999999999999999   789999999999999999999999999999987654


Q ss_pred             Ccce--eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          427 RTHV--STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       427 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      ....  .....||+.|+|||++..+.++.++|||||||++|||+| |+.||.....    .+ +...+..+         
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~----~~-~~~~i~~~---------  228 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PE-VMAFIEQG---------  228 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HH-HHHHHHTT---------
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH----HH-HHHHHHcC---------
Confidence            3322  224568999999999999999999999999999999998 8999764321    11 11112221         


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .+.+.+...+..+.+|+.+||+.+|++||||.+|++.|+.
T Consensus       229 ~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         229 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1223344455678899999999999999999999998864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-51  Score=409.66  Aligned_cols=255  Identities=25%  Similarity=0.452  Sum_probs=201.7

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCC-----CEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNG-----TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      +.|++.++||+|+||+||+|.++..     ..||||++... .....++|.+|+++|++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4567788999999999999976432     47999998654 34445679999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+.+++|.+++...  ...++|..+++++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999988543  346999999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCcc--eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          425 ADRTH--VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       425 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      .....  ......||+.|||||++.++.++.++|||||||++|||++|..|+.........    ..         .+..
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~----~~---------~i~~  228 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV----MK---------AIND  228 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HH---------HHHT
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH----HH---------HHhc
Confidence            43322  223456899999999999999999999999999999999987775433222111    11         1222


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ..+.+.+...+..+.+|+.+||+.+|++||||.||+++|+.
T Consensus       229 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence            23334445556778999999999999999999999999865

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=404.66  Aligned_cols=248  Identities=25%  Similarity=0.441  Sum_probs=208.1

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      ++|+..++||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999964 579999999998766556678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++|+|.+++..    ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++++||+|||+++.+..... 
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence            99999998843    35899999999999999999999   78999999999999999999999999999987754332 


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFP  509 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  509 (611)
                      ......||+.|+|||++.+..++.++|||||||++|||+||+.||...    ..............      +.+  ..+
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~~~~~~~~------~~~--~~~  239 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE----NPLRALYLIATNGT------PEL--QNP  239 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHHHCS------CCC--SSG
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC----CHHHHHHHHHhCCC------CCC--CCc
Confidence            234567999999999999999999999999999999999999998532    22222222222111      111  123


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007248          510 AEQVCNVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       510 ~~~~~~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                      ......+.+++.+||+.||++|||+.|++
T Consensus       240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil  268 (293)
T d1yhwa1         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELL  268 (293)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            33445688999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-51  Score=406.10  Aligned_cols=246  Identities=26%  Similarity=0.399  Sum_probs=198.6

Q ss_pred             CccccCCceeEEEEEcC---CCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeecCC
Q 007248          277 KKLGQGGAGSVYMGSLP---NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  351 (611)
                      ++||+|+||+||+|.+.   .++.||||++...  +....++|.+|+++|++++|||||+++|++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999653   3468999998643  33446789999999999999999999999865 467899999999


Q ss_pred             CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcce-
Q 007248          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-  430 (611)
Q Consensus       352 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-  430 (611)
                      |+|.+++..   ...++|..+++++.||++||+|||   +.+|+||||||+||||+.++.+||+|||+++.+....... 
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999954   345999999999999999999999   7899999999999999999999999999998775544332 


Q ss_pred             -eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          431 -STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       431 -~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                       .....||+.|||||.+.+..++.++|||||||++|||+| |+.||....    ..+ +...+..+         .+.+.
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~----~~~-~~~~i~~~---------~~~~~  231 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----GSE-VTAMLEKG---------ERMGC  231 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHH-HHHHHHTT---------CCCCC
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC----HHH-HHHHHHcC---------CCCCC
Confidence             234578999999999999999999999999999999998 899975321    111 11112111         12233


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      +...+..+.+|+.+||+.||++|||+++|++.|+.
T Consensus       232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            44455678899999999999999999999988864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-50  Score=396.46  Aligned_cols=245  Identities=25%  Similarity=0.378  Sum_probs=204.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++...   .....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            4588889999999999999965 56899999998643   2344677899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++...   ..+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            999999999999543   45899999999999999999999   789999999999999999999999999999765433


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      .   .....||+.|||||++.+..++.++|||||||++|||++|+.||...    ...+ .........      .    
T Consensus       160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~-~~~~i~~~~------~----  221 (263)
T d2j4za1         160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN----TYQE-TYKRISRVE------F----  221 (263)
T ss_dssp             C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS----SHHH-HHHHHHTTC------C----
T ss_pred             c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC----CHHH-HHHHHHcCC------C----
Confidence            2   33567999999999999999999999999999999999999998532    2211 122111111      1    


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .++......+.+++.+||+.||++|||++|+++
T Consensus       222 ~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            122333456788999999999999999999985

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=411.96  Aligned_cols=257  Identities=27%  Similarity=0.390  Sum_probs=206.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCC-C-----CEEEEEEeecc-chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPN-G-----TTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  341 (611)
                      .++|++.++||+|+||+||+|.... +     ..||||++... .....+.|.+|+.+|.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3578888999999999999996532 2     36999988644 334456799999999998 89999999999999999


Q ss_pred             ceEEEeecCCCChhhhhhccCC--------------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCc
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNK--------------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKT  401 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  401 (611)
                      .++||||+++|+|.++|+....                    ...++|..++.++.||++||+|||   +.+||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence            9999999999999999965432                    245899999999999999999999   78999999999


Q ss_pred             ccEEECCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCC
Q 007248          402 SNILLDKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQD  479 (611)
Q Consensus       402 ~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~  479 (611)
                      +|||++.++.+||+|||+++........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999876554432 2335668999999999999999999999999999999998 8988754332


Q ss_pred             CCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 007248          480 SASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLT  542 (611)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~  542 (611)
                      ....    ......         ..+.+.+......+.+|+.+||+.+|++|||++||++.|.
T Consensus       273 ~~~~----~~~~~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DANF----YKLIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHHH----HHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHH----HHHHhc---------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            2111    121111         1222334445567889999999999999999999999984

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-51  Score=403.90  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=192.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeee--CCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  345 (611)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++...  .....+.|.+|+++|++++|||||++++++.+  ++..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5688899999999999999954 57899999998654  34456779999999999999999999999865  4567999


Q ss_pred             EeecCCCChhhhhhccC-CCccCChhHHHHHHHHHHHHHHHHhcCC--CCceecCCCCcccEEECCCCCeEEeeecccee
Q 007248          346 YEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGS--ETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  422 (611)
                      |||+++|+|.+++.... ....+++..++.++.||+.||+|||+..  ..+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999985432 3456999999999999999999999421  24599999999999999999999999999987


Q ss_pred             ccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          423 FAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      +.... .......||+.|||||++.+..++.++|||||||++|||+||+.||...    ...+ ....+..+...     
T Consensus       164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~----~~~~-~~~~i~~~~~~-----  232 (269)
T d2java1         164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF----SQKE-LAGKIREGKFR-----  232 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHH-HHHHHHHTCCC-----
T ss_pred             cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC----CHHH-HHHHHHcCCCC-----
Confidence            65432 2234567999999999999999999999999999999999999998532    1111 11212222211     


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                          ..+......+.+++.+||+.||++|||+.|+++
T Consensus       233 ----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 ----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                122333456889999999999999999999873

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-50  Score=401.21  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=205.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      +.|++.+.||+|+||+||+|.. .+|+.||||++.....+..+.|.+|+++|++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4578889999999999999965 578999999998766666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++|+|.+++.+.  ...+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~  165 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q  165 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence            999999998543  245999999999999999999999   7899999999999999999999999999997653321 1


Q ss_pred             eeecccCCccccChhhhh-----cCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLV-----RGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ......||+.|+|||++.     ...++.++|||||||++|||+||+.||.....    .+..........      +. 
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~----~~~~~~i~~~~~------~~-  234 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP----MRVLLKIAKSEP------PT-  234 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG----GGHHHHHHHSCC------CC-
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH----HHHHHHHHcCCC------CC-
Confidence            223567999999999984     45678999999999999999999999754322    121122111111      11 


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                       ...+......+.+++.+||+.||++|||+.|+++
T Consensus       235 -~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 -LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             1123344556889999999999999999999864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.3e-50  Score=404.55  Aligned_cols=264  Identities=27%  Similarity=0.420  Sum_probs=211.4

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeee
Q 007248          265 TLEKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSI  337 (611)
Q Consensus       265 ~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  337 (611)
                      +|+...++|+..+.||+|+||+||+|+++      +++.||||++.... .+..++|.+|+++|++++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34445678999999999999999999753      45789999987543 344678999999999999999999999999


Q ss_pred             eCCcceEEEeecCCCChhhhhhccC---------------------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceec
Q 007248          338 EGPESLLVYEYVPNRSLDQFIFDKN---------------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH  396 (611)
Q Consensus       338 ~~~~~~lv~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  396 (611)
                      +.+..++||||+++|+|.++++...                     ....++|..++.|+.||+.||+|||   +.+|||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence            9999999999999999999996422                     1235899999999999999999999   799999


Q ss_pred             CCCCcccEEECCCCCeEEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCC
Q 007248          397 RDIKTSNILLDKDFTPKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNA  475 (611)
Q Consensus       397 ~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~  475 (611)
                      |||||+||||+.++.+||+|||+++.+..... .......+++.|+|||.+.+..++.++|||||||++|||++|..|+.
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999986644332 22335678899999999999999999999999999999999975432


Q ss_pred             CCCCCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          476 FSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       476 ~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ...+   ..+.... ...+..         .+.+...+..+.+|+.+||+.+|++||||.||+++|++.
T Consensus       244 ~~~~---~~e~~~~-v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         244 YGMA---HEEVIYY-VRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTSC---HHHHHHH-HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCC---HHHHHHH-HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            2221   1121111 222221         122334445688999999999999999999999999764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=392.52  Aligned_cols=244  Identities=25%  Similarity=0.340  Sum_probs=194.0

Q ss_pred             CCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeee----CCcceEEE
Q 007248          274 NPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE----GPESLLVY  346 (611)
Q Consensus       274 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  346 (611)
                      +..++||+|+||+||+|.. .+++.||+|++...  .....+.|.+|+++|++++|||||++++++.+    +...++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            4556899999999999965 46889999998754  34456789999999999999999999999865    34579999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCc--eecCCCCcccEEEC-CCCCeEEeeeccceec
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLD-KDFTPKIADFGLARCF  423 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~  423 (611)
                      ||+++|+|.+++...   ..+++..+..++.||++||+|||   +.+  |+||||||+||||+ +++.+||+|||+++..
T Consensus        92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            999999999999543   45899999999999999999999   666  99999999999996 5789999999999754


Q ss_pred             cCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      ...   ......||+.|||||++.+ .++.++|||||||++|||++|+.||....+.    .........+....     
T Consensus       166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~----~~~~~~i~~~~~~~-----  232 (270)
T d1t4ha_         166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTSGVKPA-----  232 (270)
T ss_dssp             CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTTTCCCG-----
T ss_pred             cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH----HHHHHHHHcCCCCc-----
Confidence            332   2345679999999998864 6999999999999999999999998533221    11122221111111     


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                         .++......+.+++.+||+.||++|||++|+++
T Consensus       233 ---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence               111222345788999999999999999999974

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-50  Score=407.81  Aligned_cols=260  Identities=22%  Similarity=0.342  Sum_probs=203.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .++|+..++||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            56788999999999999999964 57899999998754 34446789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+++|+|.+++.+.   ..+++..+..++.||+.||.|||+  +++|+||||||+||||+.++.+||+|||+|+.+... 
T Consensus        85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            99999999999643   358999999999999999999993  248999999999999999999999999999865432 


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc------------
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK------------  495 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------------  495 (611)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||........  +........+.            
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHH--HHHC-------------------
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhcCCcccCCccccccc
Confidence              22356899999999999999999999999999999999999999865332110  00000000000            


Q ss_pred             ---------------ccccc---CCCCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          496 ---------------LVEAV---DPNLKDDFP-AEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       496 ---------------~~~~i---d~~l~~~~~-~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                                     ..+..   ........+ ......+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                           00000   000000001 112345788999999999999999999985

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=391.36  Aligned_cols=248  Identities=29%  Similarity=0.445  Sum_probs=196.1

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeee-CCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-GPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~~  349 (611)
                      ++|+..+.||+|+||.||+|.+ .|+.||||+++..  ...+.|.+|++++++++||||++++|++.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            4567788999999999999998 5789999998644  345789999999999999999999999865 45689999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++|+|.++|+.. ....++|..+++|+.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC---
Confidence            999999999643 2345899999999999999999999   789999999999999999999999999999865432   


Q ss_pred             eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCCC
Q 007248          430 VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDDF  508 (611)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  508 (611)
                       .....++..|+|||++.++.++.++||||||+++|||+| |+.|+... ........             +....+.+.
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~-------------i~~~~~~~~  221 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPR-------------VEKGYKMDA  221 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHH-------------HTTTCCCCC
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-CHHHHHHH-------------HHcCCCCCC
Confidence             223457889999999999999999999999999999999 56665432 21122111             111222334


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          509 PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       509 ~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      +......+.+++.+||+.||++||||.+|+++|++
T Consensus       222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            44455678899999999999999999999999965

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=393.38  Aligned_cols=254  Identities=21%  Similarity=0.325  Sum_probs=194.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEcCC----CCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceE
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (611)
                      .++|+..+.||+|+||.||+|.+..    +..||||++... .....+.|.+|+++|++++|||||+++|++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3568888999999999999996532    356889988643 3445678999999999999999999999986 467899


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceecc
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  424 (611)
                      ||||+++|+|.+++...  ...+++..++.++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheecc
Confidence            99999999999987533  346899999999999999999999   7999999999999999999999999999998776


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      ...........||+.|+|||++.++.++.++|||||||++|||+| |..|+..... ......    +..+.        
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-~~~~~~----i~~~~--------  226 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGR----IENGE--------  226 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHH----HHTTC--------
T ss_pred             CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-HHHHHH----HHcCC--------
Confidence            554444556678999999999999999999999999999999998 7888654322 111111    11111        


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                       ..+.+...+..+.+|+.+||+.||++|||+.||++.|..
T Consensus       227 -~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         227 -RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence             112334445668899999999999999999999998864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-49  Score=393.94  Aligned_cols=247  Identities=23%  Similarity=0.283  Sum_probs=202.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++....   ....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4588899999999999999965 578999999987432   334577999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++...   +.+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccC
Confidence            999999999998543   45999999999999999999999   899999999999999999999999999999877543


Q ss_pred             Cc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          427 RT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       427 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...    +....... .....      .   
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~~~~~~~-i~~~~------~---  227 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NEYLIFQK-IIKLE------Y---  227 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHH-HHTTC------C---
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc----CHHHHHHH-HHcCC------C---
Confidence            32 2334567999999999999999999999999999999999999998632    22221111 11111      1   


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                       .++......+.+++.+||+.||++|||++|++
T Consensus       228 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         228 -DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             -CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             -CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence             12333345678999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-49  Score=399.66  Aligned_cols=245  Identities=27%  Similarity=0.451  Sum_probs=200.4

Q ss_pred             cCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      +.|+..+.||+|+||+||+|. ..+|+.||||++....   .+..+.|.+|+++|++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            358888999999999999996 4578999999987543   344567999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||   +.+|+||||||+||||+.++.+||+|||+++.... 
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            99999999877643   346999999999999999999999   78999999999999999999999999999976533 


Q ss_pred             CcceeecccCCccccChhhhhc---CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVR---GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                          .....||+.|||||++.+   +.++.++|||||||++|||++|+.||...    ...+.........      .+.
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~----~~~~~~~~i~~~~------~~~  233 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALYHIAQNE------SPA  233 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHHSC------CCC
T ss_pred             ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC----CHHHHHHHHHhCC------CCC
Confidence                234579999999999864   46899999999999999999999997532    2222222222111      111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +.   +......+.+++.+||+.||++|||++|+++
T Consensus       234 ~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         234 LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            11   1222345788999999999999999999975

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-49  Score=398.24  Aligned_cols=251  Identities=21%  Similarity=0.305  Sum_probs=189.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .+.|+..+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            46688899999999999999965 468999999987543 2334568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC---CCCCeEEeeeccceecc
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFA  424 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~~~~  424 (611)
                      |+++|+|.++|..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||+.   +++.+||+|||+++...
T Consensus        88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999954   346999999999999999999999   78999999999999994   57899999999998654


Q ss_pred             CCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCC
Q 007248          425 ADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNL  504 (611)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  504 (611)
                      ...  ......||+.|||||++.+..++.++|||||||++|||++|+.||....    ..+. .........      ..
T Consensus       162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~-~~~i~~~~~------~~  228 (307)
T d1a06a_         162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN----DAKL-FEQILKAEY------EF  228 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHH-HHHHHTTCC------CC
T ss_pred             CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC----HHHH-HHHHhccCC------CC
Confidence            332  2335679999999999999999999999999999999999999985321    1111 111111111      11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          505 KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       505 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ...........+.+++.+||+.||++|||+.|+++
T Consensus       229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            11122233456889999999999999999999985

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.9e-48  Score=396.69  Aligned_cols=253  Identities=20%  Similarity=0.267  Sum_probs=208.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35789999999999999999965 57999999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC--CCCeEEeeeccceeccCC
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK--DFTPKIADFGLARCFAAD  426 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~  426 (611)
                      +++|+|.+++...  ...+++..+..++.||+.||.|||   +.+||||||||+|||++.  ++.+||+|||+++.+...
T Consensus       105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            9999999998533  345999999999999999999999   799999999999999964  578999999999876543


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      .  ......||+.|||||++.+..++.++|||||||++|||++|+.||...    ...+..... .....      ....
T Consensus       180 ~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~~i-~~~~~------~~~~  246 (350)
T d1koaa2         180 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE----NDDETLRNV-KSCDW------NMDD  246 (350)
T ss_dssp             S--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHH-HHTCC------CSCC
T ss_pred             c--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC----CHHHHHHHH-HhCCC------CCCc
Confidence            3  234567899999999999999999999999999999999999998532    222211111 11110      1111


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      .........+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1112234567899999999999999999999863

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=398.76  Aligned_cols=252  Identities=24%  Similarity=0.397  Sum_probs=199.3

Q ss_pred             CCCCCCccccCCceeEEEEEcC-CCC----EEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSLP-NGT----TVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      +|+..++||+|+||+||+|.+. +|+    .||||++... ..+..++|.+|+++|++++|||||+++|++.++ ..+++
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v   88 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI   88 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence            5888899999999999999653 444    6899988643 345577899999999999999999999999865 56788


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      +||+.+|+|.+++...  ...+++..+++++.||++||+|||   .++|+||||||+||||+.++.+||+|||+++....
T Consensus        89 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          89 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            9999999999988543  456999999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCccccccCCC
Q 007248          426 DRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPN  503 (611)
Q Consensus       426 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  503 (611)
                      .... ......||+.|+|||++.++.++.++|||||||++|||+| |+.|+..... ...    ......         .
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-~~~----~~~i~~---------~  229 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI----SSILEK---------G  229 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-GGH----HHHHHH---------T
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-HHH----HHHHHc---------C
Confidence            4332 2234568999999999999999999999999999999999 6777643221 111    111111         1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          504 LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       504 l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      .+...+......+.+|+.+||+.+|++|||+.||++.|..
T Consensus       230 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence            1223344455678899999999999999999999988764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.6e-48  Score=397.14  Aligned_cols=251  Identities=22%  Similarity=0.272  Sum_probs=207.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEeec
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  349 (611)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5688999999999999999964 579999999998766666678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC--CCCCeEEeeeccceeccCCC
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD--KDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGla~~~~~~~  427 (611)
                      ++|+|.+++..  ....+++..+..|+.||+.||.|||   +.+|+||||||+||||+  .++.+||+|||+++.+....
T Consensus       109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999988743  3345999999999999999999999   79999999999999998  57899999999998776443


Q ss_pred             cceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCCC
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKDD  507 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  507 (611)
                        ......||+.|+|||++.+..++.++|||||||++|||+||+.||...    ...+....... ..      ......
T Consensus       184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~~~~~~i~~-~~------~~~~~~  250 (352)
T d1koba_         184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE----DDLETLQNVKR-CD------WEFDED  250 (352)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHHHHHHH-CC------CCCCSS
T ss_pred             --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHh-CC------CCCCcc
Confidence              234567899999999999999999999999999999999999998532    22221111111 11      111111


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          508 FPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       508 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ........+.+|+.+||+.||++|||+.|+++
T Consensus       251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22233455789999999999999999999985

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=389.68  Aligned_cols=254  Identities=26%  Similarity=0.385  Sum_probs=196.2

Q ss_pred             cCCCCCCccccCCceeEEEEEcC--CC--CEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcce
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP--NG--TTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (611)
                      ++|++.+.||+|+||.||+|.+.  ++  ..||||++...   ..+..++|.+|+++|++++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            45788899999999999999653  23  37899988643   34556789999999999999999999999975 4678


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      +||||+++|+|.+++...  ...+++..+++++.||++||.|||   +++|+||||||+||||+.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            999999999999988543  346999999999999999999999   789999999999999999999999999999987


Q ss_pred             cCCCcce--eecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          424 AADRTHV--STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       424 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      .......  .....|+..|+|||++.+..++.++||||||+++|||+| |+.||...    ...+........+      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~----~~~~~~~~i~~~~------  231 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEG------  231 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHTSC------
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc----CHHHHHHHHHhCC------
Confidence            5543322  234567889999999999999999999999999999998 89887522    2222222222221      


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                         .+.+.+...+..+.+++.+||+.||++||||.||++.|.+
T Consensus       232 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         232 ---ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence               1122233344568899999999999999999999999864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=389.22  Aligned_cols=252  Identities=27%  Similarity=0.399  Sum_probs=202.4

Q ss_pred             CCccccCCceeEEEEEcCCC----CEEEEEEeec-cchhhHHHHHHHHHHHhcCCCCceeeEeeeeee-CCcceEEEeec
Q 007248          276 SKKLGQGGAGSVYMGSLPNG----TTVAVKRLIF-NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-GPESLLVYEYV  349 (611)
Q Consensus       276 ~~~iG~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~~  349 (611)
                      .++||+|+||+||+|.+.++    ..||||++.. ......++|.+|+++|++++|||||+++|++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999976442    3689999864 345567889999999999999999999999876 45789999999


Q ss_pred             CCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCcc
Q 007248          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (611)
Q Consensus       350 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  429 (611)
                      ++|+|.++++.  ....+++..+++++.|+++||.|||   ..+|+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999864  3445788999999999999999999   789999999999999999999999999999876543322


Q ss_pred             ---eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          430 ---VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       430 ---~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                         ......||..|+|||.+..+.++.++||||||+++|||+||+.|+............+.    .+.         +.
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~----~g~---------~~  253 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----QGR---------RL  253 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH----TTC---------CC
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH----cCC---------CC
Confidence               22245689999999999999999999999999999999999888765443333322221    111         11


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      ..+......+.+++.+||+.||++||+|.||++.|++..
T Consensus       254 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            122333456889999999999999999999999997654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-48  Score=391.27  Aligned_cols=265  Identities=26%  Similarity=0.345  Sum_probs=200.2

Q ss_pred             hHHHHHHhcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeecc-chhhHHHHHHHHHHHhcC-CCCceeeEee
Q 007248          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLG  334 (611)
Q Consensus       263 ~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~  334 (611)
                      ...++...++|++.++||+|+||.||+|...      +++.||||++... .....+.+.+|..++.++ +|+||+.+++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            3444444567889999999999999999642      3468999998654 344466788999988877 6899999999


Q ss_pred             eeeeC-CcceEEEeecCCCChhhhhhccCC-------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 007248          335 CSIEG-PESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK  400 (611)
Q Consensus       335 ~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  400 (611)
                      ++.+. ...++||||+++|+|.++|+....             ...++|..++.++.||++||+|||   +++|+|||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCC
Confidence            87654 468999999999999999964321             245899999999999999999999   7899999999


Q ss_pred             cccEEECCCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCC-CCCCCC
Q 007248          401 TSNILLDKDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRR-SNAFSQ  478 (611)
Q Consensus       401 p~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~-p~~~~~  478 (611)
                      |+||||++++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+||.. |+....
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999876544332 2335679999999999999999999999999999999999865 543222


Q ss_pred             CCCChhHHHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          479 DSASPLQRVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                      ..    +.+......+.         ....+......+.+++.+||+.||++|||+.||++.|++
T Consensus       242 ~~----~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         242 ID----EEFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             CS----HHHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH----HHHHHHHhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            21    11122222211         112233344568899999999999999999999999865

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=394.77  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=202.8

Q ss_pred             cCCCCCCccccCCceeEEEEEcCC-CC--EEEEEEeecc-chhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPN-GT--TVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ++|++.++||+|+||+||+|.+++ |.  .||||++... ..+..+.|.+|+++|+++ +|||||+++|++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            567788999999999999997654 43  5788887543 344567899999999998 799999999999999999999


Q ss_pred             EeecCCCChhhhhhcc-------------CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCe
Q 007248          346 YEYVPNRSLDQFIFDK-------------NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  412 (611)
                      |||+++|+|.++|+..             .....++|..+++++.||++||.|||   +.+|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999653             23457999999999999999999999   7899999999999999999999


Q ss_pred             EEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc
Q 007248          413 KIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR  492 (611)
Q Consensus       413 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~  492 (611)
                      ||+|||+++......  ......||..|+|||.+..+.++.++|||||||++|||++|..|+....   ...+. .....
T Consensus       167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~-~~~i~  240 (309)
T d1fvra_         167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAEL-YEKLP  240 (309)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHH-HHHGG
T ss_pred             EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHH-HHHHH
Confidence            999999997543222  1224568999999999999999999999999999999999876532221   11111 11111


Q ss_pred             cCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 007248          493 SNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNKV  545 (611)
Q Consensus       493 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~~  545 (611)
                      .         ..+.+.+......+.+|+.+||+.||++||||+||++.|++..
T Consensus       241 ~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         241 Q---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             G---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             h---------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1         1122334445567889999999999999999999999887643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=387.78  Aligned_cols=263  Identities=25%  Similarity=0.335  Sum_probs=199.3

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC----cceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP----ESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  346 (611)
                      +.|...++||+|+||.||+|++ +|+.||||++...... ...+..|+..+.+++|||||++++++.+++    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            3456678899999999999987 6899999998644321 122334555666789999999999998654    478999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcC-----CCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG-----SETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      ||+++|+|.++|+.    ..++|..+++++.|++.||+|||+.     ..++|+||||||+||||+.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999954    3489999999999999999999942     24799999999999999999999999999998


Q ss_pred             eccCCCcc---eeecccCCccccChhhhhcC------ccccccceehhHHHHHHHHhCCCCCCCCCCCCChh--------
Q 007248          422 CFAADRTH---VSTAVAGTLGYMAPEYLVRG------QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPL--------  484 (611)
Q Consensus       422 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~--------  484 (611)
                      ........   ......||+.|+|||++...      .++.++|||||||+||||+||..|+..........        
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            77554332   22356799999999998754      36789999999999999999998876544332211        


Q ss_pred             --HHHHHhhccCccccccCCCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 007248          485 --QRVWTLYRSNKLVEAVDPNLKDDF-PAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTN  543 (611)
Q Consensus       485 --~~~~~~~~~~~~~~~id~~l~~~~-~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~  543 (611)
                        .........+    ..++.+.... +.+.+..+.+++.+||+.||++|||+.||++.|.+
T Consensus       237 ~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         237 SVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence              1111111111    1122221111 22455678899999999999999999999999864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-48  Score=393.59  Aligned_cols=260  Identities=26%  Similarity=0.374  Sum_probs=209.3

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcC------CCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc
Q 007248          269 ATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       269 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (611)
                      ..++|+..++||+|+||+||+|.+.      +++.||||++... ..+....|.+|++++++++|||||+++|++..++.
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            3467778899999999999999653      3578999999754 34445679999999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhhcc-------CCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEE
Q 007248          342 SLLVYEYVPNRSLDQFIFDK-------NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  414 (611)
                      .++||||+++|+|.++++..       .....+++..+++++.||++||.|||   ..+|+||||||+|||+++++++||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEE
Confidence            99999999999999998642       22345799999999999999999999   789999999999999999999999


Q ss_pred             eeeccceeccCCCcce-eecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc
Q 007248          415 ADFGLARCFAADRTHV-STAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS  493 (611)
Q Consensus       415 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  493 (611)
                      +|||+++......... .....+|+.|+|||.+.++.++.++||||||+++|||+||+.|+....   ...+.. .....
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~~-~~i~~  250 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVL-RFVME  250 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHHH-HHHHT
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---CHHHHH-HHHHh
Confidence            9999998765443322 234468999999999999999999999999999999999965432221   222221 11212


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      +.         ..+.+......+.+++.+||+.+|++||||.+|+++|++.
T Consensus       251 ~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         251 GG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             CC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            11         1122333445689999999999999999999999999764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-48  Score=391.93  Aligned_cols=260  Identities=28%  Similarity=0.390  Sum_probs=211.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEc------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCCc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPE  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  341 (611)
                      .++|+..++||+|+||.||+|++      .+++.||||++.... .....+|.+|+.+++++ +|||||+++|++.+++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            46778889999999999999964      346789999997543 44566899999999999 79999999999999999


Q ss_pred             ceEEEeecCCCChhhhhhccC---------------CCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEE
Q 007248          342 SLLVYEYVPNRSLDQFIFDKN---------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  406 (611)
                      .++||||+++|+|.++++...               ....+++..+++++.||++||+|||   .++|+||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence            999999999999999996532               2236899999999999999999999   7899999999999999


Q ss_pred             CCCCCeEEeeeccceeccCCCc-ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhH
Q 007248          407 DKDFTPKIADFGLARCFAADRT-HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ  485 (611)
Q Consensus       407 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~  485 (611)
                      +.++.+||+|||+++....... .......||+.|+|||++..+.++.++||||||+++|||+|+..|+.........  
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            9999999999999987765433 2334567899999999999999999999999999999999965554433322221  


Q ss_pred             HHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          486 RVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       486 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                       ++.....         ..+...+......+.+|+.+||+.||++||||.||+++|++.
T Consensus       257 -~~~~i~~---------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         257 -FYKMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             -HHHHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHhc---------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence             1222111         122223333456688999999999999999999999999753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=387.21  Aligned_cols=251  Identities=21%  Similarity=0.283  Sum_probs=204.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc------hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (611)
                      .++|+..+.||+|+||+||+|.. .+|+.||||++....      ....+.|.+|+++|++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            35788999999999999999965 579999999986432      22367899999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC----CeEEeeec
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF----TPKIADFG  418 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG  418 (611)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999999543   35999999999999999999999   79999999999999998776    49999999


Q ss_pred             cceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccc
Q 007248          419 LARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE  498 (611)
Q Consensus       419 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (611)
                      +++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....    ..+..... ....   
T Consensus       163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~~i-~~~~---  232 (293)
T d1jksa_         163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANV-SAVN---  232 (293)
T ss_dssp             TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHH-HTTC---
T ss_pred             hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC----HHHHHHHH-HhcC---
Confidence            998765432  2335678999999999999999999999999999999999999985322    22211111 1111   


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          499 AVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       499 ~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                         .......+......+.+++.+||+.||++|||++|+++
T Consensus       233 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 ---YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ---CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               00100011123345788999999999999999999975

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-48  Score=388.85  Aligned_cols=257  Identities=27%  Similarity=0.406  Sum_probs=204.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHhcC-CCCceeeEeeeeeeCC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLP--------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGP  340 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  340 (611)
                      ++|++.+.||+|+||.||+|+..        ++..||||++.... .....++.+|+..+.++ +|||||++++++.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            46778899999999999999642        23579999987654 34567899999999888 8999999999999999


Q ss_pred             cceEEEeecCCCChhhhhhccCC-------------CccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEEC
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD  407 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  407 (611)
                      ..++||||+++|+|.++|.....             ...+++..++.++.||+.||+|||   +.+||||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence            99999999999999999965432             245899999999999999999999   89999999999999999


Q ss_pred             CCCCeEEeeeccceeccCCCcc-eeecccCCccccChhhhhcCccccccceehhHHHHHHHHh-CCCCCCCCCCCCChhH
Q 007248          408 KDFTPKIADFGLARCFAADRTH-VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVC-GRRSNAFSQDSASPLQ  485 (611)
Q Consensus       408 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~~  485 (611)
                      .++.+||+|||+++........ ......+++.|+|||.+.++.++.++||||||+++|||++ |..|+....     ..
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-----~~  244 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----VE  244 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-----HH
Confidence            9999999999999877554332 3345678999999999999999999999999999999998 566654221     12


Q ss_pred             HHHHhhccCccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          486 RVWTLYRSNKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       486 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      .++..+..+         .....+...+..+.+|+.+||+.+|++|||+.||+++|++.
T Consensus       245 ~~~~~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         245 ELFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HHHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            222222222         12223334455688999999999999999999999999754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=385.31  Aligned_cols=247  Identities=23%  Similarity=0.291  Sum_probs=204.7

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|++.+.||+|+||+||++.. .+|+.||||++...   .....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5688899999999999999964 67999999999754   2334677899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            999999999998543   45889999999999999999999   899999999999999999999999999999865432


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||....    ..+ .......+.+          
T Consensus       159 ~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~----~~~-~~~~i~~~~~----------  222 (337)
T d1o6la_         159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HER-LFELILMEEI----------  222 (337)
T ss_dssp             T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHH-HHHHHHHCCC----------
T ss_pred             C-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC----HHH-HHHHHhcCCC----------
Confidence            2 22345679999999999999999999999999999999999999975432    111 1111111111          


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPS-----MAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt-----~~evl~  539 (611)
                      .+|......+.+++..||+.||++||+     ++|+++
T Consensus       223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            123334455788999999999999995     788775

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-46  Score=380.92  Aligned_cols=244  Identities=24%  Similarity=0.305  Sum_probs=203.1

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++...   .....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4688899999999999999965 56999999998743   2344678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+++|+|..++...   ..+++..+..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            999999999988543   34788888999999999999999   899999999999999999999999999999876543


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                          .....||+.|||||++.+..++.++|||||||++|||+||+.||...    ...+....... ..      .    
T Consensus       158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~~i~~-~~------~----  218 (316)
T d1fota_         158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS----NTMKTYEKILN-AE------L----  218 (316)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHH-CC------C----
T ss_pred             ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc----CHHHHHHHHHc-CC------C----
Confidence                23567999999999999999999999999999999999999998532    22222111111 11      1    


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                      .++......+.+++.+|++.||++||     |++++++
T Consensus       219 ~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            12223345578899999999999996     8999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.2e-47  Score=379.75  Aligned_cols=257  Identities=23%  Similarity=0.355  Sum_probs=200.6

Q ss_pred             hcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeecc---chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCc----
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE----  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  341 (611)
                      .++|++.+.||+|+||+||+|. ..+|+.||||++...   ..+..+.|.+|+++|++++|||||++++++...+.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            4678899999999999999996 467999999999654   34456689999999999999999999999876543    


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .|+||||+++++|.+++...   ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++..+|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhh
Confidence            78999999999999988543   35899999999999999999999   7999999999999999999999999999987


Q ss_pred             eccCCCc--ceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          422 CFAADRT--HVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       422 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      .......  .......||+.|+|||++.+..++.++|||||||++|||+||+.||..    ....+..............
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~----~~~~~~~~~~~~~~~~~~~  235 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG----DSPVSVAYQHVREDPIPPS  235 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC----SSHHHHHHHHHHCCCCCGG
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC----cCHHHHHHHHHhcCCCCCc
Confidence            6543322  233456799999999999999999999999999999999999999853    2233333333332221110


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcc
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRP-SMAQAIMLLTN  543 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RP-t~~evl~~L~~  543 (611)
                         ..    ....+..+.+++.+|++.||++|| +++++++.|.+
T Consensus       236 ---~~----~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         236 ---AR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             ---GT----SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ---hh----ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence               01    112234578899999999999999 89999887753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-45  Score=379.41  Aligned_cols=244  Identities=22%  Similarity=0.282  Sum_probs=203.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (611)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++....   ....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5788999999999999999965 579999999986432   334567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  426 (611)
                      ||+.+|+|.+++...   ..+++..+..++.||+.||.|||   +.+||||||||+||||+.++.+||+|||+++.....
T Consensus       121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            999999999999543   35899999999999999999999   789999999999999999999999999999876533


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                          .....||+.|||||++.+..++.++|||||||++|||+||+.||...    ........... ..      .    
T Consensus       195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~~i~~-~~------~----  255 (350)
T d1rdqe_         195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----QPIQIYEKIVS-GK------V----  255 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHH-CC------C----
T ss_pred             ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc----CHHHHHHHHhc-CC------C----
Confidence                23467999999999999999999999999999999999999998532    22222222111 11      0    


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCC-----CCHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALR-----PSMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~R-----Pt~~evl~  539 (611)
                      .++......+.+++.+||+.||++|     ||++++++
T Consensus       256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            1122334557899999999999999     48999875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3e-46  Score=372.24  Aligned_cols=250  Identities=21%  Similarity=0.312  Sum_probs=203.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---------hhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeC
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---------RQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEG  339 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  339 (611)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++....         ....+.+.+|+.+|++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5788899999999999999965 578999999986542         123456889999999997 99999999999999


Q ss_pred             CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecc
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  419 (611)
                      +..++||||+++|+|.++|...   ..+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchh
Confidence            9999999999999999999643   45999999999999999999999   78999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccCCccccChhhhhc------CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc
Q 007248          420 ARCFAADRTHVSTAVAGTLGYMAPEYLVR------GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS  493 (611)
Q Consensus       420 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  493 (611)
                      ++.+....  ......||..|+|||++.+      ..++.++||||+||++|||++|+.||....    .... ...+..
T Consensus       157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~----~~~~-~~~i~~  229 (277)
T d1phka_         157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK----QMLM-LRMIMS  229 (277)
T ss_dssp             CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH-HHHHHH
T ss_pred             eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC----HHHH-HHHHHh
Confidence            98775433  2345679999999999864      346889999999999999999999986322    1111 111111


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +..      .............+.+++.+||+.+|++|||++||++
T Consensus       230 ~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         230 GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111      1111122234456889999999999999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-46  Score=375.36  Aligned_cols=257  Identities=24%  Similarity=0.295  Sum_probs=193.8

Q ss_pred             CCCccccCCceeEEEEEc-CCCCEEEEEEeeccchh-----hHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          275 PSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQ-----WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ..++||+|+||+||+|.. .+|+.||||++......     ..+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999975 46899999998654321     234688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +.++++..++.   ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            99988776653   3456899999999999999999999   79999999999999999999999999999986654332


Q ss_pred             ceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc---cc---cccC
Q 007248          429 HVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK---LV---EAVD  501 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~---~~id  501 (611)
                       ......||+.|+|||++... .++.++|||||||++|||+||+.||....+. +.+..+........   +.   ....
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHhcCCCChhhccchhccch
Confidence             22345789999999998755 5799999999999999999999887533211 11111111111100   00   0000


Q ss_pred             C---CCCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          502 P---NLKDDFPA-----EQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       502 ~---~l~~~~~~-----~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .   ......+.     .....+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0   00001111     12346889999999999999999999985

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1e-45  Score=382.65  Aligned_cols=248  Identities=21%  Similarity=0.229  Sum_probs=197.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHH---HHHHHHhcCCCCceeeEeeeeeeCCcce
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFF---NEVNLISSIEHKNLVKLLGCSIEGPESL  343 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (611)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++....   ......+.   +|+.+++.++|||||++++++.+++..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            5788899999999999999965 569999999986432   12223333   4577888889999999999999999999


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      +||||+++|+|.++|...   ..+++..+..++.||+.||.|||   +.+||||||||+|||++.++.+||+|||+++.+
T Consensus        84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            999999999999999543   45889999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCC
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDP  502 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  502 (611)
                      ....   .....||+.|+|||++.. ..++.++|||||||+||||+||+.||...... ..... .......        
T Consensus       158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~-~~~~~~~--------  224 (364)
T d1omwa3         158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEI-DRMTLTM--------  224 (364)
T ss_dssp             SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-CHHHH-HHHSSSC--------
T ss_pred             CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHhcccC--------
Confidence            5432   335679999999999975 46899999999999999999999998643322 11111 1110000        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007248          503 NLKDDFPAEQVCNVLQIGLLCTQAAAALRPS-----MAQAIM  539 (611)
Q Consensus       503 ~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt-----~~evl~  539 (611)
                        ...++......+.+++.+||+.||++|||     ++|+++
T Consensus       225 --~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 --AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             --CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             --CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence              11122233445789999999999999999     588874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-46  Score=376.86  Aligned_cols=251  Identities=18%  Similarity=0.206  Sum_probs=202.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++..... ....+.+|+++|++++|||||++++++.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            46788999999999999999965 5689999999976543 345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCC--CCeEEeeeccceeccCC
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD--FTPKIADFGLARCFAAD  426 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla~~~~~~  426 (611)
                      +++|+|.++|...  ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            9999999999532  235899999999999999999999   7999999999999999854  47999999999876443


Q ss_pred             CcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCCC
Q 007248          427 RTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLKD  506 (611)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  506 (611)
                      .  ......+++.|+|||.+.+..++.++|||||||++|||++|+.||....    ..+....... ...      .+..
T Consensus       158 ~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~----~~~~~~~i~~-~~~------~~~~  224 (321)
T d1tkia_         158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----NQQIIENIMN-AEY------TFDE  224 (321)
T ss_dssp             C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHH-TCC------CCCH
T ss_pred             C--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC----HHHHHHHHHh-CCC------CCCh
Confidence            2  2344678999999999999999999999999999999999999985332    1121111111 110      0000


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          507 DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       507 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      .........+.+++..|++.||++|||++|+++
T Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000112345789999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=376.20  Aligned_cols=247  Identities=24%  Similarity=0.316  Sum_probs=201.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHh-cCCCCceeeEeeeeeeCCcceEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLIS-SIEHKNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  345 (611)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++....   .+..+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5688899999999999999955 568999999997542   344567778888765 68999999999999999999999


Q ss_pred             EeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccC
Q 007248          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (611)
Q Consensus       346 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  425 (611)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||   +.+|+||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence            9999999999999643   34889999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccccCCCCC
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAVDPNLK  505 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  505 (611)
                      .. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...    ...+ .+.....+.      +   
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~----~~~~-~~~~i~~~~------~---  220 (320)
T d1xjda_         156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ----DEEE-LFHSIRMDN------P---  220 (320)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHH-HHHHHHHCC------C---
T ss_pred             cc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC----CHHH-HHHHHHcCC------C---
Confidence            32 2334567999999999999999999999999999999999999998532    2222 122221111      1   


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 007248          506 DDFPAEQVCNVLQIGLLCTQAAAALRPSMA-QAIM  539 (611)
Q Consensus       506 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~-evl~  539 (611)
                       .++......+.+|+.+||+.||++||++. ++++
T Consensus       221 -~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 -FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence             12223345578999999999999999995 6753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=376.05  Aligned_cols=251  Identities=21%  Similarity=0.227  Sum_probs=195.6

Q ss_pred             cCCCCCC-ccccCCceeEEEEE-cCCCCEEEEEEeeccchhhHHHHHHHHHHHhcC-CCCceeeEeeeeee----CCcce
Q 007248          271 NYFNPSK-KLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE----GPESL  343 (611)
Q Consensus       271 ~~f~~~~-~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~  343 (611)
                      ++|.+.. .||+|+||+||+|. ..+++.||||++...     +.+.+|++++.++ +|||||++++++.+    +...+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5677664 59999999999995 467999999998643     3567899987654 89999999999875    45689


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC---CCCeEEeeeccc
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLA  420 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla  420 (611)
                      +|||||++|+|.++|... ....+++..+..|+.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus        86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            999999999999999643 2346999999999999999999999   899999999999999985   457999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccccc
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEAV  500 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  500 (611)
                      +......  ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ...........      
T Consensus       162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~~~~i~~~------  232 (335)
T d2ozaa1         162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKTRIRMG------  232 (335)
T ss_dssp             EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSC------
T ss_pred             eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHHHHHHhcC------
Confidence            8765433  23456799999999999999999999999999999999999999864322211 11110000000      


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          501 DPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       501 d~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ...+...........+.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            001111111234556889999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=370.99  Aligned_cols=263  Identities=25%  Similarity=0.349  Sum_probs=197.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ++|++.++||+|+||+||+|.. .+|+.||||++....  ....+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5788899999999999999964 679999999986443  2335689999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      |+.++.+. ++.. .....+++..+..++.||+.||+|||   +.+||||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~-~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKK-FMDA-SALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHH-HHHH-TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhh-hhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99765444 4422 23446999999999999999999999   7999999999999999999999999999998664332


Q ss_pred             cceeecccCCccccChhhhhcCc-cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccC------cccccc
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSN------KLVEAV  500 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~i  500 (611)
                       .......||+.|+|||.+.... .+.++|||||||++|||++|+.||....... .+..........      ......
T Consensus       157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhcccccccc
Confidence             2233457899999999887665 5789999999999999999999986432111 111111100000      000000


Q ss_pred             C------CCCCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          501 D------PNLKDDF---PAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       501 d------~~l~~~~---~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      +      ......+   .......+.+++.+|++.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0      0000000   01123457889999999999999999999863

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.5e-45  Score=366.81  Aligned_cols=260  Identities=25%  Similarity=0.367  Sum_probs=199.0

Q ss_pred             cCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|+..++||+|+||+||+|..++|+.||||++....  ....+.|.+|+.+|++++|||||++++++..++..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5788899999999999999988899999999986542  33357899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCCc
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  428 (611)
                      +.++.+..+..   ....+++..+..++.||+.||+|||   +.+||||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            98877777663   3356999999999999999999999   78999999999999999999999999999987654322


Q ss_pred             ceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc------cccc--
Q 007248          429 HVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK------LVEA--  499 (611)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~--  499 (611)
                       ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||....... .+...........      ..+.  
T Consensus       156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhccchhhhhh
Confidence             23345689999999998764 56899999999999999999999985432111 1111111110000      0000  


Q ss_pred             cCCCC-------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007248          500 VDPNL-------KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       500 id~~l-------~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                      .+...       ...........+.+++.+|++.||++|||++|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell  279 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL  279 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            00000       0111122345678999999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-45  Score=364.17  Aligned_cols=239  Identities=24%  Similarity=0.346  Sum_probs=193.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccch------hhHHHHHHHHHHHhcCC--CCceeeEeeeeeeCCc
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR------QWVDEFFNEVNLISSIE--HKNLVKLLGCSIEGPE  341 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  341 (611)
                      ++|++.++||+|+||+||+|.. .+|+.||||++.....      ....++.+|+.+|++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5788899999999999999964 5799999999864321      12234678999999986  8999999999999999


Q ss_pred             ceEEEeecCC-CChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-CCCeEEeeecc
Q 007248          342 SLLVYEYVPN-RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGL  419 (611)
Q Consensus       342 ~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl  419 (611)
                      .++||||+.+ +++.+++...   ..+++..+..++.||++||+|||   +.+|+||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 5777777433   45899999999999999999999   799999999999999985 47899999999


Q ss_pred             ceeccCCCcceeecccCCccccChhhhhcCcc-ccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCcccc
Q 007248          420 ARCFAADRTHVSTAVAGTLGYMAPEYLVRGQL-TEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVE  498 (611)
Q Consensus       420 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (611)
                      ++.....   ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||....       .+   ... .   
T Consensus       158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i---~~~-~---  220 (273)
T d1xwsa_         158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EI---IRG-Q---  220 (273)
T ss_dssp             CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HH---HHC-C---
T ss_pred             ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HH---hhc-c---
Confidence            9865432   2345679999999999987765 677999999999999999999975321       11   111 0   


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          499 AVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       499 ~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                         ..+...    ....+.+++.+||+.||++|||++|+++
T Consensus       221 ---~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 ---VFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ---CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---cCCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence               111122    2345789999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=364.04  Aligned_cols=262  Identities=25%  Similarity=0.317  Sum_probs=194.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CC-CCEEEEEEeeccc--hhhHHHHHHHHHHHhcC---CCCceeeEeeeeee----
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PN-GTTVAVKRLIFNT--RQWVDEFFNEVNLISSI---EHKNLVKLLGCSIE----  338 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  338 (611)
                      .++|++.++||+|+||+||+|.. ++ ++.||||++....  ......+.+|+.+|+.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999965 44 6779999986542  22233566777777665   79999999998853    


Q ss_pred             -CCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeee
Q 007248          339 -GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (611)
Q Consensus       339 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  417 (611)
                       ....+++|||+.++++.....  .....+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence             346799999999887765543  23456899999999999999999999   799999999999999999999999999


Q ss_pred             ccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc--
Q 007248          418 GLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK--  495 (611)
Q Consensus       418 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--  495 (611)
                      |+++.....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .+..+........  
T Consensus       161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEE  237 (305)
T ss_dssp             CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGG
T ss_pred             hhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCchh
Confidence            998764332  23345679999999999999999999999999999999999999986432111 1111111100000  


Q ss_pred             -------ccccc-C---CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          496 -------LVEAV-D---PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       496 -------~~~~i-d---~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                             ..... .   ......+.......+.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                   00000 0   00001112223445778999999999999999999874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-43  Score=363.97  Aligned_cols=259  Identities=23%  Similarity=0.278  Sum_probs=191.8

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC------CcceE
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG------PESLL  344 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  344 (611)
                      .|+..++||+|+||+||+|+. .+|+.||||++.....    .+.+|+++|++++||||+++++++...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            466778999999999999965 5699999999875432    234799999999999999999998643      24689


Q ss_pred             EEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC-CeEEeeeccceec
Q 007248          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCF  423 (611)
Q Consensus       345 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~  423 (611)
                      ||||++++.+..+.........+++..+..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987655544433334557999999999999999999999   89999999999999999775 8999999999876


Q ss_pred             cCCCcceeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhH----------HHHHhhc
Q 007248          424 AADRTHVSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ----------RVWTLYR  492 (611)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~----------~~~~~~~  492 (611)
                      .....  .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||........+..          ..+....
T Consensus       174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            54332  234578999999998875 4689999999999999999999999864432111111          0111111


Q ss_pred             cC----ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          493 SN----KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       493 ~~----~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..    .+...................+.+|+.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00    000000000000111123445788999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=350.76  Aligned_cols=262  Identities=22%  Similarity=0.316  Sum_probs=204.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCCcceEEEe
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  347 (611)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|+.+|+.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5788999999999999999964 678999999986542  3456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceeccCCC
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  427 (611)
                      ++.+++|..++..   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            9999999888743   345889999999999999999999   7899999999999999999999999999998765433


Q ss_pred             cceeecccCCccccChhhhhcCc-cccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc------ccccc
Q 007248          428 THVSTAVAGTLGYMAPEYLVRGQ-LTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK------LVEAV  500 (611)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~i  500 (611)
                      . ......++..|+|||.+.... ++.++|||||||++|||++|+.|+....+....+..+........      .....
T Consensus       156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence            2 223345678899999987665 689999999999999999999997544332222222221111100      00000


Q ss_pred             C---------CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          501 D---------PNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       501 d---------~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      +         ..-...........+.+++.+|++.||++|||++||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0         00001112233455788999999999999999999874

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-43  Score=358.25  Aligned_cols=252  Identities=23%  Similarity=0.290  Sum_probs=202.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc----CCCCEEEEEEeecc----chhhHHHHHHHHHHHhcCCC-CceeeEeeeeeeCCc
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFN----TRQWVDEFFNEVNLISSIEH-KNLVKLLGCSIEGPE  341 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  341 (611)
                      ++|++.+.||+|+||+||+|..    .+|+.||||++...    .....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5688999999999999999953    24789999988543    22345678899999999976 899999999999999


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .++||||+.+|+|.+++....   .+.+.....++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999995443   4678888999999999999999   7899999999999999999999999999998


Q ss_pred             eccCCCcceeecccCCccccChhhhhcC--ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCccccc
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVRG--QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNKLVEA  499 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (611)
                      .+............|++.|++||.+...  .++.++|||||||+||||++|+.||................... .    
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-~----  252 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-E----  252 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-C----
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-C----
Confidence            7765554445567799999999999764  46789999999999999999999986554433322221111111 1    


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007248          500 VDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRP-----SMAQAIM  539 (611)
Q Consensus       500 id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RP-----t~~evl~  539 (611)
                            ..++......+.+++.+||+.||++||     |++|+++
T Consensus       253 ------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 ------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                  112334456688899999999999999     4788874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-42  Score=356.76  Aligned_cols=262  Identities=21%  Similarity=0.299  Sum_probs=194.1

Q ss_pred             hcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeecc-chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC----cce
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP----ESL  343 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  343 (611)
                      +.+|+..++||+|+||+||+|. ..+|+.||||++... .....+.+++|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            4568889999999999999995 568999999998644 3455678999999999999999999999987654    235


Q ss_pred             EEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccceec
Q 007248          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (611)
Q Consensus       344 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  423 (611)
                      ++++|+.+|+|.+++..    ..+++..+..++.||+.||+|||   +.+||||||||+||||++++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            66677889999999943    35899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCcc--eeecccCCccccChhhhhc-CccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhccCc-----
Q 007248          424 AADRTH--VSTAVAGTLGYMAPEYLVR-GQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRSNK-----  495 (611)
Q Consensus       424 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-----  495 (611)
                      ......  ......||+.|+|||++.. ..++.++||||+||++|||++|+.||........ ............     
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhccCCChhhhh
Confidence            443222  2335678999999999854 5678899999999999999999999854321110 000000000000     


Q ss_pred             ------ccc-ccCCCCCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          496 ------LVE-AVDPNLKDDFPA-----EQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       496 ------~~~-~id~~l~~~~~~-----~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                            ... ..........+.     .....+.+++.+|++.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  000 000000001111     11235789999999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-42  Score=354.52  Aligned_cols=263  Identities=22%  Similarity=0.310  Sum_probs=193.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeee--------C
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--------G  339 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  339 (611)
                      ++|++.++||+|+||+||+|.. .+|+.||||++...  .....+.+.+|+++|++++||||+++++++..        +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6788999999999999999965 67999999998543  23345678999999999999999999998754        3


Q ss_pred             CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeecc
Q 007248          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (611)
Q Consensus       340 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  419 (611)
                      ...++||||+.++.+..+.   .....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecce
Confidence            4578999999888776555   23345888999999999999999999   79999999999999999999999999999


Q ss_pred             ceeccCCCcc---eeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc--
Q 007248          420 ARCFAADRTH---VSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS--  493 (611)
Q Consensus       420 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~--  493 (611)
                      ++.+......   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....+. ..+.........  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~  242 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSIT  242 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence            9876543221   22245689999999998765 6899999999999999999999998532211 111111111100  


Q ss_pred             ---------CccccccCCCCCCCCCHH-------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          494 ---------NKLVEAVDPNLKDDFPAE-------QVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       494 ---------~~~~~~id~~l~~~~~~~-------~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                               ......+...........       ....+.+++.+||+.||++|||++|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence                     000000000000111111       12245689999999999999999999854

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-42  Score=354.37  Aligned_cols=258  Identities=22%  Similarity=0.331  Sum_probs=191.0

Q ss_pred             hcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeCC------
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------  340 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  340 (611)
                      .++|+..++||+|+||+||+|. ..+|+.||||++...  .....+.+.+|+++|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            4678889999999999999996 457999999998643  3445678999999999999999999999987655      


Q ss_pred             cceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccc
Q 007248          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (611)
Q Consensus       341 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  420 (611)
                      ..++||||+ +.+|..++.    ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccce
Confidence            469999999 567777763    235999999999999999999999   799999999999999999999999999999


Q ss_pred             eeccCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhH----------HHHH
Q 007248          421 RCFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ----------RVWT  489 (611)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~----------~~~~  489 (611)
                      +.....    .+...||+.|+|||++.+. .++.++||||+||++|||++|+.||...........          ..+.
T Consensus       169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            876433    2356789999999998764 568999999999999999999999854321111000          0000


Q ss_pred             hhccC-------ccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007248          490 LYRSN-------KLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIML  540 (611)
Q Consensus       490 ~~~~~-------~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~  540 (611)
                      .....       .+.+.....+ ..........+.+|+.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00000       0000000000 00111223456789999999999999999999863

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.8e-42  Score=346.09  Aligned_cols=257  Identities=17%  Similarity=0.224  Sum_probs=202.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCC-CceeeEeeeeeeCCcceEEEe
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH-KNLVKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E  347 (611)
                      .++|++.++||+|+||+||+|+. .+|+.||||++.....  .+.+.+|++.++.++| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            36788999999999999999964 5689999998754322  2457788999999965 899999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC-----CCCeEEeeecccee
Q 007248          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-----DFTPKIADFGLARC  422 (611)
Q Consensus       348 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla~~  422 (611)
                      |+ +++|.+++...  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 78999988543  345899999999999999999999   899999999999999974     56899999999998


Q ss_pred             ccCCCcc------eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhc---c
Q 007248          423 FAADRTH------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYR---S  493 (611)
Q Consensus       423 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~---~  493 (611)
                      +......      ......||+.|||||++.+..++.++||||||+++|||+||+.||........ .........   .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~-~~~~~~i~~~~~~  234 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQKYERIGEKKQS  234 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-HHHHHHHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH-HHHHHHHHhccCC
Confidence            6543221      22356799999999999999999999999999999999999999865433322 111111110   0


Q ss_pred             CccccccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          494 NKLVEAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       494 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                      ....+     +....|    ..+.+++..|++.+|++||+++.+.+.|.+.
T Consensus       235 ~~~~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         235 TPLRE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             SCHHH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CChHH-----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            11111     111223    4578889999999999999999988777543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-42  Score=350.33  Aligned_cols=257  Identities=20%  Similarity=0.267  Sum_probs=194.7

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCce-eeEeeeeeeCCcceEEEee
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEY  348 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~  348 (611)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.....  .+++..|+++++.++|+|+ +.+.++..+++..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5688999999999999999964 5689999998875432  2468899999999987765 5555666788888999999


Q ss_pred             cCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECC---CCCeEEeeeccceeccC
Q 007248          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLARCFAA  425 (611)
Q Consensus       349 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~~~~  425 (611)
                      + +++|.+.+..  ....+++..++.++.||+.||+|||   +.+|+||||||+|||++.   +..+||+|||+++.+..
T Consensus        85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9 5566666533  2345899999999999999999999   799999999999999863   45799999999998754


Q ss_pred             CCcc------eeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHH--HHhhccCccc
Q 007248          426 DRTH------VSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRV--WTLYRSNKLV  497 (611)
Q Consensus       426 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~--~~~~~~~~~~  497 (611)
                      ....      ......||+.|||||.+.+..++.++|||||||++|||+||+.||.............  ..........
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            4322      2335679999999999999899999999999999999999999986544322211110  0000000000


Q ss_pred             cccCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 007248          498 EAVDPNLKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIMLLTNK  544 (611)
Q Consensus       498 ~~id~~l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~~L~~~  544 (611)
                           .+...    .+..+.+++..||+.+|++||++.++.+.|++.
T Consensus       239 -----~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         239 -----VLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             -----HHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             -----HhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                 01112    234578899999999999999999998877643

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.3e-41  Score=348.42  Aligned_cols=255  Identities=19%  Similarity=0.277  Sum_probs=195.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeC--CcceEEE
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEG--PESLLVY  346 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  346 (611)
                      ++|++.++||+|+||+||+|+. .+|+.||||++....   .+.+.+|+++|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5789999999999999999965 578999999986543   457889999999995 99999999998743  4689999


Q ss_pred             eecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCC-CeEEeeeccceeccC
Q 007248          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAA  425 (611)
Q Consensus       347 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~  425 (611)
                      ||+.+++|..+.      +.+++..+..++.||+.||.|||   +.+|+||||||+|||++.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999998764      24899999999999999999999   89999999999999998655 699999999987654


Q ss_pred             CCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHH------------hhc
Q 007248          426 DRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWT------------LYR  492 (611)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~------------~~~  492 (611)
                      ..  ......+|..|+|||.+.+. .++.++||||+|++++||++|+.|+....+..........            ...
T Consensus       183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            32  23456789999999998765 4799999999999999999999998654432111111000            000


Q ss_pred             cC---ccccccCCC--------CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          493 SN---KLVEAVDPN--------LKDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       493 ~~---~~~~~id~~--------l~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                      ..   .........        ............+.+|+.+|++.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   000011000        011111223345789999999999999999999974

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-41  Score=348.55  Aligned_cols=258  Identities=23%  Similarity=0.259  Sum_probs=186.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-CCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeee------CCc
Q 007248          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE------GPE  341 (611)
Q Consensus       271 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  341 (611)
                      ++|++.++||+|+||+||+|.. .+|+.||||++...  .....+.+.+|+.+|++++|||||++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5788899999999999999965 56999999999744  34456678999999999999999999999864      357


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .|+||||+.++.+. .+.     ..+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhh
Confidence            79999999766554 442     24889999999999999999999   7899999999999999999999999999987


Q ss_pred             eccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCChhH----------HHHHh-
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQ----------RVWTL-  490 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~----------~~~~~-  490 (611)
                      .....  .......+|+.|+|||++.+..++.++||||+||+++||++|+.||...........          ..|.. 
T Consensus       168 ~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             ccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            65432  233455789999999999999999999999999999999999999753321100000          00000 


Q ss_pred             -------hccC------ccccccCCCCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          491 -------YRSN------KLVEAVDPNLKD---DFPAEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       491 -------~~~~------~~~~~id~~l~~---~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                             ....      ............   .........+.+++.+|++.||++|||++||++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                   0000      000011000100   111234556889999999999999999999984

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-41  Score=347.94  Aligned_cols=258  Identities=23%  Similarity=0.301  Sum_probs=192.0

Q ss_pred             hcCCCCCCccccCCceeEEEEE-cCCCCEEEEEEeecc--chhhHHHHHHHHHHHhcCCCCceeeEeeeeeeC-----Cc
Q 007248          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----PE  341 (611)
Q Consensus       270 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  341 (611)
                      .++|+..++||+|+||+||+|. ..+|+.||||++...  .....+.+.+|+++|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            4678899999999999999996 567999999998644  334556789999999999999999999998643     34


Q ss_pred             ceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       342 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      .++++||+.+|+|.+++..    ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhc
Confidence            5777888899999999843    35999999999999999999999   7899999999999999999999999999986


Q ss_pred             eccCCCcceeecccCCccccChhhhhcC-ccccccceehhHHHHHHHHhCCCCCCCCCCCCChhHHHHHhhcc-------
Q 007248          422 CFAADRTHVSTAVAGTLGYMAPEYLVRG-QLTEKADVYSFGILIIEIVCGRRSNAFSQDSASPLQRVWTLYRS-------  493 (611)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~-------  493 (611)
                      ....    ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||....... ....+......       
T Consensus       170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHT
T ss_pred             ccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChHHhh
Confidence            5432    22345689999999987665 46889999999999999999999985332110 00100000000       


Q ss_pred             ----CccccccCCCCC-CCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007248          494 ----NKLVEAVDPNLK-DDFP-----AEQVCNVLQIGLLCTQAAAALRPSMAQAIM  539 (611)
Q Consensus       494 ----~~~~~~id~~l~-~~~~-----~~~~~~l~~l~~~c~~~~p~~RPt~~evl~  539 (611)
                          ............ ....     ......+.+|+.+|++.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                000000000000 0000     112345778999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4e-36  Score=311.74  Aligned_cols=261  Identities=21%  Similarity=0.217  Sum_probs=191.5

Q ss_pred             CCCCCCccccCCceeEEEEEc-CCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-----------CCceeeEeeeeeeC
Q 007248          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-----------HKNLVKLLGCSIEG  339 (611)
Q Consensus       272 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~  339 (611)
                      +|++.++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|++++++++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            488899999999999999964 679999999987543 33467788999888775           57899999987653


Q ss_pred             --CcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCC------
Q 007248          340 --PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT------  411 (611)
Q Consensus       340 --~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~------  411 (611)
                        ...+++++++..+..............+++..+..++.||++||+|||+  ..+|+||||||+||||+.++.      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence              4556777777666554444444555678899999999999999999994  488999999999999986553      


Q ss_pred             eEEeeeccceeccCCCcceeecccCCccccChhhhhcCccccccceehhHHHHHHHHhCCCCCCCCCCCCC--hhHHHH-
Q 007248          412 PKIADFGLARCFAADRTHVSTAVAGTLGYMAPEYLVRGQLTEKADVYSFGILIIEIVCGRRSNAFSQDSAS--PLQRVW-  488 (611)
Q Consensus       412 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvll~elltG~~p~~~~~~~~~--~~~~~~-  488 (611)
                      +||+|||.+......    .....||+.|+|||++....++.++||||+||+++||++|+.||........  ...... 
T Consensus       171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            899999999765432    2346789999999999999999999999999999999999999865432111  100000 


Q ss_pred             --Hhhc------------------cCccccccCCCC----------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007248          489 --TLYR------------------SNKLVEAVDPNL----------KDDFPAEQVCNVLQIGLLCTQAAAALRPSMAQAI  538 (611)
Q Consensus       489 --~~~~------------------~~~~~~~id~~l----------~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~evl  538 (611)
                        ....                  .......+....          ...........+.+++.+|++.||++|||++|++
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence              0000                  000000110000          1123455677889999999999999999999998


Q ss_pred             H
Q 007248          539 M  539 (611)
Q Consensus       539 ~  539 (611)
                      +
T Consensus       327 ~  327 (362)
T d1q8ya_         327 N  327 (362)
T ss_dssp             T
T ss_pred             c
Confidence            5

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=2.8e-23  Score=193.95  Aligned_cols=163  Identities=15%  Similarity=0.153  Sum_probs=121.9

Q ss_pred             CCCccccCCceeEEEEEcCCCCEEEEEEeeccc------------------hhhHHHHHHHHHHHhcCCCCceeeEeeee
Q 007248          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT------------------RQWVDEFFNEVNLISSIEHKNLVKLLGCS  336 (611)
Q Consensus       275 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~~~~  336 (611)
                      ..++||+|+||+||+|...+|+.||||++....                  ......+..|...+.++.|++++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            457899999999999988899999999865321                  01123456788999999999999988663


Q ss_pred             eeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCCCcccEEECCCCCeEEee
Q 007248          337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD  416 (611)
Q Consensus       337 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  416 (611)
                          ..+++|||+++..+.+          +++.....++.|++++|.|||   +.+|+||||||+|||++++ .++|+|
T Consensus        84 ----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred             ----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEE
Confidence                3479999998865533          344556789999999999999   7899999999999999965 589999


Q ss_pred             eccceeccCCCcceeecccCCccccCh------hhhhcCccccccceehhHHHHH
Q 007248          417 FGLARCFAADRTHVSTAVAGTLGYMAP------EYLVRGQLTEKADVYSFGILII  465 (611)
Q Consensus       417 fGla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~ksDV~S~Gvll~  465 (611)
                      ||++.........         .|...      |.+ ...+..++||||..--++
T Consensus       146 FG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         146 FPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred             CCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence            9999765432211         11111      111 356788999999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.66  E-value=4.8e-08  Score=93.70  Aligned_cols=149  Identities=17%  Similarity=0.075  Sum_probs=101.4

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC-CCceeeEeeeeeeCCcc
Q 007248          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPES  342 (611)
Q Consensus       264 ~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  342 (611)
                      .+|.+....|+..+..+-+....||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            34566666666555444444568999876 55667888776554444445678888877663 44467788888888889


Q ss_pred             eEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhc----------------------------------
Q 007248          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG----------------------------------  388 (611)
Q Consensus       343 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~----------------------------------  388 (611)
                      ++||+++++.++.+...        +......++.++++.|..||.                                  
T Consensus        86 ~lv~~~l~G~~~~~~~~--------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEECCSSEEHHHHTT--------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEEeccccccccccc--------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            99999999988865441        111223345556666666662                                  


Q ss_pred             ----------------------CCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          389 ----------------------GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       389 ----------------------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                                            .....++|+|+.|.|||+++++.+-|.||+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  012347999999999999987666799999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.14  E-value=7.8e-06  Score=77.25  Aligned_cols=130  Identities=19%  Similarity=0.193  Sum_probs=85.9

Q ss_pred             ccccCCc-eeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCC--CCceeeEeeeeeeCCcceEEEeecCCCCh
Q 007248          278 KLGQGGA-GSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE--HKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (611)
Q Consensus       278 ~iG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~gsL  354 (611)
                      .+..|.. ..||+....++..+++|.......   ..+..|+..|+.+.  .-.+.+++++..+++..++|||++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3445553 578999888888899997654332   24567777777663  33467788888888889999999998776


Q ss_pred             hhhhhccCCCccCChhHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 007248          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH-----------------------------------------------  387 (611)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-----------------------------------------------  387 (611)
                      .+..        +.   ...++.++++.|.-||                                               
T Consensus        94 ~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            4321        00   0111222333333333                                               


Q ss_pred             ----c----CCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          388 ----G----GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       388 ----~----~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                          .    .....++|+|+.|.|||++++..+-|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                1    113348999999999999987667899999874

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.43  E-value=0.00032  Score=70.44  Aligned_cols=76  Identities=13%  Similarity=0.156  Sum_probs=48.6

Q ss_pred             CccccCCceeEEEEEcCC-CCEEEEEEeeccc-------hhhHHHHHHHHHHHhcC-CC--CceeeEeeeeeeCCcceEE
Q 007248          277 KKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNT-------RQWVDEFFNEVNLISSI-EH--KNLVKLLGCSIEGPESLLV  345 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l-~h--~niv~l~~~~~~~~~~~lv  345 (611)
                      +.||.|....||+....+ ++.++||.-....       ....++...|.+.|+.+ .+  ..+++++.+  ++...++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999997654 6789999643211       11223445678777765 22  345666654  45567899


Q ss_pred             EeecCCCCh
Q 007248          346 YEYVPNRSL  354 (611)
Q Consensus       346 ~E~~~~gsL  354 (611)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.41  E-value=0.00021  Score=69.95  Aligned_cols=134  Identities=18%  Similarity=0.146  Sum_probs=77.6

Q ss_pred             eeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCce-----eeEe--eeeeeCCcceEEEeecCCCChhhh
Q 007248          285 GSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-----VKLL--GCSIEGPESLLVYEYVPNRSLDQF  357 (611)
Q Consensus       285 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~--~~~~~~~~~~lv~E~~~~gsL~~~  357 (611)
                      -.||+...++|+.+++|..... ....+++..|...+..|...++     +..-  ..+..++..+.++++++|..+...
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            4799999999999999976543 2234667788888877743322     1111  123456667889999987543210


Q ss_pred             --------------hhc------cCCCccCChh-------------------HHHHHHHHHHHHHHHHh----cCCCCce
Q 007248          358 --------------IFD------KNKTKLLNWN-------------------KRFNIILGTAEGLAYLH----GGSETRI  394 (611)
Q Consensus       358 --------------l~~------~~~~~~l~~~-------------------~~~~i~~~ia~~L~~LH----~~~~~~i  394 (611)
                                    +|.      ......+++.                   .+-.+...+.+.+..+.    .....++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                          010      0011111111                   11112222222333332    2234679


Q ss_pred             ecCCCCcccEEECCCCCeEEeeeccce
Q 007248          395 IHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       395 vH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      ||+|+.+.|||++++  ..+.||+-+.
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             ecCCCCcccEEEeCC--ceEEechhcc
Confidence            999999999999754  5689999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.54  E-value=0.0029  Score=63.21  Aligned_cols=73  Identities=19%  Similarity=0.319  Sum_probs=47.9

Q ss_pred             CccccCCceeEEEEEcCCC--------CEEEEEEeeccchhhHHHHHHHHHHHhcCCCCce-eeEeeeeeeCCcceEEEe
Q 007248          277 KKLGQGGAGSVYMGSLPNG--------TTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYE  347 (611)
Q Consensus       277 ~~iG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E  347 (611)
                      +.|+-|--=.+|+...+++        ..|.+++.. ... ..-...+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            5677788889999976543        456666543 322 22345578888888743344 577777743    68999


Q ss_pred             ecCCCChh
Q 007248          348 YVPNRSLD  355 (611)
Q Consensus       348 ~~~~gsL~  355 (611)
                      |+++.+|.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EeccccCC
Confidence            99876553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.52  E-value=0.013  Score=56.23  Aligned_cols=158  Identities=12%  Similarity=0.052  Sum_probs=84.9

Q ss_pred             cChHHHHHHhcCCCCCCccc-----cCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCce-----e
Q 007248          261 FKYETLEKATNYFNPSKKLG-----QGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-----V  330 (611)
Q Consensus       261 ~~~~~l~~~~~~f~~~~~iG-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v  330 (611)
                      .+.++|+....+|...+...     .|---+.|+....+| .+++|+......  .++...|++++..|.+.++     +
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            45678888888898765443     455567899987665 488998754321  2334456666666643222     1


Q ss_pred             eEe-e--eeeeCCcceEEEeecCCCChhhhh--------------hcc------CC------------------CccCCh
Q 007248          331 KLL-G--CSIEGPESLLVYEYVPNRSLDQFI--------------FDK------NK------------------TKLLNW  369 (611)
Q Consensus       331 ~l~-~--~~~~~~~~~lv~E~~~~gsL~~~l--------------~~~------~~------------------~~~l~~  369 (611)
                      ... |  +.........++.++.+......-              +..      ..                  ......
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            111 1  122334455666666654332110              000      00                  001111


Q ss_pred             hHHHHHHHHHHHHHHHHh-cCCCCceecCCCCcccEEECCCCCeEEeeeccce
Q 007248          370 NKRFNIILGTAEGLAYLH-GGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (611)
Q Consensus       370 ~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  421 (611)
                      ......+..+...+.-.+ .....++||+|+.+.||+++++...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            122222333333333333 1346789999999999999988777899999874

>d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Actin-fragmin kinase, catalytic domain
domain: Actin-fragmin kinase, catalytic domain
species: Physarum polycephalum [TaxId: 5791]

Probab=80.95  E-value=5.2  Score=36.65  Aligned_cols=136  Identities=13%  Similarity=0.145  Sum_probs=79.9

Q ss_pred             cccCCceeEEEEEcCCCCEEEEEEeeccchhhHHHHHHHHHHHhcCCCCceeeEeeee----------------------
Q 007248          279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS----------------------  336 (611)
Q Consensus       279 iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~----------------------  336 (611)
                      +..+|-+-|+-+.. ++..++||.   ...-..+.|..|+...-.+.-|...-+.-.-                      
T Consensus        76 ~s~~Gs~Gv~FV~~-e~gaiVlK~---s~tta~E~y~~eLAr~LGvpvPqmRvI~~~~~E~~~~~~~~l~~~e~d~~I~s  151 (342)
T d1cjaa_          76 RSEKGTEGLFFVET-ESGVFIVKR---STNIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAIDKSFRVITT  151 (342)
T ss_dssp             ECCSTTSCEEEEEE-SSCEEEEEC---CTTHHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHHCSSSCHHHH
T ss_pred             EeecCCceEEEEEc-CCceEEEec---CCchHHHHHHHHHHHHhCCCCCceEEecCCCHHHHHHHHHHhcCCChhHHHHH
Confidence            34455555655555 455777784   2233456788888877788888876654110                      


Q ss_pred             eeCCcceEEEeecCCCChhhhhhccCCCccCChhHHHHHHHHHHHHHHHHhcCCCCceecCCC-CcccEEECCCC-CeEE
Q 007248          337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDI-KTSNILLDKDF-TPKI  414 (611)
Q Consensus       337 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~-~~kl  414 (611)
                      .-....+++|||.+|..|.+.-.... ..... ..++.-+-.|+--=.++|+..+.++++|+- .+.||++++++ .+..
T Consensus       152 el~~A~~liMeYvpG~~l~e~~~~~a-~~~fs-~~~l~~LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~~~~~~  229 (342)
T d1cjaa_         152 LANQANILLMELVRGITLNKLTTTSA-PEVLT-KSTMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVP  229 (342)
T ss_dssp             HTTCSEEEEEECCCEEESTTCCSSSH-HHHSC-HHHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEE
T ss_pred             HHhcccceeeeccCCccccccccccc-hhhhc-HHHHHHhhhHHHHHHHHcCCccccccccCCCCccceEEecCCcEEEE
Confidence            01234579999999888765531100 00111 222222222333345788877888888843 89999999877 5666


Q ss_pred             eeeccc
Q 007248          415 ADFGLA  420 (611)
Q Consensus       415 ~DfGla  420 (611)
                      +|=|..
T Consensus       230 IDs~i~  235 (342)
T d1cjaa_         230 IDSKII  235 (342)
T ss_dssp             CSCCCC
T ss_pred             ecCCcc
Confidence            674443